Citrus Sinensis ID: 006155

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------66
Protein Sequence
MAKGCSRLVFFFSFLILAVSINAQNVCSNDVGNYTSNSAYKTNLNSVLSSIASNAAVDYGFYNESAGQEPDKVNVFALCRGDIATDVCRGCLENATQEILRVCPNQKQAIIWSAECMLRYSNKTIFGVLETGPTYYMWNVNNVTDDVSLFNQALQDLLRRLRGTAASGNSQKKFATGDTTASFRTIYALEQCTPDLSELQCSDCLDRAIGEIPNCCSGKIGGRVLKPSCNFRFETERFYNPTANSPPPSPPPPAEGNGSDTARTVIIILIPTVGFVILIIFICFFLRRKPRDNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTLPVPSEPAFFMDSIIESDMSFSLAHDSRITETDQPGCENLLLSGNNEISITDLYPR
Secondary Structure (PSIPRED)
cccccHHHHHHHHHHHHHHcccccccccccccccccccHHHHHHHHHHHHHHHccccccccEEcccccccccEEEEEEccccccHHHHHHHHHHHHHHHHHHccccccEEEEccEEEEEEcccccccccccccEEEEEccccccccHHHHHHHHHHHHHHHHHHHHcccccccEEEEccccccccEEEEEcccccccHHHHHHHHHHHHHccccccccccccEEEccccEEEEEcccccccccccccccccccccccccccccEEEEEHHHHHHHHHHHHHHHHHEEEcccccccccccccccccccccccccccHHHHHHHHcccccccccccccccccEEEEcccccEEEEEEcccccccHHHHHHHHHHHHHHccccccccHHcccccccEEEEEEEccccccccEEEccccccccccHHHHHHHHHHHHHHHHHHcccccccEEEccccccccccccccccccccccccccccccccccccccEEEccccccHHHHcccccccccccccHHEEEEHHHccccccccccccccccHHHHHHHHccccccccccccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHccccccccccccccEEccccccccccccccccccccccccccccccccccccccEEEccccc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHHHcccccHHcccccccccccccHHHHHHHHHHHHcccccccccccEcccccccccEEEEEEEEcccccHHHHHHHHHHHHHHHHHHcccccEEEEEEccEEEEEccccHcccccccccEEEEccccccccHHHHHHHHHHHHHHHHHHHHccccccHEccccccccccEEEEEEEEcccccHHHHHHHHHHHHHHcHHHcccccccEEEEcEEEEEEEEEccccccccccccccccccccccccccEEEEEEEHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccEEEcHHHHHHHHccccHHccccccccccEEccEcccccEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHHEEcccccEEEEEEEcccccccEEEEcHHHcccccHHHHHHHHHHHHHHHHHHHHccHcccccccccHHHEEEcccccEEEcccccccEcccccccccccEEEEEcccccHHHHHcccEcEcccHEHEEEEEEEEEEccccccccccccHHHHHHHHHHHHHccccHEEccHccccccHHHHHHHHHHHHHHccccccccccHHHEEEEEccccEEccccccccEEEEccccccccccccccccccccccccccccccccccccEEcccccc
Coil and Loop (DISEMBL)
makgcsrlVFFFSFLILAVSINAqnvcsndvgnytsnsayKTNLNSVLSSIASnaavdygfynesagqepdkVNVFALCrgdiatdvCRGCLENATQEILRVCPNQKQAIIWSAECmlrysnktifgvletgptyymwnvnnvtdDVSLFNQALQDLLRRLRgtaasgnsqkkfatgdttASFRTIYALEqctpdlselqcsdcldraigeipnccsgkiggrvlkpscnfrfeterfynptanspppsppppaegngsdtARTVIIILIPTVGFVILIIFICFFlrrkprdnskvkseaaagdeinraeslqfdfnTIRVatdnfsdanklgqggfgavykgrlydgAEIAVKRlsrdsgqgdlefKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYefvpntsldhfifdptrraqlDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKtsnvlldaemtpkIADFGMARLFEmdetqgntsrivgtygymapeyamhgqysvksdVFSFGVLVLEIISgqrnncfrngETVEDLLSSAWKNwregttvniidptlssgsiTEMIRCIHIGLLCvqenvasrptMASVVLMLNSYsltlpvpsepaffmdsiiesdmsfslahdsritetdqpgcenlllsgnneisitdlypr
Flexible Loop (DISEMBL)
MAKGCSRLVFFFSFLILAVSINAQNVCSNDVGNYTSNSAYKTNLNSVLSSIASNAAVDYGFYNESAGQEPDKVNVFALCRGDIATDVCRGCLENATQEILRVCPNQKQAIIWSAECMLRYSNKTIFGVLETGPTYYMWNVNNVTDDVSLFNQALQDLLRRLRgtaasgnsqkkfatgdttASFRTIYALEQCTPDLSELQCSDCLDRAIGEIPNCCSGKIGGRVLKPSCNFRFETERFYNPTANSPPPSPPPPAEGNGSDTARTVIIILIPTVGFVILIIFICFFlrrkprdnskvkseaaagdeinraeslqfdFNTIRVATDnfsdanklgqGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVpntsldhfifdptrraqldwERRYKIIGGIARGLLYLHEDSRLRIIHRDlktsnvlldaemTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWregttvniidptlssgSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTLPVPSEPAFFMDSIIESDMSFSLAHDSRITETDQPGCEnlllsgnneisitdlypr
Low Complexity Region (SEG)
MAKGCSRLVFFFSFLILAVSINAQNVCSNDVGNYTSNSAYKTNLNSVLSSIASNAAVDYGFYNESAGQEPDKVNVFALCRGDIATDVCRGCLENATQEILRVCPNQKQAIIWSAECMLRYSNKTIFGVLETGPTYYMWNVNNVTDDVSLFNQALQDLLRRLRGTAASGNSQKKFATGDTTASFRTIYALEQCTPDLSELQCSDCLDRAIGEIPNCCSGKIGGRVLKPSCNFRFETERFYNPTANspppsppppAEGNGSDTARTVIIILIPTVGfviliificfflRRKPRDNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTLPVPSEPAFFMDSIIESDMSFSLAHDSRITETDQPGCENLLLSGNNEISITDLYPR
Disordered region (IsUnstruct)
****CSRLVFFFSFLILAVSINAQNVCSNDVGNYTSNSAYKTNLNSVLSSIASNAAVDYGFYNESAGQEPDKVNVFALCRGDIATDVCRGCLENATQEILRVCPNQKQAIIWSAECMLRYSNKTIFGVLETGPTYYMWNVNNVTDDVSLFNQALQDLLRRLRGT*********FATGDTTASFRTIYALEQCTPDLSELQCSDCLDRAIGEIPNCCSGKIGGRVLKPSCNFRFETERFY***********************RTVIIILIPTVGFVILIIFICFFLR***********************SLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTLPVPSEPAFFMDSIIESDMSFSL****************LLL**************
Disordered Region (DISOPRED)
****CSRLVFFFSFLILAVSINAQNVCSNDVGNYTSNSAYKTNLNSVLSSIASNAAVDYGFYNESAGQEPDKVNVFALCRGDIATDVCRGCLENATQEILRVCPNQKQAIIWSAECMLRYSNKTIFGVLETGPTYYMWNVNNVTDDVSLFNQALQDLLRRLRGTAASGNSQKKFATGDTTASFRTIYALEQCTPDLSELQCSDCLDRAIGEIPNCCSGKIGGRVLKPSCNFRFETERFYNP************************IIILIPTVGFVILIIFICFFLRR***********************LQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTLPVPSEPAFFM*******************************SGNNEISITDLYPR
Disordered Region (DISEMBL)
MAKGCSRLVFFFSFLILAVSINAQNVCSNDVGNYTSNSAYKTNLNSVLSSIASNAAVDYGFYNESAGQEPDKVNVFALCRGDIATDVCRGCLENATQEILRVCPNQKQAIIWSAECMLRYSNKTIFGVLETGPTYYMWNVNNVTDDVSLFNQALQDLLRRLRGTAASGNSQKKFATGDTTASFRTIYALEQCTPDLSELQCSDCLDRAIGEIPNCCSGKIGGRVLKPSCNFRFETERFYN******************SDTARTVIIILIPTVGFVILIIFICFFLRRKP************GDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTLPVPSEPAFFMDSIIESDMSFSLAHDSRITETDQPGCENLLLSGNNEISITDLYPR
Disordered Region (DISPRO)
*AKGCSRLVFFFSFLILAVSINAQNVCSNDVGNYTSNSAYKTNLNSVLSSIASNAAVDYGFYNESAGQEPDKVNVFALCRGDIATDVCRGCLENATQEILRVCPNQKQAIIWSAECMLRYSNKTIFGVLETGPTYYMWNVNNVTDDVSLFNQALQDLLRRLRGTAASGNSQKKFATGDTTASFRTIYALEQCTPDLSELQCSDCLDRAIGEIPNCCSGKIGGRVLKPSCNFRFETERFYNPT******************TARTVIIILIPTVGFVILIIFICFFLRRKPRD************EINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTLPVPSEPAFFMDSI******************************************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
iiiiiiiHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MAKGCSRLVFFFSFLILAVSINAQNVCSNDVGNYTSNSAYKTNLNSVLSSIASNAAVDYGFYNESAGQEPDKVNVFALCRGDIATDVCRGCLENATQEILRVCPNQKQAIIWSAECMLRYSNKTIFGVLETGPTYYMWNVNNVTDDVSLFNQALQDLLRRLRGTAASGNSQKKFATGDTTASFRTIYALEQCTPDLSELQCSDCLDRAIGEIPNCCSGKIGGRVLKPSCNFRFETERFYNPTANSPPPSPPPPAEGNGSDTARTVIIILIPTVGFVILIIFICFFLRRKPRDNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTLPVPSEPAFFMDSIIESDMSFSLAHDSRITETDQPGCENLLLSGNNEISITDLYPR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	658	2.2.26 [Sep-21-2011]
Q8S9L6	679	Cysteine-rich receptor-li	yes	no	0.965	0.935	0.498	0.0
Q9T0J1	665	Cysteine-rich receptor-li	no	no	0.957	0.947	0.496	1e-177
Q8GYA4	669	Cysteine-rich receptor-li	no	no	0.928	0.913	0.502	1e-176
Q9M0X5	675	Cysteine-rich receptor-li	no	no	0.972	0.948	0.468	1e-172
O65468	676	Cysteine-rich receptor-li	no	no	0.925	0.900	0.496	1e-170
O65405	683	Cysteine-rich receptor-li	no	no	0.939	0.904	0.481	1e-169
O23081	665	Cysteine-rich receptor-li	no	no	0.878	0.869	0.508	1e-164
Q8W4G6	627	Cysteine-rich receptor-li	no	no	0.882	0.926	0.492	1e-164
O49564	642	Cysteine-rich receptor-li	no	no	0.886	0.908	0.495	1e-162
O65479	666	Putative cysteine-rich re	no	no	0.916	0.905	0.467	1e-160

>sp|Q8S9L6|CRK29_ARATH Cysteine-rich receptor-like protein kinase 29 OS=Arabidopsis thaliana GN=CRK29 PE=2 SV=1

 Score =  639 bits (1647), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 345/692 (49%), Positives = 448/692 (64%), Gaps = 57/692 (8%)

Query: 7   RLVFFFS-FLILAVSINAQNVCSN---------DVGNYTSNSAYKTNLNSVLSSIASNAA 56
           R++FFF+ FL LA       V S          D GN+T+NS +  NLN ++SS++S  +
Sbjct: 5   RVIFFFACFLTLAPFHAFAQVDSYEFDPDFNCVDRGNFTANSTFAGNLNRLVSSLSSLKS 64

Query: 57  VDYGFYNESAGQEP-DKVNVFALCRGDIATDVCRGCLENATQEILRVCPNQKQAIIWSAE 115
             YGFYN S+G    ++     LCR ++  D C  C++ A + + + CP  KQA++W   
Sbjct: 65  QAYGFYNLSSGDSSGERAYAIGLCRREVKRDDCVSCIQTAARNLTKQCPLTKQAVVWYTH 124

Query: 116 CMLRYSNKTIFGVLETGPTYYMWNVNNVTDDVSLFNQALQDLLRRLRGTAASGNSQKKFA 175
           CM RYSN+TI+G  ET PT        ++ +   F +  + LL RL+G AA+G   +K+A
Sbjct: 125 CMFRYSNRTIYGRKETNPTKAFIAGEEISANRDDFERLQRGLLDRLKGIAAAGGPNRKYA 184

Query: 176 TGDTTAS--FRTIYALEQCTPDLSELQCSDCLDRAIGEIPNCCSGKIGGRVLKPSCNFRF 233
            G+ +AS  +R  Y   QCTPDLSE  C+DCL      IP+CC  +IG R   PSCNFRF
Sbjct: 185 QGNGSASAGYRRFYGTVQCTPDLSEQDCNDCLVFGFENIPSCCDAEIGLRWFSPSCNFRF 244

Query: 234 ETERFY--------NPTANSPPPSPPPPAE----GNGSDTARTVIIILIPTVGFVILIIF 281
           ET RFY        +P A  P  SP   A     G G   ++ +I I+IP +   +L I 
Sbjct: 245 ETWRFYEFDADLEPDPPAIQPADSPQSAARTERTGKGKGGSKVIIAIVIPILLVALLAIC 304

Query: 282 ICFFLR-RKPRDNSKVK-------SEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLG 333
           +C  L+ RK +   K K       S + A DE +  ESL   F T++ ATDNFS  N+LG
Sbjct: 305 LCLVLKWRKNKSGYKNKVLGKSPLSGSIAEDEFSNTESLLVHFETLKTATDNFSSENELG 364

Query: 334 QGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGN 393
           +GGFG+VYKG    G EIAVKRLS +SGQGD EFKNE+LL+A LQHRNLVRL+GF ++G 
Sbjct: 365 RGGFGSVYKGVFPQGQEIAVKRLSGNSGQGDNEFKNEILLLAKLQHRNLVRLIGFCIQGE 424

Query: 394 ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLK 453
           ERLL+YEF+ N SLD FIFD  +R  LDW  RYK+IGGIARGLLYLHEDSR RIIHRDLK
Sbjct: 425 ERLLVYEFIKNASLDQFIFDTEKRQLLDWVVRYKMIGGIARGLLYLHEDSRFRIIHRDLK 484

Query: 454 TSNVLLDAEMTPKIADFGMARLFEMDETQGN--TSRIVGTYGYMAPEYAMHGQYSVKSDV 511
            SN+LLD EM PKIADFG+A+LF+  +T  +  TSRI GTYGYMAPEYAMHGQ+SVK+DV
Sbjct: 485 ASNILLDQEMNPKIADFGLAKLFDSGQTMTHRFTSRIAGTYGYMAPEYAMHGQFSVKTDV 544

Query: 512 FSFGVLVLEIISGQRNNCFRNG-----ETVEDLLSSAWKNWREGTTVNIIDPTLSSGSIT 566
           FSFGVLV+EII+G+RNN   NG     E  EDLLS  W++WRE T +++IDP+L++GS  
Sbjct: 545 FSFGVLVIEIITGKRNN---NGGSNGDEDAEDLLSWVWRSWREDTILSVIDPSLTAGSRN 601

Query: 567 EMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTLPVPSEPAFFMDSIIESDMSFSLA 626
           E++RCIHIGLLCVQE+ A+RPTMA+V LMLNSYS TLP P  PAF ++S++         
Sbjct: 602 EILRCIHIGLLCVQESAATRPTMATVSLMLNSYSFTLPTPLRPAFVLESVV--------- 652

Query: 627 HDSRITETDQPGCENLLLSGNNEISITDLYPR 658
               I        E L +S +N++++++  PR
Sbjct: 653 ----IPSNVSSSTEGLQMS-SNDVTVSEFSPR 679

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|Q9T0J1|CRK26_ARATH Cysteine-rich receptor-like protein kinase 26 OS=Arabidopsis thaliana GN=CRK26 PE=2 SV=1

 Score =  620 bits (1600), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 329/663 (49%), Positives = 442/663 (66%), Gaps = 33/663 (4%)

Query: 14  FLILAVSINAQNVCSNDVGNYTSNSAYKTNLNSVLSSIASNAAVDYGFYNESAGQEPDKV 73
           F + +  +    +CSN  GN+T N+ Y  NL+ ++SS++S      GFYN S G   +KV
Sbjct: 18  FTVKSQPVPLNQICSNVTGNFTVNTPYAVNLDRLISSLSSLRRNVNGFYNISVGDSDEKV 77

Query: 74  NVFALCRGDIATDVCRGCLENATQEILRVCPNQKQAIIWSAECMLRYSNKTIFGVLETGP 133
           N  + CRGD+  +VC  C+  A + ++ +CP QK+AIIW  +C  RYSN+TIF  LE  P
Sbjct: 78  NSISQCRGDVKLEVCINCIAMAGKRLVTLCPVQKEAIIWYDKCTFRYSNRTIFNRLEISP 137

Query: 134 TYYMWNVNNVTDDVSLFNQALQDLLRRLRGTAAS-GNSQKKFATGDTTA-SFRTIYALEQ 191
              +    N T D   + ++L+ LL  L+  A+  G S+K F  G+T+  SF+T++ L Q
Sbjct: 138 HTSITGTRNFTGDRDSWEKSLRGLLEGLKNRASVIGRSKKNFVVGETSGPSFQTLFGLVQ 197

Query: 192 CTPDLSELQCSDCLDRAIGEIPNCCSGKIGGRVLKPSCNFRFETERFYNPTANSPP---- 247
           CTPD+SE  CS CL + I +IP+CC  K+G  V+ PSC   +   RFY+P     P    
Sbjct: 198 CTPDISEEDCSYCLSQGIAKIPSCCDMKMGSYVMSPSCMLAYAPWRFYDPVDTDDPSSVP 257

Query: 248 --PSPPPPAE------GNGSDTARTVIIILIPTVGFVILIIFICFFLRRKPRDNSKVKSE 299
             PS PP  E      G+ +      +I    +V  V+L I +     +  R  +   SE
Sbjct: 258 ATPSRPPKNETRSVTQGDKNRGVPKALIFASASVAIVVLFIVLLVVFLKLRRKENIRNSE 317

Query: 300 AAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRD 359
               +E    +S++FDF+ ++ AT +FS  NKLG+GGFGAVYKG L DG +IAVKRLS++
Sbjct: 318 NKHENENISTDSMKFDFSVLQDATSHFSLENKLGEGGFGAVYKGVLSDGQKIAVKRLSKN 377

Query: 360 SGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQ 419
           + QG+ EFKNE LLVA LQHRNLV+LLG+S+EG ERLL+YEF+P+TSLD FIFDP +  +
Sbjct: 378 AQQGETEFKNEFLLVAKLQHRNLVKLLGYSIEGTERLLVYEFLPHTSLDKFIFDPIQGNE 437

Query: 420 LDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD 479
           L+WE RYKIIGG+ARGLLYLH+DSRLRIIHRDLK SN+LLD EMTPKIADFGMARLF++D
Sbjct: 438 LEWEIRYKIIGGVARGLLYLHQDSRLRIIHRDLKASNILLDEEMTPKIADFGMARLFDID 497

Query: 480 E-TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVED 538
             TQ  T+RIVGT+GYMAPEY MHGQ+S K+DV+SFGVLVLEIISG++N+ F + +++ D
Sbjct: 498 HTTQRYTNRIVGTFGYMAPEYVMHGQFSFKTDVYSFGVLVLEIISGKKNSGFSSEDSMGD 557

Query: 539 LLSSAWKNWREGTTVNIIDP---TLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM 595
           L+S AW+NW+EG  +N++D    T+SS S   ++RCI+IGLLCVQE VA RP+MASVVLM
Sbjct: 558 LISFAWRNWKEGVALNLVDKILMTMSSYSSNMIMRCINIGLLCVQEKVAERPSMASVVLM 617

Query: 596 LNSYSLTLPVPSEPAFFMDSIIESDMSFSLAHDSRITETDQPGCENLLLSGNNEISITDL 655
           L+ +++ L  PS+PAFF  S   SD S SL H+++ +               N  S T+L
Sbjct: 618 LDGHTIALSEPSKPAFFSHSNAVSDSSSSLGHNAKTS---------------NYNSNTEL 662

Query: 656 YPR 658
           YPR
Sbjct: 663 YPR 665

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3

 Score =  618 bits (1594), Expect = e-176,   Method: Compositional matrix adjust.
 Identities = 327/651 (50%), Positives = 429/651 (65%), Gaps = 40/651 (6%)

Query: 25  NVCSNDVGNYTSNSAYKTNLNSVLSSIAS-NAAVDYGFYNESAGQEPDKVNVFALCRGDI 83
           + C N   NYTSNS Y  NL ++L+S++S NA+   GF N + GQ PD+V     CRGD+
Sbjct: 42  HTCQN-TANYTSNSTYNNNLKTLLASLSSRNASYSTGFQNATVGQAPDRVTGLFNCRGDV 100

Query: 84  ATDVCRGCLENATQEILRVCPNQKQAIIWSAECMLRYSNKTIFGVLETGPTYYMWNVNNV 143
           +T+VCR C+  A  + L  CPNQK+A ++  EC+LRYSN+ I   L T     + N  NV
Sbjct: 101 STEVCRRCVSFAVNDTLTRCPNQKEATLYYDECVLRYSNQNILSTLITTGGVILVNTRNV 160

Query: 144 TDDVSLFNQA--LQDLLRRLRGTAASG--NSQKKFAT-GDTTASFRTIYALEQCTPDLSE 198
           T      NQ   L DL+      AA+   NS KKF T  +   + ++ Y L QCTPDL+ 
Sbjct: 161 TS-----NQLDLLSDLVLPTLNQAATVALNSSKKFGTRKNNFTALQSFYGLVQCTPDLTR 215

Query: 199 LQCSDCLDRAIGEIPNCCSGKIGGRVLKPSCNFRFETERFYNPTA----------NSPPP 248
             CS CL   I +IP   + +IG R++ PSC  R+E   FY  +A          ++PP 
Sbjct: 216 QDCSRCLQLVINQIP---TDRIGARIINPSCTSRYEIYAFYTESAVPPPPPPPSISTPPV 272

Query: 249 SPPPPAEGNGSDTARTVIIILIPTVGFVILIIFICFFLRRKPRDNSKVKSEAAAGDEINR 308
           S PP +  +G+     + I++   V  ++ I   CF  RR  +  S     A AGD+I  
Sbjct: 273 SAPPRSGKDGNSKVLVIAIVVPIIVAVLLFIAGYCFLTRRARK--SYYTPSAFAGDDITT 330

Query: 309 AESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFK 368
           A+SLQ D+ TI+ ATD+F ++NK+GQGGFG VYKG L DG E+AVKRLS+ SGQG++EFK
Sbjct: 331 ADSLQLDYRTIQTATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSKSSGQGEVEFK 390

Query: 369 NEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI 428
           NEV+LVA LQHRNLVRLLGF L+G ER+L+YE+VPN SLD+F+FDP ++ QLDW RRYKI
Sbjct: 391 NEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKKGQLDWTRRYKI 450

Query: 429 IGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
           IGG+ARG+LYLH+DSRL IIHRDLK SN+LLDA+M PKIADFGMAR+F +D+T+ NTSRI
Sbjct: 451 IGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQTEENTSRI 510

Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWR 548
           VGTYGYM+PEYAMHGQYS+KSDV+SFGVLVLEIISG++N+ F   +   DL+S AW  W 
Sbjct: 511 VGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAHDLVSYAWGLWS 570

Query: 549 EGTTVNIIDPTLSSG-SITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTLPVPS 607
            G  + ++DP +       E++RC+HIGLLCVQE+ A RPT++++VLML S ++TLPVP 
Sbjct: 571 NGRPLELVDPAIVENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVLMLTSNTVTLPVPR 630

Query: 608 EPAFFMDSIIESDMSFSLAHDSRITETDQPGCENLLLSGNNEISITDLYPR 658
           +P  F  S I  D              D       LL   ++ SITD++PR
Sbjct: 631 QPGLFFQSRIGKD------------PLDTDTTSKSLLGSVDDASITDIHPR 669

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9M0X5|CRK25_ARATH Cysteine-rich receptor-like protein kinase 25 OS=Arabidopsis thaliana GN=CRK25 PE=2 SV=1

 Score =  605 bits (1560), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 315/672 (46%), Positives = 434/672 (64%), Gaps = 32/672 (4%)

Query: 9   VFFFSFLILAVS--INAQNVCSNDVGNYTSNSAYKTNLNSVLSSIAS-NAAVDYGFYNES 65
           VF F  L    S      ++C N    Y+ NS+Y TNL +VLSS++S NAA    F N +
Sbjct: 14  VFLFMILKTVTSDPTYLYHICPNTT-TYSRNSSYLTNLRTVLSSLSSPNAAYASLFDNAA 72

Query: 66  AGQEPDKVNVFA--LCRGDIATDVCRGCLENATQEILRVCPNQKQAIIWSAECMLRYSNK 123
           AG+E D   V+   LCRGD++ ++CR C+  A  E L+ CP +K A+IW  ECM+RYSN+
Sbjct: 73  AGEENDSNRVYGVFLCRGDVSAEICRDCVAFAANETLQRCPREKVAVIWYDECMVRYSNQ 132

Query: 124 TIFGVLETGPTYYMWNVNNVTDD-VSLFNQALQDLLRRLRGTAASGNSQKKFATGDTTAS 182
           +I G +   P  ++ N  N+T++ VS FN++L  LL  +   AA   S +KFAT     +
Sbjct: 133 SIVGQMRIRPGVFLTNKQNITENQVSRFNESLPALLIDVAVKAAL--SSRKFATEKANFT 190

Query: 183 -FRTIYALEQCTPDLSELQCSDCLDRAIGEIPNCCSGKIGGRVLKPSCNFRFETERFYNP 241
            F+TIY+L QCTPDL+   C  CL + I  +P CC   +GGRV+ PSC+FR+E   FYN 
Sbjct: 191 VFQTIYSLVQCTPDLTNQDCESCLRQVINYLPRCCDRSVGGRVIAPSCSFRYELYPFYNE 250

Query: 242 TAN------------SPPPSPPPPAEGNGSDTARTVIIILIPTVGFVILIIFICFFLRRK 289
           T              + PP   P  +G G +    V  I +P    V+L+  +C+ L R+
Sbjct: 251 TIAAAPMAPPPSSTVTAPPLNIPSEKGKGKNLTVIVTAIAVPVSVCVLLLGAMCWLLARR 310

Query: 290 PRDNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGA 349
             +    ++E    D I   E+LQF F+ I  AT+ FS++NKLG GGFG VYKG+L  G 
Sbjct: 311 RNNKLSAETEDLDEDGITSTETLQFQFSAIEAATNKFSESNKLGHGGFGEVYKGQLITGE 370

Query: 350 EIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDH 409
            +A+KRLS+ S QG  EFKNEV +VA LQHRNL +LLG+ L+G E++L+YEFVPN SLD+
Sbjct: 371 TVAIKRLSQGSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKSLDY 430

Query: 410 FIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIAD 469
           F+FD  +R  LDW+RRYKII GIARG+LYLH DSRL IIHRDLK SN+LLDA+M PKI+D
Sbjct: 431 FLFDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDADMHPKISD 490

Query: 470 FGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNC 529
           FGMAR+F +D+TQ NT RIVGTYGYM+PEYA+HG+YSVKSDV+SFGVLVLE+I+G++N+ 
Sbjct: 491 FGMARIFGVDQTQANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLELITGKKNSS 550

Query: 530 FRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSIT-EMIRCIHIGLLCVQENVASRPT 588
           F   + + DL++  WK W E + + ++D  +     T E+IRCIHI LLCVQE+ + RP+
Sbjct: 551 FYEEDGLGDLVTYVWKLWVENSPLELVDEAMRGNFQTNEVIRCIHIALLCVQEDSSERPS 610

Query: 589 MASVVLMLNSYSLTLPVPSEPAFFMDSIIESDMSFSLAHDSRI--TETDQPGCENLLLSG 646
           M  +++M+NS+++TLP+P    F + ++ +S        D R   + +D       L   
Sbjct: 611 MDDILVMMNSFTVTLPIPKRSGFLLRTMKDS-------RDPRSGGSASDHSATSKSLPLS 663

Query: 647 NNEISITDLYPR 658
            ++ SIT +YPR
Sbjct: 664 VDDSSITIVYPR 675

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O65468|CRK8_ARATH Cysteine-rich receptor-like protein kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=2 SV=2

 Score =  598 bits (1541), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 319/643 (49%), Positives = 431/643 (67%), Gaps = 34/643 (5%)

Query: 34  YTSNSAYKTNLNSVLSSIAS-NAAVDYGFYNESAGQEPDKVNVFALCRGDIATDVCRGCL 92
           Y+SNS Y TNL ++LSS AS NA+   GF N  AGQ PD+V    LCRGD++ +VC  C+
Sbjct: 50  YSSNSTYSTNLKTLLSSFASRNASYSTGFQNIRAGQTPDRVTGLFLCRGDLSPEVCSNCV 109

Query: 93  ENATQEILRVCPNQKQAIIWSAECMLRYSNKTIFGVLETGPTYYMWNVNNVTDDVSLFNQ 152
             +  E L  CPNQ++A+ +  EC+LRYS+K     +       M N NN++   S+ NQ
Sbjct: 110 AFSVNESLTRCPNQREAVFYYEECILRYSHKNFLSTVTYEGELIMRNPNNIS---SIQNQ 166

Query: 153 ALQ--DLLRRLRGTAA--SGNSQKKFATGDTT-ASFRTIYALEQCTPDLSELQCSDCLDR 207
             Q  DL++     AA  + NS +KF+T  T   S +T+Y L QCTPDL+   C  CL  
Sbjct: 167 RDQFIDLVQSNMNQAANEAANSSRKFSTIKTELTSLQTLYGLVQCTPDLARQDCFSCLTS 226

Query: 208 AIGEIPNCCSGKIGGRVLKPSCNFRFETERFYNPTA---NSPPP-----SPP---PPAEG 256
           +I  +      +IG R   PSCN R+E   FYN TA    SPPP     +PP   P   G
Sbjct: 227 SINRMMPLF--RIGARQFWPSCNSRYELYAFYNETAIGTPSPPPLFPGSTPPLTSPSIPG 284

Query: 257 NGSDTARTVIIILIPTVGFVILIIFICFFLRRKPRDNSKVKSEAAAGDEINRAESLQFDF 316
              ++   V+ I++  V   I ++  CF  +R  +      S +  GD++  A+SLQ D+
Sbjct: 285 KSGNSTVLVVAIVVLAVLLFIALVGYCFLAQRT-KKTFDTASASEVGDDMATADSLQLDY 343

Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVAN 376
            TI+ AT++F+++NK+G+GGFG VYKG   +G E+AVKRLS++S QG+ EFK EV++VA 
Sbjct: 344 RTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKNSRQGEAEFKTEVVVVAK 403

Query: 377 LQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGL 436
           LQHRNLVRLLGFSL+G ER+L+YE++PN SLD  +FDPT++ QLDW +RY IIGGIARG+
Sbjct: 404 LQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQTQLDWMQRYNIIGGIARGI 463

Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMA 496
           LYLH+DSRL IIHRDLK SN+LLDA++ PKIADFGMAR+F +D+TQ NTSRIVGTYGYMA
Sbjct: 464 LYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLDQTQDNTSRIVGTYGYMA 523

Query: 497 PEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNII 556
           PEYAMHGQ+S+KSDV+SFGVLVLEIISG++N+ F   +  +DLL+  W+ W   T ++++
Sbjct: 524 PEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDESDGAQDLLTHTWRLWTNRTALDLV 583

Query: 557 DPTLSSG-SITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTLPVPSEPAFFMDS 615
           DP +++    +E++RCIHIGLLCVQE+ A RPT+++V +ML S ++TLPVP +P FF+ S
Sbjct: 584 DPLIANNCQNSEVVRCIHIGLLCVQEDPAKRPTISTVFMMLTSNTVTLPVPRQPGFFIQS 643

Query: 616 IIESDMSFSLAHDSRITETDQPGCENLLLSGNNEISITDLYPR 658
               D + S   D   T    P       S ++E+ ITDLYPR
Sbjct: 644 SPVKDPTDS---DQSTTTKSTPA------SIDDEL-ITDLYPR 676

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O65405|CRK28_ARATH Cysteine-rich receptor-like protein kinase 28 OS=Arabidopsis thaliana GN=CRK28 PE=3 SV=2

 Score =  597 bits (1538), Expect = e-169,   Method: Compositional matrix adjust.
 Identities = 318/661 (48%), Positives = 430/661 (65%), Gaps = 43/661 (6%)

Query: 27  CSNDVGNYTSNSAYKTNLNSVLSSIASNAAVDYGFYNESAGQEP-DKVNVFALCRGDIAT 85
           C    GN+T+NS++  NLN ++SS++S  +  YGFYN S+G    ++     LCR ++  
Sbjct: 37  CVASGGNFTANSSFAGNLNGLVSSLSSLTSKPYGFYNLSSGDSSGERAYAIGLCRREVKR 96

Query: 86  DVCRGCLENATQEILRVCPNQKQAIIWSAECMLRYSNKTIFGVLETGPTYYMWNVNNVTD 145
           D C  C++ A + ++  CP   QA++W   CM RYSN  I+G  ET PT       N++ 
Sbjct: 97  DDCLSCIQIAARNLIEQCPLTNQAVVWYTHCMFRYSNMIIYGRKETTPTLSFQAGKNISA 156

Query: 146 DVSLFNQALQDLLRRLRGTAASGNSQKKFA--TGDTTASFRTIYALEQCTPDLSELQCSD 203
           +   F++   +LL RL+G AA+G   +K+A  +G   A +   Y    CTPDLSE  C+D
Sbjct: 157 NRDEFDRLQIELLDRLKGIAAAGGPNRKYAQGSGSGVAGYPQFYGSAHCTPDLSEQDCND 216

Query: 204 CLDRAIGEIPNCCSGKIGGRVLKPSCNFRFETERFY--------NPTANSPPPSPPPPAE 255
           CL     +IP CC+G++G R   PSC++RFET RFY        +P A  P  SP   A 
Sbjct: 217 CLVFGFEKIPGCCAGQVGLRWFFPSCSYRFETWRFYEFDADLEPDPPAIQPADSPTSAAR 276

Query: 256 ----GNGSDTARTVIIILIPTVGFVILIIFICFFLRRKP----------RDNSKVKSEAA 301
               G G   ++ ++ I+IP V   +  I +C  L+ K           + N  +     
Sbjct: 277 TERTGKGKGGSKVIVAIVIPIVFVALFAICLCLLLKWKKNKSVGRVKGNKHNLLLLVIVI 336

Query: 302 AGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSG 361
              +   ++SL  DF T++ ATDNFS  N+LG+GGFG+VYKG    G EIAVKRLS  SG
Sbjct: 337 LLQKDEFSDSLVVDFETLKAATDNFSPENELGRGGFGSVYKGVFSGGQEIAVKRLSCTSG 396

Query: 362 QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLD 421
           QGD EFKNE+LL+A LQHRNLVRLLGF +EG ER+L+YEF+ N SLD+FIFD  +R  LD
Sbjct: 397 QGDSEFKNEILLLAKLQHRNLVRLLGFCIEGQERILVYEFIKNASLDNFIFDLKKRQLLD 456

Query: 422 WERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET 481
           W  RYK+IGG+ARGLLYLHEDSR RIIHRDLK SN+LLD EM PKIADFG+A+L++ D+T
Sbjct: 457 WGVRYKMIGGVARGLLYLHEDSRYRIIHRDLKASNILLDQEMNPKIADFGLAKLYDTDQT 516

Query: 482 QGN--TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFR--NGETVE 537
             +  TS+I GTYGYMAPEYA++GQ+SVK+DVFSFGVLV+EII+G+ NN  R  + E  E
Sbjct: 517 STHRFTSKIAGTYGYMAPEYAIYGQFSVKTDVFSFGVLVIEIITGKGNNNGRSNDDEEAE 576

Query: 538 DLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN 597
           +LLS  W+ WRE   +++IDP+L++GS +E++RCIHIGLLCVQE+ ASRPTM SV LMLN
Sbjct: 577 NLLSWVWRCWREDIILSVIDPSLTTGSRSEILRCIHIGLLCVQESPASRPTMDSVALMLN 636

Query: 598 SYSLTLPVPSEPAFFMDSIIESDMSFSLAHDSRITETDQPGCENLLLSGNNEISITDLYP 657
           SYS TLP PS PAF ++S++ S           ++ + +P     LL   N++++++L P
Sbjct: 637 SYSYTLPTPSRPAFALESVMPS---------MNVSSSTEP-----LLMSLNDVTVSELSP 682

Query: 658 R 658
           R
Sbjct: 683 R 683

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O23081|CRK41_ARATH Cysteine-rich receptor-like protein kinase 41 OS=Arabidopsis thaliana GN=CRK41 PE=3 SV=2

 Score =  580 bits (1494), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 304/598 (50%), Positives = 395/598 (66%), Gaps = 20/598 (3%)

Query: 26  VCSNDVGNYTSNSAYKTNLNSVLSSIASNAAVDYGFYNESAGQ--EPDKVNVFALCRGDI 83
           +C +   N+  +S +  NL+S++SSI S  +  Y FY+ S G   + ++V    +C   +
Sbjct: 46  LCLSQQSNFAKSSQFSKNLDSLVSSIPSLKSNTYNFYSLSVGSISDQERVEAIGICNRVV 105

Query: 84  ATDVCRGCLENATQEILRV-CPNQKQAIIWSAECMLRYSNKTIFGVLETGPTYYMWNVNN 142
               C  C+  A   +  + CP  + A + + +CM RYS+K IFG LET P     N +N
Sbjct: 106 NRVDCLNCIAQAAVNLTTMYCPQHRGAYVRATKCMFRYSDKPIFGKLETSPVLEAPNPSN 165

Query: 143 VTDDVSLFNQALQDLLRRLRGTAASGNSQKKFATGDTTAS--FRTIYALEQCTPDLSELQ 200
            T D + F +   +LL RLR  AASG S++K+A G    S  + T +   QCTPDLSE  
Sbjct: 166 ATGDRNEFIRLQSELLNRLRSMAASGGSKRKYAQGTDPGSPPYTTFFGAVQCTPDLSEKD 225

Query: 201 CSDCLDRAIGEIPNCCSGKIGGRVLKPSCNFRFETERFYNPTANSPPPSPPPPAEGNGSD 260
           C+DCL        N   G++G R   PSCNF+ E++  +    +   P P P     G+D
Sbjct: 226 CNDCLSYGFS---NATKGRVGIRWFCPSCNFQIESDLRFFLLDSEYEPDPKP-----GND 277

Query: 261 TARTVIIILIPTVGFVILIIFICFFLRRKPRDNSKVKSEAAAGDE--INRAESLQFDFNT 318
             + +I  +   +GF I+ +F+ FF+ R  R  +K + E    +E  I  A+ LQ DF+T
Sbjct: 278 KVKIIIATVCSVIGFAIIAVFLYFFMTRN-RRTAKQRHEGKDLEELMIKDAQLLQLDFDT 336

Query: 319 IRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQ 378
           IR+AT++FS  N+LG+GGFGAVYKG L  G EIAVKRLS  SGQGD EF NEV LVA LQ
Sbjct: 337 IRLATNDFSRDNQLGEGGFGAVYKGVLDYGEEIAVKRLSMKSGQGDNEFINEVSLVAKLQ 396

Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           HRNLVRLLGF L+G ER+LIYEF  NTSLDH+IFD  RR  LDWE RY+II G+ARGLLY
Sbjct: 397 HRNLVRLLGFCLQGEERILIYEFFKNTSLDHYIFDSNRRMILDWETRYRIISGVARGLLY 456

Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN--TSRIVGTYGYMA 496
           LHEDSR +I+HRD+K SNVLLD  M PKIADFGMA+LF+ D+T     TS++ GTYGYMA
Sbjct: 457 LHEDSRFKIVHRDMKASNVLLDDAMNPKIADFGMAKLFDTDQTSQTRFTSKVAGTYGYMA 516

Query: 497 PEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNII 556
           PEYAM G++SVK+DVFSFGVLVLEII G++NN     ++   LLS  WK+WREG  +NI+
Sbjct: 517 PEYAMSGEFSVKTDVFSFGVLVLEIIKGKKNNWSPEEDSSLFLLSYVWKSWREGEVLNIV 576

Query: 557 DPTL--SSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTLPVPSEPAFF 612
           DP+L  + G   E+++CIHIGLLCVQEN  SRPTMASVV+MLN+ S TLP PS+PAF+
Sbjct: 577 DPSLVETIGVSDEIMKCIHIGLLCVQENAESRPTMASVVVMLNANSFTLPRPSQPAFY 634

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8W4G6|CRK15_ARATH Cysteine-rich receptor-like protein kinase 15 OS=Arabidopsis thaliana GN=CRK15 PE=2 SV=2

 Score =  577 bits (1488), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 301/611 (49%), Positives = 406/611 (66%), Gaps = 30/611 (4%)

Query: 24  QNVCSNDVGNYTSNSAYKTNLNSVLSSI-ASNAAVDYGFYNESAGQEPDKVNVFALCRGD 82
           +++C N    Y+ NS Y TNL ++LSS+ A NA+   GF +  AGQ PD+V    LCRGD
Sbjct: 28  KHICPNTT-TYSRNSPYLTNLRTLLSSLSAPNASYSTGFQSARAGQAPDRVTGLFLCRGD 86

Query: 83  IATDVCRGCLENATQEILRVCPNQKQAIIWSAECMLRYSNKTIFGVLETGPTYYMWNVNN 142
           ++  VCR C+  +  + L  CP++++++ +  ECMLRYS++ I   L     +   N  N
Sbjct: 87  VSPAVCRNCVAFSINDTLVQCPSERKSVFYYDECMLRYSDQNILSTLAYDGAWIRMN-GN 145

Query: 143 VTDDVSLFNQALQDLLRRLRGTAA--SGNSQKKFATGDTT-ASFRTIYALEQCTPDLSEL 199
           ++ D +  N+  +D +      AA  + +S +KF T   T  + +T+Y L QCTPDL+  
Sbjct: 146 ISIDQNQMNR-FKDFVSSTMNQAAVKAASSPRKFYTVKATWTALQTLYGLVQCTPDLTRQ 204

Query: 200 QCSDCLDRAIGEIPNCCSGKIGGRVLKPSCNFRFETERFYNPTA--------------NS 245
            C  CL+ +I  +P     K GGR L  SCN R+E   FYN T                 
Sbjct: 205 DCFSCLESSIKLMP---LYKTGGRTLYSSCNSRYELFAFYNETTVRTQQAPPPLPPSSTP 261

Query: 246 PPPSPPPPAEGNGSDTARTVIIILIPTVGFVILIIFICFFLRRKPRDNSKVKSEAAAGDE 305
              SP  P +   S+    V I+L   V  ++LI   CF  R K   NS   + A  GD+
Sbjct: 262 LVTSPSLPGKSWNSNVL-VVAIVLTILVAALLLIAGYCFAKRVK---NSSDNAPAFDGDD 317

Query: 306 INRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDL 365
           I   ESLQ D+  IR AT+ FS+ NK+GQGGFG VYKG   +G E+AVKRLS+ SGQGD 
Sbjct: 318 IT-TESLQLDYRMIRAATNKFSENNKIGQGGFGEVYKGTFSNGTEVAVKRLSKSSGQGDT 376

Query: 366 EFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERR 425
           EFKNEV++VA LQHRNLVRLLGFS+ G ER+L+YE++PN SLD+F+FDP ++ QLDW RR
Sbjct: 377 EFKNEVVVVAKLQHRNLVRLLGFSIGGGERILVYEYMPNKSLDYFLFDPAKQNQLDWTRR 436

Query: 426 YKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNT 485
           YK+IGGIARG+LYLH+DSRL IIHRDLK SN+LLDA+M PK+ADFG+AR+F MD+TQ NT
Sbjct: 437 YKVIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKLADFGLARIFGMDQTQENT 496

Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWK 545
           SRIVGT+GYMAPEYA+HGQ+SVKSDV+SFGVLVLEIISG++NN F   +   DL++ AW+
Sbjct: 497 SRIVGTFGYMAPEYAIHGQFSVKSDVYSFGVLVLEIISGKKNNSFYETDGAHDLVTHAWR 556

Query: 546 NWREGTTVNIIDP-TLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTLP 604
            W  GT ++++DP  + +   +E++RCIHI LLCVQE+ A RP ++++ +ML S ++TLP
Sbjct: 557 LWSNGTALDLVDPIIIDNCQKSEVVRCIHICLLCVQEDPAERPILSTIFMMLTSNTVTLP 616

Query: 605 VPSEPAFFMDS 615
           VP +P F + S
Sbjct: 617 VPLQPGFPVQS 627

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O49564|CRK27_ARATH Cysteine-rich receptor-like protein kinase 27 OS=Arabidopsis thaliana GN=CRK27 PE=3 SV=2

 Score =  573 bits (1476), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 302/609 (49%), Positives = 394/609 (64%), Gaps = 26/609 (4%)

Query: 21  INAQNVCSNDVGNYTSNSAYKTNLNSVLSSIASNAAVDYGFYNESAGQEPDKVNVFALCR 80
           +    +C  D GN+TSN++Y  NLN ++SS+        GFYN S   E   VN  ALCR
Sbjct: 28  VTVHTICYYDGGNFTSNTSYSLNLNRLISSLPDLTPTINGFYNISINGE---VNAIALCR 84

Query: 81  GDIATDV-CRGCLENATQEILRVCPNQKQAIIWSAECMLRYSNKTIFGVLETGPTYYMWN 139
           GD+  +  C  C+  A ++++  CPN  +A IW  +CM RY+++ I G +E  P  Y  +
Sbjct: 85  GDVKPNQDCISCITTAAKQLVESCPNIIEANIWLEKCMFRYTSRIILGQMEPVPFSYTSS 144

Query: 140 VNNVTDDVSLFNQALQDLLRRLRGTAASGNSQK--KFATGDTTASFRTIYALEQCTPDLS 197
             +VTD    F++ L DLL  L     + N  K  KFA G       TIYAL QCTPDLS
Sbjct: 145 NVSVTDKEG-FSKGLGDLLDSLGAKIDAANETKEVKFAAGVKG----TIYALAQCTPDLS 199

Query: 198 ELQCSDCLDRAIGEIPNCCSGKIGGRVLKPSCNFRFETERFYNPTANSPPPSPPPPA--- 254
           E  C  CL +    +P CC GK GG    PSC FRFE   F++ +  S    P       
Sbjct: 200 ESDCRICLAQIFAGVPTCCDGKTGGWWTNPSCYFRFEVYPFFDLSVTSEQKQPLSSHNNN 259

Query: 255 -----EGNGSDTARTVIIILIPTVGFVILIIFICFFLRRKPRDNSKVKSEAAAGDEINRA 309
                +G   D ++T+I  ++P V  ++ ++F+  +L+R+ +  +  ++   A +E    
Sbjct: 260 TRRSDQGKSKDRSKTLIFAVVPIVAIILGLVFLFIYLKRRRKKKTLKEN---AENEFEST 316

Query: 310 ESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKN 369
           +SL FDF TIRVATD+FS  NK+G+GGFG VYKG L DG EIAVKRLS  SGQG+ EFK 
Sbjct: 317 DSLHFDFETIRVATDDFSLTNKIGEGGFGVVYKGHLPDGLEIAVKRLSIHSGQGNAEFKT 376

Query: 370 EVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKII 429
           EVLL+  LQH+NLV+L GFS++ +ERLL+YEF+PNTSLD F+FDP ++ QLDWE+RY II
Sbjct: 377 EVLLMTKLQHKNLVKLFGFSIKESERLLVYEFIPNTSLDRFLFDPIKQKQLDWEKRYNII 436

Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIV 489
            G++RGLLYLHE S   IIHRDLK+SNVLLD +M PKI+DFGMAR F+ D TQ  T R+V
Sbjct: 437 VGVSRGLLYLHEGSEFPIIHRDLKSSNVLLDEQMLPKISDFGMARQFDFDNTQAVTRRVV 496

Query: 490 GTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWRE 549
           GTYGYMAPEYAMHG++SVK+DV+SFGVLVLEII+G+RN+    GE   DL + AW+NW E
Sbjct: 497 GTYGYMAPEYAMHGRFSVKTDVYSFGVLVLEIITGKRNSGLGLGEGT-DLPTFAWQNWIE 555

Query: 550 GTTVNIIDPT-LSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLML--NSYSLTLPVP 606
           GT++ +IDP  L +    E ++C+ I L CVQEN   RPTM SVV ML  +S S  LP P
Sbjct: 556 GTSMELIDPVLLQTHDKKESMQCLEIALSCVQENPTKRPTMDSVVSMLSSDSESRQLPKP 615

Query: 607 SEPAFFMDS 615
           S+P FF  S
Sbjct: 616 SQPGFFRRS 624

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O65479|CRK20_ARATH Putative cysteine-rich receptor-like protein kinase 20 OS=Arabidopsis thaliana GN=CRK20 PE=2 SV=2

 Score =  567 bits (1460), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 304/650 (46%), Positives = 411/650 (63%), Gaps = 47/650 (7%)

Query: 34  YTSNSAYKTNLNSVLSSIAS-NAAVDYGFYNESAGQEPDKVNVFALCRGDIATDVCRGCL 92
           Y+SNS Y TNL ++LSS++S NA+   GF N +AGQ PD V    LCRG+++ +VCR C+
Sbjct: 39  YSSNSTYSTNLKTLLSSLSSRNASYSTGFQNATAGQAPDMVTGLFLCRGNVSPEVCRSCI 98

Query: 93  ENATQEILRVCPNQKQAIIWSAECMLRYSNKTIFGVLETGPTYYMWNVNNVTDDVSLFNQ 152
             +  E L  CPN+++A+ +  +CMLRYSN+ I   L T    +M N  N    +S+   
Sbjct: 99  ALSVNESLSRCPNEREAVFYYEQCMLRYSNRNILSTLNTDGGVFMQNARN---PISVKQD 155

Query: 153 ALQDLLRRLRGTAA--SGNSQKKFA-TGDTTASFRTIYALEQCTPDLSELQCSDCLDRAI 209
             +DL+      AA  +  S K+FA T     + +++Y + QCTPDL+E  C DCL ++I
Sbjct: 156 RFRDLVLNPMNLAAIEAARSIKRFAVTKFDLNALQSLYGMVQCTPDLTEQDCLDCLQQSI 215

Query: 210 GEIPNCCSGKIGGRVLKPSCNFRFETERFYNP-TANSPPPSPPPPAEGNGSDTARTVIII 268
            ++      KIGGR   PSC  R++   FYN     +P  S P P +G  S      ++ 
Sbjct: 216 NQV---TYDKIGGRTFLPSCTSRYDNYEFYNEFNVGTPQDSSPRPGKGGNSSVIVIAVV- 271

Query: 269 LIPTVGFVILIIFICFF-LRRKPRDNS-------KVK----------SEAAAGDEINRAE 310
                  V+ ++F+ FF +RR  R  +       KVK          +E   GD+I  A 
Sbjct: 272 ---VPITVLFLLFVAFFSVRRAKRKKTIGAIPLFKVKRKETEVTEPPAETTDGDDITTAG 328

Query: 311 SLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNE 370
           SLQFDF  I  ATD F   NKLGQGGFG VYKG    G ++AVKRLS++SGQG+ EF+NE
Sbjct: 329 SLQFDFKAIVAATDIFLPINKLGQGGFGEVYKGTFPSGVQVAVKRLSKNSGQGEKEFENE 388

Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIG 430
           V++VA LQHRNLV+LLG+ LEG E++L+YEFVPN SLD+F+FDPT + QLDW RRYKIIG
Sbjct: 389 VVVVAKLQHRNLVKLLGYCLEGEEKILVYEFVPNKSLDYFLFDPTMQGQLDWSRRYKIIG 448

Query: 431 GIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVG 490
           GIARG+LYLH+DSRL IIHRDLK  N+LLDA+M PK+ADFGMAR+F MD+T+ NT R+VG
Sbjct: 449 GIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGMARIFGMDQTEANTRRVVG 508

Query: 491 TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGE-TVEDLLSSAWKNWRE 549
           TYGYMAPEYAM+G++S+KSDV+SFGVLVLEI+SG +N+     + ++ +L++  W+ W  
Sbjct: 509 TYGYMAPEYAMYGKFSMKSDVYSFGVLVLEIVSGMKNSSLDQMDGSISNLVTYTWRLWSN 568

Query: 550 GTTVNIIDPTLSSG-SITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTLPVPSE 608
           G+   ++DP+       +E+ RCIHI LLCVQE+   RPTM+++V ML + S+ L VP  
Sbjct: 569 GSPSELVDPSFGDNYQTSEITRCIHIALLCVQEDANDRPTMSAIVQMLTTSSIALAVPRP 628

Query: 609 PAFFMDSIIESDMSFSLAHDSRITETDQPGCENLLLSGNNEISITDLYPR 658
           P FF+ S  E              E   P  +   L   +E SIT + PR
Sbjct: 629 PGFFLRSKQEQ------------AERACPSMDTSDLFSIDEASITSVAPR 666

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	658
359496752	751	PREDICTED: cysteine-rich receptor-like p	0.983	0.861	0.621	0.0
356574368	656	PREDICTED: cysteine-rich receptor-like p	0.987	0.990	0.625	0.0
359497268	675	PREDICTED: cysteine-rich receptor-like p	0.983	0.958	0.619	0.0
147811956	839	hypothetical protein VITISV_019620 [Viti	0.983	0.771	0.616	0.0
356575759	687	PREDICTED: cysteine-rich receptor-like p	0.984	0.943	0.608	0.0
356575761	679	PREDICTED: cysteine-rich receptor-like p	0.971	0.941	0.609	0.0
224076544	652	predicted protein [Populus trichocarpa]	0.960	0.969	0.637	0.0
224113941	637	predicted protein [Populus trichocarpa]	0.942	0.973	0.656	0.0
255555051	1390	serine-threonine protein kinase, plant-t	0.911	0.431	0.625	0.0
255555047	630	ATP binding protein, putative [Ricinus c	0.899	0.939	0.648	0.0

>gi|359496752|ref|XP_003635322.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like [Vitis vinifera]

 Score =  823 bits (2126), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 424/682 (62%), Positives = 515/682 (75%), Gaps = 35/682 (5%)

Query: 7   RLVFF-FSFLILAV--SINAQNV-----CSNDVGNYTSNSAYKTNLNSVLSSIASNAAVD 58
           RL+FF +  LIL +    NAQ       CSN VGNYT+NS YK NLN++L+S++SN  +D
Sbjct: 75  RLLFFLYPILILHLLAVTNAQPKFLYYRCSNGVGNYTNNSTYKANLNTLLTSLSSNNEID 134

Query: 59  YGFYNESAGQEPDKVNVFALCRGDIATDVCRGCLENATQEILRVCPNQKQAIIWSAECML 118
           YGFYN SAGQ  DKVN  ALCRGD+    CR C+ ++  ++ R+CPNQK+AI W   CML
Sbjct: 135 YGFYNFSAGQNSDKVNAIALCRGDVMPTACRSCINDSRIQLTRLCPNQKEAIGWYDGCML 194

Query: 119 RYSNKTIFGVLETGPTYYMWNVNNVTDDVSLFNQALQDLLRRLRGTAASGNSQKKFATGD 178
           RYSN +IFG  +T P++ MWN+ NV++ V  FNQ L +L+  LR  AASG+ ++KFAT +
Sbjct: 195 RYSNDSIFGKAQTSPSFTMWNLQNVSN-VEDFNQVLGNLMASLRSKAASGDWRRKFATEE 253

Query: 179 T-TASFRTIYALEQCTPDLSELQCSDCLDRAIGEIPNCCSGKIGGRVLKPSCNFRFETER 237
               SF++IY L QCTPDLSEL CS+CL+ AI EIP CC+ +  GRV+KPSCN R+ T R
Sbjct: 254 ANVTSFQSIYGLMQCTPDLSELSCSNCLEGAINEIPTCCNRRKAGRVVKPSCNLRYGTYR 313

Query: 238 FYNPTA--------------NSPPPSPPPPA-----EGNGSDTARTVIIILIPTVGFVIL 278
           FY  TA               S   SP P A     +   S+++RT+I+I++P+V  +I+
Sbjct: 314 FYYFTAANAPPPTATPQPSPPSADLSPQPLANTTSTQETRSNSSRTIILIIVPSVIILII 373

Query: 279 II--FICFFLRRKPRDNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGG 336
           I+  FICFF R++   +S  K E    D+I   ESL FDF+TIRVAT+NFSD+NKLGQGG
Sbjct: 374 ILVGFICFFSRKR---SSMEKLETNDEDDIINVESLHFDFDTIRVATNNFSDSNKLGQGG 430

Query: 337 FGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERL 396
           FG VYKG+L +G +IAVKRLS  SGQG+LEFKNEV+LVA LQHRNLVRLLGF L+G ERL
Sbjct: 431 FGPVYKGKLSNGQDIAVKRLSSGSGQGELEFKNEVVLVAKLQHRNLVRLLGFCLDGAERL 490

Query: 397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSN 456
           LIYEFVPNTSLDHFIFDP RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLK SN
Sbjct: 491 LIYEFVPNTSLDHFIFDPIRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKASN 550

Query: 457 VLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGV 516
           +LLDAEM PKI+DFGMARLF +D+TQGNTSRIVGTYGYMAPEYAMHG +SVK+DV+SFGV
Sbjct: 551 ILLDAEMNPKISDFGMARLFLVDQTQGNTSRIVGTYGYMAPEYAMHGHFSVKTDVYSFGV 610

Query: 517 LVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGL 576
           LVLE++SGQRNNCFR  E +E LLS AWKNWREGT  N+IDPT+   SI+E++RCIHIGL
Sbjct: 611 LVLELVSGQRNNCFRVSENIEHLLSYAWKNWREGTATNLIDPTMRISSISEIMRCIHIGL 670

Query: 577 LCVQENVASRPTMASVVLMLNSYSLTLPVPSEPAFFMDSIIESDMSFSLAHDSRITETDQ 636
           LCVQEN A RPTMAS+ LMLNSYSL+LP+PS PAFFM++ +  DMS  L  +SR+ +++ 
Sbjct: 671 LCVQENEADRPTMASIALMLNSYSLSLPLPSHPAFFMNTSMNRDMSLELEDNSRVAQSNY 730

Query: 637 PGCENLLLSGNNEISITDLYPR 658
               +   S  NE SITD YPR
Sbjct: 731 LPSRSSHFSV-NEASITDPYPR 751

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356574368|ref|XP_003555320.1| PREDICTED: cysteine-rich receptor-like protein kinase 29-like [Glycine max]

 Score =  822 bits (2123), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 415/664 (62%), Positives = 499/664 (75%), Gaps = 14/664 (2%)

Query: 1   MAKGCSRLVFFFSFL--ILAVSINAQNVCSNDVGNYTSNSAYKTNLNSVLSSIASNAAVD 58
           MA    RL+FF   L  I+    +AQ  C N  GNYT NS Y  NLN++LS+ +S+  + 
Sbjct: 1   MAAVSFRLLFFLCCLSVIIISRASAQTYCDNHKGNYTINSTYHNNLNTLLSTFSSHTDIY 60

Query: 59  YGFYNESAGQEPDKVNVFALCRGDIATDVCRGCLENATQEILRVCPNQKQAIIWSAECML 118
           YGFYN S GQ+PDKV    LCRGD   D C  CL++A     ++CPNQK+AI W  ECML
Sbjct: 61  YGFYNFSYGQDPDKVYAIGLCRGDQNQDDCLACLDDARANFTQLCPNQKEAINWDGECML 120

Query: 119 RYSNKTIFGVLETGPTYYMWNVNNVTDDVSLFNQALQDLLRRLRGTAASGNSQKKFATGD 178
           RYSN++IFG++E  P        NVT  V  FN+ALQ L+R L  TAASG+S++K+ T  
Sbjct: 121 RYSNRSIFGIMENEPFVETVLTMNVTGPVDQFNEALQSLMRNLTSTAASGDSRRKYGTAS 180

Query: 179 TTA-SFRTIYALEQCTPDLSELQCSDCLDRAIGEIPNCCSGKIGGRVLKPSCNFRFETER 237
           T A +F+TIY   QCTPDLS   C++CL  AI EIP CCSGK GG VLKPSC  RF+   
Sbjct: 181 THAPNFQTIYGYAQCTPDLSLEDCTNCLGEAIAEIPRCCSGKAGGNVLKPSCRIRFDPYN 240

Query: 238 FYNPTANSPPPSPPPPAEGNGSDTARTVIIILIPTVGFVILIIFICFFLR-RKPRDNSKV 296
           F+ PT   P PSP P ++G  S T+RT+I I++P    V+++   C +LR RKPR   K+
Sbjct: 241 FFGPTI--PLPSPSPNSQGK-SKTSRTIIAIVVPAASVVLVVSLFCIYLRARKPR--KKI 295

Query: 297 KSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRL 356
           + ++   DEI  AESLQF+F+TIR AT+ F+D+NKLGQGGFGAVY+G+L +G EIAVKRL
Sbjct: 296 EKDSHE-DEITFAESLQFNFDTIRAATNEFADSNKLGQGGFGAVYRGQLSNGQEIAVKRL 354

Query: 357 SRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTR 416
           SRDSGQG++EFKNEVLLVA LQHRNLV+LLGF LEG ERLLIYEFVPN SLD+FIFDP +
Sbjct: 355 SRDSGQGNMEFKNEVLLVAKLQHRNLVKLLGFCLEGRERLLIYEFVPNKSLDYFIFDPIK 414

Query: 417 RAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF 476
           +AQLDW+RRY IIGGIARG+LYLHEDSRLRIIHRDLK SN+LLD EM PKI+DFGMARL 
Sbjct: 415 KAQLDWQRRYNIIGGIARGILYLHEDSRLRIIHRDLKASNILLDEEMNPKISDFGMARLV 474

Query: 477 EMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETV 536
            MDETQGNTSRIVGTYGYMAPEY ++GQ+S KSDVFSFGVLVLEIISGQ+N+  R+GE V
Sbjct: 475 HMDETQGNTSRIVGTYGYMAPEYVLYGQFSAKSDVFSFGVLVLEIISGQKNSGIRHGENV 534

Query: 537 EDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLML 596
           E LLS AW+NWR+GTT +IIDPTL+ GS  E++RCIHIGLLC QENV +RPTMASVVLML
Sbjct: 535 EHLLSFAWRNWRDGTTTDIIDPTLNDGSRNEIMRCIHIGLLCAQENVTARPTMASVVLML 594

Query: 597 NSYSLTLPVPSEPAFFMDSIIES--DMSFSLAHDSRITETDQPGCENLLLSGNNEISITD 654
           NSYSLTLP+PSE AF +DS I S  DM  S  H+SR T + +   ++   S  NE SIT+
Sbjct: 595 NSYSLTLPLPSETAFVLDSNIRSFPDMLLS-EHNSRETRSSETAIKSTQKS-INEASITE 652

Query: 655 LYPR 658
           LYPR
Sbjct: 653 LYPR 656

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359497268|ref|XP_003635466.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like [Vitis vinifera]

 Score =  813 bits (2101), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 419/676 (61%), Positives = 511/676 (75%), Gaps = 29/676 (4%)

Query: 7   RLVFF-FSFLILAV--SINAQNV-----CSNDVGNYTSNSAYKTNLNSVLSSIASNAAVD 58
           RL+FF +  LIL +    NAQ       CSN VGNYT+NS YK NLN++L+S++SN  +D
Sbjct: 5   RLLFFLYPILILHLLAVTNAQPKFLYYRCSNGVGNYTNNSTYKANLNTLLTSLSSNNEID 64

Query: 59  YGFYNESAGQEPDKVNVFALCRGDIATDVCRGCLENATQEILRVCPNQKQAIIWSAECML 118
           YGFYN SAGQ  DKVN  ALCRGD+    CR C+ ++  ++ R+CPNQK+AI W   CML
Sbjct: 65  YGFYNFSAGQNSDKVNAIALCRGDVMPTACRSCINDSRIQLTRLCPNQKEAIGWYDGCML 124

Query: 119 RYSNKTIFGVLETGPTYYMWNVNNVTDDVSLFNQALQDLLRRLRGTAASGNSQKKFATGD 178
           RYSN +IFG  +T PT+ MWN+ NV++ V  FNQ L +L+  LR  AASG+ ++KFAT +
Sbjct: 125 RYSNDSIFGKAQTSPTFTMWNLQNVSN-VEDFNQVLGNLMASLRSKAASGDWRRKFATEE 183

Query: 179 T-TASFRTIYALEQCTPDLSELQCSDCLDRAIGEIPNCCSGKIGGRVLKPSCNFRFETER 237
               SF++IY L QCTPDLSEL CS+CL+ AI EIP CC+ +  GRV+KPSCN R+ T  
Sbjct: 184 ANVTSFQSIYGLMQCTPDLSELSCSNCLEGAINEIPTCCNRRKAGRVVKPSCNLRYATYH 243

Query: 238 FYNPTANSPPP-------------SPPPPAEGNGSDTARTVIIILIPTVGFVILII--FI 282
           FY+ TA + PP             +     +   S+++RT+I+I++P+V  +I+I+  FI
Sbjct: 244 FYDITAANAPPPSPPSADLSPPPLANTTSTQETRSNSSRTIILIIVPSVIILIIILVGFI 303

Query: 283 CFFLRRKPRDNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYK 342
           CFF R++   +S  K E    DEI   ESL FDF+TIRVAT+NFSD+NKLGQGGFG VYK
Sbjct: 304 CFFSRKR---SSMEKLETHDEDEITNVESLHFDFDTIRVATNNFSDSNKLGQGGFGPVYK 360

Query: 343 GRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFV 402
           G+L +G  +AVKRLS  S QG+LEFKNEV+LVA LQHRNLVRLLGF L+G ERLLIYEFV
Sbjct: 361 GKLSNGQNVAVKRLSSGSAQGELEFKNEVVLVAKLQHRNLVRLLGFCLDGAERLLIYEFV 420

Query: 403 PNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE 462
           PNTSLDHFIFD  RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLK SN+LLDAE
Sbjct: 421 PNTSLDHFIFDLIRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKASNILLDAE 480

Query: 463 MTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEII 522
           M PKI+DFGMARLF +D+TQG+TSRIVGTYGYMAPEYAMHG +SVK+DV+SFGVLVLE++
Sbjct: 481 MNPKISDFGMARLFLVDQTQGSTSRIVGTYGYMAPEYAMHGHFSVKTDVYSFGVLVLELV 540

Query: 523 SGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQEN 582
           SGQRNNCFR  E +E LLS AWKNWREGT  N+IDPT+   SI+E++RCIHIGLLCVQEN
Sbjct: 541 SGQRNNCFRVSENIEHLLSYAWKNWREGTATNLIDPTMRISSISEIMRCIHIGLLCVQEN 600

Query: 583 VASRPTMASVVLMLNSYSLTLPVPSEPAFFMDSIIESDMSFSLAHDSRITETDQPGCENL 642
            A RPTMAS+ LMLNSYSL+LPVPS PAFFM++ +  DMS  L  +SR+ +++     + 
Sbjct: 601 EADRPTMASIALMLNSYSLSLPVPSHPAFFMNTSMNRDMSLELEDNSRVAQSNYLPSRSS 660

Query: 643 LLSGNNEISITDLYPR 658
             S  NE SITD YPR
Sbjct: 661 HFSV-NEASITDPYPR 675

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147811956|emb|CAN74851.1| hypothetical protein VITISV_019620 [Vitis vinifera]

 Score =  812 bits (2098), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 417/676 (61%), Positives = 509/676 (75%), Gaps = 29/676 (4%)

Query: 7   RLVFF-FSFLILAV--SINAQ-----NVCSNDVGNYTSNSAYKTNLNSVLSSIASNAAVD 58
           RL+FF +  LIL +    NAQ       CSN VGNYT+NS YK NLN++L+S++SN  +D
Sbjct: 169 RLLFFLYPILILHLLAVTNAQPRFLSYWCSNGVGNYTNNSTYKANLNTLLTSLSSNNEID 228

Query: 59  YGFYNESAGQEPDKVNVFALCRGDIATDVCRGCLENATQEILRVCPNQKQAIIWSAECML 118
           YGFYN SAGQ  DKVN  ALCRGD+    CR C+ ++  ++ ++CPNQK+AI W   CML
Sbjct: 229 YGFYNFSAGQNSDKVNAIALCRGDVMPTACRSCINDSRIQLTQLCPNQKEAIGWYDNCML 288

Query: 119 RYSNKTIFGVLETGPTYYMWNVNNVTDDVSLFNQALQDLLRRLRGTAASGNSQKKFATGD 178
           RYSN +IFG  ++ P +YM N  N +D V  FNQ L +++  LR  AASG+ ++KFATG+
Sbjct: 289 RYSNDSIFGTQQSSPYFYMRNSKNASD-VEEFNQVLGNMMASLRSKAASGDWRRKFATGE 347

Query: 179 T-TASFRTIYALEQCTPDLSELQCSDCLDRAIGEIPNCCSGKIGGRVLKPSCNFRFETER 237
               SF++IY L QCTPDLSEL CS+CL+ A  EIP CC  + GGRV+KPSCN R+ET R
Sbjct: 348 ANVTSFQSIYGLMQCTPDLSELSCSNCLEGATNEIPTCCDSRKGGRVVKPSCNLRYETYR 407

Query: 238 FYNPTANSPPP-------------SPPPPAEGNGSDTARTVIIILIPTVGFVILII--FI 282
           FY+ TA + PP             +     +   S+++RT+I+I++P+V  +I+I+  FI
Sbjct: 408 FYDFTAANAPPPSPPSADLSPPPLANTTSTQETRSNSSRTIILIIVPSVIILIIILVGFI 467

Query: 283 CFFLRRKPRDNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYK 342
           CFF R++   +S  K E    DEI   ESL FDF+TIRVAT+NFSD+NKLGQGGFG VYK
Sbjct: 468 CFFSRKR---SSMEKLETHDEDEITNVESLHFDFDTIRVATNNFSDSNKLGQGGFGPVYK 524

Query: 343 GRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFV 402
           G+L +G  +AVKRLS  S QG+LEFKNE +LVA LQHRNLVRLLGF L+G ERLLIYEFV
Sbjct: 525 GKLSNGQYVAVKRLSSGSAQGELEFKNEAVLVAKLQHRNLVRLLGFCLDGAERLLIYEFV 584

Query: 403 PNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE 462
           PNTSLDHFIFD  RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLK SN+LLDAE
Sbjct: 585 PNTSLDHFIFDLIRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKASNILLDAE 644

Query: 463 MTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEII 522
           M PKI+DFGMARLF +D+TQG+TSRIVGTYGYMAPEYAMHG +SVK+DV+SFGVLVLE++
Sbjct: 645 MNPKISDFGMARLFLVDQTQGSTSRIVGTYGYMAPEYAMHGHFSVKTDVYSFGVLVLELV 704

Query: 523 SGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQEN 582
           SGQRNNCFR  E +E LLS AWKNWREGT  N+IDPT+   SI+E++RCIHIGLLCVQEN
Sbjct: 705 SGQRNNCFRVSENIEHLLSYAWKNWREGTATNLIDPTMRISSISEIMRCIHIGLLCVQEN 764

Query: 583 VASRPTMASVVLMLNSYSLTLPVPSEPAFFMDSIIESDMSFSLAHDSRITETDQPGCENL 642
            A RPTMAS+ LMLNSYSL+LPVPS PAFFM++ +  DMS  L  +SR+ +++     + 
Sbjct: 765 EADRPTMASIALMLNSYSLSLPVPSHPAFFMNTSMNRDMSLELEDNSRVAQSNYLPSRSS 824

Query: 643 LLSGNNEISITDLYPR 658
             S  NE SITD YPR
Sbjct: 825 HFSV-NEASITDPYPR 839

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356575759|ref|XP_003556004.1| PREDICTED: cysteine-rich receptor-like protein kinase 29-like isoform 1 [Glycine max]

 Score =  811 bits (2096), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 411/675 (60%), Positives = 501/675 (74%), Gaps = 27/675 (4%)

Query: 4   GCSRLVFFFSFLILAVSINAQNVCSND---VGNYTSNSAYKTNLNSVLSSIASNAAVDYG 60
           G S ++ FF F+IL   ++AQ   + D   VGNYT+NS Y TNLN++LS+++SN  ++YG
Sbjct: 20  GVSSMLLFFLFVILISQVSAQLSVTCDYSKVGNYTANSTYNTNLNTLLSTLSSNTEINYG 79

Query: 61  FYNESAGQEPDKVNVFALCRGDIATDVCRGCLENATQEILRVCPNQKQAIIWSAECMLRY 120
           FYN S GQ PD+VN   LCRGD+  D CR CL  A   + + CPNQK+AII    CMLRY
Sbjct: 80  FYNFSHGQSPDRVNAIGLCRGDVEPDKCRSCLNYARSNLTQDCPNQKEAIIHFDNCMLRY 139

Query: 121 SNKTIFGVLETGPTYYMWNVNNVTDDVSLFNQALQDLLRRLRGTAASGNSQKKFATGD-T 179
           SN+TIFG +E  P  YMWN+ N TD V  FNQ L +L+R L+G AASG+S++K+AT D T
Sbjct: 140 SNRTIFGQVENFPGLYMWNLKNATD-VDEFNQVLANLMRNLKGVAASGDSRRKYATDDQT 198

Query: 180 TASFRTIYALEQCTPDLSELQCSDCLDRAIGEIPNCCSGKIGGRVLKPSCNFRFETERFY 239
           + +F TIY L QCTPDLSE QC+DCLD  I EIP CC+ K+GGRV++PSCN R+E  RFY
Sbjct: 199 SGNFETIYGLVQCTPDLSETQCNDCLDGTISEIPTCCNDKVGGRVIRPSCNIRYEVYRFY 258

Query: 240 NPTANSPPP--------------SPPPPAEGNGSDTARTVIIILIPTVGFVILIIFICFF 285
             T    P               SP P   GN      ++++  +  V  + L    C +
Sbjct: 259 EQTTVLDPEIPPSSPAPPPFADTSPEPEESGNTIVIVISIVVPTVVVVLLICL----CLY 314

Query: 286 LRRKPRDNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRL 345
           LRR+    + V  E    DEI  AESLQF+FNTI+VAT++FSD+NKLGQGGFGAVY+GRL
Sbjct: 315 LRRRKARKNLVVKENDVEDEIKIAESLQFNFNTIQVATEDFSDSNKLGQGGFGAVYRGRL 374

Query: 346 YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNT 405
             G  IAVKRLSRDSGQGD EFKNEVLLVA LQHRNLVRLLGF LE NERLL+YEFVPN 
Sbjct: 375 STGQMIAVKRLSRDSGQGDTEFKNEVLLVAKLQHRNLVRLLGFCLERNERLLVYEFVPNK 434

Query: 406 SLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP 465
           SLD+FIFDP  +AQLDW  RYKII GIARGLLYLHEDSRLRIIHRDLK SN+LLD EM+P
Sbjct: 435 SLDYFIFDPNMKAQLDWNSRYKIIRGIARGLLYLHEDSRLRIIHRDLKASNILLDEEMSP 494

Query: 466 KIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           KIADFGMARL  +D+TQ NTSRIVGTYGYMAPEYAMHGQ+SVKSDVFSFGVLVLEI+SGQ
Sbjct: 495 KIADFGMARLVLVDQTQTNTSRIVGTYGYMAPEYAMHGQFSVKSDVFSFGVLVLEILSGQ 554

Query: 526 RNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVAS 585
           +N+ F +GE VEDLLS AW++W+EGT +NI+DP+L++ S  EM+RCIHIGLLCVQEN+A 
Sbjct: 555 KNSGFHHGENVEDLLSFAWRSWKEGTAINIVDPSLNNNSRNEMMRCIHIGLLCVQENLAD 614

Query: 586 RPTMASVVLMLNSYSLTLPVPSEPAFFMDSIIES--DMSFSLAHDSRITETDQPGCENLL 643
           RPTMA+++LMLNSYSL+LP+P++PAF+M+S   S  DM  S  ++SR T + +   ++  
Sbjct: 615 RPTMATIMLMLNSYSLSLPIPAKPAFYMNSRTGSLPDMQ-SWEYNSRETGSSESIIKSAQ 673

Query: 644 LSGNNEISITDLYPR 658
            S  NE SIT+LY R
Sbjct: 674 ES-ENEASITELYAR 687

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356575761|ref|XP_003556005.1| PREDICTED: cysteine-rich receptor-like protein kinase 29-like isoform 2 [Glycine max]

 Score =  804 bits (2077), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 412/676 (60%), Positives = 500/676 (73%), Gaps = 37/676 (5%)

Query: 4   GCSRLVFFFSFLILAVSINAQNVCSND---VGNYTSNSAYKTNLNSVLSSIASNAAVDYG 60
           G S ++ FF F+IL   ++AQ   + D   VGNYT+NS Y TNLN++LS+++SN  ++YG
Sbjct: 20  GVSSMLLFFLFVILISQVSAQLSVTCDYSKVGNYTANSTYNTNLNTLLSTLSSNTEINYG 79

Query: 61  FYNESAGQEPDKVNVFALCRGDIATDVCRGCLENATQEILRVCPNQKQAIIWSAECMLRY 120
           FYN S GQ PD+VN   LCRGD+  D CR CL  A   + + CPNQK+AII    CMLRY
Sbjct: 80  FYNFSHGQSPDRVNAIGLCRGDVEPDKCRSCLNYARSNLTQDCPNQKEAIIHFDNCMLRY 139

Query: 121 SNKTIFGVLETGPTYYMWNVNNVTDDVSLFNQALQDLLRRLRGTAASGNSQKKFATGD-T 179
           SN+TIFG +E  P  YMWN+ N TD V  FNQ L +L+R L+G AASG+S++K+AT D T
Sbjct: 140 SNRTIFGQVENFPGLYMWNLKNATD-VDEFNQVLANLMRNLKGVAASGDSRRKYATDDQT 198

Query: 180 TASFRTIYALEQCTPDLSELQCSDCLDRAIGEIPNCCSGKIGGRVLKPSCNFRFETERFY 239
           + +F TIY L QCTPDLSE QC+DCLD  I EIP CC+ K+GGRV++PSCN R+E  RFY
Sbjct: 199 SGNFETIYGLVQCTPDLSETQCNDCLDGTISEIPTCCNDKVGGRVIRPSCNIRYEVYRFY 258

Query: 240 NPTANSPPP--------------SPPPPAEGNGSDTARTVIIILIPTVGFVILIIFICFF 285
             T    P               SP P   GN      ++++  +  V  + L    C +
Sbjct: 259 EQTTVLDPEIPPSSPAPPPFADTSPEPEESGNTIVIVISIVVPTVVVVLLICL----CLY 314

Query: 286 LRR-KPRDNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGR 344
           LRR K R N          DEI  AESLQF+FNTI+VAT++FSD+NKLGQGGFGAVY+GR
Sbjct: 315 LRRRKARKNL---------DEIKIAESLQFNFNTIQVATEDFSDSNKLGQGGFGAVYRGR 365

Query: 345 LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPN 404
           L  G  IAVKRLSRDSGQGD EFKNEVLLVA LQHRNLVRLLGF LE NERLL+YEFVPN
Sbjct: 366 LSTGQMIAVKRLSRDSGQGDTEFKNEVLLVAKLQHRNLVRLLGFCLERNERLLVYEFVPN 425

Query: 405 TSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMT 464
            SLD+FIFDP  +AQLDW  RYKII GIARGLLYLHEDSRLRIIHRDLK SN+LLD EM+
Sbjct: 426 KSLDYFIFDPNMKAQLDWNSRYKIIRGIARGLLYLHEDSRLRIIHRDLKASNILLDEEMS 485

Query: 465 PKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           PKIADFGMARL  +D+TQ NTSRIVGTYGYMAPEYAMHGQ+SVKSDVFSFGVLVLEI+SG
Sbjct: 486 PKIADFGMARLVLVDQTQTNTSRIVGTYGYMAPEYAMHGQFSVKSDVFSFGVLVLEILSG 545

Query: 525 QRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVA 584
           Q+N+ F +GE VEDLLS AW++W+EGT +NI+DP+L++ S  EM+RCIHIGLLCVQEN+A
Sbjct: 546 QKNSGFHHGENVEDLLSFAWRSWKEGTAINIVDPSLNNNSRNEMMRCIHIGLLCVQENLA 605

Query: 585 SRPTMASVVLMLNSYSLTLPVPSEPAFFMDSIIES--DMSFSLAHDSRITETDQPGCENL 642
            RPTMA+++LMLNSYSL+LP+P++PAF+M+S   S  DM  S  ++SR T + +   ++ 
Sbjct: 606 DRPTMATIMLMLNSYSLSLPIPAKPAFYMNSRTGSLPDMQ-SWEYNSRETGSSESIIKSA 664

Query: 643 LLSGNNEISITDLYPR 658
             S  NE SIT+LY R
Sbjct: 665 QES-ENEASITELYAR 679

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224076544|ref|XP_002304959.1| predicted protein [Populus trichocarpa] gi|222847923|gb|EEE85470.1| predicted protein [Populus trichocarpa]

 Score =  801 bits (2070), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 418/656 (63%), Positives = 511/656 (77%), Gaps = 24/656 (3%)

Query: 19  VSINAQ-----NVCSNDVGNYTSNSAYKTNLNSVLSSIASNAAVDYGFYNESAGQEPDKV 73
           V I AQ     ++C  + GNYT NS Y+ NL  +L+S+ SN  +DYGFYN S G+  DKV
Sbjct: 5   VPITAQPEINFHLCVAENGNYTENSTYQANLKYLLNSVYSNTEIDYGFYNFSYGESSDKV 64

Query: 74  NVFALCRGDIATDVCRGCLENATQEILRVCPNQKQAIIWSAECMLRYSNKTIFGVLETGP 133
               LCRGD+  D CR CL  +++ +  +CP QK+AII    C+LRY++++IFG+ E  P
Sbjct: 65  YAIGLCRGDVKPDACRDCLNYSSRVLTALCPTQKEAIIGFDSCILRYASRSIFGLNEVAP 124

Query: 134 TYYMWNVNNVTDDVSLFNQALQDLLRRLRGTAASGNSQKKFATGDTTA-SFRTIYALEQC 192
            ++++++ NV+D+   FN++L  LL  L+  AA+G+S++K+AT   +A +F+TIYAL QC
Sbjct: 125 YFFVYSLTNVSDEKG-FNRSLNSLLDSLQDEAAAGDSRRKYATRKISAPNFQTIYALSQC 183

Query: 193 TPDLSELQCSDCLDRAIGEIPNCCSGKIGGRVLKPSCNFRFETERFYN-------PTANS 245
           TPDLS+ +CS CL  A   +  CC  + GGRV+ PSCNFR+E  +FY            S
Sbjct: 184 TPDLSQTECSSCLRNASARVGQCCQERQGGRVIYPSCNFRYEINQFYEIPIGEDPSPPPS 243

Query: 246 PPPSPPPPAEGNGSDTARTVIIILIPTVGFVILII-FICFFLR-RKPRDNSKVKSEAAAG 303
             P PPPPAEG   + ART+III++ TV  VIL+I  IC +LR RKP +  KV++     
Sbjct: 244 KVPPPPPPAEGKKRNNARTIIIIVVSTVSVVILMISCICLYLRIRKPEE--KVETV---- 297

Query: 304 DEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQG 363
           +E+  AESLQFDF+TIR ATDNFS+ NKLGQGGFG+VYKG L +G E+AVKRLS+DSGQG
Sbjct: 298 EEMITAESLQFDFSTIRAATDNFSEENKLGQGGFGSVYKGTLSNGQEVAVKRLSKDSGQG 357

Query: 364 DLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWE 423
           DLEFKNEVLLVA LQHRNLVRL GF L+G ERLLIYEFVPN SLDHFIF+  RRAQLDWE
Sbjct: 358 DLEFKNEVLLVAKLQHRNLVRLQGFCLQGIERLLIYEFVPNASLDHFIFNQARRAQLDWE 417

Query: 424 RRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQG 483
           RRYKIIGGIARGLLYLHEDSRLRIIHRDLK SN+LLDA+M PKI+DFGMARLF MDETQG
Sbjct: 418 RRYKIIGGIARGLLYLHEDSRLRIIHRDLKASNILLDADMNPKISDFGMARLFVMDETQG 477

Query: 484 NTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSA 543
           NTSRIVGTYGYMAPEYAMHGQ+SVKSDVFSFGVL+LEI+SGQ+NNCFRNGETVEDLLS A
Sbjct: 478 NTSRIVGTYGYMAPEYAMHGQFSVKSDVFSFGVLILEIVSGQKNNCFRNGETVEDLLSYA 537

Query: 544 WKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTL 603
           W+NWREGT +N+IDP LS+GS TEM+RCIHIGLLCVQEN+A RPTMAS+VLML+SYSLTL
Sbjct: 538 WRNWREGTGLNVIDPALSTGSRTEMMRCIHIGLLCVQENIADRPTMASIVLMLSSYSLTL 597

Query: 604 PVPSEPAFFMD-SIIESDMSFSLAHDSRITETDQPGCENLLLSGNNEISITDLYPR 658
           PVPS+PAFFM+ S  +SD+S S+ ++SR+T + +   E L LS  NE SIT+LYPR
Sbjct: 598 PVPSQPAFFMNSSTYQSDISSSMDYNSRVTNSSEAKTEALPLSA-NEASITELYPR 652

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224113941|ref|XP_002316621.1| predicted protein [Populus trichocarpa] gi|222859686|gb|EEE97233.1| predicted protein [Populus trichocarpa]

 Score =  798 bits (2061), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 422/643 (65%), Positives = 501/643 (77%), Gaps = 23/643 (3%)

Query: 32  GNYTSNSAYKTNLNSVLSSIASNAAVDYGFYNESAGQEPDKVNVFALCRGDIATDVCRGC 91
           GNYT+NS Y+ NLNS+LSS+AS+  +DYGFYN S G+ PD+VN  ALCRGD+A DVCR C
Sbjct: 2   GNYTTNSTYQRNLNSLLSSLASDTQIDYGFYNLSVGEFPDRVNAIALCRGDVAVDVCRSC 61

Query: 92  LENATQEILRVCPNQKQAIIWSAECMLRYSNKTIFGVLETGPTYYMWNVNNVTDDVSLFN 151
           + ++T +IL VCPN+ +A      CM+RYSN++IFGV+   P  Y  N  NV D V+LFN
Sbjct: 62  VNDSTHKILEVCPNKMEAFGVYELCMIRYSNRSIFGVVNEEPYIYRANRKNVLD-VTLFN 120

Query: 152 QALQDLLRRLRGTAASGNSQKKFATGDTTASFRTIYALEQCTPDLSELQCSDCLDRAIGE 211
           QALQ L  RL+  AASGNS KKFATG+ +A   T+YA+ QCTPDLSE QCS CL      
Sbjct: 121 QALQTLFARLQAKAASGNSLKKFATGNQSAGVETVYAIVQCTPDLSEGQCSSCLLDVFRM 180

Query: 212 IPNCC----SGKIGGRVLKPSCNFRFETERFYNPT----------ANSPPPSPPPPAEGN 257
           IPNCC     GKIG R++KPSCN R+E  +F+N T            S P S P PA+G 
Sbjct: 181 IPNCCDGNVQGKIGVRLIKPSCNLRWEIGKFFNGTLEILPSPPPPQISSPTSLPAPAQGK 240

Query: 258 GSDTARTVIIILIPTVGFVILIIFICFFLR-RKPRDNSKVKSEAAAGDEINRAESLQFDF 316
            S+TAR ++I ++P VG +IL+I IC F+R RK R+  +V++     DEI  AESLQF F
Sbjct: 241 KSNTARIIVITVVPAVGVMILVICICLFIRTRKQREKERVETV----DEIESAESLQFAF 296

Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVAN 376
           +TIR AT++FS+ NKLGQGGFGAVYKG L  G EIAVKRLS+DSGQGDLEFKNEVLLVA 
Sbjct: 297 STIRDATEDFSEKNKLGQGGFGAVYKGALPSGQEIAVKRLSKDSGQGDLEFKNEVLLVAR 356

Query: 377 LQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGL 436
           LQHRNLVRLLGF L+G ERLLIYEFVPN SLDHFIFDP +R  L+WERRYKIIGGIARGL
Sbjct: 357 LQHRNLVRLLGFCLQGIERLLIYEFVPNASLDHFIFDPIKRVHLNWERRYKIIGGIARGL 416

Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMA 496
           LYLHEDSRLRIIHRDLK SN+LLD EM PKI+DFGMARLF +D+TQGNTSRIVGTYGYMA
Sbjct: 417 LYLHEDSRLRIIHRDLKASNILLDEEMNPKISDFGMARLFVVDQTQGNTSRIVGTYGYMA 476

Query: 497 PEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNII 556
           PEYAM G +SVKSDVFSFGVLVLEI++G++N+ FRNG  +E LLS AW+NWREGT  ++I
Sbjct: 477 PEYAMQGHFSVKSDVFSFGVLVLEIVTGKKNS-FRNGNDIEHLLSHAWRNWREGTAQDMI 535

Query: 557 DPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTLPVPSEPAFFMD-S 615
           DP LSSGS TEM+RCIHIGLLCVQENVA RPTMASVVLML+S SLTL +PS+PAFFM+ S
Sbjct: 536 DPVLSSGSATEMMRCIHIGLLCVQENVAERPTMASVVLMLSSSSLTLQIPSQPAFFMNSS 595

Query: 616 IIESDMSFSLAHDSRITETDQPGCENLLLSGNNEISITDLYPR 658
             +SD+S S+ H+SR+TE+     E + LS  NE+SIT+LYPR
Sbjct: 596 TYQSDLSSSMGHNSRVTESSLCESEAIPLS-ENEVSITELYPR 637

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255555051|ref|XP_002518563.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223542408|gb|EEF43950.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  798 bits (2060), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 388/620 (62%), Positives = 473/620 (76%), Gaps = 20/620 (3%)

Query: 29  NDVGNYTSNSAYKTNLNSVLSS-IASNAAVDYGFYNESAGQEPDKVNVFALCRGDIATDV 87
           N++GNYT+NS Y+ NLN++LS  + SN  +DYGFYN S GQ PD+VN  ALC+GD++ D 
Sbjct: 2   NNLGNYTTNSTYQRNLNNLLSQFLVSNTQIDYGFYNLSVGQAPDQVNALALCKGDVSLDE 61

Query: 88  CRGCLENATQEILRVCPNQKQAIIWSAECMLRYSNKTIFGVLETGPTYYMWNVNNVTDDV 147
           CRGC+ N+T+EI + CPNQK+ + +   CM RYSN++IFGV+ET PT +M N  NVTD V
Sbjct: 62  CRGCIRNSTREITQHCPNQKEVLGFYDSCMFRYSNRSIFGVMETQPTIHMKNEENVTD-V 120

Query: 148 SLFNQALQDLLRRLRGTAASGNSQKKFATGDTTASFRTIYALEQCTPDLSELQCSDCLDR 207
           + FNQALQ LL RLR  AA+GNS +KFATG+ +A F TI+ L QCTPD++E  C+DC+  
Sbjct: 121 NQFNQALQTLLSRLRSKAAAGNSTRKFATGNESAGFETIFGLMQCTPDITEQDCNDCIVA 180

Query: 208 AIGEIPNCCSGKIGGRVLKPSCNFRFETERFYNPTANS----------PPPSPPPPAEGN 257
           A  +IP CC+GK+GGRV+KPSCNFR+E  RFY PT++           P  SPP P EGN
Sbjct: 181 ATRDIPICCNGKLGGRVIKPSCNFRYENYRFYQPTSDDDATHPSLPVDPSVSPPAPKEGN 240

Query: 258 GSDTARTVIIILIPTVGFVILIIFICFFLRRKPRDNSKVKSEAAAGDEINRAESLQFDFN 317
                R +III++ TV  V LII +  F++ +     K +      +EI   ESLQFDF 
Sbjct: 241 NR---RNIIIIVVLTVSIVSLIICVGIFIKVR-----KARKRIETAEEIMNVESLQFDFE 292

Query: 318 TIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANL 377
           TIR+ TD+FS+ NKLG+GGFG+VYKG L  G +IAVKRLS  S QGDLEFKNEVLLVA L
Sbjct: 293 TIRICTDDFSEENKLGEGGFGSVYKGTLPMGQDIAVKRLSNGSKQGDLEFKNEVLLVAKL 352

Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           QHRNLVRLLGF L+G ERLLIYEFVPN SLD +IFDP R  QLDWE+RYKIIGGIARGLL
Sbjct: 353 QHRNLVRLLGFCLQGIERLLIYEFVPNASLDQYIFDPVRCVQLDWEKRYKIIGGIARGLL 412

Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           YLHEDSRLRIIHRDLK SN+LLD++M PKI+DFGMARLF MD+T  NTSRIVGT+GYMAP
Sbjct: 413 YLHEDSRLRIIHRDLKASNILLDSDMNPKISDFGMARLFIMDQTHSNTSRIVGTFGYMAP 472

Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID 557
           EYAMHGQ+S KSD+FSFGVL+LEI+SG RN+C+ N  T+EDLLS AWKNW EGT+ N+ID
Sbjct: 473 EYAMHGQFSFKSDIFSFGVLILEIVSGIRNSCYYNEGTMEDLLSYAWKNWGEGTSSNLID 532

Query: 558 PTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTLPVPSEPAFFMDSII 617
             L SGS  E++RCIHIGLLCVQEN+A RP++AS+VLML+S+S TLPVPS+PAF+M S  
Sbjct: 533 HNLRSGSTAEIMRCIHIGLLCVQENIAERPSVASIVLMLSSHSHTLPVPSQPAFYMYSST 592

Query: 618 ESDMSFSLAHDSRITETDQP 637
           E  M  S+ +   I  T  P
Sbjct: 593 EISMLPSINNSRVINTTRAP 612

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255555047|ref|XP_002518561.1| ATP binding protein, putative [Ricinus communis] gi|223542406|gb|EEF43948.1| ATP binding protein, putative [Ricinus communis]

 Score =  794 bits (2051), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 391/603 (64%), Positives = 468/603 (77%), Gaps = 11/603 (1%)

Query: 24  QNVCSNDVGNYTSNSAYKTNLNSVLSSIASNAAVDYGFYNESAGQEPDKVNVFALCRGDI 83
           Q  C N  GNYT+N+ YK NL+++LSS+AS+  +DYGFYN S G+ P++VN  ALCRGD+
Sbjct: 29  QQSCDNSRGNYTANTPYKANLDNILSSLASDTEIDYGFYNLSIGESPNQVNAIALCRGDV 88

Query: 84  ATDVCRGCLENATQEILRVCPNQKQAIIWSAECMLRYSNKTIFGVLETGPTYYMWNVNNV 143
             D CRGC+ N+T++I  VCPNQ  A      C LRYSN++I GV+E  P  Y+ NVNN 
Sbjct: 89  GVDNCRGCISNSTRKITEVCPNQIDAFGIYDFCTLRYSNRSILGVVEGSPILYLINVNNA 148

Query: 144 TDDVSLFNQALQDLLRRLRGTAASGNSQKKFATGDTTASFRTIYALEQCTPDLSELQCSD 203
           +D VS + QAL  LL RLR    SG+S +KFATG+ TA F  +YAL QCTPDL+E +C  
Sbjct: 149 SD-VSQYTQALTALLDRLRSETTSGDSVRKFATGNETAGFERVYALMQCTPDLTEEECDV 207

Query: 204 CLDRAIGEIPNCCSGKIGGRVLKPSCNFRFETERFYNPTANSPPPSPPPPA---EGNGSD 260
           CL +AI EI +CC+G+ G  V KPSC+ RFE   FY  T     P P PPA   E   S+
Sbjct: 208 CLGQAISEIGSCCAGRTGAAVFKPSCHVRFEEYLFYTSTPPPVSPVPTPPAPPIEEKKSN 267

Query: 261 TARTVIIILIPTVGFVILIIFICFFLR-RKPRDNSKVKSEAAAGDEINRAESLQFDFNTI 319
            +RT+I I++PTV  +I II  C FLR R+PR       +A   +E+   ES Q DF T+
Sbjct: 268 KSRTIIAIIVPTVSVLIFIISFCIFLRKRRPR------KKAETVEEMESPESFQLDFGTV 321

Query: 320 RVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQH 379
           RVATDNFS+ NKLGQGGFGAVYKG LY+G +IAVKRLS++S QGDLEFKNE+LLVA LQH
Sbjct: 322 RVATDNFSEENKLGQGGFGAVYKGTLYNGQDIAVKRLSKNSEQGDLEFKNEILLVAKLQH 381

Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
           RNLVRLLGF LE NERLLIYEF+PNTSLDHF+FD T+   LDWERRYKII GIARGLLYL
Sbjct: 382 RNLVRLLGFCLERNERLLIYEFMPNTSLDHFLFDQTKHESLDWERRYKIICGIARGLLYL 441

Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
           HEDS++RIIHRDLKTSN+LLD +M PKIADFGMARLF +D+TQGNTSRIVGTYGYMAPEY
Sbjct: 442 HEDSQIRIIHRDLKTSNILLDMDMNPKIADFGMARLFVIDQTQGNTSRIVGTYGYMAPEY 501

Query: 500 AMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT 559
           AMHGQ+S+KSDVFSFGVL+LEI+SG++N+ F NGE +EDLLS AW+NWREGT++N+IDP+
Sbjct: 502 AMHGQFSIKSDVFSFGVLLLEILSGKKNSSFHNGERIEDLLSYAWRNWREGTSMNVIDPS 561

Query: 560 LSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTLPVPSEPAFFMDSIIES 619
           L SGS +EM+RCI IGLLCVQENVA RPTMA+VVLMLNSYSLTLPVP  PAFFM + I  
Sbjct: 562 LKSGSSSEMMRCIQIGLLCVQENVADRPTMATVVLMLNSYSLTLPVPLRPAFFMHTGIHL 621

Query: 620 DMS 622
           D+S
Sbjct: 622 DVS 624

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	658
TAIR|locus:2141201	679	CRK29 "cysteine-rich RLK (RECE	0.560	0.543	0.602	1.2e-162
TAIR|locus:2121676	669	CRK10 "cysteine-rich RLK (RECE	0.957	0.941	0.485	1.7e-160
TAIR|locus:2141762	665	CRK26 "cysteine-rich RLK (RECE	0.937	0.927	0.494	1.1e-158
TAIR|locus:2121651	676	CRK8 "cysteine-rich RLK (RECEP	0.966	0.940	0.476	1.7e-153
TAIR|locus:2115728	675	CRK25 "cysteine-rich RLK (RECE	0.968	0.943	0.469	1.1e-151
TAIR|locus:2127323	642	CRK27 "cysteine-rich RLK (RECE	0.937	0.961	0.484	5.2e-149
TAIR|locus:2121636	659	CRK7 "cysteine-rich RLK (RECEP	0.911	0.910	0.464	4e-145
TAIR|locus:2121686	645	CRK19 "cysteine-rich RLK (RECE	0.911	0.930	0.473	2.8e-144
TAIR|locus:2134603	665	CRK41 "cysteine-rich RLK (RECE	0.876	0.867	0.497	1.2e-143
TAIR|locus:2121626	830	CRK23 "cysteine-rich RLK (RECE	0.544	0.431	0.551	8.1e-140

TAIR|locus:2141201 CRK29 "cysteine-rich RLK (RECEPTOR-like protein kinase) 29" [Arabidopsis thaliana (taxid:3702)]

 Score = 1126 (401.4 bits), Expect = 1.2e-162, Sum P(2) = 1.2e-162
 Identities = 230/382 (60%), Positives = 283/382 (74%)

Query:   256 GNGSDTARTVIIILIPTVGXXXXXXXXXXXXR-RKPRDNSKVK-------SEAAAGDEIN 307
             G G   ++ +I I+IP +             + RK +   K K       S + A DE +
Sbjct:   279 GKGKGGSKVIIAIVIPILLVALLAICLCLVLKWRKNKSGYKNKVLGKSPLSGSIAEDEFS 338

Query:   308 RAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEF 367
               ESL   F T++ ATDNFS  N+LG+GGFG+VYKG    G EIAVKRLS +SGQGD EF
Sbjct:   339 NTESLLVHFETLKTATDNFSSENELGRGGFGSVYKGVFPQGQEIAVKRLSGNSGQGDNEF 398

Query:   368 KNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYK 427
             KNE+LL+A LQHRNLVRL+GF ++G ERLL+YEF+ N SLD FIFD  +R  LDW  RYK
Sbjct:   399 KNEILLLAKLQHRNLVRLIGFCIQGEERLLVYEFIKNASLDQFIFDTEKRQLLDWVVRYK 458

Query:   428 IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN--T 485
             +IGGIARGLLYLHEDSR RIIHRDLK SN+LLD EM PKIADFG+A+LF+  +T  +  T
Sbjct:   459 MIGGIARGLLYLHEDSRFRIIHRDLKASNILLDQEMNPKIADFGLAKLFDSGQTMTHRFT 518

Query:   486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCF-RNG-ETVEDLLSSA 543
             SRI GTYGYMAPEYAMHGQ+SVK+DVFSFGVLV+EII+G+RNN    NG E  EDLLS  
Sbjct:   519 SRIAGTYGYMAPEYAMHGQFSVKTDVFSFGVLVIEIITGKRNNNGGSNGDEDAEDLLSWV 578

Query:   544 WKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTL 603
             W++WRE T +++IDP+L++GS  E++RCIHIGLLCVQE+ A+RPTMA+V LMLNSYS TL
Sbjct:   579 WRSWREDTILSVIDPSLTAGSRNEILRCIHIGLLCVQESAATRPTMATVSLMLNSYSFTL 638

Query:   604 PVPSEPAFFMDSI-IESDMSFS 624
             P P  PAF ++S+ I S++S S
Sbjct:   639 PTPLRPAFVLESVVIPSNVSSS 660

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005773 "vacuole" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 1563 (555.3 bits), Expect = 1.7e-160, P = 1.7e-160
 Identities = 325/669 (48%), Positives = 432/669 (64%)

Query:     9 VFFFSFLILAVSINAQN------VCSNDVGNYTSNSAYKTNLNSVLSSIAS-NAAVDYGF 61
             +F FSFL  +  ++AQ+       C N   NYTSNS Y  NL ++L+S++S NA+   GF
Sbjct:    21 LFLFSFLT-SFRVSAQDPTYVYHTCQN-TANYTSNSTYNNNLKTLLASLSSRNASYSTGF 78

Query:    62 YNESAGQEPDKVNVFALCRGDIATDVCRGCLENATQEILRVCPNQKQAIIWSAECMLRYS 121
              N + GQ PD+V     CRGD++T+VCR C+  A  + L  CPNQK+A ++  EC+LRYS
Sbjct:    79 QNATVGQAPDRVTGLFNCRGDVSTEVCRRCVSFAVNDTLTRCPNQKEATLYYDECVLRYS 138

Query:   122 NKTIFGVLETGPTYYMWNVNNVTDD-VSLFNQALQDLLRRLRGTAASGNSQKKFATGDTT 180
             N+ I   L T     + N  NVT + + L +  +   L +    A   NS KKF T    
Sbjct:   139 NQNILSTLITTGGVILVNTRNVTSNQLDLLSDLVLPTLNQAATVAL--NSSKKFGTRKNN 196

Query:   181 -ASFRTIYALEQCTPDLSELQCSDCLDRAIGEIPNCCSGKIGGRVLKPSCNFRFETERFY 239
               + ++ Y L QCTPDL+   CS CL   I +IP   + +IG R++ PSC  R+E   FY
Sbjct:   197 FTALQSFYGLVQCTPDLTRQDCSRCLQLVINQIP---TDRIGARIINPSCTSRYEIYAFY 253

Query:   240 N-------PTANXXXXXXXXXAEGNGSD-TARTVII-ILIPTVGXXXXXXXXXXXXRRKP 290
                     P               +G D  ++ ++I I++P +              R+ 
Sbjct:   254 TESAVPPPPPPPSISTPPVSAPPRSGKDGNSKVLVIAIVVPIIVAVLLFIAGYCFLTRRA 313

Query:   291 RDNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAE 350
             R +    S A AGD+I  A+SLQ D+ TI+ ATD+F ++NK+GQGGFG VYKG L DG E
Sbjct:   314 RKSYYTPS-AFAGDDITTADSLQLDYRTIQTATDDFVESNKIGQGGFGEVYKGTLSDGTE 372

Query:   351 IAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF 410
             +AVKRLS+ SGQG++EFKNEV+LVA LQHRNLVRLLGF L+G ER+L+YE+VPN SLD+F
Sbjct:   373 VAVKRLSKSSGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYF 432

Query:   411 IFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADF 470
             +FDP ++ QLDW RRYKIIGG+ARG+LYLH+DSRL IIHRDLK SN+LLDA+M PKIADF
Sbjct:   433 LFDPAKKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADF 492

Query:   471 GMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCF 530
             GMAR+F +D+T+ NTSRIVGTYGYM+PEYAMHGQYS+KSDV+SFGVLVLEIISG++N+ F
Sbjct:   493 GMARIFGLDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSF 552

Query:   531 RNGETVEDLLSSAWKNWREGTTVNIIDPTLSSG-SITEMIRCIHIGLLCVQENVASRPTM 589
                +   DL+S AW  W  G  + ++DP +       E++RC+HIGLLCVQE+ A RPT+
Sbjct:   553 YQTDGAHDLVSYAWGLWSNGRPLELVDPAIVENCQRNEVVRCVHIGLLCVQEDPAERPTL 612

Query:   590 ASVVLMLNSYSLTLPVPSEPAFFMDSIIESDMSFSLAHDSRITETDQPGCENLLLSGNNE 649
             +++VLML S ++TLPVP +P  F  S I  D            +TD       LL   ++
Sbjct:   613 STIVLMLTSNTVTLPVPRQPGLFFQSRIGKDP----------LDTDTTS--KSLLGSVDD 660

Query:   650 ISITDLYPR 658
              SITD++PR
Sbjct:   661 ASITDIHPR 669

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

TAIR|locus:2141762 CRK26 "cysteine-rich RLK (RECEPTOR-like protein kinase) 26" [Arabidopsis thaliana (taxid:3702)]

 Score = 1546 (549.3 bits), Expect = 1.1e-158, P = 1.1e-158
 Identities = 314/635 (49%), Positives = 423/635 (66%)

Query:    14 FLILAVSINAQNVCSNDVGNYTSNSAYKTNLNSVLSSIASNAAVDYGFYNESAGQEPDKV 73
             F + +  +    +CSN  GN+T N+ Y  NL+ ++SS++S      GFYN S G   +KV
Sbjct:    18 FTVKSQPVPLNQICSNVTGNFTVNTPYAVNLDRLISSLSSLRRNVNGFYNISVGDSDEKV 77

Query:    74 NVFALCRGDIATDVCRGCLENATQEILRVCPNQKQAIIWSAECMLRYSNKTIFGVLETGP 133
             N  + CRGD+  +VC  C+  A + ++ +CP QK+AIIW  +C  RYSN+TIF  LE  P
Sbjct:    78 NSISQCRGDVKLEVCINCIAMAGKRLVTLCPVQKEAIIWYDKCTFRYSNRTIFNRLEISP 137

Query:   134 TYYMWNVNNVTDDVSLFNQALQDLLRRLRGTAAS-GNSQKKFATGDTTA-SFRTIYALEQ 191
                +    N T D   + ++L+ LL  L+  A+  G S+K F  G+T+  SF+T++ L Q
Sbjct:   138 HTSITGTRNFTGDRDSWEKSLRGLLEGLKNRASVIGRSKKNFVVGETSGPSFQTLFGLVQ 197

Query:   192 CTPDLSELQCSDCLDRAIGEIPNCCSGKIGGRVLKPSCNFRFETERFYNPTANXXXXXXX 251
             CTPD+SE  CS CL + I +IP+CC  K+G  V+ PSC   +   RFY+P          
Sbjct:   198 CTPDISEEDCSYCLSQGIAKIPSCCDMKMGSYVMSPSCMLAYAPWRFYDPVDTDDPSSVP 257

Query:   252 XXAEGNGSDTARTV------------IIILIPTVGXXXXXXXXXXXXRRKPRDNSKVKSE 299
                     +  R+V            +I    +V              +  R  +   SE
Sbjct:   258 ATPSRPPKNETRSVTQGDKNRGVPKALIFASASVAIVVLFIVLLVVFLKLRRKENIRNSE 317

Query:   300 AAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRD 359
                 +E    +S++FDF+ ++ AT +FS  NKLG+GGFGAVYKG L DG +IAVKRLS++
Sbjct:   318 NKHENENISTDSMKFDFSVLQDATSHFSLENKLGEGGFGAVYKGVLSDGQKIAVKRLSKN 377

Query:   360 SGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQ 419
             + QG+ EFKNE LLVA LQHRNLV+LLG+S+EG ERLL+YEF+P+TSLD FIFDP +  +
Sbjct:   378 AQQGETEFKNEFLLVAKLQHRNLVKLLGYSIEGTERLLVYEFLPHTSLDKFIFDPIQGNE 437

Query:   420 LDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD 479
             L+WE RYKIIGG+ARGLLYLH+DSRLRIIHRDLK SN+LLD EMTPKIADFGMARLF++D
Sbjct:   438 LEWEIRYKIIGGVARGLLYLHQDSRLRIIHRDLKASNILLDEEMTPKIADFGMARLFDID 497

Query:   480 ET-QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVED 538
              T Q  T+RIVGT+GYMAPEY MHGQ+S K+DV+SFGVLVLEIISG++N+ F + +++ D
Sbjct:   498 HTTQRYTNRIVGTFGYMAPEYVMHGQFSFKTDVYSFGVLVLEIISGKKNSGFSSEDSMGD 557

Query:   539 LLSSAWKNWREGTTVNIIDP---TLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM 595
             L+S AW+NW+EG  +N++D    T+SS S   ++RCI+IGLLCVQE VA RP+MASVVLM
Sbjct:   558 LISFAWRNWKEGVALNLVDKILMTMSSYSSNMIMRCINIGLLCVQEKVAERPSMASVVLM 617

Query:   596 LNSYSLTLPVPSEPAFFMDSIIESDMSFSLAHDSR 630
             L+ +++ L  PS+PAFF  S   SD S SL H+++
Sbjct:   618 LDGHTIALSEPSKPAFFSHSNAVSDSSSSLGHNAK 652

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

TAIR|locus:2121651 CRK8 "cysteine-rich RLK (RECEPTOR-like protein kinase) 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 1497 (532.0 bits), Expect = 1.7e-153, P = 1.7e-153
 Identities = 323/678 (47%), Positives = 437/678 (64%)

Query:     5 CSRLVFFFSFLILAVSINAQN--VCSNDVGN---YTSNSAYKTNLNSVLSSIAS-NAAVD 58
             C   +F FSFL  +   +AQN    ++D  N   Y+SNS Y TNL ++LSS AS NA+  
Sbjct:    17 CFIFLFLFSFLT-SFKASAQNPFYLNHDCPNRTTYSSNSTYSTNLKTLLSSFASRNASYS 75

Query:    59 YGFYNESAGQEPDKVNVFALCRGDIATDVCRGCLENATQEILRVCPNQKQAIIWSAECML 118
              GF N  AGQ PD+V    LCRGD++ +VC  C+  +  E L  CPNQ++A+ +  EC+L
Sbjct:    76 TGFQNIRAGQTPDRVTGLFLCRGDLSPEVCSNCVAFSVNESLTRCPNQREAVFYYEECIL 135

Query:   119 RYSNKTIFGVLETGPTYYMWNVNNVTDDVSLFNQALQ--DLLRRLRGTAAS--GNSQKKF 174
             RYS+K     +       M N NN++   S+ NQ  Q  DL++     AA+   NS +KF
Sbjct:   136 RYSHKNFLSTVTYEGELIMRNPNNIS---SIQNQRDQFIDLVQSNMNQAANEAANSSRKF 192

Query:   175 ATGDTT-ASFRTIYALEQCTPDLSELQCSDCLDRAIGEIPNCCSGKIGGRVLKPSCNFRF 233
             +T  T   S +T+Y L QCTPDL+   C  CL  +I  +      +IG R   PSCN R+
Sbjct:   193 STIKTELTSLQTLYGLVQCTPDLARQDCFSCLTSSINRMMPLF--RIGARQFWPSCNSRY 250

Query:   234 ETERFYNPTA-----------NXXXXXXXXXAEG-NGSDTARTVIIILIPTVGXXXXXXX 281
             E   FYN TA                       G +G+ T   V I+++  +        
Sbjct:   251 ELYAFYNETAIGTPSPPPLFPGSTPPLTSPSIPGKSGNSTVLVVAIVVLAVLLFIALVGY 310

Query:   282 XXXXXRRKPRDNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVY 341
                  R K   ++   SE   GD++  A+SLQ D+ TI+ AT++F+++NK+G+GGFG VY
Sbjct:   311 CFLAQRTKKTFDTASASEV--GDDMATADSLQLDYRTIQTATNDFAESNKIGRGGFGEVY 368

Query:   342 KGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF 401
             KG   +G E+AVKRLS++S QG+ EFK EV++VA LQHRNLVRLLGFSL+G ER+L+YE+
Sbjct:   369 KGTFSNGKEVAVKRLSKNSRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEY 428

Query:   402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDA 461
             +PN SLD  +FDPT++ QLDW +RY IIGGIARG+LYLH+DSRL IIHRDLK SN+LLDA
Sbjct:   429 MPNKSLDCLLFDPTKQTQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDA 488

Query:   462 EMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEI 521
             ++ PKIADFGMAR+F +D+TQ NTSRIVGTYGYMAPEYAMHGQ+S+KSDV+SFGVLVLEI
Sbjct:   489 DINPKIADFGMARIFGLDQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEI 548

Query:   522 ISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSG-SITEMIRCIHIGLLCVQ 580
             ISG++N+ F   +  +DLL+  W+ W   T ++++DP +++    +E++RCIHIGLLCVQ
Sbjct:   549 ISGRKNSSFDESDGAQDLLTHTWRLWTNRTALDLVDPLIANNCQNSEVVRCIHIGLLCVQ 608

Query:   581 ENVASRPTMASVVLMLNSYSLTLPVPSEPAFFMDSIIESDMSFSLAHDSRITETDQPGCE 640
             E+ A RPT+++V +ML S ++TLPVP +P FF+ S    D + S   D   T    P   
Sbjct:   609 EDPAKRPTISTVFMMLTSNTVTLPVPRQPGFFIQSSPVKDPTDS---DQSTTTKSTPA-- 663

Query:   641 NLLLSGNNEISITDLYPR 658
                 S ++E+ ITDLYPR
Sbjct:   664 ----SIDDEL-ITDLYPR 676

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)]

 Score = 1480 (526.0 bits), Expect = 1.1e-151, P = 1.1e-151
 Identities = 317/675 (46%), Positives = 432/675 (64%)

Query:     9 VFFFSFLILAVS--INAQNVCSNDVGNYTSNSAYKTNLNSVLSSIAS-NAAVDYGFYNES 65
             VF F  L    S      ++C N    Y+ NS+Y TNL +VLSS++S NAA    F N +
Sbjct:    14 VFLFMILKTVTSDPTYLYHICPNTT-TYSRNSSYLTNLRTVLSSLSSPNAAYASLFDNAA 72

Query:    66 AGQEPDKVNVFA--LCRGDIATDVCRGCLENATQEILRVCPNQKQAIIWSAECMLRYSNK 123
             AG+E D   V+   LCRGD++ ++CR C+  A  E L+ CP +K A+IW  ECM+RYSN+
Sbjct:    73 AGEENDSNRVYGVFLCRGDVSAEICRDCVAFAANETLQRCPREKVAVIWYDECMVRYSNQ 132

Query:   124 TIFGVLETGPTYYMWNVNNVTDD-VSLFNQALQDLLRRLRGTAASGNSQKKFATGDTTAS 182
             +I G +   P  ++ N  N+T++ VS FN++L  LL  +   AA   S +KFAT     +
Sbjct:   133 SIVGQMRIRPGVFLTNKQNITENQVSRFNESLPALLIDVAVKAAL--SSRKFATEKANFT 190

Query:   183 -FRTIYALEQCTPDLSELQCSDCLDRAIGEIPNCCSGKIGGRVLKPSCNFRFETERFYN- 240
              F+TIY+L QCTPDL+   C  CL + I  +P CC   +GGRV+ PSC+FR+E   FYN 
Sbjct:   191 VFQTIYSLVQCTPDLTNQDCESCLRQVINYLPRCCDRSVGGRVIAPSCSFRYELYPFYNE 250

Query:   241 ----------PTANXXXXXXXXXAE-GNGSDTARTVIIILIP-TVGXXXXXXXXXXXXRR 288
                       P++          +E G G +    V  I +P +V             RR
Sbjct:   251 TIAAAPMAPPPSSTVTAPPLNIPSEKGKGKNLTVIVTAIAVPVSVCVLLLGAMCWLLARR 310

Query:   289 KPRDNSKVKSEAAAGDE--INRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLY 346
             +   N+K+ +E    DE  I   E+LQF F+ I  AT+ FS++NKLG GGFG VYKG+L 
Sbjct:   311 R---NNKLSAETEDLDEDGITSTETLQFQFSAIEAATNKFSESNKLGHGGFGEVYKGQLI 367

Query:   347 DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTS 406
              G  +A+KRLS+ S QG  EFKNEV +VA LQHRNL +LLG+ L+G E++L+YEFVPN S
Sbjct:   368 TGETVAIKRLSQGSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKS 427

Query:   407 LDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPK 466
             LD+F+FD  +R  LDW+RRYKII GIARG+LYLH DSRL IIHRDLK SN+LLDA+M PK
Sbjct:   428 LDYFLFDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDADMHPK 487

Query:   467 IADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQR 526
             I+DFGMAR+F +D+TQ NT RIVGTYGYM+PEYA+HG+YSVKSDV+SFGVLVLE+I+G++
Sbjct:   488 ISDFGMARIFGVDQTQANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLELITGKK 547

Query:   527 NNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSIT-EMIRCIHIGLLCVQENVAS 585
             N+ F   + + DL++  WK W E + + ++D  +     T E+IRCIHI LLCVQE+ + 
Sbjct:   548 NSSFYEEDGLGDLVTYVWKLWVENSPLELVDEAMRGNFQTNEVIRCIHIALLCVQEDSSE 607

Query:   586 RPTMASVVLMLNSYSLTLPVPSEPAFFMDSIIES--DMSFSLAHDSRITETDQPGCENLL 643
             RP+M  +++M+NS+++TLP+P    F + ++ +S    S   A D   T    P      
Sbjct:   608 RPSMDDILVMMNSFTVTLPIPKRSGFLLRTMKDSRDPRSGGSASDHSATSKSLP------ 661

Query:   644 LSGNNEISITDLYPR 658
             LS ++  SIT +YPR
Sbjct:   662 LSVDDS-SITIVYPR 675

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2127323 CRK27 "cysteine-rich RLK (RECEPTOR-like protein kinase) 27" [Arabidopsis thaliana (taxid:3702)]

 Score = 1432 (509.1 bits), Expect = 5.2e-149, Sum P(2) = 5.2e-149
 Identities = 317/654 (48%), Positives = 405/654 (61%)

Query:     1 MAKGCSRLVFFFSFLILA--VSINAQNV-----CSNDVGNYTSNSAYKTNLNSVLSSIAS 53
             MA     L  FFSF  L   V+   QNV     C  D GN+TSN++Y  NLN ++SS+  
Sbjct:     1 MASTSIMLSSFFSFFFLTFFVTYAQQNVTVHTICYYDGGNFTSNTSYSLNLNRLISSLPD 60

Query:    54 NAAVDYGFYNESAGQEPDKVNVFALCRGDIATDV-CRGCLENATQEILRVCPNQKQAIIW 112
                   GFYN S   E   VN  ALCRGD+  +  C  C+  A ++++  CPN  +A IW
Sbjct:    61 LTPTINGFYNISINGE---VNAIALCRGDVKPNQDCISCITTAAKQLVESCPNIIEANIW 117

Query:   113 SAECMLRYSNKTIFGVLETGPTYYMWNVNNVTDDVSLFNQALQDLLRRLRGTAASGNSQK 172
               +CM RY+++ I G +E  P  Y  +  +VTD    F++ L DLL  L     + N  K
Sbjct:   118 LEKCMFRYTSRIILGQMEPVPFSYTSSNVSVTDKEG-FSKGLGDLLDSLGAKIDAANETK 176

Query:   173 --KFATGDTTASFRTIYALEQCTPDLSELQCSDCLDRAIGEIPNCCSGKIGGRVLKPSCN 230
               KFA G       TIYAL QCTPDLSE  C  CL +    +P CC GK GG    PSC 
Sbjct:   177 EVKFAAGVKG----TIYALAQCTPDLSESDCRICLAQIFAGVPTCCDGKTGGWWTNPSCY 232

Query:   231 FRFETERFYNPTA--------NXXXXXXXXXAEGNGSDTARTVIIILIPTVGXXXXXXXX 282
             FRFE   F++ +         +          +G   D ++T+I  ++P V         
Sbjct:   233 FRFEVYPFFDLSVTSEQKQPLSSHNNNTRRSDQGKSKDRSKTLIFAVVPIVAIILGLVFL 292

Query:   283 XXXXRRKPRDNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYK 342
                 +R+ R    +K  A   +E    +SL FDF TIRVATD+FS  NK+G+GGFG VYK
Sbjct:   293 FIYLKRR-RKKKTLKENAE--NEFESTDSLHFDFETIRVATDDFSLTNKIGEGGFGVVYK 349

Query:   343 GRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFV 402
             G L DG EIAVKRLS  SGQG+ EFK EVLL+  LQH+NLV+L GFS++ +ERLL+YEF+
Sbjct:   350 GHLPDGLEIAVKRLSIHSGQGNAEFKTEVLLMTKLQHKNLVKLFGFSIKESERLLVYEFI 409

Query:   403 PNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE 462
             PNTSLD F+FDP ++ QLDWE+RY II G++RGLLYLHE S   IIHRDLK+SNVLLD +
Sbjct:   410 PNTSLDRFLFDPIKQKQLDWEKRYNIIVGVSRGLLYLHEGSEFPIIHRDLKSSNVLLDEQ 469

Query:   463 MTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEII 522
             M PKI+DFGMAR F+ D TQ  T R+VGTYGYMAPEYAMHG++SVK+DV+SFGVLVLEII
Sbjct:   470 MLPKISDFGMARQFDFDNTQAVTRRVVGTYGYMAPEYAMHGRFSVKTDVYSFGVLVLEII 529

Query:   523 SGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTL-SSGSITEMIRCIHIGLLCVQE 581
             +G+RN+    GE   DL + AW+NW EGT++ +IDP L  +    E ++C+ I L CVQE
Sbjct:   530 TGKRNSGLGLGEGT-DLPTFAWQNWIEGTSMELIDPVLLQTHDKKESMQCLEIALSCVQE 588

Query:   582 NVASRPTMASVVLMLNSYSLT--LPVPSEPAFFMDSIIESDMSFSLAHDSRITE 633
             N   RPTM SVV ML+S S +  LP PS+P FF  S   +  S SL +D  +T+
Sbjct:   589 NPTKRPTMDSVVSMLSSDSESRQLPKPSQPGFFRRS---ASFSISL-NDVSLTD 638

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

TAIR|locus:2121636 CRK7 "cysteine-rich RLK (RECEPTOR-like protein kinase) 7" [Arabidopsis thaliana (taxid:3702)]

 Score = 1418 (504.2 bits), Expect = 4.0e-145, P = 4.0e-145
 Identities = 290/624 (46%), Positives = 405/624 (64%)

Query:     9 VFFFSFLILAVSINAQN------VCSNDVGNYTSNSAYKTNLNSVLSSIAS-NAAVDYGF 61
             +F FSFL  +   +AQ+       C N    Y+SNS Y TNL ++LSS++S NA+   GF
Sbjct:    10 LFLFSFLT-SFRASAQDPRFLAYYCPNAT-TYSSNSTYLTNLKTLLSSLSSRNASYSTGF 67

Query:    62 YNESAGQEPDKVNVFALCRGDIATDVCRGCLENATQEILRVCPNQKQAIIWSAECMLRYS 121
              N + GQ  D+V    LCRGD++ +VCR C+  A       CPNQ++A+ +  EC+LRYS
Sbjct:    68 QNATVGQALDRVTGLFLCRGDVSPEVCRNCVTFAVNNTFSRCPNQREAVFYYEECILRYS 127

Query:   122 NKTIFGVLETGP-TYYMWNVNNVTDDVSLFNQALQDLLRRLRGTAA-SGNSQKKFATGDT 179
             +K I     T    + + N N+++   +  NQ    +L  +   A  + ++ +KF+T  T
Sbjct:   128 HKNILSTAITNEGEFILRNPNHISPIQNQINQFTNLVLSNMNQIAIEAADNPRKFSTIKT 187

Query:   180 T-ASFRTIYALEQCTPDLSELQCSDCLDRAIGEIPNCCSGKIGGRVLKPSCNFRFETERF 238
                + +T Y L QCTPDLS   C +CL  +I  +P     +IG R   PSCN R+E   F
Sbjct:   188 ELTALQTFYGLVQCTPDLSRQNCMNCLTSSINRMP---FSRIGARQFWPSCNSRYELYDF 244

Query:   239 YNPTANXXX------XXXXXXAEGNGSDTARTVIIILIPTVGXXXXXXXXXXXXRRKPRD 292
             YN TA                ++ +G+     V+ +++P +              ++ + 
Sbjct:   245 YNETAIGTPPPPLPPLASPSLSDKSGNSNV-VVVAVVVPIIVAVLIFIAGYCFFAKRAKK 303

Query:   293 NSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIA 352
                  + A   D+    ESLQ D+  I+ AT++FS+ NK+G+GGFG VYKG   +G E+A
Sbjct:   304 TYGT-TPALDEDDKTTIESLQLDYRAIQAATNDFSENNKIGRGGFGDVYKGTFSNGTEVA 362

Query:   353 VKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIF 412
             VKRLS+ S QGD EFKNEV++VANL+H+NLVR+LGFS+E  ER+L+YE+V N SLD+F+F
Sbjct:   363 VKRLSKTSEQGDTEFKNEVVVVANLRHKNLVRILGFSIEREERILVYEYVENKSLDNFLF 422

Query:   413 DPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGM 472
             DP ++ QL W +RY IIGGIARG+LYLH+DSRL IIHRDLK SN+LLDA+M PKIADFGM
Sbjct:   423 DPAKKGQLYWTQRYHIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGM 482

Query:   473 ARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRN 532
             AR+F MD+TQ NTSRIVGTYGYM+PEYAM GQ+S+KSDV+SFGVLVLEIISG++NN F  
Sbjct:   483 ARIFGMDQTQQNTSRIVGTYGYMSPEYAMRGQFSMKSDVYSFGVLVLEIISGRKNNSFIE 542

Query:   533 GETVEDLLSSAWKNWREGTTVNIIDPTLS-SGSITEMIRCIHIGLLCVQENVASRPTMAS 591
              +  +DL++ AW+ WR GT ++++DP ++ S   +E++RC HIGLLCVQE+   RP M++
Sbjct:   543 TDDAQDLVTHAWRLWRNGTALDLVDPFIADSCRKSEVVRCTHIGLLCVQEDPVKRPAMST 602

Query:   592 VVLMLNSYSLTLPVPSEPAFFMDS 615
             + +ML S ++ LP P +P FF+ S
Sbjct:   603 ISVMLTSNTMALPAPQQPGFFVRS 626

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0034976 "response to endoplasmic reticulum stress" evidence=RCA

TAIR|locus:2121686 CRK19 "cysteine-rich RLK (RECEPTOR-like protein kinase) 19" [Arabidopsis thaliana (taxid:3702)]

 Score = 1410 (501.4 bits), Expect = 2.8e-144, P = 2.8e-144
 Identities = 296/625 (47%), Positives = 398/625 (63%)

Query:     6 SRLVFFFSFLILAVSINAQNV------CSNDVGNYTSNSAYKTNLNSVLSSIASNAAVDY 59
             S + F F FL  +++ +AQN       CS     ++SNS Y TNL ++LSS++S  A  Y
Sbjct:     3 SLISFIFLFLFSSITASAQNTFYLYHNCSVTT-TFSSNSTYSTNLKTLLSSLSSLNASSY 61

Query:    60 --GFYNESAGQEPDKVNVFALCRGDIATDVCRGCLENATQEILRVCPNQKQAIIWSAECM 117
               GF   +AGQ PD+V    LCR D++++VCR C+  A  E L  CP  K+ + +  +C+
Sbjct:    62 STGFQTATAGQAPDRVTGLFLCRVDVSSEVCRSCVTFAVNETLTRCPKDKEGVFYYEQCL 121

Query:   118 LRYSNKTIFGVLETGPTYYMWNVNNVTDDVSLFNQALQDLLRRLRGTAA--SGNSQKKFA 175
             LRYSN+ I   L T    +M +  N    +S+     +DL+      AA  +  S KK+A
Sbjct:   122 LRYSNRNIVATLNTDGGMFMQSARN---PLSVKQDQFRDLVLTPMNLAAVEAARSFKKWA 178

Query:   176 TG--DTTASFRTIYALEQCTPDLSELQCSDCLDRAIGEIPNCCSGKIGGRVLKPSCNFRF 233
                 D  AS +++Y + +CTPDL E  C DCL   I ++      KIGGR+L PSC  R+
Sbjct:   179 VRKIDLNAS-QSLYGMVRCTPDLREQDCLDCLKIGINQVTY---DKIGGRILLPSCASRY 234

Query:   234 ETERFYNPTANXXXXXXXXXAEGNGSDTARTVIIILIP-TVGXXXXXXXXXXXXRRKPRD 292
             +   FYN + N           G G +++  +I +++P TV             + K   
Sbjct:   235 DNYAFYNES-NVGTPQDSSPRPGKGGNSSVIIIAVVVPITVLFLLLVAVFSVRAKNKRTL 293

Query:   293 NSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIA 352
             N K +  A  G++I  A SLQFDF  I  AT+ F   NKLGQGGFG VYKG L  G ++A
Sbjct:   294 NEK-EPVAEDGNDITTAGSLQFDFKAIEAATNCFLPINKLGQGGFGEVYKGTLSSGLQVA 352

Query:   353 VKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIF 412
             VKRLS+ SGQG+ EF+NEV++VA LQHRNLV+LLG+ LEG E++L+YEFVPN SLDHF+F
Sbjct:   353 VKRLSKTSGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYEFVPNKSLDHFLF 412

Query:   413 DPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGM 472
             D T + +LDW RRYKIIGGIARG+LYLH+DSRL IIHRDLK  N+LLD +M PKIADFGM
Sbjct:   413 DSTMKMKLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDDDMNPKIADFGM 472

Query:   473 ARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNC-FR 531
             AR+F MD+T+  T R+VGTYGYM+PEYAM+GQ+S+KSDV+SFGVLVLEIISG +N+  ++
Sbjct:   473 ARIFGMDQTEAMTRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGMKNSSLYQ 532

Query:   532 NGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSIT-EMIRCIHIGLLCVQENVASRPTMA 590
               E+V +L++  W+ W  G+   ++DP+      T E+ RCIHI LLCVQE+   RPTM+
Sbjct:   533 MDESVGNLVTYTWRLWSNGSPSELVDPSFGDNYQTSEITRCIHIALLCVQEDAEDRPTMS 592

Query:   591 SVVLMLNSYSLTLPVPSEPAFFMDS 615
             S+V ML +  + L  P  P FF  S
Sbjct:   593 SIVQMLTTSLIALAEPRPPGFFFRS 617

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0042742 "defense response to bacterium" evidence=IEP

GO:0005886 "plasma membrane" evidence=IDA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

TAIR|locus:2134603 CRK41 "cysteine-rich RLK (RECEPTOR-like protein kinase) 41" [Arabidopsis thaliana (taxid:3702)]

 Score = 1404 (499.3 bits), Expect = 1.2e-143, P = 1.2e-143
 Identities = 298/599 (49%), Positives = 384/599 (64%)

Query:    26 VCSNDVGNYTSNSAYKTNLNSVLSSIASNAAVDYGFYNESAGQ--EPDKVNVFALCRGDI 83
             +C +   N+  +S +  NL+S++SSI S  +  Y FY+ S G   + ++V    +C   +
Sbjct:    46 LCLSQQSNFAKSSQFSKNLDSLVSSIPSLKSNTYNFYSLSVGSISDQERVEAIGICNRVV 105

Query:    84 ATDVCRGCLENATQEILRV-CPNQKQAIIWSAECMLRYSNKTIFGVLETGPTYYMWNVNN 142
                 C  C+  A   +  + CP  + A + + +CM RYS+K IFG LET P     N +N
Sbjct:   106 NRVDCLNCIAQAAVNLTTMYCPQHRGAYVRATKCMFRYSDKPIFGKLETSPVLEAPNPSN 165

Query:   143 VTDDVSLFNQALQDLLRRLRGTAASGNSQKKFATGDTTAS--FRTIYALEQCTPDLSELQ 200
              T D + F +   +LL RLR  AASG S++K+A G    S  + T +   QCTPDLSE  
Sbjct:   166 ATGDRNEFIRLQSELLNRLRSMAASGGSKRKYAQGTDPGSPPYTTFFGAVQCTPDLSEKD 225

Query:   201 CSDCLDRAIGEIPNCCSGKIGGRVLKPSCNFRFETE-RFYNPTANXXXXXXXXXAEGNGS 259
             C+DCL        N   G++G R   PSCNF+ E++ RF+                  G+
Sbjct:   226 CNDCLSYGFS---NATKGRVGIRWFCPSCNFQIESDLRFF------LLDSEYEPDPKPGN 276

Query:   260 DTARTVIIILIPTVGXXXXXXXXXXXXRRKPRDNSKVKSEAAAGDE--INRAESLQFDFN 317
             D  + +I  +   +G             R  R  +K + E    +E  I  A+ LQ DF+
Sbjct:   277 DKVKIIIATVCSVIGFAIIAVFLYFFMTRNRR-TAKQRHEGKDLEELMIKDAQLLQLDFD 335

Query:   318 TIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANL 377
             TIR+AT++FS  N+LG+GGFGAVYKG L  G EIAVKRLS  SGQGD EF NEV LVA L
Sbjct:   336 TIRLATNDFSRDNQLGEGGFGAVYKGVLDYGEEIAVKRLSMKSGQGDNEFINEVSLVAKL 395

Query:   378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
             QHRNLVRLLGF L+G ER+LIYEF  NTSLDH+IFD  RR  LDWE RY+II G+ARGLL
Sbjct:   396 QHRNLVRLLGFCLQGEERILIYEFFKNTSLDHYIFDSNRRMILDWETRYRIISGVARGLL 455

Query:   438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN--TSRIVGTYGYM 495
             YLHEDSR +I+HRD+K SNVLLD  M PKIADFGMA+LF+ D+T     TS++ GTYGYM
Sbjct:   456 YLHEDSRFKIVHRDMKASNVLLDDAMNPKIADFGMAKLFDTDQTSQTRFTSKVAGTYGYM 515

Query:   496 APEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNI 555
             APEYAM G++SVK+DVFSFGVLVLEII G++NN     ++   LLS  WK+WREG  +NI
Sbjct:   516 APEYAMSGEFSVKTDVFSFGVLVLEIIKGKKNNWSPEEDSSLFLLSYVWKSWREGEVLNI 575

Query:   556 IDPTL--SSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTLPVPSEPAFF 612
             +DP+L  + G   E+++CIHIGLLCVQEN  SRPTMASVV+MLN+ S TLP PS+PAF+
Sbjct:   576 VDPSLVETIGVSDEIMKCIHIGLLCVQENAESRPTMASVVVMLNANSFTLPRPSQPAFY 634

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2121626 CRK23 "cysteine-rich RLK (RECEPTOR-like protein kinase) 23" [Arabidopsis thaliana (taxid:3702)]

 Score = 1042 (371.9 bits), Expect = 8.1e-140, Sum P(2) = 8.1e-140
 Identities = 205/372 (55%), Positives = 267/372 (71%)

Query:   289 KPRDNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDG 348
             K +D    +  A  GD I  A SLQFDF  I  AT+NF   NKLGQGGFG VYKG    G
Sbjct:   471 KRKDTEVTEPLAENGDSITTAGSLQFDFKAIVAATNNFLPINKLGQGGFGEVYKGTFPSG 530

Query:   349 AEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLD 408
              ++AVKRLS+ SGQG+ EF+NEV++VA LQHRNLVRLLG+ LEG E++L+YEFV N SLD
Sbjct:   531 VQVAVKRLSKTSGQGEREFENEVVVVAKLQHRNLVRLLGYCLEGEEKILVYEFVHNKSLD 590

Query:   409 HFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIA 468
             +F+FD T + QLDW RRYKIIGGIARG+LYLH+DSRL IIHRDLK  N+LLDA+M PK+A
Sbjct:   591 YFLFDTTMKRQLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVA 650

Query:   469 DFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNN 528
             DFGMAR+F MD+T+ NT R+VGTYGYMAPEYAM+GQ+S+KSDV+SFGVLV EIISG +N+
Sbjct:   651 DFGMARIFGMDQTEANTRRVVGTYGYMAPEYAMYGQFSMKSDVYSFGVLVFEIISGMKNS 710

Query:   529 C-FRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSIT-EMIRCIHIGLLCVQENVASR 586
               ++  ++V +L++  W+ W  G+ ++++DP+      T ++ RCIHI LLCVQE+V  R
Sbjct:   711 SLYQMDDSVSNLVTYTWRLWSNGSQLDLVDPSFGDNYQTHDITRCIHIALLCVQEDVDDR 770

Query:   587 PTMASVVLMLNSYSLTLPVPSEPAFFMDSIIESDMSFSLAHDSRITETDQPGCENLLLSG 646
             P M+++V ML + S+ L VP +P FF          F   H+ ++ E      + L L  
Sbjct:   771 PNMSAIVQMLTTSSIVLAVPKQPGFF----------FRGRHE-QVGEVGS-SVDRLALCS 818

Query:   647 NNEISITDLYPR 658
              ++ SIT + PR
Sbjct:   819 IDDASITSVAPR 830

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006952 "defense response" evidence=TAS

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q8S9L6	CRK29_ARATH	2, ., 7, ., 1, 1, ., -	0.4985	0.9650	0.9351	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: fgenesh4_pm.C_LG_IV000044 hypothetical protein (652 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	658
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-50
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	6e-50
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	9e-50
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	5e-49
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-48
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-48
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-46
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-40
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-36
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-33
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-33
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	9e-33
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-32
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	7e-32
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-31
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-30
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-30
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-30
pfam01657	106	pfam01657, Stress-antifung, Salt stress response/a	7e-30
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-29
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-28
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-28
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	8e-28
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-27
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-27
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-27
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-27
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-27
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-26
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-26
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-26
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-26
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-26
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	7e-26
pfam01657	106	pfam01657, Stress-antifung, Salt stress response/a	1e-25
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-25
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-25
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	5e-25
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	7e-25
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	9e-25
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-24
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-24
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-24
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-24
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-24
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-24
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	5e-24
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	6e-24
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	6e-24
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	7e-24
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	7e-24
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	8e-24
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-23
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-23
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-23
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-23
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	5e-23
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	7e-23
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	8e-23
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	9e-23
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	9e-23
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-22
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-22
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-22
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-22
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-22
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-22
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-22
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	5e-22
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-22
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	6e-22
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	6e-22
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	6e-22
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	8e-22
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	8e-22
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	9e-22
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-21
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-21
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-21
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-21
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-21
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	5e-21
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-21
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	9e-21
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-20
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-20
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-20
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-20
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-20
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-20
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-20
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-20
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-20
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-20
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	5e-20
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	7e-20
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-19
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-19
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-19
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-19
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-19
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-19
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-19
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-19
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-19
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-19
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-19
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-19
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-19
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-19
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-19
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	5e-19
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-19
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-19
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	6e-19
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	7e-19
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-18
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-18
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-18
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-18
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-18
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-18
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-18
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-18
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-18
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-18
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-18
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	6e-18
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-17
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-17
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-17
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-17
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-17
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-17
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-17
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-17
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-17
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-17
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-17
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-17
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-17
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-17
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-17
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	5e-17
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-17
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	6e-17
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	7e-17
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	9e-17
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	9e-17
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-16
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-16
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-16
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-16
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-16
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-16
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-16
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-16
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-16
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-16
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-16
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-16
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	6e-16
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	7e-16
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	9e-16
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-15
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-15
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-15
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-15
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-15
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-15
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-15
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-15
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-15
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-15
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-15
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-15
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-15
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-15
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-15
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-15
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	6e-15
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	6e-15
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	6e-15
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	7e-15
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	7e-15
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	7e-15
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	8e-15
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	9e-15
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-14
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-14
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-14
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-14
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-14
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-14
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-14
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-14
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-14
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-14
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-14
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-14
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-14
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-14
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	5e-14
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-14
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	5e-14
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	6e-14
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	7e-14
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	7e-14
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	8e-14
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-13
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-13
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-13
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-13
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-13
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-13
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-13
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	5e-13
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-13
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	6e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	6e-13
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	6e-13
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-12
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-12
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-12
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-12
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-12
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	5e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	5e-12
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	6e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	6e-12
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	8e-12
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	8e-12
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-11
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-11
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-11
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-11
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-11
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	5e-11
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	6e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	7e-11
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	8e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	8e-11
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	8e-11
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	9e-11
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-10
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-10
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-10
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-10
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-10
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-10
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-10
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-10
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	5e-10
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	8e-10
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-09
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	9e-09
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	9e-09
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-08
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	6e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	9e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-07
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-07
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	9e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-06
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-06
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	5e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	6e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	9e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	2e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	4e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	4e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	2e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-04
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	8e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	0.002
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	0.002
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  173 bits (440), Expect = 4e-50
 Identities = 70/194 (36%), Positives = 104/194 (53%), Gaps = 11/194 (5%)

Query: 332 LGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLVRLLGFS 389
           LG+GGFG VY  R    G ++A+K + ++     LE    E+ ++  L H N+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 390 LEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIH 449
            + N   L+ E+    SL   + +   +  L  +   +I+  I  GL YLH      IIH
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHS---NGIIH 115

Query: 450 RDLKTSNVLLDA-EMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMH-GQYSV 507
           RDLK  N+LLD+     K+ADFG+++L      +     IVGT  YMAPE  +  G YS 
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLL--TSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173

Query: 508 KSDVFSFGVLVLEI 521
           KSD++S GV++ E+
Sbjct: 174 KSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  174 bits (443), Expect = 6e-50
 Identities = 72/200 (36%), Positives = 104/200 (52%), Gaps = 13/200 (6%)

Query: 331 KLGQGGFGAVYKGRLYDG-----AEIAVKRLSRD-SGQGDLEFKNEVLLVANLQHRNLVR 384
           KLG+G FG VYKG L         E+AVK L  D S Q   EF  E  ++  L H N+V+
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 385 LLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSR 444
           LLG   E    +++ E++P   L  ++    R  +L           IARG+ YL     
Sbjct: 66  LLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE---S 121

Query: 445 LRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQGNTSRIVGTYGYMAPEYAMHG 503
              IHRDL   N L+   +  KI+DFG++R L++ D  +    ++     +MAPE    G
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLKEG 179

Query: 504 QYSVKSDVFSFGVLVLEIIS 523
           +++ KSDV+SFGVL+ EI +
Sbjct: 180 KFTSKSDVWSFGVLLWEIFT 199

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  173 bits (442), Expect = 9e-50
 Identities = 69/200 (34%), Positives = 104/200 (52%), Gaps = 14/200 (7%)

Query: 331 KLGQGGFGAVYKGRLYD-----GAEIAVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLVR 384
           KLG+G FG VYKG+L         E+AVK L  D+ +  + EF  E  ++  L H N+V+
Sbjct: 6   KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65

Query: 385 LLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSR 444
           LLG   E     ++ E++    L  ++     R +L           IARG+ YL     
Sbjct: 66  LLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE---S 120

Query: 445 LRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQGNTSRIVGTYGYMAPEYAMHG 503
              IHRDL   N L+   +  KI+DFG++R L++ D  +    ++     +MAPE    G
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWMAPESLKEG 178

Query: 504 QYSVKSDVFSFGVLVLEIIS 523
           +++ KSDV+SFGVL+ EI +
Sbjct: 179 KFTSKSDVWSFGVLLWEIFT 198

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  171 bits (437), Expect = 5e-49
 Identities = 83/285 (29%), Positives = 133/285 (46%), Gaps = 42/285 (14%)

Query: 330 NKLGQGGFGAVYKGRLYDGA----EIAVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLVR 384
            KLG+G FG VYKG+L        E+AVK L  D+ + +  +F  E  ++  L H N+VR
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 385 LLGFSLEGNERLLIYEFVPNTSLDHFI------FDPTRRAQLDWERRYKIIGGIARGLLY 438
           LLG   E     L+ E++    L  ++      F    ++ L  +        IA+G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQGNTSRIVGTYGYMAP 497
           L      + +HRDL   N L+  ++  KI+DFG++R +++ D  +  T   +    +MAP
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAP 176

Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGET------VEDLLSSAWKNWREGT 551
           E    G ++ KSDV+SFGVL+ EI +         G T       E++L    +  R+G 
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFT--------LGATPYPGLSNEEVL----EYLRKGY 224

Query: 552 TVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLML 596
            +    P      + E++        C Q +   RPT + +V  L
Sbjct: 225 RLPK--PEYCPDELYELMLS------CWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  170 bits (434), Expect = 1e-48
 Identities = 81/272 (29%), Positives = 122/272 (44%), Gaps = 31/272 (11%)

Query: 331 KLGQGGFGAVYKGR-LYDGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLG 387
           KLG G FG VYK +    G  +AVK L + S   + D   + E+ ++  L H N+VRL+ 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 388 FSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRI 447
              + +   L+ E+     L  ++   +R   L  +   KI   I RGL YLH      I
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHS---NGI 119

Query: 448 IHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE-YAMHGQYS 506
           IHRDLK  N+LLD     KIADFG+A+     ++  + +  VGT  YMAPE       Y 
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLL--KSSSSLTTFVGTPWYMAPEVLLGGNGYG 177

Query: 507 VKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSS---G 563
            K DV+S GV++ E+++G+    F     ++ L               I+ P L      
Sbjct: 178 PKVDVWSLGVILYELLTGK--PPFSGENILDQL----------QLIRRILGPPLEFDEPK 225

Query: 564 SITEMIRCIHI--GLLCVQENVASRPTMASVV 593
             +       +    L    + + RPT   ++
Sbjct: 226 WSSGSEEAKDLIKKCLNK--DPSKRPTAEEIL 255

Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  170 bits (434), Expect = 1e-48
 Identities = 68/203 (33%), Positives = 102/203 (50%), Gaps = 17/203 (8%)

Query: 331 KLGQGGFGAVYKGRLYDGAE-----IAVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLVR 384
           KLG+G FG VYKG L    E     +AVK L   + + +  EF  E  ++  L H N+VR
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 385 LLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSR 444
           LLG   +G    ++ E++P   L  F+       +L  +   ++   IA+G+ YL     
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLES--- 120

Query: 445 LRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG---YMAPEYAM 501
              +HRDL   N L+   +  KI+DFG++R    D+         G      +MAPE   
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG---GGKLPIKWMAPESLK 177

Query: 502 HGQYSVKSDVFSFGVLVLEIISG 524
            G+++ KSDV+SFGVL+ EI + 
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  163 bits (416), Expect = 3e-46
 Identities = 66/202 (32%), Positives = 101/202 (50%), Gaps = 11/202 (5%)

Query: 326 FSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLV 383
           +    KLG+G FG VY  R    G  +A+K + +   + D E    E+ ++  L+H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 384 RLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS 443
           RL     + ++  L+ E+     L   +     R   D  R Y  +  I   L YLH   
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLL-KKRGRLSEDEARFY--LRQILSALEYLHS-- 115

Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG 503
              I+HRDLK  N+LLD +   K+ADFG+AR  +  E     +  VGT  YMAPE  +  
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAPEVLLGK 171

Query: 504 QYSVKSDVFSFGVLVLEIISGQ 525
            Y    D++S GV++ E+++G+
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  147 bits (374), Expect = 3e-40
 Identities = 69/204 (33%), Positives = 104/204 (50%), Gaps = 15/204 (7%)

Query: 330 NKLGQGGFGAVYKGRLYD-GAEIAVK--RLSRDSGQGDLEFKNEVLLVANLQHRNLVRLL 386
             LG+G FG+VY     D G  +AVK   LS DS +     + E+ ++++LQH N+VR  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 387 GFSL--EGNERLLIYEFVPNTSLDHFI--FDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           G     E N   +  E+V   SL   +  F       +   R+Y     I  GL YLH  
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVI---RKY--TRQILEGLAYLH-- 118

Query: 443 SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMH 502
               I+HRD+K +N+L+D++   K+ADFG A+     ET   T  + GT  +MAPE    
Sbjct: 119 -SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177

Query: 503 GQYSVKSDVFSFGVLVLEIISGQR 526
            +Y   +D++S G  V+E+ +G+ 
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKP 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  136 bits (345), Expect = 3e-36
 Identities = 69/201 (34%), Positives = 105/201 (52%), Gaps = 7/201 (3%)

Query: 326 FSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRL 385
           F+   KLG G FG V++G   +   +A+K L  D      +F+ EV  +  L+H++L+ L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 386 LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRL 445
                 G    +I E +   SL  F+  P  +  L       +   +A G+ YL E    
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV-LPVASLIDMACQVAEGMAYLEEQ--- 123

Query: 446 RIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQY 505
             IHRDL   N+L+  ++  K+ADFG+ARL + D    +  +I   Y + APE A HG +
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTF 181

Query: 506 SVKSDVFSFGVLVLEIIS-GQ 525
           S KSDV+SFG+L+ E+ + GQ
Sbjct: 182 STKSDVWSFGILLYEMFTYGQ 202

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  128 bits (325), Expect = 1e-33
 Identities = 66/207 (31%), Positives = 104/207 (50%), Gaps = 21/207 (10%)

Query: 326 FSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVR 384
           F    K+G+GGFG VYK R    G E+A+K +  +S +   +  NE+ ++   +H N+V+
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 385 LLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL----YLH 440
             G  L+ +E  ++ EF    SL   +    +            I  + + LL    YLH
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ------IAYVCKELLKGLEYLH 115

Query: 441 EDSRLRIIHRDLKTSNVLL--DAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
                 IIHRD+K +N+LL  D E+  K+ DFG++     D    NT  +VGT  +MAPE
Sbjct: 116 S---NGIIHRDIKAANILLTSDGEV--KLIDFGLSAQLS-DTKARNT--MVGTPYWMAPE 167

Query: 499 YAMHGQYSVKSDVFSFGVLVLEIISGQ 525
                 Y  K+D++S G+  +E+  G+
Sbjct: 168 VINGKPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  129 bits (326), Expect = 2e-33
 Identities = 64/211 (30%), Positives = 105/211 (49%), Gaps = 18/211 (8%)

Query: 330 NKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQGDL-EFKNEVLLVANLQHRNL 382
            +LG+G FG V   R YD      G ++AVK L+    +    +F+ E+ ++  L H N+
Sbjct: 10  KQLGEGHFGKVELCR-YDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68

Query: 383 VRLLGFSLE--GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH 440
           V+  G   +  G    LI E++P+ SL  ++     R Q++ +R       I +G+ YL 
Sbjct: 69  VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLG 126

Query: 441 EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET--QGNTSRIVGTYGYMAPE 498
                R IHRDL   N+L+++E   KI+DFG+A++   D+             + Y APE
Sbjct: 127 S---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APE 182

Query: 499 YAMHGQYSVKSDVFSFGVLVLEIISGQRNNC 529
                ++S  SDV+SFGV + E+ +    + 
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGDPSQ 213

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  127 bits (320), Expect = 9e-33
 Identities = 70/220 (31%), Positives = 114/220 (51%), Gaps = 21/220 (9%)

Query: 332 LGQGGFGAVYKGR---LYDGAEI--AVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRL 385
           LG G FG VYKG      +  +I  A+K L  ++  + + E  +E  ++A++ H ++VRL
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 386 LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRR----AQLDWERRYKIIGGIARGLLYLHE 441
           LG  L  ++  LI + +P   L  ++ +          L+W  +      IA+G+ YL E
Sbjct: 75  LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEE 127

Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM 501
               R++HRDL   NVL+      KI DFG+A+L ++DE + +         +MA E  +
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184

Query: 502 HGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLL 540
           H  Y+ KSDV+S+GV V E+++ G +         + DLL
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL 224

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  127 bits (320), Expect = 4e-32
 Identities = 83/299 (27%), Positives = 128/299 (42%), Gaps = 22/299 (7%)

Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRD---SGQGDLEFKNEVLLVANLQH-RNLVRLL 386
           KLG+G FG VY  R  D   +A+K L++      +    F  E+ ++A+L H  N+V+L 
Sbjct: 7   KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 387 GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLR 446
            F  +     L+ E+V   SL+  +    R+  L       I+  I   L YLH      
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KG 121

Query: 447 IIHRDLKTSNVLLDAE-MTPKIADFGMARLF----EMDETQGNTSRIVGTYGYMAPEYAM 501
           IIHRD+K  N+LLD +    K+ DFG+A+L              S  VGT GYMAPE  +
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 502 H---GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP 558
                  S  SD++S G+ + E+++G        GE      S   K   E  T ++  P
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPP---FEGEKNSSATSQTLKIILELPTPSLASP 238

Query: 559 TLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL--MLNSYSLTLPVPSEPAFFMDS 615
              S           +    + ++  +R + +S +   +L    L     S+     DS
Sbjct: 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDS 297

Length = 384

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  124 bits (312), Expect = 7e-32
 Identities = 73/220 (33%), Positives = 115/220 (52%), Gaps = 19/220 (8%)

Query: 332 LGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLE 391
           +G+G FG V  G  Y G ++AVK L  DS      F  E  ++  L+H NLV+LLG  L+
Sbjct: 14  IGKGEFGDVMLG-DYRGQKVAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 392 GNERLLIYEFVPNTSLDHFIFDPTR-RAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHR 450
           GN   ++ E++   SL  ++   +R RA +   ++      +  G+ YL E      +HR
Sbjct: 72  GNPLYIVTEYMAKGSLVDYL--RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHR 126

Query: 451 DLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY--GYMAPEYAMHGQYSVK 508
           DL   NVL+  ++  K++DFG+A+    + +QG  S   G     + APE     ++S K
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK----EASQGQDS---GKLPVKWTAPEALREKKFSTK 179

Query: 509 SDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWR 548
           SDV+SFG+L+ EI S  R    R    ++D++    K +R
Sbjct: 180 SDVWSFGILLWEIYSFGRVPYPR--IPLKDVVPHVEKGYR 217

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  122 bits (308), Expect = 2e-31
 Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 35/216 (16%)

Query: 325 NFSDANKLGQGGFGAVYKG-RLYDGAEIAVKRLSR-DSGQGDL-EFKNEVLLVANLQHRN 381
           N+   + +G+G FG VYKG  L  G  +A+K++S     +  L     E+ L+ NL+H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG---------- 431
           +V+ +G     +   +I E+  N SL                +  K  G           
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSL---------------RQIIKKFGPFPESLVAVYV 105

Query: 432 --IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIV 489
             + +GL YLHE     +IHRD+K +N+L   +   K+ADFG+A   ++++   + + +V
Sbjct: 106 YQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVAT--KLNDVSKDDASVV 160

Query: 490 GTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           GT  +MAPE       S  SD++S G  V+E+++G 
Sbjct: 161 GTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  119 bits (301), Expect = 3e-30
 Identities = 70/198 (35%), Positives = 103/198 (52%), Gaps = 16/198 (8%)

Query: 331 KLGQGGFGAVYKGRLYDGA-EIAVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLVRLLGF 388
           KLG G FG V+ G  ++G  ++AVK L    G    E F  E  ++  L+H  LV+L   
Sbjct: 13  KLGAGQFGEVWMG-TWNGTTKVAVKTLK--PGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69

Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRII 448
             E     ++ E++   SL  F+     +  L   +   +   IA G+ YL        I
Sbjct: 70  CSEEEPIYIVTEYMSKGSLLDFLKSGEGKK-LRLPQLVDMAAQIAEGMAYLE---SRNYI 125

Query: 449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDE---TQGNTSRIVGTYGYMAPEYAMHGQY 505
           HRDL   N+L+   +  KIADFG+ARL E DE    +G    I  T    APE A +G++
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEAANYGRF 181

Query: 506 SVKSDVFSFGVLVLEIIS 523
           ++KSDV+SFG+L+ EI++
Sbjct: 182 TIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  119 bits (301), Expect = 4e-30
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 31/215 (14%)

Query: 332 LGQGGFGAVYKGRLY------DGAEIAVKRLSRDSGQGDLE--FKNEVLLVANLQHRNLV 383
           LG+G FG V+ G  Y      D   +AVK L +++   D    F+ E  L+ N QH N+V
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDARKDFEREAELLTNFQHENIV 71

Query: 384 RLLGFSLEGNERLLIYEFVPNTSLDHF-----------IFDPTRRAQLDWERRYKIIGGI 432
           +  G   EG+  ++++E++ +  L+ F               +   +L   +  +I   I
Sbjct: 72  KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131

Query: 433 ARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT- 491
           A G++YL   +    +HRDL T N L+  ++  KI DFGM+R    D    +  R+ G  
Sbjct: 132 ASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRVGGHT 184

Query: 492 ---YGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
                +M PE  M+ +++ +SDV+SFGV++ EI +
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  118 bits (299), Expect = 5e-30
 Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 23/208 (11%)

Query: 330 NKLGQGGFGAVYKGR-LYDGAEIAVKR--LSRDSGQGDLEFKNEVLLVANLQHRNLVRLL 386
            ++G+G FG VY  R   DG    +K   LS  S +   +  NEV ++  L H N+++  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 387 GFSLEGNERLLI-YEFVPNTSLDHFIFDPTRRAQ-------LDWERRYKIIGGIARGLLY 438
             S E   +L I  E+     L   I    +  +       LDW  +      +   L Y
Sbjct: 66  E-SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ------LCLALKY 118

Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
           LH     +I+HRD+K  N+ L +    K+ DFG++++         T  +VGT  Y++PE
Sbjct: 119 LHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPE 173

Query: 499 YAMHGQYSVKSDVFSFGVLVLEIISGQR 526
              +  Y+ KSD++S G ++ E+ + + 
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLKH 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal

 Score =  113 bits (284), Expect = 7e-30
 Identities = 47/100 (47%), Positives = 62/100 (62%), Gaps = 4/100 (4%)

Query: 27  CS-NDVGNYTS-NSAYKTNLNSVLSSIASNAAVDY--GFYNESAGQEPDKVNVFALCRGD 82
           CS N  GNYT+ NS +++NLN++LSS++SNAA     GF   ++G  PD V   A CRGD
Sbjct: 4   CSSNTSGNYTTANSTFESNLNALLSSLSSNAASSSGKGFAAGTSGAAPDTVYGLAQCRGD 63

Query: 83  IATDVCRGCLENATQEILRVCPNQKQAIIWSAECMLRYSN 122
           ++   CR CL  A  E+ R CPN+K   IW   C LRY +
Sbjct: 64  LSASDCRSCLATAVSELRRCCPNKKGGRIWYDSCFLRYES 103

This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  116 bits (293), Expect = 6e-29
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 27/213 (12%)

Query: 323 TDNFSDANKLGQGGFGAVYKG-RLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRN 381
            + + +  K+G+G  G VYK      G E+A+K++ R   Q      NE+L++ + +H N
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPN 76

Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSL----DHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           +V      L G+E  ++ E++   SL               Q+ +     +   + +GL 
Sbjct: 77  IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNE-PQIAY-----VCREVLQGLE 130

Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSR-----IVGTY 492
           YLH      +IHRD+K+ N+LL  + + K+ADFG A        Q    +     +VGT 
Sbjct: 131 YLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFA-------AQLTKEKSKRNSVVGTP 180

Query: 493 GYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
            +MAPE      Y  K D++S G++ +E+  G+
Sbjct: 181 YWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  115 bits (289), Expect = 1e-28
 Identities = 82/269 (30%), Positives = 122/269 (45%), Gaps = 36/269 (13%)

Query: 332 LGQGGFGAVYKG-RLYDGAEIAVKRLSRDSGQGDL-----EFKNEVLLVANLQHRNLVRL 385
           LG G FG+VY+G  L DG   AVK +S             + + E+ L++ LQH N+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 386 LGFSLEGNERLLIY-EFVPNTSLDHFI--FDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           LG   E  + L I+ E VP  SL   +  +       +    R      I  GL YLH+ 
Sbjct: 68  LGTEREE-DNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQ-----ILLGLEYLHDR 121

Query: 443 SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMH 502
                +HRD+K +N+L+D     K+ADFGMA+               G+  +MAPE    
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEVIAQ 175

Query: 503 -GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLS 561
            G Y + +D++S G  VLE+ +G+    +   E V  +    +K  R      I D  LS
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPP--WSQLEGVAAV----FKIGRSKELPPIPD-HLS 228

Query: 562 SGSITEMIRCIHIGLLCVQENVASRPTMA 590
             +  + I        C+Q + + RPT A
Sbjct: 229 DEA-KDFIL------KCLQRDPSLRPTAA 250

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  114 bits (286), Expect = 4e-28
 Identities = 72/229 (31%), Positives = 118/229 (51%), Gaps = 27/229 (11%)

Query: 332 LGQGGFGAVYKGRLYDGAE------IAVKRLSRDSGQGDL--EFKNEVLLVANLQHRNLV 383
           LG+G FG VYKG L    E      +A+K L +++ +  +  EF+ E  L+++LQH N+V
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTL-KENAEPKVQQEFRQEAELMSDLQHPNIV 71

Query: 384 RLLGFSLEGNERLLIYEFVPNTSLDHFIF-------------DPTRRAQLDWERRYKIIG 430
            LLG   +     +++E++ +  L  F+              D T ++ LD      I  
Sbjct: 72  CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131

Query: 431 GIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVG 490
            IA G+ YL   S    +HRDL   N L+   +T KI+DFG++R     +     S+ + 
Sbjct: 132 QIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188

Query: 491 TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNC-FRNGETVE 537
              +M PE  ++G+++ +SD++SFGV++ EI S G +    F N E +E
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE 237

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  112 bits (281), Expect = 8e-28
 Identities = 70/262 (26%), Positives = 123/262 (46%), Gaps = 25/262 (9%)

Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSL 390
           ++G G FG V+ G   +  ++A+K + R+    + +F  E  ++  L H  LV+L G   
Sbjct: 11  EIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 391 EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHR 450
           E +   L++EF+ +  L  ++    +R +   E    +   +  G+ YL   +   +IHR
Sbjct: 70  ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124

Query: 451 DLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSD 510
           DL   N L+      K++DFGM R F +D+   +++       + +PE     +YS KSD
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183

Query: 511 VFSFGVLVLEIISGQRN--NCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEM 568
           V+SFGVL+ E+ S  +       N E VE +               +  P L+S S+ E+
Sbjct: 184 VWSFGVLMWEVFSEGKTPYENRSNSEVVETI----------NAGFRLYKPRLASQSVYEL 233

Query: 569 IRCIHIGLLCVQENVASRPTMA 590
           ++       C +E    RP+ +
Sbjct: 234 MQ------HCWKERPEDRPSFS 249

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  112 bits (282), Expect = 1e-27
 Identities = 64/205 (31%), Positives = 111/205 (54%), Gaps = 19/205 (9%)

Query: 332 LGQGGFGAVYKGRLYDGAE----IAVKRL-SRDSGQGDLEFKNEVLLVANLQHRNLVRLL 386
           +G G FG V +GRL    +    +A+K L +  S +  L+F  E  ++    H N++RL 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 387 GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLR 446
           G   +    ++I E++ N SLD F+ +     +    +   ++ GIA G+ YL   S + 
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKYL---SEMN 126

Query: 447 IIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE----TQGNTSRIVGTYGYMAPEYAMH 502
            +HRDL   N+L+++ +  K++DFG++R  E  E    T+G    I  T    APE   +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEAIAY 182

Query: 503 GQYSVKSDVFSFGVLVLEIIS-GQR 526
            +++  SDV+SFG+++ E++S G+R
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGER 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  111 bits (279), Expect = 2e-27
 Identities = 63/204 (30%), Positives = 99/204 (48%), Gaps = 24/204 (11%)

Query: 332 LGQGGFGAVYK------GRLYDGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNL 382
           LG+G FG V        G+LY     A+K L +      +       E  +++ + H  +
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLY-----AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFI 55

Query: 383 VRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           V+L  ++ +  E+L L+ E+ P   L   +     R   +  R Y     I   L YLH 
Sbjct: 56  VKLH-YAFQTEEKLYLVLEYAPGGELFSHL-SKEGRFSEERARFY--AAEIVLALEYLH- 110

Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM 501
              L II+RDLK  N+LLDA+   K+ DFG+A+    + ++ NT    GT  Y+APE  +
Sbjct: 111 --SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLL 166

Query: 502 HGQYSVKSDVFSFGVLVLEIISGQ 525
              Y    D +S GVL+ E+++G+
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  111 bits (280), Expect = 2e-27
 Identities = 70/272 (25%), Positives = 121/272 (44%), Gaps = 29/272 (10%)

Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVL----LVANLQ 378
           D+     +LG G  G V K      G  +AVK +  +    +   + ++L    ++    
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI---NEAIQKQILRELDILHKCN 57

Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
              +V   G      +  +  E++   SLD  +     + ++      KI   + +GL Y
Sbjct: 58  SPYIVGFYGAFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILGKIAVAVLKGLTY 115

Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
           LHE    +IIHRD+K SN+L+++    K+ DFG++   ++  +   T   VGT  YMAPE
Sbjct: 116 LHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSG--QLVNSLAKTF--VGTSSYMAPE 169

Query: 499 YAMHGQYSVKSDVFSFGVLVLEIISGQ--RNNCFRNGETVEDLLSSAWKNWREGTTVNII 556
                 YSVKSD++S G+ ++E+ +G+          + + +LL            VN  
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQY---------IVNEP 220

Query: 557 DPTLSSGSITEMIRCIHIGLLCVQENVASRPT 588
            P L SG  +   +      LC+ ++   RP+
Sbjct: 221 PPRLPSGKFSPDFQ--DFVNLCLIKDPRERPS 250

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  111 bits (279), Expect = 3e-27
 Identities = 63/211 (29%), Positives = 106/211 (50%), Gaps = 23/211 (10%)

Query: 324 DNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFK----NEVLLVANLQ 378
            +      LGQG  G VYK R    G   A+K++      GD EF+     E+  + + +
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIH---VDGDEEFRKQLLRELKTLRSCE 57

Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR---- 434
              +V+  G   +  E  ++ E++   SL   +    ++     E    ++  IAR    
Sbjct: 58  SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLL----KKVGKIPEP---VLAYIARQILK 110

Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
           GL YLH  ++  IIHRD+K SN+L++++   KIADFG++++  ++ T    +  VGT  Y
Sbjct: 111 GLDYLH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKV--LENTLDQCNTFVGTVTY 166

Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           M+PE      YS  +D++S G+ +LE   G+
Sbjct: 167 MSPERIQGESYSYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  109 bits (275), Expect = 5e-27
 Identities = 62/197 (31%), Positives = 99/197 (50%), Gaps = 10/197 (5%)

Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLVRLLGFS 389
           K+G+G FG VYKG L    E+AVK             F  E  ++    H N+V+L+G  
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 390 LEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIH 449
           ++     ++ E VP  SL  F+    ++ +L  ++  ++    A G+ YL  +S+   IH
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYL--ESK-NCIH 116

Query: 450 RDLKTSNVLLDAEMTPKIADFGMARLFE--MDETQGNTSRIVGTYGYMAPEYAMHGQYSV 507
           RDL   N L+      KI+DFGM+R  E  +        +I     + APE   +G+Y+ 
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI--PIKWTAPEALNYGRYTS 174

Query: 508 KSDVFSFGVLVLEIISG 524
           +SDV+S+G+L+ E  S 
Sbjct: 175 ESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  108 bits (273), Expect = 2e-26
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 31/213 (14%)

Query: 332 LGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQGD-LEFKNEVLLVANLQHRNLVR 384
           LGQG FG VY+G             +A+K ++ ++   + +EF NE  ++      ++VR
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 385 LLGFSLEGNERLLIYEFV-------------PNTSLDHFIFDPTRRAQLDWERRYKIIGG 431
           LLG    G   L++ E +             P    +  +  PT       ++  ++   
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTL------QKFIQMAAE 127

Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQGNTSRIVG 490
           IA G+ YL      + +HRDL   N ++  ++T KI DFGM R ++E D  +     ++ 
Sbjct: 128 IADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLP 184

Query: 491 TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
              +MAPE    G ++ KSDV+SFGV++ E+ +
Sbjct: 185 VR-WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  108 bits (272), Expect = 3e-26
 Identities = 74/218 (33%), Positives = 106/218 (48%), Gaps = 19/218 (8%)

Query: 321 VATDNFSDANKLGQGGFGAVYKGRLYDGA-------EIAVKRLSRD-SGQGDLEFKNEVL 372
           V  D+ +    LG G FG VY+G LY G        ++AVK L    S Q + +F  E L
Sbjct: 3   VPRDSITLLRALGHGAFGEVYEG-LYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61

Query: 373 LVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFD----PTRRAQLDWERRYKI 428
           +++   H+N+VRL+G S E   R ++ E +    L  F+ +    P R + L  +     
Sbjct: 62  IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121

Query: 429 IGGIARGLLYLHEDSRLRIIHRDLKTSNVLLD---AEMTPKIADFGMARLFEMDETQGNT 485
              +A+G  YL E+     IHRD+   N LL         KIADFGMAR           
Sbjct: 122 ARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178

Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
            R +    +M PE  + G ++ K+DV+SFGVL+ EI S
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  107 bits (270), Expect = 3e-26
 Identities = 60/196 (30%), Positives = 98/196 (50%), Gaps = 12/196 (6%)

Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSL 390
           KLG G FG V++G   +   +AVK L   +     +F  E  ++  L+H  L++L     
Sbjct: 13  KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 391 EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHR 450
                 ++ E +   SL  ++     R  L   +   +   +A G+ YL   +    IHR
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGR-ALKLPQLIDMAAQVASGMAYLEAQN---YIHR 127

Query: 451 DLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT---YGYMAPEYAMHGQYSV 507
           DL   NVL+      K+ADFG+AR+ + D      +R  G      + APE A++ ++S+
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIY---EAR-EGAKFPIKWTAPEAALYNRFSI 183

Query: 508 KSDVFSFGVLVLEIIS 523
           KSDV+SFG+L+ EI++
Sbjct: 184 KSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  107 bits (268), Expect = 5e-26
 Identities = 68/264 (25%), Positives = 115/264 (43%), Gaps = 31/264 (11%)

Query: 332 LGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLE 391
           LG G FG V+ G+     ++A+K +   +   D +F  E  ++  L H NLV+L G   +
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED-DFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 392 GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRD 451
                ++ E++ N  L +++    R+ +L  E    +   +   + YL  +     IHRD
Sbjct: 71  QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125

Query: 452 LKTSNVLLDAEMTPKIADFGMARLFEMDE---TQGNTSRIVGTYGYMAPEYAMHGQYSVK 508
           L   N L+  +   K++DFG+AR    D+   +QG    +     +  PE   + ++S K
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPV----KWAPPEVFDYSRFSSK 181

Query: 509 SDVFSFGVLVLEIISGQRN--NCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSIT 566
           SDV+SFGVL+ E+ S  +     F N E VE +               +  P L+   + 
Sbjct: 182 SDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS----------AGYRLYRPKLAPTEVY 231

Query: 567 EMIRCIHIGLLCVQENVASRPTMA 590
            ++        C  E    RP   
Sbjct: 232 TIMY------SCWHEKPEDRPAFK 249

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  107 bits (268), Expect = 6e-26
 Identities = 76/275 (27%), Positives = 126/275 (45%), Gaps = 32/275 (11%)

Query: 325 NFSDANKLGQGGFGAVYK-GRLYDGAEIAVKR--LSRDSGQGDLEFKNEVLLVANLQHRN 381
           +F    KLG+G +G+VYK  RL D    A+K   L   S +   +  NE+ ++A++ H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTR-RAQLDWERRYKIIGGIARGLLYLH 440
           ++      L+GN+  ++ E+ P   L   I    + R  +  +  ++I   + RGL  LH
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 441 EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA 500
           E    +I+HRDLK++N+LL A    KI D G++++      +      +GT  YMAPE  
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMAPEVW 173

Query: 501 MHGQYSVKSDVFSFGVLVLEIISGQRNNCFR---NGETVEDLLSSAWKNWREGTTVNIID 557
               YS KSD++S G L+ E+ +      F       +++DL     +   +      I 
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMAT------FAPPFEARSMQDL-----RYKVQRGKYPPIP 222

Query: 558 PTLSSGSITEMIRCIHIGLLCVQENVASRPTMASV 592
           P  S     ++   I      +Q     RP    +
Sbjct: 223 PIYSQ----DLQNFIR---SMLQVKPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  107 bits (269), Expect = 7e-26
 Identities = 66/211 (31%), Positives = 109/211 (51%), Gaps = 23/211 (10%)

Query: 332 LGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRL 385
           LG+G FG+V   R YD      G  +AVK+L   + +   +F+ E+ ++ +LQH N+V+ 
Sbjct: 12  LGKGNFGSVELCR-YDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70

Query: 386 LG--FSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS 443
            G  +S       L+ E++P  SL  ++     R +LD  +       I +G+ YL    
Sbjct: 71  KGVCYSAGRRNLRLVMEYLPYGSLRDYL--QKHRERLDHRKLLLYASQICKGMEYL---G 125

Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE-----TQGNTSRIVGTYGYMAPE 498
             R +HRDL T N+L+++E   KI DFG+ ++   D+      +   S I     + APE
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF----WYAPE 181

Query: 499 YAMHGQYSVKSDVFSFGVLVLEIISGQRNNC 529
                ++SV SDV+SFGV++ E+ +    +C
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFTYSDKSC 212

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal

 Score =  100 bits (252), Expect = 1e-25
 Identities = 40/100 (40%), Positives = 49/100 (49%), Gaps = 1/100 (1%)

Query: 139 NVNNVTDDVSLFNQALQDLLRRLRGTAASGNSQKKFATGDTTASFRTIYALEQCTPDLSE 198
              N T   S F   L  LL  L   AAS +  K FA G + A+  T+Y L QC  DLS 
Sbjct: 8   TSGNYTTANSTFESNLNALLSSLSSNAASSSG-KGFAAGTSGAAPDTVYGLAQCRGDLSA 66

Query: 199 LQCSDCLDRAIGEIPNCCSGKIGGRVLKPSCNFRFETERF 238
             C  CL  A+ E+  CC  K GGR+   SC  R+E+  F
Sbjct: 67  SDCRSCLATAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106

This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  106 bits (266), Expect = 1e-25
 Identities = 71/202 (35%), Positives = 109/202 (53%), Gaps = 19/202 (9%)

Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLE---FKNEVLLVANLQHRNLVRLLG 387
           KLG G FG V+ G      ++A+K L     QG +    F  E  L+  LQH  LVRL  
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSLK----QGSMSPEAFLAEANLMKQLQHPRLVRL-- 66

Query: 388 FSLEGNERLLIY-EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLR 446
           +++   E + I  E++ N SL  F+  P    +L   +   +   IA G+ ++    R  
Sbjct: 67  YAVVTQEPIYIITEYMENGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIE---RKN 122

Query: 447 IIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY--GYMAPEYAMHGQ 504
            IHRDL+ +N+L+   +  KIADFG+ARL E +E    T+R    +   + APE   +G 
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAINYGT 179

Query: 505 YSVKSDVFSFGVLVLEIISGQR 526
           +++KSDV+SFG+L+ EI++  R
Sbjct: 180 FTIKSDVWSFGILLTEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  104 bits (261), Expect = 5e-25
 Identities = 52/195 (26%), Positives = 96/195 (49%), Gaps = 10/195 (5%)

Query: 331 KLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFS 389
           KLG+G +G+VYK      G  +A+K +  +    ++    E+ ++       +V+  G  
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEII--KEISILKQCDSPYIVKYYGSY 67

Query: 390 LEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIH 449
            +  +  ++ E+    S+   +        L  E    I+    +GL YLH     + IH
Sbjct: 68  FKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIH 122

Query: 450 RDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKS 509
           RD+K  N+LL+ E   K+ADFG++   ++ +T    + ++GT  +MAPE      Y+ K+
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKA 180

Query: 510 DVFSFGVLVLEIISG 524
           D++S G+  +E+  G
Sbjct: 181 DIWSLGITAIEMAEG 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  104 bits (262), Expect = 5e-25
 Identities = 57/201 (28%), Positives = 99/201 (49%), Gaps = 11/201 (5%)

Query: 326 FSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKN-EVLLVANLQHRNLV 383
           F+    +G+G FG VYK         +A+K +  +  + ++E    E+  ++  +   + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 384 RLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS 443
           +  G  L+G++  +I E+    S      D  +  +LD      I+  +  GL YLHE+ 
Sbjct: 63  KYYGSFLKGSKLWIIMEYCGGGS----CLDLLKPGKLDETYIAFILREVLLGLEYLHEE- 117

Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG 503
               IHRD+K +N+LL  E   K+ADFG++   ++  T    +  VGT  +MAPE     
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVSG--QLTSTMSKRNTFVGTPFWMAPEVIKQS 173

Query: 504 QYSVKSDVFSFGVLVLEIISG 524
            Y  K+D++S G+  +E+  G
Sbjct: 174 GYDEKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  103 bits (259), Expect = 7e-25
 Identities = 67/209 (32%), Positives = 116/209 (55%), Gaps = 13/209 (6%)

Query: 321 VATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHR 380
           +  ++     KLG G FG V+ G      ++AVK L   +   +  F  E  ++  L+H 
Sbjct: 3   IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE-SFLEEAQIMKKLRHD 61

Query: 381 NLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            LV+L  +++   E + ++ E++   SL  F+ D   RA L       +   +A G+ Y+
Sbjct: 62  KLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRA-LKLPNLVDMAAQVAAGMAYI 118

Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY--GYMAP 497
               R+  IHRDL+++N+L+   +  KIADFG+ARL E +E    T+R    +   + AP
Sbjct: 119 E---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY---TARQGAKFPIKWTAP 172

Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQR 526
           E A++G++++KSDV+SFG+L+ E+++  R
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  103 bits (258), Expect = 9e-25
 Identities = 69/198 (34%), Positives = 110/198 (55%), Gaps = 17/198 (8%)

Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRD-SGQGDLEFKNEVLLVANLQHRNLVRLLGFS 389
            +G+G FGAV +G  Y G ++AVK +  D + Q  LE   E  ++  L H+NLVRLLG  
Sbjct: 13  IIGEGEFGAVLQGE-YTGQKVAVKNIKCDVTAQAFLE---ETAVMTKLHHKNLVRLLGVI 68

Query: 390 LEGNERLLIYEFVPNTSLDHFIFDPTR-RAQLDWERRYKIIGGIARGLLYLHEDSRLRII 448
           L  N   ++ E +   +L +F+   TR RA +   +  +    +A G+ YL      +++
Sbjct: 69  LH-NGLYIVMELMSKGNLVNFL--RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLV 122

Query: 449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVK 508
           HRDL   N+L+  +   K++DFG+AR+  M     + S++     + APE   H ++S K
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSM---GVDNSKL--PVKWTAPEALKHKKFSSK 177

Query: 509 SDVFSFGVLVLEIISGQR 526
           SDV+S+GVL+ E+ S  R
Sbjct: 178 SDVWSYGVLLWEVFSYGR 195

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  103 bits (259), Expect = 1e-24
 Identities = 66/208 (31%), Positives = 96/208 (46%), Gaps = 22/208 (10%)

Query: 330 NKLGQGGFGAVYKG--RLYDGAEI--AVKRLSRD-SGQGDLEFKNEVLLVANLQHRNLVR 384
            +LG G FG+V KG   +  G E+  AVK L ++    G  EF  E  ++A L H  +VR
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 385 LLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLD---WERRYKIIGGIARGLLYLHE 441
           L+G    G   +L+ E  P   L  ++         D      +      +A G+ YL  
Sbjct: 61  LIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLES 113

Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY--GYMAPEY 499
                 +HRDL   NVLL      KI+DFGM+R           +   G +   + APE 
Sbjct: 114 K---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY-YRATTAGRWPLKWYAPEC 169

Query: 500 AMHGQYSVKSDVFSFGVLVLEIIS-GQR 526
             +G++S KSDV+S+GV + E  S G +
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFSYGAK 197

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score =  104 bits (260), Expect = 1e-24
 Identities = 68/202 (33%), Positives = 113/202 (55%), Gaps = 20/202 (9%)

Query: 332 LGQGGFGAVYKGRLYDGAE-----IAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRL 385
           LG G FG VYKG      E     +A+K L+  +G + ++EF +E L++A++ H +LVRL
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 386 LGFSLEGNERLLIYEFVPNTSLDHFIFDPT----RRAQLDWERRYKIIGGIARGLLYLHE 441
           LG  L    +L + + +P+  L  ++ +       +  L+W  +      IA+G++YL E
Sbjct: 75  LGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127

Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM 501
               R++HRDL   NVL+ +    KI DFG+ARL E DE + N         +MA E   
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184

Query: 502 HGQYSVKSDVFSFGVLVLEIIS 523
           + +++ +SDV+S+GV + E+++
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  102 bits (257), Expect = 2e-24
 Identities = 63/207 (30%), Positives = 107/207 (51%), Gaps = 15/207 (7%)

Query: 325 NFSDANKLGQGGFGAVYK------GRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQ 378
           +F   NK+G+G FG V+K       R+Y   +I + +++R   +   E  +E  ++A L 
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRERE---EAIDEARVLAKLD 57

Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
              ++R     L+  +  ++ E+  N  L H +    R   L  ++ ++    I  GL +
Sbjct: 58  SSYIIRYYESFLDKGKLNIVMEYAENGDL-HKLLKMQRGRPLPEDQVWRFFIQILLGLAH 116

Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
           LH     +I+HRD+K+ N+ LDA    KI D G+A+L   +    NT  IVGT  Y++PE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171

Query: 499 YAMHGQYSVKSDVFSFGVLVLEIISGQ 525
                 Y+ KSDV++ GV++ E  +G+
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  103 bits (257), Expect = 2e-24
 Identities = 68/210 (32%), Positives = 103/210 (49%), Gaps = 24/210 (11%)

Query: 330 NKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDL------EFKNEVLLVANLQHRNLV 383
             LG+G +G VY G    G  IAVK++  D+           + + EV L+ +L+H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 384 RLLGFSLEGNERLLIYEFVPNTSLDHFI--FDPTRRAQLDWERRY--KIIGGIARGLLYL 439
           + LG  L+ N   +  EFVP  S+   +  F P          +Y  +I+ G+A    YL
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVF---CKYTKQILDGVA----YL 118

Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIV----GTYGYM 495
           H +    ++HRD+K +NV+L      K+ DFG AR        G  S ++    GT  +M
Sbjct: 119 HNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175

Query: 496 APEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           APE      Y  KSD++S G  V E+ +G+
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  102 bits (257), Expect = 4e-24
 Identities = 57/207 (27%), Positives = 105/207 (50%), Gaps = 25/207 (12%)

Query: 330 NKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQ--GDLEFKNEVLLVANLQHRNLVRLL 386
            ++G+G +G VYK R    G  +A+K++  ++ +    +    E+ L+  L+H N+VRL 
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 387 G--FSLEGNERLLIYEFVPN--TSLDH---FIFDPTRRAQLDWERRYK-IIGGIARGLLY 438
               S       +++E++ +  T L       F     +Q+      K  +  +  GL Y
Sbjct: 65  EIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTE---SQI------KCYMKQLLEGLQY 115

Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
           LH +    I+HRD+K SN+L++ +   K+ADFG+AR +    +   T+R++ T  Y  PE
Sbjct: 116 LHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPE 171

Query: 499 YAMHG-QYSVKSDVFSFGVLVLEIISG 524
             +   +Y  + D++S G ++ E+  G
Sbjct: 172 LLLGATRYGPEVDMWSVGCILAELFLG 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  101 bits (254), Expect = 4e-24
 Identities = 71/214 (33%), Positives = 111/214 (51%), Gaps = 23/214 (10%)

Query: 332 LGQGGFGAVYKGRLYD----GAE---IAVKRLSRDS-GQGDLEFKNEVLLVANLQHRNLV 383
           LG G FG VY+G   D    G+    +AVK L + +  Q   EF  E  L++N  H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 384 RLLGFSLEGNERLLIYEFVPNTSLDHFIFDP----TRRAQLDWERRYKIIGGIARGLLYL 439
           +LLG  L    + +I E +    L  ++ D          L  +    I   +A+G +YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 440 HEDSRLRIIHRDLKTSNVLL-----DAEMTPKIADFGMAR-LFEMDETQGNTSRIVGTYG 493
               ++  IHRDL   N L+     DA+   KI DFG+AR +++ D  +     ++    
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178

Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQR 526
           +MAPE  + G+++ +SDV+SFGVL+ EI++ GQ+
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQ 212

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  101 bits (254), Expect = 5e-24
 Identities = 69/227 (30%), Positives = 112/227 (49%), Gaps = 28/227 (12%)

Query: 332 LGQGGFGAVYKG-RLYDGAEIAVKRLSRDSGQGDLE---------FKNEVLLVANLQHRN 381
           +G G FG+VY G     G  +AVK++   S     +            E+ L+  LQH N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           +V+ LG SL+ +   +  E+VP  S+   +         +       +  I +GL YLH 
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALL---NNYGAFEETLVRNFVRQILKGLNYLH- 123

Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQG--NTSR--IVGTYGYMAP 497
            +R  IIHRD+K +N+L+D +   KI+DFG+++  E +      N +R  + G+  +MAP
Sbjct: 124 -NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISG--------QRNNCFRNGETV 536
           E      Y+ K+D++S G LV+E+++G        Q    F+ GE  
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA 228

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  101 bits (254), Expect = 6e-24
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 14/206 (6%)

Query: 330 NKLGQGGFGAVYK-GRLYDGAEIAVKRLSRDSGQGDLEFK----NEVLLVANLQHRNLVR 384
             +G+G FG V K  R  DG  +  K +  D G    + K    +EV ++  L+H N+VR
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEI--DYGNMTEKEKQQLVSEVNILRELKHPNIVR 63

Query: 385 LLG-FSLEGNERLLIY-EFVPNTSLDHFIFDPTR-RAQLDWERRYKIIGGIARGLLYLH- 440
                    N+ L I  E+     L   I    + R  ++ E  ++I+  +   L   H 
Sbjct: 64  YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123

Query: 441 -EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
             D    ++HRDLK +N+ LDA    K+ DFG+A++  +          VGT  YM+PE 
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI--LGHDSSFAKTYVGTPYYMSPEQ 181

Query: 500 AMHGQYSVKSDVFSFGVLVLEIISGQ 525
             H  Y  KSD++S G L+ E+ +  
Sbjct: 182 LNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score =  102 bits (254), Expect = 6e-24
 Identities = 75/245 (30%), Positives = 132/245 (53%), Gaps = 35/245 (14%)

Query: 319 IRVATDNFSDANKLGQGGFGAVYKGRLYDGA------EIAVKRLSRDSGQGDL--EFKNE 370
           I ++T  F +  +LG+  FG VYKG L+  A       +A+K L +D  +G L  EFK+E
Sbjct: 2   INLSTVRFME--ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKAEGPLREEFKHE 58

Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIF-------------DPTRR 417
            ++ + LQH N+V LLG   +     +I+ +  ++ L  F+              D T +
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 418 AQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LF 476
           + L+      I+  IA G+ +L   S   ++H+DL T NVL+  ++  KI+D G+ R ++
Sbjct: 119 STLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175

Query: 477 EMD--ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNC-FRN 532
             D  +  GN+   +    +M+PE  M+G++S+ SD++S+GV++ E+ S G +  C + N
Sbjct: 176 AADYYKLMGNSLLPIR---WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 232

Query: 533 GETVE 537
            + +E
Sbjct: 233 QDVIE 237

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  101 bits (254), Expect = 7e-24
 Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 31/219 (14%)

Query: 332 LGQGGFGAVYKGR---LYDGAE---IAVKRLSRD-SGQGDLEFKNEVLLVANLQHRNLVR 384
           +GQG FG V++ R   L        +AVK L  + S     +F+ E  L+A   H N+V+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 385 LLGFSLEGNERLLIYEFVPNTSLDHFIFD-------------------PTRRAQLDWERR 425
           LLG    G    L++E++    L+ F+                           L    +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 426 YKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQGN 484
             I   +A G+ YL E    + +HRDL T N L+   M  KIADFG++R ++  D  + +
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 485 TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
            +  +    +M PE   + +Y+ +SDV+++GV++ EI S
Sbjct: 190 ENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  101 bits (252), Expect = 7e-24
 Identities = 69/197 (35%), Positives = 103/197 (52%), Gaps = 14/197 (7%)

Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLVRLLGFS 389
           KLG G FG V+ G   +  ++AVK L    G   ++ F  E  L+  LQH  LVRL    
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTLK--PGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70

Query: 390 LEGNERLLIYEFVPNTSLDHFI-FDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRII 448
            +     +I E++   SL  F+  D   +  L   +       IA G+ Y+    R   I
Sbjct: 71  TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE---RKNYI 125

Query: 449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY--GYMAPEYAMHGQYS 506
           HRDL+ +NVL+   +  KIADFG+AR+ E +E    T+R    +   + APE    G ++
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFGSFT 182

Query: 507 VKSDVFSFGVLVLEIIS 523
           +KSDV+SFG+L+ EI++
Sbjct: 183 IKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  101 bits (254), Expect = 8e-24
 Identities = 62/203 (30%), Positives = 108/203 (53%), Gaps = 19/203 (9%)

Query: 331 KLGQGGFGAVYKGR-LYDGAEIAVKR--LSRDSGQGDLEFKNEVLLVANLQHRNLVRLLG 387
           ++G+G  G V+K +    G  +A+K+  L R  G    +   E+  +   QH  +V+LL 
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 388 FSLEGNERLLIYEFVPNTSLDHFIFD---PTRRAQLDWERRYKIIGGIARGLLYLHEDSR 444
               G+  +L+ E++P + L   + D   P   AQ+   + Y  +  + +G+ Y+H    
Sbjct: 67  VFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQV---KSYMRM--LLKGVAYMHA--- 117

Query: 445 LRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQ 504
             I+HRDLK +N+L+ A+   KIADFG+ARLF  +E +  + + V T  Y APE  ++G 
Sbjct: 118 NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPEL-LYGA 175

Query: 505 --YSVKSDVFSFGVLVLEIISGQ 525
             Y    D+++ G +  E+++G 
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  101 bits (253), Expect = 1e-23
 Identities = 66/202 (32%), Positives = 103/202 (50%), Gaps = 18/202 (8%)

Query: 331 KLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK----NEVLLVANLQHRNLVRL 385
           KLG+G +G VYK R    G  +A+K++  D    +         E+ L+  L+H N+V+L
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHPNIVKL 63

Query: 386 LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IARGLLYLHEDSR 444
           L       +  L++E+  +  L  ++    R   L      K I   + RGL Y H  S 
Sbjct: 64  LDVIHTERKLYLVFEYC-DMDLKKYL--DKRPGPLS-PNLIKSIMYQLLRGLAYCH--SH 117

Query: 445 LRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQ 504
            RI+HRDLK  N+L++ +   K+ADFG+AR F +      T  +V T  Y APE  +  +
Sbjct: 118 -RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-YTHEVV-TLWYRAPEILLGSK 174

Query: 505 -YSVKSDVFSFGVLVLEIISGQ 525
            YS   D++S G +  E+I+G+
Sbjct: 175 HYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  100 bits (251), Expect = 1e-23
 Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 14/206 (6%)

Query: 323 TDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLS----RDSGQGDLEFKNEVLLVANL 377
             NF    K+G+G F  VYK   L DG  +A+K++      D+       K E+ L+  L
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQL 59

Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERR-YKIIGGIARGL 436
            H N+++ L   +E NE  ++ E      L   I    ++ +L  ER  +K    +   L
Sbjct: 60  DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119

Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMA 496
            ++H     RI+HRD+K +NV + A    K+ D G+ R F    T  ++  +VGT  YM+
Sbjct: 120 EHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMS 174

Query: 497 PEYAMHGQ-YSVKSDVFSFGVLVLEI 521
           PE  +H   Y+ KSD++S G L+ E+
Sbjct: 175 PE-RIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 99.5 bits (248), Expect = 3e-23
 Identities = 67/211 (31%), Positives = 109/211 (51%), Gaps = 25/211 (11%)

Query: 332 LGQGGFGAVYKGRLYDGAE-IAVKRLS--------RDSGQGDL--EFKNEVLLVANLQHR 380
           +G+G +G VY        E +AVK++          DS Q D+    ++E+  + +L H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 381 NLVRLLGFSLEGNERLLIY-EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
           N+V+ LGF     E L I+ E+VP  S+   +    R    + +        +  GL YL
Sbjct: 69  NIVQYLGFE-TTEEYLSIFLEYVPGGSIGSCLRTYGR---FEEQLVRFFTEQVLEGLAYL 124

Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN--TSRIVGTYGYMAP 497
           H      I+HRDLK  N+L+DA+   KI+DFG+++  + D+   N     + G+  +MAP
Sbjct: 125 HSKG---ILHRDLKADNLLVDADGICKISDFGISK--KSDDIYDNDQNMSMQGSVFWMAP 179

Query: 498 E--YAMHGQYSVKSDVFSFGVLVLEIISGQR 526
           E  ++    YS K D++S G +VLE+ +G+R
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 99.7 bits (248), Expect = 4e-23
 Identities = 63/211 (29%), Positives = 103/211 (48%), Gaps = 21/211 (9%)

Query: 331 KLGQGGFGAVYKGRLY------DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVR 384
           +LG+G FG V+    +      D   +AVK L   S     +F+ E  L+  LQH+++VR
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 385 LLGFSLEGNERLLIYEFVPNTSLDHF---------IFDPTRRA---QLDWERRYKIIGGI 432
             G   EG   L+++E++ +  L+ F         I          QL   +   I   I
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 433 ARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY 492
           A G++YL   + L  +HRDL T N L+   +  KI DFGM+R     +      R +   
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188

Query: 493 GYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
            +M PE  ++ +++ +SD++SFGV++ EI +
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 99.7 bits (248), Expect = 5e-23
 Identities = 66/228 (28%), Positives = 113/228 (49%), Gaps = 30/228 (13%)

Query: 331 KLGQGGFGAVYKGRLY------DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVR 384
           +LG+G FG V+    Y      D   +AVK L   +     +F+ E  L+ NLQH ++V+
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71

Query: 385 LLGFSLEGNERLLIYEFVPNTSLDHFIF------------DPTR-RAQLDWERRYKIIGG 431
             G   +G+  ++++E++ +  L+ F+              P + + +L   +   I   
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131

Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVG- 490
           IA G++YL   +    +HRDL T N L+ A +  KI DFGM+R    D    +  R+ G 
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVGGH 184

Query: 491 ---TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGET 535
                 +M PE  M+ +++ +SDV+SFGV++ EI +  +   F+   T
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 232

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 98.4 bits (245), Expect = 7e-23
 Identities = 61/194 (31%), Positives = 102/194 (52%), Gaps = 9/194 (4%)

Query: 330 NKLGQGGFGAVYKG--RLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLG 387
           +KLG G +G VY+G  + Y    +AVK L  D+ + + EF  E  ++  ++H NLV+LLG
Sbjct: 12  HKLGGGQYGEVYEGVWKKYS-LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 69

Query: 388 FSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRI 447
                    +I EF+   +L  ++ +   R +++      +   I+  + YL + +    
Sbjct: 70  VCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKN---F 125

Query: 448 IHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSV 507
           IHRDL   N L+      K+ADFG++RL    +T    +       + APE   + ++S+
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSI 184

Query: 508 KSDVFSFGVLVLEI 521
           KSDV++FGVL+ EI
Sbjct: 185 KSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 98.2 bits (244), Expect = 8e-23
 Identities = 63/199 (31%), Positives = 110/199 (55%), Gaps = 13/199 (6%)

Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSL 390
           KLGQG FG V+ G       +A+K L   +   +  F  E  ++  L+H  LV+L  +++
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL--YAV 69

Query: 391 EGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIH 449
              E + ++ E++   SL  F+     +  L   +   +   IA G+ Y+    R+  +H
Sbjct: 70  VSEEPIYIVTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVH 125

Query: 450 RDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY--GYMAPEYAMHGQYSV 507
           RDL+ +N+L+   +  K+ADFG+ARL E +E    T+R    +   + APE A++G++++
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTI 182

Query: 508 KSDVFSFGVLVLEIISGQR 526
           KSDV+SFG+L+ E+ +  R
Sbjct: 183 KSDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 98.5 bits (245), Expect = 9e-23
 Identities = 70/205 (34%), Positives = 113/205 (55%), Gaps = 22/205 (10%)

Query: 332 LGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLVR 384
           LG+G FG V   R YD      G ++AVK L  +SG   + + K E+ ++ NL H N+V+
Sbjct: 12  LGEGHFGKVELCR-YDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70

Query: 385 LLGFSLE--GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
             G   E  GN   LI EF+P+ SL  ++  P  + +++ +++ K    I +G+ YL   
Sbjct: 71  YKGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYL--G 126

Query: 443 SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE----TQGNTSRIVGTYGYMAPE 498
           SR + +HRDL   NVL+++E   KI DFG+ +  E D+     + +    V  Y   APE
Sbjct: 127 SR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY---APE 182

Query: 499 YAMHGQYSVKSDVFSFGVLVLEIIS 523
             +  ++ + SDV+SFGV + E+++
Sbjct: 183 CLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 97.8 bits (243), Expect = 9e-23
 Identities = 79/272 (29%), Positives = 137/272 (50%), Gaps = 27/272 (9%)

Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSL 390
           KLGQG FG V+ G      ++A+K L   +   +  F  E  ++  L+H  LV L  +++
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE-AFLQEAQIMKKLRHDKLVPL--YAV 69

Query: 391 EGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIH 449
              E + ++ EF+   SL  F+ +   +  L   +   +   IA G+ Y+    R+  IH
Sbjct: 70  VSEEPIYIVTEFMGKGSLLDFLKEGDGK-YLKLPQLVDMAAQIADGMAYIE---RMNYIH 125

Query: 450 RDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY--GYMAPEYAMHGQYSV 507
           RDL+ +N+L+   +  KIADFG+ARL E +E    T+R    +   + APE A++G++++
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTI 182

Query: 508 KSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITE 567
           KSDV+SFG+L+ E+++  R      G    ++L    + +R         P     S+ E
Sbjct: 183 KSDVWSFGILLTELVTKGR--VPYPGMVNREVLEQVERGYRMPC------PQGCPESLHE 234

Query: 568 MIRCIHIGLLCVQENVASRPTMASVVLMLNSY 599
           +++      LC +++   RPT   +   L  Y
Sbjct: 235 LMK------LCWKKDPDERPTFEYIQSFLEDY 260

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 98.2 bits (245), Expect = 1e-22
 Identities = 66/197 (33%), Positives = 105/197 (53%), Gaps = 13/197 (6%)

Query: 331 KLGQGGFGAVYKGR-LYDGAEIAVKRL---SRDSGQGDLEFKNEVLLVANLQHRNLVRLL 386
           K+G+G +G VYK R    G  +A+K++   + D G      + E+ L+  L H N+VRLL
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR-EISLLKELNHPNIVRLL 64

Query: 387 GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLR 446
                 N+  L++EF+ +  L  ++ D +    LD       +  + +G+ Y H  S  R
Sbjct: 65  DVVHSENKLYLVFEFL-DLDLKKYM-DSSPLTGLDPPLIKSYLYQLLQGIAYCH--SH-R 119

Query: 447 IIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG-QY 505
           ++HRDLK  N+L+D E   K+ADFG+AR F +   +  T  +V T  Y APE  +   QY
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEILLGSRQY 177

Query: 506 SVKSDVFSFGVLVLEII 522
           S   D++S G +  E++
Sbjct: 178 STPVDIWSIGCIFAEMV 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 97.9 bits (244), Expect = 1e-22
 Identities = 60/203 (29%), Positives = 107/203 (52%), Gaps = 23/203 (11%)

Query: 332 LGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDL-EFKNEVLLVANLQH---RNLVRLL 386
           +G+G +GAVY+G+ +  G  +A+K ++ D+   D+ + + EV L++ L+     N+ +  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 387 GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL----YLHED 442
           G  L+G    +I E+    S+   +     +A    E+    I  I R +L    Y+H+ 
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSVRTLM-----KAGPIAEK---YISVIIREVLVALKYIHKV 120

Query: 443 SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMH 502
               +IHRD+K +N+L+      K+ DFG+A L   ++     S  VGT  +MAPE    
Sbjct: 121 G---VIHRDIKAANILVTNTGNVKLCDFGVAALL--NQNSSKRSTFVGTPYWMAPEVITE 175

Query: 503 GQ-YSVKSDVFSFGVLVLEIISG 524
           G+ Y  K+D++S G+ + E+ +G
Sbjct: 176 GKYYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 97.6 bits (243), Expect = 1e-22
 Identities = 66/215 (30%), Positives = 99/215 (46%), Gaps = 25/215 (11%)

Query: 323 TDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRN 381
            D   +   LG+G +G VY  R L     IA+K +     +       E+ L + L+HRN
Sbjct: 7   YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66

Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFI---FDPTRRAQLDWERRYKIIGG-IARGLL 437
           +V+ LG   E     +  E VP  SL   +   + P +    D E+        I  GL 
Sbjct: 67  IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLK----DNEQTIIFYTKQILEGLK 122

Query: 438 YLHEDSRLRIIHRDLKTSNVLLDA-EMTPKIADFG----MARLFEMDETQGNTSRIVGTY 492
           YLH+    +I+HRD+K  NVL++      KI+DFG    +A +    ET        GT 
Sbjct: 123 YLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET------FTGTL 173

Query: 493 GYMAPEYAMHGQ--YSVKSDVFSFGVLVLEIISGQ 525
            YMAPE    G   Y   +D++S G  ++E+ +G+
Sbjct: 174 QYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 97.4 bits (243), Expect = 2e-22
 Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 14/200 (7%)

Query: 331 KLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKN--EVLLVANLQHRNLVRLLG 387
           K+G+G +G VYK R    G  +A+K++        +      E+ L+  L H N+++LL 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 388 FSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRI 447
                 +  L++EF+ +T L   I D  R+  L        +  + +GL + H      I
Sbjct: 66  VFRHKGDLYLVFEFM-DTDLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCH---SHGI 119

Query: 448 IHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE--YAMHGQY 505
           +HRDLK  N+L++ E   K+ADFG+AR F         +  V T  Y APE        Y
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSP--VRPYTHYVVTRWYRAPELLLGD-KGY 176

Query: 506 SVKSDVFSFGVLVLEIISGQ 525
           S   D++S G +  E++S +
Sbjct: 177 STPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 97.8 bits (243), Expect = 2e-22
 Identities = 68/229 (29%), Positives = 114/229 (49%), Gaps = 29/229 (12%)

Query: 331 KLGQGGFGAVYKGRLY------DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVR 384
           +LG+G FG V+    Y      D   +AVK L   S     +F  E  L+ NLQH ++V+
Sbjct: 12  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71

Query: 385 LLGFSLEGNERLLIYEFVPNTSLDHFI----------FDPTRRAQLDWERRYKIIGGIAR 434
             G  +EG+  ++++E++ +  L+ F+           +  R A+L   +   I   IA 
Sbjct: 72  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131

Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVG---- 490
           G++YL   +    +HRDL T N L+   +  KI DFGM+R    D    +  R+ G    
Sbjct: 132 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTDYYRVGGHTML 184

Query: 491 TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFR--NGETVE 537
              +M PE  M+ +++ +SDV+S GV++ EI +  +   ++  N E +E
Sbjct: 185 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 233

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 96.8 bits (241), Expect = 2e-22
 Identities = 72/265 (27%), Positives = 127/265 (47%), Gaps = 25/265 (9%)

Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSL 390
           +LG G FG V+ G+     ++A+K +  +    + +F  E  ++  L H  LV+L G   
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 391 EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHR 450
           +     ++ EF+ N  L +++    R+ +L  +    +   +  G+ YL  +S    IHR
Sbjct: 70  QQKPLYIVTEFMENGCLLNYLRQ--RQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124

Query: 451 DLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSD 510
           DL   N L+ +    K++DFGM R + +D+   ++S       +  PE     +YS KSD
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSD 183

Query: 511 VFSFGVLVLEIISGQRN--NCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEM 568
           V+SFGVL+ E+ +  +       N E VE ++S  ++ +R         P L+S ++ E+
Sbjct: 184 VWSFGVLMWEVFTEGKMPFEKKSNYEVVE-MISRGFRLYR---------PKLASMTVYEV 233

Query: 569 IRCIHIGLLCVQENVASRPTMASVV 593
           +        C  E    RPT A ++
Sbjct: 234 M------YSCWHEKPEGRPTFAELL 252

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 96.1 bits (239), Expect = 4e-22
 Identities = 76/270 (28%), Positives = 125/270 (46%), Gaps = 33/270 (12%)

Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSL 390
           +LG G FG V  G+     ++A+K +   S   D EF  E  ++  L H  LV+L G   
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 391 EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHR 450
           +     ++ E++ N  L +++ +  +R Q    +  ++   +  G+ YL      + IHR
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLREHGKRFQP--SQLLEMCKDVCEGMAYLESK---QFIHR 124

Query: 451 DLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT---YGYMAPEYAMHGQYSV 507
           DL   N L+D +   K++DFG++R    DE   +    VG+     +  PE  ++ ++S 
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYSKFSS 180

Query: 508 KSDVFSFGVLVLEIIS--GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSI 565
           KSDV++FGVL+ E+ S        F N ETVE  +S   + +R         P L+S  +
Sbjct: 181 KSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK-VSQGLRLYR---------PHLASEKV 230

Query: 566 -TEMIRCIHIGLLCVQENVASRPTMASVVL 594
              M  C H       E    RPT   ++ 
Sbjct: 231 YAIMYSCWH-------EKAEERPTFQQLLS 253

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 96.2 bits (239), Expect = 5e-22
 Identities = 71/229 (31%), Positives = 113/229 (49%), Gaps = 25/229 (10%)

Query: 331 KLGQGGFGAVYKGRLY----DGAE-IAVKRLSR-DSGQGDLEFKNEVLLVANLQHRNLVR 384
           +LG+  FG +YKG LY    D A+ +A+K L   ++ Q   EF+ E  L+A L H N+V 
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 385 LLGFSLEGNERLLIYEFVPNTSLDHFIF--------------DPTRRAQLDWERRYKIIG 430
           LLG   +     +++E++    L  F+               D T ++ LD      I  
Sbjct: 72  LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131

Query: 431 GIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVG 490
            IA G+ YL   S    +H+DL   N+L+  ++  KI+D G++R     +      + + 
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188

Query: 491 TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG--QRNNCFRNGETVE 537
              +M PE  M+G++S  SD++SFGV++ EI S   Q    F N E +E
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE 237

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 95.6 bits (238), Expect = 6e-22
 Identities = 65/202 (32%), Positives = 101/202 (50%), Gaps = 19/202 (9%)

Query: 332 LGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLE-----FKNEVLLVANLQHRNLV 383
           LGQG FG VY    YD   G E+AVK++  D    + +      + E+ L+ NLQH  +V
Sbjct: 10  LGQGAFGRVY--LCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 384 RLLGFSLEGNERLLIY-EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           +  G  L  +E L I+ E++P  S+   +        L      K    I  G+ YLH +
Sbjct: 68  QYYG-CLRDDETLSIFMEYMPGGSVKDQL---KAYGALTETVTRKYTRQILEGVEYLHSN 123

Query: 443 SRLRIIHRDLKTSNVLLDAEMTPKIADFGMA-RLFEMDETQGNTSRIVGTYGYMAPEYAM 501
               I+HRD+K +N+L D+    K+ DFG + RL  +  +      + GT  +M+PE   
Sbjct: 124 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180

Query: 502 HGQYSVKSDVFSFGVLVLEIIS 523
              Y  K+DV+S G  V+E+++
Sbjct: 181 GEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 96.1 bits (240), Expect = 6e-22
 Identities = 62/229 (27%), Positives = 103/229 (44%), Gaps = 37/229 (16%)

Query: 324 DNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLS-----RDSGQGDLEFKNEVLLVANL 377
           D+F     +G+G F  V   +      E A+K L      ++     ++ + EVL   N 
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN- 59

Query: 378 QHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWER--RYKIIGGIAR 434
            H  +++L  ++ +  E L  + E+ PN  L  +I    +   LD E+  R+     I  
Sbjct: 60  GHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI---RKYGSLD-EKCTRF-YAAEILL 113

Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF-------------EMDET 481
            L YLH      IIHRDLK  N+LLD +M  KI DFG A++                 ++
Sbjct: 114 ALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170

Query: 482 QGNTSRI-----VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           Q   +R      VGT  Y++PE          SD+++ G ++ ++++G+
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 95.7 bits (238), Expect = 6e-22
 Identities = 64/209 (30%), Positives = 110/209 (52%), Gaps = 26/209 (12%)

Query: 332 LGQGGFGAVYKGR-LYDGAEIAVKRLS----RDSGQGDL--EFKNEVLLVANLQHRNLVR 384
           LG G F + Y+ R +  G  +AVK+++      S Q ++    + E+ L+A L H +++R
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 385 LLGFSLEGNERLLIYEFVPNTSLDHFI--FDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           +LG + E +   L  E++   S+ H +  +   + A +           + RGL YLHE+
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVII-----NYTEQLLRGLSYLHEN 122

Query: 443 SRLRIIHRDLKTSNVLLDAE-MTPKIADFGMA-----RLFEMDETQGNTSRIVGTYGYMA 496
              +IIHRD+K +N+L+D+     +IADFG A     +     E QG   +++GT  +MA
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG---QLLGTIAFMA 176

Query: 497 PEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           PE     QY    DV+S G +++E+ + +
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 95.5 bits (238), Expect = 6e-22
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 26/211 (12%)

Query: 330 NKLGQGGFGAVYKG-RLYDGAEIAVK--RLSRDSGQGDLEFKNEVLLVANLQHRNLVRLL 386
           NK+G G FG VY    L  G  +AVK  R+  +  +   E  +E+ ++  L+H NLV+  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 387 GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLR 446
           G  +   +  +  E+    +L+  + +  R       R Y +   +  GL YLH      
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELL-EHGRILDEHVIRVYTL--QLLEGLAYLHSH---G 119

Query: 447 IIHRDLKTSNVLLDAEMTPKIADFGMA--------RLFEMDETQGNTSRIVGTYGYMAPE 498
           I+HRD+K +N+ LD     K+ DFG A         + E  ++      + GT  YMAPE
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS------LAGTPAYMAPE 173

Query: 499 YAMHGQYSVK---SDVFSFGVLVLEIISGQR 526
               G+       +D++S G +VLE+ +G+R
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 95.2 bits (237), Expect = 8e-22
 Identities = 66/205 (32%), Positives = 106/205 (51%), Gaps = 23/205 (11%)

Query: 332 LGQGGFGAVYKGRLYDGAEI----AVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLVRLL 386
           +G+G FG VY G L D        AVK L+R +   ++E F  E +++ +  H N++ LL
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 387 GFSL--EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIG---GIARGLLYLHE 441
           G  L  EG+  L++  ++ +  L +FI   T    +       +IG    +A+G+ YL  
Sbjct: 63  GICLPSEGSP-LVVLPYMKHGDLRNFIRSETHNPTVK-----DLIGFGLQVAKGMEYLAS 116

Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF---EMDETQGNTSRIVGTYGYMAPE 498
               + +HRDL   N +LD   T K+ADFG+AR     E      +T   +    +MA E
Sbjct: 117 K---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV-KWMALE 172

Query: 499 YAMHGQYSVKSDVFSFGVLVLEIIS 523
                +++ KSDV+SFGVL+ E+++
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 95.6 bits (238), Expect = 8e-22
 Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 14/205 (6%)

Query: 325 NFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRL---SRDSGQGDLEFKNEVLLVANLQHR 380
           +++   K+G+G +G VYKGR    G  +A+K++   S + G      + E+ L+  LQH 
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR-EISLLKELQHP 59

Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQ-LDWERRYKIIGGIARGLLYL 439
           N+V L    ++ +   LI+EF+ +  L  ++ D   + Q +D E     +  I +G+L+ 
Sbjct: 60  NIVCLQDVLMQESRLYLIFEFL-SMDLKKYL-DSLPKGQYMDAELVKSYLYQILQGILFC 117

Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
           H     R++HRDLK  N+L+D +   K+ADFG+AR F +   +  T  +V T  Y APE 
Sbjct: 118 H---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYTHEVV-TLWYRAPEV 172

Query: 500 AMHGQ-YSVKSDVFSFGVLVLEIIS 523
            +    YS   D++S G +  E+ +
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMAT 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 95.5 bits (237), Expect = 9e-22
 Identities = 62/203 (30%), Positives = 107/203 (52%), Gaps = 13/203 (6%)

Query: 326 FSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLV 383
           F+   ++G+G FG VYKG      E+ A+K +  +  + ++E  + E+ +++      + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 384 RLLGFSLEGNERLLIYEFVPN-TSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           R  G  L+G +  +I E++   ++LD     P     +       I+  I +GL YLH +
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA-----TILREILKGLDYLHSE 120

Query: 443 SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMH 502
              R IHRD+K +NVLL  +   K+ADFG+A   ++ +TQ   +  VGT  +MAPE    
Sbjct: 121 ---RKIHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIKQ 175

Query: 503 GQYSVKSDVFSFGVLVLEIISGQ 525
             Y  K+D++S G+  +E+  G+
Sbjct: 176 SAYDFKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 94.7 bits (236), Expect = 1e-21
 Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 10/201 (4%)

Query: 330 NKLGQGGFGAVYKGRLYDGAE-IAVKRLSRDSGQGDLEF-KNEVLLVANLQHRNLVRLLG 387
             +G G    VY        E +A+KR+  +  Q  ++  + EV  ++   H N+V+   
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66

Query: 388 FSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRI 447
             + G+E  L+  ++   SL   +     R  LD      ++  + +GL YLH + +   
Sbjct: 67  SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ--- 123

Query: 448 IHRDLKTSNVLLDAEMTPKIADFGM-ARLFE-MDETQGNTSRIVGTYGYMAPEYAMHGQ- 504
           IHRD+K  N+LL  + + KIADFG+ A L +  D T+      VGT  +MAPE  M    
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE-VMEQVH 182

Query: 505 -YSVKSDVFSFGVLVLEIISG 524
            Y  K+D++SFG+  +E+ +G
Sbjct: 183 GYDFKADIWSFGITAIELATG 203

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 94.4 bits (235), Expect = 1e-21
 Identities = 78/280 (27%), Positives = 119/280 (42%), Gaps = 40/280 (14%)

Query: 331 KLGQGGFGAVYKGR----LYDGAEIAVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLVRL 385
           KLG G FG V +G           +AVK L  D     + +F  E  ++ +L H NL+RL
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 386 LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLD-------WERRYKIIGGIARGLLY 438
            G  L  +  +++ E  P  SL     D  R+  L         +  Y +   IA G+ Y
Sbjct: 62  YGVVLT-HPLMMVTELAPLGSL----LDRLRKDALGHFLISTLCD--YAV--QIANGMRY 112

Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQGNTSRIVGTYGYMAP 497
           L      R IHRDL   N+LL ++   KI DFG+ R L + ++       +   + + AP
Sbjct: 113 LESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAP 169

Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNII 556
           E      +S  SDV+ FGV + E+ + G+      +G  +   +       +EG    + 
Sbjct: 170 ESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID------KEGE--RLE 221

Query: 557 DPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLML 596
            P      I  ++      L C   N A RPT A++   L
Sbjct: 222 RPEACPQDIYNVM------LQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 94.3 bits (234), Expect = 2e-21
 Identities = 70/199 (35%), Positives = 105/199 (52%), Gaps = 14/199 (7%)

Query: 332 LGQGGFGAVYKG-RLYDGAEI----AVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLVRL 385
           LG G FG V+KG  + +G  I    A+K +   SG+    E  + +L + +L H  +VRL
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 386 LGFSLEGNERLLIYEFVPNTSL-DHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSR 444
           LG    G    L+ +  P  SL DH       R  LD +R       IA+G+ YL E   
Sbjct: 75  LGIC-PGASLQLVTQLSPLGSLLDHV---RQHRDSLDPQRLLNWCVQIAKGMYYLEEH-- 128

Query: 445 LRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQ 504
            R++HR+L   N+LL ++   +IADFG+A L   D+ +   S       +MA E  + G+
Sbjct: 129 -RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR 187

Query: 505 YSVKSDVFSFGVLVLEIIS 523
           Y+ +SDV+S+GV V E++S
Sbjct: 188 YTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 93.5 bits (232), Expect = 2e-21
 Identities = 63/193 (32%), Positives = 97/193 (50%), Gaps = 7/193 (3%)

Query: 332 LGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQG-DLEFKNEVLLVANLQHRNLVRLLGFSL 390
           LG+G FG V+KG L D   +AVK    D  Q   ++F +E  ++    H N+V+L+G   
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 391 EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHR 450
           +     ++ E VP    D   F   ++ +L  ++  K     A G+ YL   +    IHR
Sbjct: 63  QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117

Query: 451 DLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSD 510
           DL   N L+      KI+DFGM+R  E D    ++        + APE   +G+YS +SD
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQ-EDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176

Query: 511 VFSFGVLVLEIIS 523
           V+S+G+L+ E  S
Sbjct: 177 VWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 93.4 bits (232), Expect = 5e-21
 Identities = 57/201 (28%), Positives = 102/201 (50%), Gaps = 10/201 (4%)

Query: 326 FSDANKLGQGGFGAVYKG-RLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVR 384
           ++   K+GQG  G VY    +  G E+A+K+++           NE+L++   +H N+V 
Sbjct: 21  YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80

Query: 385 LLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSR 444
            L   L G+E  ++ E++   SL     D      +D  +   +     + L +LH +  
Sbjct: 81  YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN-- 134

Query: 445 LRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQ 504
            ++IHRD+K+ N+LL  + + K+ DFG     ++   Q   S +VGT  +MAPE      
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKA 191

Query: 505 YSVKSDVFSFGVLVLEIISGQ 525
           Y  K D++S G++ +E++ G+
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 93.0 bits (231), Expect = 5e-21
 Identities = 64/212 (30%), Positives = 109/212 (51%), Gaps = 23/212 (10%)

Query: 332 LGQGGFGAVYKGRLY--DGA--EIAVKRLSRD-SGQGDLE-FKNEVLLVANLQHRNLVRL 385
           LG+G FG+V +G+L   DG+  ++AVK +  D     ++E F +E   + +  H N+++L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 386 LGFSLEGNER------LLIYEFVPNTSLDHFIFDP---TRRAQLDWERRYKIIGGIARGL 436
           +G   E +        ++I  F+ +  L  F+          +L  +   K +  IA G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMD-ETQGNTSRIVGTYGY 494
            YL   S    IHRDL   N +L  +MT  +ADFG+++ ++  D   QG  +++     +
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM--PVKW 181

Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQ 525
           +A E      Y+ KSDV++FGV + EI + GQ
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQ 213

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 92.8 bits (230), Expect = 5e-21
 Identities = 66/200 (33%), Positives = 105/200 (52%), Gaps = 15/200 (7%)

Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLVRLLGFS 389
           KLG G FG V+        ++AVK +    G   +E F  E  ++  LQH  LV+L    
Sbjct: 13  KLGAGQFGEVWMATYNKHTKVAVKTMK--PGSMSVEAFLAEANVMKTLQHDKLVKLHAV- 69

Query: 390 LEGNERLLIYEFVPNTSLDHFI-FDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRII 448
           +      +I EF+   SL  F+  D   +  L   +       IA G+ ++ + +    I
Sbjct: 70  VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YI 124

Query: 449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY--GYMAPEYAMHGQYS 506
           HRDL+ +N+L+ A +  KIADFG+AR+ E +E    T+R    +   + APE    G ++
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFGSFT 181

Query: 507 VKSDVFSFGVLVLEIISGQR 526
           +KSDV+SFG+L++EI++  R
Sbjct: 182 IKSDVWSFGILLMEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 92.0 bits (228), Expect = 9e-21
 Identities = 65/197 (32%), Positives = 102/197 (51%), Gaps = 15/197 (7%)

Query: 332 LGQGGFGAVYKGRLYDGAEIAVKRLSRD-SGQGDLEFKNEVLLVANLQHRNLVRLLGFSL 390
           +G+G FG V  G  Y G ++AVK +  D + Q    F  E  ++  L+H NLV+LLG  +
Sbjct: 14  IGKGEFGDVMLGD-YRGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 69

Query: 391 EGNERLLIY-EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIH 449
           E    L I  E++   SL  ++     R+ L  +   K    +   + YL  ++    +H
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVH 125

Query: 450 RDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKS 509
           RDL   NVL+  +   K++DFG+ +  E   TQ +T ++     + APE     ++S KS
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK--EASSTQ-DTGKL--PVKWTAPEALREKKFSTKS 180

Query: 510 DVFSFGVLVLEIISGQR 526
           DV+SFG+L+ EI S  R
Sbjct: 181 DVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 92.1 bits (229), Expect = 1e-20
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 17/205 (8%)

Query: 332 LGQGGFGAVYKGRLYDGAE------IAVKRL-SRDSGQGDLEFKNEVLLVANLQHRNLVR 384
           LG+G FG V+  +     E      + VK L          EF+ E+ +   L H+N+VR
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 385 LLGFSLEGNERLLIYEFVPNTSLDHFIF-----DPTRRAQ-LDWERRYKIIGGIARGLLY 438
           LLG   E     +I E+     L  F+      D   +   L  +++  +   IA G+ +
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132

Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
           L   S  R +HRDL   N L+ ++   K++   +++     E     + ++    ++APE
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAPE 188

Query: 499 YAMHGQYSVKSDVFSFGVLVLEIIS 523
                 +S KSDV+SFGVL+ E+ +
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 92.0 bits (229), Expect = 1e-20
 Identities = 67/257 (26%), Positives = 105/257 (40%), Gaps = 31/257 (12%)

Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAEI-------AVKRLSRDSGQGDLEFKNEVLLVANL 377
           +F     +G+G FG V   +  D  ++         K + + S +  L   NE  ++  L
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVL---NERRILQEL 57

Query: 378 QHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGL 436
            H  LV L  +S +  E + L+ + +    L + +   +++ +   E+    I  I   L
Sbjct: 58  NHPFLVNLW-YSFQDEENMYLVVDLLLGGDLRYHL---SQKVKFSEEQVKFWICEIVLAL 113

Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMA 496
            YLH      IIHRD+K  N+LLD +    I DF +A     D     T+   GT GYMA
Sbjct: 114 EYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMA 167

Query: 497 PEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNII 556
           PE      YSV  D +S GV   E + G+R     +    + + +               
Sbjct: 168 PEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETA---------- 217

Query: 557 DPTLSSGSITEMIRCIH 573
           D    +   TE I  I+
Sbjct: 218 DVLYPATWSTEAIDAIN 234

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 92.0 bits (228), Expect = 1e-20
 Identities = 60/207 (28%), Positives = 107/207 (51%), Gaps = 15/207 (7%)

Query: 326 FSDANKLGQGGFGAVYKGRLYDG---AEIAVKRLSRDSGQGDLE-FKNEVLLVANLQHRN 381
           F+   ++G+G FG V+KG   D      +A+K +  +  + ++E  + E+ +++      
Sbjct: 6   FTKLERIGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           + +  G  L+G +  +I E++   S      D  R    D  +   ++  I +GL YLH 
Sbjct: 64  VTKYYGSYLKGTKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDYLHS 119

Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM 501
           + +   IHRD+K +NVLL  +   K+ADFG+A   ++ +TQ   +  VGT  +MAPE   
Sbjct: 120 EKK---IHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIQ 174

Query: 502 HGQYSVKSDVFSFGVLVLEIISGQRNN 528
              Y  K+D++S G+  +E+  G+  N
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPPN 201

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 91.7 bits (228), Expect = 2e-20
 Identities = 68/221 (30%), Positives = 104/221 (47%), Gaps = 34/221 (15%)

Query: 324 DNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQG-------DLEFKNEVLLVA 375
           +   + ++LG+G  G+V K RL +   I A+K ++ D           +LE         
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINK------ 54

Query: 376 NLQHRNLVRLLG-FSLEGNERLLI-YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA 433
           + +   +V+  G F  E +  + I  E+    SLD       +R     E   K++G IA
Sbjct: 55  SCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGE---KVLGKIA 111

Query: 434 ----RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIV 489
               +GL YLH     +IIHRD+K SN+LL  +   K+ DFG++   E+  +   T    
Sbjct: 112 ESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSG--ELVNSLAGT--FT 164

Query: 490 GTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCF 530
           GT  YMAPE      YS+ SDV+S G+ +LE+      N F
Sbjct: 165 GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVA----QNRF 201

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 90.7 bits (225), Expect = 4e-20
 Identities = 67/206 (32%), Positives = 99/206 (48%), Gaps = 26/206 (12%)

Query: 332 LGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLVR 384
           LG+G FG V     YD      G  +AVK L R+ GQ +   +K E+ ++  L H N+V+
Sbjct: 12  LGEGHFGKVSLYC-YDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70

Query: 385 LLGFSLEGNER--LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
             G   E   +   LI E+VP  SL  ++     + +L+  +       I  G+ YLH  
Sbjct: 71  YKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYLHSQ 126

Query: 443 SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG-----YMAP 497
                IHRDL   NVLLD +   KI DFG+A+       +G+    V   G     + A 
Sbjct: 127 ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV----PEGHEYYRVREDGDSPVFWYAV 179

Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIIS 523
           E     ++S  SDV+SFGV + E+++
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 90.9 bits (225), Expect = 4e-20
 Identities = 57/201 (28%), Positives = 103/201 (51%), Gaps = 10/201 (4%)

Query: 326 FSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVR 384
           ++   K+GQG  G V+    +  G E+A+K+++           NE+L++  L++ N+V 
Sbjct: 21  YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80

Query: 385 LLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSR 444
            L   L G+E  ++ E++   SL     D      +D  +   +     + L +LH +  
Sbjct: 81  FLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECLQALEFLHAN-- 134

Query: 445 LRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQ 504
            ++IHRD+K+ NVLL  + + K+ DFG     ++   Q   S +VGT  +MAPE      
Sbjct: 135 -QVIHRDIKSDNVLLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKA 191

Query: 505 YSVKSDVFSFGVLVLEIISGQ 525
           Y  K D++S G++ +E++ G+
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 90.6 bits (225), Expect = 4e-20
 Identities = 63/202 (31%), Positives = 95/202 (47%), Gaps = 19/202 (9%)

Query: 332 LGQGGFGAVY------KGRLYDGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVR 384
           LG+GGFG V        G++Y   ++  KRL +  G Q  L   NE  ++  +  R +V 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMAL---NEKKILEKVSSRFIVS 57

Query: 385 LLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS 443
           L  ++ E  + L L+   +    L + I++          R       I  GL +LH   
Sbjct: 58  L-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPG-FPEARAIFYAAQIICGLEHLH--- 112

Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG 503
           + RI++RDLK  NVLLD     +I+D G+A   E+   +    R  GT GYMAPE     
Sbjct: 113 QRRIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGR-AGTPGYMAPEVLQGE 169

Query: 504 QYSVKSDVFSFGVLVLEIISGQ 525
            Y    D F+ G  + E+I+G+
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 90.5 bits (224), Expect = 5e-20
 Identities = 66/201 (32%), Positives = 107/201 (53%), Gaps = 18/201 (8%)

Query: 332 LGQGGFGAVYKG-RLYDGAEI----AVKRLSRD-SGQGDLEFKNEVLLVANLQHRNLVRL 385
           LG G FG VYKG  + DG  +    A+K L  + S + + E  +E  ++A +    + RL
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 386 LGFSLEGNERLLIYEFVPNTSLDHFIFDPTR---RAQLDWERRYKIIGGIARGLLYLHED 442
           LG  L    +L+         LD+   +  R   +  L+W  +      IA+G+ YL E 
Sbjct: 75  LGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE- 127

Query: 443 SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMH 502
             +R++HRDL   NVL+ +    KI DFG+ARL ++DET+ +         +MA E  +H
Sbjct: 128 --VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILH 185

Query: 503 GQYSVKSDVFSFGVLVLEIIS 523
            +++ +SDV+S+GV V E+++
Sbjct: 186 RRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 89.7 bits (222), Expect = 5e-20
 Identities = 65/200 (32%), Positives = 99/200 (49%), Gaps = 17/200 (8%)

Query: 331 KLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLE--FKNEVLLVANLQHRNLVRLLG 387
           ++G+G FG V+ GRL  D   +AVK   R++   DL+  F  E  ++    H N+VRL+G
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKS-CRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 388 FSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRI 447
              +     ++ E V     D   F  T   +L  +   +++   A G+ YL        
Sbjct: 61  VCTQKQPIYIVMELVQGG--DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---C 115

Query: 448 IHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT----YGYMAPEYAMHG 503
           IHRDL   N L+  +   KI+DFGM+R    +E  G  +   G       + APE   +G
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALNYG 171

Query: 504 QYSVKSDVFSFGVLVLEIIS 523
           +YS +SDV+SFG+L+ E  S
Sbjct: 172 RYSSESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 90.2 bits (224), Expect = 5e-20
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 14/211 (6%)

Query: 319 IRVATDNFSDANKLGQGGFGAVYKGRLY-----DGAEIAVKRLSRDSGQGDLE-FKNEVL 372
             +  ++ +    +G+G FG VY+G +Y     +   +AVK     +     E F  E  
Sbjct: 1   YEIQREDITLGRCIGEGQFGDVYQG-VYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAY 59

Query: 373 LVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGI 432
           ++    H ++V+L+G  +  N   ++ E  P   L  ++     +  LD          +
Sbjct: 60  IMRQFDHPHIVKLIGV-ITENPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQL 116

Query: 433 ARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY 492
           +  L YL      R +HRD+   NVL+ +    K+ DFG++R  E DE+    S+     
Sbjct: 117 STALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPI 172

Query: 493 GYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
            +MAPE     +++  SDV+ FGV + EI+ 
Sbjct: 173 KWMAPESINFRRFTSASDVWMFGVCMWEILM 203

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 90.0 bits (223), Expect = 5e-20
 Identities = 62/207 (29%), Positives = 114/207 (55%), Gaps = 22/207 (10%)

Query: 332 LGQGGFGAVYKGRL----YDGAEIAVKRLSRD-SGQGDLEFKNEVLLVANLQHRNLVRLL 386
           +G G FG V++G L         +A+K L    + +   +F +E  ++    H N++RL 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 387 GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWE-RRYKIIG---GIARGLLYLHED 442
           G   +    ++I E++ N +LD ++ D       D E   Y+++G   GIA G+ YL   
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYLRDH------DGEFSSYQLVGMLRGIAAGMKYL--- 123

Query: 443 SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG--YMAPEYA 500
           S +  +HRDL   N+L+++ +  K++DFG++R+ E D+ +G  +   G     + APE  
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE-DDPEGTYTTSGGKIPIRWTAPEAI 182

Query: 501 MHGQYSVKSDVFSFGVLVLEIIS-GQR 526
            + +++  SDV+SFG+++ E++S G+R
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFGER 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 89.3 bits (222), Expect = 7e-20
 Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 21/205 (10%)

Query: 330 NKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGF 388
            ++G G +G VYK R     E+ A+K +  + G      + E+ ++   +H N+V   G 
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFG- 67

Query: 389 SLEGNERLLI-YEFVPNTSLDHFIFDPTRRA----QLDWERRYKIIGGIARGLLYLHEDS 443
           S    ++L I  E+    SL   I+  TR      Q+ +  R  +     +GL YLHE  
Sbjct: 68  SYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETL-----KGLAYLHE-- 119

Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA--- 500
               IHRD+K +N+LL  +   K+ADFG++   ++  T       +GT  +MAPE A   
Sbjct: 120 -TGKIHRDIKGANILLTEDGDVKLADFGVSA--QLTATIAKRKSFIGTPYWMAPEVAAVE 176

Query: 501 MHGQYSVKSDVFSFGVLVLEIISGQ 525
             G Y  K D+++ G+  +E+   Q
Sbjct: 177 RKGGYDGKCDIWALGITAIELAELQ 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 89.2 bits (221), Expect = 1e-19
 Identities = 62/201 (30%), Positives = 100/201 (49%), Gaps = 17/201 (8%)

Query: 332 LGQGGFGAV------YKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRL 385
           LG+GGFG V        G++Y   ++  KRL + SG+     + E+L   N      +  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN---SPFIVN 57

Query: 386 LGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSR 444
           L ++ E    L L+   +    L + I++   R  L+ ER       I  G+L+LH    
Sbjct: 58  LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG-LEMERVIHYSAQITCGILHLHS--- 113

Query: 445 LRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQ 504
           + I++RD+K  NVLLD +   +++D G+A   E+ + +  T R  GT GYMAPE      
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQR-AGTNGYMAPEILKEEP 170

Query: 505 YSVKSDVFSFGVLVLEIISGQ 525
           YS   D F+ G  + E+++G+
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 88.8 bits (220), Expect = 1e-19
 Identities = 61/209 (29%), Positives = 109/209 (52%), Gaps = 26/209 (12%)

Query: 332 LGQGGFGAVYKGRLY--DGAEIAVKRLSRDSGQGDLE---FKNEVLLVANLQHRNLVRLL 386
           +G G FG V  GRL      EI V   +  +G  + +   F +E  ++    H N++ L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 387 GFSLEGNERLLIYEFVPNTSLDHFIFDPTRR--AQLDWERRYKIIGGIARGLLYLHEDSR 444
           G   +    +++ E++ N SLD F+    R+   Q    +   ++ GIA G+ YL   S 
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFL----RKHDGQFTVIQLVGMLRGIASGMKYL---SD 124

Query: 445 LRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG------YMAPE 498
           +  +HRDL   N+L+++ +  K++DFG++R+ E D     T+R     G      + APE
Sbjct: 125 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR-----GGKIPIRWTAPE 179

Query: 499 YAMHGQYSVKSDVFSFGVLVLEIIS-GQR 526
              + +++  SDV+S+G+++ E++S G+R
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMSYGER 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 89.1 bits (221), Expect = 2e-19
 Identities = 67/204 (32%), Positives = 107/204 (52%), Gaps = 11/204 (5%)

Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQGDLEFK-NEVLLVANLQHRNL 382
           NF    KLG+G +  VYKGR     EI A+K +  D+ +G       E+ L+  L+H N+
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           VRL       N+ +L++E++    L  ++     R  LD          + +G+ + HE+
Sbjct: 61  VRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119

Query: 443 SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNT-SRIVGTYGYMAPEYAM 501
              R++HRDLK  N+L++     K+ADFG+AR F +     NT S  V T  Y AP+  +
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV---NTFSNEVVTLWYRAPDVLL 173

Query: 502 HGQ-YSVKSDVFSFGVLVLEIISG 524
             + YS   D++S G ++ E+I+G
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITG 197

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 89.0 bits (220), Expect = 2e-19
 Identities = 61/205 (29%), Positives = 109/205 (53%), Gaps = 17/205 (8%)

Query: 326 FSDANKLGQGGFGAVYKGRLYDGAE---IAVKRLSRDSGQGDLE-FKNEVLLVANLQHRN 381
           F+   K+G+G FG V+KG   D      +A+K +  +  + ++E  + E+ +++      
Sbjct: 6   FTKLEKIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 382 LVRLLGFSLEGNERLLIYEFVPN-TSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH 440
           + +  G  L+  +  +I E++   ++LD  + +P     LD  +   I+  I +GL YLH
Sbjct: 64  VTKYYGSYLKDTKLWIIMEYLGGGSALD--LLEP---GPLDETQIATILREILKGLDYLH 118

Query: 441 EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA 500
            + +   IHRD+K +NVLL      K+ADFG+A   ++ +TQ   +  VGT  +MAPE  
Sbjct: 119 SEKK---IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVI 173

Query: 501 MHGQYSVKSDVFSFGVLVLEIISGQ 525
               Y  K+D++S G+  +E+  G+
Sbjct: 174 KQSAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 88.6 bits (219), Expect = 2e-19
 Identities = 64/216 (29%), Positives = 111/216 (51%), Gaps = 19/216 (8%)

Query: 321 VATDNFSDANKLGQGGFGAVY----KGRLYDGAE--IAVKRLSRDSGQGD-LEFKNEVLL 373
           VA +  + + +LGQG FG VY    KG + D  E  +A+K ++  +   + +EF NE  +
Sbjct: 3   VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 62

Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLD-------WERRY 426
           +      ++VRLLG   +G   L+I E +    L  ++       + +        ++  
Sbjct: 63  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122

Query: 427 KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQGNT 485
           ++ G IA G+ YL+ +   + +HRDL   N ++  + T KI DFGM R ++E D  +   
Sbjct: 123 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179

Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEI 521
             ++    +M+PE    G ++  SDV+SFGV++ EI
Sbjct: 180 KGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 88.4 bits (219), Expect = 2e-19
 Identities = 58/204 (28%), Positives = 108/204 (52%), Gaps = 14/204 (6%)

Query: 332 LGQGGFGAVYKGRLYDGAE----IAVKRLSRD-SGQGDLEFKNEVLLVANLQHRNLVRLL 386
           +G G FG V +GRL    +    +A+K L    + +   +F +E  ++    H N++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 387 GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLR 446
           G   +    ++I EF+ N +LD F+       Q    +   ++ GIA G+ YL E   + 
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYLSE---MN 126

Query: 447 IIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVG---TYGYMAPEYAMHG 503
            +HRDL   N+L+++ +  K++DFG++R  E D +    +  +G      + APE   + 
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186

Query: 504 QYSVKSDVFSFGVLVLEIIS-GQR 526
           +++  SDV+S+G+++ E++S G+R
Sbjct: 187 KFTSASDVWSYGIVMWEVMSYGER 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 89.3 bits (221), Expect = 2e-19
 Identities = 69/214 (32%), Positives = 104/214 (48%), Gaps = 32/214 (14%)

Query: 326 FSDANKLGQGGFGAVYKGRLYDGAE-----IAVKRLSR-DSGQGDLEFKNEVLLVANLQH 379
           F     LG G FG VYKG      E     +A+K L    S + + E  +E  ++A++ +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYK-IIGG------- 431
            ++ RLLG  L    +L I + +P   L            LD+ R +K  IG        
Sbjct: 69  PHVCRLLGICLTSTVQL-ITQLMPFGCL------------LDYVREHKDNIGSQYLLNWC 115

Query: 432 --IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIV 489
             IA+G+ YL E    R++HRDL   NVL+      KI DFG+A+L   DE + +     
Sbjct: 116 VQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGK 172

Query: 490 GTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
               +MA E  +H  Y+ +SDV+S+GV V E+++
Sbjct: 173 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 88.0 bits (218), Expect = 2e-19
 Identities = 58/202 (28%), Positives = 102/202 (50%), Gaps = 17/202 (8%)

Query: 332 LGQGGFGAVYKGRLYDGA------EIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRL 385
           +G+G FG V+  R           +I V+++++D        +NE  ++  L H N++  
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLA---AQNECQVLKLLSHPNIIEY 64

Query: 386 LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRL 445
               LE    +++ E+ P  +L  +I      + LD +    I+    + LL LH     
Sbjct: 65  YENFLEDKALMIVMEYAPGGTLAEYIQK-RCNSLLDED---TILHFFVQILLALHHVHTK 120

Query: 446 RIIHRDLKTSNVLLDA-EMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQ 504
            I+HRDLKT N+LLD  +M  KI DFG++++     ++     +VGT  Y++PE      
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPCYISPELCEGKP 177

Query: 505 YSVKSDVFSFGVLVLEIISGQR 526
           Y+ KSD+++ G ++ E+ S +R
Sbjct: 178 YNQKSDIWALGCVLYELASLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 88.2 bits (218), Expect = 3e-19
 Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 10/206 (4%)

Query: 325 NFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLS---RDSGQGDLEFKNEVLLVANLQHR 380
           NF    K+G+G F  VY+   L DG  +A+K++        +   +   E+ L+  L H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERR-YKIIGGIARGLLYL 439
           N+++     +E NE  ++ E      L   I    ++ +L  E+  +K    +   L ++
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122

Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
           H  SR R++HRD+K +NV + A    K+ D G+ R F    T  ++  +VGT  YM+PE 
Sbjct: 123 H--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 177

Query: 500 AMHGQYSVKSDVFSFGVLVLEIISGQ 525
                Y+ KSD++S G L+ E+ + Q
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQ 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 88.0 bits (219), Expect = 4e-19
 Identities = 67/219 (30%), Positives = 101/219 (46%), Gaps = 35/219 (15%)

Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRD----SGQGDLEFKN 369
           DF  I+           LG G FG V   R     +  A+K LS+       Q +    N
Sbjct: 2   DFEFIKT----------LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVE-HVLN 50

Query: 370 EVLLVANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQ---LDWERR 425
           E  ++ +++H  LV L G S + +  L L+ E+VP   L    F   R++        R 
Sbjct: 51  EKRILQSIRHPFLVNLYG-SFQDDSNLYLVMEYVPGGEL----FSHLRKSGRFPEPVARF 105

Query: 426 YKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNT 485
           Y     +   L YLH    L I++RDLK  N+LLD++   KI DFG A+  +     G T
Sbjct: 106 Y--AAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK-----GRT 155

Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
             + GT  Y+APE  +   Y    D ++ G+L+ E+++G
Sbjct: 156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 88.2 bits (218), Expect = 4e-19
 Identities = 61/208 (29%), Positives = 110/208 (52%), Gaps = 15/208 (7%)

Query: 320 RVATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLS-RDSGQGDLEFKNEVLLVANL 377
           R   +N+    K+G+G  G V   R  + G ++AVK +  R   + +L F NEV+++ + 
Sbjct: 20  RSLLENYI---KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLF-NEVVIMRDY 75

Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           QH+N+V +    L G E  ++ EF+   +L     D   + +L+ E+   +   + + L 
Sbjct: 76  QHQNVVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALC 131

Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           YLH      +IHRD+K+ ++LL  +   K++DFG       D  +  +  +VGT  +MAP
Sbjct: 132 YLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAP 186

Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           E      Y  + D++S G++V+E++ G+
Sbjct: 187 EVISRTPYGTEVDIWSLGIMVIEMVDGE 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 88.1 bits (218), Expect = 4e-19
 Identities = 82/290 (28%), Positives = 133/290 (45%), Gaps = 50/290 (17%)

Query: 332 LGQGGFGAVYKGRLY-DGAEI--AVKRLSRDSGQGD-LEFKNEVLLVANL-QHRNLVRLL 386
           +G+G FG V K R+  DG  +  A+KR+   + + D  +F  E+ ++  L  H N++ LL
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 387 GFSLEGNERLLIYEFVPNTSLDHFI-------FDP------TRRAQLDWERRYKIIGGIA 433
           G         L  E+ P+ +L  F+        DP      +  + L  ++       +A
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134

Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
           RG+ YL   S+ + IHRDL   N+L+      KIADFG++R        G    +  T G
Sbjct: 135 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--------GQEVYVKKTMG 183

Query: 494 -----YMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNW 547
                +MA E   +  Y+  SDV+S+GVL+ EI+S G    C   G T  +L     + +
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC---GMTCAELYEKLPQGY 240

Query: 548 REGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN 597
           R    +N  D       + +++R       C +E    RP+ A +++ LN
Sbjct: 241 RLEKPLNCDD------EVYDLMR------QCWREKPYERPSFAQILVSLN 278

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 87.1 bits (216), Expect = 4e-19
 Identities = 66/274 (24%), Positives = 123/274 (44%), Gaps = 36/274 (13%)

Query: 332 LGQGGFG-AVYKGRLYDGAEIAVKR--LSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGF 388
           LG+G FG A    R  D + +  K   L+R S +   +  NE+++++ LQH N++     
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67

Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI--IGGIARGLLYLHEDSRLR 446
            ++ N  L+  E+    +L   I    R+    +E    +  +  I   + Y+H+     
Sbjct: 68  FMDDNTLLIEMEYANGGTLYDKI---VRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--- 121

Query: 447 IIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYS 506
           I+HRD+KT N+ L      K+ DFG++++   + +   T  +VGT  YM+PE     +Y+
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVKYN 179

Query: 507 VKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWK----NWREGTTVNIIDPTLSS 562
            KSD+++ G ++ E++        +      + L+   K    N+              S
Sbjct: 180 FKSDIWALGCVLYELL------TLKRTFDATNPLNLVVKIVQGNYTPVV----------S 223

Query: 563 GSITEMIRCIHIGLLCVQENVASRPTMASVVLML 596
              +E+I  +H     +Q++   RPT   V+   
Sbjct: 224 VYSSELISLVH---SLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 87.5 bits (216), Expect = 5e-19
 Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 18/210 (8%)

Query: 332 LGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEV-LLVANLQHRNLVRLLGFSL 390
           +G G +G VYKGR     ++A  ++   +G  + E K E+ +L     HRN+    G  +
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73

Query: 391 EGN------ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSR 444
           + N      +  L+ EF    S+   I + T+   L  E    I   I RGL +LH+   
Sbjct: 74  KKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICREILRGLSHLHQH-- 130

Query: 445 LRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM--- 501
            ++IHRD+K  NVLL      K+ DFG++   ++D T G  +  +GT  +MAPE      
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAPEVIACDE 187

Query: 502 --HGQYSVKSDVFSFGVLVLEIISGQRNNC 529
                Y  KSD++S G+  +E+  G    C
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEGAPPLC 217

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 87.5 bits (217), Expect = 5e-19
 Identities = 57/203 (28%), Positives = 107/203 (52%), Gaps = 12/203 (5%)

Query: 325 NFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLS-RDSGQGDLEFKNEVLLVANLQHRNL 382
              +  K+G+G  G V        G ++AVK++  R   + +L F NEV+++ + QH N+
Sbjct: 20  YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLF-NEVVIMRDYQHPNI 78

Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           V +    L G+E  ++ EF+   +L   I   TR   ++ E+   +   + + L +LH  
Sbjct: 79  VEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTR---MNEEQIATVCLAVLKALSFLHAQ 134

Query: 443 SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMH 502
               +IHRD+K+ ++LL ++   K++DFG       +  +  +  +VGT  +MAPE    
Sbjct: 135 ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPEVISR 189

Query: 503 GQYSVKSDVFSFGVLVLEIISGQ 525
             Y  + D++S G++V+E++ G+
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 87.8 bits (217), Expect = 5e-19
 Identities = 62/199 (31%), Positives = 104/199 (52%), Gaps = 17/199 (8%)

Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLVRLLG-F 388
           +LG G FG VYK +  +   +A  ++     + +LE +  E+ ++A   H  +V+LLG F
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKII-GGIARGLLYLHEDSRLRI 447
             +G   ++I EF P  ++D  + +  R      E + ++I   +   L YLH    ++I
Sbjct: 79  YWDGKLWIMI-EFCPGGAVDAIMLELDRGLT---EPQIQVICRQMLEALQYLHS---MKI 131

Query: 448 IHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM-----H 502
           IHRDLK  NVLL  +   K+ADFG++   +  +T       +GT  +MAPE  M      
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSA--KNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189

Query: 503 GQYSVKSDVFSFGVLVLEI 521
             Y  K+D++S G+ ++E+
Sbjct: 190 TPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 87.0 bits (215), Expect = 5e-19
 Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 10/202 (4%)

Query: 325 NFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLS---RDSGQGDLEFKNEVLLVANLQHR 380
           NF    K+G+G F  VY+   L D   +A+K++        +   +   E+ L+  L H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERR-YKIIGGIARGLLYL 439
           N+++ L   +E NE  ++ E      L   I    ++ +L  ER  +K    +   + ++
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
           H  SR R++HRD+K +NV + A    K+ D G+ R F    T  ++  +VGT  YM+PE 
Sbjct: 123 H--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 177

Query: 500 AMHGQYSVKSDVFSFGVLVLEI 521
                Y+ KSD++S G L+ E+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 87.5 bits (217), Expect = 5e-19
 Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 15/206 (7%)

Query: 323 TDNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRN 381
            D +    +LG G FG VYK +  + G   A K +  +S +   +F  E+ +++  +H N
Sbjct: 4   NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63

Query: 382 LVRLL-GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH 440
           +V L   +  E    +LI EF    +LD  I     R   + + RY +   +   L +LH
Sbjct: 64  IVGLYEAYFYENKLWILI-EFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLH 120

Query: 441 EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA 500
                ++IHRDLK  N+LL  +   K+ADFG++   +    Q   +  +GT  +MAPE  
Sbjct: 121 SH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNK-STLQKRDT-FIGTPYWMAPEVV 175

Query: 501 M-----HGQYSVKSDVFSFGVLVLEI 521
                    Y  K+D++S G+ ++E+
Sbjct: 176 ACETFKDNPYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 88.1 bits (218), Expect = 6e-19
 Identities = 70/223 (31%), Positives = 106/223 (47%), Gaps = 26/223 (11%)

Query: 324 DNFSDANKLGQGGFGAVYKGRLY--------DGAEIAVKRLSRDSGQGDL-EFKNEVLLV 374
           D       LG+G FG V +   Y            +AVK L  ++   DL +  +E+ L+
Sbjct: 12  DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71

Query: 375 ANL-QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI-----------FDPTR--RAQL 420
             + +H+N++ LLG   +     +I E+    +L  F+           FD T+    QL
Sbjct: 72  KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131

Query: 421 DWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE 480
            ++        +ARG+ YL  +SR R IHRDL   NVL+  +   KIADFG+AR     +
Sbjct: 132 SFKDLVSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDID 188

Query: 481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
               TS       +MAPE      Y+ +SDV+SFG+L+ EI +
Sbjct: 189 YYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 87.4 bits (217), Expect = 7e-19
 Identities = 68/222 (30%), Positives = 100/222 (45%), Gaps = 35/222 (15%)

Query: 331 KLGQGGFGAVY------------KGRLYDG-----AEIAVKRLSRDSGQGDL-EFKNEVL 372
           KLG+G FG V+            K    +        +AVK L  D+      +F  EV 
Sbjct: 12  KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71

Query: 373 LVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI--------FDPTRRAQLDWER 424
           +++ L   N+ RLLG         +I E++ N  L+ F+                L +  
Sbjct: 72  ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131

Query: 425 RYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMD--ET 481
              +   IA G+ YL     L  +HRDL T N L+    T KIADFGM+R L+  D    
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188

Query: 482 QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
           QG   R      +MA E  + G+++ KSDV++FGV + EI++
Sbjct: 189 QG---RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 86.6 bits (214), Expect = 1e-18
 Identities = 63/218 (28%), Positives = 106/218 (48%), Gaps = 19/218 (8%)

Query: 321 VATDNFSDANKLGQGGFGAVYKGRLYD------GAEIAVKRLSRD-SGQGDLEFKNEVLL 373
           V+ +  +   +LGQG FG VY+G   D         +AVK ++   S +  +EF NE  +
Sbjct: 3   VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 62

Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIF-------DPTRRAQLDWERRY 426
           +      ++VRLLG   +G   L++ E + +  L  ++        +   R     +   
Sbjct: 63  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 122

Query: 427 KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQGNT 485
           ++   IA G+ YL+     + +HRDL   N ++  + T KI DFGM R ++E D  +   
Sbjct: 123 QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG 179

Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
             ++     MAPE    G ++  SD++SFGV++ EI S
Sbjct: 180 KGLLPVRW-MAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 86.3 bits (213), Expect = 2e-18
 Identities = 56/201 (27%), Positives = 102/201 (50%), Gaps = 10/201 (4%)

Query: 326 FSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVR 384
           ++   K+GQG  G VY    +  G E+A+++++           NE+L++   ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 385 LLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSR 444
            L   L G+E  ++ E++   SL     D      +D  +   +     + L +LH +  
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN-- 135

Query: 445 LRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQ 504
            ++IHRD+K+ N+LL  + + K+ DFG     ++   Q   S +VGT  +MAPE      
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKA 192

Query: 505 YSVKSDVFSFGVLVLEIISGQ 525
           Y  K D++S G++ +E+I G+
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 85.9 bits (212), Expect = 2e-18
 Identities = 56/201 (27%), Positives = 102/201 (50%), Gaps = 10/201 (4%)

Query: 326 FSDANKLGQGGFGAVYKG-RLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVR 384
           ++   K+GQG  G VY    +  G E+A+K+++           NE+L++   ++ N+V 
Sbjct: 21  YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVN 80

Query: 385 LLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSR 444
            L   L G+E  ++ E++   SL     D      +D  +   +     + L +LH +  
Sbjct: 81  YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALDFLHSN-- 134

Query: 445 LRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQ 504
            ++IHRD+K+ N+LL  + + K+ DFG     ++   Q   S +VGT  +MAPE      
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKA 191

Query: 505 YSVKSDVFSFGVLVLEIISGQ 525
           Y  K D++S G++ +E++ G+
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 85.2 bits (211), Expect = 2e-18
 Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 23/206 (11%)

Query: 332 LGQGGFGAVYKGRLYDGAE--IAVKRLS------------RDSGQGDLEFKNEVLLV-AN 376
           LG G FG VYK R  +  +  +A+K ++            RD   GD+   +EV ++   
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDI--VSEVTIIKEQ 65

Query: 377 LQHRNLVRLLGFSLEGNERLLIYEFVPNTSL-DHFIFDPTRRAQLDWERRYKIIGGIARG 435
           L+H N+VR     LE +   ++ + +    L +HF     ++ +   ER + I   +   
Sbjct: 66  LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125

Query: 436 LLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYM 495
           L YLH++ R  I+HRDL  +N++L  +    I DFG+A+  +       TS +VGT  Y 
Sbjct: 126 LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTS-VVGTILYS 180

Query: 496 APEYAMHGQYSVKSDVFSFGVLVLEI 521
            PE   +  Y  K+DV++FG ++ ++
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQM 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 85.9 bits (212), Expect = 2e-18
 Identities = 60/208 (28%), Positives = 109/208 (52%), Gaps = 15/208 (7%)

Query: 320 RVATDNFSDANKLGQGGFGAV-YKGRLYDGAEIAVKRLS-RDSGQGDLEFKNEVLLVANL 377
           R   D+F    K+G+G  G V      + G ++AVK++  R   + +L F NEV+++ + 
Sbjct: 21  REYLDSFI---KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF-NEVVIMRDY 76

Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
            H N+V +    L G+E  ++ EF+   +L     D     +++ E+   +   + R L 
Sbjct: 77  HHENVVDMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALS 132

Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           YLH      +IHRD+K+ ++LL ++   K++DFG     ++ +       +VGT  +MAP
Sbjct: 133 YLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCA--QVSKEVPKRKSLVGTPYWMAP 187

Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           E      Y  + D++S G++V+E+I G+
Sbjct: 188 EVISRLPYGTEVDIWSLGIMVIEMIDGE 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 85.6 bits (212), Expect = 3e-18
 Identities = 69/203 (33%), Positives = 103/203 (50%), Gaps = 19/203 (9%)

Query: 326 FSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQGDLEFKN---EVLLVANLQHRN 381
           F+D  ++G G FGAVY  R     E+ A+K++S    Q + ++++   EV  +  L+H N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
            +   G  L  +   L+ E+   ++ D  I +  ++   + E    I  G  +GL YLH 
Sbjct: 77  TIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHKKPLQEVEIA-AICHGALQGLAYLHS 133

Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE--Y 499
             R   IHRD+K  N+LL    T K+ADFG A L  +          VGT  +MAPE   
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSASL--VSPANS----FVGTPYWMAPEVIL 184

Query: 500 AM-HGQYSVKSDVFSFGVLVLEI 521
           AM  GQY  K DV+S G+  +E+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 84.9 bits (210), Expect = 4e-18
 Identities = 63/203 (31%), Positives = 105/203 (51%), Gaps = 11/203 (5%)

Query: 325 NFSDANKLGQGGFGAVYKGR-LYDGAEIAVK--RLSRDSGQGDLEFKNEVLLVANLQHRN 381
           NF    K+G+G +G VYK R    G  +A+K  RL  ++         E+ L+  L H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           +V+LL      N+  L++EF+ +  L  F+ D +  + +        +  + +GL + H 
Sbjct: 61  IVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHS 118

Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM 501
               R++HRDLK  N+L++ E   K+ADFG+AR F +   +  T  +V T  Y APE  +
Sbjct: 119 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEILL 173

Query: 502 HGQ-YSVKSDVFSFGVLVLEIIS 523
             + YS   D++S G +  E+++
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 85.0 bits (210), Expect = 4e-18
 Identities = 74/287 (25%), Positives = 131/287 (45%), Gaps = 42/287 (14%)

Query: 331 KLGQGGFGAVYKGRLYDGAE---------------IAVKRLSRD-SGQGDLEFKNEVLLV 374
           KLG+G FG V+       AE               +AVK L  D +     +F  E+ ++
Sbjct: 12  KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71

Query: 375 ANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQL---------DWERR 425
           + L++ N++RLLG  +  +   +I E++ N  L+ F+      +                
Sbjct: 72  SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131

Query: 426 YKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMD--ETQ 482
             +   IA G+ YL   + L  +HRDL T N L+    T KIADFGM+R L+  D    Q
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188

Query: 483 GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSS 542
           G   R V    +MA E  + G+++  SDV++FGV + E+ +  +   + +  + E ++ +
Sbjct: 189 G---RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPY-SLLSDEQVIEN 244

Query: 543 AWKNWR-EGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPT 588
             + +R +G  + +    L    + +++      + C   ++  RPT
Sbjct: 245 TGEFFRNQGRQIYLSQTPLCPSPVFKLM------MRCWSRDIKDRPT 285

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 85.2 bits (211), Expect = 4e-18
 Identities = 69/211 (32%), Positives = 102/211 (48%), Gaps = 18/211 (8%)

Query: 324 DNFSDANKLGQGGFGAVYKGRLY-----DGA-EIAVKRLSRDSGQGDLE-FKNEVLLVAN 376
           +N S    LG G FG V +   Y     D   ++AVK L   +   + E   +E+ ++++
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 377 L-QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARG 435
           L  H N+V LLG    G   L+I E+     L +F+    R + L  E        +A+G
Sbjct: 95  LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKG 153

Query: 436 LLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE---TQGNTSRIVGTY 492
           + +L   +    IHRDL   NVLL      KI DFG+AR    D     +GN    V   
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK-- 208

Query: 493 GYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
            +MAPE   +  Y+ +SDV+S+G+L+ EI S
Sbjct: 209 -WMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 84.7 bits (210), Expect = 5e-18
 Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 21/204 (10%)

Query: 331 KLGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQGDLEFKN----EVLLVANLQHRNLVRL 385
            +G+G +G V K R     EI A+K+  ++S + D + K     EV ++  L+H N+V L
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKF-KES-EDDEDVKKTALREVKVLRQLRHENIVNL 65

Query: 386 LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRL 445
                      L++E+V  T L+           L  +     I  + + + Y H     
Sbjct: 66  KEAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAYCH---SH 119

Query: 446 RIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI---VGTYGYMAPEYAM- 501
            IIHRD+K  N+L+      K+ DFG AR           S +   V T  Y APE  + 
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARAL----RARPASPLTDYVATRWYRAPELLVG 175

Query: 502 HGQYSVKSDVFSFGVLVLEIISGQ 525
              Y    DV++ G ++ E++ G+
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 85.1 bits (210), Expect = 6e-18
 Identities = 62/203 (30%), Positives = 98/203 (48%), Gaps = 19/203 (9%)

Query: 326 FSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQGDLEFKN---EVLLVANLQHRN 381
           F+D  ++G G FGAVY  R     E+ A+K++S    Q + ++++   EV  +  ++H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
            +   G  L  +   L+ E+   ++ D        +  L       I  G  +GL YLH 
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 143

Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM 501
            +   +IHRD+K  N+LL      K+ADFG A +          +  VGT  +MAPE  +
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASIAS------PANSFVGTPYWMAPEVIL 194

Query: 502 ---HGQYSVKSDVFSFGVLVLEI 521
               GQY  K DV+S G+  +E+
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 85.6 bits (212), Expect = 6e-18
 Identities = 69/236 (29%), Positives = 106/236 (44%), Gaps = 56/236 (23%)

Query: 317 NTIRVATDNFSD---ANKLGQGGFGAVYK------GR------LYDGAEIAVKRLSRDSG 361
            +   A  + S+    N++G G  G VYK      GR      +Y   E  V+R      
Sbjct: 64  GSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR------ 117

Query: 362 QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLD-------HFIFDP 414
               +   E+ ++ ++ H N+V+         E  ++ EF+   SL+        F+ D 
Sbjct: 118 ----QICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADV 173

Query: 415 TRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR 474
            R          +I+ GIA    YLH   R  I+HRD+K SN+L+++    KIADFG++R
Sbjct: 174 AR----------QILSGIA----YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSR 216

Query: 475 LFEMDETQGNTSRIVGTYGYMAPEYA----MHGQYS-VKSDVFSFGVLVLEIISGQ 525
           +        N+S  VGT  YM+PE       HG Y     D++S GV +LE   G+
Sbjct: 217 ILAQTMDPCNSS--VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 83.8 bits (208), Expect = 1e-17
 Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 29/207 (14%)

Query: 330 NKLGQGGFGAVYKGR-LYDGAEIAVKRL---SRDSGQGDLEFK--NEVLLVANLQHRNLV 383
            KLG+G +  VYK R    G  +A+K++    R   +  + F    E+ L+  L+H N++
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 384 RLLG-FSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYK-IIGGIARGLLYLHE 441
            LL  F  + N  L ++EF+  T L+  I D +           K  +    RGL YLH 
Sbjct: 66  GLLDVFGHKSNINL-VFEFME-TDLEKVIKDKSIVLT---PADIKSYMLMTLRGLEYLH- 119

Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI----VGTYGYMAP 497
                I+HRDLK +N+L+ ++   K+ADFG+AR F      G+ +R     V T  Y AP
Sbjct: 120 --SNWILHRDLKPNNLLIASDGVLKLADFGLARSF------GSPNRKMTHQVVTRWYRAP 171

Query: 498 EYAMHG--QYSVKSDVFSFGVLVLEII 522
           E    G   Y V  D++S G +  E++
Sbjct: 172 ELLF-GARHYGVGVDMWSVGCIFAELL 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 83.1 bits (205), Expect = 1e-17
 Identities = 80/281 (28%), Positives = 130/281 (46%), Gaps = 39/281 (13%)

Query: 331 KLGQGGFGAVYKG--RLYDGAE-IAVKRLSRDSGQGDLEFKNEVLLVAN----LQHRNLV 383
           +LG G FG V KG  ++    + +AVK L  D+   D   K+E+L  AN    L +  +V
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN--DPALKDELLREANVMQQLDNPYIV 59

Query: 384 RLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS 443
           R++G   E    +L+ E      L+ F+    +   +  +   +++  ++ G+ YL E +
Sbjct: 60  RMIGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN 115

Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE----TQGNTSRIVGTYGYMAPEY 499
               +HRDL   NVLL  +   KI+DFG+++    DE     + +    V  Y   APE 
Sbjct: 116 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY---APEC 169

Query: 500 AMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP 558
             + ++S KSDV+SFGVL+ E  S GQ+      G  V  ++ S  +         +  P
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER---------MECP 220

Query: 559 TLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY 599
                 + ++++      LC    V  RP  A V L L +Y
Sbjct: 221 QRCPPEMYDLMK------LCWTYGVDERPGFAVVELRLRNY 255

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 83.5 bits (206), Expect = 1e-17
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 47/228 (20%)

Query: 332 LGQGGFGAVYKGRLYDGA------EIAVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLVR 384
           LG+G FG V K   +          +AVK L  ++   +L +  +E  L+  + H ++++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 385 LLGFSLEGNERLLIYEFVPNTSLDHFI----------------------FDPTRRA---- 418
           L G   +    LLI E+    SL  F+                       +P  RA    
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 419 ---QLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL 475
                 W+        I+RG+ YL E   ++++HRDL   NVL+      KI+DFG++R 
Sbjct: 128 DLISFAWQ--------ISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRD 176

Query: 476 FEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
              +++    S+      +MA E      Y+ +SDV+SFGVL+ EI++
Sbjct: 177 VYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 83.9 bits (207), Expect = 1e-17
 Identities = 62/203 (30%), Positives = 99/203 (48%), Gaps = 19/203 (9%)

Query: 326 FSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQGDLEFKN---EVLLVANLQHRN 381
           FSD  ++G G FGAVY  R    +E+ A+K++S    Q + ++++   EV  +  L+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
            ++  G  L  +   L+ E+   ++ D        +  L       +  G  +GL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133

Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM 501
            +   +IHRD+K  N+LL      K+ DFG A +          +  VGT  +MAPE  +
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 184

Query: 502 ---HGQYSVKSDVFSFGVLVLEI 521
               GQY  K DV+S G+  +E+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 83.3 bits (206), Expect = 1e-17
 Identities = 61/201 (30%), Positives = 95/201 (47%), Gaps = 21/201 (10%)

Query: 332 LGQGGFGAVYK-GRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHR----NLVRLL 386
           LG G  G+V K   +  G  +A K +           + ++L    + H      +V   
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIG---AKSSVRKQILRELQIMHECRSPYIVSFY 69

Query: 387 GFSLEGNERLLIYEFVPNTSLDHFI--FDPTRRAQLDWERRYKIIGGIARGLLYLHEDSR 444
           G  L  N   +  EF+   SLD       P     L      KI   +  GL YL+    
Sbjct: 70  GAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLYN--V 122

Query: 445 LRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQ 504
            RI+HRD+K SN+L+++    K+ DFG++   E+  +  +T   VGT  YM+PE    G+
Sbjct: 123 HRIMHRDIKPSNILVNSRGQIKLCDFGVSG--ELINSIADT--FVGTSTYMSPERIQGGK 178

Query: 505 YSVKSDVFSFGVLVLEIISGQ 525
           Y+VKSDV+S G+ ++E+  G+
Sbjct: 179 YTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 67/209 (32%), Positives = 109/209 (52%), Gaps = 23/209 (11%)

Query: 326 FSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLS-RDSGQG-DLEFKNEVLLVANLQ---H 379
           + +  ++G+G +G VYK R L  G  +A+K++    S +G  L    E+ L+  L+   H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 380 RNLVRLL----GFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
            N+VRLL    G   +   +L L++E V +  L  ++     +  L  E    ++  + R
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL-SKCPKPGLPPETIKDLMRQLLR 118

Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL--FEMDETQGNTSRIVGTY 492
           G+ +LH     RI+HRDLK  N+L+ ++   KIADFG+AR+  FEM  T      +V T 
Sbjct: 119 GVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTS-----VVVTL 170

Query: 493 GYMAPEYAMHGQYSVKSDVFSFGVLVLEI 521
            Y APE  +   Y+   D++S G +  E+
Sbjct: 171 WYRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 83.1 bits (205), Expect = 2e-17
 Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 26/223 (11%)

Query: 324 DNFSDANKLGQGGFGAVY--------KGRLYDGAEIAVKRLSRDSGQGDL-EFKNEVLLV 374
           D  +    LG+G FG V         K +  +   +AVK L  D+ + DL +  +E+ ++
Sbjct: 15  DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74

Query: 375 ANL-QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI-----------FDPTR--RAQL 420
             + +H+N++ LLG   +     +I E+    +L  ++           +D  R    Q+
Sbjct: 75  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134

Query: 421 DWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE 480
            ++        +ARG+ YL   +  + IHRDL   NVL+      KIADFG+AR     +
Sbjct: 135 TFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNID 191

Query: 481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
               T+       +MAPE      Y+ +SDV+SFGVL+ EI +
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 82.8 bits (204), Expect = 3e-17
 Identities = 79/277 (28%), Positives = 123/277 (44%), Gaps = 37/277 (13%)

Query: 326 FSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQGDLEFKN---EVLLVANLQHRN 381
           F   +++G G FGAVY        E+ AVK++S    Q + ++++   EV  +  L+H N
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
            +   G  L+ +   L+ E+   ++ D        +  L       I  G  +GL YLH 
Sbjct: 83  TIEYKGCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 139

Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM 501
            +   +IHRD+K  N+LL      K+ADFG A       +  N+   VGT  +MAPE  +
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSASK----SSPANS--FVGTPYWMAPEVIL 190

Query: 502 ---HGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP 558
               GQY  K DV+S G+  +E+   +R     N   +  L   A  +           P
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHIAQND----------SP 238

Query: 559 TLSSGSITEMIRCIHIGLL--CVQENVASRPTMASVV 593
           TL S   T+  R    G +  C+Q+    RP  A ++
Sbjct: 239 TLQSNEWTDSFR----GFVDYCLQKIPQERPASAELL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 81.9 bits (203), Expect = 3e-17
 Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 30/223 (13%)

Query: 322 ATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQGDLEFKNEVLLVANL-QH 379
            T  F     +G+G +G VYK R     ++ A+K +     + + E K E  ++     H
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEE-EIKEEYNILRKYSNH 62

Query: 380 RNLVRLLGFSL------EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYK------ 427
            N+    G  +        ++  L+ E     S+   +     +      +R K      
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV-----KGLRKKGKRLKEEWIAY 117

Query: 428 IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSR 487
           I+    RGL YLHE+   ++IHRD+K  N+LL      K+ DFG++   ++D T G  + 
Sbjct: 118 ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA--QLDSTLGRRNT 172

Query: 488 IVGTYGYMAPE-----YAMHGQYSVKSDVFSFGVLVLEIISGQ 525
            +GT  +MAPE           Y  +SDV+S G+  +E+  G+
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 82.2 bits (203), Expect = 4e-17
 Identities = 66/211 (31%), Positives = 105/211 (49%), Gaps = 24/211 (11%)

Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRL---SRDSGQGDLEFKNEVLLVANLQH 379
           D +    K+G+G +G VYK R       IA+K++     D G      + E+ L+  +QH
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEMQH 60

Query: 380 RNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG----IAR 434
            N+VRL    +   +RL L++E++      H    P      D+ +  ++I      I R
Sbjct: 61  GNIVRLQDV-VHSEKRLYLVFEYLDLDLKKHMDSSP------DFAKNPRLIKTYLYQILR 113

Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEM-TPKIADFGMARLFEMDETQGNTSRIVGTYG 493
           G+ Y H  S  R++HRDLK  N+L+D      K+ADFG+AR F +   +  T  +V T  
Sbjct: 114 GIAYCH--SH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-PVRTFTHEVV-TLW 168

Query: 494 YMAPEYAMHG-QYSVKSDVFSFGVLVLEIIS 523
           Y APE  +    YS   D++S G +  E+++
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199

Length = 294

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 81.5 bits (202), Expect = 4e-17
 Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 46/218 (21%)

Query: 332 LGQGGFGAVY------KGRLYDGAEIAVKRLSRDSGQGDLEFKNEV--LLV-----ANLQ 378
           + +G +G V+       G +Y     A+K + +     D+  KN+V  +L      +  Q
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIY-----AIKVIKKA----DMIRKNQVDQVLTERDILSQAQ 51

Query: 379 HRNLVRLLGFSLEGNERL-LIYEFVPN----TSLDHF-IFDPTRRAQLDWERRYKIIGGI 432
              +V+L  +S +G + L L+ E++P     + L++    D       D  R Y  I  I
Sbjct: 52  SPYVVKLY-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDE------DVARIY--IAEI 102

Query: 433 ARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFG------MARLFEMDETQGNTS 486
              L YLH      IIHRDLK  N+L+D+    K+ DFG      + R   +++ +    
Sbjct: 103 VLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK 159

Query: 487 RIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           RIVGT  Y+APE  +   +S   D +S G ++ E + G
Sbjct: 160 RIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 81.8 bits (202), Expect = 4e-17
 Identities = 68/216 (31%), Positives = 103/216 (47%), Gaps = 19/216 (8%)

Query: 332 LGQGGFGAVY------KGRLYDGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVR 384
           LG+GGFG V        G+LY   ++  KRL +  G +G +  K    ++A +  R +V 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKR---ILAKVHSRFIVS 57

Query: 385 LLGFSLEGNERL-LIYEFVPNTSLDHFIFD-PTRRAQLDWERRYKIIGGIARGLLYLHED 442
           L  ++ +    L L+   +    L + I++           R       I  GL +LH+ 
Sbjct: 58  L-AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR 116

Query: 443 SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMH 502
              RII+RDLK  NVLLD +   +I+D G+A   E+ + Q  T    GT G+MAPE    
Sbjct: 117 ---RIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFMAPELLQG 171

Query: 503 GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVED 538
            +Y    D F+ GV + E+I+  R      GE VE+
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAA-RGPFRARGEKVEN 206

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 82.0 bits (202), Expect = 4e-17
 Identities = 59/208 (28%), Positives = 107/208 (51%), Gaps = 15/208 (7%)

Query: 320 RVATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLS-RDSGQGDLEFKNEVLLVANL 377
           R   DNF    K+G+G  G V    +   G  +AVK++  R   + +L F NEV+++ + 
Sbjct: 19  RTYLDNFI---KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDY 74

Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           QH N+V +    L G+E  ++ EF+   +L     D     +++ E+   +   + + L 
Sbjct: 75  QHENVVEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALS 130

Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
            LH      +IHRD+K+ ++LL  +   K++DFG     ++ +       +VGT  +MAP
Sbjct: 131 VLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAP 185

Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           E      Y  + D++S G++V+E++ G+
Sbjct: 186 ELISRLPYGPEVDIWSLGIMVIEMVDGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 82.0 bits (203), Expect = 5e-17
 Identities = 66/211 (31%), Positives = 110/211 (52%), Gaps = 22/211 (10%)

Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQGDLEFKN--EVLLVANLQHRN 381
            F   N++G+G +G VY+ R     EI A+K++  D+ +  +   +  E+ L+ NL+H N
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67

Query: 382 LVRLL----GFSLEGNERLLIYEFVPN--TSLDHFIFDPTRRAQLDWERRYKIIGGIARG 435
           +V L     G  L+     L+ E+      SL   +  P   +Q+       ++  + RG
Sbjct: 68  IVELKEVVVGKHLD--SIFLVMEYCEQDLASLLDNMPTPFSESQVK-----CLMLQLLRG 120

Query: 436 LLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYM 495
           L YLHE+    IIHRDLK SN+LL  +   KIADFG+AR + +      T ++V T  Y 
Sbjct: 121 LQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP-MTPKVV-TLWYR 175

Query: 496 APEYAMHGQ-YSVKSDVFSFGVLVLEIISGQ 525
           APE  +    Y+   D+++ G ++ E+++ +
Sbjct: 176 APELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 82.5 bits (204), Expect = 5e-17
 Identities = 64/230 (27%), Positives = 97/230 (42%), Gaps = 33/230 (14%)

Query: 331 KLGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQGDLEFKNEV---------LLVANLQHR 380
           ++GQGG+G V+  +  D  EI A+KR+ +      L   NEV         L        
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEIVALKRMKKSL----LFKLNEVRHVLTERDILTTTK--SE 61

Query: 381 NLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            LV+LL ++ + +E L L  E+VP       + +       D  R Y     +A     +
Sbjct: 62  WLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNN-LGVLSEDHARFY-----MAEMFEAV 114

Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
                L  IHRDLK  N L+DA    K+ DFG+++           + +VG+  YMAPE 
Sbjct: 115 DALHELGYIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYMAPEV 169

Query: 500 AMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWRE 549
                Y    D +S G ++ E + G        G T  +   +  K W+E
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLCGFPPFS---GSTPNETWENL-KYWKE 215

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 81.6 bits (201), Expect = 5e-17
 Identities = 62/199 (31%), Positives = 102/199 (51%), Gaps = 17/199 (8%)

Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLVRLL-GF 388
           +LG G FG VYK +  +   +A  ++     + +LE +  E+ ++A+  H N+V+LL  F
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKII-GGIARGLLYLHEDSRLRI 447
             E N  +LI EF    ++D  + +  R      E + +++       L YLHE+   +I
Sbjct: 72  YYENNLWILI-EFCAGGAVDAVMLELERPLT---EPQIRVVCKQTLEALNYLHEN---KI 124

Query: 448 IHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM-----H 502
           IHRDLK  N+L   +   K+ADFG++   +   T       +GT  +MAPE  M      
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182

Query: 503 GQYSVKSDVFSFGVLVLEI 521
             Y  K+DV+S G+ ++E+
Sbjct: 183 RPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 81.6 bits (201), Expect = 5e-17
 Identities = 70/215 (32%), Positives = 101/215 (46%), Gaps = 19/215 (8%)

Query: 323 TDNFSDANKLGQGGFGAVYK-GRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANL-QHR 380
           TD +     +G+G +G VYK     DG+  AVK L   S   D E + E  ++ +L  H 
Sbjct: 21  TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV-DEEIEAEYNILQSLPNHP 79

Query: 381 NLVRLLGF-----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQ-LDWERRYKIIGGIAR 434
           N+V+  G       L G +  L+ E     S+   +       Q LD      I+ G   
Sbjct: 80  NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALL 139

Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
           GL +LH +   RIIHRD+K +N+LL  E   K+ DFG++        + NTS  VGT  +
Sbjct: 140 GLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFW 194

Query: 495 MAPEYAMHGQ-----YSVKSDVFSFGVLVLEIISG 524
           MAPE     Q     Y  + DV+S G+  +E+  G
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 82.3 bits (204), Expect = 6e-17
 Identities = 61/228 (26%), Positives = 104/228 (45%), Gaps = 55/228 (24%)

Query: 324 DNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKN---------EVLL 373
           D + + + +G G +G V        G ++A+K+LSR        F++         E+ L
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSR-------PFQSAIHAKRTYRELRL 67

Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF-------------IFDPTRRAQL 420
           + ++ H N++ LL              F P +SL+ F             + +  +  +L
Sbjct: 68  LKHMDHENVIGLLDV------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKL 115

Query: 421 DWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE 480
             +    ++  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR  + + 
Sbjct: 116 SDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM 172

Query: 481 TQGNTSRIVGTYGYMAPEYA---MHGQYSVKSDVFSFGVLVLEIISGQ 525
           T       V T  Y APE     MH  Y+   D++S G ++ E+++G+
Sbjct: 173 TG-----YVATRWYRAPEIMLNWMH--YNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 81.5 bits (201), Expect = 7e-17
 Identities = 83/284 (29%), Positives = 133/284 (46%), Gaps = 54/284 (19%)

Query: 331 KLGQGGFGAVY--------------------KGRLYDGAEIAVKRLSRDSGQGDL-EFKN 369
           KLG+G FG V+                    KGR      +AVK L  D+ +    +F  
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGR---PLLVAVKILRPDANKNARNDFLK 68

Query: 370 EVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI-----FDPTRRAQ----- 419
           EV +++ L+  N++RLLG  ++ +   +I E++ N  L+ F+      D           
Sbjct: 69  EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128

Query: 420 ------LDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMA 473
                 + +     +   IA G+ YL   S L  +HRDL T N L+   +T KIADFGM+
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185

Query: 474 R-LFEMD--ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCF 530
           R L+  D    QG   R V    +MA E  + G+++  SDV++FGV + EI+   +   +
Sbjct: 186 RNLYAGDYYRIQG---RAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242

Query: 531 RNGE-TVEDLLSSAWKNWRE-GTTVNIIDPTLSSGSITE-MIRC 571
             GE T E ++ +A + +R+ G  V +  P      + E M++C
Sbjct: 243 --GELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQC 284

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 81.4 bits (201), Expect = 9e-17
 Identities = 69/201 (34%), Positives = 95/201 (47%), Gaps = 17/201 (8%)

Query: 332 LGQGGFGAVYKGRLYDGAEI-AVKRLSRDS--GQGDLE---FKNEVLLVANLQHRNLVRL 385
           LG+G FG V    L    E  A+K L +D      D+E    +  VL +A  +H  L  L
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAW-EHPFLTHL 61

Query: 386 LGFSLEGNERLL-IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSR 444
              + +  E L  + E++    L   I    R    D  R       I  GL +LH+   
Sbjct: 62  F-CTFQTKEHLFFVMEYLNGGDLMFHIQSSGR---FDEARARFYAAEIICGLQFLHKKG- 116

Query: 445 LRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQ 504
             II+RDLK  NVLLD +   KIADFGM +     E + +T    GT  Y+APE     +
Sbjct: 117 --IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGTPDYIAPEILKGQK 172

Query: 505 YSVKSDVFSFGVLVLEIISGQ 525
           Y+   D +SFGVL+ E++ GQ
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 80.5 bits (198), Expect = 9e-17
 Identities = 56/208 (26%), Positives = 104/208 (50%), Gaps = 16/208 (7%)

Query: 320 RVATDNFSDANKLGQGGFGAVYKGRLYDGAEIA-VKRLSRDSGQGDLEFKNEVLLVANLQ 378
           R   ++F    ++G G +G VYK R  +  E+A +K +  + G+     + E++++ + +
Sbjct: 5   RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCK 64

Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLD--HFIFDPTRRAQLDWERRYKIIGGIARGL 436
           H N+V   G  L  ++  +  EF    SL   + +  P   +Q+ +  R  +     +GL
Sbjct: 65  HSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGL 119

Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMA 496
            YLH   +   +HRD+K +N+LL      K+ADFG++   ++  T       +GT  +MA
Sbjct: 120 YYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSA--QITATIAKRKSFIGTPYWMA 174

Query: 497 PEYAM---HGQYSVKSDVFSFGVLVLEI 521
           PE A     G Y+   D+++ G+  +E+
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 80.5 bits (199), Expect = 1e-16
 Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 34/218 (15%)

Query: 332 LGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQGDL-EFKNEVLLVANL-QHRNLV 383
           LG+G FG V K            + +AVK L  D+ + DL +  +E+ ++  + +H+N++
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 384 RLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGI----------- 432
            LLG   +     ++ E+  + +L  F+     RA+                        
Sbjct: 80  NLLGVCTQEGPLYVVVEYAAHGNLRDFL-----RARRPPGEYASPDDPRPPEETLTQKDL 134

Query: 433 -------ARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNT 485
                  ARG+ +L   S+ + IHRDL   NVL+  +   KIADFG+AR     +    T
Sbjct: 135 VSFAYQVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191

Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
           +       +MAPE      Y+ +SDV+SFGVL+ EI +
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 80.8 bits (200), Expect = 1e-16
 Identities = 59/232 (25%), Positives = 107/232 (46%), Gaps = 43/232 (18%)

Query: 322 ATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKN--------EVL 372
              ++    KLG+G FG VYK R +  G  +A+K++   +       K+        E+ 
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHN------EKDGFPITALREIK 59

Query: 373 LVANLQHRNLVRLLGFSLE-----GNERLLIYEFVPNTSLDH----FIFDPTRRAQLDWE 423
           ++  L+H N+V L+  ++E       +R  +Y   P   +DH     + +P    +L   
Sbjct: 60  ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTP--YMDHDLSGLLENP--SVKLTES 115

Query: 424 RRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQG 483
           +    +  +  G+ YLHE+    I+HRD+K +N+L+D +   KIADFG+AR ++      
Sbjct: 116 QIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNP 172

Query: 484 N----------TSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISG 524
                      T+ +V T  Y  PE  +   +Y+   D++  G +  E+ + 
Sbjct: 173 KGGGGGGTRKYTNLVV-TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 80.3 bits (198), Expect = 2e-16
 Identities = 67/222 (30%), Positives = 106/222 (47%), Gaps = 35/222 (15%)

Query: 331 KLGQGGFGAVY------------KGRLYDGAE-----IAVKRLSRDSGQGDL-EFKNEVL 372
           KLG+G FG V+            K    D +      +AVK L  D+ +    +F  E+ 
Sbjct: 12  KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71

Query: 373 LVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG- 431
           +++ L+  N++RLL   +  +   +I E++ N  L+ F+     +   +      I    
Sbjct: 72  IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131

Query: 432 -------IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMD--ET 481
                  IA G+ YL   S L  +HRDL T N L+    T KIADFGM+R L+  D    
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188

Query: 482 QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
           QG   R V    +M+ E  + G+++  SDV++FGV + EI++
Sbjct: 189 QG---RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 83.4 bits (206), Expect = 2e-16
 Identities = 80/339 (23%), Positives = 147/339 (43%), Gaps = 42/339 (12%)

Query: 276 VILIIFICFFLRRKPRDNSKVKSEAAAGDEINRAESLQFDFNTIRVATDN-----FSDAN 330
           + L+ F   F+R   R+N ++K      +E    E   FD    +  T N       + N
Sbjct: 642 LALVAFGFVFIRG--RNNLELKR---VENEDGTWELQFFDSKVSKSITINDILSSLKEEN 696

Query: 331 KLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFS 389
            + +G  GA YKG+ + +G +  VK ++  +     E  +    +  LQH N+V+L+G  
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLIGLC 752

Query: 390 LEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIH 449
                  LI+E++   +L   +        L WERR KI  GIA+ L +LH      ++ 
Sbjct: 753 RSEKGAYLIHEYIEGKNLSEVL------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVV 806

Query: 450 RDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKS 509
            +L    +++D +  P +    +  L   D     +S       Y+APE       + KS
Sbjct: 807 GNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS------AYVAPETRETKDITEKS 859

Query: 510 DVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNI-----IDPTLS--- 561
           D++ FG++++E+++G      ++    E  +  +   W      +      IDP++    
Sbjct: 860 DIYGFGLILIELLTG------KSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV 913

Query: 562 SGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYS 600
           S +  E++  +++ L C   +  +RP    V+  L S S
Sbjct: 914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952

Length = 968

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 80.3 bits (198), Expect = 2e-16
 Identities = 81/254 (31%), Positives = 112/254 (44%), Gaps = 32/254 (12%)

Query: 332 LGQGGFGAVYKGRLY-DGAEIAVKRLSRDS--GQGDLE---FKNEVLLVANLQHRNLVRL 385
           LG+G FG V   RL   G   AVK L +D      D+E    +  +L +A   H  L +L
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQL 61

Query: 386 LGFSLEGNERLL-IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSR 444
                +  +RL  + EFV    L  F    +RR      R Y     I   L++LH+   
Sbjct: 62  Y-CCFQTPDRLFFVMEFVNGGDL-MFHIQKSRRFDEARARFYA--AEITSALMFLHDKG- 116

Query: 445 LRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQ 504
             II+RDLK  NVLLD E   K+ADFGM +  E       TS   GT  Y+APE      
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEML 172

Query: 505 YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKN------WREGTTVNII-- 556
           Y    D ++ GVL+ E++ G         E  +DL  +   +      W     V+I+  
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAP---FEAENEDDLFEAILNDEVVYPTWLSQDAVDILKA 229

Query: 557 ----DPTLSSGSIT 566
               +PT+  GS+T
Sbjct: 230 FMTKNPTMRLGSLT 243

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 79.4 bits (196), Expect = 3e-16
 Identities = 68/220 (30%), Positives = 106/220 (48%), Gaps = 36/220 (16%)

Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHR-- 380
           D+     +LG+G +G V K R +  G  +AVKR+   +     E K  +L+  ++  R  
Sbjct: 1   DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIR--ATVNSQEQK-RLLMDLDISMRSV 57

Query: 381 ---NLVRLLGFSLEGNERLLIYEFVPNTSLDHF---IFDPTRRAQLDWERRYKIIGGIA- 433
                V   G +L     + I   V +TSLD F   ++D       D      I+G IA 
Sbjct: 58  DCPYTVTFYG-ALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPED------ILGKIAV 110

Query: 434 ---RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF--EMDETQGNTSRI 488
              + L YLH   +L +IHRD+K SNVL++     K+ DFG++      + +T       
Sbjct: 111 SIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID----- 163

Query: 489 VGTYGYMAPEY---AMHGQ-YSVKSDVFSFGVLVLEIISG 524
            G   YMAPE     ++ + Y VKSDV+S G+ ++E+ +G
Sbjct: 164 AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATG 203

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 78.8 bits (195), Expect = 3e-16
 Identities = 54/204 (26%), Positives = 92/204 (45%), Gaps = 27/204 (13%)

Query: 332 LGQGGFGAVY------KGRLYDGAEIAVKRLSRDS-GQGDLE--FKNEVLLVANLQHRNL 382
           LG GGFG V       K R +     A+K + +    +   +    +E  ++    H  +
Sbjct: 1   LGVGGFGRVELVKVKSKNRTF-----ALKCVKKRHIVETGQQEHIFSEKEILEECNHPFI 55

Query: 383 VRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLD-WERRYKIIGGIARGLLYLH 440
           V+L   + +  + + ++ E+     L   + D   R   D +  R+  I  +     YLH
Sbjct: 56  VKLYR-TFKDKKYIYMLMEYCLGGELWTILRD---RGLFDEYTARF-YIACVVLAFEYLH 110

Query: 441 EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA 500
                 II+RDLK  N+LLD+    K+ DFG A+     ++   T    GT  Y+APE  
Sbjct: 111 ---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL---KSGQKTWTFCGTPEYVAPEII 164

Query: 501 MHGQYSVKSDVFSFGVLVLEIISG 524
           ++  Y    D +S G+L+ E+++G
Sbjct: 165 LNKGYDFSVDYWSLGILLYELLTG 188

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 79.7 bits (197), Expect = 3e-16
 Identities = 73/205 (35%), Positives = 99/205 (48%), Gaps = 25/205 (12%)

Query: 332 LGQGGFGAVYKGRLYDGAEI-AVKRLSRDS--GQGDLEF---KNEVLLVANLQHRNLVRL 385
           LG+G FG V    L    E+ AVK L +D      D+E    +  VL +A  +H  L +L
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFLTQL 61

Query: 386 LGFS-LEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS 443
              S  +  +RL  + E+V    L   +F   R  + D  R       I  GL +LHE  
Sbjct: 62  --HSCFQTKDRLFFVMEYVNGGDL---MFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG 116

Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN---TSRIVGTYGYMAPEYA 500
              II+RDLK  NVLLD+E   KIADFGM +     E       TS   GT  Y+APE  
Sbjct: 117 ---IIYRDLKLDNVLLDSEGHIKIADFGMCK-----EGILGGVTTSTFCGTPDYIAPEIL 168

Query: 501 MHGQYSVKSDVFSFGVLVLEIISGQ 525
            +  Y    D ++ GVL+ E+++GQ
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 79.8 bits (197), Expect = 3e-16
 Identities = 43/95 (45%), Positives = 56/95 (58%), Gaps = 7/95 (7%)

Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSR-IVG 490
           IA GL +LH      II+RDLK  NV+LDAE   KIADFGM +        G T+R   G
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG---GKTTRTFCG 163

Query: 491 TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           T  Y+APE   +  Y    D ++FGVL+ E+++GQ
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 79.2 bits (196), Expect = 4e-16
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 26/212 (12%)

Query: 331 KLGQGGFGAVYKGRL---YDGAEIAVKRLSRDSGQGD---LEFKNEVLLVANLQHRNLVR 384
            +G+G +G VYK +     DG E A+K+   D  Q          E+ L+  L+H N+V 
Sbjct: 7   CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66

Query: 385 LLGFSLEGNERL--LIYEFVPNTSLDHFIFD--PTRRAQLDWERRYK-IIGGIARGLLYL 439
           L+   LE  ++   L++++  +  L   I      +R  +      K ++  I  G+ YL
Sbjct: 67  LVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIP-PSMVKSLLWQILNGVHYL 124

Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTP----KIADFGMARLF-EMDETQGNTSRIVGTYGY 494
           H +    ++HRDLK +N+L+  E       KI D G+ARLF    +   +   +V T  Y
Sbjct: 125 HSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWY 181

Query: 495 MAPEY---AMHGQYSVKSDVFSFGVLVLEIIS 523
            APE    A H  Y+   D+++ G +  E+++
Sbjct: 182 RAPELLLGARH--YTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 78.4 bits (193), Expect = 4e-16
 Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 18/204 (8%)

Query: 332 LGQGGFGAVYKG--RLYDGAE--IAVKRLSRD--SGQGDLEFKNEVLLVANLQHRNLVRL 385
           LG G FG + +G  +L    E  +A+  L R   S +    F  E L +    H N+VRL
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTL-RAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 386 LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRR--AQLDWERRYKIIGGIARGLLYLHEDS 443
            G    GN  +++ E++ N +LD F+    R+   QL   +   ++ G+A G+ YL E  
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFL----RKHEGQLVAGQLMGMLPGLASGMKYLSE-- 125

Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG 503
            +  +H+ L    VL+++++  KI+ F   +  +  E    T        + APE   + 
Sbjct: 126 -MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS-EAIYTTMSGKSPVLWAAPEAIQYH 183

Query: 504 QYSVKSDVFSFGVLVLEIIS-GQR 526
            +S  SDV+SFG+++ E++S G+R
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGER 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 78.9 bits (194), Expect = 5e-16
 Identities = 65/224 (29%), Positives = 115/224 (51%), Gaps = 28/224 (12%)

Query: 331 KLGQGGFGAVYKGR-LYDGAE-IAVKRLSRDSGQGDLEFKN--EVLLVANLQ---HRNLV 383
           ++G+G +G V+K R L +G   +A+KR+   +G+  +      EV ++ +L+   H N+V
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 384 RLLGF-SLEGNER----LLIYEFVPN---TSLDHFIFDPTRRAQLDWERRYKIIGGIARG 435
           RL    ++   +R     L++E V     T LD  + +P    +   +  ++++    RG
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLL----RG 122

Query: 436 LLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYM 495
           L +LH     R++HRDLK  N+L+ +    K+ADFG+AR++     Q   + +V T  Y 
Sbjct: 123 LDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYR 176

Query: 496 APEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDL 539
           APE  +   Y+   D++S G +  E+   +R   FR    V+ L
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMF--RRKPLFRGSSDVDQL 218

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 78.5 bits (193), Expect = 6e-16
 Identities = 64/207 (30%), Positives = 100/207 (48%), Gaps = 17/207 (8%)

Query: 326 FSDANKLGQGGFGAV------YKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQH 379
           F     LG+GGFG V        G++Y   ++  KR+ +  G+      NE  ++  +  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGES--MALNEKQILEKVNS 59

Query: 380 RNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           R +V L  ++ E  + L L+   +    L   I+     A  +  R       I  GL  
Sbjct: 60  RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYH-MGEAGFEEGRAVFYAAEICCGLED 117

Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
           LH++   RI++RDLK  N+LLD     +I+D G+A    + E Q    R VGT GYMAPE
Sbjct: 118 LHQE---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGR-VGTVGYMAPE 171

Query: 499 YAMHGQYSVKSDVFSFGVLVLEIISGQ 525
              + +Y+   D ++ G L+ E+I+GQ
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 79.3 bits (196), Expect = 7e-16
 Identities = 64/249 (25%), Positives = 104/249 (41%), Gaps = 61/249 (24%)

Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRD----SGQGDLEFKN 369
           DF  I+V          +G+G FG V+  R    G   A+K L +       Q     + 
Sbjct: 2   DFEVIKV----------IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRA 50

Query: 370 EVLLVANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSL-----DHFIFDPTRRAQLDWE 423
           E  ++A+     +V+L  +S +  E L L+ E++P   L        +F        +  
Sbjct: 51  ERDILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE------ETA 103

Query: 424 RRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMA--------RL 475
           R Y     IA  +L L    +L  IHRD+K  N+L+DA+   K+ADFG+         R 
Sbjct: 104 RFY-----IAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158

Query: 476 FEMDETQGNTSR-------------------IVGTYGYMAPEYAMHGQYSVKSDVFSFGV 516
           + ++++     R                    VGT  Y+APE      Y ++ D +S GV
Sbjct: 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGV 218

Query: 517 LVLEIISGQ 525
           ++ E++ G 
Sbjct: 219 ILYEMLYGF 227

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 78.1 bits (192), Expect = 9e-16
 Identities = 66/226 (29%), Positives = 108/226 (47%), Gaps = 26/226 (11%)

Query: 321 VATDNFSDANKLGQGGFGAVY--------KGRLYDGAEIAVKRLSRDSGQGDL-EFKNEV 371
           V  D       LG+G FG V         K +     ++AVK L  D+ + DL +  +E+
Sbjct: 15  VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEM 74

Query: 372 LLVANL-QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI-----------FDPTR--R 417
            ++  + +H+N++ LLG   +     +I E+    +L  ++           ++PT+   
Sbjct: 75  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPE 134

Query: 418 AQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
            QL ++        +ARG+ YL   +  + IHRDL   NVL+  +   KIADFG+AR   
Sbjct: 135 EQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 191

Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
             +    T+       +MAPE      Y+ +SDV+SFGVL+ EI +
Sbjct: 192 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 78.8 bits (194), Expect = 1e-15
 Identities = 67/228 (29%), Positives = 108/228 (47%), Gaps = 43/228 (18%)

Query: 318 TIRVATDNFSDANKLGQGGFGAV-YKGRLYDGAEIAVKRLSRDSGQGDLEFKN---EVLL 373
           TI    D + D  ++G G +G V        GA++A+K+L R   Q +L  K    E+ L
Sbjct: 9   TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRL 67

Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI-------FDPT------RRAQL 420
           + +++H N++ LL              F P+ SLD F        F  T      +  +L
Sbjct: 68  LKHMKHENVIGLLDV------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKL 115

Query: 421 DWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE 480
             +R   ++  + +GL Y+H      IIHRDLK  N+ ++ +   KI DFG+AR     +
Sbjct: 116 SEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----Q 167

Query: 481 TQGNTSRIVGTYGYMAPEYA---MHGQYSVKSDVFSFGVLVLEIISGQ 525
           T    +  V T  Y APE     MH  Y+   D++S G ++ E+++G+
Sbjct: 168 TDSEMTGYVVTRWYRAPEVILNWMH--YTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 77.4 bits (190), Expect = 1e-15
 Identities = 62/203 (30%), Positives = 97/203 (47%), Gaps = 19/203 (9%)

Query: 332 LGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLE-----FKNEVLLVANLQHRNLV 383
           LGQG FG VY    YD   G E+A K++  D    +        + E+ L+ NLQH  +V
Sbjct: 10  LGQGAFGRVY--LCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67

Query: 384 RLLGFSLEGNERLL--IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           +  G   +  E+ L    E++P  S+   +        L      K    I  G+ YLH 
Sbjct: 68  QYYGCLRDRAEKTLTIFMEYMPGGSVKDQL---KAYGALTESVTRKYTRQILEGMSYLHS 124

Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSR-IVGTYGYMAPEYA 500
           +    I+HRD+K +N+L D+    K+ DFG ++  +     G   R + GT  +M+PE  
Sbjct: 125 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181

Query: 501 MHGQYSVKSDVFSFGVLVLEIIS 523
               Y  K+DV+S G  V+E+++
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 12/200 (6%)

Query: 331 KLGQGGFGAVYKGRLYDGAEI-AVKRLSRDS-GQGDLEFK-NEVLLVANLQHRNLVRLLG 387
           K+G+G +G V+K +  +  EI A+KR+  D   +G       E+ L+  L+H+N+VRL  
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 388 FSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRI 447
                 +  L++E+  +  L  + FD      +D E     +  + +GL + H      +
Sbjct: 67  VLHSDKKLTLVFEYC-DQDLKKY-FDSCN-GDIDPEIVKSFMFQLLKGLAFCHSH---NV 120

Query: 448 IHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQ-YS 506
           +HRDLK  N+L++     K+ADFG+AR F +       S  V T  Y  P+     + YS
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYS 178

Query: 507 VKSDVFSFGVLVLEIISGQR 526
              D++S G +  E+ +  R
Sbjct: 179 TSIDMWSAGCIFAELANAGR 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 19/203 (9%)

Query: 332 LGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLE-----FKNEVLLVANLQHRNLV 383
           LGQG FG VY    YD   G E+AVK++  D    +        + E+ L+ NL H  +V
Sbjct: 10  LGQGAFGRVY--LCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67

Query: 384 RLLGFSLEGNERLL--IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           +  G   +  ER L    E +P  S+   +       + +  R+Y     I  G+ YLH 
Sbjct: 68  QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTE-NVTRKYT--RQILEGVSYLHS 124

Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSR-IVGTYGYMAPEYA 500
           +    I+HRD+K +N+L D+    K+ DFG ++  +     G   + + GT  +M+PE  
Sbjct: 125 N---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181

Query: 501 MHGQYSVKSDVFSFGVLVLEIIS 523
               Y  K+D++S G  V+E+++
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 77.0 bits (190), Expect = 2e-15
 Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 22/204 (10%)

Query: 331 KLGQGGFGAVYKGRLYD-GAEIAVKRL--SRDSGQGDLEFKN----EVLLVANLQHRNLV 383
           K+G+G +G V+K R  + G  +A+K+   S D    D   K     E+ ++  L+H NLV
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVESED----DPVIKKIALREIRMLKQLKHPNLV 63

Query: 384 RLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
            L+        +L L++E+  +T L+    +P     +      KII    + + + H  
Sbjct: 64  NLIEV-FRRKRKLHLVFEYCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCH-- 117

Query: 443 SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM- 501
            +   IHRD+K  N+L+  +   K+ DFG AR+  +     + +  V T  Y APE  + 
Sbjct: 118 -KHNCIHRDVKPENILITKQGQIKLCDFGFARI--LTGPGDDYTDYVATRWYRAPELLVG 174

Query: 502 HGQYSVKSDVFSFGVLVLEIISGQ 525
             QY    DV++ G +  E+++GQ
Sbjct: 175 DTQYGPPVDVWAIGCVFAELLTGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 78.1 bits (192), Expect = 2e-15
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 26/215 (12%)

Query: 332 LGQGGFGAVY--------KGRLYDGAEIAVKRLSRDSGQGDL-EFKNEVLLVANL-QHRN 381
           LG+G FG V         K +      +AVK L  D+   DL +  +E+ ++  + +H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFI-----------FDPTR--RAQLDWERRYKI 428
           ++ LLG   +     ++ E+    +L  ++           FD  +    QL ++     
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 429 IGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
              +ARG+ YL   +  + IHRDL   NVL+  +   KIADFG+AR     +    T+  
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
                +MAPE      Y+ +SDV+SFGVL+ EI +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 16/203 (7%)

Query: 325 NFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
           ++    ++G G +G VYK R L+ G   AVK +  + G      + E+ +V   +H N+V
Sbjct: 10  DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIV 69

Query: 384 RLLGFSLEGNERLLIYEFVPNTSLD--HFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
              G  L   +  +  E+    SL   + +  P    Q+ +  R  +     +GL YLH 
Sbjct: 70  AYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHS 124

Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM 501
             ++   HRD+K +N+LL      K+ADFG+A   ++  T       +GT  +MAPE A 
Sbjct: 125 KGKM---HRDIKGANILLTDNGDVKLADFGVAA--KITATIAKRKSFIGTPYWMAPEVAA 179

Query: 502 ---HGQYSVKSDVFSFGVLVLEI 521
              +G Y+   D+++ G+  +E+
Sbjct: 180 VEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 76.6 bits (188), Expect = 3e-15
 Identities = 62/222 (27%), Positives = 103/222 (46%), Gaps = 18/222 (8%)

Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEV-LL 373
           D + +R     F     +G G +G VYKGR     ++A  ++   +   + E K E+ +L
Sbjct: 7   DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINML 66

Query: 374 VANLQHRNLVRLLGFSLE------GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYK 427
                HRN+    G  ++       ++  L+ EF    S+   + + T+   L  +    
Sbjct: 67  KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKN-TKGNALKEDWIAY 125

Query: 428 IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSR 487
           I   I RGL +LH     ++IHRD+K  NVLL      K+ DFG++   ++D T G  + 
Sbjct: 126 ICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNT 180

Query: 488 IVGTYGYMAPEYAM-----HGQYSVKSDVFSFGVLVLEIISG 524
            +GT  +MAPE           Y  +SD++S G+  +E+  G
Sbjct: 181 FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 76.7 bits (189), Expect = 3e-15
 Identities = 60/214 (28%), Positives = 107/214 (50%), Gaps = 25/214 (11%)

Query: 324 DNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQGDLEFK--NEVLLVANLQHR 380
           D F    ++G+G +G VYK R  D  E+ A+K++  D+ +         E+ ++  L HR
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHR 66

Query: 381 NLVRL----------LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRY--KI 428
           N+V L          L F  +     L++E++     DH +        + +   +    
Sbjct: 67  NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSEDHIKSF 121

Query: 429 IGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
           +  +  GL Y H+ + L   HRD+K SN+LL+ +   K+ADFG+ARL+  +E++  T+++
Sbjct: 122 MKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178

Query: 489 VGTYGYMAPEYAM-HGQYSVKSDVFSFGVLVLEI 521
           + T  Y  PE  +   +Y    DV+S G ++ E+
Sbjct: 179 I-TLWYRPPELLLGEERYGPAIDVWSCGCILGEL 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 76.3 bits (188), Expect = 3e-15
 Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 12/199 (6%)

Query: 331 KLGQGGFGAVYKGRLYDGAEI-AVKRL--SRDSGQGDLEFKNEVLLVANLQHRNLVRLLG 387
            +G+G +G V K +  +  +I A+K+   S D          E+ ++  L+H NLV L+ 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 388 FSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRI 447
                    L++EFV +T LD     P     LD  R  K +  I RG+ + H  +   I
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSHN---I 121

Query: 448 IHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM-HGQYS 506
           IHRD+K  N+L+      K+ DFG AR   +       +  V T  Y APE  +   +Y 
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFART--LAAPGEVYTDYVATRWYRAPELLVGDTKYG 179

Query: 507 VKSDVFSFGVLVLEIISGQ 525
              D+++ G LV E+++G+
Sbjct: 180 RAVDIWAVGCLVTEMLTGE 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 76.1 bits (187), Expect = 3e-15
 Identities = 64/212 (30%), Positives = 100/212 (47%), Gaps = 32/212 (15%)

Query: 331 KLGQGGFGAVYKGRLYDG---AEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLL 386
           ++G G FG V  G +  G   A++ VK L   +  Q  ++F  E     +LQH NL++ L
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 387 GFSLEGNERLLIYEFVPNTSL----------DHFIFDPTRRAQLDWERRYKIIGGIARGL 436
           G   E    LL+ EF P   L          +    DPT   ++  E        IA GL
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACE--------IALGL 113

Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMA 496
           L+LH+++    IH DL   N LL A++T KI D+G++     ++      ++     ++A
Sbjct: 114 LHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIA 170

Query: 497 PEYA--MHGQYSV-----KSDVFSFGVLVLEI 521
           PE    +HG   V     +S+V+S GV + E+
Sbjct: 171 PELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 24/214 (11%)

Query: 324 DNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGD---LEFKNEVLLVANLQH 379
           ++  D  ++G+G FG V K      G  +AVKR+     + +   L    +V++ ++   
Sbjct: 4   EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS-DC 62

Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRY--KIIGGIA---- 433
             +V+  G      +  +  E + + SLD F     +      +     +I+G IA    
Sbjct: 63  PYIVKFYGALFREGDCWICMELM-DISLDKF----YKYVYEVLKSVIPEEILGKIAVATV 117

Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
           + L YL E+  L+IIHRD+K SN+LLD     K+ DFG++        +   +R  G   
Sbjct: 118 KALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK---TRDAGCRP 172

Query: 494 YMAPEYAMHGQ---YSVKSDVFSFGVLVLEIISG 524
           YMAPE         Y V+SDV+S G+ + E+ +G
Sbjct: 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 75.9 bits (186), Expect = 3e-15
 Identities = 80/289 (27%), Positives = 130/289 (44%), Gaps = 50/289 (17%)

Query: 332 LGQGGFGAVYKGRLY-DGAEI--AVKRLSRDSGQGD-LEFKNEVLLVANL-QHRNLVRLL 386
           +G+G FG V K R+  DG  +  A+KR+   + + D  +F  E+ ++  L  H N++ LL
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 387 GFSLEGNERLLIYEFVPNTSLDHFI-------FDPT------RRAQLDWERRYKIIGGIA 433
           G         L  E+ P+ +L  F+        DP         + L  ++       +A
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
           RG+ YL +    + IHRDL   N+L+      KIADFG++R        G    +  T G
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR--------GQEVYVKKTMG 171

Query: 494 -----YMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNW 547
                +MA E   +  Y+  SDV+S+GVL+ EI+S G    C   G T  +L     + +
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC---GMTCAELYEKLPQGY 228

Query: 548 REGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLML 596
           R    +N  D       + +++R       C +E    RP+ A +++ L
Sbjct: 229 RLEKPLNCDD------EVYDLMR------QCWREKPYERPSFAQILVSL 265

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 75.4 bits (185), Expect = 4e-15
 Identities = 64/196 (32%), Positives = 98/196 (50%), Gaps = 14/196 (7%)

Query: 332 LGQGGFGAVYKGR-LYDGAEIAVKRLS--RDSGQGDLEFKNEVLLVANLQHRNLVRLLGF 388
           +G+G +G V   R   DG +  +K+L+    S +     + E  L++ L+H N+V     
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV-AYRE 66

Query: 389 SLEGNERLL--IYEFVPNTSLDHFIFDPTRRAQLDWERR-YKIIGGIARGLLYLHEDSRL 445
           S EG + LL  +  F     L H +    ++ +L  E +  +    IA  L YLHE    
Sbjct: 67  SWEGEDGLLYIVMGFCEGGDLYHKL--KEQKGKLLPENQVVEWFVQIAMALQYLHEK--- 121

Query: 446 RIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQY 505
            I+HRDLKT NV L      K+ D G+AR+ E      +T  ++GT  YM+PE   +  Y
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFSNKPY 179

Query: 506 SVKSDVFSFGVLVLEI 521
           + KSDV++ G  V E+
Sbjct: 180 NYKSDVWALGCCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 75.8 bits (186), Expect = 4e-15
 Identities = 64/211 (30%), Positives = 104/211 (49%), Gaps = 22/211 (10%)

Query: 332 LGQGGFGAVYKGRLYDGAEI---AVKRLS-RDSGQGDLE-FKNEVLLVANLQHRNLVRLL 386
           LG+G FG+V +G+L     I   AVK +      + ++E F +E + +    H N++RL+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 387 GFSLEGNER------LLIYEFVPNTSLDHFIFDPTRRAQ---LDWERRYKIIGGIARGLL 437
           G  L+  E       ++I  F+ +  L  F+           L  +   K +  IA G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMA-RLFEMD-ETQGNTSRIVGTYGYM 495
           YL   S    IHRDL   N +L+  M   +ADFG++ +++  D   QG  +++     ++
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM--PVKWI 181

Query: 496 APEYAMHGQYSVKSDVFSFGVLVLEIIS-GQ 525
           A E      Y+ KSDV+SFGV + EI + GQ
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQ 212

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 75.7 bits (186), Expect = 4e-15
 Identities = 65/219 (29%), Positives = 108/219 (49%), Gaps = 25/219 (11%)

Query: 326 FSDANKLGQGGFGAVYKGRLY----DGAEIAVKRLSRD-SGQGDLE-FKNEVLLVANLQH 379
           F+    LG+G FG+V + +L        ++AVK L  D     D+E F  E   +    H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 380 RNLVRLLGFSLEGNER------LLIYEFVPNTSLDHFIFDPTRRAQ----LDWERRYKII 429
            N+++L+G SL    +      ++I  F+ +  L  F+   +R  +    L  +   + +
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-MSRIGEEPFTLPLQTLVRFM 119

Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMD-ETQGNTSR 487
             IA G+ YL   S    IHRDL   N +L+  MT  +ADFG+++ ++  D   QG  S+
Sbjct: 120 IDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176

Query: 488 IVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQ 525
           +     ++A E      Y+  SDV++FGV + EI++ GQ
Sbjct: 177 L--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 75.0 bits (184), Expect = 6e-15
 Identities = 55/204 (26%), Positives = 103/204 (50%), Gaps = 16/204 (7%)

Query: 331 KLGQGGFGAVYKGRLY----DGAEIAVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLVRL 385
           +LG G FG V KG +Y       ++A+K L  ++ +    E   E  ++  L +  +VR+
Sbjct: 2   ELGSGNFGCVKKG-VYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRM 60

Query: 386 LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRL 445
           +G   E    +L+ E      L+ F+    ++ ++      +++  ++ G+ YL   +  
Sbjct: 61  IGVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN-- 115

Query: 446 RIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY--GYMAPEYAMHG 503
             +HRDL   NVLL  +   KI+DFG+++    D++    +R  G +   + APE     
Sbjct: 116 -FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY-YKARSAGKWPLKWYAPECINFR 173

Query: 504 QYSVKSDVFSFGVLVLEIIS-GQR 526
           ++S +SDV+S+G+ + E  S GQ+
Sbjct: 174 KFSSRSDVWSYGITMWEAFSYGQK 197

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 75.4 bits (185), Expect = 6e-15
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 19/208 (9%)

Query: 326 FSDANKLGQGGFGAV------YKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQH 379
           F     LG+GGFG V        G++Y    +  KR+ +  G+     + ++L   N Q 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ- 60

Query: 380 RNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
              V  L ++ E  + L L+   +    L   I++       + ER       I  GL  
Sbjct: 61  --FVVNLAYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFEEERALFYAAEILCGLED 117

Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMA-RLFEMDETQGNTSRIVGTYGYMAP 497
           LH ++    ++RDLK  N+LLD     +I+D G+A ++ E +  +G     VGT GYMAP
Sbjct: 118 LHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVGYMAP 170

Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           E   + +Y++  D +  G L+ E+I GQ
Sbjct: 171 EVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 75.3 bits (186), Expect = 6e-15
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 28/207 (13%)

Query: 331 KLGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQGDLEFKN--------EVLLVANLQ-HR 380
           +LG G FG+VY  R  +  E+ A+K++ +       +F +        EV  +  L  H 
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKK-------KFYSWEECMNLREVKSLRKLNEHP 58

Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYK-IIGGIARGLLYL 439
           N+V+L     E +E   ++E++   +L   + D  R+ +   E   + II  I +GL ++
Sbjct: 59  NIVKLKEVFRENDELYFVFEYM-EGNLYQLMKD--RKGKPFSESVIRSIIYQILQGLAHI 115

Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
           H   +    HRDLK  N+L+      KIADFG+AR  E+      T   V T  Y APE 
Sbjct: 116 H---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTD-YVSTRWYRAPEI 169

Query: 500 AMHGQ-YSVKSDVFSFGVLVLEIISGQ 525
            +    YS   D+++ G ++ E+ + +
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 75.3 bits (186), Expect = 7e-15
 Identities = 60/218 (27%), Positives = 112/218 (51%), Gaps = 36/218 (16%)

Query: 324 DNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDS-GQGDLEFK----NEVLLVANL 377
           D +   N++ +G +G VY+ R     EI A+K+L  +   +G   F      E+ ++  L
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG---FPITSLREINILLKL 61

Query: 378 QHRNLVRL----LGFSLEGNERLLIYEFVPN---TSLDHFIFDPTRRAQLDWERR---YK 427
           QH N+V +    +G +L  ++  ++ E+V +   + ++       ++  L  E +    +
Sbjct: 62  QHPNIVTVKEVVVGSNL--DKIYMVMEYVEHDLKSLMETM-----KQPFLQSEVKCLMLQ 114

Query: 428 IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSR 487
           ++ G+A    +LH++    I+HRDLKTSN+LL+     KI DFG+AR +         ++
Sbjct: 115 LLSGVA----HLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG--SPLKPYTQ 165

Query: 488 IVGTYGYMAPEYAM-HGQYSVKSDVFSFGVLVLEIISG 524
           +V T  Y APE  +   +YS   D++S G +  E+++ 
Sbjct: 166 LVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK 203

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 75.6 bits (186), Expect = 7e-15
 Identities = 64/201 (31%), Positives = 100/201 (49%), Gaps = 18/201 (8%)

Query: 332 LGQGGFGAVYKGRLYDGAE----IAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRL 385
           LGQG FG V+  R   G +     A+K L + +   +  +  K E  ++A + H  +V+L
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63

Query: 386 -LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI-IGGIARGLLYLHEDS 443
              F  EG +  LI +F+    L    F    +  +  E   K  +  +A  L +LH   
Sbjct: 64  HYAFQTEG-KLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLH--- 115

Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG 503
            L II+RDLK  N+LLD E   K+ DFG+++  E  + +       GT  YMAPE     
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRR 173

Query: 504 QYSVKSDVFSFGVLVLEIISG 524
            ++  +D +SFGVL+ E+++G
Sbjct: 174 GHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 75.4 bits (185), Expect = 7e-15
 Identities = 80/290 (27%), Positives = 128/290 (44%), Gaps = 50/290 (17%)

Query: 332 LGQGGFGAVYKGRLY-DGAEI--AVKRLSRDSGQGD-LEFKNEVLLVANL-QHRNLVRLL 386
           +G+G FG V +  +  DG ++  A+K L   + + D  +F  E+ ++  L  H N++ LL
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 387 GFSLEGNERLLIYEFVPNTSLDHFI-------FDPT------RRAQLDWERRYKIIGGIA 433
           G         +  E+ P  +L  F+        DP         + L  ++  +    +A
Sbjct: 70  GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129

Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
            G+ YL E    + IHRDL   NVL+   +  KIADFG++R        G    +  T G
Sbjct: 130 TGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR--------GEEVYVKKTMG 178

Query: 494 -----YMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNW 547
                +MA E   +  Y+ KSDV+SFGVL+ EI+S G    C   G T  +L     + +
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYC---GMTCAELYEKLPQGY 235

Query: 548 REGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN 597
           R     N  D       + E++R       C ++    RP  A + + L+
Sbjct: 236 RMEKPRNCDD------EVYELMR------QCWRDRPYERPPFAQISVQLS 273

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 75.0 bits (184), Expect = 8e-15
 Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 17/201 (8%)

Query: 332 LGQGGFGAV------YKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRL 385
           LG+GGFG V        G++Y   ++  KR+ +  G+      NE  ++  +  R +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEA--MALNEKRILEKVNSRFVVSL 65

Query: 386 LGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSR 444
             ++ E  + L L+   +    L   I++       D +R       +  GL  L    R
Sbjct: 66  -AYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFDEQRAIFYAAELCCGLEDLQ---R 120

Query: 445 LRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQ 504
            RI++RDLK  N+LLD     +I+D G+A   ++ E +    R VGT GYMAPE   + +
Sbjct: 121 ERIVYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGR-VGTVGYMAPEVINNEK 177

Query: 505 YSVKSDVFSFGVLVLEIISGQ 525
           Y+   D +  G L+ E+I GQ
Sbjct: 178 YTFSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 74.9 bits (184), Expect = 9e-15
 Identities = 64/201 (31%), Positives = 98/201 (48%), Gaps = 17/201 (8%)

Query: 332 LGQGGFGAV------YKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRL 385
           LG+GGFG V        G++Y   ++  KR+ +  G+      NE  ++  +  R +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEA--MALNEKQILEKVNSRFVVSL 65

Query: 386 LGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSR 444
             ++ E  + L L+   +    L   I++       D ER       I  GL  LH   R
Sbjct: 66  -AYAYETKDALCLVLTLMNGGDLKFHIYN-MGNPGFDEERAVFYAAEITCGLEDLH---R 120

Query: 445 LRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQ 504
            RI++RDLK  N+LLD     +I+D G+A   E+ E +    R VGT GYMAPE   + +
Sbjct: 121 ERIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGR-VGTVGYMAPEVVKNER 177

Query: 505 YSVKSDVFSFGVLVLEIISGQ 525
           Y+   D +  G L+ E+I G+
Sbjct: 178 YTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 74.2 bits (182), Expect = 1e-14
 Identities = 60/206 (29%), Positives = 105/206 (50%), Gaps = 20/206 (9%)

Query: 325 NFSDANKLGQGGFGAVY--KGRLYDGAEIAVKR--LSRDSGQGDLEFKNEVLLVANLQHR 380
            +    K+G+G FG +Y  K +  D     +K   L++   +     K EV+L+A ++H 
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKS-DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59

Query: 381 NLVRLLGFSLEGNERLLI-YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIG---GIARGL 436
           N+V     S + N RL I  E+     L   I    +R  L  E   +I+     I+ GL
Sbjct: 60  NIVTFFA-SFQENGRLFIVMEYCDGGDLMKRI--NRQRGVLFSED--QILSWFVQISLGL 114

Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAE-MTPKIADFGMARLFEMDETQGNTSRIVGTYGYM 495
            ++H+    +I+HRD+K+ N+ L    M  K+ DFG+AR  +++++       VGT  Y+
Sbjct: 115 KHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIAR--QLNDSMELAYTCVGTPYYL 169

Query: 496 APEYAMHGQYSVKSDVFSFGVLVLEI 521
           +PE   +  Y+ K+D++S G ++ E+
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYEL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 75.9 bits (187), Expect = 1e-14
 Identities = 37/95 (38%), Positives = 56/95 (58%), Gaps = 5/95 (5%)

Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT 491
           I RGL YLH      I+HRD+K  N+L+++    KI DFG+AR+ E DE++  T  +V  
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168

Query: 492 YGYMAPEYAMHGQ-YSVKSDVFSFGVLVLEIISGQ 525
           Y Y APE  M  + Y+   D++S G +  E++  +
Sbjct: 169 Y-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 75.3 bits (185), Expect = 1e-14
 Identities = 62/200 (31%), Positives = 92/200 (46%), Gaps = 15/200 (7%)

Query: 332 LGQGGFGAVYKGRLYDGAEI-AVKRLSRDS----GQGDLEFKNEVLLVANLQHRNLVRLL 386
           LG+G FG V    L    E+ A+K L +D        D     + +L    +H  L  L 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 387 GFSLEGNERLL-IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRL 445
               +  +RL  + E+V    L   +F   R  + D  R       +   L++LH     
Sbjct: 63  C-CFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG-- 116

Query: 446 RIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQY 505
            +I+RDLK  N+LLDAE   K+ADFGM +  E       T+   GT  Y+APE     +Y
Sbjct: 117 -VIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQELEY 173

Query: 506 SVKSDVFSFGVLVLEIISGQ 525
               D ++ GVL+ E+++GQ
Sbjct: 174 GPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 75.0 bits (184), Expect = 1e-14
 Identities = 67/200 (33%), Positives = 91/200 (45%), Gaps = 15/200 (7%)

Query: 332 LGQGGFGAVYKGRLYDGAE-IAVKRLSRDSG--QGDLE---FKNEVLLVANLQHRNLVRL 385
           LG+G FG V    L    E  AVK L +D      D+E    +  VL +A  ++  L  L
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALA-WENPFLTHL 61

Query: 386 LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRL 445
                       + EF+    L   I D  R    D  R       I  GL +LH     
Sbjct: 62  YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR---FDLYRATFYAAEIVCGLQFLHSKG-- 116

Query: 446 RIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQY 505
            II+RDLK  NV+LD +   KIADFGM +     + + +T    GT  Y+APE     +Y
Sbjct: 117 -IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST--FCGTPDYIAPEILQGLKY 173

Query: 506 SVKSDVFSFGVLVLEIISGQ 525
           +   D +SFGVL+ E++ GQ
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 75.2 bits (185), Expect = 1e-14
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 16/214 (7%)

Query: 316 FNTIRVATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKN--EVL 372
           F T+   T+ + D   +G G FG V   R    G  +A+K++ +      L  +   E+ 
Sbjct: 2   FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61

Query: 373 LVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGI 432
           L+ +L+H N++ L    +   E +     +  T L   +       Q      Y+I+   
Sbjct: 62  LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQIL--- 118

Query: 433 ARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY 492
            RGL Y+H      ++HRDLK SN+L++     KI DFG+AR+ +   T       V T 
Sbjct: 119 -RGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTG-----YVSTR 169

Query: 493 GYMAPEYAMHGQ-YSVKSDVFSFGVLVLEIISGQ 525
            Y APE  +  Q Y V+ D++S G +  E++ G+
Sbjct: 170 YYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 74.6 bits (183), Expect = 1e-14
 Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 19/202 (9%)

Query: 331 KLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKN--EVLLVANLQ---HRNLVR 384
           ++G G +G VYK R  + G  +A+K +   + +  L      EV L+  L+   H N+VR
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 385 LLGF--SLEGNERL---LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
           L+    +   +      L++E V +  L  ++ D      L  E    ++    RGL +L
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124

Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
           H +    I+HRDLK  N+L+ +    K+ADFG+AR++     Q   + +V T  Y APE 
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPEV 178

Query: 500 AMHGQYSVKSDVFSFGVLVLEI 521
            +   Y+   D++S G +  E+
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 75.3 bits (186), Expect = 1e-14
 Identities = 67/210 (31%), Positives = 113/210 (53%), Gaps = 26/210 (12%)

Query: 330 NKLGQGGFGAVYKGRLYDGAEI-AVKRLS---RDSGQGDLEFKNEVLLVANL-QHRNLVR 384
            KLG+G +G V+K       E+ A+K++    R++      F+ E++ +  L  H N+V+
Sbjct: 13  QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVK 71

Query: 385 LLGFSLEGNER--LLIYEFVPNTSLDHFIFDPTRRAQL--DWERRYKIIGGIARGLLYLH 440
           LL      N++   L++E++  T L   I     RA +  D  +RY I+  + + L Y+H
Sbjct: 72  LLNVIKAENDKDIYLVFEYM-ETDLHAVI-----RANILEDVHKRY-IMYQLLKALKYIH 124

Query: 441 EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF-EMDETQGNT--SRIVGTYGYMAP 497
             S   +IHRDLK SN+LL+++   K+ADFG+AR   E++E   N   +  V T  Y AP
Sbjct: 125 --SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAP 181

Query: 498 E--YAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           E       +Y+   D++S G ++ E++ G+
Sbjct: 182 EILLGST-RYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 74.5 bits (183), Expect = 1e-14
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 21/216 (9%)

Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVK--RLSRDSGQGDLEFKNEVLLVANLQHR 380
           D +    K+G+G +G VYK R    G  +A+K  RL  D          E+ L+  L   
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 381 N-LVRLLGF--SLEGNERLLIY---EFVPNTSLDHFIFDPTRRAQ---LDWERRYKIIGG 431
             +VRLL      E N +  +Y   E++ ++ L  F+ D   R     L  +     +  
Sbjct: 61  IYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFM-DSNGRGPGRPLPAKTIKSFMYQ 118

Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAE-MTPKIADFGMARLFEMDETQGNTSRIVG 490
           + +G+ + H   +  ++HRDLK  N+L+D +    KIAD G+ R F +   +  T  IV 
Sbjct: 119 LLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI-PVKSYTHEIV- 173

Query: 491 TYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
           T  Y APE  +    YS   D++S G +  E+   Q
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 75.3 bits (185), Expect = 2e-14
 Identities = 43/154 (27%), Positives = 77/154 (50%), Gaps = 9/154 (5%)

Query: 370 EVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKII 429
           E +L+ N+ H +++R+    + G    ++   +P+ S D + +   R   L  ++   I 
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163

Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIV 489
             I  GL YLH     RIIHRD+KT N+ ++      I D G A+ F +         + 
Sbjct: 164 KQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVVAP--AFLGLA 217

Query: 490 GTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
           GT    APE     +Y+ K+D++S G+++ E+++
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 74.0 bits (182), Expect = 2e-14
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 21/205 (10%)

Query: 334 QGGFGAVYKGRLYDGA-----EIAVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLVRLLG 387
           +G FG ++ G L D       E+ VK +   + +  +     E  L+  L H+N++ +L 
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75

Query: 388 FSLEGNER-LLIYEFVPNTSLDHFIFD----PTRRAQLDWERRYKIIG-GIARGLLYLHE 441
             +E  E   ++Y ++   +L  F+           Q    ++   +   IA G+ YLH 
Sbjct: 76  VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH- 134

Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMD-ETQG-NTSRIVGTYGYMAPE 498
             +  +IH+D+   N ++D E+  KI D  ++R LF MD    G N +R V    +MA E
Sbjct: 135 --KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV---KWMALE 189

Query: 499 YAMHGQYSVKSDVFSFGVLVLEIIS 523
             ++ +YS  SDV+SFGVL+ E+++
Sbjct: 190 SLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 73.4 bits (180), Expect = 3e-14
 Identities = 57/218 (26%), Positives = 91/218 (41%), Gaps = 42/218 (19%)

Query: 330 NKLGQGGFGAVYKGRLYDG---AEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVR 384
           +++G G FG V  G  + G   A + VK L R S      L F  EV     L H N+++
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKEL-RASATPDEQLLFLQEVQPYRELNHPNVLQ 59

Query: 385 LLGFSLEGNERLLIYEFVPNTSLDHFI--------FDPTRRAQLDWERRYKIIGGIARGL 436
            LG  +E    LL+ EF P   L +++            +          ++   +A GL
Sbjct: 60  CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQ------RMACEVASGL 113

Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR------LFEMDETQGNTSRIVG 490
           L+LH   +   IH DL   N  L A+++ KI D+G+A        +   +      R   
Sbjct: 114 LWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR--- 167

Query: 491 TYGYMAPEYAMHGQYSV-------KSDVFSFGVLVLEI 521
              ++APE        +       KS+++S GV + E+
Sbjct: 168 ---WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 74.1 bits (183), Expect = 3e-14
 Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 57/223 (25%)

Query: 332 LGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---------EVLLVANLQH 379
           +G G +G V      D   G ++A+K++S         F +         E+ L+ +L+H
Sbjct: 8   IGSGAYGVVCSA--VDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRH 58

Query: 380 RNLVRLLGF-----SLEGNERLLIYEFVP-----------NTSLDHFIFDPTRRAQLDWE 423
            N++ LL         + N+  ++ E +              + DH              
Sbjct: 59  ENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHI------------- 105

Query: 424 RRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE-TQ 482
            +Y  +  I RGL YLH  +   +IHRDLK SN+L+++    KI DFG+AR  + DE  +
Sbjct: 106 -QY-FLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK 160

Query: 483 GNTSRIVGTYGYMAPEYAMHGQ-YSVKSDVFSFGVLVLEIISG 524
           G  +  V T  Y APE  +    Y+   D++S G +  E+++ 
Sbjct: 161 GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR 203

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 73.6 bits (181), Expect = 4e-14
 Identities = 36/98 (36%), Positives = 62/98 (63%), Gaps = 6/98 (6%)

Query: 427 KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTS 486
           KI   + RGL YL E  + +I+HRD+K SN+L+++    K+ DFG++   ++ ++  N+ 
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS- 157

Query: 487 RIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
             VGT  YM+PE      Y+V+SD++S G+ ++E+  G
Sbjct: 158 -FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 72.7 bits (178), Expect = 4e-14
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 35/218 (16%)

Query: 325 NFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLE-----FKNEVLLVAN 376
           N+     LG+G FG VY    YD   G E+AVK++  D    +        + E+ L+ N
Sbjct: 3   NWRLGKLLGRGAFGEVY--LCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKN 60

Query: 377 LQHRNLVRLLGFSLEGNERLL--IYEFVPNTSLDHFIFDPTRRAQL--------DWERRY 426
           L+H  +V+  G   +  E+ L    E++P  S+         + QL        +  RRY
Sbjct: 61  LRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSI---------KDQLKAYGALTENVTRRY 111

Query: 427 KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN-T 485
                I +G+ YLH +    I+HRD+K +N+L D+    K+ DFG ++  +     G   
Sbjct: 112 T--RQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGI 166

Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
             + GT  +M+PE      Y  K+DV+S    V+E+++
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 73.5 bits (180), Expect = 4e-14
 Identities = 41/95 (43%), Positives = 58/95 (61%), Gaps = 7/95 (7%)

Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSR-IVG 490
           I+ GL +LH      II+RDLK  NV+LD+E   KIADFGM +   +D   G T+R   G
Sbjct: 110 ISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD---GVTTRTFCG 163

Query: 491 TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           T  Y+APE   +  Y    D +++GVL+ E+++GQ
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 72.6 bits (178), Expect = 5e-14
 Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 26/209 (12%)

Query: 330 NKLGQGGFGAVYKGR-LYDGAEIAVK--RLSRDSGQGDLEFKNEVLLVANLQHR----NL 382
           ++LG+G +G+VYK      G  +A+K  RL  D    + +F N++++  ++ H+     +
Sbjct: 7   DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD----ESKF-NQIIMELDILHKAVSPYI 61

Query: 383 VRLLG-FSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           V   G F +EG   + + E++   SLD           +  +   +I   + +GL +L E
Sbjct: 62  VDFYGAFFIEGAVYMCM-EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120

Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY-- 499
           +    IIHRD+K +NVL++     K+ DFG++        + N    +G   YMAPE   
Sbjct: 121 E--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN----IGCQSYMAPERIK 174

Query: 500 ----AMHGQYSVKSDVFSFGVLVLEIISG 524
                 +  Y+V+SDV+S G+ +LE+  G
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALG 203

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 73.5 bits (180), Expect = 5e-14
 Identities = 68/230 (29%), Positives = 106/230 (46%), Gaps = 47/230 (20%)

Query: 318 TIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---EV 371
           TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E+
Sbjct: 11  TIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPF-QSIIHAKRTYREL 67

Query: 372 LLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK-- 427
            L+ +++H N++ LL              F P  SL+ F  ++  T     D     K  
Sbjct: 68  RLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 115

Query: 428 ---------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM 478
                    +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR    
Sbjct: 116 KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 168

Query: 479 DETQGNTSRIVGTYGYMAPEYA---MHGQYSVKSDVFSFGVLVLEIISGQ 525
             T    +  V T  Y APE     MH  Y+   D++S G ++ E+++G+
Sbjct: 169 -HTDDEMTGYVATRWYRAPEIMLNWMH--YNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 73.3 bits (180), Expect = 5e-14
 Identities = 64/207 (30%), Positives = 96/207 (46%), Gaps = 31/207 (14%)

Query: 332 LGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEV--------LLVANLQHRNL 382
           +G+G FG V   +   DG   AVK L + +    +  K E         +L+ N++H  L
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKA----ILKKKEQKHIMAERNVLLKNVKHPFL 58

Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHF----IFDPTRRAQLDWERRYKIIGG-IARGLL 437
           V L  +S +  ++L    FV    LD+     +F   +R +   E R +     IA  L 
Sbjct: 59  VGL-HYSFQTADKLY---FV----LDYVNGGELFFHLQRERSFPEPRARFYAAEIASALG 110

Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           YLH    L II+RDLK  N+LLD++    + DFG+ +  E  E    TS   GT  Y+AP
Sbjct: 111 YLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAP 165

Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISG 524
           E      Y    D +  G ++ E++ G
Sbjct: 166 EVLRKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 72.7 bits (178), Expect = 6e-14
 Identities = 65/216 (30%), Positives = 110/216 (50%), Gaps = 18/216 (8%)

Query: 330 NKLGQGGFGAVYKGR--LYDGAEIAVK--RLSRDSGQGDLEFKNEVLLVANLQHRNLVRL 385
            KLG+G +  V+KGR  L +   +A+K  RL  + G      + EV L+ +L+H N+V L
Sbjct: 12  EKLGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTL 69

Query: 386 LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRL 445
                      L++E++ +  L  ++ D      +   + +  +  I RGL Y H   R 
Sbjct: 70  HDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIF--LYQILRGLAYCH---RR 123

Query: 446 RIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM-HGQ 504
           +++HRDLK  N+L++     K+ADFG+AR   +  T+  ++ +V T  Y  P+  +   +
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSV-PTKTYSNEVV-TLWYRPPDVLLGSSE 181

Query: 505 YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
           YS + D++  G +  E+ SG+       G TVED L
Sbjct: 182 YSTQIDMWGVGCIFFEMASGRP---LFPGSTVEDEL 214

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 71.9 bits (176), Expect = 7e-14
 Identities = 61/201 (30%), Positives = 96/201 (47%), Gaps = 19/201 (9%)

Query: 331 KLGQGGFGAVY---------KGRLYDGAEIAVKRLS-RDSGQGDLEFKNEVLLVANLQHR 380
           +LG+G FG VY         + RL    EI V  L+  ++ Q + E +    L++ L H 
Sbjct: 7   RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQ----LLSKLDHP 62

Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH 440
            +V+     LE +   +I E+     LD  + +     +   E   ++     + LL +H
Sbjct: 63  AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSEN--QVCEWFIQLLLGVH 120

Query: 441 EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA 500
              + RI+HRDLK  N+ L   +  KI DFG++RL  M      T+   GT  YM+PE  
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLL-MGSCDLATT-FTGTPYYMSPEAL 177

Query: 501 MHGQYSVKSDVFSFGVLVLEI 521
            H  Y  KSD++S G ++ E+
Sbjct: 178 KHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 72.8 bits (178), Expect = 7e-14
 Identities = 60/210 (28%), Positives = 105/210 (50%), Gaps = 19/210 (9%)

Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQG-DLEFKNEVLLVANLQHRNLVRLLGFS 389
           K+G+G +G VYK +  DG +     L +  G G  +    E+ L+  L+H N++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67

Query: 390 LEGNER--LLIYEFVPNTSLDHFI-FDPTRRA-----QLDWERRYKIIGGIARGLLYLHE 441
           L  ++R   L++++  +  L H I F    +A     QL       ++  I  G+ YLH 
Sbjct: 68  LSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126

Query: 442 DSRLRIIHRDLKTSNVLLDAEMTP----KIADFGMARLFEMD-ETQGNTSRIVGTYGYMA 496
           +    ++HRDLK +N+L+  E       KIAD G ARLF    +   +   +V T+ Y A
Sbjct: 127 N---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 497 PEYAMHGQYSVKS-DVFSFGVLVLEIISGQ 525
           PE  +  ++  K+ D+++ G +  E+++ +
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 71.8 bits (176), Expect = 8e-14
 Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 31/212 (14%)

Query: 332 LGQGGFGAVYKG-RLYDGAEIAVKRLSRD-SGQGDLEFKNEVLLVANLQHRNLVRLLGFS 389
           LG G  G VYK   L     +AVK +  D + +   +  +E+ ++       ++   G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 390 LEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA----RGLLYLHEDSRL 445
              N   +  EF+   SLD +            +    ++G IA    +GL YL     L
Sbjct: 69  FVENRISICTEFMDGGSLDVY-----------RKIPEHVLGRIAVAVVKGLTYLWS---L 114

Query: 446 RIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQY 505
           +I+HRD+K SN+L++     K+ DFG++   ++  +   T   VGT  YMAPE     QY
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVST--QLVNSIAKT--YVGTNAYMAPERISGEQY 170

Query: 506 SVKSDVFSFGVLVLEIISG-------QRNNCF 530
            + SDV+S G+  +E+  G       Q+N   
Sbjct: 171 GIHSDVWSLGISFMELALGRFPYPQIQKNQGS 202

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 72.4 bits (178), Expect = 1e-13
 Identities = 67/211 (31%), Positives = 97/211 (45%), Gaps = 36/211 (17%)

Query: 332 LGQGGFGAV----YK--GRLYDGAEIAVKR---LSRDSGQGDLEFKNEVLLVAN-LQHRN 381
           LG+G FG V    YK  G LY  A  A+K+   ++RD  +  L  +  +   AN  +H  
Sbjct: 7   LGRGHFGKVLLAEYKKTGELY--AIKALKKGDIIARDEVE-SLMCEKRIFETANSERHPF 63

Query: 382 LVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFD---PTRRAQLDWERRYKIIGGIARGLL 437
           LV L     +  + +  + E+     L   I        RA       Y     +  GL 
Sbjct: 64  LVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVF-----Y--AACVVLGLQ 115

Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQG---NTSRIVGTYGY 494
           YLHE+   +I++RDLK  N+LLD E   KIADFG+ +     E  G    TS   GT  +
Sbjct: 116 YLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK-----EGMGFGDRTSTFCGTPEF 167

Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           +APE      Y+   D +  GVL+ E++ G+
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVGE 198

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 52/189 (27%), Positives = 94/189 (49%), Gaps = 21/189 (11%)

Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK--NEVLLVANLQHR 380
             +    K+GQG FG V+K R       +A+K++  ++ +         E+ ++  L+H 
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHE 71

Query: 381 NLVRLLGF----SLEGNER----LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGI 432
           N+V L+      +   N       L++EF  +  L   + +   +  L      K++  +
Sbjct: 72  NVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTL--SEIKKVMKML 128

Query: 433 ARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE-TQGN--TSRIV 489
             GL Y+H   R +I+HRD+K +N+L+  +   K+ADFG+AR F + + ++ N  T+R+V
Sbjct: 129 LNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV 185

Query: 490 GTYGYMAPE 498
            T  Y  PE
Sbjct: 186 -TLWYRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 72.0 bits (176), Expect = 1e-13
 Identities = 41/94 (43%), Positives = 54/94 (57%), Gaps = 5/94 (5%)

Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT 491
           IA GL +LH      II+RDLK  NV+LD+E   KIADFGM +    D     T    GT
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGT 164

Query: 492 YGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
             Y+APE   +  Y    D ++FGVL+ E+++GQ
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 72.0 bits (176), Expect = 2e-13
 Identities = 61/210 (29%), Positives = 105/210 (50%), Gaps = 23/210 (10%)

Query: 324 DNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFK----NEVLLVANLQH 379
           D+F   ++LG G  G V K +      I  ++L        LE K    N+++    + H
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIH------LEIKPAIRNQIIRELQVLH 58

Query: 380 R-NLVRLLGFS---LEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARG 435
             N   ++GF        E  +  E +   SLD  + +  R  +   E   K+   + RG
Sbjct: 59  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE---EILGKVSIAVLRG 115

Query: 436 LLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYM 495
           L YL E  + +I+HRD+K SN+L+++    K+ DFG++   ++ ++  N+   VGT  YM
Sbjct: 116 LAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRSYM 169

Query: 496 APEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           +PE      YSV+SD++S G+ ++E+  G+
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 71.3 bits (175), Expect = 2e-13
 Identities = 64/220 (29%), Positives = 100/220 (45%), Gaps = 53/220 (24%)

Query: 332 LGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLL---VANLQHR--NLVRL 385
           +G G  G VYK R    G  +AVK++ R    G+ E    +L+   V    H    +V+ 
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRT---GNKEENKRILMDLDVVLKSHDCPYIVKC 79

Query: 386 LG-FSLEGN------------ERLL--IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIG 430
            G F  + +            ++LL  I   +P   L                   K+  
Sbjct: 80  YGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG------------------KMTV 121

Query: 431 GIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMA-RLFEMDETQGNTSRIV 489
            I + L YL E     +IHRD+K SN+LLDA    K+ DFG++ RL    +++  T R  
Sbjct: 122 AIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKT-RSA 175

Query: 490 GTYGYMAPEY----AMHGQYSVKSDVFSFGVLVLEIISGQ 525
           G   YMAPE       + +Y +++DV+S G+ ++E+ +GQ
Sbjct: 176 GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 71.5 bits (175), Expect = 2e-13
 Identities = 64/201 (31%), Positives = 97/201 (48%), Gaps = 17/201 (8%)

Query: 332 LGQGGFGAVYKGRLYDGAEI-AVKRLSRDS--GQGDLE---FKNEVLLVANLQHRNLVRL 385
           LG+G FG V+   L    +  A+K L +D      D+E    +  VL +A  +H  L  L
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTHL 61

Query: 386 LGFSLEGNERLL-IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSR 444
              + +  E L  + E++    L   +F      + D  R       I  GL +LH    
Sbjct: 62  Y-CTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG- 116

Query: 445 LRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQ 504
             I++RDLK  N+LLD +   KIADFGM +   + + +  T    GT  Y+APE  +  +
Sbjct: 117 --IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDYIAPEILLGQK 172

Query: 505 YSVKSDVFSFGVLVLEIISGQ 525
           Y+   D +SFGVL+ E++ GQ
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 73.3 bits (180), Expect = 3e-13
 Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 21/205 (10%)

Query: 348 GAEIAVKRLSRDSGQGDLE---FKNEVLLVANLQHRNLVRLLGFSLEGNERLL-IYEFVP 403
           G E+A+K L  D+ + + +   F+ E  L A L H N+V LL         L  ++E+VP
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 404 NTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLL---D 460
             +L   +        L      +++  +   L   H      I+HRDLK  N+++    
Sbjct: 63  GRTLREVL---AADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTG 116

Query: 461 AEMTPKIADFGMARLF----EMDETQGN-TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFG 515
                K+ DFG+  L     + D      T+ ++GT  Y APE       +  SD++++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176

Query: 516 VLVLEIISGQRNNCFRNGETVEDLL 540
           ++ LE ++GQR      G +V ++L
Sbjct: 177 LIFLECLTGQR---VVQGASVAEIL 198

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 29/204 (14%)

Query: 334 QGGFGAVY--KGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNL--------V 383
           +G FG+VY  K R   G   A+K L +     D+  KN+V  V   +   +        V
Sbjct: 6   KGAFGSVYLAKKRS-TGDYFAIKVLKK----SDMIAKNQVTNV-KAERAIMMIQGESPYV 59

Query: 384 RLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
             L +S +  + L L+ E++        I         DW ++Y  I  +  G+  LH+ 
Sbjct: 60  AKLYYSFQSKDYLYLVMEYLNGGDCASLI-KTLGGLPEDWAKQY--IAEVVLGVEDLHQR 116

Query: 443 SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMH 502
               IIHRD+K  N+L+D     K+ DFG++R    ++      + VGT  Y+APE  + 
Sbjct: 117 G---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------KFVGTPDYLAPETILG 167

Query: 503 GQYSVKSDVFSFGVLVLEIISGQR 526
                 SD +S G ++ E + G  
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFGYP 191

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 70.4 bits (172), Expect = 3e-13
 Identities = 64/216 (29%), Positives = 110/216 (50%), Gaps = 18/216 (8%)

Query: 330 NKLGQGGFGAVYKGR--LYDGAEIAVK--RLSRDSGQGDLEFKNEVLLVANLQHRNLVRL 385
           +KLG+G +  VYKGR  L D   +A+K  RL  + G      + EV L+ +L+H N+V L
Sbjct: 12  DKLGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTL 69

Query: 386 LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRL 445
                      L++E++ +  L  ++ D      +   + +  +  + RGL Y H   R 
Sbjct: 70  HDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--LFQLLRGLNYCH---RR 123

Query: 446 RIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG-Q 504
           +++HRDLK  N+L++     K+ADFG+AR   +  T+  ++ +V T  Y  P+  +    
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYSNEVV-TLWYRPPDILLGSTD 181

Query: 505 YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
           YS + D++  G +  E+ +G+       G TVE+ L
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGRP---LFPGSTVEEQL 214

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 70.5 bits (173), Expect = 5e-13
 Identities = 71/248 (28%), Positives = 106/248 (42%), Gaps = 73/248 (29%)

Query: 316 FNTIRVATDNF------SDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLE 366
           F ++ V    F       +   +G G  G V     YD   G  +A+K+LSR        
Sbjct: 2   FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAA--YDTVTGQNVAIKKLSR-------P 52

Query: 367 FKN---------EVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF------- 410
           F+N         E++L+  + H+N++ LL              F P  SL+ F       
Sbjct: 53  FQNVTHAKRAYRELVLMKLVNHKNIIGLLNV------------FTPQKSLEEFQDVYLVM 100

Query: 411 -IFDPTR----RAQLDWERR----YKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDA 461
            + D       +  LD ER     Y+++ GI     +LH      IIHRDLK SN+++ +
Sbjct: 101 ELMDANLCQVIQMDLDHERMSYLLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKS 153

Query: 462 EMTPKIADFGMARL----FEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVL 517
           + T KI DFG+AR     F M      T  +V  Y Y APE  +   Y    D++S G +
Sbjct: 154 DCTLKILDFGLARTAGTSFMM------TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCI 206

Query: 518 VLEIISGQ 525
           + E+I G 
Sbjct: 207 MGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 69.6 bits (170), Expect = 5e-13
 Identities = 63/210 (30%), Positives = 105/210 (50%), Gaps = 17/210 (8%)

Query: 322 ATDNFSDANKLGQGGFGAVYKG--RLYDGAEIAVKRLSRDSGQGDLEFK--NEVLLVANL 377
           A  ++ +  KLG+G +  VYKG  R+ +G  +A+K +S  + +G + F    E  L+  L
Sbjct: 3   AATSYLNLEKLGEGSYATVYKGISRI-NGQLVALKVISMKTEEG-VPFTAIREASLLKGL 60

Query: 378 QHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGL 436
           +H N+V LL   +   E L  ++E++      + I  P     L        +  + RGL
Sbjct: 61  KHANIV-LLHDIIHTKETLTFVFEYMHTDLAQYMIQHP---GGLHPYNVRLFMFQLLRGL 116

Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMA 496
            Y+H      I+HRDLK  N+L+      K+ADFG+AR   +  +Q  +S +V T  Y  
Sbjct: 117 AYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSI-PSQTYSSEVV-TLWYRP 171

Query: 497 PEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
           P+  +    YS   D++  G + +E++ GQ
Sbjct: 172 PDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 70.1 bits (171), Expect = 6e-13
 Identities = 58/209 (27%), Positives = 104/209 (49%), Gaps = 17/209 (8%)

Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQG-DLEFKNEVLLVANLQHRNLVRLLGFS 389
           K+G+G +G VYK +  DG +     L +  G G  +    E+ L+  L+H N++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 390 LEGNER--LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY-----LHED 442
           L   +R   L++++  +  L H I     RA    ++  ++  G+ + LLY     +H  
Sbjct: 68  LSHADRKVWLLFDYAEH-DLWHII--KFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124

Query: 443 SRLRIIHRDLKTSNVLLDAEMTP----KIADFGMARLFEMD-ETQGNTSRIVGTYGYMAP 497
               ++HRDLK +N+L+  E       KIAD G ARLF    +   +   +V T+ Y AP
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184

Query: 498 EYAMHGQYSVKS-DVFSFGVLVLEIISGQ 525
           E  +  ++  K+ D+++ G +  E+++ +
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 70.0 bits (171), Expect = 6e-13
 Identities = 64/201 (31%), Positives = 97/201 (48%), Gaps = 19/201 (9%)

Query: 332 LGQGGFGAVY-KGRLYDGAEIAVKRLSRDS-----GQGDLEFKNEVLLVANLQHRNLVRL 385
           +G+G FG V    R  DG+  AVK L + +      Q  +  +  VLL  NL+H  LV L
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLL-KNLKHPFLVGL 61

Query: 386 LGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IARGLLYLHEDS 443
             +S +  E+L  + ++V    L    F   +R +   E R +     +A  + YLH   
Sbjct: 62  -HYSFQTAEKLYFVLDYVNGGEL----FFHLQRERCFLEPRARFYAAEVASAIGYLHS-- 114

Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG 503
            L II+RDLK  N+LLD++    + DFG+ +  E  E +  TS   GT  Y+APE     
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKE 171

Query: 504 QYSVKSDVFSFGVLVLEIISG 524
            Y    D +  G ++ E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 70.4 bits (172), Expect = 6e-13
 Identities = 69/243 (28%), Positives = 108/243 (44%), Gaps = 65/243 (26%)

Query: 316 FNTIRVATDNFSDANK------LGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLE 366
           F +++VA   F+   +      +G G  G V     +D   G  +AVK+LSR        
Sbjct: 7   FYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAA--FDTVLGINVAVKKLSR-------P 57

Query: 367 FKN---------EVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF------- 410
           F+N         E++L+  + H+N++ LL              F P  SL+ F       
Sbjct: 58  FQNQTHAKRAYRELVLLKCVNHKNIISLLNV------------FTPQKSLEEFQDVYLVM 105

Query: 411 -IFDPTR----RAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP 465
            + D         +LD ER   ++  +  G+ +LH      IIHRDLK SN+++ ++ T 
Sbjct: 106 ELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 162

Query: 466 KIADFGMARL----FEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEI 521
           KI DFG+AR     F M      T  +V  Y Y APE  +   Y    D++S G ++ E+
Sbjct: 163 KILDFGLARTACTNFMM------TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEL 215

Query: 522 ISG 524
           + G
Sbjct: 216 VKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 55/210 (26%), Positives = 102/210 (48%), Gaps = 27/210 (12%)

Query: 326 FSDANKLGQGGFGAVY------KGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQH 379
           +    K+G+G FG          G+ Y   EI + ++S    +   E + EV +++N++H
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMKH 58

Query: 380 RNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDP-----TRRAQLDWERRYKIIGGIA 433
            N+V+    S E N  L ++ ++     L   I             LDW  +      I 
Sbjct: 59  PNIVQYQE-SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQ------IC 111

Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             L ++H+    +I+HRD+K+ N+ L  + T K+ DFG+AR+  ++ T       +GT  
Sbjct: 112 LALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCIGTPY 166

Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
           Y++PE   +  Y+ KSD+++ G ++ E+ +
Sbjct: 167 YLSPEICENRPYNNKSDIWALGCVLYEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 68.5 bits (168), Expect = 2e-12
 Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 8/95 (8%)

Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF--EMDETQGNTSRIV 489
           + RGL Y+H  +   +IHRDLK SN+L++ +   +I DFGMAR       E +   +  V
Sbjct: 116 LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172

Query: 490 GTYGYMAPE--YAMHGQYSVKSDVFSFGVLVLEII 522
            T  Y APE   ++  +Y+   D++S G +  E++
Sbjct: 173 ATRWYRAPELLLSLP-EYTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 68.2 bits (166), Expect = 3e-12
 Identities = 67/215 (31%), Positives = 102/215 (47%), Gaps = 45/215 (20%)

Query: 332 LGQGGFGAV---YKGRLYDGAEIAVKRLSR--DSGQGDLEFKNEVLLVANLQHRNLVRLL 386
           +G G +G+V   Y  RL    ++AVK+LSR   S         E+ L+ +++H N++ LL
Sbjct: 23  VGSGAYGSVCSAYDTRLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80

Query: 387 GFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK-----------IIGGIA 433
                         F P TS+++F  ++  T     D     K           +I  + 
Sbjct: 81  DV------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLL 128

Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
           RGL Y+H      IIHRDLK SNV ++ +   +I DFG+AR  + DE  G     V T  
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQAD-DEMTG----YVATRW 180

Query: 494 YMAPEYA---MHGQYSVKSDVFSFGVLVLEIISGQ 525
           Y APE     MH  Y+   D++S G ++ E++ G+
Sbjct: 181 YRAPEIMLNWMH--YNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 68.5 bits (167), Expect = 3e-12
 Identities = 68/249 (27%), Positives = 114/249 (45%), Gaps = 26/249 (10%)

Query: 288 RKPRDNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYD 347
           +K  +  +  +  A  DE    + +  D N  R    ++   N +G G FG VY+    D
Sbjct: 33  KKLDEEERSHNNNAGEDEDEE-KMIDNDIN--RSPNKSYKLGNIIGNGSFGVVYEAICID 89

Query: 348 GAE-IAVKRLSRDSGQGDLEFKN-EVLLVANLQHRNLVRLLGF----SLEGNERLL---- 397
            +E +A+K++ +D      ++KN E+L++ NL H N++ L  +      + NE+ +    
Sbjct: 90  TSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV 144

Query: 398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNV 457
           + EF+P T   +          L           + R L Y+H      I HRDLK  N+
Sbjct: 145 VMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNL 201

Query: 458 LLDAEM-TPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFG 515
           L+D    T K+ DFG A+   +   Q + S I   + Y APE  +    Y+   D++S G
Sbjct: 202 LIDPNTHTLKLCDFGSAK--NLLAGQRSVSYICSRF-YRAPELMLGATNYTTHIDLWSLG 258

Query: 516 VLVLEIISG 524
            ++ E+I G
Sbjct: 259 CIIAEMILG 267

Length = 440

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 67.4 bits (164), Expect = 4e-12
 Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 15/206 (7%)

Query: 324 DNFSDANKLGQGGFGAVYKGRL-YDGAEIAVK--RLSRDSGQGDLEFKNEVLLVANLQHR 380
           D++    KLG+G +  VYKG+   +G  +A+K  RL  + G      + E  L+  L+H 
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63

Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH 440
           N+V L           L++E+V +T L  ++        L  E     +  + RGL Y+H
Sbjct: 64  NIVLLHDIIHTKETLTLVFEYV-HTDLCQYM--DKHPGGLHPENVKLFLFQLLRGLSYIH 120

Query: 441 EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM-DETQGNTSRIVGTYGYMAPEY 499
           +     I+HRDLK  N+L+      K+ADFG+AR   +   T  N    V T  Y  P+ 
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNE---VVTLWYRPPDV 174

Query: 500 AMHG-QYSVKSDVFSFGVLVLEIISG 524
            +   +YS   D++  G + +E+I G
Sbjct: 175 LLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 67.0 bits (163), Expect = 4e-12
 Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 15/201 (7%)

Query: 330 NKLGQGGFGAVYKGRL-YDGAEIAVK--RLSRDSGQGDLEFKNEVLLVANLQHRNLVRLL 386
           +KLG+G +  V+KGR       +A+K  RL  + G      + EV L+ NL+H N+V L 
Sbjct: 11  DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLH 69

Query: 387 GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI-IGGIARGLLYLHEDSRL 445
                     L++E++ ++ L  ++        L      KI +  + RGL Y H   + 
Sbjct: 70  DIIHTERCLTLVFEYL-DSDLKQYL---DNCGNLMSMHNVKIFMFQLLRGLSYCH---KR 122

Query: 446 RIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG-Q 504
           +I+HRDLK  N+L++ +   K+ADFG+AR   +  T+  ++ +V T  Y  P+  +   +
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLARAKSV-PTKTYSNEVV-TLWYRPPDVLLGSTE 180

Query: 505 YSVKSDVFSFGVLVLEIISGQ 525
           YS   D++  G ++ E+ +G+
Sbjct: 181 YSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 67.4 bits (164), Expect = 5e-12
 Identities = 60/214 (28%), Positives = 106/214 (49%), Gaps = 31/214 (14%)

Query: 324 DNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFK----NEVLLVANLQH 379
           D+F   ++LG G  G V+K        I  ++L        LE K    N+++    + H
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIH------LEIKPAIRNQIIRELQVLH 58

Query: 380 R-NLVRLLGFS---LEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA-- 433
             N   ++GF        E  +  E +   SLD  +    R  +       +I+G ++  
Sbjct: 59  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-------QILGKVSIA 111

Query: 434 --RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT 491
             +GL YL E  + +I+HRD+K SN+L+++    K+ DFG++   ++ ++  N+   VGT
Sbjct: 112 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGT 165

Query: 492 YGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
             YM+PE      YSV+SD++S G+ ++E+  G+
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 66.7 bits (163), Expect = 5e-12
 Identities = 46/140 (32%), Positives = 64/140 (45%), Gaps = 17/140 (12%)

Query: 397 LIYEFVPNTSLDHFIFDPTR----------RAQLDWERRYKIIGGIARGLLYLHEDSRLR 446
           L Y F  +T L H I D             R           I  I   L +LH+   L 
Sbjct: 70  LHYAFQTDTKL-HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQ---LG 125

Query: 447 IIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQ-- 504
           II+RD+K  N+LLD+E    + DFG+++ F  +E +   S   GT  YMAPE    G   
Sbjct: 126 IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAPEVIRGGSGG 184

Query: 505 YSVKSDVFSFGVLVLEIISG 524
           +    D +S GVL  E+++G
Sbjct: 185 HDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 67.2 bits (164), Expect = 6e-12
 Identities = 46/129 (35%), Positives = 64/129 (49%), Gaps = 8/129 (6%)

Query: 397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSN 456
            + EFV    L   +F   R+ +L  E        I+  L +LHE     II+RDLK  N
Sbjct: 73  FVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDN 126

Query: 457 VLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGV 516
           VLLDAE   K+ D+GM +  E       TS   GT  Y+APE      Y    D ++ GV
Sbjct: 127 VLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGV 184

Query: 517 LVLEIISGQ 525
           L+ E+++G+
Sbjct: 185 LMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 66.9 bits (164), Expect = 6e-12
 Identities = 58/225 (25%), Positives = 103/225 (45%), Gaps = 47/225 (20%)

Query: 324 DNFSDANKLGQGGFGAVYKG-RLYDGAEIAVKRLSRDSGQG-DLEFKNEVLLVANLQHRN 381
             + + + +G+G +G V        G ++A+K++S    Q        E+ ++   +H N
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64

Query: 382 LVRLLGF----SLEG-NERLLIYEFVP----------NTSLDH---FIFDPTRRAQLDWE 423
           ++ +L      S E  N+  ++ E +           + S DH   F+            
Sbjct: 65  IIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFL------------ 112

Query: 424 RRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQG 483
             Y+I+    RGL Y+H  +   ++HRDLK SN+LL+     KI DFG+AR+   D    
Sbjct: 113 --YQIL----RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHD 161

Query: 484 NTSRI---VGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISG 524
           +T  +   V T  Y APE  ++   Y+   D++S G ++ E++S 
Sbjct: 162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 66.7 bits (163), Expect = 8e-12
 Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 38/217 (17%)

Query: 331 KLGQGGFGAV----YKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQ-------- 378
           +LGQG +G V          +   +A+K+++         F  ++L    L+        
Sbjct: 7   ELGQGAYGIVCSARNAET-SEEETVAIKKITN-------VFSKKILAKRALRELKLLRHF 58

Query: 379 --HRNLVRLLG----FSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYK-IIGG 431
             H+N+  L      F    NE L +YE +    L   I    R  Q   +  ++  I  
Sbjct: 59  RGHKNITCLYDMDIVFPGNFNE-LYLYEELMEADLHQII----RSGQPLTDAHFQSFIYQ 113

Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD--ETQGNTSRIV 489
           I  GL Y+H  +   ++HRDLK  N+L++A+   KI DFG+AR F  +  E  G  +  V
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170

Query: 490 GTYGYMAPEYAMHGQ-YSVKSDVFSFGVLVLEIISGQ 525
            T  Y APE  +  Q Y+   DV+S G ++ E++  +
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 66.8 bits (163), Expect = 8e-12
 Identities = 60/219 (27%), Positives = 106/219 (48%), Gaps = 24/219 (10%)

Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKG-RLYDGAEIAVKRLSRDSGQGDLEFKN---EVL 372
            T+    + ++   ++G G +G+V        G ++A+K+LSR   Q ++  K    E+ 
Sbjct: 8   KTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF-QSEIFAKRAYRELT 66

Query: 373 LVANLQHRNLVRLLGF---SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKII 429
           L+ ++QH N++ LL     ++ G+E    Y  +P    D           L  ++   ++
Sbjct: 67  LLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD---LQKIMGHPLSEDKVQYLV 123

Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIV 489
             +  GL Y+H      IIHRDLK  N+ ++ +   KI DFG+AR  + + T       V
Sbjct: 124 YQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG-----YV 175

Query: 490 GTYGYMAPEYA---MHGQYSVKSDVFSFGVLVLEIISGQ 525
            T  Y APE     MH  Y+   D++S G ++ E+++G+
Sbjct: 176 VTRWYRAPEVILNWMH--YNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 52/198 (26%), Positives = 92/198 (46%), Gaps = 12/198 (6%)

Query: 332 LGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKN----EVLLVANLQHRNLVRLLG 387
           +G+G +G V K R  +  EI   +  +DS + + E K     E+ ++  L+  N+V L  
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDS-EENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 388 FSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRI 447
                 +  L++E+V    L+     P      +  R Y  I  + + + + H++    I
Sbjct: 68  AFRRRGKLYLVFEYVEKNMLELLEEMPNG-VPPEKVRSY--IYQLIKAIHWCHKND---I 121

Query: 448 IHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSV 507
           +HRD+K  N+L+      K+ DFG AR    + +  N +  V T  Y +PE  +   Y  
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSPELLLGAPYGK 180

Query: 508 KSDVFSFGVLVLEIISGQ 525
             D++S G ++ E+  GQ
Sbjct: 181 AVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 65.7 bits (160), Expect = 2e-11
 Identities = 70/244 (28%), Positives = 110/244 (45%), Gaps = 38/244 (15%)

Query: 332 LGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSL 390
           +G+G FG VY+ R  D   I A+K LS+     ++  K EV     +  RN+  L+   L
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKK----EIVAKKEV--AHTIGERNI--LVRTLL 52

Query: 391 EGNERLLIYEFVPNTSLD-HFIFDPTRRAQLDW---------ERRYKI-IGGIARGLLYL 439
           + +  ++  +F   T  D + + D     +L W         E R K  I  +   L +L
Sbjct: 53  DESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHL 112

Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
           H+     I++RDLK  N+LLDA     + DFG+++    D    NT    GT  Y+APE 
Sbjct: 113 HKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT--FCGTTEYLAPEV 167

Query: 500 AMHGQ-YSVKSDVFSFGVLVLEIISG------------QRNNCFRNGETVEDLLSSAWKN 546
            +  + Y+   D +S GVLV E+  G             RN  F      +++LS   + 
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQ 227

Query: 547 WREG 550
           + +G
Sbjct: 228 FVKG 231

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 65.8 bits (160), Expect = 2e-11
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 33/215 (15%)

Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSR---DSGQGDLEFKNEVLLVANLQH 379
           + +   +G G  G V     YD      +A+K+LSR   +       ++ E++L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAA--YDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82

Query: 380 RNLVRLLGF-----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
           +N++ LL       SLE  + + I   + + +L   I     + +LD ER   ++  +  
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI-----QMELDHERMSYLLYQMLC 137

Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN----TSRIVG 490
           G+ +LH      IIHRDLK SN+++ ++ T KI DFG+AR      T G     T  +V 
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFMMTPYVVT 188

Query: 491 TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
            Y Y APE  +   Y    D++S G ++ E+I G 
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 63/238 (26%), Positives = 104/238 (43%), Gaps = 35/238 (14%)

Query: 297 KSEAAAGDEINRAESLQF-DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDG--AEIAV 353
           K ++ +  E  R   +++ DFN IR           LG G FG V      +     +A+
Sbjct: 12  KKDSDSTKEPKRKNKMKYEDFNFIRT----------LGTGSFGRVILATYKNEDFPPVAI 61

Query: 354 KRLSR----DSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDH 409
           KR  +       Q D  F +E  ++  + H   V L G   + +   L+ EFV       
Sbjct: 62  KRFEKSKIIKQKQVDHVF-SERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFT 120

Query: 410 FIFDPTRRAQLDWERRYKIIGGI---ARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPK 466
           F+    RR      +R+    G    A+ +L       L I++RDLK  N+LLD +   K
Sbjct: 121 FL----RR-----NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIK 171

Query: 467 IADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           + DFG A++ +       T  + GT  Y+APE  ++  +   +D ++ G+ + EI+ G
Sbjct: 172 MTDFGFAKVVDT-----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 39/94 (41%), Positives = 54/94 (57%), Gaps = 7/94 (7%)

Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF--EMDETQGNTSRIV 489
           +ARG+ +L   SR + IHRDL   N+LL      KI DFG+AR    + D  +   +R+ 
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 237

Query: 490 GTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
               +MAPE      Y+ +SDV+SFGVL+ EI S
Sbjct: 238 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 17/200 (8%)

Query: 332 LGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEV----LLVANLQHRNLVRLL 386
           +G+G FG V   R   +    AVK L + +     E K+ +    +L+ N++H  LV L 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 61

Query: 387 GFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IARGLLYLHEDSR 444
            FS +  ++L  + +++    L    F   +R +   E R +     IA  L YLH    
Sbjct: 62  HFSFQTADKLYFVLDYINGGEL----FYHLQRERCFLEPRARFYAAEIASALGYLHS--- 114

Query: 445 LRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQ 504
           L I++RDLK  N+LLD++    + DFG+ +  E  E  G TS   GT  Y+APE      
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172

Query: 505 YSVKSDVFSFGVLVLEIISG 524
           Y    D +  G ++ E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 64.4 bits (157), Expect = 3e-11
 Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 27/211 (12%)

Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLS-RD--SGQGDLEFKNEVLLVANLQH 379
           D+      +G G FG V+  R        A+K ++  +    + +    NE  ++  + H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG------IA 433
             ++RL     +     ++ E+VP   L    F   R +      R+    G      I 
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGEL----FSYLRNS-----GRFSNSTGLFYASEIV 111

Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             L YLH      I++RDLK  N+LLD E   K+ DFG A+     + +  T  + GT  
Sbjct: 112 CALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPE 163

Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           Y+APE      ++   D ++ G+L+ E++ G
Sbjct: 164 YLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 64.2 bits (156), Expect = 4e-11
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 20/212 (9%)

Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE----IAVKRLSRDS----GQGDLEFKNEVLLVAN 376
           NF     LG G +G V+  R   G +     A+K L + +     +     + E  ++ +
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSL-DHFIFDPTRRAQLDWERRYKIIGGIAR 434
           ++    +  L ++ + + +L LI +++    L  H     ++R +   +      G I  
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL----SQRERFKEQEVQIYSGEIVL 116

Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
            L +LH   +L II+RD+K  N+LLD+     + DFG+++ F  DE +   S   GT  Y
Sbjct: 117 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGTIEY 172

Query: 495 MAPEYAMHGQ--YSVKSDVFSFGVLVLEIISG 524
           MAP+    G   +    D +S GVL+ E+++G
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 63.9 bits (156), Expect = 4e-11
 Identities = 65/224 (29%), Positives = 112/224 (50%), Gaps = 25/224 (11%)

Query: 331 KLGQGGFGAVYKGR-LYDGAEIAVK--RLSRDSGQGDLEFK--NEVLLVANLQHRNLVRL 385
           KLG+G +  VYKGR    G  +A+K  RL  + G     F    E  L+ +L+H N+V  
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG---APFTAIREASLLKDLKHANIV-T 67

Query: 386 LGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWER--RYKIIGGIARGLLYLHED 442
           L   +   + L L++E++ +T L  ++ D      +   R   ++++    RGL Y H  
Sbjct: 68  LHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQLL----RGLAYCH-- 120

Query: 443 SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMH 502
            + R++HRDLK  N+L+      K+ADFG+AR   +  ++  ++ +V T  Y  P+  + 
Sbjct: 121 -QRRVLHRDLKPQNLLISERGELKLADFGLARAKSV-PSKTYSNEVV-TLWYRPPDVLLG 177

Query: 503 G-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWK 545
             +YS   D++  G +  E+ +G+    F     VED L   ++
Sbjct: 178 STEYSTSLDMWGVGCIFYEMATGR--PLFPGSTDVEDQLHKIFR 219

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 63.9 bits (155), Expect = 5e-11
 Identities = 64/225 (28%), Positives = 104/225 (46%), Gaps = 25/225 (11%)

Query: 316 FNTIRVATDNFSDANKLGQGGFGAVYK-GRLYDGAEIAVKRLSRDSGQGDLEFKNEV-LL 373
           F++    +D +     +G+G +G V+K     +G++ AVK L       D E + E  +L
Sbjct: 10  FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILD-PIHDIDEEIEAEYNIL 68

Query: 374 VANLQHRNLVRLLGFSLE-----GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI 428
            A   H N+V+  G   +     G++  L+ E     S+   +    +R +   E    I
Sbjct: 69  KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEE---PI 125

Query: 429 IGGIAR----GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN 484
           I  I      GL +LH +   + IHRD+K +N+LL  E   K+ DFG++        + N
Sbjct: 126 IAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 182

Query: 485 TSRIVGTYGYMAPEY-----AMHGQYSVKSDVFSFGVLVLEIISG 524
           TS  VGT  +MAPE       +   Y  + DV+S G+  +E+  G
Sbjct: 183 TS--VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 64.0 bits (155), Expect = 6e-11
 Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 47/219 (21%)

Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSR---DSGQGDLEFKNEVLLVANLQH 379
           + +   +G G  G V     YD      +A+K+LSR   +       ++ E++L+  + H
Sbjct: 19  YQNLKPIGSGAQGIVCAA--YDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 75

Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--------IFDPTR----RAQLDWERRYK 427
           +N++ LL              F P  SL+ F        + D       + +LD ER   
Sbjct: 76  KNIISLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSY 123

Query: 428 IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN--- 484
           ++  +  G+ +LH      IIHRDLK SN+++ ++ T KI DFG+AR      T G    
Sbjct: 124 LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFM 174

Query: 485 -TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEII 522
            T  +V  Y Y APE  +   Y    D++S G ++ E++
Sbjct: 175 MTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 64.9 bits (158), Expect = 7e-11
 Identities = 35/105 (33%), Positives = 61/105 (58%), Gaps = 3/105 (2%)

Query: 436 LLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYM 495
           LL +H      +IHRD+K++N+LL +    K+ DFG ++++    +        GT  Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 496 APEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
           APE      YS K+D+FS GVL+ E+++ +R     +GE +E+++
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRP---FDGENMEEVM 254

Length = 496

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 63.3 bits (154), Expect = 8e-11
 Identities = 61/203 (30%), Positives = 96/203 (47%), Gaps = 18/203 (8%)

Query: 332 LGQGGFGAVYKGRLYDGAE----IAVKRLSRDS---GQGDLEF-KNEVLLVANLQHRNLV 383
           LG+GG+G V++ R   GA+     A+K L + +    Q D    K E  ++  ++H  +V
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 384 RLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI-IGGIARGLLYLHED 442
            L+     G +  LI E++    L    F    R  +  E      +  I+  L +LH  
Sbjct: 64  DLIYAFQTGGKLYLILEYLSGGEL----FMHLEREGIFMEDTACFYLSEISLALEHLH-- 117

Query: 443 SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMH 502
            +  II+RDLK  N+LLDA+   K+ DFG+ +  E       T    GT  YMAPE  M 
Sbjct: 118 -QQGIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIEYMAPEILMR 174

Query: 503 GQYSVKSDVFSFGVLVLEIISGQ 525
             +    D +S G L+ ++++G 
Sbjct: 175 SGHGKAVDWWSLGALMYDMLTGA 197

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 63.1 bits (153), Expect = 8e-11
 Identities = 59/212 (27%), Positives = 106/212 (50%), Gaps = 20/212 (9%)

Query: 332 LGQGGFGAVYKGRLYD-GAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRN--LVRL 385
           +G+GGFG VY  R  D G   A+K L +      QG+    NE ++++ +   +   +  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 386 LGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSR 444
           + ++    ++L  I + +    L + +      ++ +  R Y     I  GL ++H  +R
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEM-RFYA--TEIILGLEHMH--NR 116

Query: 445 LRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQ 504
             +++RDLK +N+LLD     +I+D G+A  F   +   +    VGT+GYMAPE    G 
Sbjct: 117 F-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGT 171

Query: 505 -YSVKSDVFSFGVLVLEIISGQRNNCFRNGET 535
            Y   +D FS G ++ +++ G  ++ FR  +T
Sbjct: 172 AYDSSADWFSLGCMLFKLLRG--HSPFRQHKT 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 63.6 bits (155), Expect = 8e-11
 Identities = 56/225 (24%), Positives = 103/225 (45%), Gaps = 37/225 (16%)

Query: 330 NKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKN--------------EVLLV 374
             LG+G +G V K      G  +A+K++       D+                  E+ ++
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 375 ANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
             ++H N++ L+   +EG+   L+ + +  + L   + D  R+ +L   +   I+  I  
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVD--RKIRLTESQVKCILLQILN 130

Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF-------------EMDET 481
           GL  LH+      +HRDL  +N+ ++++   KIADFG+AR +              M   
Sbjct: 131 GLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187

Query: 482 QGNTSRIVGTYGYMAPEYAMHGQ-YSVKSDVFSFGVLVLEIISGQ 525
           +  TS++V T  Y APE  M  + Y    D++S G +  E+++G+
Sbjct: 188 EEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 63.7 bits (155), Expect = 9e-11
 Identities = 37/95 (38%), Positives = 52/95 (54%), Gaps = 9/95 (9%)

Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET---QGNTSRI 488
           +A+G+ +L   +    IHRD+   NVLL      KI DFG+AR    D     +GN    
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277

Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
           V    +MAPE      Y+V+SDV+S+G+L+ EI S
Sbjct: 278 VK---WMAPESIFDCVYTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 63.3 bits (154), Expect = 1e-10
 Identities = 61/232 (26%), Positives = 104/232 (44%), Gaps = 26/232 (11%)

Query: 306 INRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDS--GQ 362
           ++R E        +R+  ++F     +G+G FG V   R     ++ A+K LS+     +
Sbjct: 25  LSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKR 84

Query: 363 GDLEFK-NEVLLVANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFD---PTRR 417
            D  F   E  ++A+     +V+L  ++ + ++ L ++ E++P   L + + +   P   
Sbjct: 85  SDSAFFWEERDIMAHANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE-- 141

Query: 418 AQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
               W R Y      A  +L L     +  IHRD+K  N+LLD     K+ADFG     +
Sbjct: 142 ---KWARFY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC--MK 191

Query: 478 MDET-QGNTSRIVGTYGYMAPEYAM----HGQYSVKSDVFSFGVLVLEIISG 524
           MD          VGT  Y++PE        G Y  + D +S GV + E++ G
Sbjct: 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 63.2 bits (153), Expect = 1e-10
 Identities = 42/116 (36%), Positives = 59/116 (50%), Gaps = 5/116 (4%)

Query: 410 FIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIAD 469
            +F   R+ +L  E        I+  L YLHE     II+RDLK  NVLLD+E   K+ D
Sbjct: 83  LMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTD 139

Query: 470 FGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           +GM +  E       TS   GT  Y+APE      Y    D ++ GVL+ E+++G+
Sbjct: 140 YGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 64.4 bits (157), Expect = 1e-10
 Identities = 55/225 (24%), Positives = 99/225 (44%), Gaps = 39/225 (17%)

Query: 331 KLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDL---EFKNEVLLVANLQHRNLVR 384
            +G+GG G VY    YD      +A+K++  D  +  L    F  E  + A+L H  +V 
Sbjct: 9   LIGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66

Query: 385 LLGFSLEGNERLLIYE--FVPNTSLDHFIFDPTRRAQLDWERRYK--------IIGGIAR 434
           +  +S+  +   + Y   ++   +L   +    ++  L  E   K        I   I  
Sbjct: 67  V--YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124

Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE-TQGNTS------- 486
            + Y+H  S+  ++HRDLK  N+LL       I D+G A   +++E    +         
Sbjct: 125 TIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181

Query: 487 --------RIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
                   +IVGT  YMAPE  +    S  +D+++ GV++ ++++
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 39/94 (41%), Positives = 55/94 (58%), Gaps = 7/94 (7%)

Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF--EMDETQGNTSRIV 489
           +ARG+ +L   SR + IHRDL   N+LL      KI DFG+AR    + D  +  ++R+ 
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL- 238

Query: 490 GTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
               +MAPE      Y+ +SDV+SFGVL+ EI S
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 65/259 (25%), Positives = 111/259 (42%), Gaps = 43/259 (16%)

Query: 332 LGQGGFGAVYKGRL-----YD----GAEIAVKRLSRDSGQ-GDLEFKNEVLLVANLQHRN 381
           LGQG F  +YKG L      D    G E++V      S     L F     L++ L H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           LV+L G  +  +E +++ E+V    LD F+        L W  +  +   +A  L YL +
Sbjct: 63  LVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119

Query: 442 DSRLRIIHRDLKTSNVLL-----DAEMTP--KIADFGMAR-LFEMDETQGNTSRIVGTYG 493
               +++H ++   N+L+     +    P  K++D G+   +   +E      RI     
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERV---ERI----P 169

Query: 494 YMAPEYAMHGQYSVKS--DVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGT 551
           ++APE   +GQ S+    D +SFG  +LEI       C    E +  L SS  + + +  
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEI-------CSNGEEPLSTLSSSEKERFYQ-- 220

Query: 552 TVNIIDPTLSSGSITEMIR 570
             + + P      +  +I 
Sbjct: 221 DQHRL-PMPDCAELANLIN 238

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 36/210 (17%)

Query: 332 LGQGGFGAVY------KGRLYDGAEIAVKRLSRDSGQGDLEFKNEVL-------LVANLQ 378
           LG+G FG V        G+ Y     A+K L ++     +  K+EV        ++ N +
Sbjct: 3   LGKGTFGKVILVREKATGKYY-----AMKILKKEV----IIAKDEVAHTLTESRVLQNTR 53

Query: 379 HRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IARGL 436
           H  L  L  +S + ++RL  + E+     L    F    R ++  E R +  G  I   L
Sbjct: 54  HPFLTAL-KYSFQTHDRLCFVMEYANGGEL----FFHLSRERVFSEDRARFYGAEIVSAL 108

Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNT-SRIVGTYGYM 495
            YLH      +++RDLK  N++LD +   KI DFG+ +      + G T     GT  Y+
Sbjct: 109 GYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYL 162

Query: 496 APEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           APE      Y    D +  GV++ E++ G+
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 60/199 (30%), Positives = 90/199 (45%), Gaps = 15/199 (7%)

Query: 332 LGQGGFGAVY-KGRLYDGAEIAVKRLSRDSGQGDLEFKNEV----LLVANLQHRNLVRLL 386
           +G+G FG V    R  DG   AVK L +       E K+ +    +L+ N++H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61

Query: 387 GFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRL 445
            +S +  E+L  + +FV    L    F   R       R       IA  L YLH    +
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLHS---I 115

Query: 446 RIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQY 505
            I++RDLK  N+LLD++    + DFG+ +  E       T+   GT  Y+APE      Y
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQPY 173

Query: 506 SVKSDVFSFGVLVLEIISG 524
               D +  G ++ E++ G
Sbjct: 174 DNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 62.4 bits (151), Expect = 2e-10
 Identities = 45/130 (34%), Positives = 65/130 (50%), Gaps = 8/130 (6%)

Query: 396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTS 455
            L+ E+V    L   +F   R+ +L  E        I   L +LHE     II+RDLK  
Sbjct: 72  FLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLD 125

Query: 456 NVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFG 515
           NVLLDA+   K+ D+GM +  E       TS   GT  Y+APE     +Y    D ++ G
Sbjct: 126 NVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALG 183

Query: 516 VLVLEIISGQ 525
           VL+ E+++G+
Sbjct: 184 VLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 61.5 bits (150), Expect = 2e-10
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 22/203 (10%)

Query: 330 NKLGQGGFGAVYKGR-LYDGAEIAVKRLSR--DSGQGDLEFKNEVLLVANLQ-HRNLVRL 385
            K+G+G F  V K +    G   A+K + +   S +       E+  +  L  H N++RL
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-REIQALRRLSPHPNILRL 63

Query: 386 LGFSLE-GNERL-LIYEFVPNTSLDHFIFDPT--RRAQLDWERRYKIIGGIARGLLYLHE 441
           +    +    RL L++E      +D  +++    R+  L  +R    +  + + L ++H 
Sbjct: 64  IEVLFDRKTGRLALVFEL-----MDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH- 117

Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM 501
             R  I HRD+K  N+L+  +   K+ADFG  R   +      T  I  T  Y APE  +
Sbjct: 118 --RNGIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYI-STRWYRAPECLL 171

Query: 502 -HGQYSVKSDVFSFGVLVLEIIS 523
             G Y  K D+++ G +  EI+S
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 61.9 bits (150), Expect = 3e-10
 Identities = 58/198 (29%), Positives = 95/198 (47%), Gaps = 14/198 (7%)

Query: 332 LGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQGDLEFKN---EVLLVANLQHRNLVRLLG 387
           +G+G FG V + R  D   I A+K + +       E  +   E  ++A +    +V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59

Query: 388 FSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLR 446
           FS +  E+L L+  F+    L H +    R  + D  R       +   L  LH+     
Sbjct: 60  FSFQSPEKLYLVLAFINGGELFHHL---QREGRFDLSRARFYTAELLCALENLHK---FN 113

Query: 447 IIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYS 506
           +I+RDLK  N+LLD +    + DFG+ +L   D+ + NT    GT  Y+APE  +   Y+
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGTPEYLAPELLLGHGYT 171

Query: 507 VKSDVFSFGVLVLEIISG 524
              D ++ GVL+ E+++G
Sbjct: 172 KAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 62.0 bits (150), Expect = 3e-10
 Identities = 38/94 (40%), Positives = 55/94 (58%), Gaps = 7/94 (7%)

Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF--EMDETQGNTSRIV 489
           +A+G+ +L   SR + IHRDL   N+LL      KI DFG+AR    + D  +   +R+ 
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 243

Query: 490 GTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
               +MAPE      Y+++SDV+SFGVL+ EI S
Sbjct: 244 -PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 61.6 bits (150), Expect = 4e-10
 Identities = 35/95 (36%), Positives = 53/95 (55%), Gaps = 6/95 (6%)

Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT 491
           + RGL Y+H  +   ++HRDLK SN+LL+A    KI DFG+AR     E     +  V T
Sbjct: 117 LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDFMTEYVVT 171

Query: 492 YGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQ 525
             Y APE  ++  +Y+   DV+S G +  E++  +
Sbjct: 172 RWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 60.3 bits (146), Expect = 5e-10
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 28/207 (13%)

Query: 332 LGQGGFGAVYKGRLYD-GAEIAVKRLSRDS---GQGDLEFKNE--VLLVANLQHRNLVRL 385
           +G+GGFG VY  R  D G   A+K L +      QG+    NE  +L + +      +  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 386 LGFSLEGNERL-LIYEFVPNTSL-----DHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
           + ++    ++L  I + +    L      H +F        + E R+     I  GL ++
Sbjct: 62  MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-------EAEMRF-YAAEIILGLEHM 113

Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
           H  +R  +++RDLK +N+LLD     +I+D G+A  F   +   +    VGT+GYMAPE 
Sbjct: 114 H--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 166

Query: 500 AMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              G  Y   +D FS G ++ +++ G 
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGH 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 60.9 bits (148), Expect = 5e-10
 Identities = 52/218 (23%), Positives = 96/218 (44%), Gaps = 26/218 (11%)

Query: 326 FSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVR 384
           + D   LG G  G V+     D    +AVK++     Q       E+ ++  L H N+V+
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66

Query: 385 LLGFSLEGNERL--------------LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIG 430
           +          L              ++ E++  T L + +     +  L  E     + 
Sbjct: 67  VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVL----EQGPLSEEHARLFMY 121

Query: 431 GIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE-MTPKIADFGMARLFEMD-ETQGNTSRI 488
            + RGL Y+H  +   ++HRDLK +NV ++ E +  KI DFG+AR+ +     +G  S  
Sbjct: 122 QLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG 178

Query: 489 VGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQ 525
           + T  Y +P   +    Y+   D+++ G +  E+++G+
Sbjct: 179 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 60.4 bits (146), Expect = 8e-10
 Identities = 44/142 (30%), Positives = 69/142 (48%), Gaps = 22/142 (15%)

Query: 397 LIYEFVPNTSLDHFIFDPTRRAQLD---WERRY------KIIGG-IARGLLYLHEDSRLR 446
           L Y F     L H I D     ++    ++R        +   G I   L +LH   +L 
Sbjct: 70  LHYAFQTEAKL-HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLH---KLG 125

Query: 447 IIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY----AMH 502
           I++RD+K  N+LLD+E    + DFG+++ F + E +  T    GT  YMAPE       H
Sbjct: 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYSFCGTIEYMAPEIIRGKGGH 184

Query: 503 GQYSVKSDVFSFGVLVLEIISG 524
           G+     D +S G+L+ E+++G
Sbjct: 185 GK---AVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 60.3 bits (146), Expect = 1e-09
 Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 9/95 (9%)

Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET---QGNTSRI 488
           +A+G+ +L   +    IHRDL   N+LL      KI DFG+AR    D     +GN    
Sbjct: 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279

Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
           V    +MAPE   +  Y+ +SDV+S+G+L+ EI S
Sbjct: 280 V---KWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 58.9 bits (142), Expect = 3e-09
 Identities = 60/200 (30%), Positives = 91/200 (45%), Gaps = 16/200 (8%)

Query: 332 LGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKN---EVLLVANLQHRNLVRLLG 387
           LG+G FG V   R    G   A+K L ++      E  +   E  ++ N +H  L  L  
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL-K 61

Query: 388 FSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IARGLLYLHEDSRL 445
           +S +  +RL  + E+V    L    F    R ++  E R +  G  I   L YLH     
Sbjct: 62  YSFQTKDRLCFVMEYVNGGEL----FFHLSRERVFSEDRTRFYGAEIVSALDYLHSG--- 114

Query: 446 RIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQY 505
           +I++RDLK  N++LD +   KI DFG+ +    D     T    GT  Y+APE      Y
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPEVLEDNDY 172

Query: 506 SVKSDVFSFGVLVLEIISGQ 525
               D +  GV++ E++ G+
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 53/198 (26%), Positives = 90/198 (45%), Gaps = 20/198 (10%)

Query: 332 LGQGGFG-AVYKGRLYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLVRLLGFS 389
           +G+G FG A+    +    + A+K +        +E  + E +L+A ++H N+V     S
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE-S 66

Query: 390 LEGNERL-LIYEFVPNTSLDHFIFDP-----TRRAQLDWERRYKIIGGIARGLLYLHEDS 443
            E +  L ++ E+     L   I             L W  +      +  G+ ++HE  
Sbjct: 67  FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ------MCLGVQHIHEK- 119

Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG 503
             R++HRD+K+ N+ L      K+ DFG ARL         T   VGT  Y+ PE   + 
Sbjct: 120 --RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENM 175

Query: 504 QYSVKSDVFSFGVLVLEI 521
            Y+ KSD++S G ++ E+
Sbjct: 176 PYNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 58.5 bits (141), Expect = 4e-09
 Identities = 34/92 (36%), Positives = 47/92 (51%), Gaps = 3/92 (3%)

Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT 491
           +ARG+ +L   +    +HRDL   NVLL      KI DFG+AR    D    +       
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302

Query: 492 YGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
             +MAPE      Y+  SDV+S+G+L+ EI S
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 57.7 bits (139), Expect = 9e-09
 Identities = 30/91 (32%), Positives = 52/91 (57%)

Query: 436 LLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYM 495
           +L L E    +++HRDLK++N+ L      K+ DFG ++ +    +    S   GT  Y+
Sbjct: 179 VLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYL 238

Query: 496 APEYAMHGQYSVKSDVFSFGVLVLEIISGQR 526
           APE     +YS K+D++S GV++ E+++  R
Sbjct: 239 APELWERKRYSKKADMWSLGVILYELLTLHR 269

Length = 478

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 57.3 bits (138), Expect = 9e-09
 Identities = 36/99 (36%), Positives = 54/99 (54%), Gaps = 6/99 (6%)

Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT 491
           IA  +L +H   +L  +HRD+K  NVLLD     ++ADFG   L    +    +S  VGT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSC-LKMNQDGTVQSSVAVGT 166

Query: 492 YGYMAPEY--AMH---GQYSVKSDVFSFGVLVLEIISGQ 525
             Y++PE   AM    G+Y  + D +S GV + E++ G+
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 57.1 bits (138), Expect = 1e-08
 Identities = 43/140 (30%), Positives = 65/140 (46%), Gaps = 23/140 (16%)

Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           YLH      II+RDLK  N+LLD +   K+ DFG A+     +    T  + GT  Y+AP
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYLAP 184

Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQ----RNNCFRNGETVEDLLSSAWK--NWREGT 551
           E      +    D ++ GVL+ E I+G      +  FR     E +L+   K  NW +G 
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR---IYEKILAGRLKFPNWFDGR 241

Query: 552 TVNII------DPTLSSGSI 565
             +++      D T   G++
Sbjct: 242 ARDLVKGLLQTDHTKRLGTL 261

Length = 329

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 56.7 bits (137), Expect = 2e-08
 Identities = 33/95 (34%), Positives = 52/95 (54%), Gaps = 6/95 (6%)

Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL-FEMDETQGNTSRIVGTY 492
           R L Y+H  +   + HRDLK  N+L +A+   KI DFG+AR+ F    T    +  V T 
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 493 GYMAPEY--AMHGQYSVKSDVFSFGVLVLEIISGQ 525
            Y APE   +   +Y+   D++S G +  E+++G+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 56.9 bits (137), Expect = 2e-08
 Identities = 32/92 (34%), Positives = 47/92 (51%), Gaps = 3/92 (3%)

Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT 491
           +A G+ +L   +    +HRDL   NVL+      KI DFG+AR    D    +       
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304

Query: 492 YGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
             +MAPE   +  Y+  SDV+SFG+L+ EI +
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 41/156 (26%), Positives = 73/156 (46%), Gaps = 26/156 (16%)

Query: 331 KLGQGGFGAVYKGRLYDGAEIA---VKRLSRDSGQGDLEFKNEVLLVAN----LQHRNLV 383
           ++G G FG V    +Y    +A   VK L  ++   +   +NE L   +    LQH N++
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKE---QNEFLQQGDPYRILQHPNIL 58

Query: 384 RLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERR-------YKIIGGIARGL 436
           + LG  +E    LL++E+     L  ++      +Q  W RR        ++   IA G+
Sbjct: 59  QCLGQCVEAIPYLLVFEYCELGDLKSYL------SQEQWHRRNSQLLLLQRMACEIAAGV 112

Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGM 472
            ++H   +   +H DL   N  L +++T K+ D+G+
Sbjct: 113 THMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 55.2 bits (133), Expect = 4e-08
 Identities = 36/100 (36%), Positives = 54/100 (54%), Gaps = 8/100 (8%)

Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMA-RLFEMDETQGNTSRIVG 490
           +A  +L +    +L  +HRD+K  NVLLD     ++ADFG   RL      Q N +  VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA--VG 165

Query: 491 TYGYMAPEY--AMH---GQYSVKSDVFSFGVLVLEIISGQ 525
           T  Y++PE   AM    G+Y  + D +S GV + E++ G+
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 55.4 bits (133), Expect = 4e-08
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 25/205 (12%)

Query: 332 LGQGGFGAVY------KGRLYDGAEIAVKRLSRDSGQGDLEFKN---EVLLVANLQHRNL 382
           LG+G FG V        GR Y     A+K L ++      E  +   E  ++ N +H  L
Sbjct: 3   LGKGTFGKVILVKEKATGRYY-----AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 57

Query: 383 VRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IARGLLYLH 440
             L  +S + ++RL  + E+     L    F    R ++  E R +  G  I   L YLH
Sbjct: 58  TAL-KYSFQTHDRLCFVMEYANGGEL----FFHLSRERVFSEDRARFYGAEIVSALDYLH 112

Query: 441 EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA 500
             S   +++RDLK  N++LD +   KI DFG+ +  E  +         GT  Y+APE  
Sbjct: 113 --SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVL 168

Query: 501 MHGQYSVKSDVFSFGVLVLEIISGQ 525
               Y    D +  GV++ E++ G+
Sbjct: 169 EDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 55.8 bits (134), Expect = 4e-08
 Identities = 40/164 (24%), Positives = 71/164 (43%), Gaps = 8/164 (4%)

Query: 370 EVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKII 429
           E  ++  + H ++++L G         LI   +P    D + +   +R  +       I 
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKR-NIAICDILAIE 188

Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIV 489
             + R + YLHE+   RIIHRD+K  N+ ++      + DFG A  F +D          
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDINANKYYGWA 244

Query: 490 GTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNG 533
           GT    APE      Y    D++S G+++ E+ +   +   ++G
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDG 288

Length = 391

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 55.0 bits (132), Expect = 6e-08
 Identities = 60/232 (25%), Positives = 105/232 (45%), Gaps = 26/232 (11%)

Query: 306 INRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDS--GQ 362
           +NR E +      +++  +++     +G+G FG V   R     ++ A+K LS+     +
Sbjct: 25  LNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKR 84

Query: 363 GDLEF---KNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI--FDPTRR 417
            D  F   + +++  AN     +V+L     +     ++ E++P   L + +  +D   +
Sbjct: 85  SDSAFFWEERDIMAFANSPW--VVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK 142

Query: 418 AQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
               W + Y      A  +L L     + +IHRD+K  N+LLD     K+ADFG     +
Sbjct: 143 ----WAKFYT-----AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC--MK 191

Query: 478 MDET-QGNTSRIVGTYGYMAPEY----AMHGQYSVKSDVFSFGVLVLEIISG 524
           MDET        VGT  Y++PE        G Y  + D +S GV + E++ G
Sbjct: 192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 54.1 bits (130), Expect = 9e-08
 Identities = 36/100 (36%), Positives = 55/100 (55%), Gaps = 7/100 (7%)

Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT 491
           +A  +L +H   ++  +HRD+K  NVL+D     K+ADFG A     ++   N+   VGT
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGT 166

Query: 492 YGYMAPEY--AMHG----QYSVKSDVFSFGVLVLEIISGQ 525
             Y+APE    M+G     Y V+ D +S GV+  E+I G+
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 57/205 (27%), Positives = 91/205 (44%), Gaps = 26/205 (12%)

Query: 332 LGQGGFGAVY------KGRLYDGAEIAVKRLSRDSGQGDLEFKN---EVLLVANLQHRNL 382
           LG+G FG V        GR Y     A+K L ++      E  +   E  ++ N +H  L
Sbjct: 3   LGKGTFGKVILVREKATGRYY-----AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 57

Query: 383 VRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IARGLLYLH 440
             L  ++ + ++RL  + E+     L    F    R ++  E R +  G  I   L YLH
Sbjct: 58  TAL-KYAFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFYGAEIVSALEYLH 112

Query: 441 EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA 500
                 +++RD+K  N++LD +   KI DFG+ +    D     T    GT  Y+APE  
Sbjct: 113 SRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVL 167

Query: 501 MHGQYSVKSDVFSFGVLVLEIISGQ 525
               Y    D +  GV++ E++ G+
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 54.3 bits (130), Expect = 1e-07
 Identities = 44/180 (24%), Positives = 86/180 (47%), Gaps = 21/180 (11%)

Query: 353 VKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLG-FSLEGNERLLI--YEFVPNTSLDH 409
           + +  +   +  ++ +NE+L +  L H N++++      E N  ++   Y+F     L  
Sbjct: 196 IAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYS 251

Query: 410 FIFDPTRRAQLDWERR------YKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM 463
           F++D       DW+ R        I+  +   + Y+H+    ++IHRD+K  N+ L+ + 
Sbjct: 252 FMYD----EAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDG 304

Query: 464 TPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
              + DFG A  FE  E +      VGT    +PE      Y   +D++S G+++L+++S
Sbjct: 305 KIVLGDFGTAMPFE-KEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 53.1 bits (128), Expect = 2e-07
 Identities = 45/219 (20%), Positives = 84/219 (38%), Gaps = 46/219 (21%)

Query: 332 LGQGGFGAVYK----GRLYDGAEIAVKRLSRDSGQGDLEFK---NEVLLVANLQHRNLVR 384
                   + K      L     +AVK+++ DS     + K    E++    LQH N++ 
Sbjct: 10  FEDLMIVHLAKHKPTNTL-----VAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILP 63

Query: 385 LLGFSLEGNERLLIYEFVPNTSL-----DHFI--FDPTRRAQLDWERRYKIIGGIARGLL 437
            +   +  +E  ++   +   S       HF         A         I+  +   L 
Sbjct: 64  YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF--------ILKDVLNALD 115

Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG---- 493
           Y+H       IHR +K S++LL  +    ++  G+     M +  G   R+V  +     
Sbjct: 116 YIH---SKGFIHRSVKASHILLSGDGKVVLS--GLRYSVSMIK-HGKRQRVVHDFPKSSV 169

Query: 494 ----YMAPEY---AMHGQYSVKSDVFSFGVLVLEIISGQ 525
               +++PE     + G Y+ KSD++S G+   E+ +G 
Sbjct: 170 KNLPWLSPEVLQQNLQG-YNEKSDIYSVGITACELANGH 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 53.5 bits (129), Expect = 2e-07
 Identities = 64/263 (24%), Positives = 102/263 (38%), Gaps = 82/263 (31%)

Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQGDLEFKNEV-- 371
           DF +I+V          +G+G FG V   +  D   I A+K+L R S   ++  K +V  
Sbjct: 2   DFESIKV----------IGRGAFGEVRLVQKKDTGHIYAMKKL-RKS---EMLEKEQVAH 47

Query: 372 ------LLVANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSL-------DHFIFDPTRR 417
                 +L         V  L +S +    L LI E++P   +       D F  + TR 
Sbjct: 48  VRAERDILAEA--DNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRF 105

Query: 418 AQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                   Y     IA  +L +    +L  IHRD+K  N+LLDA+   K++DFG+    +
Sbjct: 106 --------Y-----IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152

Query: 478 ----------MDETQGNTSR--------------------------IVGTYGYMAPEYAM 501
                     +     +                              VGT  Y+APE  +
Sbjct: 153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL 212

Query: 502 HGQYSVKSDVFSFGVLVLEIISG 524
              Y+ + D +S GV++ E++ G
Sbjct: 213 QTGYNKECDWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 52.0 bits (124), Expect = 4e-07
 Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 15/211 (7%)

Query: 324 DNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQGDLE---FKNEVLLVANLQH 379
           ++F     +G+G FG V   +L +  ++ A+K L++       E   F+ E  ++ N  +
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
           + +  L     + N   L+ ++     L   +     R   D  R Y     +A  ++ +
Sbjct: 61  QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----LAEMVIAI 115

Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
               +L  +HRD+K  N+L+D     ++ADFG   L  M++    +S  VGT  Y++PE 
Sbjct: 116 DSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSC-LKLMEDGTVQSSVAVGTPDYISPEI 174

Query: 500 --AMH---GQYSVKSDVFSFGVLVLEIISGQ 525
             AM    G+Y  + D +S GV + E++ G+
Sbjct: 175 LQAMEDGKGKYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 51.4 bits (123), Expect = 9e-07
 Identities = 40/162 (24%), Positives = 67/162 (41%), Gaps = 9/162 (5%)

Query: 360 SGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQ 419
           +G        E+ ++  + HR ++ L+      +   ++   +P    D F +   R   
Sbjct: 128 TGGKTPG--REIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTY-VDRSGP 181

Query: 420 LDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD 479
           L  E+   I   +   L YLH      IIHRD+KT N+ LD      + DFG A   +  
Sbjct: 182 LPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238

Query: 480 ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEI 521
                     GT    +PE      Y  K+D++S G+++ E+
Sbjct: 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 64/264 (24%), Positives = 107/264 (40%), Gaps = 49/264 (18%)

Query: 324 DNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLE----FKNEVLLVANLQH 379
           D+F     +G+G FG V   +  D   I   ++ R +   + E     + E  ++     
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 380 RNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
             +V++  +S +    L LI EF+P   +   +    ++  L  E     I      +  
Sbjct: 61  AWVVKMF-YSFQDKRNLYLIMEFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDA 116

Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQ--------------- 482
           +H+   L  IHRD+K  N+LLDA+   K++DFG+   L +   T+               
Sbjct: 117 IHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSF 173

Query: 483 --GNTSR---------------IVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
              N+ R                VGT  Y+APE  M   Y+   D +S GV++ E++ G 
Sbjct: 174 QNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233

Query: 526 RNNCFRNGETVEDLLSSAWKNWRE 549
              C    ET ++       NW+E
Sbjct: 234 PPFC---SETPQETYRKV-MNWKE 253

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 52/210 (24%), Positives = 92/210 (43%), Gaps = 28/210 (13%)

Query: 332 LGQGGFGAVYKG---RLYDGA-----EIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
           LGQG F  ++KG    + D       E+ +K L +        F     +++ L H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 384 RLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS 443
              G  + G+E +++ E+V   SLD ++        + W  + ++   +A  L +L +  
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120

Query: 444 RLRIIHRDLKTSNVLL-----DAEMTP---KIADFGMARLFEMDETQGNTSRIVGTYGYM 495
              + H ++   NVLL          P   K++D G++      E      RI     ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL--LERI----PWV 171

Query: 496 APEYAMHGQY-SVKSDVFSFGVLVLEIISG 524
            PE   + Q  S+ +D +SFG  + EI SG
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 73/302 (24%), Positives = 113/302 (37%), Gaps = 105/302 (34%)

Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQGDLEFKNEVLL 373
           DF+T++V          +G+G FG V   +  D  +I A+K L           K+E+  
Sbjct: 2   DFHTVKV----------IGKGAFGEVRLVQKKDTGKIYAMKTL----------LKSEMFK 41

Query: 374 VANLQH----RNL--------VRLLGFSLEGNERL-LIYEFVPNTSL-------DHFIFD 413
              L H    R++        V  L +S +  + L LI EF+P   L       D F  D
Sbjct: 42  KDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED 101

Query: 414 PTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMA 473
            TR               +A  +L +    +L  IHRD+K  N+L+D     K++DFG++
Sbjct: 102 VTRFY-------------MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148

Query: 474 -------------RLFEMDE------------------TQGNTSRI-------------- 488
                        +L +                     T  +  +I              
Sbjct: 149 TGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYST 208

Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNG-ETVEDLLSSAWKNW 547
           VGT  Y+APE  +   Y  + D +S G ++ E + G    C  N  ET   ++     NW
Sbjct: 209 VGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKII-----NW 263

Query: 548 RE 549
           RE
Sbjct: 264 RE 265

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 49.2 bits (117), Expect = 4e-06
 Identities = 58/230 (25%), Positives = 102/230 (44%), Gaps = 22/230 (9%)

Query: 306 INRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDS--GQ 362
           +NR +        +R+  +++     +G+G FG V   R     ++ A+K LS+     +
Sbjct: 25  LNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR 84

Query: 363 GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFI--FDPTRRAQ 419
            D  F  E   +    +   V  L ++ + +  L ++ E++P   L + +  +D   +  
Sbjct: 85  SDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK-- 142

Query: 420 LDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD 479
             W R Y      A  +L L     +  IHRD+K  N+LLD     K+ADFG       +
Sbjct: 143 --WARFYT-----AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195

Query: 480 -ETQGNTSRIVGTYGYMAPEY----AMHGQYSVKSDVFSFGVLVLEIISG 524
              + +T+  VGT  Y++PE        G Y  + D +S GV + E++ G
Sbjct: 196 GMVRCDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 49.7 bits (118), Expect = 5e-06
 Identities = 61/235 (25%), Positives = 97/235 (41%), Gaps = 54/235 (22%)

Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKN---EVLLVANLQHRNLVRLLG 387
           K+G G FG V+  +     E    +     G  + E      EV ++  L+H+N+VR + 
Sbjct: 20  KIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYID 79

Query: 388 -FSLEGNERLLI-YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIG--------GIARGLL 437
            F  + N++L I  EF     L   I           ++ YK+ G         I R LL
Sbjct: 80  RFLNKANQKLYILMEFCDAGDLSRNI-----------QKCYKMFGKIEEHAIVDITRQLL 128

Query: 438 ----YLHE----DSRLRIIHRDLKTSNVL-----------------LDAEMTPKIADFGM 472
               Y H      +  R++HRDLK  N+                  L+     KI DFG+
Sbjct: 129 HALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL 188

Query: 473 ARLFEMDETQGNTSRIVGTYGYMAPEYAMH--GQYSVKSDVFSFGVLVLEIISGQ 525
           ++   ++         VGT  Y +PE  +H    Y  KSD+++ G ++ E+ SG+
Sbjct: 189 SKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240

Length = 1021

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 48.5 bits (115), Expect = 6e-06
 Identities = 62/269 (23%), Positives = 112/269 (41%), Gaps = 53/269 (19%)

Query: 324 DNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQ------GDLEFKNEVLLVANL 377
           ++F     +G+G FG V   +  D   +   ++ R +        G +  + ++L+ A+ 
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD- 59

Query: 378 QHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGL 436
               +V++  +S +    L LI EF+P   +   +    +    + E ++ I    A  +
Sbjct: 60  -SLWVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLM--KKDTLTEEETQFYI----AETV 111

Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQ------------- 482
           L +    +L  IHRD+K  N+LLD++   K++DFG+   L +   T+             
Sbjct: 112 LAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171

Query: 483 ----GNTSR---------------IVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
                N+ R                VGT  Y+APE  M   Y+   D +S GV++ E++ 
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231

Query: 524 GQRNNCFRNGETVEDLLSSAWKNWREGTT 552
           G    C    ET ++       NW+E   
Sbjct: 232 GYPPFC---SETPQETYKKV-MNWKETLI 256

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 47.9 bits (114), Expect = 9e-06
 Identities = 36/122 (29%), Positives = 59/122 (48%), Gaps = 25/122 (20%)

Query: 436 LLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET----QGNTSR---- 487
           L YLH      I+HRDLK  N+L+ +    K+ DFG++++  M  T    +G+  +    
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 488 -----IVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNC---FRNGETVEDL 539
                + GT  Y+APE  +   Y    D ++ G+++ E + G    C   F  G+T E+L
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG----CVPFF--GDTPEEL 224

Query: 540 LS 541
             
Sbjct: 225 FG 226

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 47.2 bits (113), Expect = 1e-05
 Identities = 32/100 (32%), Positives = 46/100 (46%), Gaps = 10/100 (10%)

Query: 427 KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP-KIADFGMARLFEMDETQGNT 485
           KII  +   L  LH   +  IIH D+K  NVL D       + D+G+ +        G  
Sbjct: 113 KIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK------IIGTP 163

Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           S   GT  Y +PE      Y V  D ++ GVL  E+++G+
Sbjct: 164 SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203

Length = 267

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 44.7 bits (106), Expect = 2e-05
 Identities = 33/157 (21%), Positives = 56/157 (35%), Gaps = 17/157 (10%)

Query: 327 SDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV-RL 385
           S    L  G    VY     D  +  +K         D E +  +L +   +    V ++
Sbjct: 1   SSIKLLKGGLTNRVYLLGTKDE-DYVLKINPSREKGADREREVAILQLLA-RKGLPVPKV 58

Query: 386 LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRL 445
           L          L+ E++   +LD          ++  E +  I   +A  L  LH+   L
Sbjct: 59  LASGESDGWSYLLMEWIEGETLD----------EVSEEEKEDIAEQLAELLAKLHQLPLL 108

Query: 446 RIIHRDLKTSNVLLDAEMTPKIADFGMA----RLFEM 478
            + H DL   N+L+D      I D+  A      F++
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWEYAGYGPPAFDL 145

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 40/225 (17%)

Query: 332 LGQGGFGAVYKGRLYD---------GAEIAVKRLSR--DSGQGD--LEFKNEVLLVANLQ 378
           LG+G    +Y G L             E  +K + +  D    D  L F     ++  + 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           H+++V L G  +   E +++ EFV    LD F+   +      W  ++K+   +A  L Y
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120

Query: 439 LHEDSRLRIIHRDLKTSNVLL-----DAEMTP--KIADFGMARLFEMDETQGNTSRIVGT 491
           L ED  L  +H ++ T N+LL     D E  P  K++D G+     +   Q    RI   
Sbjct: 121 L-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGIP--ITVLSRQECVERI--- 172

Query: 492 YGYMAPEYAMHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGET 535
             ++APE     +  S+ +D +SFG  + EI       C+ NGE 
Sbjct: 173 -PWIAPECVEDSKNLSIAADKWSFGTTLWEI-------CY-NGEI 208

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 45.7 bits (108), Expect = 4e-05
 Identities = 30/109 (27%), Positives = 61/109 (55%), Gaps = 18/109 (16%)

Query: 428 IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSR 487
           I+ G  RGL YLH++     IHR++K S++L+  +    ++  G++ L+ +    G  ++
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLS--GLSHLYSLVR-NGQKAK 159

Query: 488 IVGTYG--------YMAPEYA---MHGQYSVKSDVFSFGVLVLEIISGQ 525
           +V  +         +++PE     ++G Y+VKSD++S G+   E+ +G+
Sbjct: 160 VVYDFPQFSTSVLPWLSPELLRQDLYG-YNVKSDIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 46.0 bits (109), Expect = 4e-05
 Identities = 58/255 (22%), Positives = 97/255 (38%), Gaps = 71/255 (27%)

Query: 326 FSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQGDLEFKNEVLLV-------ANL 377
           F     +G G FG V   R  D   + A+K L +     D+  +N+   V       A  
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRK----ADVLMRNQAAHVKAERDILAEA 58

Query: 378 QHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHF-----IFDPTRRAQLDWERRYKIIGG 431
            +  +V+L  +S +  + L  + +++P   +        IF+       D  R Y  I  
Sbjct: 59  DNEWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEE------DLARFY--IAE 109

Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF--------------- 476
           +   +  +H   ++  IHRD+K  N+L+D +   K+ DFG+   F               
Sbjct: 110 LTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHH 166

Query: 477 -----EMDETQGNTSR---------------------IVGTYGYMAPEYAMHGQYSVKSD 510
                E  E      R                     +VGT  Y+APE  +   Y+   D
Sbjct: 167 RQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 226

Query: 511 VFSFGVLVLEIISGQ 525
            +S GV++ E++ GQ
Sbjct: 227 WWSVGVILYEMLVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 44.6 bits (105), Expect = 1e-04
 Identities = 56/254 (22%), Positives = 98/254 (38%), Gaps = 65/254 (25%)

Query: 326 FSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFKNEVL-------LVANL 377
           F     LG G FG V      D  A  A+K L +     D+  +N+V        ++A  
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKK----DVLNRNQVAHVKAERDILAEA 58

Query: 378 QHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGL 436
            +  +V+L  +S +  + L  + +++P   +   +     R ++  E   +    IA   
Sbjct: 59  DNEWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLI----RMEVFPEVLARFY--IAELT 111

Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET-----QGNTSR---- 487
           L +    ++  IHRD+K  N+L+D +   K+ DFG+   F          +G+  R    
Sbjct: 112 LAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSM 171

Query: 488 ------------------------------------IVGTYGYMAPEYAMHGQYSVKSDV 511
                                               +VGT  Y+APE  +   Y+   D 
Sbjct: 172 EPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDW 231

Query: 512 FSFGVLVLEIISGQ 525
           +S GV++ E++ GQ
Sbjct: 232 WSVGVILFEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 44.1 bits (104), Expect = 2e-04
 Identities = 33/101 (32%), Positives = 49/101 (48%), Gaps = 17/101 (16%)

Query: 429 IGGIARGLL----YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN 484
           +  +AR LL    Y+H +    IIHRD+KT NVL++      + DFG A        +G+
Sbjct: 262 VTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACF-----ARGS 313

Query: 485 TSR-----IVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLE 520
            S      I GT    APE      Y+   D++S G+++ E
Sbjct: 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 44.4 bits (105), Expect = 2e-04
 Identities = 44/188 (23%), Positives = 76/188 (40%), Gaps = 46/188 (24%)

Query: 320 RVATDNFSDANKLGQGGFGAVYKGRLYD-----GAEIAVKRLSRDSGQGDLEFKNEVLL- 373
               D+F    KLG+G FG VYK  L +       +  +K+ + + G  ++ + NE +  
Sbjct: 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKK-ATEYGAVEI-WMNERVRR 185

Query: 374 -----VANLQHRNLVRLLGF-----SLEGNERLLIYEFVPNTSL-------------DHF 410
                 A+  +       GF     S + +E  L++ +   ++L             + +
Sbjct: 186 ACPNSCADFVY-------GFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPY 238

Query: 411 IFDPTRRAQLDWERRYKIIGGIARGLLY----LHEDSRLRIIHRDLKTSNVLLDAEM-TP 465
           +    +      ER  KII  I R +L+    LH      I+HRD+K  N++      + 
Sbjct: 239 LLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSF 295

Query: 466 KIADFGMA 473
           KI D G A
Sbjct: 296 KIIDLGAA 303

Length = 566

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 43.8 bits (103), Expect = 2e-04
 Identities = 60/256 (23%), Positives = 99/256 (38%), Gaps = 69/256 (26%)

Query: 326 FSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFKNEVL-------LVANL 377
           F     LG G FG V   R  D  A  A+K L +     D+  +N+V        ++A  
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKK----DVLLRNQVAHVKAERDILAEA 58

Query: 378 QHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRA--QLDWERRYKIIGGIAR 434
            +  +VRL  +S +  + L  + +++P   +   +    R      D  R Y     IA 
Sbjct: 59  DNEWVVRLY-YSFQDKDNLYFVMDYIPGGDMMSLLI---RMGIFPEDLARFY-----IAE 109

Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE----------------- 477
               +    ++  IHRD+K  N+L+D +   K+ DFG+   F                  
Sbjct: 110 LTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQD 169

Query: 478 -MDETQ--GNTSR-------------------------IVGTYGYMAPEYAMHGQYSVKS 509
            MD +   G+ +                          +VGT  Y+APE  +   Y+   
Sbjct: 170 SMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC 229

Query: 510 DVFSFGVLVLEIISGQ 525
           D +S GV++ E++ GQ
Sbjct: 230 DWWSVGVILYEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 42.9 bits (101), Expect = 5e-04
 Identities = 23/55 (41%), Positives = 31/55 (56%), Gaps = 3/55 (5%)

Query: 421 DWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL 475
           D E   K I  +A  L YLH      IIHRDLK  N+L+  E   K+ DFG++++
Sbjct: 102 DEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 41.5 bits (98), Expect = 8e-04
 Identities = 62/263 (23%), Positives = 97/263 (36%), Gaps = 66/263 (25%)

Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQGD-----LEFK 368
            F  I++          LG+G  G V+  RL    ++ A+K L +           +  +
Sbjct: 2   HFKKIKL----------LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTE 51

Query: 369 NEVLLVANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFI-FDPTRRAQLDWERRY 426
            E+L  A L H  L  L   S +    L L+ ++ P   L   +   P +    +  R Y
Sbjct: 52  QEIL--ATLDHPFLPTLYA-SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFY 108

Query: 427 KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLL-----------------DAEMTPKIAD 469
                +   L YLH    L I++RDLK  N+LL                 D E  P    
Sbjct: 109 --AAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKA 163

Query: 470 FG----------MARLFEMDETQGNTSRIVGTYGYMAPEY---AMHGQYSVKSDVFSFGV 516
                       +      +E    ++  VGT  Y+APE      HG  +V  D ++ G+
Sbjct: 164 LRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHG-SAV--DWWTLGI 220

Query: 517 LVLEIISG-------QRNNCFRN 532
           L+ E++ G        R+  F N
Sbjct: 221 LLYEMLYGTTPFKGSNRDETFSN 243

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 41.1 bits (96), Expect = 0.002
 Identities = 60/240 (25%), Positives = 99/240 (41%), Gaps = 54/240 (22%)

Query: 319 IRVATDNFSDANKLGQGGFGAVY-----KGRLYDGAEIA--VKRLSRDSGQGDLEFKNEV 371
           I V+T  F   + LG+G FG V      K + Y   +I   V + +RD+ + +++F  +V
Sbjct: 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDA-KIEIQFMEKV 182

Query: 372 LLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTR-RAQLDWERRY---- 426
              A+   R       F L     + I  +  N +    I  P      LDW  ++    
Sbjct: 183 RQ-ADPADR-------FPL-----MKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFS 229

Query: 427 -----KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLL---DAEMTP------------- 465
                +II      L Y H  + L ++H DLK  N+L+   D  + P             
Sbjct: 230 HRHLAQIIFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRV 287

Query: 466 KIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           +I D G       DE    T+ IV T  Y +PE  +   +   +D++S G ++ E+ +G+
Sbjct: 288 RICDLGGC----CDERHSRTA-IVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 40.1 bits (94), Expect = 0.002
 Identities = 36/195 (18%), Positives = 87/195 (44%), Gaps = 22/195 (11%)

Query: 340 VYKGRLYDGAEIAVKRLSRDS-GQGDL--EFKNEVLLVANLQHRNLVRLLGFSLEGNERL 396
           +YKG  ++  E+ ++   +   G   L    +NE+  +  +   N++++ GF ++  + L
Sbjct: 36  IYKGI-FNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94

Query: 397 ----LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE-DSRLRIIHRD 451
               LI E+     L   +    +   L ++ +  +     +GL  L++  ++    +++
Sbjct: 95  PRLSLILEYCTRGYLREVL---DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNK---PYKN 148

Query: 452 LKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA--MHGQYSVKS 509
           L + + L+      KI   G+ ++           + V    Y + +    +  +Y++K 
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKILSSP-----PFKNVNFMVYFSYKMLNDIFSEYTIKD 203

Query: 510 DVFSFGVLVLEIISG 524
           D++S GV++ EI +G
Sbjct: 204 DIYSLGVVLWEIFTG 218

Length = 283

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 38.8 bits (91), Expect = 0.004
 Identities = 20/96 (20%), Positives = 40/96 (41%), Gaps = 14/96 (14%)

Query: 388 FSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRI 447
           + ++ +  L++ E++    L   +           E R  ++  + R +  LH+     I
Sbjct: 67  YDVDPDNGLIVMEYIEGELLKDAL----------EEARPDLLREVGRLVGKLHKAG---I 113

Query: 448 IHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQG 483
           +H DL TSN++L         DFG+    +  E + 
Sbjct: 114 VHGDLTTSNIILSGG-RIYFIDFGLGEFSDEVEDKA 148

Length = 204

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	658
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
PTZ00284	467	protein kinase; Provisional	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.98
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.98
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.98
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.93
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.93
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.93
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.93
PLN00181	793	protein SPA1-RELATED; Provisional	99.92
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.92
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.91
PRK09188	365	serine/threonine protein kinase; Provisional	99.9
PF01657	106	Stress-antifung: Salt stress response/antifungal;	99.9
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.89
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.87
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.87
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.84
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.84
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.84
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.83
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.83
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.83
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.82
PF01657	106	Stress-antifung: Salt stress response/antifungal;	99.8
PRK12274	218	serine/threonine protein kinase; Provisional	99.79
PRK10345	210	hypothetical protein; Provisional	99.78
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.76
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.75
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.75
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.72
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.72
PRK14879	211	serine/threonine protein kinase; Provisional	99.72
smart00090	237	RIO RIO-like kinase.	99.71
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.71
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.7
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.7
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.64
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.62
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.61
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.61
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.57
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.55
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.44
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.44
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.31
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.29
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.24
KOG1243	690	consensus Protein kinase [General function predict	99.19
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.15
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.13
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.03
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.01
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.0
KOG3087	229	consensus Serine/threonine protein kinase [General	98.9
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.89
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.79
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.77
COG4248	637	Uncharacterized protein with protein kinase and he	98.76
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.63
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.49
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.48
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.46
PRK09902	216	hypothetical protein; Provisional	98.41
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.36
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.28
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.14
PF01636	239	APH: Phosphotransferase enzyme family This family	98.08
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.07
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.07
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.06
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.06
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.05
PLN02876	822	acyl-CoA dehydrogenase	97.88
PRK10593	297	hypothetical protein; Provisional	97.82
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.73
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.72
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.6
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.6
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.53
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.27
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.23
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.21
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	96.86
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.83
PF11883	48	DUF3403: Domain of unknown function (DUF3403); Int	96.82
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.81
PRK05231	319	homoserine kinase; Provisional	96.77
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.77
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.68
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.62
PLN02236	344	choline kinase	96.61
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.12
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.12
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.83
KOG2270	520	consensus Serine/threonine protein kinase involved	95.77
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.73
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.71
COG2334	331	Putative homoserine kinase type II (protein kinase	95.58
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.57
PLN02756	418	S-methyl-5-thioribose kinase	95.51
PRK06148	1013	hypothetical protein; Provisional	95.25
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	95.14
PF08693	40	SKG6: Transmembrane alpha-helix domain; InterPro:	95.0
PRK11768	325	serine/threonine protein kinase; Provisional	94.88
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	94.85
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	94.64

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-58  Score=486.55  Aligned_cols=287  Identities=45%  Similarity=0.757  Sum_probs=255.8

Q ss_pred             cccccchhhhhhhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeee
Q 006155          310 ESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFS  389 (658)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~  389 (658)
                      ....|++.+++.+|++|+..+.||+|+||.||+|.+.+|..||||++.....+...+|.+|+.++.+++|||||+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            34568999999999999999999999999999999999999999998876544255699999999999999999999999


Q ss_pred             ccCC-ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEe
Q 006155          390 LEGN-ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIA  468 (658)
Q Consensus       390 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~  468 (658)
                      .+++ +.+||||||++|+|+++|+..... .++|..|++|+.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            9999 599999999999999999875544 89999999999999999999999988899999999999999999999999


Q ss_pred             ccccccccccCCCccccccc-cccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhc
Q 006155          469 DFGMARLFEMDETQGNTSRI-VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNW  547 (658)
Q Consensus       469 DFGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~  547 (658)
                      |||+++.......  ..... .||.+|+|||++..+..|.|+|||||||+++||+||+++.+.........++.|++..+
T Consensus       220 DFGLa~~~~~~~~--~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  220 DFGLAKLGPEGDT--SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             CccCcccCCcccc--ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            9999976443111  11112 89999999999999999999999999999999999999887665555566999999999


Q ss_pred             cCCCcccccCCCCC-CC-CH-HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          548 REGTTVNIIDPTLS-SG-SI-TEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       548 ~~~~~~~~~dp~l~-~~-~~-~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      .++...+++||.+. .. .. .++.++..++++|++.+|.+||+|.||+++|+..
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~  352 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI  352 (361)
T ss_pred             HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence            99999999999997 33 33 6899999999999999999999999999999554

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-47  Score=399.94  Aligned_cols=260  Identities=32%  Similarity=0.511  Sum_probs=208.5

Q ss_pred             cCCcccCcccccCceEEEEeEecCCcc-eeEEEeccCCccc--HHHHHHHHHHHHhcCCCCceeeeeeeccCC-ceEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLYDGAE-IAVKRLSRDSGQG--DLEFKNEVLLVANLQHRNLVRLLGFSLEGN-ERLLIY  399 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~-vavK~l~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lv~  399 (658)
                      +++...+.||+|+||+||+|.+ .|.. ||||++.......  ..+|.+|+.+|.+++|||||+++|+|.+.. ...+||
T Consensus        41 ~~l~~~~~iG~G~~g~V~~~~~-~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt  119 (362)
T KOG0192|consen   41 DELPIEEVLGSGSFGTVYKGKW-RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT  119 (362)
T ss_pred             HHhhhhhhcccCCceeEEEEEe-CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence            3444556699999999999985 5665 9999998754333  448999999999999999999999999988 799999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCC-CeEEecccccccccc
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM-TPKIADFGMARLFEM  478 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~-~~kl~DFGla~~~~~  478 (658)
                      |||++|+|.++++.. ....++|..+++|+.|||+||.|||+++.  ||||||||+||||+.++ ++||+|||+++....
T Consensus       120 Ey~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~  196 (362)
T KOG0192|consen  120 EYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVI  196 (362)
T ss_pred             EeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence            999999999999764 46789999999999999999999999873  99999999999999998 999999999987543


Q ss_pred             CCCccccccccccccccCccccc--cCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccccc
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAM--HGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNII  556 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  556 (658)
                      ..  .......||+.|||||++.  ...|+.|+|||||||++|||+||+.||.....   ......+.   ..+..    
T Consensus       197 ~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~---~~~~~~v~---~~~~R----  264 (362)
T KOG0192|consen  197 SK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP---VQVASAVV---VGGLR----  264 (362)
T ss_pred             cc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH---HHHHHHHH---hcCCC----
Confidence            22  2233368999999999999  66999999999999999999999999854332   22222222   22221    


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCC
Q 006155          557 DPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTL  603 (658)
Q Consensus       557 dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~~~~  603 (658)
                       |.+.......   +..++.+||+.||++||++.+++.+|+......
T Consensus       265 -p~~p~~~~~~---l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~  307 (362)
T KOG0192|consen  265 -PPIPKECPPH---LSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI  307 (362)
T ss_pred             -CCCCccCCHH---HHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence             2222223333   345556799999999999999999998654433

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-46  Score=389.83  Aligned_cols=259  Identities=28%  Similarity=0.474  Sum_probs=214.8

Q ss_pred             hhhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          320 RVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       320 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ++..+.+...+.||+|-||.||.|.+.....||+|.++.. .....+|.+|+++|++|+|+|||+++|+|..+..++|||
T Consensus       202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt  280 (468)
T KOG0197|consen  202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT  280 (468)
T ss_pred             eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence            3344556667899999999999999877779999999876 345567899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      |||++|+|.++|.. .....+...+.+.++.|||+||+||++++   +|||||.++||||+++..+||+|||||+....+
T Consensus       281 E~m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~  356 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDD  356 (468)
T ss_pred             EecccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCC
Confidence            99999999999965 34567899999999999999999999998   999999999999999999999999999965544


Q ss_pred             CCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccCC
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP  558 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp  558 (658)
                      ... ......-+..|.|||.+..+.|+.|||||||||+||||+| |+.|+.   .....+++..+-+..|...+..    
T Consensus       357 ~Y~-~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~---~msn~ev~~~le~GyRlp~P~~----  428 (468)
T KOG0197|consen  357 EYT-ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP---GMSNEEVLELLERGYRLPRPEG----  428 (468)
T ss_pred             cee-ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC---CCCHHHHHHHHhccCcCCCCCC----
Confidence            332 2233345678999999999999999999999999999999 555553   3445566666666555443222    


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          559 TLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       559 ~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                           .+++   +.+|+..||+.+|++|||++.+...|+..
T Consensus       429 -----CP~~---vY~lM~~CW~~~P~~RPtF~~L~~~l~~~  461 (468)
T KOG0197|consen  429 -----CPDE---VYELMKSCWHEDPEDRPTFETLREVLEDF  461 (468)
T ss_pred             -----CCHH---HHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence                 2333   44577899999999999999999998765

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-45  Score=368.18  Aligned_cols=209  Identities=33%  Similarity=0.536  Sum_probs=183.3

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccC--CcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRD--SGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ..+|...++||+|.||+||+|++. ++.+||||.+...  ..+..+.+..|+.+|+.++|||||+|++++..++..+|||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            467888899999999999999854 5889999999776  4445556789999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCC------CCeEEeccccc
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE------MTPKIADFGMA  473 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~------~~~kl~DFGla  473 (658)
                      |||.+|+|.+||+   +++.+++.....++.|||.||++||+++   ||||||||.||||+..      -.+||+|||+|
T Consensus        89 EyC~gGDLs~yi~---~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   89 EYCNGGDLSDYIR---RRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             EeCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            9999999999995   3457999999999999999999999998   9999999999999765      45899999999


Q ss_pred             cccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHH
Q 006155          474 RLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSA  543 (658)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~  543 (658)
                      +.+..+.   ...+.+|++-|||||+++.++|+.|+|+||.|+|+||+++|+.||..   .+..+++.+.
T Consensus       163 R~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a---~t~~eL~~~~  226 (429)
T KOG0595|consen  163 RFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA---ETPKELLLYI  226 (429)
T ss_pred             hhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc---cCHHHHHHHH
Confidence            9887443   34568999999999999999999999999999999999999999953   3344555533

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.4e-45  Score=400.00  Aligned_cols=266  Identities=28%  Similarity=0.494  Sum_probs=218.0

Q ss_pred             hhhhhhccCCcccCcccccCceEEEEeEecC------CcceeEEEeccCCcc-cHHHHHHHHHHHHhcCCCCceeeeeee
Q 006155          317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQ-GDLEFKNEVLLVANLQHRNLVRLLGFS  389 (658)
Q Consensus       317 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~  389 (658)
                      ...+..+.+.+..+.||+|.||+||+|+...      ...||||.++..... ...+|++|++++..++|||||+|+|+|
T Consensus       479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC  558 (774)
T KOG1026|consen  479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVC  558 (774)
T ss_pred             ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence            3345556777888999999999999998543      346999999887665 778999999999999999999999999


Q ss_pred             ccCCceEEEEEecCCCChhhhhcCcC-------C----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCcee
Q 006155          390 LEGNERLLIYEFVPNTSLDHFIFDPT-------R----RAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVL  458 (658)
Q Consensus       390 ~~~~~~~lv~e~~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIL  458 (658)
                      .+++..++|+|||..|+|.+||....       .    ..+|+..+.+.|+.|||.||+||-+..   +|||||..+|+|
T Consensus       559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCL  635 (774)
T KOG1026|consen  559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCL  635 (774)
T ss_pred             ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhce
Confidence            99999999999999999999995321       1    334899999999999999999999887   999999999999


Q ss_pred             eCCCCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcc
Q 006155          459 LDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVE  537 (658)
Q Consensus       459 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~  537 (658)
                      |.++..+||+||||+|.....+.........-..+||+||.++.++||.+||||||||+||||++ |+.|+....   .+
T Consensus       636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS---n~  712 (774)
T KOG1026|consen  636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS---NQ  712 (774)
T ss_pred             eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc---hH
Confidence            99999999999999997766554444434455789999999999999999999999999999999 777774333   33


Q ss_pred             hHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 006155          538 DLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYS  600 (658)
Q Consensus       538 ~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~  600 (658)
                      +.++.    .++++..+.  |+   ..+.   ++..|++.||+.+|.+||+++||-..|+...
T Consensus       713 EVIe~----i~~g~lL~~--Pe---~CP~---~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~  763 (774)
T KOG1026|consen  713 EVIEC----IRAGQLLSC--PE---NCPT---EVYSLMLECWNENPKRRPSFKEIHSRLQAWA  763 (774)
T ss_pred             HHHHH----HHcCCcccC--CC---CCCH---HHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence            44443    344544332  11   2333   4566788999999999999999999998653

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-44  Score=379.73  Aligned_cols=246  Identities=27%  Similarity=0.437  Sum_probs=205.7

Q ss_pred             cCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ..|...+.||+|||++||+++. ..|+.||+|++.+..   ......+.+||++.+.|+|||||+++++|.+.+..|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5688999999999999999996 789999999997742   233456889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      |+|++++|..++   .+++++++.+++.++.||+.||.|||+.+   |||||||..|+||++++++||+|||||..+..+
T Consensus        98 ELC~~~sL~el~---Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELL---KRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHH---HhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence            999999999998   36788999999999999999999999988   999999999999999999999999999988755


Q ss_pred             CCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCC
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT  559 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~  559 (658)
                      ..  ...+.+|||.|+|||++.....+..+||||+||++|-|+.|++||+...   ..+....+    ...      +..
T Consensus       172 ~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~---vkety~~I----k~~------~Y~  236 (592)
T KOG0575|consen  172 GE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT---VKETYNKI----KLN------EYS  236 (592)
T ss_pred             cc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch---HHHHHHHH----Hhc------Ccc
Confidence            33  3456899999999999999999999999999999999999999995432   22222211    111      112


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 006155          560 LSSGSITEMIRCIHIGLLCVQENVASRPTMASVV  593 (658)
Q Consensus       560 l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv  593 (658)
                      ++..-..+..   +++...|+.||.+|||+.+|+
T Consensus       237 ~P~~ls~~A~---dLI~~lL~~~P~~Rpsl~~vL  267 (592)
T KOG0575|consen  237 MPSHLSAEAK---DLIRKLLRPNPSERPSLDEVL  267 (592)
T ss_pred             cccccCHHHH---HHHHHHhcCCcccCCCHHHHh
Confidence            2222222222   444577999999999999998

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-44  Score=360.50  Aligned_cols=251  Identities=28%  Similarity=0.401  Sum_probs=205.8

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC-cccHHHHHHHHHHHHhcCCCCceeeeeeeccCC-ceEEEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS-GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGN-ERLLIY  399 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lv~  399 (658)
                      .++++..+.||+|..|+|||+++. +++.+|+|.+.... .....++.+|++++.+.+||+||.++|.|.... +..++|
T Consensus        78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m  157 (364)
T KOG0581|consen   78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM  157 (364)
T ss_pred             HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence            346677889999999999999865 57778999985443 334567899999999999999999999999888 599999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      |||++|||++++..   .+.+++...-+|+.+|++||.|||+..  +||||||||+|||++..|++||+|||.++.+...
T Consensus       158 EYMDgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS  232 (364)
T KOG0581|consen  158 EYMDGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS  232 (364)
T ss_pred             hhcCCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence            99999999999843   356999999999999999999999732  4999999999999999999999999999876543


Q ss_pred             CCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCC--CCCcchHHHHHHHhccCCCcccccC
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRN--GETVEDLLSSAWKNWREGTTVNIID  557 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~--~~~~~~l~~~~~~~~~~~~~~~~~d  557 (658)
                          .....+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+....  .....+++.+....    .     -
T Consensus       233 ----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~----p-----p  299 (364)
T KOG0581|consen  233 ----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE----P-----P  299 (364)
T ss_pred             ----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC----C-----C
Confidence                4456899999999999999999999999999999999999999986531  23344444444321    1     1


Q ss_pred             CCCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          558 PTLSSG-SITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       558 p~l~~~-~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      |.+... -.+|+   .+++-.||+.||.+||++.|+++
T Consensus       300 P~lP~~~fS~ef---~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  300 PRLPEGEFSPEF---RSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             CCCCcccCCHHH---HHHHHHHhcCCcccCCCHHHHhc
Confidence            344433 33333   45667899999999999999873

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.4e-44  Score=357.64  Aligned_cols=253  Identities=23%  Similarity=0.348  Sum_probs=199.6

Q ss_pred             hccCCcccCcccccCceEEEEeE-ecCCcceeEEEeccCCcc-------cHHHHHHHHHHHHhcCCCCceeeeeeeccCC
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQ-------GDLEFKNEVLLVANLQHRNLVRLLGFSLEGN  393 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  393 (658)
                      ..+.|.+.+.||+|+||.|-+|. ..+|+.||||++++....       ......+|+++|++|+|||||++++++...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            45678889999999999999997 457999999999764221       1223579999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCC---CCeEEecc
Q 006155          394 ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE---MTPKIADF  470 (658)
Q Consensus       394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~---~~~kl~DF  470 (658)
                      ..|+||||++||+|.+++..   .+.+.+..-..++.|++.|+.|||+++   |+||||||+||||..+   ..+||+||
T Consensus       250 s~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             ceEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence            99999999999999999843   455777888899999999999999999   9999999999999765   78999999


Q ss_pred             ccccccccCCCccccccccccccccCccccccCC---CCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhc
Q 006155          471 GMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQ---YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNW  547 (658)
Q Consensus       471 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~  547 (658)
                      |+|+....   .....+.+||+.|.|||++.++.   +..|+|+||+||+||-+++|.+||.....+.  .+.+...+  
T Consensus       324 GlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~eQI~~--  396 (475)
T KOG0615|consen  324 GLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKEQILK--  396 (475)
T ss_pred             chhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHHHHhc--
Confidence            99997652   33456789999999999998765   3348899999999999999999996433322  22222221  


Q ss_pred             cCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          548 REGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       548 ~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                        |+...  .|.......   .+.++++-++|+.||++|||+.|+++
T Consensus       397 --G~y~f--~p~~w~~Is---eea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  397 --GRYAF--GPLQWDRIS---EEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             --Ccccc--cChhhhhhh---HHHHHHHHHhhEeCcccCcCHHHHhc
Confidence              22111  111111112   24556777999999999999999873

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-43  Score=358.50  Aligned_cols=264  Identities=30%  Similarity=0.455  Sum_probs=208.1

Q ss_pred             ccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHh--cCCCCceeeeeeeccCC----ceE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVAN--LQHRNLVRLLGFSLEGN----ERL  396 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~----~~~  396 (658)
                      ....+..++||+|+||.||||++ +++.||||++...   ..+.|.+|-++.+.  ++|+||+++++....+.    +++
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhc-cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            45566678999999999999997 5699999999654   44567777776654  58999999999987666    899


Q ss_pred             EEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhc------CCCcEEEeccCCCceeeCCCCCeEEecc
Q 006155          397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED------SRLRIIHRDLKTSNVLLDAEMTPKIADF  470 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~ivHrDlk~~NILl~~~~~~kl~DF  470 (658)
                      ||+||.++|+|.++|    +...++|....+|+..+++||+|||+.      .+++|+|||||++||||..++++.|+||
T Consensus       285 LVt~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF  360 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF  360 (534)
T ss_pred             EEeeeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence            999999999999999    557799999999999999999999976      3567999999999999999999999999


Q ss_pred             ccccccccCCCccccccccccccccCccccccCC-CC-----cccccccccchHhHHHhCCCCCc--------------c
Q 006155          471 GMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQ-YS-----VKSDVFSFGVLVLEIISGQRNNC--------------F  530 (658)
Q Consensus       471 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-----~ksDV~S~Gvll~elltG~~p~~--------------~  530 (658)
                      |||..+..+.....+...+||.+|||||++.+.. +.     .+.||||+|.|||||++......              .
T Consensus       361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev  440 (534)
T KOG3653|consen  361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV  440 (534)
T ss_pred             ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence            9999999888887777899999999999997643 22     47999999999999999654331              1


Q ss_pred             CCCCCcchHHHHHHHhccCCCcccccCCCCCCC--CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCC
Q 006155          531 RNGETVEDLLSSAWKNWREGTTVNIIDPTLSSG--SITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLT  602 (658)
Q Consensus       531 ~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~--~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~~~  602 (658)
                      ......+++...+.+.-        ..|.+...  .-..+.-+.+.+..||..||+-|-|+.=|-+.+......
T Consensus       441 G~hPt~e~mq~~VV~kK--------~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~  506 (534)
T KOG3653|consen  441 GNHPTLEEMQELVVRKK--------QRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML  506 (534)
T ss_pred             cCCCCHHHHHHHHHhhc--------cCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence            11223333333332221        12333322  113445566888899999999999999998888765443

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.6e-44  Score=340.43  Aligned_cols=260  Identities=27%  Similarity=0.432  Sum_probs=206.0

Q ss_pred             ccCCcccCcccccCceEEEEeE-ecCCcceeEEEeccC--CcccHHHHHHHHHHHHhcCCCCceeeeee-eccCCc-eEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRD--SGQGDLEFKNEVLLVANLQHRNLVRLLGF-SLEGNE-RLL  397 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~-~~~~~~-~~l  397 (658)
                      ..+|++.++||+|.||+|||++ +.+|..+|.|.+.-.  +.+..++...|+.+|++|+|||||+++++ +.++++ +.|
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni   97 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI   97 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence            4578899999999999999997 678999999988744  33445668899999999999999999994 455555 789


Q ss_pred             EEEecCCCChhhhhcC-cCCCCCCCHHHHHHHHHHHHHHHHHhhhcC-CCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          398 IYEFVPNTSLDHFIFD-PTRRAQLDWERRYKIIGGIARGLLYLHEDS-RLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ||||+.+|+|...+.. ...++.++++.+|+++.|++.||..+|.+- +..|+||||||.||+|+.+|.+||+||||++.
T Consensus        98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            9999999999999854 234567999999999999999999999842 12399999999999999999999999999999


Q ss_pred             cccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccc
Q 006155          476 FEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNI  555 (658)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  555 (658)
                      +....+.  ....+|||.||+||.+.+..|+.||||||+||++|||..-++||...      ++.+. .+...++..   
T Consensus       178 l~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L-~~KI~qgd~---  245 (375)
T KOG0591|consen  178 LSSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSL-CKKIEQGDY---  245 (375)
T ss_pred             hcchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHH-HHHHHcCCC---
Confidence            8765443  44579999999999999999999999999999999999999999543      22222 222333322   


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          556 IDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       556 ~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                        |.+..+  .--..+-.|+-.|+..||+.||+...+++.+.+
T Consensus       246 --~~~p~~--~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  246 --PPLPDE--HYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             --CCCcHH--HhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence              222222  111233455667999999999996655555543

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-42  Score=386.40  Aligned_cols=262  Identities=31%  Similarity=0.486  Sum_probs=210.7

Q ss_pred             hhccCCcccCcccccCceEEEEeEecC--Cc----ceeEEEeccCC-cccHHHHHHHHHHHHhcCCCCceeeeeeeccCC
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLYD--GA----EIAVKRLSRDS-GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGN  393 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~--g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  393 (658)
                      +..++....+.||+|.||.||.|...+  |.    .||||.+.+.. .+...+|.+|..+|++++|||||+++|+|.+..
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~  768 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG  768 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence            345667778899999999999998543  33    38999998864 455567999999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhhhhcCcC----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEec
Q 006155          394 ERLLIYEFVPNTSLDHFIFDPT----RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIAD  469 (658)
Q Consensus       394 ~~~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~D  469 (658)
                      ..++++|||++|+|..||.+..    ....|+..+.+.++.|||+|+.||++++   +|||||..+|+||++...+||+|
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaD  845 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIAD  845 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcc
Confidence            9999999999999999997642    2457999999999999999999999987   99999999999999999999999


Q ss_pred             cccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhcc
Q 006155          470 FGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWR  548 (658)
Q Consensus       470 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~  548 (658)
                      ||+|+.+...+......+..-...|||||.+..+.||.|+|||||||++|||+| |..|+...   ...+++..+..   
T Consensus       846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~---~n~~v~~~~~~---  919 (1025)
T KOG1095|consen  846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSR---SNFEVLLDVLE---  919 (1025)
T ss_pred             cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCc---chHHHHHHHHh---
Confidence            999995554443333333344579999999999999999999999999999999 55566332   23334333322   


Q ss_pred             CCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 006155          549 EGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYS  600 (658)
Q Consensus       549 ~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~  600 (658)
                       +.  ++--|...   +   .++++|+..||+.+|++||++..+++.+..+.
T Consensus       920 -gg--RL~~P~~C---P---~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~  962 (1025)
T KOG1095|consen  920 -GG--RLDPPSYC---P---EKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS  962 (1025)
T ss_pred             -CC--ccCCCCCC---C---hHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence             22  22223322   2   24557889999999999999999999887653

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-42  Score=343.61  Aligned_cols=204  Identities=28%  Similarity=0.416  Sum_probs=180.9

Q ss_pred             hhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc---ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceE
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG---QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERL  396 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  396 (658)
                      ...++|+..++||+|+||+||+++.. .++.+|+|++++...   ......++|..+|.+++||.||+++..|++.+.++
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy  101 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY  101 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence            34688999999999999999999854 477889999976532   23445789999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccc
Q 006155          397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF  476 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~  476 (658)
                      ||+||+.||.|..+|   ++...+++..+.-++.+|+.||.|||+++   ||||||||+|||||.+|+++|+||||++..
T Consensus       102 lVld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~  175 (357)
T KOG0598|consen  102 LVLDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKED  175 (357)
T ss_pred             EEEeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhc
Confidence            999999999999999   44567999999999999999999999998   999999999999999999999999999864


Q ss_pred             ccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCC
Q 006155          477 EMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRN  532 (658)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~  532 (658)
                      -...  ..+.+.+||+.|||||++.+..|+..+|+||+|+++|||++|.+||...+
T Consensus       176 ~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~  229 (357)
T KOG0598|consen  176 LKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED  229 (357)
T ss_pred             ccCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc
Confidence            3322  23455899999999999999999999999999999999999999995443

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-42  Score=358.05  Aligned_cols=267  Identities=26%  Similarity=0.439  Sum_probs=211.2

Q ss_pred             hhhhhhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCc
Q 006155          317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNE  394 (658)
Q Consensus       317 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  394 (658)
                      .++++..+++.+...||+|+||+||+|++.  ..||||++.....  +..+.|++|+..+++-+|.||+-+.|+|.....
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            456667778888999999999999999863  4699999977643  345679999999999999999999999998877


Q ss_pred             eEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          395 RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                       .+|+.+|+|.+|..+||..+  ..++..+.+.|++||++||.|||.++   |||||||+.||||.+++++||+||||+.
T Consensus       463 -AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat  536 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT  536 (678)
T ss_pred             -eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence             99999999999999998644  56899999999999999999999998   9999999999999999999999999986


Q ss_pred             ccccCCCccccccccccccccCccccccC---CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCC
Q 006155          475 LFEMDETQGNTSRIVGTYGYMAPEYAMHG---QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGT  551 (658)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  551 (658)
                      .-.............|...|||||+++.+   +|+.++||||||+++|||++|..|+.....+   .++-.+      |+
T Consensus       537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d---qIifmV------Gr  607 (678)
T KOG0193|consen  537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD---QIIFMV------GR  607 (678)
T ss_pred             eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh---heEEEe------cc
Confidence            43322222233445678899999999743   6999999999999999999999998632222   221111      11


Q ss_pred             cccccCCCCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCC
Q 006155          552 TVNIIDPTLSS-GSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTL  603 (658)
Q Consensus       552 ~~~~~dp~l~~-~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~~~~  603 (658)
                      -.-..|..... +...++.+   |...||..++++||.+.+|+.+|+....++
T Consensus       608 G~l~pd~s~~~s~~pk~mk~---Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~  657 (678)
T KOG0193|consen  608 GYLMPDLSKIRSNCPKAMKR---LLSDCWKFDREERPLFPQLLSKLEELLPSL  657 (678)
T ss_pred             cccCccchhhhccCHHHHHH---HHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence            11111222222 24445555   567899999999999999999888765444

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-43  Score=371.94  Aligned_cols=258  Identities=26%  Similarity=0.447  Sum_probs=215.8

Q ss_pred             hccCCcccCcccccCceEEEEeEecC----CcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLYD----GAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERL  396 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  396 (658)
                      ......+.++||.|.||+|++|+++-    ...||||.|+.... +...+|..|..+|.+.+||||++|.|+.......+
T Consensus       627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvM  706 (996)
T KOG0196|consen  627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVM  706 (996)
T ss_pred             ChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeE
Confidence            33456778899999999999999753    34699999987643 44567999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccc
Q 006155          397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF  476 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~  476 (658)
                      +|.|||+||+|+.||..  +..+++|.++.-++++||.||.||-+.+   +|||||.++|||++.+..+|++||||+|.+
T Consensus       707 IiTEyMENGsLDsFLR~--~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvl  781 (996)
T KOG0196|consen  707 IITEYMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL  781 (996)
T ss_pred             EEhhhhhCCcHHHHHhh--cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeec
Confidence            99999999999999965  3466999999999999999999999988   999999999999999999999999999988


Q ss_pred             ccCCCccc-cccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          477 EMDETQGN-TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       477 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      +.+..... +....=..+|.|||.+...++|..+|||||||++||.++ |++|+-   +...++.+..+-..++.....+
T Consensus       782 edd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW---dmSNQdVIkaIe~gyRLPpPmD  858 (996)
T KOG0196|consen  782 EDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW---DMSNQDVIKAIEQGYRLPPPMD  858 (996)
T ss_pred             ccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccc---ccchHHHHHHHHhccCCCCCCC
Confidence            76653222 222223578999999999999999999999999999987 888873   3445667766666655433222


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          555 IIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       555 ~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      .            -..+.+|++.|||.|-.+||++.+||.+|++.
T Consensus       859 C------------P~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl  891 (996)
T KOG0196|consen  859 C------------PAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL  891 (996)
T ss_pred             C------------cHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence            2            23466889999999999999999999999764

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=355.23  Aligned_cols=251  Identities=28%  Similarity=0.475  Sum_probs=208.1

Q ss_pred             hccCCcccCcccccCceEEEEeE-ecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      ....|....+||+|..|.||.++ ...++.||||++.........-+.+|+.+|+..+|+|||.++..+..++++|+|||
T Consensus       271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME  350 (550)
T KOG0578|consen  271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME  350 (550)
T ss_pred             hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence            34578888899999999999997 45688999999988776666678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      ||++|+|.+.+    ....+++.++..|.+++++||+|||.++   |||||||.+||||+.+|.+||+|||++..+....
T Consensus       351 ym~ggsLTDvV----t~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~  423 (550)
T KOG0578|consen  351 YMEGGSLTDVV----TKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ  423 (550)
T ss_pred             ecCCCchhhhh----hcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence            99999999998    3345999999999999999999999998   9999999999999999999999999998776554


Q ss_pred             CccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCC
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTL  560 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l  560 (658)
                      .  .....+||+.|||||+.....|..|.||||||++++||+-|++|+-..++      +...|.....| ..++-.|..
T Consensus       424 ~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P------lrAlyLIa~ng-~P~lk~~~k  494 (550)
T KOG0578|consen  424 S--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP------LRALYLIATNG-TPKLKNPEK  494 (550)
T ss_pred             C--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh------HHHHHHHhhcC-CCCcCCccc
Confidence            3  45568999999999999999999999999999999999999999844222      12222221222 222222222


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          561 SSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       561 ~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .+   .+   +-++..+||+.|+++||++.|+++
T Consensus       495 lS---~~---~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  495 LS---PE---LKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             cC---HH---HHHHHHHHhhcchhcCCCHHHHhc
Confidence            21   12   335566899999999999999984

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=5.5e-41  Score=355.58  Aligned_cols=263  Identities=29%  Similarity=0.400  Sum_probs=203.5

Q ss_pred             hhhccCCcccCcccccCceEEEEeEe------cCCcceeEEEeccCCcc-cHHHHHHHHHHHHhc-CCCCceeeeeeecc
Q 006155          320 RVATDNFSDANKLGQGGFGAVYKGRL------YDGAEIAVKRLSRDSGQ-GDLEFKNEVLLVANL-QHRNLVRLLGFSLE  391 (658)
Q Consensus       320 ~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l-~H~niv~l~~~~~~  391 (658)
                      ++..++|...++||+|+||.||+|..      ..+..||||++...... ....+.+|+.++..+ +||||+++++++..
T Consensus         3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (338)
T cd05102           3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK   82 (338)
T ss_pred             ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence            34567899999999999999999963      23567999998754332 334688999999999 89999999998876


Q ss_pred             CC-ceEEEEEecCCCChhhhhcCcCC------------------------------------------------------
Q 006155          392 GN-ERLLIYEFVPNTSLDHFIFDPTR------------------------------------------------------  416 (658)
Q Consensus       392 ~~-~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------  416 (658)
                      .+ ..++||||+++|+|.+++.....                                                      
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (338)
T cd05102          83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE  162 (338)
T ss_pred             CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence            44 57899999999999998854211                                                      


Q ss_pred             -----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCcccccccccc
Q 006155          417 -----RAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT  491 (658)
Q Consensus       417 -----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt  491 (658)
                           ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++...............++
T Consensus       163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~  239 (338)
T cd05102         163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP  239 (338)
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence                 235889999999999999999999987   999999999999999999999999999865433322222334567


Q ss_pred             ccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHH
Q 006155          492 YGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIR  570 (658)
Q Consensus       492 ~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~  570 (658)
                      ..|+|||++.+..++.++||||||+++|||++ |+.||......  ..+..    ....+..     +.......   ..
T Consensus       240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~--~~~~~----~~~~~~~-----~~~~~~~~---~~  305 (338)
T cd05102         240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN--EEFCQ----RLKDGTR-----MRAPENAT---PE  305 (338)
T ss_pred             ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHH----HHhcCCC-----CCCCCCCC---HH
Confidence            89999999999999999999999999999997 98888543221  11111    1111111     11111111   23


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          571 CIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       571 ~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      +.+++..||+.||++|||+.+|+++|+..
T Consensus       306 l~~li~~cl~~dp~~RPs~~el~~~l~~~  334 (338)
T cd05102         306 IYRIMLACWQGDPKERPTFSALVEILGDL  334 (338)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            55788899999999999999999999863

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-41  Score=340.69  Aligned_cols=268  Identities=26%  Similarity=0.356  Sum_probs=208.6

Q ss_pred             hhhhhhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHH--HhcCCCCceeeeeeeccCC-
Q 006155          317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLV--ANLQHRNLVRLLGFSLEGN-  393 (658)
Q Consensus       317 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l--~~l~H~niv~l~~~~~~~~-  393 (658)
                      -..+....+....+.||+|.||+||+|+ +.|+.||||++....   +..+.+|.++.  ..|+|+||+.+++.-..++ 
T Consensus       204 LVQRTiarqI~L~e~IGkGRyGEVwrG~-wrGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g  279 (513)
T KOG2052|consen  204 LVQRTIARQIVLQEIIGKGRFGEVWRGR-WRGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNG  279 (513)
T ss_pred             HhHHhhhheeEEEEEecCccccceeecc-ccCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence            3456777889999999999999999998 479999999996543   33455555555  4569999999999877654 


Q ss_pred             ---ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhh-----cCCCcEEEeccCCCceeeCCCCCe
Q 006155          394 ---ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE-----DSRLRIIHRDLKTSNVLLDAEMTP  465 (658)
Q Consensus       394 ---~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~ivHrDlk~~NILl~~~~~~  465 (658)
                         +++||.+|.++|||.+||    .+.+++.+..++++..+|.||++||.     +++|.|.|||||++|||+.+++.+
T Consensus       280 s~TQLwLvTdYHe~GSL~DyL----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C  355 (513)
T KOG2052|consen  280 SWTQLWLVTDYHEHGSLYDYL----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  355 (513)
T ss_pred             ceEEEEEeeecccCCcHHHHH----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcE
Confidence               678999999999999999    45789999999999999999999994     478899999999999999999999


Q ss_pred             EEeccccccccccCCC--ccccccccccccccCccccccCC------CCcccccccccchHhHHHhC----------CCC
Q 006155          466 KIADFGMARLFEMDET--QGNTSRIVGTYGYMAPEYAMHGQ------YSVKSDVFSFGVLVLEIISG----------QRN  527 (658)
Q Consensus       466 kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~------~s~ksDV~S~Gvll~elltG----------~~p  527 (658)
                      .|+|+|||.....+..  ....+..+||.+|||||++....      --..+||||||.|+||+...          +.|
T Consensus       356 ~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~P  435 (513)
T KOG2052|consen  356 CIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLP  435 (513)
T ss_pred             EEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence            9999999987765432  23455679999999999986532      12469999999999999752          224


Q ss_pred             CccCC--CCCcchHHHHHHHhccCCCcccccCCCCCCC--CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 006155          528 NCFRN--GETVEDLLSSAWKNWREGTTVNIIDPTLSSG--SITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYS  600 (658)
Q Consensus       528 ~~~~~--~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~--~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~  600 (658)
                      |....  +...++...        ---.+-+.|.+...  +.+.+..+.+++..||..||.-|-|+-.+-+.|.+..
T Consensus       436 yyd~Vp~DPs~eeMrk--------VVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~  504 (513)
T KOG2052|consen  436 YYDVVPSDPSFEEMRK--------VVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS  504 (513)
T ss_pred             cccCCCCCCCHHHHhc--------ceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence            42211  122222211        11122334555544  5667778889999999999999999999999987754

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-41  Score=339.10  Aligned_cols=255  Identities=28%  Similarity=0.415  Sum_probs=200.3

Q ss_pred             cCCcccCcccccCceEEEEeEecC-CcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCC--ceEEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGN--ERLLIYE  400 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lv~e  400 (658)
                      .++...+.||+|.||+||++...+ |...|||.+..........+.+|+.+|.+++|||||+++|.....+  .+.++||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            456778899999999999998554 8999999887764333566899999999999999999999855554  5889999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCC-CCCeEEecccccccccc-
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDA-EMTPKIADFGMARLFEM-  478 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~-~~~~kl~DFGla~~~~~-  478 (658)
                      |+++|+|.+++.....  .|++..+.++..||++||.|||+++   ||||||||+||||+. ++.+||+|||+++.... 
T Consensus        97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            9999999999954332  6999999999999999999999988   999999999999999 79999999999987664 


Q ss_pred             CCCccccccccccccccCccccccCCC-CcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccC
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAMHGQY-SVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID  557 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  557 (658)
                      ...........||+.|||||++..+.. ..++|||||||++.||+||++||...     .....+..........     
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~-----  241 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSL-----  241 (313)
T ss_pred             cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCC-----
Confidence            112223445789999999999996543 35999999999999999999998532     1122222222222211     


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 006155          558 PTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLML  596 (658)
Q Consensus       558 p~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L  596 (658)
                      |.+...-.++..   +++..|++.||+.|||+.+++..-
T Consensus       242 P~ip~~ls~~a~---~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  242 PEIPDSLSDEAK---DFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             CCCCcccCHHHH---HHHHHHhhcCcccCcCHHHHhhCh
Confidence            233333222333   455689999999999999998654

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-41  Score=356.10  Aligned_cols=264  Identities=28%  Similarity=0.394  Sum_probs=207.7

Q ss_pred             hhhhccCCcccCcccccCceEEEEeEecCC-----cceeEEEecc---CCcccHHHHHHHHHHHHhcCCCCceeeeeeec
Q 006155          319 IRVATDNFSDANKLGQGGFGAVYKGRLYDG-----AEIAVKRLSR---DSGQGDLEFKNEVLLVANLQHRNLVRLLGFSL  390 (658)
Q Consensus       319 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g-----~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~  390 (658)
                      +++..++....++||+|.||.||+|++..+     ..||||....   .......+|.+|.++|++++|||||+++|++.
T Consensus       152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV  231 (474)
T ss_pred             cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            445556666779999999999999986542     2289998875   23556678999999999999999999999999


Q ss_pred             cCCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecc
Q 006155          391 EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADF  470 (658)
Q Consensus       391 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DF  470 (658)
                      ....+++|||+|+||+|+++|....  ..++..+++.++.+.|+||+|||+++   +|||||.++|+|++.++.+||+||
T Consensus       232 ~~~Pl~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDF  306 (474)
T KOG0194|consen  232 LEEPLMLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDF  306 (474)
T ss_pred             CCCccEEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcc
Confidence            9999999999999999999995432  36999999999999999999999998   999999999999999999999999


Q ss_pred             ccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHH-hcc
Q 006155          471 GMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWK-NWR  548 (658)
Q Consensus       471 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~-~~~  548 (658)
                      ||++.-..  .........-...|+|||.+..+.|+.++|||||||++||+++ |..|+..   ....++..++.. .++
T Consensus       307 GLs~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g---~~~~~v~~kI~~~~~r  381 (474)
T KOG0194|consen  307 GLSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPG---MKNYEVKAKIVKNGYR  381 (474)
T ss_pred             ccccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCC---CCHHHHHHHHHhcCcc
Confidence            99875321  1111111134579999999999999999999999999999999 7777633   223333333311 222


Q ss_pred             CCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCCC
Q 006155          549 EGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTLP  604 (658)
Q Consensus       549 ~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~~~~~  604 (658)
                      ..         .....+.++..   +...||+.+|++||+|.+|.+.|+.......
T Consensus       382 ~~---------~~~~~p~~~~~---~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  382 MP---------IPSKTPKELAK---VMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             CC---------CCCCCHHHHHH---HHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence            11         11134555554   4459999999999999999999987655443

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-41  Score=351.61  Aligned_cols=266  Identities=27%  Similarity=0.402  Sum_probs=219.7

Q ss_pred             hhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccH-HHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGD-LEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~-~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ...+.....++||+|.||.|.+.....+..||||.++....... .+|..|+.+|.+|+|||||+|+|+|..++.+++|+
T Consensus       535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~  614 (807)
T KOG1094|consen  535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT  614 (807)
T ss_pred             cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence            34556678889999999999999988889999999988765444 78999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      |||++|+|..||....-. .+.-....+|+.||+.||+||.+.+   +|||||.++|+|+|.++++||+|||++|-+..+
T Consensus       615 EYmEnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg  690 (807)
T KOG1094|consen  615 EYMENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG  690 (807)
T ss_pred             HHHhcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccC
Confidence            999999999999654322 2456677889999999999999887   999999999999999999999999999988777


Q ss_pred             CCccccccccccccccCccccccCCCCcccccccccchHhHHHhC--CCCCccCCCCCcchHHHHHHHhccCCCccc-cc
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG--QRNNCFRNGETVEDLLSSAWKNWREGTTVN-II  556 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG--~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~  556 (658)
                      +......+.+-..+|||||.+..+++|.++|||+|||.+||+++-  ++|+..   ...++.++......+.+.... +.
T Consensus       691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~---lt~e~vven~~~~~~~~~~~~~l~  767 (807)
T KOG1094|consen  691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQ---LTDEQVVENAGEFFRDQGRQVVLS  767 (807)
T ss_pred             CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhh---hhHHHHHHhhhhhcCCCCcceecc
Confidence            666666677888999999999999999999999999999999774  456632   334455666555554433222 22


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          557 DPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       557 dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      .|..   .+   ..++++++.||..+-++||+++++...|...
T Consensus       768 ~P~~---cp---~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  768 RPPA---CP---QGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             CCCc---Cc---HHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            2322   22   2455788999999999999999999988754

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.9e-40  Score=397.03  Aligned_cols=259  Identities=24%  Similarity=0.451  Sum_probs=213.9

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      ...+...+.||+|+||.||+|+. .+|..||||++......    ..+|+..+++++|||||+++|++.+++..++||||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            35677888999999999999985 57899999998654322    23568899999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      +++|+|.++++      .++|..+.+|+.||++||+|||....++|+||||||+||+++.++.+++. ||........  
T Consensus       765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--  835 (968)
T PLN00113        765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--  835 (968)
T ss_pred             CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--
Confidence            99999999993      38999999999999999999997655669999999999999999988875 6665432211  


Q ss_pred             ccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCC
Q 006155          482 QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLS  561 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~  561 (658)
                          ....||+.|||||++.+..++.|+|||||||++|||++|+.|++... .....+..++...+.......++||.+.
T Consensus       836 ----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  910 (968)
T PLN00113        836 ----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSDCHLDMWIDPSIR  910 (968)
T ss_pred             ----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHHHhcCccchhheeCcccc
Confidence                12368899999999999999999999999999999999999985332 2234455565555555556667777775


Q ss_pred             CC---CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          562 SG---SITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       562 ~~---~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      ..   ..+++.++++++.+||+.+|++||||.||+++|+..
T Consensus       911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  951 (968)
T PLN00113        911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA  951 (968)
T ss_pred             CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence            43   556778889999999999999999999999999875

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=4.5e-41  Score=324.52  Aligned_cols=262  Identities=21%  Similarity=0.310  Sum_probs=202.2

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc-ccH-HHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG-QGD-LEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~-~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      +.|+...++|+|+||.|||.+.+ .|+.||||++..... ... +-..+|+.+|++|+|+|+|.|+.+|.....+.||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            46778889999999999999855 489999999976533 222 235789999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      |++..-|+++-.   ....++.+.+.+++.|+++|+.|+|+++   +|||||||+||||+.++.+||||||+|+.+... 
T Consensus        82 ~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-  154 (396)
T KOG0593|consen   82 YCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP-  154 (396)
T ss_pred             ecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC-
Confidence            999887776642   2345889999999999999999999998   999999999999999999999999999988642 


Q ss_pred             CccccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHh--------ccCCC
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKN--------WREGT  551 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~--------~~~~~  551 (658)
                       ....+..+.|.+|.|||.+.+ -+|...+|||+.||++.||++|++.|....+-+...++......        +....
T Consensus       155 -gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~  233 (396)
T KOG0593|consen  155 -GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP  233 (396)
T ss_pred             -cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence             123345688999999999987 78999999999999999999999988655443322222222211        11111


Q ss_pred             c-ccccCCCCC-----CC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 006155          552 T-VNIIDPTLS-----SG-SITEMIRCIHIGLLCVQENVASRPTMASVV  593 (658)
Q Consensus       552 ~-~~~~dp~l~-----~~-~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv  593 (658)
                      . ..+.-|...     .. -+.-..-+++++..|++.||++|++-++++
T Consensus       234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll  282 (396)
T KOG0593|consen  234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL  282 (396)
T ss_pred             ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence            1 001111111     01 111122467889999999999999999987

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-40  Score=342.03  Aligned_cols=263  Identities=25%  Similarity=0.401  Sum_probs=203.4

Q ss_pred             hccCCcccCcccccCceEEEEeE-ecCCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeeccC--CceE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEG--NERL  396 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~  396 (658)
                      ..+.|+.+++||+|.||.||+++ +.+|+.||+|++....  .....-..+||.+|++|+||||++|.+...+.  ..+|
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            35678889999999999999998 5678999999987764  23334567999999999999999999998776  6899


Q ss_pred             EEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccc
Q 006155          397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF  476 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~  476 (658)
                      ||+|||++ +|..++..  ....++..++..++.|++.||+|+|.++   |+|||||.+|||||.+|.+||+|||||+++
T Consensus       195 lVFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  195 LVFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             EEEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence            99999976 67777643  3456999999999999999999999998   999999999999999999999999999988


Q ss_pred             ccCCCccccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHh--------c
Q 006155          477 EMDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKN--------W  547 (658)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~--------~  547 (658)
                      ........+. .+-|.+|.|||++.+. .|+..+|+||.||||.||+.|++.+....+.   +.++.+.+.        |
T Consensus       269 ~~~~~~~~T~-rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv---eQl~kIfklcGSP~e~~W  344 (560)
T KOG0600|consen  269 TPSGSAPYTS-RVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV---EQLHKIFKLCGSPTEDYW  344 (560)
T ss_pred             cCCCCccccc-ceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH---HHHHHHHHHhCCCChhcc
Confidence            7766554444 4569999999999876 6999999999999999999999887443322   222222221        2


Q ss_pred             cCCCcc--cccCCCCCCC-CHHHHH-----HHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          548 REGTTV--NIIDPTLSSG-SITEMI-----RCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       548 ~~~~~~--~~~dp~l~~~-~~~e~~-----~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ....+.  ..+.|..... ...|..     ..++++...|..||.+|.|+.++++
T Consensus       345 ~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  345 PVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             ccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            211111  1222222111 222221     2456777789999999999998873

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=336.43  Aligned_cols=259  Identities=24%  Similarity=0.355  Sum_probs=205.3

Q ss_pred             hhccCCcccCcccccCceEEEEeE-ecCCcceeEEEeccCCccc-HHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEE
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQG-DLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  398 (658)
                      ...+.|+..+.||.|..++||+|+ ...++.||||++....... ..++.+|+..|..++||||++++..|..+.++|+|
T Consensus        23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV  102 (516)
T KOG0582|consen   23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV  102 (516)
T ss_pred             CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence            456889999999999999999998 5668999999998765444 46789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccc-c
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF-E  477 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~-~  477 (658)
                      |.||.+||+.+++...-. ..+++..+..|++++++||.|||+++   .||||||+.||||+.+|.+||+|||.+-.+ .
T Consensus       103 mpfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~  178 (516)
T KOG0582|consen  103 MPFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFD  178 (516)
T ss_pred             ehhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence            999999999999965332 34899999999999999999999998   999999999999999999999999986543 4


Q ss_pred             cCCCcccc-ccccccccccCccccccC--CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          478 MDETQGNT-SRIVGTYGYMAPEYAMHG--QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       478 ~~~~~~~~-~~~~gt~~y~aPE~~~~~--~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      .+...... ...+||+.|||||+++..  .|+.|+||||||+...||.+|..||....+.   ..+....    ++....
T Consensus       179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm---kvLl~tL----qn~pp~  251 (516)
T KOG0582|consen  179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM---KVLLLTL----QNDPPT  251 (516)
T ss_pred             cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH---HHHHHHh----cCCCCC
Confidence            34332222 667999999999996543  5999999999999999999999999543322   1111111    111111


Q ss_pred             ccCCCCCCCCHHHH----HHHHHHHHHhcCCCCCCCCCHHHHH
Q 006155          555 IIDPTLSSGSITEM----IRCIHIGLLCVQENVASRPTMASVV  593 (658)
Q Consensus       555 ~~dp~l~~~~~~e~----~~~~~i~~~Cl~~~p~~RPtm~evv  593 (658)
                      ..   ....+.++.    ..+.+++-.|++.||++|||+++++
T Consensus       252 ~~---t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLl  291 (516)
T KOG0582|consen  252 LL---TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLL  291 (516)
T ss_pred             cc---cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHh
Confidence            11   001111111    2345677789999999999999998

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=4e-40  Score=343.59  Aligned_cols=264  Identities=27%  Similarity=0.411  Sum_probs=203.1

Q ss_pred             ccCCcccCcccccCceEEEEeEecC-----------------CcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCcee
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLYD-----------------GAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVR  384 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----------------g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~  384 (658)
                      .++|...++||+|+||.||+++..+                 +..||+|.+..... ....+|.+|+.++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            4678889999999999999997432                 33699999876432 23456899999999999999999


Q ss_pred             eeeeeccCCceEEEEEecCCCChhhhhcCcC----------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEE
Q 006155          385 LLGFSLEGNERLLIYEFVPNTSLDHFIFDPT----------------RRAQLDWERRYKIIGGIARGLLYLHEDSRLRII  448 (658)
Q Consensus       385 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv  448 (658)
                      +++++.+.+..++||||+++++|.+++....                ....++|..+++++.||+.||.|||+.+   |+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence            9999999999999999999999999884321                1235789999999999999999999987   99


Q ss_pred             EeccCCCceeeCCCCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCC--C
Q 006155          449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ--R  526 (658)
Q Consensus       449 HrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~--~  526 (658)
                      ||||||+|||++.++.+||+|||+++.+.............++..|+|||++..+.++.++||||||+++|||+++.  .
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            99999999999999999999999998664433322333456688999999999999999999999999999999854  4


Q ss_pred             CCccCCCCCcchHHHHHHHhccCCCc-ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          527 NNCFRNGETVEDLLSSAWKNWREGTT-VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       527 p~~~~~~~~~~~l~~~~~~~~~~~~~-~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      |+...   ...+.+......++.... .....+   ....   ..+.+++.+||+.+|++||||.+|++.|++
T Consensus       241 p~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~---~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         241 PYGEL---TDEQVIENAGEFFRDQGRQVYLFRP---PPCP---QGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCCcC---CHHHHHHHHHHHhhhccccccccCC---CCCC---HHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            54322   222333333222221111 111111   1111   235678889999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-41  Score=349.21  Aligned_cols=248  Identities=27%  Similarity=0.421  Sum_probs=200.1

Q ss_pred             CCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecCC
Q 006155          325 NFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPN  404 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  404 (658)
                      ....++-||.|..|.||+|++ .++.||||++....       ..+|..|++|+|+||+.+.|+|....-+++|||||..
T Consensus       125 ~IsELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~  196 (904)
T KOG4721|consen  125 EISELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQ  196 (904)
T ss_pred             HhhhhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccc
Confidence            344567899999999999997 57899999875421       4578899999999999999999999999999999999


Q ss_pred             CChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCccc
Q 006155          405 TSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN  484 (658)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~  484 (658)
                      |-|..+|.   ....++......|..+||.||.|||.+.   |||||||+-||||..+..+||+|||-++.....   ..
T Consensus       197 GqL~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---ST  267 (904)
T KOG4721|consen  197 GQLYEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---ST  267 (904)
T ss_pred             ccHHHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hh
Confidence            99999994   3557888999999999999999999986   999999999999999999999999999865432   33


Q ss_pred             cccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCC
Q 006155          485 TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGS  564 (658)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~  564 (658)
                      ...++||..|||||++...+.++|+||||||||||||+||..|+.......      .+|..  -.+...+.-|   +..
T Consensus       268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA------IIwGV--GsNsL~LpvP---stc  336 (904)
T KOG4721|consen  268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA------IIWGV--GSNSLHLPVP---STC  336 (904)
T ss_pred             hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe------eEEec--cCCcccccCc---ccC
Confidence            456799999999999999999999999999999999999999984322211      11211  0112222222   223


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCC
Q 006155          565 ITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTL  603 (658)
Q Consensus       565 ~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~~~~  603 (658)
                      ++-+.   -++.+||+..|..||++++++..|+-....+
T Consensus       337 P~Gfk---lL~Kqcw~sKpRNRPSFrqil~HldIa~pel  372 (904)
T KOG4721|consen  337 PDGFK---LLLKQCWNSKPRNRPSFRQILLHLDIASPEL  372 (904)
T ss_pred             chHHH---HHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence            33333   3456899999999999999999997554433

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-41  Score=341.17  Aligned_cols=265  Identities=24%  Similarity=0.339  Sum_probs=206.5

Q ss_pred             hhccCCcccCcccccCceEEEEeE-ecCCcceeEEEeccCCcccHHH--HHHHHHHHHhcC-CCCceeeeeeeccCC-ce
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLE--FKNEVLLVANLQ-HRNLVRLLGFSLEGN-ER  395 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~--~~~E~~~l~~l~-H~niv~l~~~~~~~~-~~  395 (658)
                      ..-++|...++||.|.||.||+|+ ...|..||||++++.-.. +++  -.+|+..|++|. ||||++|..++.+.+ .+
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L   85 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL   85 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence            345789999999999999999998 456889999999876332 333  368999999998 999999999999888 89


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ++|||||+ .+|.+++.++  ++.+++..+..|+.||++||+|+|.+|   +.||||||+|||+..+..+||+|||+||.
T Consensus        86 ~fVfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARe  159 (538)
T KOG0661|consen   86 YFVFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLARE  159 (538)
T ss_pred             eeeHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccc
Confidence            99999994 6899998654  778999999999999999999999998   99999999999999999999999999997


Q ss_pred             cccCCCccccccccccccccCccccc-cCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHH-----HhccC
Q 006155          476 FEMDETQGNTSRIVGTYGYMAPEYAM-HGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAW-----KNWRE  549 (658)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~-----~~~~~  549 (658)
                      .....   ..+..+.|.+|.|||++. .+-|+.+.|+|++|||++||.+-++.|...++.+...-+-.+.     ..|.+
T Consensus       160 v~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e  236 (538)
T KOG0661|consen  160 VRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE  236 (538)
T ss_pred             cccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence            65432   344568899999999875 5779999999999999999999998875443321111111111     11222


Q ss_pred             CC----cccccCCCCCCCCHH-----HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          550 GT----TVNIIDPTLSSGSIT-----EMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       550 ~~----~~~~~dp~l~~~~~~-----e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                      +.    ...+.-|...+....     ....+++++..|+..||.+|||+.|.+++
T Consensus       237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            10    011112222222222     23457788889999999999999999865

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.1e-39  Score=310.20  Aligned_cols=275  Identities=27%  Similarity=0.376  Sum_probs=210.7

Q ss_pred             cCCcccCcccccCceEEEEeE-ecCCcceeEEEeccCCccc--HHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQG--DLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      ++|...++||+|.||.||+|+ ...|+.||||+++.....+  .....+|+..|+.++|+||+.|++++...+..-||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            467788999999999999998 4569999999997764332  2346899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      ||+ .+|+..|.+  +...++...+..++.++++||+|||++.   |+||||||.|+|++++|.+||+|||+++.+....
T Consensus        82 fm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             ecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            995 689999965  4567999999999999999999999998   9999999999999999999999999999987544


Q ss_pred             CccccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccccc---
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNII---  556 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~---  556 (658)
                      ....  ..+-|.+|.|||.+.+. +|+...|+||.|||+.||+-|.+-+....   ..+.+....+.+.-.+..++-   
T Consensus       156 ~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s---DidQL~~If~~LGTP~~~~WP~~~  230 (318)
T KOG0659|consen  156 RIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS---DIDQLSKIFRALGTPTPDQWPEMT  230 (318)
T ss_pred             cccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc---hHHHHHHHHHHcCCCCcccCcccc
Confidence            3222  23779999999998775 69999999999999999999887653322   233334333333222211111   


Q ss_pred             ---C---------CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCCCCCCCCCc
Q 006155          557 ---D---------PTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTLPVPSEPAF  611 (658)
Q Consensus       557 ---d---------p~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~~~~~~p~~p~~  611 (658)
                         |         |.+..--.......++++..++..||.+|+|++|++++=-=  .++|.|+.|.-
T Consensus       231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf--~~~P~pt~~~~  295 (318)
T KOG0659|consen  231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYF--KSLPLPTPPSK  295 (318)
T ss_pred             ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhh--hcCCCCCChhh
Confidence               0         11111111222345678889999999999999999865321  23556655543

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.4e-39  Score=334.24  Aligned_cols=244  Identities=17%  Similarity=0.285  Sum_probs=195.8

Q ss_pred             CcccccCceEEEEeEecCCcceeEEEeccCCccc---HHHHHHHHHHHHhcCCCCceeeeeeecc----CCceEEEEEec
Q 006155          330 NKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQG---DLEFKNEVLLVANLQHRNLVRLLGFSLE----GNERLLIYEFV  402 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lv~e~~  402 (658)
                      ..||+|++|.||+|+. +|+.||||++.......   ...+.+|+.++.+++||||++++|++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            5799999999999986 78999999997654333   3567899999999999999999999876    34678999999


Q ss_pred             CCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          403 PNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED-SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      ++|+|.+++..   ...++|...++++.+++.||.|||+. +   ++||||||+|||+++++.+||+|||+++.+.... 
T Consensus       105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-  177 (283)
T PHA02988        105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-  177 (283)
T ss_pred             CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence            99999999953   34689999999999999999999985 4   7799999999999999999999999998654321 


Q ss_pred             ccccccccccccccCcccccc--CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCC
Q 006155          482 QGNTSRIVGTYGYMAPEYAMH--GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT  559 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~  559 (658)
                          ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||....   ..++.......   +.     .+.
T Consensus       178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~---~~~~~~~i~~~---~~-----~~~  242 (283)
T PHA02988        178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT---TKEIYDLIINK---NN-----SLK  242 (283)
T ss_pred             ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhc---CC-----CCC
Confidence                23468899999999976  689999999999999999999999985332   22333322211   11     111


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          560 LSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       560 l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      +.....++   +.+++..||+.||++|||+.||++.|+..
T Consensus       243 ~~~~~~~~---l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        243 LPLDCPLE---IKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             CCCcCcHH---HHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            22122233   44677899999999999999999999764

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.5e-39  Score=347.45  Aligned_cols=261  Identities=27%  Similarity=0.383  Sum_probs=202.6

Q ss_pred             hhccCCcccCcccccCceEEEEeEe------cCCcceeEEEeccCCc-ccHHHHHHHHHHHHhc-CCCCceeeeeeeccC
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRL------YDGAEIAVKRLSRDSG-QGDLEFKNEVLLVANL-QHRNLVRLLGFSLEG  392 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~  392 (658)
                      ...++|+..++||+|+||.||+++.      ..+..||||+++.... .....+.+|+.++..+ +||||+++++++..+
T Consensus        32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~  111 (375)
T cd05104          32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG  111 (375)
T ss_pred             cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence            3456899999999999999999963      2356799999875432 3345688999999999 899999999999999


Q ss_pred             CceEEEEEecCCCChhhhhcCcCC--------------------------------------------------------
Q 006155          393 NERLLIYEFVPNTSLDHFIFDPTR--------------------------------------------------------  416 (658)
Q Consensus       393 ~~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------  416 (658)
                      +..++||||+++|+|.+++.....                                                        
T Consensus       112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence            999999999999999998853211                                                        


Q ss_pred             ----------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          417 ----------------RAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       417 ----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                                      ...++|..+++++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+....
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~  268 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDS  268 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence                            125889999999999999999999987   9999999999999999999999999998664432


Q ss_pred             CccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccCCC
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT  559 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~  559 (658)
                      .........++..|+|||++.+..++.++||||||+++|||++ |..|+.....  ...+...    +..+...  ..|.
T Consensus       269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~--~~~~~~~----~~~~~~~--~~~~  340 (375)
T cd05104         269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV--DSKFYKM----IKEGYRM--LSPE  340 (375)
T ss_pred             cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc--hHHHHHH----HHhCccC--CCCC
Confidence            2222222345678999999999999999999999999999998 7777743221  1122222    1111110  0111


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          560 LSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       560 l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                         ....   .+.+++.+||+.||++||++.+|+++|+.
T Consensus       341 ---~~~~---~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         341 ---CAPS---EMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             ---CCCH---HHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence               1122   35577889999999999999999999975

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-40  Score=338.75  Aligned_cols=252  Identities=24%  Similarity=0.334  Sum_probs=203.6

Q ss_pred             hccCCcccCcccccCceEEEEeE-ecCCcceeEEEeccCC---cccHHHHHHHHHHHHhc-CCCCceeeeeeeccCCceE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDS---GQGDLEFKNEVLLVANL-QHRNLVRLLGFSLEGNERL  396 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~  396 (658)
                      ..++|...+.||+|+|++|++++ ...++++|||++.+.-   .....-+..|-..|.+| .||.|++|+-.|.+...+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            45788889999999999999998 4468999999987642   12223366788889999 7999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccc
Q 006155          397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF  476 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~  476 (658)
                      +|+||.+||+|.++|.   +.+.+++...+.++.+|+.||+|||+.+   ||||||||+|||||++|++||+|||.|+.+
T Consensus       151 FvLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l  224 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL  224 (604)
T ss_pred             EEEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence            9999999999999994   4467999999999999999999999998   999999999999999999999999999988


Q ss_pred             ccCCCc-----------cccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHH
Q 006155          477 EMDETQ-----------GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWK  545 (658)
Q Consensus       477 ~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~  545 (658)
                      ......           ......+||..|.+||++..+..+..+|+|+|||+||+|+.|++||...++.   ..++.+..
T Consensus       225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney---liFqkI~~  301 (604)
T KOG0592|consen  225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY---LIFQKIQA  301 (604)
T ss_pred             ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH---HHHHHHHH
Confidence            643221           1124489999999999999999999999999999999999999999544321   22222221


Q ss_pred             hccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          546 NWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       546 ~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                                +|-.+..+-.+++.   +|+..-|..||.+|+|..+|-+.
T Consensus       302 ----------l~y~fp~~fp~~a~---dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  302 ----------LDYEFPEGFPEDAR---DLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             ----------hcccCCCCCCHHHH---HHHHHHHccCccccccHHHHhhC
Confidence                      22333333233333   34446688999999999999754

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=4.2e-39  Score=345.42  Aligned_cols=262  Identities=27%  Similarity=0.390  Sum_probs=202.6

Q ss_pred             hhhccCCcccCcccccCceEEEEeEec------CCcceeEEEeccCCcc-cHHHHHHHHHHHHhc-CCCCceeeeeeecc
Q 006155          320 RVATDNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRDSGQ-GDLEFKNEVLLVANL-QHRNLVRLLGFSLE  391 (658)
Q Consensus       320 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l-~H~niv~l~~~~~~  391 (658)
                      ....++|+..+.||+|+||.||+++..      ++..||||++...... ....+.+|+.+++.+ +|+||+++++++..
T Consensus        34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~  113 (374)
T cd05106          34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH  113 (374)
T ss_pred             cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence            445678999999999999999998732      2357999999764332 234578999999999 89999999999999


Q ss_pred             CCceEEEEEecCCCChhhhhcCcC--------------------------------------------------------
Q 006155          392 GNERLLIYEFVPNTSLDHFIFDPT--------------------------------------------------------  415 (658)
Q Consensus       392 ~~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------------------------  415 (658)
                      ....++||||+++|+|.+++....                                                        
T Consensus       114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (374)
T cd05106         114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ  193 (374)
T ss_pred             CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence            999999999999999999884321                                                        


Q ss_pred             -----------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCccc
Q 006155          416 -----------RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN  484 (658)
Q Consensus       416 -----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~  484 (658)
                                 ....+++..+++++.||++||.|||+.+   |+||||||+|||+++++.+||+|||+++.+........
T Consensus       194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~  270 (374)
T cd05106         194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV  270 (374)
T ss_pred             cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence                       1135789999999999999999999987   99999999999999999999999999976543322222


Q ss_pred             cccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCC
Q 006155          485 TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSG  563 (658)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~  563 (658)
                      .....++..|||||++.+..++.++||||||+++|||++ |+.||.......  ..... .   ..+.     .+.....
T Consensus       271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~~-~---~~~~-----~~~~~~~  339 (374)
T cd05106         271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYKM-V---KRGY-----QMSRPDF  339 (374)
T ss_pred             ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHHH-H---Hccc-----CccCCCC
Confidence            222345678999999999999999999999999999997 999985432211  11111 1   1110     0111111


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          564 SITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       564 ~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      ...   .+.+++..||+.+|++||++.+|+++|+.
T Consensus       340 ~~~---~l~~li~~cl~~dp~~RPs~~~l~~~l~~  371 (374)
T cd05106         340 APP---EIYSIMKMCWNLEPTERPTFSQISQLIQR  371 (374)
T ss_pred             CCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            122   34567789999999999999999999976

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.6e-39  Score=329.56  Aligned_cols=250  Identities=31%  Similarity=0.528  Sum_probs=192.3

Q ss_pred             ccCcccccCceEEEEeEec-----CCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          328 DANKLGQGGFGAVYKGRLY-----DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       328 ~~~~lG~G~fg~Vy~~~~~-----~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      ..+.||.|.||.||+|.+.     .+..|+||.++.... ....+|.+|++.+.+++||||++++|++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3568999999999999876     256799999965433 3367899999999999999999999999988889999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      +++|+|.++|... ....+++..+++|+.||++||.|||+.+   ++|+||+++|||+++++.+||+|||++........
T Consensus        83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            9999999999653 2457899999999999999999999987   99999999999999999999999999987633322


Q ss_pred             ccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCC
Q 006155          482 QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTL  560 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l  560 (658)
                      ........+...|+|||.+....++.++||||||+++|||++ |+.|+...   ...++.....    ++.....     
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~---~~~~~~~~~~----~~~~~~~-----  226 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY---DNEEIIEKLK----QGQRLPI-----  226 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS---CHHHHHHHHH----TTEETTS-----
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccc----cccccee-----
Confidence            222333457789999999999999999999999999999999 66776322   3333333332    2221111     


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 006155          561 SSGSITEMIRCIHIGLLCVQENVASRPTMASVVLML  596 (658)
Q Consensus       561 ~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L  596 (658)
                      ......   .+.+++..||+.+|++||+|.++++.|
T Consensus       227 ~~~~~~---~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  227 PDNCPK---DIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             BTTSBH---HHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ccchhH---HHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            111122   345678899999999999999999986

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=4.1e-39  Score=333.72  Aligned_cols=291  Identities=21%  Similarity=0.282  Sum_probs=217.6

Q ss_pred             hhhhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcc---cHHHHHHHHHHHHhcCCCCceeeeeeeccCCc
Q 006155          319 IRVATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQ---GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNE  394 (658)
Q Consensus       319 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  394 (658)
                      .+...++|+.+..||+|+||.||+++.. .|..+|+|++++....   ....++.|-.+|...++|+||+|+..|++.+.
T Consensus       136 ~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~  215 (550)
T KOG0605|consen  136 TRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEY  215 (550)
T ss_pred             ccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCe
Confidence            3567799999999999999999999854 5888999999876433   33457889999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          395 RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      +||||||++||++..+|   .+...|++.....++.+++.|++-||+.+   +|||||||+|+|||..|++||+||||+.
T Consensus       216 LYLiMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~  289 (550)
T KOG0605|consen  216 LYLIMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLST  289 (550)
T ss_pred             eEEEEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccc
Confidence            99999999999999999   45678999999999999999999999998   9999999999999999999999999985


Q ss_pred             cccc---------------C------CCcc-----c-------------------cccccccccccCccccccCCCCccc
Q 006155          475 LFEM---------------D------ETQG-----N-------------------TSRIVGTYGYMAPEYAMHGQYSVKS  509 (658)
Q Consensus       475 ~~~~---------------~------~~~~-----~-------------------~~~~~gt~~y~aPE~~~~~~~s~ks  509 (658)
                      -+..               .      ....     .                   ....+|||.|||||++.+..|+..+
T Consensus       290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c  369 (550)
T KOG0605|consen  290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC  369 (550)
T ss_pred             hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence            3321               0      0000     0                   0125899999999999999999999


Q ss_pred             ccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-
Q 006155          510 DVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPT-  588 (658)
Q Consensus       510 DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPt-  588 (658)
                      |+||+|||+||||.|-+||+...+.+...-+.    .|+..    +.-|.-.. ..+|.   .+++.+|+. ||++|-- 
T Consensus       370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~----nwr~~----l~fP~~~~-~s~eA---~DLI~rll~-d~~~RLG~  436 (550)
T KOG0605|consen  370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIV----NWRET----LKFPEEVD-LSDEA---KDLITRLLC-DPENRLGS  436 (550)
T ss_pred             cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----HHhhh----ccCCCcCc-ccHHH---HHHHHHHhc-CHHHhcCc
Confidence            99999999999999999997655432221111    12211    11111111 11333   344556666 9999965 


Q ss_pred             --HHHHHH--HhccCCCCCCCCCCCCcccccccccccccccccC
Q 006155          589 --MASVVL--MLNSYSLTLPVPSEPAFFMDSIIESDMSFSLAHD  628 (658)
Q Consensus       589 --m~evv~--~L~~~~~~~~~p~~p~~~~~~~~~~~~~~~~~~~  628 (658)
                        ..||-+  .+++..+.--....|+|...-..+.|.+++..+.
T Consensus       437 ~G~~EIK~HPfF~~v~W~~l~~~~apfvP~v~~~~DT~yFddF~  480 (550)
T KOG0605|consen  437 KGAEEIKKHPFFKGVDWDHLREMPAPFVPQVNSELDTQYFDDFP  480 (550)
T ss_pred             ccHHHHhcCCccccCCcchhhcCCCCCCCCCCCcccccccccCc
Confidence              555543  2345555444444566666555555555555443

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.1e-38  Score=329.57  Aligned_cols=250  Identities=26%  Similarity=0.353  Sum_probs=197.0

Q ss_pred             CcccCcccccCceEEEEeEe-cCCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          326 FSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       326 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      |+..+.||+|+||.||++.. .+|+.||||.+....   ......+.+|+.++.+++|+||+++++++.+++..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            67788999999999999985 468999999886542   22334578899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      +++|+|..++... ....+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++..+.... 
T Consensus        82 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05631          82 MNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-  156 (285)
T ss_pred             cCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence            9999998887532 2346899999999999999999999987   9999999999999999999999999998654322 


Q ss_pred             ccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCC
Q 006155          482 QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLS  561 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~  561 (658)
                        ......||..|+|||++.+..++.++|||||||++|||++|+.||.........+.+.   ....... .     ...
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~~~~~~~-~-----~~~  225 (285)
T cd05631         157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD---RRVKEDQ-E-----EYS  225 (285)
T ss_pred             --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH---HHhhccc-c-----cCC
Confidence              1234578999999999999999999999999999999999999986443322111111   1111110 0     011


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 006155          562 SGSITEMIRCIHIGLLCVQENVASRPT-----MASVVL  594 (658)
Q Consensus       562 ~~~~~e~~~~~~i~~~Cl~~~p~~RPt-----m~evv~  594 (658)
                      .....   .+.+++..||+.||++||+     ++++++
T Consensus       226 ~~~s~---~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         226 EKFSE---DAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             ccCCH---HHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            11112   3446777999999999997     777774

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=336.75  Aligned_cols=250  Identities=24%  Similarity=0.404  Sum_probs=202.7

Q ss_pred             hhccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccC----Cc-ccHHHHHHHHHHHHhcC-CCCceeeeeeeccCC
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRD----SG-QGDLEFKNEVLLVANLQ-HRNLVRLLGFSLEGN  393 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~  393 (658)
                      ...++|...+.||+|+||+|+.|+. ..|+.||+|.+.+.    .. .....+.+|+.+++.++ ||||++++.++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            4467899999999999999999974 46899999977664    11 23345678999999999 999999999999999


Q ss_pred             ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCC-CCeEEecccc
Q 006155          394 ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE-MTPKIADFGM  472 (658)
Q Consensus       394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~-~~~kl~DFGl  472 (658)
                      ..++||||+.+|+|.+++.+   ...+.+....+++.|++.|++|||+.+   |+||||||+|||++.+ +++||+|||+
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence            99999999999999999954   567888999999999999999999998   9999999999999999 9999999999


Q ss_pred             ccccccCCCccccccccccccccCccccccCC-CC-cccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCC
Q 006155          473 ARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQ-YS-VKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREG  550 (658)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  550 (658)
                      +....  .........+||+.|+|||++.+.. |+ .++||||+||+||-|++|+-||+.   .....+...    ...+
T Consensus       168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d---~~~~~l~~k----i~~~  238 (370)
T KOG0583|consen  168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD---SNVPNLYRK----IRKG  238 (370)
T ss_pred             ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC---ccHHHHHHH----HhcC
Confidence            99764  1223345679999999999999877 86 689999999999999999999965   222222222    1111


Q ss_pred             CcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 006155          551 TTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVV  593 (658)
Q Consensus       551 ~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv  593 (658)
                      .   ..-|....     -..+..++..|++.||.+|+|+.+|+
T Consensus       239 ~---~~~p~~~~-----S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  239 E---FKIPSYLL-----SPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             C---ccCCCCcC-----CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            1   11111110     12345667789999999999999998

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.2e-38  Score=325.87  Aligned_cols=256  Identities=25%  Similarity=0.388  Sum_probs=201.1

Q ss_pred             hccCCcccCcccccCceEEEEeEec----CCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY----DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERL  396 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  396 (658)
                      ..++|+..+.||+|+||.||+|.+.    .+..||+|.+..... .....+.+|+..+.+++||||+++++++..++..+
T Consensus         3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   82 (266)
T cd05064           3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM   82 (266)
T ss_pred             chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence            3467888999999999999999753    356899999876533 23346889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccc
Q 006155          397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF  476 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~  476 (658)
                      +||||+++|+|.+++...  ...++|..++.++.||+.||+|||+.+   ++||||||+|||++.++.+|++|||.+...
T Consensus        83 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          83 IVTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             EEEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            999999999999998542  346899999999999999999999987   999999999999999999999999987643


Q ss_pred             ccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccc
Q 006155          477 EMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNI  555 (658)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  555 (658)
                      ..... .......++..|+|||++.++.++.++||||||+++||+++ |+.|+....   ..+++...    .++..   
T Consensus       158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~---~~~~~~~~----~~~~~---  226 (266)
T cd05064         158 KSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS---GQDVIKAV----EDGFR---  226 (266)
T ss_pred             cccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC---HHHHHHHH----HCCCC---
Confidence            22111 11222345678999999999999999999999999999775 998884332   22222222    11111   


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          556 IDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       556 ~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                        +......+.   .+.+++..||+.+|++||++.+|++.|+.
T Consensus       227 --~~~~~~~~~---~~~~li~~c~~~~p~~RP~~~~i~~~l~~  264 (266)
T cd05064         227 --LPAPRNCPN---LLHQLMLDCWQKERGERPRFSQIHSILSK  264 (266)
T ss_pred             --CCCCCCCCH---HHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence              111111122   34567789999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2e-38  Score=322.91  Aligned_cols=256  Identities=29%  Similarity=0.457  Sum_probs=206.5

Q ss_pred             hccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      ..++|+..++||+|+||.||+|...++..||+|.+.... .....+.+|+.+++.++|+||+++++.+..++..+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            457889999999999999999998788899999886543 3456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      +++++|.+++... ....+++..++.++.++++||.|||+.+   ++||||||+||+++.++.+||+|||+++.......
T Consensus        83 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          83 MAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            9999999998542 2346899999999999999999999987   99999999999999999999999999987643322


Q ss_pred             ccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCC
Q 006155          482 QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTL  560 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l  560 (658)
                      . ......++..|+|||++..+.++.++||||||+++|||++ |+.|+....   ...........++.        +..
T Consensus       159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~---~~~~~~~~~~~~~~--------~~~  226 (261)
T cd05072         159 T-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS---NSDVMSALQRGYRM--------PRM  226 (261)
T ss_pred             e-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC---HHHHHHHHHcCCCC--------CCC
Confidence            1 1223346778999999999999999999999999999998 888874322   22222222221111        111


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          561 SSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       561 ~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                       ....   ..+.+++.+|++.+|++||++.++.++|+.
T Consensus       227 -~~~~---~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         227 -ENCP---DELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             -CCCC---HHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence             1111   235578889999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.3e-38  Score=321.64  Aligned_cols=252  Identities=26%  Similarity=0.443  Sum_probs=202.6

Q ss_pred             cCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecC
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVP  403 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~  403 (658)
                      ++|...+.||+|+||.||+++..++..+|+|.+... .....++.+|+.++++++||||+++++++..++..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            567888899999999999999888888999988644 3345678999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCcc
Q 006155          404 NTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQG  483 (658)
Q Consensus       404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  483 (658)
                      +|+|.+++...  ...++|..++.++.+++.||.|||+.+   ++||||||+||+++.++.+||+|||+++........ 
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05114          83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-  156 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence            99999998542  245899999999999999999999987   999999999999999999999999998765332211 


Q ss_pred             ccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCC
Q 006155          484 NTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSS  562 (658)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~  562 (658)
                      ......++..|+|||++.+..++.++||||||+++|||++ |+.|+....   ..+.+.......+      ...|..  
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~---~~~~~~~i~~~~~------~~~~~~--  225 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS---NYEVVEMISRGFR------LYRPKL--  225 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHHCCCC------CCCCCC--
Confidence            1122345678999999998899999999999999999999 888874322   2233333222111      111211  


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 006155          563 GSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN  597 (658)
Q Consensus       563 ~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~  597 (658)
                       ..   ..+.+++.+||+.+|++||++.+++++|+
T Consensus       226 -~~---~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         226 -AS---MTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             -CC---HHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence             11   24567888999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-38  Score=321.69  Aligned_cols=257  Identities=27%  Similarity=0.420  Sum_probs=205.7

Q ss_pred             hhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      +..++|+..+.||+|+||.||+|...+++.||+|.+.... ....++.+|+.++++++||||+++++++...+..++|||
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05068           3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE   81 (261)
T ss_pred             cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence            4457788999999999999999997778889999986543 345678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      |+++++|.+++.... ...++|..+.+++.+++.||.|||+.+   ++||||||+||++++++.+||+|||+++.+....
T Consensus        82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05068          82 LMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDI  157 (261)
T ss_pred             cccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence            999999999985432 346899999999999999999999987   9999999999999999999999999998765322


Q ss_pred             CccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccCCC
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT  559 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~  559 (658)
                      . .......++..|+|||++.+..++.++||||||+++|||++ |+.|+...   ....+.......+.    .     .
T Consensus       158 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~---~~~~~~~~~~~~~~----~-----~  224 (261)
T cd05068         158 Y-EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM---TNAEVLQQVDQGYR----M-----P  224 (261)
T ss_pred             c-cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC---CHHHHHHHHHcCCC----C-----C
Confidence            1 11122233568999999999999999999999999999999 88887432   22222222211111    0     0


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          560 LSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       560 l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      .....   ...+.+++.+|++.+|++||++.++++.|+.
T Consensus       225 ~~~~~---~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         225 CPPGC---PKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCCcC---CHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            01111   1345678889999999999999999999975

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.5e-38  Score=327.07  Aligned_cols=260  Identities=27%  Similarity=0.447  Sum_probs=203.1

Q ss_pred             hhccCCcccCcccccCceEEEEeEec------CCcceeEEEeccCC-cccHHHHHHHHHHHHhcCCCCceeeeeeeccCC
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRDS-GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGN  393 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  393 (658)
                      +.+++|+..+.||+|+||.||+|...      .+..||||++.... .....++.+|+.+++.++||||+++++++..+.
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            45788999999999999999998742      24679999886533 233456889999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhhhhcCcCC-------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeE
Q 006155          394 ERLLIYEFVPNTSLDHFIFDPTR-------RAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPK  466 (658)
Q Consensus       394 ~~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~k  466 (658)
                      ..++||||+++++|.+++.....       ...++|..++.++.|+++||.|||+.+   ++||||||+|||+++++.++
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence            99999999999999999854221       235788999999999999999999987   99999999999999999999


Q ss_pred             EeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHH
Q 006155          467 IADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWK  545 (658)
Q Consensus       467 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~  545 (658)
                      |+|||+++.+.............++..|+|||++.++.++.++||||||+++|||++ |..|+....   ......... 
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~---~~~~~~~~~-  235 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS---NEQVLRFVM-  235 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHH-
Confidence            999999876543332222222356788999999999999999999999999999999 677774322   222222211 


Q ss_pred             hccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          546 NWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       546 ~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                         ++....     .......   .+.+++.+|++.+|++|||+.|++++|++
T Consensus       236 ---~~~~~~-----~~~~~~~---~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         236 ---EGGLLD-----KPDNCPD---MLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             ---cCCcCC-----CCCCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence               111111     1111222   35578889999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.3e-38  Score=326.46  Aligned_cols=258  Identities=28%  Similarity=0.471  Sum_probs=204.3

Q ss_pred             ccCCcccCcccccCceEEEEeEecC------CcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCce
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNER  395 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  395 (658)
                      .++|+..+.||+|+||.||+|....      ...||+|.+..... ....++.+|+.++.+++||||+++++++.+....
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT   83 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence            3578889999999999999998543      24699998865432 2345689999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCcCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCC
Q 006155          396 LLIYEFVPNTSLDHFIFDPTR-------------RAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE  462 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~  462 (658)
                      +++|||+++++|.+++.....             ...+++..++.++.|++.||.|||+.+   ++||||||+||+++++
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~  160 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEG  160 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCC
Confidence            999999999999999854211             146899999999999999999999987   9999999999999999


Q ss_pred             CCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHH
Q 006155          463 MTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLS  541 (658)
Q Consensus       463 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~  541 (658)
                      +.+||+|||+++...............+++.|+|||++.++.++.++||||||+++|||++ |..|+.....   .++..
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~---~~~~~  237 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN---QEVIE  237 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH
Confidence            9999999999986544333223334567889999999999999999999999999999998 9988743222   22222


Q ss_pred             HHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          542 SAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       542 ~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      .    +..+....     ......   ..+.+++..||+.||.+||++.+|++.|++
T Consensus       238 ~----i~~~~~~~-----~~~~~~---~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         238 M----IRSRQLLP-----CPEDCP---ARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             H----HHcCCcCC-----CcccCC---HHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            2    22221111     111222   335567789999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.9e-38  Score=328.77  Aligned_cols=260  Identities=26%  Similarity=0.452  Sum_probs=207.7

Q ss_pred             cCCcccCcccccCceEEEEeEec------CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  397 (658)
                      .+|...+.||+|+||.||+++..      ++..+++|.+..........+.+|+.++.+++|+||+++++++..++..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            46778899999999999999743      345689999877665556678999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCC
Q 006155          398 IYEFVPNTSLDHFIFDPT-------------RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMT  464 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~  464 (658)
                      ||||+++++|.+++....             ....++|..+++++.||+.||.|||+.+   ++||||||+|||++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            999999999999985421             1245899999999999999999999988   999999999999999999


Q ss_pred             eEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHH
Q 006155          465 PKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSA  543 (658)
Q Consensus       465 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~  543 (658)
                      ++|+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.|+.....   .+.+.. 
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~~-  237 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN---TEVIEC-  237 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH-
Confidence            99999999976544332222334567889999999999999999999999999999999 8888743322   222222 


Q ss_pred             HHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 006155          544 WKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSL  601 (658)
Q Consensus       544 ~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~~  601 (658)
                         ...+...+.     ....   ...+.+++.+||+.+|++||++.+|+++|+....
T Consensus       238 ---~~~~~~~~~-----~~~~---~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         238 ---ITQGRVLER-----PRVC---PKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             ---HhCCCCCCC-----CccC---CHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence               222222111     0111   1245678889999999999999999999988644

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.5e-38  Score=325.62  Aligned_cols=258  Identities=27%  Similarity=0.460  Sum_probs=205.4

Q ss_pred             ccCCcccCcccccCceEEEEeEecC------CcceeEEEeccCCcc-cHHHHHHHHHHHHhcCCCCceeeeeeeccCCce
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQ-GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNER  395 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  395 (658)
                      .++|...+.||+|+||.||+|+..+      +..||||.+...... ....+.+|++++.+++|+||+++++++..+...
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            4568888999999999999998643      467999998765444 456799999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCc-----------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCC
Q 006155          396 LLIYEFVPNTSLDHFIFDP-----------TRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMT  464 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~  464 (658)
                      ++||||+++++|.+++...           .....+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence            9999999999999998542           12345899999999999999999999987   999999999999999999


Q ss_pred             eEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHH
Q 006155          465 PKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSA  543 (658)
Q Consensus       465 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~  543 (658)
                      +||+|||+++...............+++.|+|||++.++.++.++||||||+++|||++ |+.|+....   ..+.+...
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~---~~~~~~~~  237 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS---NEEVIECI  237 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHH
Confidence            99999999976543322222233456789999999999999999999999999999999 998874322   22222222


Q ss_pred             HHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          544 WKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       544 ~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      .    .+.....     .....   ..+.+++..||+.||++||++.||++.|++
T Consensus       238 ~----~~~~~~~-----~~~~~---~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         238 T----QGRLLQR-----PRTCP---SEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             H----cCCcCCC-----CCCCC---HHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            2    1211111     11111   235577889999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-38  Score=335.28  Aligned_cols=253  Identities=22%  Similarity=0.315  Sum_probs=200.2

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ++|+..+.||+|+||.||+|+.. +++.||||++....   ......+.+|+.++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            46888999999999999999865 47899999987542   223446788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.... 
T Consensus        81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            99999999999843   346899999999999999999999988   99999999999999999999999999976433 


Q ss_pred             CCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCC
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT  559 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~  559 (658)
                          ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....   .+..... ..+...    +..|.
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---~~~~~~i-~~~~~~----~~~~~  221 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP---NETWENL-KYWKET----LQRPV  221 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH---HHHHHHH-Hhcccc----ccCCC
Confidence                22346799999999999999999999999999999999999999854322   2222211 111110    00111


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          560 LSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       560 l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                      ...........+.+++..||+.+|.+||++.++++.
T Consensus       222 ~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            110000011234466778999999999999999865

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3e-38  Score=321.57  Aligned_cols=257  Identities=30%  Similarity=0.458  Sum_probs=209.9

Q ss_pred             hhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      ....+|...++||+|+||.||+|+..++..+++|.+.........++.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            45577899999999999999999987899999999987766566778999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      |+++++|.+++.+.. ...+++..+++++.+|+.||.|||+.+   ++|+||||+||+++.++.+||+|||++.......
T Consensus        83 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          83 LMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             ecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            999999999996532 356899999999999999999999987   9999999999999999999999999997654322


Q ss_pred             CccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccCCC
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT  559 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~  559 (658)
                      ..  .....++..|+|||.+.++.++.++||||||+++|||++ |+.|+....   ..+.+.......+         +.
T Consensus       159 ~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~---~~~~~~~~~~~~~---------~~  224 (261)
T cd05148         159 YL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN---NHEVYDQITAGYR---------MP  224 (261)
T ss_pred             cc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC---HHHHHHHHHhCCc---------CC
Confidence            11  123356778999999998899999999999999999998 788874332   2223333222111         11


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          560 LSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       560 l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      ......   ..+.+++.+||+.+|++|||+.++++.|+.
T Consensus       225 ~~~~~~---~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         225 CPAKCP---QEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             CCCCCC---HHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            111111   234577889999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.9e-38  Score=340.65  Aligned_cols=264  Identities=25%  Similarity=0.352  Sum_probs=205.2

Q ss_pred             hhhhccCCcccCcccccCceEEEEeEecC------CcceeEEEeccCCcc-cHHHHHHHHHHHHhcC-CCCceeeeeeec
Q 006155          319 IRVATDNFSDANKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQ-GDLEFKNEVLLVANLQ-HRNLVRLLGFSL  390 (658)
Q Consensus       319 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~-H~niv~l~~~~~  390 (658)
                      .....++|.+.++||+|+||.||+|+...      +..||||++...... ....+.+|+.++.++. ||||+++++++.
T Consensus        32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~  111 (400)
T cd05105          32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT  111 (400)
T ss_pred             eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence            34557789999999999999999997421      346999999754332 3356889999999996 999999999999


Q ss_pred             cCCceEEEEEecCCCChhhhhcCcC-------------------------------------------------------
Q 006155          391 EGNERLLIYEFVPNTSLDHFIFDPT-------------------------------------------------------  415 (658)
Q Consensus       391 ~~~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------------------------  415 (658)
                      +....+|||||+++|+|.++|+...                                                       
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (400)
T cd05105         112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM  191 (400)
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence            9999999999999999998885321                                                       


Q ss_pred             --------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCce
Q 006155          416 --------------------------------------RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNV  457 (658)
Q Consensus       416 --------------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NI  457 (658)
                                                            ....+++..+++++.||++||.|||+.+   |+||||||+||
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Ni  268 (400)
T cd05105         192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNV  268 (400)
T ss_pred             hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhE
Confidence                                                  0134889999999999999999999987   99999999999


Q ss_pred             eeCCCCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCc
Q 006155          458 LLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETV  536 (658)
Q Consensus       458 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~  536 (658)
                      |++.++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|||++ |..|+......  
T Consensus       269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~--  346 (400)
T cd05105         269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD--  346 (400)
T ss_pred             EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh--
Confidence            999999999999999986644332222333467789999999999999999999999999999997 88887432211  


Q ss_pred             chHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          537 EDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       537 ~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      ..+..    ....+..     +.......   ..+.+++.+||+.+|++||++.+|+++|+..
T Consensus       347 ~~~~~----~~~~~~~-----~~~~~~~~---~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l  397 (400)
T cd05105         347 STFYN----KIKSGYR-----MAKPDHAT---QEVYDIMVKCWNSEPEKRPSFLHLSDIVESL  397 (400)
T ss_pred             HHHHH----HHhcCCC-----CCCCccCC---HHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence            11111    1111111     11111111   2355788899999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=4e-38  Score=330.44  Aligned_cols=256  Identities=28%  Similarity=0.460  Sum_probs=200.6

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCc----ceeEEEeccCC-cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGA----EIAVKRLSRDS-GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERL  396 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  396 (658)
                      ..+|+..+.||+|+||.||+|+.. +|.    .||||.+.... .....++.+|+.+++.++||||++++|++... ..+
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~   84 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   84 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence            467999999999999999999853 343    38999987543 23455788999999999999999999999865 567


Q ss_pred             EEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccc
Q 006155          397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF  476 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~  476 (658)
                      +|+||+++|+|.+++...  ...+++..+++++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus        85 ~v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          85 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             eeeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence            999999999999998542  345889999999999999999999987   999999999999999999999999999876


Q ss_pred             ccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccc
Q 006155          477 EMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNI  555 (658)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  555 (658)
                      .............++..|+|||++.+..++.++||||||+++|||++ |+.|+....   ..++....    ..+..  .
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~---~~~~~~~~----~~~~~--~  230 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP---ASEISSIL----EKGER--L  230 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHH----hCCCC--C
Confidence            54433222223345678999999999999999999999999999998 888874322   11221111    11110  1


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          556 IDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       556 ~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      ..+.   ...   ..+..++..||+.+|++||++.+++..|...
T Consensus       231 ~~~~---~~~---~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~  268 (316)
T cd05108         231 PQPP---ICT---IDVYMIMVKCWMIDADSRPKFRELIIEFSKM  268 (316)
T ss_pred             CCCC---CCC---HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            1111   111   2355788899999999999999999998754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1e-38  Score=307.85  Aligned_cols=201  Identities=29%  Similarity=0.392  Sum_probs=180.1

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccH---HHHHHHHHHHHhcCCCCceeeeeeeccCCceEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGD---LEFKNEVLLVANLQHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~---~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  397 (658)
                      ..++|+..+.||.|+||.|.+++.+ +|..+|+|++++...-..   +...+|..+|+.+.||.++++.+.+.+.+..+|
T Consensus        42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym  121 (355)
T KOG0616|consen   42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM  121 (355)
T ss_pred             chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence            4578999999999999999999854 477899999987643322   346789999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE  477 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~  477 (658)
                      ||||++||.|..+|+   +.+.++....+.++.+|+.||+|||+.+   |++|||||+|||||.+|.+||+|||+|+...
T Consensus       122 vmeyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~  195 (355)
T KOG0616|consen  122 VMEYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS  195 (355)
T ss_pred             EEeccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec
Confidence            999999999999994   4567999999999999999999999998   9999999999999999999999999998754


Q ss_pred             cCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCC
Q 006155          478 MDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNG  533 (658)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~  533 (658)
                      .     .+.+.+|||.|+|||++....|...+|+|+|||++|||+.|..||...+.
T Consensus       196 ~-----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~  246 (355)
T KOG0616|consen  196 G-----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP  246 (355)
T ss_pred             C-----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence            2     35678999999999999999999999999999999999999999965544

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.7e-38  Score=333.98  Aligned_cols=200  Identities=28%  Similarity=0.377  Sum_probs=174.7

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ..++|+..+.||+|+||.||+++.. +|..+|+|.+..... .....+.+|+.++.+++||||+++++++..++..++||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (331)
T cd06649           3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (331)
T ss_pred             CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence            3578999999999999999999854 577899998876432 23456899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ||+++++|.+++..   ...+++..+..++.|++.||.|||+.+  .|+||||||+|||++.++.+||+|||++..+...
T Consensus        83 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  157 (331)
T cd06649          83 EHMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (331)
T ss_pred             ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence            99999999999843   346899999999999999999999853  3999999999999999999999999998765322


Q ss_pred             CCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCcc
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCF  530 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~  530 (658)
                          ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       158 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~  204 (331)
T cd06649         158 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP  204 (331)
T ss_pred             ----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence                22345789999999999999999999999999999999999999853

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=7.2e-38  Score=319.91  Aligned_cols=256  Identities=28%  Similarity=0.477  Sum_probs=203.3

Q ss_pred             ccCCcccCcccccCceEEEEeEecC----CcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLYD----GAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  397 (658)
                      .++|...+.||+|+||.||+|+...    ...||||.+..... ....+|.+|+.++.+++||||+++++++...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            4678899999999999999998642    35789998875432 334568899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE  477 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~  477 (658)
                      ||||+++++|.+++...  ...+++..+++++.|++.||.|||+.+   |+|+||||+|||+++++.++|+|||+++.+.
T Consensus        83 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          83 ITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            99999999999998542  236899999999999999999999987   9999999999999999999999999998775


Q ss_pred             cCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCccccc
Q 006155          478 MDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNII  556 (658)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  556 (658)
                      ............++..|+|||.+.+..++.++||||||+++|||++ |..|+...   ...++.......+..       
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~---~~~~~~~~~~~~~~~-------  227 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM---SNQDVIKAVEDGYRL-------  227 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC---CHHHHHHHHHcCCCC-------
Confidence            2222222223345678999999999999999999999999999998 88887322   122222222111111       


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          557 DPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       557 dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                       +. .....   ..+.+++.+|++.+|++||++.+|+++|+.
T Consensus       228 -~~-~~~~~---~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~  264 (266)
T cd05033         228 -PP-PMDCP---SALYQLMLDCWQKDRNERPTFSQIVSTLDK  264 (266)
T ss_pred             -CC-CCCCC---HHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence             10 01111   235678889999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=6.1e-39  Score=331.73  Aligned_cols=246  Identities=28%  Similarity=0.427  Sum_probs=202.2

Q ss_pred             cCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      ++|.+.+.||+|.||.||||+. .+.+.||+|.+.+...  +....+.+|++++++++|||||.++++|....+.++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            5788889999999999999984 4578899998876533  334558899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      |+.+ +|..+|.+   ...++++.+..|+.+++.||.|||+..   |+|||+||.||||+.++.+|++|||+|+.+..+ 
T Consensus        82 ~a~g-~L~~il~~---d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-  153 (808)
T KOG0597|consen   82 YAVG-DLFTILEQ---DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-  153 (808)
T ss_pred             hhhh-hHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC-
Confidence            9977 99999943   456999999999999999999999987   999999999999999999999999999977653 


Q ss_pred             CccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCC
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTL  560 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l  560 (658)
                       ......+.|||-|||||+..++.|+..+|.||+|||+||+.+|++||...   ....++.....           ||..
T Consensus       154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~---si~~Lv~~I~~-----------d~v~  218 (808)
T KOG0597|consen  154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR---SITQLVKSILK-----------DPVK  218 (808)
T ss_pred             -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH---HHHHHHHHHhc-----------CCCC
Confidence             33456689999999999999999999999999999999999999999432   22333333222           1111


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          561 SSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       561 ~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ...  ..-..+.++...-++.||..|-|..+++.
T Consensus       219 ~p~--~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  219 PPS--TASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             Ccc--cccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            111  11123445555679999999999999873

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=7.3e-38  Score=323.96  Aligned_cols=260  Identities=27%  Similarity=0.460  Sum_probs=206.4

Q ss_pred             ccCCcccCcccccCceEEEEeEec------CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERL  396 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  396 (658)
                      .++|...+.||+|+||.||++...      ++..+|+|.+..........+.+|++++.+++||||+++++++..++..+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            467888999999999999999742      24568999987665555667999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCcC----------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeE
Q 006155          397 LIYEFVPNTSLDHFIFDPT----------RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPK  466 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~k  466 (658)
                      +||||+++++|.+++....          ....++|..+++++.|++.||+|||+.+   ++||||||+|||+++++.+|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence            9999999999999985321          2235899999999999999999999987   99999999999999999999


Q ss_pred             EeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHH
Q 006155          467 IADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWK  545 (658)
Q Consensus       467 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~  545 (658)
                      |+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.|+....   ..+.+...  
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~---~~~~~~~i--  235 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS---NNEVIECI--  235 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHH--
Confidence            999999986543322222233456788999999999999999999999999999999 888874322   12222221  


Q ss_pred             hccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 006155          546 NWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYS  600 (658)
Q Consensus       546 ~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~  600 (658)
                        ..+....     ......   ..+.+++.+||+.||.+|||+.+|++.|+...
T Consensus       236 --~~~~~~~-----~~~~~~---~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~  280 (288)
T cd05093         236 --TQGRVLQ-----RPRTCP---KEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA  280 (288)
T ss_pred             --HcCCcCC-----CCCCCC---HHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence              2221111     111111   23567888999999999999999999997653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.4e-38  Score=347.34  Aligned_cols=252  Identities=20%  Similarity=0.240  Sum_probs=201.3

Q ss_pred             CCcccCcccccCceEEEEeEec-C-CcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEec
Q 006155          325 NFSDANKLGQGGFGAVYKGRLY-D-GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFV  402 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~-~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  402 (658)
                      .|...+.||+|+||.||++... + +..||+|.+..........+.+|+.+++.++||||+++++++..++..+|||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4888899999999999999743 3 5678888776555444556788999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          403 PNTSLDHFIFDP-TRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       403 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      ++|+|.++|... .....+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999988542 23456899999999999999999999987   99999999999999999999999999987654333


Q ss_pred             ccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCC
Q 006155          482 QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLS  561 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~  561 (658)
                      .......+||++|+|||++.+..++.++||||||+++|||++|+.||....   ..+++.....    +...    + ..
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~---~~~~~~~~~~----~~~~----~-~~  292 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS---QREIMQQVLY----GKYD----P-FP  292 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHh----CCCC----C-CC
Confidence            223445679999999999999999999999999999999999999984322   2222222221    1110    1 11


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          562 SGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       562 ~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ....   ..+.+++..||+.+|++||++.+++.
T Consensus       293 ~~~s---~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        293 CPVS---SGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             ccCC---HHHHHHHHHHhccChhhCcCHHHHHh
Confidence            1111   23556778999999999999999864

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-39  Score=332.17  Aligned_cols=260  Identities=26%  Similarity=0.389  Sum_probs=209.3

Q ss_pred             hhhhhhccCCcccCcccccCceEEEEeEecC-CcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCce
Q 006155          317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNER  395 (658)
Q Consensus       317 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  395 (658)
                      +.++....+....++||-|.||.||.|.++. .-.||||.++.+. ....+|..|..+|+.++|||+|+|+|+|..+...
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            4556666777888999999999999999765 5679999998765 4566899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      |+|.|||..|+|.+||... ++..++-..++.++.||+.||+||..++   +|||||.++|+|+.++..+||+||||+++
T Consensus       339 YIiTEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             EEEEecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence            9999999999999999653 4456788889999999999999999988   99999999999999999999999999999


Q ss_pred             cccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          476 FEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      +..+.... .....-.+.|.|||-+....++.|+|||+|||+||||.| |..|+...   +..++....-+.++..... 
T Consensus       415 MtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi---dlSqVY~LLEkgyRM~~Pe-  489 (1157)
T KOG4278|consen  415 MTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI---DLSQVYGLLEKGYRMDGPE-  489 (1157)
T ss_pred             hcCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc---cHHHHHHHHhccccccCCC-
Confidence            87654322 222334678999999999999999999999999999988 55565322   2222222222222221111 


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 006155          555 IIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN  597 (658)
Q Consensus       555 ~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~  597 (658)
                              ..++   ++.++++.||+.+|.+||++.|+.+.++
T Consensus       490 --------GCPp---kVYeLMraCW~WsPsDRPsFaeiHqafE  521 (1157)
T KOG4278|consen  490 --------GCPP---KVYELMRACWNWSPSDRPSFAEIHQAFE  521 (1157)
T ss_pred             --------CCCH---HHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence                    1222   4566788999999999999999988774

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=5.4e-38  Score=332.26  Aligned_cols=261  Identities=28%  Similarity=0.407  Sum_probs=201.6

Q ss_pred             hhccCCcccCcccccCceEEEEeEec------CCcceeEEEeccCCcc-cHHHHHHHHHHHHhc-CCCCceeeeeeecc-
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRDSGQ-GDLEFKNEVLLVANL-QHRNLVRLLGFSLE-  391 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l-~H~niv~l~~~~~~-  391 (658)
                      +..++|++.+.||+|+||.||+|+..      .++.||+|++...... ....+..|+.++.++ +|+||+++++++.. 
T Consensus         4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054           4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            44568999999999999999999632      2468999998754322 234577899999999 79999999998764 


Q ss_pred             CCceEEEEEecCCCChhhhhcCcCC-------------------------------------------------------
Q 006155          392 GNERLLIYEFVPNTSLDHFIFDPTR-------------------------------------------------------  416 (658)
Q Consensus       392 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------  416 (658)
                      +...++++||+++++|.+++.....                                                       
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence            4567899999999999998853211                                                       


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCcccccccccccc
Q 006155          417 ---RAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG  493 (658)
Q Consensus       417 ---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~  493 (658)
                         ...++|..+.+++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.............++..
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence               136899999999999999999999987   99999999999999999999999999987644333223334456788


Q ss_pred             ccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHH
Q 006155          494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCI  572 (658)
Q Consensus       494 y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~  572 (658)
                      |+|||++.+..++.++|||||||++|||++ |+.|+......   +.+..   ....+...     ......   ...+.
T Consensus       241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~---~~~~~---~~~~~~~~-----~~~~~~---~~~~~  306 (337)
T cd05054         241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID---EEFCR---RLKEGTRM-----RAPEYA---TPEIY  306 (337)
T ss_pred             ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc---HHHHH---HHhccCCC-----CCCccC---CHHHH
Confidence            999999999999999999999999999998 98887532211   11111   11111110     011111   12456


Q ss_pred             HHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          573 HIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       573 ~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      +++.+||+.+|++||++.||+++|+.
T Consensus       307 ~l~~~cl~~~p~~RPs~~ell~~l~~  332 (337)
T cd05054         307 SIMLDCWHNNPEDRPTFSELVEILGD  332 (337)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHH
Confidence            78889999999999999999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-37  Score=323.65  Aligned_cols=263  Identities=26%  Similarity=0.407  Sum_probs=200.5

Q ss_pred             ccCCcccCcccccCceEEEEeEecC-------------C--cceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeee
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLYD-------------G--AEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLL  386 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~~-------------g--~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~  386 (658)
                      .++|+..++||+|+||.||+++..+             +  ..||+|.+..... .....+.+|++++.+++|+||++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            4678899999999999999987432             1  2489999876432 2344688999999999999999999


Q ss_pred             eeeccCCceEEEEEecCCCChhhhhcCcC---------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCce
Q 006155          387 GFSLEGNERLLIYEFVPNTSLDHFIFDPT---------RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNV  457 (658)
Q Consensus       387 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NI  457 (658)
                      +++..++..++||||+++++|.+++....         ....++|..+++++.++++||.|||+.+   ++||||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence            99999999999999999999999985421         1124789999999999999999999987   99999999999


Q ss_pred             eeCCCCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhC--CCCCccCCCCC
Q 006155          458 LLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG--QRNNCFRNGET  535 (658)
Q Consensus       458 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG--~~p~~~~~~~~  535 (658)
                      +++.++.+||+|||++..+.............++..|+|||++.++.++.++||||||+++|||+++  ..|+....   
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~---  237 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS---  237 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC---
Confidence            9999999999999999765433222222334557889999999999999999999999999999984  44553222   


Q ss_pred             cchHHHHHHHhccCC-CcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 006155          536 VEDLLSSAWKNWREG-TTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN  597 (658)
Q Consensus       536 ~~~l~~~~~~~~~~~-~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~  597 (658)
                      ..+.+......+... .......+..   ..   ..+.+++.+|++.+|++||+|.+|++.|.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~---~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         238 DEQVIENTGEFFRNQGRQIYLSQTPL---CP---SPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             hHHHHHHHHHhhhhccccccCCCCCC---CC---HHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            222332222222211 1111111111   11   24667889999999999999999999985

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1e-37  Score=321.81  Aligned_cols=257  Identities=27%  Similarity=0.420  Sum_probs=201.9

Q ss_pred             cCCcccCcccccCceEEEEeEe-----cCCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRL-----YDGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  397 (658)
                      ++|+..+.||+|+||.||+|+.     ..+..|++|.+..... +...++.+|+.++++++||||+++++++..++..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            5677889999999999999974     2457899999875432 333568899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcC--------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCC
Q 006155          398 IYEFVPNTSLDHFIFDPT--------------RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM  463 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~  463 (658)
                      ||||+++++|.+++....              ....+++...+.++.+++.||.|||+.+   ++||||||+|||++.++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            999999999999985321              1235889999999999999999999987   99999999999999999


Q ss_pred             CeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHH
Q 006155          464 TPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSS  542 (658)
Q Consensus       464 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~  542 (658)
                      .+||+|||+++...............++..|+|||++.++.++.++||||||+++|||++ |..|+....   ...+...
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~---~~~~~~~  238 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS---NQEVIEM  238 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC---HHHHHHH
Confidence            999999999986644332222333456778999999998899999999999999999999 888874322   1222222


Q ss_pred             HHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          543 AWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       543 ~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      ..    .....     ........   .+.+++..|++.+|++||++.+|.++|..
T Consensus       239 ~~----~~~~~-----~~~~~~~~---~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         239 VR----KRQLL-----PCSEDCPP---RMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HH----cCCcC-----CCCCCCCH---HHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            21    11111     11111122   34567789999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.2e-37  Score=321.37  Aligned_cols=264  Identities=27%  Similarity=0.395  Sum_probs=205.5

Q ss_pred             ccCCcccCcccccCceEEEEeEecC-----------------CcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCcee
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLYD-----------------GAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVR  384 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----------------g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~  384 (658)
                      .++|+..++||+|+||.||+++..+                 +..||+|++..... ....++.+|+.++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4678899999999999999987532                 24589999876543 34456889999999999999999


Q ss_pred             eeeeeccCCceEEEEEecCCCChhhhhcCcC--------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCc
Q 006155          385 LLGFSLEGNERLLIYEFVPNTSLDHFIFDPT--------RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSN  456 (658)
Q Consensus       385 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~N  456 (658)
                      +++++..++..++++||+++++|.+++....        ....+++..++.++.|++.||.|||+.+   ++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            9999999999999999999999999985432        1236899999999999999999999987   9999999999


Q ss_pred             eeeCCCCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh--CCCCCccCCCC
Q 006155          457 VLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS--GQRNNCFRNGE  534 (658)
Q Consensus       457 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt--G~~p~~~~~~~  534 (658)
                      |+++.++.++|+|||+++...............++..|+|||++.++.++.++||||||+++|||++  |..|+...   
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~---  237 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL---  237 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc---
Confidence            9999999999999999986544333223334567789999999998899999999999999999998  45555322   


Q ss_pred             CcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 006155          535 TVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN  597 (658)
Q Consensus       535 ~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~  597 (658)
                      ...+.+......+.........+ . .....   ..+.+++.+|++.+|++|||+.+|++.|+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~---~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         238 TDQQVIENAGHFFRDDGRQIYLP-R-PPNCP---KDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             ChHHHHHHHHhccccccccccCC-C-ccCCC---HHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            22333343333322222111111 0 01111   34667889999999999999999999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1e-37  Score=323.45  Aligned_cols=264  Identities=28%  Similarity=0.400  Sum_probs=206.1

Q ss_pred             hhhhhccCCcccCcccccCceEEEEeEecC------CcceeEEEeccCC-cccHHHHHHHHHHHHhc-CCCCceeeeeee
Q 006155          318 TIRVATDNFSDANKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDS-GQGDLEFKNEVLLVANL-QHRNLVRLLGFS  389 (658)
Q Consensus       318 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~  389 (658)
                      ++.+..++|+..+.||+|+||.||++...+      ...+|+|.+.... .....++.+|+.++.++ +|+||+++++++
T Consensus         6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   85 (293)
T cd05053           6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC   85 (293)
T ss_pred             ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            345566788999999999999999998532      3578999887542 23345688999999999 799999999999


Q ss_pred             ccCCceEEEEEecCCCChhhhhcCc-------------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCc
Q 006155          390 LEGNERLLIYEFVPNTSLDHFIFDP-------------TRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSN  456 (658)
Q Consensus       390 ~~~~~~~lv~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~N  456 (658)
                      ..+...+++|||+++|+|..++...             .....++|..+++++.|++.||.|||+.+   |+||||||+|
T Consensus        86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~N  162 (293)
T cd05053          86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARN  162 (293)
T ss_pred             cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceee
Confidence            9999999999999999999998532             22456899999999999999999999987   9999999999


Q ss_pred             eeeCCCCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCC
Q 006155          457 VLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGET  535 (658)
Q Consensus       457 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~  535 (658)
                      ||++.++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|||++ |..|+....   
T Consensus       163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---  239 (293)
T cd05053         163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP---  239 (293)
T ss_pred             EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC---
Confidence            9999999999999999987654332222223345678999999999999999999999999999998 888874322   


Q ss_pred             cchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          536 VEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       536 ~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      ..++....    ..+...     ......   ...+.+++..|++.+|++|||+.+|++.|+..
T Consensus       240 ~~~~~~~~----~~~~~~-----~~~~~~---~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         240 VEELFKLL----KEGYRM-----EKPQNC---TQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             HHHHHHHH----HcCCcC-----CCCCCC---CHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence            12222211    111110     111111   23456788999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-37  Score=317.05  Aligned_cols=256  Identities=25%  Similarity=0.384  Sum_probs=199.4

Q ss_pred             CcccCcccccCceEEEEeEecC----CcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCc-----
Q 006155          326 FSDANKLGQGGFGAVYKGRLYD----GAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNE-----  394 (658)
Q Consensus       326 ~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-----  394 (658)
                      |.+.+.||+|+||.||+|+...    +..||||++.....  .....+.+|+..++.++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            4667899999999999998643    36799999875432  233568899999999999999999998876554     


Q ss_pred             -eEEEEEecCCCChhhhhcCcC---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecc
Q 006155          395 -RLLIYEFVPNTSLDHFIFDPT---RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADF  470 (658)
Q Consensus       395 -~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DF  470 (658)
                       .++++||+++++|..++....   ....+++..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             789999999999999885432   2346899999999999999999999987   999999999999999999999999


Q ss_pred             ccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccC
Q 006155          471 GMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWRE  549 (658)
Q Consensus       471 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~  549 (658)
                      |+++.+.............++..|+|||++....++.++||||||+++|||++ |..|+....   ..++.......   
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~---~~~~~~~~~~~---  231 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE---NHEIYDYLRHG---  231 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcC---
Confidence            99987654333222222345678999999988899999999999999999999 777774322   22333333221   


Q ss_pred             CCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          550 GTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       550 ~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                       ...     ......   ...+.+++..||+.||.+||++.||++.|+..
T Consensus       232 -~~~-----~~~~~~---~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         232 -NRL-----KQPEDC---LDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             -CCC-----CCCcCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence             111     111111   22456777899999999999999999999753

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6.6e-38  Score=347.02  Aligned_cols=261  Identities=21%  Similarity=0.283  Sum_probs=204.4

Q ss_pred             hhhhhhccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeeccCC
Q 006155          317 NTIRVATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGN  393 (658)
Q Consensus       317 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  393 (658)
                      .+.+...++|...+.||+|+||+||+++. .+|+.||||++....  ......+.+|+..+..++|+||+++...+...+
T Consensus        25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~  104 (496)
T PTZ00283         25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD  104 (496)
T ss_pred             ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence            34445568999999999999999999974 468999999986543  233445788999999999999999987765432


Q ss_pred             --------ceEEEEEecCCCChhhhhcCcC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCC
Q 006155          394 --------ERLLIYEFVPNTSLDHFIFDPT-RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMT  464 (658)
Q Consensus       394 --------~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~  464 (658)
                              ..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.
T Consensus       105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~  181 (496)
T PTZ00283        105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGL  181 (496)
T ss_pred             ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCC
Confidence                    3579999999999999986432 2356899999999999999999999987   999999999999999999


Q ss_pred             eEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHH
Q 006155          465 PKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAW  544 (658)
Q Consensus       465 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~  544 (658)
                      +||+|||+++.+.............||+.|+|||++.+..++.++||||||+++|||++|+.||...   ...+++....
T Consensus       182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~---~~~~~~~~~~  258 (496)
T PTZ00283        182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE---NMEEVMHKTL  258 (496)
T ss_pred             EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHh
Confidence            9999999998765433333344568999999999999999999999999999999999999998532   2222222221


Q ss_pred             HhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          545 KNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       545 ~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                      .    +...     .+.....+   .+.+++..||+.||.+||++.+++..
T Consensus       259 ~----~~~~-----~~~~~~~~---~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        259 A----GRYD-----PLPPSISP---EMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             c----CCCC-----CCCCCCCH---HHHHHHHHHcccChhhCcCHHHHHhC
Confidence            1    1111     11112222   34567789999999999999999864

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.1e-37  Score=329.51  Aligned_cols=200  Identities=27%  Similarity=0.381  Sum_probs=173.8

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ..++|+..++||+|+||.||+++.. ++..+|+|.+..... .....+.+|+.++.+++||||+++++++.+++..++||
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence            4578999999999999999999865 577889998876432 23356889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ||+++++|.+++..   ...+++.....++.+++.||.|||+.+  .|+||||||+|||++.++.+||+|||++..+...
T Consensus        83 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~  157 (333)
T cd06650          83 EHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (333)
T ss_pred             ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence            99999999999843   346899999999999999999999753  3999999999999999999999999998755322


Q ss_pred             CCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCcc
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCF  530 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~  530 (658)
                          ......||..|+|||++.+..++.++|||||||++|||++|+.|+..
T Consensus       158 ----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         158 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             ----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence                12235789999999999988999999999999999999999999854

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.1e-37  Score=322.36  Aligned_cols=264  Identities=20%  Similarity=0.249  Sum_probs=198.6

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      ++|+..+.||+|+||.||+++.. +++.||||++....  ......+.+|+.++..++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46888999999999999999865 57889999987542  2234467899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      |++++++..+..   ....+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+++.+....
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            999988776542   2346899999999999999999999987   9999999999999999999999999998764322


Q ss_pred             CccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHH--------HHHhc-cCCC
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSS--------AWKNW-REGT  551 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~--------~~~~~-~~~~  551 (658)
                      . .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+..        .++.+ ....
T Consensus       155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07848         155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR  233 (287)
T ss_pred             c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence            1 122345789999999999998999999999999999999999999854322111000000        00100 0000


Q ss_pred             cccccCCCCCCC-CHH------HHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          552 TVNIIDPTLSSG-SIT------EMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       552 ~~~~~dp~l~~~-~~~------e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ......|..... ...      .-..+.+++..||+.||++|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            001111111110 000      0123668888999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.6e-37  Score=315.62  Aligned_cols=252  Identities=25%  Similarity=0.411  Sum_probs=201.0

Q ss_pred             cCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecC
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVP  403 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~  403 (658)
                      ++|...+.||+|+||.||+++..++..+|||.+.... ....++.+|+.++.+++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            5677888999999999999987777789999887543 345678999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCcc
Q 006155          404 NTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQG  483 (658)
Q Consensus       404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  483 (658)
                      +++|.+++...  ...++|..+++++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||+++........ 
T Consensus        83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05113          83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-  156 (256)
T ss_pred             CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence            99999998542  236899999999999999999999987   999999999999999999999999998765433211 


Q ss_pred             ccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCC
Q 006155          484 NTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSS  562 (658)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~  562 (658)
                      ......++..|+|||++.++.++.++||||||+++|||++ |+.|+.....   .+.......    +.....  +.   
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~----~~~~~~--~~---  224 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN---SETVEKVSQ----GLRLYR--PH---  224 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHHHhc----CCCCCC--CC---
Confidence            1112345678999999998899999999999999999999 8888743221   122222211    111000  11   


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 006155          563 GSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN  597 (658)
Q Consensus       563 ~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~  597 (658)
                      ..   ...+.+++..||+.+|++||++.+|++.|+
T Consensus       225 ~~---~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         225 LA---SEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CC---CHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            11   234567888999999999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.1e-37  Score=332.38  Aligned_cols=248  Identities=25%  Similarity=0.341  Sum_probs=192.0

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      .++|+..++||+|+||.||+++.. +|+.||||++..... .....+.+|+.+++.++|+||+++++++..++..++|||
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  152 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE  152 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence            456777889999999999999854 588999999865432 234568899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      |+++++|....       ..++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+....
T Consensus       153 ~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~  222 (353)
T PLN00034        153 FMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM  222 (353)
T ss_pred             cCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence            99999986532       3567788899999999999999987   9999999999999999999999999998764322


Q ss_pred             CccccccccccccccCcccccc-----CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccc
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMH-----GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNI  555 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  555 (658)
                      .  ......||..|+|||++..     ...+.++|||||||++|||++|+.||......+...+......    ..    
T Consensus       223 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~----~~----  292 (353)
T PLN00034        223 D--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM----SQ----  292 (353)
T ss_pred             c--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhc----cC----
Confidence            1  2234579999999998743     2245689999999999999999999863332222222111110    00    


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          556 IDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       556 ~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                       .+.......   ..+.+++..||+.||++||++.||++
T Consensus       293 -~~~~~~~~~---~~l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        293 -PPEAPATAS---REFRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             -CCCCCCccC---HHHHHHHHHHccCChhhCcCHHHHhc
Confidence             011111111   23556778999999999999999986

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-38  Score=328.69  Aligned_cols=244  Identities=22%  Similarity=0.270  Sum_probs=196.3

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ++|+..+.||+|+||.||+++.. +|+.||+|++....   ......+.+|+.++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46888999999999999999854 58899999986532   123445789999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ||+++|+|.+++..   ...+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            99999999999843   356899999999999999999999988   999999999999999999999999999865322


Q ss_pred             CCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCC
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT  559 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~  559 (658)
                           .....||+.|+|||++.+..++.++||||||+++|||++|+.||....   ...+......    +.      +.
T Consensus       155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~---~~~~~~~i~~----~~------~~  216 (291)
T cd05612         155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN---PFGIYEKILA----GK------LE  216 (291)
T ss_pred             -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHh----CC------cC
Confidence                 223578999999999999899999999999999999999999985322   2222222111    11      01


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 006155          560 LSSGSITEMIRCIHIGLLCVQENVASRPT-----MASVVL  594 (658)
Q Consensus       560 l~~~~~~e~~~~~~i~~~Cl~~~p~~RPt-----m~evv~  594 (658)
                      +......   .+.+++..||+.||.+||+     +.++++
T Consensus       217 ~~~~~~~---~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         217 FPRHLDL---YAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             CCccCCH---HHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence            1111111   2446777999999999995     777663

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.7e-38  Score=323.24  Aligned_cols=266  Identities=26%  Similarity=0.356  Sum_probs=198.3

Q ss_pred             CcccCcccccCceEEEEeE-----ecCCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccC--CceEE
Q 006155          326 FSDANKLGQGGFGAVYKGR-----LYDGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEG--NERLL  397 (658)
Q Consensus       326 ~~~~~~lG~G~fg~Vy~~~-----~~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~l  397 (658)
                      |...+.||+|+||+||++.     ..++..||+|.+..... .....+.+|+.++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            3788999999999998764     23577899999876532 3455688999999999999999999987653  45789


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE  477 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~  477 (658)
                      ||||+++++|.+++..    ..++|..++.++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+.
T Consensus        86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence            9999999999999843    35899999999999999999999987   9999999999999999999999999998765


Q ss_pred             cCCCcc-ccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccccc
Q 006155          478 MDETQG-NTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNII  556 (658)
Q Consensus       478 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  556 (658)
                      ...... ......++..|+|||.+....++.++||||||+++|||++|+.|+..... ...+...............+.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPK-KFEEMIGPKQGQMTVVRLIELL  237 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcc-hhhhhhcccccccchhhhhhhh
Confidence            432211 11223456679999999988999999999999999999999998743221 1111111111111111111111


Q ss_pred             CCCCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          557 DPTLSSG-SITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       557 dp~l~~~-~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      +...... .......+.+++..||+.+|++|||+.+|+++|+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            1111100 001113455778899999999999999999999753

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.2e-37  Score=327.73  Aligned_cols=241  Identities=22%  Similarity=0.244  Sum_probs=192.0

Q ss_pred             CcccccCceEEEEeEe-cCCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecCCC
Q 006155          330 NKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNT  405 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g  405 (658)
                      +.||+|+||.||+++. .+|+.||||++....   ......+.+|+.++.+++||||+++++++..++..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999985 468899999987542   222345778999999999999999999999999999999999999


Q ss_pred             ChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCcccc
Q 006155          406 SLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNT  485 (658)
Q Consensus       406 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  485 (658)
                      +|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~  152 (323)
T cd05571          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATM  152 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcc
Confidence            99988843   456899999999999999999999988   999999999999999999999999998753221  1123


Q ss_pred             ccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCCH
Q 006155          486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSI  565 (658)
Q Consensus       486 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~  565 (658)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||....   ...+......    +.      ..+.....
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~~~~~~----~~------~~~p~~~~  219 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELILM----EE------IRFPRTLS  219 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC---HHHHHHHHHc----CC------CCCCCCCC
Confidence            34679999999999999999999999999999999999999984322   2222222211    11      11111222


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 006155          566 TEMIRCIHIGLLCVQENVASRP-----TMASVVL  594 (658)
Q Consensus       566 ~e~~~~~~i~~~Cl~~~p~~RP-----tm~evv~  594 (658)
                      .   .+.+++..||+.||++||     ++.++++
T Consensus       220 ~---~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         220 P---EAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             H---HHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            2   244667799999999999     7888874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1e-37  Score=321.36  Aligned_cols=256  Identities=29%  Similarity=0.440  Sum_probs=198.5

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCc----ceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGA----EIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERL  396 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  396 (658)
                      .++|+..+.||+|+||.||+|+.. +|+    .+++|.+..... ....++..|+..+.+++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~   84 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ   84 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence            357888899999999999999853 344    477887754432 233567888889999999999999998864 4578


Q ss_pred             EEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccc
Q 006155          397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF  476 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~  476 (658)
                      +++||+++|+|.+++..  ....++|..++.|+.||+.||.|||+.+   ++||||||+|||+++++.+||+|||+++.+
T Consensus        85 ~i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          85 LVTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLL  159 (279)
T ss_pred             EEEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceec
Confidence            89999999999999954  2346899999999999999999999987   999999999999999999999999999876


Q ss_pred             ccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccc
Q 006155          477 EMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNI  555 (658)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  555 (658)
                      .............++..|+|||++.++.++.++||||||+++|||++ |+.|+......   ..... .   ..+..  .
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~~~~-~---~~~~~--~  230 (279)
T cd05111         160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH---EVPDL-L---EKGER--L  230 (279)
T ss_pred             cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH-H---HCCCc--C
Confidence            54333223334567789999999999999999999999999999998 88887433221   11111 1   11111  1


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          556 IDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       556 ~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      ..+..   ..   ..+..++..||+.+|++|||+.|+++.|...
T Consensus       231 ~~~~~---~~---~~~~~li~~c~~~~p~~Rps~~el~~~l~~~  268 (279)
T cd05111         231 AQPQI---CT---IDVYMVMVKCWMIDENVRPTFKELANEFTRM  268 (279)
T ss_pred             CCCCC---CC---HHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            11111   11   2345677899999999999999999998763

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.1e-37  Score=315.97  Aligned_cols=255  Identities=27%  Similarity=0.399  Sum_probs=202.6

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      ..+|...++||+|+||.||+|... .++.||+|.+... .....++.+|+.++..++|+||+++++++..++..++||||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   83 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence            456788899999999999999854 4788999988654 33456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      +++++|.+++... ....+++..++.++.|+++||.|||+.+   ++||||||+|||+++++.+||+|||+++.......
T Consensus        84 ~~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          84 MTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             CCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence            9999999998542 2346899999999999999999999987   99999999999999999999999999986543321


Q ss_pred             ccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCC
Q 006155          482 QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTL  560 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l  560 (658)
                      . ......++..|+|||++.+..++.++||||||+++|||++ |..|+...   ...++.    .....+.     .+..
T Consensus       160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~---~~~~~~----~~~~~~~-----~~~~  226 (263)
T cd05052         160 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI---DLSQVY----ELLEKGY-----RMER  226 (263)
T ss_pred             e-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC---CHHHHH----HHHHCCC-----CCCC
Confidence            1 1112334678999999999999999999999999999998 88887432   222222    2211111     1111


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          561 SSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       561 ~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      ......   .+.+++.+||+.+|++||++.+++++|+.
T Consensus       227 ~~~~~~---~~~~li~~cl~~~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         227 PEGCPP---KVYELMRACWQWNPSDRPSFAEIHQAFET  261 (263)
T ss_pred             CCCCCH---HHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence            111222   34567789999999999999999999975

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-38  Score=333.27  Aligned_cols=253  Identities=23%  Similarity=0.340  Sum_probs=199.1

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ++|...+.||+|+||.||+++.. +|+.||||++....   ......+.+|+.++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46888999999999999999854 58899999987542   233456889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            99999999999854   256899999999999999999999987   999999999999999999999999999866443


Q ss_pred             C---------------------------CccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCC
Q 006155          480 E---------------------------TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRN  532 (658)
Q Consensus       480 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~  532 (658)
                      .                           .........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            2                           0012234579999999999999999999999999999999999999985432


Q ss_pred             CCCcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHH
Q 006155          533 GETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPT-MASVVLM  595 (658)
Q Consensus       533 ~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPt-m~evv~~  595 (658)
                      .   ........ .|...    +.-|... ....+   +.+++..|++ +|.+||+ +.++++.
T Consensus       235 ~---~~~~~~i~-~~~~~----~~~p~~~-~~~~~---~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         235 L---QETYNKII-NWKES----LRFPPDP-PVSPE---AIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             H---HHHHHHHh-ccCCc----ccCCCCC-CCCHH---HHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            1   11111111 11111    1111111 01223   3355567887 9999999 9999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=8.4e-38  Score=329.86  Aligned_cols=244  Identities=24%  Similarity=0.275  Sum_probs=196.8

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  398 (658)
                      .++|...+.||+|+||.||+++.. +|+.||||.+....   ......+.+|+.++.+++||||+++++++.+++..++|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            367888999999999999999864 57889999986532   22344688999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccccc
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~  478 (658)
                      |||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        97 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         97 LEFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             EcCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            999999999999843   346889999999999999999999988   99999999999999999999999999986533


Q ss_pred             CCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCC
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP  558 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp  558 (658)
                      .     .....||+.|+|||++.+..++.++|||||||++|||++|+.||....   .......    ..++..      
T Consensus       171 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~----i~~~~~------  232 (329)
T PTZ00263        171 R-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT---PFRIYEK----ILAGRL------  232 (329)
T ss_pred             C-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC---HHHHHHH----HhcCCc------
Confidence            2     223579999999999999999999999999999999999999984322   1122221    112211      


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHH
Q 006155          559 TLSSGSITEMIRCIHIGLLCVQENVASRPT-----MASVV  593 (658)
Q Consensus       559 ~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPt-----m~evv  593 (658)
                      .+......   ++.+++..||+.||.+||+     +.+++
T Consensus       233 ~~p~~~~~---~~~~li~~~L~~dP~~R~~~~~~~~~~ll  269 (329)
T PTZ00263        233 KFPNWFDG---RARDLVKGLLQTDHTKRLGTLKGGVADVK  269 (329)
T ss_pred             CCCCCCCH---HHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence            11111111   3456778999999999997     67766

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.5e-38  Score=330.55  Aligned_cols=247  Identities=26%  Similarity=0.355  Sum_probs=205.5

Q ss_pred             cCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCc---ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSG---QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      .-|...+.||+|+-|.|-.|+. ..|+.+|||++.....   .....+.+|+.+|+-+.||||+++++++.+..++|||.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            3467788999999999999984 4699999999976522   22345789999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ||+++|-|.+++.   .++.+++.+..+++.||+.|+.|+|..+   |+||||||+|+|||.++++||+|||+|-+-..+
T Consensus        92 Eyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g  165 (786)
T KOG0588|consen   92 EYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG  165 (786)
T ss_pred             EecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence            9999999999994   5678999999999999999999999987   999999999999999999999999999764332


Q ss_pred             CCccccccccccccccCccccccCCCC-cccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCC
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMHGQYS-VKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP  558 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp  558 (658)
                         ....+.+|.+.|.+||++++.+|. .++||||.|||||.|+||+.||+   ++....++..+.+..-          
T Consensus       166 ---klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd---DdNir~LLlKV~~G~f----------  229 (786)
T KOG0588|consen  166 ---KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD---DDNIRVLLLKVQRGVF----------  229 (786)
T ss_pred             ---ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC---CccHHHHHHHHHcCcc----------
Confidence               234557999999999999999986 58999999999999999999995   4556666666554311          


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          559 TLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       559 ~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                      .+......+.   .+++..++..||++|.|++||++.
T Consensus       230 ~MPs~Is~ea---QdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  230 EMPSNISSEA---QDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             cCCCcCCHHH---HHHHHHHhccCccccccHHHHhhC
Confidence            1112222233   345557899999999999999864

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.3e-37  Score=320.97  Aligned_cols=257  Identities=27%  Similarity=0.448  Sum_probs=201.1

Q ss_pred             cCCcccCcccccCceEEEEeEecC------CcceeEEEeccCCccc-HHHHHHHHHHHHhcCCCCceeeeeeeccCCceE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQG-DLEFKNEVLLVANLQHRNLVRLLGFSLEGNERL  396 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  396 (658)
                      .+|...++||+|+||.||+|+..+      +..||||++....... ...+.+|+.++..++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            457778899999999999998532      4679999997554322 345889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCc-------------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCC
Q 006155          397 LIYEFVPNTSLDHFIFDP-------------TRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM  463 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~  463 (658)
                      +++||+++++|.+++...             .....+++..+++++.|++.||.|||+.+   |+||||||+|||+++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence            999999999999998421             11345899999999999999999999987   99999999999999999


Q ss_pred             CeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHH
Q 006155          464 TPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSS  542 (658)
Q Consensus       464 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~  542 (658)
                      .+||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |..|+....   ..++...
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~---~~~~~~~  238 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS---NQDVIEM  238 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHH
Confidence            999999999886543322222333456789999999998999999999999999999998 777764321   2222222


Q ss_pred             HHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          543 AWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       543 ~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      .    ..+...     ........+   +.+++..||+.+|++||++.+|++.|+.
T Consensus       239 i----~~~~~~-----~~~~~~~~~---~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         239 I----RNRQVL-----PCPDDCPAW---VYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             H----HcCCcC-----CCCCCCCHH---HHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            1    111111     111222233   4467789999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.9e-37  Score=316.33  Aligned_cols=255  Identities=25%  Similarity=0.385  Sum_probs=195.3

Q ss_pred             CcccCcccccCceEEEEeEecCCc---ceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeeccC------Cc
Q 006155          326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEG------NE  394 (658)
Q Consensus       326 ~~~~~~lG~G~fg~Vy~~~~~~g~---~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~  394 (658)
                      |.+.++||+|+||.||+|+..+..   .+|+|.++...  ......+.+|+.++..++|+||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            345688999999999999865433   58999886542  33345688999999999999999999987532      24


Q ss_pred             eEEEEEecCCCChhhhhcCc---CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccc
Q 006155          395 RLLIYEFVPNTSLDHFIFDP---TRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFG  471 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFG  471 (658)
                      .++++||+++|+|.+++...   .....++|...+.++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence            68999999999999887422   12345899999999999999999999987   9999999999999999999999999


Q ss_pred             cccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCC
Q 006155          472 MARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREG  550 (658)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~  550 (658)
                      +++.+.............+++.|+|||++.+..++.++||||||+++|||++ |+.|+...   ....+....    ..+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~---~~~~~~~~~----~~~  230 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV---ENSEIYDYL----RQG  230 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC---CHHHHHHHH----HcC
Confidence            9987654322112222346778999999999999999999999999999999 77777432   122222222    222


Q ss_pred             CcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          551 TTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       551 ~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      ....     ......   ..+.+++.+||+.+|++|||+.++++.|+.
T Consensus       231 ~~~~-----~~~~~~---~~~~~li~~~l~~~p~~Rps~~~l~~~l~~  270 (272)
T cd05075         231 NRLK-----QPPDCL---DGLYSLMSSCWLLNPKDRPSFETLRCELEK  270 (272)
T ss_pred             CCCC-----CCCCCC---HHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            1111     111111   235578889999999999999999999975

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.8e-37  Score=319.40  Aligned_cols=262  Identities=23%  Similarity=0.363  Sum_probs=205.3

Q ss_pred             hhccCCcccCcccccCceEEEEeEecC-----CcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeecc-CC
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLYD-----GAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLE-GN  393 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~-----g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~  393 (658)
                      +..++|...+.||+|+||.||+|...+     +..|++|++..... .....+.+|+.++.+++|+||+++++++.. +.
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            456788999999999999999998665     67899998875432 234558899999999999999999998766 56


Q ss_pred             ceEEEEEecCCCChhhhhcCcCCC-----CCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEe
Q 006155          394 ERLLIYEFVPNTSLDHFIFDPTRR-----AQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIA  468 (658)
Q Consensus       394 ~~~lv~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~  468 (658)
                      ..++++||+++++|.+++......     ..+++..++.++.+|+.||+|||+.+   ++||||||+||++++++.+||+
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEEC
Confidence            789999999999999998543222     56899999999999999999999987   9999999999999999999999


Q ss_pred             ccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhc
Q 006155          469 DFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNW  547 (658)
Q Consensus       469 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~  547 (658)
                      |||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.|+....   ..++....    
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---~~~~~~~~----  232 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID---PFEMAAYL----  232 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC---HHHHHHHH----
Confidence            9999986644332222223356778999999998899999999999999999999 998884322   22222211    


Q ss_pred             cCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 006155          548 REGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYS  600 (658)
Q Consensus       548 ~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~  600 (658)
                      ..+..     +.......+   .+.+++.+||+.+|++|||+.+|+++|+...
T Consensus       233 ~~~~~-----~~~~~~~~~---~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         233 KDGYR-----LAQPINCPD---ELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             HcCCC-----CCCCCcCCH---HHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            11110     011111122   3557888999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1e-37  Score=322.92  Aligned_cols=260  Identities=22%  Similarity=0.318  Sum_probs=196.1

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      ++|...++||+|+||.||+|+.. ++..||+|++..... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            56888999999999999999854 578899999865432 2344678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      +++ +|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            975 88888743  2345789999999999999999999987   99999999999999999999999999976432221


Q ss_pred             ccccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCC----------
Q 006155          482 QGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREG----------  550 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~----------  550 (658)
                        ......|++.|+|||++.+ ..++.++||||+|+++|||++|+.||.....   .+.+..........          
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07871         159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV---KEELHLIFRLLGTPTEETWPGITS  233 (288)
T ss_pred             --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCChHHhhcccc
Confidence              2233578999999998865 5689999999999999999999999854322   22222221111100          


Q ss_pred             --CcccccCCCCCCCCHH-----HHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          551 --TTVNIIDPTLSSGSIT-----EMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       551 --~~~~~~dp~l~~~~~~-----e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                        .......|........     .-..+++++..|++.||.+|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence              0001111111110000     0123457788999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.6e-37  Score=320.13  Aligned_cols=257  Identities=27%  Similarity=0.382  Sum_probs=200.6

Q ss_pred             CCcccCcccccCceEEEEeEec------CCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEE
Q 006155          325 NFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  397 (658)
                      +|+..+.||+|+||.||+|+..      ....+++|.+..... .....+.+|+.++..++||||+++++.+..++..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4778899999999999999742      235689998875533 234568899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcC---------------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCc
Q 006155          398 IYEFVPNTSLDHFIFDPT---------------------RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSN  456 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~N  456 (658)
                      ++||+++++|.+++....                     ....+++..++.++.|++.||.|||+.+   ++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999999875321                     1235899999999999999999999987   9999999999


Q ss_pred             eeeCCCCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCC
Q 006155          457 VLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGET  535 (658)
Q Consensus       457 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~  535 (658)
                      ||+++++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|||++ |+.|+....   
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---  234 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA---  234 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC---
Confidence            9999999999999999986543322222233456778999999988899999999999999999999 888874322   


Q ss_pred             cchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          536 VEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       536 ~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      ...+....    ..+..     +.......   ..+.+++..|++.+|++||++.++++.|++.
T Consensus       235 ~~~~~~~~----~~~~~-----~~~~~~~~---~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~  286 (290)
T cd05045         235 PERLFNLL----KTGYR-----MERPENCS---EEMYNLMLTCWKQEPDKRPTFADISKELEKM  286 (290)
T ss_pred             HHHHHHHH----hCCCC-----CCCCCCCC---HHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence            22222221    11111     11111111   2455788899999999999999999999864

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=331.20  Aligned_cols=246  Identities=27%  Similarity=0.314  Sum_probs=199.1

Q ss_pred             hhhhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc---ccHHHHHHHHHHHHhc-CCCCceeeeeeeccCC
Q 006155          319 IRVATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG---QGDLEFKNEVLLVANL-QHRNLVRLLGFSLEGN  393 (658)
Q Consensus       319 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~  393 (658)
                      .....++|...++||+|.||+|+++.+. +++.+|||.+++...   ...+..+.|..++... +||.|+.|+.+++..+
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~  442 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE  442 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence            3456789999999999999999999865 467889999988743   3334467787777766 5999999999999999


Q ss_pred             ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccc
Q 006155          394 ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMA  473 (658)
Q Consensus       394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla  473 (658)
                      ++++||||+.||++..+.    ....+++....-++..|+.||.|||+++   ||+||||.+|||||.+|++||+|||++
T Consensus       443 ~l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlc  515 (694)
T KOG0694|consen  443 HLFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLC  515 (694)
T ss_pred             eEEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccc
Confidence            999999999999965554    4467999999999999999999999998   999999999999999999999999999


Q ss_pred             cccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcc
Q 006155          474 RLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTV  553 (658)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  553 (658)
                      +.--.  ....+.+.+||+.|||||++.+..|+..+|+|||||+||||+.|+.||...++   +++......        
T Consensus       516 Ke~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE---ee~FdsI~~--------  582 (694)
T KOG0694|consen  516 KEGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE---EEVFDSIVN--------  582 (694)
T ss_pred             cccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHhc--------
Confidence            85321  23367789999999999999999999999999999999999999999954433   334333322        


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 006155          554 NIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTM  589 (658)
Q Consensus       554 ~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm  589 (658)
                        .|+.....-..|   .+.|+...+..||++|--+
T Consensus       583 --d~~~yP~~ls~e---a~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  583 --DEVRYPRFLSKE---AIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             --CCCCCCCcccHH---HHHHHHHHhccCcccccCC
Confidence              122333232223   3345567799999999877

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.2e-37  Score=319.04  Aligned_cols=257  Identities=27%  Similarity=0.429  Sum_probs=202.7

Q ss_pred             ccCCcccCcccccCceEEEEeEec------CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERL  396 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  396 (658)
                      .++|+..++||+|+||.||+++..      ++..+|+|.+..........+.+|++++..++|+||+++++++..+...+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            457788899999999999999632      35678999887766566678999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCcCC------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCC
Q 006155          397 LIYEFVPNTSLDHFIFDPTR------------RAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMT  464 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~  464 (658)
                      ++|||+++++|.+++.....            ...+++..++.++.||+.||+|||+.+   ++||||||+|||+++++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence            99999999999999854221            135899999999999999999999987   999999999999999999


Q ss_pred             eEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHH
Q 006155          465 PKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSA  543 (658)
Q Consensus       465 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~  543 (658)
                      +||+|||+++.+.............+++.|+|||++.+..++.++||||||+++|||++ |+.|+.....   .+.....
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~  237 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN---TEAIECI  237 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH---HHHHHHH
Confidence            99999999976543322222233445788999999999999999999999999999998 8888743221   1222221


Q ss_pred             HHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 006155          544 WKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN  597 (658)
Q Consensus       544 ~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~  597 (658)
                      ..    +....  .+   .....   .+.+++.+||+.+|++||++.+|++.|+
T Consensus       238 ~~----~~~~~--~~---~~~~~---~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         238 TQ----GRELE--RP---RTCPP---EVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             Hc----CccCC--CC---CCCCH---HHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            11    11100  01   11112   3457778999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-37  Score=317.42  Aligned_cols=260  Identities=26%  Similarity=0.449  Sum_probs=205.3

Q ss_pred             hhccCCcccCcccccCceEEEEeEecC------CcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCC
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGN  393 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  393 (658)
                      +..++|...+.||+|+||.||+|...+      +..||+|.+..... ....++.+|+.++..++||||+++++++....
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   82 (277)
T cd05032           3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ   82 (277)
T ss_pred             cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence            345788899999999999999998542      36799999865432 33456889999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhhhhcCcC-------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeE
Q 006155          394 ERLLIYEFVPNTSLDHFIFDPT-------RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPK  466 (658)
Q Consensus       394 ~~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~k  466 (658)
                      ..++||||+++++|.+++....       ....++|..++.++.||+.||.|||+.+   ++||||||+|||++.++.+|
T Consensus        83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~k  159 (277)
T cd05032          83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEE
Confidence            9999999999999999985422       2235789999999999999999999987   99999999999999999999


Q ss_pred             EeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHH
Q 006155          467 IADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWK  545 (658)
Q Consensus       467 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~  545 (658)
                      |+|||+++.+.............++..|+|||.+.++.++.++||||||+++||+++ |+.|+....   ......... 
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~---~~~~~~~~~-  235 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS---NEEVLKFVI-  235 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC---HHHHHHHHh-
Confidence            999999986644332222333457889999999998999999999999999999998 888874322   222322221 


Q ss_pred             hccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          546 NWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       546 ~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                         .+....     ......   ..+.+++..||+.+|++|||+.++++.|+.
T Consensus       236 ---~~~~~~-----~~~~~~---~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         236 ---DGGHLD-----LPENCP---DKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             ---cCCCCC-----CCCCCC---HHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence               111111     111122   245578889999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8.4e-38  Score=322.61  Aligned_cols=264  Identities=25%  Similarity=0.424  Sum_probs=199.3

Q ss_pred             ccCCcccCcccccCceEEEEeEe-----cCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeecc--CCce
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-----YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLE--GNER  395 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~  395 (658)
                      .++|+..+.||+|+||.||++..     .++..||+|++..........+.+|+.++.+++||||+++++++..  ....
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            35788889999999999999974     2578899999877665556678999999999999999999998653  3467


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ++|+||+++++|.+++...  ...++|..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.
T Consensus        83 ~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             EEEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence            8999999999999998532  346899999999999999999999987   99999999999999999999999999987


Q ss_pred             cccCCCcc-ccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCC---------CcchHHHHHHH
Q 006155          476 FEMDETQG-NTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGE---------TVEDLLSSAWK  545 (658)
Q Consensus       476 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~---------~~~~l~~~~~~  545 (658)
                      +....... ......++..|+|||++.+..++.++||||||+++|||++|..++......         ...........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE  237 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence            64432211 111223445699999999999999999999999999999987764321100         00000000000


Q ss_pred             hccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          546 NWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       546 ~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      ....+..     ........   ..+.+++.+||+.+|++|||+.+|++.|+..
T Consensus       238 ~~~~~~~-----~~~~~~~~---~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         238 LLKNNGR-----LPAPPGCP---AEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHhcCCc-----CCCCCCCC---HHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            0000000     00011111   2355788899999999999999999999753

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=325.45  Aligned_cols=242  Identities=22%  Similarity=0.289  Sum_probs=190.4

Q ss_pred             ccccCceEEEEeEec-CCcceeEEEeccC---CcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecCCCCh
Q 006155          332 LGQGGFGAVYKGRLY-DGAEIAVKRLSRD---SGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSL  407 (658)
Q Consensus       332 lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  407 (658)
                      ||+|+||.||+++.. +++.||+|++...   .......+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999854 4788999998653   223344578899999999999999999999999999999999999999


Q ss_pred             hhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCcccccc
Q 006155          408 DHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSR  487 (658)
Q Consensus       408 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  487 (658)
                      .+++..   ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++......  .....
T Consensus        81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~  152 (312)
T cd05585          81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT  152 (312)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence            999843   346899999999999999999999987   9999999999999999999999999997543221  22334


Q ss_pred             ccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCCHHH
Q 006155          488 IVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITE  567 (658)
Q Consensus       488 ~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e  567 (658)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||...   ....+......    +.      ..+...... 
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~---~~~~~~~~~~~----~~------~~~~~~~~~-  218 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE---NVNEMYRKILQ----EP------LRFPDGFDR-  218 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC---CHHHHHHHHHc----CC------CCCCCcCCH-
Confidence            67999999999999999999999999999999999999998532   12222222111    11      111111122 


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 006155          568 MIRCIHIGLLCVQENVASRPTMASVVLMLN  597 (658)
Q Consensus       568 ~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~  597 (658)
                        .+.+++..||+.||++||+..++.+.|+
T Consensus       219 --~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         219 --DAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             --HHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence              2346677999999999986544444443

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-37  Score=315.40  Aligned_cols=252  Identities=25%  Similarity=0.399  Sum_probs=199.8

Q ss_pred             cCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecC
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVP  403 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~  403 (658)
                      .+|+..+.||+|+||.||+++..++..+|+|.+.... ....++.+|+.++.+++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            4578889999999999999987777789999886543 334568899999999999999999999999999999999999


Q ss_pred             CCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCcc
Q 006155          404 NTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQG  483 (658)
Q Consensus       404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  483 (658)
                      +++|.+++...  ...++|..++.++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||+++........ 
T Consensus        83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-  156 (256)
T cd05059          83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-  156 (256)
T ss_pred             CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc-
Confidence            99999998542  236899999999999999999999988   999999999999999999999999998765432211 


Q ss_pred             ccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCC
Q 006155          484 NTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSS  562 (658)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~  562 (658)
                      ......++..|+|||++.+..++.++||||||+++|||++ |+.|+.....   .+.........+         +....
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~---------~~~~~  224 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN---SEVVESVSAGYR---------LYRPK  224 (256)
T ss_pred             ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH---HHHHHHHHcCCc---------CCCCC
Confidence            1112234568999999999999999999999999999999 7888753222   222222211111         11111


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 006155          563 GSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN  597 (658)
Q Consensus       563 ~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~  597 (658)
                      ..   ...+.+++.+||+.+|++||||.+|+++|.
T Consensus       225 ~~---~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         225 LA---PTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             CC---CHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence            11   124567888999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.8e-37  Score=332.70  Aligned_cols=194  Identities=21%  Similarity=0.273  Sum_probs=167.4

Q ss_pred             hccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      ..++|+..++||+|+||.||++.. ..++.||+|....      ..+.+|+.++++++||||+++++++..+...++|+|
T Consensus        90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e  163 (391)
T PHA03212         90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP  163 (391)
T ss_pred             ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence            346799999999999999999984 4578899997532      246889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      ++. ++|..++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..... 
T Consensus       164 ~~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-  235 (391)
T PHA03212        164 RYK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-  235 (391)
T ss_pred             cCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccc-
Confidence            985 688887743   346899999999999999999999987   999999999999999999999999999753221 


Q ss_pred             CccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCc
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNC  529 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~  529 (658)
                      .........||+.|+|||++.+..++.++|||||||++|||++|+.|+.
T Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~  284 (391)
T PHA03212        236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF  284 (391)
T ss_pred             cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence            1122334679999999999999999999999999999999999998763

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-39  Score=324.09  Aligned_cols=249  Identities=24%  Similarity=0.373  Sum_probs=202.2

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcc-cHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQ-GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      ...|...+.||+|.||.||+|... .++.||+|++...... ...++.+|+.++.+++|+||.+++|.+..+..++++||
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe   91 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME   91 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence            345777789999999999999844 4788999999876444 34568999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      ||.+|++.+.|.   ....+++....-++++++.||.|||.++   .+|||||+.|||+..+|.+||+|||++-.+....
T Consensus        92 y~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~  165 (467)
T KOG0201|consen   92 YCGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV  165 (467)
T ss_pred             HhcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh
Confidence            999999999983   3334577888889999999999999998   9999999999999999999999999997665443


Q ss_pred             CccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCC
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTL  560 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l  560 (658)
                      .  ...+.+||+-|||||++....|+.|+||||||++.+||.+|.+|+....+.....++       .+.     .-|.+
T Consensus       166 ~--rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI-------pk~-----~PP~L  231 (467)
T KOG0201|consen  166 K--RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI-------PKS-----APPRL  231 (467)
T ss_pred             h--ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec-------cCC-----CCCcc
Confidence            3  336789999999999999889999999999999999999999998644432221111       111     12333


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          561 SSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       561 ~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .+....   -+.+++..||+.||+.||++.++++
T Consensus       232 ~~~~S~---~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  232 DGDFSP---PFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             ccccCH---HHHHHHHHHhhcCcccCcCHHHHhh
Confidence            332111   1335666899999999999999983

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.8e-37  Score=317.62  Aligned_cols=258  Identities=30%  Similarity=0.469  Sum_probs=200.4

Q ss_pred             hccCCcccCcccccCceEEEEeEecC------CcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCc
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNE  394 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  394 (658)
                      ..++|...+.||+|+||.||+|...+      +..|++|.+..... .....+.+|+.++++++|+||+++++++.+...
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            45788999999999999999998643      46789998865432 334568999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhcCcC----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCC---CeEE
Q 006155          395 RLLIYEFVPNTSLDHFIFDPT----RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM---TPKI  467 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~---~~kl  467 (658)
                      .++||||+++++|.+++....    ....++|..+++++.||+.||.|||+.+   ++||||||+|||++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence            999999999999999985432    1236899999999999999999999987   99999999999998754   5899


Q ss_pred             eccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHh
Q 006155          468 ADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKN  546 (658)
Q Consensus       468 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~  546 (658)
                      +|||+++.+..............+..|+|||++.++.++.++|||||||++|||++ |+.||....   ...+.......
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~---~~~~~~~~~~~  237 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT---NQEVMEFVTGG  237 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHHcC
Confidence            99999987633222111222344568999999999999999999999999999997 888875322   22222222111


Q ss_pred             ccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 006155          547 WREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN  597 (658)
Q Consensus       547 ~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~  597 (658)
                         ..      +.......   ..+.+++..|++.+|++||++.+|++.|+
T Consensus       238 ---~~------~~~~~~~~---~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         238 ---GR------LDPPKGCP---GPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             ---Cc------CCCCCCCC---HHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence               00      01111111   24557788999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.6e-37  Score=314.53  Aligned_cols=248  Identities=26%  Similarity=0.376  Sum_probs=193.2

Q ss_pred             CcccccCceEEEEeEec-CCcceeEEEeccCC-cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecCCCCh
Q 006155          330 NKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS-GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSL  407 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  407 (658)
                      +.||+|+||.||+|+.. +++.+|+|.+.... ......+.+|+.++++++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46999999999999864 68889999876543 23345689999999999999999999999999999999999999999


Q ss_pred             hhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCcccccc
Q 006155          408 DHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSR  487 (658)
Q Consensus       408 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  487 (658)
                      .+++..  ....++|..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++..............
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            999853  2346899999999999999999999987   99999999999999999999999999875443211111111


Q ss_pred             ccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCCHH
Q 006155          488 IVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSIT  566 (658)
Q Consensus       488 ~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~  566 (658)
                      ..++..|+|||.+.++.++.++||||||+++|||++ |..|+.....   ............         +....... 
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~---~~~~~~~~~~~~---------~~~~~~~~-  222 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN---QQTREAIEQGVR---------LPCPELCP-  222 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH---HHHHHHHHcCCC---------CCCcccCC-
Confidence            223567999999999999999999999999999998 7777743221   111111111100         01111111 


Q ss_pred             HHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 006155          567 EMIRCIHIGLLCVQENVASRPTMASVVLMLN  597 (658)
Q Consensus       567 e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~  597 (658)
                        ..+.+++.+|++.+|++|||+.+|.++|.
T Consensus       223 --~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         223 --DAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             --HHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence              24557888999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-38  Score=343.38  Aligned_cols=261  Identities=25%  Similarity=0.270  Sum_probs=207.7

Q ss_pred             hhhhhhccCCcccCcccccCceEEEEeEecCC-cceeEEEeccCCcccHHHHHHHHHHHHhcC-CCCceeeee-eecc--
Q 006155          317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYDG-AEIAVKRLSRDSGQGDLEFKNEVLLVANLQ-HRNLVRLLG-FSLE--  391 (658)
Q Consensus       317 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~-~~~~--  391 (658)
                      ..+.+...++++.+.|.+|||+.||.++...+ .++|+|++-..+......+++||++|++|+ |+|||.+++ ....  
T Consensus        30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~  109 (738)
T KOG1989|consen   30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS  109 (738)
T ss_pred             eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence            34456677888999999999999999997766 999999998887788888999999999998 999999999 3321  


Q ss_pred             ----CCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEE
Q 006155          392 ----GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKI  467 (658)
Q Consensus       392 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl  467 (658)
                          .-+.+|.||||++|.|-+++....... |++.++++|+.++++|+.+||... ++|||||||-+||||+.+++.||
T Consensus       110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KL  187 (738)
T KOG1989|consen  110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKL  187 (738)
T ss_pred             CCCceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEe
Confidence                236789999999999999996544433 999999999999999999999975 78999999999999999999999


Q ss_pred             eccccccccccCCCcc-c------cccccccccccCcccc---ccCCCCcccccccccchHhHHHhCCCCCccCCCCCcc
Q 006155          468 ADFGMARLFEMDETQG-N------TSRIVGTYGYMAPEYA---MHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVE  537 (658)
Q Consensus       468 ~DFGla~~~~~~~~~~-~------~~~~~gt~~y~aPE~~---~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~  537 (658)
                      ||||.+...-...+.. .      .-...-|+.|+|||++   .+..+++|+|||+|||+||-|+....||+.....   
T Consensus       188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l---  264 (738)
T KOG1989|consen  188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL---  264 (738)
T ss_pred             CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce---
Confidence            9999986432222110 0      1113569999999987   4668999999999999999999999999543211   


Q ss_pred             hHHHHHHHhccCCCcccccCCCCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          538 DLLSSAWKNWREGTTVNIIDPTLSSG-SITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       538 ~l~~~~~~~~~~~~~~~~~dp~l~~~-~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                                      .|++-...-- ......++..|+..||++||++||++-+|+..+-.
T Consensus       265 ----------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~  310 (738)
T KOG1989|consen  265 ----------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE  310 (738)
T ss_pred             ----------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence                            1222111111 23344556677889999999999999999877643

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.5e-37  Score=325.62  Aligned_cols=251  Identities=24%  Similarity=0.301  Sum_probs=195.0

Q ss_pred             CCcccCcccccCceEEEEeEe----cCCcceeEEEeccCC----cccHHHHHHHHHHHHhcC-CCCceeeeeeeccCCce
Q 006155          325 NFSDANKLGQGGFGAVYKGRL----YDGAEIAVKRLSRDS----GQGDLEFKNEVLLVANLQ-HRNLVRLLGFSLEGNER  395 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~  395 (658)
                      +|+..++||+|+||.||+++.    ..++.||+|++....    ......+..|+.++..++ |+||+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            477889999999999999874    357889999986532    122345788999999994 99999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ++||||+++|+|.+++..   +..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            999999999999999843   356899999999999999999999987   99999999999999999999999999986


Q ss_pred             cccCCCccccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          476 FEMDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      +..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+..   ....     
T Consensus       155 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~---~~~~-----  225 (332)
T cd05614         155 FLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR---RILK-----  225 (332)
T ss_pred             ccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH---HHhc-----
Confidence            543322 123346799999999998765 478899999999999999999999864433222221111   1111     


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 006155          555 IIDPTLSSGSITEMIRCIHIGLLCVQENVASRP-----TMASVVL  594 (658)
Q Consensus       555 ~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RP-----tm~evv~  594 (658)
                       .++.+......+   +.+++..||+.||++||     +++++++
T Consensus       226 -~~~~~~~~~~~~---~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         226 -CDPPFPSFIGPE---AQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             -CCCCCCCCCCHH---HHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence             112222222222   34667799999999999     6667764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=6.9e-37  Score=317.94  Aligned_cols=264  Identities=25%  Similarity=0.383  Sum_probs=200.9

Q ss_pred             ccCCcccCcccccCceEEEEeEec-----------------CCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCcee
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-----------------DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVR  384 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-----------------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~  384 (658)
                      .++|+..++||+|+||.||++...                 ++..+|+|++..... ....++.+|+.++++++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            467899999999999999998532                 234689999876532 33457899999999999999999


Q ss_pred             eeeeeccCCceEEEEEecCCCChhhhhcCcC--------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCc
Q 006155          385 LLGFSLEGNERLLIYEFVPNTSLDHFIFDPT--------RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSN  456 (658)
Q Consensus       385 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~N  456 (658)
                      +++++..++..++||||+++++|.+++....        ....+++..+++++.||+.||.|||+.+   ++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence            9999999999999999999999999986422        1235888999999999999999999987   9999999999


Q ss_pred             eeeCCCCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh--CCCCCccCCCC
Q 006155          457 VLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS--GQRNNCFRNGE  534 (658)
Q Consensus       457 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt--G~~p~~~~~~~  534 (658)
                      ||++.++.++|+|||+++.+.............++..|++||+...+.++.++||||||+++|||++  |..|+....  
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~--  238 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS--  238 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC--
Confidence            9999999999999999986544322222233445678999999988999999999999999999998  556664322  


Q ss_pred             CcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 006155          535 TVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN  597 (658)
Q Consensus       535 ~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~  597 (658)
                       ..+.+......+.... .....+.. ....   ..+.+++.+||+.||.+||+|.+|++.|+
T Consensus       239 -~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~---~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         239 -DEQVIENTGEFFRDQG-RQVYLPKP-ALCP---DSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             -hHHHHHHHHHHHhhcc-ccccCCCC-CCCC---HHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence             1222222211111111 01111111 1111   34557888999999999999999999986

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.3e-37  Score=328.16  Aligned_cols=242  Identities=23%  Similarity=0.257  Sum_probs=192.4

Q ss_pred             CcccccCceEEEEeEe-cCCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecCCC
Q 006155          330 NKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNT  405 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g  405 (658)
                      +.||+|+||.||+++. .+|+.||||++....   ......+.+|+.++..++||||+++++++..++..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999984 458899999987542   223446788999999999999999999999999999999999999


Q ss_pred             ChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCcccc
Q 006155          406 SLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNT  485 (658)
Q Consensus       406 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  485 (658)
                      +|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~  152 (328)
T cd05593          81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM  152 (328)
T ss_pred             CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence            99988843   346899999999999999999999987   9999999999999999999999999987532211  122


Q ss_pred             ccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCCH
Q 006155          486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSI  565 (658)
Q Consensus       486 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~  565 (658)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||....   ...+......    +      +..+.....
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~---~~~~~~~~~~----~------~~~~p~~~~  219 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELILM----E------DIKFPRTLS  219 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC---HHHHHHHhcc----C------CccCCCCCC
Confidence            34579999999999999999999999999999999999999985322   1222221111    1      111111222


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 006155          566 TEMIRCIHIGLLCVQENVASRP-----TMASVVLM  595 (658)
Q Consensus       566 ~e~~~~~~i~~~Cl~~~p~~RP-----tm~evv~~  595 (658)
                      .   .+.+++..||+.||++||     ++.++++.
T Consensus       220 ~---~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         220 A---DAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             H---HHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            2   244666799999999997     88888753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-37  Score=315.62  Aligned_cols=257  Identities=24%  Similarity=0.361  Sum_probs=198.6

Q ss_pred             hhhhccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcc--------------cHHHHHHHHHHHHhcCCCCce
Q 006155          319 IRVATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQ--------------GDLEFKNEVLLVANLQHRNLV  383 (658)
Q Consensus       319 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~--------------~~~~~~~E~~~l~~l~H~niv  383 (658)
                      -+...++|++.+.||+|.||.|-+++. .+++.||||++.+....              ..+...+|+.+|++++|||||
T Consensus        92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV  171 (576)
T KOG0585|consen   92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV  171 (576)
T ss_pred             cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence            344568899999999999999999983 46889999998654221              123578999999999999999


Q ss_pred             eeeeeecc--CCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCC
Q 006155          384 RLLGFSLE--GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDA  461 (658)
Q Consensus       384 ~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~  461 (658)
                      +|+.+..+  .+.+|||+|||..|.+...-   .....++..+.+++++++..||+|||.++   ||||||||+|+||++
T Consensus       172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~  245 (576)
T KOG0585|consen  172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSS  245 (576)
T ss_pred             EEEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcC
Confidence            99999865  45789999999999886543   22233999999999999999999999998   999999999999999


Q ss_pred             CCCeEEeccccccccccCCC---ccccccccccccccCccccccCC----CCcccccccccchHhHHHhCCCCCccCCCC
Q 006155          462 EMTPKIADFGMARLFEMDET---QGNTSRIVGTYGYMAPEYAMHGQ----YSVKSDVFSFGVLVLEIISGQRNNCFRNGE  534 (658)
Q Consensus       462 ~~~~kl~DFGla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDV~S~Gvll~elltG~~p~~~~~~~  534 (658)
                      +|++||+|||.+..+..+..   .....+.+||+.|||||...++.    .+.+.||||+||.||.|+.|+-||-.   +
T Consensus       246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~---~  322 (576)
T KOG0585|consen  246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD---D  322 (576)
T ss_pred             CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc---c
Confidence            99999999999987743311   12234579999999999987743    34678999999999999999999832   2


Q ss_pred             CcchHHHHHHHhccCCCcccccCCCCC-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 006155          535 TVEDLLSSAWKNWREGTTVNIIDPTLS-SGSITEMIRCIHIGLLCVQENVASRPTMASVVLML  596 (658)
Q Consensus       535 ~~~~l~~~~~~~~~~~~~~~~~dp~l~-~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L  596 (658)
                      ...++....            +...+. ....++-..+-+|++.+|+.||+.|-+..+|....
T Consensus       323 ~~~~l~~KI------------vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  323 FELELFDKI------------VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             hHHHHHHHH------------hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence            222222222            111111 11222233444778889999999999999997654

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.5e-37  Score=318.87  Aligned_cols=262  Identities=27%  Similarity=0.439  Sum_probs=203.7

Q ss_pred             hhhccCCcccCcccccCceEEEEeEec------CCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccC
Q 006155          320 RVATDNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEG  392 (658)
Q Consensus       320 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~  392 (658)
                      ++..++|++.++||+|+||.||+|...      .+..||+|.+..... .....+.+|+.+++.++||||+++++++.+.
T Consensus         2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (288)
T cd05061           2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG   81 (288)
T ss_pred             cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            356788999999999999999999643      245799998865432 2334678899999999999999999999999


Q ss_pred             CceEEEEEecCCCChhhhhcCcC-------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCe
Q 006155          393 NERLLIYEFVPNTSLDHFIFDPT-------RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP  465 (658)
Q Consensus       393 ~~~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~  465 (658)
                      +..++||||+++|+|.+++....       ....+++..+++++.|++.||.|||+.+   |+||||||+|||++.++.+
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~  158 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTV  158 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcE
Confidence            99999999999999999985421       1345678889999999999999999987   9999999999999999999


Q ss_pred             EEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHH
Q 006155          466 KIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAW  544 (658)
Q Consensus       466 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~  544 (658)
                      ||+|||+++...............++..|+|||.+.++.++.++||||||+++|||++ |+.|+...   ...+......
T Consensus       159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~---~~~~~~~~~~  235 (288)
T cd05061         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL---SNEQVLKFVM  235 (288)
T ss_pred             EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHH
Confidence            9999999986543322222223345778999999999999999999999999999999 67776322   2222222221


Q ss_pred             HhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          545 KNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       545 ~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      .    +...     .......   ..+.+++.+|++.+|++|||+.++++.|.+.
T Consensus       236 ~----~~~~-----~~~~~~~---~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         236 D----GGYL-----DQPDNCP---ERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             c----CCCC-----CCCCCCC---HHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            1    1110     1111111   2456788899999999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=8e-38  Score=331.09  Aligned_cols=263  Identities=22%  Similarity=0.303  Sum_probs=191.9

Q ss_pred             CCcccCcccccCceEEEEeEec-CCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeeccC-----CceE
Q 006155          325 NFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEG-----NERL  396 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~  396 (658)
                      +|+..++||+|+||.||+|+.. +|..||||++....  ......+.+|+.++++++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4778899999999999999844 68899999986432  23344688999999999999999999987543     2479


Q ss_pred             EEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccc
Q 006155          397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF  476 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~  476 (658)
                      +||||+. ++|.+++.   ....+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999995 68888874   3346899999999999999999999988   999999999999999999999999999865


Q ss_pred             ccCCC-ccccccccccccccCcccccc--CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHH--------HHH
Q 006155          477 EMDET-QGNTSRIVGTYGYMAPEYAMH--GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSS--------AWK  545 (658)
Q Consensus       477 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~--------~~~  545 (658)
                      ..... ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||...........+..        .+.
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS  233 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            33221 112234679999999999876  6789999999999999999999999854322111000000        000


Q ss_pred             hccCCCccccc---CCCCCCCCH----HHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          546 NWREGTTVNII---DPTLSSGSI----TEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       546 ~~~~~~~~~~~---dp~l~~~~~----~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .++.....+.+   .+.......    ..-..+.+++..||+.||++|||++|+++
T Consensus       234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            01100000000   000000000    00123457888999999999999999985

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2e-37  Score=333.65  Aligned_cols=255  Identities=22%  Similarity=0.325  Sum_probs=194.1

Q ss_pred             CCcccCcccccCceEEEEeEe-cCCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          325 NFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      .|+..+.||+|+||+||+|+. .+++.||||++....   ......+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            578889999999999999974 457889999986542   2233468899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      |+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+....
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            9999999999843   346889999999999999999999987   9999999999999999999999999986442110


Q ss_pred             Cc---------------------------------------------cccccccccccccCccccccCCCCccccccccc
Q 006155          481 TQ---------------------------------------------GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFG  515 (658)
Q Consensus       481 ~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~G  515 (658)
                      ..                                             ......+||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            00                                             001235799999999999998999999999999


Q ss_pred             chHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          516 VLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       516 vll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                      |++|||++|+.||......   +..... ..+...  ..+  |... ....+...++.- +.|+..+|..||++.+++..
T Consensus       236 ~il~elltG~~Pf~~~~~~---~~~~~i-~~~~~~--~~~--~~~~-~~s~~~~dli~~-ll~~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         236 VILFEMLVGQPPFLAPTPT---ETQLKV-INWENT--LHI--PPQV-KLSPEAVDLITK-LCCSAEERLGRNGADDIKAH  305 (381)
T ss_pred             hHHHHHHhCCCCCcCCCHH---HHHHHH-Hccccc--cCC--CCCC-CCCHHHHHHHHH-HccCcccccCCCCHHHHhcC
Confidence            9999999999998543221   111111 111110  011  1110 112333333322 24778888889999999853

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.6e-37  Score=327.91  Aligned_cols=252  Identities=21%  Similarity=0.268  Sum_probs=195.6

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc---ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG---QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ++|...+.||+|+||.||+++.. +|+.||+|++.....   .....+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46888999999999999999854 688999999875422   23445788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ||+++|+|.+++...  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            999999999998542  246899999999999999999999988   999999999999999999999999999876543


Q ss_pred             CCccccccccccccccCccccc------cCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcc
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAM------HGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTV  553 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  553 (658)
                      ... ......||+.|+|||++.      ...++.++||||||+++|||++|+.||.....   ..........   ....
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~---~~~~~~i~~~---~~~~  228 (330)
T cd05601         156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS---AKTYNNIMNF---QRFL  228 (330)
T ss_pred             Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH---HHHHHHHHcC---CCcc
Confidence            222 223357899999999986      45688999999999999999999999853221   1111211111   1111


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          554 NIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       554 ~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ..  |.. .....+   +.+++..|++ +|++||++.+++.
T Consensus       229 ~~--~~~-~~~~~~---~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         229 KF--PED-PKVSSD---FLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             CC--CCC-CCCCHH---HHHHHHHHcc-ChhhCCCHHHHhC
Confidence            11  110 111223   3345557887 9999999999884

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.6e-37  Score=321.20  Aligned_cols=259  Identities=28%  Similarity=0.469  Sum_probs=202.8

Q ss_pred             hccCCcccCcccccCceEEEEeEec------CCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCc
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNE  394 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  394 (658)
                      ..++|+..+.||+|+||.||+++..      ++..||+|++..... ....++.+|+.++++++||||+++++++.++..
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            4578999999999999999999853      467899999875432 334568899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhcCcC-------------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCC
Q 006155          395 RLLIYEFVPNTSLDHFIFDPT-------------------RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTS  455 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~  455 (658)
                      .++|+||+++++|.+++....                   ....+++..++.++.||+.||.|||+.+   ++||||||+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~  159 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR  159 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence            999999999999999985321                   1235789999999999999999999987   999999999


Q ss_pred             ceeeCCCCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCC
Q 006155          456 NVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGE  534 (658)
Q Consensus       456 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~  534 (658)
                      |||++.++.++|+|||++..+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+...   
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~---  236 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM---  236 (288)
T ss_pred             heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---
Confidence            99999999999999999876543322222222345678999999998999999999999999999998 77776321   


Q ss_pred             CcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          535 TVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       535 ~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      ...+.+..    ...+....     .....   ...+.+++.+|++.+|++|||+.|+++.|+.
T Consensus       237 ~~~~~~~~----~~~~~~~~-----~~~~~---~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         237 AHEEVIYY----VRDGNVLS-----CPDNC---PLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             CHHHHHHH----HhcCCCCC-----CCCCC---CHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            12222222    12221111     11111   1345678889999999999999999999863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.5e-37  Score=324.26  Aligned_cols=241  Identities=22%  Similarity=0.253  Sum_probs=191.0

Q ss_pred             CcccccCceEEEEeEe-cCCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecCCC
Q 006155          330 NKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNT  405 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g  405 (658)
                      +.||+|+||.||+++. .+|..||+|++....   ......+.+|+.++..++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4699999999999984 468899999987542   223345678999999999999999999999999999999999999


Q ss_pred             ChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCcccc
Q 006155          406 SLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNT  485 (658)
Q Consensus       406 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  485 (658)
                      +|..++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~  152 (323)
T cd05595          81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM  152 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence            99888843   346899999999999999999999987   9999999999999999999999999987532221  122


Q ss_pred             ccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCCH
Q 006155          486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSI  565 (658)
Q Consensus       486 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~  565 (658)
                      ....||+.|+|||++.++.++.++|||||||++|||++|+.||....   ..........    +.      ..+.....
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~---~~~~~~~~~~----~~------~~~p~~~~  219 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLFELILM----EE------IRFPRTLS  219 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHhc----CC------CCCCCCCC
Confidence            34579999999999999999999999999999999999999984322   1222222111    10      11111222


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 006155          566 TEMIRCIHIGLLCVQENVASRP-----TMASVVL  594 (658)
Q Consensus       566 ~e~~~~~~i~~~Cl~~~p~~RP-----tm~evv~  594 (658)
                      ++   +.+++..||+.||++||     ++.++++
T Consensus       220 ~~---~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         220 PE---AKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             HH---HHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            23   34566789999999998     7888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.4e-37  Score=329.78  Aligned_cols=256  Identities=23%  Similarity=0.336  Sum_probs=194.7

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ++|+..+.||+|+||+||+++.. +++.||||++....   ......+.+|+.++.+++|+||+++++.+.++...++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47888999999999999999754 58899999986532   222345788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            99999999999843   456899999999999999999999988   999999999999999999999999998765321


Q ss_pred             CCc---------------------------------cccccccccccccCccccccCCCCcccccccccchHhHHHhCCC
Q 006155          480 ETQ---------------------------------GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQR  526 (658)
Q Consensus       480 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~  526 (658)
                      ...                                 ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            100                                 00123579999999999999999999999999999999999999


Q ss_pred             CCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          527 NNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       527 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                      ||....   ..+....... +..    .+..|... ...++...++.- +.|...++..||++.||++.
T Consensus       235 Pf~~~~---~~~~~~~i~~-~~~----~~~~p~~~-~~s~~~~~li~~-l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         235 PFCSET---PQETYKKVMN-WKE----TLIFPPEV-PISEKAKDLILR-FCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCCC---HHHHHHHHHc-CcC----cccCCCcC-CCCHHHHHHHHH-HcCChhhcCCCCCHHHHhCC
Confidence            985322   2222222211 111    11111111 112233333322 23555566678999999854

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=4.1e-37  Score=331.59  Aligned_cols=263  Identities=25%  Similarity=0.373  Sum_probs=204.0

Q ss_pred             hhhhccCCcccCcccccCceEEEEeEec------CCcceeEEEeccCCccc-HHHHHHHHHHHHhcC-CCCceeeeeeec
Q 006155          319 IRVATDNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRDSGQG-DLEFKNEVLLVANLQ-HRNLVRLLGFSL  390 (658)
Q Consensus       319 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~-H~niv~l~~~~~  390 (658)
                      .+...++|...++||+|+||.||+|+..      .+..||||++....... ...+.+|+.++.++. ||||+++++++.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            4556678889999999999999999853      24579999997653332 346889999999997 999999999999


Q ss_pred             cCCceEEEEEecCCCChhhhhcCcC-------------------------------------------------------
Q 006155          391 EGNERLLIYEFVPNTSLDHFIFDPT-------------------------------------------------------  415 (658)
Q Consensus       391 ~~~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------------------------  415 (658)
                      .....++|+||+++|+|.++++...                                                       
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            9999999999999999999985321                                                       


Q ss_pred             ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCC
Q 006155          416 ----------------------------------------RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTS  455 (658)
Q Consensus       416 ----------------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~  455 (658)
                                                              ....++|..+++++.||+.||.|||+.+   ++||||||+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~  268 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR  268 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc
Confidence                                                    1124788899999999999999999887   999999999


Q ss_pred             ceeeCCCCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCC
Q 006155          456 NVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGE  534 (658)
Q Consensus       456 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~  534 (658)
                      |||+++++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|||++ |+.|+..... 
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~-  347 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM-  347 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc-
Confidence            99999999999999999986543322222223457889999999999999999999999999999998 7888743221 


Q ss_pred             CcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          535 TVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       535 ~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                       ...+.......++         +........   .+.+++..||+.+|++||++++|++.|+.
T Consensus       348 -~~~~~~~~~~~~~---------~~~p~~~~~---~l~~li~~cl~~~P~~RPs~~ell~~L~~  398 (401)
T cd05107         348 -NEQFYNAIKRGYR---------MAKPAHASD---EIYEIMQKCWEEKFEIRPDFSQLVHLVGD  398 (401)
T ss_pred             -hHHHHHHHHcCCC---------CCCCCCCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence             1111111111111         111111122   34567779999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=4.2e-37  Score=320.81  Aligned_cols=262  Identities=27%  Similarity=0.385  Sum_probs=204.4

Q ss_pred             hhhccCCcccCcccccCceEEEEeEec--------CCcceeEEEeccCC-cccHHHHHHHHHHHHhc-CCCCceeeeeee
Q 006155          320 RVATDNFSDANKLGQGGFGAVYKGRLY--------DGAEIAVKRLSRDS-GQGDLEFKNEVLLVANL-QHRNLVRLLGFS  389 (658)
Q Consensus       320 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~  389 (658)
                      .+..++|...+.||+|+||.||+++..        ++..||+|.+.... .....++.+|+.++..+ +||||+++++++
T Consensus        11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   90 (304)
T cd05101          11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC   90 (304)
T ss_pred             cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence            345678889999999999999999631        24469999886542 23445688999999999 799999999999


Q ss_pred             ccCCceEEEEEecCCCChhhhhcCcC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCc
Q 006155          390 LEGNERLLIYEFVPNTSLDHFIFDPT-------------RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSN  456 (658)
Q Consensus       390 ~~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~N  456 (658)
                      ......++||||+++++|.+++....             ....++|..++.++.||++||.|||+.+   ++||||||+|
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~N  167 (304)
T cd05101          91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARN  167 (304)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccce
Confidence            99999999999999999999986421             1245889999999999999999999987   9999999999


Q ss_pred             eeeCCCCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCC
Q 006155          457 VLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGET  535 (658)
Q Consensus       457 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~  535 (658)
                      ||++.++.+||+|||+++.+.............+++.|+|||++.+..++.++||||||+++|||++ |..|+...   .
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~---~  244 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI---P  244 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC---C
Confidence            9999999999999999987654332222333456778999999998899999999999999999998 66776322   2


Q ss_pred             cchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          536 VEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       536 ~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      ..++.....    .+....     ......   ..+.+++..||+.+|++||+|.+|++.|+.+
T Consensus       245 ~~~~~~~~~----~~~~~~-----~~~~~~---~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~  296 (304)
T cd05101         245 VEELFKLLK----EGHRMD-----KPANCT---NELYMMMRDCWHAIPSHRPTFKQLVEDLDRI  296 (304)
T ss_pred             HHHHHHHHH----cCCcCC-----CCCCCC---HHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence            222222221    111110     011122   2345677899999999999999999999764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.5e-38  Score=311.43  Aligned_cols=248  Identities=23%  Similarity=0.393  Sum_probs=205.5

Q ss_pred             ccCCcccCcccccCceEEEEeE-ecCCcceeEEEeccCCcccHH---HHHHHHHHHHhcCCCCceeeeeeeccCCceEEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDL---EFKNEVLLVANLQHRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~---~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  398 (658)
                      ..+|++.+.||+|.||.|-++. ...|+.||||.+.+...++.+   .+.+|+++|..|+||||+.++.+|...+.+.+|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            3568888999999999999997 467999999998776544444   478999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccccc
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~  478 (658)
                      |||..+|.|.+|+.   .+..|++.+...+++||..|+.|+|.+.   ++|||||.+|||||.|+++||+||||+.++..
T Consensus       132 MEYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  132 MEYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EEecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            99999999999994   5677999999999999999999999987   99999999999999999999999999998764


Q ss_pred             CCCccccccccccccccCccccccCCCC-cccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccC
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAMHGQYS-VKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID  557 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  557 (658)
                      +.   ..++.+|++.|.+||++.+.+|. +.+|-||+||+||-|+.|..||+..+.   ..++...    ..|..   ..
T Consensus       206 ~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---k~lvrQI----s~GaY---rE  272 (668)
T KOG0611|consen  206 KK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---KRLVRQI----SRGAY---RE  272 (668)
T ss_pred             cc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---HHHHHHh----hcccc---cC
Confidence            43   34568999999999999999885 689999999999999999999964432   2333222    22222   22


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 006155          558 PTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLML  596 (658)
Q Consensus       558 p~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L  596 (658)
                      |.-.+    +   ..-++.|+|-.||++|-|+.+|....
T Consensus       273 P~~PS----d---A~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  273 PETPS----D---ASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             CCCCc----h---HHHHHHHHHhcCcccchhHHHHhhhh
Confidence            22221    1   22345688999999999999998543

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.6e-37  Score=318.88  Aligned_cols=259  Identities=25%  Similarity=0.373  Sum_probs=191.8

Q ss_pred             cCCcccCcccccCceEEEEeEec--CCcceeEEEeccCCcc--cHHHHHHHHHHHHhc---CCCCceeeeeeec-----c
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY--DGAEIAVKRLSRDSGQ--GDLEFKNEVLLVANL---QHRNLVRLLGFSL-----E  391 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~--~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l---~H~niv~l~~~~~-----~  391 (658)
                      ++|+..+.||+|+||.||+++..  +|..||||++......  ....+.+|+.++..+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            46888999999999999999852  4678999988654322  233566777777666   6999999999875     3


Q ss_pred             CCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccc
Q 006155          392 GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFG  471 (658)
Q Consensus       392 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFG  471 (658)
                      ....++||||++ ++|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence            456789999996 6888888542 2345899999999999999999999988   9999999999999999999999999


Q ss_pred             cccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccC--
Q 006155          472 MARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWRE--  549 (658)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--  549 (658)
                      +++.....   .......||+.|+|||++.+..++.++||||||+++|||++|+.||......   +.+.........  
T Consensus       156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~---~~~~~i~~~~~~~~  229 (290)
T cd07862         156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGLPG  229 (290)
T ss_pred             ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH---HHHHHHHHHhCCCC
Confidence            99865432   2233457899999999999999999999999999999999999998543321   222222111100  


Q ss_pred             --CCcc------cccCCCCCCCCHHHH-----HHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          550 --GTTV------NIIDPTLSSGSITEM-----IRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       550 --~~~~------~~~dp~l~~~~~~e~-----~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                        ....      ..+.+.. ....+++     ..+.+++.+|++.||++|||+.|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         230 EEDWPRDVALPRQAFHSKS-AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhhchhhhcccchhccCCC-CCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence              0000      0000000 0011111     12457888999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-38  Score=295.86  Aligned_cols=249  Identities=27%  Similarity=0.380  Sum_probs=205.5

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  397 (658)
                      ..++|++.+.||+|.||.||.|+.+ ++-.||+|++.+..   .+-..++.+|+++-..|+||||+++++++.+....+|
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            4578999999999999999999844 46678999986642   2344568999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE  477 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~  477 (658)
                      ++||.++|+|...|.+ .....++......++.|+|.||.|+|..+   ||||||||+|+|++..+..||+|||-+..-.
T Consensus       100 ilEya~~gel~k~L~~-~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p  175 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQE-GRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP  175 (281)
T ss_pred             EEEecCCchHHHHHHh-cccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence            9999999999999964 24566889999999999999999999987   9999999999999999999999999986422


Q ss_pred             cCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccC
Q 006155          478 MDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID  557 (658)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  557 (658)
                          .......+||..|.+||+..+..++.++|+|++|++.+|++.|.+||.....   .+......+       .++.+
T Consensus       176 ----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~---~etYkrI~k-------~~~~~  241 (281)
T KOG0580|consen  176 ----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH---SETYKRIRK-------VDLKF  241 (281)
T ss_pred             ----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh---HHHHHHHHH-------ccccC
Confidence                3445668999999999999999999999999999999999999999965432   222222211       23344


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          558 PTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       558 p~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      |...   ..+   +.+++..|+..+|.+|.+..||+.
T Consensus       242 p~~i---s~~---a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  242 PSTI---SGG---AADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             Cccc---Chh---HHHHHHHHhccCccccccHHHHhh
Confidence            4222   222   335667899999999999999875

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=9.4e-37  Score=310.56  Aligned_cols=256  Identities=28%  Similarity=0.448  Sum_probs=202.6

Q ss_pred             hhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      +..++|+..++||+|+||.||++...++..+|+|.+..... ....+.+|+.++++++|+|++++++++. ....+++||
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e   80 (260)
T cd05070           3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE   80 (260)
T ss_pred             CchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence            34567889999999999999999987888999999876433 4567899999999999999999999875 456789999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      |+++++|.+++... ....+++..++.++.+++.||.|||+.+   ++||||||+||++++++.++|+|||++..+....
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          81 YMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             ecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence            99999999998642 2345899999999999999999999987   9999999999999999999999999998764332


Q ss_pred             CccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccCCC
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT  559 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~  559 (658)
                      .. ......++..|+|||++.+..++.++||||||+++|||++ |+.|+....   ..+.......    +..     +.
T Consensus       157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~---~~~~~~~~~~----~~~-----~~  223 (260)
T cd05070         157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN---NREVLEQVER----GYR-----MP  223 (260)
T ss_pred             cc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHHc----CCC-----CC
Confidence            21 1122345678999999988899999999999999999999 788874322   2222222111    100     11


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          560 LSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       560 l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      ......   ..+.+++.+|++.+|++|||+.++++.|+.
T Consensus       224 ~~~~~~---~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         224 CPQDCP---ISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCcCC---HHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            111111   235678889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1e-37  Score=330.30  Aligned_cols=247  Identities=22%  Similarity=0.284  Sum_probs=197.8

Q ss_pred             hccCCcccCcccccCceEEEEeEecC--CcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLYD--GAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERL  396 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~~--g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  396 (658)
                      ..++|...+.||+|+||.||+|+...  +..||+|++....   ......+.+|+.++..++||||+++++++.+++..+
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence            45678999999999999999997543  3579999986532   223446788999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccc
Q 006155          397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF  476 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~  476 (658)
                      +||||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus       108 lv~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~  181 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV  181 (340)
T ss_pred             EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence            99999999999999843   346899999999999999999999988   999999999999999999999999999865


Q ss_pred             ccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccccc
Q 006155          477 EMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNII  556 (658)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  556 (658)
                      ...     .....||+.|+|||++.+..++.++|||||||++|||++|+.||....   ........    ..+..    
T Consensus       182 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~---~~~~~~~i----~~~~~----  245 (340)
T PTZ00426        182 DTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE---PLLIYQKI----LEGII----  245 (340)
T ss_pred             CCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC---HHHHHHHH----hcCCC----
Confidence            422     234579999999999999889999999999999999999999985322   11111211    11111    


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 006155          557 DPTLSSGSITEMIRCIHIGLLCVQENVASRP-----TMASVVLM  595 (658)
Q Consensus       557 dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RP-----tm~evv~~  595 (658)
                        .+.....+   .+.+++..|++.+|++|+     +++++++.
T Consensus       246 --~~p~~~~~---~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        246 --YFPKFLDN---NCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             --CCCCCCCH---HHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence              11111112   234677799999999995     88888754

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-37  Score=331.62  Aligned_cols=252  Identities=23%  Similarity=0.332  Sum_probs=194.1

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ++|+..+.||+|+||.||+++.. +|+.||||++....   ......+.+|+.++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47888999999999999999854 58899999987532   223345788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            99999999999853   346899999999999999999999988   999999999999999999999999998754321


Q ss_pred             CCcc------------------------------------ccccccccccccCccccccCCCCcccccccccchHhHHHh
Q 006155          480 ETQG------------------------------------NTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS  523 (658)
Q Consensus       480 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt  523 (658)
                      ....                                    .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            1000                                    0112469999999999999999999999999999999999


Q ss_pred             CCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHH
Q 006155          524 GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPT---MASVVL  594 (658)
Q Consensus       524 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPt---m~evv~  594 (658)
                      |+.||....   ......... .+...    +..|... ...+++.   +++..|+. +|.+|++   +.++++
T Consensus       235 G~~Pf~~~~---~~~~~~~i~-~~~~~----~~~~~~~-~~s~~~~---~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         235 GYPPFCSDN---PQETYRKII-NWKET----LQFPDEV-PLSPEAK---DLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCCCC---HHHHHHHHH-cCCCc----cCCCCCC-CCCHHHH---HHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            999985332   122222111 11111    1111110 1122333   44456775 8999998   888875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=6.2e-37  Score=313.26  Aligned_cols=258  Identities=26%  Similarity=0.477  Sum_probs=202.3

Q ss_pred             hccCCcccCcccccCceEEEEeEecC-Cc---ceeEEEeccCC-cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLYD-GA---EIAVKRLSRDS-GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERL  396 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-g~---~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  396 (658)
                      ..++|+..+.||+|+||.||+|+... +.   .+|+|.+.... .....++..|+.++.+++||||+++++++...+..+
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (268)
T cd05063           3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM   82 (268)
T ss_pred             ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence            35678889999999999999998643 33   68999887553 233456889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccc
Q 006155          397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF  476 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~  476 (658)
                      +||||+++++|.+++..  ....++|..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus        83 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  157 (268)
T cd05063          83 IITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVL  157 (268)
T ss_pred             EEEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceec
Confidence            99999999999999854  2356899999999999999999999987   999999999999999999999999999766


Q ss_pred             ccCCCccc-cccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          477 EMDETQGN-TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       477 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      ........ ......+..|+|||++..+.++.++||||||+++|||++ |+.|+.....   .++....    ..+..  
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~~~~~~i----~~~~~--  228 (268)
T cd05063         158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---HEVMKAI----NDGFR--  228 (268)
T ss_pred             ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHHH----hcCCC--
Confidence            43322111 111233567999999998899999999999999999998 9999843221   2222221    11110  


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          555 IIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       555 ~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                        .|.. ...   ...+.+++.+||+.+|++||+|.+|++.|++.
T Consensus       229 --~~~~-~~~---~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         229 --LPAP-MDC---PSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             --CCCC-CCC---CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence              0111 111   13456888999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1e-36  Score=309.88  Aligned_cols=246  Identities=28%  Similarity=0.419  Sum_probs=193.3

Q ss_pred             cccccCceEEEEeEe---cCCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecCCC
Q 006155          331 KLGQGGFGAVYKGRL---YDGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNT  405 (658)
Q Consensus       331 ~lG~G~fg~Vy~~~~---~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g  405 (658)
                      +||+|+||.||+|.+   .++..+|+|+++....  ....++.+|+.++..++||||+++++++. ++..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            689999999999964   3578899999865432  23456889999999999999999999875 45678999999999


Q ss_pred             ChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCcc-c
Q 006155          406 SLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQG-N  484 (658)
Q Consensus       406 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~-~  484 (658)
                      +|.+++..   ...+++..+.+++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.+....... .
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            99999843   346899999999999999999999987   9999999999999999999999999998765433211 1


Q ss_pred             cccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCC
Q 006155          485 TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSG  563 (658)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~  563 (658)
                      .....++..|+|||.+....++.++||||||+++|||++ |+.||.....   ..+....    .++...     .....
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~i----~~~~~~-----~~~~~  222 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---NEVTQMI----ESGERM-----ECPQR  222 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----HCCCCC-----CCCCC
Confidence            122344678999999988889999999999999999998 8888853322   2222222    122111     11112


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          564 SITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       564 ~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      ...   .+.+++.+||+.||++||++.+|+++|++
T Consensus       223 ~~~---~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         223 CPP---EMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCH---HHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            222   34567889999999999999999999976

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=7.5e-37  Score=318.81  Aligned_cols=262  Identities=24%  Similarity=0.346  Sum_probs=195.6

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      .++|...++||+|+||.||+|+.. +++.||||++..... .....+.+|+.+++.++||||+++++++.++...++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            478999999999999999999854 688999999875432 223457889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      |++ ++|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            996 677777643  2345889999999999999999999988   9999999999999999999999999987543221


Q ss_pred             CccccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCC---c----
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGT---T----  552 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~----  552 (658)
                        .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....  +..+.+......+....   .    
T Consensus       158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  233 (303)
T cd07869         158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK--DIQDQLERIFLVLGTPNEDTWPGVH  233 (303)
T ss_pred             --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc--cHHHHHHHHHHHhCCCChhhccchh
Confidence              12233568999999998865 458899999999999999999999985432  12222222211110000   0    


Q ss_pred             -ccccCCCC----CCCCHHH-------HHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          553 -VNIIDPTL----SSGSITE-------MIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       553 -~~~~dp~l----~~~~~~e-------~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                       ....++..    ......+       ...+.+++..|++.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence             00001100    0000000       123457778999999999999999974

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.2e-36  Score=311.48  Aligned_cols=254  Identities=27%  Similarity=0.392  Sum_probs=193.1

Q ss_pred             CcccccCceEEEEeEecC---CcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecCCC
Q 006155          330 NKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNT  405 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~~~---g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g  405 (658)
                      +.||+|+||.||+|+..+   +..+|+|.+..... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999998543   35689998865533 33346889999999999999999999999999999999999999


Q ss_pred             ChhhhhcCcC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCcc
Q 006155          406 SLDHFIFDPT--RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQG  483 (658)
Q Consensus       406 sL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  483 (658)
                      +|.+++....  ....+++..+..++.|+++||.|||+.+   ++||||||+||+++.++++||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999986422  2345678888999999999999999987   9999999999999999999999999987543322222


Q ss_pred             ccccccccccccCccccccC-------CCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccc
Q 006155          484 NTSRIVGTYGYMAPEYAMHG-------QYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNI  555 (658)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~~-------~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  555 (658)
                      ......|+..|+|||++...       .++.++||||||+++|||++ |+.||.....   .+.....+.    +.....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---~~~~~~~~~----~~~~~~  230 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD---EQVLTYTVR----EQQLKL  230 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHHhh----cccCCC
Confidence            22345678899999988642       35789999999999999996 9988853322   222222211    222233


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 006155          556 IDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN  597 (658)
Q Consensus       556 ~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~  597 (658)
                      .+|.+.....+++   .+++..|+ .+|++|||+.+|++.|+
T Consensus       231 ~~~~~~~~~~~~~---~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPRLKLPLSDRW---YEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCccCCCCChHH---HHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            3344433333333   34556788 58999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=8.8e-37  Score=311.83  Aligned_cols=259  Identities=24%  Similarity=0.373  Sum_probs=204.2

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ++|+..+.||+|+||.||+|+.. +++.||||.+....   ......+.+|+.+++.++||||+++++++.+.+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57888999999999999999854 68899999876432   223346889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccccc
Q 006155          400 EFVPNTSLDHFIFDPT-RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~  478 (658)
                      ||+++++|.+++.... ....+++..++.++.||++||.|||+.+   ++|+||||+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999998885322 2346889999999999999999999987   99999999999999999999999999887643


Q ss_pred             CCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCC
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP  558 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp  558 (658)
                      ...  ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+..... ...++....    ....     .+
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-~~~~~~~~~----~~~~-----~~  226 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLFSLCQKI----EQCD-----YP  226 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-cHHHHHHHH----hcCC-----CC
Confidence            221  12235688899999999988899999999999999999999999743221 111222111    1111     11


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          559 TLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       559 ~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      .....  .....+.+++.+||+.+|++||++.+|++.|+..
T Consensus       227 ~~~~~--~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         227 PLPTE--HYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             CCChh--hcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            11111  1113455777899999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=5.3e-37  Score=320.59  Aligned_cols=262  Identities=28%  Similarity=0.381  Sum_probs=202.4

Q ss_pred             hhhccCCcccCcccccCceEEEEeEec--------CCcceeEEEeccCC-cccHHHHHHHHHHHHhc-CCCCceeeeeee
Q 006155          320 RVATDNFSDANKLGQGGFGAVYKGRLY--------DGAEIAVKRLSRDS-GQGDLEFKNEVLLVANL-QHRNLVRLLGFS  389 (658)
Q Consensus       320 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~  389 (658)
                      ++..++|.+.+.||+|+||.||+++..        ++..+|+|.+.... .....++.+|+.++.++ +||||+++++++
T Consensus        14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            344578999999999999999999742        23469999987543 23345688899999999 799999999999


Q ss_pred             ccCCceEEEEEecCCCChhhhhcCcC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCc
Q 006155          390 LEGNERLLIYEFVPNTSLDHFIFDPT-------------RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSN  456 (658)
Q Consensus       390 ~~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~N  456 (658)
                      ...+..++||||+++++|.+++....             ....++|..+++++.|++.||+|||+.+   ++||||||+|
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~N  170 (307)
T cd05098          94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARN  170 (307)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHh
Confidence            99999999999999999999996432             1235899999999999999999999987   9999999999


Q ss_pred             eeeCCCCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCC
Q 006155          457 VLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGET  535 (658)
Q Consensus       457 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~  535 (658)
                      ||++.++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|||++ |+.|+....   
T Consensus       171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~---  247 (307)
T cd05098         171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---  247 (307)
T ss_pred             eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC---
Confidence            9999999999999999876543222122222334578999999999999999999999999999998 777774322   


Q ss_pred             cchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          536 VEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       536 ~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      ..++.....    .+...     .......   ..+.+++..|++.+|++||+|.+|++.|+..
T Consensus       248 ~~~~~~~~~----~~~~~-----~~~~~~~---~~~~~li~~~l~~~p~~Rps~~evl~~l~~~  299 (307)
T cd05098         248 VEELFKLLK----EGHRM-----DKPSNCT---NELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  299 (307)
T ss_pred             HHHHHHHHH----cCCCC-----CCCCcCC---HHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            222222211    11111     1111112   2344678899999999999999999999764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=9e-37  Score=312.34  Aligned_cols=255  Identities=27%  Similarity=0.462  Sum_probs=199.2

Q ss_pred             cCCcccCcccccCceEEEEeEecC-C---cceeEEEeccCC-cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLYD-G---AEIAVKRLSRDS-GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~~-g---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  398 (658)
                      .+|...+.||+|+||.||+|+... +   ..||||.+.... .....+|..|+.+++.++||||+++++++.++...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            457788999999999999998643 3   359999987642 33345789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccccc
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~  478 (658)
                      |||+++++|.+++...  ...+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++.....
T Consensus        84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence            9999999999998542  346899999999999999999999987   99999999999999999999999999876543


Q ss_pred             CCCcccccc-c--cccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          479 DETQGNTSR-I--VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       479 ~~~~~~~~~-~--~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      ......... .  ..+..|+|||++.++.++.++||||||+++||+++ |+.|+....   ..+........+..     
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~---~~~~~~~i~~~~~~-----  230 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS---NQDVINAIEQDYRL-----  230 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC---HHHHHHHHHcCCcC-----
Confidence            322111111 1  12457999999999999999999999999999886 988874322   22222222111110     


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          555 IIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       555 ~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                          ....+...   .+.+++..||+.+|++||+|.+|+.+|+.
T Consensus       231 ----~~~~~~~~---~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  267 (269)
T cd05065         231 ----PPPMDCPT---ALHQLMLDCWQKDRNARPKFGQIVSTLDK  267 (269)
T ss_pred             ----CCcccCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence                00111122   24567889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=6e-37  Score=318.58  Aligned_cols=256  Identities=27%  Similarity=0.401  Sum_probs=197.6

Q ss_pred             cCCcccCcccccCceEEEEeEecC-Cc--ceeEEEeccC-CcccHHHHHHHHHHHHhc-CCCCceeeeeeeccCCceEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLYD-GA--EIAVKRLSRD-SGQGDLEFKNEVLLVANL-QHRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~~-g~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv  398 (658)
                      ++|+..+.||+|+||.||+|+..+ +.  .+++|.++.. .......+.+|+.++.++ +||||+++++++......++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578888999999999999998654 33  4688888743 223445688999999999 799999999999999999999


Q ss_pred             EEecCCCChhhhhcCcC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCe
Q 006155          399 YEFVPNTSLDHFIFDPT-------------RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP  465 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~  465 (658)
                      +||+++++|.+++....             ....+++..++.++.||+.||+|||+.+   ++||||||+|||++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            99999999999985421             1235899999999999999999999987   9999999999999999999


Q ss_pred             EEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHH
Q 006155          466 KIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAW  544 (658)
Q Consensus       466 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~  544 (658)
                      ||+|||++.......   .......+..|+|||++....++.++||||||+++|||++ |+.||....   ..++.....
T Consensus       159 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~---~~~~~~~~~  232 (297)
T cd05089         159 KIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT---CAELYEKLP  232 (297)
T ss_pred             EECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHh
Confidence            999999986432111   1111223567999999998899999999999999999998 988884322   222222221


Q ss_pred             HhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 006155          545 KNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYS  600 (658)
Q Consensus       545 ~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~  600 (658)
                      ..+         .+.......   ..+.+++..||+.+|.+||++.++++.|+...
T Consensus       233 ~~~---------~~~~~~~~~---~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  276 (297)
T cd05089         233 QGY---------RMEKPRNCD---DEVYELMRQCWRDRPYERPPFAQISVQLSRML  276 (297)
T ss_pred             cCC---------CCCCCCCCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            111         111111111   23457888999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-38  Score=294.87  Aligned_cols=266  Identities=23%  Similarity=0.256  Sum_probs=209.4

Q ss_pred             hhhhhhccCCcccCcccccCceEEEEeE-ecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCC--
Q 006155          317 NTIRVATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGN--  393 (658)
Q Consensus       317 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--  393 (658)
                      .++.+..++|.+.++||+|||+.||.++ +.+++.+|+|++.....++.....+|++..++++||||++++++...+.  
T Consensus        14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D   93 (302)
T KOG2345|consen   14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD   93 (302)
T ss_pred             CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence            3455677899999999999999999998 6678999999998887778888999999999999999999999886544  


Q ss_pred             ---ceEEEEEecCCCChhhhhcCcC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEec
Q 006155          394 ---ERLLIYEFVPNTSLDHFIFDPT-RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIAD  469 (658)
Q Consensus       394 ---~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~D  469 (658)
                         +.||+++|...|+|.+.+.... +...+++.+.+.|+.+|.+||++||+.. +++.||||||.|||+.+.+.++|.|
T Consensus        94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D  172 (302)
T KOG2345|consen   94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMD  172 (302)
T ss_pred             CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEe
Confidence               4899999999999999885433 3347999999999999999999999986 5799999999999999999999999


Q ss_pred             cccccccccCCC---c----cccccccccccccCccccc---cCCCCcccccccccchHhHHHhCCCCCccCCC--CCcc
Q 006155          470 FGMARLFEMDET---Q----GNTSRIVGTYGYMAPEYAM---HGQYSVKSDVFSFGVLVLEIISGQRNNCFRNG--ETVE  537 (658)
Q Consensus       470 FGla~~~~~~~~---~----~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~--~~~~  537 (658)
                      ||.+....-.-.   .    ........|..|.|||.+.   +...++++|||||||+||+|+.|..||+....  +...
T Consensus       173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla  252 (302)
T KOG2345|consen  173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA  252 (302)
T ss_pred             ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence            999875431110   0    0111235688999999884   45688999999999999999999999963221  1111


Q ss_pred             hHHHHHHHhccCCCcccccCCCC--CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          538 DLLSSAWKNWREGTTVNIIDPTL--SSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       538 ~l~~~~~~~~~~~~~~~~~dp~l--~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      -.               +..+.+  ...+ .--..+.+++.+|+|.||.+||++.+++..++..
T Consensus       253 LA---------------v~n~q~s~P~~~-~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  253 LA---------------VQNAQISIPNSS-RYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             Ee---------------eeccccccCCCC-CccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence            10               111111  1110 0223456788899999999999999999988753

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-38  Score=310.46  Aligned_cols=279  Identities=24%  Similarity=0.357  Sum_probs=205.7

Q ss_pred             hhccCCcccCcccccCceEEEEeEe-cCCcceeEEEecc--CCcccHHHHHHHHHHHHhcCCCCceeeeeeecc-----C
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSR--DSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLE-----G  392 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-----~  392 (658)
                      .....|...+.||+|.||.|+.+.. .+|+.||||++.+  ......+.-.+|+.+++.++|+||+.+++.+..     -
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f   98 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF   98 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence            3455677788999999999999974 4689999999973  344445567899999999999999999998865     3


Q ss_pred             CceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccc
Q 006155          393 NERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGM  472 (658)
Q Consensus       393 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGl  472 (658)
                      +..|+|+|+| +.+|...|.   ....|+......+++||++||.|+|+.+   |+||||||+|+|++.+..+||+|||+
T Consensus        99 ~DvYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGL  171 (359)
T KOG0660|consen   99 NDVYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGL  171 (359)
T ss_pred             ceeEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccc
Confidence            5779999999 788999883   3445999999999999999999999998   99999999999999999999999999


Q ss_pred             ccccccCCCccccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHh-----
Q 006155          473 ARLFEMDETQGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKN-----  546 (658)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~-----  546 (658)
                      |+...........+..+-|.+|.|||++.. ..||...||||.|||+.||++|+..|...+.-+...++......     
T Consensus       172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~  251 (359)
T KOG0660|consen  172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED  251 (359)
T ss_pred             eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence            998765433344456788999999998765 57999999999999999999999988655433222222211111     


Q ss_pred             ---ccCCCccccc--CCCCCCCCHHHH-----HHHHHHHHHhcCCCCCCCCCHHHHHHH--hccCCCCCCCC
Q 006155          547 ---WREGTTVNII--DPTLSSGSITEM-----IRCIHIGLLCVQENVASRPTMASVVLM--LNSYSLTLPVP  606 (658)
Q Consensus       547 ---~~~~~~~~~~--dp~l~~~~~~e~-----~~~~~i~~~Cl~~~p~~RPtm~evv~~--L~~~~~~~~~p  606 (658)
                         ...+.....+  -|.....+...+     -..+++..++|..||.+|+|++|.++.  |.....+-.+|
T Consensus       252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP  323 (359)
T KOG0660|consen  252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP  323 (359)
T ss_pred             HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence               1100000000  011111111111     124566678999999999999999853  34433334444

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.4e-36  Score=309.28  Aligned_cols=256  Identities=29%  Similarity=0.454  Sum_probs=204.0

Q ss_pred             hhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      +..++|+..++||+|+||.||++...+++.||+|.+.... ....++.+|+.++++++|+||+++++++. .+..+++||
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e   80 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE   80 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence            4567889999999999999999998889999999987543 34567899999999999999999999874 456899999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      |+++++|.+++... ....+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          81 YMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             cCCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence            99999999988542 2356899999999999999999999987   9999999999999999999999999998665322


Q ss_pred             CccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccCCC
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT  559 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~  559 (658)
                      .. ......++..|+|||++..+.++.++||||||+++|||++ |+.|+....   ..+.....    ..+..     +.
T Consensus       157 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---~~~~~~~~----~~~~~-----~~  223 (260)
T cd05067         157 YT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT---NPEVIQNL----ERGYR-----MP  223 (260)
T ss_pred             cc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC---hHHHHHHH----HcCCC-----CC
Confidence            11 1222346778999999999999999999999999999999 898885322   12222221    11111     11


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          560 LSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       560 l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      .......   .+.+++.+|++.+|++||++++++.+|+.
T Consensus       224 ~~~~~~~---~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         224 RPDNCPE---ELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCCCH---HHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            1111122   35677889999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.1e-36  Score=310.72  Aligned_cols=255  Identities=26%  Similarity=0.406  Sum_probs=201.2

Q ss_pred             hccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      ..++|...++||+|+||.||+|+..++..||+|++.... .....+.+|+.++..++||||+++++++.+ ...++||||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~   81 (262)
T cd05071           4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY   81 (262)
T ss_pred             ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence            346789999999999999999987777789999987533 344578999999999999999999998754 557899999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      +++++|.+++... ....++|..++.++.++++||.|||+.+   ++||||||+||+++.++.+||+|||+++.+.....
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          82 MSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             CCCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            9999999999542 2345799999999999999999999987   99999999999999999999999999986654322


Q ss_pred             ccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCC
Q 006155          482 QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTL  560 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l  560 (658)
                      . ......++..|+|||++.++.++.++||||||+++|||++ |+.|+....   ..........    +..     ...
T Consensus       158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~---~~~~~~~~~~----~~~-----~~~  224 (262)
T cd05071         158 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---NREVLDQVER----GYR-----MPC  224 (262)
T ss_pred             c-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---hHHHHHHHhc----CCC-----CCC
Confidence            1 1223456778999999999999999999999999999999 777764322   1122221111    100     011


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          561 SSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       561 ~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      ...   ....+.+++..|++.+|++||++.+++++|+.
T Consensus       225 ~~~---~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~  259 (262)
T cd05071         225 PPE---CPESLHDLMCQCWRKEPEERPTFEYLQAFLED  259 (262)
T ss_pred             ccc---cCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence            111   12345678899999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=7e-37  Score=324.74  Aligned_cols=261  Identities=28%  Similarity=0.395  Sum_probs=199.6

Q ss_pred             hccCCcccCcccccCceEEEEeEe------cCCcceeEEEeccCCcc-cHHHHHHHHHHHHhc-CCCCceeeeeeecc-C
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRL------YDGAEIAVKRLSRDSGQ-GDLEFKNEVLLVANL-QHRNLVRLLGFSLE-G  392 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l-~H~niv~l~~~~~~-~  392 (658)
                      ..++|...+.||+|+||.||+|+.      ..++.||||++...... ....+.+|+.++.++ +||||+++++++.. +
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            457899999999999999999962      34678999999764322 334678999999999 68999999998765 4


Q ss_pred             CceEEEEEecCCCChhhhhcCcCC--------------------------------------------------------
Q 006155          393 NERLLIYEFVPNTSLDHFIFDPTR--------------------------------------------------------  416 (658)
Q Consensus       393 ~~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------  416 (658)
                      ...++||||+++|+|.+++.....                                                        
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            567899999999999998853210                                                        


Q ss_pred             --------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCccccccc
Q 006155          417 --------RAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI  488 (658)
Q Consensus       417 --------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~  488 (658)
                              ...++|..+.+++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++..+............
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence                    124789999999999999999999987   999999999999999999999999999865433222222234


Q ss_pred             cccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCCHHH
Q 006155          489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITE  567 (658)
Q Consensus       489 ~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e  567 (658)
                      .++..|+|||.+.+..++.++||||||+++|||++ |..|+.....  ...+...    ..++.....  |.   ...  
T Consensus       242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~----~~~~~~~~~--~~---~~~--  308 (343)
T cd05103         242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI--DEEFCRR----LKEGTRMRA--PD---YTT--  308 (343)
T ss_pred             CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc--cHHHHHH----HhccCCCCC--CC---CCC--
Confidence            46678999999999999999999999999999997 8888743211  1112111    111111111  11   111  


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          568 MIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       568 ~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                       ..+.+++..||+.+|++||++.+|++.|+..
T Consensus       309 -~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~  339 (343)
T cd05103         309 -PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  339 (343)
T ss_pred             -HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence             1356778899999999999999999999753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-36  Score=313.92  Aligned_cols=251  Identities=26%  Similarity=0.331  Sum_probs=196.8

Q ss_pred             CCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc---ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          325 NFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG---QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      +|+..++||+|+||+||++... +++.||||++.....   .....+.+|+.+++.++||||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4778899999999999999853 588999999865422   223456789999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      |+++|+|.+++... ....+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||+++......
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            99999999887542 2346899999999999999999999987   9999999999999999999999999998654322


Q ss_pred             CccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCC
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTL  560 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l  560 (658)
                      .   .....|+..|+|||++.+..++.++||||||+++|||++|+.||.......   .............      +..
T Consensus       157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~------~~~  224 (285)
T cd05605         157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVERRVKEDQ------EEY  224 (285)
T ss_pred             c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHHHhhhcc------ccc
Confidence            1   223478999999999999999999999999999999999999986433211   1111111111110      011


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 006155          561 SSGSITEMIRCIHIGLLCVQENVASRP-----TMASVVL  594 (658)
Q Consensus       561 ~~~~~~e~~~~~~i~~~Cl~~~p~~RP-----tm~evv~  594 (658)
                      .....   ..+.+++..||+.||++||     ++.++++
T Consensus       225 ~~~~~---~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         225 SEKFS---EAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             CcccC---HHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            11111   2345677899999999999     7778754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.6e-36  Score=312.37  Aligned_cols=250  Identities=24%  Similarity=0.330  Sum_probs=196.3

Q ss_pred             cCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCC-cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          324 DNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDS-GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      ++|+..++||+|+||.||+++. .+++.||+|.+.... .....++.+|+.++.+++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3677889999999999999984 468889999986542 23345688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      +++++|..+.       .+++..+..++.|++.||.|||+.+   |+|+||||+|||++.++.++|+|||++..+...  
T Consensus        81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--  148 (279)
T cd06619          81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--  148 (279)
T ss_pred             CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence            9999997553       4688899999999999999999987   999999999999999999999999999765432  


Q ss_pred             ccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCC
Q 006155          482 QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLS  561 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~  561 (658)
                        ......||..|+|||++.+..++.++||||||+++|||++|+.||.......................     .+.+.
T Consensus       149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~  221 (279)
T cd06619         149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVLP  221 (279)
T ss_pred             --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCCC
Confidence              22335789999999999999999999999999999999999999854322211111111111111111     11111


Q ss_pred             CC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          562 SG-SITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       562 ~~-~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                      .. ...   .+.+++..|++.+|++||++.++++.
T Consensus       222 ~~~~~~---~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         222 VGQFSE---KFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CCcCCH---HHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            11 112   34577789999999999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.8e-36  Score=306.40  Aligned_cols=247  Identities=27%  Similarity=0.396  Sum_probs=196.0

Q ss_pred             CcccccCceEEEEeEecCCcceeEEEeccCCcc-cHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecCCCChh
Q 006155          330 NKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQ-GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLD  408 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~  408 (658)
                      ++||+|+||.||+|...++..+|+|.+...... ....+.+|+.++.+++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            369999999999999888899999998765432 2346889999999999999999999999999999999999999999


Q ss_pred             hhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCccccccc
Q 006155          409 HFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI  488 (658)
Q Consensus       409 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~  488 (658)
                      +++..  ....++|..++.++.+++.+|.|||+.+   ++||||||+||+++.++.+||+|||++......... .....
T Consensus        81 ~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~  154 (250)
T cd05085          81 SFLRK--KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK  154 (250)
T ss_pred             HHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence            98853  2346899999999999999999999987   999999999999999999999999998754332211 11122


Q ss_pred             cccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCCHHH
Q 006155          489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITE  567 (658)
Q Consensus       489 ~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e  567 (658)
                      .++..|+|||++..+.++.++||||||+++||+++ |..|+....   ............+    .     ......   
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~---~~~~~~~~~~~~~----~-----~~~~~~---  219 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT---NQQAREQVEKGYR----M-----SCPQKC---  219 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC---HHHHHHHHHcCCC----C-----CCCCCC---
Confidence            44678999999999999999999999999999998 888874322   1222222211111    0     111111   


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 006155          568 MIRCIHIGLLCVQENVASRPTMASVVLMLN  597 (658)
Q Consensus       568 ~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~  597 (658)
                      ...+.+++..|++.+|++||++.+++++|.
T Consensus       220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         220 PDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            134567888999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9.7e-37  Score=320.94  Aligned_cols=241  Identities=26%  Similarity=0.339  Sum_probs=190.7

Q ss_pred             CcccccCceEEEEeEe----cCCcceeEEEeccCC----cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          330 NKLGQGGFGAVYKGRL----YDGAEIAVKRLSRDS----GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      ++||+|+||.||+++.    ..++.||||.+....    ......+.+|+.++..++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999974    357889999987532    22334578899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      +++++|.+++.   +...+.+..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  154 (323)
T cd05584          82 LSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-  154 (323)
T ss_pred             CCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence            99999999884   3456788899999999999999999988   9999999999999999999999999987533221 


Q ss_pred             ccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCC
Q 006155          482 QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLS  561 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~  561 (658)
                       .......||+.|+|||++.+..++.++||||||+++|||++|+.||....   ....+....    .+.      ..+.
T Consensus       155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~---~~~~~~~~~----~~~------~~~~  220 (323)
T cd05584         155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN---RKKTIDKIL----KGK------LNLP  220 (323)
T ss_pred             -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC---HHHHHHHHH----cCC------CCCC
Confidence             12234579999999999999899999999999999999999999985322   112222211    111      1111


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 006155          562 SGSITEMIRCIHIGLLCVQENVASRP-----TMASVVL  594 (658)
Q Consensus       562 ~~~~~e~~~~~~i~~~Cl~~~p~~RP-----tm~evv~  594 (658)
                      ....+   .+.+++..||+.+|++||     ++.++++
T Consensus       221 ~~~~~---~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         221 PYLTP---EARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CCCCH---HHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            11112   345677899999999999     7888765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.8e-36  Score=310.12  Aligned_cols=254  Identities=25%  Similarity=0.372  Sum_probs=188.7

Q ss_pred             CcccccCceEEEEeEecCC---cceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecCCC
Q 006155          330 NKLGQGGFGAVYKGRLYDG---AEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNT  405 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~~~g---~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g  405 (658)
                      ++||+|+||.||+|+..++   ..+++|.+..... .....+.+|+..++.++|+||+++++.+......++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            3699999999999975543   4578887754432 23446889999999999999999999999999999999999999


Q ss_pred             ChhhhhcCcCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCcc
Q 006155          406 SLDHFIFDPTR--RAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQG  483 (658)
Q Consensus       406 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  483 (658)
                      +|.+++.....  ....++...+.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999865322  234578889999999999999999987   9999999999999999999999999987543322222


Q ss_pred             ccccccccccccCcccccc-------CCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccc
Q 006155          484 NTSRIVGTYGYMAPEYAMH-------GQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNI  555 (658)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~-------~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  555 (658)
                      ......++..|+|||++..       ..++.++||||||+++|||++ |+.|+....   ..+.+.....    .....+
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~---~~~~~~~~~~----~~~~~~  230 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS---DEQVLKQVVR----EQDIKL  230 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC---HHHHHHHHhh----ccCccC
Confidence            2233456778999998743       357889999999999999999 666764321   1222222211    112223


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 006155          556 IDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN  597 (658)
Q Consensus       556 ~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~  597 (658)
                      .+|.+......+..   ++...|+ .||++|||+++|+++|.
T Consensus       231 ~~~~~~~~~~~~~~---~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         231 PKPQLDLKYSDRWY---EVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCCcccccCCHHHH---HHHHHHh-cCcccccCHHHHHHHhc
Confidence            33333322223332   3455677 59999999999999984

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-36  Score=307.09  Aligned_cols=250  Identities=32%  Similarity=0.482  Sum_probs=201.3

Q ss_pred             CcccccCceEEEEeEecC----CcceeEEEeccCCccc-HHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecCC
Q 006155          330 NKLGQGGFGAVYKGRLYD----GAEIAVKRLSRDSGQG-DLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPN  404 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~~~----g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  404 (658)
                      +.||+|+||.||++....    +..|++|.+....... ...+.+|+..+..++|+||+++++++..+...++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999998654    7889999997764433 56789999999999999999999999999999999999999


Q ss_pred             CChhhhhcCcCC------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccccc
Q 006155          405 TSLDHFIFDPTR------RAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       405 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~  478 (658)
                      ++|.+++.....      ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999965321      367999999999999999999999987   99999999999999999999999999987655


Q ss_pred             CCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccC
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID  557 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  557 (658)
                      ...........++..|+|||.+....++.++||||||++++||++ |+.|+....   ..++......    +....  .
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~~~~----~~~~~--~  228 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS---NEEVLEYLRK----GYRLP--K  228 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHHc----CCCCC--C
Confidence            432223344567889999999998899999999999999999999 588875432   2222222211    11111  1


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 006155          558 PTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN  597 (658)
Q Consensus       558 p~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~  597 (658)
                      +   ...   -..+.+++..||+.+|++||++.+++..|+
T Consensus       229 ~---~~~---~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         229 P---EYC---PDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             C---ccC---ChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            1   111   124556778999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-36  Score=308.38  Aligned_cols=257  Identities=29%  Similarity=0.447  Sum_probs=206.3

Q ss_pred             hhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      +..++|.+.++||+|+||.||++...++..+|||.+.... ....++.+|+.++++++|+||+++++++..+...++|||
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE   81 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence            4567899999999999999999998778889999987543 345678999999999999999999999999899999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      |+++++|.+++... ....+++..+..++.+++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.+....
T Consensus        82 ~~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          82 YMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             ccCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            99999999999653 2346899999999999999999999987   9999999999999999999999999998765321


Q ss_pred             CccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccCCC
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT  559 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~  559 (658)
                      . .......++..|+|||.+.+..++.++||||||+++||+++ |+.|+...   .....+.......+.         .
T Consensus       158 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~---~~~~~~~~~~~~~~~---------~  224 (261)
T cd05034         158 Y-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM---TNREVLEQVERGYRM---------P  224 (261)
T ss_pred             h-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHHcCCCC---------C
Confidence            1 11122334678999999998899999999999999999999 88887432   222222222221110         0


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          560 LSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       560 l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      ......   ..+.+++.+|++.+|++||++.++++.|+.
T Consensus       225 ~~~~~~---~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         225 RPPNCP---EELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCC---HHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            011111   235577889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-37  Score=331.40  Aligned_cols=201  Identities=24%  Similarity=0.349  Sum_probs=171.4

Q ss_pred             cCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ++|...++||+|+||.||+++. .+|+.||||++....   ......+.+|+.++.+++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            4688899999999999999974 468899999986532   223345788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            99999999999843   356889999999999999999999988   999999999999999999999999999643211


Q ss_pred             CCc------------c---------------------------------ccccccccccccCccccccCCCCcccccccc
Q 006155          480 ETQ------------G---------------------------------NTSRIVGTYGYMAPEYAMHGQYSVKSDVFSF  514 (658)
Q Consensus       480 ~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~  514 (658)
                      ...            .                                 .....+||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            000            0                                 0012469999999999999999999999999


Q ss_pred             cchHhHHHhCCCCCcc
Q 006155          515 GVLVLEIISGQRNNCF  530 (658)
Q Consensus       515 Gvll~elltG~~p~~~  530 (658)
                      ||++|||++|+.||..
T Consensus       235 Gvil~elltG~~Pf~~  250 (377)
T cd05629         235 GAIMFECLIGWPPFCS  250 (377)
T ss_pred             chhhhhhhcCCCCCCC
Confidence            9999999999999854

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=6.5e-37  Score=328.13  Aligned_cols=258  Identities=20%  Similarity=0.245  Sum_probs=198.7

Q ss_pred             hhhhhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCC
Q 006155          318 TIRVATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGN  393 (658)
Q Consensus       318 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  393 (658)
                      ..+...++|+..++||+|+||.||+++.. +++.||+|++....   ......+.+|+.+++.++||||+++++++.+++
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~  116 (370)
T cd05596          37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK  116 (370)
T ss_pred             cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            34456688999999999999999999854 57889999986431   223345778999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccc
Q 006155          394 ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMA  473 (658)
Q Consensus       394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla  473 (658)
                      ..++||||+++|+|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~  189 (370)
T cd05596         117 YLYMVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC  189 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccce
Confidence            99999999999999999843    35788889999999999999999987   999999999999999999999999999


Q ss_pred             cccccCCCccccccccccccccCccccccC----CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccC
Q 006155          474 RLFEMDETQGNTSRIVGTYGYMAPEYAMHG----QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWRE  549 (658)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  549 (658)
                      +.+..... .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||.....   .........    
T Consensus       190 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~~i~~----  261 (370)
T cd05596         190 MKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---VGTYSKIMD----  261 (370)
T ss_pred             eeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH---HHHHHHHHc----
Confidence            86543221 122345799999999998653    488999999999999999999999853321   112222111    


Q ss_pred             CCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 006155          550 GTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVAS--RPTMASVVLM  595 (658)
Q Consensus       550 ~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~--RPtm~evv~~  595 (658)
                      ... .+..|... ....   .+.+++..|++.+|.+  ||++.+++..
T Consensus       262 ~~~-~~~~~~~~-~~s~---~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         262 HKN-SLTFPDDI-EISK---QAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             CCC-cCCCCCcC-CCCH---HHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            110 01111100 1112   3345667899999988  9999999753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-36  Score=307.66  Aligned_cols=250  Identities=29%  Similarity=0.462  Sum_probs=203.1

Q ss_pred             ccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEec
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFV  402 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  402 (658)
                      .++|+..+.||+|+||.||++.. .|+.||+|.+..... ....+.+|+.++.+++|+||+++++++.+.+..++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            46788899999999999999985 589999999976644 4567899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCc
Q 006155          403 PNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ  482 (658)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  482 (658)
                      ++++|.+++.... ...++|..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++....... 
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-  157 (256)
T cd05039          83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-  157 (256)
T ss_pred             CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence            9999999985422 236899999999999999999999987   99999999999999999999999999986532221 


Q ss_pred             cccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCC
Q 006155          483 GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLS  561 (658)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~  561 (658)
                          ...++..|+|||++..+.++.++||||||+++||+++ |+.|+...   ...++.......+.    ..     ..
T Consensus       158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~---~~~~~~~~~~~~~~----~~-----~~  221 (256)
T cd05039         158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPHVEKGYR----ME-----AP  221 (256)
T ss_pred             ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC---CHHHHHHHHhcCCC----CC-----Cc
Confidence                2334668999999998999999999999999999998 88887432   22233332222111    01     11


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          562 SGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       562 ~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      ....   ..+.+++.+|++.+|++||++.+++++|+.
T Consensus       222 ~~~~---~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         222 EGCP---PEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             cCCC---HHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            1112   234567789999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.9e-36  Score=307.74  Aligned_cols=259  Identities=25%  Similarity=0.389  Sum_probs=205.5

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ++|+..+.||+|+||.||+|... +|+.||+|.++...   ......+.+|+.++++++|+||+++++++.+++..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57889999999999999999865 78999999886432   223456889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccccc
Q 006155          400 EFVPNTSLDHFIFDP-TRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       400 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~  478 (658)
                      ||+++++|..++... .....+++..++.++.++++||.|||+.+   ++||||||+||+++.++.++|+|||+++.+..
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999988542 23456899999999999999999999987   99999999999999999999999999876543


Q ss_pred             CCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCC
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP  558 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp  558 (658)
                      ...  ......|+..|+|||++.+..++.++||||||+++|||++|+.|+.... ....++...    ...+..     +
T Consensus       159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~----~~~~~~-----~  226 (267)
T cd08224         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-MNLYSLCKK----IEKCDY-----P  226 (267)
T ss_pred             CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC-ccHHHHHhh----hhcCCC-----C
Confidence            221  1223468889999999998899999999999999999999999974322 111122111    111111     1


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          559 TLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       559 ~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      .+...  .....+.+++.+||+.+|++||++.+|+++|+..
T Consensus       227 ~~~~~--~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         227 PLPAD--HYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             CCChh--hcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence            11110  1112345778899999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3e-37  Score=325.18  Aligned_cols=242  Identities=21%  Similarity=0.246  Sum_probs=191.0

Q ss_pred             CcccccCceEEEEeEe-cCCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecCCC
Q 006155          330 NKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNT  405 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g  405 (658)
                      +.||+|+||.||+++. .+|+.||+|.+....   ......+.+|+.++..++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999974 468899999987542   223345778999999999999999999999999999999999999


Q ss_pred             ChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCccc
Q 006155          406 SLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE-DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN  484 (658)
Q Consensus       406 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~  484 (658)
                      +|..++..   ...+++..+..++.||+.||.|||+ .+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~  152 (325)
T cd05594          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT  152 (325)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence            99988843   3468999999999999999999997 56   9999999999999999999999999987532221  12


Q ss_pred             cccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCC
Q 006155          485 TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGS  564 (658)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~  564 (658)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||....   ...+......    +.      ..+....
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~---~~~~~~~i~~----~~------~~~p~~~  219 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELILM----EE------IRFPRTL  219 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC---HHHHHHHHhc----CC------CCCCCCC
Confidence            234579999999999999999999999999999999999999985322   1222222211    10      1111111


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 006155          565 ITEMIRCIHIGLLCVQENVASRP-----TMASVVLM  595 (658)
Q Consensus       565 ~~e~~~~~~i~~~Cl~~~p~~RP-----tm~evv~~  595 (658)
                      ..+   +.+++..||+.||++|+     ++.++++.
T Consensus       220 ~~~---~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         220 SPE---AKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CHH---HHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            222   34567789999999996     89998743

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.6e-36  Score=320.11  Aligned_cols=247  Identities=23%  Similarity=0.265  Sum_probs=191.3

Q ss_pred             CcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHhc-CCCCceeeeeeeccCCceEEEEEecCC
Q 006155          330 NKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANL-QHRNLVRLLGFSLEGNERLLIYEFVPN  404 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~  404 (658)
                      +.||+|+||.||+++.. +++.||||+++...   ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999854 57889999997642   22234577899999888 699999999999999999999999999


Q ss_pred             CChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCccc
Q 006155          405 TSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN  484 (658)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~  484 (658)
                      |+|..++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~  152 (329)
T cd05588          81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDT  152 (329)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCc
Confidence            99988874   2356999999999999999999999988   999999999999999999999999998742211  112


Q ss_pred             cccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCC--cchHHHHHHHhccCCCcccccCCCCCC
Q 006155          485 TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGET--VEDLLSSAWKNWREGTTVNIIDPTLSS  562 (658)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~dp~l~~  562 (658)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ......+.........      ..+..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~~p~  226 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ------IRIPR  226 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC------CCCCC
Confidence            334679999999999999999999999999999999999999996432211  1111122222222111      11111


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCC------HHHHH
Q 006155          563 GSITEMIRCIHIGLLCVQENVASRPT------MASVV  593 (658)
Q Consensus       563 ~~~~e~~~~~~i~~~Cl~~~p~~RPt------m~evv  593 (658)
                      ....   .+.+++..||+.||.+||+      +.+++
T Consensus       227 ~~~~---~~~~li~~~L~~dP~~R~~~~~~~~~~~i~  260 (329)
T cd05588         227 SLSV---KASSVLKGFLNKDPKERLGCHPQTGFRDIK  260 (329)
T ss_pred             CCCH---HHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence            1112   3456778999999999997      66765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=6.5e-37  Score=312.80  Aligned_cols=258  Identities=24%  Similarity=0.381  Sum_probs=203.8

Q ss_pred             cCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCc---ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSG---QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ++|+..+.||+|+||.||+++. .+++.++||.+.....   ....++.+|+.+++.++|+||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4688889999999999999984 4789999998765322   23356889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccccc
Q 006155          400 EFVPNTSLDHFIFDP-TRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       400 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~  478 (658)
                      ||+++++|.+++... .....++|..++.++.+|++||.|||+.+   ++|+||||+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999988532 23456899999999999999999999987   99999999999999999999999999876543


Q ss_pred             CCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCC
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP  558 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp  558 (658)
                      ...  ......|+..|+|||++.+..++.++||||||+++|||++|..|+.... .+...+..    ...     ....+
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~----~~~-----~~~~~  226 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-MNLYSLCK----KIE-----QCDYP  226 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc-chHHHHhh----hhh-----cCCCC
Confidence            321  1223568899999999998899999999999999999999999974321 11111111    111     11112


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          559 TLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       559 ~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      .+.....  ...+.+++.+||+.+|++||||.+|++++.+
T Consensus       227 ~~~~~~~--~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~  264 (267)
T cd08229         227 PLPSDHY--SEELRQLVNMCINPDPEKRPDITYVYDVAKR  264 (267)
T ss_pred             CCCcccc--cHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence            2222211  1234467789999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.4e-36  Score=320.53  Aligned_cols=242  Identities=24%  Similarity=0.286  Sum_probs=187.6

Q ss_pred             CcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHhc-CCCCceeeeeeeccCCceEEEEEecCC
Q 006155          330 NKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANL-QHRNLVRLLGFSLEGNERLLIYEFVPN  404 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~  404 (658)
                      +.||+|+||.||+++.. +++.+|+|++....   ......+.+|+.++.++ +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999854 57889999987642   22334567888888777 799999999999999999999999999


Q ss_pred             CChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCccc
Q 006155          405 TSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN  484 (658)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~  484 (658)
                      |+|..++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~  152 (329)
T cd05618          81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT  152 (329)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence            99988874   3356899999999999999999999987   9999999999999999999999999987532211  12


Q ss_pred             cccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCC--cchHHHHHHHhccCCCcccccCCCCCC
Q 006155          485 TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGET--VEDLLSSAWKNWREGTTVNIIDPTLSS  562 (658)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~dp~l~~  562 (658)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......  ......+.+.....+..      .+..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~p~  226 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RIPR  226 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------CCCC
Confidence            334679999999999999999999999999999999999999985322111  11112222222222111      1111


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCC
Q 006155          563 GSITEMIRCIHIGLLCVQENVASRPT  588 (658)
Q Consensus       563 ~~~~e~~~~~~i~~~Cl~~~p~~RPt  588 (658)
                      ...   ..+.+++..||+.||++||+
T Consensus       227 ~~~---~~~~~ll~~~L~~dP~~R~~  249 (329)
T cd05618         227 SLS---VKAASVLKSFLNKDPKERLG  249 (329)
T ss_pred             CCC---HHHHHHHHHHhcCCHHHcCC
Confidence            111   23456778999999999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.3e-36  Score=316.78  Aligned_cols=261  Identities=28%  Similarity=0.368  Sum_probs=203.2

Q ss_pred             hhhccCCcccCcccccCceEEEEeEec------CCcceeEEEeccCCc-ccHHHHHHHHHHHHhc-CCCCceeeeeeecc
Q 006155          320 RVATDNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANL-QHRNLVRLLGFSLE  391 (658)
Q Consensus       320 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~  391 (658)
                      ....++|...+.||+|+||.||++...      .+..||||+++.... .....+.+|+.+++++ +||||+++++++..
T Consensus        31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  110 (302)
T cd05055          31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI  110 (302)
T ss_pred             cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence            344578999999999999999999742      245799998876532 2335688999999999 79999999999999


Q ss_pred             CCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccc
Q 006155          392 GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFG  471 (658)
Q Consensus       392 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFG  471 (658)
                      .+..++||||+++|+|.+++.... ...+++..+..++.+|+.||.|||+.+   ++|+||||+|||++.++.++|+|||
T Consensus       111 ~~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg  186 (302)
T cd05055         111 GGPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFG  186 (302)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCc
Confidence            999999999999999999985422 234899999999999999999999987   9999999999999999999999999


Q ss_pred             cccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCC
Q 006155          472 MARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREG  550 (658)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~  550 (658)
                      +++.+.............++..|+|||++.++.++.++||||||+++|||++ |+.|+.....  ...+.....    .+
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~--~~~~~~~~~----~~  260 (302)
T cd05055         187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV--DSKFYKLIK----EG  260 (302)
T ss_pred             ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc--hHHHHHHHH----cC
Confidence            9986543322212223356788999999999999999999999999999998 8888743221  111111111    11


Q ss_pred             CcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          551 TTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       551 ~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      ..     +.......   ..+.+++..|++.+|++||++.+|++.|+.
T Consensus       261 ~~-----~~~~~~~~---~~~~~li~~cl~~~p~~Rpt~~ell~~l~~  300 (302)
T cd05055         261 YR-----MAQPEHAP---AEIYDIMKTCWDADPLKRPTFKQIVQLIGK  300 (302)
T ss_pred             Cc-----CCCCCCCC---HHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence            10     00111111   245678889999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=5.7e-37  Score=322.87  Aligned_cols=244  Identities=26%  Similarity=0.296  Sum_probs=189.2

Q ss_pred             CcccCcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHH---HhcCCCCceeeeeeeccCCceEEE
Q 006155          326 FSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLV---ANLQHRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       326 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l---~~l~H~niv~l~~~~~~~~~~~lv  398 (658)
                      |...+.||+|+||.||+++.. +|+.||||++....   ......+..|+.++   ..++||||+++++++..++..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            566789999999999999854 58899999987542   22233466666554   566899999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccccc
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~  478 (658)
                      |||+++++|..++.    ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            99999999998874    246999999999999999999999987   99999999999999999999999999874322


Q ss_pred             CCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCC
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP  558 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp  558 (658)
                      .  ........||+.|+|||++.+..++.++||||||+++|||++|+.||....   ..+.......    +.      +
T Consensus       154 ~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~---~~~~~~~i~~----~~------~  218 (324)
T cd05589         154 F--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD---EEEVFDSIVN----DE------V  218 (324)
T ss_pred             C--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHh----CC------C
Confidence            1  122334679999999999999999999999999999999999999985322   2222222111    11      1


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 006155          559 TLSSGSITEMIRCIHIGLLCVQENVASRPT-----MASVVL  594 (658)
Q Consensus       559 ~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPt-----m~evv~  594 (658)
                      ........   .+.+++.+||+.||.+||+     +.++++
T Consensus       219 ~~p~~~~~---~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         219 RYPRFLSR---EAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             CCCCCCCH---HHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            11111112   2446778999999999994     555554

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4e-37  Score=330.91  Aligned_cols=202  Identities=23%  Similarity=0.367  Sum_probs=171.8

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ++|+..+.||+|+||.||+++.. .++.||||++....   ......+.+|+.++.+++|+||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36889999999999999999844 58899999986532   223445789999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ||+++|+|.+++..   ...+++.....++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~  154 (376)
T cd05598          81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (376)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence            99999999999843   346888999999999999999999988   999999999999999999999999997543210


Q ss_pred             CC-----------------------------------------ccccccccccccccCccccccCCCCcccccccccchH
Q 006155          480 ET-----------------------------------------QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLV  518 (658)
Q Consensus       480 ~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll  518 (658)
                      ..                                         .......+||+.|||||++.+..++.++|||||||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  234 (376)
T cd05598         155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  234 (376)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence            00                                         0011235799999999999999999999999999999


Q ss_pred             hHHHhCCCCCccC
Q 006155          519 LEIISGQRNNCFR  531 (658)
Q Consensus       519 ~elltG~~p~~~~  531 (658)
                      |||++|+.||...
T Consensus       235 yell~G~~Pf~~~  247 (376)
T cd05598         235 YEMLVGQPPFLAD  247 (376)
T ss_pred             eehhhCCCCCCCC
Confidence            9999999998543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.4e-36  Score=313.10  Aligned_cols=246  Identities=24%  Similarity=0.295  Sum_probs=191.0

Q ss_pred             ccccCceEEEEeEec-CCcceeEEEeccCCcc---cHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecCCCCh
Q 006155          332 LGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQ---GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSL  407 (658)
Q Consensus       332 lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  407 (658)
                      ||+|+||+||+++.. +|+.+|+|.+......   ....+..|+.+++.++|+||+++.+++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999854 6889999998654222   234567899999999999999999999999999999999999999


Q ss_pred             hhhhcCc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCccccc
Q 006155          408 DHFIFDP-TRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTS  486 (658)
Q Consensus       408 ~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  486 (658)
                      ..++... .....+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++..+.....  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            9887532 23456899999999999999999999987   99999999999999999999999999976544322  223


Q ss_pred             cccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCCHH
Q 006155          487 RIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSIT  566 (658)
Q Consensus       487 ~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~  566 (658)
                      ...||+.|+|||++.+..++.++||||||+++|||++|+.||.........   .........+.      ........ 
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~------~~~~~~~~-  225 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN---KELKQRILNDS------VTYPDKFS-  225 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH---HHHHHhhcccC------CCCcccCC-
Confidence            457899999999999999999999999999999999999998543221111   11111111110      01111111 


Q ss_pred             HHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 006155          567 EMIRCIHIGLLCVQENVASRP-----TMASVVL  594 (658)
Q Consensus       567 e~~~~~~i~~~Cl~~~p~~RP-----tm~evv~  594 (658)
                        ..+.+++..||+.||++||     +++++++
T Consensus       226 --~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         226 --PASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             --HHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence              2345677899999999999     6666664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.1e-36  Score=311.16  Aligned_cols=256  Identities=24%  Similarity=0.344  Sum_probs=199.6

Q ss_pred             hccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      ..++|+..+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++.+++||||+++++.+..++..++|+|
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e   86 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME   86 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence            346799999999999999999985 4688899999876554555568899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      |+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++..+....
T Consensus        87 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          87 YCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence            9999999998843   346899999999999999999999987   9999999999999999999999999998654321


Q ss_pred             CccccccccccccccCccccc---cCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccC
Q 006155          481 TQGNTSRIVGTYGYMAPEYAM---HGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID  557 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  557 (658)
                        .......|+..|+|||.+.   ...++.++||||||+++|||++|+.|+........  .     ..+....   ...
T Consensus       161 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--~-----~~~~~~~---~~~  228 (267)
T cd06646         161 --AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--L-----FLMSKSN---FQP  228 (267)
T ss_pred             --cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--h-----eeeecCC---CCC
Confidence              1223356889999999874   44578899999999999999999998742221110  0     0000000   011


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 006155          558 PTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLML  596 (658)
Q Consensus       558 p~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L  596 (658)
                      +..... ......+.+++..||+.+|++||+++++++.|
T Consensus       229 ~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         229 PKLKDK-TKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCCccc-cccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            111110 01112345677899999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.1e-36  Score=306.83  Aligned_cols=250  Identities=27%  Similarity=0.388  Sum_probs=201.1

Q ss_pred             CCcccCcccccCceEEEEeEec-CCcceeEEEeccC--CcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          325 NFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRD--SGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      +|...+.||+|++|.||+++.. +++.|++|.+...  ......++.+|+.++++++||||+++++++.+++..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4677889999999999999854 5888999988643  233455688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      +++++|.+++... ....+++..+++++.+++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++.+.....
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            9999999998653 2356899999999999999999999987   99999999999999999999999999886654322


Q ss_pred             ccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCC
Q 006155          482 QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLS  561 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~  561 (658)
                        ......|++.|+|||++.++.++.++||||||+++|||++|+.|+....   ........    ..+..     +.+.
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~----~~~~~-----~~~~  222 (256)
T cd08529         157 --FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN---QGALILKI----IRGVF-----PPVS  222 (256)
T ss_pred             --hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHH----HcCCC-----CCCc
Confidence              1233568899999999999999999999999999999999999985332   11222211    11111     1111


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          562 SGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       562 ~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                      ..   .-..+.+++.+||+.+|++||++.++++.
T Consensus       223 ~~---~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         223 QM---YSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             cc---cCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            11   11245678889999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2e-36  Score=317.25  Aligned_cols=262  Identities=29%  Similarity=0.403  Sum_probs=202.2

Q ss_pred             hhccCCcccCcccccCceEEEEeEec--------CCcceeEEEeccCCc-ccHHHHHHHHHHHHhc-CCCCceeeeeeec
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLY--------DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANL-QHRNLVRLLGFSL  390 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~  390 (658)
                      ...++|...++||+|+||.||+++..        ....+|+|.+..... ....++.+|+.++.++ +||||+++++++.
T Consensus         9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099           9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            34567888999999999999999732        245689998875432 3345688999999999 6999999999999


Q ss_pred             cCCceEEEEEecCCCChhhhhcCcC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCce
Q 006155          391 EGNERLLIYEFVPNTSLDHFIFDPT-------------RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNV  457 (658)
Q Consensus       391 ~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NI  457 (658)
                      ++...++||||+++|+|.+++....             ....++|..+.+++.||+.||.|||+.+   ++||||||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni  165 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNV  165 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeE
Confidence            9999999999999999999985422             1245899999999999999999999987   99999999999


Q ss_pred             eeCCCCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCc
Q 006155          458 LLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETV  536 (658)
Q Consensus       458 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~  536 (658)
                      |++.++.+||+|||+++...............++..|+|||++.++.++.++||||||+++|||++ |..|+....   .
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~---~  242 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP---V  242 (314)
T ss_pred             EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC---H
Confidence            999999999999999986643222211222334568999999999999999999999999999999 787774322   2


Q ss_pred             chHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 006155          537 EDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYS  600 (658)
Q Consensus       537 ~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~  600 (658)
                      .++.....    .+...+     .......   .+.+++.+||+.+|++||++.++++.|....
T Consensus       243 ~~~~~~~~----~~~~~~-----~~~~~~~---~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~  294 (314)
T cd05099         243 EELFKLLR----EGHRMD-----KPSNCTH---ELYMLMRECWHAVPTQRPTFKQLVEALDKVL  294 (314)
T ss_pred             HHHHHHHH----cCCCCC-----CCCCCCH---HHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            22222221    111111     1111122   3446788999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.1e-36  Score=310.73  Aligned_cols=240  Identities=23%  Similarity=0.354  Sum_probs=186.6

Q ss_pred             CcccccCceEEEEeEecC-------------CcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceE
Q 006155          330 NKLGQGGFGAVYKGRLYD-------------GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERL  396 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~~~-------------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  396 (658)
                      +.||+|+||.||+|+...             ...|++|.+..........+.+|+.++..++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998532             2258999887655555567889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCC-------eEEec
Q 006155          397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMT-------PKIAD  469 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~-------~kl~D  469 (658)
                      +||||+++++|+.++..  ....+++..+++++.||++||.|||+.+   |+||||||+|||++.++.       ++++|
T Consensus        81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            99999999999988843  2346899999999999999999999987   999999999999987664       89999


Q ss_pred             cccccccccCCCccccccccccccccCccccc-cCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhc
Q 006155          470 FGMARLFEMDETQGNTSRIVGTYGYMAPEYAM-HGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNW  547 (658)
Q Consensus       470 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~  547 (658)
                      ||++..+...      ....++..|+|||++. +..++.++||||||+++|||++ |+.|+......   +.. ..+   
T Consensus       156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~-~~~---  222 (262)
T cd05077         156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA---EKE-RFY---  222 (262)
T ss_pred             CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh---HHH-HHH---
Confidence            9998754321      2246788999999887 4668999999999999999984 76665322111   111 111   


Q ss_pred             cCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 006155          548 REGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN  597 (658)
Q Consensus       548 ~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~  597 (658)
                      . +. ....     ....+   .+.+++..||+.||++||++.+|++.|+
T Consensus       223 ~-~~-~~~~-----~~~~~---~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         223 E-GQ-CMLV-----TPSCK---ELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             h-cC-ccCC-----CCChH---HHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            1 10 0011     11122   3457788999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.1e-36  Score=307.25  Aligned_cols=249  Identities=30%  Similarity=0.428  Sum_probs=197.7

Q ss_pred             CcccccCceEEEEeEecC--C--cceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecCC
Q 006155          330 NKLGQGGFGAVYKGRLYD--G--AEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPN  404 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~~~--g--~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  404 (658)
                      ++||+|++|.||+|...+  +  ..||||.+..... .....+.+|+.++++++||||+++++++.+ ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998643  2  2589999987655 455678999999999999999999999988 889999999999


Q ss_pred             CChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCc-c
Q 006155          405 TSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ-G  483 (658)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~-~  483 (658)
                      ++|.+++.+... ..++|...+.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.+...... .
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999865332 56899999999999999999999987   999999999999999999999999999876543221 1


Q ss_pred             ccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCC
Q 006155          484 NTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSS  562 (658)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~  562 (658)
                      ......++..|+|||++.+..++.++||||||+++|||++ |+.|+...   ...+.......   ...  ....+   .
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~---~~~~~~~~~~~---~~~--~~~~~---~  224 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL---SGSQILKKIDK---EGE--RLERP---E  224 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHHh---cCC--cCCCC---c
Confidence            2223457889999999999999999999999999999999 99987432   22223222221   110  00001   1


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 006155          563 GSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN  597 (658)
Q Consensus       563 ~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~  597 (658)
                      ..   ...+.+++.+|++.+|++||++.+|++.|.
T Consensus       225 ~~---~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         225 AC---PQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             cC---CHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            11   124557888999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=7.4e-37  Score=327.43  Aligned_cols=206  Identities=23%  Similarity=0.314  Sum_probs=175.4

Q ss_pred             hhhhhhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccC---CcccHHHHHHHHHHHHhcCCCCceeeeeeeccC
Q 006155          317 NTIRVATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRD---SGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEG  392 (658)
Q Consensus       317 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~  392 (658)
                      ..+....++|+..+.||+|+||.||+++.. +++.+|+|.+...   .......+.+|+.++..++||||+++++++.++
T Consensus        36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (370)
T cd05621          36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD  115 (370)
T ss_pred             HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            344556789999999999999999999854 4788999998642   122334578899999999999999999999999


Q ss_pred             CceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccc
Q 006155          393 NERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGM  472 (658)
Q Consensus       393 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGl  472 (658)
                      +..++||||+++|+|.+++..    ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~  188 (370)
T cd05621         116 KYLYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGT  188 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccc
Confidence            999999999999999999842    35889999999999999999999987   99999999999999999999999999


Q ss_pred             ccccccCCCccccccccccccccCccccccC----CCCcccccccccchHhHHHhCCCCCcc
Q 006155          473 ARLFEMDETQGNTSRIVGTYGYMAPEYAMHG----QYSVKSDVFSFGVLVLEIISGQRNNCF  530 (658)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDV~S~Gvll~elltG~~p~~~  530 (658)
                      +..+..... .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||..
T Consensus       189 a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~  249 (370)
T cd05621         189 CMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA  249 (370)
T ss_pred             ceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC
Confidence            987643221 122346799999999998654    378999999999999999999999853

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=5.9e-37  Score=330.26  Aligned_cols=200  Identities=25%  Similarity=0.367  Sum_probs=170.7

Q ss_pred             CCcccCcccccCceEEEEeEe-cCCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          325 NFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      .|+..++||+|+||.||+++. .+++.+|+|++....   ......+.+|+.++++++||||+++++.+.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            578899999999999999985 457889999986542   2233467899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      |+++|+|.+++..   ...+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+....
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            9999999999843   346889999999999999999999987   9999999999999999999999999975432100


Q ss_pred             C---------------------------------------------ccccccccccccccCccccccCCCCccccccccc
Q 006155          481 T---------------------------------------------QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFG  515 (658)
Q Consensus       481 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~G  515 (658)
                      .                                             .......+||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence            0                                             0001235799999999999999999999999999


Q ss_pred             chHhHHHhCCCCCcc
Q 006155          516 VLVLEIISGQRNNCF  530 (658)
Q Consensus       516 vll~elltG~~p~~~  530 (658)
                      |++|||++|+.||..
T Consensus       236 vil~elltG~~Pf~~  250 (382)
T cd05625         236 VILYEMLVGQPPFLA  250 (382)
T ss_pred             HHHHHHHhCCCCCCC
Confidence            999999999999854

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.7e-36  Score=310.64  Aligned_cols=256  Identities=27%  Similarity=0.440  Sum_probs=199.3

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCc----ceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGA----EIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERL  396 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  396 (658)
                      .++|+..++||+|+||+||+|+. .+|.    .||+|.+..... ....++.+|+.++..++|+||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            46788899999999999999984 3454    379998865433 3345688999999999999999999998754 567


Q ss_pred             EEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccc
Q 006155          397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF  476 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~  476 (658)
                      +++||+++|+|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+
T Consensus        85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence            999999999999998542  346899999999999999999999987   999999999999999999999999999876


Q ss_pred             ccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccc
Q 006155          477 EMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNI  555 (658)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  555 (658)
                      .............++..|+|||.+.+..++.++||||||+++|||++ |..|+....   ...+... ..   .+.... 
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~-~~---~~~~~~-  231 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP---AREIPDL-LE---KGERLP-  231 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHH-HH---CCCcCC-
Confidence            54332222222345678999999999999999999999999999998 888874322   1122211 11   111111 


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          556 IDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       556 ~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                          ......   ..+.+++..||+.||++||++.+++..|+..
T Consensus       232 ----~~~~~~---~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~  268 (279)
T cd05109         232 ----QPPICT---IDVYMIMVKCWMIDSECRPRFRELVDEFSRM  268 (279)
T ss_pred             ----CCccCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence                111111   2355678899999999999999999998764

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2e-36  Score=309.55  Aligned_cols=256  Identities=25%  Similarity=0.446  Sum_probs=200.6

Q ss_pred             ccCCcccCcccccCceEEEEeEec-C---CcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-D---GAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~---g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  397 (658)
                      .++|...+.||+|+||.||+|+.. .   +..+|+|.++.... .....+.+|+.++.+++||||+++++++..++..++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            357888899999999999999853 2   33689998865432 234568999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE  477 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~  477 (658)
                      ||||+++++|.+++...  ...+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++..+.
T Consensus        83 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          83 VTEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence            99999999999998542  346899999999999999999999987   9999999999999999999999999998765


Q ss_pred             cCCCcc-ccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccc
Q 006155          478 MDETQG-NTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNI  555 (658)
Q Consensus       478 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  555 (658)
                      ...... ......++..|+|||++.++.++.++||||||+++||+++ |+.|+.....   .+........++       
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~---~~~~~~~~~~~~-------  227 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN---QDVIKAIEEGYR-------  227 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH---HHHHHHHhCCCc-------
Confidence            432211 1122234568999999999999999999999999999887 9988743221   222222211111       


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          556 IDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       556 ~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                        +........   .+.+++..|++.+|.+||+|.++++.|+.
T Consensus       228 --~~~~~~~~~---~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  265 (267)
T cd05066         228 --LPAPMDCPA---ALHQLMLDCWQKDRNERPKFEQIVSILDK  265 (267)
T ss_pred             --CCCCCCCCH---HHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence              011111112   34577889999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.5e-37  Score=315.12  Aligned_cols=239  Identities=23%  Similarity=0.312  Sum_probs=185.4

Q ss_pred             cccccCceEEEEeEecC-------------------------CcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceee
Q 006155          331 KLGQGGFGAVYKGRLYD-------------------------GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRL  385 (658)
Q Consensus       331 ~lG~G~fg~Vy~~~~~~-------------------------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l  385 (658)
                      .||+|+||.||+|.+..                         ...|++|++.........++.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997421                         13488998866544445578899999999999999999


Q ss_pred             eeeeccCCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCC--
Q 006155          386 LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM--  463 (658)
Q Consensus       386 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~--  463 (658)
                      ++++.++...++||||+++|+|..++..  ....+++..+.+++.||++||+|||+.+   |+||||||+|||++..+  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence            9999999999999999999999999853  2346889999999999999999999987   99999999999997654  


Q ss_pred             -----CeEEeccccccccccCCCccccccccccccccCcccccc-CCCCcccccccccchHhHHH-hCCCCCccCCCCCc
Q 006155          464 -----TPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEII-SGQRNNCFRNGETV  536 (658)
Q Consensus       464 -----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~ell-tG~~p~~~~~~~~~  536 (658)
                           .+|++|||++......      ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+....... 
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-  229 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE-  229 (274)
T ss_pred             cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH-
Confidence                 3799999987643221      12357788999998865 56899999999999999995 6888875332211 


Q ss_pred             chHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 006155          537 EDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN  597 (658)
Q Consensus       537 ~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~  597 (658)
                        ........           ..+.....   ..+.+++..||+.+|++||++.+|++.|+
T Consensus       230 --~~~~~~~~-----------~~~~~~~~---~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         230 --KERFYEKK-----------HRLPEPSC---KELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             --HHHHHHhc-----------cCCCCCCC---hHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence              11111110           00111111   23567888999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.3e-37  Score=319.17  Aligned_cols=251  Identities=25%  Similarity=0.372  Sum_probs=205.7

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCc-eEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNE-RLLIY  399 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~lv~  399 (658)
                      ++|...+++|+|.||.++..+.+ ++..+++|.+....  ........+|+.++++++|||||.+.+.+.+++. .++||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57888999999999999988743 57789999876543  3333457889999999999999999999998888 89999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      +|++||+|.+.|... +...++++.+++|+.||+.|+.|||++.   |+|||||+.|||++.+..+||+|||+|+.+...
T Consensus        84 ~Y~eGg~l~~~i~~~-k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQ-KGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            999999999999653 3567899999999999999999999876   999999999999999999999999999988765


Q ss_pred             CCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCC
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT  559 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~  559 (658)
                      .  ......+||+.||.||++.+.+|..|+|||||||++|||++-+++|...   +...++....+..        ++| 
T Consensus       160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~---~m~~Li~ki~~~~--------~~P-  225 (426)
T KOG0589|consen  160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS---NMSELILKINRGL--------YSP-  225 (426)
T ss_pred             h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc---chHHHHHHHhhcc--------CCC-
Confidence            4  2345579999999999999999999999999999999999999998533   3334444333221        222 


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          560 LSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       560 l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                      +.+....++.   .++..|++.+|+.||++.+++.+
T Consensus       226 lp~~ys~el~---~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  226 LPSMYSSELR---SLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CCccccHHHH---HHHHHHhhcCCccCCCHHHHhhC
Confidence            2222233333   45568999999999999999965

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2e-36  Score=316.32  Aligned_cols=261  Identities=24%  Similarity=0.317  Sum_probs=197.7

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      ++|+..++||+|+||.||+++.. ++..+|+|.+..... ....++.+|++++.+++||||+++++++.+++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46888999999999999999854 577889998865432 2234588999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      +++++|.+++..   ...+++..+..++.|+++||.|||+..  +++||||||+|||++.++.+||+|||++......  
T Consensus        81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  153 (308)
T cd06615          81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  153 (308)
T ss_pred             cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence            999999999843   356899999999999999999999742  3999999999999999999999999998754322  


Q ss_pred             ccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcc--------
Q 006155          482 QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTV--------  553 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~--------  553 (658)
                        ......|+..|+|||++.+..++.++||||||+++|||++|+.|+...........+.............        
T Consensus       154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (308)
T cd06615         154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP  231 (308)
T ss_pred             --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence              1233578999999999988889999999999999999999999985332211111111000000000000        


Q ss_pred             ---------c-------ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          554 ---------N-------IIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       554 ---------~-------~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                               +       -..|.+....  .-..+.+++.+||+.+|++||++.+|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         232 DSPRPMAIFELLDYIVNEPPPKLPSGA--FSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CccchhhHHHHHHHHhcCCCccCcCcc--cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                     0       0001111110  01235678889999999999999999854

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.1e-37  Score=315.04  Aligned_cols=262  Identities=26%  Similarity=0.407  Sum_probs=199.8

Q ss_pred             cCCcccCcccccCceEEEEeEe-----cCCcceeEEEeccCC-cccHHHHHHHHHHHHhcCCCCceeeeeeeccC--Cce
Q 006155          324 DNFSDANKLGQGGFGAVYKGRL-----YDGAEIAVKRLSRDS-GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEG--NER  395 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~  395 (658)
                      ..|+..+.||+|+||.||+++.     .++..||+|.+.... ......+.+|+.+++.++||||+++.+++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4568889999999999999973     357789999987553 23345689999999999999999999998765  567


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ++||||+++++|.+++...  ...++|..++.++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence            8999999999999998432  236899999999999999999999987   99999999999999999999999999987


Q ss_pred             cccCCCc-cccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCC--------CCcchHHHHHHHh
Q 006155          476 FEMDETQ-GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNG--------ETVEDLLSSAWKN  546 (658)
Q Consensus       476 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~--------~~~~~l~~~~~~~  546 (658)
                      +...... .......++..|+|||++.+..++.++||||||+++|||++++.|......        .............
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            6543221 122234567789999999988999999999999999999998765422110        0011111111111


Q ss_pred             ccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          547 WREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       547 ~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      ...+....     .....   ...+.+++.+|++.+|++||++.++++.|+.
T Consensus       239 ~~~~~~~~-----~~~~~---~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  282 (284)
T cd05079         239 LEEGKRLP-----RPPNC---PEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA  282 (284)
T ss_pred             HHcCccCC-----CCCCC---CHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence            11111111     11111   2346678889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-38  Score=337.09  Aligned_cols=253  Identities=30%  Similarity=0.476  Sum_probs=209.5

Q ss_pred             CCcccCcccccCceEEEEeEe-cCCc----ceeEEEeccC-CcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEE
Q 006155          325 NFSDANKLGQGGFGAVYKGRL-YDGA----EIAVKRLSRD-SGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~-~~g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  398 (658)
                      .....++||+|.||+||+|.+ .+|+    +||+|++... ..+...++.+|+..|.+|+||||++|+|+|.... ..||
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv  775 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV  775 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence            345577899999999999984 3443    6899988665 4456678999999999999999999999998877 8899


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccccc
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~  478 (658)
                      ++||+.|+|.++++.  .+..+.-+..+.|..|||+||.|||++.   +|||||..+||||.+-..+||.|||+++++..
T Consensus       776 tq~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~  850 (1177)
T KOG1025|consen  776 TQLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAP  850 (1177)
T ss_pred             HHhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence            999999999999965  5567888999999999999999999886   99999999999999999999999999999988


Q ss_pred             CCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccC
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID  557 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  557 (658)
                      +..........-.+.|||-|.+....|+.++|||||||.+|||+| |.+|.......++.++++.       +..  +-.
T Consensus       851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~-------geR--Lsq  921 (1177)
T KOG1025|consen  851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK-------GER--LSQ  921 (1177)
T ss_pred             ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc-------ccc--CCC
Confidence            776666655666789999999999999999999999999999999 7778755444444444332       211  222


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          558 PTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       558 p~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      |.+      --+.+..+++.||..|+..||+++++...+..
T Consensus       922 Ppi------CtiDVy~~mvkCwmid~~~rp~fkel~~~fs~  956 (1177)
T KOG1025|consen  922 PPI------CTIDVYMVMVKCWMIDADSRPTFKELAEEFSR  956 (1177)
T ss_pred             CCC------ccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence            222      23557778899999999999999999876653

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=4.8e-36  Score=305.44  Aligned_cols=254  Identities=28%  Similarity=0.434  Sum_probs=199.6

Q ss_pred             ccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEec
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFV  402 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  402 (658)
                      .++|...++||+|+||.||++....+..+|+|++.... .....+.+|+.++++++|+|++++++++. .+..++||||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM   82 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence            45688889999999999999987777789999876543 34456889999999999999999999875 45678999999


Q ss_pred             CCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCc
Q 006155          403 PNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ  482 (658)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  482 (658)
                      ++++|.+++... ....++|..+..++.+++.||.|||+.+   ++|+||||+||++++++.++|+|||++..+......
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05069          83 GKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence            999999998542 2345899999999999999999999987   999999999999999999999999999866433211


Q ss_pred             cccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCC
Q 006155          483 GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLS  561 (658)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~  561 (658)
                       ......++..|+|||++.++.++.++||||||+++|||++ |+.|+....   ..+........+.         +...
T Consensus       159 -~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~~~~~~~---------~~~~  225 (260)
T cd05069         159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV---NREVLEQVERGYR---------MPCP  225 (260)
T ss_pred             -ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCC---------CCCC
Confidence             1122346778999999998999999999999999999999 888874322   1222222111110         1111


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          562 SGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       562 ~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      ....   ..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       226 ~~~~---~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         226 QGCP---ESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             cccC---HHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            1112   234567789999999999999999999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.2e-36  Score=317.16  Aligned_cols=239  Identities=28%  Similarity=0.346  Sum_probs=185.5

Q ss_pred             CcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHh-cCCCCceeeeeeeccCCceEEEEEecCC
Q 006155          330 NKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVAN-LQHRNLVRLLGFSLEGNERLLIYEFVPN  404 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~  404 (658)
                      +.||+|+||.||+++.. +++.||||.+....   ......+..|..++.. .+||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999854 47789999987542   1223344556666665 4799999999999999999999999999


Q ss_pred             CChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCccc
Q 006155          405 TSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN  484 (658)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~  484 (658)
                      |+|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~  152 (316)
T cd05592          81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence            999998843   346899999999999999999999987   9999999999999999999999999997543222  22


Q ss_pred             cccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCC
Q 006155          485 TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGS  564 (658)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~  564 (658)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||....   ..++.....    ..      .+.+....
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~---~~~~~~~i~----~~------~~~~~~~~  219 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED---EDELFDSIL----ND------RPHFPRWI  219 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC---HHHHHHHHH----cC------CCCCCCCC
Confidence            334679999999999999999999999999999999999999985332   222222211    11      01111112


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHHH
Q 006155          565 ITEMIRCIHIGLLCVQENVASRPTMASV  592 (658)
Q Consensus       565 ~~e~~~~~~i~~~Cl~~~p~~RPtm~ev  592 (658)
                      ..+   +.+++..||+.+|++||++.+.
T Consensus       220 ~~~---~~~ll~~~l~~~P~~R~~~~~~  244 (316)
T cd05592         220 SKE---AKDCLSKLFERDPTKRLGVDGD  244 (316)
T ss_pred             CHH---HHHHHHHHccCCHHHcCCChHH
Confidence            222   3456679999999999998643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.7e-36  Score=314.69  Aligned_cols=256  Identities=28%  Similarity=0.428  Sum_probs=197.7

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCc--ceeEEEeccCC-cccHHHHHHHHHHHHhc-CCCCceeeeeeeccCCceEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGA--EIAVKRLSRDS-GQGDLEFKNEVLLVANL-QHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~--~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l  397 (658)
                      .++|+..+.||+|+||.||+|+.. ++.  .+++|++.... ......+.+|+.++.++ +|+||+++++++..++..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            467888899999999999999854 344  45888776432 23445688999999999 89999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCC
Q 006155          398 IYEFVPNTSLDHFIFDPT-------------RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMT  464 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~  464 (658)
                      ||||+++++|.+++....             ....+++..++.++.||++||+|||+.+   ++||||||+|||++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence            999999999999986422             1236899999999999999999999987   999999999999999999


Q ss_pred             eEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHH
Q 006155          465 PKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSA  543 (658)
Q Consensus       465 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~  543 (658)
                      +||+|||+++.....   .......++..|+|||++.+..++.++||||||+++|||+| |..||.....   .+.....
T Consensus       163 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~~  236 (303)
T cd05088         163 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEKL  236 (303)
T ss_pred             EEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh---HHHHHHH
Confidence            999999998642211   11112234678999999988889999999999999999998 8888743221   2222221


Q ss_pred             HHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          544 WKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       544 ~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      ..    +..     +........   .+.+++.+||+.+|++||++.+++++|...
T Consensus       237 ~~----~~~-----~~~~~~~~~---~~~~li~~~l~~~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         237 PQ----GYR-----LEKPLNCDD---EVYDLMRQCWREKPYERPSFAQILVSLNRM  280 (303)
T ss_pred             hc----CCc-----CCCCCCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11    100     001111112   345788899999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.1e-36  Score=317.61  Aligned_cols=257  Identities=28%  Similarity=0.488  Sum_probs=198.8

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCc----ceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCce
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGA----EIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNER  395 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  395 (658)
                      ..++|+..+.||+|+||.||+|+.. +|.    .||+|.+..... ....++.+|+.++..++||||+++++++... ..
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~   83 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI   83 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence            3467888899999999999999853 344    468898865433 2234688999999999999999999998754 46


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      .+++||+++|+|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        84 ~~v~e~~~~g~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~  158 (303)
T cd05110          84 QLVTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARL  158 (303)
T ss_pred             eeeehhcCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccc
Confidence            799999999999999853  2345899999999999999999999987   99999999999999999999999999987


Q ss_pred             cccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          476 FEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      +.............++..|+|||++.+..++.++||||||+++|||++ |+.|+....   ..+.....    ..+..  
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~---~~~~~~~~----~~~~~--  229 (303)
T cd05110         159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP---TREIPDLL----EKGER--  229 (303)
T ss_pred             ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHH----HCCCC--
Confidence            654332222333456778999999998999999999999999999998 888874322   11221111    11110  


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          555 IIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       555 ~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      ...+   ...   ...+..++..||..+|++||++.+++++|+..
T Consensus       230 ~~~~---~~~---~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~  268 (303)
T cd05110         230 LPQP---PIC---TIDVYMVMVKCWMIDADSRPKFKELAAEFSRM  268 (303)
T ss_pred             CCCC---CCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            0011   111   12456778899999999999999999999764

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.7e-36  Score=329.28  Aligned_cols=194  Identities=23%  Similarity=0.278  Sum_probs=166.9

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      ...|.+.+.||+|+||.||+++.. .++.||||....      ..+.+|+.++++++|+|||++++++..+...++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            347899999999999999999865 477899996432      2357899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      +. ++|..++..  ....++|..++.|+.||++||.|||+.+   |+||||||+||||+.++.+||+|||+++.+.....
T Consensus       242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            95 688887743  2346999999999999999999999987   99999999999999999999999999987644322


Q ss_pred             ccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCC
Q 006155          482 QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNN  528 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~  528 (658)
                      ........||..|+|||++.+..++.++|||||||++|||++|..++
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l  362 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL  362 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence            22233467999999999999999999999999999999999988754

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=5.1e-36  Score=304.90  Aligned_cols=248  Identities=25%  Similarity=0.400  Sum_probs=192.4

Q ss_pred             cccccCceEEEEeEec---CCcceeEEEeccCCcc-cHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecCCCC
Q 006155          331 KLGQGGFGAVYKGRLY---DGAEIAVKRLSRDSGQ-GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTS  406 (658)
Q Consensus       331 ~lG~G~fg~Vy~~~~~---~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs  406 (658)
                      .||+|+||.||+|+..   .+..||+|++...... ...++.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999999753   3556999998765432 3356899999999999999999999885 457899999999999


Q ss_pred             hhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCcc-cc
Q 006155          407 LDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQG-NT  485 (658)
Q Consensus       407 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~  485 (658)
                      |.+++..  ....+++..+++++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||++..+....... ..
T Consensus        81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            9999853  3456899999999999999999999987   9999999999999999999999999998654432211 11


Q ss_pred             ccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCC
Q 006155          486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGS  564 (658)
Q Consensus       486 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~  564 (658)
                      ....++..|+|||++....++.++||||||+++||+++ |+.|+....   ..+.....    ..+..     +......
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---~~~~~~~~----~~~~~-----~~~~~~~  223 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK---GPEVMSFI----EQGKR-----LDCPAEC  223 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC---HHHHHHHH----HCCCC-----CCCCCCC
Confidence            12234678999999988889999999999999999996 998884322   12222222    12211     1111122


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          565 ITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       565 ~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      .++   +.+++..||+.+|++||++.+|.+.|+..
T Consensus       224 ~~~---l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         224 PPE---MYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CHH---HHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            233   44577899999999999999999999753

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.1e-36  Score=304.62  Aligned_cols=248  Identities=29%  Similarity=0.426  Sum_probs=194.5

Q ss_pred             CcccccCceEEEEeEecC----CcceeEEEeccCCcc-cHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecCC
Q 006155          330 NKLGQGGFGAVYKGRLYD----GAEIAVKRLSRDSGQ-GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPN  404 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~~~----g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  404 (658)
                      ++||+|+||.||+|+...    +..+|+|.+...... ...++.+|+.+++.++|+||+++++++. ++..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            479999999999997422    267999998765442 4456899999999999999999999876 5568999999999


Q ss_pred             CChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCcc-
Q 006155          405 TSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQG-  483 (658)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~-  483 (658)
                      ++|.+++..   ...+++..++.++.|++.||.|||+.+   ++|+||||+|||++.++.+||+|||+++.+....... 
T Consensus        80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          80 GPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            999999954   236899999999999999999999987   9999999999999999999999999998765433221 


Q ss_pred             ccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCC
Q 006155          484 NTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSS  562 (658)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~  562 (658)
                      ......++..|+|||.+.+..++.++||||||+++||+++ |+.|+....   ..++.......    ....  .+   .
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~---~~~~~~~~~~~----~~~~--~~---~  221 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK---GAEVIAMLESG----ERLP--RP---E  221 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC---HHHHHHHHHcC----CcCC--CC---C
Confidence            1112234568999999999999999999999999999998 888875332   22333332221    1111  01   1


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          563 GSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       563 ~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      ...   ..+.+++.+||+.+|++||++.+|++.|+..
T Consensus       222 ~~~---~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         222 ECP---QEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CCC---HHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            111   2455788899999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.7e-36  Score=305.27  Aligned_cols=253  Identities=26%  Similarity=0.463  Sum_probs=201.8

Q ss_pred             ccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEec
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFV  402 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  402 (658)
                      ..+|+..+.||+|+||.||++...++..+|+|.+.... ....++.+|+.++++++||||+++++++......++|+||+
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            35677889999999999999987778899999886543 34457899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCc
Q 006155          403 PNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ  482 (658)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  482 (658)
                      ++++|.+++...  ...++++.++.++.+++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++....... 
T Consensus        82 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  155 (256)
T cd05112          82 EHGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-  155 (256)
T ss_pred             CCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcc-
Confidence            999999998532  345899999999999999999999987   99999999999999999999999999876533221 


Q ss_pred             cccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCC
Q 006155          483 GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLS  561 (658)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~  561 (658)
                      .......++.+|+|||++.++.++.++||||||+++|||++ |+.|+....   ...+....    .++.  ....|...
T Consensus       156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~---~~~~~~~~----~~~~--~~~~~~~~  226 (256)
T cd05112         156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS---NSEVVETI----NAGF--RLYKPRLA  226 (256)
T ss_pred             cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC---HHHHHHHH----hCCC--CCCCCCCC
Confidence            11122345678999999998999999999999999999998 888874322   12222221    1111  11122221


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 006155          562 SGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN  597 (658)
Q Consensus       562 ~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~  597 (658)
                            ...+.+++.+||+.+|++||++.+|+++|.
T Consensus       227 ------~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         227 ------SQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             ------CHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence                  134667889999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.1e-37  Score=323.97  Aligned_cols=238  Identities=26%  Similarity=0.288  Sum_probs=189.2

Q ss_pred             CcccccCceEEEEeEe----cCCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecC
Q 006155          330 NKLGQGGFGAVYKGRL----YDGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVP  403 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~----~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~  403 (658)
                      +.||+|+||.||+++.    ..|+.+|+|++.....  .....+..|+.++.+++||||+++++++.+++..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999874    3578899999875422  233456789999999999999999999999999999999999


Q ss_pred             CCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCcc
Q 006155          404 NTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQG  483 (658)
Q Consensus       404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  483 (658)
                      +|+|.+++..   ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++......  .
T Consensus        82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~  153 (318)
T cd05582          82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K  153 (318)
T ss_pred             CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence            9999999843   346899999999999999999999988   9999999999999999999999999987643321  1


Q ss_pred             ccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCC
Q 006155          484 NTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSG  563 (658)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~  563 (658)
                      ......||+.|+|||++.+..++.++||||||+++|||++|+.||....   ..+.......    ..      ..+...
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~---~~~~~~~i~~----~~------~~~p~~  220 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD---RKETMTMILK----AK------LGMPQF  220 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC---HHHHHHHHHc----CC------CCCCCC
Confidence            2234679999999999998889999999999999999999999985322   2222222211    11      011111


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 006155          564 SITEMIRCIHIGLLCVQENVASRPTMAS  591 (658)
Q Consensus       564 ~~~e~~~~~~i~~~Cl~~~p~~RPtm~e  591 (658)
                      ...   .+.+++..||+.||++||++.+
T Consensus       221 ~~~---~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         221 LSP---EAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCH---HHHHHHHHHhhcCHhHcCCCCC
Confidence            112   2346677999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=9.3e-37  Score=314.32  Aligned_cols=263  Identities=27%  Similarity=0.440  Sum_probs=201.9

Q ss_pred             cCCcccCcccccCceEEEEeEec-----CCcceeEEEeccCCcc-cHHHHHHHHHHHHhcCCCCceeeeeeecc--CCce
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-----DGAEIAVKRLSRDSGQ-GDLEFKNEVLLVANLQHRNLVRLLGFSLE--GNER  395 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-----~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~  395 (658)
                      +.|...+.||+|+||.||+++..     .+..+|||.+...... ...++.+|+.+++.++|+||+++++++..  +...
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            46777889999999999999853     3678999999765443 45679999999999999999999999877  5678


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ++||||+++++|.+++...  ...++|..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++..
T Consensus        84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            9999999999999999542  235999999999999999999999987   99999999999999999999999999987


Q ss_pred             cccCCCcc-ccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcc--------hHHHHHHHh
Q 006155          476 FEMDETQG-NTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVE--------DLLSSAWKN  546 (658)
Q Consensus       476 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~--------~l~~~~~~~  546 (658)
                      ........ ......++..|+|||++.+..++.++||||||+++|||++|+.|+.........        .........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL  238 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence            65332211 111234566799999999889999999999999999999999887432211100        001111111


Q ss_pred             ccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          547 WREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       547 ~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      ...+..  .  + ......   ..+.+++.+||+.+|++||||.||+++|+..
T Consensus       239 ~~~~~~--~--~-~~~~~~---~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         239 LKEGER--L--P-RPPSCP---DEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHcCCc--C--C-CCccCC---HHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            111100  0  0 001111   3466788899999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1e-36  Score=327.20  Aligned_cols=257  Identities=25%  Similarity=0.326  Sum_probs=193.9

Q ss_pred             CCcccCcccccCceEEEEeEe-cCCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeeccCC-----ceE
Q 006155          325 NFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGN-----ERL  396 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~  396 (658)
                      +|+..++||+|+||.||+++. .+|+.||||++....  ......+.+|+.++..++|+||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478889999999999999985 468999999986532  223456889999999999999999999998776     789


Q ss_pred             EEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccc
Q 006155          397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF  476 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~  476 (658)
                      +|+||+. ++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999996 57777763   3356899999999999999999999987   999999999999999999999999999865


Q ss_pred             ccCCCccccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcc--
Q 006155          477 EMDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTV--  553 (658)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~--  553 (658)
                      ...... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||......   +.+.............  
T Consensus       154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~g~~~~~~~  229 (372)
T cd07853         154 EPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI---QQLDLITDLLGTPSLEAM  229 (372)
T ss_pred             ccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHHcCCCCHHHH
Confidence            433221 22334688999999998774 4799999999999999999999998543321   1111111100000000  


Q ss_pred             -------------cccCC-------CCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          554 -------------NIIDP-------TLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       554 -------------~~~dp-------~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                                   ....+       .+....   -..+.+++.+|++.||++|||+.|+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         230 RSACEGARAHILRGPHKPPSLPVLYTLSSQA---THEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHhhHHHHHHHHhCCCCCCchHHhcccCCCC---CHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                         00000       000111   1235578889999999999999999853

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-36  Score=305.36  Aligned_cols=252  Identities=27%  Similarity=0.380  Sum_probs=197.8

Q ss_pred             cCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCc-----ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSG-----QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  397 (658)
                      ++|...+.||+|++|.||++.. .+++.+|+|.+.....     .....+.+|+.++.+++||||+++++++.+++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            5788999999999999999985 4588999998864421     123457889999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE  477 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~  477 (658)
                      |+||+++++|.+++..   ...+++.....++.+++.||.|||+.+   ++||||+|+||++++++.++|+|||+++...
T Consensus        82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            9999999999998843   346889999999999999999999987   9999999999999999999999999987654


Q ss_pred             cCCCcc-ccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccccc
Q 006155          478 MDETQG-NTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNII  556 (658)
Q Consensus       478 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  556 (658)
                      ...... ......|+..|+|||++.+..++.++||||||+++|||++|+.|+....   .....   .........    
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~---~~~~~~~~~----  225 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE---AMAAI---FKIATQPTN----  225 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc---hHHHH---HHHhccCCC----
Confidence            321111 1123567889999999999999999999999999999999999974221   11111   111111111    


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          557 DPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       557 dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                       +.+......   .+.+++..||+.+|.+|||+.++++.
T Consensus       226 -~~~~~~~~~---~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         226 -PQLPSHVSP---DARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             -CCCCccCCH---HHHHHHHHHhhcCcccCCCHHHHhhC
Confidence             111111112   34467779999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.9e-36  Score=318.86  Aligned_cols=263  Identities=27%  Similarity=0.378  Sum_probs=203.4

Q ss_pred             hhhccCCcccCcccccCceEEEEeEec--------CCcceeEEEeccCC-cccHHHHHHHHHHHHhc-CCCCceeeeeee
Q 006155          320 RVATDNFSDANKLGQGGFGAVYKGRLY--------DGAEIAVKRLSRDS-GQGDLEFKNEVLLVANL-QHRNLVRLLGFS  389 (658)
Q Consensus       320 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~  389 (658)
                      ++...+|.+.+.||+|+||.||+++..        .+..||+|.+.... .....++.+|+.++.++ +||||+++++++
T Consensus         8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (334)
T cd05100           8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC   87 (334)
T ss_pred             ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence            344567889999999999999999732        12368999886543 23345789999999999 799999999999


Q ss_pred             ccCCceEEEEEecCCCChhhhhcCcC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCc
Q 006155          390 LEGNERLLIYEFVPNTSLDHFIFDPT-------------RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSN  456 (658)
Q Consensus       390 ~~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~N  456 (658)
                      ..++..++++||+++|+|.+++....             ....++|..++.++.||++||.|||+.+   ++||||||+|
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~N  164 (334)
T cd05100          88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARN  164 (334)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccce
Confidence            99999999999999999999985421             2345899999999999999999999987   9999999999


Q ss_pred             eeeCCCCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCC
Q 006155          457 VLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGET  535 (658)
Q Consensus       457 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~  535 (658)
                      ||++.++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|||++ |..|+...   .
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~---~  241 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI---P  241 (334)
T ss_pred             EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC---C
Confidence            9999999999999999986543322222223345678999999999999999999999999999998 77776422   2


Q ss_pred             cchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 006155          536 VEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYS  600 (658)
Q Consensus       536 ~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~  600 (658)
                      ..++.....    .+....     ......   ..+.+++..||+.+|++||++.++++.|....
T Consensus       242 ~~~~~~~~~----~~~~~~-----~~~~~~---~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         242 VEELFKLLK----EGHRMD-----KPANCT---HELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             HHHHHHHHH----cCCCCC-----CCCCCC---HHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence            222222221    111111     111111   24557788999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.3e-36  Score=317.39  Aligned_cols=243  Identities=23%  Similarity=0.266  Sum_probs=189.4

Q ss_pred             CcccccCceEEEEeEec-CCcceeEEEeccCCc---ccHHHHHHHHHHHHhc-CCCCceeeeeeeccCCceEEEEEecCC
Q 006155          330 NKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG---QGDLEFKNEVLLVANL-QHRNLVRLLGFSLEGNERLLIYEFVPN  404 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~  404 (658)
                      +.||+|+||.||+++.. +++.+|+|++.....   .....+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999854 578899999976422   2334577899999888 699999999999999999999999999


Q ss_pred             CChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCccc
Q 006155          405 TSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN  484 (658)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~  484 (658)
                      |+|..++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~  152 (327)
T cd05617          81 GDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDT  152 (327)
T ss_pred             CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCc
Confidence            99998874   2346999999999999999999999987   999999999999999999999999998743211  112


Q ss_pred             cccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCC
Q 006155          485 TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGS  564 (658)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~  564 (658)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||...............+........      .+....
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~p~~~  226 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI------RIPRFL  226 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC------CCCCCC
Confidence            33467999999999999999999999999999999999999999643332222222223332222111      111111


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCH
Q 006155          565 ITEMIRCIHIGLLCVQENVASRPTM  589 (658)
Q Consensus       565 ~~e~~~~~~i~~~Cl~~~p~~RPtm  589 (658)
                      .   ..+.+++..||+.||++||++
T Consensus       227 ~---~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         227 S---VKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             C---HHHHHHHHHHhccCHHHcCCC
Confidence            1   224467778999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=5.9e-36  Score=304.79  Aligned_cols=256  Identities=27%  Similarity=0.428  Sum_probs=202.8

Q ss_pred             hhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      +..++|...++||+|+||.||++...++..+++|.+.... .....+.+|+.++++++|+||+++.+++.+ ...+++||
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e   80 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE   80 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence            4457889999999999999999997778889999886542 334568899999999999999999999887 77899999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      |+++++|.+++... ....++|..++.++.+++.||.|||+.+   ++||||||+||+++.++.+||+|||++..+....
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          81 FMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             eCCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            99999999998543 2346899999999999999999999987   9999999999999999999999999997664332


Q ss_pred             CccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccCCC
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT  559 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~  559 (658)
                      .. ......++..|+|||++..+.++.++||||||+++||+++ |+.|+....   ..++....    ..+....     
T Consensus       157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~---~~~~~~~~----~~~~~~~-----  223 (260)
T cd05073         157 YT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS---NPEVIRAL----ERGYRMP-----  223 (260)
T ss_pred             cc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC---HHHHHHHH----hCCCCCC-----
Confidence            21 1222345678999999998899999999999999999999 888874322   11222211    1111111     


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          560 LSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       560 l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      ......   ..+.+++.+|++.+|++||++.++.++|+.
T Consensus       224 ~~~~~~---~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         224 RPENCP---EELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CcccCC---HHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            011111   235577789999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.7e-36  Score=309.46  Aligned_cols=247  Identities=23%  Similarity=0.300  Sum_probs=191.0

Q ss_pred             ccccCceEEEEeEec-CCcceeEEEeccCCc---ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecCCCCh
Q 006155          332 LGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG---QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSL  407 (658)
Q Consensus       332 lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  407 (658)
                      ||+|+||.||+++.. +|+.+|+|++.....   .....+..|++++.+++||||+++++++..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999854 589999999865321   1233456799999999999999999999999999999999999999


Q ss_pred             hhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCcccccc
Q 006155          408 DHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSR  487 (658)
Q Consensus       408 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  487 (658)
                      .+++... ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.++|+|||++..+....   ....
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~  153 (277)
T cd05607          81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ  153 (277)
T ss_pred             HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence            9888542 2345899999999999999999999987   9999999999999999999999999987654322   1223


Q ss_pred             ccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCC-cchHHHHHHHhccCCCcccccCCCCCCCCHH
Q 006155          488 IVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGET-VEDLLSSAWKNWREGTTVNIIDPTLSSGSIT  566 (658)
Q Consensus       488 ~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~  566 (658)
                      ..|+..|+|||++.+..++.++|||||||++|||++|+.|+....... ...+..   ..+. ...    ... ......
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~---~~~~-~~~----~~~-~~~~~~  224 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR---RTLE-DEV----KFE-HQNFTE  224 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHH---Hhhc-ccc----ccc-cccCCH
Confidence            578999999999999999999999999999999999999985332211 111111   1111 110    000 001112


Q ss_pred             HHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 006155          567 EMIRCIHIGLLCVQENVASRPTMASVVLMLN  597 (658)
Q Consensus       567 e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~  597 (658)
                         .+.+++..||+.||++||+++|+++.+.
T Consensus       225 ---~~~~li~~~L~~~P~~R~~~~~~~~~~~  252 (277)
T cd05607         225 ---ESKDICRLFLAKKPEDRLGSREKNDDPR  252 (277)
T ss_pred             ---HHHHHHHHHhccCHhhCCCCccchhhhh
Confidence               2456778999999999999988764443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=5.7e-36  Score=314.85  Aligned_cols=237  Identities=25%  Similarity=0.316  Sum_probs=184.1

Q ss_pred             CcccccCceEEEEeEec-CCcceeEEEeccCCc---ccHHHHHHHHH-HHHhcCCCCceeeeeeeccCCceEEEEEecCC
Q 006155          330 NKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG---QGDLEFKNEVL-LVANLQHRNLVRLLGFSLEGNERLLIYEFVPN  404 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  404 (658)
                      ++||+|+||.||+++.. +|+.||+|++.....   .....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999854 578899999865321   22234455544 57889999999999999999999999999999


Q ss_pred             CChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCccc
Q 006155          405 TSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN  484 (658)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~  484 (658)
                      ++|..++.   ....+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~  152 (321)
T cd05603          81 GELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ET  152 (321)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cc
Confidence            99988874   3356888999999999999999999987   9999999999999999999999999987532211  22


Q ss_pred             cccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCC
Q 006155          485 TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGS  564 (658)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~  564 (658)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||....   ...+......    ..      ..+....
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~----~~------~~~~~~~  219 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD---VSQMYDNILH----KP------LQLPGGK  219 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC---HHHHHHHHhc----CC------CCCCCCC
Confidence            334679999999999999999999999999999999999999984322   2222222211    11      0111111


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHH
Q 006155          565 ITEMIRCIHIGLLCVQENVASRPTMA  590 (658)
Q Consensus       565 ~~e~~~~~~i~~~Cl~~~p~~RPtm~  590 (658)
                      .   ..+.+++.+|++.+|.+||+..
T Consensus       220 ~---~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         220 T---VAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             C---HHHHHHHHHHccCCHhhcCCCC
Confidence            1   2345677899999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=6.5e-36  Score=306.04  Aligned_cols=254  Identities=21%  Similarity=0.346  Sum_probs=189.0

Q ss_pred             CcccccCceEEEEeEecCCc---ceeEEEeccCC-cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecCCC
Q 006155          330 NKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDS-GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNT  405 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~~~g~---~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g  405 (658)
                      +.||+|+||.||+|+..++.   .+++|.+.... ......+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            36999999999999755443   35667665443 234557899999999999999999999999999999999999999


Q ss_pred             ChhhhhcCcC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCccc
Q 006155          406 SLDHFIFDPT-RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN  484 (658)
Q Consensus       406 sL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~  484 (658)
                      +|.+++.... ....+++.....++.||++||.|||+.+   ++||||||+|||++.++.+||+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            9999986432 2345677788899999999999999987   99999999999999999999999999864322211112


Q ss_pred             cccccccccccCcccccc-------CCCCcccccccccchHhHHHhC-CCCCccCCCCCcchHHHHHHHhccCCCccccc
Q 006155          485 TSRIVGTYGYMAPEYAMH-------GQYSVKSDVFSFGVLVLEIISG-QRNNCFRNGETVEDLLSSAWKNWREGTTVNII  556 (658)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~-------~~~s~ksDV~S~Gvll~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  556 (658)
                      .....++..|+|||++..       ..++.++||||||+++|||+++ ..|+...   ...+.+...+.    +....+.
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~---~~~~~~~~~~~----~~~~~~~  230 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL---SDREVLNHVIK----DQQVKLF  230 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHHh----hcccccC
Confidence            234567899999998753       2457899999999999999985 4565321   12222222221    2223444


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 006155          557 DPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN  597 (658)
Q Consensus       557 dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~  597 (658)
                      +|.+.....++   +.+++..|| .+|++||++.+|++.|.
T Consensus       231 ~~~~~~~~~~~---~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         231 KPQLELPYSER---WYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCccCCCCcHH---HHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            55554332233   334556788 57999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-36  Score=327.08  Aligned_cols=260  Identities=18%  Similarity=0.237  Sum_probs=198.6

Q ss_pred             hccCCcccCcccccCceEEEEeEec---CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY---DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  398 (658)
                      ...+|...+.||+|+||.||++...   .+..||||.+...     ....+|+.++++++||||+++++++......++|
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv  164 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV  164 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence            3467999999999999999998743   3567999987543     2356899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccccc
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~  478 (658)
                      ||++. ++|.+++   .....++|..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       165 ~e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~  237 (392)
T PHA03207        165 MPKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA  237 (392)
T ss_pred             ehhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence            99986 6788877   23457999999999999999999999987   99999999999999999999999999986654


Q ss_pred             CCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCc------
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTT------  552 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~------  552 (658)
                      ...........||+.|+|||++....++.++|||||||++|||++|+.||...........+....+.......      
T Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~  317 (392)
T PHA03207        238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG  317 (392)
T ss_pred             ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence            43333334567999999999999999999999999999999999999998544333222222222211110000      


Q ss_pred             ----------------ccccCCC-CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          553 ----------------VNIIDPT-LSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       553 ----------------~~~~dp~-l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                                      .....|. +....  .-..+.+++..|++.||++|||+.|++..
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        318 STNLCKHFKQYAIVLRPPYTIPPVIRKYG--MHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             chhHHHHHHhhcccccCCccccchhhccC--cchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                            0000000 00000  01234467789999999999999999864

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=5.5e-36  Score=311.24  Aligned_cols=251  Identities=25%  Similarity=0.406  Sum_probs=201.8

Q ss_pred             hccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      ...+|+..+.||+|+||.||+|+. .+++.|++|.+..........+.+|+.++..++|+||+++++.+..+...++|||
T Consensus        18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e   97 (296)
T cd06654          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (296)
T ss_pred             cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence            346889999999999999999984 4688999999987666666778999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      |+++++|.+++..    ..+++.++..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus        98 ~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~  170 (296)
T cd06654          98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (296)
T ss_pred             ccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence            9999999999842    35899999999999999999999987   9999999999999999999999999987654322


Q ss_pred             CccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCC
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTL  560 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l  560 (658)
                      .  ......|++.|+|||++.+..++.++|||||||++|||++|+.||.....   .......+   ..+. ..+..+  
T Consensus       171 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~---~~~~~~~~---~~~~-~~~~~~--  239 (296)
T cd06654         171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRALYLIA---TNGT-PELQNP--  239 (296)
T ss_pred             c--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH---HHhHHHHh---cCCC-CCCCCc--
Confidence            1  12234788999999999988899999999999999999999999853221   11111111   1111 011011  


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          561 SSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       561 ~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                       ...   ...+.+++.+||+.+|++||++.+|++
T Consensus       240 -~~~---~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         240 -EKL---SAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             -ccc---CHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence             011   123456778999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-36  Score=304.79  Aligned_cols=248  Identities=27%  Similarity=0.385  Sum_probs=196.1

Q ss_pred             CcccccCceEEEEeEecCCcceeEEEeccCCcc-cHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecCCCChh
Q 006155          330 NKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQ-GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLD  408 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~  408 (658)
                      ++||+|+||.||++...+++.|++|++...... ....+.+|+.++++++|+||+++++++.+.+..++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            479999999999999777999999988765443 4557899999999999999999999999999999999999999999


Q ss_pred             hhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCccccccc
Q 006155          409 HFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI  488 (658)
Q Consensus       409 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~  488 (658)
                      +++...  ...+++..++.++.+++.||.|||+++   ++||||||+|||++.++.+||+|||++...............
T Consensus        81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            998542  236889999999999999999999987   999999999999999999999999999765432221111223


Q ss_pred             cccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCCHHH
Q 006155          489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITE  567 (658)
Q Consensus       489 ~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e  567 (658)
                      .++..|+|||.+.++.++.++||||||+++|||++ |..|+.....   .........    +.  ..   .......  
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~---~~~~~~~~~----~~--~~---~~~~~~~--  221 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN---QQTRERIES----GY--RM---PAPQLCP--  221 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH---HHHHHHHhc----CC--CC---CCCccCC--
Confidence            34667999999998999999999999999999999 7777643221   111111111    10  00   0111111  


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 006155          568 MIRCIHIGLLCVQENVASRPTMASVVLMLN  597 (658)
Q Consensus       568 ~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~  597 (658)
                       ..+.+++..|++.+|.+|||+.||++.|+
T Consensus       222 -~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         222 -EEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             -HHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence             24567888999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.6e-36  Score=317.42  Aligned_cols=241  Identities=27%  Similarity=0.333  Sum_probs=189.8

Q ss_pred             CcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHhc-CCCCceeeeeeeccCCceEEEEEecCC
Q 006155          330 NKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANL-QHRNLVRLLGFSLEGNERLLIYEFVPN  404 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~  404 (658)
                      +.||+|+||.||+|+.. .++.||||++....   ......+..|..++..+ +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999854 47889999987542   22334567788888866 799999999999999999999999999


Q ss_pred             CChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCccc
Q 006155          405 TSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN  484 (658)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~  484 (658)
                      ++|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~  152 (321)
T cd05591          81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT  152 (321)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence            999988843   346899999999999999999999988   9999999999999999999999999987532221  12


Q ss_pred             cccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCC
Q 006155          485 TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGS  564 (658)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~  564 (658)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||....   ...+......    +.   ...|.   ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~---~~~~~~~i~~----~~---~~~p~---~~  219 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN---EDDLFESILH----DD---VLYPV---WL  219 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC---HHHHHHHHHc----CC---CCCCC---CC
Confidence            234579999999999999999999999999999999999999985432   2222222211    11   11111   11


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCC-------CHHHHHH
Q 006155          565 ITEMIRCIHIGLLCVQENVASRP-------TMASVVL  594 (658)
Q Consensus       565 ~~e~~~~~~i~~~Cl~~~p~~RP-------tm~evv~  594 (658)
                      ..   .+.+++..|++.||++||       ++.++++
T Consensus       220 ~~---~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         220 SK---EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             CH---HHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence            12   345667789999999999       7777764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.6e-36  Score=306.63  Aligned_cols=238  Identities=24%  Similarity=0.400  Sum_probs=187.1

Q ss_pred             CcccccCceEEEEeEecCCc-----------ceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEE
Q 006155          330 NKLGQGGFGAVYKGRLYDGA-----------EIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~~~g~-----------~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  398 (658)
                      +.||+|+||.||+|...+..           .|++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46999999999999865433           4788877654433 6678999999999999999999999988 778999


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCC-------CeEEeccc
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM-------TPKIADFG  471 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~-------~~kl~DFG  471 (658)
                      |||+++|+|.+++....  ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++       .+||+|||
T Consensus        79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            99999999999985422  26899999999999999999999987   99999999999999887       79999999


Q ss_pred             cccccccCCCccccccccccccccCccccccC--CCCcccccccccchHhHHHhC-CCCCccCCCCCcchHHHHHHHhcc
Q 006155          472 MARLFEMDETQGNTSRIVGTYGYMAPEYAMHG--QYSVKSDVFSFGVLVLEIISG-QRNNCFRNGETVEDLLSSAWKNWR  548 (658)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDV~S~Gvll~elltG-~~p~~~~~~~~~~~l~~~~~~~~~  548 (658)
                      ++.....      .....++..|+|||++...  .++.++||||||+++|||++| ..|+......   .... .+.   
T Consensus       154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~---~~~~-~~~---  220 (259)
T cd05037         154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS---EKER-FYQ---  220 (259)
T ss_pred             ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch---hHHH-HHh---
Confidence            9876433      2224567789999999876  789999999999999999995 5555332211   1111 111   


Q ss_pred             CCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 006155          549 EGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN  597 (658)
Q Consensus       549 ~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~  597 (658)
                      ...  ....+     .   ...+.+++..||+.+|++|||+.+|++.|+
T Consensus       221 ~~~--~~~~~-----~---~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 DQH--RLPMP-----D---CAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             cCC--CCCCC-----C---chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            000  00001     1   145667888999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-36  Score=306.87  Aligned_cols=249  Identities=28%  Similarity=0.442  Sum_probs=191.8

Q ss_pred             CcccccCceEEEEeEecC-Cc--ceeEEEeccCC-cccHHHHHHHHHHHHhc-CCCCceeeeeeeccCCceEEEEEecCC
Q 006155          330 NKLGQGGFGAVYKGRLYD-GA--EIAVKRLSRDS-GQGDLEFKNEVLLVANL-QHRNLVRLLGFSLEGNERLLIYEFVPN  404 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~~~-g~--~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~  404 (658)
                      +.||+|+||.||+|+..+ +.  .+++|.+.... ......+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999998654 33  46888887533 23445688999999999 799999999999999999999999999


Q ss_pred             CChhhhhcCcC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccc
Q 006155          405 TSLDHFIFDPT-------------RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFG  471 (658)
Q Consensus       405 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFG  471 (658)
                      ++|.+++....             ....+++..++.++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99999985421             1235889999999999999999999987   9999999999999999999999999


Q ss_pred             cccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCC
Q 006155          472 MARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREG  550 (658)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~  550 (658)
                      ++......   ........+..|+|||++....++.++||||||+++|||++ |+.||....   ..+.......    +
T Consensus       158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~---~~~~~~~~~~----~  227 (270)
T cd05047         158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYEKLPQ----G  227 (270)
T ss_pred             Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC---HHHHHHHHhC----C
Confidence            98632211   11111234567999999988899999999999999999997 888884322   2222222111    1


Q ss_pred             CcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          551 TTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       551 ~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      ...+     ......   ..+.+++..|++.+|.+|||+.++++.|+..
T Consensus       228 ~~~~-----~~~~~~---~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         228 YRLE-----KPLNCD---DEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             CCCC-----CCCcCC---HHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence            1001     111111   2355788899999999999999999999753

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=7.9e-36  Score=303.05  Aligned_cols=249  Identities=27%  Similarity=0.413  Sum_probs=197.1

Q ss_pred             ccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeec-cCCceEEEEEe
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSL-EGNERLLIYEF  401 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~-~~~~~~lv~e~  401 (658)
                      -++|...+.||+|+||.||++.. .|..+|+|.+....  ....+.+|+.++++++|+|++++++++. .++..++|+||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            35788889999999999999975 58889999886542  3456899999999999999999999764 55678999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      +++++|.+++... ....++|..+++++.+++.||.|||+.+   ++||||||+||++++++.+||+|||+++...... 
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  156 (256)
T cd05082          82 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  156 (256)
T ss_pred             CCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence            9999999998542 2345899999999999999999999987   9999999999999999999999999987543221 


Q ss_pred             ccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCC
Q 006155          482 QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTL  560 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l  560 (658)
                          ....++..|+|||++.+..++.++||||||+++|||++ |+.|+...   ...++......    +..     +..
T Consensus       157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~---~~~~~~~~~~~----~~~-----~~~  220 (256)
T cd05082         157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPRVEK----GYK-----MDA  220 (256)
T ss_pred             ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHhc----CCC-----CCC
Confidence                12344668999999998899999999999999999998 88887422   22222222211    111     111


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          561 SSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       561 ~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      ......   .+.+++.+|++.+|++|||+.++++.|+.
T Consensus       221 ~~~~~~---~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         221 PDGCPP---VVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             CCCCCH---HHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            111222   34567789999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.4e-36  Score=319.73  Aligned_cols=241  Identities=27%  Similarity=0.289  Sum_probs=189.7

Q ss_pred             CCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc---ccHHHHHHHHHHHHhc-CCCCceeeeeeeccCCceEEEE
Q 006155          325 NFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG---QGDLEFKNEVLLVANL-QHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      +|...+.||+|+||.||+++.. +++.||||.+.....   .....+..|..++..+ +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4778899999999999999854 467899999875422   2223456677777777 5899999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            99999999988843   346899999999999999999999987   999999999999999999999999998753321


Q ss_pred             CCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCC
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT  559 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~  559 (658)
                      .  .......||+.|+|||++.+..++.++|||||||++|||++|+.||....   ...+......    ..      ..
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~---~~~~~~~i~~----~~------~~  219 (323)
T cd05616         155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---EDELFQSIME----HN------VA  219 (323)
T ss_pred             C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC---HHHHHHHHHh----CC------CC
Confidence            1  12334679999999999999999999999999999999999999985322   2233322221    11      11


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 006155          560 LSSGSITEMIRCIHIGLLCVQENVASRPTM  589 (658)
Q Consensus       560 l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm  589 (658)
                      +......   .+.+++..|++.+|++|++.
T Consensus       220 ~p~~~s~---~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         220 YPKSMSK---EAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             CCCcCCH---HHHHHHHHHcccCHHhcCCC
Confidence            1111112   34567789999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.8e-36  Score=302.50  Aligned_cols=264  Identities=25%  Similarity=0.357  Sum_probs=201.0

Q ss_pred             ccCCcccCcccccCceEEEEeE-ecCCcceeEEEeccCCcc--cHHHHHHHHHHHHhcCCCC-ceeeeeeeccCC-----
Q 006155          323 TDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQ--GDLEFKNEVLLVANLQHRN-LVRLLGFSLEGN-----  393 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~-----  393 (658)
                      ...|...++||+|.||+||+|+ ..+|+.||+|++.....+  ......+|+.++++|+|+| ||+|.+++...+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            3557778899999999999998 446889999998766442  2334689999999999999 999999998877     


Q ss_pred             -ceEEEEEecCCCChhhhhcCcCCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccc
Q 006155          394 -ERLLIYEFVPNTSLDHFIFDPTRR-AQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFG  471 (658)
Q Consensus       394 -~~~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFG  471 (658)
                       ..+||+||+ ..+|..++...... ..++...+..++.||++||+|||+++   |+||||||.||||++.|.+||+|||
T Consensus        90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence             778999999 56888888543221 35677889999999999999999998   9999999999999999999999999


Q ss_pred             cccccccCCCccccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCC
Q 006155          472 MARLFEMDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREG  550 (658)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  550 (658)
                      +|+.+.-+...  ....++|..|.|||++.+. .|+...|+||+|||+.||++++..|....+   .+.+....+.+...
T Consensus       166 lAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se---~~ql~~If~~lGtP  240 (323)
T KOG0594|consen  166 LARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE---IDQLFRIFRLLGTP  240 (323)
T ss_pred             hHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH---HHHHHHHHHHcCCC
Confidence            99976644332  3446789999999999887 699999999999999999998887754332   33333333332211


Q ss_pred             C---cccc-----cCCCC---C-CCCHHH-----HHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          551 T---TVNI-----IDPTL---S-SGSITE-----MIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       551 ~---~~~~-----~dp~l---~-~~~~~e-----~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                      .   +...     .++..   . ......     .....+++.+|++.+|.+|.|++..+.+
T Consensus       241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            1   1111     11111   1 001000     0245678889999999999999999875

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=5.2e-36  Score=305.23  Aligned_cols=250  Identities=27%  Similarity=0.374  Sum_probs=190.5

Q ss_pred             CcccccCceEEEEeEecC----CcceeEEEeccCC-cccHHHHHHHHHHHHhcCCCCceeeeeeec-cCCceEEEEEecC
Q 006155          330 NKLGQGGFGAVYKGRLYD----GAEIAVKRLSRDS-GQGDLEFKNEVLLVANLQHRNLVRLLGFSL-EGNERLLIYEFVP  403 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~-~~~~~~lv~e~~~  403 (658)
                      +.||+|+||.||+|+..+    +..+|+|++.... ......+.+|+.+++.++||||+++++++. .+...++|+||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998532    3569999886432 233456889999999999999999999775 4556789999999


Q ss_pred             CCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCc-
Q 006155          404 NTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ-  482 (658)
Q Consensus       404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~-  482 (658)
                      +++|.+++...  ...+++..++.++.||++||.|||+.+   ++||||||+|||++.++.+||+|||+++.+...... 
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            99999998542  334688889999999999999999987   999999999999999999999999999765432211 


Q ss_pred             -cccccccccccccCccccccCCCCcccccccccchHhHHHhCCC-CCccCCCCCcchHHHHHHHhccCCCcccccCCCC
Q 006155          483 -GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQR-NNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTL  560 (658)
Q Consensus       483 -~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~-p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l  560 (658)
                       .......++..|+|||++.+..++.++||||||+++|||++|.. |+..   ....++....+.    +..     +..
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~---~~~~~~~~~~~~----~~~-----~~~  223 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD---VDSFDITVYLLQ----GRR-----LLQ  223 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC---CCHHHHHHHHhc----CCC-----CCC
Confidence             11123456778999999998999999999999999999999655 4422   122223322221    110     111


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          561 SSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       561 ~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      .....   ..+.+++..||+.+|++||++.+|++.|+..
T Consensus       224 ~~~~~---~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         224 PEYCP---DPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             CCcCC---HHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            11111   2355788899999999999999999999763

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=7.7e-36  Score=305.26  Aligned_cols=258  Identities=25%  Similarity=0.370  Sum_probs=199.2

Q ss_pred             hhhhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEE
Q 006155          319 IRVATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       319 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  397 (658)
                      ++.+++++.....||+|+||.||+|+.. ++..|++|.+..........+.+|+.++..++|+||+++++++..++..++
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            3456677777789999999999999854 577899999887666666789999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCC-CCCeEEecccccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDA-EMTPKIADFGMARLF  476 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~-~~~~kl~DFGla~~~  476 (658)
                      |+||+++++|.+++.........++..+..++.||+.||.|||+.+   |+||||||+||+++. ++.++|+|||++...
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~  159 (268)
T cd06624          83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL  159 (268)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence            9999999999999864322222388889999999999999999987   999999999999986 679999999998765


Q ss_pred             ccCCCccccccccccccccCccccccCC--CCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          477 EMDETQGNTSRIVGTYGYMAPEYAMHGQ--YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      .....  ......|+..|+|||++.+..  ++.++||||||+++|||++|+.|+.......   ...+......      
T Consensus       160 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~~~~~~------  228 (268)
T cd06624         160 AGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKVGMFK------  228 (268)
T ss_pred             ccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhhhhhhc------
Confidence            33221  122346889999999987654  7899999999999999999999984322111   0000000000      


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          555 IIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       555 ~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                       ..+.+.....+   .+..++.+||+.+|++|||+.+|+.
T Consensus       229 -~~~~~~~~~~~---~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         229 -IHPEIPESLSA---EAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             -cCCCCCcccCH---HHHHHHHHHcCCCchhCCCHHHHHh
Confidence             11222222222   3456778999999999999999985

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3e-36  Score=316.77  Aligned_cols=236  Identities=29%  Similarity=0.367  Sum_probs=186.5

Q ss_pred             CcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHhc-CCCCceeeeeeeccCCceEEEEEecCC
Q 006155          330 NKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANL-QHRNLVRLLGFSLEGNERLLIYEFVPN  404 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~  404 (658)
                      +.||+|+||.||+++.. +++.||||++....   ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999854 57889999986532   22334567788888776 699999999999999999999999999


Q ss_pred             CChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCccc
Q 006155          405 TSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN  484 (658)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~  484 (658)
                      |+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~  152 (320)
T cd05590          81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT  152 (320)
T ss_pred             chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence            999988843   346899999999999999999999987   9999999999999999999999999987532211  12


Q ss_pred             cccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCC
Q 006155          485 TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGS  564 (658)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~  564 (658)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||....   ...+.....    .+.   ...|   ...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~---~~~~~~~i~----~~~---~~~~---~~~  219 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN---EDDLFEAIL----NDE---VVYP---TWL  219 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC---HHHHHHHHh----cCC---CCCC---CCC
Confidence            334679999999999999999999999999999999999999985332   222222221    111   1111   111


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCH
Q 006155          565 ITEMIRCIHIGLLCVQENVASRPTM  589 (658)
Q Consensus       565 ~~e~~~~~~i~~~Cl~~~p~~RPtm  589 (658)
                      ..   .+.+++..|++.||++||++
T Consensus       220 ~~---~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         220 SQ---DAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CH---HHHHHHHHHcccCHHHCCCC
Confidence            12   34467779999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.2e-36  Score=320.28  Aligned_cols=241  Identities=27%  Similarity=0.300  Sum_probs=189.8

Q ss_pred             CCcccCcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCC-CceeeeeeeccCCceEEEE
Q 006155          325 NFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHR-NLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~lv~  399 (658)
                      +|+..+.||+|+||.||+|+.. .++.||||++....   ......+..|+.++..++|+ +|+++++++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4778899999999999999854 46789999987542   23344577899999999764 6888999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            99999999998843   346899999999999999999999987   999999999999999999999999998743221


Q ss_pred             CCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCC
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT  559 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~  559 (658)
                      .  .......||+.|+|||++.+..++.++|||||||++|||++|+.||....   ..++......    ..      +.
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~---~~~~~~~i~~----~~------~~  219 (324)
T cd05587         155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED---EDELFQSIME----HN------VS  219 (324)
T ss_pred             C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHc----CC------CC
Confidence            1  12234579999999999999999999999999999999999999985322   2223222221    11      11


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 006155          560 LSSGSITEMIRCIHIGLLCVQENVASRPTM  589 (658)
Q Consensus       560 l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm  589 (658)
                      +......   .+.+++..||+.||.+||+.
T Consensus       220 ~~~~~~~---~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         220 YPKSLSK---EAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             CCCCCCH---HHHHHHHHHhhcCHHHcCCC
Confidence            1111112   34567789999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.2e-36  Score=320.67  Aligned_cols=242  Identities=25%  Similarity=0.332  Sum_probs=187.1

Q ss_pred             CcccccCceEEEEeEe-cCCcceeEEEeccCC---cccHHHHHHHHH-HHHhcCCCCceeeeeeeccCCceEEEEEecCC
Q 006155          330 NKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDS---GQGDLEFKNEVL-LVANLQHRNLVRLLGFSLEGNERLLIYEFVPN  404 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  404 (658)
                      +.||+|+||.||+++. .+|+.+|+|++....   .....++..|.. +++.++||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999984 468899999986542   222334555554 46778999999999999999999999999999


Q ss_pred             CChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCccc
Q 006155          405 TSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN  484 (658)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~  484 (658)
                      |+|..++.   +...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~  152 (325)
T cd05604          81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDT  152 (325)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCC
Confidence            99988884   3456899999999999999999999988   999999999999999999999999998753221  112


Q ss_pred             cccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCC
Q 006155          485 TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGS  564 (658)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~  564 (658)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||....   ..++.....    ....  .+.|    ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~---~~~~~~~~~----~~~~--~~~~----~~  219 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD---VAEMYDNIL----HKPL--VLRP----GA  219 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC---HHHHHHHHH----cCCc--cCCC----CC
Confidence            334679999999999999999999999999999999999999985322   222222211    1110  1111    11


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          565 ITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       565 ~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                      .   ..+.+++..|++.+|.+||++.+.++.
T Consensus       220 ~---~~~~~ll~~ll~~~p~~R~~~~~~~~~  247 (325)
T cd05604         220 S---LTAWSILEELLEKDRQRRLGAKEDFLE  247 (325)
T ss_pred             C---HHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence            1   234467778999999999998744433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.7e-36  Score=317.98  Aligned_cols=240  Identities=27%  Similarity=0.361  Sum_probs=187.6

Q ss_pred             CcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHh-cCCCCceeeeeeeccCCceEEEEEecCC
Q 006155          330 NKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVAN-LQHRNLVRLLGFSLEGNERLLIYEFVPN  404 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~  404 (658)
                      +.||+|+||.||+|+.. +++.||||++....   ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999865 47789999987542   2223345667777775 4899999999999999999999999999


Q ss_pred             CChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCccc
Q 006155          405 TSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN  484 (658)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~  484 (658)
                      |+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  152 (316)
T cd05619          81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence            999999843   346899999999999999999999987   9999999999999999999999999987532211  12


Q ss_pred             cccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCC
Q 006155          485 TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGS  564 (658)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~  564 (658)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||....   ..++....    ....      +.+....
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~---~~~~~~~i----~~~~------~~~~~~~  219 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD---EEELFQSI----RMDN------PCYPRWL  219 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC---HHHHHHHH----HhCC------CCCCccC
Confidence            334579999999999999999999999999999999999999985322   22222221    1111      1111111


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHH-HHH
Q 006155          565 ITEMIRCIHIGLLCVQENVASRPTMA-SVV  593 (658)
Q Consensus       565 ~~e~~~~~~i~~~Cl~~~p~~RPtm~-evv  593 (658)
                      ..   .+.+++..||+.||++||++. ++.
T Consensus       220 ~~---~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         220 TR---EAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             CH---HHHHHHHHHhccCHhhcCCChHHHH
Confidence            12   244677799999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=6e-36  Score=309.23  Aligned_cols=246  Identities=26%  Similarity=0.329  Sum_probs=191.7

Q ss_pred             CcccCcccccCceEEEEeEec-CCcceeEEEeccCCc---ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          326 FSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG---QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       326 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      |+..+.||+|+||+||+++.. +++.+|+|.+.....   .....+.+|+.++..++|+||+++.+.+..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            566788999999999999853 588999999865422   2233477899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++....... 
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05632          82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-  156 (285)
T ss_pred             ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence            9999999888542 2346999999999999999999999987   9999999999999999999999999987643221 


Q ss_pred             ccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCC
Q 006155          482 QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLS  561 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~  561 (658)
                        ......|+..|+|||++.+..++.++||||||+++|||++|+.||.......   .............      +...
T Consensus       157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~---~~~~~~~~~~~~~------~~~~  225 (285)
T cd05632         157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV---KREEVDRRVLETE------EVYS  225 (285)
T ss_pred             --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhhhccc------cccC
Confidence              1223578999999999999999999999999999999999999985432211   1111111111110      0111


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 006155          562 SGSITEMIRCIHIGLLCVQENVASRPTMA  590 (658)
Q Consensus       562 ~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~  590 (658)
                      .....   .+.+++..|++.||++||++.
T Consensus       226 ~~~~~---~~~~li~~~l~~~P~~R~~~~  251 (285)
T cd05632         226 AKFSE---EAKSICKMLLTKDPKQRLGCQ  251 (285)
T ss_pred             ccCCH---HHHHHHHHHccCCHhHcCCCc
Confidence            11112   234677789999999999943

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=6.5e-36  Score=319.42  Aligned_cols=197  Identities=29%  Similarity=0.384  Sum_probs=166.5

Q ss_pred             hccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeeccCC-----
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGN-----  393 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----  393 (658)
                      ..++|+..+.||+|+||.||+++. ..|..||||++....  ......+.+|+.++..++||||+++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            357899999999999999999985 358899999986542  233456789999999999999999999886543     


Q ss_pred             -ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccc
Q 006155          394 -ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGM  472 (658)
Q Consensus       394 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGl  472 (658)
                       ..++||||+++ +|...+.     ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence             46899999975 4555552     24788999999999999999999988   99999999999999999999999999


Q ss_pred             ccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCcc
Q 006155          473 ARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCF  530 (658)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~  530 (658)
                      ++......   ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       170 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~  224 (359)
T cd07876         170 ARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG  224 (359)
T ss_pred             ccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence            97543221   22345789999999999999999999999999999999999999854

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=7.6e-36  Score=305.76  Aligned_cols=254  Identities=28%  Similarity=0.420  Sum_probs=196.5

Q ss_pred             hhhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhc-CCCCceeeeeeeccC-----
Q 006155          320 RVATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANL-QHRNLVRLLGFSLEG-----  392 (658)
Q Consensus       320 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-----  392 (658)
                      +.+++.|+..+.||+|+||.||+|+.. +++.||+|++.... ....++..|+.++.++ +|+||+++++++...     
T Consensus         2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (272)
T cd06637           2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   80 (272)
T ss_pred             CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence            345678899999999999999999854 57889999986543 4455788999999998 699999999998653     


Q ss_pred             -CceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccc
Q 006155          393 -NERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFG  471 (658)
Q Consensus       393 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFG  471 (658)
                       ...++||||+++++|.+++... ....++|..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg  156 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG  156 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCC
Confidence             4578999999999999998542 2346899999999999999999999987   9999999999999999999999999


Q ss_pred             cccccccCCCccccccccccccccCccccc-----cCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHh
Q 006155          472 MARLFEMDETQGNTSRIVGTYGYMAPEYAM-----HGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKN  546 (658)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~  546 (658)
                      ++.......  .......|+..|+|||++.     +..++.++|||||||++|||++|+.|+......   ...   ...
T Consensus       157 ~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~---~~~---~~~  228 (272)
T cd06637         157 VSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM---RAL---FLI  228 (272)
T ss_pred             Cceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH---HHH---HHH
Confidence            997654322  1233467899999999986     346888999999999999999999998432111   111   111


Q ss_pred             ccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          547 WREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       547 ~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .. .......+.    ....   .+.+++.+||+.+|.+|||+.++++
T Consensus       229 ~~-~~~~~~~~~----~~~~---~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         229 PR-NPAPRLKSK----KWSK---KFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             hc-CCCCCCCCC----CcCH---HHHHHHHHHcCCChhhCCCHHHHhh
Confidence            11 111111111    1112   3457778999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.3e-36  Score=319.92  Aligned_cols=237  Identities=24%  Similarity=0.301  Sum_probs=184.8

Q ss_pred             CcccccCceEEEEeEec-CCcceeEEEeccCCc---ccHHHHHHHHH-HHHhcCCCCceeeeeeeccCCceEEEEEecCC
Q 006155          330 NKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG---QGDLEFKNEVL-LVANLQHRNLVRLLGFSLEGNERLLIYEFVPN  404 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  404 (658)
                      +.||+|+||+||+++.. +|+.||||++.....   ....++..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999854 688999999865421   22233445544 56789999999999999999999999999999


Q ss_pred             CChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCccc
Q 006155          405 TSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN  484 (658)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~  484 (658)
                      |+|..++..   ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~  152 (323)
T cd05575          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKT  152 (323)
T ss_pred             CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCc
Confidence            999998843   456899999999999999999999988   999999999999999999999999998753221  122


Q ss_pred             cccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCC
Q 006155          485 TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGS  564 (658)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~  564 (658)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||....   ..++......    +.      ..+....
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~---~~~~~~~i~~----~~------~~~~~~~  219 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD---TAEMYDNILN----KP------LRLKPNI  219 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC---HHHHHHHHHc----CC------CCCCCCC
Confidence            334679999999999999999999999999999999999999985322   2222222111    11      0111111


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHH
Q 006155          565 ITEMIRCIHIGLLCVQENVASRPTMA  590 (658)
Q Consensus       565 ~~e~~~~~~i~~~Cl~~~p~~RPtm~  590 (658)
                      .   ..+.+++..|++.||.+||++.
T Consensus       220 ~---~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         220 S---VSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             C---HHHHHHHHHHhhcCHHhCCCCC
Confidence            1   2345677799999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.2e-36  Score=309.26  Aligned_cols=252  Identities=28%  Similarity=0.458  Sum_probs=197.7

Q ss_pred             CcccCcccccCceEEEEeEecC-CcceeEEEeccCCcccHH--HHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEec
Q 006155          326 FSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDL--EFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFV  402 (658)
Q Consensus       326 ~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~--~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  402 (658)
                      |+..+.||+|+||+||+++... ++.+|+|++.........  ....|+.++.+++||||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            5677899999999999998554 568999999876543332  2356999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCc
Q 006155          403 PNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ  482 (658)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  482 (658)
                      ++++|.+++.   ....+++..++.++.||++||.|||+.+   ++|+||||+||++++++.++|+|||.+..+.  ...
T Consensus        81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~  152 (260)
T PF00069_consen   81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENN  152 (260)
T ss_dssp             TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST--STT
T ss_pred             cccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--ccc
Confidence            9999999995   4567899999999999999999999987   9999999999999999999999999987541  122


Q ss_pred             cccccccccccccCccccc-cCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCC
Q 006155          483 GNTSRIVGTYGYMAPEYAM-HGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLS  561 (658)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~-~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~  561 (658)
                      .......++..|+|||++. +..++.++||||+|+++|+|++|+.|+......+....+......   .    ...+...
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~---~----~~~~~~~  225 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKR---P----LPSSSQQ  225 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHT---H----HHHHTTS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc---c----ccccccc
Confidence            2344567899999999998 888999999999999999999999998543111111222111110   0    0000000


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          562 SGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       562 ~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ..  .....+.+++..||+.||++||++.++++
T Consensus       226 ~~--~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  226 SR--EKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HT--TSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             cc--hhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00  00145667888999999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=5.6e-36  Score=306.24  Aligned_cols=250  Identities=30%  Similarity=0.481  Sum_probs=194.9

Q ss_pred             CcccccCceEEEEeEecC-------CcceeEEEeccCC-cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          330 NKLGQGGFGAVYKGRLYD-------GAEIAVKRLSRDS-GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~~~-------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      +.||+|+||.||+|+..+       +..+|+|.+.... .....++.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            469999999999998543       2578999876543 23455788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcC----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCC-----CeEEecccc
Q 006155          402 VPNTSLDHFIFDPT----RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM-----TPKIADFGM  472 (658)
Q Consensus       402 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~-----~~kl~DFGl  472 (658)
                      +++++|.+++....    ....++|..++.++.|++.||.|||+.+   ++|+||||+||+++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999986422    2245889999999999999999999987   99999999999999877     899999999


Q ss_pred             ccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCC
Q 006155          473 ARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGT  551 (658)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~  551 (658)
                      ++...............++..|+|||++.++.++.++||||||+++|||++ |+.|+....   ..+......    .+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~---~~~~~~~~~----~~~  230 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN---NQEVLQHVT----AGG  230 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC---HHHHHHHHh----cCC
Confidence            976543322222223456788999999999999999999999999999998 888874322   122222211    111


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 006155          552 TVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN  597 (658)
Q Consensus       552 ~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~  597 (658)
                      ..     ........   .+.+++.+||+.+|.+||++.+|+++|+
T Consensus       231 ~~-----~~~~~~~~---~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         231 RL-----QKPENCPD---KIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             cc-----CCcccchH---HHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            00     11111222   3457788999999999999999999986

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=5.9e-36  Score=303.49  Aligned_cols=250  Identities=24%  Similarity=0.366  Sum_probs=200.6

Q ss_pred             ccCCcccCcccccCceEEEEeEecC-CcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      .++|+..+.||+|+||.||+++..+ +..+++|.+.....  ..++.+|+.++++++|+||+++++++..+...++++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            4678999999999999999998665 78899999875533  56799999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      +++++|.+++..  ....++|..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.+||+|||++........
T Consensus        80 ~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (256)
T cd06612          80 CGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA  154 (256)
T ss_pred             CCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence            999999999843  2356899999999999999999999987   99999999999999999999999999886543321


Q ss_pred             ccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCC
Q 006155          482 QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLS  561 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~  561 (658)
                        ......|+..|+|||++.+..++.++||||||+++|||++|+.|+.......   ...    ......     .+.+.
T Consensus       155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~---~~~----~~~~~~-----~~~~~  220 (256)
T cd06612         155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR---AIF----MIPNKP-----PPTLS  220 (256)
T ss_pred             --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh---hhh----hhccCC-----CCCCC
Confidence              2233468899999999998899999999999999999999999985332211   100    000000     01111


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          562 SGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       562 ~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      . ....-..+.+++..||+.+|++|||+.+|++
T Consensus       221 ~-~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         221 D-PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             c-hhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            0 1111123556778999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=7.3e-36  Score=308.61  Aligned_cols=250  Identities=26%  Similarity=0.343  Sum_probs=194.7

Q ss_pred             CcccCcccccCceEEEEeEec-CCcceeEEEeccCCcc---cHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          326 FSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQ---GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       326 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      |+..+.||+|+||.||++... +++.||||.+......   ....+.+|+.++.+++|+||+++++.+.+++..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            667789999999999999854 5889999998654322   223467899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++........
T Consensus        82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence            9999999988532 2345899999999999999999999987   99999999999999999999999999876543221


Q ss_pred             ccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCC
Q 006155          482 QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLS  561 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~  561 (658)
                         .....|+..|+|||++.+..++.++||||||+++|||++|+.||.....................         ...
T Consensus       158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~---------~~~  225 (285)
T cd05630         158 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQE---------EYS  225 (285)
T ss_pred             ---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhh---------hcC
Confidence               12347899999999999999999999999999999999999998543221111111111111110         111


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 006155          562 SGSITEMIRCIHIGLLCVQENVASRPT-----MASVVL  594 (658)
Q Consensus       562 ~~~~~e~~~~~~i~~~Cl~~~p~~RPt-----m~evv~  594 (658)
                      .....+   +.+++..||+.||++|||     +.|+++
T Consensus       226 ~~~~~~---~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         226 EKFSPD---ARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             ccCCHH---HHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            111222   346677899999999999     777774

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=7.4e-36  Score=326.64  Aligned_cols=259  Identities=22%  Similarity=0.327  Sum_probs=189.2

Q ss_pred             hhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccC-------
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEG-------  392 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-------  392 (658)
                      ...++|...++||+|+||.||+|+.. .++.||||++....    ....+|+.+++.++||||+++++++...       
T Consensus        63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~  138 (440)
T PTZ00036         63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK  138 (440)
T ss_pred             CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence            34568999999999999999999854 57899999885432    2345799999999999999999876432       


Q ss_pred             -CceEEEEEecCCCChhhhhcC-cCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCC-CeEEec
Q 006155          393 -NERLLIYEFVPNTSLDHFIFD-PTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM-TPKIAD  469 (658)
Q Consensus       393 -~~~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~-~~kl~D  469 (658)
                       ...++||||+++ +|.+++.. ......+++..++.++.||+.||.|||+.+   |+||||||+||||+.++ .+||+|
T Consensus       139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~D  214 (440)
T PTZ00036        139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCD  214 (440)
T ss_pred             ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeec
Confidence             135689999985 66665532 223457899999999999999999999988   99999999999999665 799999


Q ss_pred             cccccccccCCCccccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhcc
Q 006155          470 FGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWR  548 (658)
Q Consensus       470 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~  548 (658)
                      ||+++.+.....   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.....   .+.+........
T Consensus       215 FGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~---~~~~~~i~~~~~  288 (440)
T PTZ00036        215 FGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS---VDQLVRIIQVLG  288 (440)
T ss_pred             cccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhC
Confidence            999986643321   2235789999999998764 689999999999999999999999853322   122222221111


Q ss_pred             CCC----------cccccCCCCCCCCHH------HHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 006155          549 EGT----------TVNIIDPTLSSGSIT------EMIRCIHIGLLCVQENVASRPTMASVV  593 (658)
Q Consensus       549 ~~~----------~~~~~dp~l~~~~~~------e~~~~~~i~~~Cl~~~p~~RPtm~evv  593 (658)
                      ...          ..++--|........      .-..+.+++..||+.||.+|||+.|++
T Consensus       289 ~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l  349 (440)
T PTZ00036        289 TPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL  349 (440)
T ss_pred             CCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence            100          001100111110000      012456778899999999999999998

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=6.4e-36  Score=313.67  Aligned_cols=240  Identities=28%  Similarity=0.352  Sum_probs=187.6

Q ss_pred             CcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHhc-CCCCceeeeeeeccCCceEEEEEecCC
Q 006155          330 NKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANL-QHRNLVRLLGFSLEGNERLLIYEFVPN  404 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~  404 (658)
                      +.||+|+||.||+++.. +|+.||+|.+....   ......+..|..++..+ +||||+++++++.+++..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999854 57889999987542   22334456677777654 899999999999999999999999999


Q ss_pred             CChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCccc
Q 006155          405 TSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN  484 (658)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~  484 (658)
                      |+|..++..   ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  152 (316)
T cd05620          81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence            999988843   346899999999999999999999987   9999999999999999999999999987432211  12


Q ss_pred             cccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCC
Q 006155          485 TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGS  564 (658)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~  564 (658)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||....   ...+.....    .+      .+.+....
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~---~~~~~~~~~----~~------~~~~~~~~  219 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD---EDELFESIR----VD------TPHYPRWI  219 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHH----hC------CCCCCCCC
Confidence            334679999999999999999999999999999999999999985322   222222221    11      11111111


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHH-HHH
Q 006155          565 ITEMIRCIHIGLLCVQENVASRPTMA-SVV  593 (658)
Q Consensus       565 ~~e~~~~~~i~~~Cl~~~p~~RPtm~-evv  593 (658)
                      ..   .+.+++..||+.||++||++. ++.
T Consensus       220 ~~---~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         220 TK---ESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CH---HHHHHHHHHccCCHHHcCCChHHHH
Confidence            12   244667799999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=9.5e-37  Score=310.34  Aligned_cols=240  Identities=22%  Similarity=0.362  Sum_probs=187.2

Q ss_pred             CcccccCceEEEEeEecC--------CcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          330 NKLGQGGFGAVYKGRLYD--------GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      +.||+|+||.||+|....        ..+|++|.+.........++.+|+.++..++||||+++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999997432        235888988665555556788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCC--------eEEeccccc
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMT--------PKIADFGMA  473 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~--------~kl~DFGla  473 (658)
                      +++|+|..++...  ...++|..+++++.||+.||.|||+.+   |+||||||+|||++.++.        ++++|||++
T Consensus        81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            9999999998543  236899999999999999999999987   999999999999987765        589999988


Q ss_pred             cccccCCCccccccccccccccCccccccC-CCCcccccccccchHhHHHhCCC-CCccCCCCCcchHHHHHHHhccCCC
Q 006155          474 RLFEMDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQR-NNCFRNGETVEDLLSSAWKNWREGT  551 (658)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~-p~~~~~~~~~~~l~~~~~~~~~~~~  551 (658)
                      .....      .....++..|+|||++.+. .++.++||||||+++|||++|.. |+....   ....... ..   . .
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~---~~~~~~~-~~---~-~  221 (258)
T cd05078         156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD---SQKKLQF-YE---D-R  221 (258)
T ss_pred             cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc---HHHHHHH-HH---c-c
Confidence            65432      2234678899999999874 58999999999999999999964 432211   1111110 00   0 0


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 006155          552 TVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN  597 (658)
Q Consensus       552 ~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~  597 (658)
                            +.+....   ...+.+++..||+.+|++|||++++++.|+
T Consensus       222 ------~~~~~~~---~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         222 ------HQLPAPK---WTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ------ccCCCCC---cHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                  1111111   124567788999999999999999999885

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.4e-35  Score=311.20  Aligned_cols=197  Identities=28%  Similarity=0.463  Sum_probs=160.6

Q ss_pred             cCcccccCceEEEEeEec---CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeecc--CCceEEEEEecC
Q 006155          329 ANKLGQGGFGAVYKGRLY---DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLE--GNERLLIYEFVP  403 (658)
Q Consensus       329 ~~~lG~G~fg~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~~~  403 (658)
                      .++||+|+||.||+|+..   +++.+|+|.+....  ....+.+|+.++++++||||+++++++..  +...++|+||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999854   45789999986542  23457889999999999999999998854  456789999986


Q ss_pred             CCChhhhhcCc------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceee----CCCCCeEEeccccc
Q 006155          404 NTSLDHFIFDP------TRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLL----DAEMTPKIADFGMA  473 (658)
Q Consensus       404 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl----~~~~~~kl~DFGla  473 (658)
                      + +|.+++...      .....+++..+..++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            4 777766321      12235899999999999999999999988   9999999999999    45678999999999


Q ss_pred             cccccCCC-ccccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccC
Q 006155          474 RLFEMDET-QGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFR  531 (658)
Q Consensus       474 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~  531 (658)
                      +.+..... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            87654322 1223446789999999998774 5899999999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.9e-36  Score=308.16  Aligned_cols=254  Identities=24%  Similarity=0.389  Sum_probs=198.6

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      ..++|...+.||+|+||.||+++.. +++.||+|.++.........+.+|+.++..++||||+++++.+..++..++|+|
T Consensus         7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e   86 (267)
T cd06645           7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME   86 (267)
T ss_pred             cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence            3467888899999999999999854 588899999876655555568899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      |+++++|.+++..   ...+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++..+... 
T Consensus        87 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-  159 (267)
T cd06645          87 FCGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT-  159 (267)
T ss_pred             ccCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc-
Confidence            9999999998843   346899999999999999999999987   999999999999999999999999998765322 


Q ss_pred             CccccccccccccccCccccc---cCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccC
Q 006155          481 TQGNTSRIVGTYGYMAPEYAM---HGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID  557 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  557 (658)
                       ........|+..|+|||++.   .+.++.++|||||||++|||++|+.|+......  ..+.........        .
T Consensus       160 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~--~~~~~~~~~~~~--------~  228 (267)
T cd06645         160 -IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM--RALFLMTKSNFQ--------P  228 (267)
T ss_pred             -ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch--hhHHhhhccCCC--------C
Confidence             12223457899999999874   456889999999999999999999987432211  111111111000        0


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          558 PTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       558 p~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      +..... ..--..+.+++..|++.+|++||++.+|++
T Consensus       229 ~~~~~~-~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         229 PKLKDK-MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             Cccccc-CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            111100 000113457788999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=7.1e-36  Score=320.08  Aligned_cols=261  Identities=20%  Similarity=0.261  Sum_probs=197.8

Q ss_pred             hhhhhhhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeecc
Q 006155          316 FNTIRVATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLE  391 (658)
Q Consensus       316 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~  391 (658)
                      +..++...++|+..+.||+|+||.||+++.. +++.+|+|++....   ......+.+|+.++..++||||+++++.+.+
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            4455667799999999999999999999855 57789999986421   2233457889999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccc
Q 006155          392 GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFG  471 (658)
Q Consensus       392 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFG  471 (658)
                      ++..++||||+++|+|.+++..    ..++...+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG  187 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG  187 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence            9999999999999999999843    35788899999999999999999988   9999999999999999999999999


Q ss_pred             cccccccCCCccccccccccccccCccccccC----CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhc
Q 006155          472 MARLFEMDETQGNTSRIVGTYGYMAPEYAMHG----QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNW  547 (658)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~  547 (658)
                      +++.+..... .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||....   .........   
T Consensus       188 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~~~~~~i~---  260 (371)
T cd05622         188 TCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS---LVGTYSKIM---  260 (371)
T ss_pred             ceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC---HHHHHHHHH---
Confidence            9986543221 122346799999999998653    37899999999999999999999985322   111222111   


Q ss_pred             cCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHHh
Q 006155          548 REGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVAS--RPTMASVVLML  596 (658)
Q Consensus       548 ~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~--RPtm~evv~~L  596 (658)
                      .........++   .....+   +.+++..|++.++.+  ||++.++++..
T Consensus       261 ~~~~~~~~~~~---~~~s~~---~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         261 NHKNSLTFPDD---NDISKE---AKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             cCCCcccCCCc---CCCCHH---HHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            11111111111   111222   334556788744433  78999988753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.1e-36  Score=296.00  Aligned_cols=202  Identities=26%  Similarity=0.415  Sum_probs=170.5

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccH--HHHHHHHHHHHhcCCCCceeeeeeeccC--CceEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGD--LEFKNEVLLVANLQHRNLVRLLGFSLEG--NERLL  397 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~--~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~l  397 (658)
                      .++|+..++|++|.||.||+|+.. +++.||+|+++......-  ..-.+||.+|.+.+|||||.+..+....  +..|+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            367899999999999999999843 578899999976543221  2357899999999999999999887643  57899


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE  477 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~  477 (658)
                      |||||++ +|..++..  ...++...++.-++.|+++|++|||...   |+|||||++|+|+...|.+||+|||+||.+.
T Consensus       155 VMe~~Eh-DLksl~d~--m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMET--MKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             eHHHHHh-hHHHHHHh--ccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence            9999975 78888744  2357888999999999999999999998   9999999999999999999999999999887


Q ss_pred             cCCCccccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCC
Q 006155          478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRN  532 (658)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~  532 (658)
                      ....  ..+..+-|.+|.|||++.+. .|+...|+||+|||+.|++++++.|....
T Consensus       229 sp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s  282 (419)
T KOG0663|consen  229 SPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS  282 (419)
T ss_pred             CCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc
Confidence            5422  33456779999999998875 59999999999999999999999875443

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-37  Score=324.56  Aligned_cols=252  Identities=29%  Similarity=0.393  Sum_probs=201.3

Q ss_pred             cCCcccCcccccCceEEEEeEecC--Cc--ceeEEEeccCCcc-cHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLYD--GA--EIAVKRLSRDSGQ-GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~~--g~--~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  398 (658)
                      ++....++||+|.||.|++|.+..  |+  .||||.+...... ...+|.+|+.+|.+|+|+|+++|+|+..+ ....||
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV  188 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV  188 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence            445567899999999999998643  44  5799999776544 55689999999999999999999999988 788999


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccccc
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~  478 (658)
                      +|.++.|||.+.|++ ..+..|-......++.|||.||.||..+.   +|||||..+|+||-....+||+||||.+.+..
T Consensus       189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence            999999999999987 56677888999999999999999999987   99999999999999999999999999998876


Q ss_pred             CCCcccc-ccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCccccc
Q 006155          479 DETQGNT-SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNII  556 (658)
Q Consensus       479 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  556 (658)
                      ++..... ....-...|.|||.+.++.|+.++|||+|||.||||+| |+.||-....   .++++.+-    ++.  .+-
T Consensus       265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g---~qIL~~iD----~~e--rLp  335 (1039)
T KOG0199|consen  265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG---IQILKNID----AGE--RLP  335 (1039)
T ss_pred             CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH---HHHHHhcc----ccc--cCC
Confidence            5543322 22233568999999999999999999999999999999 4557633222   22222221    111  111


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          557 DPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       557 dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                            .....-.++.+++..||..+|++|||+..+.+.
T Consensus       336 ------RPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  336 ------RPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             ------CCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence                  122223456788899999999999999999743

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.4e-35  Score=303.41  Aligned_cols=254  Identities=25%  Similarity=0.429  Sum_probs=196.7

Q ss_pred             CCcccCcccccCceEEEEeEecC--CcceeEEEeccCC----------cccHHHHHHHHHHHHh-cCCCCceeeeeeecc
Q 006155          325 NFSDANKLGQGGFGAVYKGRLYD--GAEIAVKRLSRDS----------GQGDLEFKNEVLLVAN-LQHRNLVRLLGFSLE  391 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~~--g~~vavK~l~~~~----------~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~  391 (658)
                      +|+..+.||+|+||.||+|+...  ++.+|+|.+....          .....++..|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788899999999999999655  6789999875431          1222346778888865 789999999999999


Q ss_pred             CCceEEEEEecCCCChhhhhcC-cCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecc
Q 006155          392 GNERLLIYEFVPNTSLDHFIFD-PTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADF  470 (658)
Q Consensus       392 ~~~~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DF  470 (658)
                      ++..++||||+++++|.+++.. ......+++..+++++.|++.||.|||+..  .++|+||||+|||++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence            9999999999999999988743 123456899999999999999999999632  3999999999999999999999999


Q ss_pred             ccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCC
Q 006155          471 GMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREG  550 (658)
Q Consensus       471 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  550 (658)
                      |++.......   ......|+..|+|||++.++.++.++||||||+++|||++|+.|+....   ........    .++
T Consensus       159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~---~~~~~~~~----~~~  228 (269)
T cd08528         159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN---MLSLATKI----VEA  228 (269)
T ss_pred             cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC---HHHHHHHH----hhc
Confidence            9998654332   2334578999999999999999999999999999999999999974321   11111111    111


Q ss_pred             CcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 006155          551 TTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN  597 (658)
Q Consensus       551 ~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~  597 (658)
                      ...    +........   .+.+++.+||+.||++||++.||.++|+
T Consensus       229 ~~~----~~~~~~~~~---~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         229 VYE----PLPEGMYSE---DVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             cCC----cCCcccCCH---HHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            111    111111112   3456777999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.1e-37  Score=305.10  Aligned_cols=257  Identities=25%  Similarity=0.346  Sum_probs=190.8

Q ss_pred             cCCcccCcccccCceEEEEeEecC-CcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCC-----ceEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGN-----ERLL  397 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~l  397 (658)
                      -.|...+++|.|+||.||+|++.. +++||||+...+...    -..|+++|++++|||||+|+-++....     ...|
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            346678899999999999999654 689999998665432    256899999999999999998875432     2358


Q ss_pred             EEEecCCCChhhhhcCc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCC-CCeEEeccccccc
Q 006155          398 IYEFVPNTSLDHFIFDP-TRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE-MTPKIADFGMARL  475 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~-~~~kl~DFGla~~  475 (658)
                      ||||||. +|..++... ..+..++...+.-+..||.+||.|||+.+   |+||||||.|+|+|.+ |.+||||||.|+.
T Consensus       100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence            9999986 677776431 23456777788889999999999999987   9999999999999976 9999999999998


Q ss_pred             cccCCCccccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcc-
Q 006155          476 FEMDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTV-  553 (658)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-  553 (658)
                      +..++..   ....-|..|.|||.+.+. .|+.+.||||.||++.||+-|+.-|....   ..+.+....+.+.-.... 
T Consensus       176 L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s---~~dQL~eIik~lG~Pt~e~  249 (364)
T KOG0658|consen  176 LVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS---SVDQLVEIIKVLGTPTRED  249 (364)
T ss_pred             eccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC---HHHHHHHHHHHhCCCCHHH
Confidence            8766543   223558899999999875 69999999999999999999999885433   223333333332222211 


Q ss_pred             ---------cccCCCCCCCCH------HHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          554 ---------NIIDPTLSSGSI------TEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       554 ---------~~~dp~l~~~~~------~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                               +.-.|.+.....      ..-...+++..++++.+|.+|.++.|++.
T Consensus       250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence                     111222221111      01123456777899999999999999883

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.5e-36  Score=322.69  Aligned_cols=201  Identities=26%  Similarity=0.383  Sum_probs=172.8

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ++|+..+.||+|+||.||+++.. +++.||||++....   ......+.+|+.++..++||||+++++.+.+++..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999854 58889999986432   223445788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ||+++|+|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            99999999999843   456899999999999999999999988   999999999999999999999999998754321


Q ss_pred             CCc---------------------------------cccccccccccccCccccccCCCCcccccccccchHhHHHhCCC
Q 006155          480 ETQ---------------------------------GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQR  526 (658)
Q Consensus       480 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~  526 (658)
                      ...                                 ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            100                                 00123579999999999999999999999999999999999999


Q ss_pred             CCcc
Q 006155          527 NNCF  530 (658)
Q Consensus       527 p~~~  530 (658)
                      ||..
T Consensus       235 Pf~~  238 (360)
T cd05627         235 PFCS  238 (360)
T ss_pred             CCCC
Confidence            9854

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.7e-36  Score=308.58  Aligned_cols=257  Identities=26%  Similarity=0.354  Sum_probs=201.6

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      .++|+..+.||+|+||+||+++.. +|+.||+|++..... .....+.+|++++..++||||+++++++...+..++|||
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            467888899999999999999854 588899998865432 334578999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      |+++++|.+++..   ...+++.....++.+++.||.|||+..  .++||||||+||+++.++.++|+|||++..+... 
T Consensus        84 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-  157 (284)
T cd06620          84 FMDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-  157 (284)
T ss_pred             cCCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence            9999999998843   346899999999999999999999742  3999999999999999999999999998654322 


Q ss_pred             CccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCC-----CcchHHHHHHHhccCCCcccc
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGE-----TVEDLLSSAWKNWREGTTVNI  555 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~-----~~~~l~~~~~~~~~~~~~~~~  555 (658)
                         ......|+..|+|||++.++.++.++||||||+++||+++|+.||......     ....+......... +.    
T Consensus       158 ---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~----  229 (284)
T cd06620         158 ---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ-EP----  229 (284)
T ss_pred             ---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh-cc----
Confidence               122457899999999998889999999999999999999999998643321     11111221111111 11    


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 006155          556 IDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLML  596 (658)
Q Consensus       556 ~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L  596 (658)
                       .+.+...  .....+.+++.+|++.||++|||+.||+++.
T Consensus       230 -~~~~~~~--~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         230 -PPRLPSS--DFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             -CCCCCch--hcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence             1111111  0112355677899999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=3.1e-36  Score=315.08  Aligned_cols=263  Identities=24%  Similarity=0.339  Sum_probs=194.9

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      ++|...++||+|+||.||+|+.. +++.||+|++..... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56888999999999999999854 577899999875432 2334578899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      +++ +|.+++...  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            975 787777432  345889999999999999999999987   99999999999999999999999999976433221


Q ss_pred             ccccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHH--------HHHhccCCCc
Q 006155          482 QGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSS--------AWKNWREGTT  552 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~--------~~~~~~~~~~  552 (658)
                        ......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+..        .|..+.....
T Consensus       160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07872         160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE  237 (309)
T ss_pred             --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence              1223467899999998865 4689999999999999999999999854332211111111        1111110000


Q ss_pred             -ccccCCCCCCCC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          553 -VNIIDPTLSSGS-----ITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       553 -~~~~dp~l~~~~-----~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                       ...-.+......     ..--..+.+++..|++.||.+|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence             000001100000     000113457788999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.1e-36  Score=341.81  Aligned_cols=259  Identities=20%  Similarity=0.315  Sum_probs=198.3

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcc---cHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQ---GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ++|++.++||+|+||.||+|+.. .|+.||||++......   ....+.+|+.++++++||||+++++++.+++..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57889999999999999999854 5889999998754322   2346889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCc--------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccc
Q 006155          400 EFVPNTSLDHFIFDP--------TRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFG  471 (658)
Q Consensus       400 e~~~~gsL~~~l~~~--------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFG  471 (658)
                      ||+++++|.+++...        .....+++..+++++.||++||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            999999999988531        11234678889999999999999999987   9999999999999999999999999


Q ss_pred             cccccccCCC----------------ccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCC
Q 006155          472 MARLFEMDET----------------QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGET  535 (658)
Q Consensus       472 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~  535 (658)
                      +++.......                .......+||+.|||||++.+..++.++|||||||++|||++|+.||...... 
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~-  237 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR-  237 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh-
Confidence            9986622110                00112357999999999999999999999999999999999999998542211 


Q ss_pred             cchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHhcc
Q 006155          536 VEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRP-TMASVVLMLNS  598 (658)
Q Consensus       536 ~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RP-tm~evv~~L~~  598 (658)
                        ....   .... ...... .+  ......   .+.+++.+|++.||++|| +++++++.|+.
T Consensus       238 --ki~~---~~~i-~~P~~~-~p--~~~iP~---~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~  289 (932)
T PRK13184        238 --KISY---RDVI-LSPIEV-AP--YREIPP---FLSQIAMKALAVDPAERYSSVQELKQDLEP  289 (932)
T ss_pred             --hhhh---hhhc-cChhhc-cc--cccCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence              1111   0000 000000 00  001112   244677899999999995 66777776654

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-36  Score=306.82  Aligned_cols=248  Identities=25%  Similarity=0.377  Sum_probs=200.1

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC-cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS-GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      ++|+..+.||.|+||.||+|+.. +++.||+|.+.... ......+.+|+.+++.++|+||+++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            46888899999999999999854 58899999987653 33445688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      +++++|.+++..    ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+++.+.... 
T Consensus        81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  152 (274)
T cd06609          81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-  152 (274)
T ss_pred             eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence            999999999843    27899999999999999999999987   9999999999999999999999999998765432 


Q ss_pred             ccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCC
Q 006155          482 QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLS  561 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~  561 (658)
                       .......|+..|+|||++.+..++.++||||||+++|||++|+.|+.....   .........    ...     +.+.
T Consensus       153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~---~~~~~~~~~----~~~-----~~~~  219 (274)
T cd06609         153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP---MRVLFLIPK----NNP-----PSLE  219 (274)
T ss_pred             -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch---HHHHHHhhh----cCC-----CCCc
Confidence             122345788899999999998999999999999999999999999853321   111111111    111     1111


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          562 SGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       562 ~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ...  .-..+.+++..||+.+|++|||++++++
T Consensus       220 ~~~--~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         220 GNK--FSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             ccc--cCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            110  1113456778999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.6e-35  Score=305.29  Aligned_cols=250  Identities=26%  Similarity=0.366  Sum_probs=195.8

Q ss_pred             CCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecC
Q 006155          325 NFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVP  403 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~  403 (658)
                      .|+..+.||+|+||.||+|+.. .+..+++|.+..........+.+|+.+++.++||||+++++++..++..++|+||++
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            3577889999999999999865 467789998876655556678899999999999999999999999999999999999


Q ss_pred             CCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCcc
Q 006155          404 NTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQG  483 (658)
Q Consensus       404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  483 (658)
                      +++|..++..  ....+++..+..++.|+++||.|||+.+   ++||||||+|||++.++.+||+|||++.......  .
T Consensus        86 ~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~  158 (282)
T cd06643          86 GGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q  158 (282)
T ss_pred             CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--c
Confidence            9999988753  2356899999999999999999999987   9999999999999999999999999987643221  1


Q ss_pred             ccccccccccccCccccc-----cCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCC
Q 006155          484 NTSRIVGTYGYMAPEYAM-----HGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP  558 (658)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp  558 (658)
                      ......|+..|+|||++.     +..++.++|||||||++|||++|+.|+.....   .........    ........|
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~----~~~~~~~~~  231 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP---MRVLLKIAK----SEPPTLAQP  231 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH---HHHHHHHhh----cCCCCCCCc
Confidence            223356899999999984     44578899999999999999999999743221   111111111    111111111


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          559 TLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       559 ~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .   ...   ..+.+++..||+.+|.+||++.++++
T Consensus       232 ~---~~~---~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         232 S---RWS---SEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             c---ccC---HHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1   111   23456778999999999999998863

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.6e-36  Score=307.74  Aligned_cols=256  Identities=28%  Similarity=0.460  Sum_probs=201.0

Q ss_pred             ccCCcccCcccccCceEEEEeEecC-Cc----ceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLYD-GA----EIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERL  396 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~~-g~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  396 (658)
                      ..+|+..+.||+|+||.||+|...+ |.    .+|+|.+..... ....++.+|+.++.+++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            4678888999999999999998543 33    589998876543 234568899999999999999999999887 7889


Q ss_pred             EEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccc
Q 006155          397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF  476 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~  476 (658)
                      +|+||+++|+|.+++...  ...+++..++.++.||+.||+|||+.+   ++||||||+|||++.++.+||+|||+++.+
T Consensus        85 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          85 LITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (279)
T ss_pred             EEEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence            999999999999998542  345899999999999999999999987   999999999999999999999999999876


Q ss_pred             ccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccc
Q 006155          477 EMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNI  555 (658)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  555 (658)
                      .............++..|+|||.+....++.++||||||+++||+++ |+.|+....   ..++.....    .+..  .
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---~~~~~~~~~----~~~~--~  230 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP---AVEIPDLLE----KGER--L  230 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC---HHHHHHHHh----CCCC--C
Confidence            54332222222334678999999988899999999999999999999 999885432   222222221    1111  0


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          556 IDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       556 ~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      -.|.   ...   ..+.+++..||..+|.+||++.++++.|+..
T Consensus       231 ~~~~---~~~---~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~  268 (279)
T cd05057         231 PQPP---ICT---IDVYMVLVKCWMIDAESRPTFKELINEFSKM  268 (279)
T ss_pred             CCCC---CCC---HHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            0111   111   2355677899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2e-36  Score=317.78  Aligned_cols=241  Identities=29%  Similarity=0.316  Sum_probs=190.0

Q ss_pred             CcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHhc-CCCCceeeeeeeccCCceEEEEEecCC
Q 006155          330 NKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANL-QHRNLVRLLGFSLEGNERLLIYEFVPN  404 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~  404 (658)
                      +.||+|+||.||+++.. +++.||||++....   ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999865 47789999987542   22334567888888887 699999999999999999999999999


Q ss_pred             CChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCccc
Q 006155          405 TSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN  484 (658)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~  484 (658)
                      ++|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~  152 (318)
T cd05570          81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT  152 (318)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence            999988843   346899999999999999999999987   9999999999999999999999999987432211  12


Q ss_pred             cccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCC
Q 006155          485 TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGS  564 (658)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~  564 (658)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||....   ...+.....    ...      +......
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~---~~~~~~~i~----~~~------~~~~~~~  219 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD---EDELFQSIL----EDE------VRYPRWL  219 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC---HHHHHHHHH----cCC------CCCCCcC
Confidence            234578999999999999999999999999999999999999985322   222222111    111      1111111


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHH
Q 006155          565 ITEMIRCIHIGLLCVQENVASRPTM-----ASVVL  594 (658)
Q Consensus       565 ~~e~~~~~~i~~~Cl~~~p~~RPtm-----~evv~  594 (658)
                      ..   .+.+++..||+.||.+||++     .++++
T Consensus       220 ~~---~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         220 SK---EAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CH---HHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            12   34567789999999999999     77764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=5.6e-36  Score=308.96  Aligned_cols=200  Identities=30%  Similarity=0.474  Sum_probs=169.4

Q ss_pred             CCcccCcccccCceEEEEeEec-CCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          325 NFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      +|+..+.||+|+||.||+|+.. ++..||||++....  ......+.+|+.++.+++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4778899999999999999854 58899999886542  22345688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      ++ ++|.+++........+++..++.++.||++||.|||+.+   ++||||||+|||++.++.+||+|||++..+.... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 688888754444467899999999999999999999987   9999999999999999999999999997654322 


Q ss_pred             ccccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCcc
Q 006155          482 QGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCF  530 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~  530 (658)
                       .......+++.|+|||++.+. .++.++||||||+++|||++|+.|+..
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~  204 (285)
T cd07861         156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHG  204 (285)
T ss_pred             -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence             112234678899999988654 578999999999999999999998853

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.3e-35  Score=304.02  Aligned_cols=256  Identities=23%  Similarity=0.368  Sum_probs=198.9

Q ss_pred             hccCCcccCcccccCceEEEEeEecCC----cceeEEEeccCC-cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLYDG----AEIAVKRLSRDS-GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERL  396 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  396 (658)
                      ..++|...++||+|+||.||+|...+.    ..|+||...... ......+.+|+.++++++||||+++++++.+ +..+
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~   82 (270)
T cd05056           4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW   82 (270)
T ss_pred             chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence            346688889999999999999985432    468999887654 3344578999999999999999999998875 4578


Q ss_pred             EEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccc
Q 006155          397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF  476 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~  476 (658)
                      +||||+++++|.+++...  ...+++..++.++.+++.||.|||+.+   ++||||||+|||++.++.+||+|||+++..
T Consensus        83 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          83 IVMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             EEEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeec
Confidence            999999999999998542  335899999999999999999999987   999999999999999999999999999865


Q ss_pred             ccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccc
Q 006155          477 EMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNI  555 (658)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  555 (658)
                      ...... ......++..|+|||.+....++.++||||||+++||+++ |+.||.....   .+......    .+...  
T Consensus       158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~~~~~~----~~~~~--  227 (270)
T cd05056         158 EDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN---NDVIGRIE----NGERL--  227 (270)
T ss_pred             ccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHH----cCCcC--
Confidence            443221 1122344568999999988889999999999999999996 9998843321   12222211    11111  


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          556 IDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       556 ~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                         ........   .+.+++.+|+..+|++|||+.+++..|+..
T Consensus       228 ---~~~~~~~~---~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~  265 (270)
T cd05056         228 ---PMPPNCPP---TLYSLMTKCWAYDPSKRPRFTELKAQLSDI  265 (270)
T ss_pred             ---CCCCCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               11112222   345677899999999999999999999764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=9e-36  Score=305.87  Aligned_cols=258  Identities=25%  Similarity=0.410  Sum_probs=200.8

Q ss_pred             ccCCcccCcccccCceEEEEeEec------CCcceeEEEeccCCcc-cHHHHHHHHHHHHhcCCCCceeeeeeeccCCce
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRDSGQ-GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNER  395 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  395 (658)
                      .++|+..+.||+|+||.||+++..      +...|++|.+...... ...++.+|+.++++++|+||+++++++.+.+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   83 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH   83 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence            367888999999999999999853      2456899988665433 345789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCcCCC------CCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEec
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRR------AQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIAD  469 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~D  469 (658)
                      ++||||+++++|.+++......      ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~  160 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSL  160 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEcc
Confidence            9999999999999998643321      26899999999999999999999987   99999999999999999999999


Q ss_pred             cccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhcc
Q 006155          470 FGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWR  548 (658)
Q Consensus       470 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~  548 (658)
                      ||+++...... ........++..|+|||.+.++.++.++||||||+++|||++ |..|+.....   ...+..    ..
T Consensus       161 ~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~~----~~  232 (275)
T cd05046         161 LSLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLNR----LQ  232 (275)
T ss_pred             cccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHHH----HH
Confidence            99987543221 112233456788999999988889999999999999999999 6677632211   122221    11


Q ss_pred             CCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          549 EGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       549 ~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      .+... ..   ......   ..+.+++.+||+.+|++||++.+++.+|++
T Consensus       233 ~~~~~-~~---~~~~~~---~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         233 AGKLE-LP---VPEGCP---SRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             cCCcC-CC---CCCCCC---HHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            11111 00   011111   245578889999999999999999999863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.6e-35  Score=303.62  Aligned_cols=256  Identities=25%  Similarity=0.378  Sum_probs=197.0

Q ss_pred             CcccCcccccCceEEEEeEec----CCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeeccCC------
Q 006155          326 FSDANKLGQGGFGAVYKGRLY----DGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGN------  393 (658)
Q Consensus       326 ~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------  393 (658)
                      |...+.||+|+||.||+|...    .+..||||++....  .....++.+|+.++++++||||+++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            556789999999999999753    36789999987642  233456889999999999999999999876532      


Q ss_pred             ceEEEEEecCCCChhhhhcCc---CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecc
Q 006155          394 ERLLIYEFVPNTSLDHFIFDP---TRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADF  470 (658)
Q Consensus       394 ~~~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DF  470 (658)
                      ..++++||+++|+|.+++...   .....+++...++++.||+.||+|||+.+   |+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            237889999999998887432   12235899999999999999999999987   999999999999999999999999


Q ss_pred             ccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccC
Q 006155          471 GMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWRE  549 (658)
Q Consensus       471 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~  549 (658)
                      |+++.+.............+++.|++||.+....++.++||||||+++|||++ |+.|+...   ...++......    
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~---~~~~~~~~~~~----  230 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV---ENSEIYNYLIK----  230 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC---CHHHHHHHHHc----
Confidence            99986644332222223455678999999998899999999999999999999 77776422   22233222221    


Q ss_pred             CCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          550 GTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       550 ~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      +...     .....   ....+.+++.+|++.+|++||++.+|++.|++.
T Consensus       231 ~~~~-----~~~~~---~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         231 GNRL-----KQPPD---CLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCcC-----CCCCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1110     01111   123566788899999999999999999999753

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-37  Score=316.94  Aligned_cols=244  Identities=30%  Similarity=0.438  Sum_probs=195.1

Q ss_pred             cCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCc---ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSG---QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      .-|+..+.||.|+||.||.++. .+.+.||||+++-...   +.+.++..|+..|.+++|||++.+.|++..+...||||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            4577888999999999999984 4567899999976544   34567899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      |||- ||-.++|.  ..++++.+.++..|..+.+.||.|||+.+   .||||||+.||||.+.|.+||+|||.+.+..+ 
T Consensus       106 EYCl-GSAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-  178 (948)
T KOG0577|consen  106 EYCL-GSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP-  178 (948)
T ss_pred             HHHh-ccHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc-
Confidence            9994 55556652  23567899999999999999999999988   99999999999999999999999999976543 


Q ss_pred             CCccccccccccccccCccccc---cCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccccc
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAM---HGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNII  556 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  556 (658)
                           ...++|||.|||||++.   .|+|+-|+||||+|+...||.-.++|.-..+   ....+..+..+    .     
T Consensus       179 -----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN---AMSALYHIAQN----e-----  241 (948)
T KOG0577|consen  179 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSALYHIAQN----E-----  241 (948)
T ss_pred             -----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch---HHHHHHHHHhc----C-----
Confidence                 34579999999999984   6899999999999999999999888752221   11111111111    1     


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 006155          557 DPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVV  593 (658)
Q Consensus       557 dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv  593 (658)
                      .|.+......+  .+.+++-.||+.-|.+|||..+++
T Consensus       242 sPtLqs~eWS~--~F~~Fvd~CLqKipqeRptse~ll  276 (948)
T KOG0577|consen  242 SPTLQSNEWSD--YFRNFVDSCLQKIPQERPTSEELL  276 (948)
T ss_pred             CCCCCCchhHH--HHHHHHHHHHhhCcccCCcHHHHh
Confidence            24444432222  234667789999999999998876

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=7.4e-36  Score=308.09  Aligned_cols=263  Identities=22%  Similarity=0.319  Sum_probs=197.7

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      ++|+..+.||+|+||.||+++.. +|+.||+|++.....  .....+.+|+.++++++|+||+++++++..++..++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888899999999999999865 588999998865422  233457899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      |+++++|..++..   ...++|..++.++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            9999999887632   345899999999999999999999987   9999999999999999999999999998764432


Q ss_pred             CccccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhc--------cCCC
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNW--------REGT  551 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~--------~~~~  551 (658)
                      .  ......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+....+......+        ....
T Consensus       155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07847         155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ  232 (286)
T ss_pred             c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence            1  1223467889999999876 568899999999999999999999985333211111111100000        0000


Q ss_pred             c-ccccCCCCCCC-CHHH-----HHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          552 T-VNIIDPTLSSG-SITE-----MIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       552 ~-~~~~dp~l~~~-~~~e-----~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      . .....|..... ....     -..+.+++.+||+.+|++||++.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            0 00111111110 1111     134568889999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-35  Score=312.51  Aligned_cols=257  Identities=22%  Similarity=0.294  Sum_probs=193.8

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccC---CcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRD---SGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ++|+..+.||+|+||.||+++.. +++.||+|++...   .......+.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47888999999999999999854 5889999998642   1223345788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ||+++|+|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            99999999999843  2346899999999999999999999988   999999999999999999999999998765432


Q ss_pred             CCccccccccccccccCcccccc-----CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMH-----GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      .. .......||+.|+|||++..     +.++.++|||||||++|||++|+.||....   ..+.....+.   ......
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~---~~~~~~~i~~---~~~~~~  228 (331)
T cd05597         156 GT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYGKIMN---HKEHFQ  228 (331)
T ss_pred             CC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC---HHHHHHHHHc---CCCccc
Confidence            22 11223469999999999863     457889999999999999999999984321   1222222211   111111


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          555 IIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       555 ~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                      +  +.......+++..+++- ++|...++..||++.+++..
T Consensus       229 ~--~~~~~~~~~~~~~li~~-ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         229 F--PPDVTDVSEEAKDLIRR-LICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             C--CCccCCCCHHHHHHHHH-HccCcccccCCCCHHHHhcC
Confidence            1  11111123344444432 23666667778999998855

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.8e-35  Score=300.18  Aligned_cols=250  Identities=21%  Similarity=0.298  Sum_probs=198.5

Q ss_pred             CCcccCcccccCceEEEEeEec-CCcceeEEEeccCC-cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEec
Q 006155          325 NFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS-GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFV  402 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  402 (658)
                      +|+..+.||+|+||.||+++.. +++.+|+|.+.... ......+.+|+.+++.++|+||+++++.+.+++..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4777899999999999999854 58889999886432 334456888999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCc
Q 006155          403 PNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ  482 (658)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  482 (658)
                      ++++|.+++... ....+++...+.++.||+.||.|||+.+   ++|+||||+||++++++.++|+|||+++.+..... 
T Consensus        81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-  155 (255)
T cd08219          81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-  155 (255)
T ss_pred             CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence            999999887432 3345789999999999999999999987   99999999999999999999999999976543221 


Q ss_pred             cccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCC
Q 006155          483 GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSS  562 (658)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~  562 (658)
                       ......|++.|+|||++.+..++.++||||||+++|+|++|+.||....   .........    .+....     +..
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~---~~~~~~~~~----~~~~~~-----~~~  222 (255)
T cd08219         156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS---WKNLILKVC----QGSYKP-----LPS  222 (255)
T ss_pred             -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC---HHHHHHHHh----cCCCCC-----CCc
Confidence             1233578899999999998899999999999999999999999984321   122222211    111111     111


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          563 GSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       563 ~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                      ...   ..+.+++.+||+.||++||++.+|+..
T Consensus       223 ~~~---~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         223 HYS---YELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ccC---HHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            111   134567789999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.7e-35  Score=300.62  Aligned_cols=251  Identities=28%  Similarity=0.435  Sum_probs=197.0

Q ss_pred             CCcccCcccccCceEEEEeEecCCcceeEEEeccCCcc------cHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEE
Q 006155          325 NFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQ------GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  398 (658)
                      +|...+.||+|+||.||+|...+|+.+|||.+......      ....+.+|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            46778899999999999998778899999988654221      123578899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccccc
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~  478 (658)
                      +||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+|+||+|+||++++++.++|+|||++..+..
T Consensus        81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            999999999999843   346889999999999999999999987   99999999999999999999999999876532


Q ss_pred             CCC----ccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          479 DET----QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       479 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      ...    ........|+..|+|||++.+..++.++||||||+++|||++|+.|+.....  ....... ..  ...    
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--~~~~~~~-~~--~~~----  225 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR--LAAMFYI-GA--HRG----  225 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh--HHHHHHh-hh--ccC----
Confidence            111    1112235689999999999998999999999999999999999999853221  1111110 00  000    


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          555 IIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       555 ~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                       ..+.+......   .+..++.+||+.+|++||++.++++
T Consensus       226 -~~~~~~~~~~~---~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         226 -LMPRLPDSFSA---AAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             -CCCCCCCCCCH---HHHHHHHHHhcCCcccCCCHHHHhc
Confidence             11222222222   2456778999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.4e-35  Score=306.41  Aligned_cols=253  Identities=25%  Similarity=0.381  Sum_probs=196.5

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC-cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS-GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      ++|+..+.||+|+||.||+++.. .|..||+|.+.... ......+.+|+.++.+++|+||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            46788899999999999999865 68899999886542 22345688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      +++++|..++........+++..+..++.+|+.||.|||+..  +++||||||+||+++.++.+||+|||++..+...  
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  156 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--  156 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence            999999999865333447899999999999999999999742  3999999999999999999999999998765322  


Q ss_pred             ccccccccccccccCccccccCC------CCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccc
Q 006155          482 QGNTSRIVGTYGYMAPEYAMHGQ------YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNI  555 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~------~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  555 (658)
                        ......|+..|+|||++.+..      ++.++|||||||++|||++|+.||.....   ....... .....+..   
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~-~~~~~~~~---  227 (286)
T cd06622         157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY---ANIFAQL-SAIVDGDP---  227 (286)
T ss_pred             --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch---hhHHHHH-HHHhhcCC---
Confidence              122346888999999985543      58899999999999999999999853221   1111111 11111111   


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          556 IDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       556 ~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                        +.+...   .-..+..++.+||+.+|++||++.+++.
T Consensus       228 --~~~~~~---~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         228 --PTLPSG---YSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             --CCCCcc---cCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence              111111   1123446778999999999999999885

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.8e-36  Score=316.75  Aligned_cols=243  Identities=23%  Similarity=0.312  Sum_probs=186.0

Q ss_pred             CcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHH-HHHHhcCCCCceeeeeeeccCCceEEEEEecCC
Q 006155          330 NKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEV-LLVANLQHRNLVRLLGFSLEGNERLLIYEFVPN  404 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~-~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  404 (658)
                      +.||+|+||.||+++.. +++.||+|++....   ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999854 46789999986532   12223344444 456788999999999999999999999999999


Q ss_pred             CChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCccc
Q 006155          405 TSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN  484 (658)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~  484 (658)
                      ++|.+++..   ...+.+.....++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~  152 (325)
T cd05602          81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGT  152 (325)
T ss_pred             CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCC
Confidence            999998843   345788888999999999999999988   999999999999999999999999998753221  112


Q ss_pred             cccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCC
Q 006155          485 TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGS  564 (658)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~  564 (658)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||....   ..+.......    ... . +.+    ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~----~~~-~-~~~----~~  219 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN---TAEMYDNILN----KPL-Q-LKP----NI  219 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC---HHHHHHHHHh----CCc-C-CCC----CC
Confidence            334679999999999999999999999999999999999999985322   2222222211    110 0 111    11


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 006155          565 ITEMIRCIHIGLLCVQENVASRPTMASVVLML  596 (658)
Q Consensus       565 ~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L  596 (658)
                      ..   .+.+++..|++.+|.+||++.+.+..+
T Consensus       220 ~~---~~~~li~~~l~~~p~~R~~~~~~~~~i  248 (325)
T cd05602         220 TN---SARHLLEGLLQKDRTKRLGAKDDFMEI  248 (325)
T ss_pred             CH---HHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence            22   234566789999999999987554433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.4e-35  Score=306.48  Aligned_cols=249  Identities=25%  Similarity=0.418  Sum_probs=200.5

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      ..+|+..+.||.|+||.||+|+. .+|+.|++|.+..........+.+|+.+++.++||||+++++++..++..++|+||
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            35688999999999999999974 56889999999776555666789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      +++++|..++..    ..+++..+..++.+++.||.|||+.+   ++||||||+||+++.++.+||+|||++..+.....
T Consensus        98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~  170 (296)
T cd06655          98 LAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS  170 (296)
T ss_pred             cCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence            999999998842    35899999999999999999999987   99999999999999999999999999876543322


Q ss_pred             ccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCC
Q 006155          482 QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLS  561 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~  561 (658)
                        ......|+..|+|||.+.+..++.++|||||||++|||++|+.||.....   ..........    ....+..+   
T Consensus       171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~---~~~~~~~~~~----~~~~~~~~---  238 (296)
T cd06655         171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP---LRALYLIATN----GTPELQNP---  238 (296)
T ss_pred             --cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhc----CCcccCCc---
Confidence              12235688999999999998999999999999999999999999844322   1111111111    11111111   


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 006155          562 SGSITEMIRCIHIGLLCVQENVASRPTMASVV  593 (658)
Q Consensus       562 ~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv  593 (658)
                      .....   .+.+++.+||+.+|++||++.+|+
T Consensus       239 ~~~~~---~~~~li~~~l~~dp~~Rpt~~~il  267 (296)
T cd06655         239 EKLSP---IFRDFLNRCLEMDVEKRGSAKELL  267 (296)
T ss_pred             ccCCH---HHHHHHHHHhhcChhhCCCHHHHh
Confidence            11112   244677899999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.5e-35  Score=311.30  Aligned_cols=200  Identities=25%  Similarity=0.328  Sum_probs=171.5

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ++|...+.||+|+||.||+++.. +++.||+|.+....   ......+.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47888999999999999999854 57789999986531   222344788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ||+++|+|.+++...  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            999999999999542  346899999999999999999999987   999999999999999999999999999765433


Q ss_pred             CCccccccccccccccCcccccc-----CCCCcccccccccchHhHHHhCCCCCc
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMH-----GQYSVKSDVFSFGVLVLEIISGQRNNC  529 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~S~Gvll~elltG~~p~~  529 (658)
                      .. .......||+.|+|||++.+     +.++.++||||||+++|||++|+.||.
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~  209 (331)
T cd05624         156 GT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY  209 (331)
T ss_pred             Cc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCcc
Confidence            22 12233579999999999875     568899999999999999999999985

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-35  Score=301.07  Aligned_cols=254  Identities=24%  Similarity=0.355  Sum_probs=201.9

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      .++|+..+.||+|+||.||+++.. +++.+++|.+..........+.+|+.++++++||||+++++++.++...+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            367888999999999999999854 4778999999876555667889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      +++++|.+++..  ....+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||++..+.... 
T Consensus        82 ~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  155 (262)
T cd06613          82 CGGGSLQDIYQV--TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-  155 (262)
T ss_pred             CCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence            999999998853  2256899999999999999999999987   9999999999999999999999999987654321 


Q ss_pred             ccccccccccccccCccccccC---CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCC
Q 006155          482 QGNTSRIVGTYGYMAPEYAMHG---QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP  558 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp  558 (658)
                       .......++..|+|||.+.+.   .++.++||||||+++|||++|+.|+......   .......    ...   ...+
T Consensus       156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~---~~~~~~~----~~~---~~~~  224 (262)
T cd06613         156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM---RALFLIS----KSN---FPPP  224 (262)
T ss_pred             -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH----hcc---CCCc
Confidence             122235688899999999776   8899999999999999999999998432211   1111110    010   0001


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          559 TLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       559 ~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .+. ........+.+++.+||+.+|.+|||+.+|+.
T Consensus       225 ~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         225 KLK-DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             ccc-chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            111 11112234668889999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.6e-35  Score=305.37  Aligned_cols=252  Identities=26%  Similarity=0.373  Sum_probs=198.3

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      .+.|++.++||+|+||.||+|+.. ++..+++|.+..........+.+|+.+++.++||||+++++.+..+...++||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            467889999999999999999865 4788999999876655667788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      +++++|..++...  ...+++..++.++.|++.+|.|||+.+   ++||||||+||+++.++.+||+|||++....... 
T Consensus        91 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-  164 (292)
T cd06644          91 CPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-  164 (292)
T ss_pred             CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence            9999998887432  346899999999999999999999987   9999999999999999999999999987543221 


Q ss_pred             ccccccccccccccCccccc-----cCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccccc
Q 006155          482 QGNTSRIVGTYGYMAPEYAM-----HGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNII  556 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  556 (658)
                       .......++..|+|||++.     ...++.++||||||+++|||++|+.|+.....   ......    ..........
T Consensus       165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~----~~~~~~~~~~  236 (292)
T cd06644         165 -QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRVLLK----IAKSEPPTLS  236 (292)
T ss_pred             -cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH---HHHHHH----HhcCCCccCC
Confidence             1223356888999999984     34578899999999999999999998743221   111111    1111111111


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          557 DPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       557 dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .+   ...   ...+.+++.+||+.+|++||++.+|++
T Consensus       237 ~~---~~~---~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         237 QP---SKW---SMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             CC---ccc---CHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            11   111   123556778999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=4.4e-36  Score=331.76  Aligned_cols=263  Identities=18%  Similarity=0.240  Sum_probs=190.2

Q ss_pred             hhhhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCC------Cceeeeeeecc
Q 006155          319 IRVATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHR------NLVRLLGFSLE  391 (658)
Q Consensus       319 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~------niv~l~~~~~~  391 (658)
                      +....++|.+.++||+|+||+||+++.. .++.||||++.... ....++..|+.++..++|.      +++++++++..
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            3455788999999999999999999854 57789999986532 2233456777777777554      58888888865


Q ss_pred             C-CceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCcEEEeccCCCceeeCCCC------
Q 006155          392 G-NERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED-SRLRIIHRDLKTSNVLLDAEM------  463 (658)
Q Consensus       392 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlk~~NILl~~~~------  463 (658)
                      . ...++|||++ +++|.+++..   ...+++..+..|+.||+.||.|||++ +   ||||||||+|||++.++      
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~  275 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPV  275 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccc
Confidence            4 4678999988 6788887743   35699999999999999999999974 6   99999999999998765      


Q ss_pred             ----------CeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCC
Q 006155          464 ----------TPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNG  533 (658)
Q Consensus       464 ----------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~  533 (658)
                                .+||+|||++.....     .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       276 ~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~  350 (467)
T PTZ00284        276 TNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN  350 (467)
T ss_pred             cccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence                      499999998754221     22346899999999999999999999999999999999999999864332


Q ss_pred             CCcchHHHHHHHh----ccC----CCccccc------CCCCCC---------CCH---HHHHHHHHHHHHhcCCCCCCCC
Q 006155          534 ETVEDLLSSAWKN----WRE----GTTVNII------DPTLSS---------GSI---TEMIRCIHIGLLCVQENVASRP  587 (658)
Q Consensus       534 ~~~~~l~~~~~~~----~~~----~~~~~~~------dp~l~~---------~~~---~e~~~~~~i~~~Cl~~~p~~RP  587 (658)
                      .+...++......    |..    ....+++      .+....         ...   .+-..+.+++..||+.||++||
T Consensus       351 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~  430 (467)
T PTZ00284        351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL  430 (467)
T ss_pred             HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence            2111111111000    000    0000000      010000         000   0112356888999999999999


Q ss_pred             CHHHHHH
Q 006155          588 TMASVVL  594 (658)
Q Consensus       588 tm~evv~  594 (658)
                      |+.|+++
T Consensus       431 ta~e~L~  437 (467)
T PTZ00284        431 NARQMTT  437 (467)
T ss_pred             CHHHHhc
Confidence            9999985

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.9e-36  Score=317.58  Aligned_cols=193  Identities=24%  Similarity=0.361  Sum_probs=164.8

Q ss_pred             hhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ....+|...+.||+|+||.||+|+.. .+..||+|.....      ....|+.++.+++||||+++++++..+...++|+
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            34568999999999999999999854 4678999975432      2356899999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ||+. ++|.+++..  ....++|..++.|+.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  210 (357)
T PHA03209        137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA  210 (357)
T ss_pred             EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence            9995 678877743  3456899999999999999999999987   999999999999999999999999998753221


Q ss_pred             CCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCC
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNN  528 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~  528 (658)
                         .......||+.|+|||++.+..++.++|||||||++|||+++..++
T Consensus       211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence               1223457899999999999999999999999999999999976654

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3e-35  Score=300.52  Aligned_cols=248  Identities=28%  Similarity=0.443  Sum_probs=195.6

Q ss_pred             CcccCcccccCceEEEEeEec-CCcceeEEEeccCCccc---------HHHHHHHHHHHHhcCCCCceeeeeeeccCCce
Q 006155          326 FSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQG---------DLEFKNEVLLVANLQHRNLVRLLGFSLEGNER  395 (658)
Q Consensus       326 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~---------~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  395 (658)
                      |...+.||+|+||.||+|... +++.+|+|.+.......         ...+.+|+.++.+++||||+++++++.+.+..
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            566789999999999999853 57889999886543221         13578899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ++|+||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||+++.
T Consensus        82 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~  155 (267)
T cd06628          82 NIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKK  155 (267)
T ss_pred             EEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence            999999999999999843   356899999999999999999999987   99999999999999999999999999987


Q ss_pred             cccCCCc----cccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCC
Q 006155          476 FEMDETQ----GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGT  551 (658)
Q Consensus       476 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  551 (658)
                      +......    .......|+..|+|||.+.+..++.++||||||+++|||++|+.|+.....   ...+.....      
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~------  226 (267)
T cd06628         156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ---LQAIFKIGE------  226 (267)
T ss_pred             cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH---HHHHHHHhc------
Confidence            6532111    111234688999999999999999999999999999999999999853211   111111111      


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          552 TVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       552 ~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                         ...+.+.....+   .+.+++.+||+.+|.+||++.+|++
T Consensus       227 ---~~~~~~~~~~~~---~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         227 ---NASPEIPSNISS---EAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             ---cCCCcCCcccCH---HHHHHHHHHccCCchhCcCHHHHhh
Confidence               111222222222   3446667999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.7e-35  Score=300.39  Aligned_cols=251  Identities=24%  Similarity=0.351  Sum_probs=200.5

Q ss_pred             CCcccCcccccCceEEEEeEe-cCCcceeEEEeccC--CcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          325 NFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRD--SGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      +|+..+.||+|+||.||.++. .+++.+++|.+...  ......++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            478889999999999988873 45888999987654  234455688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      +++++|.+++.... ...+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            99999999985432 356899999999999999999999987   99999999999999999999999999986644332


Q ss_pred             ccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCC
Q 006155          482 QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLS  561 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~  561 (658)
                        ......|++.|+|||++.+..++.++||||||+++|||++|+.|+....   ..+.....    ..+......     
T Consensus       157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~---~~~~~~~~----~~~~~~~~~-----  222 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN---PLNLVVKI----VQGNYTPVV-----  222 (256)
T ss_pred             --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC---HHHHHHHH----HcCCCCCCc-----
Confidence              2234578999999999988889999999999999999999999984322   12222211    111111110     


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 006155          562 SGSITEMIRCIHIGLLCVQENVASRPTMASVVLML  596 (658)
Q Consensus       562 ~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L  596 (658)
                      ....   ..+.+++..||+.+|++||++.++++.+
T Consensus       223 ~~~~---~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         223 SVYS---SELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             cccC---HHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            1111   2355677899999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.6e-35  Score=310.55  Aligned_cols=196  Identities=28%  Similarity=0.460  Sum_probs=159.7

Q ss_pred             cCcccccCceEEEEeEecC---CcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeecc--CCceEEEEEecC
Q 006155          329 ANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLE--GNERLLIYEFVP  403 (658)
Q Consensus       329 ~~~lG~G~fg~Vy~~~~~~---g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~~~  403 (658)
                      ..+||+|+||.||+|+..+   +..||+|.+....  ....+.+|+.++++++||||+++++++..  +...++|+||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            3589999999999998543   4679999886543  23457899999999999999999998853  557789999987


Q ss_pred             CCChhhhhcCc------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceee----CCCCCeEEeccccc
Q 006155          404 NTSLDHFIFDP------TRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLL----DAEMTPKIADFGMA  473 (658)
Q Consensus       404 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl----~~~~~~kl~DFGla  473 (658)
                      + +|.+++...      .....+++..+..++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 666665321      12346899999999999999999999987   9999999999999    56679999999999


Q ss_pred             cccccCCCc-cccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCcc
Q 006155          474 RLFEMDETQ-GNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCF  530 (658)
Q Consensus       474 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~  530 (658)
                      +.+...... .......||+.|+|||++.+. .++.++||||||+++|||++|+.||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            876543221 223346789999999998764 589999999999999999999999854

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.1e-35  Score=301.41  Aligned_cols=255  Identities=26%  Similarity=0.394  Sum_probs=195.1

Q ss_pred             CCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcc----------cHHHHHHHHHHHHhcCCCCceeeeeeeccCC
Q 006155          325 NFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQ----------GDLEFKNEVLLVANLQHRNLVRLLGFSLEGN  393 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~----------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  393 (658)
                      +|...+.||+|+||.||+|+. .+|+.||+|.+......          ....+.+|+.++..++||||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            466778999999999999974 46889999987542111          1235788999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccc
Q 006155          394 ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMA  473 (658)
Q Consensus       394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla  473 (658)
                      ..++||||+++++|.+++...   ..+++..+..++.||+.||.|||+.+   ++||||+|+||+++.++.++|+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence            999999999999999998542   56899999999999999999999987   999999999999999999999999999


Q ss_pred             cccccCCCccccccccccccccCccccccCC--CCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCC
Q 006155          474 RLFEMDETQGNTSRIVGTYGYMAPEYAMHGQ--YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGT  551 (658)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  551 (658)
                      +...............|+..|+|||++....  ++.++||||||+++||+++|+.|+....  .    ........... 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--~----~~~~~~~~~~~-  228 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE--A----IAAMFKLGNKR-  228 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc--h----HHHHHHhhccc-
Confidence            7654322222233456889999999987655  8899999999999999999999974211  1    11111111111 


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          552 TVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       552 ~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                      ....+++......   ...+.+++..||+.+|++||++.+|++.
T Consensus       229 ~~~~~~~~~~~~~---~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         229 SAPPIPPDVSMNL---SPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             cCCcCCccccccC---CHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            1111111111111   1344567789999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.1e-35  Score=304.91  Aligned_cols=262  Identities=24%  Similarity=0.357  Sum_probs=200.9

Q ss_pred             chhhhhhhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhc-CCCCceeeeeeec--
Q 006155          315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANL-QHRNLVRLLGFSL--  390 (658)
Q Consensus       315 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~--  390 (658)
                      .+..+..+.++|+..+.||+|+||.||+++.. .++.+|+|.+.... ....++.+|+.++.++ +||||+++++++.  
T Consensus         9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638           9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            34556678899999999999999999999853 57889999876432 2345678899999999 6999999999874  


Q ss_pred             ---cCCceEEEEEecCCCChhhhhcCc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeE
Q 006155          391 ---EGNERLLIYEFVPNTSLDHFIFDP-TRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPK  466 (658)
Q Consensus       391 ---~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~k  466 (658)
                         .++..++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+|
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~k  164 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVK  164 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEE
Confidence               345689999999999999987532 23356899999999999999999999987   99999999999999999999


Q ss_pred             EeccccccccccCCCccccccccccccccCcccccc-----CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHH
Q 006155          467 IADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMH-----GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLS  541 (658)
Q Consensus       467 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~  541 (658)
                      |+|||+++.+.....  ......|++.|+|||++..     ..++.++|||||||++|||++|+.|+.....  ...+  
T Consensus       165 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~--~~~~--  238 (286)
T cd06638         165 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP--MRAL--  238 (286)
T ss_pred             EccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch--hHHH--
Confidence            999999876543221  2233568999999998853     4578899999999999999999999843221  1111  


Q ss_pred             HHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          542 SAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       542 ~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                         ............++...   .   ..+.+++.+||+.+|++|||+.||++.
T Consensus       239 ---~~~~~~~~~~~~~~~~~---~---~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         239 ---FKIPRNPPPTLHQPELW---S---NEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             ---hhccccCCCcccCCCCc---C---HHHHHHHHHHccCCcccCCCHHHHhhc
Confidence               11111111112222111   1   235577889999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=4.7e-35  Score=298.66  Aligned_cols=256  Identities=26%  Similarity=0.410  Sum_probs=201.8

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC-cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS-GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      ++|+..+.||.|+||+||+|... ++..+++|++.... ......+.+|+..++.++|+||+++++.+..++..++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47888999999999999999843 57889999986543 23456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      +++++|.+++........+++.....++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999864333356899999999999999999999987   99999999999999999999999999876654332


Q ss_pred             cc--ccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCC
Q 006155          482 QG--NTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP  558 (658)
Q Consensus       482 ~~--~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp  558 (658)
                      ..  ......|+..|+|||++... .++.++||||||+++|||++|+.|+......   .......   .. .     .+
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~~~~~~---~~-~-----~~  225 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM---KVLMLTL---QN-D-----PP  225 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh---hhHHHHh---cC-C-----CC
Confidence            21  22345789999999998877 7899999999999999999999998533221   1111111   11 1     01


Q ss_pred             CCCCCC--HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          559 TLSSGS--ITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       559 ~l~~~~--~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .+....  ..-...+.+++..||+.||++||++.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            111110  011133457778999999999999999985

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.9e-35  Score=307.42  Aligned_cols=251  Identities=25%  Similarity=0.407  Sum_probs=201.1

Q ss_pred             hccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      ..++|...+.||+|+||.||+++. .+++.||+|.+..........+.+|+.+++.++|+||+++++++..++..++|||
T Consensus        17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   96 (297)
T cd06656          17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   96 (297)
T ss_pred             hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence            347889999999999999999984 4689999999977655556678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      |+++++|.+++..    ..+++..+..++.+++.||.|||+.+   ++||||||+|||++.++.++|+|||++.......
T Consensus        97 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~  169 (297)
T cd06656          97 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (297)
T ss_pred             ccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence            9999999999842    45899999999999999999999987   9999999999999999999999999987654332


Q ss_pred             CccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCC
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTL  560 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l  560 (658)
                      .  ......+++.|+|||.+.+..++.++||||||+++|++++|+.||.......  .+. ..   +..+ ......+. 
T Consensus       170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~--~~~-~~---~~~~-~~~~~~~~-  239 (297)
T cd06656         170 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--ALY-LI---ATNG-TPELQNPE-  239 (297)
T ss_pred             c--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch--hee-ee---ccCC-CCCCCCcc-
Confidence            1  1223568899999999999899999999999999999999999985322211  100 00   0101 00010110 


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          561 SSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       561 ~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                        ...   ..+.+++..||+.+|++||++.+|++
T Consensus       240 --~~~---~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         240 --RLS---AVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             --ccC---HHHHHHHHHHccCChhhCcCHHHHhc
Confidence              111   12346778999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.6e-35  Score=298.97  Aligned_cols=247  Identities=30%  Similarity=0.434  Sum_probs=196.2

Q ss_pred             CCcccCcccccCceEEEEeEec-CCcceeEEEeccCC-----cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEE
Q 006155          325 NFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS-----GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  398 (658)
                      +|+..+.||+|+||.||+|... +++.|++|.+....     .+....+.+|+.+++.++|+||+++++++.++...++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            3667789999999999999865 68899999886543     22345688999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccccc
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~  478 (658)
                      +||+++++|.+++..   ...+++..+..++.+|++||.|||+.+   ++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            999999999999843   345899999999999999999999987   99999999999999999999999999876543


Q ss_pred             CCCccccccccccccccCccccccCC-CCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccC
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAMHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID  557 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  557 (658)
                      ..   ......|+..|++||.+.... ++.++|+||||+++|||++|+.|+....  .. ..   .+........     
T Consensus       155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~--~~-~~---~~~~~~~~~~-----  220 (258)
T cd06632         155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE--GV-AA---VFKIGRSKEL-----  220 (258)
T ss_pred             cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc--HH-HH---HHHHHhcccC-----
Confidence            32   223456889999999987776 8999999999999999999999985322  11 11   1111110111     


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          558 PTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       558 p~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      +.+.....   ..+.+++.+||+.+|.+||++.+++.
T Consensus       221 ~~~~~~~~---~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         221 PPIPDHLS---DEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             CCcCCCcC---HHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            11111111   23446778999999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=9.8e-36  Score=306.09  Aligned_cols=248  Identities=26%  Similarity=0.403  Sum_probs=197.7

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC-cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS-GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      +.|+..+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            34667788999999999999854 57789999887543 23345688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      +++++|.+++.    ...+++..+..++.++++||.|||+.+   ++|+||+|+||++++++.++|+|||++..+.... 
T Consensus        84 ~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-  155 (277)
T cd06642          84 LGGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-  155 (277)
T ss_pred             cCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc-
Confidence            99999999883    246899999999999999999999987   9999999999999999999999999997654322 


Q ss_pred             ccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCC
Q 006155          482 QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLS  561 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~  561 (658)
                       .......|+..|+|||++.+..++.++||||||+++|||++|+.|+......   .....    ...+.     .+.+.
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~~~----~~~~~-----~~~~~  222 (277)
T cd06642         156 -IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM---RVLFL----IPKNS-----PPTLE  222 (277)
T ss_pred             -hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh---hHHhh----hhcCC-----CCCCC
Confidence             1122346888999999999989999999999999999999999987432211   11111    11111     12222


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          562 SGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       562 ~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                      ...   ...+.+++..||+.+|++||+|.+|++.
T Consensus       223 ~~~---~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         223 GQY---SKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             ccc---CHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            211   2235577789999999999999999974

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.7e-35  Score=305.93  Aligned_cols=259  Identities=25%  Similarity=0.384  Sum_probs=189.7

Q ss_pred             CCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcc--cHHHHHHHHHHHHhc---CCCCceeeeeeecc-----CC
Q 006155          325 NFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQ--GDLEFKNEVLLVANL---QHRNLVRLLGFSLE-----GN  393 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l---~H~niv~l~~~~~~-----~~  393 (658)
                      +|+..+.||+|+||.||+++.. +|+.||+|.+......  ....+.+|+.++..+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4778899999999999999854 5888999988754222  233456777777665   69999999998764     24


Q ss_pred             ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccc
Q 006155          394 ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMA  473 (658)
Q Consensus       394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla  473 (658)
                      ..++||||+++ +|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence            57899999984 888887432 2345899999999999999999999988   999999999999999999999999999


Q ss_pred             cccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHh-------
Q 006155          474 RLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKN-------  546 (658)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~-------  546 (658)
                      +.+....   ......||..|+|||++.+..++.++|||||||++|||++|+.||......   +.+......       
T Consensus       156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~---~~~~~~~~~~~~~~~~  229 (288)
T cd07863         156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA---DQLGKIFDLIGLPPED  229 (288)
T ss_pred             ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH---HHHHHHHHHhCCCChh
Confidence            8654322   122357899999999999999999999999999999999999988533221   111111111       


Q ss_pred             -ccCCC--cccccCCCCCCC----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          547 -WREGT--TVNIIDPTLSSG----SITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       547 -~~~~~--~~~~~dp~l~~~----~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                       |....  ......+.....    ....-..+.+++..|++.||++|||+.|++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence             11000  000000000000    0001123457888999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=4e-35  Score=299.70  Aligned_cols=250  Identities=26%  Similarity=0.372  Sum_probs=191.4

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc-----ccHHHHHHHHHHHHhcCCCCceeeeeeecc--CCce
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG-----QGDLEFKNEVLLVANLQHRNLVRLLGFSLE--GNER  395 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~  395 (658)
                      .+|...+.||+|+||.||++... .+..|++|++.....     .....+.+|+.++++++||||+++++++.+  +...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            47888999999999999999854 588999998864321     223457889999999999999999998865  3567


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ++++||+++++|.+++..   ...+++...+.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            899999999999999843   345899999999999999999999887   99999999999999999999999999876


Q ss_pred             cccCC-CccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          476 FEMDE-TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       476 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      +.... .........++..|+|||++.+..++.++||||||+++|||++|+.||....  .. ..   ........    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~--~~-~~---~~~~~~~~----  225 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE--AM-AA---IFKIATQP----  225 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc--hH-HH---HHHHhcCC----
Confidence            54321 1112223568899999999998889999999999999999999999984321  11 11   11111111    


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          555 IIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       555 ~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                       ..|.+.....+.+.    .++.||..+|++||++.||++
T Consensus       226 -~~~~~~~~~~~~~~----~li~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         226 -TNPQLPSHISEHAR----DFLGCIFVEARHRPSAEELLR  260 (266)
T ss_pred             -CCCCCchhcCHHHH----HHHHHhcCChhhCcCHHHHhc
Confidence             11222211122222    233688899999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.3e-35  Score=316.53  Aligned_cols=197  Identities=27%  Similarity=0.357  Sum_probs=166.2

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeeccC------
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLEG------  392 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------  392 (658)
                      ..++|+..+.||+|+||.||++... .++.||||++.....  .....+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4578999999999999999999743 588899999876432  2334677899999999999999999987643      


Q ss_pred             CceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccc
Q 006155          393 NERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGM  472 (658)
Q Consensus       393 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGl  472 (658)
                      ...++||||+++ +|.+.+.     ..+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence            346899999975 5655552     24889999999999999999999988   99999999999999999999999999


Q ss_pred             ccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCcc
Q 006155          473 ARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCF  530 (658)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~  530 (658)
                      ++......   ......||..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       166 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  220 (355)
T cd07874         166 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG  220 (355)
T ss_pred             cccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            98643221   22345789999999999999999999999999999999999999853

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.1e-35  Score=310.75  Aligned_cols=257  Identities=20%  Similarity=0.281  Sum_probs=192.1

Q ss_pred             cCCcccCcccccCceEEEEeEecC-CcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ++|...++||+|+||.||+++... ++.+|+|++.+..   ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            478889999999999999998654 6779999986421   122334788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ||+++|+|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 ey~~~g~L~~~l~~--~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            99999999999953  2346899999999999999999999987   999999999999999999999999998755332


Q ss_pred             CCccccccccccccccCccccc-----cCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAM-----HGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      .. .......||+.|+|||++.     .+.++.++|||||||++|||++|+.||....   ..+.......   ...  .
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~---~~~~~~~i~~---~~~--~  226 (332)
T cd05623         156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYGKIMN---HKE--R  226 (332)
T ss_pred             Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC---HHHHHHHHhC---CCc--c
Confidence            21 1223457999999999986     3468899999999999999999999985322   2222222211   110  0


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          555 IIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       555 ~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                      ..-|........++..+++- +.|..+++..||++.++++.
T Consensus       227 ~~~p~~~~~~s~~~~~li~~-ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         227 FQFPAQVTDVSEDAKDLIRR-LICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             ccCCCccccCCHHHHHHHHH-HccChhhhcCCCCHHHHhCC
Confidence            10111111223344444332 22455566668999998755

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.8e-35  Score=316.62  Aligned_cols=197  Identities=28%  Similarity=0.364  Sum_probs=166.8

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeeccC------
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEG------  392 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------  392 (658)
                      ..++|...+.||+|+||.||++... .++.||||++....  ......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3578999999999999999999843 57889999987542  23345678899999999999999999987543      


Q ss_pred             CceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccc
Q 006155          393 NERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGM  472 (658)
Q Consensus       393 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGl  472 (658)
                      ...++||||+++ +|..++.     ..+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence            356999999975 6666652     24889999999999999999999987   99999999999999999999999999


Q ss_pred             ccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCcc
Q 006155          473 ARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCF  530 (658)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~  530 (658)
                      ++......   ......||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       173 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  227 (364)
T cd07875         173 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG  227 (364)
T ss_pred             ccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence            98653321   22345789999999999999999999999999999999999999853

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-36  Score=314.26  Aligned_cols=257  Identities=25%  Similarity=0.396  Sum_probs=203.6

Q ss_pred             hhhccCCcccCcccccCceEEEEeEec---CCc--ceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCC
Q 006155          320 RVATDNFSDANKLGQGGFGAVYKGRLY---DGA--EIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGN  393 (658)
Q Consensus       320 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~---~g~--~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  393 (658)
                      ++..+.....+.||.|-||.||+|+..   .|+  .||||..+.+.. ...+.|..|..+|++++||||++|+|+|.+ .
T Consensus       385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~  463 (974)
T KOG4257|consen  385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q  463 (974)
T ss_pred             eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence            344455566778999999999999843   233  489999988543 445669999999999999999999999976 4


Q ss_pred             ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccc
Q 006155          394 ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMA  473 (658)
Q Consensus       394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla  473 (658)
                      ..|+|||.++-|.|..||..  +...|+......++.||..+|.|||+..   +|||||..+|||+.....+||+|||++
T Consensus       464 P~WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLS  538 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLS  538 (974)
T ss_pred             ceeEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchh
Confidence            67999999999999999954  4456888999999999999999999987   999999999999999999999999999


Q ss_pred             cccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCc
Q 006155          474 RLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTT  552 (658)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~  552 (658)
                      |.++.+... ..++..-...|||||.+.-.++|..+|||.|||.+|||++ |.+||......+..       ..+.+|..
T Consensus       539 R~~ed~~yY-kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-------~~iEnGeR  610 (974)
T KOG4257|consen  539 RYLEDDAYY-KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-------GHIENGER  610 (974)
T ss_pred             hhccccchh-hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-------EEecCCCC
Confidence            988755433 3334556789999999999999999999999999999987 88898533222211       11122221


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          553 VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       553 ~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                           +.+....++   .+..++.+||..+|.+||.+.++...|+.
T Consensus       611 -----lP~P~nCPp---~LYslmskcWayeP~kRPrftei~~~lsd  648 (974)
T KOG4257|consen  611 -----LPCPPNCPP---ALYSLMSKCWAYEPSKRPRFTEIKAILSD  648 (974)
T ss_pred             -----CCCCCCCCh---HHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence                 112222333   34567889999999999999999988754

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.8e-35  Score=300.75  Aligned_cols=253  Identities=26%  Similarity=0.420  Sum_probs=197.2

Q ss_pred             CCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCc------ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEE
Q 006155          325 NFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSG------QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  397 (658)
                      +|+..+.||+|+||.||+++. .+++.||+|.+.....      .....+.+|+.++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477788999999999999974 5688999998865431      123568899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCC-CeEEecccccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM-TPKIADFGMARLF  476 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~-~~kl~DFGla~~~  476 (658)
                      |+||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   ++|+||||+||+++.++ .+||+|||++..+
T Consensus        81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            9999999999999843   346899999999999999999999987   99999999999998776 5999999998766


Q ss_pred             ccCCCc--cccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          477 EMDETQ--GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       477 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      ......  .......|+..|+|||++.+..++.++||||+|+++|||++|+.|+...........   .+.. ....   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~-~~~~---  227 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL---IFKI-ASAT---  227 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH---HHHH-hccC---
Confidence            543211  112335688999999999888899999999999999999999999853322211111   1111 0000   


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          555 IIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       555 ~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                       ..+.+...   .-..+.+++..|++.+|++||++.++++
T Consensus       228 -~~~~~~~~---~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         228 -TAPSIPEH---LSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             -CCCCCchh---hCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence             01111111   1134556788999999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.5e-35  Score=297.94  Aligned_cols=247  Identities=29%  Similarity=0.480  Sum_probs=195.6

Q ss_pred             cCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecC
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVP  403 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~  403 (658)
                      ++|...+.||+|+||.||++. ..++.||+|.+....  ....+.+|+.++.+++||||+++++++... ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~-~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGE-YTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEecc-cCCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            568889999999999999997 478889999986542  345688999999999999999999998654 4799999999


Q ss_pred             CCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCcc
Q 006155          404 NTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQG  483 (658)
Q Consensus       404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  483 (658)
                      +++|.+++.... ...+++..+++++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......   
T Consensus        82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---  154 (254)
T cd05083          82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---  154 (254)
T ss_pred             CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence            999999985432 345899999999999999999999987   9999999999999999999999999987543211   


Q ss_pred             ccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCC
Q 006155          484 NTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSS  562 (658)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~  562 (658)
                        .....+..|+|||++.++.++.++||||||+++|||++ |+.|+....   ..++......    +...   ++  ..
T Consensus       155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~---~~~~~~~~~~----~~~~---~~--~~  220 (254)
T cd05083         155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS---LKEVKECVEK----GYRM---EP--PE  220 (254)
T ss_pred             --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC---HHHHHHHHhC----CCCC---CC--CC
Confidence              12234568999999998999999999999999999998 888874322   2222222211    1111   11  11


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          563 GSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       563 ~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      ...   ..+.+++..||+.+|++||++.+|+..|+.
T Consensus       221 ~~~---~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         221 GCP---ADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             cCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            111   234577889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=7.2e-36  Score=314.29  Aligned_cols=241  Identities=26%  Similarity=0.300  Sum_probs=189.1

Q ss_pred             CCcccCcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHhcC-CCCceeeeeeeccCCceEEEE
Q 006155          325 NFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQ-HRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~  399 (658)
                      +|+..+.||+|+||.||+++.. +|+.||+|++....   ......+..|..++..+. |++|+++++++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3667789999999999999854 58889999987542   223345677888888886 577888999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ||+++|+|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            99999999998843   346899999999999999999999987   999999999999999999999999998754322


Q ss_pred             CCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCC
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT  559 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~  559 (658)
                      .  .......||+.|+|||++.+..++.++|||||||++|||++|+.||....   ...+......    ..      ..
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~---~~~~~~~i~~----~~------~~  219 (323)
T cd05615         155 G--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED---EDELFQSIME----HN------VS  219 (323)
T ss_pred             C--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHh----CC------CC
Confidence            1  12234579999999999999999999999999999999999999985332   2222222221    11      01


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 006155          560 LSSGSITEMIRCIHIGLLCVQENVASRPTM  589 (658)
Q Consensus       560 l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm  589 (658)
                      +.....   ..+.+++..|++.+|.+|++.
T Consensus       220 ~p~~~~---~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         220 YPKSLS---KEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             CCccCC---HHHHHHHHHHcccCHhhCCCC
Confidence            111111   234567789999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=6.7e-36  Score=308.51  Aligned_cols=260  Identities=25%  Similarity=0.352  Sum_probs=196.8

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcc--cHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQ--GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      ++|+..++||+|+||.||++... .++.||+|++......  ....+.+|++++..++||||+++++++..++..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888899999999999999865 4889999988654322  34568899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      |+++++|..+...   ...++|..++.++.||++||.|||+.+   ++|+||+|+||++++++.++|+|||++..+....
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            9999999887632   234899999999999999999999987   9999999999999999999999999988654432


Q ss_pred             CccccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHh---ccCC------
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKN---WREG------  550 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~---~~~~------  550 (658)
                      .  ......++..|+|||++.+ ..++.++||||||+++|||++|+.|+.....   .+........   +.+.      
T Consensus       155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07846         155 E--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD---IDQLYHIIKCLGNLIPRHQEIFQ  229 (286)
T ss_pred             c--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch---HHHHHHHHHHhCCCchhhHHHhc
Confidence            2  2233568899999999875 4578899999999999999999988743221   1111111110   0000      


Q ss_pred             --Cc-ccccCCCCCCC-C-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          551 --TT-VNIIDPTLSSG-S-----ITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       551 --~~-~~~~dp~l~~~-~-----~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                        .. .....+..... .     ......+.+++..||+.+|++||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence              00 00001111100 0     011234667889999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=5.1e-35  Score=296.63  Aligned_cols=251  Identities=31%  Similarity=0.474  Sum_probs=198.1

Q ss_pred             CcccCcccccCceEEEEeEecC-----CcceeEEEeccCCcc-cHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          326 FSDANKLGQGGFGAVYKGRLYD-----GAEIAVKRLSRDSGQ-GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       326 ~~~~~~lG~G~fg~Vy~~~~~~-----g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ++..+.||.|+||.||+++..+     +..||+|.+...... ....+..|+.++..++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567889999999999998654     377999999765443 4567899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ||+++++|.+++..... ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++.....
T Consensus        81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            99999999999854221 12899999999999999999999987   999999999999999999999999999876544


Q ss_pred             CCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccCC
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP  558 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp  558 (658)
                      ...... ...+++.|+|||.+....++.++||||+|++++||++ |+.|+..   ....++.......    ....    
T Consensus       157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~---~~~~~~~~~~~~~----~~~~----  224 (258)
T smart00219      157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG---MSNEEVLEYLKKG----YRLP----  224 (258)
T ss_pred             cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC---CCHHHHHHHHhcC----CCCC----
Confidence            222111 2347889999999988889999999999999999999 6677643   2222333322221    1111    


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 006155          559 TLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLML  596 (658)
Q Consensus       559 ~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L  596 (658)
                       ......   ..+.+++.+|++.+|++|||+.+++++|
T Consensus       225 -~~~~~~---~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      225 -KPENCP---PEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -CCCcCC---HHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence             111112   2355678899999999999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.6e-35  Score=308.40  Aligned_cols=260  Identities=22%  Similarity=0.320  Sum_probs=194.7

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      ++|...++||+|+||.||+|+.. +++.||+|.+..... .....+.+|+.++.+++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            57888999999999999999854 578899999865432 2334678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      ++ ++|..++...  ...+++..+..++.||++||.|||+.+   |+|+||||+|||++.++.+||+|||++........
T Consensus        86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            97 5888887542  346889999999999999999999987   99999999999999999999999999875432221


Q ss_pred             ccccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHH-----------hccC
Q 006155          482 QGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWK-----------NWRE  549 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~-----------~~~~  549 (658)
                        ......+++.|+|||++.+. .++.++||||||+++|||++|+.||.....   .+.+.....           .+..
T Consensus       160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  234 (301)
T cd07873         160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV---EEQLHFIFRILGTPTEETWPGILS  234 (301)
T ss_pred             --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHcCCCChhhchhhhc
Confidence              12234578899999988654 578899999999999999999999854322   122211111           1100


Q ss_pred             CC-cccccCCCCCCCCHH-----HHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          550 GT-TVNIIDPTLSSGSIT-----EMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       550 ~~-~~~~~dp~l~~~~~~-----e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .. ....-.|........     --..+.+++.+|++.||.+|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00 000000111100000     0113457788999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.1e-36  Score=289.87  Aligned_cols=254  Identities=24%  Similarity=0.352  Sum_probs=198.8

Q ss_pred             hhhccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCc----ccHH----HHHHHHHHHHhcC-CCCceeeeeee
Q 006155          320 RVATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSG----QGDL----EFKNEVLLVANLQ-HRNLVRLLGFS  389 (658)
Q Consensus       320 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~----~~~~----~~~~E~~~l~~l~-H~niv~l~~~~  389 (658)
                      .-.-++|...+.||.|..+.|-+... ..|.+.|+|++.....    +...    +-..|+.+|+++. ||+|+.+.+++
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            33456788899999999999988764 4588999998864321    1122    2457999999985 99999999999


Q ss_pred             ccCCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEec
Q 006155          390 LEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIAD  469 (658)
Q Consensus       390 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~D  469 (658)
                      ..+.-.++|+|.|+.|.|.++|.   ....+++++..+|++|+.+|++|||..+   ||||||||+|||+|++.++||+|
T Consensus        93 es~sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isD  166 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISD  166 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEec
Confidence            99999999999999999999993   4567999999999999999999999998   99999999999999999999999


Q ss_pred             cccccccccCCCccccccccccccccCcccccc------CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHH
Q 006155          470 FGMARLFEMDETQGNTSRIVGTYGYMAPEYAMH------GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSA  543 (658)
Q Consensus       470 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~  543 (658)
                      ||++..+..++.   ....+|||+|+|||.+..      ..|+...|.|+.|||+|.|+.|.+||....     +++  -
T Consensus       167 FGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-----Qml--M  236 (411)
T KOG0599|consen  167 FGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-----QML--M  236 (411)
T ss_pred             cceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-----HHH--H
Confidence            999998776543   335799999999998853      358889999999999999999999983211     110  1


Q ss_pred             HHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          544 WKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       544 ~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .++..+|.... -.|..    .+--....+++.+|||.||.+|-|.+|+++
T Consensus       237 LR~ImeGkyqF-~speW----adis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  237 LRMIMEGKYQF-RSPEW----ADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             HHHHHhccccc-CCcch----hhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            12222222211 11111    111123456778999999999999999873

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=5.4e-35  Score=297.70  Aligned_cols=253  Identities=27%  Similarity=0.390  Sum_probs=205.1

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      ++|+..+.||+|++|.||+++.. +++.|+||++..... ....++.+|+..+.+++|+||+++++++..++..++|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            46888899999999999999865 489999999877644 3456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE-DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      +++++|.+++..   ...+++..++.++.|+++||.|||+ .+   ++|+||+|+||+++.++.++|+|||++..+....
T Consensus        81 ~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          81 MDGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            999999999843   2678999999999999999999999 77   9999999999999999999999999998764432


Q ss_pred             CccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCC
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTL  560 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l  560 (658)
                      ..  .....++..|+|||.+.+..++.++||||||+++|||++|+.|+.........++......    ...     +.+
T Consensus       155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~----~~~-----~~~  223 (264)
T cd06623         155 DQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD----GPP-----PSL  223 (264)
T ss_pred             Cc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc----CCC-----CCC
Confidence            22  2245688999999999999999999999999999999999999855433233333333221    111     111


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          561 SSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       561 ~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                      ....  ....+.+++..|++.+|++||++.++++.
T Consensus       224 ~~~~--~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         224 PAEE--FSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             Cccc--CCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            1110  11345567788999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=5.8e-35  Score=296.48  Aligned_cols=250  Identities=26%  Similarity=0.357  Sum_probs=196.9

Q ss_pred             CCcccCcccccCceEEEEeEec-CCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeecc-CCceEEEEE
Q 006155          325 NFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLE-GNERLLIYE  400 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e  400 (658)
                      +|+..+.||+|++|.||+++.. +++.+|+|++....  ......+.+|++++++++|+|++++++.+.. +...++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4788899999999999999854 47889999986543  2334568899999999999999999988764 446789999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      |+++++|.+++... ....+++.+++.++.+++.||.|||+.+   ++||||||+||+++.++.++|+|||++..+....
T Consensus        81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            99999999998542 2346899999999999999999999988   9999999999999999999999999998664322


Q ss_pred             CccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCC
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTL  560 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l  560 (658)
                      .  ......|++.|+|||++.+..++.++||||||++++||++|+.|+....   .........    .+..     +.+
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~---~~~~~~~~~----~~~~-----~~~  222 (257)
T cd08223         157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD---MNSLVYRII----EGKL-----PPM  222 (257)
T ss_pred             C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHH----hcCC-----CCC
Confidence            2  2234568999999999999999999999999999999999999875322   112211111    1111     111


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          561 SSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       561 ~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                      .....   ..+.+++..|++.+|++||++.++++.
T Consensus       223 ~~~~~---~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         223 PKDYS---PELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             ccccC---HHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            11111   235577889999999999999999853

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3e-35  Score=312.28  Aligned_cols=258  Identities=24%  Similarity=0.343  Sum_probs=192.6

Q ss_pred             hhccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeeccC-----
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLEG-----  392 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----  392 (658)
                      ...++|...+.||+|+||.||++.. .+++.||||++.....  .....+.+|+.++++++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            3457899999999999999999984 4578899999875422  2334577899999999999999999987543     


Q ss_pred             -CceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccc
Q 006155          393 -NERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFG  471 (658)
Q Consensus       393 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFG  471 (658)
                       ...++++|++ +++|.+++.    ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence             3568999987 788988773    346999999999999999999999988   9999999999999999999999999


Q ss_pred             cccccccCCCccccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccC-
Q 006155          472 MARLFEMDETQGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWRE-  549 (658)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-  549 (658)
                      +++.....     .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.....   .+.+......... 
T Consensus       164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~~~~~~~~~  235 (343)
T cd07878         164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY---IDQLKRIMEVVGTP  235 (343)
T ss_pred             cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHHhCCC
Confidence            99865432     233578999999999877 5689999999999999999999999853221   1111111110000 


Q ss_pred             ----------CCcccccC--CCCCCCCHHHH-----HHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          550 ----------GTTVNIID--PTLSSGSITEM-----IRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       550 ----------~~~~~~~d--p~l~~~~~~e~-----~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                                ......+.  +........+.     ..+.+++..|++.||.+|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             CHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                      00000000  00000000000     12457888999999999999999984

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.5e-35  Score=301.26  Aligned_cols=248  Identities=25%  Similarity=0.391  Sum_probs=198.8

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC-cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS-GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      ..|+..++||+|+||.||+|+.. .+..||+|.+.... ......+.+|+.++.+++||||+++++++.+++..++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            45777889999999999999854 57889999887543 33445688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      +++++|.+++..    ..+++.....++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus        84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            999999998842    45889999999999999999999987   99999999999999999999999999976543221


Q ss_pred             ccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCC
Q 006155          482 QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLS  561 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~  561 (658)
                        ......++..|+|||++.+..++.++||||||+++|||++|+.|+......   ......    ....     .+.+.
T Consensus       157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~~~~----~~~~-----~~~~~  222 (277)
T cd06640         157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM---RVLFLI----PKNN-----PPTLT  222 (277)
T ss_pred             --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH---hHhhhh----hcCC-----CCCCc
Confidence              222346788999999999889999999999999999999999997432211   111110    0010     11111


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          562 SGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       562 ~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                         ......+.+++..||+.+|++||++.++++.
T Consensus       223 ---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         223 ---GEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             ---hhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence               1122345678889999999999999999754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.2e-35  Score=308.01  Aligned_cols=250  Identities=23%  Similarity=0.372  Sum_probs=197.0

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEec
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFV  402 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  402 (658)
                      +.|.....||+|+||.||++... ++..||||++..........+.+|+..+..++|+||+++++.+..++..++||||+
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~  101 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL  101 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence            44445567999999999999853 58889999987655555667889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCc
Q 006155          403 PNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ  482 (658)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  482 (658)
                      ++++|.+++.    ...+++..++.++.+|+.||.|||+.+   |+||||||+||++++++.++|+|||++..+....  
T Consensus       102 ~~~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--  172 (292)
T cd06658         102 EGGALTDIVT----HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--  172 (292)
T ss_pred             CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--
Confidence            9999999883    235899999999999999999999987   9999999999999999999999999987653322  


Q ss_pred             cccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCC
Q 006155          483 GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSS  562 (658)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~  562 (658)
                      .......|+..|+|||++.+..++.++||||||+++|||++|+.|+.....   ...+.....    .     +.+.+..
T Consensus       173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~----~-----~~~~~~~  240 (292)
T cd06658         173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP---LQAMRRIRD----N-----LPPRVKD  240 (292)
T ss_pred             ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHh----c-----CCCcccc
Confidence            122335689999999999888999999999999999999999999853221   111111111    1     1111111


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          563 GSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       563 ~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                      .. ..-..+..++..|++.+|.+|||+.++++.
T Consensus       241 ~~-~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         241 SH-KVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             cc-ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            10 001123456678999999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-36  Score=314.61  Aligned_cols=239  Identities=23%  Similarity=0.277  Sum_probs=181.6

Q ss_pred             ccccCceEEEEeEec-CCcceeEEEeccCCcc---cHHHHHHHHHHHHhc---CCCCceeeeeeeccCCceEEEEEecCC
Q 006155          332 LGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQ---GDLEFKNEVLLVANL---QHRNLVRLLGFSLEGNERLLIYEFVPN  404 (658)
Q Consensus       332 lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~~~lv~e~~~~  404 (658)
                      ||+|+||+||+++.. +|+.||||++......   ....+..|..++..+   +||||+++++++...+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999854 5889999998653221   222344566666555   699999999999999999999999999


Q ss_pred             CChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCccc
Q 006155          405 TSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN  484 (658)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~  484 (658)
                      |+|..++.   ....+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~  152 (330)
T cd05586          81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT  152 (330)
T ss_pred             ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence            99998884   3456899999999999999999999988   9999999999999999999999999987532221  12


Q ss_pred             cccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCC
Q 006155          485 TSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSG  563 (658)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~  563 (658)
                      .....||+.|+|||++.+. .++.++|||||||++|||++|+.||....   ...+....    ..+..      .+...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~---~~~~~~~i----~~~~~------~~~~~  219 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED---TQQMYRNI----AFGKV------RFPKN  219 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC---HHHHHHHH----HcCCC------CCCCc
Confidence            3346799999999998765 48999999999999999999999984322   22222211    11111      11111


Q ss_pred             -CHHHHHHHHHHHHHhcCCCCCCCCC----HHHHHH
Q 006155          564 -SITEMIRCIHIGLLCVQENVASRPT----MASVVL  594 (658)
Q Consensus       564 -~~~e~~~~~~i~~~Cl~~~p~~RPt----m~evv~  594 (658)
                       ..+   .+.+++..||+.||.+||+    +.++++
T Consensus       220 ~~~~---~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         220 VLSD---EGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             cCCH---HHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence             112   2345677999999999985    555543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-36  Score=315.24  Aligned_cols=244  Identities=28%  Similarity=0.453  Sum_probs=197.3

Q ss_pred             cccccCceEEEEeEecC-CcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecCCCChhh
Q 006155          331 KLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDH  409 (658)
Q Consensus       331 ~lG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  409 (658)
                      +||+|.||+||-|+..+ ...+|||.+........+.+.+|+.+-+.|+|+|||+++|.+.++...-+.||-++||||.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            69999999999998544 45689999988777777789999999999999999999999999999999999999999999


Q ss_pred             hhcCcCCCCCC--CHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeC-CCCCeEEeccccccccccCCCccccc
Q 006155          410 FIFDPTRRAQL--DWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLD-AEMTPKIADFGMARLFEMDETQGNTS  486 (658)
Q Consensus       410 ~l~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~  486 (658)
                      +|..  +-+++  ++...-.+..||++||.|||++.   |||||||-.|||++ -.|.+||+|||-++.+..  ....+.
T Consensus       662 LLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TE  734 (1226)
T KOG4279|consen  662 LLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTE  734 (1226)
T ss_pred             HHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCcccc
Confidence            9953  33455  67788889999999999999987   99999999999996 468999999999886532  234566


Q ss_pred             cccccccccCccccccCC--CCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCC
Q 006155          487 RIVGTYGYMAPEYAMHGQ--YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGS  564 (658)
Q Consensus       487 ~~~gt~~y~aPE~~~~~~--~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~  564 (658)
                      +..||..|||||++..|+  |...+|||||||.+.||.||++||--......        .++.-|..  .+-|.+..+ 
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------AMFkVGmy--KvHP~iPee-  803 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------AMFKVGMY--KVHPPIPEE-  803 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------hhhhhcce--ecCCCCcHH-
Confidence            789999999999998875  88899999999999999999999843222111        11111111  112333322 


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          565 ITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       565 ~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                        --.++..++++|+.++|.+||+++++++
T Consensus       804 --lsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  804 --LSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             --HHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence              2234567889999999999999999984

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.4e-35  Score=308.41  Aligned_cols=249  Identities=24%  Similarity=0.369  Sum_probs=197.3

Q ss_pred             CCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecC
Q 006155          325 NFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVP  403 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~  403 (658)
                      .|.....||+|+||.||++... +++.||+|.+..........+.+|+.++..++||||+++++++..++..++|+||++
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~  101 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ  101 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence            3444568999999999999854 688999999876555556678899999999999999999999999999999999999


Q ss_pred             CCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCcc
Q 006155          404 NTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQG  483 (658)
Q Consensus       404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  483 (658)
                      +++|..++.    ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++..+.....  
T Consensus       102 ~~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--  172 (297)
T cd06659         102 GGALTDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--  172 (297)
T ss_pred             CCCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--
Confidence            999998873    245899999999999999999999987   99999999999999999999999999876543221  


Q ss_pred             ccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCC
Q 006155          484 NTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSG  563 (658)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~  563 (658)
                      ......|+..|+|||++.+..++.++||||||+++|||++|+.|+.....   .+.+...    .........   ....
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~~----~~~~~~~~~---~~~~  242 (297)
T cd06659         173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAMKRL----RDSPPPKLK---NAHK  242 (297)
T ss_pred             cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH----hccCCCCcc---ccCC
Confidence            22335789999999999988999999999999999999999999853221   1111111    111100000   0001


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          564 SITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       564 ~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                      ...   .+.+++..||+.+|++||++.+|++.
T Consensus       243 ~~~---~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         243 ISP---VLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CCH---HHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            111   24467779999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.1e-34  Score=299.44  Aligned_cols=261  Identities=24%  Similarity=0.347  Sum_probs=198.9

Q ss_pred             CCcccCcccccCceEEEEeEec-CCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          325 NFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      +|+..+.||+|+||.||+|+.. +|+.|+||++....  ......+.+|+.++++++||||+++++++..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4778899999999999999854 68899999987654  23345789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      + +++|.+++...  ...+++..++.++.||++||.|||+.+   ++|+||||+||+++.++.++|+|||++..+.....
T Consensus        81 ~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          81 M-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            9 99999998542  256999999999999999999999987   99999999999999999999999999987654321


Q ss_pred             ccccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCc--------
Q 006155          482 QGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTT--------  552 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~--------  552 (658)
                       .......|+..|+|||++.+. .++.++||||+|++++||++|+.++.....   ...+......+.....        
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07832         155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND---IEQLAIVFRTLGTPNEETWPGLTS  230 (286)
T ss_pred             -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH---HHHHHHHHHHcCCCChHHHhhccC
Confidence             122335789999999998654 468999999999999999999776643221   1222222221111100        


Q ss_pred             ----ccccCCCCCCCCH-----HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          553 ----VNIIDPTLSSGSI-----TEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       553 ----~~~~dp~l~~~~~-----~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                          ..+..+.......     +.-..+.+++.+|++.+|++||+++++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                0011010000000     111455678889999999999999999863

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-35  Score=302.69  Aligned_cols=252  Identities=25%  Similarity=0.362  Sum_probs=199.0

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      .++|++.+.||+|+||.||+++.. ++..+|+|.+..........+..|+.++++++||||+++++.+..+...++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            467899999999999999999864 5788999998766555566788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      +++++|.+++...  ...+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++....... 
T Consensus        84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-  157 (280)
T cd06611          84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-  157 (280)
T ss_pred             cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence            9999999998542  346899999999999999999999988   9999999999999999999999999987543221 


Q ss_pred             ccccccccccccccCccccc-----cCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccccc
Q 006155          482 QGNTSRIVGTYGYMAPEYAM-----HGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNII  556 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  556 (658)
                       .......|++.|+|||++.     ...++.++||||||+++|||++|+.|+....   ....+...    ..+....+.
T Consensus       158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~---~~~~~~~~----~~~~~~~~~  229 (280)
T cd06611         158 -QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN---PMRVLLKI----LKSEPPTLD  229 (280)
T ss_pred             -cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC---HHHHHHHH----hcCCCCCcC
Confidence             1223456899999999875     3457789999999999999999999984322   11111111    111111111


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          557 DPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       557 dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .+.   ....   .+.+++..||+.+|++||++.+|++
T Consensus       230 ~~~---~~~~---~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         230 QPS---KWSS---SFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             Ccc---cCCH---HHHHHHHHHhccChhhCcCHHHHhc
Confidence            111   1112   3446777999999999999999975

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=6.8e-35  Score=295.94  Aligned_cols=249  Identities=22%  Similarity=0.360  Sum_probs=198.0

Q ss_pred             CCcccCcccccCceEEEEeEe-cCCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          325 NFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      +|+..+.||+|+||.||+++. .+|+.+|+|++....  .....++.+|+.++++++||||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            478889999999999999984 468899999986532  23345789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      +++++|.+++... ....+++..+++++.|++.||.|||+.+   ++|+||+|+|||++.++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            9999999988532 2235789999999999999999999987   99999999999999999999999999976543221


Q ss_pred             ccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCC
Q 006155          482 QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLS  561 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~  561 (658)
                        ......|++.|+|||++.++.++.++||||||++++||++|+.|+...   +..+......    .+..     +...
T Consensus       157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~---~~~~~~~~~~----~~~~-----~~~~  222 (256)
T cd08218         157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG---NMKNLVLKII----RGSY-----PPVS  222 (256)
T ss_pred             --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC---CHHHHHHHHh----cCCC-----CCCc
Confidence              122346888999999999999999999999999999999999987432   1222222111    1111     1111


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          562 SGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       562 ~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ....   ..+.+++.+||+.+|++||+|.+|++
T Consensus       223 ~~~~---~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         223 SHYS---YDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             ccCC---HHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            1111   23456778999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=8.6e-35  Score=302.31  Aligned_cols=260  Identities=25%  Similarity=0.327  Sum_probs=196.0

Q ss_pred             CCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcc-----cHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEE
Q 006155          325 NFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQ-----GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  398 (658)
                      +|...+.||+|+||.||+|... +|+.||||++......     ....+..|+.++.+++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4677889999999999999854 5889999999765432     234567899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccccc
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~  478 (658)
                      |||+ +++|.+++....  ..+++..++.++.||++||.|||+.+   ++|+||||+||+++.++.++|+|||+++....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 999999985422  36999999999999999999999988   99999999999999999999999999987644


Q ss_pred             CCCccccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCC-------
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREG-------  550 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-------  550 (658)
                      ...  ......++..|+|||.+.+ ..++.++||||||+++|||++|..++.....   .+.+..........       
T Consensus       155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  229 (298)
T cd07841         155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD---IDQLGKIFEALGTPTEENWPG  229 (298)
T ss_pred             CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc---HHHHHHHHHHcCCCchhhhhh
Confidence            321  1222356788999998865 4578999999999999999999776643222   11121111110000       


Q ss_pred             --CcccccCCCCCCC-C-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          551 --TTVNIIDPTLSSG-S-----ITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       551 --~~~~~~dp~l~~~-~-----~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                        ............. .     ......+.+++..||+.+|++|||+.||++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence              0000000000000 1     1112346688899999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-35  Score=309.49  Aligned_cols=251  Identities=25%  Similarity=0.350  Sum_probs=203.8

Q ss_pred             hccCCcccCcccccCceEEEEeEecC-CcceeEEEeccCCcc---cHHHHHHHHHHHHhcC-CCCceeeeeeeccCCceE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQ---GDLEFKNEVLLVANLQ-HRNLVRLLGFSLEGNERL  396 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~  396 (658)
                      ..+.|+..+.||+|.||.||+++... |+.+|+|.+.+....   ....+.+|+.+|+++. |||||.+.+.+.+....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            45678888999999999999998655 999999999776443   3357899999999998 999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCC----CCeEEecccc
Q 006155          397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE----MTPKIADFGM  472 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~----~~~kl~DFGl  472 (658)
                      +|||++.||.|.+.|...    .+++.....++.||+.++.|||+.+   |+||||||+|+|+...    +.+|++|||+
T Consensus       113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            999999999999998654    3999999999999999999999988   9999999999999643    5799999999


Q ss_pred             ccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCc
Q 006155          473 ARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTT  552 (658)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  552 (658)
                      +.....   .......+||+.|+|||++....|+..+||||.||++|.|++|..||........  .. .    ...+..
T Consensus       186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~--~~-~----i~~~~~  255 (382)
T KOG0032|consen  186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI--FL-A----ILRGDF  255 (382)
T ss_pred             ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH--HH-H----HHcCCC
Confidence            998765   3355678999999999999999999999999999999999999999954432211  11 1    111111


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          553 VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       553 ~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                       +.-++...  ...  ...-+++..++..||.+|+|+.++++
T Consensus       256 -~f~~~~w~--~is--~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  256 -DFTSEPWD--DIS--ESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             -CCCCCCcc--ccC--HHHHHHHHHhcccCcccCCCHHHHhc
Confidence             11111111  111  12235566889999999999999998

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1e-34  Score=300.69  Aligned_cols=263  Identities=27%  Similarity=0.387  Sum_probs=201.0

Q ss_pred             cchhhhhhhccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhc-CCCCceeeeeeecc
Q 006155          314 FDFNTIRVATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANL-QHRNLVRLLGFSLE  391 (658)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~  391 (658)
                      +....+..+.++|...+.||+|+||.||+++. .+++.+|+|.+.... ....++.+|+.++.++ +||||+++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            34455666789999999999999999999985 457889999886542 2345678899999999 79999999999864


Q ss_pred             C-----CceEEEEEecCCCChhhhhcCc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCe
Q 006155          392 G-----NERLLIYEFVPNTSLDHFIFDP-TRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP  465 (658)
Q Consensus       392 ~-----~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~  465 (658)
                      .     ...++|+||+++++|.+++... .....++|..++.++.|++.||.|||+.+   ++||||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence            3     3579999999999999988532 23456899999999999999999999987   9999999999999999999


Q ss_pred             EEeccccccccccCCCccccccccccccccCccccccCC-----CCcccccccccchHhHHHhCCCCCccCCCCCcchHH
Q 006155          466 KIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQ-----YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL  540 (658)
Q Consensus       466 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~  540 (658)
                      ||+|||+++.......  ......|+..|+|||++....     ++.++|||||||++|||++|+.|+.....  ...+ 
T Consensus       168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~--~~~~-  242 (291)
T cd06639         168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP--VKTL-  242 (291)
T ss_pred             EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH--HHHH-
Confidence            9999999876543221  122346889999999986543     68899999999999999999999843211  1111 


Q ss_pred             HHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          541 SSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       541 ~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                         .. +.......+.++      ......+.+++.+||+.+|++||++.|+++.
T Consensus       243 ---~~-~~~~~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         243 ---FK-IPRNPPPTLLHP------EKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             ---HH-HhcCCCCCCCcc------cccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence               11 111111111111      1111245678889999999999999999853

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=6.8e-35  Score=307.50  Aligned_cols=199  Identities=19%  Similarity=0.250  Sum_probs=163.8

Q ss_pred             ccCccccc--CceEEEEeEe-cCCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEec
Q 006155          328 DANKLGQG--GFGAVYKGRL-YDGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFV  402 (658)
Q Consensus       328 ~~~~lG~G--~fg~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  402 (658)
                      ..++||+|  +|++||+++. .+|+.||||++.....  .....+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            35789999  7899999975 4688999999875432  22345778999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccccc-CCC
Q 006155          403 PNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM-DET  481 (658)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~-~~~  481 (658)
                      ++|+|.+++.... ...+++..+++++.|++.||.|||+.+   |+||||||+|||++.++.++++||+....... ...
T Consensus        82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            9999999985322 235899999999999999999999987   99999999999999999999999987543321 110


Q ss_pred             c----cccccccccccccCcccccc--CCCCcccccccccchHhHHHhCCCCCcc
Q 006155          482 Q----GNTSRIVGTYGYMAPEYAMH--GQYSVKSDVFSFGVLVLEIISGQRNNCF  530 (658)
Q Consensus       482 ~----~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~S~Gvll~elltG~~p~~~  530 (658)
                      .    .......++..|+|||++.+  ..++.++|||||||++|||++|+.||..
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  212 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD  212 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            0    01122356788999999976  4589999999999999999999999853

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.5e-35  Score=335.44  Aligned_cols=256  Identities=23%  Similarity=0.365  Sum_probs=195.0

Q ss_pred             hhhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeecc--CCc
Q 006155          320 RVATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLE--GNE  394 (658)
Q Consensus       320 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~  394 (658)
                      ....++|.+.++||+|+||+||+++.. .+..+|+|.+....  ......+..|+.++.+|+|||||++++++..  ...
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            445678999999999999999999854 46778999886542  2234568899999999999999999998754  456


Q ss_pred             eEEEEEecCCCChhhhhcCc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCC----CcEEEeccCCCceeeCC--------
Q 006155          395 RLLIYEFVPNTSLDHFIFDP-TRRAQLDWERRYKIIGGIARGLLYLHEDSR----LRIIHRDLKTSNVLLDA--------  461 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~ivHrDlk~~NILl~~--------  461 (658)
                      .+|||||+++++|.++|... .....+++..++.|+.||+.||.|||+.+.    .+||||||||+||||+.        
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            89999999999999998542 223569999999999999999999998541    24999999999999964        


Q ss_pred             ---------CCCeEEeccccccccccCCCccccccccccccccCcccccc--CCCCcccccccccchHhHHHhCCCCCcc
Q 006155          462 ---------EMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMH--GQYSVKSDVFSFGVLVLEIISGQRNNCF  530 (658)
Q Consensus       462 ---------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~S~Gvll~elltG~~p~~~  530 (658)
                               .+.+||+|||+++.+....   ......||+.|+|||++.+  ..++.++|||||||++|||++|+.||..
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             cccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                     2358999999998654322   2234579999999999864  4588999999999999999999999853


Q ss_pred             CCCCCcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 006155          531 RNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVV  593 (658)
Q Consensus       531 ~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv  593 (658)
                      ..  ....++..    +..+.     +..+. ...   ..+.+++..||+.+|.+||++.+++
T Consensus       246 ~~--~~~qli~~----lk~~p-----~lpi~-~~S---~eL~dLI~~~L~~dPeeRPSa~QlL  293 (1021)
T PTZ00266        246 AN--NFSQLISE----LKRGP-----DLPIK-GKS---KELNILIKNLLNLSAKERPSALQCL  293 (1021)
T ss_pred             CC--cHHHHHHH----HhcCC-----CCCcC-CCC---HHHHHHHHHHhcCChhHCcCHHHHh
Confidence            22  22222221    11111     01111 111   2345677899999999999999998

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3e-35  Score=303.89  Aligned_cols=261  Identities=22%  Similarity=0.323  Sum_probs=198.0

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      ++|+..+.||+|+||.||+++.. +++.|+||++....  ......+.+|+.++++++|+||+++++++..++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888999999999999999865 47889999886542  2334568999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      |++++.+..++.   +...+++..+..++.+|+.||.|||+.+   ++|+||+|+||++++++.+||+|||++..+....
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            999888776653   2345899999999999999999999987   9999999999999999999999999998765433


Q ss_pred             CccccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHH--HH--------hccC
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSA--WK--------NWRE  549 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~--~~--------~~~~  549 (658)
                      . .......++..|+|||++.+. .++.++||||||+++|||++|+.|+......  ..+....  +.        .+..
T Consensus       155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd07833         155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI--DQLYLIQKCLGPLPPSHQELFSS  231 (288)
T ss_pred             c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHhhhccc
Confidence            2 122335788999999999888 8899999999999999999999988533221  1111100  00        0000


Q ss_pred             C-Ccc--cccCCCCCCCCHH------HHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          550 G-TTV--NIIDPTLSSGSIT------EMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       550 ~-~~~--~~~dp~l~~~~~~------e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      . ...  +..++.. ....+      .-..+.+++..||+.+|++||+++++++
T Consensus       232 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         232 NPRFAGVAFPEPSQ-PESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             CccccccccCCCCC-cHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            0 000  0000000 00000      0234667888999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=5.3e-35  Score=298.21  Aligned_cols=253  Identities=26%  Similarity=0.376  Sum_probs=199.4

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      ++|+..+.||+|+||.||++... +++.+++|++..... ....++.+|++++++++||||+++++.+..++..++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            46778889999999999999865 588899999876543 3445688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE-DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      +++++|.+++....  ..+++.....++.|+++||.|||+ .+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            99999999985422  678999999999999999999999 66   9999999999999999999999999987653322


Q ss_pred             CccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCC
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTL  560 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l  560 (658)
                      .    ....++..|+|||++.+..++.++||||||+++|||++|+.|+..... ......... +.+.....     +.+
T Consensus       156 ~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~-~~~~~~~~-----~~~  224 (265)
T cd06605         156 A----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND-PPDGIFELL-QYIVNEPP-----PRL  224 (265)
T ss_pred             h----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccc-ccccHHHHH-HHHhcCCC-----CCC
Confidence            1    125788899999999999999999999999999999999999854321 111111111 11111111     111


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          561 SSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       561 ~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ....  .-..+.+++..||+.+|++|||+.+++.
T Consensus       225 ~~~~--~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         225 PSGK--FSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             Chhh--cCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            1110  1123456778999999999999999974

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-34  Score=300.49  Aligned_cols=261  Identities=25%  Similarity=0.380  Sum_probs=195.8

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcc-cHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQ-GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      ++|+..+.||+|+||.||+|+.. +++.||||.+...... ....+.+|+.++++++|+||+++++++.+++..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            67888999999999999999854 5789999998654322 234567899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      +++ +|.+++...  ...+++.....++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++.......
T Consensus        85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            985 898888542  236899999999999999999999987   99999999999999999999999999875432211


Q ss_pred             ccccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccc---c--
Q 006155          482 QGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVN---I--  555 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~---~--  555 (658)
                        ......++..|+|||++.+ ..++.++||||||+++|||++|+.||.....  ..+.+...+..+.......   .  
T Consensus       159 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07844         159 --TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD--VEDQLHKIFRVLGTPTEETWPGVSS  234 (291)
T ss_pred             --cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHhcCCCChhhhhhhhh
Confidence              1122356889999998875 4588999999999999999999999853321  1222222222211110000   0  


Q ss_pred             -----------c-CCCCCCC--CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          556 -----------I-DPTLSSG--SITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       556 -----------~-dp~l~~~--~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                                 . ...+...  .......+.+++..|++.+|++|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                       0 0000000  0111144567888999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1e-34  Score=303.01  Aligned_cols=256  Identities=20%  Similarity=0.252  Sum_probs=199.5

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc---ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG---QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ++|+..+.||+|+||.||+++.. .++.|++|.+.....   .....+.+|+.++..++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46888999999999999999854 478899998876532   23346789999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ||+++++|.+++..   ...+++..+..++.++++||.|||+.+   ++||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            99999999999843   346899999999999999999999987   999999999999999999999999998642111


Q ss_pred             CC-------------ccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHh
Q 006155          480 ET-------------QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKN  546 (658)
Q Consensus       480 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~  546 (658)
                      ..             ........|+..|+|||++.+..++.++|+||||+++|||++|+.|+...   ...++...... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~---~~~~~~~~~~~-  230 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD---TPEELFGQVIS-  230 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHh-
Confidence            00             00111246788999999999889999999999999999999999998422   22222222111 


Q ss_pred             ccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          547 WREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       547 ~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                         +.   ...|........   .+.+++.+||+.+|++||++.++.+.|+.
T Consensus       231 ---~~---~~~~~~~~~~~~---~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         231 ---DD---IEWPEGDEALPA---DAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             ---cc---cCCCCccccCCH---HHHHHHHHHhccChhhccCccCHHHHHhC
Confidence               11   111111111122   24567789999999999998888888865

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.7e-34  Score=292.70  Aligned_cols=249  Identities=26%  Similarity=0.406  Sum_probs=196.9

Q ss_pred             CCcccCcccccCceEEEEeEe-cCCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          325 NFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      +|+..+.||+|+||.||++.. .+++.+|||++....  ......+.+|+.++++++||||+++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            477889999999999999875 367889999986543  23345688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCC-CCeEEeccccccccccCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE-MTPKIADFGMARLFEMDE  480 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~-~~~kl~DFGla~~~~~~~  480 (658)
                      +++++|.+++... ....+++..+.+++.++++||.|||+.+   ++|+||||+||+++.+ +.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            9999999999542 2345899999999999999999999987   9999999999999865 457999999998654332


Q ss_pred             CccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCC
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTL  560 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l  560 (658)
                         ......|+..|+|||.+.+..++.++||||||+++|||++|+.|+....   ..........    +....+     
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~---~~~~~~~~~~----~~~~~~-----  221 (256)
T cd08220         157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN---LPALVLKIMS----GTFAPI-----  221 (256)
T ss_pred             ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc---hHHHHHHHHh----cCCCCC-----
Confidence               1223568899999999998889999999999999999999999984322   1222222111    111111     


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          561 SSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       561 ~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                      .....   ..+.+++..||+.+|++|||+.|+++.
T Consensus       222 ~~~~~---~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         222 SDRYS---PDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             CCCcC---HHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            11111   234577789999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-35  Score=305.21  Aligned_cols=204  Identities=27%  Similarity=0.433  Sum_probs=168.3

Q ss_pred             CCcccCcccccCceEEEEeEec---CCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccC--CceE
Q 006155          325 NFSDANKLGQGGFGAVYKGRLY---DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEG--NERL  396 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~---~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~  396 (658)
                      +|+..++||+|+||.||+|+..   .+..||+|.+....   ......+.+|+.++.+++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4677889999999999999854   47899999997743   33345678899999999999999999999888  7899


Q ss_pred             EEEEecCCCChhhhhcCcC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCC----CCCeEEecc
Q 006155          397 LIYEFVPNTSLDHFIFDPT--RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDA----EMTPKIADF  470 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~----~~~~kl~DF  470 (658)
                      +||||+++ +|.+++....  ....+++..++.++.||+.||.|||+.+   |+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 5666553221  2236899999999999999999999987   999999999999999    999999999


Q ss_pred             ccccccccCCC-ccccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCC
Q 006155          471 GMARLFEMDET-QGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRN  532 (658)
Q Consensus       471 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~  532 (658)
                      |+++.+..... ........++..|+|||++.+. .++.++||||||++++||++|+.|+....
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  220 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE  220 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence            99987644322 1223345788999999988764 58899999999999999999999986443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.4e-34  Score=294.89  Aligned_cols=252  Identities=26%  Similarity=0.398  Sum_probs=197.6

Q ss_pred             CCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcc--cHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          325 NFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQ--GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      +|...+.||+|+||.||+|+.. +++.|++|.+......  ....+.+|+.+++.++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4777899999999999999854 6889999998766443  456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      +++++|.+++..   ...+++..+..++.++++||.|||+.+   ++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            999999999853   345889999999999999999999987   99999999999999999999999999887644322


Q ss_pred             ccc--cccccccccccCccccccCC---CCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccccc
Q 006155          482 QGN--TSRIVGTYGYMAPEYAMHGQ---YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNII  556 (658)
Q Consensus       482 ~~~--~~~~~gt~~y~aPE~~~~~~---~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  556 (658)
                      ...  .....++..|+|||++....   ++.++||||||+++||+++|+.||.....  .... ......   +     .
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~--~~~~-~~~~~~---~-----~  223 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN--EFQI-MFHVGA---G-----H  223 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc--hHHH-HHHHhc---C-----C
Confidence            111  22356788999999998766   88999999999999999999999853221  1111 111010   1     0


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          557 DPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       557 dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .+.+.... .--..+.+++..||+.+|++||++.+++.
T Consensus       224 ~~~~~~~~-~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         224 KPPIPDSL-QLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCCCccc-ccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            11111111 00122346777999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-34  Score=297.98  Aligned_cols=247  Identities=25%  Similarity=0.412  Sum_probs=196.1

Q ss_pred             CCcccCcccccCceEEEEeEe-cCCcceeEEEeccCC-cccHHHHHHHHHHHHhcC---CCCceeeeeeeccCCceEEEE
Q 006155          325 NFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDS-GQGDLEFKNEVLLVANLQ---HRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lv~  399 (658)
                      .|+..+.||+|+||.||+|+. .+++.+|+|.+.... .....++.+|+.++++++   |||++++++++.++...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            577788999999999999985 468899999987543 334456889999999997   999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ||+++++|.+++..    ..+++...+.++.++++||.|||+.+   ++|+||+|+||+++.++.++|+|||++..+...
T Consensus        82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            99999999998843    36899999999999999999999987   999999999999999999999999999876543


Q ss_pred             CCccccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCC
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP  558 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp  558 (658)
                      .  .......|+..|+|||++.++ .++.++||||||+++|||++|+.|+......   ....    .....     ..+
T Consensus       155 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~---~~~~----~~~~~-----~~~  220 (277)
T cd06917         155 S--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF---RAMM----LIPKS-----KPP  220 (277)
T ss_pred             c--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh---hhhh----ccccC-----CCC
Confidence            2  122335789999999998765 4689999999999999999999998532211   1110    00111     112


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          559 TLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       559 ~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .+....  ....+.+++..||+.||++||++.+++.
T Consensus       221 ~~~~~~--~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         221 RLEDNG--YSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             CCCccc--CCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            222210  1123556778999999999999999975

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.1e-34  Score=301.13  Aligned_cols=251  Identities=25%  Similarity=0.411  Sum_probs=200.4

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      .++|...+.||+|+||.||++.. .++..|++|.+..........+.+|+.++++++||||+++++.+...+..++|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            46888899999999999999974 46788999998765555556789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      +++++|.+++..    ..+++..+..++.+++.||.|||+.+   ++|+||||+||+++.++.+||+|||++..+.....
T Consensus        98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            999999999843    35889999999999999999999987   99999999999999999999999999876543322


Q ss_pred             ccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCC
Q 006155          482 QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLS  561 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~  561 (658)
                        ......|++.|+|||++.++.++.++||||||+++||+++|+.||.......   .+....   ..+.      +...
T Consensus       171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~---~~~~~~---~~~~------~~~~  236 (293)
T cd06647         171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---ALYLIA---TNGT------PELQ  236 (293)
T ss_pred             --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh---heeehh---cCCC------CCCC
Confidence              2233468899999999988889999999999999999999999985432211   111111   0110      0110


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          562 SGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       562 ~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                      . .......+.+++..||+.+|++||++.+++.+
T Consensus       237 ~-~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         237 N-PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             C-ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0 00011234467789999999999999999854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.1e-34  Score=294.11  Aligned_cols=250  Identities=25%  Similarity=0.347  Sum_probs=191.0

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc-----ccHHHHHHHHHHHHhcCCCCceeeeeeeccC--Cce
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG-----QGDLEFKNEVLLVANLQHRNLVRLLGFSLEG--NER  395 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~  395 (658)
                      ++|...+.||+|+||.||+|+.. +|..||||.+.....     .....+.+|+.++.+++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57888999999999999999854 588999998753321     1234678899999999999999999988764  457


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ++||||+++++|.+++..   ...+++...++++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence            799999999999999843   345889999999999999999999987   99999999999999999999999999886


Q ss_pred             cccCCC-ccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          476 FEMDET-QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       476 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      +..... ........|+..|+|||.+.+..++.++||||||+++|||++|+.|+....  .....    .......    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~--~~~~~----~~~~~~~----  225 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE--AMAAI----FKIATQP----  225 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc--hHHHH----HHHhcCC----
Confidence            543211 112233568899999999988889999999999999999999999984221  11111    1111110    


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          555 IIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       555 ~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                       ..+...   ......+..++..|+. +|++||++++|++
T Consensus       226 -~~~~~~---~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         226 -TNPVLP---PHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             -CCCCCc---hhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence             011111   1112234456667774 8999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.5e-34  Score=294.34  Aligned_cols=254  Identities=26%  Similarity=0.392  Sum_probs=197.8

Q ss_pred             CCcccCcccccCceEEEEeEe-cCCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeecc--CCceEEEE
Q 006155          325 NFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLE--GNERLLIY  399 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv~  399 (658)
                      +|+..+.||.|+||.||++.. .++..+|+|.+....  ......+.+|+.++++++|+||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            477889999999999999974 467889999886542  2334468889999999999999999997754  45678999


Q ss_pred             EecCCCChhhhhcCc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcC--CCcEEEeccCCCceeeCCCCCeEEecccccccc
Q 006155          400 EFVPNTSLDHFIFDP-TRRAQLDWERRYKIIGGIARGLLYLHEDS--RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF  476 (658)
Q Consensus       400 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~  476 (658)
                      ||+++++|.+++... .....+++..++.++.+|+.||.|||..+  ...++|+||||+||+++.++.+||+|||++..+
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998542 22457899999999999999999999332  234999999999999999999999999999876


Q ss_pred             ccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccccc
Q 006155          477 EMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNII  556 (658)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  556 (658)
                      ......  .....|+..|+|||++....++.++||||||+++|+|++|+.|+....   ...+....    ..+..    
T Consensus       161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~----~~~~~----  227 (265)
T cd08217         161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLASKI----KEGKF----  227 (265)
T ss_pred             cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC---HHHHHHHH----hcCCC----
Confidence            543321  223568999999999999999999999999999999999999985432   22222221    11111    


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          557 DPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       557 dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                       +.+...   ....+.+++..|++.+|++||++.+|+++
T Consensus       228 -~~~~~~---~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         228 -RRIPYR---YSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             -CCCccc---cCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence             111111   12345678889999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.2e-34  Score=300.32  Aligned_cols=263  Identities=24%  Similarity=0.345  Sum_probs=195.3

Q ss_pred             hccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcc-cHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQ-GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ++++|...+.||+|+||.||+|.. .+|..||+|++...... ....+.+|+.+++.++|+||+++.+++..++..++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            357899999999999999999974 46889999998755332 2346788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ||+. ++|.+++..  ....+++..+..++.||+.||.|||+.+   |+|+||||+|||++.++.+||+|||+++.....
T Consensus        83 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          83 EYMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             eccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            9996 677666633  2345788899999999999999999987   999999999999999999999999998754322


Q ss_pred             CCccccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCC-------
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGT-------  551 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-------  551 (658)
                      ..  ......+++.|+|||++.+. .++.++||||||+++|||++|+.||.....  ..+.+...|..+....       
T Consensus       157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  232 (291)
T cd07870         157 SQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD--VFEQLEKIWTVLGVPTEDTWPGV  232 (291)
T ss_pred             CC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh--HHHHHHHHHHHcCCCChhhhhhh
Confidence            11  12234578999999998764 578899999999999999999999853322  2233333332211100       


Q ss_pred             -----c-ccccCCCCCCC------CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          552 -----T-VNIIDPTLSSG------SITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       552 -----~-~~~~dp~l~~~------~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                           . .+.........      ...+...+.+++.+|++.||++|||+.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence                 0 00000000000      0001123456778999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3e-34  Score=296.76  Aligned_cols=258  Identities=26%  Similarity=0.339  Sum_probs=198.1

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccC--CceEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEG--NERLLIY  399 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~  399 (658)
                      ++|...+.||.|++|.||++... +++.+|+|.+..... .....+.+|++++++++||||+++++++.+.  ...++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            46788899999999999999864 578899998875433 3445689999999999999999999988653  4679999


Q ss_pred             EecCCCChhhhhcCc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccccc
Q 006155          400 EFVPNTSLDHFIFDP-TRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       400 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~  478 (658)
                      ||+++++|.+++... .....+++.....++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            999999999887431 23456899999999999999999999987   99999999999999999999999999875432


Q ss_pred             CCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCC--CCcchHHHHHHHhccCCCccccc
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNG--ETVEDLLSSAWKNWREGTTVNII  556 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~--~~~~~l~~~~~~~~~~~~~~~~~  556 (658)
                      ..    .....++..|+|||.+.+..++.++||||||+++|||++|+.|+.....  ....++..+...    .....+.
T Consensus       158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~  229 (287)
T cd06621         158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNPELK  229 (287)
T ss_pred             cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCchhhc
Confidence            21    1234578899999999999999999999999999999999999864422  111222222111    1111111


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          557 DPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       557 dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      +. .... ..-...+.+++.+||+.+|++|||+.||++
T Consensus       230 ~~-~~~~-~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         230 DE-PGNG-IKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             cC-CCCC-CchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            11 1100 011234567889999999999999999986

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.1e-35  Score=303.46  Aligned_cols=256  Identities=23%  Similarity=0.343  Sum_probs=204.5

Q ss_pred             hhhhhccCCcccCcccccCceEEEEeEecCCcceeEEEeccC--CcccHHHHHHHHHHHHhcC-CCCceeeeeeeccCCc
Q 006155          318 TIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRD--SGQGDLEFKNEVLLVANLQ-HRNLVRLLGFSLEGNE  394 (658)
Q Consensus       318 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~  394 (658)
                      -+.+....|++.++||+||.+.||++...+.+.+|+|++...  +.+...-|.+|+.+|.+|+ |.+||+|++|...++.
T Consensus       355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~  434 (677)
T KOG0596|consen  355 IIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY  434 (677)
T ss_pred             eEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence            345566789999999999999999998777788898876543  3344456999999999996 9999999999999999


Q ss_pred             eEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          395 RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      +||||||= ..+|..+|... .....+| .+..+..||+.++.++|+.+   |||.||||.|+|+- .|.+||+|||+|.
T Consensus       435 lYmvmE~G-d~DL~kiL~k~-~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~  507 (677)
T KOG0596|consen  435 LYMVMECG-DIDLNKILKKK-KSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIAN  507 (677)
T ss_pred             EEEEeecc-cccHHHHHHhc-cCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhc
Confidence            99999975 67899998543 2334456 77789999999999999998   99999999999986 4689999999999


Q ss_pred             ccccCCCccccccccccccccCccccccC-----------CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHH
Q 006155          475 LFEMDETQGNTSRIVGTYGYMAPEYAMHG-----------QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSA  543 (658)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~  543 (658)
                      .+..+.+.......+||+.||+||.+...           +.+.++||||+|||||+|+.|+.||..     ..+    .
T Consensus       508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~-----~~n----~  578 (677)
T KOG0596|consen  508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ-----IIN----Q  578 (677)
T ss_pred             ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH-----HHH----H
Confidence            99888887778889999999999988532           256789999999999999999999842     111    2


Q ss_pred             HHhccCCCcccccCCCCCCC--CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          544 WKNWREGTTVNIIDPTLSSG--SITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       544 ~~~~~~~~~~~~~dp~l~~~--~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      |..     ...+.||.....  ...+-..+++++..||+.||.+||++.++++
T Consensus       579 ~aK-----l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  579 IAK-----LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             HHH-----HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            221     123445533111  1112222778888999999999999999985

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2e-34  Score=297.83  Aligned_cols=248  Identities=24%  Similarity=0.367  Sum_probs=198.0

Q ss_pred             CCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecC
Q 006155          325 NFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVP  403 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~  403 (658)
                      .|...+.||+|++|.||++.. .+++.+++|++..........+.+|+.+++.++||||+++++++..++..++|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            455667999999999999984 4688899999876555555668899999999999999999999999999999999999


Q ss_pred             CCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCcc
Q 006155          404 NTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQG  483 (658)
Q Consensus       404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  483 (658)
                      +++|.+++..    ..+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++........  
T Consensus       100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--  170 (285)
T cd06648         100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--  170 (285)
T ss_pred             CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence            9999999843    45899999999999999999999987   99999999999999999999999998875543221  


Q ss_pred             ccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCC
Q 006155          484 NTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSG  563 (658)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~  563 (658)
                      ......|+..|+|||.+.+..++.++||||||+++|||++|+.|+....   ..........    ...     +.+...
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~---~~~~~~~~~~----~~~-----~~~~~~  238 (285)
T cd06648         171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP---PLQAMKRIRD----NLP-----PKLKNL  238 (285)
T ss_pred             ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC---HHHHHHHHHh----cCC-----CCCccc
Confidence            2223568999999999998889999999999999999999999974322   1122221111    111     111110


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          564 SITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       564 ~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                       ...-..+.+++.+||+.+|++||++.++++
T Consensus       239 -~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         239 -HKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             -ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence             001124567888999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.8e-34  Score=289.80  Aligned_cols=251  Identities=27%  Similarity=0.416  Sum_probs=201.6

Q ss_pred             CCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeeccC--CceEEEE
Q 006155          325 NFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLEG--NERLLIY  399 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~  399 (658)
                      +|...+.||+|++|.||+|+.. ++..|++|++.....  .....+.+|+..+++++|+||+++++.+...  +..++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677889999999999999865 688999999876543  3456789999999999999999999999988  8899999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ||+++++|.+++..   ...++|..++.++.++++||.|||+.+   ++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            99999999999853   237999999999999999999999987   999999999999999999999999999876544


Q ss_pred             CCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCC
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT  559 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~  559 (658)
                      ..........++..|+|||.+.....+.++||||||+++++|++|+.|+....     +.....+........     +.
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~-----~~  224 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGEP-----PE  224 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCCC-----cC
Confidence            32112334578899999999998889999999999999999999999985433     122222222111111     11


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          560 LSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       560 l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      +....   -..+.+++.+|++.+|++||++.++++
T Consensus       225 ~~~~~---~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         225 IPEHL---SEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CCccc---CHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            11111   234556778999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-34  Score=291.54  Aligned_cols=277  Identities=19%  Similarity=0.219  Sum_probs=214.0

Q ss_pred             hhhccCCcccCcccccCceEEEEeEecC-CcceeEEEeccCCccc---HHHHHHHHHHHHhcCCCCceeeeeeeccCCce
Q 006155          320 RVATDNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQG---DLEFKNEVLLVANLQHRNLVRLLGFSLEGNER  395 (658)
Q Consensus       320 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  395 (658)
                      .+..+.|+..+.||+|.-|+||++++.+ +...|+|++.+..-..   ......|-++|..++||.++.|++.+..++..
T Consensus        73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~  152 (459)
T KOG0610|consen   73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS  152 (459)
T ss_pred             ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence            3455678889999999999999999765 4788999998764333   33466799999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      +|+||||+||+|..+++. +..+.+++..++.++.+|+-||+|||-.|   ||.|||||+||||.++|++.|+||.|+..
T Consensus       153 cl~meyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~  228 (459)
T KOG0610|consen  153 CLVMEYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLR  228 (459)
T ss_pred             EEEEecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeecccccc
Confidence            999999999999988854 45567999999999999999999999998   99999999999999999999999998753


Q ss_pred             cccC----------------------------------C--------------------CccccccccccccccCccccc
Q 006155          476 FEMD----------------------------------E--------------------TQGNTSRIVGTYGYMAPEYAM  501 (658)
Q Consensus       476 ~~~~----------------------------------~--------------------~~~~~~~~~gt~~y~aPE~~~  501 (658)
                      ....                                  .                    ........+||..|+|||++.
T Consensus       229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~  308 (459)
T KOG0610|consen  229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR  308 (459)
T ss_pred             CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence            3110                                  0                    001122368999999999999


Q ss_pred             cCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCC
Q 006155          502 HGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQE  581 (658)
Q Consensus       502 ~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~  581 (658)
                      +...+..+|+|+|||++|||+.|+.||...+..  +.+...+.+           ++.+.... .....+-+++..-|..
T Consensus       309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~--~Tl~NIv~~-----------~l~Fp~~~-~vs~~akDLIr~LLvK  374 (459)
T KOG0610|consen  309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK--ETLRNIVGQ-----------PLKFPEEP-EVSSAAKDLIRKLLVK  374 (459)
T ss_pred             cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCch--hhHHHHhcC-----------CCcCCCCC-cchhHHHHHHHHHhcc
Confidence            999999999999999999999999999654332  112111111           11222111 1223344566677999


Q ss_pred             CCCCCCC----HHHHH--HHhccCCCCCCCCCCCCcccc
Q 006155          582 NVASRPT----MASVV--LMLNSYSLTLPVPSEPAFFMD  614 (658)
Q Consensus       582 ~p~~RPt----m~evv--~~L~~~~~~~~~p~~p~~~~~  614 (658)
                      ||.+|--    +.||-  ..+++.++.+-.-..|++...
T Consensus       375 dP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~  413 (459)
T KOG0610|consen  375 DPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPK  413 (459)
T ss_pred             ChhhhhccccchHHhhcCccccCCChhheeccCCCcCCC
Confidence            9999988    77875  456777777765556665443

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.9e-34  Score=296.01  Aligned_cols=261  Identities=28%  Similarity=0.404  Sum_probs=197.1

Q ss_pred             CCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcc-cHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEec
Q 006155          325 NFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQ-GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFV  402 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  402 (658)
                      +|+..++||+|++|.||+|+.. +|..||||++...... ....+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5788899999999999999864 5888999998765433 3345778999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCc
Q 006155          403 PNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ  482 (658)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  482 (658)
                      ++ +|.+++........+++..+.+++.||++||.|||+.+   ++||||||+||++++++.++|+|||++..+..... 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            85 88888765444457999999999999999999999987   99999999999999999999999999976543221 


Q ss_pred             cccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCC---c-----c
Q 006155          483 GNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGT---T-----V  553 (658)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~-----~  553 (658)
                       ......++..|++||++.+. .++.++||||||+++|||++|+.|+.....   .+........+....   .     .
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN---EDQLLKIFRIMGTPTESTWPGISQL  231 (284)
T ss_pred             -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCCCChhhHHHHhcC
Confidence             12234578899999988664 478999999999999999999999854332   122221111110000   0     0


Q ss_pred             cccCCCCCC---CCHH-----HHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          554 NIIDPTLSS---GSIT-----EMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       554 ~~~dp~l~~---~~~~-----e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .........   ....     .-..+.+++..|++.||++||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            000001100   0111     1123557888999999999999999984

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.2e-34  Score=299.07  Aligned_cols=260  Identities=24%  Similarity=0.348  Sum_probs=192.6

Q ss_pred             CCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          325 NFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      +|+..+.||+|+||.||+++.. +|+.+|+|++.....  .....+.+|+.++++++||||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4777889999999999999854 588999999865422  2234578899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      ++ ++|.+++..  ....+++..++.++.||++||.|||+.+   ++||||||+||+++.++.+||+|||+++.+.....
T Consensus        81 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          81 CD-QDLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence            97 477777643  2346899999999999999999999987   99999999999999999999999999986543221


Q ss_pred             ccccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCC------ccc
Q 006155          482 QGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGT------TVN  554 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~~~  554 (658)
                        ......++..|+|||++.+. .++.++||||||+++|||++|+.|+....  +....+....+......      ..+
T Consensus       155 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07839         155 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEESWPGVSK  230 (284)
T ss_pred             --CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCC--CHHHHHHHHHHHhCCCChHHhHHhhh
Confidence              12234678899999998765 47899999999999999999998863221  11222221111100000      000


Q ss_pred             ccC----CCCCCC-C-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          555 IID----PTLSSG-S-----ITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       555 ~~d----p~l~~~-~-----~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ..+    +..... .     ..-...+.+++..||+.||.+|||+.+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            000    000000 0     001123457888999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-36  Score=281.51  Aligned_cols=252  Identities=25%  Similarity=0.309  Sum_probs=198.7

Q ss_pred             hhccCCcccCcccccCceEEEEeE-ecCCcceeEEEeccC--CcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEE
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRD--SGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  397 (658)
                      ..+++|++.+.||+|.|+.|++.. ...|+.+|+|++...  +..+.+++.+|+.+-..|+||||++|..........+|
T Consensus         8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl   87 (355)
T KOG0033|consen    8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   87 (355)
T ss_pred             ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence            346788999999999999999875 456899999977543  34467789999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCC---CCCeEEecccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDA---EMTPKIADFGMAR  474 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~---~~~~kl~DFGla~  474 (658)
                      |+|+|.|++|..-|.   .+...++...-..++||+++|.|+|.++   |||||+||+|+||-.   .--+||+|||++.
T Consensus        88 vFe~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi  161 (355)
T KOG0033|consen   88 VFDLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAI  161 (355)
T ss_pred             EEecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEE
Confidence            999999999965552   2345677788889999999999999998   999999999999953   3358999999998


Q ss_pred             ccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          475 LFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      .+..+   ......+|||+|||||++...+|+..+|||+.||+||-|+.|..||..   ++...+.+...+.--     +
T Consensus       162 ~l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~---~~~~rlye~I~~g~y-----d  230 (355)
T KOG0033|consen  162 EVNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD---EDQHRLYEQIKAGAY-----D  230 (355)
T ss_pred             EeCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC---ccHHHHHHHHhcccc-----C
Confidence            87632   234457999999999999999999999999999999999999999843   233344443332211     1


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 006155          555 IIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVV  593 (658)
Q Consensus       555 ~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv  593 (658)
                       +++..-....++..   +++.++|..||.+|.|+.|.+
T Consensus       231 -~~~~~w~~is~~Ak---~LvrrML~~dP~kRIta~EAL  265 (355)
T KOG0033|consen  231 -YPSPEWDTVTPEAK---SLIRRMLTVNPKKRITADEAL  265 (355)
T ss_pred             -CCCcccCcCCHHHH---HHHHHHhccChhhhccHHHHh
Confidence             11211112222332   455588999999999999876

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.3e-34  Score=293.98  Aligned_cols=248  Identities=25%  Similarity=0.391  Sum_probs=196.9

Q ss_pred             cCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          324 DNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      +-|+..+.||+|+||.||+|.. .++..||||.+..... .....+.+|+.++.+++||||+++++++..++..++||||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            3467788999999999999975 4678899998765432 3345688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      +++++|.+++.    ...+++..+..++.+++.+|.|||+.+   ++|+||||+||+++.++.++|+|||++..+.... 
T Consensus        84 ~~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-  155 (277)
T cd06641          84 LGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-  155 (277)
T ss_pred             CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch-
Confidence            99999999984    246899999999999999999999987   9999999999999999999999999987654321 


Q ss_pred             ccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCC
Q 006155          482 QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLS  561 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~  561 (658)
                       .......|+..|+|||++.+..++.++||||||+++|||++|..|+.....   .......    ....     .+.+.
T Consensus       156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~~----~~~~-----~~~~~  222 (277)
T cd06641         156 -IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP---MKVLFLI----PKNN-----PPTLE  222 (277)
T ss_pred             -hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch---HHHHHHH----hcCC-----CCCCC
Confidence             112234688899999999988899999999999999999999999743221   1111111    1111     11121


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          562 SGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       562 ~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                      ....   ..+.+++.+||+.+|++||++.++++.
T Consensus       223 ~~~~---~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         223 GNYS---KPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             cccC---HHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            1112   234467789999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.3e-34  Score=296.84  Aligned_cols=258  Identities=24%  Similarity=0.382  Sum_probs=193.3

Q ss_pred             CCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          325 NFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      +|+..+.||.|+||.||+|+.. +|+.||||++.....  .....+.+|++++++++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788899999999999999854 588999998865432  2334688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      +. ++|..++... ....+++..++.++.|+++||+|||+.+   ++|+||+|+||+++.++.+||+|||++..+.....
T Consensus        81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            96 6888887542 2356899999999999999999999987   99999999999999999999999999876543221


Q ss_pred             ccccccccccccccCccccccCC-CCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccC---
Q 006155          482 QGNTSRIVGTYGYMAPEYAMHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID---  557 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d---  557 (658)
                        ......++..|+|||++.+.. ++.++||||||+++|||++|+.|+.....  ...+.. ........  ...+.   
T Consensus       156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~-~~~~~~~~--~~~~~~~~  228 (284)
T cd07860         156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE--IDQLFR-IFRTLGTP--DEVVWPGV  228 (284)
T ss_pred             --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH--HHHHHH-HHHHhCCC--Chhhhhhh
Confidence              122335688999999887654 68899999999999999999998853321  111111 11100000  00000   


Q ss_pred             ----------CCCCCCCHHH-----HHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          558 ----------PTLSSGSITE-----MIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       558 ----------p~l~~~~~~e-----~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                                +........+     -..+.+++.+|++.||++|||+.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         229 TSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             hHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                      0000000000     022457888999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2e-34  Score=298.81  Aligned_cols=263  Identities=22%  Similarity=0.312  Sum_probs=194.2

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcc--cHHHHHHHHHHHHhcCCCCceeeeeeeccC--CceEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQ--GDLEFKNEVLLVANLQHRNLVRLLGFSLEG--NERLLI  398 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv  398 (658)
                      ++|+..+.||+|+||.||+|+.. +++.+++|.++.....  ....+.+|+.++.+++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            57888999999999999999865 5788999998754322  223467899999999999999999998877  889999


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccccc
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~  478 (658)
                      |||++ ++|.+++...  ...+++..++.++.||+.||.|||+.+   ++|+||||+|||++.++.+||+|||+++.+..
T Consensus        85 ~e~~~-~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVE-HDLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcC-cCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            99997 4898887432  236899999999999999999999987   99999999999999999999999999987654


Q ss_pred             CCCccccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHH--------HHHHhccC
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLS--------SAWKNWRE  549 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~--------~~~~~~~~  549 (658)
                      ...  ......+++.|+|||.+.+. .++.++|+||||+++|||++|+.|+...........+.        ..|..+..
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         159 PLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             Ccc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence            321  12234678899999988764 46899999999999999999999985433211111000        01111100


Q ss_pred             ------CCcccccCCCCCCCCHH--HHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          550 ------GTTVNIIDPTLSSGSIT--EMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       550 ------~~~~~~~dp~l~~~~~~--e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                            ..........+...-..  ....+.+++..||+.+|++|||+.|++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                  00000000011111000  1223457788999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=4.6e-34  Score=294.32  Aligned_cols=250  Identities=27%  Similarity=0.385  Sum_probs=190.0

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc-ccHHHHHHHHHH-HHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG-QGDLEFKNEVLL-VANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      ++|+..+.||+|+||.||+++.. +|+.||+|++..... ....++..|+.. ++.++||||+++++++..++..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            47888999999999999999854 589999999875432 233455566665 566789999999999999999999999


Q ss_pred             ecCCCChhhhhcCc-CCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCcEEEeccCCCceeeCCCCCeEEecccccccccc
Q 006155          401 FVPNTSLDHFIFDP-TRRAQLDWERRYKIIGGIARGLLYLHED-SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       401 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~  478 (658)
                      |++ ++|.+++... .....+++..++.++.||+.||.|||++ +   ++||||||+|||++.++.+||+|||+++.+..
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 6887777432 2335789999999999999999999986 5   99999999999999999999999999986543


Q ss_pred             CCCccccccccccccccCcccccc----CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAMH----GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      ..   ......|+..|+|||++.+    ..++.++|+||||+++|||++|+.|+..... .... +....    .+.   
T Consensus       157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~-~~~~~----~~~---  224 (283)
T cd06617         157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT-PFQQ-LKQVV----EEP---  224 (283)
T ss_pred             cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc-CHHH-HHHHH----hcC---
Confidence            21   1223468889999998864    4578899999999999999999999842211 1111 11111    111   


Q ss_pred             ccCCCCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          555 IIDPTLSSG-SITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       555 ~~dp~l~~~-~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                        .+.+... ...   .+.+++..||+.+|++||++.+|++
T Consensus       225 --~~~~~~~~~~~---~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         225 --SPQLPAEKFSP---EFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             --CCCCCccccCH---HHHHHHHHHccCChhhCcCHHHHhc
Confidence              1111111 112   3456778999999999999999975

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-35  Score=307.93  Aligned_cols=265  Identities=22%  Similarity=0.315  Sum_probs=195.4

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCC-cccHHHHHHHHHHHHhcCCCCceeeeeeeccC-----Cce
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDS-GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEG-----NER  395 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~  395 (658)
                      .++|+..++||+|+||.||+|+. .+|+.||||++.... ......+.+|+.++.+++|+||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            47899999999999999999974 468899999986532 22345578899999999999999999986544     357


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ++|+||+++ +|..++.    ...+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence            999999974 7777763    346899999999999999999999987   99999999999999999999999999976


Q ss_pred             cccCCCc-cccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCc-
Q 006155          476 FEMDETQ-GNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTT-  552 (658)
Q Consensus       476 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~-  552 (658)
                      ....... .......||..|+|||.+.+ ..++.++||||||+++|||++|+.||....   ................. 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~---~~~~~~~~~~~~~~~~~~  232 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD---YLHQLNLILGVLGTPSQE  232 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHcCCCCHH
Confidence            5432211 12233578999999998755 468999999999999999999999884322   11111111111111100 


Q ss_pred             --ccccCC----------CCCCCCH-----HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--hcc
Q 006155          553 --VNIIDP----------TLSSGSI-----TEMIRCIHIGLLCVQENVASRPTMASVVLM--LNS  598 (658)
Q Consensus       553 --~~~~dp----------~l~~~~~-----~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~--L~~  598 (658)
                        ..+.+.          .......     .....+.+++..||+.+|++|||+.++++.  ++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~  297 (336)
T cd07849         233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQ  297 (336)
T ss_pred             HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccc
Confidence              000000          0000000     112346688899999999999999999875  544

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-34  Score=295.72  Aligned_cols=259  Identities=25%  Similarity=0.362  Sum_probs=192.9

Q ss_pred             CcccCcccccCceEEEEeEec-CCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEec
Q 006155          326 FSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFV  402 (658)
Q Consensus       326 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  402 (658)
                      |+..+.||.|++|.||+|... +|..||+|++.....  .....+.+|+.++++++||||+++++++.+++..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567789999999999999854 689999999875432  22346788999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCc
Q 006155          403 PNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ  482 (658)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  482 (658)
                      + ++|.+++.... ...+++..+++++.|+++||.|||+.+   ++||||+|+||+++.++.++|+|||+++.+..... 
T Consensus        81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-  154 (283)
T cd07835          81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-  154 (283)
T ss_pred             C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence            5 68988884322 246899999999999999999999987   99999999999999999999999999976543221 


Q ss_pred             cccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCC----------
Q 006155          483 GNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGT----------  551 (658)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~----------  551 (658)
                       ......++..|+|||++.+. .++.++||||||+++|||++|+.||.....  ...+.. ..+......          
T Consensus       155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~~  230 (283)
T cd07835         155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE--IDQLFR-IFRTLGTPDEDVWPGVTSL  230 (283)
T ss_pred             -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHH-HHHHhCCCChHHhhhhhhc
Confidence             12223568899999988664 578999999999999999999998853221  111111 111000000          


Q ss_pred             ------cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          552 ------TVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       552 ------~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                            ......+.........-..+.+++.+|++.+|++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                  0000000000000001134567888999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-34  Score=299.29  Aligned_cols=254  Identities=21%  Similarity=0.232  Sum_probs=196.4

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcc---cHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQ---GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ++|+..+.||+|+||.||+++.. +++.+|+|.+......   ....+.+|++++..++|+||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            46888899999999999999865 4889999998765332   3446889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ||+.+++|.+++.. .....+++..+..++.||++||.|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQR-QPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHh-CCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            99999999999853 23356899999999999999999999987   999999999999999999999999998754322


Q ss_pred             CCc---------------------------cccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCC
Q 006155          480 ETQ---------------------------GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRN  532 (658)
Q Consensus       480 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~  532 (658)
                      ...                           .......||..|+|||++.+..++.++||||||+++|||++|+.|+....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            110                           01123468999999999999999999999999999999999999985332


Q ss_pred             CCCcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          533 GETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       533 ~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                      .   ........   . ..      +..... ...-..+.+++.+||+.+|++||++...++.
T Consensus       237 ~---~~~~~~~~---~-~~------~~~~~~-~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~  285 (316)
T cd05574         237 R---DETFSNIL---K-KE------VTFPGS-PPVSSSARDLIRKLLVKDPSKRLGSKRGAAE  285 (316)
T ss_pred             h---HHHHHHHh---c-CC------ccCCCc-cccCHHHHHHHHHHccCCHhHCCCchhhHHH
Confidence            1   11111111   1 00      001111 0012345577789999999999994333333

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.9e-34  Score=301.15  Aligned_cols=266  Identities=21%  Similarity=0.325  Sum_probs=193.4

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeeccCC------
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGN------  393 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------  393 (658)
                      -++|+..++||+|+||.||+++.. +++.||||.+.....  .....+.+|+.++++++||||+++++++....      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            357899999999999999999854 588999998865432  22334678999999999999999999886654      


Q ss_pred             --ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccc
Q 006155          394 --ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFG  471 (658)
Q Consensus       394 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFG  471 (658)
                        ..++||||+.+ +|.+++..  ....+++..++.++.||++||.|||+.+   ++|+||||+||+++.++.+||+|||
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence              34999999964 77777743  2346899999999999999999999987   9999999999999999999999999


Q ss_pred             cccccccCCCc--cccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhcc
Q 006155          472 MARLFEMDETQ--GNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWR  548 (658)
Q Consensus       472 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~  548 (658)
                      ++..+......  .......++..|+|||++.+. .++.++||||||+++|||++|+.|+...........+...+....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~  244 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT  244 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99876433221  122334678899999988665 478899999999999999999988854332222222222211111


Q ss_pred             CCCcccc-----cC----CCCCCC-CHH------HHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          549 EGTTVNI-----ID----PTLSSG-SIT------EMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       549 ~~~~~~~-----~d----p~l~~~-~~~------e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .+.....     .+    +.-... ...      +...+.+++..||+.||++|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            1100000     00    000000 000      1123457889999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2e-34  Score=292.93  Aligned_cols=247  Identities=24%  Similarity=0.282  Sum_probs=197.3

Q ss_pred             CCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc---ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          325 NFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG---QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      +|+..+.||+|+||.||+++.. ++..+|+|.+.....   .....+.+|++++++++||||+++++.+.+++..++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4778899999999999999865 488999999875432   335578999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      |+++++|.+++..   ...+++.....++.||++||.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            9999999999843   257899999999999999999999987   9999999999999999999999999987654332


Q ss_pred             CccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCC
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTL  560 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l  560 (658)
                         ......|+..|+|||++.+..++.++|+||||+++|+|++|+.|+..........+..    ....  ..    +..
T Consensus       155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----~~~~--~~----~~~  221 (258)
T cd05578         155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA----KQET--AD----VLY  221 (258)
T ss_pred             ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHH----Hhcc--cc----ccC
Confidence               2233568889999999998889999999999999999999999986444321222111    1110  00    111


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCH--HHHH
Q 006155          561 SSGSITEMIRCIHIGLLCVQENVASRPTM--ASVV  593 (658)
Q Consensus       561 ~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm--~evv  593 (658)
                      .....   ..+.+++.+||+.+|.+||++  +|++
T Consensus       222 ~~~~~---~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         222 PATWS---TEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             cccCc---HHHHHHHHHHccCChhHcCCccHHHHh
Confidence            11111   345567789999999999999  5543

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=7e-34  Score=286.63  Aligned_cols=250  Identities=28%  Similarity=0.432  Sum_probs=201.2

Q ss_pred             CCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecC
Q 006155          325 NFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVP  403 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~  403 (658)
                      +|...+.||+|++|.||+++.. ++..+++|++..........+.+|+.++++++|+||+++++++..+...++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4677889999999999999865 688899999977655556778999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCcc
Q 006155          404 NTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQG  483 (658)
Q Consensus       404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  483 (658)
                      +++|.+++...  ...+++..+..++.+++.+|.|||+.+   ++|+||+|+||++++++.++|+|||.+........  
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          81 GGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            99999998542  257899999999999999999999977   99999999999999999999999999876654321  


Q ss_pred             ccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCC
Q 006155          484 NTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSG  563 (658)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~  563 (658)
                       .....|+..|++||++....++.++||||||++++||++|+.|+.....   ...+.....    .......++..   
T Consensus       154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~----~~~~~~~~~~~---  222 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP---MKALFKIAT----NGPPGLRNPEK---  222 (253)
T ss_pred             -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch---HHHHHHHHh----cCCCCcCcccc---
Confidence             3345788999999999988899999999999999999999998753221   111111111    11111111100   


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          564 SITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       564 ~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                      .   -..+.+++..||+.||++|||+.++++.
T Consensus       223 ~---~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         223 W---SDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             c---CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0   1235567789999999999999999853

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3.2e-34  Score=290.91  Aligned_cols=250  Identities=23%  Similarity=0.364  Sum_probs=196.7

Q ss_pred             CCcccCcccccCceEEEEeEec-CCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          325 NFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      +|...+.||+|+||.||++... +|..+|+|.+....  ......+.+|+.+++.++|+||+++++.+..+...++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4777889999999999999864 57889999986542  23345678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCC-CeEEeccccccccccCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM-TPKIADFGMARLFEMDE  480 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~-~~kl~DFGla~~~~~~~  480 (658)
                      +++++|.+++... ....++|..+..++.++++||.|||+.+   ++|+||||+||++++++ .+||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            9999999998542 2235899999999999999999999987   99999999999999886 46999999998664322


Q ss_pred             CccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCC
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTL  560 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l  560 (658)
                      .  ......|++.|+|||++.+..++.++||||||+++||+++|+.|+....   ....+....    .+.... ..+  
T Consensus       157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~----~~~~~~-~~~--  224 (257)
T cd08225         157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN---LHQLVLKIC----QGYFAP-ISP--  224 (257)
T ss_pred             c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHh----cccCCC-CCC--
Confidence            1  1223468899999999998899999999999999999999999974322   122222111    111111 111  


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          561 SSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       561 ~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                        ...   ..+.+++.+|++.+|++|||+.+|++.
T Consensus       225 --~~~---~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         225 --NFS---RDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             --CCC---HHHHHHHHHHhccChhhCcCHHHHhhC
Confidence              111   235567789999999999999999853

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=5.7e-34  Score=297.65  Aligned_cols=248  Identities=30%  Similarity=0.406  Sum_probs=192.9

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc---ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG---QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  397 (658)
                      ..+.|...+.||+|+||.||+|+.. +|+.||+|.+.....   ....++.+|+.+++.++||||+++++++.+++..++
T Consensus        13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l   92 (307)
T cd06607          13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL   92 (307)
T ss_pred             cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence            3466888999999999999999854 588999998865432   223468899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE  477 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~  477 (658)
                      |+||++ |+|.+++..  ....+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++....
T Consensus        93 v~e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~  166 (307)
T cd06607          93 VMEYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS  166 (307)
T ss_pred             EHHhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence            999997 566666532  2346899999999999999999999987   9999999999999999999999999987543


Q ss_pred             cCCCccccccccccccccCccccc---cCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          478 MDETQGNTSRIVGTYGYMAPEYAM---HGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      ..      ....|+..|+|||++.   .+.++.++||||||+++|||++|+.|+....   ........    ....   
T Consensus       167 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~---~~~~~~~~----~~~~---  230 (307)
T cd06607         167 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSALYHI----AQND---  230 (307)
T ss_pred             CC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc---HHHHHHHH----hcCC---
Confidence            22      2346788999999874   4668899999999999999999999874321   11111111    0000   


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          555 IIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       555 ~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                        .+.+...  ..-..+.+++..||+.+|++||++.+|+..
T Consensus       231 --~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         231 --SPTLSSN--DWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             --CCCCCch--hhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence              0111111  111235677889999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=3.9e-34  Score=303.03  Aligned_cols=263  Identities=23%  Similarity=0.326  Sum_probs=194.8

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccC--CcccHHHHHHHHHHHHhc-CCCCceeeeeeecc--CCce
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRD--SGQGDLEFKNEVLLVANL-QHRNLVRLLGFSLE--GNER  395 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~--~~~~  395 (658)
                      ..++|+..+.||+|+||.||+|... +|+.+|||++...  .......+..|+.++.++ +||||+++++++..  +...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4578899999999999999999865 5788999988543  223344577899999999 99999999998764  3467


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ++||||++ ++|..++..    ..++|..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            99999997 589888743    26899999999999999999999987   99999999999999999999999999986


Q ss_pred             cccCCCc---cccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHh-----
Q 006155          476 FEMDETQ---GNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKN-----  546 (658)
Q Consensus       476 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~-----  546 (658)
                      +......   .......|+..|+|||++.+ ..++.++||||||+++|||++|+.|+......   +........     
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~---~~~~~~~~~~~~~~  233 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL---NQLEKIIEVIGPPS  233 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCC
Confidence            6443221   22334578999999998765 45789999999999999999999988532211   111111110     


Q ss_pred             ------ccCCCcccccCCCC--CCCCHH-----HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          547 ------WREGTTVNIIDPTL--SSGSIT-----EMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       547 ------~~~~~~~~~~dp~l--~~~~~~-----e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                            +.......+++...  ......     .-..+.+++.+||+.+|++|||+.++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                  00000001111000  000001     11345678889999999999999999964

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-34  Score=293.08  Aligned_cols=255  Identities=26%  Similarity=0.397  Sum_probs=197.3

Q ss_pred             hhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhc-CCCCceeeeeeeccCC-----
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANL-QHRNLVRLLGFSLEGN-----  393 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~-----  393 (658)
                      ..+++|+..+.||+|+||.||+|+.. +++.+++|++..... ....+.+|+.++.++ +|+||+++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            35689999999999999999999864 577899998876543 345789999999999 6999999999987644     


Q ss_pred             -ceEEEEEecCCCChhhhhcCcC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccc
Q 006155          394 -ERLLIYEFVPNTSLDHFIFDPT-RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFG  471 (658)
Q Consensus       394 -~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFG  471 (658)
                       ..++||||+++++|.+++.... ....+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence             4899999999999999885422 2457899999999999999999999987   9999999999999999999999999


Q ss_pred             cccccccCCCccccccccccccccCcccccc-----CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHh
Q 006155          472 MARLFEMDETQGNTSRIVGTYGYMAPEYAMH-----GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKN  546 (658)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~  546 (658)
                      ++.......  .......|+..|+|||++..     ..++.++||||||++++||++|+.|+.....   ...+...   
T Consensus       159 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~---  230 (275)
T cd06608         159 VSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP---MRALFKI---  230 (275)
T ss_pred             cceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch---HHHHHHh---
Confidence            987653321  12233568999999998753     3477899999999999999999999843211   1111111   


Q ss_pred             ccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          547 WREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       547 ~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                       .......+..      .......+.+++.+||+.||++|||+.++++
T Consensus       231 -~~~~~~~~~~------~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         231 -PRNPPPTLKS------PENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             -hccCCCCCCc------hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence             1111111111      1111224557788999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-34  Score=297.04  Aligned_cols=259  Identities=22%  Similarity=0.354  Sum_probs=195.2

Q ss_pred             CcccCcccccCceEEEEeEec-CCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeeccC--CceEEEEE
Q 006155          326 FSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEG--NERLLIYE  400 (658)
Q Consensus       326 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e  400 (658)
                      |+..++||+|+||.||+|+.. +|+.+|+|++....  ......+.+|+.++.+++|+|++++++++.+.  ...++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            566789999999999999865 47899999997663  33345688999999999999999999999887  78999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      |+++ +|.+++...  ...+++..++.++.||++||+|||+.+   ++|+||||+||++++++.+||+|||++.......
T Consensus        81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9975 888887442  246899999999999999999999987   9999999999999999999999999998765432


Q ss_pred             CccccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCc---cc--
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTT---VN--  554 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~---~~--  554 (658)
                      . .......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+.....   ...+............   ..  
T Consensus       155 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07840         155 S-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE---LEQLEKIFELCGSPTDENWPGVS  230 (287)
T ss_pred             c-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCchhhccccc
Confidence            2 11223456889999998765 4588999999999999999999999854332   1222211111110000   00  


Q ss_pred             ------ccCCCCCCC-CH----H--HHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          555 ------IIDPTLSSG-SI----T--EMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       555 ------~~dp~l~~~-~~----~--e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                            ...+..... ..    .  ....+++++..||+.+|++||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                  000000000 00    0  1235678899999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.3e-35  Score=311.09  Aligned_cols=249  Identities=24%  Similarity=0.375  Sum_probs=192.8

Q ss_pred             cccCcccccCceEEEEeEec-CCcceeEEEeccC----CcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCc--eEEEE
Q 006155          327 SDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRD----SGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNE--RLLIY  399 (658)
Q Consensus       327 ~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~--~~lv~  399 (658)
                      ....+||+|.|-+||||... +|.+||--.++..    .......|.+|+.+|+.|+||||++++..+.+...  ..+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            34568999999999999743 4777765433221    22333579999999999999999999999877654  78999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCC-CCCeEEecccccccccc
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDA-EMTPKIADFGMARLFEM  478 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~-~~~~kl~DFGla~~~~~  478 (658)
                      |.+..|+|..|+.   +.+.++.+.+.+|++||++||.|||++. |+|||||||-.||+|+. -|.+||+|+|||.+...
T Consensus       123 EL~TSGtLr~Y~k---k~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  123 ELFTSGTLREYRK---KHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             ecccCCcHHHHHH---HhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            9999999999984   4566889999999999999999999985 78999999999999975 58999999999998654


Q ss_pred             CCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCC
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP  558 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp  558 (658)
                      .    .....+|||.|||||+.. ..|.+.+||||||+.++||+|+.-|+.--  ....+    +++....|.....+..
T Consensus       199 s----~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC--~n~AQ----IYKKV~SGiKP~sl~k  267 (632)
T KOG0584|consen  199 S----HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC--TNPAQ----IYKKVTSGIKPAALSK  267 (632)
T ss_pred             c----ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh--CCHHH----HHHHHHcCCCHHHhhc
Confidence            3    233479999999999876 88999999999999999999999997422  12223    3444444433332211


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--Hhcc
Q 006155          559 TLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL--MLNS  598 (658)
Q Consensus       559 ~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~--~L~~  598 (658)
                      -    ...+   +.+++..|+.. .++|||+.|++.  .|..
T Consensus       268 V----~dPe---vr~fIekCl~~-~~~R~sa~eLL~d~Ff~~  301 (632)
T KOG0584|consen  268 V----KDPE---VREFIEKCLAT-KSERLSAKELLKDPFFDE  301 (632)
T ss_pred             c----CCHH---HHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence            1    1223   33566799999 999999999984  4443

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=5.7e-34  Score=295.16  Aligned_cols=243  Identities=26%  Similarity=0.328  Sum_probs=195.1

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ++|+..+.||+|+||.||+++.. +++.+|+|.+....   ......+.+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46888899999999999999854 58899999986542   123455889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   ++|+||+|+|||++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            99999999999843   356899999999999999999999987   999999999999999999999999999865433


Q ss_pred             CCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCC
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT  559 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~  559 (658)
                           .....|++.|+|||.+.+...+.++||||||+++|||++|+.|+....   ........    ..+.      +.
T Consensus       155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~----~~~~------~~  216 (290)
T cd05580         155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN---PIQIYEKI----LEGK------VR  216 (290)
T ss_pred             -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHH----hcCC------cc
Confidence                 234568999999999988889999999999999999999999984322   11111111    1111      11


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHH
Q 006155          560 LSSGSITEMIRCIHIGLLCVQENVASRP-----TMASVV  593 (658)
Q Consensus       560 l~~~~~~e~~~~~~i~~~Cl~~~p~~RP-----tm~evv  593 (658)
                      +.....   ..+.+++..||+.||.+||     ++.|++
T Consensus       217 ~~~~~~---~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         217 FPSFFS---PDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             CCccCC---HHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence            111111   2345677899999999999     556655

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4.6e-34  Score=298.63  Aligned_cols=261  Identities=25%  Similarity=0.359  Sum_probs=193.0

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcc--cHHHHHHHHHHHHhcCCCCceeeeeeeccC--CceEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQ--GDLEFKNEVLLVANLQHRNLVRLLGFSLEG--NERLL  397 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~l  397 (658)
                      .++|+..+.||+|+||.||+|+.. +|+.||+|++......  ....+.+|+.++.+++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            467999999999999999999854 5889999998654322  233467899999999999999999998755  46799


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE  477 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~  477 (658)
                      ||||+.+ +|.+++..  ....+++..++.++.||++||.|||+.+   ++||||||+||+++.++.+||+|||++..+.
T Consensus        86 v~e~~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCEQ-DLASLLDN--MPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999974 78877743  2356899999999999999999999988   9999999999999999999999999998764


Q ss_pred             cCCCccccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCC------
Q 006155          478 MDETQGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREG------  550 (658)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~------  550 (658)
                      ....  ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+.....   .+.+..........      
T Consensus       160 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~---~~~~~~~~~~~~~~~~~~~~  234 (309)
T cd07845         160 LPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE---IEQLDLIIQLLGTPNESIWP  234 (309)
T ss_pred             CccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCChhhch
Confidence            3321  1222345788999999865 4578999999999999999999999853322   22222221111100      


Q ss_pred             -----CcccccC-CCCCCCCHH-----HHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          551 -----TTVNIID-PTLSSGSIT-----EMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       551 -----~~~~~~d-p~l~~~~~~-----e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                           .....+. +........     ....+.+++..|++.||++|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                 0000000 000000000     0123456788999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2e-36  Score=291.32  Aligned_cols=249  Identities=24%  Similarity=0.356  Sum_probs=202.4

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEec
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFV  402 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  402 (658)
                      +-|.++.+||+|+||.||++.++ .|+.+|||++...  .+.+++..|+.+|.+.+.|++|+++|.+.....+++|||||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC  110 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC  110 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence            44677889999999999999754 5899999998755  45678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCc
Q 006155          403 PNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ  482 (658)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  482 (658)
                      ..|+..+++.  .++++|++.++..+++..++||+|||...   -||||||+.||||+.+|.+||+|||.+-.+..  +.
T Consensus       111 GAGSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TM  183 (502)
T KOG0574|consen  111 GAGSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TM  183 (502)
T ss_pred             CCCcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh--hH
Confidence            9999999984  46788999999999999999999999876   79999999999999999999999999975543  33


Q ss_pred             cccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCC
Q 006155          483 GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSS  562 (658)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~  562 (658)
                      ....+..||+-|||||++..-.|..++||||+|+...||.-|++|+..-.+....       -+.....     .|.+..
T Consensus       184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI-------FMIPT~P-----PPTF~K  251 (502)
T KOG0574|consen  184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI-------FMIPTKP-----PPTFKK  251 (502)
T ss_pred             HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee-------EeccCCC-----CCCCCC
Confidence            4456689999999999999999999999999999999999999998533221110       0000000     011110


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          563 GSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       563 ~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                       +..--..+-+++..||-.+|++|-|+.++++
T Consensus       252 -PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  252 -PEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             -hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence             1111223456667999999999999988874

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=6e-34  Score=293.55  Aligned_cols=258  Identities=28%  Similarity=0.429  Sum_probs=197.5

Q ss_pred             chhhhhhhccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhc-CCCCceeeeeeecc-
Q 006155          315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANL-QHRNLVRLLGFSLE-  391 (658)
Q Consensus       315 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~-  391 (658)
                      +...+....+.|+..+.||+|+||.||+|+. .+++.+|+|.+.... ....++..|+.++.++ +|+||+++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            3444556678899999999999999999985 457889999886543 3345678899999998 69999999999853 


Q ss_pred             -----CCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeE
Q 006155          392 -----GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPK  466 (658)
Q Consensus       392 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~k  466 (658)
                           .+..+++|||+++|+|.+++... ....+++..+..++.||++||.|||+.+   |+|+||||+||++++++.++
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence                 45779999999999999988542 2345888999999999999999999987   99999999999999999999


Q ss_pred             EeccccccccccCCCccccccccccccccCccccc-----cCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHH
Q 006155          467 IADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM-----HGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLS  541 (658)
Q Consensus       467 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~  541 (658)
                      |+|||++.......  .......|+..|+|||.+.     ...++.++||||||+++|||++|+.|+......  ... .
T Consensus       162 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~--~~~-~  236 (282)
T cd06636         162 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM--RAL-F  236 (282)
T ss_pred             EeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH--hhh-h
Confidence            99999987653221  1223457899999999875     346888999999999999999999998432211  111 1


Q ss_pred             HHHHhccCCCcccccCCCCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          542 SAWKNWREGTTVNIIDPTLSS-GSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       542 ~~~~~~~~~~~~~~~dp~l~~-~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ....         ...+.+.. ....   .+.+++..||+.||.+||++.|+++
T Consensus       237 ~~~~---------~~~~~~~~~~~~~---~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         237 LIPR---------NPPPKLKSKKWSK---KFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             hHhh---------CCCCCCcccccCH---HHHHHHHHHhCCChhhCcCHHHHhc
Confidence            1100         00111111 1112   3556778999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=7.3e-34  Score=293.60  Aligned_cols=253  Identities=25%  Similarity=0.400  Sum_probs=201.8

Q ss_pred             hhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ...+.|+..+.||+|+||.||++... ++..+++|++..... ....+.+|++++..++|+||+++++.+...+..++|+
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            35677888999999999999999865 588899999876544 4567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ||+++++|.+++....  ..+++..++.++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614          95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            9999999999995422  37999999999999999999999987   999999999999999999999999998754432


Q ss_pred             CCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCC
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT  559 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~  559 (658)
                      ..  ......++..|++||++.+..++.++||||||+++|||++|+.|+.....   ........    ........++.
T Consensus       170 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~---~~~~~~~~----~~~~~~~~~~~  240 (286)
T cd06614         170 KS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP---LRALFLIT----TKGIPPLKNPE  240 (286)
T ss_pred             hh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHH----hcCCCCCcchh
Confidence            21  22334678899999999988899999999999999999999999743221   11111111    11111111110


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          560 LSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       560 l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                         ...   ..+.+++.+|++.+|.+||++.+|++
T Consensus       241 ---~~~---~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         241 ---KWS---PEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             ---hCC---HHHHHHHHHHhccChhhCcCHHHHhh
Confidence               011   23557788999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4.5e-34  Score=296.34  Aligned_cols=262  Identities=23%  Similarity=0.318  Sum_probs=191.9

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcc--cHHHHHHHHHHHHhcC-CCCceeeeeeeccCCc-----
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQ--GDLEFKNEVLLVANLQ-HRNLVRLLGFSLEGNE-----  394 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~-----  394 (658)
                      ++|+..+.||+|+||.||+|+.. +|+.||||++......  ....+.+|+.++..++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888999999999999999854 5889999987654322  2356788999999995 6999999999877665     


Q ss_pred             eEEEEEecCCCChhhhhcCcCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCC-CCCeEEeccc
Q 006155          395 RLLIYEFVPNTSLDHFIFDPTR--RAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDA-EMTPKIADFG  471 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~-~~~~kl~DFG  471 (658)
                      .++||||+++ +|.+++.....  ...+++..++.++.||++||.|||+.+   |+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999985 78888754222  356899999999999999999999987   999999999999998 8999999999


Q ss_pred             cccccccCCCccccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCC
Q 006155          472 MARLFEMDETQGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREG  550 (658)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  550 (658)
                      +++.+.....  ......+++.|+|||++.+ ..++.++||||||+++|||++|+.|+.....  ...+.. ....+...
T Consensus       157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~--~~~~~~-~~~~~~~~  231 (295)
T cd07837         157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE--LQQLLH-IFKLLGTP  231 (295)
T ss_pred             cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH--HHHHHH-HHHHhCCC
Confidence            9986543221  1122356889999998865 4579999999999999999999998853221  111111 11111000


Q ss_pred             Ccc---ccc-------CCCCCCCC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          551 TTV---NII-------DPTLSSGS-----ITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       551 ~~~---~~~-------dp~l~~~~-----~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ...   ...       -+......     ...-..+.+++..||+.||.+||++.|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            000   000       00000000     011133567888999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=6.1e-34  Score=303.51  Aligned_cols=197  Identities=29%  Similarity=0.380  Sum_probs=166.8

Q ss_pred             hccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeeccC------
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEG------  392 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------  392 (658)
                      ..++|+..+.||+|+||.||+++. .+|+.||||++....  ......+.+|+.++.+++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            457899999999999999999984 368899999986532  23334677899999999999999999987643      


Q ss_pred             CceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccc
Q 006155          393 NERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGM  472 (658)
Q Consensus       393 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGl  472 (658)
                      ...++||||+. ++|.+.+..     .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence            35699999996 477777632     2889999999999999999999987   99999999999999999999999999


Q ss_pred             ccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCcc
Q 006155          473 ARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCF  530 (658)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~  530 (658)
                      ++......   ......++..|+|||.+.+..++.++||||||+++|+|++|+.||..
T Consensus       165 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~  219 (353)
T cd07850         165 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPG  219 (353)
T ss_pred             ceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCC
Confidence            98654322   12234678999999999999999999999999999999999999854

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=5.7e-34  Score=296.61  Aligned_cols=264  Identities=23%  Similarity=0.325  Sum_probs=195.0

Q ss_pred             hhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeeccCC----
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGN----  393 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----  393 (658)
                      ...++|+..+.||+|+||.||+|+.. +|+.||+|++.....  .....+.+|+.+++.++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45678999999999999999999865 578899999865432  23346788999999999999999999887654    


Q ss_pred             ------ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEE
Q 006155          394 ------ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKI  467 (658)
Q Consensus       394 ------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl  467 (658)
                            ..++|+||+++ +|..++..  ....+++..++.++.||+.||.|||+.+   |+||||||+||++++++.+||
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence                  78999999986 66666643  2346899999999999999999999987   999999999999999999999


Q ss_pred             eccccccccccCCCccccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHh
Q 006155          468 ADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKN  546 (658)
Q Consensus       468 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~  546 (658)
                      +|||++..+..... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+.....   .+.+......
T Consensus       158 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~---~~~~~~~~~~  233 (302)
T cd07864         158 ADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE---LAQLELISRL  233 (302)
T ss_pred             CcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHH
Confidence            99999986643321 11122356788999998865 4578999999999999999999998853322   1222222221


Q ss_pred             ccCCC---cccc--------cCC------CCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          547 WREGT---TVNI--------IDP------TLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       547 ~~~~~---~~~~--------~dp------~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .....   ...+        .++      ........-...+.+++..||+.+|++||++.+|+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             hCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11100   0000        000      000000000134567888999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.5e-33  Score=287.11  Aligned_cols=236  Identities=23%  Similarity=0.303  Sum_probs=187.8

Q ss_pred             ccccCceEEEEeEec-CCcceeEEEeccCCc---ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecCCCCh
Q 006155          332 LGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG---QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSL  407 (658)
Q Consensus       332 lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  407 (658)
                      ||.|+||.||+++.. .++.+++|.+.....   .....+.+|+.+++.++||||+++++.+.+++..++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999864 388999999865432   2345689999999999999999999999999999999999999999


Q ss_pred             hhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCcccccc
Q 006155          408 DHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSR  487 (658)
Q Consensus       408 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  487 (658)
                      .+++..   ...+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||+++......   ....
T Consensus        81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~  151 (262)
T cd05572          81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT  151 (262)
T ss_pred             HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence            999843   345899999999999999999999987   9999999999999999999999999998664432   1223


Q ss_pred             ccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCCHHH
Q 006155          488 IVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITE  567 (658)
Q Consensus       488 ~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e  567 (658)
                      ..|+..|++||++....++.++|+||||+++|||++|+.|+.....+ ...........   ..     .+......   
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~---~~-----~~~~~~~~---  219 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED-PMEIYNDILKG---NG-----KLEFPNYI---  219 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC-HHHHHHHHhcc---CC-----CCCCCccc---
Confidence            46889999999998888999999999999999999999998543321 12222211110   00     01111111   


Q ss_pred             HHHHHHHHHHhcCCCCCCCCC
Q 006155          568 MIRCIHIGLLCVQENVASRPT  588 (658)
Q Consensus       568 ~~~~~~i~~~Cl~~~p~~RPt  588 (658)
                      -..+.+++..||+.+|++||+
T Consensus       220 ~~~~~~~i~~~l~~~p~~R~~  240 (262)
T cd05572         220 DKAAKDLIKQLLRRNPEERLG  240 (262)
T ss_pred             CHHHHHHHHHHccCChhhCcC
Confidence            124567788999999999999

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.2e-34  Score=303.65  Aligned_cols=261  Identities=21%  Similarity=0.296  Sum_probs=194.1

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccC--CcccHHHHHHHHHHHHhcCCCCceeeeeeeccC-----Cc
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRD--SGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEG-----NE  394 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~  394 (658)
                      .++|...+.||+|+||.||+++. .++..||||.+...  .......+.+|+.++..++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            45788999999999999999984 45889999988653  223344677899999999999999999987644     34


Q ss_pred             eEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          395 RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      .++|+||+. ++|.+++..   ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++
T Consensus        84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            799999996 688888743   356999999999999999999999987   9999999999999999999999999998


Q ss_pred             ccccCCCccccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhcc-----
Q 006155          475 LFEMDETQGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWR-----  548 (658)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~-----  548 (658)
                      ......  .......++..|+|||.+.. ..++.++||||||+++|||++|+.||.....   ..........+.     
T Consensus       157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~  231 (337)
T cd07858         157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY---VHQLKLITELLGSPSEE  231 (337)
T ss_pred             ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHHHhCCCChH
Confidence            654322  12223467889999998865 4689999999999999999999999854321   111111111100     


Q ss_pred             ------CCCccc-------ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          549 ------EGTTVN-------IIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       549 ------~~~~~~-------~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                            .+...+       ..++.+..........+.+++.+||+.+|++|||+.++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             HhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence                  000000       00000000001112345688889999999999999999865

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=5.9e-34  Score=294.49  Aligned_cols=254  Identities=26%  Similarity=0.376  Sum_probs=191.1

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc-ccHHHHHHHHHHHHhcC-CCCceeeeeeeccCCceEEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQ-HRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      ++|...+.||+|+||.||+++.. +++.+|+|++..... .....+.+|+.++.++. |+||+++++++..+...+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            45667789999999999999854 578999999875432 33456889999999996 9999999999999999999999


Q ss_pred             ecCCCChhhhhcC--cCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccccc
Q 006155          401 FVPNTSLDHFIFD--PTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       401 ~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~  478 (658)
                      |+.. +|.++...  ......+++..+.+++.+++.||+|||+..  .++||||||+||+++.++.+||+|||+++.+..
T Consensus        84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            9864 55443211  112356899999999999999999999752  299999999999999999999999999976543


Q ss_pred             CCCccccccccccccccCccccccC---CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccc
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAMHG---QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNI  555 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  555 (658)
                      ..   ......|+..|+|||++.+.   .++.++||||||+++|||++|+.||....     .......... .+..   
T Consensus       161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~-~~~~---  228 (288)
T cd06616         161 SI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVV-KGDP---  228 (288)
T ss_pred             CC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhc-CCCC---
Confidence            22   12234688999999998776   68999999999999999999999985332     1112211111 1111   


Q ss_pred             cCCCCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          556 IDPTLSSG-SITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       556 ~dp~l~~~-~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                        |.+... .......+.+++.+||+.+|++|||+.+|++
T Consensus       229 --~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         229 --PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             --CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              111111 1111224567788999999999999999985

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=8.7e-34  Score=294.23  Aligned_cols=261  Identities=24%  Similarity=0.325  Sum_probs=192.0

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      ++|+..+.||+|++|.||+|+.. +|+.||+|++.....  .....+.+|+.++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            56888999999999999999854 688999998865432  233567899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCC-CCCeEEeccccccccccC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDA-EMTPKIADFGMARLFEMD  479 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~-~~~~kl~DFGla~~~~~~  479 (658)
                      |++ ++|.+++... ....+++.....++.||+.||.|||+.+   ++||||+|+||+++. ++.+||+|||++......
T Consensus        82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            996 5777776332 2234688889999999999999999987   999999999999985 567999999999765432


Q ss_pred             CCccccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcc-----
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTV-----  553 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-----  553 (658)
                      ..  ......+++.|+|||++.+. .++.++||||||+++|||++|+.|+.....   .+.+......+......     
T Consensus       157 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~  231 (294)
T PLN00009        157 VR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE---IDELFKIFRILGTPNEETWPGV  231 (294)
T ss_pred             cc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCChhhcccc
Confidence            11  12234678899999988664 578999999999999999999999854322   11111111111110000     


Q ss_pred             -cc-----cCCCCCCC-----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          554 -NI-----IDPTLSSG-----SITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       554 -~~-----~dp~l~~~-----~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                       .+     .-+.....     ....-..+.+++.+|++.+|++||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence             00     00000000     0011123567888999999999999999986

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=5.1e-34  Score=295.90  Aligned_cols=245  Identities=24%  Similarity=0.357  Sum_probs=194.1

Q ss_pred             ccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecCCCC
Q 006155          328 DANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTS  406 (658)
Q Consensus       328 ~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs  406 (658)
                      ...+||+|+||.||++.. .+|+.||||++..........+.+|+.+++.++|+||+++++.+..++..++||||+++++
T Consensus        24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  103 (292)
T cd06657          24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA  103 (292)
T ss_pred             hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence            346799999999999985 4688999999866555555678999999999999999999999999999999999999999


Q ss_pred             hhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCccccc
Q 006155          407 LDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTS  486 (658)
Q Consensus       407 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  486 (658)
                      |.+++.    ...+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++........  ...
T Consensus       104 L~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~  174 (292)
T cd06657         104 LTDIVT----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRK  174 (292)
T ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--ccc
Confidence            999873    235899999999999999999999987   99999999999999999999999999875543221  223


Q ss_pred             cccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCCHH
Q 006155          487 RIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSIT  566 (658)
Q Consensus       487 ~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~  566 (658)
                      ...|+..|+|||++.+..++.++||||||+++|||++|+.|+.....   ...+......+.    ..+  +.+. ....
T Consensus       175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~---~~~~~~~~~~~~----~~~--~~~~-~~~~  244 (292)
T cd06657         175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMIRDNLP----PKL--KNLH-KVSP  244 (292)
T ss_pred             ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhhCC----ccc--CCcc-cCCH
Confidence            35688999999999888899999999999999999999999743221   111111111110    000  0000 1111


Q ss_pred             HHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          567 EMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       567 e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                         .+.+++.+||+.+|.+||++.++++
T Consensus       245 ---~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         245 ---SLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             ---HHHHHHHHHHhCCcccCcCHHHHhc
Confidence               2446677999999999999999886

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-34  Score=293.75  Aligned_cols=248  Identities=24%  Similarity=0.352  Sum_probs=204.5

Q ss_pred             ccCCcccCcccccCceEEEEeE-ecCCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ..-|...+.||+|.|..|-+++ ...|..||||++.+..-  -....+..|+.-|+-++|||||+|+.+......+|||+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            4567788899999999999987 45899999999977532  23446889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceee-CCCCCeEEecccccccccc
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLL-DAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl-~~~~~~kl~DFGla~~~~~  478 (658)
                      |.-.+|+|.+||....  ..+.+....+++.||+.|+.|+|+.+   +|||||||+||.+ .+-|-+||.|||++..|.+
T Consensus        97 ELGD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             EecCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            9999999999996533  45899999999999999999999887   9999999999865 5678999999999998877


Q ss_pred             CCCccccccccccccccCccccccCCCC-cccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccC
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAMHGQYS-VKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID  557 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  557 (658)
                      ++.   ....+|+..|-|||++.+..|. +.+||||+|||||.|++|+.||...++.               +.+..++|
T Consensus       172 G~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS---------------ETLTmImD  233 (864)
T KOG4717|consen  172 GKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS---------------ETLTMIMD  233 (864)
T ss_pred             cch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch---------------hhhhhhhc
Confidence            653   3457999999999999999886 5799999999999999999999544332               22233444


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          558 PTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       558 p~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ....- +..--..|.+++..||+.||.+|-+.+||+.
T Consensus       234 CKYtv-PshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  234 CKYTV-PSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             ccccC-chhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            33211 1112235667888999999999999999984

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.1e-33  Score=293.74  Aligned_cols=258  Identities=17%  Similarity=0.203  Sum_probs=181.7

Q ss_pred             hhccCCcccCcccccCceEEEEeEecCC----cceeEEEeccCCcccHH-----------HHHHHHHHHHhcCCCCceee
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLYDG----AEIAVKRLSRDSGQGDL-----------EFKNEVLLVANLQHRNLVRL  385 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g----~~vavK~l~~~~~~~~~-----------~~~~E~~~l~~l~H~niv~l  385 (658)
                      +..++|.+.++||+|+||.||+|+..++    ..+|+|...........           ....+...+..++|+||+++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   88 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY   88 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence            4457899999999999999999986543    45566654322211111           11223344556789999999


Q ss_pred             eeeeccCC----ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCC
Q 006155          386 LGFSLEGN----ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDA  461 (658)
Q Consensus       386 ~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~  461 (658)
                      ++++....    ..++++|++.. ++.+.+.   .....++..+..++.|+++||.|||+.+   |+||||||+|||++.
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~  161 (294)
T PHA02882         89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFK---RIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDG  161 (294)
T ss_pred             EEeeeEecCCceEEEEEEehhcc-CHHHHHH---hhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcC
Confidence            99765543    33677777643 5555552   2233578889999999999999999987   999999999999999


Q ss_pred             CCCeEEeccccccccccCCCc-----cccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCc
Q 006155          462 EMTPKIADFGMARLFEMDETQ-----GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETV  536 (658)
Q Consensus       462 ~~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~  536 (658)
                      ++.++|+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||......  
T Consensus       162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~--  239 (294)
T PHA02882        162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN--  239 (294)
T ss_pred             CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc--
Confidence            999999999999876432211     1122347999999999999999999999999999999999999999644221  


Q ss_pred             chHHHHH----HHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 006155          537 EDLLSSA----WKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN  597 (658)
Q Consensus       537 ~~l~~~~----~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~  597 (658)
                      .+++...    +.....+..    .   ......+   +.+++..|++.+|++||++.++++.|+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~----~---~~~~~~~---~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        240 GNLIHAAKCDFIKRLHEGKI----K---IKNANKF---IYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             hHHHHHhHHHHHHHhhhhhh----c---cCCCCHH---HHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            1222211    111111110    0   0112223   446677899999999999999998874

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=6.7e-34  Score=292.84  Aligned_cols=256  Identities=22%  Similarity=0.304  Sum_probs=190.1

Q ss_pred             CcccCcccccCceEEEEeEec-CCcceeEEEeccCCc-ccHHHHHHHHHHHHhcC-CCCceeeeeeeccC--CceEEEEE
Q 006155          326 FSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQ-HRNLVRLLGFSLEG--NERLLIYE  400 (658)
Q Consensus       326 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~lv~e  400 (658)
                      |...++||+|+||.||+++.. +++.||+|+++.... .......+|+..+.++. |+||+++++++.++  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            566789999999999999854 688999999875422 22234567888898885 99999999999887  88999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      |++ ++|.+++..  ....++|..++.++.||+.||.|||+.+   ++||||||+||+++. +.+||+|||+++.+....
T Consensus        81 ~~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          81 LMD-MNLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             cCC-ccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            997 577777743  2346899999999999999999999987   999999999999999 999999999998654322


Q ss_pred             CccccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHH-----------hcc
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWK-----------NWR  548 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~-----------~~~  548 (658)
                      .   .....++..|+|||++.. +.++.++|||||||++|||++|+.|+.....   .+.+.....           ...
T Consensus       154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  227 (282)
T cd07831         154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE---LDQIAKIHDVLGTPDAEVLKKFR  227 (282)
T ss_pred             C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH---HHHHHHHHHHcCCCCHHHHHhhc
Confidence            1   123467889999997654 5578899999999999999999999854322   111111111           111


Q ss_pred             CCCcccccCCCCCCCC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          549 EGTTVNIIDPTLSSGS-----ITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       549 ~~~~~~~~dp~l~~~~-----~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .........+......     ......+.+++..||+.+|++||++.++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            1111111111111100     111245678889999999999999999985

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=7e-34  Score=292.73  Aligned_cols=258  Identities=24%  Similarity=0.345  Sum_probs=196.1

Q ss_pred             CcccCcccccCceEEEEeEec-CCcceeEEEeccCCcc--cHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEec
Q 006155          326 FSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQ--GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFV  402 (658)
Q Consensus       326 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  402 (658)
                      |...+.||+|++|.||+++.. +|+.+++|++......  ....+.+|+.++++++|+||+++++++..++..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            456788999999999999854 6888999998765333  3456888999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCc
Q 006155          403 PNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ  482 (658)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  482 (658)
                      ++ +|.+++...  ...+++..+..++.+|+.||.|||+.+   ++|+||||+||+++.++.++|+|||.+..+....  
T Consensus        81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--  152 (283)
T cd05118          81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--  152 (283)
T ss_pred             CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence            75 887777442  257899999999999999999999987   9999999999999999999999999998765433  


Q ss_pred             cccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCC---cccccC-
Q 006155          483 GNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGT---TVNIID-  557 (658)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~d-  557 (658)
                      .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||.....   .+.+......+....   .....+ 
T Consensus       153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd05118         153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE---IDQLFKIFRTLGTPDPEVWPKFTSL  229 (283)
T ss_pred             ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHcCCCchHhcccchhh
Confidence            112234678899999998876 789999999999999999999988743322   112211111111100   000000 


Q ss_pred             --------CCCCCCCHH-----HHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          558 --------PTLSSGSIT-----EMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       558 --------p~l~~~~~~-----e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                              +........     --..+.+++..||+.||.+||++++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                    000000111     1235668899999999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-34  Score=306.08  Aligned_cols=203  Identities=29%  Similarity=0.473  Sum_probs=176.3

Q ss_pred             CCcccCcccccCceEEEEeE-ecCCcceeEEEeccCCcc-cHHHHHHHHHHHHhcCCCCceeeeeeeccCC------ceE
Q 006155          325 NFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQ-GDLEFKNEVLLVANLQHRNLVRLLGFSLEGN------ERL  396 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~  396 (658)
                      .+...+.||+|+||.||+|+ ...|+.||||.+...... ..+....|+++|++++|+|||++++.-.+..      ...
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            34566789999999999999 557999999999775433 3345789999999999999999999866544      668


Q ss_pred             EEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeC--CCC--CeEEecccc
Q 006155          397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLD--AEM--TPKIADFGM  472 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~--~~~--~~kl~DFGl  472 (658)
                      +|||||.+|||+..|.++.+...|++.+.+.++.++..||.|||+++   ||||||||.||++-  ++|  --||+|||.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            99999999999999999999999999999999999999999999988   99999999999983  334  359999999


Q ss_pred             ccccccCCCccccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCC
Q 006155          473 ARLFEMDETQGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNG  533 (658)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~  533 (658)
                      |+.++.+.   .....+||..|.+||+... +.|+..+|.|||||++||+.||..||.....
T Consensus       171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~  229 (732)
T KOG4250|consen  171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG  229 (732)
T ss_pred             cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence            99877654   4556899999999999984 8899999999999999999999999964443

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.6e-33  Score=289.78  Aligned_cols=241  Identities=25%  Similarity=0.322  Sum_probs=186.1

Q ss_pred             ccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecCCCCh
Q 006155          332 LGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSL  407 (658)
Q Consensus       332 lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  407 (658)
                      ||+|+||+||++... +|+.+|+|.+....   ......+.+|+.+++.++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999743 58899999886532   12233467899999999999999999999999999999999999999


Q ss_pred             hhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCcccccc
Q 006155          408 DHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSR  487 (658)
Q Consensus       408 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  487 (658)
                      .+++.... ...+++..++.++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++.......   ....
T Consensus        81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~  153 (277)
T cd05577          81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG  153 (277)
T ss_pred             HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence            99985432 246899999999999999999999987   9999999999999999999999999987654321   1223


Q ss_pred             ccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCCHHH
Q 006155          488 IVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITE  567 (658)
Q Consensus       488 ~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e  567 (658)
                      ..++..|+|||++.++.++.++||||||++++||++|+.||...........+.   ..... .     .........+ 
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~-~-----~~~~~~~~~~-  223 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK---RRTLE-M-----AVEYPDKFSP-  223 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH---hcccc-c-----cccCCccCCH-
Confidence            467889999999988889999999999999999999999985433211111111   11000 0     0111111112 


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCHHH
Q 006155          568 MIRCIHIGLLCVQENVASRPTMAS  591 (658)
Q Consensus       568 ~~~~~~i~~~Cl~~~p~~RPtm~e  591 (658)
                        .+.+++..||+.+|++||+..+
T Consensus       224 --~~~~li~~~l~~~p~~R~~~~~  245 (277)
T cd05577         224 --EAKDLCEALLQKDPEKRLGCRG  245 (277)
T ss_pred             --HHHHHHHHHccCChhHccCCCc
Confidence              3446778999999999994444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.6e-33  Score=295.69  Aligned_cols=248  Identities=29%  Similarity=0.407  Sum_probs=192.5

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc---ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG---QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      +.|...+.||+|+||.||+++.. ++..||+|++.....   .....+.+|+.++++++|||++++++++.+++..++||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            34777889999999999999854 578999999865422   22346888999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ||+++ +|.+++..  ....++|..+..++.+|+.||.|||+.+   ++||||+|+||+++.++.+||+|||++..... 
T Consensus       105 e~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-  177 (317)
T cd06635         105 EYCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP-  177 (317)
T ss_pred             eCCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence            99974 77666643  2346899999999999999999999987   99999999999999999999999999875432 


Q ss_pred             CCccccccccccccccCccccc---cCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccccc
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAM---HGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNII  556 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  556 (658)
                           .....|+..|+|||++.   .+.++.++||||||+++|||++|+.|+....   ....+...    ..+..    
T Consensus       178 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~---~~~~~~~~----~~~~~----  241 (317)
T cd06635         178 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSALYHI----AQNES----  241 (317)
T ss_pred             -----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc---HHHHHHHH----HhccC----
Confidence                 22346888999999974   4678999999999999999999999874321   11111111    11110    


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 006155          557 DPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN  597 (658)
Q Consensus       557 dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~  597 (658)
                       +......  ....+.+++.+||+.+|.+||++.+|++.+-
T Consensus       242 -~~~~~~~--~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~  279 (317)
T cd06635         242 -PTLQSNE--WSDYFRNFVDSCLQKIPQDRPTSEELLKHMF  279 (317)
T ss_pred             -CCCCCcc--ccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence             1111111  1123457778999999999999999997653

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2.5e-33  Score=283.86  Aligned_cols=250  Identities=23%  Similarity=0.367  Sum_probs=201.6

Q ss_pred             CCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          325 NFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      +|...+.||+|+||.||++... ++..+++|++.....  ....++.+|+++++.++|+|++++++.+..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4778889999999999999854 588999999876543  4456688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          402 VPNTSLDHFIFDPT-RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       402 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      +++++|.+++.... ....+++..+..++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999985421 2367999999999999999999999987   9999999999999999999999999998765432


Q ss_pred             CccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCC
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTL  560 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l  560 (658)
                        .......|++.|+|||.+.+..++.++||||||+++|+|++|+.|+....   ...+.....    ....     +.+
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~---~~~~~~~~~----~~~~-----~~~  223 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN---LLELALKIL----KGQY-----PPI  223 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc---HHHHHHHHh----cCCC-----CCC
Confidence              12233578899999999999999999999999999999999999984332   222222211    1111     111


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          561 SSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       561 ~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .....   ..+.+++.+||+.+|++||++.++++
T Consensus       224 ~~~~~---~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         224 PSQYS---SELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CCCCC---HHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            11111   23456778999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=4.5e-34  Score=290.76  Aligned_cols=247  Identities=23%  Similarity=0.316  Sum_probs=194.6

Q ss_pred             ccccCceEEEEeEecC-CcceeEEEeccCCc---ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecCCCCh
Q 006155          332 LGQGGFGAVYKGRLYD-GAEIAVKRLSRDSG---QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSL  407 (658)
Q Consensus       332 lG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  407 (658)
                      ||+|+||.||+++..+ |+.+++|.+.....   .....+.+|+.++.+++||||+++++.+..++..++|+||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999764 88999999866533   3445688999999999999999999999999999999999999999


Q ss_pred             hhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC------
Q 006155          408 DHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET------  481 (658)
Q Consensus       408 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~------  481 (658)
                      .+++..   ...+++..+.+++.||++||.|||+.+   ++|+||+|+||++++++.++|+|||++........      
T Consensus        81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            999853   236899999999999999999999987   99999999999999999999999999875433211      


Q ss_pred             ccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCC
Q 006155          482 QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLS  561 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~  561 (658)
                      ........++..|++||.+.....+.++||||||+++|||++|+.|+....   ........    ..+..    .+  .
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~---~~~~~~~~----~~~~~----~~--~  221 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET---PEEIFQNI----LNGKI----EW--P  221 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC---HHHHHHHH----hcCCc----CC--C
Confidence            112234567889999999988889999999999999999999999985332   12222111    11110    00  0


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          562 SGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       562 ~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      ... .....+.+++..|++.+|++|||+.+|.+.|+.
T Consensus       222 ~~~-~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~  257 (265)
T cd05579         222 EDV-EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH  257 (265)
T ss_pred             ccc-cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence            000 001234577789999999999999888877764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-34  Score=320.13  Aligned_cols=264  Identities=27%  Similarity=0.377  Sum_probs=206.0

Q ss_pred             hhhhhccCCcccCcccccCceEEEEeEecC--------CcceeEEEeccCCcc-cHHHHHHHHHHHHhc-CCCCceeeee
Q 006155          318 TIRVATDNFSDANKLGQGGFGAVYKGRLYD--------GAEIAVKRLSRDSGQ-GDLEFKNEVLLVANL-QHRNLVRLLG  387 (658)
Q Consensus       318 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~--------g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l-~H~niv~l~~  387 (658)
                      .++...++....+.||+|.||.|++|....        ...||||.++..... ....+..|+++|..+ +|+||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            456666777777799999999999997431        346899999876444 455689999999999 5999999999


Q ss_pred             eeccCCceEEEEEecCCCChhhhhcCcC-----C------C--CCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCC
Q 006155          388 FSLEGNERLLIYEFVPNTSLDHFIFDPT-----R------R--AQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKT  454 (658)
Q Consensus       388 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----~------~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~  454 (658)
                      +|.++...++|+||+..|+|.++|....     .      .  ..++....+.++.|||.||+||++..   +|||||..
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence            9999999999999999999999996533     0      0  24899999999999999999999987   99999999


Q ss_pred             CceeeCCCCCeEEeccccccccccCCCcccccccc--ccccccCccccccCCCCcccccccccchHhHHHhCC-CCCccC
Q 006155          455 SNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIV--GTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ-RNNCFR  531 (658)
Q Consensus       455 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~-~p~~~~  531 (658)
                      +|||+.++..+||+|||+++........... ...  -...|||||.+....|+.|+|||||||+||||+|.. .|+.. 
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~-  524 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG-  524 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC-
Confidence            9999999999999999999965543332211 112  345699999999999999999999999999999954 45422 


Q ss_pred             CCCCcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          532 NGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       532 ~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                       -....++.+    .+++|...+.  |..   ..   .++.+|+..||+.+|++||++.++++.|+..
T Consensus       525 -~~~~~~l~~----~l~~G~r~~~--P~~---c~---~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  525 -IPPTEELLE----FLKEGNRMEQ--PEH---CS---DEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             -CCcHHHHHH----HHhcCCCCCC--CCC---CC---HHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence             111233333    3334432222  211   22   2455788899999999999999999999873

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-33  Score=313.27  Aligned_cols=201  Identities=22%  Similarity=0.390  Sum_probs=158.7

Q ss_pred             hccCCcccCcccccCceEEEEeEecC--CcceeEE------------------EeccCCcccHHHHHHHHHHHHhcCCCC
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLYD--GAEIAVK------------------RLSRDSGQGDLEFKNEVLLVANLQHRN  381 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~~--g~~vavK------------------~l~~~~~~~~~~~~~E~~~l~~l~H~n  381 (658)
                      ..++|++.++||+|+||+||++....  +...++|                  ++.. .......+.+|+.++.+++|||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCC
Confidence            45789999999999999999986432  2222222                  1111 1123345789999999999999


Q ss_pred             ceeeeeeeccCCceEEEEEecCCCChhhhhcCcCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceee
Q 006155          382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTR--RAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLL  459 (658)
Q Consensus       382 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl  459 (658)
                      |+++++++...+..++|+|++. ++|..++.....  ...........|+.||+.||.|||+.+   ||||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence            9999999999999999999985 566666643211  122345667789999999999999987   9999999999999


Q ss_pred             CCCCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCC
Q 006155          460 DAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNN  528 (658)
Q Consensus       460 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~  528 (658)
                      +.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|+.++
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p  368 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP  368 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            9999999999999987654322 1223467999999999999999999999999999999999998643

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.2e-33  Score=298.85  Aligned_cols=266  Identities=21%  Similarity=0.310  Sum_probs=195.1

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeecc----CCce
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLE----GNER  395 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~  395 (658)
                      .++|+..+.||+|+||.||+++.. +|..||+|++.....  .....+.+|+.++.+++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            378899999999999999999854 588999999876422  334567789999999999999999998753    3467


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ++|+||+. ++|.+++..   ...+++..+..++.||++||.|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence            99999995 689888843   345899999999999999999999987   99999999999999999999999999976


Q ss_pred             cccCCCc--cccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHH--------HH
Q 006155          476 FEMDETQ--GNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSS--------AW  544 (658)
Q Consensus       476 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~--------~~  544 (658)
                      .......  .......|+..|+|||++.+ ..++.++||||||+++|||++|+.||...........+..        .+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence            5432211  11234578999999998865 4689999999999999999999999854322111000000        00


Q ss_pred             HhccCCCcccccC--CCCCCCCH-----HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          545 KNWREGTTVNIID--PTLSSGSI-----TEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       545 ~~~~~~~~~~~~d--p~l~~~~~-----~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                      .........+..+  +.......     .....+.+++..|++.+|++||++.+++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            0000011101000  00000011     112346678889999999999999998863

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=4.6e-34  Score=304.21  Aligned_cols=200  Identities=27%  Similarity=0.355  Sum_probs=169.0

Q ss_pred             hccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhcC-C-----CCceeeeeeeccCCc
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQ-H-----RNLVRLLGFSLEGNE  394 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~~~~~~~~~  394 (658)
                      ..-+|.+.+.||+|.||.|.++.. ..++.||||++++..... .+-..|+.+|..|+ |     -|+|++++++...++
T Consensus       184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~-~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H  262 (586)
T KOG0667|consen  184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFL-RQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH  262 (586)
T ss_pred             eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHH-HHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence            344889999999999999999974 458999999998764332 34477999999996 4     389999999999999


Q ss_pred             eEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCC--CCeEEecccc
Q 006155          395 RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE--MTPKIADFGM  472 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~--~~~kl~DFGl  472 (658)
                      .+||+|.+ ..+|.++|... +...++...++.++.||+.||.+||+.+   |||+||||+||||.+-  ..+||+|||+
T Consensus       263 lciVfELL-~~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGS  337 (586)
T KOG0667|consen  263 LCIVFELL-STNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGS  337 (586)
T ss_pred             eeeeehhh-hhhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccc
Confidence            99999988 67999999653 3456999999999999999999999887   9999999999999653  4799999999


Q ss_pred             ccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCC
Q 006155          473 ARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRN  532 (658)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~  532 (658)
                      +......-    . ..+-+.-|.|||++.+.+|+.+.|+||||||+.||++|.+.|...+
T Consensus       338 Sc~~~q~v----y-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n  392 (586)
T KOG0667|consen  338 SCFESQRV----Y-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN  392 (586)
T ss_pred             ccccCCcc----e-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence            98643221    1 4566789999999999999999999999999999999987764433

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-33  Score=288.03  Aligned_cols=245  Identities=20%  Similarity=0.232  Sum_probs=187.0

Q ss_pred             CcccccCceEEEEeEec-CCcceeEEEeccCCcc---cHHHHHHHHHH-HHhcCCCCceeeeeeeccCCceEEEEEecCC
Q 006155          330 NKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQ---GDLEFKNEVLL-VANLQHRNLVRLLGFSLEGNERLLIYEFVPN  404 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  404 (658)
                      +.||+|+||.||+++.. +|+.||||.+......   ....+..|..+ ....+|+||+++++++..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56999999999999853 5889999998654321   12233445444 3445899999999999999999999999999


Q ss_pred             CChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCccc
Q 006155          405 TSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN  484 (658)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~  484 (658)
                      ++|.+++..   ...+++..+..++.||+.||.|||+.+   ++||||+|+||+++.++.+||+|||+++....      
T Consensus        82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------  149 (260)
T cd05611          82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------  149 (260)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence            999999843   346899999999999999999999987   99999999999999999999999999875432      


Q ss_pred             cccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCC
Q 006155          485 TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGS  564 (658)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~  564 (658)
                      .....|+..|+|||.+.+..++.++||||||+++|||++|+.|+.....   .......    ..+...  ..+......
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~----~~~~~~--~~~~~~~~~  220 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP---DAVFDNI----LSRRIN--WPEEVKEFC  220 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH---HHHHHHH----HhcccC--CCCcccccC
Confidence            2234688899999999888899999999999999999999999853221   2221111    111100  000111111


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          565 ITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       565 ~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      .   ..+.+++..||+.+|++||++.++.+.|+.
T Consensus       221 ~---~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~  251 (260)
T cd05611         221 S---PEAVDLINRLLCMDPAKRLGANGYQEIKSH  251 (260)
T ss_pred             C---HHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence            1   234577789999999999998877777754

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.5e-33  Score=285.68  Aligned_cols=249  Identities=28%  Similarity=0.403  Sum_probs=199.7

Q ss_pred             CCcccCcccccCceEEEEeEec-CCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          325 NFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      +|+..++||+|+||.||+++.. +++.+++|.+....  .....++.+|+.++++++|+||+++++++.++...++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4778899999999999999744 67889999987543  23345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          402 VPNTSLDHFIFDP-TRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       402 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      +++++|.+++... .....+++..++.++.+++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999999988542 22356899999999999999999999987   999999999999999999999999999876543 


Q ss_pred             CccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCC
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTL  560 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l  560 (658)
                         ......++..|++||.+.+..++.++|+||||+++|||++|+.|+....   ...+....    ..+....     +
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~---~~~~~~~~----~~~~~~~-----~  221 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS---MQDLRYKV----QRGKYPP-----I  221 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHH----hcCCCCC-----C
Confidence               1223467889999999999999999999999999999999999985332   22222211    1111111     1


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          561 SSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       561 ~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                      .   ......+..++..|++.+|++||++.++++.
T Consensus       222 ~---~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         222 P---PIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             c---hhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            1   1122346678889999999999999999853

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2e-33  Score=289.53  Aligned_cols=242  Identities=23%  Similarity=0.294  Sum_probs=182.8

Q ss_pred             cccccCceEEEEeEec-CCcceeEEEeccCCcc---cHHHHHHHHHHH---HhcCCCCceeeeeeeccCCceEEEEEecC
Q 006155          331 KLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQ---GDLEFKNEVLLV---ANLQHRNLVRLLGFSLEGNERLLIYEFVP  403 (658)
Q Consensus       331 ~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~~l---~~l~H~niv~l~~~~~~~~~~~lv~e~~~  403 (658)
                      .||+|+||.||++... +++.+|+|.+......   ....+.+|..++   ...+||||+.+++++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999854 5889999988654221   122334444433   33479999999999999999999999999


Q ss_pred             CCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCcc
Q 006155          404 NTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQG  483 (658)
Q Consensus       404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  483 (658)
                      +++|.+++..   ...++|..+..++.|++.||.|||+.+   |+||||||+|||+++++.++|+|||++..+....   
T Consensus        81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---  151 (279)
T cd05633          81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (279)
T ss_pred             CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence            9999998843   346999999999999999999999988   9999999999999999999999999987553321   


Q ss_pred             ccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCC
Q 006155          484 NTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSS  562 (658)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~  562 (658)
                       .....|+..|+|||.+.+ ..++.++||||||+++|||++|+.||..........+ .....         ...+.+..
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~~---------~~~~~~~~  220 (279)
T cd05633         152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-DRMTL---------TVNVELPD  220 (279)
T ss_pred             -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH-HHHhh---------cCCcCCcc
Confidence             123468999999998864 4589999999999999999999999854332222111 11100         01112221


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 006155          563 GSITEMIRCIHIGLLCVQENVASRP-----TMASVVLM  595 (658)
Q Consensus       563 ~~~~e~~~~~~i~~~Cl~~~p~~RP-----tm~evv~~  595 (658)
                      ....   .+.+++..||+.||++||     +++++++.
T Consensus       221 ~~~~---~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         221 SFSP---ELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             ccCH---HHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            2222   344566799999999999     58888764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=5.5e-34  Score=297.79  Aligned_cols=263  Identities=22%  Similarity=0.315  Sum_probs=192.9

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcc--cHHHHHHHHHHHHhcCCCCceeeeeeeccCC------
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQ--GDLEFKNEVLLVANLQHRNLVRLLGFSLEGN------  393 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------  393 (658)
                      .++|+..++||+|+||.||+|+.. +++.+|||++......  ....+.+|+++++.++||||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            578999999999999999999854 5889999988654322  2345788999999999999999999875443      


Q ss_pred             --ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccc
Q 006155          394 --ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFG  471 (658)
Q Consensus       394 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFG  471 (658)
                        ..++|+||+.+ +|...+..  ....+++..+..++.||++||.|||+.+   ++|+||||+||++++++.+||+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence              45899999975 56666643  2346999999999999999999999988   9999999999999999999999999


Q ss_pred             cccccccCCCcc---------ccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHH
Q 006155          472 MARLFEMDETQG---------NTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLS  541 (658)
Q Consensus       472 la~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~  541 (658)
                      +++.........         ......|++.|+|||++.+. .++.++||||||+++|||++|+.|+......   +...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~---~~~~  237 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI---DQLH  237 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH---HHHH
Confidence            998654322111         11234678899999987654 5889999999999999999999988533322   2222


Q ss_pred             HHHHhccCCCc---------cc----ccCCCCCCCCH----HHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          542 SAWKNWREGTT---------VN----IIDPTLSSGSI----TEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       542 ~~~~~~~~~~~---------~~----~~dp~l~~~~~----~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ..+..+.....         ..    ...+.......    .....+.+++.+|++.||++|||+.|++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            22211110000         00    00011110000    11134668889999999999999999874

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-33  Score=283.88  Aligned_cols=247  Identities=28%  Similarity=0.436  Sum_probs=198.2

Q ss_pred             CCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          325 NFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      +|+..+.||+|++|.||+++.. +++.+++|.+.....  .....+.+|++++.+++|+|++++++++.+++..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4777899999999999999854 578899999877643  3445689999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      +++++|.+++..   ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            999999999843   357899999999999999999999987   99999999999999999999999999987654322


Q ss_pred             ccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCC
Q 006155          482 QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLS  561 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~  561 (658)
                      .  .....++..|+|||...+..++.++||||||+++|||++|+.|+....  ..    ...+.... ..     .+.+.
T Consensus       155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~--~~----~~~~~~~~-~~-----~~~~~  220 (254)
T cd06627         155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN--PM----AALFRIVQ-DD-----HPPLP  220 (254)
T ss_pred             c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc--HH----HHHHHHhc-cC-----CCCCC
Confidence            1  233568899999999988889999999999999999999999874322  11    11111111 11     01111


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          562 SGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       562 ~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ....   ..+..++.+|++.+|++||++.+++.
T Consensus       221 ~~~~---~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         221 EGIS---PELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCC---HHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            1111   23446778999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-33  Score=290.01  Aligned_cols=259  Identities=25%  Similarity=0.338  Sum_probs=193.3

Q ss_pred             CcccCcccccCceEEEEeEec-CCcceeEEEeccCCc-ccHHHHHHHHHHHHhcC-CCCceeeeeeeccCCceEEEEEec
Q 006155          326 FSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQ-HRNLVRLLGFSLEGNERLLIYEFV  402 (658)
Q Consensus       326 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~  402 (658)
                      |...+.||+|+||+||+|+.. +++.|+||++..... .......+|+..+.+++ |+||+++++++.+++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            566789999999999999965 478899999866432 22334567999999999 999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCc
Q 006155          403 PNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ  482 (658)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  482 (658)
                       +++|.+++.... ...++|..+..++.|++++|.|||+.+   ++|+||+|+||+++.++.++|+|||++........ 
T Consensus        81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-  154 (283)
T cd07830          81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-  154 (283)
T ss_pred             -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence             889988875422 246899999999999999999999987   99999999999999999999999999976543221 


Q ss_pred             cccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHh--------ccCCC-c
Q 006155          483 GNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKN--------WREGT-T  552 (658)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~--------~~~~~-~  552 (658)
                        .....++..|+|||++.. ..++.++|+||||+++|||++|+.|+......+   ........        |.++. .
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd07830         155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID---QLYKICSVLGTPTKQDWPEGYKL  229 (283)
T ss_pred             --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH---HHHHHHHhcCCCChhhhhhHhhh
Confidence              223467889999998754 558999999999999999999998875432211   11100000        00000 0


Q ss_pred             ccccCCCCC---CCCH-----HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          553 VNIIDPTLS---SGSI-----TEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       553 ~~~~dp~l~---~~~~-----~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                      ...++..+.   ....     .....+.+++.+||+.+|++|||+.|++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            000000000   0001     112456788999999999999999999753

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-35  Score=303.52  Aligned_cols=251  Identities=25%  Similarity=0.378  Sum_probs=199.4

Q ss_pred             cCCcccCcccccCceEEEEeEecCC-cceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEec
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLYDG-AEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFV  402 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~~g-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  402 (658)
                      +-|.++..||.|.||.||+++..+. -..|.|.+...+.+...+|.-|+++|+..+||+||+|++.+...+.++++.|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            4456777899999999999985543 334778887777777888999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCc
Q 006155          403 PNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ  482 (658)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  482 (658)
                      .||-.+.++..  -.+.|++.++.-+.++++.||.|||++.   |||||||+.|||++-+|.++|+|||.+-...  .+.
T Consensus       112 ~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~  184 (1187)
T KOG0579|consen  112 GGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STR  184 (1187)
T ss_pred             CCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch--hHH
Confidence            99999998854  3467999999999999999999999998   9999999999999999999999999975422  122


Q ss_pred             cccccccccccccCccccc-----cCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccC
Q 006155          483 GNTSRIVGTYGYMAPEYAM-----HGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID  557 (658)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  557 (658)
                      .......|||.|||||+.+     ..+|+.++||||||+.|.||..+.+|-...+   ...++..+    .+....-++.
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln---pMRVllKi----aKSePPTLlq  257 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN---PMRVLLKI----AKSEPPTLLQ  257 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc---hHHHHHHH----hhcCCCcccC
Confidence            3345689999999999874     5679999999999999999999998853222   11222111    2222333333


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          558 PTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       558 p~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      |+--...      +-++...||..||..||++.++++
T Consensus       258 PS~Ws~~------F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  258 PSHWSRS------FSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             cchhhhH------HHHHHHHHHhcCCccCCCHHHHhh
Confidence            3332222      334555899999999999999874

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-34  Score=290.47  Aligned_cols=205  Identities=29%  Similarity=0.412  Sum_probs=179.7

Q ss_pred             hhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceE
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERL  396 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  396 (658)
                      +..+.|..-++||+||||.||-.+.. .|+-+|.|++.+..   .++..--.+|-.++.+++.+.||.+-..+...+.++
T Consensus       182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC  261 (591)
T KOG0986|consen  182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC  261 (591)
T ss_pred             ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence            44577889999999999999998754 58889999886542   233444678999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccc
Q 006155          397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF  476 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~  476 (658)
                      ||+..|.||+|.-+|.+... ..+++..++.++.+|+.||++||+..   ||.|||||+|||||+.|+++|+|+|||..+
T Consensus       262 lVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei  337 (591)
T KOG0986|consen  262 LVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEI  337 (591)
T ss_pred             EEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEec
Confidence            99999999999999976543 57999999999999999999999987   999999999999999999999999999887


Q ss_pred             ccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCC
Q 006155          477 EMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRN  532 (658)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~  532 (658)
                      ..++..   ...+||.||||||++.++.|+...|+||+||+||||+.|+.||....
T Consensus       338 ~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K  390 (591)
T KOG0986|consen  338 PEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK  390 (591)
T ss_pred             CCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh
Confidence            655432   23499999999999999999999999999999999999999995433

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-33  Score=287.14  Aligned_cols=258  Identities=24%  Similarity=0.374  Sum_probs=191.1

Q ss_pred             CcccCcccccCceEEEEeEecC-CcceeEEEeccCCcc--cHHHHHHHHHHHHhc---CCCCceeeeeeeccCCc-----
Q 006155          326 FSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQ--GDLEFKNEVLLVANL---QHRNLVRLLGFSLEGNE-----  394 (658)
Q Consensus       326 ~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~-----  394 (658)
                      |+..+.||+|+||.||+|+... ++.+|+|++......  ....+.+|+.++.++   +|+||+++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            5667899999999999999654 889999998754322  223466787777666   59999999999987776     


Q ss_pred             eEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          395 RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      .+++|||+++ +|.+++.... ...++|..++.++.|+++||.|||+.+   ++|+||+|+||+++.++.+||+|||++.
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence            8999999974 7888874322 235899999999999999999999987   9999999999999999999999999998


Q ss_pred             ccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          475 LFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      .+.....   .....++..|+|||++.+..++.++||||||+++|||++|+.|+.....   .+.+..............
T Consensus       156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  229 (287)
T cd07838         156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE---ADQLDKIFDVIGLPSEEE  229 (287)
T ss_pred             eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh---HHHHHHHHHHcCCCChHh
Confidence            7643321   1234578899999999999999999999999999999999888753222   222222211110000000


Q ss_pred             cc------C---CCCCCCC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          555 II------D---PTLSSGS-----ITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       555 ~~------d---p~l~~~~-----~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ..      .   +......     ..-...+.+++.+||+.||++||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            00      0   0000001     111234567889999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.3e-33  Score=290.19  Aligned_cols=254  Identities=24%  Similarity=0.307  Sum_probs=196.8

Q ss_pred             CCcccCcccccCceEEEEeEe----cCCcceeEEEeccCC----cccHHHHHHHHHHHHhc-CCCCceeeeeeeccCCce
Q 006155          325 NFSDANKLGQGGFGAVYKGRL----YDGAEIAVKRLSRDS----GQGDLEFKNEVLLVANL-QHRNLVRLLGFSLEGNER  395 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~  395 (658)
                      +|+..+.||+|+||.||+++.    .++..||||.+....    ......+.+|+.++.++ +||||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            467788999999999999874    356789999886432    12234578899999999 599999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ++||||+++++|.+++..   ...+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.++|+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence            999999999999998843   346899999999999999999999987   99999999999999999999999999876


Q ss_pred             cccCCCccccccccccccccCccccccCC--CCcccccccccchHhHHHhCCCCCccCCCCC-cchHHHHHHHhccCCCc
Q 006155          476 FEMDETQGNTSRIVGTYGYMAPEYAMHGQ--YSVKSDVFSFGVLVLEIISGQRNNCFRNGET-VEDLLSSAWKNWREGTT  552 (658)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDV~S~Gvll~elltG~~p~~~~~~~~-~~~l~~~~~~~~~~~~~  552 (658)
                      +...... ......|+..|+|||.+.+..  .+.++||||||+++|||++|..|+....... ...+......   .   
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---~---  227 (288)
T cd05583         155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK---S---  227 (288)
T ss_pred             ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc---c---
Confidence            5443221 122356889999999987665  7889999999999999999999985332211 1111111111   0   


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          553 VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       553 ~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                          .+........   .+.+++.+||+.+|++|||+.+|.+.|+.
T Consensus       228 ----~~~~~~~~~~---~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         228 ----KPPFPKTMSA---EARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             ----CCCCCcccCH---HHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence                1111111112   24467779999999999999999988875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=3.6e-33  Score=292.46  Aligned_cols=260  Identities=18%  Similarity=0.202  Sum_probs=190.0

Q ss_pred             ccCcccccCceEEEEeEecCCcceeEEEeccC--CcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecCCC
Q 006155          328 DANKLGQGGFGAVYKGRLYDGAEIAVKRLSRD--SGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNT  405 (658)
Q Consensus       328 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g  405 (658)
                      +.+.+|.|+++.|++++. +++.||||++...  .......+.+|+.+++.++|+||+++++++.+.+..+++|||++++
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            344556666777777764 7899999998764  2334457899999999999999999999999999999999999999


Q ss_pred             ChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC----
Q 006155          406 SLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET----  481 (658)
Q Consensus       406 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~----  481 (658)
                      +|.+++.... ...+++.....++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||.+..+.....    
T Consensus        85 ~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          85 SCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             CHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            9999986432 245889999999999999999999987   99999999999999999999999998875432211    


Q ss_pred             -ccccccccccccccCcccccc--CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhc----cC-----
Q 006155          482 -QGNTSRIVGTYGYMAPEYAMH--GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNW----RE-----  549 (658)
Q Consensus       482 -~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~----~~-----  549 (658)
                       ........++..|+|||++..  ..++.++||||||+++|||++|+.||.....  ...++.......    ..     
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  238 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA--TQMLLEKVRGTVPCLLDKSTYPL  238 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhccCccccccCchhh
Confidence             111233467889999999876  3588999999999999999999999853221  111111110000    00     


Q ss_pred             --CCccc----ccCCCCCCC-----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          550 --GTTVN----IIDPTLSSG-----SITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       550 --~~~~~----~~dp~l~~~-----~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                        .....    ..++.....     ....-..+.+++.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence              00000    001111000     1111234667888999999999999999885

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=5.9e-33  Score=284.08  Aligned_cols=242  Identities=22%  Similarity=0.269  Sum_probs=182.9

Q ss_pred             ccCCcccCcc--cccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhc-CCCCceeeeeeeccCCceEEE
Q 006155          323 TDNFSDANKL--GQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANL-QHRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       323 ~~~~~~~~~l--G~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv  398 (658)
                      .++|...+.+  |+|+||.||+++. .++..+|+|.+........     |+.....+ +||||+++++.+...+..++|
T Consensus        13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv   87 (267)
T PHA03390         13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLI   87 (267)
T ss_pred             HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence            4566666666  9999999999985 3577889998865422111     22222222 699999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCC-CeEEeccccccccc
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM-TPKIADFGMARLFE  477 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~-~~kl~DFGla~~~~  477 (658)
                      |||+++++|.+++..   ...++|..+..++.||++||.|||+.+   ++||||||+||+++.++ .++|+|||+++...
T Consensus        88 ~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~  161 (267)
T PHA03390         88 MDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG  161 (267)
T ss_pred             EEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence            999999999999843   237999999999999999999999988   99999999999999998 99999999987653


Q ss_pred             cCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccC
Q 006155          478 MDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID  557 (658)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  557 (658)
                      ..      ....|+..|+|||++.+..++.++||||||+++|||++|+.|+....... .+........  ..   ..  
T Consensus       162 ~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~--~~---~~--  227 (267)
T PHA03390        162 TP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ--QK---KL--  227 (267)
T ss_pred             CC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh--cc---cC--
Confidence            22      22468899999999999999999999999999999999999986332221 1111111111  10   00  


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-HHHHH
Q 006155          558 PTLSSGSITEMIRCIHIGLLCVQENVASRPT-MASVV  593 (658)
Q Consensus       558 p~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPt-m~evv  593 (658)
                       .......   ..+.+++..||+.+|.+||+ +++++
T Consensus       228 -~~~~~~~---~~~~~li~~~l~~~p~~R~~~~~~~l  260 (267)
T PHA03390        228 -PFIKNVS---KNANDFVQSMLKYNINYRLTNYNEII  260 (267)
T ss_pred             -CcccccC---HHHHHHHHHHhccChhhCCchHHHHh
Confidence             0011111   23456677999999999996 68877

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-33  Score=283.05  Aligned_cols=250  Identities=25%  Similarity=0.360  Sum_probs=191.7

Q ss_pred             cCCcccCcccccCceEEEEeEe-cCCcceeEEEeccC-----CcccHHHHHHHHHHHHhcCCCCceeeeeeeccC--Cce
Q 006155          324 DNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRD-----SGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEG--NER  395 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~  395 (658)
                      .+|...+.||+|+||.||+++. .++..||+|.+...     .......+.+|+.++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            5788899999999999999985 45889999987532     122334688999999999999999999998664  457


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ++++||+++++|.+++..   ...+++....+++.+|+.||.|||+.+   ++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence            899999999999998843   345889999999999999999999987   99999999999999999999999999986


Q ss_pred             cccCCC-ccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          476 FEMDET-QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       476 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      ...... ........|+..|+|||++.+..++.++||||||+++|||++|+.||...  ...... ..   ....+.   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~~-~~---~~~~~~---  226 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY--EAMAAI-FK---IATQPT---  226 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc--CHHHHH-HH---HHcCCC---
Confidence            543211 11122356899999999999888999999999999999999999998422  111111 11   111111   


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          555 IIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       555 ~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                        .+.+.....++   +.+++..|++ +|.+||+..+++.
T Consensus       227 --~~~~p~~~~~~---~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         227 --KPMLPDGVSDA---CRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             --CCCCCcccCHH---HHHHHHHHhc-CcccCccHHHHhc
Confidence              11122222222   4456678898 5799999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.9e-33  Score=296.06  Aligned_cols=261  Identities=22%  Similarity=0.306  Sum_probs=193.5

Q ss_pred             cCCcc-cCcccccCceEEEEeEec-CCcceeEEEeccCCccc--------------HHHHHHHHHHHHhcCCCCceeeee
Q 006155          324 DNFSD-ANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQG--------------DLEFKNEVLLVANLQHRNLVRLLG  387 (658)
Q Consensus       324 ~~~~~-~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~~  387 (658)
                      ++|.. .+.||+|+||.||+++.. .++.||||.+.......              ...+.+|+.++..++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            45553 467999999999999854 68899999886543222              124678999999999999999999


Q ss_pred             eeccCCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEE
Q 006155          388 FSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKI  467 (658)
Q Consensus       388 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl  467 (658)
                      ++..++..++||||++ ++|.+++.   ....+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.++|
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence            9999999999999997 68888883   3446899999999999999999999987   999999999999999999999


Q ss_pred             eccccccccccCC------------CccccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCC
Q 006155          468 ADFGMARLFEMDE------------TQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGE  534 (658)
Q Consensus       468 ~DFGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~  534 (658)
                      +|||++..+....            .........++..|+|||++.+. .++.++||||||+++|||++|+.|+..... 
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~-  239 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE-  239 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-
Confidence            9999998664111            01111223568899999998764 478999999999999999999999854332 


Q ss_pred             CcchHHHHHHHhccCCCc---ccc-----cC---CCCCCC----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          535 TVEDLLSSAWKNWREGTT---VNI-----ID---PTLSSG----SITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       535 ~~~~l~~~~~~~~~~~~~---~~~-----~d---p~l~~~----~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                        .+.+............   .+.     ..   +.....    .......+.+++..|++.+|++||++.|++.
T Consensus       240 --~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        240 --IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             --HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence              2222222221111110   000     00   000000    0011234567888999999999999999985

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-34  Score=282.99  Aligned_cols=266  Identities=22%  Similarity=0.333  Sum_probs=212.4

Q ss_pred             hhhhhhhccCCcccCcccccCceEEEEeEec------CCcceeEEEeccCCccc-HHHHHHHHHHHHhcCCCCceeeeee
Q 006155          316 FNTIRVATDNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRDSGQG-DLEFKNEVLLVANLQHRNLVRLLGF  388 (658)
Q Consensus       316 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~  388 (658)
                      .+++.+...+++....+-+|.||.||.|.+.      +.+.|-||.++....+- ...+..|-.++..+.|||+..+.++
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            4556667788888899999999999999643      34578888887654332 2347789899999999999999999


Q ss_pred             eccC-CceEEEEEecCCCChhhhhc-----CcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCC
Q 006155          389 SLEG-NERLLIYEFVPNTSLDHFIF-----DPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE  462 (658)
Q Consensus       389 ~~~~-~~~~lv~e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~  462 (658)
                      +.++ ...+++|.++.-|+|..||.     ++.....++..+...++.|++.||+|||..+   +||.||..+|++||+.
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence            8754 57789999999999999997     6666778899999999999999999999988   9999999999999999


Q ss_pred             CCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHH
Q 006155          463 MTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLS  541 (658)
Q Consensus       463 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~  541 (658)
                      .++||+|=.++|-+-+.+..........+..||+||.+.+..|+..+|||||||++|||+| |+.|+.   +-+..+...
T Consensus       433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pya---eIDPfEm~~  509 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYA---EIDPFEMEH  509 (563)
T ss_pred             eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcc---ccCHHHHHH
Confidence            9999999999986655444333333445779999999999999999999999999999998 666763   233344445


Q ss_pred             HHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          542 SAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       542 ~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      +..+.+|-....         +.++|+   ..++.-||...|++||+.++++.-|+..
T Consensus       510 ylkdGyRlaQP~---------NCPDeL---f~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  510 YLKDGYRLAQPF---------NCPDEL---FTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             HHhccceecCCC---------CCcHHH---HHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence            544444422211         244444   4567789999999999999999998764

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4.8e-33  Score=293.41  Aligned_cols=264  Identities=23%  Similarity=0.341  Sum_probs=195.2

Q ss_pred             hhhhccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeecc-CCc
Q 006155          319 IRVATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLE-GNE  394 (658)
Q Consensus       319 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~  394 (658)
                      +...+++|+..+.||+|+||.||+++. .+++.||||++....  ......+.+|+.++..++||||+++++++.. ++.
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            345678999999999999999999974 468899999886432  2234567899999999999999999998865 567


Q ss_pred             eEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          395 RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      .++|+||+ +++|..++.    ...+++.....++.|+++||.|||+.+   |+||||+|+|||+++++.++|+|||++.
T Consensus        85 ~~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~  156 (328)
T cd07856          85 IYFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR  156 (328)
T ss_pred             EEEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccc
Confidence            88999998 568988873    345788889999999999999999987   9999999999999999999999999987


Q ss_pred             ccccCCCccccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHH--------HHH
Q 006155          475 LFEMDETQGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSS--------AWK  545 (658)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~--------~~~  545 (658)
                      .....     .....++..|+|||++.+ ..++.++||||||+++|||++|+.||...........+..        .+.
T Consensus       157 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  231 (328)
T cd07856         157 IQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN  231 (328)
T ss_pred             ccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            54321     123467889999998766 5689999999999999999999998854322111000000        011


Q ss_pred             hccCCCcccccCC-CCCC-CCHHH-----HHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          546 NWREGTTVNIIDP-TLSS-GSITE-----MIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       546 ~~~~~~~~~~~dp-~l~~-~~~~e-----~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                      .+..+...+.+.. .... ....+     -..+.+++..|++.+|++||++.+++..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            1111111111000 0000 01111     1345677889999999999999998744

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=6.3e-33  Score=287.22  Aligned_cols=249  Identities=24%  Similarity=0.305  Sum_probs=191.1

Q ss_pred             CCcccCcccccCceEEEEeEe----cCCcceeEEEeccCCc----ccHHHHHHHHHHHHhc-CCCCceeeeeeeccCCce
Q 006155          325 NFSDANKLGQGGFGAVYKGRL----YDGAEIAVKRLSRDSG----QGDLEFKNEVLLVANL-QHRNLVRLLGFSLEGNER  395 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~l~~~~~----~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~  395 (658)
                      +|+..+.||+|+||.||+++.    .+|..||+|++.....    .....+.+|+.++.++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477788999999999999975    3688999999875322    2335678899999999 599999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ++|+||+++++|.+++..   ...+++..+..++.|+++||.|||+.+   ++||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            999999999999999843   346889999999999999999999987   99999999999999999999999999986


Q ss_pred             cccCCCccccccccccccccCccccccC--CCCcccccccccchHhHHHhCCCCCccCCCCC-cchHHHHHHHhccCCCc
Q 006155          476 FEMDETQGNTSRIVGTYGYMAPEYAMHG--QYSVKSDVFSFGVLVLEIISGQRNNCFRNGET-VEDLLSSAWKNWREGTT  552 (658)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~-~~~l~~~~~~~~~~~~~  552 (658)
                      +..... .......|+..|+|||++.+.  .++.++||||||+++|||++|+.|+....... ...+......   .   
T Consensus       155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~---~---  227 (290)
T cd05613         155 FHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK---S---  227 (290)
T ss_pred             cccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc---c---
Confidence            543322 122235689999999998753  47889999999999999999999985432211 1111111111   0   


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHH
Q 006155          553 VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRP-----TMASVV  593 (658)
Q Consensus       553 ~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RP-----tm~evv  593 (658)
                          .+.......   ..+.+++..||+.+|++||     +..+++
T Consensus       228 ----~~~~~~~~~---~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~  266 (290)
T cd05613         228 ----EPPYPQEMS---ALAKDIIQRLLMKDPKKRLGCGPSDADEIK  266 (290)
T ss_pred             ----CCCCCccCC---HHHHHHHHHHhcCCHHHhcCCCCCCHHHHH
Confidence                011111111   2344677899999999997     555554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.5e-33  Score=289.56  Aligned_cols=249  Identities=23%  Similarity=0.318  Sum_probs=197.6

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHhcC-CCCceeeeeeeccCCceEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQ-HRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv  398 (658)
                      ++|...+.||+|+||.||+++.. +|..||+|++....   ......+.+|+.++.+++ ||||+++++++..++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888899999999999999864 68899999986532   233456888999999998 99999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccccc
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~  478 (658)
                      |||+++++|.+++..   ...+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..+..
T Consensus        81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            999999999999843   347999999999999999999999987   99999999999999999999999999886643


Q ss_pred             CCCc------------------cccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHH
Q 006155          479 DETQ------------------GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL  540 (658)
Q Consensus       479 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~  540 (658)
                      ....                  .......|+..|+|||.+....++.++||||||++++|+++|+.|+.....   ....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~  231 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---YLTF  231 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH---HHHH
Confidence            2211                  122335678999999999888899999999999999999999999853321   1111


Q ss_pred             HHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH----HHHHH
Q 006155          541 SSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTM----ASVVL  594 (658)
Q Consensus       541 ~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm----~evv~  594 (658)
                      .....    .      ...+....   -..+.+++..||+.+|++||++    +++++
T Consensus       232 ~~~~~----~------~~~~~~~~---~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         232 QKILK----L------EYSFPPNF---PPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHHHh----c------CCCCCCcc---CHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            11111    0      00111111   1235577889999999999999    66653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-33  Score=296.81  Aligned_cols=261  Identities=25%  Similarity=0.336  Sum_probs=197.3

Q ss_pred             CCcccCcccccCceEEEEeEec-CCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeeccCC-----ceE
Q 006155          325 NFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGN-----ERL  396 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~  396 (658)
                      +|...+.||+|+||.||+++.. .+..+|||++....  ......+.+|+.+++.++|+||+++++++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4778899999999999999865 48899999987653  334456889999999999999999999988775     789


Q ss_pred             EEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccc
Q 006155          397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF  476 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~  476 (658)
                      +||||++ ++|.+++..   ...+++..++.++.+|+.||.|||+.+   |+||||||+|||++.++.++|+|||++...
T Consensus        81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            9999998 588888843   337999999999999999999999988   999999999999999999999999999876


Q ss_pred             ccCCC-ccccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccC-----
Q 006155          477 EMDET-QGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWRE-----  549 (658)
Q Consensus       477 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-----  549 (658)
                      ..... ........++..|+|||++.+. .++.++||||||+++|+|++|+.||......   +...........     
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~  230 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI---DQLNLIVEVLGTPSEED  230 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH---HHHHHHHHhcCCCChhH
Confidence            54321 1122335678899999999888 7999999999999999999999998543321   111111111000     


Q ss_pred             ------CCcccccC--CCCCCCCHH-----HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          550 ------GTTVNIID--PTLSSGSIT-----EMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       550 ------~~~~~~~d--p~l~~~~~~-----e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                            ....+.+.  +........     .-..+.+++..||+.+|++||++.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                  00000000  000000000     11235678889999999999999999863

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=4.1e-33  Score=289.64  Aligned_cols=254  Identities=25%  Similarity=0.411  Sum_probs=191.8

Q ss_pred             hhccCCcccCcccccCceEEEEeEecC-CcceeEEEeccCCc-ccHHHHHHHHHHHHhcC-CCCceeeeeeeccCCceEE
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQ-HRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~l  397 (658)
                      ..-++|...+.||+|+||.||+|+..+ ++.||||++..... ....++..|+.++.++. ||||+++++++.++...++
T Consensus        12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~   91 (296)
T cd06618          12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI   91 (296)
T ss_pred             CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence            345778889999999999999999764 88999999876432 23345667777777775 9999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCcEEEeccCCCceeeCCCCCeEEecccccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED-SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF  476 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~  476 (658)
                      ||||++ ++|.+++..  ....+++..+.+++.+|++||.|||+. +   |+||||+|+||++++++.+||+|||++..+
T Consensus        92 v~e~~~-~~l~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~  165 (296)
T cd06618          92 CMELMS-TCLDKLLKR--IQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRL  165 (296)
T ss_pred             EeeccC-cCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhc
Confidence            999985 467666533  224789999999999999999999974 5   999999999999999999999999998765


Q ss_pred             ccCCCccccccccccccccCccccccCC----CCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCc
Q 006155          477 EMDETQGNTSRIVGTYGYMAPEYAMHGQ----YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTT  552 (658)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  552 (658)
                      .....   .....++..|+|||++.+..    ++.++||||||+++|||++|+.|+.....  ..+.+.....   . ..
T Consensus       166 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~---~-~~  236 (296)
T cd06618         166 VDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT--EFEVLTKILQ---E-EP  236 (296)
T ss_pred             cCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh--HHHHHHHHhc---C-CC
Confidence            43222   12345788999999987553    88999999999999999999999843211  1112221111   1 10


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          553 VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       553 ~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                           +.+.... .....+.+++.+||+.+|++||++.++++.
T Consensus       237 -----~~~~~~~-~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         237 -----PSLPPNE-GFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             -----CCCCCCC-CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                 1111100 011235677789999999999999999854

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8e-33  Score=293.65  Aligned_cols=258  Identities=24%  Similarity=0.363  Sum_probs=192.6

Q ss_pred             hhhccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeeccCC---
Q 006155          320 RVATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGN---  393 (658)
Q Consensus       320 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---  393 (658)
                      ....++|...+.||+|+||.||++.. .+|..||||++.....  .....+.+|+.++++++||||+++++++..+.   
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            34567899999999999999999974 4688999999865322  22345789999999999999999999887654   


Q ss_pred             ---ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecc
Q 006155          394 ---ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADF  470 (658)
Q Consensus       394 ---~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DF  470 (658)
                         ..++||||+ +++|.+++.    ...+++..++.++.||++||.|||+.+   |+||||||+||+++.++.+||+||
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~df  162 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDF  162 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence               358999998 779988873    346899999999999999999999987   999999999999999999999999


Q ss_pred             ccccccccCCCccccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHH-----
Q 006155          471 GMARLFEMDETQGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAW-----  544 (658)
Q Consensus       471 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~-----  544 (658)
                      |++......     .....+++.|+|||++.+ ..++.++||||||+++|+|++|+.||......   .......     
T Consensus       163 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~---~~~~~~~~~~~~  234 (343)
T cd07880         163 GLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL---DQLMEIMKVTGT  234 (343)
T ss_pred             ccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCC
Confidence            999764322     223467889999999876 45889999999999999999999998533211   1111100     


Q ss_pred             ------HhccCCCcccccC--CCCCCCCH-----HHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 006155          545 ------KNWREGTTVNIID--PTLSSGSI-----TEMIRCIHIGLLCVQENVASRPTMASVV  593 (658)
Q Consensus       545 ------~~~~~~~~~~~~d--p~l~~~~~-----~e~~~~~~i~~~Cl~~~p~~RPtm~evv  593 (658)
                            ..+..........  +.......     ..-..+.+++.+|++.||++|||+.+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l  296 (343)
T cd07880         235 PSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL  296 (343)
T ss_pred             CCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence                  0000000000000  00000000     0011356788899999999999999998

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=5e-34  Score=318.81  Aligned_cols=255  Identities=28%  Similarity=0.425  Sum_probs=187.9

Q ss_pred             hhccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCC-cccHHHHHHHHHHHHhcCCCCceeeeeeeccC------
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDS-GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEG------  392 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------  392 (658)
                      .-..+|+..+.||+||||.|||++- -||+.+|||++.... ...-..+.+|+..+++|+|||||+++..+.+.      
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            4567899999999999999999983 389999999997653 22334578999999999999999987432110      


Q ss_pred             --------------------------------------------------------------------------------
Q 006155          393 --------------------------------------------------------------------------------  392 (658)
Q Consensus       393 --------------------------------------------------------------------------------  392 (658)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ---------------------------------CceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHh
Q 006155          393 ---------------------------------NERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL  439 (658)
Q Consensus       393 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL  439 (658)
                                                       ..+|+-||||+..+|.+++.......  .-...++++++|++||.|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHH
Confidence                                             01256688888888887774322111  3567899999999999999


Q ss_pred             hhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccc----------------cCCCccccccccccccccCccccccC
Q 006155          440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE----------------MDETQGNTSRIVGTYGYMAPEYAMHG  503 (658)
Q Consensus       440 H~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~  503 (658)
                      |+++   ||||||||.||+||++..+||+|||++....                .+......+..+||.-|+|||++.+.
T Consensus       714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            9998   9999999999999999999999999998621                01112234567999999999999654


Q ss_pred             ---CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcC
Q 006155          504 ---QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQ  580 (658)
Q Consensus       504 ---~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~  580 (658)
                         +|+.|+|+||+|||++||+.   ||..  ..+.    ..+...++.+.+..-  +.+   ..++...-.+++.++++
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~T--sMER----a~iL~~LR~g~iP~~--~~f---~~~~~~~e~slI~~Ll~  856 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY---PFGT--SMER----ASILTNLRKGSIPEP--ADF---FDPEHPEEASLIRWLLS  856 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc---cCCc--hHHH----HHHHHhcccCCCCCC--ccc---ccccchHHHHHHHHHhc
Confidence               49999999999999999986   3421  1111    123344555544433  111   22222233466778999


Q ss_pred             CCCCCCCCHHHHHH
Q 006155          581 ENVASRPTMASVVL  594 (658)
Q Consensus       581 ~~p~~RPtm~evv~  594 (658)
                      .||.+|||+.|++.
T Consensus       857 hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  857 HDPSKRPTATELLN  870 (1351)
T ss_pred             CCCccCCCHHHHhh
Confidence            99999999999873

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=4.3e-33  Score=295.63  Aligned_cols=261  Identities=21%  Similarity=0.303  Sum_probs=190.9

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccC---------
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEG---------  392 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~---------  392 (658)
                      ..+|...+.||.|+||.||+|+.. +|..||+|++..........+.+|+.++++++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            368899999999999999999854 5889999998776666667789999999999999999999876543         


Q ss_pred             -----CceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCC-CCCeE
Q 006155          393 -----NERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDA-EMTPK  466 (658)
Q Consensus       393 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~-~~~~k  466 (658)
                           ...++|+||++ ++|.+++.    ...+++.....++.||++||.|||+.+   |+||||||+||+++. ++.+|
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence                 34689999997 58888773    245899999999999999999999987   999999999999974 56789


Q ss_pred             EeccccccccccCCCc-cccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHH
Q 006155          467 IADFGMARLFEMDETQ-GNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAW  544 (658)
Q Consensus       467 l~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~  544 (658)
                      |+|||+++.+...... .......++..|+|||++.. ..++.++|||||||++|||++|+.||......  ..... ..
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~--~~~~~-~~  232 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL--EQMQL-IL  232 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH-HH
Confidence            9999999765432111 11223467889999998754 45888999999999999999999998533221  11110 00


Q ss_pred             HhccCC-----------Cccccc-CCCCCCCCHHH-----HHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          545 KNWREG-----------TTVNII-DPTLSSGSITE-----MIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       545 ~~~~~~-----------~~~~~~-dp~l~~~~~~e-----~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ......           ...... +.........+     ...+.+++..|++.||++|||+.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            000000           000000 00000001111     123557888999999999999999983

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-34  Score=315.23  Aligned_cols=298  Identities=23%  Similarity=0.271  Sum_probs=221.9

Q ss_pred             cccccccccccchhhhhhhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHhcCC
Q 006155          304 DEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQH  379 (658)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H  379 (658)
                      +.++...+.......++...++|.++++||+|+||.|..++.. .++.+|+|++++..   .....-|.+|-.+|..-..
T Consensus        55 ~fl~~~kp~v~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns  134 (1317)
T KOG0612|consen   55 EFLNRYKPIVKKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNS  134 (1317)
T ss_pred             HHHHHhHHHHHHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCc
Confidence            3444445555667788899999999999999999999999865 47778999997742   2334458899999999999


Q ss_pred             CCceeeeeeeccCCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceee
Q 006155          380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLL  459 (658)
Q Consensus       380 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl  459 (658)
                      +.|+.|.-.|.+.+.+|||||||+||+|-.++...   ..+++..+..++..|+-||.-||+.|   +|||||||+||||
T Consensus       135 ~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~---~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLl  208 (1317)
T KOG0612|consen  135 EWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKF---DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLL  208 (1317)
T ss_pred             HHHHHHHHHhcCccceEEEEecccCchHHHHHhhc---CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEe
Confidence            99999999999999999999999999999999543   36899999999999999999999998   9999999999999


Q ss_pred             CCCCCeEEeccccccccccCCCccccccccccccccCccccc----c-CCCCcccccccccchHhHHHhCCCCCccCCCC
Q 006155          460 DAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM----H-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGE  534 (658)
Q Consensus       460 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~  534 (658)
                      |..|++||+|||.+..+..+.. ......+|||.|++||++.    + +.|...+|+||+||++|||+.|..||...   
T Consensus       209 d~~GHikLADFGsClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad---  284 (1317)
T KOG0612|consen  209 DKSGHIKLADFGSCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD---  284 (1317)
T ss_pred             cccCcEeeccchhHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH---
Confidence            9999999999999987765433 2344579999999999985    3 67999999999999999999999999432   


Q ss_pred             CcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC---HHHHH--HHhccCCCCCCCCCCC
Q 006155          535 TVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPT---MASVV--LMLNSYSLTLPVPSEP  609 (658)
Q Consensus       535 ~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPt---m~evv--~~L~~~~~~~~~p~~p  609 (658)
                         .++..--+...........|..   ...++...+|. ++.   -+|+.|-.   ++++-  ..+.++.+.--..+.|
T Consensus       285 ---slveTY~KIm~hk~~l~FP~~~---~VSeeakdLI~-~ll---~~~e~RLgrngiedik~HpFF~g~~W~~iR~~~p  354 (1317)
T KOG0612|consen  285 ---SLVETYGKIMNHKESLSFPDET---DVSEEAKDLIE-ALL---CDREVRLGRNGIEDIKNHPFFEGIDWDNIRESVP  354 (1317)
T ss_pred             ---HHHHHHHHHhchhhhcCCCccc---ccCHHHHHHHH-HHh---cChhhhcccccHHHHHhCccccCCChhhhhhcCC
Confidence               2222211222221111221111   12233333332 223   45667766   88885  3456666655455566


Q ss_pred             Cccccccccccc
Q 006155          610 AFFMDSIIESDM  621 (658)
Q Consensus       610 ~~~~~~~~~~~~  621 (658)
                      +|+..-...+|.
T Consensus       355 P~vPevssd~DT  366 (1317)
T KOG0612|consen  355 PVVPEVSSDDDT  366 (1317)
T ss_pred             CCCCcCCCCCcc
Confidence            665544443333

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.1e-32  Score=283.70  Aligned_cols=241  Identities=24%  Similarity=0.302  Sum_probs=183.7

Q ss_pred             cccccCceEEEEeEec-CCcceeEEEeccCCcc---cHHHHHHHHH---HHHhcCCCCceeeeeeeccCCceEEEEEecC
Q 006155          331 KLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQ---GDLEFKNEVL---LVANLQHRNLVRLLGFSLEGNERLLIYEFVP  403 (658)
Q Consensus       331 ~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~---~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~  403 (658)
                      .||+|+||.||+++.. .++.||+|.+......   ....+.+|..   .+....||||+++++++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999854 5789999988654221   1222344433   3444579999999999999999999999999


Q ss_pred             CCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCcc
Q 006155          404 NTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQG  483 (658)
Q Consensus       404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  483 (658)
                      +++|..++.   ....++|..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||++..+....   
T Consensus        81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---  151 (278)
T cd05606          81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (278)
T ss_pred             CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence            999998884   3356999999999999999999999987   9999999999999999999999999987653321   


Q ss_pred             ccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCC
Q 006155          484 NTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSS  562 (658)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~  562 (658)
                       .....|+..|+|||++.++ .++.++||||||+++|||++|+.||........... ......         .++.+..
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~---------~~~~~~~  220 (278)
T cd05606         152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-DRMTLT---------MAVELPD  220 (278)
T ss_pred             -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH-HHHhhc---------cCCCCCC
Confidence             2234789999999998755 689999999999999999999999854332222111 111110         1112211


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 006155          563 GSITEMIRCIHIGLLCVQENVASRP-----TMASVVL  594 (658)
Q Consensus       563 ~~~~e~~~~~~i~~~Cl~~~p~~RP-----tm~evv~  594 (658)
                      ...   ..+.+++..|++.+|++||     ++.++++
T Consensus       221 ~~s---~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         221 SFS---PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             cCC---HHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            111   2345667799999999999     9999974

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=5.8e-33  Score=290.25  Aligned_cols=248  Identities=29%  Similarity=0.417  Sum_probs=190.9

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccC---CcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRD---SGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  398 (658)
                      .+.|...+.||+|+||.||+|+.. ++..+|+|.+...   ......++.+|+.+++.++|+|++++++++......++|
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   93 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence            345777889999999999999854 5778999988643   222334678899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccccc
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~  478 (658)
                      |||+. |+|.+++..  ....+++..+..++.+++.||.|||+.+   ++||||||+||+++.++.++|+|||++.....
T Consensus        94 ~e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          94 MEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             EEccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            99997 577776643  2345899999999999999999999987   99999999999999999999999999876432


Q ss_pred             CCCccccccccccccccCccccc---cCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccc
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAM---HGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNI  555 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  555 (658)
                      .      ....|+..|+|||++.   .+.++.++||||||+++|||++|+.|+.....   .+....    +..+..   
T Consensus       168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~----~~~~~~---  231 (308)
T cd06634         168 A------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYH----IAQNES---  231 (308)
T ss_pred             c------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH---HHHHHH----HhhcCC---
Confidence            2      2346788999999974   45688999999999999999999998732211   111111    111111   


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 006155          556 IDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLML  596 (658)
Q Consensus       556 ~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L  596 (658)
                        +......  .-..+.+++.+||+.+|++||++.+|+...
T Consensus       232 --~~~~~~~--~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         232 --PALQSGH--WSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             --CCcCccc--ccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence              1111111  112244677899999999999999998653

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.3e-32  Score=290.22  Aligned_cols=197  Identities=21%  Similarity=0.307  Sum_probs=160.3

Q ss_pred             Cccccc--CceEEEEeEe-cCCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecCC
Q 006155          330 NKLGQG--GFGAVYKGRL-YDGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPN  404 (658)
Q Consensus       330 ~~lG~G--~fg~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  404 (658)
                      ..||+|  +||+||+++. ..|+.||+|++.....  ...+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456766  8999999985 4689999999875432  2335688999999999999999999999999999999999999


Q ss_pred             CChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCcc-
Q 006155          405 TSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQG-  483 (658)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~-  483 (658)
                      ++|.+++.... ...+++..+..++.||+.||+|||+.+   ++||||||+|||++.++.++++||+.+.......... 
T Consensus        84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            99999885432 235899999999999999999999987   9999999999999999999999998654332111100 


Q ss_pred             ----ccccccccccccCccccccC--CCCcccccccccchHhHHHhCCCCCcc
Q 006155          484 ----NTSRIVGTYGYMAPEYAMHG--QYSVKSDVFSFGVLVLEIISGQRNNCF  530 (658)
Q Consensus       484 ----~~~~~~gt~~y~aPE~~~~~--~~s~ksDV~S~Gvll~elltG~~p~~~  530 (658)
                          ......++..|+|||++.+.  .++.++||||||+++|||++|+.|+..
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~  212 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD  212 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence                01112356679999999764  478999999999999999999999853

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=9.6e-33  Score=289.25  Aligned_cols=244  Identities=30%  Similarity=0.406  Sum_probs=188.6

Q ss_pred             CcccCcccccCceEEEEeEe-cCCcceeEEEeccCCc---ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          326 FSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSG---QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       326 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      |...++||+|+||+||+|+. .+|..|++|++.....   .....+.+|+.+++.++|||++++++++.+++..++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            66677899999999999985 3588899999865432   2234678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      +. ++|.+++..  ....++|..++.++.||+.+|.|||+.+   ++|+||+|+||+++.++.+||+|||++....    
T Consensus       103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~----  172 (313)
T cd06633         103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS----  172 (313)
T ss_pred             CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC----
Confidence            96 567666632  2346899999999999999999999987   9999999999999999999999999986422    


Q ss_pred             ccccccccccccccCccccc---cCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCC
Q 006155          482 QGNTSRIVGTYGYMAPEYAM---HGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP  558 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp  558 (658)
                        ......|+..|+|||++.   .+.++.++||||||+++|||++|+.|+.....   ...+....   . ...     +
T Consensus       173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~---~~~~~~~~---~-~~~-----~  238 (313)
T cd06633         173 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIA---Q-NDS-----P  238 (313)
T ss_pred             --CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHH---h-cCC-----C
Confidence              122457889999999984   46788999999999999999999998743221   11111111   1 111     1


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          559 TLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       559 ~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                      ........  ..+.+++.+||+.+|.+||++.+++..
T Consensus       239 ~~~~~~~~--~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         239 TLQSNEWT--DSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             CCCccccC--HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11111111  124567789999999999999999843

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-34  Score=323.91  Aligned_cols=255  Identities=27%  Similarity=0.372  Sum_probs=196.8

Q ss_pred             hhccCCcccCcccccCceEEEEeE-ecCCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEE
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  397 (658)
                      ..+-+++-..+||.|.||.||.+. ..+|.-.|+|.+.....  .....+.+|+.++..++|||+|+++|+-..+++.+|
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence            344567778899999999999998 55688889997765433  333457899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE  477 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~  477 (658)
                      .||||++|+|.+.+.   ..+..++....-+..|++.|+.|||+.+   ||||||||.||||+.+|.+|++|||.|..+.
T Consensus      1312 FMEyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred             HHHHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEec
Confidence            999999999999983   3345666666778899999999999998   9999999999999999999999999998876


Q ss_pred             cCC--CccccccccccccccCccccccCC---CCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCc
Q 006155          478 MDE--TQGNTSRIVGTYGYMAPEYAMHGQ---YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTT  552 (658)
Q Consensus       478 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  552 (658)
                      ...  .....+...||+.|||||++.+..   -..+.||||+|||++||+||++||...+.+  ..+.-.+    ..|..
T Consensus      1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne--~aIMy~V----~~gh~ 1459 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE--WAIMYHV----AAGHK 1459 (1509)
T ss_pred             CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch--hHHHhHH----hccCC
Confidence            542  122344679999999999997643   456899999999999999999999533221  1111111    12222


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          553 VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       553 ~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                           |.++..-..+-   .+++..|++.||++|-++.|+++.
T Consensus      1460 -----Pq~P~~ls~~g---~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1460 -----PQIPERLSSEG---RDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             -----CCCchhhhHhH---HHHHHHHHhcCchhhhHHHHHHHh
Confidence                 22222211122   255668999999999888877654

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.2e-33  Score=273.78  Aligned_cols=203  Identities=28%  Similarity=0.449  Sum_probs=169.1

Q ss_pred             ccCCcccCcccccCceEEEEeEecC-----CcceeEEEeccCCccc--HHHHHHHHHHHHhcCCCCceeeeeeecc-CCc
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLYD-----GAEIAVKRLSRDSGQG--DLEFKNEVLLVANLQHRNLVRLLGFSLE-GNE  394 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----g~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~  394 (658)
                      ...|+....||+|.||.||++...+     ...+|+|+++......  .....+|+.+++.++||||+.|..++.. +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            3568888999999999999996332     3378999997653221  2345789999999999999999999987 778


Q ss_pred             eEEEEEecCCCChhhhhc--CcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCC----CCeEEe
Q 006155          395 RLLIYEFVPNTSLDHFIF--DPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE----MTPKIA  468 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~--~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~----~~~kl~  468 (658)
                      .+|++||.+. +|..+|+  ...+.+.++-..+.+|+.||+.|+.|||++-   |+||||||.|||+..+    |.+||+
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence            8999999976 5666664  2334468899999999999999999999998   9999999999999877    899999


Q ss_pred             ccccccccccCCCc-cccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCc
Q 006155          469 DFGMARLFEMDETQ-GNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNC  529 (658)
Q Consensus       469 DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~  529 (658)
                      |||++|++...-.. .....++-|.+|.|||.+.+. .||...|||+.|||+.||++-++.|.
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~  241 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK  241 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence            99999998765332 245567789999999999876 59999999999999999999887764

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-33  Score=284.41  Aligned_cols=258  Identities=27%  Similarity=0.383  Sum_probs=195.4

Q ss_pred             CcccCcccccCceEEEEeEec-CCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEec
Q 006155          326 FSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFV  402 (658)
Q Consensus       326 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  402 (658)
                      |+..+.||+|+||.||+|+.. +++.+|+|.+....  ......+..|+.++++++|+||+++++++.+.+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            456778999999999999865 48899999987653  233456788999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCc
Q 006155          403 PNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ  482 (658)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  482 (658)
                      + ++|.+++....  ..+++..++.++.+++.||.|||+.+   |+||||+|+||++++++.++|+|||+++.+..... 
T Consensus        81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  153 (282)
T cd07829          81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-  153 (282)
T ss_pred             C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence            8 58999985421  46999999999999999999999987   99999999999999999999999999986543321 


Q ss_pred             cccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHH-----------HHhccCC
Q 006155          483 GNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSA-----------WKNWREG  550 (658)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~-----------~~~~~~~  550 (658)
                       ......++..|+|||++.+. .++.++||||||+++|||++|+.|+.....   .+.+...           |..+..-
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
T cd07829         154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE---IDQLFKIFQILGTPTEESWPGVTKL  229 (282)
T ss_pred             -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHHHHhCCCcHHHHHhhccc
Confidence             12223567789999998776 789999999999999999999888743321   1111111           1111100


Q ss_pred             CcccccCCCCCCCCH-----HHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          551 TTVNIIDPTLSSGSI-----TEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       551 ~~~~~~dp~l~~~~~-----~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ...+..-+.......     ..-..+.+++..||+.+|++||++.+|+.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            000000011111101     11234678889999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.8e-33  Score=294.64  Aligned_cols=260  Identities=23%  Similarity=0.364  Sum_probs=191.8

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeeccCC------
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGN------  393 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------  393 (658)
                      .++|...+.||+|+||.||+|+. .+|+.||||++....  ......+.+|+.+++.++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            46899999999999999999985 468999999987542  222345789999999999999999999886543      


Q ss_pred             ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccc
Q 006155          394 ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMA  473 (658)
Q Consensus       394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla  473 (658)
                      ..++|+||+.. +|..++     ...+++..+..++.|+++||.|||+.+   ++||||||+|||++.++.+||+|||++
T Consensus        94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            46899999964 676654     235899999999999999999999987   999999999999999999999999998


Q ss_pred             cccccCCCccccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhcc----
Q 006155          474 RLFEMDETQGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWR----  548 (658)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~----  548 (658)
                      +.....     .....++..|+|||++.+ ..++.++||||||+++|||++|+.||.....   ...+...+....    
T Consensus       165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~~  236 (342)
T cd07879         165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY---LDQLTQILKVTGVPGP  236 (342)
T ss_pred             cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCCH
Confidence            754321     223467889999999876 4689999999999999999999999853321   111221111100    


Q ss_pred             -------CCCcccccC--CCCCCCCH-----HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--hccC
Q 006155          549 -------EGTTVNIID--PTLSSGSI-----TEMIRCIHIGLLCVQENVASRPTMASVVLM--LNSY  599 (658)
Q Consensus       549 -------~~~~~~~~d--p~l~~~~~-----~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~--L~~~  599 (658)
                             .......++  +.......     ..-..+.+++..||+.||++||++.+++..  ++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~  303 (342)
T cd07879         237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF  303 (342)
T ss_pred             HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence                   000000000  00000000     011235678889999999999999999843  5443

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-33  Score=267.68  Aligned_cols=252  Identities=24%  Similarity=0.380  Sum_probs=190.5

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc-ccHHHHHHHHHHHHhcC-CCCceeeeeeeccCCceEEEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQ-HRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~  399 (658)
                      .++.+.+..||.|..|.||+.+.. .|..+|||.+.+... +..+.+...+.++.+-+ .|.||+.+|+|..+...++.|
T Consensus        91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM  170 (391)
T KOG0983|consen   91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM  170 (391)
T ss_pred             hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence            345556778999999999999855 488899999987643 33345666777666654 899999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      |.| ..-++.++..  -.+++++.-+-++...+.+||.||.+++  .|||||+||+|||+|+.|++|++|||++-.+-..
T Consensus       171 elM-s~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS  245 (391)
T KOG0983|consen  171 ELM-STCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS  245 (391)
T ss_pred             HHH-HHHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc
Confidence            988 3445555532  3456888888899999999999999876  5999999999999999999999999998665433


Q ss_pred             CCccccccccccccccCcccccc---CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccccc
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMH---GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNII  556 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  556 (658)
                      .   ..++..|-+.|||||.+.-   ..|+.++||||||+.++||.||+.|+....  ...+.+..+...   +      
T Consensus       246 k---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~--tdFe~ltkvln~---e------  311 (391)
T KOG0983|consen  246 K---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK--TDFEVLTKVLNE---E------  311 (391)
T ss_pred             c---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC--ccHHHHHHHHhc---C------
Confidence            2   2345689999999999853   468999999999999999999999985322  222333333321   1      


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          557 DPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       557 dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .|.|.+.. .---.+.++...||+.|+.+||...++++
T Consensus       312 PP~L~~~~-gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  312 PPLLPGHM-GFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             CCCCCccc-CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            13333220 01113445666899999999999998874

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.9e-33  Score=294.39  Aligned_cols=263  Identities=25%  Similarity=0.326  Sum_probs=193.5

Q ss_pred             hhhhhhccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeeccC-
Q 006155          317 NTIRVATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEG-  392 (658)
Q Consensus       317 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-  392 (658)
                      .++...+++|...+.||+|+||.||++.. .+|+.||+|++....  ......+.+|+.++.+++||||+++++++... 
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            34556778999999999999999999974 468899999987542  22344578899999999999999999987543 


Q ss_pred             -----CceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEE
Q 006155          393 -----NERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKI  467 (658)
Q Consensus       393 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl  467 (658)
                           ...+++++++ +++|.+++.    ...+++..+..++.||++||.|||+.+   |+||||||+||++++++.+||
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl  161 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI  161 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence                 3467788876 789988873    235899999999999999999999987   999999999999999999999


Q ss_pred             eccccccccccCCCccccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHh
Q 006155          468 ADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKN  546 (658)
Q Consensus       468 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~  546 (658)
                      +|||+++....     ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.|+......   ..+......
T Consensus       162 ~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~---~~~~~~~~~  233 (345)
T cd07877         162 LDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLILRL  233 (345)
T ss_pred             ecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHH
Confidence            99999875432     1223567899999998866 56889999999999999999999998432211   111111110


Q ss_pred             -----------ccCCCccccc--CCCCCCCCH-----HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          547 -----------WREGTTVNII--DPTLSSGSI-----TEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       547 -----------~~~~~~~~~~--dp~l~~~~~-----~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                                 +........+  -+.......     ..-..+.+++..|++.+|.+||++.+++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence                       0000000000  000000000     011235578889999999999999998843

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.1e-33  Score=293.91  Aligned_cols=248  Identities=24%  Similarity=0.379  Sum_probs=198.4

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcc--cHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQ--GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  398 (658)
                      ....|.+...||+|.|+.|..++.. .+.+||||.+.+..-.  ....+.+|+.+|..|.|||||+++.+......+++|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            3567889999999999999999844 5899999999876433  234588999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccccc
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~  478 (658)
                      |||..+|.+.++|..   ...+.......++.|+.++++|||+++   |||||||++||||+.++++||+|||++..+..
T Consensus       134 ~eya~~ge~~~yl~~---~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~  207 (596)
T KOG0586|consen  134 MEYASGGELFDYLVK---HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY  207 (596)
T ss_pred             EEeccCchhHHHHHh---cccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence            999999999999954   344555888899999999999999998   99999999999999999999999999998864


Q ss_pred             CCCccccccccccccccCccccccCCCC-cccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccC
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAMHGQYS-VKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID  557 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  557 (658)
                      +.   .....+|++.|.|||++.+.+|. +++|+||+|+++|-|+.|..||+...-.   .+-..+...  +-+    + 
T Consensus       208 ~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk---~Lr~rvl~g--k~r----I-  274 (596)
T KOG0586|consen  208 GL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK---ELRPRVLRG--KYR----I-  274 (596)
T ss_pred             cc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc---cccchheee--eec----c-
Confidence            32   34457999999999999988764 7999999999999999999999643221   111111110  000    0 


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          558 PTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       558 p~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      |....      ..|-+++...+-.+|.+|+++.++.+
T Consensus       275 p~~ms------~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  275 PFYMS------CDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             cceee------chhHHHHHHhhccCccccCCHHHhhh
Confidence            11111      12334555678899999999999973

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=6.2e-33  Score=293.20  Aligned_cols=259  Identities=24%  Similarity=0.299  Sum_probs=187.1

Q ss_pred             CCcccCcccccCceEEEEeEec-C--CcceeEEEeccCCc--ccHHHHHHHHHHHHhc-CCCCceeeeeeeccC----Cc
Q 006155          325 NFSDANKLGQGGFGAVYKGRLY-D--GAEIAVKRLSRDSG--QGDLEFKNEVLLVANL-QHRNLVRLLGFSLEG----NE  394 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~-~--g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~----~~  394 (658)
                      +|...+.||+|+||.||+++.. .  +..||+|++.....  .....+.+|+.++.++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4677889999999999999854 3  67899998865322  2244678899999999 599999999875432    45


Q ss_pred             eEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          395 RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      .++++||+. ++|.+++.   ....+++..++.++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            678888886 68888874   3456899999999999999999999988   9999999999999999999999999998


Q ss_pred             ccccCCC--ccccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHh-----
Q 006155          475 LFEMDET--QGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKN-----  546 (658)
Q Consensus       475 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~-----  546 (658)
                      .+.....  ........||..|+|||++.+ ..++.++||||||+++|||++|+.|+......   ..+......     
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~  230 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV---DQLNQILQVLGTPD  230 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH---HHHHHHHHHhCCCC
Confidence            6543221  112234578999999998765 46899999999999999999999988543211   111111100     


Q ss_pred             ------ccCCCcccc---c----CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 006155          547 ------WREGTTVNI---I----DPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVV  593 (658)
Q Consensus       547 ------~~~~~~~~~---~----dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv  593 (658)
                            +........   .    ...+.......-..+.+++.+|++.||++|||+.+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll  290 (332)
T cd07857         231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL  290 (332)
T ss_pred             HHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence                  000000000   0    0000000000112455788899999999999999986

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.7e-32  Score=279.19  Aligned_cols=249  Identities=26%  Similarity=0.351  Sum_probs=190.7

Q ss_pred             CCcccCcccccCceEEEEeEecC-CcceeEEEeccCC-----cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEE
Q 006155          325 NFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDS-----GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  398 (658)
                      +|...++||+|+||.||+++... +..+++|.++...     .....++..|+.++++++||||+++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47788999999999999997543 4456666554321     22334567899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccc
Q 006155          399 YEFVPNTSLDHFIFDP-TRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE  477 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~  477 (658)
                      +||+++++|.+++... .....+++..++.++.|+++||.|||+.+   ++|+||||+||+++. +.++|+|||+++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999988542 23457999999999999999999999987   999999999999975 569999999987654


Q ss_pred             cCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccC
Q 006155          478 MDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID  557 (658)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  557 (658)
                      ....  ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.|+....   ........    ..+.     .
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~---~~~~~~~~----~~~~-----~  222 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN---FLSVVLRI----VEGP-----T  222 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHHHH----HcCC-----C
Confidence            3322  2223467889999999988889999999999999999999999974221   11111111    1111     1


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          558 PTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       558 p~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      +.+.....   ..+.+++.+||+.+|++||++.++++
T Consensus       223 ~~~~~~~~---~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         223 PSLPETYS---RQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             CCCcchhc---HHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            22211111   23456778999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.9e-33  Score=294.15  Aligned_cols=257  Identities=24%  Similarity=0.343  Sum_probs=193.4

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCc----
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNE----  394 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----  394 (658)
                      ..++|...+.||+|+||.||+|+.. ++..||||++....  ......+.+|+.++++++||||+++++++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4678999999999999999999864 57889999886532  2233457789999999999999999998776654    


Q ss_pred             --eEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccc
Q 006155          395 --RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGM  472 (658)
Q Consensus       395 --~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGl  472 (658)
                        .++|+||+ +++|.+++..    ..+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence              89999998 6799888842    46999999999999999999999987   99999999999999999999999999


Q ss_pred             ccccccCCCccccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHh-----
Q 006155          473 ARLFEMDETQGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKN-----  546 (658)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~-----  546 (658)
                      +......     .....++..|+|||.+.+ ..++.++||||||+++||+++|+.||.....   .+.+......     
T Consensus       165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~---~~~~~~i~~~~~~~~  236 (343)
T cd07851         165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH---IDQLKRIMNLVGTPD  236 (343)
T ss_pred             ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCC
Confidence            9765332     223467889999998865 3678999999999999999999999853221   1111111111     


Q ss_pred             ------ccCCCcccccCC--CCCCCCH-----HHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          547 ------WREGTTVNIIDP--TLSSGSI-----TEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       547 ------~~~~~~~~~~dp--~l~~~~~-----~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                            +........+..  .......     ..-..+.+++..|++.+|++|||+.+|++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence                  100000000000  0000000     01235668889999999999999999874

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=5.7e-32  Score=309.68  Aligned_cols=145  Identities=28%  Similarity=0.380  Sum_probs=129.4

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc---ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG---QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ++|.+.++||+|+||.||+|+.. +++.||||++.....   .....+..|+.++..++||||+++++++......+|||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            67888999999999999999865 588999999865432   22356788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      ||+++++|.+++..   ...+++..++.|+.||+.||.|||+.+   ||||||||+||||+.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999843   345889999999999999999999987   9999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=5.9e-33  Score=279.51  Aligned_cols=261  Identities=26%  Similarity=0.371  Sum_probs=197.1

Q ss_pred             hhhhhhhccCCcccCcccccCceEEEEeE-ecCCcceeEEEeccCC-cccH------HHHHHHHHHHHhcCCCCceeeee
Q 006155          316 FNTIRVATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDS-GQGD------LEFKNEVLLVANLQHRNLVRLLG  387 (658)
Q Consensus       316 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~~-~~~~------~~~~~E~~~l~~l~H~niv~l~~  387 (658)
                      |+.-....++|-.+++||+|||+.||++. +...+.||||+-.... +.++      +...+|..+-+.|+||.||++++
T Consensus       455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD  534 (775)
T KOG1151|consen  455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD  534 (775)
T ss_pred             hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence            34445566788899999999999999997 5668889999764432 2111      12457899999999999999999


Q ss_pred             eec-cCCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeC---CCC
Q 006155          388 FSL-EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLD---AEM  463 (658)
Q Consensus       388 ~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~---~~~  463 (658)
                      ++. +.+..+-|+||++|.+|+-+|.   ..+.+++.+.+.|+.||+.||.||.+.. ++|||-||||.||||-   .-|
T Consensus       535 yfslDtdsFCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacG  610 (775)
T KOG1151|consen  535 YFSLDTDSFCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACG  610 (775)
T ss_pred             eeeeccccceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccc
Confidence            985 5567789999999999999993   4567999999999999999999999875 7799999999999994   458


Q ss_pred             CeEEeccccccccccCCCc-----cccccccccccccCccccccC----CCCcccccccccchHhHHHhCCCCCccCCCC
Q 006155          464 TPKIADFGMARLFEMDETQ-----GNTSRIVGTYGYMAPEYAMHG----QYSVKSDVFSFGVLVLEIISGQRNNCFRNGE  534 (658)
Q Consensus       464 ~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~s~ksDV~S~Gvll~elltG~~p~~~~~~~  534 (658)
                      .+||+||||+++++.+...     ..+....||++|++||.+.-+    +.+.|+||||.|||+|.++.|++||....  
T Consensus       611 eIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq--  688 (775)
T KOG1151|consen  611 EIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ--  688 (775)
T ss_pred             eeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch--
Confidence            8999999999998765433     235567999999999988644    57889999999999999999999995432  


Q ss_pred             CcchHHHHHHHhccCCCcccccCCCCCCC--CHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Q 006155          535 TVEDLLSSAWKNWREGTTVNIIDPTLSSG--SITEMIRCIHIGLLCVQENVASRPTMASV  592 (658)
Q Consensus       535 ~~~~l~~~~~~~~~~~~~~~~~dp~l~~~--~~~e~~~~~~i~~~Cl~~~p~~RPtm~ev  592 (658)
                      ..++++.+       +++...-.-.+...  ...+..   .++.+||+..-++|-...++
T Consensus       689 sQQdILqe-------NTIlkAtEVqFP~KPvVsseAk---aFIRRCLaYRKeDR~DV~qL  738 (775)
T KOG1151|consen  689 SQQDILQE-------NTILKATEVQFPPKPVVSSEAK---AFIRRCLAYRKEDRIDVQQL  738 (775)
T ss_pred             hHHHHHhh-------hchhcceeccCCCCCccCHHHH---HHHHHHHHhhhhhhhhHHHH
Confidence            22333332       22221111111111  112222   34558999999999765443

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.98  E-value=7.9e-32  Score=272.17  Aligned_cols=236  Identities=25%  Similarity=0.317  Sum_probs=189.1

Q ss_pred             ccccCceEEEEeEec-CCcceeEEEeccCCcc---cHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecCCCCh
Q 006155          332 LGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQ---GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSL  407 (658)
Q Consensus       332 lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  407 (658)
                      ||+|+||.||+++.. +++.+++|.+......   ....+.+|+.++++++|+||+++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999854 4889999998765332   344688999999999999999999999999999999999999999


Q ss_pred             hhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCcccccc
Q 006155          408 DHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSR  487 (658)
Q Consensus       408 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  487 (658)
                      .+++..   ...+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......  .....
T Consensus        81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~  152 (250)
T cd05123          81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT  152 (250)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence            999843   236899999999999999999999987   9999999999999999999999999987654322  12334


Q ss_pred             ccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCCHHH
Q 006155          488 IVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITE  567 (658)
Q Consensus       488 ~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e  567 (658)
                      ..++..|++||...+...+.++|+||||+++||+++|+.|+.....   .........    +.      ..+.....  
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~----~~------~~~~~~~~--  217 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKILK----DP------LRFPEFLS--  217 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHhc----CC------CCCCCCCC--
Confidence            5788899999999888899999999999999999999999843321   122221111    10      11111111  


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCHHH
Q 006155          568 MIRCIHIGLLCVQENVASRPTMAS  591 (658)
Q Consensus       568 ~~~~~~i~~~Cl~~~p~~RPtm~e  591 (658)
                       ..+.+++..||+.||++||++.+
T Consensus       218 -~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         218 -PEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             -HHHHHHHHHHhcCCHhhCCCccc
Confidence             23456778999999999999965

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=7e-33  Score=269.56  Aligned_cols=209  Identities=26%  Similarity=0.330  Sum_probs=179.4

Q ss_pred             hccCCcccCcccccCceEEEEeE-ecCCcceeEEEeccCCcccHHH---HHHHHHHHHhcCCCCceeeeeeeccCCceEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLE---FKNEVLLVANLQHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~---~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  397 (658)
                      .-++|..+++||+|.||+|.+.+ ...|+.+|+|++++...-...+   -..|-.+|..-+||.+..|...++..+.+++
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            34788889999999999999987 3468899999998775444433   3568889999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE  477 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~  477 (658)
                      ||||..||.|..+|   .+.+.+++...+.+-.+|+.||.|||+++   ||.||||.+|.|||.+|++||+|||+++.--
T Consensus       246 VMeyanGGeLf~HL---srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I  319 (516)
T KOG0690|consen  246 VMEYANGGELFFHL---SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI  319 (516)
T ss_pred             EEEEccCceEeeeh---hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence            99999999999888   34567889999999999999999999988   9999999999999999999999999997421


Q ss_pred             cCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcch
Q 006155          478 MDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVED  538 (658)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~  538 (658)
                        .....+...+|||.|+|||++....|....|+|.+||++|||++|+.||.....+..-+
T Consensus       320 --~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFe  378 (516)
T KOG0690|consen  320 --KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFE  378 (516)
T ss_pred             --cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHH
Confidence              12234567899999999999999999999999999999999999999996554443333

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-31  Score=290.30  Aligned_cols=261  Identities=26%  Similarity=0.426  Sum_probs=209.2

Q ss_pred             cchhhhhhhccCCcccCcccccCceEEEEeE-ecCCcceeEEEeccCCcccHHHHHHHHHHHHhc-CCCCceeeeeeecc
Q 006155          314 FDFNTIRVATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANL-QHRNLVRLLGFSLE  391 (658)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~  391 (658)
                      .+++.+...++.|++.+.||+|.+|.||+++ .++|+..|||++.... ....+++.|.++++.+ .|||++.++|++..
T Consensus         9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k   87 (953)
T KOG0587|consen    9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIK   87 (953)
T ss_pred             cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence            4455666778899999999999999999998 5578889999887654 4455778899999888 59999999998863


Q ss_pred             -----CCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeE
Q 006155          392 -----GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPK  466 (658)
Q Consensus       392 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~k  466 (658)
                           ++++|||||||.+||..+++..-. ...+.|+.+..|+++++.||.+||...   ++|||||-.||||+.++.+|
T Consensus        88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK  163 (953)
T KOG0587|consen   88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK  163 (953)
T ss_pred             ecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence                 568999999999999999986544 667999999999999999999999986   99999999999999999999


Q ss_pred             EeccccccccccCCCccccccccccccccCccccccC-----CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHH
Q 006155          467 IADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG-----QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLS  541 (658)
Q Consensus       467 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~  541 (658)
                      |.|||++..++  .+.....+.+||+.|||||++...     .|+.++|+||+|++..||--|.+|+....+..      
T Consensus       164 LvDFGvSaQld--sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr------  235 (953)
T KOG0587|consen  164 LVDFGVSAQLD--STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR------  235 (953)
T ss_pred             Eeeeeeeeeee--cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh------
Confidence            99999987654  344566678999999999998643     47789999999999999999999985433211      


Q ss_pred             HHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          542 SAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       542 ~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                       +.-.......     |.+. ....-..++.+.+..|+..|-++||++.++++
T Consensus       236 -aLF~IpRNPP-----PkLk-rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  236 -ALFLIPRNPP-----PKLK-RPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             -hhccCCCCCC-----cccc-chhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence             0001111111     1111 12333456778889999999999999998874

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1e-31  Score=261.23  Aligned_cols=255  Identities=24%  Similarity=0.339  Sum_probs=191.6

Q ss_pred             cCcccccCceEEEEeE-ecCCcceeEEEeccCCcccHHHHHHHHHHHHhcC-CCCceeeeeeeccCCceEEEEEecCCCC
Q 006155          329 ANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQ-HRNLVRLLGFSLEGNERLLIYEFVPNTS  406 (658)
Q Consensus       329 ~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~gs  406 (658)
                      .+.||+|.|+.|-..+ +..|.++|||++.+........+.+|++++..-+ |+||+.|+.+|.++...|||||-|.||+
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            3579999999999886 6789999999999988778888999999999886 9999999999999999999999999999


Q ss_pred             hhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCC---CeEEeccccccccc--cCCC
Q 006155          407 LDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM---TPKIADFGMARLFE--MDET  481 (658)
Q Consensus       407 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~---~~kl~DFGla~~~~--~~~~  481 (658)
                      |..+|+   +++.+++.+..+++.+|+.||.|||.++   |.||||||+|||..+..   -+||+||.|..-+.  .+-+
T Consensus       163 lLshI~---~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s  236 (463)
T KOG0607|consen  163 LLSHIQ---KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS  236 (463)
T ss_pred             HHHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence            999984   5667999999999999999999999998   99999999999996543   47999998874332  2211


Q ss_pred             ---ccccccccccccccCccccc-----cCCCCcccccccccchHhHHHhCCCCCccCCCCC--------cchHHHHHHH
Q 006155          482 ---QGNTSRIVGTYGYMAPEYAM-----HGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGET--------VEDLLSSAWK  545 (658)
Q Consensus       482 ---~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~--------~~~l~~~~~~  545 (658)
                         .....+.+|+..|||||+..     .-.|+.+.|.||+|||+|-|++|..||...-+.+        -..-......
T Consensus       237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe  316 (463)
T KOG0607|consen  237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE  316 (463)
T ss_pred             CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence               22334578999999999863     2358889999999999999999999995322211        1111111111


Q ss_pred             hccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          546 NWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       546 ~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ...+|.. +..|.... ....+..+   ++..-+-.++.+|-++.+|+.
T Consensus       317 sIQEGkY-eFPdkdWa-hIS~eakd---lisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  317 SIQEGKY-EFPDKDWA-HISSEAKD---LISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HHhccCC-cCChhhhH-HhhHHHHH---HHHHHHhccHHhhhhhhhccC
Confidence            1222221 11111110 01223333   333445699999999998875

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=5.7e-33  Score=263.95  Aligned_cols=257  Identities=24%  Similarity=0.333  Sum_probs=192.1

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc-ccHHHHHHHHHHHHhc-CCCCceeeeeeeccCCceEEEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANL-QHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      .++.+....||.|.||+|+|-.++ .|+.+|||++..... ...+++..|.+...+- +.||||+++|.+..+...|+.|
T Consensus        63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM  142 (361)
T KOG1006|consen   63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM  142 (361)
T ss_pred             cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence            456677789999999999998754 589999999987654 4556678888766554 6999999999999999999999


Q ss_pred             EecCCCChhhhhcC--cCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccc
Q 006155          400 EFVPNTSLDHFIFD--PTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE  477 (658)
Q Consensus       400 e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~  477 (658)
                      |.| ..||+.+-..  ..+...+++.-+-+|...++.||.||.+.-  +|||||+||+|||||..|.+||+|||++-.+.
T Consensus       143 ELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv  219 (361)
T KOG1006|consen  143 ELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV  219 (361)
T ss_pred             HHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH
Confidence            999 4676654311  123456888888889999999999999864  69999999999999999999999999986543


Q ss_pred             cCCCccccccccccccccCcccccc--CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccc
Q 006155          478 MDETQGNTSRIVGTYGYMAPEYAMH--GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNI  555 (658)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  555 (658)
                      ..   ...+..+|-..|||||.+..  ..|..+|||||+|+.|+|+.||+.|+...+     ++++.... ...+....+
T Consensus       220 ~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-----svfeql~~-Vv~gdpp~l  290 (361)
T KOG1006|consen  220 DS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-----SVFEQLCQ-VVIGDPPIL  290 (361)
T ss_pred             HH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-----HHHHHHHH-HHcCCCCee
Confidence            22   12334578899999999853  348999999999999999999999974332     22232222 222333222


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          556 IDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       556 ~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ..+.-   ..+--..+...+-.|+-.|-.+||+..++.+
T Consensus       291 ~~~~~---~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  291 LFDKE---CVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             cCccc---ccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            22111   1222234455666899999999999998764

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=7e-31  Score=286.57  Aligned_cols=204  Identities=23%  Similarity=0.331  Sum_probs=155.8

Q ss_pred             hhccCCcccCcccccCceEEEEeEe-----------------cCCcceeEEEeccCCcccHHHH--------------HH
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRL-----------------YDGAEIAVKRLSRDSGQGDLEF--------------KN  369 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~-----------------~~g~~vavK~l~~~~~~~~~~~--------------~~  369 (658)
                      ...++|++.++||+|+||.||+|..                 .+++.||||++.........+|              ..
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            3578999999999999999999963                 2356799999875443322333              34


Q ss_pred             HHHHHHhcCCCCc-----eeeeeeecc--------CCceEEEEEecCCCChhhhhcCcC---------------------
Q 006155          370 EVLLVANLQHRNL-----VRLLGFSLE--------GNERLLIYEFVPNTSLDHFIFDPT---------------------  415 (658)
Q Consensus       370 E~~~l~~l~H~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~---------------------  415 (658)
                      |+.++.+++|.++     ++++++|..        ..+.+|||||+++++|.++++...                     
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            6777777877654     677787653        356899999999999999986421                     


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCcccccccccccccc
Q 006155          416 RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYM  495 (658)
Q Consensus       416 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~  495 (658)
                      ....++|..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...... ......+|+.|+
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~  377 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYS  377 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCccee
Confidence            1124578889999999999999999987   999999999999999999999999999765433211 112234588999


Q ss_pred             CccccccCCC----------------------CcccccccccchHhHHHhCCC-CC
Q 006155          496 APEYAMHGQY----------------------SVKSDVFSFGVLVLEIISGQR-NN  528 (658)
Q Consensus       496 aPE~~~~~~~----------------------s~ksDV~S~Gvll~elltG~~-p~  528 (658)
                      |||.+.....                      ..+.||||+||+++||++|.. |+
T Consensus       378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~  433 (507)
T PLN03224        378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPV  433 (507)
T ss_pred             ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCc
Confidence            9998754321                      235799999999999999875 54

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=275.36  Aligned_cols=243  Identities=27%  Similarity=0.388  Sum_probs=190.9

Q ss_pred             cCcccccCceEEEEeEe-cCCcceeEEEeccC--CcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecCCC
Q 006155          329 ANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRD--SGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNT  405 (658)
Q Consensus       329 ~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g  405 (658)
                      .+.||.|.||+||-|+. +.|+.||||++.+.  ..+....+++|+.+|.+++||.||.|.-.|...+..++|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            56899999999999984 46999999998764  3345567899999999999999999999999999999999999655


Q ss_pred             ChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCC---CCeEEeccccccccccCCCc
Q 006155          406 SLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE---MTPKIADFGMARLFEMDETQ  482 (658)
Q Consensus       406 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~---~~~kl~DFGla~~~~~~~~~  482 (658)
                      =|+-+|..  ....|++..-..++.||+.||.|||.++   |+|.||||+||||...   -.+||+|||+||++....  
T Consensus       649 MLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--  721 (888)
T KOG4236|consen  649 MLEMILSS--EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--  721 (888)
T ss_pred             HHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh--
Confidence            55555532  3456888888889999999999999998   9999999999999653   479999999999886532  


Q ss_pred             cccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCC
Q 006155          483 GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSS  562 (658)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~  562 (658)
                       -....+||+.|+|||+++.+.|...-|+||.|||+|--++|..||.  .++++.+.++.+.-++....+.++       
T Consensus       722 -FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN--EdEdIndQIQNAaFMyPp~PW~ei-------  791 (888)
T KOG4236|consen  722 -FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN--EDEDINDQIQNAAFMYPPNPWSEI-------  791 (888)
T ss_pred             -hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC--CccchhHHhhccccccCCCchhhc-------
Confidence             2335799999999999999999999999999999999999999873  344555555555444433332222       


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 006155          563 GSITEMIRCIHIGLLCVQENVASRPTMASVV  593 (658)
Q Consensus       563 ~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv  593 (658)
                        ..+.   ++++-.-||..-++|-+..+-+
T Consensus       792 --s~~A---idlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  792 --SPEA---IDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             --CHHH---HHHHHHHHHHHHHHhcchHhhc
Confidence              1222   2333345677777787766544

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=4.5e-31  Score=265.17  Aligned_cols=221  Identities=18%  Similarity=0.146  Sum_probs=172.9

Q ss_pred             cCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecCCCChhhhhcC
Q 006155          335 GGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFD  413 (658)
Q Consensus       335 G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  413 (658)
                      |.||.||+++. .+++.+|+|++....     .+..|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            88999999985 467889999986643     234455556666899999999999999999999999999999998843


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCcccccccccccc
Q 006155          414 PTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG  493 (658)
Q Consensus       414 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~  493 (658)
                         ...+++.....++.|+++||.|||+.+   ++||||||+||+++.++.++++|||++..+...     .....++..
T Consensus        79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~  147 (237)
T cd05576          79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM  147 (237)
T ss_pred             ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence               345899999999999999999999987   999999999999999999999999987655432     122345778


Q ss_pred             ccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHH
Q 006155          494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIH  573 (658)
Q Consensus       494 y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~  573 (658)
                      |+|||.+..+.++.++||||+|+++|||++|+.++......            ....     ....+.....   ..+.+
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------------~~~~-----~~~~~~~~~~---~~~~~  207 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------------INTH-----TTLNIPEWVS---EEARS  207 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------------cccc-----cccCCcccCC---HHHHH
Confidence            99999998888999999999999999999999876321110            0000     0001111111   23456


Q ss_pred             HHHHhcCCCCCCCCCHHH
Q 006155          574 IGLLCVQENVASRPTMAS  591 (658)
Q Consensus       574 i~~~Cl~~~p~~RPtm~e  591 (658)
                      ++.+|++.||++||++.+
T Consensus       208 li~~~l~~dp~~R~~~~~  225 (237)
T cd05576         208 LLQQLLQFNPTERLGAGV  225 (237)
T ss_pred             HHHHHccCCHHHhcCCCc
Confidence            778999999999999743

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=1.6e-30  Score=260.12  Aligned_cols=238  Identities=26%  Similarity=0.353  Sum_probs=191.0

Q ss_pred             CceEEEEeEecC-CcceeEEEeccCCccc-HHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecCCCChhhhhcC
Q 006155          336 GFGAVYKGRLYD-GAEIAVKRLSRDSGQG-DLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFD  413 (658)
Q Consensus       336 ~fg~Vy~~~~~~-g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  413 (658)
                      +||.||+++..+ |+.+++|++....... ...+.+|+..+++++|+||+++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            589999999764 8899999997765544 67899999999999999999999999999999999999999999999854


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCcccccccccccc
Q 006155          414 PTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG  493 (658)
Q Consensus       414 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~  493 (658)
                      .   ..+++..++.++.++++++.|||+.+   ++|+||+|+||+++.++.++|+|||.+.......   ......++..
T Consensus        81 ~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~  151 (244)
T smart00220       81 R---GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE  151 (244)
T ss_pred             c---cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence            2   22899999999999999999999987   9999999999999999999999999998765432   2334568889


Q ss_pred             ccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHH
Q 006155          494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIH  573 (658)
Q Consensus       494 y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~  573 (658)
                      |++||.+....++.++||||||+++|||++|+.|+...  ..........    ..+......    ...  .....+.+
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~--~~~~~~~~~~----~~~~~~~~~----~~~--~~~~~~~~  219 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD--DQLLELFKKI----GKPKPPFPP----PEW--KISPEAKD  219 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CcHHHHHHHH----hccCCCCcc----ccc--cCCHHHHH
Confidence            99999999888999999999999999999999887432  1122222221    111111000    000  01135667


Q ss_pred             HHHHhcCCCCCCCCCHHHHHH
Q 006155          574 IGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       574 i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ++.+|+..+|++||++.++++
T Consensus       220 ~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      220 LIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHccCCchhccCHHHHhh
Confidence            888999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.4e-31  Score=280.06  Aligned_cols=240  Identities=23%  Similarity=0.289  Sum_probs=187.0

Q ss_pred             hccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhc-CCCCceeeeeeeccCCceEEEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANL-QHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      .++.|.....+|.|+|+.|-++.. ..++..+||++.+...    +-.+|+.++... +||||+++.+.+.++.+.++||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            466788888899999999998874 4688899999977622    234566555555 6999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceee-CCCCCeEEecccccccccc
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLL-DAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl-~~~~~~kl~DFGla~~~~~  478 (658)
                      |.+.++-|.+.+..   ..... ..+..|+.+|+.++.|||+++   +|||||||+|||+ +..++++|+|||.++....
T Consensus       396 e~l~g~ell~ri~~---~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  396 ELLDGGELLRRIRS---KPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER  468 (612)
T ss_pred             hhccccHHHHHHHh---cchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence            99999988776632   22223 677789999999999999988   9999999999999 6899999999999987654


Q ss_pred             CCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCC
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP  558 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp  558 (658)
                      .     ....+-|..|.|||++....|++.+||||||++||||++|+.|+.....+  .++.    .....+...     
T Consensus       469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~----~~i~~~~~s-----  532 (612)
T KOG0603|consen  469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIH----TRIQMPKFS-----  532 (612)
T ss_pred             h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHH----HhhcCCccc-----
Confidence            3     23346788999999999999999999999999999999999998644333  2222    222222111     


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          559 TLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       559 ~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                         ....++   ..+++.+|||.||.+||+|.++..
T Consensus       533 ---~~vS~~---AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  533 ---ECVSDE---AKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             ---cccCHH---HHHHHHHhccCChhhCcChhhhcc
Confidence               111122   225666899999999999999863

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=268.48  Aligned_cols=213  Identities=30%  Similarity=0.354  Sum_probs=173.6

Q ss_pred             hhhccCCcccCcccccCceEEEEeEecC-CcceeEEEeccCCcccHHH---HHHHHHHHHhc-CCCCceeeeeeeccCCc
Q 006155          320 RVATDNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLE---FKNEVLLVANL-QHRNLVRLLGFSLEGNE  394 (658)
Q Consensus       320 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~---~~~E~~~l~~l-~H~niv~l~~~~~~~~~  394 (658)
                      ++-..+|..+.+||+|+||.|.++..+. .+.+|||+++++..-...+   -..|-.+|+.. +-|.++++..+++.-+.
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            4455688889999999999999997443 4568999998764322222   23455566554 57899999999999999


Q ss_pred             eEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          395 RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      +++||||+.||+|-.+|..   -..+.+..+..++.+||-||-+||+++   ||.||||..|||||.+|++||+|||+++
T Consensus       425 LyFVMEyvnGGDLMyhiQQ---~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcK  498 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQ---VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK  498 (683)
T ss_pred             eeeEEEEecCchhhhHHHH---hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccc
Confidence            9999999999999888843   345677888899999999999999998   9999999999999999999999999997


Q ss_pred             ccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHH
Q 006155          475 LFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSA  543 (658)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~  543 (658)
                      .--.  ....+.+.+||+.|+|||++...+|...+|+|||||+||||+.|+.||+..+   ..++....
T Consensus       499 Eni~--~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD---E~elF~aI  562 (683)
T KOG0696|consen  499 ENIF--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED---EDELFQAI  562 (683)
T ss_pred             cccc--CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHH
Confidence            4211  1234556899999999999999999999999999999999999999995433   34444443

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-30  Score=234.11  Aligned_cols=196  Identities=29%  Similarity=0.459  Sum_probs=164.3

Q ss_pred             CCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          325 NFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      +|...++||+|.||+||+|+.. .++.||+|++..+..  .......+|+-+++.++|+|||+++++...++..-||+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4566789999999999999854 477899998865432  2334578999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      |. .+|..+..  .-...++.+....++.|+++||.|+|+.+   +.||||||.|.|++.+|+.|++|||+++.|.-.-.
T Consensus        83 cd-qdlkkyfd--slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr  156 (292)
T KOG0662|consen   83 CD-QDLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR  156 (292)
T ss_pred             hh-HHHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence            94 46766652  23567899999999999999999999988   99999999999999999999999999998865432


Q ss_pred             ccccccccccccccCccccccCC-CCcccccccccchHhHHHhCCCCC
Q 006155          482 QGNTSRIVGTYGYMAPEYAMHGQ-YSVKSDVFSFGVLVLEIISGQRNN  528 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDV~S~Gvll~elltG~~p~  528 (658)
                        .....+-|.+|.+|.++.+.+ |+...|+||-|||+.||-...+|.
T Consensus       157 --cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrpl  202 (292)
T KOG0662|consen  157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL  202 (292)
T ss_pred             --eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCC
Confidence              122345689999999998765 889999999999999998865554

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=1.4e-30  Score=291.10  Aligned_cols=257  Identities=19%  Similarity=0.238  Sum_probs=167.6

Q ss_pred             hhccCCcccCcccccCceEEEEeEecC-----CcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeee------e
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLYD-----GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGF------S  389 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~-----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~------~  389 (658)
                      ...++|+..++||+|+||.||+|+..+     +..||||++.....  ...+.+|  .+....+.+++.++..      .
T Consensus       129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~  204 (566)
T PLN03225        129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSS  204 (566)
T ss_pred             CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence            356789999999999999999998654     68899998764321  1111111  1222223333333222      2


Q ss_pred             ccCCceEEEEEecCCCChhhhhcCcCCC-----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEecc
Q 006155          390 LEGNERLLIYEFVPNTSLDHFIFDPTRR-----------------AQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDL  452 (658)
Q Consensus       390 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl  452 (658)
                      ..+.+.++||||+++++|.+++......                 ....+..+..++.||+.||.|||+.+   |+||||
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDL  281 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDV  281 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcC
Confidence            4566889999999999999988542110                 01123345679999999999999987   999999


Q ss_pred             CCCceeeCC-CCCeEEeccccccccccCCCccccccccccccccCccccccC----------------------CCCccc
Q 006155          453 KTSNVLLDA-EMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG----------------------QYSVKS  509 (658)
Q Consensus       453 k~~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~ks  509 (658)
                      ||+|||++. ++.+||+|||+++.+...... ......||+.|||||.+...                      .++.++
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            999999986 589999999999865433222 23346789999999965322                      244567


Q ss_pred             ccccccchHhHHHhCCCCCccCCCCCcchHHHHH------HHhccCCCcccccCCCCCCCC-------HHHHHHHHHHHH
Q 006155          510 DVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSA------WKNWREGTTVNIIDPTLSSGS-------ITEMIRCIHIGL  576 (658)
Q Consensus       510 DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~------~~~~~~~~~~~~~dp~l~~~~-------~~e~~~~~~i~~  576 (658)
                      |||||||++|||+++..+.+.    ....+....      ...|+.     .+.+....+.       ..+-....+++.
T Consensus       361 DVwSlGviL~el~~~~~~~~~----~~~~~~~~l~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~d~~~~~~~dLi~  431 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDS----NLIQFNRQLKRNDYDLVAWRK-----LVEPRASPDLRRGFEVLDLDGGAGWELLK  431 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCch----HHHHHHHHHHhcCCcHHHHHH-----hhccccchhhhhhhhhccccchHHHHHHH
Confidence            999999999999997655321    111111000      001110     1111100000       000112346888


Q ss_pred             HhcCCCCCCCCCHHHHHH
Q 006155          577 LCVQENVASRPTMASVVL  594 (658)
Q Consensus       577 ~Cl~~~p~~RPtm~evv~  594 (658)
                      .|++.||++|||+.++++
T Consensus       432 ~mL~~dP~kR~ta~e~L~  449 (566)
T PLN03225        432 SMMRFKGRQRISAKAALA  449 (566)
T ss_pred             HHccCCcccCCCHHHHhC
Confidence            999999999999999985

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-30  Score=252.23  Aligned_cols=252  Identities=22%  Similarity=0.256  Sum_probs=189.5

Q ss_pred             hccCCccc-CcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhc-CCCCceeeeeeecc----CCc
Q 006155          322 ATDNFSDA-NKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANL-QHRNLVRLLGFSLE----GNE  394 (658)
Q Consensus       322 ~~~~~~~~-~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~~  394 (658)
                      .+++|++. ++||-|-.|.|-.... ..|+.+|+|++...     ...++|+++--.. .|||||.+++++.+    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            45666553 5799999999988864 45889999988533     2346777765544 69999999998754    456


Q ss_pred             eEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCC---CCCeEEeccc
Q 006155          395 RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDA---EMTPKIADFG  471 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~---~~~~kl~DFG  471 (658)
                      +++|||.|+||.|...+.+. ....+++.++-.|+.||..|+.|||+.+   |.||||||+|+|...   |-.+||+|||
T Consensus       134 LLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence            78999999999999998653 3456999999999999999999999988   999999999999964   4568999999


Q ss_pred             cccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCC
Q 006155          472 MARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGT  551 (658)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  551 (658)
                      +|+.-.   ......+.+-|+.|.|||++...+|+...|+||+||++|-|++|-+||....+....--....   .+.+.
T Consensus       210 FAK~t~---~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~r---I~~gq  283 (400)
T KOG0604|consen  210 FAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRR---IRTGQ  283 (400)
T ss_pred             cccccC---CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhH---hhccC
Confidence            998633   234455678899999999999999999999999999999999999999654432222111111   11111


Q ss_pred             cccccCCCCCCCCHHHHHH-HHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          552 TVNIIDPTLSSGSITEMIR-CIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       552 ~~~~~dp~l~~~~~~e~~~-~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      . +.     .....+++.+ ..+++...|..+|++|-|+.+++.
T Consensus       284 y-~F-----P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  284 Y-EF-----PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             c-cC-----CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            1 11     1111222222 225556678999999999999974

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.6e-30  Score=270.40  Aligned_cols=209  Identities=24%  Similarity=0.357  Sum_probs=174.7

Q ss_pred             hhccCCcccCcccccCceEEEEeEecC-CcceeEEEeccCCc---ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceE
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSG---QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERL  396 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  396 (658)
                      ....-|..++.||-|.||+|.++...| ...+|.|.|.+.+.   ......+.|-.+|+..+.+.||+|+-.|.+++.+|
T Consensus       626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY  705 (1034)
T KOG0608|consen  626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY  705 (1034)
T ss_pred             ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence            344568888999999999999997444 55679998866532   22334788999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccc
Q 006155          397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF  476 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~  476 (658)
                      +||||++||++-.+|.   +...+.+...+.++.++..|+++.|..+   +|||||||+|||||.+|++||+||||+.-|
T Consensus       706 FVMdYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGf  779 (1034)
T KOG0608|consen  706 FVMDYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF  779 (1034)
T ss_pred             EEEeccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccc
Confidence            9999999999999884   4467888889999999999999999988   999999999999999999999999998643


Q ss_pred             cc---------CCCc-------------------------------cccccccccccccCccccccCCCCcccccccccc
Q 006155          477 EM---------DETQ-------------------------------GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGV  516 (658)
Q Consensus       477 ~~---------~~~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gv  516 (658)
                      .-         +...                               ......+||+.|+|||++....|+..+|+||.||
T Consensus       780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gv  859 (1034)
T KOG0608|consen  780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGV  859 (1034)
T ss_pred             eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhH
Confidence            20         0000                               0011258999999999999999999999999999


Q ss_pred             hHhHHHhCCCCCccCCCCC
Q 006155          517 LVLEIISGQRNNCFRNGET  535 (658)
Q Consensus       517 ll~elltG~~p~~~~~~~~  535 (658)
                      ||+||+.|+.||......+
T Consensus       860 il~em~~g~~pf~~~tp~~  878 (1034)
T KOG0608|consen  860 ILYEMLVGQPPFLADTPGE  878 (1034)
T ss_pred             HHHHHhhCCCCccCCCCCc
Confidence            9999999999996554443

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-31  Score=272.42  Aligned_cols=245  Identities=22%  Similarity=0.269  Sum_probs=199.3

Q ss_pred             hhccCCcccCcccccCceEEEEeEecCCc-ceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceE
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLYDGA-EIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERL  396 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~-~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  396 (658)
                      +...++..+..||-||||.|-+.+..... .+|+|.+++..   ......+..|-.+|...+.|.||+++-.+.+....|
T Consensus       417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY  496 (732)
T KOG0614|consen  417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY  496 (732)
T ss_pred             cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence            34456777788999999999998865433 48998887653   233345788999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccc
Q 006155          397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF  476 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~  476 (658)
                      ++||-|-||.|...|.   .+..++......++..+++|++|||.++   ||.|||||+|.+||.+|-+||.|||+|+.+
T Consensus       497 mLmEaClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki  570 (732)
T KOG0614|consen  497 MLMEACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKI  570 (732)
T ss_pred             hhHHhhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHh
Confidence            9999999999999994   4566888889999999999999999998   999999999999999999999999999987


Q ss_pred             ccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccccc
Q 006155          477 EMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNII  556 (658)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  556 (658)
                      ..+.   .+.+.+||+.|.|||++.+...+..+|.||+|++++||++|++||...++....+++......|.-       
T Consensus       571 ~~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~-------  640 (732)
T KOG0614|consen  571 GSGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEF-------  640 (732)
T ss_pred             ccCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhc-------
Confidence            6543   466789999999999999999999999999999999999999999776666555555544433321       


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC
Q 006155          557 DPTLSSGSITEMIRCIHIGLLCVQENVASRPT  588 (658)
Q Consensus       557 dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPt  588 (658)
                       |+.-..      ...+++..-...+|.+|--
T Consensus       641 -Pr~I~k------~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  641 -PRRITK------TATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             -ccccch------hHHHHHHHHHhcCcHhhhc
Confidence             111111      2234444556789999965

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-30  Score=259.16  Aligned_cols=263  Identities=19%  Similarity=0.249  Sum_probs=198.6

Q ss_pred             hhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcCC--C----CceeeeeeeccCC
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQH--R----NLVRLLGFSLEGN  393 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~----niv~l~~~~~~~~  393 (658)
                      ..+++|.+..++|+|.||.|-+.... .+..||||+++.-... .+.-+-|++++.++.+  |    -+|.+.+|+.-.+
T Consensus        86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg  164 (415)
T KOG0671|consen   86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG  164 (415)
T ss_pred             ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence            34789999999999999999988643 3678999998664433 3344678999999842  2    3788889999999


Q ss_pred             ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCC------------
Q 006155          394 ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDA------------  461 (658)
Q Consensus       394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~------------  461 (658)
                      +.++|+|.+ |.|+.++|.. .+..+++...++.++.|++++++|||+..   ++|-||||+|||+-+            
T Consensus       165 hiCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  165 HICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             ceEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCc
Confidence            999999988 6789999954 34567899999999999999999999987   999999999999831            


Q ss_pred             --------CCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCC
Q 006155          462 --------EMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNG  533 (658)
Q Consensus       462 --------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~  533 (658)
                              +..+||.|||.|+.-..     ....++.|..|.|||++.+-.++..+||||+||||.|+.+|...|....+
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen  314 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN  314 (415)
T ss_pred             cceeccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence                    34689999999986332     22557889999999999999999999999999999999999998754432


Q ss_pred             CCcchHHHHHHH--------------hccCCC-------c----ccccCCCC-----CCCCHHHHHHHHHHHHHhcCCCC
Q 006155          534 ETVEDLLSSAWK--------------NWREGT-------T----VNIIDPTL-----SSGSITEMIRCIHIGLLCVQENV  583 (658)
Q Consensus       534 ~~~~~l~~~~~~--------------~~~~~~-------~----~~~~dp~l-----~~~~~~e~~~~~~i~~~Cl~~~p  583 (658)
                      .+...+.+.+..              ....+.       .    ....++..     ......+..++.+++..+|..||
T Consensus       315 ~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP  394 (415)
T KOG0671|consen  315 LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP  394 (415)
T ss_pred             HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence            221122222211              111110       0    00011110     01134566778999999999999


Q ss_pred             CCCCCHHHHHH
Q 006155          584 ASRPTMASVVL  594 (658)
Q Consensus       584 ~~RPtm~evv~  594 (658)
                      .+|+|+.|++.
T Consensus       395 ~~RiTl~EAL~  405 (415)
T KOG0671|consen  395 ARRITLREALS  405 (415)
T ss_pred             cccccHHHHhc
Confidence            99999999874

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.5e-31  Score=252.14  Aligned_cols=265  Identities=22%  Similarity=0.379  Sum_probs=193.7

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc-c-cHHHHHHHHHHHHhcCCCCceeeeeeeccC--------
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG-Q-GDLEFKNEVLLVANLQHRNLVRLLGFSLEG--------  392 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--------  392 (658)
                      ..|....+||+|.||+||+++.. .|+.||+|+...... . -...-.+|+.+|..|+|+|++.++..|...        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            45666789999999999999854 578889986644221 1 123457899999999999999999987532        


Q ss_pred             CceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccc
Q 006155          393 NERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGM  472 (658)
Q Consensus       393 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGl  472 (658)
                      ...+||+.+++. +|..+|.+.  ...++..++.+++.++..||.|+|...   |+|||+|+.|+||+.++.+||+|||+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence            347999999965 777777543  345888999999999999999999887   99999999999999999999999999


Q ss_pred             ccccccCCCc--cccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccC
Q 006155          473 ARLFEMDETQ--GNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWRE  549 (658)
Q Consensus       473 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  549 (658)
                      ++.|...+..  ...+..+-|..|.+||.+.+ ..|+.+.|||.-|||+.||+++.+-+..........++.........
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk  250 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK  250 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence            9988654332  22333456999999998876 46999999999999999999998876444333333444433333333


Q ss_pred             CCcccccC---------CCCCCC---CHHH-HH------HHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          550 GTTVNIID---------PTLSSG---SITE-MI------RCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       550 ~~~~~~~d---------p~l~~~---~~~e-~~------~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      +.+.+...         +.+...   ..++ +.      ..++++...+..||.+||+..+++.
T Consensus       251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence            32222211         112111   1111 11      2456667789999999999998873

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=2.1e-30  Score=280.44  Aligned_cols=246  Identities=25%  Similarity=0.348  Sum_probs=185.7

Q ss_pred             CCcccCcccccCceE-EEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcC-CCCceeeeeeeccCCceEEEEEec
Q 006155          325 NFSDANKLGQGGFGA-VYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQ-HRNLVRLLGFSLEGNERLLIYEFV  402 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~-Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~  402 (658)
                      -|...+.+|.|.-|+ ||+|. .+|++||||++-...   ..-..+|+..+..-+ |||||++++...+++..|+..|.|
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~-ye~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGV-YEGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEe-eCCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            355667789999886 79997 589999999985432   223478999998874 999999999999999999999999


Q ss_pred             CCCChhhhhcCcCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCC---C--CCeEEecccccccc
Q 006155          403 PNTSLDHFIFDPTR-RAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDA---E--MTPKIADFGMARLF  476 (658)
Q Consensus       403 ~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~---~--~~~kl~DFGla~~~  476 (658)
                       ..+|.+++..... .....-...+.++.|+++||++||+.+   ||||||||.||||+.   +  ..++|+|||+++.+
T Consensus       586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence             5799999855311 111111456778999999999999976   999999999999975   3  57899999999998


Q ss_pred             ccCCCc-cccccccccccccCccccccCCCCcccccccccchHhHHHhC-CCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          477 EMDETQ-GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG-QRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       477 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      ..++.. .......||.||+|||++....-+..+|+||+||++|+.++| .+||......+. ++       +.......
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-NI-------l~~~~~L~  733 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-NI-------LTGNYTLV  733 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-hh-------hcCcccee
Confidence            876543 345668899999999999998888899999999999999997 789853221110 11       11111011


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 006155          555 IIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVV  593 (658)
Q Consensus       555 ~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv  593 (658)
                      .+.+    ....   ...+++..++..+|..||++.+|+
T Consensus       734 ~L~~----~~d~---eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  734 HLEP----LPDC---EAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             eecc----CchH---HHHHHHHHhcCCCcccCCCHHHHh
Confidence            1111    1111   334677789999999999999998

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=5e-30  Score=235.59  Aligned_cols=210  Identities=27%  Similarity=0.379  Sum_probs=171.4

Q ss_pred             chhhhhhhccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccC-CcccHHHHHHHHHHHHhc-CCCCceeeeeeecc
Q 006155          315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRD-SGQGDLEFKNEVLLVANL-QHRNLVRLLGFSLE  391 (658)
Q Consensus       315 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~  391 (658)
                      ....+++..++......||+|++|.|-+-++ .+|..+|||++... ..+..+....|+.+..+- .+|.+|.++|...+
T Consensus        37 ~~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r  116 (282)
T KOG0984|consen   37 GDRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR  116 (282)
T ss_pred             ecCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence            3444677788888899999999999988764 57899999998765 334455677788876554 69999999999999


Q ss_pred             CCceEEEEEecCCCChhhhhcC-cCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecc
Q 006155          392 GNERLLIYEFVPNTSLDHFIFD-PTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADF  470 (658)
Q Consensus       392 ~~~~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DF  470 (658)
                      ....++.||.| ..||+.+-.. -.+...+++.-.-+|+..+.+||.|||++-  .+||||+||+|||++.+|++|||||
T Consensus       117 egdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDF  193 (282)
T KOG0984|consen  117 EGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDF  193 (282)
T ss_pred             cccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccc
Confidence            99999999998 5678766432 134567889999999999999999999964  6999999999999999999999999


Q ss_pred             ccccccccCCCccccccccccccccCcccccc----CCCCcccccccccchHhHHHhCCCCCcc
Q 006155          471 GMARLFEMDETQGNTSRIVGTYGYMAPEYAMH----GQYSVKSDVFSFGVLVLEIISGQRNNCF  530 (658)
Q Consensus       471 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDV~S~Gvll~elltG~~p~~~  530 (658)
                      |++-.+...-.   .+-..|...|||||.+..    ..|+.|+||||+|+.+.||.+++.|++.
T Consensus       194 GIsG~L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  194 GISGYLVDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             ccceeehhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence            99876643221   122467889999998853    3699999999999999999999999753

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=8.5e-30  Score=248.81  Aligned_cols=205  Identities=27%  Similarity=0.343  Sum_probs=175.2

Q ss_pred             hhhhccCCcccCcccccCceEEEEeEecC-CcceeEEEeccCC---cccHHHHHHHHHHHHhc-CCCCceeeeeeeccCC
Q 006155          319 IRVATDNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDS---GQGDLEFKNEVLLVANL-QHRNLVRLLGFSLEGN  393 (658)
Q Consensus       319 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~  393 (658)
                      ..+..++|...++||+|+|.+|-.+++.. .+.+|+|++++.-   .++..-.+.|-.+.... +||.+|-|..++..+.
T Consensus       245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes  324 (593)
T KOG0695|consen  245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES  324 (593)
T ss_pred             cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence            34567899999999999999999998654 6678999887652   22333356676777665 6999999999999999


Q ss_pred             ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccc
Q 006155          394 ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMA  473 (658)
Q Consensus       394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla  473 (658)
                      .+++|.||+++|+|--++   ++++.|+++..+.+..+|.-+|.|||+.+   ||.||||..|||||.+|++||+|+|++
T Consensus       325 rlffvieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmc  398 (593)
T KOG0695|consen  325 RLFFVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMC  398 (593)
T ss_pred             eEEEEEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchh
Confidence            999999999999997666   45667999999999999999999999998   999999999999999999999999998


Q ss_pred             cccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccC
Q 006155          474 RLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFR  531 (658)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~  531 (658)
                      +.--  .....+.+.+||+.|+|||++.+..|....|+|++||+++||+.|+.||+..
T Consensus       399 ke~l--~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv  454 (593)
T KOG0695|consen  399 KEGL--GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV  454 (593)
T ss_pred             hcCC--CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence            7421  1223466789999999999999999999999999999999999999999753

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=3.7e-29  Score=233.08  Aligned_cols=204  Identities=24%  Similarity=0.422  Sum_probs=170.3

Q ss_pred             hccCCcccCcccccCceEEEEeE-ecCCcceeEEEeccCCcccHHHHHHHHHHHHhcC-CCCceeeeeeeccC--CceEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQ-HRNLVRLLGFSLEG--NERLL  397 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~l  397 (658)
                      ..++|++.+++|+|.|++||.|. ..++++++||+++.-   ..+.+++|+.+|..|. ||||++|++...+.  ....|
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            35789999999999999999997 557888999999764   3456899999999998 99999999998765  45689


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCC-CCeEEecccccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE-MTPKIADFGMARLF  476 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~-~~~kl~DFGla~~~  476 (658)
                      |+||+.+.+...+-      ..|+...+..++.++++||.|+|+.|   |.|||+||.|+++|.. -.++|+|+|+|..+
T Consensus       113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY  183 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  183 (338)
T ss_pred             HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence            99999999887665      45777888999999999999999998   9999999999999964 57999999999988


Q ss_pred             ccCCCccccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHH
Q 006155          477 EMDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLS  541 (658)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~  541 (658)
                      ..+...+   ..+.+..|--||.+..- .|+..-|+|||||++.+|+..+.|| +......++++.
T Consensus       184 Hp~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepF-FhG~dN~DQLVk  245 (338)
T KOG0668|consen  184 HPGKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF-FHGHDNYDQLVK  245 (338)
T ss_pred             CCCceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcc-cCCCCCHHHHHH
Confidence            7665543   23567788999998765 5888999999999999999999998 333333444443

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=6.3e-28  Score=235.23  Aligned_cols=211  Identities=35%  Similarity=0.564  Sum_probs=181.9

Q ss_pred             ccccCceEEEEeEecC-CcceeEEEeccCCcc-cHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecCCCChhh
Q 006155          332 LGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQ-GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDH  409 (658)
Q Consensus       332 lG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  409 (658)
                      ||+|++|.||+++..+ ++.+++|++...... ....+.+|+..+..++|++|+++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999998654 889999998766443 34578999999999999999999999999999999999999999999


Q ss_pred             hhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCC-CCCeEEeccccccccccCCCccccccc
Q 006155          410 FIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDA-EMTPKIADFGMARLFEMDETQGNTSRI  488 (658)
Q Consensus       410 ~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~  488 (658)
                      ++....  ..+++..++.++.+++++|.|||+.+   ++|+||+|.||+++. ++.++|+|||.+........  .....
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~  153 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI  153 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence            984321  46899999999999999999999987   999999999999999 89999999999986543321  12234


Q ss_pred             cccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCCHHH
Q 006155          489 VGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITE  567 (658)
Q Consensus       489 ~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e  567 (658)
                      .+...|++||.+... ..+.+.|+|++|+++++|                                              
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence            578899999999887 888999999999999999                                              


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 006155          568 MIRCIHIGLLCVQENVASRPTMASVVLML  596 (658)
Q Consensus       568 ~~~~~~i~~~Cl~~~p~~RPtm~evv~~L  596 (658)
                       ..+.+++..|++.+|++||++.++++.|
T Consensus       188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence             2456778899999999999999998643

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4e-30  Score=244.97  Aligned_cols=264  Identities=22%  Similarity=0.325  Sum_probs=191.4

Q ss_pred             CCcccCcccccCceEEEEeEe-cCCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeeccC-----CceE
Q 006155          325 NFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEG-----NERL  396 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~  396 (658)
                      +.+..+.||-|.||.||..+. .+|+.||+|++..--  -...+.+.+|+.++...+|.|++..++.....     +++|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            345567899999999999874 469999999986532  22345688999999999999999999876544     3668


Q ss_pred             EEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccc
Q 006155          397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF  476 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~  476 (658)
                      +++|.| ..+|..+|..   ...++-..+.-+++||++||.|||+.+   |.||||||.|.|++.|..+||+|||+++.-
T Consensus       134 V~TELm-QSDLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARve  206 (449)
T KOG0664|consen  134 VLTELM-QSDLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTW  206 (449)
T ss_pred             HHHHHH-Hhhhhheecc---CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccccc
Confidence            888988 5688888854   345777888889999999999999988   999999999999999999999999999987


Q ss_pred             ccCCCccccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHH--------Hhc
Q 006155          477 EMDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAW--------KNW  547 (658)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~--------~~~  547 (658)
                      +.++....+. .+-|..|.|||++++. .|+...||||.|||+.||+..+..|...++....+++....        +.-
T Consensus       207 e~d~~~hMTq-EVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A  285 (449)
T KOG0664|consen  207 DQRDRLNMTH-EVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA  285 (449)
T ss_pred             chhhhhhhHH-HHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence            6665544443 3558899999999876 59999999999999999998887775443322222222110        111


Q ss_pred             cCCCccccc-----CCC------CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 006155          548 REGTTVNII-----DPT------LSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN  597 (658)
Q Consensus       548 ~~~~~~~~~-----dp~------l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~  597 (658)
                      -+|....++     .|.      +.+....+. ..+++..+.+..+|++|.+-.+.+..+.
T Consensus       286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~h-eav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNH-EAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             hhhhHHHhhccCCCCCCccceeeecCCcccch-HHHHHHHHHhCCCCcccccHhhhccccc
Confidence            111111111     111      111111111 2234555678999999999988886653

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=5.8e-27  Score=232.05  Aligned_cols=198  Identities=32%  Similarity=0.488  Sum_probs=171.2

Q ss_pred             CcccCcccccCceEEEEeEecC-CcceeEEEeccCCcc-cHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecC
Q 006155          326 FSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQ-GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVP  403 (658)
Q Consensus       326 ~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~  403 (658)
                      |...+.||+|++|.||++...+ ++.+++|.+...... ....+.+|+..+.+++|+|++++++++...+..++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4567889999999999999765 789999999876544 56678999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCcc
Q 006155          404 NTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQG  483 (658)
Q Consensus       404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  483 (658)
                      +++|.+++....  ..+++.....++.+++.++.|||+.+   ++|+||+|+||+++.++.++|+|||++..+..... .
T Consensus        81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~  154 (225)
T smart00221       81 GGDLFDYLRKKG--GKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-A  154 (225)
T ss_pred             CCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-c
Confidence            999999985322  12899999999999999999999987   99999999999999999999999999987654321 1


Q ss_pred             ccccccccccccCcccc-ccCCCCcccccccccchHhHHHhCCCCCc
Q 006155          484 NTSRIVGTYGYMAPEYA-MHGQYSVKSDVFSFGVLVLEIISGQRNNC  529 (658)
Q Consensus       484 ~~~~~~gt~~y~aPE~~-~~~~~s~ksDV~S~Gvll~elltG~~p~~  529 (658)
                      ......++..|++||.+ ....++.++|||+||++++||++|+.||.
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS  201 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence            22335678899999998 66778889999999999999999999984

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=5.7e-28  Score=251.32  Aligned_cols=195  Identities=26%  Similarity=0.422  Sum_probs=166.2

Q ss_pred             cCCcccCcccccCceEEEEeEecC-CcceeEEEeccCCc-----ccHH---HHHHHHHHHHhcC---CCCceeeeeeecc
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSG-----QGDL---EFKNEVLLVANLQ---HRNLVRLLGFSLE  391 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~-----~~~~---~~~~E~~~l~~l~---H~niv~l~~~~~~  391 (658)
                      .+|...+.||+|.||.|+.+..+. ..+|+||.+.+...     -...   .+-.|+++|..|+   |+||++++++|.+
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            358889999999999999998654 56789998765421     1111   1456999999997   9999999999999


Q ss_pred             CCceEEEEEec-CCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecc
Q 006155          392 GNERLLIYEFV-PNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADF  470 (658)
Q Consensus       392 ~~~~~lv~e~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DF  470 (658)
                      ++.++|+||-. ++.+|.++|   .....+++.+...|+.||+.|+++||+++   |||||||-+||.++.+|-+||+||
T Consensus       641 dd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence            99999999986 466888888   44567999999999999999999999998   999999999999999999999999


Q ss_pred             ccccccccCCCccccccccccccccCccccccCCCCc-ccccccccchHhHHHhCCCCC
Q 006155          471 GMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSV-KSDVFSFGVLVLEIISGQRNN  528 (658)
Q Consensus       471 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~-ksDV~S~Gvll~elltG~~p~  528 (658)
                      |.+.+...+    .....+||.+|.|||++.+.+|-- .-|||++|++||.++..+.|+
T Consensus       715 gsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  715 GSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             cchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence            999765433    345679999999999999988754 589999999999999887776

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=1.2e-27  Score=252.86  Aligned_cols=251  Identities=26%  Similarity=0.355  Sum_probs=197.5

Q ss_pred             hccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      ..++|+...++|.|.||.|||++. ..++..|||.++........-+..|+.+++.-+|||||.++|-+...+..++.||
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            457899999999999999999983 4688899999988877777778899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      |+.+|+|.+.-+   ...++++.++....++.++||.|||+.+   -+|||||-.|||+++.|.+|++|||.+-.+..  
T Consensus        93 ycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita--  164 (829)
T KOG0576|consen   93 YCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA--  164 (829)
T ss_pred             ecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh--
Confidence            999999998864   3467889999999999999999999998   79999999999999999999999999865432  


Q ss_pred             CccccccccccccccCcccc---ccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccC
Q 006155          481 TQGNTSRIVGTYGYMAPEYA---MHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID  557 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~---~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  557 (658)
                      +-.......||+.|||||+.   +.+.|..++|||+.|+...|+---+.|.-...+.       .+.....+    ...+
T Consensus       165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm-------r~l~LmTk----S~~q  233 (829)
T KOG0576|consen  165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM-------RALFLMTK----SGFQ  233 (829)
T ss_pred             hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH-------HHHHHhhc----cCCC
Confidence            22344557999999999987   4677999999999999999997666553111110       11111111    1112


Q ss_pred             C-CCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 006155          558 P-TLSSG-SITEMIRCIHIGLLCVQENVASRPTMASVV  593 (658)
Q Consensus       558 p-~l~~~-~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv  593 (658)
                      | .+... -..+  .+-+++..|+..||.+||+++.++
T Consensus       234 pp~lkDk~kws~--~fh~fvK~altknpKkRptaeklL  269 (829)
T KOG0576|consen  234 PPTLKDKTKWSE--FFHNFVKGALTKNPKKRPTAEKLL  269 (829)
T ss_pred             CCcccCCccchH--HHHHHHHHHhcCCCccCCChhhhe
Confidence            2 22211 1122  223566678999999999998766

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.93  E-value=1.4e-26  Score=226.36  Aligned_cols=195  Identities=30%  Similarity=0.400  Sum_probs=161.7

Q ss_pred             hccCCcccCcccccCceEEEEeE-ecCCcceeEEEeccC--CcccHHHHHHHHHHHHhcCCCCceeeeeeeccCC-----
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRD--SGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGN-----  393 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----  393 (658)
                      ...+|...+.+|.|.- .|-.+. .-.++.||+|++...  .........+|..++..+.|+||++++.++.-..     
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~   93 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF   93 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence            4567888888999988 444443 235889999988654  3344556788999999999999999999987543     


Q ss_pred             -ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccc
Q 006155          394 -ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGM  472 (658)
Q Consensus       394 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGl  472 (658)
                       +.++|||+| ..+|...++     -.++-+...+|+.|+..|+.|||+.+   |+||||||+||++..+..+||.|||+
T Consensus        94 ~e~y~v~e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~  164 (369)
T KOG0665|consen   94 QEVYLVMELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGL  164 (369)
T ss_pred             HhHHHHHHhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchh
Confidence             568999999 567877774     34777889999999999999999998   99999999999999999999999999


Q ss_pred             ccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCc
Q 006155          473 ARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNC  529 (658)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~  529 (658)
                      ++.-..+   -..+..+.|..|.|||++.+-.+.+.+||||.||++.||++|+-.|.
T Consensus       165 ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~  218 (369)
T KOG0665|consen  165 ARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP  218 (369)
T ss_pred             hcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec
Confidence            9853322   23445678999999999998889999999999999999999997664

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.93  E-value=3.8e-26  Score=231.46  Aligned_cols=200  Identities=24%  Similarity=0.410  Sum_probs=166.8

Q ss_pred             hhhhccCCcccCcccccCceEEEEeEec----CCcceeEEEeccCCcccHHHHHHHHHHHHhcC-CCCceeeeeeeccCC
Q 006155          319 IRVATDNFSDANKLGQGGFGAVYKGRLY----DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQ-HRNLVRLLGFSLEGN  393 (658)
Q Consensus       319 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~  393 (658)
                      +....+.|...++||+|.|++||++.+.    ..+.||+|.+...+.  ...+.+|+++|..+. +.||+++.+++..++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            3445678899999999999999999854    367899999877643  345789999999996 999999999999999


Q ss_pred             ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCC-CCeEEecccc
Q 006155          394 ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE-MTPKIADFGM  472 (658)
Q Consensus       394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~-~~~kl~DFGl  472 (658)
                      ...+|+||+++....++..      .++...+..+++.++.||.++|.++   ||||||||+|+|.+.. +.-.|.|||+
T Consensus       109 ~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL  179 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL  179 (418)
T ss_pred             eeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence            9999999999999999883      4778899999999999999999998   9999999999999754 5678999999


Q ss_pred             ccccccCC-------------Cc-----------------------------cccccccccccccCcccccc-CCCCccc
Q 006155          473 ARLFEMDE-------------TQ-----------------------------GNTSRIVGTYGYMAPEYAMH-GQYSVKS  509 (658)
Q Consensus       473 a~~~~~~~-------------~~-----------------------------~~~~~~~gt~~y~aPE~~~~-~~~s~ks  509 (658)
                      |...+..+             ..                             .......||+||.|||++.. +..+.++
T Consensus       180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai  259 (418)
T KOG1167|consen  180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI  259 (418)
T ss_pred             HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence            97321100             00                             00012579999999999865 4578999


Q ss_pred             ccccccchHhHHHhCCCCCc
Q 006155          510 DVFSFGVLVLEIISGQRNNC  529 (658)
Q Consensus       510 DV~S~Gvll~elltG~~p~~  529 (658)
                      ||||-|||++-+++++.||-
T Consensus       260 Diws~GVI~Lslls~~~PFf  279 (418)
T KOG1167|consen  260 DIWSAGVILLSLLSRRYPFF  279 (418)
T ss_pred             ceeeccceeehhhccccccc
Confidence            99999999999999999983

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.93  E-value=2e-26  Score=237.06  Aligned_cols=266  Identities=19%  Similarity=0.205  Sum_probs=202.7

Q ss_pred             hhhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcC------CCCceeeeeeeccC
Q 006155          320 RVATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQ------HRNLVRLLGFSLEG  392 (658)
Q Consensus       320 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~~~~~~~  392 (658)
                      ++....|.+....|+|-|++|.+|... .|.+||||++....... +.=+.|+++|.+|.      .-|.++|+-.|...
T Consensus       428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~-KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk  506 (752)
T KOG0670|consen  428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH-KTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK  506 (752)
T ss_pred             hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh-hhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence            456678888899999999999999843 48899999997653222 23367999999995      34899999999999


Q ss_pred             CceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCC-CeEEeccc
Q 006155          393 NERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM-TPKIADFG  471 (658)
Q Consensus       393 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~-~~kl~DFG  471 (658)
                      ++++||+|-+ .-+|.++|........|....+..++.|+.-||..|..-+   |+|.||||.|||+++.- .+||||||
T Consensus       507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfG  582 (752)
T KOG0670|consen  507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFG  582 (752)
T ss_pred             ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCc
Confidence            9999999987 6789999988777788999999999999999999999887   99999999999998764 57999999


Q ss_pred             cccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHH-----HHh
Q 006155          472 MARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSA-----WKN  546 (658)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~-----~~~  546 (658)
                      .|.....++..    ...-+.-|.|||++.+-.|+...|+||.||.||||.||+..|..........+.-..     -++
T Consensus       583 SA~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Km  658 (752)
T KOG0670|consen  583 SASFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKM  658 (752)
T ss_pred             ccccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHH
Confidence            99765443321    122345799999999999999999999999999999999887543322211111100     011


Q ss_pred             ccCCCc---------------------------cccc------------CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC
Q 006155          547 WREGTT---------------------------VNII------------DPTLSSGSITEMIRCIHIGLLCVQENVASRP  587 (658)
Q Consensus       547 ~~~~~~---------------------------~~~~------------dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RP  587 (658)
                      ++++..                           ...+            .+.+..+....+..+..|.-.|+..||++|-
T Consensus       659 lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi  738 (752)
T KOG0670|consen  659 LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI  738 (752)
T ss_pred             hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC
Confidence            111110                           0001            1223334556677788899999999999999


Q ss_pred             CHHHHHH
Q 006155          588 TMASVVL  594 (658)
Q Consensus       588 tm~evv~  594 (658)
                      |..+.++
T Consensus       739 t~nqAL~  745 (752)
T KOG0670|consen  739 TVNQALK  745 (752)
T ss_pred             CHHHHhc
Confidence            9988764

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.2e-25  Score=230.50  Aligned_cols=132  Identities=26%  Similarity=0.354  Sum_probs=107.9

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhcC-----C---CCceeeeeeec---
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQ-----H---RNLVRLLGFSL---  390 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~~~~~---  390 (658)
                      ..+|.+.++||-|.|++||++.. .+.+.||+|+.+... .-.+.-..||.+|.+++     |   ..||+|+++|.   
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            37899999999999999999973 356789999886432 23334578999998883     3   36999999985   


Q ss_pred             -cCCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceee
Q 006155          391 -EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLL  459 (658)
Q Consensus       391 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl  459 (658)
                       .+.+.+||+|++ |-+|..+|.. ...+-++...+.+|++||+.||.|||.++  .|||-||||+||||
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~-s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKY-SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHH-hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence             467899999999 5567666643 23456899999999999999999999987  59999999999999

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.92  E-value=3.2e-26  Score=268.60  Aligned_cols=195  Identities=19%  Similarity=0.295  Sum_probs=138.7

Q ss_pred             cCC-CCceeeeeee-------ccCCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEE
Q 006155          377 LQH-RNLVRLLGFS-------LEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRII  448 (658)
Q Consensus       377 l~H-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv  448 (658)
                      ++| +||+++++++       ......++++||+ +++|.++|...  ...+++.+++.++.||++||.|||+++   |+
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---Iv  102 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---IV  102 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence            455 6888888877       2334567888987 66999999542  356999999999999999999999988   99


Q ss_pred             EeccCCCceeeCC-------------------CCCeEEeccccccccccCCC--------------cccccccccccccc
Q 006155          449 HRDLKTSNVLLDA-------------------EMTPKIADFGMARLFEMDET--------------QGNTSRIVGTYGYM  495 (658)
Q Consensus       449 HrDlk~~NILl~~-------------------~~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~  495 (658)
                      ||||||+||||+.                   ++.+||+|||+++.......              ........||+.||
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            9999999999954                   45566777777654321000              00011246899999


Q ss_pred             CccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHH
Q 006155          496 APEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIG  575 (658)
Q Consensus       496 aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~  575 (658)
                      |||++.+..++.++|||||||+||||++|..|+...     ...+...    ...    .+.+..    .....+...++
T Consensus       183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~-----~~~~~~~----~~~----~~~~~~----~~~~~~~~~~~  245 (793)
T PLN00181        183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK-----SRTMSSL----RHR----VLPPQI----LLNWPKEASFC  245 (793)
T ss_pred             ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH-----HHHHHHH----HHh----hcChhh----hhcCHHHHHHH
Confidence            999999999999999999999999999988775311     1111111    100    111111    11122345677


Q ss_pred             HHhcCCCCCCCCCHHHHHH
Q 006155          576 LLCVQENVASRPTMASVVL  594 (658)
Q Consensus       576 ~~Cl~~~p~~RPtm~evv~  594 (658)
                      .+||+.+|.+||+|.||++
T Consensus       246 ~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        246 LWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHhCCCChhhCcChHHHhh
Confidence            8899999999999999975

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2.9e-25  Score=212.06  Aligned_cols=253  Identities=18%  Similarity=0.298  Sum_probs=187.3

Q ss_pred             ccCCcccCcccccCceEEEEeEecC-CcceeEEEeccCCcccHHHHHHHHHHHHhc-CCCCceeeeee-eccCCceEEEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFKNEVLLVANL-QHRNLVRLLGF-SLEGNERLLIY  399 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~-~~~~~~~~lv~  399 (658)
                      .+.|.+.+.||+|.||.+-++.+.. ...+++|-+.+.. ....+|.+|...--.| .|.||+.-+++ |...+.+++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            4788899999999999999998654 6678999887653 3456889998776666 49999988765 56667788999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeC--CCCCeEEeccccccccc
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLD--AEMTPKIADFGMARLFE  477 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~--~~~~~kl~DFGla~~~~  477 (658)
                      ||+|.|+|..-+-.    ..+.+....+++.|+++|+.|+|+++   +||||||.+||||-  +...+||+|||+.+..+
T Consensus       102 E~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             ccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence            99999999887733    44778888999999999999999998   99999999999993  34489999999987543


Q ss_pred             cCCCccccccccccccccCccccccC-----CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCc
Q 006155          478 MDETQGNTSRIVGTYGYMAPEYAMHG-----QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTT  552 (658)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  552 (658)
                      .     ......-+..|.+||.....     +..+.+|||.||++++.++||+.|+...   ...+-..+.|..|..+..
T Consensus       175 ~-----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka---~~~d~~Y~~~~~w~~rk~  246 (378)
T KOG1345|consen  175 T-----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA---SIMDKPYWEWEQWLKRKN  246 (378)
T ss_pred             c-----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh---hccCchHHHHHHHhcccC
Confidence            2     12223346679999976432     3467899999999999999999999532   233444456666665554


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 006155          553 VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLML  596 (658)
Q Consensus       553 ~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L  596 (658)
                      ..+.  ..-..-.+   +++++..+-+..+|++|=...++.+|-
T Consensus       247 ~~~P--~~F~~fs~---~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  247 PALP--KKFNPFSE---KALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             ccCc--hhhcccCH---HHHHHHHHhcCCcccccchhHHHHHHH
Confidence            4331  11111112   333445567899999996666666554

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.91  E-value=9.5e-25  Score=208.55  Aligned_cols=165  Identities=18%  Similarity=0.203  Sum_probs=124.2

Q ss_pred             CChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCccc
Q 006155          405 TSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN  484 (658)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~  484 (658)
                      |+|.+++..  ....++|..++.|+.||++||.|||+.+         ||+|||++.++.+|+  ||+++......    
T Consensus         1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence            688898853  2346999999999999999999999875         999999999999999  99988654321    


Q ss_pred             cccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCC
Q 006155          485 TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGS  564 (658)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~  564 (658)
                         ..||+.|||||++.+..++.++|||||||++|||++|+.|+.....  ....+..........      ++... ..
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~--~~~~~~~~~~~~~~~------~~~~~-~~  131 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE--LSAILEILLNGMPAD------DPRDR-SN  131 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch--hcHHHHHHHHHhccC------Ccccc-cc
Confidence               2688999999999999999999999999999999999999843221  122222222111111      01100 11


Q ss_pred             HHHH---HHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          565 ITEM---IRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       565 ~~e~---~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      ...+   ..+.+++..||+.+|++||++.++++.+..
T Consensus       132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~  168 (176)
T smart00750      132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA  168 (176)
T ss_pred             HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence            1222   247788999999999999999999988753

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=9.1e-24  Score=221.48  Aligned_cols=170  Identities=19%  Similarity=0.228  Sum_probs=132.8

Q ss_pred             hhhhhhccCCcccCcccccCceEEEEeEec--CCcceeEEEeccCC-----cccHHHHHHHHHHHHhcCCCCcee-eeee
Q 006155          317 NTIRVATDNFSDANKLGQGGFGAVYKGRLY--DGAEIAVKRLSRDS-----GQGDLEFKNEVLLVANLQHRNLVR-LLGF  388 (658)
Q Consensus       317 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~--~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~-l~~~  388 (658)
                      +..+...++|...+.||+|+||+||+|+..  +++.||||++....     ......|.+|+.++.+++|+|++. ++.+
T Consensus        11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~   90 (365)
T PRK09188         11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT   90 (365)
T ss_pred             cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc
Confidence            345567789999999999999999999754  47778999875331     112445899999999999999985 4432


Q ss_pred             eccCCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEecc-CCCceeeCCCCCeEE
Q 006155          389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDL-KTSNVLLDAEMTPKI  467 (658)
Q Consensus       389 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl-k~~NILl~~~~~~kl  467 (658)
                          ...+|||||+++++|....    ...      ...++.+++++|.|||+.+   |+|||| ||+|||++.++.+||
T Consensus        91 ----~~~~LVmE~~~G~~L~~~~----~~~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikL  153 (365)
T PRK09188         91 ----GKDGLVRGWTEGVPLHLAR----PHG------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAV  153 (365)
T ss_pred             ----CCcEEEEEccCCCCHHHhC----ccc------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEE
Confidence                4579999999999996321    101      1467899999999999987   999999 999999999999999


Q ss_pred             eccccccccccCCCccc------cccccccccccCccccccC
Q 006155          468 ADFGMARLFEMDETQGN------TSRIVGTYGYMAPEYAMHG  503 (658)
Q Consensus       468 ~DFGla~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~  503 (658)
                      +|||+++.+........      .....+++.|+|||++...
T Consensus       154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            99999997754332111      1356789999999998644

>PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function

Probab=99.90  E-value=4.2e-24  Score=185.41  Aligned_cols=101  Identities=46%  Similarity=0.828  Sum_probs=78.3

Q ss_pred             CCCC-CCCCcc-CCCchHHHHHHHHHHHhhhcccCC--CCcceeccCCCCCeEEEEEeccCCCChhhhhHHHHHHHHHHH
Q 006155           25 NVCS-NDVGNY-TSNSAYKTNLNSVLSSIASNAAVD--YGFYNESAGQEPDKVNVFALCRGDIATDVCRGCLENATQEIL  100 (658)
Q Consensus        25 ~~C~-~~~~~~-~~~s~~~~nl~~l~~~l~~~a~~~--~~~~~~~~g~~~~~vygl~~C~~D~~~~~C~~Cl~~a~~~~~  100 (658)
                      +.|+ +..++| +++++|++||+.||+.|+.+++..  .+|+++..|.++++|||++||++|+++.+|..||+.|+..+.
T Consensus         2 ~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~~~~f~~~~~~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~~   81 (106)
T PF01657_consen    2 HFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSSSKGFATGSAGSGPDTVYGLAQCRGDLSPSDCRACLADAVANIS   81 (106)
T ss_dssp             --E---SSB----TT-THHHHHHHHHHHHHHHGGGTT-TEEEEEE--ST---EEEEEEE-TTS-HHHHHHHHHHHHCCHH
T ss_pred             CcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhccccCcEEeecCCCCCeEEEEEEcCCCCChhhhHHHHHHHHHHHH
Confidence            3577 435677 678889999999999999987654  469999889999999999999999999999999999999999


Q ss_pred             hhCCCcccEEEEcceeEEEEccccc
Q 006155          101 RVCPNQKQAIIWSAECMLRYSNKTI  125 (658)
Q Consensus       101 ~~C~~~~~~~i~~~~C~~ry~~~~f  125 (658)
                      +.|+++++|+||++.|+||||+++|
T Consensus        82 ~~C~~~~g~~v~~~~C~lRY~~~~F  106 (106)
T PF01657_consen   82 SCCPGSRGGRVWYDSCFLRYENYPF  106 (106)
T ss_dssp             HHTTSBSSEEEEESSEEEEEESS--
T ss_pred             HhCCCCceEEEECCCEEEEEECCCC
Confidence            9999999999999999999999998

The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D.

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.89  E-value=4.6e-24  Score=203.68  Aligned_cols=245  Identities=20%  Similarity=0.307  Sum_probs=185.1

Q ss_pred             ccCcccccCceEEEEeEecCCcceeEEEeccCCcc--cHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecCCC
Q 006155          328 DANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQ--GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNT  405 (658)
Q Consensus       328 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g  405 (658)
                      ..-+|.+...|+.|+|++ .|..+++|++......  -..+|.+|.-.++-..||||+.++|.|.....+.++..||+-|
T Consensus       194 l~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g  272 (448)
T KOG0195|consen  194 LITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG  272 (448)
T ss_pred             hhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence            344788899999999995 6777888887654332  2346899999999999999999999999999999999999999


Q ss_pred             ChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEe--ccccccccccCCCcc
Q 006155          406 SLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIA--DFGMARLFEMDETQG  483 (658)
Q Consensus       406 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~--DFGla~~~~~~~~~~  483 (658)
                      ||...|++. ....++-.+..+++.+||+|++|||+..+ -|.---|.++.|++|++.+++|+  |--++.         
T Consensus       273 slynvlhe~-t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~kfsf---------  341 (448)
T KOG0195|consen  273 SLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADTKFSF---------  341 (448)
T ss_pred             HHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheecccceeee---------
Confidence            999999864 34457788899999999999999999863 24445699999999999998875  211111         


Q ss_pred             ccccccccccccCccccccCCCC---cccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCC
Q 006155          484 NTSRIVGTYGYMAPEYAMHGQYS---VKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTL  560 (658)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~~~~s---~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l  560 (658)
                      ........+.||+||.+...+.+   ..+|+|||++++|||.|.+-||....+.+  .-...+...         +.+.+
T Consensus       342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme--cgmkialeg---------lrv~i  410 (448)
T KOG0195|consen  342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME--CGMKIALEG---------LRVHI  410 (448)
T ss_pred             eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh--hhhhhhhcc---------ccccC
Confidence            11123457899999999877644   47999999999999999999986444322  112222222         22334


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          561 SSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       561 ~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      .......+.++   +.-|..+||.+||.+..|+-+|++
T Consensus       411 ppgis~hm~kl---m~icmnedpgkrpkfdmivpilek  445 (448)
T KOG0195|consen  411 PPGISRHMNKL---MNICMNEDPGKRPKFDMIVPILEK  445 (448)
T ss_pred             CCCccHHHHHH---HHHHhcCCCCcCCCcceehhhHHH
Confidence            44433444444   445999999999999999999875

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=2.4e-21  Score=203.43  Aligned_cols=259  Identities=19%  Similarity=0.264  Sum_probs=190.5

Q ss_pred             CCcccCcccccCceEEEEeEecCC--cceeEEEeccCCcccHHHHHHHHHHHHhcCC----CCceeeeeee-ccCCceEE
Q 006155          325 NFSDANKLGQGGFGAVYKGRLYDG--AEIAVKRLSRDSGQGDLEFKNEVLLVANLQH----RNLVRLLGFS-LEGNERLL  397 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~~g--~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~~~~-~~~~~~~l  397 (658)
                      +|.+.++||+|+||.||++.....  ..+|+|............+..|+.++..+.+    +++..+++.. ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            899999999999999999985443  4788887766544333367888998888873    5888999888 47778899


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCC-----CCeEEecccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE-----MTPKIADFGM  472 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~-----~~~kl~DFGl  472 (658)
                      ||+.+ |.+|.++..... ...++..+.++|+.|++.+|++||+.+   ++||||||.|+++...     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99977 889999774333 567999999999999999999999998   9999999999999765     4689999999


Q ss_pred             ccccc--cCCC----ccc--cccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHH
Q 006155          473 ARLFE--MDET----QGN--TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAW  544 (658)
Q Consensus       473 a~~~~--~~~~----~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~  544 (658)
                      ++.+.  ....    ...  .....||..|.++....+...+.+.|+||++.++.|++.|..|+...........+....
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~  253 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP  253 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence            98332  2111    111  223569999999999999999999999999999999999999984433221111111111


Q ss_pred             HhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          545 KNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       545 ~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      ..       ..... +....+.++..+...   +-..+..++|....+...|...
T Consensus       254 ~~-------~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~Pdy~~~~~~l~~~  297 (322)
T KOG1164|consen  254 RK-------LLTDR-FGDLKPEEFAKILEY---IDSLDYEDKPDYEKLAELLKDV  297 (322)
T ss_pred             hh-------hcccc-ccCCChHHHHHHHHH---hhccCCcCCCCHHHHHHHHHHH
Confidence            11       01111 222244455444333   3347889999999998887543

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.87  E-value=6.4e-21  Score=198.45  Aligned_cols=261  Identities=27%  Similarity=0.376  Sum_probs=195.9

Q ss_pred             CcccCcccccCceEEEEeEecCCcceeEEEeccCCccc---HHHHHHHHHHHHhcCCC-CceeeeeeeccCCceEEEEEe
Q 006155          326 FSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQG---DLEFKNEVLLVANLQHR-NLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       326 ~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~lv~e~  401 (658)
                      |...+.||.|+||.||++...  ..+++|.+.......   ...+.+|+.++..+.|+ +|+++.+++......++++|+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            566788999999999999865  788999987764433   56789999999999988 799999999777778999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCC-CeEEeccccccccccCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM-TPKIADFGMARLFEMDE  480 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~-~~kl~DFGla~~~~~~~  480 (658)
                      +.++++.+++........+.......++.+++.++.|+|+.+   ++|||+||+||+++..+ .+++.|||+++.+....
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999977633211136889999999999999999999998   99999999999999988 79999999998665433


Q ss_pred             Ccc----ccccccccccccCcccccc---CCCCcccccccccchHhHHHhCCCCCccCCCC-CcchHHHHHHHhccCCCc
Q 006155          481 TQG----NTSRIVGTYGYMAPEYAMH---GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGE-TVEDLLSSAWKNWREGTT  552 (658)
Q Consensus       481 ~~~----~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~-~~~~l~~~~~~~~~~~~~  552 (658)
                      ...    ......||..|+|||.+.+   ..++...|+||+|++++++++|..|+...... .........+..... ..
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~  235 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SL  235 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-cc
Confidence            221    2456789999999999987   57889999999999999999999996433321 112222222222111 00


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          553 VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       553 ~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                      .....+..   .......+.++...|+..+|..|.++.+....
T Consensus       236 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         236 ASPLSPSN---PELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ccccCccc---cchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            00000000   01112344567778888999999999987753

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=2e-21  Score=216.98  Aligned_cols=252  Identities=23%  Similarity=0.302  Sum_probs=183.3

Q ss_pred             cccCcccccCceEEEEeEec-CCcceeEEEeccC--CcccH----HHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          327 SDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRD--SGQGD----LEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       327 ~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~----~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ...+.+|.|.+|.|+..+.. .....+.|.+...  .....    ..+..|+.+-..++|+|++..+....+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            45678999999977776532 3333444433210  11111    12556777778889999999888888777777779


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ||+++ +|..++..   ...++..++..++.|+..|+.|||+.+   |.|||||++|+++..+|.+||+|||.+..+..+
T Consensus       401 E~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hcccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            99999 99998833   236888889999999999999999998   999999999999999999999999999887655


Q ss_pred             CCc--cccccccccccccCccccccCCCCcc-cccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccccc
Q 006155          480 ETQ--GNTSRIVGTYGYMAPEYAMHGQYSVK-SDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNII  556 (658)
Q Consensus       480 ~~~--~~~~~~~gt~~y~aPE~~~~~~~s~k-sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  556 (658)
                      -..  ......+|+..|+|||++.+..|... .||||.|+++..|++|+.||......+... .......+..     + 
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~~~~~~~~~~-----~-  546 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-KTNNYSDQRN-----I-  546 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-hhhccccccc-----c-
Confidence            443  45567899999999999999998864 899999999999999999986443332211 0111000000     0 


Q ss_pred             CCCCCCCC--HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          557 DPTLSSGS--ITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       557 dp~l~~~~--~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                        ......  ...-.+...++..++|.+|.+|-||.+|++
T Consensus       547 --~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  547 --FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             --ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence              000000  111123457788899999999999999984

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=2.6e-20  Score=183.10  Aligned_cols=205  Identities=22%  Similarity=0.368  Sum_probs=171.1

Q ss_pred             ccCCcccCcccccCceEEEEeE-ecCCcceeEEEeccCCcccHHHHHHHHHHHHhcC-CCCceeeeeeeccCCceEEEEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQ-HRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      .-.|.+.++||+|.||.++.|+ +.+++.||||.-.+.+  ..-++..|....+.|. .++|...+-|-..+.+-.||+|
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid  104 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID  104 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence            3478899999999999999998 7789999999765543  2335678888888885 7999999999899999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCC-----CCeEEeccccccc
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE-----MTPKIADFGMARL  475 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~-----~~~kl~DFGla~~  475 (658)
                      .+ |.||+++..-  -.+.++.+++..++.|++.-++|+|++.   +|.|||||+|+||..-     ..+.|.|||+|+.
T Consensus       105 LL-GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  105 LL-GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hh-CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            88 7888887521  2346899999999999999999999998   9999999999999643     3588999999998


Q ss_pred             cccCCCcc-----ccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCC
Q 006155          476 FEMDETQG-----NTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGET  535 (658)
Q Consensus       476 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~  535 (658)
                      +....+..     ......||.+||+-....+...+.+.|+=|+|-+++..+.|..||..-....
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t  243 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT  243 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc
Confidence            76554432     2344689999999999999999999999999999999999999996444333

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.84  E-value=7.6e-21  Score=185.69  Aligned_cols=172  Identities=13%  Similarity=0.195  Sum_probs=135.0

Q ss_pred             hhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHH---------HHHHHHHHHhcCCCCceeeeeeecc
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLE---------FKNEVLLVANLQHRNLVRLLGFSLE  391 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~---------~~~E~~~l~~l~H~niv~l~~~~~~  391 (658)
                      ...++|...+.||.|+||.||.... ++..+|||.+..........         +.+|+..+.++.|++|..+..++..
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            4568999999999999999999764 67789999997654333322         5789999999999999999888553


Q ss_pred             C--------CceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCC
Q 006155          392 G--------NERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM  463 (658)
Q Consensus       392 ~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~  463 (658)
                      .        ...+|||||++|.+|.++..       ++.    ....+++.+|..||+.+   ++|||+||+||+++.++
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g  172 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG  172 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence            2        35789999999999987741       222    34669999999999998   99999999999999988


Q ss_pred             CeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHH
Q 006155          464 TPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEII  522 (658)
Q Consensus       464 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ell  522 (658)
                       ++|+|||.......+...              ..+.....|..++|+|+||+.+.-+.
T Consensus       173 -i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 -LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             -EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence             999999988754322111              11344555778999999999987664

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.83  E-value=1.1e-20  Score=201.71  Aligned_cols=216  Identities=25%  Similarity=0.385  Sum_probs=164.1

Q ss_pred             HHhcCCCCceeeeeeeccCCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccC
Q 006155          374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLK  453 (658)
Q Consensus       374 l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk  453 (658)
                      |+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+..  ....++|.....++++|++||.|||...  -..|+.|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence            3568999999999999999999999999999999999965  4567999999999999999999999864  23999999


Q ss_pred             CCceeeCCCCCeEEeccccccccccCCCccccccccccccccCccccccC-------CCCcccccccccchHhHHHhCCC
Q 006155          454 TSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG-------QYSVKSDVFSFGVLVLEIISGQR  526 (658)
Q Consensus       454 ~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~ksDV~S~Gvll~elltG~~  526 (658)
                      ++|+++|..+.+||+|||+..+..............-..-|.|||.+...       ..+.+.||||||++++|+++.+.
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            99999999999999999998776431111111122334579999998763       25778999999999999999999


Q ss_pred             CCccCCCC-CcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          527 NNCFRNGE-TVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       527 p~~~~~~~-~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      ||+..... +..+++.++.+.     ....+-|.+.... +....++.++..||.++|++||++.+|-..++..
T Consensus       157 ~~~~~~~~~~~~eii~~~~~~-----~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~  224 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRVKKG-----GSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI  224 (484)
T ss_pred             ccccccccCChHHHHHHHHhc-----CCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence            99754332 223444443331     1122233333221 1112577888899999999999999998888754

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.83  E-value=2.2e-20  Score=180.27  Aligned_cols=139  Identities=17%  Similarity=0.184  Sum_probs=108.2

Q ss_pred             cCcccccCceEEEEeEecCCcceeEEEeccCCcc--c-------HHH-----------------HHHHHHHHHhcCCCCc
Q 006155          329 ANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQ--G-------DLE-----------------FKNEVLLVANLQHRNL  382 (658)
Q Consensus       329 ~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~--~-------~~~-----------------~~~E~~~l~~l~H~ni  382 (658)
                      ...||+|+||.||+|...+|+.||||+++.....  .       ...                 ...|+..+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999999778999999998654211  1       111                 2349999999988876


Q ss_pred             eeeeeeeccCCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHh-hhcCCCcEEEeccCCCceeeCC
Q 006155          383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL-HEDSRLRIIHRDLKTSNVLLDA  461 (658)
Q Consensus       383 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDlk~~NILl~~  461 (658)
                      .....+..  ...+|||||++++++...+.   ....+++.....++.|++.+|.|| |+.+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence            44333222  23489999999987765432   234688999999999999999999 6777   99999999999998 


Q ss_pred             CCCeEEecccccccc
Q 006155          462 EMTPKIADFGMARLF  476 (658)
Q Consensus       462 ~~~~kl~DFGla~~~  476 (658)
                      ++.++|+|||++...
T Consensus       153 ~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCcEEEEEccccccC
Confidence            478999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.83  E-value=1.9e-20  Score=176.50  Aligned_cols=203  Identities=20%  Similarity=0.302  Sum_probs=167.4

Q ss_pred             hccCCcccCcccccCceEEEEeE-ecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCC-CCceeeeeeeccCCceEEEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQH-RNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lv~  399 (658)
                      ...+|..+++||.|+||.+|.|. ..+|++||||.-+......  .+.-|..+...|+| ..|..+..+..++..-.|||
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp--qL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP--QLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc--chhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            35789999999999999999997 6689999999876554333  46778888888875 67888888888899999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCC---CCeEEecccccccc
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE---MTPKIADFGMARLF  476 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~---~~~kl~DFGla~~~  476 (658)
                      +.+ |.||+++..-  -.+.++..+++-++.|++.-++|+|..+   +|||||||+|+|..-+   ..+.++|||+++.+
T Consensus        91 dLL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             ecc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence            988 8899888732  2345888999999999999999999998   9999999999999644   46889999999987


Q ss_pred             ccCCCcc-----ccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCC
Q 006155          477 EMDETQG-----NTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRN  532 (658)
Q Consensus       477 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~  532 (658)
                      ....+..     ......||.+|.+-....+...+.+.|+=|+|.+|..+-.|..||..-.
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk  225 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK  225 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence            6543321     1233679999998887777778899999999999999999999995433

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.82  E-value=1.4e-19  Score=175.04  Aligned_cols=141  Identities=20%  Similarity=0.227  Sum_probs=111.2

Q ss_pred             cCcccccCceEEEEeEecCCcceeEEEeccCCcc---------------------c-----HHHHHHHHHHHHhcCCCCc
Q 006155          329 ANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQ---------------------G-----DLEFKNEVLLVANLQHRNL  382 (658)
Q Consensus       329 ~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~---------------------~-----~~~~~~E~~~l~~l~H~ni  382 (658)
                      ...||+|+||.||+|+..+|+.||||++......                     .     ...+..|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4689999999999999778999999998765211                     0     1123578999999999987


Q ss_pred             eeeeeeeccCCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCcEEEeccCCCceeeCC
Q 006155          383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE-DSRLRIIHRDLKTSNVLLDA  461 (658)
Q Consensus       383 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NILl~~  461 (658)
                      .....+...  ..+|||||++++++.....   ....++.....+++.+++.+|.+||+ .+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence            554443332  3489999999886543321   22457788999999999999999999 77   99999999999999 


Q ss_pred             CCCeEEecccccccccc
Q 006155          462 EMTPKIADFGMARLFEM  478 (658)
Q Consensus       462 ~~~~kl~DFGla~~~~~  478 (658)
                      ++.++|+|||++.....
T Consensus       153 ~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCCEEEEEcccceecCC
Confidence            88999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function

Probab=99.80  E-value=4.9e-20  Score=159.91  Aligned_cols=103  Identities=43%  Similarity=0.709  Sum_probs=76.7

Q ss_pred             eeeec---ccCccCChHHHHHHHHHHHHHHHHHhcCCCCccceeeccccCCccceeEEeccCCCCChHhHHHHHHHHHhc
Q 006155          135 YYMWN---VNNVTDDVSLFNQALQDLLRRLRGTAASGNSQKKFATGDTTASFRTIYALEQCTPDLSELQCSDCLDRAIGE  211 (658)
Q Consensus       135 ~~~~~---~~~~~~~~~~f~~~~~~l~~~l~~~a~~~~~~~~fa~g~~~~~~~~~Y~laQCt~dls~~~C~~Cl~~~~~~  211 (658)
                      |..|+   .++.+.+...|+.++.+||..|+..|+... ..+|++++...+.++||||+||++||++.||..||..++..
T Consensus         1 ~~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~-~~~f~~~~~~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~   79 (106)
T PF01657_consen    1 WHFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSS-SKGFATGSAGSGPDTVYGLAQCRGDLSPSDCRACLADAVAN   79 (106)
T ss_dssp             ---E---SSB----TT-THHHHHHHHHHHHHHHGGGTT--TEEEEEE--ST---EEEEEEE-TTS-HHHHHHHHHHHHCC
T ss_pred             CCcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhcc-ccCcEEeecCCCCCeEEEEEEcCCCCChhhhHHHHHHHHHH
Confidence            45676   333322234499999999999999988653 46899998766778999999999999999999999999999


Q ss_pred             CCCccCCCccceEeCCccCCccccccc
Q 006155          212 IPNCCSGKIGGRVLKPSCNFRFETERF  238 (658)
Q Consensus       212 ~~~~c~~~~gg~v~~~~C~lrye~~~f  238 (658)
                      ++.+|+++.||++++++|++||+.++|
T Consensus        80 ~~~~C~~~~g~~v~~~~C~lRY~~~~F  106 (106)
T PF01657_consen   80 ISSCCPGSRGGRVWYDSCFLRYENYPF  106 (106)
T ss_dssp             HHHHTTSBSSEEEEESSEEEEEESS--
T ss_pred             HHHhCCCCceEEEECCCEEEEEECCCC
Confidence            999999999999999999999999887

The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D.

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=9.3e-19  Score=167.36  Aligned_cols=186  Identities=18%  Similarity=0.137  Sum_probs=139.8

Q ss_pred             cccCcccccCceEEEEeEecCCcceeEEEeccCCcccH----HHHHHHHHHHHhcC-CCCceeeeeeeccCCceEEEEEe
Q 006155          327 SDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGD----LEFKNEVLLVANLQ-HRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       327 ~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~----~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      .....|++|+||+||.+.. .+.+++.+.+........    .-+.+|+++|.+|+ |+++++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3456899999999998764 778888887766544222    14789999999995 5889999886    456999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEecc-CCCceeeCCCCCeEEeccccccccccCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDL-KTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl-k~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      +.|.+|...+..          ....++.+++++|.++|+.+   |+|||| ||+|||++.++.++|+|||++.......
T Consensus        80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            999998654311          12357889999999999998   999999 7999999999999999999998654322


Q ss_pred             Cc----c-------ccccccccccccCccccccC-CCC-cccccccccchHhHHHhCCCCCcc
Q 006155          481 TQ----G-------NTSRIVGTYGYMAPEYAMHG-QYS-VKSDVFSFGVLVLEIISGQRNNCF  530 (658)
Q Consensus       481 ~~----~-------~~~~~~gt~~y~aPE~~~~~-~~s-~ksDV~S~Gvll~elltG~~p~~~  530 (658)
                      ..    .       .......++.|++|+-..-- ..+ ...++++-|.-+|.++|++.+.-.
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence            10    0       01113367788888743221 223 567899999999999999987643

>PRK10345 hypothetical protein; Provisional

Probab=99.78  E-value=2e-18  Score=168.22  Aligned_cols=137  Identities=23%  Similarity=0.335  Sum_probs=107.4

Q ss_pred             CcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhc-----CCCCceeeeeeeccCC---c-eE
Q 006155          326 FSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANL-----QHRNLVRLLGFSLEGN---E-RL  396 (658)
Q Consensus       326 ~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~~~~~~~~---~-~~  396 (658)
                      +...+.||+|+||.||.  ..+....+||++..........+.+|+.++..+     +||||++++|++.++.   . ..
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            34567899999999996  333344479988765555566799999999999     5799999999998764   2 33


Q ss_pred             EEEEe--cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHH-HHhhhcCCCcEEEeccCCCceeeCC----CCCeEEec
Q 006155          397 LIYEF--VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGL-LYLHEDSRLRIIHRDLKTSNVLLDA----EMTPKIAD  469 (658)
Q Consensus       397 lv~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivHrDlk~~NILl~~----~~~~kl~D  469 (658)
                      +|+||  +++++|.+++.+    ..+++.  ..++.+++.++ +|||+++   |+||||||+|||++.    ++.++|+|
T Consensus        82 ~I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             EEecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence            78999  568999999943    235555  35688888888 9999988   999999999999974    34799999


Q ss_pred             cccc
Q 006155          470 FGMA  473 (658)
Q Consensus       470 FGla  473 (658)
                      |+.+
T Consensus       153 g~G~  156 (210)
T PRK10345        153 NIGE  156 (210)
T ss_pred             CCCC
Confidence            5444

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.76  E-value=1.8e-19  Score=200.66  Aligned_cols=251  Identities=18%  Similarity=0.176  Sum_probs=178.6

Q ss_pred             CCcccCcccccCceEEEEeEecCCcceeEEEeccCC-cccHHHHHHHHHH--HHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          325 NFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDS-GQGDLEFKNEVLL--VANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~-~~~~~~~~~E~~~--l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      ++...+.||.+.|=+|.+++.++|. |+||++-+.. .-....|+++++-  ...++|||.+++.-+-....--|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            5667789999999999999987777 9999886654 3334445554443  4455899999998887777777888888


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      ..+ +|.+.|   ..+.-+...+..=|+.|++.||.-+|..+   |+|+|||.+||||+.-..+.|+||...+...-.+.
T Consensus       103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence            854 677766   34455666777779999999999999998   99999999999999999999999998764432211


Q ss_pred             -cccccc----ccccccccCccccccC-----------CCCcccccccccchHhHHHhC-CCCCccCCCCCcchHHHHHH
Q 006155          482 -QGNTSR----IVGTYGYMAPEYAMHG-----------QYSVKSDVFSFGVLVLEIISG-QRNNCFRNGETVEDLLSSAW  544 (658)
Q Consensus       482 -~~~~~~----~~gt~~y~aPE~~~~~-----------~~s~ksDV~S~Gvll~elltG-~~p~~~~~~~~~~~l~~~~~  544 (658)
                       ......    ...-..|+|||.+...           ..+++-||||+||++.||++- +++|.      ..+|+.+..
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~------LSQL~aYr~  249 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT------LSQLLAYRS  249 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc------HHHHHhHhc
Confidence             111111    1222479999987431           267889999999999999985 66663      223333322


Q ss_pred             Hh-c-cCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 006155          545 KN-W-REGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYS  600 (658)
Q Consensus       545 ~~-~-~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~  600 (658)
                      .. . .+....++-|+           .+.++++.|+|.||++|-++++.++.-.+.-
T Consensus       250 ~~~~~~e~~Le~Ied~-----------~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~  296 (1431)
T KOG1240|consen  250 GNADDPEQLLEKIEDV-----------SLRNLILSMIQRDPSKRLSAEDYLQKYRGLV  296 (1431)
T ss_pred             cCccCHHHHHHhCcCc-----------cHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence            11 0 00001112122           2447778999999999999999998876643

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.75  E-value=2.5e-19  Score=191.00  Aligned_cols=186  Identities=29%  Similarity=0.318  Sum_probs=155.1

Q ss_pred             cccccCceEEEEeE----ecCCcceeEEEeccCCccc--HHHHHHHHHHHHhcC-CCCceeeeeeeccCCceEEEEEecC
Q 006155          331 KLGQGGFGAVYKGR----LYDGAEIAVKRLSRDSGQG--DLEFKNEVLLVANLQ-HRNLVRLLGFSLEGNERLLIYEFVP  403 (658)
Q Consensus       331 ~lG~G~fg~Vy~~~----~~~g~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~  403 (658)
                      .+|+|.||.|+..+    ...|.-+|+|.+.+.....  ......|..++...+ ||.+|++...+..+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999999764    2346778888776543211  113466888888887 9999999999999999999999999


Q ss_pred             CCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCcc
Q 006155          404 NTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQG  483 (658)
Q Consensus       404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  483 (658)
                      +|.|...+.   +...++......+...++-+++++|+.+   |+|||+|++||+++.+|++++.|||+++.+-..+.  
T Consensus        81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--  152 (612)
T KOG0603|consen   81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--  152 (612)
T ss_pred             cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence            999988873   3455777788888999999999999988   99999999999999999999999999986543322  


Q ss_pred             ccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCcc
Q 006155          484 NTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCF  530 (658)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~  530 (658)
                          .+||..|||||++.  .....+|.||||++.+||+||..||..
T Consensus       153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence                28999999999988  457789999999999999999999843

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.75  E-value=1.3e-18  Score=197.89  Aligned_cols=200  Identities=20%  Similarity=0.241  Sum_probs=160.8

Q ss_pred             hhhhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcC---CCCceeeeeeeccCCce
Q 006155          319 IRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQ---HRNLVRLLGFSLEGNER  395 (658)
Q Consensus       319 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~  395 (658)
                      .++..+.|.+.+.||+|+||+||+|...+|+.||+|+-+.....   +|.-=.+++.+|+   -+.|..+.....-.+..
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S  769 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNAS  769 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence            34566788999999999999999999888999999987665433   2333334555555   33455555556667888


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeC-------CCCCeEEe
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLD-------AEMTPKIA  468 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~-------~~~~~kl~  468 (658)
                      +||+||.+-|+|.+++.   ..+.++|.....++.|+++-++.||..+   |||+||||+|.||.       +..-++|+
T Consensus       770 ~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lI  843 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLI  843 (974)
T ss_pred             eeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEE
Confidence            99999999999999994   5678999999999999999999999988   99999999999994       23458999


Q ss_pred             ccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCC
Q 006155          469 DFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRN  527 (658)
Q Consensus       469 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p  527 (658)
                      |||-+.-+..-.........++|-++--+|+..+..++.++|.|.++-+++-|+.|+..
T Consensus       844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            99988543322222334556789999999999999999999999999999999999854

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.72  E-value=9.3e-19  Score=183.25  Aligned_cols=174  Identities=23%  Similarity=0.349  Sum_probs=131.1

Q ss_pred             ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccc
Q 006155          394 ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMA  473 (658)
Q Consensus       394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla  473 (658)
                      ..++.|+++...+|.++|..+......+|...+.++.|++.|++|   ++   .+|||+||.||+...+..+||+|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence            467999999999999999766666678899999999999999999   55   899999999999999999999999998


Q ss_pred             cccccCC----CccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhcc
Q 006155          474 RLFEMDE----TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWR  548 (658)
Q Consensus       474 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~  548 (658)
                      .......    .....+..+||..||+||.+.+.+|+.|+|||+||+||+||+. -...++-          .......+
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----------~~t~~d~r  473 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----------IATLTDIR  473 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----------HHhhhhhh
Confidence            7665544    2234556799999999999999999999999999999999998 2222110          01122233


Q ss_pred             CCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 006155          549 EGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMAS  591 (658)
Q Consensus       549 ~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~e  591 (658)
                      ++.+.    |....+.+.+.    .+.++.+...|.+||+..+
T Consensus       474 ~g~ip----~~~~~d~p~e~----~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  474 DGIIP----PEFLQDYPEEY----TLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             cCCCC----hHHhhcCcHHH----HHHHHhcCCCcccCchHHH
Confidence            33222    22222222222    3445789999999994443

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.72  E-value=1.3e-17  Score=167.80  Aligned_cols=233  Identities=18%  Similarity=0.250  Sum_probs=142.8

Q ss_pred             CCcccCcccccCceEEEEeEecC-CcceeEEEeccCCc---ccHHHHHHHHHHHHhcCC----------CCceeeeeeec
Q 006155          325 NFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSG---QGDLEFKNEVLLVANLQH----------RNLVRLLGFSL  390 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H----------~niv~l~~~~~  390 (658)
                      .+...+.||.|+++.||.++..+ |+++|||.+.....   ...+++++|...+..+.+          -.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            34456789999999999998654 89999998765432   234556777655555332          12222222111


Q ss_pred             ---------cC---C-----ceEEEEEecCCCChhhhhc---CcC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEE
Q 006155          391 ---------EG---N-----ERLLIYEFVPNTSLDHFIF---DPT-RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIH  449 (658)
Q Consensus       391 ---------~~---~-----~~~lv~e~~~~gsL~~~l~---~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH  449 (658)
                               .+   +     ..+++|+-+ .++|.+++.   ... ....+....++.+..|+++.+++||..+   ++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence                     11   1     225667766 678877752   111 1233555667788899999999999998   999


Q ss_pred             eccCCCceeeCCCCCeEEeccccccccccCCCccccccccccccccCccccccC--------CCCcccccccccchHhHH
Q 006155          450 RDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG--------QYSVKSDVFSFGVLVLEI  521 (658)
Q Consensus       450 rDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~s~ksDV~S~Gvll~el  521 (658)
                      +||+|+|+|++.+|.++|+||+.....+....   .  ...+..|.+||.....        .++.+.|.|++|+++|.|
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l  243 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR---C--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL  243 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEEEE---G--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCceee---c--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence            99999999999999999999988764332111   0  2345789999977442        478899999999999999


Q ss_pred             HhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCC
Q 006155          522 ISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASR  586 (658)
Q Consensus       522 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~R  586 (658)
                      ++|+.|+.........+.                 +-....+.++.+.   .++...|+.||++|
T Consensus       244 WC~~lPf~~~~~~~~~~~-----------------~f~~C~~~Pe~v~---~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  244 WCGRLPFGLSSPEADPEW-----------------DFSRCRDMPEPVQ---FLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHSS-STCCCGGGSTSGG-----------------GGTTSS---HHHH---HHHHHHT-SSGGGS
T ss_pred             HHccCCCCCCCccccccc-----------------cchhcCCcCHHHH---HHHHHHccCCcccC
Confidence            999999965433222211                 0111112222333   45567899999988

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.72  E-value=4.3e-17  Score=160.50  Aligned_cols=134  Identities=19%  Similarity=0.297  Sum_probs=113.3

Q ss_pred             CcccccCceEEEEeEecCCcceeEEEeccCCccc--------HHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          330 NKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQG--------DLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~--------~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      +.||+|++|.||+|.. .|..++||+........        ...+.+|+.++..++|++|.....++.+.+..++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999985 78889999865432211        13467899999999999998888777777888999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      +++++|.+++...      .+ .+..++.+++.+|.+||+.+   ++|+|++|.|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999988421      22 78899999999999999988   99999999999999 78999999999864

>smart00090 RIO RIO-like kinase

Probab=99.71  E-value=5.8e-17  Score=161.80  Aligned_cols=143  Identities=17%  Similarity=0.217  Sum_probs=111.3

Q ss_pred             CCcccCcccccCceEEEEeE--ecCCcceeEEEeccCCcc------------------------cHHHHHHHHHHHHhcC
Q 006155          325 NFSDANKLGQGGFGAVYKGR--LYDGAEIAVKRLSRDSGQ------------------------GDLEFKNEVLLVANLQ  378 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~--~~~g~~vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l~  378 (658)
                      .|.+.+.||+|+||.||+|.  ..+|+.||||++......                        ....+..|+..+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47788999999999999998  568999999988654210                        0123568999999997


Q ss_pred             CCC--ceeeeeeeccCCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCc
Q 006155          379 HRN--LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSN  456 (658)
Q Consensus       379 H~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~N  456 (658)
                      |.+  +.+++++    ...++||||+++.+|.....   ....+.......++.||+.+|.+||+.+  .++||||||+|
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~N  179 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYN  179 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhh
Confidence            633  4444443    23589999999988876542   2234556667899999999999999876  49999999999


Q ss_pred             eeeCCCCCeEEeccccccccc
Q 006155          457 VLLDAEMTPKIADFGMARLFE  477 (658)
Q Consensus       457 ILl~~~~~~kl~DFGla~~~~  477 (658)
                      |+++ +++++|+|||.+....
T Consensus       180 Ili~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      180 ILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EEEE-CCCEEEEEChhhhccC
Confidence            9999 8899999999987543

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.71  E-value=7.5e-17  Score=157.19  Aligned_cols=139  Identities=20%  Similarity=0.211  Sum_probs=109.8

Q ss_pred             cCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcc----------------------cHHHHHHHHHHHHhcCCCC
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQ----------------------GDLEFKNEVLLVANLQHRN  381 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~----------------------~~~~~~~E~~~l~~l~H~n  381 (658)
                      ..|...+.||+|+||.||++...+|+.||||++......                      ....+..|..++..+.|++
T Consensus        15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            347778999999999999999878999999987543200                      0112567888999998874


Q ss_pred             --ceeeeeeeccCCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceee
Q 006155          382 --LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLL  459 (658)
Q Consensus       382 --iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl  459 (658)
                        ++..++    ....++||||+++++|..+...         .....++.+++.++.++|+.+   |+||||||+||++
T Consensus        95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill  158 (198)
T cd05144          95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILV  158 (198)
T ss_pred             CCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEE
Confidence              444443    2455899999999999766420         235678899999999999987   9999999999999


Q ss_pred             CCCCCeEEecccccccccc
Q 006155          460 DAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       460 ~~~~~~kl~DFGla~~~~~  478 (658)
                      ++++.++|+|||++..+..
T Consensus       159 ~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         159 DDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             cCCCcEEEEECCccccCCC
Confidence            9999999999999975543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.70  E-value=7.4e-17  Score=157.33  Aligned_cols=130  Identities=20%  Similarity=0.375  Sum_probs=106.9

Q ss_pred             cccccCceEEEEeEecCCcceeEEEeccCCcc--------cHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEec
Q 006155          331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQ--------GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFV  402 (658)
Q Consensus       331 ~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  402 (658)
                      .||+|+||.||+|. .+|..+++|+.......        ....+.+|+.++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~-~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGD-FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEee-cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            48999999999998 57889999986543211        1234678999999999987766666666677789999999


Q ss_pred             CCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          403 PNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ++++|.+++....          ..++.+++++|.+||+.+   ++|+|++|+||+++ ++.+++.|||++..
T Consensus        80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999998873311          078999999999999988   99999999999999 88999999999864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.70  E-value=8e-17  Score=180.62  Aligned_cols=140  Identities=16%  Similarity=0.312  Sum_probs=113.4

Q ss_pred             hhhccCCcccCcccccCceEEEEeEecCCcceeEEEe-ccCCc-------ccHHHHHHHHHHHHhcCCCCceeeeeeecc
Q 006155          320 RVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRL-SRDSG-------QGDLEFKNEVLLVANLQHRNLVRLLGFSLE  391 (658)
Q Consensus       320 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l-~~~~~-------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~  391 (658)
                      ......|...+.||+|+||.||+|... +..+++|+. .....       .....+.+|+.++..++|++++....++..
T Consensus       329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~  407 (535)
T PRK09605        329 EEVKRRKIPDHLIGKGAEADIKKGEYL-GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD  407 (535)
T ss_pred             cccccccCccceeccCCcEEEEEEeec-CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence            334455677899999999999999864 444555543 22111       112357899999999999999988888877


Q ss_pred             CCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccc
Q 006155          392 GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFG  471 (658)
Q Consensus       392 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFG  471 (658)
                      ....++||||+++++|.+++.           ....++.+++++|.|||+.+   ++||||||+|||+ +++.++|+|||
T Consensus       408 ~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFG  472 (535)
T PRK09605        408 PEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFG  472 (535)
T ss_pred             CCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCc
Confidence            778899999999999998873           45779999999999999987   9999999999999 67899999999


Q ss_pred             cccc
Q 006155          472 MARL  475 (658)
Q Consensus       472 la~~  475 (658)
                      +++.
T Consensus       473 la~~  476 (535)
T PRK09605        473 LGKY  476 (535)
T ss_pred             cccc
Confidence            9975

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.64  E-value=1e-15  Score=154.08  Aligned_cols=198  Identities=22%  Similarity=0.291  Sum_probs=133.3

Q ss_pred             CCCCceeeeeeeccC---------------------------CceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHH
Q 006155          378 QHRNLVRLLGFSLEG---------------------------NERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIG  430 (658)
Q Consensus       378 ~H~niv~l~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~  430 (658)
                      +|||||++.++|.+.                           ...||||.-.+ -+|..++.    ....+.....-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~----~~~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLW----TRHRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHh----cCCCchHHHHHHHH
Confidence            699999999877642                           24577877663 47888873    23456666777999


Q ss_pred             HHHHHHHHhhhcCCCcEEEeccCCCceee--CCCC--CeEEeccccccccccC--C--CccccccccccccccCcccccc
Q 006155          431 GIARGLLYLHEDSRLRIIHRDLKTSNVLL--DAEM--TPKIADFGMARLFEMD--E--TQGNTSRIVGTYGYMAPEYAMH  502 (658)
Q Consensus       431 ~ia~gL~yLH~~~~~~ivHrDlk~~NILl--~~~~--~~kl~DFGla~~~~~~--~--~~~~~~~~~gt~~y~aPE~~~~  502 (658)
                      |+++|+.|||.++   |.|||||++||||  |+++  .+.|+|||.+..-+.-  +  .....-..-|...-||||+...
T Consensus       349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            9999999999998   9999999999998  3343  5689999987432210  0  0011112346777899998754


Q ss_pred             C--C----CCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHH
Q 006155          503 G--Q----YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGL  576 (658)
Q Consensus       503 ~--~----~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~  576 (658)
                      .  +    --.|+|.|+.|.+.|||++...||.. .++...+.-.          ..+-.-|.+.+..+..+.   +++.
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~-rGem~L~~r~----------Yqe~qLPalp~~vpp~~r---qlV~  491 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK-RGEMLLDTRT----------YQESQLPALPSRVPPVAR---QLVF  491 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccc-cchheechhh----------hhhhhCCCCcccCChHHH---HHHH
Confidence            3  2    23599999999999999999889843 2222212111          222333555555444443   3445


Q ss_pred             HhcCCCCCCCCCHHHHHHHhc
Q 006155          577 LCVQENVASRPTMASVVLMLN  597 (658)
Q Consensus       577 ~Cl~~~p~~RPtm~evv~~L~  597 (658)
                      .-++.||++||+..=....|+
T Consensus       492 ~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  492 DLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHhcCCccccCCccHHHhHHH
Confidence            669999999998765555543

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.62  E-value=4e-15  Score=137.34  Aligned_cols=135  Identities=21%  Similarity=0.220  Sum_probs=115.4

Q ss_pred             ccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCC--CCceeeeeeeccCCceEEEEEecCCC
Q 006155          328 DANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQH--RNLVRLLGFSLEGNERLLIYEFVPNT  405 (658)
Q Consensus       328 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lv~e~~~~g  405 (658)
                      +.+.||+|.++.||+++.. +..+++|.......  ...+.+|+..+..++|  .++++++++....+..++++||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEec-CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            4578999999999999864 47899998865433  5578999999999986  58999999988888899999999988


Q ss_pred             ChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          406 SLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       406 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ++..+          ++.....++.+++++|.+||......++|+||+|+||++++.+.+++.|||.++.
T Consensus        79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77543          5667788999999999999986545699999999999999989999999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.61  E-value=2.6e-15  Score=144.86  Aligned_cols=137  Identities=21%  Similarity=0.239  Sum_probs=97.7

Q ss_pred             cCcccccCceEEEEeEecCCcceeEEEeccCCccc--HHH----------------------HHHHHHHHHhcCCCC--c
Q 006155          329 ANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQG--DLE----------------------FKNEVLLVANLQHRN--L  382 (658)
Q Consensus       329 ~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~--~~~----------------------~~~E~~~l~~l~H~n--i  382 (658)
                      .+.||+|+||+||++...+|+.||||++.......  ...                      ...|...+..+.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            46799999999999998789999999886542211  111                      134555555554432  4


Q ss_pred             eeeeeeeccCCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCcEEEeccCCCceeeCC
Q 006155          383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE-DSRLRIIHRDLKTSNVLLDA  461 (658)
Q Consensus       383 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NILl~~  461 (658)
                      .+.+++    ...++||||++++.+.........   .. .....++.+++.++.++|. .+   |+||||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence            444443    245899999999654322111000   11 5678899999999999998 66   99999999999999 


Q ss_pred             CCCeEEeccccccccc
Q 006155          462 EMTPKIADFGMARLFE  477 (658)
Q Consensus       462 ~~~~kl~DFGla~~~~  477 (658)
                      ++.++|+|||.+....
T Consensus       150 ~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CCcEEEEECccccccc
Confidence            8999999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.61  E-value=4.8e-16  Score=173.70  Aligned_cols=212  Identities=23%  Similarity=0.352  Sum_probs=138.1

Q ss_pred             ccCCcccCcccccCceEEEEeEecC-CcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      ..+|..++.|..|.||.||..++.. .+.+|+|+ .++.           .++     +||..+.+      ..+.|   
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~-----------lil-----Rnilt~a~------npfvv---  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN-----------LIL-----RNILTFAG------NPFVV---  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcc-cccc-----------hhh-----hccccccC------Cccee---
Confidence            4678889999999999999998654 45677743 2211           011     12222221      11111   


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                         |+-...+..   ...++.        +++.+++|||+.+   |+|||+||+|.||+.-|++|++|||+++..-....
T Consensus       136 ---gDc~tllk~---~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  136 ---GDCATLLKN---IGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             ---chhhhhccc---CCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence               333333321   122222        2278999999988   99999999999999999999999999875322111


Q ss_pred             -------------ccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhcc
Q 006155          482 -------------QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWR  548 (658)
Q Consensus       482 -------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~  548 (658)
                                   .-.....+||+.|+|||++....|..-+|+|++|+|+||.+-|+-||..   ++.++|+..+.....
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffG---dtpeelfg~visd~i  275 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG---DTPEELFGQVISDDI  275 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccC---CCHHHHHhhhhhhhc
Confidence                         1112346999999999999999999999999999999999999999843   444566655544311


Q ss_pred             CCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 006155          549 EGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMA  590 (658)
Q Consensus       549 ~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~  590 (658)
                        .+.+- |+.    ...|...   ++..-|+.+|..|--..
T Consensus       276 --~wpE~-dea----~p~Ea~d---li~~LL~qnp~~Rlgt~  307 (1205)
T KOG0606|consen  276 --EWPEE-DEA----LPPEAQD---LIEQLLRQNPLCRLGTG  307 (1205)
T ss_pred             --ccccc-CcC----CCHHHHH---HHHHHHHhChHhhcccc
Confidence              11111 222    2233333   33355889999995333

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.57  E-value=1.4e-14  Score=144.97  Aligned_cols=135  Identities=22%  Similarity=0.291  Sum_probs=104.8

Q ss_pred             cCccc-ccCceEEEEeEecCCcceeEEEeccCC-------------cccHHHHHHHHHHHHhcCCCCc--eeeeeeeccC
Q 006155          329 ANKLG-QGGFGAVYKGRLYDGAEIAVKRLSRDS-------------GQGDLEFKNEVLLVANLQHRNL--VRLLGFSLEG  392 (658)
Q Consensus       329 ~~~lG-~G~fg~Vy~~~~~~g~~vavK~l~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~~~~~~~  392 (658)
                      ...|| .||.|+||+... ++..++||++.+..             ......+.+|+.++..|+|++|  ++.+++...+
T Consensus        36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35687 899999999986 47889999885421             1222457889999999998885  6777764433


Q ss_pred             C----ceEEEEEecCC-CChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEE
Q 006155          393 N----ERLLIYEFVPN-TSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKI  467 (658)
Q Consensus       393 ~----~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl  467 (658)
                      .    ..++|+|++++ .+|.+++..    ..++..    .+.+|+.+|.+||+.+   |+||||||.|||++.++.++|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence            2    22599999997 689888743    234443    3678999999999998   999999999999999999999


Q ss_pred             eccccccc
Q 006155          468 ADFGMARL  475 (658)
Q Consensus       468 ~DFGla~~  475 (658)
                      +|||.+..
T Consensus       184 IDfg~~~~  191 (239)
T PRK01723        184 IDFDRGEL  191 (239)
T ss_pred             EECCCccc
Confidence            99999875

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.55  E-value=1e-15  Score=171.32  Aligned_cols=256  Identities=21%  Similarity=0.281  Sum_probs=183.8

Q ss_pred             ccCCcccCcccccCceEEEEeEecC--CcceeEEEeccCC--cccHHHHHHHHHHHHhcC-CCCceeeeeeeccCCceEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLYD--GAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQ-HRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~~--g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~l  397 (658)
                      ...|...+.||+|.|+.|-......  ...+|+|.+....  .........|..+-..+. |+|++.+++...+.+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            3456677789999999998876433  3456777665553  222233445777767776 9999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhh-hcCCCcEEEeccCCCceeeCCCC-CeEEeccccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH-EDSRLRIIHRDLKTSNVLLDAEM-TPKIADFGMARL  475 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivHrDlk~~NILl~~~~-~~kl~DFGla~~  475 (658)
                      +.||..++++...+... .....+....-.++.|+..++.|+| ..+   +.||||||+|.+++..+ ..+++|||+|..
T Consensus        99 ~~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA  174 (601)
T ss_pred             ccCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence            99999999998887321 1113555667778999999999999 776   99999999999999999 999999999988


Q ss_pred             ccc-CCCccccccccc-cccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCc
Q 006155          476 FEM-DETQGNTSRIVG-TYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTT  552 (658)
Q Consensus       476 ~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  552 (658)
                      +.. ..........+| ++.|+|||...+. ......|+||.|+++.-+++|..|+.........      ...|.+...
T Consensus       175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~------~~~~~~~~~  248 (601)
T KOG0590|consen  175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR------YSSWKSNKG  248 (601)
T ss_pred             ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc------ceeeccccc
Confidence            776 444455556788 9999999998874 4567899999999999999999998755443311      111111110


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 006155          553 VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVV  593 (658)
Q Consensus       553 ~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv  593 (658)
                      .....  ......   ...+++...++..+|..|.+.+++.
T Consensus       249 ~~~~~--~~~~~~---~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  249 RFTQL--PWNSIS---DQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             ccccC--ccccCC---hhhhhcccccccCCchhcccccccc
Confidence            00000  000111   1223444567779999999888774

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.44  E-value=1.4e-13  Score=135.97  Aligned_cols=205  Identities=20%  Similarity=0.242  Sum_probs=142.4

Q ss_pred             HHHHHHHhcCCCCceeeeeeeccC-----CceEEEEEecCCCChhhhhcCc-CCCCCCCHHHHHHHHHHHHHHHHHhhhc
Q 006155          369 NEVLLVANLQHRNLVRLLGFSLEG-----NERLLIYEFVPNTSLDHFIFDP-TRRAQLDWERRYKIIGGIARGLLYLHED  442 (658)
Q Consensus       369 ~E~~~l~~l~H~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~  442 (658)
                      .-...|-.+.|.|||++..|+.+.     .+..++.|||..|+|..+|..- .....+......+|..||+.||.|||+-
T Consensus       116 ~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~  195 (458)
T KOG1266|consen  116 AVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC  195 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc
Confidence            344556667899999999987654     3568999999999999999653 2345677888889999999999999997


Q ss_pred             CCCcEEEeccCCCceeeCCCCCeEEecccccccccc---CCCccccccccccccccCccccccCCCCcccccccccchHh
Q 006155          443 SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM---DETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVL  519 (658)
Q Consensus       443 ~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~  519 (658)
                      . ++|+|+++.-+.|++..++-+||+--. ...+..   ......+..-.+-++|.+||+-..-+.+..+|||+||+..+
T Consensus       196 ~-PpiihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAl  273 (458)
T KOG1266|consen  196 D-PPIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCAL  273 (458)
T ss_pred             C-CccccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHH
Confidence            5 779999999999999999999885311 111110   00111233345778999999877777888999999999999


Q ss_pred             HHHhCCCCC-ccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          520 EIISGQRNN-CFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       520 elltG~~p~-~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ||--|.--. ........+.-+..+.-....+...                   ..+..|++..|.+||+|.+++.
T Consensus       274 emailEiq~tnseS~~~~ee~ia~~i~~len~lqr-------------------~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  274 EMAILEIQSTNSESKVEVEENIANVIIGLENGLQR-------------------GSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HHHHheeccCCCcceeehhhhhhhheeeccCcccc-------------------CcCcccccCCCCCCcchhhhhc
Confidence            998877532 1111111222222222111111111                   2233699999999999998873

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.44  E-value=4.1e-13  Score=145.92  Aligned_cols=141  Identities=24%  Similarity=0.312  Sum_probs=99.9

Q ss_pred             cCcccccCceEEEEeEecCCcceeEEEeccCCccc----------------------------------------HHHHH
Q 006155          329 ANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQG----------------------------------------DLEFK  368 (658)
Q Consensus       329 ~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~----------------------------------------~~~~~  368 (658)
                      .+.||.|++|.||+|++.+|+.||||+........                                        +.+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            36799999999999999999999999986542110                                        01244


Q ss_pred             HHHHHHHhc----CCCCceeeeeee-ccCCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHH-HHHHhhhc
Q 006155          369 NEVLLVANL----QHRNLVRLLGFS-LEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR-GLLYLHED  442 (658)
Q Consensus       369 ~E~~~l~~l----~H~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~  442 (658)
                      +|...+.++    +|.+-+.+-.++ ......+|||||++|++|.++.....  ...   .+.+++..++. .+..+|..
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~--~~~---~~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE--AGL---DRKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh--cCC---CHHHHHHHHHHHHHHHHHhC
Confidence            455555554    233333333333 23456799999999999988763211  112   23456666666 46788987


Q ss_pred             CCCcEEEeccCCCceeeCCCCCeEEeccccccccc
Q 006155          443 SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE  477 (658)
Q Consensus       443 ~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~  477 (658)
                      +   ++|+|+||.||++++++.+++.|||++..+.
T Consensus       277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             C---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            7   9999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.31  E-value=7.9e-12  Score=118.32  Aligned_cols=131  Identities=21%  Similarity=0.188  Sum_probs=98.0

Q ss_pred             cCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCce-eeeeeeccCCceEEEEEecCCCCh
Q 006155          329 ANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV-RLLGFSLEGNERLLIYEFVPNTSL  407 (658)
Q Consensus       329 ~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~~~~lv~e~~~~gsL  407 (658)
                      .+.|+.|.++.||+.+. .+..+++|....... ....+..|+..+..+.+.+++ +++.+.  ....++||||+++.++
T Consensus         3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            45789999999999985 478899998755432 233568899999988765544 455443  3345899999999887


Q ss_pred             hhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcC--CCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          408 DHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS--RLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       408 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ....        .   ....++.+++++|..||+..  ...++|+|++|.||+++ ++.+++.|||.+..
T Consensus        79 ~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            5430        0   11345788999999999876  23469999999999999 66899999998763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.29  E-value=7.2e-12  Score=134.40  Aligned_cols=250  Identities=24%  Similarity=0.289  Sum_probs=177.3

Q ss_pred             hccCCcccCcccc--cCceEEEEeEe---cCCcceeEEEeccCCc--ccHHHHHHHHHHHHhcC-CCCceeeeeeeccCC
Q 006155          322 ATDNFSDANKLGQ--GGFGAVYKGRL---YDGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQ-HRNLVRLLGFSLEGN  393 (658)
Q Consensus       322 ~~~~~~~~~~lG~--G~fg~Vy~~~~---~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~  393 (658)
                      ....|...+.+|.  |.+|.||.+..   .++..+|+|+-+....  .....=.+|+....+++ |+|.++....+..++
T Consensus       112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~  191 (524)
T KOG0601|consen  112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG  191 (524)
T ss_pred             hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence            3455677788999  99999999975   4578899997433322  22233356777777775 999999888888999


Q ss_pred             ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHH----HHHHhhhcCCCcEEEeccCCCceeeCCC-CCeEEe
Q 006155          394 ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR----GLLYLHEDSRLRIIHRDLKTSNVLLDAE-MTPKIA  468 (658)
Q Consensus       394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivHrDlk~~NILl~~~-~~~kl~  468 (658)
                      ..++-+|++. .+|..+.+...  ..++....+.+..+...    ||.++|...   ++|-|+||.||++..+ ...+++
T Consensus       192 ~lfiqtE~~~-~sl~~~~~~~~--~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~  265 (524)
T KOG0601|consen  192 ILFIQTELCG-ESLQSYCHTPC--NFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLT  265 (524)
T ss_pred             cceeeecccc-chhHHhhhccc--ccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecC
Confidence            9999999885 77777765432  33556667777777777    999999987   9999999999999999 889999


Q ss_pred             ccccccccccCCCccc---cccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHH
Q 006155          469 DFGMARLFEMDETQGN---TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWK  545 (658)
Q Consensus       469 DFGla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~  545 (658)
                      |||+...+....-...   ..+..|...|++||.. .+.++...|+|++|.+++|-.+|.........        ..|.
T Consensus       266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~--------~~W~  336 (524)
T KOG0601|consen  266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKN--------SSWS  336 (524)
T ss_pred             CcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCC--------CCcc
Confidence            9999988765542221   2234677889999965 55678899999999999999998876532210        1233


Q ss_pred             hccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 006155          546 NWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVV  593 (658)
Q Consensus       546 ~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv  593 (658)
                      ..+...   +.+........    ++-....++++++|..|++.+.+.
T Consensus       337 ~~r~~~---ip~e~~~~~s~----~l~~~~~~~~d~~~~~~~~~q~~~  377 (524)
T KOG0601|consen  337 QLRQGY---IPLEFCEGGSS----SLRSVTSQMLDEDPRLRLTAQILT  377 (524)
T ss_pred             cccccc---CchhhhcCcch----hhhhHHHHhcCcchhhhhHHHHHh
Confidence            333222   11111111111    111256678999999999877665

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.24  E-value=9e-12  Score=137.04  Aligned_cols=144  Identities=18%  Similarity=0.238  Sum_probs=94.0

Q ss_pred             cCCcccCcccccCceEEEEeEecC-CcceeEEEeccCCccc----------------------------------H----
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQG----------------------------------D----  364 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~----------------------------------~----  364 (658)
                      ..|+. +.||.|++|.||+|++.+ |++||||++.+...+.                                  .    
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45665 789999999999999887 9999999987542110                                  0    


Q ss_pred             --HHHHHHHHHHHhcC----CCCceeeeeeecc-CCceEEEEEecCCCChhhhhcCcCC---CCCCCHHHHHHHHHHHHH
Q 006155          365 --LEFKNEVLLVANLQ----HRNLVRLLGFSLE-GNERLLIYEFVPNTSLDHFIFDPTR---RAQLDWERRYKIIGGIAR  434 (658)
Q Consensus       365 --~~~~~E~~~l~~l~----H~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~ia~  434 (658)
                        .+|.+|+..+.+++    +.+.+.+-.++.+ ..+.+|||||++|+.+.++-.-...   ...+.......++.|+  
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--  276 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--  276 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence              12344444444442    3344443343333 4567899999999999775211111   1122222233333333  


Q ss_pred             HHHHhhhcCCCcEEEeccCCCceeeCCCC----CeEEecccccccccc
Q 006155          435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEM----TPKIADFGMARLFEM  478 (658)
Q Consensus       435 gL~yLH~~~~~~ivHrDlk~~NILl~~~~----~~kl~DFGla~~~~~  478 (658)
                           +..+   ++|+|+||.||+++.++    .+++.|||++..++.
T Consensus       277 -----f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 -----FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -----HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                 3445   99999999999999888    999999999876643

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.19  E-value=2.9e-10  Score=123.23  Aligned_cols=166  Identities=19%  Similarity=0.237  Sum_probs=125.2

Q ss_pred             ecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecCCCChhhhhcCcCCCCCCCHHH
Q 006155          345 LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWER  424 (658)
Q Consensus       345 ~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~  424 (658)
                      ..++.+|.|...+...........+-+..|+.++||||++++.........|||+|-+  ..|..++..      +....
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~------l~~~~  105 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE------LGKEE  105 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH------hHHHH
Confidence            4578889999888776633445678889999999999999999999999999999987  356655522      33455


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCccccccccccccccCccccccCC
Q 006155          425 RYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQ  504 (658)
Q Consensus       425 ~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  504 (658)
                      ..-.+.||+.||.|||+.+  .++|++|.-..|+++..|+.||++|.++........  ......--..|..|+.+....
T Consensus       106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence            5667899999999999776  599999999999999999999999998764322111  111112223466666443222


Q ss_pred             CCcccccccccchHhHHHhC
Q 006155          505 YSVKSDVFSFGVLVLEIISG  524 (658)
Q Consensus       505 ~s~ksDV~S~Gvll~elltG  524 (658)
                        -..|.|-||+++||++.|
T Consensus       182 --~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             --cchhhhhHHHHHHHHhCc
Confidence              346999999999999999

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.15  E-value=5e-10  Score=110.75  Aligned_cols=143  Identities=19%  Similarity=0.256  Sum_probs=111.3

Q ss_pred             cCcccccCceEEEEeEecCCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCC--CCceeeeeeeccCC---ceEEEEEec
Q 006155          329 ANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQH--RNLVRLLGFSLEGN---ERLLIYEFV  402 (658)
Q Consensus       329 ~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~---~~~lv~e~~  402 (658)
                      .+.|+.|..+.||+++..+|..+++|....... .....+..|+.++..+++  .++.+++.+.....   ..++||||+
T Consensus         3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            356899999999999877678999998755432 134568899999999976  34677777766543   568999999


Q ss_pred             CCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcC---------------------------------------
Q 006155          403 PNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS---------------------------------------  443 (658)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------  443 (658)
                      ++.++.+.+..    ..++...+..++.++++.|.+||+..                                       
T Consensus        83 ~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          83 DGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            99988776521    34677888888999999999998531                                       


Q ss_pred             --------------CCcEEEeccCCCceeeCC--CCCeEEeccccccc
Q 006155          444 --------------RLRIIHRDLKTSNVLLDA--EMTPKIADFGMARL  475 (658)
Q Consensus       444 --------------~~~ivHrDlk~~NILl~~--~~~~kl~DFGla~~  475 (658)
                                    ...++|+|+++.||+++.  ++.+.|.||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          234899999999999998  56689999998763

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.13  E-value=6.3e-10  Score=106.71  Aligned_cols=136  Identities=15%  Similarity=0.117  Sum_probs=97.9

Q ss_pred             CcccccCceEEEEeEecC-------CcceeEEEeccCC---------------------ccc-HHHH----HHHHHHHHh
Q 006155          330 NKLGQGGFGAVYKGRLYD-------GAEIAVKRLSRDS---------------------GQG-DLEF----KNEVLLVAN  376 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~~~-------g~~vavK~l~~~~---------------------~~~-~~~~----~~E~~~l~~  376 (658)
                      ..||.|.-+.||.|.-.+       +..+|||+.+...                     ... ...+    ++|+..|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999997543       4789999764210                     001 1122    379999988


Q ss_pred             cCC--CCceeeeeeeccCCceEEEEEecCCCChhh-hhcCcCCCCCCCHHHHHHHHHHHHHHHHHh-hhcCCCcEEEecc
Q 006155          377 LQH--RNLVRLLGFSLEGNERLLIYEFVPNTSLDH-FIFDPTRRAQLDWERRYKIIGGIARGLLYL-HEDSRLRIIHRDL  452 (658)
Q Consensus       377 l~H--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDl  452 (658)
                      +..  -++..++++    ...+|||||+.+..+.. .+.    ...++......+..+++.+|..| |+.+   +||+||
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL  151 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL  151 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence            853  466666654    56789999998754422 221    12344556677889999999999 7776   999999


Q ss_pred             CCCceeeCCCCCeEEeccccccccc
Q 006155          453 KTSNVLLDAEMTPKIADFGMARLFE  477 (658)
Q Consensus       453 k~~NILl~~~~~~kl~DFGla~~~~  477 (658)
                      ++.|||++ ++.+.|+|||.+...+
T Consensus       152 s~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         152 SEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CHHHEEEE-CCcEEEEECCCceeCC
Confidence            99999997 4689999999887544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.03  E-value=2.9e-10  Score=122.20  Aligned_cols=247  Identities=21%  Similarity=0.217  Sum_probs=171.0

Q ss_pred             hhccCCcccCcccccCceEEEEeEe--cCCcceeEEEeccCCcccHHHH--HHHHHHHHhc-CCCCceeeeeeeccCCce
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRL--YDGAEIAVKRLSRDSGQGDLEF--KNEVLLVANL-QHRNLVRLLGFSLEGNER  395 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~~g~~vavK~l~~~~~~~~~~~--~~E~~~l~~l-~H~niv~l~~~~~~~~~~  395 (658)
                      ....+|..+..||.|.|+.|++...  .++..+++|.+.+.......++  ..|+.+...+ .|.+++++...+..-...
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            3456888999999999999998763  3577889998876644333332  3466666655 488999887777777777


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCC-CCeEEecccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE-MTPKIADFGMAR  474 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~-~~~kl~DFGla~  474 (658)
                      ++=-||++++++...+   .....++...++++..+++.++.++|+..   ++|+|+||+||++..+ +..+++|||.+.
T Consensus       342 ~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t  415 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT  415 (524)
T ss_pred             cCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence            7999999999987665   23345778889999999999999999887   9999999999999876 788999999986


Q ss_pred             ccccCCCcccccccccccccc--CccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCc
Q 006155          475 LFEMDETQGNTSRIVGTYGYM--APEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTT  552 (658)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  552 (658)
                      .+.....     .....-+++  +|+......+-.+.|++|||.-+.|.++|..-.....          .|...+.+..
T Consensus       416 ~~~~~~~-----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----------~~~~i~~~~~  480 (524)
T KOG0601|consen  416 RLAFSSG-----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----------QSLTIRSGDT  480 (524)
T ss_pred             ccceecc-----cccccccccccchhhccccccccccccccccccccccccCcccCcccc----------cceeeecccc
Confidence            3221111     112233444  5555566778889999999999999999876432111          1222222221


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 006155          553 VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN  597 (658)
Q Consensus       553 ~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~  597 (658)
                           |.+.... .+..   .++.....+++..||.+.+...+..
T Consensus       481 -----p~~~~~~-~~~q---~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  481 -----PNLPGLK-LQLQ---VLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             -----cCCCchH-Hhhh---hhhhhhcCCccccchhhhhhcccch
Confidence                 2222111 2222   2333457789999998888776554

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.01  E-value=4.7e-09  Score=110.46  Aligned_cols=169  Identities=22%  Similarity=0.339  Sum_probs=131.8

Q ss_pred             ceEEEEeE-ecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeec----cCCceEEEEEecCC-CChhhh
Q 006155          337 FGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSL----EGNERLLIYEFVPN-TSLDHF  410 (658)
Q Consensus       337 fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~----~~~~~~lv~e~~~~-gsL~~~  410 (658)
                      -.+.||+. -.||..+++||+.....+.......-+++++++.|+|||++..++.    .+..++|||+|.|+ ++|.++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            35678886 3479999999995554444434466788999999999999999886    34578999999986 577666


Q ss_pred             hcCc------------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccccc
Q 006155          411 IFDP------------TRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       411 l~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~  478 (658)
                      -+..            ......++..+|.++.|+..||.++|+.|   +.-+-|.+++||++.+.+++|+..|...++..
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            5532            12335778999999999999999999998   77899999999999999999999998877655


Q ss_pred             CCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCC
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRN  527 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p  527 (658)
                      +...                -+..   -.+-|.=.||.+++.|-||..+
T Consensus       446 d~~~----------------~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DPTE----------------PLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCCc----------------chhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            4311                1111   2357888899999999999765

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.00  E-value=3.6e-09  Score=98.11  Aligned_cols=131  Identities=20%  Similarity=0.338  Sum_probs=100.6

Q ss_pred             CcccccCceEEEEeEecCCcceeEEEe-ccCCccc-------HHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          330 NKLGQGGFGAVYKGRLYDGAEIAVKRL-SRDSGQG-------DLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~~~g~~vavK~l-~~~~~~~-------~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      ..+++|+-+.+|.+.+ -|.++.+|.= ++.-...       ...-.+|..++.+++--.|...+-+..+.+...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            3578999999999965 4555666633 2221111       11246799999998766666666677788888999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ++|..|.+.+...          +..++..+-+-+.-||..+   |||+||.++||++..+. +.++||||+..
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999888432          3567888888899999998   99999999999998765 99999999874

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.90  E-value=1.1e-08  Score=94.41  Aligned_cols=143  Identities=24%  Similarity=0.342  Sum_probs=104.8

Q ss_pred             ccCcccccCceEEEEeEecCCcceeEEE-eccCCcc-------cHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          328 DANKLGQGGFGAVYKGRLYDGAEIAVKR-LSRDSGQ-------GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       328 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~-l~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ....|-||.-+.|+++.. .|+...||. +.+.-..       .....++|+..+.+++--.|.-..-++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            456789999999999974 677777773 3322111       1223678999999987666666566677777788999


Q ss_pred             EecCC-CChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCC---CeEEeccccccc
Q 006155          400 EFVPN-TSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM---TPKIADFGMARL  475 (658)
Q Consensus       400 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~---~~kl~DFGla~~  475 (658)
                      ||+++ .++.+++....... ...+....++..|-+.+.-||.++   |||+||..+||+|..++   .+.+.|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99987 47788875432222 222333678899999999999988   99999999999996554   458999999853

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.89  E-value=5.1e-10  Score=126.23  Aligned_cols=206  Identities=19%  Similarity=0.208  Sum_probs=144.6

Q ss_pred             hhhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccC---CcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCce
Q 006155          320 RVATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRD---SGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNER  395 (658)
Q Consensus       320 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  395 (658)
                      +...+.+.+.+-+-+|.++.++...-. .|...+.|.....   ..........+-.++-..+||-++....-+......
T Consensus       800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~  879 (1205)
T KOG0606|consen  800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL  879 (1205)
T ss_pred             cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence            345677888888889999999876521 2322333322111   111111222222222233456666655555667788


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      .|+++|..+++|...|+...   ..+.+-....+..+...++|||...   ++|||++|.|+|...++..+++|||....
T Consensus       880 ~L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~  953 (1205)
T KOG0606|consen  880 PLVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSK  953 (1205)
T ss_pred             chhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccc
Confidence            99999999999998886533   4555556677888899999999875   89999999999999999999999984332


Q ss_pred             ccc---------------------CCCc--------cccccccccccccCccccccCCCCcccccccccchHhHHHhCCC
Q 006155          476 FEM---------------------DETQ--------GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQR  526 (658)
Q Consensus       476 ~~~---------------------~~~~--------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~  526 (658)
                      ...                     ....        .......||+.|.+||.+.+......+|+|++|++++|.++|..
T Consensus       954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen  954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred             cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence            110                     0000        11233679999999999999999999999999999999999999


Q ss_pred             CCccC
Q 006155          527 NNCFR  531 (658)
Q Consensus       527 p~~~~  531 (658)
                      ||...
T Consensus      1034 p~na~ 1038 (1205)
T KOG0606|consen 1034 PFNAE 1038 (1205)
T ss_pred             CCCCc
Confidence            98543

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.79  E-value=4.7e-08  Score=99.10  Aligned_cols=132  Identities=19%  Similarity=0.181  Sum_probs=95.7

Q ss_pred             EEEEeEecCCcceeEEEeccCCcc-----------cHHHHHHHHHHHHhcCCCCc--eeeeeeecc-----CCceEEEEE
Q 006155          339 AVYKGRLYDGAEIAVKRLSRDSGQ-----------GDLEFKNEVLLVANLQHRNL--VRLLGFSLE-----GNERLLIYE  400 (658)
Q Consensus       339 ~Vy~~~~~~g~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~ni--v~l~~~~~~-----~~~~~lv~e  400 (658)
                      .|.+..+ +|+.+.||+.......           ....+.+|...+.++...+|  +.++++...     ....+||+|
T Consensus        37 rvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte  115 (268)
T PRK15123         37 RTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE  115 (268)
T ss_pred             eEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence            3666654 6788999977443311           11136789998888854443  344555433     234689999


Q ss_pred             ecCCC-ChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCC-------CCCeEEecccc
Q 006155          401 FVPNT-SLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDA-------EMTPKIADFGM  472 (658)
Q Consensus       401 ~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~-------~~~~kl~DFGl  472 (658)
                      ++++. +|.+++.+.. ....+...+..++.+++..+.-||..+   |+|+||+++|||++.       +..+.|+||+.
T Consensus       116 ~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r  191 (268)
T PRK15123        116 DLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLHR  191 (268)
T ss_pred             eCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence            99986 8988874321 234556777899999999999999998   999999999999975       46889999998


Q ss_pred             ccc
Q 006155          473 ARL  475 (658)
Q Consensus       473 a~~  475 (658)
                      ++.
T Consensus       192 ~~~  194 (268)
T PRK15123        192 AQI  194 (268)
T ss_pred             ccc
Confidence            853

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.77  E-value=5.1e-08  Score=93.20  Aligned_cols=125  Identities=23%  Similarity=0.300  Sum_probs=81.9

Q ss_pred             EEEEeEecCCcceeEEEeccCCc---------------------cc-----HHHHHHHHHHHHhcCCC--Cceeeeeeec
Q 006155          339 AVYKGRLYDGAEIAVKRLSRDSG---------------------QG-----DLEFKNEVLLVANLQHR--NLVRLLGFSL  390 (658)
Q Consensus       339 ~Vy~~~~~~g~~vavK~l~~~~~---------------------~~-----~~~~~~E~~~l~~l~H~--niv~l~~~~~  390 (658)
                      .||.|...+|..+|||+......                     ..     ....++|...|.++..-  ++.+++.+. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            38999888899999997643210                     00     11256799999999865  566666552 


Q ss_pred             cCCceEEEEEecC--CCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHh-hhcCCCcEEEeccCCCceeeCCCCCeEE
Q 006155          391 EGNERLLIYEFVP--NTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL-HEDSRLRIIHRDLKTSNVLLDAEMTPKI  467 (658)
Q Consensus       391 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDlk~~NILl~~~~~~kl  467 (658)
                         ...|||||++  +..+..+...     .++......++.+++..+..+ |..+   |||+||.+.|||++++ .+.|
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence               4579999998  6555444311     111344566788888866664 6766   9999999999999988 9999


Q ss_pred             ecccccccc
Q 006155          468 ADFGMARLF  476 (658)
Q Consensus       468 ~DFGla~~~  476 (658)
                      +|||.+...
T Consensus       148 IDf~qav~~  156 (188)
T PF01163_consen  148 IDFGQAVDS  156 (188)
T ss_dssp             --GTTEEET
T ss_pred             EecCcceec
Confidence            999988653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.76  E-value=1.2e-07  Score=97.70  Aligned_cols=192  Identities=15%  Similarity=0.184  Sum_probs=128.3

Q ss_pred             cccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhc-CCCCceeeeee------eccCCc-eEEE
Q 006155          327 SDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANL-QHRNLVRLLGF------SLEGNE-RLLI  398 (658)
Q Consensus       327 ~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~------~~~~~~-~~lv  398 (658)
                      ...+.||+|+-+.+|-.-  +-..-+.|+..........+.   +..|.+. .||-+-.=+.|      --++.. ..+.
T Consensus        14 ~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          14 PPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCCccccCCccceeeecc--hhhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            346789999999999642  222234566655433332222   2233333 46644332222      112222 5677


Q ss_pred             EEecCCCC-hhhhhcC---cCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          399 YEFVPNTS-LDHFIFD---PTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       399 ~e~~~~gs-L~~~l~~---~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      |+.+++.- ...++..   .+.....+|.-.++.++.+|.+.+-||+.+   .+-+|++++|+|+.+++.+.|.|=..-.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence            88776642 2233221   122345789999999999999999999998   8889999999999999999999866544


Q ss_pred             ccccCCCccccccccccccccCccccc-----cCCCCcccccccccchHhHHHhC-CCCCc
Q 006155          475 LFEMDETQGNTSRIVGTYGYMAPEYAM-----HGQYSVKSDVFSFGVLVLEIISG-QRNNC  529 (658)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvll~elltG-~~p~~  529 (658)
                      +..   ........+|...|.+||...     +..-+...|.|.+||++++++.| ++|+.
T Consensus       166 i~~---ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPys  223 (637)
T COG4248         166 INA---NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYS  223 (637)
T ss_pred             ecc---CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCC
Confidence            332   222333468899999999765     33456789999999999999998 88986

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.63  E-value=2.2e-07  Score=91.36  Aligned_cols=134  Identities=21%  Similarity=0.238  Sum_probs=94.7

Q ss_pred             CcccCcccccCceEEEEeEecCCcceeEEEeccCC--------------------c--ccHHHHHHHHHHHHhcCCC--C
Q 006155          326 FSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDS--------------------G--QGDLEFKNEVLLVANLQHR--N  381 (658)
Q Consensus       326 ~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~--------------------~--~~~~~~~~E~~~l~~l~H~--n  381 (658)
                      ..+.++||.|.-+.||.|...+|.++|||.-....                    +  ......++|.+.|.+|.-.  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            34567899999999999998899999999432110                    0  0112346789999988754  6


Q ss_pred             ceeeeeeeccCCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCC
Q 006155          382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDA  461 (658)
Q Consensus       382 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~  461 (658)
                      +.+.+++    +...+||||+++-.|...-        ++-+..-.++..|++-+.-+-..+   |||+|+.+-||++++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~  237 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence            6666654    5668999999987764432        122333344444544444444555   999999999999999


Q ss_pred             CCCeEEecccccc
Q 006155          462 EMTPKIADFGMAR  474 (658)
Q Consensus       462 ~~~~kl~DFGla~  474 (658)
                      +|.+.++||--+.
T Consensus       238 dg~~~vIDwPQ~v  250 (304)
T COG0478         238 DGDIVVIDWPQAV  250 (304)
T ss_pred             CCCEEEEeCcccc
Confidence            9999999997554

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.49  E-value=1.3e-07  Score=103.52  Aligned_cols=153  Identities=21%  Similarity=0.330  Sum_probs=98.5

Q ss_pred             HHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCccc-------cccccccccccCccccc
Q 006155          429 IGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN-------TSRIVGTYGYMAPEYAM  501 (658)
Q Consensus       429 ~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~  501 (658)
                      +.+++.||.|+|...  ++||++|.|++|.++.++..||+.|+++.....+.....       ..-..-...|.|||++.
T Consensus       105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            445569999999864  699999999999999999999999998765433211110       00112345799999999


Q ss_pred             cCCCCcccccccccchHhHHHhCCCC-CccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcC
Q 006155          502 HGQYSVKSDVFSFGVLVLEIISGQRN-NCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQ  580 (658)
Q Consensus       502 ~~~~s~ksDV~S~Gvll~elltG~~p-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~  580 (658)
                      +...+.++|+||+|++++-+..|.++ +.......     .+.......+.......    ...+.|+.+.+   .+.+.
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~-----~~~~~~~~~~~~~~~~s----~~~p~el~~~l---~k~l~  250 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL-----SYSFSRNLLNAGAFGYS----NNLPSELRESL---KKLLN  250 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcc-----hhhhhhccccccccccc----ccCcHHHHHHH---HHHhc
Confidence            98889999999999999999955544 33222211     11111111111111111    12344444433   35688


Q ss_pred             CCCCCCCCHHHHHHH
Q 006155          581 ENVASRPTMASVVLM  595 (658)
Q Consensus       581 ~~p~~RPtm~evv~~  595 (658)
                      .++.-||++.++...
T Consensus       251 ~~~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  251 GDSAVRPTLDLLLSI  265 (700)
T ss_pred             CCcccCcchhhhhcc
Confidence            999999987776643

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.48  E-value=4.8e-07  Score=99.29  Aligned_cols=142  Identities=18%  Similarity=0.249  Sum_probs=91.4

Q ss_pred             CcccccCceEEEEeEecCCcceeEEEeccCCccc----------------------------------------HHHHHH
Q 006155          330 NKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQG----------------------------------------DLEFKN  369 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~----------------------------------------~~~~~~  369 (658)
                      +.|+.++-|.||+|++.+|++||||+....-.+.                                        +.++..
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            6799999999999999999999999875442111                                        011334


Q ss_pred             HHHHHHhcC----CCCceeeeeeec-cCCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 006155          370 EVLLVANLQ----HRNLVRLLGFSL-EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSR  444 (658)
Q Consensus       370 E~~~l~~l~----H~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~  444 (658)
                      |...+.+++    +..-+++=.++. -.....|+|||++|..+.++..-.  ...++-..+.....++.  +..+-..+ 
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~--~~g~d~k~ia~~~~~~f--~~q~~~dg-  285 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK--SAGIDRKELAELLVRAF--LRQLLRDG-  285 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH--hcCCCHHHHHHHHHHHH--HHHHHhcC-
Confidence            444444442    222222223333 356779999999999998884221  13344333322222222  22222234 


Q ss_pred             CcEEEeccCCCceeeCCCCCeEEecccccccccc
Q 006155          445 LRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       445 ~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~  478 (658)
                        ++|.|..|.||+++.++++.+.|||+...++.
T Consensus       286 --ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         286 --FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             --ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence              99999999999999999999999999876543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.46  E-value=8e-07  Score=87.00  Aligned_cols=105  Identities=25%  Similarity=0.325  Sum_probs=82.1

Q ss_pred             HHHHHHHHHHHhcCCC--CceeeeeeeccCC----ceEEEEEecCCC-ChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHH
Q 006155          365 LEFKNEVLLVANLQHR--NLVRLLGFSLEGN----ERLLIYEFVPNT-SLDHFIFDPTRRAQLDWERRYKIIGGIARGLL  437 (658)
Q Consensus       365 ~~~~~E~~~l~~l~H~--niv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~  437 (658)
                      ....+|...+..|...  ...+.+++.....    ..+||+|++++. +|.+++.+..   .++......++.++++.+.
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~---~~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE---QLDPSQRRELLRALARLIA  132 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc---ccchhhHHHHHHHHHHHHH
Confidence            3467888888777533  3455566655432    448999999984 8999884321   2566778899999999999


Q ss_pred             HhhhcCCCcEEEeccCCCceeeCCCC---CeEEeccccccc
Q 006155          438 YLHEDSRLRIIHRDLKTSNVLLDAEM---TPKIADFGMARL  475 (658)
Q Consensus       438 yLH~~~~~~ivHrDlk~~NILl~~~~---~~kl~DFGla~~  475 (658)
                      -||+.+   |+|+|++++|||++.+.   .+.++||+-++.
T Consensus       133 ~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  133 KLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999998   99999999999999887   899999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.41  E-value=2.6e-06  Score=82.09  Aligned_cols=139  Identities=17%  Similarity=0.178  Sum_probs=102.0

Q ss_pred             ccccCceEEEEeEecCCcceeEEEeccC---C---cccHHHHHHHHHHHHhcCCCC--ceeeeeeeccC----CceEEEE
Q 006155          332 LGQGGFGAVYKGRLYDGAEIAVKRLSRD---S---GQGDLEFKNEVLLVANLQHRN--LVRLLGFSLEG----NERLLIY  399 (658)
Q Consensus       332 lG~G~fg~Vy~~~~~~g~~vavK~l~~~---~---~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~----~~~~lv~  399 (658)
                      -|+||-+-|++-.+ +|..+-+|+-...   +   ..+...|.+|+..|.+|...+  +.+.+......    ..-+||+
T Consensus        26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            46788888988764 5557899976421   1   235567999999999986433  44444222221    2357999


Q ss_pred             EecCC-CChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCC--eEEeccccccc
Q 006155          400 EFVPN-TSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMT--PKIADFGMARL  475 (658)
Q Consensus       400 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~--~kl~DFGla~~  475 (658)
                      |-+++ .+|.+++.+. ...+.+...+..++.++++.+.-||+.+   +.|+|+.+.|||++.++.  ++++||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            97764 5888887442 2235677788899999999999999998   999999999999986667  89999987653

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.36  E-value=5.5e-06  Score=82.21  Aligned_cols=139  Identities=16%  Similarity=0.213  Sum_probs=85.9

Q ss_pred             cCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCC--ceeeeeeeccCCceEEEEEecCCCC
Q 006155          329 ANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRN--LVRLLGFSLEGNERLLIYEFVPNTS  406 (658)
Q Consensus       329 ~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~lv~e~~~~gs  406 (658)
                      ..+||+|..+.||+.   .|..+++|......  ......+|.+++..+..-.  +.+.+++....+...+|||+++|.+
T Consensus         6 ~~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         6 WTQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             heeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            357999999999984   35567788776432  3445789999999886443  4667777777777889999999963


Q ss_pred             -hhhhh---------------------cCcCCCCCCCHHHHHH-H---HH-------HHHH-HHHHhhh-cCCCcEEEec
Q 006155          407 -LDHFI---------------------FDPTRRAQLDWERRYK-I---IG-------GIAR-GLLYLHE-DSRLRIIHRD  451 (658)
Q Consensus       407 -L~~~l---------------------~~~~~~~~l~~~~~~~-i---~~-------~ia~-gL~yLH~-~~~~~ivHrD  451 (658)
                       +...+                     |.-.. .......... +   +.       .+.+ ...+|.. .....++|+|
T Consensus        81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~-~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD  159 (226)
T TIGR02172        81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKC-DTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD  159 (226)
T ss_pred             chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCC-CCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence             22111                     11000 0111111100 0   00       0001 1122211 1234579999


Q ss_pred             cCCCceeeCCCCCeEEecccccc
Q 006155          452 LKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       452 lk~~NILl~~~~~~kl~DFGla~  474 (658)
                      +.|.||++++++ +.|.||+.+.
T Consensus       160 ~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       160 FQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCCcEEEcCCC-cEEEechhcC
Confidence            999999999888 9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.28  E-value=3.4e-07  Score=99.03  Aligned_cols=189  Identities=18%  Similarity=0.119  Sum_probs=136.7

Q ss_pred             hccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCC-ceeeeeeeccCCceEEEEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRN-LVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~lv~e  400 (658)
                      .+.-+...+.+++|.+++++|.+-...+...++.+...     .+..-++++|.+++||| .++.++-+..+...+++++
T Consensus       240 k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~  314 (829)
T KOG0576|consen  240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR  314 (829)
T ss_pred             CccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence            34445556678999999999987433444455555332     45677899999999999 7777777777778889999


Q ss_pred             ecCCC-ChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          401 FVPNT-SLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       401 ~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ++..+ +-.....  .....+...+...+.+.-.++++|||+..   -+|||    ||+..+ +..+..||+....+...
T Consensus       315 i~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~  384 (829)
T KOG0576|consen  315 ICSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT  384 (829)
T ss_pred             hhcCCccccccCC--hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc
Confidence            99877 2211110  11122344445566777788999999864   48998    777665 67899999998766543


Q ss_pred             CCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCC
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNN  528 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~  528 (658)
                      .   ......+|+.|+|||+...+.+..+.|+|+.|+--.++--|-+|-
T Consensus       385 ~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  385 M---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             c---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            2   234468899999999999999999999999999777776666654

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.14  E-value=1.3e-05  Score=77.05  Aligned_cols=104  Identities=25%  Similarity=0.213  Sum_probs=83.5

Q ss_pred             HHHHHHHHhcCC-CCceeeeeeeccCCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCc
Q 006155          368 KNEVLLVANLQH-RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLR  446 (658)
Q Consensus       368 ~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~  446 (658)
                      .+|..++..+++ +++++++|+|-    .++|.||...+++...-..-..-...+|..|.+|+.++++.+++|++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            468888999986 69999999994    4789999988766432100012234789999999999999999999865445


Q ss_pred             EEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          447 IIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       447 ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      +...|++++|+-+++++++|+.|.+.+..
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcch
Confidence            88999999999999999999999987654

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.08  E-value=2.1e-05  Score=78.12  Aligned_cols=143  Identities=20%  Similarity=0.234  Sum_probs=84.0

Q ss_pred             cCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCC--CceeeeeeeccC---CceEEEEEecC
Q 006155          329 ANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHR--NLVRLLGFSLEG---NERLLIYEFVP  403 (658)
Q Consensus       329 ~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~~~~~~---~~~~lv~e~~~  403 (658)
                      ++.|+.|..+.||+....+ ..+++|.....  .....+..|..++..+...  .+.+++.+....   ...+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            3578999999999998766 68999986544  3455678898888888533  355666644322   24689999999


Q ss_pred             CCChhh----------------hh---cCc-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHhhh
Q 006155          404 NTSLDH----------------FI---FDP-TRRAQLDWER---------RYKI------------IGGIAR-GLLYLHE  441 (658)
Q Consensus       404 ~gsL~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~~ia~-gL~yLH~  441 (658)
                      +.++..                .+   +.. .....+.+..         ....            ...+.+ .+..+++
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            988877                11   111 0111111111         0000            112222 3333332


Q ss_pred             ----cCCCcEEEeccCCCceeeC-CCCCeEEecccccc
Q 006155          442 ----DSRLRIIHRDLKTSNVLLD-AEMTPKIADFGMAR  474 (658)
Q Consensus       442 ----~~~~~ivHrDlk~~NILl~-~~~~~kl~DFGla~  474 (658)
                          .....++|+|+.|+|||++ +++.+.|.||+.+.
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence                1345699999999999999 56666799998875

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.07  E-value=4.6e-05  Score=73.51  Aligned_cols=129  Identities=19%  Similarity=0.306  Sum_probs=92.8

Q ss_pred             ccCcccccCceEEEEeEecCCcceeEEEeccCC----------------cccHHHHHHHHHHHHhcC------CCCceee
Q 006155          328 DANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDS----------------GQGDLEFKNEVLLVANLQ------HRNLVRL  385 (658)
Q Consensus       328 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~----------------~~~~~~~~~E~~~l~~l~------H~niv~l  385 (658)
                      ....||+|+.-.||.  +++.....||+.....                .....+..+|+.....+.      +.+|.++
T Consensus         5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            456799999999997  4677888999887655                223445667777666665      8899999


Q ss_pred             eeeeccCCceEEEEEecCC------CChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceee
Q 006155          386 LGFSLEGNERLLIYEFVPN------TSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLL  459 (658)
Q Consensus       386 ~~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl  459 (658)
                      +|+...+....+|+|.+.+      .+|.+++.    ...++. ...+.+.++   ..||-+..   |+.+||+|+||++
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~~~L~~f---~~~l~~~~---Iv~~dl~~~NIv~  151 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELRQALDEF---KRYLLDHH---IVIRDLNPHNIVV  151 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHHHHHHHH---HHHHHHcC---CeecCCCcccEEE
Confidence            9999999999999998743      35677773    334555 444444444   44555554   9999999999999


Q ss_pred             CCC--C--CeEEec
Q 006155          460 DAE--M--TPKIAD  469 (658)
Q Consensus       460 ~~~--~--~~kl~D  469 (658)
                      ..+  +  .+.|.|
T Consensus       152 ~~~~~~~~~lvlID  165 (199)
T PF10707_consen  152 QRRDSGEFRLVLID  165 (199)
T ss_pred             EecCCCceEEEEEe
Confidence            543  2  466776

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.07  E-value=1.4e-05  Score=87.52  Aligned_cols=142  Identities=15%  Similarity=0.240  Sum_probs=92.1

Q ss_pred             cCcccccCceEEEEeEecCCcceeEEEeccCCccc-------------------------------------HHHHHHHH
Q 006155          329 ANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQG-------------------------------------DLEFKNEV  371 (658)
Q Consensus       329 ~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~-------------------------------------~~~~~~E~  371 (658)
                      .+.||.-+.|.||++++++|+.||||+-...-...                                     +.+|..|.
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            35799999999999999999999999765432111                                     11244455


Q ss_pred             HHHHhc----CCCCc---eeeeeeecc-CCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcC
Q 006155          372 LLVANL----QHRNL---VRLLGFSLE-GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS  443 (658)
Q Consensus       372 ~~l~~l----~H~ni---v~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~  443 (658)
                      +-..+.    .|-++   |.+=.++.+ .....|+||||+|..+.+.-.-  ....++-..+..-+.+...-+-+-|  |
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~i~~~l~~~~~~qIf~~--G  321 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI--DKRGISPHDILNKLVEAYLEQIFKT--G  321 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH--HHcCCCHHHHHHHHHHHHHHHHHhc--C
Confidence            444333    45551   112233332 3567999999999988766421  2233555544444444433333333  3


Q ss_pred             CCcEEEeccCCCceeeCC----CCCeEEeccccccccc
Q 006155          444 RLRIIHRDLKTSNVLLDA----EMTPKIADFGMARLFE  477 (658)
Q Consensus       444 ~~~ivHrDlk~~NILl~~----~~~~kl~DFGla~~~~  477 (658)
                         ++|.|=.|.||++..    ++.+.+-|||+...+.
T Consensus       322 ---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  322 ---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             ---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence               999999999999984    6789999999987554

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.06  E-value=4.2e-05  Score=74.07  Aligned_cols=137  Identities=14%  Similarity=0.173  Sum_probs=90.6

Q ss_pred             hccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHH---------HHHHHHHHHhcCC---CCceeeeeee
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLE---------FKNEVLLVANLQH---RNLVRLLGFS  389 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~---------~~~E~~~l~~l~H---~niv~l~~~~  389 (658)
                      ..++|...+.+-......|.+-.. +|..+.+|.........+..         ..+++..+.+++.   -....++.+.
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            456777777777777777777664 67889999776543322222         2334444444432   2233322222


Q ss_pred             c-----cCCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCC
Q 006155          390 L-----EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMT  464 (658)
Q Consensus       390 ~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~  464 (658)
                      .     -....+|+|||++|..|.++.       .++.    .+...+++.+.-||+.+   ++|+|..|+|+++++++ 
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~-------~i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-  172 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIE-------DIDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-  172 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccch-------hcCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-
Confidence            2     234557999999999886653       1222    24566778899999998   99999999999998655 


Q ss_pred             eEEecccccc
Q 006155          465 PKIADFGMAR  474 (658)
Q Consensus       465 ~kl~DFGla~  474 (658)
                      +++.||+..+
T Consensus       173 i~iID~~~k~  182 (229)
T PF06176_consen  173 IRIIDTQGKR  182 (229)
T ss_pred             EEEEECcccc
Confidence            9999998765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.06  E-value=1.5e-05  Score=77.88  Aligned_cols=136  Identities=19%  Similarity=0.276  Sum_probs=88.6

Q ss_pred             cccccCceEEEEeEecCCcceeEEEeccCCcccHH---------H---------------HHHHHHHHHhcC--CCCcee
Q 006155          331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDL---------E---------------FKNEVLLVANLQ--HRNLVR  384 (658)
Q Consensus       331 ~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~---------~---------------~~~E~~~l~~l~--H~niv~  384 (658)
                      .|+.|.-+.||+|...++..+|||++.........         .               ...|+.-|.++.  +-.+.+
T Consensus        55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~  134 (268)
T COG1718          55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE  134 (268)
T ss_pred             eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence            46677888999998778999999988644221110         0               124555555553  223333


Q ss_pred             eeeeeccCCceEEEEEecCCCCh-hhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCC
Q 006155          385 LLGFSLEGNERLLIYEFVPNTSL-DHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM  463 (658)
Q Consensus       385 l~~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~  463 (658)
                      -+++    ..-.|||||+....+ .-.|    +...+.......+..++++.+.-|-...  .+||+||..-|||+. ++
T Consensus       135 Pi~~----~~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a--~LVHgDLSEyNiL~~-~~  203 (268)
T COG1718         135 PIAF----RNNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEA--GLVHGDLSEYNILVH-DG  203 (268)
T ss_pred             ceee----cCCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhc--CcccccchhhheEEE-CC
Confidence            3333    234799999965411 1112    1122333356677788888888887733  399999999999999 88


Q ss_pred             CeEEeccccccccc
Q 006155          464 TPKIADFGMARLFE  477 (658)
Q Consensus       464 ~~kl~DFGla~~~~  477 (658)
                      .+.|+|||-+....
T Consensus       204 ~p~iID~~QaV~~~  217 (268)
T COG1718         204 EPYIIDVSQAVTID  217 (268)
T ss_pred             eEEEEECccccccC
Confidence            99999999887544

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.05  E-value=3.8e-05  Score=77.23  Aligned_cols=140  Identities=15%  Similarity=0.199  Sum_probs=85.3

Q ss_pred             cccccCc-eEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcC-CCCceeeeeeeccCCceEEEEEecCCCChh
Q 006155          331 KLGQGGF-GAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQ-HRNLVRLLGFSLEGNERLLIYEFVPNTSLD  408 (658)
Q Consensus       331 ~lG~G~f-g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~gsL~  408 (658)
                      .|-.|.. ..||+... ++..+.||+.....   ..++..|+.++..+. +--+.+++++...++..++|||+++|.+|.
T Consensus         5 ~~~~g~~~~~v~~~~~-~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           5 RVTEGQSGATVYRLDG-KNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             ecCCCCCcCeEEEEcC-CCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            3445555 78899875 45778888875543   335678888888874 444667787777666789999999998876


Q ss_pred             hhh-------------------cCcCC-CCCCC--HHHHHHHHHH--------------------HHHHHHHhhh----c
Q 006155          409 HFI-------------------FDPTR-RAQLD--WERRYKIIGG--------------------IARGLLYLHE----D  442 (658)
Q Consensus       409 ~~l-------------------~~~~~-~~~l~--~~~~~~i~~~--------------------ia~gL~yLH~----~  442 (658)
                      ...                   |.-.. ...+.  +...+.....                    +...+..|-.    .
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            432                   11000 00111  0011100000                    1111122211    1


Q ss_pred             CCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          443 SRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       443 ~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      ..+.++|+|+.|.|||++++....|.||+.+.
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            23459999999999999998778899999775

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=97.88  E-value=0.00015  Score=85.80  Aligned_cols=79  Identities=11%  Similarity=0.258  Sum_probs=57.9

Q ss_pred             cCcccccCceEEEEeEecCC---cceeEEEeccCCc-ccHHHHHHHHHHHHhcC-CCCc--eeeeeeeccC---CceEEE
Q 006155          329 ANKLGQGGFGAVYKGRLYDG---AEIAVKRLSRDSG-QGDLEFKNEVLLVANLQ-HRNL--VRLLGFSLEG---NERLLI  398 (658)
Q Consensus       329 ~~~lG~G~fg~Vy~~~~~~g---~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~ni--v~l~~~~~~~---~~~~lv  398 (658)
                      .+.++.|.+..+|+....++   ..+++|+...... .....+.+|+.+++.+. |.+|  .+++.++.+.   ...++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            56789999999999876544   3677787654322 23456889999999996 6665  7788887664   357899


Q ss_pred             EEecCCCCh
Q 006155          399 YEFVPNTSL  407 (658)
Q Consensus       399 ~e~~~~gsL  407 (658)
                      |||+++..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999998654

>PRK10593 hypothetical protein; Provisional

Probab=97.82  E-value=0.00032  Score=72.75  Aligned_cols=80  Identities=11%  Similarity=0.068  Sum_probs=57.7

Q ss_pred             CCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCC---CCceeeeeeeccC---CceEEE
Q 006155          325 NFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQH---RNLVRLLGFSLEG---NERLLI  398 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~~~~~~~---~~~~lv  398 (658)
                      .....+.||.|..+.||+-...++ .+.+|..+.  ......+..|...++.|..   -.+.++++++..+   +..+||
T Consensus        15 ~~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV   91 (297)
T PRK10593         15 KLSRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL   91 (297)
T ss_pred             hhheeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence            344466899999999999875455 466776432  1123468899999988853   3678888877543   568999


Q ss_pred             EEecCCCCh
Q 006155          399 YEFVPNTSL  407 (658)
Q Consensus       399 ~e~~~~gsL  407 (658)
                      ||+++++++
T Consensus        92 mE~i~G~~~  100 (297)
T PRK10593         92 LERLRGVSV  100 (297)
T ss_pred             EeccCCEec
Confidence            999998765

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.73  E-value=0.00028  Score=70.55  Aligned_cols=74  Identities=16%  Similarity=0.238  Sum_probs=46.6

Q ss_pred             cCcccccCce-EEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCC---CceeeeeeeccCC---ceEEEEEe
Q 006155          329 ANKLGQGGFG-AVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHR---NLVRLLGFSLEGN---ERLLIYEF  401 (658)
Q Consensus       329 ~~~lG~G~fg-~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~~~~~~~~---~~~lv~e~  401 (658)
                      ++.|+.||.. .||+.    +..+++|.....  .....+..|...+..+...   -+.+.++.....+   ..+++||+
T Consensus         2 ~~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           2 IEPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             ceeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            3567877776 48874    345777764432  2344788999999887532   3444444433322   34789999


Q ss_pred             cCCCChh
Q 006155          402 VPNTSLD  408 (658)
Q Consensus       402 ~~~gsL~  408 (658)
                      ++|.++.
T Consensus        76 i~G~~l~   82 (235)
T cd05155          76 LEGETAT   82 (235)
T ss_pred             ecCCCCC
Confidence            9998774

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.72  E-value=0.0003  Score=67.42  Aligned_cols=125  Identities=30%  Similarity=0.409  Sum_probs=89.4

Q ss_pred             cCCcccCcccccCc-eEEEEeEecCCcceeEEEeccC---C---------c---------ccHHHHHHHHHHHHhcC---
Q 006155          324 DNFSDANKLGQGGF-GAVYKGRLYDGAEIAVKRLSRD---S---------G---------QGDLEFKNEVLLVANLQ---  378 (658)
Q Consensus       324 ~~~~~~~~lG~G~f-g~Vy~~~~~~g~~vavK~l~~~---~---------~---------~~~~~~~~E~~~l~~l~---  378 (658)
                      .+++..+.||.|.- |.||+.++ +|+.+|+|.+...   .         .         .....|..|.....+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            67788899999999 99999986 6889999983221   0         0         01124778888888775   


Q ss_pred             CCCc--eeeeeeeccC------------------CceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHH
Q 006155          379 HRNL--VRLLGFSLEG------------------NERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY  438 (658)
Q Consensus       379 H~ni--v~l~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~y  438 (658)
                      +.++  |+.+||..-.                  ....+|.||++...            .+    ..+-+.+|.+-|..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~----~~~~~~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PL----QIRDIPQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------cc----chhHHHHHHHHHHH
Confidence            4566  9999986322                  12257777765432            11    22346677888889


Q ss_pred             hhhcCCCcEEEeccCCCceeeCCCCCeEEeccccc
Q 006155          439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMA  473 (658)
Q Consensus       439 LH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla  473 (658)
                      +|..+   |+-+|+++.|..     .-||+|||.+
T Consensus       180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            99988   999999999986     4589999864

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.60  E-value=0.00056  Score=68.28  Aligned_cols=140  Identities=18%  Similarity=0.236  Sum_probs=81.7

Q ss_pred             CcccccCceEEEEeEecC--CcceeEEEeccCCcccHHHHHHHHHHHHhcCCCC-ceeeeeeeccCCceEEEEEecCCCC
Q 006155          330 NKLGQGGFGAVYKGRLYD--GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRN-LVRLLGFSLEGNERLLIYEFVPNTS  406 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~~~--g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~lv~e~~~~gs  406 (658)
                      +.|..|-...+|+....+  +..+++|+..... ....+..+|+.++..+...+ .+++++...    ..+||||++|.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~-~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT-ELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCc-cceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            467778888999987654  5678888765432 22234467888888885433 344444332    248999999977


Q ss_pred             hhhh-----------------hcCcCCC--------CCC-CHHHHHHHHHH----------------------HHHHHHH
Q 006155          407 LDHF-----------------IFDPTRR--------AQL-DWERRYKIIGG----------------------IARGLLY  438 (658)
Q Consensus       407 L~~~-----------------l~~~~~~--------~~l-~~~~~~~i~~~----------------------ia~gL~y  438 (658)
                      +...                 +|.....        ... -|.....+...                      +..-+..
T Consensus        79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  158 (235)
T cd05157          79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW  158 (235)
T ss_pred             CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence            6321                 1111111        111 12222222111                      1111111


Q ss_pred             h----hhc-CCCcEEEeccCCCceeeCC-CCCeEEecccccc
Q 006155          439 L----HED-SRLRIIHRDLKTSNVLLDA-EMTPKIADFGMAR  474 (658)
Q Consensus       439 L----H~~-~~~~ivHrDlk~~NILl~~-~~~~kl~DFGla~  474 (658)
                      |    ... ....++|+|+.+.|||+++ ++.+.|.||..+.
T Consensus       159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            1    111 2345999999999999998 5789999998775

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.60  E-value=0.00032  Score=71.15  Aligned_cols=138  Identities=14%  Similarity=0.116  Sum_probs=79.7

Q ss_pred             cccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCc-eeeeeeeccCCceEEEEEecCCCChhh
Q 006155          331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNL-VRLLGFSLEGNERLLIYEFVPNTSLDH  409 (658)
Q Consensus       331 ~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~~~gsL~~  409 (658)
                      .+..|-...+|+.. .++..+++|........-..+..+|..+++.+....+ .++++...    .++||||++|..+..
T Consensus         3 ~~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            35567778899887 4677888887654322221245788888888864333 34444432    368999999877642


Q ss_pred             h-----------------hcCcC-CCCCCCHHHH-HHHHHHH---------HHHHHHhhhc-----CCCcEEEeccCCCc
Q 006155          410 F-----------------IFDPT-RRAQLDWERR-YKIIGGI---------ARGLLYLHED-----SRLRIIHRDLKTSN  456 (658)
Q Consensus       410 ~-----------------l~~~~-~~~~l~~~~~-~~i~~~i---------a~gL~yLH~~-----~~~~ivHrDlk~~N  456 (658)
                      .                 ||... ...+++.... ..+..++         ..-+..+-..     ....++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1                 12111 1112222211 1111111         1112222111     12358999999999


Q ss_pred             eeeCCCCCeEEecccccc
Q 006155          457 VLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       457 ILl~~~~~~kl~DFGla~  474 (658)
                      |++++++ +.|.||..+.
T Consensus       158 il~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             EEEeCCC-CEEEeccccC
Confidence            9999877 7899999875

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.53  E-value=0.00053  Score=63.68  Aligned_cols=128  Identities=23%  Similarity=0.318  Sum_probs=85.2

Q ss_pred             cccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCcee-eeeeeccCCceEEEEEecCCC
Q 006155          327 SDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVR-LLGFSLEGNERLLIYEFVPNT  405 (658)
Q Consensus       327 ~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~~~~~~~~~~~lv~e~~~~g  405 (658)
                      ...+.|++|++|.||+|.+ .|.++|+|+-..++  ....+..|++++..+.-.++-+ ++.|.    +..+.|||+.|.
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~   97 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEW-RGGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGR   97 (201)
T ss_pred             hhhhhhhcccccEEEEeec-cCceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCc
Confidence            4567899999999999985 56789999765543  3446788999999887666543 33332    223459999998


Q ss_pred             ChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccC-C-CceeeCCCCCeEEeccccccc
Q 006155          406 SLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLK-T-SNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       406 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk-~-~NILl~~~~~~kl~DFGla~~  475 (658)
                      +|.+.-..      .+-+    -+..+++.---|...+   |-|..|. | +||++.++ .+.|+||..|..
T Consensus        98 ~L~~~~~~------~~rk----~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~-~~~iIDFd~At~  155 (201)
T COG2112          98 PLGKLEIG------GDRK----HLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDR-DVYIIDFDSATF  155 (201)
T ss_pred             chhhhhhc------ccHH----HHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCC-cEEEEEccchhh
Confidence            88766421      1222    2334444433344444   7888876 3 45666554 899999999873

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.27  E-value=0.0014  Score=67.88  Aligned_cols=143  Identities=20%  Similarity=0.177  Sum_probs=86.7

Q ss_pred             ccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCC--ceeeeee------eccCCceEEEE
Q 006155          328 DANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRN--LVRLLGF------SLEGNERLLIY  399 (658)
Q Consensus       328 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~------~~~~~~~~lv~  399 (658)
                      ..+.|..|....+|+... ++..+++|+...   .....+..|+.++..+.+.+  +.+++..      ....+..++|+
T Consensus        18 ~i~~i~~G~~n~~y~v~~-~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          18 SFEGISAGIENTNYFVTT-DSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV   93 (296)
T ss_pred             heecccCccccceEEEEe-CCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence            355677787789999875 445788898754   23445677888888885433  4454432      12234568999


Q ss_pred             EecCCCChhhh--------------hcCc----C----CCCCCCHHHHHH----------HHHHHHHHHHHhhhc----C
Q 006155          400 EFVPNTSLDHF--------------IFDP----T----RRAQLDWERRYK----------IIGGIARGLLYLHED----S  443 (658)
Q Consensus       400 e~~~~gsL~~~--------------l~~~----~----~~~~l~~~~~~~----------i~~~ia~gL~yLH~~----~  443 (658)
                      ||++|..+...              +|..    .    ......|.....          ....+...+.++.+.    .
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            99998776320              1110    0    011223332211          111233444555431    1


Q ss_pred             CCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       444 ~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      ...++|+|+.|.|||++++..+.|.||+.+.
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            2359999999999999998777899999875

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.23  E-value=0.00073  Score=78.69  Aligned_cols=197  Identities=19%  Similarity=0.192  Sum_probs=134.0

Q ss_pred             HHHHHHHHHhcCCCCceeeeeeeccCCceE----EEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhc
Q 006155          367 FKNEVLLVANLQHRNLVRLLGFSLEGNERL----LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED  442 (658)
Q Consensus       367 ~~~E~~~l~~l~H~niv~l~~~~~~~~~~~----lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~  442 (658)
                      ..-|...+.++.|+|++.++.|-.++....    +..|++..-++...+.   .-..++....+.+..++.+||.|+|+.
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~h~~  305 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYLHSL  305 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHHHHh
Confidence            345777888899999999999876654332    4457777777777763   345678888999999999999999998


Q ss_pred             CCCcEEEeccCCC---ceeeCCCCCeEEe--ccccccccccCCCccccccccccccccCccccccCCCCc--cccccccc
Q 006155          443 SRLRIIHRDLKTS---NVLLDAEMTPKIA--DFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSV--KSDVFSFG  515 (658)
Q Consensus       443 ~~~~ivHrDlk~~---NILl~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--ksDV~S~G  515 (658)
                      .   ..|.-|..+   +...+.++...++  ||+....+......   ....-+..|.+||......+..  ..|+|.+|
T Consensus       306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg  379 (1351)
T KOG1035|consen  306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLG  379 (1351)
T ss_pred             c---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHH
Confidence            5   666666555   5556677777777  99988765432211   1123355678888776665544  47999999


Q ss_pred             chHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          516 VLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       516 vll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                      .+...+..|..+......      .            ..+++    .....   ........|+..++++|++..+++..
T Consensus       380 ll~~~~~~~~~i~~~~~~------~------------~~~l~----~~~~~---~~~d~~~~~~~~~~~~Rl~~~~ll~~  434 (1351)
T KOG1035|consen  380 LLLLQLSQGEDISEKSAV------P------------VSLLD----VLSTS---ELLDALPKCLDEDSEERLSALELLTH  434 (1351)
T ss_pred             HHHhhhhhcCcccccccc------h------------hhhhc----cccch---hhhhhhhhhcchhhhhccchhhhhhc
Confidence            999999998765421110      0            00111    01111   12234457999999999999999876


Q ss_pred             hc
Q 006155          596 LN  597 (658)
Q Consensus       596 L~  597 (658)
                      .-
T Consensus       435 ~f  436 (1351)
T KOG1035|consen  435 PF  436 (1351)
T ss_pred             hh
Confidence            53

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.21  E-value=0.0039  Score=66.81  Aligned_cols=76  Identities=13%  Similarity=0.138  Sum_probs=52.5

Q ss_pred             cCcccccCceEEEEeEecCC-cceeEEEeccC------C-cccHHHHHHHHHHHHhcC---CCCceeeeeeeccCCceEE
Q 006155          329 ANKLGQGGFGAVYKGRLYDG-AEIAVKRLSRD------S-GQGDLEFKNEVLLVANLQ---HRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       329 ~~~lG~G~fg~Vy~~~~~~g-~~vavK~l~~~------~-~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~l  397 (658)
                      .+.||.|.+..||+....+| +.|.||.-...      . ......+..|.+.|..+.   ..++.+++.+  +.+..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            35799999999999998777 48999974321      1 112334566777777652   3457777777  3355789


Q ss_pred             EEEecCCCC
Q 006155          398 IYEFVPNTS  406 (658)
Q Consensus       398 v~e~~~~gs  406 (658)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998643

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=96.86  E-value=0.0085  Score=62.29  Aligned_cols=140  Identities=26%  Similarity=0.323  Sum_probs=82.8

Q ss_pred             CcccccCceEEEEeEecC-------CcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCc-eeeeeeeccCCceEEEEEe
Q 006155          330 NKLGQGGFGAVYKGRLYD-------GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNL-VRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~~~-------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~  401 (658)
                      +.|..|-.-.+|+....+       ++.+++|+..... ....+..+|..++..+...++ .++++++..    .+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            345556666889887654       4778889865543 233456788888888853333 345555532    368999


Q ss_pred             cCCCChhhh-----------------hcCcCCC--------CCCCHHHHHHH--------------------------HH
Q 006155          402 VPNTSLDHF-----------------IFDPTRR--------AQLDWERRYKI--------------------------IG  430 (658)
Q Consensus       402 ~~~gsL~~~-----------------l~~~~~~--------~~l~~~~~~~i--------------------------~~  430 (658)
                      ++|.++...                 +|.....        ...-|....++                          ..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            998776431                 1111111        01111111111                          11


Q ss_pred             HHHHHHHHhhh------cCCCcEEEeccCCCceeeCCC----CCeEEecccccc
Q 006155          431 GIARGLLYLHE------DSRLRIIHRDLKTSNVLLDAE----MTPKIADFGMAR  474 (658)
Q Consensus       431 ~ia~gL~yLH~------~~~~~ivHrDlk~~NILl~~~----~~~kl~DFGla~  474 (658)
                      .+..-+..|..      .....++|+|+.+.|||++++    +.++++||..+.
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            22223334432      234569999999999999985    889999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.83  E-value=0.0065  Score=62.36  Aligned_cols=141  Identities=20%  Similarity=0.263  Sum_probs=73.5

Q ss_pred             cccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcC---CCCceeeeeeeccCCceEEEEEecC
Q 006155          327 SDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQ---HRNLVRLLGFSLEGNERLLIYEFVP  403 (658)
Q Consensus       327 ~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lv~e~~~  403 (658)
                      ...+.|+.|....+|+.. .+++.+.||.-..   .....|..|..-|+.|.   --.+.+.+++....+..+||+||++
T Consensus        20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~   95 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE   95 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred             eeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence            445678889999999987 6788899998752   23345788888888883   4457788888877777799999998


Q ss_pred             CCCh--------hh---hhcC-c-C-----------------CCCCCCHHHH-----HHHHHH--------------HHH
Q 006155          404 NTSL--------DH---FIFD-P-T-----------------RRAQLDWERR-----YKIIGG--------------IAR  434 (658)
Q Consensus       404 ~gsL--------~~---~l~~-~-~-----------------~~~~l~~~~~-----~~i~~~--------------ia~  434 (658)
                      .+..        ..   .||. . .                 +.-.-+|..-     +....+              +.+
T Consensus        96 ~~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~~  175 (288)
T PF03881_consen   96 MGSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLVE  175 (288)
T ss_dssp             -----CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHHH
T ss_pred             CCCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHHH
Confidence            7611        00   1122 0 0                 0011234321     111111              111


Q ss_pred             HH-HHhhhc-CCCcEEEeccCCCceeeCCCCCeEEeccc
Q 006155          435 GL-LYLHED-SRLRIIHRDLKTSNVLLDAEMTPKIADFG  471 (658)
Q Consensus       435 gL-~yLH~~-~~~~ivHrDlk~~NILl~~~~~~kl~DFG  471 (658)
                      .+ ..|+.. ..|.++|+||-+.|++.+.++.+.|.|=.
T Consensus       176 ~~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa  214 (288)
T PF03881_consen  176 RLPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPA  214 (288)
T ss_dssp             HHHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred             HHHHHhcCCCCCceeeEcCccccceeecCCCCceeeccc
Confidence            11 123321 24679999999999999999989998844

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins

Probab=96.82  E-value=0.001  Score=47.78  Aligned_cols=47  Identities=32%  Similarity=0.400  Sum_probs=31.5

Q ss_pred             CCCCCCCCCCCCcccccccccccccccccCCCCcCCCCCCCccccCCCCcccccccccCC
Q 006155          599 YSLTLPVPSEPAFFMDSIIESDMSFSLAHDSRITETDQPGCENLLLSGNNEISITDLYPR  658 (658)
Q Consensus       599 ~~~~~~~p~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r  658 (658)
                      ....||.|.+|+|+..+.....       ++++...     . -...|+|++|+|.|++|
T Consensus         2 e~~~LP~PKqPgF~~~r~~~e~-------~sSss~~-----~-~~~~SvNevTiT~l~~R   48 (48)
T PF11883_consen    2 ETATLPQPKQPGFFTGRSPSET-------DSSSSKQ-----R-DESCSVNEVTITMLEAR   48 (48)
T ss_pred             CcccCCCCCCCCEEeEcCCCCc-------CCCcccc-----c-CCCCCeeeEEEEeEecC
Confidence            3567999999999998774221       1111110     0 02568999999999998

; GO: 0004674 protein serine/threonine kinase activity

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.81  E-value=0.0013  Score=66.62  Aligned_cols=134  Identities=18%  Similarity=0.197  Sum_probs=91.1

Q ss_pred             CCcccCcccccCceEEEEeEecCCcceeEEEecc--C------------------Ccc--cHHHHHHHHHHHHhcCCC--
Q 006155          325 NFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSR--D------------------SGQ--GDLEFKNEVLLVANLQHR--  380 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~--~------------------~~~--~~~~~~~E~~~l~~l~H~--  380 (658)
                      -++..++||-|.-+-||.+...+|++.++|.-..  .                  +|.  +......|+..|+.|...  
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            4577899999999999999988899999983211  0                  000  112245688888888532  


Q ss_pred             CceeeeeeeccCCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeC
Q 006155          381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLD  460 (658)
Q Consensus       381 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~  460 (658)
                      -+.+.+    +.+..++|||++.+-.|...-+      ..+.+.+   ...+..-+--|-..+   +||+|.+--||+++
T Consensus       173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v~~------v~d~~~l---y~~lm~~Iv~la~~G---lIHgDFNEFNimv~  236 (465)
T KOG2268|consen  173 PVPKPI----DHNRHCVVMELVDGYPLRQVRH------VEDPPTL---YDDLMGLIVRLANHG---LIHGDFNEFNIMVK  236 (465)
T ss_pred             CCCCcc----cccceeeHHHhhcccceeeeee------cCChHHH---HHHHHHHHHHHHHcC---ceecccchheeEEe
Confidence            233333    3456789999999888865431      1223333   333333344555666   99999999999999


Q ss_pred             CCCCeEEecccccc
Q 006155          461 AEMTPKIADFGMAR  474 (658)
Q Consensus       461 ~~~~~kl~DFGla~  474 (658)
                      +++.++++||--..
T Consensus       237 dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  237 DDDKIVVIDFPQMV  250 (465)
T ss_pred             cCCCEEEeechHhh
Confidence            99999999996543

>PRK05231 homoserine kinase; Provisional

Probab=96.77  E-value=0.02  Score=60.04  Aligned_cols=142  Identities=17%  Similarity=0.170  Sum_probs=77.6

Q ss_pred             cCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCC--ceeeeee------eccCCceEEEEE
Q 006155          329 ANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRN--LVRLLGF------SLEGNERLLIYE  400 (658)
Q Consensus       329 ~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~------~~~~~~~~lv~e  400 (658)
                      .+.|+.|....+|+....+| .+++|++..   ........|+.++..|...+  +.+.+..      ....+..++++|
T Consensus        27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~  102 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT  102 (319)
T ss_pred             cchhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence            45677777789999876555 688898752   12233445556665553222  3333321      122455789999


Q ss_pred             ecCCCChhh-----------h---hcCcC--------CCCCCCH-HHHHHH------------HHH-HHHHHHHhhhc--
Q 006155          401 FVPNTSLDH-----------F---IFDPT--------RRAQLDW-ERRYKI------------IGG-IARGLLYLHED--  442 (658)
Q Consensus       401 ~~~~gsL~~-----------~---l~~~~--------~~~~l~~-~~~~~i------------~~~-ia~gL~yLH~~--  442 (658)
                      |++|..+..           .   +|...        ....+.| .....-            +.+ +...+..+.+.  
T Consensus       103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  182 (319)
T PRK05231        103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW  182 (319)
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence            999875421           1   11110        0111222 221111            111 11122333211  


Q ss_pred             --CCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          443 --SRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       443 --~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                        -+..+||+|+.+.|||++.+...-|.||+.+.
T Consensus       183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence              23359999999999999966556799999875

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.77  E-value=0.017  Score=60.31  Aligned_cols=143  Identities=18%  Similarity=0.192  Sum_probs=83.0

Q ss_pred             cCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCC--ceeeeeee------ccCCceEEEEE
Q 006155          329 ANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRN--LVRLLGFS------LEGNERLLIYE  400 (658)
Q Consensus       329 ~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~------~~~~~~~lv~e  400 (658)
                      .+.++.|-...+|+....+| .+++|+.....  ...++..|++++..|....  +.+++...      ...+..++++|
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            45677777789999875444 67788764421  2334566777777774322  34444321      22345689999


Q ss_pred             ecCCCChhhh--------------hcCcCCC---------CCCCHHHHHH------------HHHHHHHHHHHhhh----
Q 006155          401 FVPNTSLDHF--------------IFDPTRR---------AQLDWERRYK------------IIGGIARGLLYLHE----  441 (658)
Q Consensus       401 ~~~~gsL~~~--------------l~~~~~~---------~~l~~~~~~~------------i~~~ia~gL~yLH~----  441 (658)
                      |++|..+...              +|.....         ..-.|.....            ....+.+.++++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            9998654211              1110000         0112322111            11223345555543    


Q ss_pred             cCCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       442 ~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      .....++|+|+++.||++++++...|.||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            123459999999999999988767899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.68  E-value=0.0011  Score=78.77  Aligned_cols=158  Identities=10%  Similarity=-0.066  Sum_probs=114.1

Q ss_pred             HHHHHHHhcCCCCceeeeeeecc--CCceEEEEEecCCCChhhhhcCcC-CCCCCCHHHHHHHHHHHHHHHHHhhhc--C
Q 006155          369 NEVLLVANLQHRNLVRLLGFSLE--GNERLLIYEFVPNTSLDHFIFDPT-RRAQLDWERRYKIIGGIARGLLYLHED--S  443 (658)
Q Consensus       369 ~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~--~  443 (658)
                      .|...+++..|+++.....-...  ..+.+.+++|+..|.+.+.|.+.. +...++..-+.....+......-+|..  .
T Consensus      1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred             hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence            34445566789988776654432  346688999999999999886543 333444444443333335555555543  2


Q ss_pred             CCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh
Q 006155          444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS  523 (658)
Q Consensus       444 ~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt  523 (658)
                      ....+|++||+-|.+|..+.++|++++|+.+...+..  .......+++-|+.|+....-.++.++|+|..|..+++..-
T Consensus      1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred             CccchhhhhhhhccceecCCcccccccccccccCchH--hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence            3457999999999999999999999999998433322  12334577889999999999999999999999999999988


Q ss_pred             CCCCC
Q 006155          524 GQRNN  528 (658)
Q Consensus       524 G~~p~  528 (658)
                      |..++
T Consensus      1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred             ccHHH
Confidence            88765

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.62  E-value=0.016  Score=59.33  Aligned_cols=31  Identities=23%  Similarity=0.498  Sum_probs=25.7

Q ss_pred             CcEEEeccCCCceeeCCCCCe-EEeccccccc
Q 006155          445 LRIIHRDLKTSNVLLDAEMTP-KIADFGMARL  475 (658)
Q Consensus       445 ~~ivHrDlk~~NILl~~~~~~-kl~DFGla~~  475 (658)
                      +.++|+|+++.|||+++++.+ -|.||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            458999999999999975654 5999998764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02236 choline kinase

Probab=96.61  E-value=0.015  Score=61.61  Aligned_cols=140  Identities=19%  Similarity=0.265  Sum_probs=81.9

Q ss_pred             cccccCceEEEEeEecC-----CcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCce-eeeeeeccCCceEEEEEecCC
Q 006155          331 KLGQGGFGAVYKGRLYD-----GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV-RLLGFSLEGNERLLIYEFVPN  404 (658)
Q Consensus       331 ~lG~G~fg~Vy~~~~~~-----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~~~~lv~e~~~~  404 (658)
                      .|-.|-.-.+|+....+     ++.+.+|+..... ....+..+|..++..+...++. ++++.+..+    .|+||+++
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g  117 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-ELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA  117 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-CeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence            44446666788876432     3578888776543 2333447788888888644443 455665433    58999988


Q ss_pred             CChhhh-----------------hcCcC---CCCCCCHHHHHHHHHHH-----------------HHHHHHh----hh-c
Q 006155          405 TSLDHF-----------------IFDPT---RRAQLDWERRYKIIGGI-----------------ARGLLYL----HE-D  442 (658)
Q Consensus       405 gsL~~~-----------------l~~~~---~~~~l~~~~~~~i~~~i-----------------a~gL~yL----H~-~  442 (658)
                      .+|...                 +|...   .....-|.+..++..++                 ..-+..|    .. .
T Consensus       118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~  197 (344)
T PLN02236        118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD  197 (344)
T ss_pred             CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence            776421                 12111   01122244443443222                 1112222    21 2


Q ss_pred             CCCcEEEeccCCCceeeCC-CCCeEEeccccccc
Q 006155          443 SRLRIIHRDLKTSNVLLDA-EMTPKIADFGMARL  475 (658)
Q Consensus       443 ~~~~ivHrDlk~~NILl~~-~~~~kl~DFGla~~  475 (658)
                      ....++|+|+++.|||+++ ++.+.|.||..+..
T Consensus       198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            2345899999999999986 46899999988753

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.12  E-value=0.022  Score=55.85  Aligned_cols=122  Identities=21%  Similarity=0.282  Sum_probs=61.9

Q ss_pred             CcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCc-eeeeeeeccCCceEEEEEecCCCChhhh-h--------------
Q 006155          348 GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNL-VRLLGFSLEGNERLLIYEFVPNTSLDHF-I--------------  411 (658)
Q Consensus       348 g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l--------------  411 (658)
                      ++.|.||+.... .........|..+++.+...++ .++++++.++    .|+||+++.+|..- +              
T Consensus         2 ~~~~~~Ri~g~~-t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~   76 (211)
T PF01633_consen    2 PEKYLVRIPGEG-TENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLLA   76 (211)
T ss_dssp             TSEEEEEEEESC-GCSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred             CCEEEEEeCCCC-cccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHHH
Confidence            456778877655 3445667889999988864444 5566665432    67899977665321 1              


Q ss_pred             --cCc----CCCCCCCHHHHHHH----------------------HHHHHHHHHHhhh---c--CCCcEEEeccCCCcee
Q 006155          412 --FDP----TRRAQLDWERRYKI----------------------IGGIARGLLYLHE---D--SRLRIIHRDLKTSNVL  458 (658)
Q Consensus       412 --~~~----~~~~~l~~~~~~~i----------------------~~~ia~gL~yLH~---~--~~~~ivHrDlk~~NIL  458 (658)
                        |..    .....--|.....+                      +..+.+-+..+.+   .  ....+.|.||.+.|||
T Consensus        77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil  156 (211)
T PF01633_consen   77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL  156 (211)
T ss_dssp             HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred             HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence              110    01111123333222                      1111112222211   1  1234899999999999


Q ss_pred             e-CCCCCeEEecccccc
Q 006155          459 L-DAEMTPKIADFGMAR  474 (658)
Q Consensus       459 l-~~~~~~kl~DFGla~  474 (658)
                      + +.++.++++||..+.
T Consensus       157 ~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  157 INNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             ETSSSSCEEE--GTT-E
T ss_pred             eccCCCeEEEecHHHHh
Confidence            9 889999999999875

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.12  E-value=0.067  Score=55.45  Aligned_cols=127  Identities=19%  Similarity=0.316  Sum_probs=74.0

Q ss_pred             CcceeEEEecc--CCcccHHHHHHHHHHHHhcCC--CCceeeeeeeccCC--ceEEEEEecCCCChhhhhcCcC------
Q 006155          348 GAEIAVKRLSR--DSGQGDLEFKNEVLLVANLQH--RNLVRLLGFSLEGN--ERLLIYEFVPNTSLDHFIFDPT------  415 (658)
Q Consensus       348 g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~--~~~lv~e~~~~gsL~~~l~~~~------  415 (658)
                      +++++++ ...  ..........+|..+|+.+.-  --+.+.++.|.++.  ..+.||+|++|..+...+....      
T Consensus        48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~  126 (321)
T COG3173          48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFA  126 (321)
T ss_pred             CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHH
Confidence            7777777 332  222334456788888887743  23445567777666  6699999998854322221100      


Q ss_pred             -----------------------------CCCCCCHHHHHHHH--------HHHHHHHHHhhhc-----CCCcEEEeccC
Q 006155          416 -----------------------------RRAQLDWERRYKII--------GGIARGLLYLHED-----SRLRIIHRDLK  453 (658)
Q Consensus       416 -----------------------------~~~~l~~~~~~~i~--------~~ia~gL~yLH~~-----~~~~ivHrDlk  453 (658)
                                                   .++.-.|...++.+        -....-..+|++.     +.+.++|+|+.
T Consensus       127 ~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~  206 (321)
T COG3173         127 LDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYR  206 (321)
T ss_pred             HHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcc
Confidence                                         00011121111100        0111223444433     23459999999


Q ss_pred             CCceeeCCCCCeEEeccccccc
Q 006155          454 TSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       454 ~~NILl~~~~~~kl~DFGla~~  475 (658)
                      +.|++++.+..+-|.||+++.+
T Consensus       207 ~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         207 PGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             cCCEEEeCCCeeEEEecccccc
Confidence            9999999988899999999865

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.83  E-value=0.057  Score=56.90  Aligned_cols=139  Identities=16%  Similarity=0.277  Sum_probs=79.7

Q ss_pred             cccccCceEEEEeEecC----CcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCc-eeeeeeeccCCceEEEEEecCCC
Q 006155          331 KLGQGGFGAVYKGRLYD----GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNL-VRLLGFSLEGNERLLIYEFVPNT  405 (658)
Q Consensus       331 ~lG~G~fg~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~~~g  405 (658)
                      .|..|=.-.+|+....+    +..|.+|+...... ...+..+|..++..+..-++ .++++++..+    +|.+|+++.
T Consensus        21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~   95 (330)
T PLN02421         21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINAR   95 (330)
T ss_pred             EeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCC
Confidence            44445556788776433    23688887765433 23345788888888865555 3556655322    589999877


Q ss_pred             Chhhh-----------------hcCcC---CCCCCCHHHHHHHHHHHH----------------------HHHHH----h
Q 006155          406 SLDHF-----------------IFDPT---RRAQLDWERRYKIIGGIA----------------------RGLLY----L  439 (658)
Q Consensus       406 sL~~~-----------------l~~~~---~~~~l~~~~~~~i~~~ia----------------------~gL~y----L  439 (658)
                      .|..-                 +|...   ....--|....++..++-                      +-+..    +
T Consensus        96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~  175 (330)
T PLN02421         96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT  175 (330)
T ss_pred             CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence            66321                 12111   111112444333332221                      11111    1


Q ss_pred             hh-cCCCcEEEeccCCCceeeCC-CCCeEEecccccc
Q 006155          440 HE-DSRLRIIHRDLKTSNVLLDA-EMTPKIADFGMAR  474 (658)
Q Consensus       440 H~-~~~~~ivHrDlk~~NILl~~-~~~~kl~DFGla~  474 (658)
                      .. .....++|.|+.+.|||+++ ++.++++||..+-
T Consensus       176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            11 12235899999999999975 5789999999874

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=95.77  E-value=0.067  Score=55.60  Aligned_cols=141  Identities=19%  Similarity=0.250  Sum_probs=92.1

Q ss_pred             cCcccccCceEEEEeEecCCcceeEEEeccCC---------cccHHH-----------------HHHHHHHHHhcCCCCc
Q 006155          329 ANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDS---------GQGDLE-----------------FKNEVLLVANLQHRNL  382 (658)
Q Consensus       329 ~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~---------~~~~~~-----------------~~~E~~~l~~l~H~ni  382 (658)
                      .-.|..|.-+.||.+.-.+|..+|||+++..-         ..+...                 ...|+.-|.+|+...|
T Consensus       149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI  228 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI  228 (520)
T ss_pred             ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence            34678899999999998899999999774320         001111                 1345555555544333


Q ss_pred             eeeeeeeccCCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCC
Q 006155          383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE  462 (658)
Q Consensus       383 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~  462 (658)
                      .-.--...  ....|||+|+....   +-....+...++...+..+-.+++.-|.-|-+.+  ++||.||.--|+|+. +
T Consensus       229 P~PePIlL--k~hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh-d  300 (520)
T KOG2270|consen  229 PCPEPILL--KNHVLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH-D  300 (520)
T ss_pred             CCCCceee--ecceEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-C
Confidence            21111111  12369999996322   1111123455777788888889999999998887  599999999999985 5


Q ss_pred             CCeEEeccccccccc
Q 006155          463 MTPKIADFGMARLFE  477 (658)
Q Consensus       463 ~~~kl~DFGla~~~~  477 (658)
                      |.+.|+|-+-+...+
T Consensus       301 G~lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  301 GKLYIIDVSQSVEHD  315 (520)
T ss_pred             CEEEEEEccccccCC
Confidence            678999987665433

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.73  E-value=0.081  Score=55.09  Aligned_cols=29  Identities=24%  Similarity=0.340  Sum_probs=25.2

Q ss_pred             CcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          445 LRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       445 ~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      ..++|+|+.+.||+++. +.+.|.||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            45899999999999987 678999999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.71  E-value=0.054  Score=52.38  Aligned_cols=154  Identities=18%  Similarity=0.182  Sum_probs=95.9

Q ss_pred             cCceEEEEeEecCCcceeEEEeccCCcc-cHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecCCCChhhhhcC
Q 006155          335 GGFGAVYKGRLYDGAEIAVKRLSRDSGQ-GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFD  413 (658)
Q Consensus       335 G~fg~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  413 (658)
                      ||-.+.-+|+..-| +..+|++..-.-. ...-|.++..++++++  .|++|..=  +.-.+.++.|+|.....      
T Consensus        73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------  141 (308)
T PF07387_consen   73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------  141 (308)
T ss_pred             CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence            44555555554333 3456666444333 4556788899988875  57777732  34456789998843211      


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCcccccccccccc
Q 006155          414 PTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG  493 (658)
Q Consensus       414 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~  493 (658)
                            ..    ..++..=++.|.-.|+.+ ...+|+|-.|+||+-|+.|.+||.|-+....  .            +..
T Consensus       142 ------~~----~N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--~------------~V~  196 (308)
T PF07387_consen  142 ------NF----SNFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--N------------QVN  196 (308)
T ss_pred             ------ch----hHHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhhh--h------------eee
Confidence                  10    122222257788899654 4699999999999999999999999775321  0            112


Q ss_pred             ccCccccccCCCCcccccccccchHhHHHhCCCC
Q 006155          494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRN  527 (658)
Q Consensus       494 y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p  527 (658)
                      |.--||   ...|+++.+-+|=.-+++++.-.+.
T Consensus       197 ~vN~~Y---~~lT~~aE~~~fv~s~l~~v~~~~~  227 (308)
T PF07387_consen  197 MVNIEY---ESLTQEAEVKVFVKSCLKLVEKQRS  227 (308)
T ss_pred             EEeeec---cccChHHHHHHHHHHHHHHHHHHhc
Confidence            222121   3356778887777777888775543

The function of this family is unknown.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.58  E-value=0.17  Score=53.07  Aligned_cols=136  Identities=23%  Similarity=0.319  Sum_probs=81.5

Q ss_pred             CceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCce---e---eee----eeccCCceEEEEEecCCC
Q 006155          336 GFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV---R---LLG----FSLEGNERLLIYEFVPNT  405 (658)
Q Consensus       336 ~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv---~---l~~----~~~~~~~~~lv~e~~~~g  405 (658)
                      .--.+|+....+|+. ++|+....  ....++..|+..+..|.-.+|.   +   +=|    ....+...+-+++|++|.
T Consensus        37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~  113 (331)
T COG2334          37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR  113 (331)
T ss_pred             ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence            445688888766666 78877654  4556777888888777422221   1   111    111223678899999998


Q ss_pred             Chhh-h--------------hc----C-----cCCCCCCCHHH-------------HHHHHHHHHHHHHHhhhc----CC
Q 006155          406 SLDH-F--------------IF----D-----PTRRAQLDWER-------------RYKIIGGIARGLLYLHED----SR  444 (658)
Q Consensus       406 sL~~-~--------------l~----~-----~~~~~~l~~~~-------------~~~i~~~ia~gL~yLH~~----~~  444 (658)
                      .+.. .              ||    +     +.......|..             ......++...+..+.+.    -.
T Consensus       114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp  193 (331)
T COG2334         114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP  193 (331)
T ss_pred             CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence            8873 1              11    0     01112344431             011233344445554433    11


Q ss_pred             ---CcEEEeccCCCceeeCCCCC-eEEecccccc
Q 006155          445 ---LRIIHRDLKTSNVLLDAEMT-PKIADFGMAR  474 (658)
Q Consensus       445 ---~~ivHrDlk~~NILl~~~~~-~kl~DFGla~  474 (658)
                         ..+||+|+.|.|||++.+.. +.+.|||-+.
T Consensus       194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence               22899999999999999885 8899999775

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.57  E-value=0.19  Score=49.09  Aligned_cols=136  Identities=18%  Similarity=0.248  Sum_probs=82.7

Q ss_pred             cCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcC---CCCceeeeeeeccCCceEEEEEecCCC
Q 006155          329 ANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQ---HRNLVRLLGFSLEGNERLLIYEFVPNT  405 (658)
Q Consensus       329 ~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lv~e~~~~g  405 (658)
                      .+.+.-|.--..|... .+..++.||+=.   .+....|..|+.-|..|.   --++.+++.+-....+.+||+||++-+
T Consensus        21 r~~v~gG~inea~~v~-dg~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~   96 (286)
T COG3001          21 REEVSGGDINEAWRLR-DGTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTG   96 (286)
T ss_pred             ccccCCccccceeEee-cCCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCC
Confidence            3445555545556554 356678888532   233345788877776664   456888888889999999999999987


Q ss_pred             Chhh---h--------hcCcC---------------CCCCCCHH---------HHHHHHHHH--------------HHHH
Q 006155          406 SLDH---F--------IFDPT---------------RRAQLDWE---------RRYKIIGGI--------------ARGL  436 (658)
Q Consensus       406 sL~~---~--------l~~~~---------------~~~~l~~~---------~~~~i~~~i--------------a~gL  436 (658)
                      .++.   +        ||...               ...+-+|.         +|+-+..++              ...+
T Consensus        97 ~~d~~~~~~~GqqLA~LH~~~~~~~fG~d~dn~iG~t~QpN~W~~~Wa~FfaeqRig~qlqlar~rg~~f~did~~~~~v  176 (286)
T COG3001          97 PLDAHSAFILGQQLARLHQWGGQAQFGLDFDNYIGTTPQPNTWQRRWATFFAEQRIGWQLQLARERGLTFGDIDAIVEKI  176 (286)
T ss_pred             CCCchhHHHHHHHHHHHHhhcCccccCcccccccCCCCCCCCCcchHHHHHHHhhhhHHHHHHHHhCCCccCHHHHHHHH
Confidence            7751   1        12110               01112232         222222222              2333


Q ss_pred             HHhhhcC--CCcEEEeccCCCceeeCCCCCeEEec
Q 006155          437 LYLHEDS--RLRIIHRDLKTSNVLLDAEMTPKIAD  469 (658)
Q Consensus       437 ~yLH~~~--~~~ivHrDlk~~NILl~~~~~~kl~D  469 (658)
                      .-+-...  +|..+|+||-..|+....+| +.|-|
T Consensus       177 ~elL~~hqpqPsLlHGDLW~gN~a~~~~G-Pv~fD  210 (286)
T COG3001         177 QELLADHQPQPSLLHGDLWSGNCAFGKDG-PVIFD  210 (286)
T ss_pred             HHHHhcCCCCcceeecccccccccccCCC-Ceeec
Confidence            3333332  36799999999999999998 66655

>PLN02756 S-methyl-5-thioribose kinase

Probab=95.51  E-value=0.23  Score=53.31  Aligned_cols=73  Identities=11%  Similarity=0.097  Sum_probs=48.1

Q ss_pred             cCcccccCceEEEEeEecCCcceeEEEeccCCc-------ccHHHHHHHHHHHHhcC---CCCceeeeeeeccCCceEEE
Q 006155          329 ANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSG-------QGDLEFKNEVLLVANLQ---HRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       329 ~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lv  398 (658)
                      .+.||.|..-.||+... ++..++||+-.....       .....-..|...|..+.   ..++.+++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            56789999999999875 456799997552111       11222234455555443   357888888877  446889


Q ss_pred             EEecCC
Q 006155          399 YEFVPN  404 (658)
Q Consensus       399 ~e~~~~  404 (658)
                      |||+++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999976

>PRK06148 hypothetical protein; Provisional

Probab=95.25  E-value=0.18  Score=61.24  Aligned_cols=140  Identities=23%  Similarity=0.325  Sum_probs=77.5

Q ss_pred             cccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcC-------CCCceeee-e----eec--cCC-ce
Q 006155          331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQ-------HRNLVRLL-G----FSL--EGN-ER  395 (658)
Q Consensus       331 ~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-------H~niv~l~-~----~~~--~~~-~~  395 (658)
                      .|+ |..-.+|+.+..+|..+++|+.....  .......|...|..|.       -|.+++-. |    ...  ++. ..
T Consensus        32 ~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~  108 (1013)
T PRK06148         32 PLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL  108 (1013)
T ss_pred             ecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence            453 34567888877778889999987643  2333444555555442       22333322 1    111  122 45


Q ss_pred             EEEEEecCCCChhhhh-----------------c----C---cCCCCCCCHHH-----------------HHHHHHHHHH
Q 006155          396 LLIYEFVPNTSLDHFI-----------------F----D---PTRRAQLDWER-----------------RYKIIGGIAR  434 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l-----------------~----~---~~~~~~l~~~~-----------------~~~i~~~ia~  434 (658)
                      +-+++|++|..|.+..                 +    +   +.....+.|..                 ...++.++.+
T Consensus       109 vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~  188 (1013)
T PRK06148        109 LRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLA  188 (1013)
T ss_pred             EEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHH
Confidence            6789999998775411                 0    0   11112344432                 1222333333


Q ss_pred             HHH-----HhhhcCCCcEEEeccCCCceeeCCCC--CeE-Eecccccc
Q 006155          435 GLL-----YLHEDSRLRIIHRDLKTSNVLLDAEM--TPK-IADFGMAR  474 (658)
Q Consensus       435 gL~-----yLH~~~~~~ivHrDlk~~NILl~~~~--~~k-l~DFGla~  474 (658)
                      .+.     .|.+ -+..+||+|+++.|||++.+.  ++. |.|||-+.
T Consensus       189 ~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        189 RFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             HHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            222     1211 233599999999999999875  565 99999875

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=95.14  E-value=0.2  Score=52.86  Aligned_cols=72  Identities=15%  Similarity=0.123  Sum_probs=43.7

Q ss_pred             cccccCceEEEEeEecCC-cceeEEEeccC------C-cccHHHHHHHHHHHHhcC--CC-CceeeeeeeccCCceEEEE
Q 006155          331 KLGQGGFGAVYKGRLYDG-AEIAVKRLSRD------S-GQGDLEFKNEVLLVANLQ--HR-NLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       331 ~lG~G~fg~Vy~~~~~~g-~~vavK~l~~~------~-~~~~~~~~~E~~~l~~l~--H~-niv~l~~~~~~~~~~~lv~  399 (658)
                      .||.|..-.||++...+| +.|+||.-...      + .-......-|.+.|....  -| .+.+++.+  +.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            579999999999987654 58999954321      1 112223345556665542  34 34444443  445567999


Q ss_pred             EecCC
Q 006155          400 EFVPN  404 (658)
Q Consensus       400 e~~~~  404 (658)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99864

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ]

Probab=95.00  E-value=0.04  Score=37.60  Aligned_cols=30  Identities=20%  Similarity=0.397  Sum_probs=16.9

Q ss_pred             CCCceEEEEeehhhHHHHHHhhhheeeccc
Q 006155          260 DTARTVIIILIPTVGFVILIIFICFFLRRK  289 (658)
Q Consensus       260 ~~~~~~iiiv~~v~~~vll~i~~~~~~rr~  289 (658)
                      ....+...+++|+++++++++++++++|||
T Consensus         9 ~~vaIa~~VvVPV~vI~~vl~~~l~~~~rR   38 (40)
T PF08693_consen    9 NTVAIAVGVVVPVGVIIIVLGAFLFFWYRR   38 (40)
T ss_pred             ceEEEEEEEEechHHHHHHHHHHhheEEec
Confidence            344455666677766666655555544444

This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis [].

>PRK11768 serine/threonine protein kinase; Provisional

Probab=94.88  E-value=0.33  Score=51.04  Aligned_cols=71  Identities=17%  Similarity=0.126  Sum_probs=44.3

Q ss_pred             CceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCC--ceeee---e--eeccCCceEEEEEecCCCCh
Q 006155          336 GFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRN--LVRLL---G--FSLEGNERLLIYEFVPNTSL  407 (658)
Q Consensus       336 ~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~---~--~~~~~~~~~lv~e~~~~gsL  407 (658)
                      .--.||+....+|..+++|+... ......++..|+..+..|....  ++..+   |  +...++..+.++++++|...
T Consensus        37 ~eN~vy~v~~~~~~~~vlKv~r~-~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         37 YENRVYQFGDEDGRRVVAKFYRP-ERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             ccceEEEEecCCCCEEEEEEcCc-ccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence            44568998877788888887743 2334566778888887774221  22222   1  11223456789999988654

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=94.85  E-value=0.18  Score=52.62  Aligned_cols=30  Identities=23%  Similarity=0.289  Sum_probs=27.4

Q ss_pred             CcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          445 LRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       445 ~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      ..++|+|+.++|||+++++.+.|.||..+.
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            459999999999999999999999999875

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=94.64  E-value=0.094  Score=54.49  Aligned_cols=71  Identities=23%  Similarity=0.238  Sum_probs=55.4

Q ss_pred             ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccc
Q 006155          394 ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMA  473 (658)
Q Consensus       394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla  473 (658)
                      ..+++|++. |+++.-       ...-.|++...++.+-+.-+.-+..+  .++-|||+.-.||||+ +|++-|+||-++
T Consensus       300 y~yl~~kdh-gt~is~-------ik~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfkls  368 (488)
T COG5072         300 YLYLHFKDH-GTPISI-------IKADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLS  368 (488)
T ss_pred             EEEEEEecC-Cceeee-------eecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeee
Confidence            345666665 444422       23457899999999988877777664  4689999999999999 999999999999


Q ss_pred             cc
Q 006155          474 RL  475 (658)
Q Consensus       474 ~~  475 (658)
                      |+
T Consensus       369 Rl  370 (488)
T COG5072         369 RL  370 (488)
T ss_pred             ec
Confidence            85

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	658
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-57
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-54
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-40
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-40
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		8e-40
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		9e-40
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-39
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		8e-39
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-23
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-23
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-23
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-23
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		6e-23
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-22
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-22
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-22
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-22
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-22
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-22
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-22
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-22
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-22
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-22
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-22
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-22
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-22
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-22
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-21
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-21
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-21
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-21
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-21
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-21
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-21
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-21
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		6e-21
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-21
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-21
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-20
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-20
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-20
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-20
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-20
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-20
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-20
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-20
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-20
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-20
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-20
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-20
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-20
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-20
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-20
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-20
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		5e-20
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-20
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-20
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		5e-20
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-20
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		6e-20
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		6e-20
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		6e-20
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		6e-20
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		6e-20
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		6e-20
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-20
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-20
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		7e-20
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-20
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		8e-20
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		9e-20
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-20
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-20
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-20
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		9e-20
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-19
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-19
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-19
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-19
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-19
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-19
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-19
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-19
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-19
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-19
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-19
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		4e-19
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-19
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		5e-19
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		6e-19
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		6e-19
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		6e-19
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		8e-19
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		8e-19
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		8e-19
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-18
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-18
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-18
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-18
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-18
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-18
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-18
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-18
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-18
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-18
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-18
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-18
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-18
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-18
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-18
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-18
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-18
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-18
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-18
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-18
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-18
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-18
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-18
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-18
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-18
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-18
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-18
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-18
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-18
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-18
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-18
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		5e-18
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		6e-18
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-18
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-18
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-18
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		7e-18
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		7e-18
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		7e-18
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		8e-18
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-18
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		8e-18
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		8e-18
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		9e-18
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		9e-18
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-17
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-17
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-17
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-17
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-17
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-17
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-17
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-17
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-17
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-17
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-17
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-17
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-17
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-17
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-17
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-17
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-17
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-17
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-17
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-17
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-17
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-17
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-17
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-17
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-17
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-17
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-17
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-17
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-17
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-17
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-17
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-17
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-17
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-17
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-17
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-17
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-17
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-17
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-17
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-17
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-17
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-17
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-17
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-17
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		4e-17
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-17
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-17
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-17
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-17
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		5e-17
1fvr_A	327	Tie2 Kinase Domain Length = 327		5e-17
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		5e-17
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-17
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		6e-17
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		6e-17
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		6e-17
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		6e-17
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		7e-17
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		8e-17
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		8e-17
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		8e-17
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-17
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-17
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		9e-17
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		9e-17
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		9e-17
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		9e-17
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-17
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		9e-17
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-17
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		9e-17
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-16
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-16
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-16
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-16
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-16
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-16
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-16
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-16
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-16
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-16
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-16
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-16
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-16
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-16
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-16
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-16
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-16
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-16
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-16
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-16
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-16
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-16
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-16
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-16
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-16
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-16
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-16
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-16
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-16
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-16
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-16
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-16
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-16
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-16
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-16
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-16
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-16
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-16
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-16
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-16
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-16
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-16
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-16
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-16
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-16
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-16
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-16
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-16
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-16
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-16
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-16
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-16
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-16
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-16
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-16
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-16
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-16
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-16
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-16
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-16
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-16
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-16
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-16
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-16
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-16
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-16
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-16
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-16
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-16
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-16
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-16
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-16
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-16
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-16
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-16
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-16
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-16
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-16
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-16
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-16
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-16
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-16
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-16
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-16
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-16
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-16
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-16
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		5e-16
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-16
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		5e-16
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		5e-16
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-16
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-16
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-16
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-16
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		5e-16
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		5e-16
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-16
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-16
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-16
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		6e-16
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-16
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-16
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		6e-16
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		6e-16
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-16
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		6e-16
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-16
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		6e-16
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		7e-16
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-16
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-16
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-16
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		8e-16
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		9e-16
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		9e-16
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		9e-16
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		9e-16
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		9e-16
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		9e-16
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-15
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-15
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-15
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-15
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-15
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-15
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-15
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-15
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-15
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-15
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-15
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-15
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-15
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-15
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-15
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-15
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-15
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-15
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-15
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-15
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-15
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-15
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-15
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-15
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-15
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-15
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-15
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-15
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-15
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-15
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		5e-15
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-15
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		6e-15
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-15
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		6e-15
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		6e-15
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		7e-15
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-15
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		7e-15
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		9e-15
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-15
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		9e-15
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		9e-15
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-14
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-14
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-14
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-14
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-14
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-14
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-14
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-14
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-14
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-14
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-14
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-14
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-14
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-14
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-14
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-14
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-14
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-14
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-14
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-14
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-14
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-14
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-14
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-14
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-14
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-14
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-14
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-14
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-14
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-14
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-14
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-14
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-14
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-14
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-14
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-14
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-14
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-14
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-14
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-14
4fl2_A	636	Structural And Biophysical Characterization Of The		4e-14
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-14
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-14
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-14
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-14
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		5e-14
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-14
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-14
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		6e-14
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		6e-14
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-14
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-14
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		6e-14
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-14
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		7e-14
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		7e-14
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		7e-14
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		7e-14
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-14
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		8e-14
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		8e-14
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		8e-14
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		8e-14
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-14
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		8e-14
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		8e-14
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		9e-14
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		9e-14
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		9e-14
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-14
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		9e-14
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		9e-14
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		9e-14
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		9e-14
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		9e-14
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		9e-14
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-13
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-13
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-13
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-13
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-13
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-13
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-13
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-13
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-13
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-13
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-13
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-13
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-13
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-13
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-13
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-13
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-13
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-13
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-13
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-13
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-13
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-13
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-13
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-13
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-13
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-13
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-13
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-13
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-13
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-13
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-13
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-13
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-13
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-13
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-13
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		5e-13
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-13
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		5e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		5e-13
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		6e-13
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		6e-13
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		6e-13
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		6e-13
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		6e-13
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		6e-13
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		8e-13
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		8e-13
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-13
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		8e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		9e-13
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-13
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		9e-13
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		9e-13
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-13
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		9e-13
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-12
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-12
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-12
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-12
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-12
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-12
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-12
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-12
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-12
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-12
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-12
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-12
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-12
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-12
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-12
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-12
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-12
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-12
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-12
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-12
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-12
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-12
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-12
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-12
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-12
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-12
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-12
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-12
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-12
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-12
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-12
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-12
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-12
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-12
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-12
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-12
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-12
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-12
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-12
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-12
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-12
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-12
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-12
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-12
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-12
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-12
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-12
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-12
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-12
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-12
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-12
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-12
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-12
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-12
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-12
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-12
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-12
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-12
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-12
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-12
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-12
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-12
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-12
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-12
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-12
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-12
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-12
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-12
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-12
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-12
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-12
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-12
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-12
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-12
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-12
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-12
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-12
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-12
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-12
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-12
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-12
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-12
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-12
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-12
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-12
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-12
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-12
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		5e-12
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		5e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-12
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-12
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-12
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		5e-12
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-12
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		5e-12
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		6e-12
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		7e-12
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-12
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-12
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		7e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-12
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		7e-12
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		8e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		9e-12
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		9e-12
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		9e-12
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		9e-12
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		9e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-12
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-11
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-11
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-11
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-11
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-11
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-11
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-11
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-11
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-11
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-11
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-11
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-11
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-11
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-11
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-11
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-11
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-11
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-11
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-11
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-11
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-11
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-11
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-11
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		4e-11
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		4e-11
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-11
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-11
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-11
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-11
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-11
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-11
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		5e-11
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		5e-11
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		5e-11
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-11
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-11
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		6e-11
3kk8_A	284	Camkii Substrate Complex A Length = 284		6e-11
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		6e-11
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		6e-11
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-11
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		6e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		6e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		6e-11
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		6e-11
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-11
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		7e-11
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		8e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-11
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		9e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		9e-11
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		9e-11
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-10
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-10
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-10
3soa_A	444	Full-Length Human Camkii Length = 444		1e-10
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-10
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-10
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-10
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-10
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-10
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-10
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-10
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-10
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-10
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-10
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-10
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-10
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-10
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-10
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-10
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-10
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-10
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-10
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-10
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-10
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-10
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-10
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-10
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-10
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-10
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-10
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-10
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-10
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-10
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-10
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-10
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-10
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-10
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-10
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-10
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-10
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-10
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		4e-10
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		4e-10
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-10
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		4e-10
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		4e-10
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-10
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-10
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-10
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		4e-10
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		4e-10
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-10
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		4e-10
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-10
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-10
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		5e-10
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		5e-10
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		5e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-10
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		5e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		5e-10
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-10
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		6e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		6e-10
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		6e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		6e-10
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		6e-10
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		6e-10
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		6e-10
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		6e-10
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		6e-10
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		7e-10
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		7e-10
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		8e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		8e-10
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		8e-10
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		8e-10
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		9e-10
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		9e-10
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		9e-10
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		9e-10
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		9e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-09
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-09
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-09
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-09
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-09
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-09
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-09
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-09
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-09
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-09
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-09
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-09
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-09
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-09
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-09
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-09
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-09
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-09
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-09
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-09
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		5e-09
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		5e-09
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		5e-09
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-09
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		5e-09
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		6e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		7e-09
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		7e-09
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		7e-09
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		8e-09
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		8e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		8e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		8e-09
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-09
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		9e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		9e-09
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		9e-09
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-09
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		9e-09
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-09
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-09
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		9e-09
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		9e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		9e-09
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-08
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-08
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-08
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-08
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-08
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-08
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-08
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-08
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-08
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-08
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-08
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-08
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-08
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-08
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-08
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-08
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-08
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-08
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		4e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		5e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-08
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		5e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		5e-08
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		6e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		6e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		9e-08
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-07
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-07
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-07
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-07
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-07
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-07
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-07
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-07
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-07
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-07
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		5e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-06
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-06
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		4e-06
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-06
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		4e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		7e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		9e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-05
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-05
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-05

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  219 bits (557), Expect = 5e-57,   Method: Compositional matrix adjust.
 Identities = 124/321 (38%), Positives = 187/321 (58%), Gaps = 7/321 (2%)
Query: 287 RRKPRDNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLY 346
           R+KP+D+      A    E++  +  +F    ++VA+DNFS+ N LG+GGFG VYKGRL 
Sbjct: 2   RKKPQDHF-FDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA 60
Query: 347 DGAEIAVKRLSRDSGQ-GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNT 405
           DG  +AVKRL  +  Q G+L+F+ EV +++   HRNL+RL GF +   ERLL+Y ++ N 
Sbjct: 61  DGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 120
Query: 406 SLDHFIFD-PTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMT 464
           S+   + + P  +  LDW +R +I  G ARGL YLH+    +IIHRD+K +N+LLD E  
Sbjct: 121 SVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 180
Query: 465 PKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
             + DFG+A+L +  +     + + GT G++APEY   G+ S K+DVF +GV++LE+I+G
Sbjct: 181 AVVGDFGLAKLMDYKDXHVXXA-VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 239
Query: 525 QRNNCFRNGETVEDLLSSAWKN--WREGTTVNIIDPTLSSGSITEMI-RCIHIGLLCVQE 581
           QR          +D++   W     +E     ++D  L      E + + I + LLC Q 
Sbjct: 240 QRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQS 299
Query: 582 NVASRPTMASVVLMLNSYSLT 602
           +   RP M+ VV ML    L 
Sbjct: 300 SPMERPKMSEVVRMLEGDGLA 320

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  211 bits (536), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 117/303 (38%), Positives = 177/303 (58%), Gaps = 6/303 (1%)
Query: 305 EINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQG- 363
           E++  +  +F    ++VA+DNF + N LG+GGFG VYKGRL DG  +AVKRL  +  QG 
Sbjct: 11  EVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGG 70
Query: 364 DLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFD-PTRRAQLDW 422
           +L+F+ EV +++   HRNL+RL GF +   ERLL+Y ++ N S+   + + P  +  LDW
Sbjct: 71  ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDW 130
Query: 423 ERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ 482
            +R +I  G ARGL YLH+    +IIHRD+K +N+LLD E    + DFG+A+L +  +  
Sbjct: 131 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXH 190
Query: 483 GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSS 542
              + + G  G++APEY   G+ S K+DVF +GV++LE+I+GQR          +D++  
Sbjct: 191 VXXA-VRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 249
Query: 543 AWKN--WREGTTVNIIDPTLSSGSITEMI-RCIHIGLLCVQENVASRPTMASVVLMLNSY 599
            W     +E     ++D  L      E + + I + LLC Q +   RP M+ VV ML   
Sbjct: 250 DWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309
Query: 600 SLT 602
            L 
Sbjct: 310 GLA 312

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  164 bits (414), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 109/299 (36%), Positives = 168/299 (56%), Gaps = 12/299 (4%)
Query: 310 ESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKN 369
           ES +     +  AT+NF     +G G FG VYKG L DGA++A+KR + +S QG  EF+ 
Sbjct: 25  ESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFET 84
Query: 370 EVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFD---PTRRAQLDWERRY 426
           E+  ++  +H +LV L+GF  E NE +LIY+++ N +L   ++    PT    + WE+R 
Sbjct: 85  EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPT--MSMSWEQRL 142
Query: 427 KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL-FEMDETQGNT 485
           +I  G ARGL YLH  +   IIHRD+K+ N+LLD    PKI DFG+++   E+D+T    
Sbjct: 143 EICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXX 199
Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWK 545
             + GT GY+ PEY + G+ + KSDV+SFGV++ E++  +          + +L   A +
Sbjct: 200 V-VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE 258
Query: 546 NWREGTTVNIIDPTLSSGSITEMIRCI-HIGLLCVQENVASRPTMASVVLMLNSYSLTL 603
           +   G    I+DP L+     E +R      + C+  +   RP+M  V+  L  Y+L L
Sbjct: 259 SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE-YALRL 316

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  164 bits (414), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 97/230 (42%), Positives = 139/230 (60%), Gaps = 15/230 (6%)
Query: 305 EINRAESLQFDFNTIRVATDNFSD------ANKLGQGGFGAVYKGRLYDGAEIAVKRLSR 358
           E++      F F  ++  T+NF +       NK+G+GGFG VYKG + +   +AVK+L+ 
Sbjct: 6   EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64
Query: 359 --DSGQGDL--EFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDP 414
             D    +L  +F  E+ ++A  QH NLV LLGFS +G++  L+Y ++PN SL   +   
Sbjct: 65  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 415 TRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR 474
                L W  R KI  G A G+ +LHE+     IHRD+K++N+LLD   T KI+DFG+AR
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 475 LFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
             E        SRIVGT  YMAPE A+ G+ + KSD++SFGV++LEII+G
Sbjct: 182 ASEKFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 230

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  162 bits (409), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 95/221 (42%), Positives = 135/221 (61%), Gaps = 15/221 (6%)
Query: 314 FDFNTIRVATDNFSD------ANKLGQGGFGAVYKGRLYDGAEIAVKRLSR--DSGQGDL 365
           F F  ++  T+NF +       NK+G+GGFG VYKG + +   +AVK+L+   D    +L
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 67
Query: 366 --EFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWE 423
             +F  E+ ++A  QH NLV LLGFS +G++  L+Y ++PN SL   +        L W 
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 127
Query: 424 RRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQG 483
            R KI  G A G+ +LHE+     IHRD+K++N+LLD   T KI+DFG+AR  E      
Sbjct: 128 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 184
Query: 484 NTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
              RIVGT  YMAPE A+ G+ + KSD++SFGV++LEII+G
Sbjct: 185 MXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 224

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  161 bits (408), Expect = 9e-40,   Method: Compositional matrix adjust.
 Identities = 96/230 (41%), Positives = 138/230 (60%), Gaps = 15/230 (6%)
Query: 305 EINRAESLQFDFNTIRVATDNFSD------ANKLGQGGFGAVYKGRLYDGAEIAVKRLSR 358
           E++      F F  ++  T+NF +       NK+G+GGFG VYKG + +   +AVK+L+ 
Sbjct: 6   EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64
Query: 359 --DSGQGDL--EFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDP 414
             D    +L  +F  E+ ++A  QH NLV LLGFS +G++  L+Y ++PN SL   +   
Sbjct: 65  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 415 TRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR 474
                L W  R KI  G A G+ +LHE+     IHRD+K++N+LLD   T KI+DFG+AR
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 475 LFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
             E         RIVGT  YMAPE A+ G+ + KSD++SFGV++LEII+G
Sbjct: 182 ASEKFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 230

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  161 bits (407), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 108/299 (36%), Positives = 167/299 (55%), Gaps = 12/299 (4%)
Query: 310 ESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKN 369
           ES +     +  AT+NF     +G G FG VYKG L DGA++A+KR + +S QG  EF+ 
Sbjct: 25  ESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFET 84
Query: 370 EVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFD---PTRRAQLDWERRY 426
           E+  ++  +H +LV L+GF  E NE +LIY+++ N +L   ++    PT    + WE+R 
Sbjct: 85  EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPT--MSMSWEQRL 142
Query: 427 KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL-FEMDETQGNT 485
           +I  G ARGL YLH  +   IIHRD+K+ N+LLD    PKI DFG+++   E+ +T    
Sbjct: 143 EICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXX 199
Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWK 545
             + GT GY+ PEY + G+ + KSDV+SFGV++ E++  +          + +L   A +
Sbjct: 200 V-VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE 258
Query: 546 NWREGTTVNIIDPTLSSGSITEMIRCI-HIGLLCVQENVASRPTMASVVLMLNSYSLTL 603
           +   G    I+DP L+     E +R      + C+  +   RP+M  V+  L  Y+L L
Sbjct: 259 SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE-YALRL 316

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  158 bits (400), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 95/221 (42%), Positives = 132/221 (59%), Gaps = 15/221 (6%)
Query: 314 FDFNTIRVATDNFSD------ANKLGQGGFGAVYKGRLYDGAEIAVKRLSR--DSGQGDL 365
           F F  ++  T+NF +       NK G+GGFG VYKG + +   +AVK+L+   D    +L
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 64
Query: 366 --EFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWE 423
             +F  E+ + A  QH NLV LLGFS +G++  L+Y + PN SL   +        L W 
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWH 124
Query: 424 RRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQG 483
            R KI  G A G+ +LHE+     IHRD+K++N+LLD   T KI+DFG+AR  E      
Sbjct: 125 XRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 484 NTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
             SRIVGT  Y APE A+ G+ + KSD++SFGV++LEII+G
Sbjct: 182 XXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITG 221

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 124/220 (56%), Gaps = 25/220 (11%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLE-------FKNEVL 372
           +A +      ++G+GGFG V+KGRL  D + +A+K L     +G+ E       F+ EV 
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 373 LVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGI 432
           +++NL H N+V+L G  L  N   ++ EFVP   L H + D  +   + W  + +++  I
Sbjct: 76  IMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDI 131
Query: 433 ARGLLYLHEDSRLRIIHRDLKTSNVLL-----DAEMTPKIADFGMARLFEMDETQGNTSR 487
           A G+ Y+ ++    I+HRDL++ N+ L     +A +  K+ADFG+++     ++  + S 
Sbjct: 132 ALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSG 185
Query: 488 IVGTYGYMAPEY--AMHGQYSVKSDVFSFGVLVLEIISGQ 525
           ++G + +MAPE   A    Y+ K+D +SF +++  I++G+
Sbjct: 186 LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 109/198 (55%), Gaps = 6/198 (3%)
Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDL--EFKNEVLLVANLQHRNLVRLLGF 388
           K+G G FG V++   + G+++AVK L       +   EF  EV ++  L+H N+V  +G 
Sbjct: 44  KIGAGSFGTVHRAE-WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRII 448
             +     ++ E++   SL   +     R QLD  RR  +   +A+G+ YLH +    I+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIV 161
Query: 449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVK 508
           HR+LK+ N+L+D + T K+ DFG++RL     T  ++    GT  +MAPE       + K
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEK 219
Query: 509 SDVFSFGVLVLEIISGQR 526
           SDV+SFGV++ E+ + Q+
Sbjct: 220 SDVYSFGVILWELATLQQ 237

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 119/228 (52%), Gaps = 10/228 (4%)
Query: 305 EINRAESLQF----DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDS 360
           +I   E+L F    D + + +   + +   K+G G FG V++   + G+++AVK L    
Sbjct: 14  DIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAE-WHGSDVAVKILMEQD 72
Query: 361 GQGDL--EFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRA 418
              +   EF  EV ++  L+H N+V  +G   +     ++ E++   SL   +     R 
Sbjct: 73  FHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGARE 132
Query: 419 QLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM 478
           QLD  RR  +   +A+G+ YLH +    I+HRDLK+ N+L+D + T K+ DFG++RL   
Sbjct: 133 QLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAS 191
Query: 479 DETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQR 526
                  +   GT  +MAPE       + KSDV+SFGV++ E+ + Q+
Sbjct: 192 XFLXSKXA--AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ 237

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 123/220 (55%), Gaps = 25/220 (11%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLE-------FKNEVL 372
           +A +      ++G+GGFG V+KGRL  D + +A+K L     +G+ E       F+ EV 
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 373 LVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGI 432
           +++NL H N+V+L G  L  N   ++ EFVP   L H + D  +   + W  + +++  I
Sbjct: 76  IMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDI 131
Query: 433 ARGLLYLHEDSRLRIIHRDLKTSNVLL-----DAEMTPKIADFGMARLFEMDETQGNTSR 487
           A G+ Y+ ++    I+HRDL++ N+ L     +A +  K+ADFG ++     ++  + S 
Sbjct: 132 ALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-----QSVHSVSG 185
Query: 488 IVGTYGYMAPEY--AMHGQYSVKSDVFSFGVLVLEIISGQ 525
           ++G + +MAPE   A    Y+ K+D +SF +++  I++G+
Sbjct: 186 LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 123/220 (55%), Gaps = 25/220 (11%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLE-------FKNEVL 372
           +A +      ++G+GGFG V+KGRL  D + +A+K L     +G+ E       F+ EV 
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 373 LVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGI 432
           +++NL H N+V+L G  L  N   ++ EFVP   L H + D  +   + W  + +++  I
Sbjct: 76  IMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDI 131
Query: 433 ARGLLYLHEDSRLRIIHRDLKTSNVLL-----DAEMTPKIADFGMARLFEMDETQGNTSR 487
           A G+ Y+ ++    I+HRDL++ N+ L     +A +  K+ADF +++     ++  + S 
Sbjct: 132 ALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QSVHSVSG 185
Query: 488 IVGTYGYMAPEY--AMHGQYSVKSDVFSFGVLVLEIISGQ 525
           ++G + +MAPE   A    Y+ K+D +SF +++  I++G+
Sbjct: 186 LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 113/202 (55%), Gaps = 20/202 (9%)
Query: 332 LGQGGFGAVYKGRLYDGAE-----IAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRL 385
           LG G FG VYKG      E     +A+K L+  +G + ++EF +E L++A++ H +LVRL
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 386 LGFSLEGNERLLIYEFVPNTSLDHFIFDPT----RRAQLDWERRYKIIGGIARGLLYLHE 441
           LG  L    +L + + +P+  L  ++ +       +  L+W  +      IA+G++YL E
Sbjct: 106 LGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 158
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM 501
               R++HRDL   NVL+ +    KI DFG+ARL E DE + N         +MA E   
Sbjct: 159 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 215
Query: 502 HGQYSVKSDVFSFGVLVLEIIS 523
           + +++ +SDV+S+GV + E+++
Sbjct: 216 YRKFTHQSDVWSYGVTIWELMT 237

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 140/271 (51%), Gaps = 27/271 (9%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHR 380
           V  +      +LG G FG V+ G      ++AVK L + S   D  F  E  L+  LQH+
Sbjct: 16  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 74
Query: 381 NLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            LVRL  +++   E + +I E++ N SL  F+  P+   +L   +   +   IA G+ ++
Sbjct: 75  RLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFI 131
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY--GYMAP 497
            E +    IHRDL+ +N+L+   ++ KIADFG+ARL E +E    T+R    +   + AP
Sbjct: 132 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAKFPIKWTAP 185
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID 557
           E   +G +++KSDV+SFG+L+ EI++  R      G T  +++ +  + +R      ++ 
Sbjct: 186 EAINYGTFTIKSDVWSFGILLTEIVTHGR--IPYPGMTNPEVIQNLERGYR------MVR 237
Query: 558 PTLSSGSITEMIRCIHIGLLCVQENVASRPT 588
           P      + +++R      LC +E    RPT
Sbjct: 238 PDNCPEELYQLMR------LCWKERPEDRPT 262

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  103 bits (258), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 140/271 (51%), Gaps = 27/271 (9%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHR 380
           V  +      +LG G FG V+ G      ++AVK L + S   D  F  E  L+  LQH+
Sbjct: 12  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 70
Query: 381 NLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            LVRL  +++   E + +I E++ N SL  F+  P+   +L   +   +   IA G+ ++
Sbjct: 71  RLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFI 127
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY--GYMAP 497
            E +    IHRDL+ +N+L+   ++ KIADFG+ARL E +E    T+R    +   + AP
Sbjct: 128 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAKFPIKWTAP 181
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID 557
           E   +G +++KSDV+SFG+L+ EI++  R      G T  +++ +  + +R      ++ 
Sbjct: 182 EAINYGTFTIKSDVWSFGILLTEIVTHGR--IPYPGMTNPEVIQNLERGYR------MVR 233
Query: 558 PTLSSGSITEMIRCIHIGLLCVQENVASRPT 588
           P      + +++R      LC +E    RPT
Sbjct: 234 PDNCPEELYQLMR------LCWKERPEDRPT 258

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 140/271 (51%), Gaps = 27/271 (9%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHR 380
           V  +      +LG G FG V+ G      ++AVK L + S   D  F  E  L+  LQH+
Sbjct: 19  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 77
Query: 381 NLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            LVRL  +++   E + +I E++ N SL  F+  P+   +L   +   +   IA G+ ++
Sbjct: 78  RLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFI 134
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY--GYMAP 497
            E +    IHRDL+ +N+L+   ++ KIADFG+ARL E +E    T+R    +   + AP
Sbjct: 135 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAKFPIKWTAP 188
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID 557
           E   +G +++KSDV+SFG+L+ EI++  R      G T  +++ +  + +R      ++ 
Sbjct: 189 EAINYGTFTIKSDVWSFGILLTEIVTHGR--IPYPGMTNPEVIQNLERGYR------MVR 240
Query: 558 PTLSSGSITEMIRCIHIGLLCVQENVASRPT 588
           P      + +++R      LC +E    RPT
Sbjct: 241 PDNCPEELYQLMR------LCWKERPEDRPT 265

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 140/271 (51%), Gaps = 27/271 (9%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHR 380
           V  +      +LG G FG V+ G      ++AVK L + S   D  F  E  L+  LQH+
Sbjct: 18  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 76
Query: 381 NLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            LVRL  +++   E + +I E++ N SL  F+  P+   +L   +   +   IA G+ ++
Sbjct: 77  RLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFI 133
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY--GYMAP 497
            E +    IHRDL+ +N+L+   ++ KIADFG+ARL E +E    T+R    +   + AP
Sbjct: 134 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAKFPIKWTAP 187
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID 557
           E   +G +++KSDV+SFG+L+ EI++  R      G T  +++ +  + +R      ++ 
Sbjct: 188 EAINYGTFTIKSDVWSFGILLTEIVTHGR--IPYPGMTNPEVIQNLERGYR------MVR 239
Query: 558 PTLSSGSITEMIRCIHIGLLCVQENVASRPT 588
           P      + +++R      LC +E    RPT
Sbjct: 240 PDNCPEELYQLMR------LCWKERPEDRPT 264

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 140/271 (51%), Gaps = 27/271 (9%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHR 380
           V  +      +LG G FG V+ G      ++AVK L + S   D  F  E  L+  LQH+
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 68
Query: 381 NLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            LVRL  +++   E + +I E++ N SL  F+  P+   +L   +   +   IA G+ ++
Sbjct: 69  RLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFI 125
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY--GYMAP 497
            E +    IHRDL+ +N+L+   ++ KIADFG+ARL E +E    T+R    +   + AP
Sbjct: 126 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAKFPIKWTAP 179
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID 557
           E   +G +++KSDV+SFG+L+ EI++  R      G T  +++ +  + +R      ++ 
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGR--IPYPGMTNPEVIQNLERGYR------MVR 231
Query: 558 PTLSSGSITEMIRCIHIGLLCVQENVASRPT 588
           P      + +++R      LC +E    RPT
Sbjct: 232 PDNCPEELYQLMR------LCWKERPEDRPT 256

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 140/271 (51%), Gaps = 27/271 (9%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHR 380
           V  +      +LG G FG V+ G      ++AVK L + S   D  F  E  L+  LQH+
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 68
Query: 381 NLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            LVRL  +++   E + +I E++ N SL  F+  P+   +L   +   +   IA G+ ++
Sbjct: 69  RLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFI 125
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY--GYMAP 497
            E +    IHRDL+ +N+L+   ++ KIADFG+ARL E +E    T+R    +   + AP
Sbjct: 126 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAKFPIKWTAP 179
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID 557
           E   +G +++KSDV+SFG+L+ EI++  R      G T  +++ +  + +R      ++ 
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGR--IPYPGMTNPEVIQNLERGYR------MVR 231
Query: 558 PTLSSGSITEMIRCIHIGLLCVQENVASRPT 588
           P      + +++R      LC +E    RPT
Sbjct: 232 PDNCPEELYQLMR------LCWKERPEDRPT 256

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 140/271 (51%), Gaps = 27/271 (9%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHR 380
           V  +      +LG G FG V+ G      ++AVK L + S   D  F  E  L+  LQH+
Sbjct: 11  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 69
Query: 381 NLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            LVRL  +++   E + +I E++ N SL  F+  P+   +L   +   +   IA G+ ++
Sbjct: 70  RLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFI 126
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY--GYMAP 497
            E +    IHRDL+ +N+L+   ++ KIADFG+ARL E +E    T+R    +   + AP
Sbjct: 127 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAKFPIKWTAP 180
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID 557
           E   +G +++KSDV+SFG+L+ EI++  R      G T  +++ +  + +R      ++ 
Sbjct: 181 EAINYGTFTIKSDVWSFGILLTEIVTHGR--IPYPGMTNPEVIQNLERGYR------MVR 232
Query: 558 PTLSSGSITEMIRCIHIGLLCVQENVASRPT 588
           P      + +++R      LC +E    RPT
Sbjct: 233 PDNCPEELYQLMR------LCWKERPEDRPT 257

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 140/271 (51%), Gaps = 27/271 (9%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHR 380
           V  +      +LG G FG V+ G      ++AVK L + S   D  F  E  L+  LQH+
Sbjct: 16  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 74
Query: 381 NLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            LVRL  +++   E + +I E++ N SL  F+  P+   +L   +   +   IA G+ ++
Sbjct: 75  RLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFI 131
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY--GYMAP 497
            E +    IHRDL+ +N+L+   ++ KIADFG+ARL E +E    T+R    +   + AP
Sbjct: 132 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAP 185
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID 557
           E   +G +++KSDV+SFG+L+ EI++  R      G T  +++ +  + +R      ++ 
Sbjct: 186 EAINYGTFTIKSDVWSFGILLTEIVTHGR--IPYPGMTNPEVIQNLERGYR------MVR 237
Query: 558 PTLSSGSITEMIRCIHIGLLCVQENVASRPT 588
           P      + +++R      LC +E    RPT
Sbjct: 238 PDNCPEELYQLMR------LCWKERPEDRPT 262

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 113/202 (55%), Gaps = 20/202 (9%)
Query: 332 LGQGGFGAVYKGRLYDGAE-----IAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRL 385
           LG G FG VYKG      E     +A+K L+  +G + ++EF +E L++A++ H +LVRL
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 386 LGFSLEGNERLLIYEFVPNTSLDHFIFDPT----RRAQLDWERRYKIIGGIARGLLYLHE 441
           LG  L    +L + + +P+  L  ++ +       +  L+W  +      IA+G++YL E
Sbjct: 83  LGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 135
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM 501
               R++HRDL   NVL+ +    KI DFG+ARL E DE + N         +MA E   
Sbjct: 136 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 192
Query: 502 HGQYSVKSDVFSFGVLVLEIIS 523
           + +++ +SDV+S+GV + E+++
Sbjct: 193 YRKFTHQSDVWSYGVTIWELMT 214

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 140/271 (51%), Gaps = 27/271 (9%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHR 380
           V  +      +LG G FG V+ G      ++AVK L + S   D  F  E  L+  LQH+
Sbjct: 5   VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 63
Query: 381 NLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            LVRL  +++   E + +I E++ N SL  F+  P+   +L   +   +   IA G+ ++
Sbjct: 64  RLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFI 120
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY--GYMAP 497
            E +    IHRDL+ +N+L+   ++ KIADFG+ARL E +E    T+R    +   + AP
Sbjct: 121 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAP 174
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID 557
           E   +G +++KSDV+SFG+L+ EI++  R      G T  +++ +  + +R      ++ 
Sbjct: 175 EAINYGTFTIKSDVWSFGILLTEIVTHGR--IPYPGMTNPEVIQNLERGYR------MVR 226
Query: 558 PTLSSGSITEMIRCIHIGLLCVQENVASRPT 588
           P      + +++R      LC +E    RPT
Sbjct: 227 PDNCPEELYQLMR------LCWKERPEDRPT 251

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 140/271 (51%), Gaps = 27/271 (9%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHR 380
           V  +      +LG G FG V+ G      ++AVK L + S   D  F  E  L+  LQH+
Sbjct: 15  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 73
Query: 381 NLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            LVRL  +++   E + +I E++ N SL  F+  P+   +L   +   +   IA G+ ++
Sbjct: 74  RLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFI 130
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY--GYMAP 497
            E +    IHRDL+ +N+L+   ++ KIADFG+ARL E +E    T+R    +   + AP
Sbjct: 131 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAP 184
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID 557
           E   +G +++KSDV+SFG+L+ EI++  R      G T  +++ +  + +R      ++ 
Sbjct: 185 EAINYGTFTIKSDVWSFGILLTEIVTHGR--IPYPGMTNPEVIQNLERGYR------MVR 236
Query: 558 PTLSSGSITEMIRCIHIGLLCVQENVASRPT 588
           P      + +++R      LC +E    RPT
Sbjct: 237 PDNCPEELYQLMR------LCWKERPEDRPT 261

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 140/271 (51%), Gaps = 27/271 (9%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHR 380
           V  +      +LG G FG V+ G      ++AVK L + S   D  F  E  L+  LQH+
Sbjct: 20  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 78
Query: 381 NLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            LVRL  +++   E + +I E++ N SL  F+  P+   +L   +   +   IA G+ ++
Sbjct: 79  RLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFI 135
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY--GYMAP 497
            E +    IHRDL+ +N+L+   ++ KIADFG+ARL E +E    T+R    +   + AP
Sbjct: 136 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAP 189
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID 557
           E   +G +++KSDV+SFG+L+ EI++  R      G T  +++ +  + +R      ++ 
Sbjct: 190 EAINYGTFTIKSDVWSFGILLTEIVTHGR--IPYPGMTNPEVIQNLERGYR------MVR 241
Query: 558 PTLSSGSITEMIRCIHIGLLCVQENVASRPT 588
           P      + +++R      LC +E    RPT
Sbjct: 242 PDNCPEELYQLMR------LCWKERPEDRPT 266

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 140/271 (51%), Gaps = 27/271 (9%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHR 380
           V  +      +LG G FG V+ G      ++AVK L + S   D  F  E  L+  LQH+
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 68
Query: 381 NLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            LVRL  +++   E + +I E++ N SL  F+  P+   +L   +   +   IA G+ ++
Sbjct: 69  RLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFI 125
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY--GYMAP 497
            E +    IHRDL+ +N+L+   ++ KIADFG+ARL E +E    T+R    +   + AP
Sbjct: 126 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAP 179
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID 557
           E   +G +++KSDV+SFG+L+ EI++  R      G T  +++ +  + +R      ++ 
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGR--IPYPGMTNPEVIQNLERGYR------MVR 231
Query: 558 PTLSSGSITEMIRCIHIGLLCVQENVASRPT 588
           P      + +++R      LC +E    RPT
Sbjct: 232 PDNCPEELYQLMR------LCWKERPEDRPT 256

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 82/271 (30%), Positives = 140/271 (51%), Gaps = 27/271 (9%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHR 380
           V  +      +LG G FG V+ G      ++AVK L + S   D  F  E  L+  LQH+
Sbjct: 6   VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 64
Query: 381 NLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            LVRL  +++   E + +I E++ N SL  F+  P+   +L   +   +   IA G+ ++
Sbjct: 65  RLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFI 121
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY--GYMAP 497
            E +    IHR+L+ +N+L+   ++ KIADFG+ARL E +E    T+R    +   + AP
Sbjct: 122 EERN---YIHRNLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAP 175
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID 557
           E   +G +++KSDV+SFG+L+ EI++  R      G T  +++ +  + +R      ++ 
Sbjct: 176 EAINYGTFTIKSDVWSFGILLTEIVTHGR--IPYPGMTNPEVIQNLERGYR------MVR 227
Query: 558 PTLSSGSITEMIRCIHIGLLCVQENVASRPT 588
           P      + +++R      LC +E    RPT
Sbjct: 228 PDNCPEELYQLMR------LCWKERPEDRPT 252

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 125/234 (53%), Gaps = 33/234 (14%)
Query: 330 NKLGQGGFGAVYKGRLYDGAE------IAVKRLSRDSGQGDL--EFKNEVLLVANLQHRN 381
            +LG+  FG VYKG L+  A       +A+K L +D  +G L  EF++E +L A LQH N
Sbjct: 32  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHEAMLRARLQHPN 90
Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIF-------------DPTRRAQLDWERRYKI 428
           +V LLG   +     +I+ +  +  L  F+              D T ++ L+      +
Sbjct: 91  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 150
Query: 429 IGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQ--GNT 485
           +  IA G+ YL   S   ++H+DL T NVL+  ++  KI+D G+ R ++  D  +  GN+
Sbjct: 151 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 207
Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNC-FRNGETVE 537
              +    +MAPE  M+G++S+ SD++S+GV++ E+ S G +  C + N + VE
Sbjct: 208 LLPIR---WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 125/234 (53%), Gaps = 33/234 (14%)
Query: 330 NKLGQGGFGAVYKGRLYDGAE------IAVKRLSRDSGQGDL--EFKNEVLLVANLQHRN 381
            +LG+  FG VYKG L+  A       +A+K L +D  +G L  EF++E +L A LQH N
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIF-------------DPTRRAQLDWERRYKI 428
           +V LLG   +     +I+ +  +  L  F+              D T ++ L+      +
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 429 IGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQ--GNT 485
           +  IA G+ YL   S   ++H+DL T NVL+  ++  KI+D G+ R ++  D  +  GN+
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190
Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNC-FRNGETVE 537
              +    +MAPE  M+G++S+ SD++S+GV++ E+ S G +  C + N + VE
Sbjct: 191 LLPIR---WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 241

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 108/206 (52%), Gaps = 21/206 (10%)
Query: 332 LGQGGFGAVYKGRLYDGAEIAVKRLSRDS----GQGDLEFKNEVLLVANLQHRNLVRLLG 387
           +G GGFG VY+   + G E+AVK    D      Q     + E  L A L+H N++ L G
Sbjct: 15  IGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 388 FSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRI 447
             L+     L+ EF     L+  +    +R   D    + +   IARG+ YLH+++ + I
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAV--QIARGMNYLHDEAIVPI 129
Query: 448 IHRDLKTSNVLLDAEM--------TPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
           IHRDLK+SN+L+  ++          KI DFG+AR  E   T   ++   G Y +MAPE 
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTTKMSA--AGAYAWMAPEV 185
Query: 500 AMHGQYSVKSDVFSFGVLVLEIISGQ 525
                +S  SDV+S+GVL+ E+++G+
Sbjct: 186 IRASMFSKGSDVWSYGVLLWELLTGE 211

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 71/203 (34%), Positives = 112/203 (55%), Gaps = 18/203 (8%)
Query: 332 LGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLVR 384
           LG+G FG V   R YD      G ++AVK L  +SG   + + K E+ ++ NL H N+V+
Sbjct: 29  LGEGHFGKVELCR-YDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 385 LLGFSLE--GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
             G   E  GN   LI EF+P+ SL  ++  P  + +++ +++ K    I +G+ YL   
Sbjct: 88  YKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL--G 143
Query: 443 SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTS--RIVGTYGYMAPEYA 500
           SR + +HRDL   NVL+++E   KI DFG+ +  E D+        R    + Y APE  
Sbjct: 144 SR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECL 201
Query: 501 MHGQYSVKSDVFSFGVLVLEIIS 523
           M  ++ + SDV+SFGV + E+++
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLT 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 71/203 (34%), Positives = 112/203 (55%), Gaps = 18/203 (8%)
Query: 332 LGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLVR 384
           LG+G FG V   R YD      G ++AVK L  +SG   + + K E+ ++ NL H N+V+
Sbjct: 17  LGEGHFGKVELCR-YDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 75
Query: 385 LLGFSLE--GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
             G   E  GN   LI EF+P+ SL  ++  P  + +++ +++ K    I +G+ YL   
Sbjct: 76  YKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL--G 131
Query: 443 SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTS--RIVGTYGYMAPEYA 500
           SR + +HRDL   NVL+++E   KI DFG+ +  E D+        R    + Y APE  
Sbjct: 132 SR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECL 189
Query: 501 MHGQYSVKSDVFSFGVLVLEIIS 523
           M  ++ + SDV+SFGV + E+++
Sbjct: 190 MQSKFYIASDVWSFGVTLHELLT 212

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 108/200 (54%), Gaps = 9/200 (4%)
Query: 329 ANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGF 388
             ++G G FG VYKG+ +    + +  ++  + Q    FKNEV ++   +H N++  +G+
Sbjct: 17  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRII 448
           S +  +  ++ ++   +SL H +       + + ++   I    ARG+ YLH  S   II
Sbjct: 77  STK-PQLAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTARGMDYLHAKS---II 130
Query: 449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM---HGQY 505
           HRDLK++N+ L  + T KI DFG+A +           ++ G+  +MAPE         Y
Sbjct: 131 HRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 190
Query: 506 SVKSDVFSFGVLVLEIISGQ 525
           S +SDV++FG+++ E+++GQ
Sbjct: 191 SFQSDVYAFGIVLYELMTGQ 210

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 127/270 (47%), Gaps = 25/270 (9%)
Query: 329 ANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGF 388
             ++G G FG V+ G   +  ++A+K + R+    + +F  E  ++  L H  LV+L G 
Sbjct: 12  VQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRII 448
            LE     L++EF+ +  L  ++   T+R     E    +   +  G+ YL E S   +I
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAS---VI 125
Query: 449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVK 508
           HRDL   N L+      K++DFGM R F +D+   +++       + +PE     +YS K
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 184
Query: 509 SDVFSFGVLVLEIISGQR--NNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSIT 566
           SDV+SFGVL+ E+ S  +       N E VED+           T   +  P L+S  + 
Sbjct: 185 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI----------STGFRLYKPRLASTHVY 234
Query: 567 EMIRCIHIGLLCVQENVASRPTMASVVLML 596
           +++   H    C +E    RP  + ++  L
Sbjct: 235 QIMN--H----CWKERPEDRPAFSRLLRQL 258

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 82/271 (30%), Positives = 138/271 (50%), Gaps = 27/271 (9%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHR 380
           V  +      +LG G  G V+ G      ++AVK L + S   D  F  E  L+  LQH+
Sbjct: 10  VPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 68
Query: 381 NLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            LVRL  +++   E + +I E++ N SL  F+  P+   +L   +   +   IA G+ ++
Sbjct: 69  RLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFI 125
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY--GYMAP 497
            E +    IHRDL+ +N+L+   ++ KIADFG+ARL E  E    T+R    +   + AP
Sbjct: 126 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDAEX---TAREGAKFPIKWTAP 179
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID 557
           E   +G +++KSDV+SFG+L+ EI++  R      G T  +++ +  + +R      ++ 
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGR--IPYPGMTNPEVIQNLERGYR------MVR 231
Query: 558 PTLSSGSITEMIRCIHIGLLCVQENVASRPT 588
           P      + +++R      LC +E    RPT
Sbjct: 232 PDNCPEELYQLMR------LCWKERPEDRPT 256

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 107/200 (53%), Gaps = 9/200 (4%)
Query: 329 ANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGF 388
             ++G G FG VYKG+ +    + +  ++  + Q    FKNEV ++   +H N++  +G+
Sbjct: 29  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRII 448
           S +  +  ++ ++   +SL H +       + + ++   I    ARG+ YLH  S   II
Sbjct: 89  STK-PQLAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTARGMDYLHAKS---II 142
Query: 449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM---HGQY 505
           HRDLK++N+ L  + T KI DFG+A             ++ G+  +MAPE         Y
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 506 SVKSDVFSFGVLVLEIISGQ 525
           S +SDV++FG+++ E+++GQ
Sbjct: 203 SFQSDVYAFGIVLYELMTGQ 222

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 106/200 (53%), Gaps = 9/200 (4%)
Query: 329 ANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGF 388
             ++G G FG VYKG+ +    + +  ++  + Q    FKNEV ++   +H N++  +G+
Sbjct: 29  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRII 448
           S    +  ++ ++   +SL H +       + + ++   I    ARG+ YLH  S   II
Sbjct: 89  ST-APQLAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTARGMDYLHAKS---II 142
Query: 449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM---HGQY 505
           HRDLK++N+ L  + T KI DFG+A             ++ G+  +MAPE         Y
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 506 SVKSDVFSFGVLVLEIISGQ 525
           S +SDV++FG+++ E+++GQ
Sbjct: 203 SFQSDVYAFGIVLYELMTGQ 222

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 108/200 (54%), Gaps = 9/200 (4%)
Query: 329 ANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGF 388
             ++G G FG VYKG+ +    + +  ++  + Q    FKNEV ++   +H N++  +G+
Sbjct: 18  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRII 448
           S +  +  ++ ++   +SL H +       + +  +   I    A+G+ YLH  S   II
Sbjct: 78  STK-PQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---II 131
Query: 449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM---HGQY 505
           HRDLK++N+ L  ++T KI DFG+A +           ++ G+  +MAPE         Y
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 191
Query: 506 SVKSDVFSFGVLVLEIISGQ 525
           S +SDV++FG+++ E+++GQ
Sbjct: 192 SFQSDVYAFGIVLYELMTGQ 211

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 108/200 (54%), Gaps = 9/200 (4%)
Query: 329 ANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGF 388
             ++G G FG VYKG+ +    + +  ++  + Q    FKNEV ++   +H N++  +G+
Sbjct: 18  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRII 448
           S +  +  ++ ++   +SL H +       + +  +   I    A+G+ YLH  S   II
Sbjct: 78  STK-PQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---II 131
Query: 449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM---HGQY 505
           HRDLK++N+ L  ++T KI DFG+A +           ++ G+  +MAPE         Y
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 191
Query: 506 SVKSDVFSFGVLVLEIISGQ 525
           S +SDV++FG+++ E+++GQ
Sbjct: 192 SFQSDVYAFGIVLYELMTGQ 211

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 108/200 (54%), Gaps = 9/200 (4%)
Query: 329 ANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGF 388
             ++G G FG VYKG+ +    + +  ++  + Q    FKNEV ++   +H N++  +G+
Sbjct: 15  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRII 448
           S +  +  ++ ++   +SL H +       + +  +   I    A+G+ YLH  S   II
Sbjct: 75  STK-PQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---II 128
Query: 449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM---HGQY 505
           HRDLK++N+ L  ++T KI DFG+A +           ++ G+  +MAPE         Y
Sbjct: 129 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 188
Query: 506 SVKSDVFSFGVLVLEIISGQ 525
           S +SDV++FG+++ E+++GQ
Sbjct: 189 SFQSDVYAFGIVLYELMTGQ 208

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 107/200 (53%), Gaps = 9/200 (4%)
Query: 329 ANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGF 388
             ++G G FG VYKG+ +    + +  ++  + Q    FKNEV ++   +H N++  +G+
Sbjct: 13  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRII 448
           S    +  ++ ++   +SL H +       + +  +   I    A+G+ YLH  S   II
Sbjct: 73  S-TAPQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---II 126
Query: 449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM---HGQY 505
           HRDLK++N+ L  ++T KI DFG+A +           ++ G+  +MAPE         Y
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 506 SVKSDVFSFGVLVLEIISGQ 525
           S +SDV++FG+++ E+++GQ
Sbjct: 187 SFQSDVYAFGIVLYELMTGQ 206

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 108/200 (54%), Gaps = 9/200 (4%)
Query: 329 ANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGF 388
             ++G G FG VYKG+ +    + +  ++  + Q    FKNEV ++   +H N++  +G+
Sbjct: 13  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRII 448
           S +  +  ++ ++   +SL H +       + +  +   I    A+G+ YLH  S   II
Sbjct: 73  STK-PQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---II 126
Query: 449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM---HGQY 505
           HRDLK++N+ L  ++T KI DFG+A +           ++ G+  +MAPE         Y
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 506 SVKSDVFSFGVLVLEIISGQ 525
           S +SDV++FG+++ E+++GQ
Sbjct: 187 SFQSDVYAFGIVLYELMTGQ 206

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 108/200 (54%), Gaps = 9/200 (4%)
Query: 329 ANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGF 388
             ++G G FG VYKG+ +    + +  ++  + Q    FKNEV ++   +H N++  +G+
Sbjct: 40  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 99
Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRII 448
           S +  +  ++ ++   +SL H +       + +  +   I    A+G+ YLH  S   II
Sbjct: 100 STK-PQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---II 153
Query: 449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM---HGQY 505
           HRDLK++N+ L  ++T KI DFG+A +           ++ G+  +MAPE         Y
Sbjct: 154 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 213
Query: 506 SVKSDVFSFGVLVLEIISGQ 525
           S +SDV++FG+++ E+++GQ
Sbjct: 214 SFQSDVYAFGIVLYELMTGQ 233

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 108/200 (54%), Gaps = 9/200 (4%)
Query: 329 ANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGF 388
             ++G G FG VYKG+ +    + +  ++  + Q    FKNEV ++   +H N++  +G+
Sbjct: 41  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRII 448
           S +  +  ++ ++   +SL H +       + +  +   I    A+G+ YLH  S   II
Sbjct: 101 STK-PQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---II 154
Query: 449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM---HGQY 505
           HRDLK++N+ L  ++T KI DFG+A +           ++ G+  +MAPE         Y
Sbjct: 155 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 214
Query: 506 SVKSDVFSFGVLVLEIISGQ 525
           S +SDV++FG+++ E+++GQ
Sbjct: 215 SFQSDVYAFGIVLYELMTGQ 234

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 126/270 (46%), Gaps = 25/270 (9%)
Query: 329 ANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGF 388
             ++G G FG V+ G   +  ++A+K + R+    + +F  E  ++  L H  LV+L G 
Sbjct: 10  VQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRII 448
            LE     L++EF+ +  L  ++   T+R     E    +   +  G+ YL E     +I
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 123
Query: 449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVK 508
           HRDL   N L+      K++DFGM R F +D+   +++       + +PE     +YS K
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 509 SDVFSFGVLVLEIISGQR--NNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSIT 566
           SDV+SFGVL+ E+ S  +       N E VED+           T   +  P L+S  + 
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI----------STGFRLYKPRLASTHVY 232
Query: 567 EMIRCIHIGLLCVQENVASRPTMASVVLML 596
           +++   H    C +E    RP  + ++  L
Sbjct: 233 QIMN--H----CWKERPEDRPAFSRLLRQL 256

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 126/270 (46%), Gaps = 25/270 (9%)
Query: 329 ANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGF 388
             ++G G FG V+ G   +  ++A+K + R+    + +F  E  ++  L H  LV+L G 
Sbjct: 12  VQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRII 448
            LE     L++EF+ +  L  ++   T+R     E    +   +  G+ YL E     +I
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 125
Query: 449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVK 508
           HRDL   N L+      K++DFGM R F +D+   +++       + +PE     +YS K
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 184
Query: 509 SDVFSFGVLVLEIISGQR--NNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSIT 566
           SDV+SFGVL+ E+ S  +       N E VED+           T   +  P L+S  + 
Sbjct: 185 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI----------STGFRLYKPRLASTHVY 234
Query: 567 EMIRCIHIGLLCVQENVASRPTMASVVLML 596
           +++   H    C +E    RP  + ++  L
Sbjct: 235 QIMN--H----CWKERPEDRPAFSRLLRQL 258

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/221 (33%), Positives = 107/221 (48%), Gaps = 25/221 (11%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRD-SGQGDLEFKNEVLL 373
           V   N +    LG G FG VY+G++          ++AVK L    S Q +L+F  E L+
Sbjct: 28  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 87
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFD----PTRRAQLDWERRYKII 429
           ++ L H+N+VR +G SL+   R ++ E +    L  F+ +    P++ + L       + 
Sbjct: 88  ISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 147
Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE---MTPKIADFGMARLFEMDETQGNTS 486
             IA G  YL E+     IHRD+   N LL         KI DFGMAR    D  + +  
Sbjct: 148 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYY 200
Query: 487 RIVG----TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
           R  G       +M PE  M G ++ K+D +SFGVL+ EI S
Sbjct: 201 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 126/270 (46%), Gaps = 25/270 (9%)
Query: 329 ANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGF 388
             ++G G FG V+ G   +  ++A+K + R+    + +F  E  ++  L H  LV+L G 
Sbjct: 15  VQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 73
Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRII 448
            LE     L++EF+ +  L  ++   T+R     E    +   +  G+ YL E     +I
Sbjct: 74  CLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 128
Query: 449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVK 508
           HRDL   N L+      K++DFGM R F +D+   +++       + +PE     +YS K
Sbjct: 129 HRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 187
Query: 509 SDVFSFGVLVLEIISGQR--NNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSIT 566
           SDV+SFGVL+ E+ S  +       N E VED+           T   +  P L+S  + 
Sbjct: 188 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI----------STGFRLYKPRLASTHVY 237
Query: 567 EMIRCIHIGLLCVQENVASRPTMASVVLML 596
           +++   H    C +E    RP  + ++  L
Sbjct: 238 QIMN--H----CWRERPEDRPAFSRLLRQL 261

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 115/210 (54%), Gaps = 15/210 (7%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHR 380
           +  ++     +LG G FG V+ G      ++A+K L   +   +  F  E  ++  L+H 
Sbjct: 6   IPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPE-SFLEEAQIMKKLKHD 64
Query: 381 NLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            LV+L  +++   E + ++ E++   SL  F+ D   RA L       +   +A G+ Y+
Sbjct: 65  KLVQL--YAVVSEEPIYIVTEYMNKGSLLDFLKDGEGRA-LKLPNLVDMAAQVAAGMAYI 121
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET---QGNTSRIVGTYGYMA 496
               R+  IHRDL+++N+L+   +  KIADFG+ARL E +E    QG    I  T    A
Sbjct: 122 E---RMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWT----A 174
Query: 497 PEYAMHGQYSVKSDVFSFGVLVLEIISGQR 526
           PE A++G++++KSDV+SFG+L+ E+++  R
Sbjct: 175 PEAALYGRFTIKSDVWSFGILLTELVTKGR 204

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 73/221 (33%), Positives = 107/221 (48%), Gaps = 25/221 (11%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRD-SGQGDLEFKNEVLL 373
           V   N +    LG G FG VY+G++          ++AVK L    S Q +L+F  E L+
Sbjct: 42  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 101
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFD----PTRRAQLDWERRYKII 429
           ++ L H+N+VR +G SL+   R ++ E +    L  F+ +    P++ + L       + 
Sbjct: 102 ISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 161
Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE---MTPKIADFGMARLFEMDETQGNTS 486
             IA G  YL E+     IHRD+   N LL         KI DFGMAR    D  + +  
Sbjct: 162 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYY 214
Query: 487 RIVG----TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
           R  G       +M PE  M G ++ K+D +SFGVL+ EI S
Sbjct: 215 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 116/232 (50%), Gaps = 32/232 (13%)
Query: 331 KLGQGGFGAVYKGRLY------DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVR 384
           +LG+G FG V+    Y      D   +AVK L   +     +F+ E  L+ NLQH ++V+
Sbjct: 22  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81
Query: 385 LLGFSLEGNERLLIYEFVPNTSLDHFIF------------DPTR-RAQLDWERRYKIIGG 431
             G   +G+  ++++E++ +  L+ F+              P + + +L   +   I   
Sbjct: 82  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVG- 490
           IA G++YL   +    +HRDL T N L+ A +  KI DFGM+R    D    +  R+ G 
Sbjct: 142 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVGGH 194
Query: 491 ---TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFR--NGETVE 537
                 +M PE  M+ +++ +SDV+SFGV++ EI +  +   F+  N E +E
Sbjct: 195 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 246

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 114/243 (46%), Gaps = 35/243 (14%)
Query: 320 RVATDNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRDSGQGDLEFKNEVLL 373
            +   N     +LG+G FG V+    Y      D   +AVK L   S     +F  E  L
Sbjct: 9   HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAEL 68
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIF-------------DPTRRAQL 420
           + NLQH ++V+  G  +EG+  ++++E++ +  L+ F+               PT   Q 
Sbjct: 69  LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQ- 127
Query: 421 DWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE 480
              +   I   IA G++YL   +    +HRDL T N L+   +  KI DFGM+R    D 
Sbjct: 128 --SQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DV 178
Query: 481 TQGNTSRIVG----TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFR--NGE 534
              +  R+ G       +M PE  M+ +++ +SDV+S GV++ EI +  +   ++  N E
Sbjct: 179 YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE 238
Query: 535 TVE 537
            +E
Sbjct: 239 VIE 241

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 107/200 (53%), Gaps = 9/200 (4%)
Query: 329 ANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGF 388
             ++G G FG VYKG+ +    + +  ++  + Q    FKNEV ++   +H N++  +G+
Sbjct: 13  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRII 448
           S +  +  ++ ++   +SL H +       + +  +   I    A+G+ YLH  S   II
Sbjct: 73  STK-PQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---II 126
Query: 449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM---HGQY 505
           HRDLK++N+ L  ++T KI DFG+A             ++ G+  +MAPE         Y
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 506 SVKSDVFSFGVLVLEIISGQ 525
           S +SDV++FG+++ E+++GQ
Sbjct: 187 SFQSDVYAFGIVLYELMTGQ 206

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 107/198 (54%), Gaps = 11/198 (5%)
Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSL 390
           KLGQG FG V+ G       +A+K L   +   +  F  E  ++  L+H  LV+L     
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 391 EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHR 450
           E     ++ E++   SL  F+   T +  L   +   +   IA G+ Y+    R+  +HR
Sbjct: 333 E-EPIYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 387
Query: 451 DLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY--GYMAPEYAMHGQYSVK 508
           DL+ +N+L+   +  K+ADFG+ARL E +E    T+R    +   + APE A++G++++K
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 509 SDVFSFGVLVLEIISGQR 526
           SDV+SFG+L+ E+ +  R
Sbjct: 445 SDVWSFGILLTELTTKGR 462

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 107/200 (53%), Gaps = 9/200 (4%)
Query: 329 ANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGF 388
             ++G G FG VYKG+ +    + +  ++  + Q    FKNEV ++   +H N++  +G+
Sbjct: 33  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRII 448
           S +  +  ++ ++   +SL H +       + +  +   I    A+G+ YLH  S   II
Sbjct: 93  STK-PQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---II 146
Query: 449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM---HGQY 505
           HRDLK++N+ L  ++T KI DFG+A             ++ G+  +MAPE         Y
Sbjct: 147 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 206
Query: 506 SVKSDVFSFGVLVLEIISGQ 525
           S +SDV++FG+++ E+++GQ
Sbjct: 207 SFQSDVYAFGIVLYELMTGQ 226

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 106/221 (47%), Gaps = 25/221 (11%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRD-SGQGDLEFKNEVLL 373
           V   N +    LG G FG VY+G++          ++AVK L    S Q +L+F  E L+
Sbjct: 27  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 86
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFD----PTRRAQLDWERRYKII 429
           ++   H+N+VR +G SL+   R ++ E +    L  F+ +    P++ + L       + 
Sbjct: 87  ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146
Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE---MTPKIADFGMARLFEMDETQGNTS 486
             IA G  YL E+     IHRD+   N LL         KI DFGMAR    D  + +  
Sbjct: 147 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYY 199
Query: 487 RIVG----TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
           R  G       +M PE  M G ++ K+D +SFGVL+ EI S
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 106/221 (47%), Gaps = 25/221 (11%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRD-SGQGDLEFKNEVLL 373
           V   N +    LG G FG VY+G++          ++AVK L    S Q +L+F  E L+
Sbjct: 27  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 86
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFD----PTRRAQLDWERRYKII 429
           ++   H+N+VR +G SL+   R ++ E +    L  F+ +    P++ + L       + 
Sbjct: 87  ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146
Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE---MTPKIADFGMARLFEMDETQGNTS 486
             IA G  YL E+     IHRD+   N LL         KI DFGMAR    D  + +  
Sbjct: 147 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYY 199
Query: 487 RIVG----TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
           R  G       +M PE  M G ++ K+D +SFGVL+ EI S
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 125/270 (46%), Gaps = 25/270 (9%)
Query: 329 ANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGF 388
             ++G G FG V+ G   +  ++A+K +   S   D +F  E  ++  L H  LV+L G 
Sbjct: 32  VQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSED-DFIEEAEVMMKLSHPKLVQLYGV 90
Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRII 448
            LE     L++EF+ +  L  ++   T+R     E    +   +  G+ YL E     +I
Sbjct: 91  CLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 145
Query: 449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVK 508
           HRDL   N L+      K++DFGM R F +D+   +++       + +PE     +YS K
Sbjct: 146 HRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 204
Query: 509 SDVFSFGVLVLEIISGQR--NNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSIT 566
           SDV+SFGVL+ E+ S  +       N E VED+           T   +  P L+S  + 
Sbjct: 205 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI----------STGFRLYKPRLASTHVY 254
Query: 567 EMIRCIHIGLLCVQENVASRPTMASVVLML 596
           +++   H    C +E    RP  + ++  L
Sbjct: 255 QIMN--H----CWKERPEDRPAFSRLLRQL 278

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 110/200 (55%), Gaps = 15/200 (7%)
Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSL 390
           KLGQG FG V+ G       +A+K L   +   +  F  E  ++  L+H  LV+L  +++
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL--YAV 247
Query: 391 EGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIH 449
              E + ++ E++   SL  F+   T +  L   +   +   IA G+ Y+    R+  +H
Sbjct: 248 VSEEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 450 RDLKTSNVLLDAEMTPKIADFGMARLFEMDE---TQGNTSRIVGTYGYMAPEYAMHGQYS 506
           RDL+ +N+L+   +  K+ADFG+ARL E +E    QG    I  T    APE A++G+++
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAALYGRFT 359
Query: 507 VKSDVFSFGVLVLEIISGQR 526
           +KSDV+SFG+L+ E+ +  R
Sbjct: 360 IKSDVWSFGILLTELTTKGR 379

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 110/200 (55%), Gaps = 15/200 (7%)
Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSL 390
           KLGQG FG V+ G       +A+K L   +   +  F  E  ++  L+H  LV+L  +++
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL--YAV 247
Query: 391 EGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIH 449
              E + ++ E++   SL  F+   T +  L   +   +   IA G+ Y+    R+  +H
Sbjct: 248 VSEEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 450 RDLKTSNVLLDAEMTPKIADFGMARLFEMDE---TQGNTSRIVGTYGYMAPEYAMHGQYS 506
           RDL+ +N+L+   +  K+ADFG+ARL E +E    QG    I  T    APE A++G+++
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAALYGRFT 359
Query: 507 VKSDVFSFGVLVLEIISGQR 526
           +KSDV+SFG+L+ E+ +  R
Sbjct: 360 IKSDVWSFGILLTELTTKGR 379

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 107/200 (53%), Gaps = 9/200 (4%)
Query: 329 ANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGF 388
             ++G G FG VYKG+ +    + +  ++  + Q    FKNEV ++   +H N++  +G+
Sbjct: 41  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRII 448
           S +  +  ++ ++   +SL H +       + +  +   I    A+G+ YLH  S   II
Sbjct: 101 STK-PQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---II 154
Query: 449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM---HGQY 505
           HRDLK++N+ L  ++T KI DFG+A             ++ G+  +MAPE         Y
Sbjct: 155 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 214
Query: 506 SVKSDVFSFGVLVLEIISGQ 525
           S +SDV++FG+++ E+++GQ
Sbjct: 215 SFQSDVYAFGIVLYELMTGQ 234

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 106/221 (47%), Gaps = 25/221 (11%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRD-SGQGDLEFKNEVLL 373
           V   N +    LG G FG VY+G++          ++AVK L    S Q +L+F  E L+
Sbjct: 19  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 78
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFD----PTRRAQLDWERRYKII 429
           ++   H+N+VR +G SL+   R ++ E +    L  F+ +    P++ + L       + 
Sbjct: 79  ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 138
Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE---MTPKIADFGMARLFEMDETQGNTS 486
             IA G  YL E+     IHRD+   N LL         KI DFGMAR    D  + +  
Sbjct: 139 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYY 191
Query: 487 RIVG----TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
           R  G       +M PE  M G ++ K+D +SFGVL+ EI S
Sbjct: 192 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 110/200 (55%), Gaps = 15/200 (7%)
Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSL 390
           KLGQG FG V+ G       +A+K L   +   +  F  E  ++  L+H  LV+L  +++
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL--YAV 71
Query: 391 EGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIH 449
              E + ++ E++   SL  F+   T +  L   +   +   IA G+ Y+    R+  +H
Sbjct: 72  VSEEPIXIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVH 127
Query: 450 RDLKTSNVLLDAEMTPKIADFGMARLFEMDET---QGNTSRIVGTYGYMAPEYAMHGQYS 506
           RDL+ +N+L+   +  K+ADFG+ARL E +E    QG    I  T    APE A++G+++
Sbjct: 128 RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWT----APEAALYGRFT 183
Query: 507 VKSDVFSFGVLVLEIISGQR 526
           +KSDV+SFG+L+ E+ +  R
Sbjct: 184 IKSDVWSFGILLTELTTKGR 203

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 106/221 (47%), Gaps = 25/221 (11%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRD-SGQGDLEFKNEVLL 373
           V   N +    LG G FG VY+G++          ++AVK L    S Q +L+F  E L+
Sbjct: 44  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 103
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFD----PTRRAQLDWERRYKII 429
           ++   H+N+VR +G SL+   R ++ E +    L  F+ +    P++ + L       + 
Sbjct: 104 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 163
Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE---MTPKIADFGMARLFEMDETQGNTS 486
             IA G  YL E+     IHRD+   N LL         KI DFGMAR    D  + +  
Sbjct: 164 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYY 216
Query: 487 RIVG----TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
           R  G       +M PE  M G ++ K+D +SFGVL+ EI S
Sbjct: 217 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 106/221 (47%), Gaps = 25/221 (11%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRD-SGQGDLEFKNEVLL 373
           V   N +    LG G FG VY+G++          ++AVK L    S Q +L+F  E L+
Sbjct: 28  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 87
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFD----PTRRAQLDWERRYKII 429
           ++   H+N+VR +G SL+   R ++ E +    L  F+ +    P++ + L       + 
Sbjct: 88  ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 147
Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE---MTPKIADFGMARLFEMDETQGNTS 486
             IA G  YL E+     IHRD+   N LL         KI DFGMAR    D  + +  
Sbjct: 148 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYY 200
Query: 487 RIVG----TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
           R  G       +M PE  M G ++ K+D +SFGVL+ EI S
Sbjct: 201 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 106/221 (47%), Gaps = 25/221 (11%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRD-SGQGDLEFKNEVLL 373
           V   N +    LG G FG VY+G++          ++AVK L    S Q +L+F  E L+
Sbjct: 42  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 101
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFD----PTRRAQLDWERRYKII 429
           ++   H+N+VR +G SL+   R ++ E +    L  F+ +    P++ + L       + 
Sbjct: 102 ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 161
Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE---MTPKIADFGMARLFEMDETQGNTS 486
             IA G  YL E+     IHRD+   N LL         KI DFGMAR    D  + +  
Sbjct: 162 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYY 214
Query: 487 RIVG----TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
           R  G       +M PE  M G ++ K+D +SFGVL+ EI S
Sbjct: 215 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 67/200 (33%), Positives = 109/200 (54%), Gaps = 15/200 (7%)
Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSL 390
           KLGQG FG V+ G       +A+K L   +   +  F  E  ++  L+H  LV+L  +++
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL--YAV 247
Query: 391 EGNERLLIY-EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIH 449
              E + I  E++   SL  F+   T +  L   +   +   IA G+ Y+    R+  +H
Sbjct: 248 VSEEPIYIVGEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 450 RDLKTSNVLLDAEMTPKIADFGMARLFEMDE---TQGNTSRIVGTYGYMAPEYAMHGQYS 506
           RDL+ +N+L+   +  K+ADFG+ARL E +E    QG    I  T    APE A++G+++
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAALYGRFT 359
Query: 507 VKSDVFSFGVLVLEIISGQR 526
           +KSDV+SFG+L+ E+ +  R
Sbjct: 360 IKSDVWSFGILLTELTTKGR 379

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 105/221 (47%), Gaps = 25/221 (11%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRD-SGQGDLEFKNEVLL 373
           V   N +    LG G FG VY+G++          ++AVK L    S Q +L+F  E L+
Sbjct: 68  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 127
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFD----PTRRAQLDWERRYKII 429
           ++   H+N+VR +G SL+   R ++ E +    L  F+ +    P++ + L       + 
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187
Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE---MTPKIADFGMARLFEMDETQGNTS 486
             IA G  YL E+     IHRD+   N LL         KI DFGMAR    D  +    
Sbjct: 188 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYY 240
Query: 487 RIVG----TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
           R  G       +M PE  M G ++ K+D +SFGVL+ EI S
Sbjct: 241 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 125/272 (45%), Gaps = 24/272 (8%)
Query: 330 NKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFS 389
            KLG G FG V+ G   +  ++AVK L +        F  E  L+  LQH  LVRL    
Sbjct: 18  KKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 76
Query: 390 LEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIH 449
            +     +I EF+   SL  F+       ++   +       IA G+ Y+    R   IH
Sbjct: 77  TKEEPIYIITEFMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIH 132
Query: 450 RDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY--GYMAPEYAMHGQYSV 507
           RDL+ +NVL+   +  KIADFG+AR+ E +E    T+R    +   + APE    G +++
Sbjct: 133 RDLRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFGCFTI 189
Query: 508 KSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITE 567
           KS+V+SFG+L+ EI++         G T  D++S+  + +R     N  D          
Sbjct: 190 KSNVWSFGILLYEIVT--YGKIPYPGRTNADVMSALSQGYRMPRMENCPD---------- 237
Query: 568 MIRCIHIGLLCVQENVASRPTMASVVLMLNSY 599
                 I  +C +E    RPT   +  +L+ +
Sbjct: 238 --ELYDIMKMCWKEKAEERPTFDYLQSVLDDF 267

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 106/221 (47%), Gaps = 25/221 (11%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSR-DSGQGDLEFKNEVLL 373
           V   N +    LG G FG VY+G++          ++AVK L    S Q +L+F  E L+
Sbjct: 42  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALI 101
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFD----PTRRAQLDWERRYKII 429
           ++   H+N+VR +G SL+   R ++ E +    L  F+ +    P++ + L       + 
Sbjct: 102 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 161
Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE---MTPKIADFGMARLFEMDETQGNTS 486
             IA G  YL E+     IHRD+   N LL         KI DFGMAR    D  + +  
Sbjct: 162 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYY 214
Query: 487 RIVG----TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
           R  G       +M PE  M G ++ K+D +SFGVL+ EI S
Sbjct: 215 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 106/221 (47%), Gaps = 25/221 (11%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRD-SGQGDLEFKNEVLL 373
           V   N +    LG G FG VY+G++          ++AVK L    S Q +L+F  E L+
Sbjct: 34  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 93
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFD----PTRRAQLDWERRYKII 429
           ++   H+N+VR +G SL+   R ++ E +    L  F+ +    P++ + L       + 
Sbjct: 94  ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 153
Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE---MTPKIADFGMARLFEMDETQGNTS 486
             IA G  YL E+     IHRD+   N LL         KI DFGMAR    D  + +  
Sbjct: 154 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYY 206
Query: 487 RIVG----TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
           R  G       +M PE  M G ++ K+D +SFGVL+ EI S
Sbjct: 207 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 105/221 (47%), Gaps = 25/221 (11%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRD-SGQGDLEFKNEVLL 373
           V   N +    LG G FG VY+G++          ++AVK L    S Q +L+F  E L+
Sbjct: 45  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 104
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFD----PTRRAQLDWERRYKII 429
           ++   H+N+VR +G SL+   R ++ E +    L  F+ +    P++ + L       + 
Sbjct: 105 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 164
Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE---MTPKIADFGMARLFEMDETQGNTS 486
             IA G  YL E+     IHRD+   N LL         KI DFGMAR    D  +    
Sbjct: 165 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYY 217
Query: 487 RIVG----TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
           R  G       +M PE  M G ++ K+D +SFGVL+ EI S
Sbjct: 218 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 106/221 (47%), Gaps = 25/221 (11%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRD-SGQGDLEFKNEVLL 373
           V   N +    LG G FG VY+G++          ++AVK L    S Q +L+F  E L+
Sbjct: 54  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 113
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFD----PTRRAQLDWERRYKII 429
           ++   H+N+VR +G SL+   R ++ E +    L  F+ +    P++ + L       + 
Sbjct: 114 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 173
Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE---MTPKIADFGMARLFEMDETQGNTS 486
             IA G  YL E+     IHRD+   N LL         KI DFGMAR    D  + +  
Sbjct: 174 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYY 226
Query: 487 RIVG----TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
           R  G       +M PE  M G ++ K+D +SFGVL+ EI S
Sbjct: 227 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 110/200 (55%), Gaps = 15/200 (7%)
Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSL 390
           KLGQG FG V+ G       +A+K L   +   +  F  E  ++  L+H  LV+L  +++
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL--YAV 74
Query: 391 EGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIH 449
              E + ++ E++   SL  F+   T +  L   +   +   IA G+ Y+    R+  +H
Sbjct: 75  VSEEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVH 130
Query: 450 RDLKTSNVLLDAEMTPKIADFGMARLFEMDE---TQGNTSRIVGTYGYMAPEYAMHGQYS 506
           RDL+ +N+L+   +  K+ADFG+ARL E +E    QG    I  T    APE A++G+++
Sbjct: 131 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAALYGRFT 186
Query: 507 VKSDVFSFGVLVLEIISGQR 526
           +KSDV+SFG+L+ E+ +  R
Sbjct: 187 IKSDVWSFGILLTELTTKGR 206

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 130/288 (45%), Gaps = 24/288 (8%)
Query: 314 FDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLL 373
           +D +   +  ++     +LG G FG V+ G   +  ++AVK L +        F  E  L
Sbjct: 3   WDKDAWEIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANL 61
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA 433
           +  LQH  LVRL           +I E++   SL  F+       ++   +       IA
Sbjct: 62  MKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIA 120
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY- 492
            G+ Y+    R   IHRDL+ +NVL+   +  KIADFG+AR+ E +E    T+R    + 
Sbjct: 121 EGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFP 174
Query: 493 -GYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGT 551
             + APE    G +++KSDV+SFG+L+ EI++         G T  D++++  + +R   
Sbjct: 175 IKWTAPEAINFGCFTIKSDVWSFGILLYEIVT--YGKIPYPGRTNADVMTALSQGYRMPR 232
Query: 552 TVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY 599
             N  D                I  +C +E    RPT   +  +L+ +
Sbjct: 233 VENCPD------------ELYDIMKMCWKEKAEERPTFDYLQSVLDDF 268

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 125/270 (46%), Gaps = 25/270 (9%)
Query: 329 ANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGF 388
             ++G G FG V+ G   +  ++A+K + R+    + +F  E  ++  L H  LV+L G 
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRII 448
            LE     L+ EF+ +  L  ++   T+R     E    +   +  G+ YL E     +I
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 126
Query: 449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVK 508
           HRDL   N L+      K++DFGM R F +D+   +++       + +PE     +YS K
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 185
Query: 509 SDVFSFGVLVLEIISGQR--NNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSIT 566
           SDV+SFGVL+ E+ S  +       N E VED+           T   +  P L+S  + 
Sbjct: 186 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI----------STGFRLYKPRLASTHVY 235
Query: 567 EMIRCIHIGLLCVQENVASRPTMASVVLML 596
           +++   H    C +E    RP  + ++  L
Sbjct: 236 QIMN--H----CWRERPEDRPAFSRLLRQL 259

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDS--GQGDLE-FKNEVLLVANLQH 379
           ++F   N LG+G F  VY+   ++ G E+A+K + + +    G ++  +NEV +   L+H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            +++ L  +  + N   L+ E   N  ++ ++ +  +    +  R +  +  I  G+LYL
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF--MHQIITGMLYL 128
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
           H      I+HRDL  SN+LL   M  KIADFG+A   +M   +  T  + GT  Y++PE 
Sbjct: 129 HSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEI 183
Query: 500 AMHGQYSVKSDVFSFGVLVLEIISGQ 525
           A    + ++SDV+S G +   ++ G+
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGR 209

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 110/200 (55%), Gaps = 15/200 (7%)
Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSL 390
           KLGQG FG V+ G       +A+K L   +   +  F  E  ++  L+H  LV+L  +++
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL--YAV 78
Query: 391 EGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIH 449
              E + ++ E++   SL  F+   T +  L   +   +   IA G+ Y+    R+  +H
Sbjct: 79  VSEEPIYIVTEYMNKGSLLDFLKGETGKY-LRLPQLVDMSAQIASGMAYVE---RMNYVH 134
Query: 450 RDLKTSNVLLDAEMTPKIADFGMARLFEMDE---TQGNTSRIVGTYGYMAPEYAMHGQYS 506
           RDL+ +N+L+   +  K+ADFG+ARL E +E    QG    I  T    APE A++G+++
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWT----APEAALYGRFT 190
Query: 507 VKSDVFSFGVLVLEIISGQR 526
           +KSDV+SFG+L+ E+ +  R
Sbjct: 191 IKSDVWSFGILLTELTTKGR 210

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 110/200 (55%), Gaps = 15/200 (7%)
Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSL 390
           KLGQG FG V+ G       +A+K L   +   +  F  E  ++  L+H  LV+L  +++
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL--YAV 78
Query: 391 EGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIH 449
              E + ++ E++   SL  F+   T +  L   +   +   IA G+ Y+    R+  +H
Sbjct: 79  VSEEPIYIVTEYMNKGSLLDFLKGETGKY-LRLPQLVDMSAQIASGMAYVE---RMNYVH 134
Query: 450 RDLKTSNVLLDAEMTPKIADFGMARLFEMDE---TQGNTSRIVGTYGYMAPEYAMHGQYS 506
           RDL+ +N+L+   +  K+ADFG+ARL E +E    QG    I  T    APE A++G+++
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAALYGRFT 190
Query: 507 VKSDVFSFGVLVLEIISGQR 526
           +KSDV+SFG+L+ E+ +  R
Sbjct: 191 IKSDVWSFGILLTELTTKGR 210

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/221 (32%), Positives = 106/221 (47%), Gaps = 25/221 (11%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRD-SGQGDLEFKNEVLL 373
           V   N +    LG G FG VY+G++          ++AVK L    S Q +L+F  E L+
Sbjct: 28  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 87
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFD----PTRRAQLDWERRYKII 429
           ++   H+N+VR +G SL+   R ++ E +    L  F+ +    P++ + L       + 
Sbjct: 88  ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 147
Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE---MTPKIADFGMARLFEMDETQGNTS 486
             IA G  YL E+     IHRD+   N LL         KI DFGMA+    D  + +  
Sbjct: 148 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ----DIYRASYY 200
Query: 487 RIVG----TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
           R  G       +M PE  M G ++ K+D +SFGVL+ EI S
Sbjct: 201 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/307 (25%), Positives = 150/307 (48%), Gaps = 32/307 (10%)
Query: 299 EAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGA-----EIAV 353
           + A G + N+A  L+F   T  +     +    +G G FG VYKG L   +      +A+
Sbjct: 23  QGAMGSDPNQA-VLKF---TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAI 78
Query: 354 KRLSRD-SGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIF 412
           K L    + +  ++F  E  ++    H N++RL G   +    ++I E++ N +LD F+ 
Sbjct: 79  KTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR 138
Query: 413 DPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGM 472
           +  +  +    +   ++ GIA G+ YL   + +  +HRDL   N+L+++ +  K++DFG+
Sbjct: 139 E--KDGEFSVLQLVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGL 193
Query: 473 ARLFEMD-ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCF 530
           +R+ E D E    TS       + APE   + +++  SDV+SFG+++ E+++ G+R    
Sbjct: 194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 253
Query: 531 RNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMA 590
            +   V   ++  ++         +  P     +I +++      + C Q+  A RP  A
Sbjct: 254 LSNHEVMKAINDGFR---------LPTPMDCPSAIYQLM------MQCWQQERARRPKFA 298
Query: 591 SVVLMLN 597
            +V +L+
Sbjct: 299 DIVSILD 305

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 106/199 (53%), Gaps = 13/199 (6%)
Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSL 390
           KLGQG FG V+ G       +A+K L   +   +  F  E  ++  L+H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 391 EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHR 450
           E    ++I E++   SL  F+     +  L   +   +   IA G+ Y+    R+  +HR
Sbjct: 84  EEPIYIVI-EYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 451 DLKTSNVLLDAEMTPKIADFGMARLFEMDET---QGNTSRIVGTYGYMAPEYAMHGQYSV 507
           DL+ +N+L+   +  K+ADFG+ARL E +E    QG    I  T    APE A++G++++
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWT----APEAALYGRFTI 194
Query: 508 KSDVFSFGVLVLEIISGQR 526
           KSDV+SFG+L+ E+ +  R
Sbjct: 195 KSDVWSFGILLTELTTKGR 213

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 109/200 (54%), Gaps = 15/200 (7%)
Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSL 390
           KLGQG FG V+ G       +A+K L   +   +  F  E  ++  L+H  LV+L  +++
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL--YAV 70
Query: 391 EGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIH 449
              E + ++ E++   SL  F+     +  L   +   +   IA G+ Y+    R+  +H
Sbjct: 71  VSEEPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVH 126
Query: 450 RDLKTSNVLLDAEMTPKIADFGMARLFEMDE---TQGNTSRIVGTYGYMAPEYAMHGQYS 506
           RDL+ +N+L+   +  K+ADFG+ARL E +E    QG    I  T    APE A++G+++
Sbjct: 127 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAALYGRFT 182
Query: 507 VKSDVFSFGVLVLEIISGQR 526
           +KSDV+SFG+L+ E+ +  R
Sbjct: 183 IKSDVWSFGILLTELTTKGR 202

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 106/199 (53%), Gaps = 13/199 (6%)
Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSL 390
           KLGQG FG V+ G       +A+K L   +   +  F  E  ++  L+H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 391 EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHR 450
           E    ++I E++   SL  F+     +  L   +   +   IA G+ Y+    R+  +HR
Sbjct: 84  EEPIYIVI-EYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 451 DLKTSNVLLDAEMTPKIADFGMARLFEMDE---TQGNTSRIVGTYGYMAPEYAMHGQYSV 507
           DL+ +N+L+   +  K+ADFG+ARL E +E    QG    I  T    APE A++G++++
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAALYGRFTI 194
Query: 508 KSDVFSFGVLVLEIISGQR 526
           KSDV+SFG+L+ E+ +  R
Sbjct: 195 KSDVWSFGILLTELTTKGR 213

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 109/200 (54%), Gaps = 15/200 (7%)
Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSL 390
           KLGQG FG V+ G       +A+K L   +   +  F  E  ++  L+H  LV+L  +++
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL--YAV 72
Query: 391 EGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIH 449
              E + ++ E++   SL  F+     +  L   +   +   IA G+ Y+    R+  +H
Sbjct: 73  VSEEPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVH 128
Query: 450 RDLKTSNVLLDAEMTPKIADFGMARLFEMDE---TQGNTSRIVGTYGYMAPEYAMHGQYS 506
           RDL+ +N+L+   +  K+ADFG+ARL E +E    QG    I  T    APE A++G+++
Sbjct: 129 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAALYGRFT 184
Query: 507 VKSDVFSFGVLVLEIISGQR 526
           +KSDV+SFG+L+ E+ +  R
Sbjct: 185 IKSDVWSFGILLTELTTKGR 204

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 108/200 (54%), Gaps = 15/200 (7%)
Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSL 390
           KLGQG FG V+ G       +A+K L   +   +  F  E  ++  L+H  LV+L  +++
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 391 EGNERLLIY-EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIH 449
              E + I  E++   SL  F+     +  L   +   +   IA G+ Y+    R+  +H
Sbjct: 82  VSEEPIYIVCEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 450 RDLKTSNVLLDAEMTPKIADFGMARLFEMDE---TQGNTSRIVGTYGYMAPEYAMHGQYS 506
           RDL+ +N+L+   +  K+ADFG+ARL E +E    QG    I  T    APE A++G+++
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAALYGRFT 193
Query: 507 VKSDVFSFGVLVLEIISGQR 526
           +KSDV+SFG+L+ E+ +  R
Sbjct: 194 IKSDVWSFGILLTELTTKGR 213

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 109/200 (54%), Gaps = 15/200 (7%)
Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSL 390
           KLGQG FG V+ G       +A+K L   +   +  F  E  ++  L+H  LV+L  +++
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 391 EGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIH 449
              E + ++ E++   SL  F+     +  L   +   +   IA G+ Y+    R+  +H
Sbjct: 82  VSEEPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 450 RDLKTSNVLLDAEMTPKIADFGMARLFEMDE---TQGNTSRIVGTYGYMAPEYAMHGQYS 506
           RDL+ +N+L+   +  K+ADFG+ARL E +E    QG    I  T    APE A++G+++
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAALYGRFT 193
Query: 507 VKSDVFSFGVLVLEIISGQR 526
           +KSDV+SFG+L+ E+ +  R
Sbjct: 194 IKSDVWSFGILLTELTTKGR 213

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 331 KLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVR 384
           +LG+G FG+V   R YD      G  +AVK+L   + +   +F+ E+ ++ +LQH N+V+
Sbjct: 20  QLGKGNFGSVEMCR-YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 385 LLGFSLEGNER--LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
             G       R   LI EF+P  SL  ++     + ++D  +  +    I +G+ YL   
Sbjct: 79  YKGVCYSAGRRNLKLIMEFLPYGSLREYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 133
Query: 443 SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI-VGTYGYMAPEYAM 501
              R IHRDL T N+L++ E   KI DFG+ ++   D+              + APE   
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 502 HGQYSVKSDVFSFGVLVLEIIS 523
             ++SV SDV+SFGV++ E+ +
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 104/211 (49%), Gaps = 21/211 (9%)
Query: 331 KLGQGGFGAVYKGRLY------DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVR 384
           +LG+G FG V+    +      D   +AVK L   S     +F+ E  L+  LQH+++VR
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 385 LLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQ------------LDWERRYKIIGGI 432
             G   EG   L+++E++ +  L+ F+      A+            L   +   +   +
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 433 ARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY 492
           A G++YL   + L  +HRDL T N L+   +  KI DFGM+R     +      R +   
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 493 GYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
            +M PE  ++ +++ +SDV+SFGV++ EI +
Sbjct: 196 RWMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 104/211 (49%), Gaps = 21/211 (9%)
Query: 331 KLGQGGFGAVYKGRLY------DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVR 384
           +LG+G FG V+    +      D   +AVK L   S     +F+ E  L+  LQH+++VR
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 385 LLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQ------------LDWERRYKIIGGI 432
             G   EG   L+++E++ +  L+ F+      A+            L   +   +   +
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 433 ARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY 492
           A G++YL   + L  +HRDL T N L+   +  KI DFGM+R     +      R +   
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 493 GYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
            +M PE  ++ +++ +SDV+SFGV++ EI +
Sbjct: 202 RWMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 104/211 (49%), Gaps = 21/211 (9%)
Query: 331 KLGQGGFGAVYKGRLY------DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVR 384
           +LG+G FG V+    +      D   +AVK L   S     +F+ E  L+  LQH+++VR
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 385 LLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQ------------LDWERRYKIIGGI 432
             G   EG   L+++E++ +  L+ F+      A+            L   +   +   +
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 433 ARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY 492
           A G++YL   + L  +HRDL T N L+   +  KI DFGM+R     +      R +   
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 493 GYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
            +M PE  ++ +++ +SDV+SFGV++ EI +
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 15/200 (7%)
Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSL 390
           KLGQG FG V+ G       +A+K L +        F  E  ++  L+H  LV+L  +++
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGNMSPEAFLQEAQVMKKLRHEKLVQL--YAV 248
Query: 391 EGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIH 449
              E + ++ E++   SL  F+     +  L   +   +   IA G+ Y+    R+  +H
Sbjct: 249 VSEEPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVH 304
Query: 450 RDLKTSNVLLDAEMTPKIADFGMARLFEMDE---TQGNTSRIVGTYGYMAPEYAMHGQYS 506
           RDL+ +N+L+   +  K+ADFG+ RL E +E    QG    I  T    APE A++G+++
Sbjct: 305 RDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWT----APEAALYGRFT 360
Query: 507 VKSDVFSFGVLVLEIISGQR 526
           +KSDV+SFG+L+ E+ +  R
Sbjct: 361 IKSDVWSFGILLTELTTKGR 380

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 108/200 (54%), Gaps = 15/200 (7%)
Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSL 390
           KLGQG FG V+ G       +A+K L   +   +  F  E  ++  L+H  LV+L  +++
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 391 EGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIH 449
              E + ++ E++   SL  F+     +  L   +   +   IA G+ Y+    R+  +H
Sbjct: 82  VSEEPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 450 RDLKTSNVLLDAEMTPKIADFGMARLFEMDE---TQGNTSRIVGTYGYMAPEYAMHGQYS 506
           RDL  +N+L+   +  K+ADFG+ARL E +E    QG    I  T    APE A++G+++
Sbjct: 138 RDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAALYGRFT 193
Query: 507 VKSDVFSFGVLVLEIISGQR 526
           +KSDV+SFG+L+ E+ +  R
Sbjct: 194 IKSDVWSFGILLTELTTKGR 213

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 109/200 (54%), Gaps = 15/200 (7%)
Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSL 390
           KLGQG FG V+ G       +A+K L   +   +  F  E  ++  ++H  LV+L  +++
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKIRHEKLVQL--YAV 81
Query: 391 EGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIH 449
              E + ++ E++   SL  F+     +  L   +   +   IA G+ Y+    R+  +H
Sbjct: 82  VSEEPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 450 RDLKTSNVLLDAEMTPKIADFGMARLFEMDE---TQGNTSRIVGTYGYMAPEYAMHGQYS 506
           RDL+ +N+L+   +  K+ADFG+ARL E +E    QG    I  T    APE A++G+++
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAALYGRFT 193
Query: 507 VKSDVFSFGVLVLEIISGQR 526
           +KSDV+SFG+L+ E+ +  R
Sbjct: 194 IKSDVWSFGILLTELTTKGR 213

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 108/200 (54%), Gaps = 15/200 (7%)
Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSL 390
           KLGQG FG V+ G       +A+K L   +   +  F  E  ++  L+H  LV+L  +++
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 391 EGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIH 449
              E + ++ E++    L  F+     +  L   +   +   IA G+ Y+    R+  +H
Sbjct: 82  VSEEPIYIVMEYMSKGCLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 450 RDLKTSNVLLDAEMTPKIADFGMARLFEMDE---TQGNTSRIVGTYGYMAPEYAMHGQYS 506
           RDL+ +N+L+   +  K+ADFG+ARL E +E    QG    I  T    APE A++G+++
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAALYGRFT 193
Query: 507 VKSDVFSFGVLVLEIISGQR 526
           +KSDV+SFG+L+ E+ +  R
Sbjct: 194 IKSDVWSFGILLTELTTKGR 213

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 15/203 (7%)
Query: 330 NKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
            +LG+G FG+V   R YD      G  +AVK+L   + +   +F+ E+ ++ +LQH N+V
Sbjct: 23  QQLGKGNFGSVEMCR-YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 81
Query: 384 RLLGFSLEGNER--LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           +  G       R   LI E++P  SL  ++     + ++D  +  +    I +G+ YL  
Sbjct: 82  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL-- 137
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI-VGTYGYMAPEYA 500
               R IHRDL T N+L++ E   KI DFG+ ++   D+              + APE  
Sbjct: 138 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 196
Query: 501 MHGQYSVKSDVFSFGVLVLEIIS 523
              ++SV SDV+SFGV++ E+ +
Sbjct: 197 TESKFSVASDVWSFGVVLYELFT 219

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 15/203 (7%)
Query: 330 NKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
            +LG+G FG+V   R YD      G  +AVK+L   + +   +F+ E+ ++ +LQH N+V
Sbjct: 47  QQLGKGNFGSVEMCR-YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 384 RLLGFSLEGNER--LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           +  G       R   LI E++P  SL  ++     + ++D  +  +    I +G+ YL  
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL-- 161
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI-VGTYGYMAPEYA 500
               R IHRDL T N+L++ E   KI DFG+ ++   D+              + APE  
Sbjct: 162 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 220
Query: 501 MHGQYSVKSDVFSFGVLVLEIIS 523
              ++SV SDV+SFGV++ E+ +
Sbjct: 221 TESKFSVASDVWSFGVVLYELFT 243

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 15/203 (7%)
Query: 330 NKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
            +LG+G FG+V   R YD      G  +AVK+L   + +   +F+ E+ ++ +LQH N+V
Sbjct: 15  QQLGKGNFGSVEMCR-YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 73
Query: 384 RLLGFSLEGNER--LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           +  G       R   LI E++P  SL  ++     + ++D  +  +    I +G+ YL  
Sbjct: 74  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL-- 129
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI-VGTYGYMAPEYA 500
               R IHRDL T N+L++ E   KI DFG+ ++   D+              + APE  
Sbjct: 130 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 188
Query: 501 MHGQYSVKSDVFSFGVLVLEIIS 523
              ++SV SDV+SFGV++ E+ +
Sbjct: 189 TESKFSVASDVWSFGVVLYELFT 211

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 15/203 (7%)
Query: 330 NKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
            +LG+G FG+V   R YD      G  +AVK+L   + +   +F+ E+ ++ +LQH N+V
Sbjct: 14  QQLGKGNFGSVEMCR-YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 72
Query: 384 RLLGFSLEGNER--LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           +  G       R   LI E++P  SL  ++     + ++D  +  +    I +G+ YL  
Sbjct: 73  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL-- 128
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI-VGTYGYMAPEYA 500
               R IHRDL T N+L++ E   KI DFG+ ++   D+              + APE  
Sbjct: 129 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 187
Query: 501 MHGQYSVKSDVFSFGVLVLEIIS 523
              ++SV SDV+SFGV++ E+ +
Sbjct: 188 TESKFSVASDVWSFGVVLYELFT 210

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 15/203 (7%)
Query: 330 NKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
            +LG+G FG+V   R YD      G  +AVK+L   + +   +F+ E+ ++ +LQH N+V
Sbjct: 19  QQLGKGNFGSVEMCR-YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 77
Query: 384 RLLGFSLEGNER--LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           +  G       R   LI E++P  SL  ++     + ++D  +  +    I +G+ YL  
Sbjct: 78  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL-- 133
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI-VGTYGYMAPEYA 500
               R IHRDL T N+L++ E   KI DFG+ ++   D+              + APE  
Sbjct: 134 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 501 MHGQYSVKSDVFSFGVLVLEIIS 523
              ++SV SDV+SFGV++ E+ +
Sbjct: 193 TESKFSVASDVWSFGVVLYELFT 215

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 15/203 (7%)
Query: 330 NKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
            +LG+G FG+V   R YD      G  +AVK+L   + +   +F+ E+ ++ +LQH N+V
Sbjct: 20  QQLGKGNFGSVEMCR-YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 78
Query: 384 RLLGFSLEGNER--LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           +  G       R   LI E++P  SL  ++     + ++D  +  +    I +G+ YL  
Sbjct: 79  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL-- 134
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI-VGTYGYMAPEYA 500
               R IHRDL T N+L++ E   KI DFG+ ++   D+              + APE  
Sbjct: 135 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 193
Query: 501 MHGQYSVKSDVFSFGVLVLEIIS 523
              ++SV SDV+SFGV++ E+ +
Sbjct: 194 TESKFSVASDVWSFGVVLYELFT 216

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 15/203 (7%)
Query: 330 NKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
            +LG+G FG+V   R YD      G  +AVK+L   + +   +F+ E+ ++ +LQH N+V
Sbjct: 16  QQLGKGNFGSVEMCR-YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 384 RLLGFSLEGNER--LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           +  G       R   LI E++P  SL  ++     + ++D  +  +    I +G+ YL  
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL-- 130
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI-VGTYGYMAPEYA 500
               R IHRDL T N+L++ E   KI DFG+ ++   D+              + APE  
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 189
Query: 501 MHGQYSVKSDVFSFGVLVLEIIS 523
              ++SV SDV+SFGV++ E+ +
Sbjct: 190 TESKFSVASDVWSFGVVLYELFT 212

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 15/203 (7%)
Query: 330 NKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
            +LG+G FG+V   R YD      G  +AVK+L   + +   +F+ E+ ++ +LQH N+V
Sbjct: 21  QQLGKGNFGSVEMCR-YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 79
Query: 384 RLLGFSLEGNER--LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           +  G       R   LI E++P  SL  ++     + ++D  +  +    I +G+ YL  
Sbjct: 80  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL-- 135
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI-VGTYGYMAPEYA 500
               R IHRDL T N+L++ E   KI DFG+ ++   D+              + APE  
Sbjct: 136 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 194
Query: 501 MHGQYSVKSDVFSFGVLVLEIIS 523
              ++SV SDV+SFGV++ E+ +
Sbjct: 195 TESKFSVASDVWSFGVVLYELFT 217

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 108/200 (54%), Gaps = 15/200 (7%)
Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSL 390
           KLGQG FG V+ G       +A+K L   +   +  F  E  ++  L+H  LV+L  +++
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 391 EGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIH 449
              E + ++ E++    L  F+     +  L   +   +   IA G+ Y+    R+  +H
Sbjct: 82  VSEEPIYIVTEYMSKGCLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 450 RDLKTSNVLLDAEMTPKIADFGMARLFEMDE---TQGNTSRIVGTYGYMAPEYAMHGQYS 506
           RDL+ +N+L+   +  K+ADFG+ARL E +E    QG    I  T    APE A++G+++
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAALYGRFT 193
Query: 507 VKSDVFSFGVLVLEIISGQR 526
           +KSDV+SFG+L+ E+ +  R
Sbjct: 194 IKSDVWSFGILLTELTTKGR 213

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 15/203 (7%)
Query: 330 NKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
            +LG+G FG+V   R YD      G  +AVK+L   + +   +F+ E+ ++ +LQH N+V
Sbjct: 16  QQLGKGNFGSVEMCR-YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 384 RLLGFSLEGNER--LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           +  G       R   LI E++P  SL  ++     + ++D  +  +    I +G+ YL  
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL-- 130
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI-VGTYGYMAPEYA 500
               R IHRDL T N+L++ E   KI DFG+ ++   D+              + APE  
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 189
Query: 501 MHGQYSVKSDVFSFGVLVLEIIS 523
              ++SV SDV+SFGV++ E+ +
Sbjct: 190 TESKFSVASDVWSFGVVLYELFT 212

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 15/203 (7%)
Query: 330 NKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
            +LG+G FG+V   R YD      G  +AVK+L   + +   +F+ E+ ++ +LQH N+V
Sbjct: 22  QQLGKGNFGSVEMCR-YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 80
Query: 384 RLLGFSLEGNER--LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           +  G       R   LI E++P  SL  ++     + ++D  +  +    I +G+ YL  
Sbjct: 81  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL-- 136
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI-VGTYGYMAPEYA 500
               R IHRDL T N+L++ E   KI DFG+ ++   D+              + APE  
Sbjct: 137 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 195
Query: 501 MHGQYSVKSDVFSFGVLVLEIIS 523
              ++SV SDV+SFGV++ E+ +
Sbjct: 196 TESKFSVASDVWSFGVVLYELFT 218

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 127/278 (45%), Gaps = 31/278 (11%)
Query: 316 FNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVA 375
           + +  +   + +   +LG G FG V  G+     ++A+K +   S   D EF  E  ++ 
Sbjct: 16  YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMM 74
Query: 376 NLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARG 435
           NL H  LV+L G   +     +I E++ N  L +++ +   R Q   ++  ++   +   
Sbjct: 75  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEA 132
Query: 436 LLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG-- 493
           + YL      + +HRDL   N L++ +   K++DFG++R    DE    TS +   +   
Sbjct: 133 MEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---ETSSVGSKFPVR 186
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQR--NNCFRNGETVEDLLSSAWKNWREGT 551
           +  PE  M+ ++S KSD+++FGVL+ EI S  +     F N ET E +            
Sbjct: 187 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI----------AQ 236
Query: 552 TVNIIDPTLSSGSI-TEMIRCIHIGLLCVQENVASRPT 588
            + +  P L+S  + T M  C H       E    RPT
Sbjct: 237 GLRLYRPHLASEKVYTIMYSCWH-------EKADERPT 267

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 15/203 (7%)
Query: 330 NKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
            +LG+G FG+V   R YD      G  +AVK+L   + +   +F+ E+ ++ +LQH N+V
Sbjct: 34  QQLGKGNFGSVEMCR-YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 92
Query: 384 RLLGFSLEGNER--LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           +  G       R   LI E++P  SL  ++     + ++D  +  +    I +G+ YL  
Sbjct: 93  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL-- 148
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI-VGTYGYMAPEYA 500
               R IHRDL T N+L++ E   KI DFG+ ++   D+              + APE  
Sbjct: 149 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 207
Query: 501 MHGQYSVKSDVFSFGVLVLEIIS 523
              ++SV SDV+SFGV++ E+ +
Sbjct: 208 TESKFSVASDVWSFGVVLYELFT 230

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 15/203 (7%)
Query: 330 NKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
            +LG+G FG+V   R YD      G  +AVK+L   + +   +F+ E+ ++ +LQH N+V
Sbjct: 34  QQLGKGNFGSVEMCR-YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 92
Query: 384 RLLGFSLEGNER--LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           +  G       R   LI E++P  SL  ++     + ++D  +  +    I +G+ YL  
Sbjct: 93  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL-- 148
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI-VGTYGYMAPEYA 500
               R IHRDL T N+L++ E   KI DFG+ ++   D+              + APE  
Sbjct: 149 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 207
Query: 501 MHGQYSVKSDVFSFGVLVLEIIS 523
              ++SV SDV+SFGV++ E+ +
Sbjct: 208 TESKFSVASDVWSFGVVLYELFT 230

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 97/204 (47%), Gaps = 18/204 (8%)
Query: 332 LGQGGFGAVYKGRLYDGAEIAV-KRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSL 390
           LG+G FG   K    +  E+ V K L R   +    F  EV ++  L+H N+++ +G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 391 EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHR 450
           +      I E++   +L   I   +  +Q  W +R      IA G+ YLH    + IIHR
Sbjct: 78  KDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHR 132
Query: 451 DLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSR------------IVGTYGYMAPE 498
           DL + N L+       +ADFG+ARL   ++TQ    R            +VG   +MAPE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 499 YAMHGQYSVKSDVFSFGVLVLEII 522
                 Y  K DVFSFG+++ EII
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEII 216

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 127/278 (45%), Gaps = 31/278 (11%)
Query: 316 FNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVA 375
           + +  +   + +   +LG G FG V  G+     ++A+K +   S   D EF  E  ++ 
Sbjct: 16  YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMM 74
Query: 376 NLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARG 435
           NL H  LV+L G   +     +I E++ N  L +++ +   R Q   ++  ++   +   
Sbjct: 75  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEA 132
Query: 436 LLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG-- 493
           + YL      + +HRDL   N L++ +   K++DFG++R    DE    TS +   +   
Sbjct: 133 MEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVR 186
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQR--NNCFRNGETVEDLLSSAWKNWREGT 551
           +  PE  M+ ++S KSD+++FGVL+ EI S  +     F N ET E +            
Sbjct: 187 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI----------AQ 236
Query: 552 TVNIIDPTLSSGSI-TEMIRCIHIGLLCVQENVASRPT 588
            + +  P L+S  + T M  C H       E    RPT
Sbjct: 237 GLRLYRPHLASEKVYTIMYSCWH-------EKADERPT 267

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 107/207 (51%), Gaps = 23/207 (11%)
Query: 330 NKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
            +LG+G FG+V   R YD      G  +AVK+L   + +   +F+ E+ ++ +LQH N+V
Sbjct: 16  QQLGKGNFGSVEMCR-YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 384 RLLGFSLEGNER--LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           +  G       R   LI E++P  SL  ++     + ++D  +  +    I +G+ YL  
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL-- 130
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE-----TQGNTSRIVGTYGYMA 496
               R IHRDL T N+L++ E   KI DFG+ ++   D+      +   S I     + A
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF----WYA 185
Query: 497 PEYAMHGQYSVKSDVFSFGVLVLEIIS 523
           PE     ++SV SDV+SFGV++ E+ +
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 330 NKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
            +LG+G FG+V   R YD      G  +AVK+L   + +   +F+ E+ ++ +LQH N+V
Sbjct: 19  QQLGKGNFGSVEMCR-YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 77
Query: 384 RLLGFSLEGNER--LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           +  G       R   LI E++P  SL  ++     R  +D  +  +    I +G+ YL  
Sbjct: 78  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAER--IDHIKLLQYTSQICKGMEYL-- 133
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI-VGTYGYMAPEYA 500
               R IHRDL T N+L++ E   KI DFG+ ++   D+              + APE  
Sbjct: 134 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 501 MHGQYSVKSDVFSFGVLVLEIIS 523
              ++SV SDV+SFGV++ E+ +
Sbjct: 193 TESKFSVASDVWSFGVVLYELFT 215

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 122/264 (46%), Gaps = 31/264 (11%)
Query: 330 NKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFS 389
            +LG G FG V  G+     ++A+K +   S   D EF  E  ++ NL H  LV+L G  
Sbjct: 14  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 390 LEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIH 449
            +     +I E++ N  L +++ +   R Q   ++  ++   +   + YL      + +H
Sbjct: 73  TKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESK---QFLH 127
Query: 450 RDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG--YMAPEYAMHGQYSV 507
           RDL   N L++ +   K++DFG++R    DE    TS +   +   +  PE  M+ ++S 
Sbjct: 128 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSKFSS 184
Query: 508 KSDVFSFGVLVLEIISGQR--NNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSI 565
           KSD+++FGVL+ EI S  +     F N ET E +             + +  P L+S  +
Sbjct: 185 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI----------AQGLRLYRPHLASEKV 234
Query: 566 -TEMIRCIHIGLLCVQENVASRPT 588
            T M  C H       E    RPT
Sbjct: 235 YTIMYSCWH-------EKADERPT 251

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/218 (33%), Positives = 114/218 (52%), Gaps = 23/218 (10%)
Query: 330 NKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
           ++LG+G FG+V   R YD      GA +AVK+L         +F+ E+ ++  L    +V
Sbjct: 29  SQLGKGNFGSVELCR-YDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 384 RLLGFSL-EGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           +  G S   G + L L+ E++P+  L  F+     RA+LD  R       I +G+ YL  
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL-- 143
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE-----TQGNTSRIVGTYGYMA 496
            SR R +HRDL   N+L+++E   KIADFG+A+L  +D+      +   S I     + A
Sbjct: 144 GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF----WYA 198
Query: 497 PEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGE 534
           PE      +S +SDV+SFGV++ E+ +    +C  + E
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE 236

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 127/278 (45%), Gaps = 31/278 (11%)
Query: 316 FNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVA 375
           + +  +   + +   +LG G FG V  G+     ++A+K +   S   D EF  E  ++ 
Sbjct: 7   YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMM 65
Query: 376 NLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARG 435
           NL H  LV+L G   +     +I E++ N  L +++ +   R Q   ++  ++   +   
Sbjct: 66  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEA 123
Query: 436 LLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG-- 493
           + YL      + +HRDL   N L++ +   K++DFG++R    DE    TS +   +   
Sbjct: 124 MEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVR 177
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQR--NNCFRNGETVEDLLSSAWKNWREGT 551
           +  PE  M+ ++S KSD+++FGVL+ EI S  +     F N ET E +            
Sbjct: 178 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI----------AQ 227
Query: 552 TVNIIDPTLSSGSI-TEMIRCIHIGLLCVQENVASRPT 588
            + +  P L+S  + T M  C H       E    RPT
Sbjct: 228 GLRLYRPHLASEKVYTIMYSCWH-------EKADERPT 258

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/218 (33%), Positives = 114/218 (52%), Gaps = 23/218 (10%)
Query: 330 NKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
           ++LG+G FG+V   R YD      GA +AVK+L         +F+ E+ ++  L    +V
Sbjct: 16  SQLGKGNFGSVELCR-YDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 74
Query: 384 RLLGFSL-EGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           +  G S   G + L L+ E++P+  L  F+     RA+LD  R       I +G+ YL  
Sbjct: 75  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL-- 130
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE-----TQGNTSRIVGTYGYMA 496
            SR R +HRDL   N+L+++E   KIADFG+A+L  +D+      +   S I     + A
Sbjct: 131 GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF----WYA 185
Query: 497 PEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGE 534
           PE      +S +SDV+SFGV++ E+ +    +C  + E
Sbjct: 186 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE 223

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/218 (33%), Positives = 114/218 (52%), Gaps = 23/218 (10%)
Query: 330 NKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
           ++LG+G FG+V   R YD      GA +AVK+L         +F+ E+ ++  L    +V
Sbjct: 17  SQLGKGNFGSVELCR-YDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 75
Query: 384 RLLGFSL-EGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           +  G S   G + L L+ E++P+  L  F+     RA+LD  R       I +G+ YL  
Sbjct: 76  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL-- 131
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE-----TQGNTSRIVGTYGYMA 496
            SR R +HRDL   N+L+++E   KIADFG+A+L  +D+      +   S I     + A
Sbjct: 132 GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF----WYA 186
Query: 497 PEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGE 534
           PE      +S +SDV+SFGV++ E+ +    +C  + E
Sbjct: 187 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE 224

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 130/298 (43%), Gaps = 38/298 (12%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQGDLEFKN---EVLLVANLQHRN 381
           FSD  ++G G FGAVY  R    +E+ A+K++S    Q + ++++   EV  +  L+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
            ++  G  L  +   L+ E+   ++ D        +  L       +  G  +GL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM 501
            +   +IHRD+K  N+LL      K+ DFG A +          +  VGT  +MAPE  +
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 184
Query: 502 ---HGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP 558
               GQY  K DV+S G+  +E+   +R     N   +  L   A              P
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHIAQNE----------SP 232
Query: 559 TLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTLPVPSEPAFFMDSI 616
            L SG  +E  R       C+Q+    RPT  S VL+ + + L       P   MD I
Sbjct: 233 ALQSGHWSEYFRNFVDS--CLQKIPQDRPT--SEVLLKHRFVLR---ERPPTVIMDLI 283

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 130/298 (43%), Gaps = 38/298 (12%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQGDLEFKN---EVLLVANLQHRN 381
           FSD  ++G G FGAVY  R    +E+ A+K++S    Q + ++++   EV  +  L+H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
            ++  G  L  +   L+ E+   ++ D        +  L       +  G  +GL YLH 
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 172
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM 501
            +   +IHRD+K  N+LL      K+ DFG A +          +  VGT  +MAPE  +
Sbjct: 173 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 223
Query: 502 ---HGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP 558
               GQY  K DV+S G+  +E+   +R     N   +  L   A              P
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHIAQNE----------SP 271
Query: 559 TLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTLPVPSEPAFFMDSI 616
            L SG  +E  R       C+Q+    RPT  S VL+ + + L       P   MD I
Sbjct: 272 ALQSGHWSEYFRNFVDS--CLQKIPQDRPT--SEVLLKHRFVLR---ERPPTVIMDLI 322

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 122/264 (46%), Gaps = 31/264 (11%)
Query: 330 NKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFS 389
            +LG G FG V  G+     ++A+K +   S   D EF  E  ++ NL H  LV+L G  
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 390 LEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIH 449
            +     +I E++ N  L +++ +   R Q   ++  ++   +   + YL      + +H
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESK---QFLH 123
Query: 450 RDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG--YMAPEYAMHGQYSV 507
           RDL   N L++ +   K++DFG++R    DE    TS +   +   +  PE  M+ ++S 
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 508 KSDVFSFGVLVLEIISGQR--NNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSI 565
           KSD+++FGVL+ EI S  +     F N ET E +             + +  P L+S  +
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI----------AQGLRLYRPHLASEKV 230
Query: 566 -TEMIRCIHIGLLCVQENVASRPT 588
            T M  C H       E    RPT
Sbjct: 231 YTIMYSCWH-------EKADERPT 247

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 10/206 (4%)
Query: 325 NFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLS---RDSGQGDLEFKNEVLLVANLQHR 380
           NF    K+G+G F  VY+   L DG  +A+K++        +   +   E+ L+  L H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERR-YKIIGGIARGLLYL 439
           N+++     +E NE  ++ E      L   I    ++ +L  ER  +K    +   L ++
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
           H  SR R++HRD+K +NV + A    K+ D G+ R F    T  ++  +VGT  YM+PE 
Sbjct: 153 H--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 207
Query: 500 AMHGQYSVKSDVFSFGVLVLEIISGQ 525
                Y+ KSD++S G L+ E+ + Q
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQ 233

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 121/263 (46%), Gaps = 29/263 (11%)
Query: 330 NKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFS 389
            +LG G FG V  G+     ++A+K +   S   D EF  E  ++ NL H  LV+L G  
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 390 LEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIH 449
            +     +I E++ N  L +++ +   R Q   ++  ++   +   + YL      + +H
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESK---QFLH 128
Query: 450 RDLKTSNVLLDAEMTPKIADFGMARLFEMDE-TQGNTSRIVGTYGYMAPEYAMHGQYSVK 508
           RDL   N L++ +   K++DFG++R    DE T    S+    +    PE  M+ ++S K
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWS--PPEVLMYSKFSSK 186
Query: 509 SDVFSFGVLVLEIISGQR--NNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSI- 565
           SD+++FGVL+ EI S  +     F N ET E +             + +  P L+S  + 
Sbjct: 187 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI----------AQGLRLYRPHLASEKVY 236
Query: 566 TEMIRCIHIGLLCVQENVASRPT 588
           T M  C H       E    RPT
Sbjct: 237 TIMYSCWH-------EKADERPT 252

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 122/264 (46%), Gaps = 31/264 (11%)
Query: 330 NKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFS 389
            +LG G FG V  G+     ++A+K +   S   D EF  E  ++ NL H  LV+L G  
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 390 LEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIH 449
            +     +I E++ N  L +++ +   R Q   ++  ++   +   + YL      + +H
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESK---QFLH 128
Query: 450 RDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG--YMAPEYAMHGQYSV 507
           RDL   N L++ +   K++DFG++R    DE    TS +   +   +  PE  M+ ++S 
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSKFSS 185
Query: 508 KSDVFSFGVLVLEIISGQR--NNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSI 565
           KSD+++FGVL+ EI S  +     F N ET E +             + +  P L+S  +
Sbjct: 186 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI----------AQGLRLYRPHLASEKV 235
Query: 566 -TEMIRCIHIGLLCVQENVASRPT 588
            T M  C H       E    RPT
Sbjct: 236 YTIMYSCWH-------EKADERPT 252

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 109/209 (52%), Gaps = 12/209 (5%)
Query: 325 NFSDANKLGQGGFGAVYKGRLY--DGAEIAVKRLSRDSGQGDLE---FKNEVLLVANLQH 379
           N S    +G G FG V  GRL      EI+V   +   G  + +   F  E  ++    H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            N++RL G   +    +++ E++ N SLD F+      AQ    +   ++ GIA G+ YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVG-TYGYMAPE 498
              S +  +HRDL   N+L+++ +  K++DFG+AR+ E D     T+R       + +PE
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 499 YAMHGQYSVKSDVFSFGVLVLEIIS-GQR 526
              + +++  SDV+S+G+++ E++S G+R
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 72/218 (33%), Positives = 113/218 (51%), Gaps = 23/218 (10%)
Query: 330 NKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
           ++LG+G FG+V   R YD      GA +AVK+L         +F+ E+ ++  L    +V
Sbjct: 13  SQLGKGNFGSVELCR-YDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 71
Query: 384 RLLGFSL-EGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           +  G S   G   L L+ E++P+  L  F+     RA+LD  R       I +G+ YL  
Sbjct: 72  KYRGVSYGPGRPELRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL-- 127
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG-----YMA 496
            SR R +HRDL   N+L+++E   KIADFG+A+L  +D+       +V   G     + A
Sbjct: 128 GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK----DXXVVREPGQSPIFWYA 182
Query: 497 PEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGE 534
           PE      +S +SDV+SFGV++ E+ +    +C  + E
Sbjct: 183 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE 220

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 109/209 (52%), Gaps = 12/209 (5%)
Query: 325 NFSDANKLGQGGFGAVYKGRLY--DGAEIAVKRLSRDSGQGDLE---FKNEVLLVANLQH 379
           N S    +G G FG V  GRL      EI+V   +   G  + +   F  E  ++    H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            N++RL G   +    +++ E++ N SLD F+      AQ    +   ++ GIA G+ YL
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL 134
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT-YGYMAPE 498
              S +  +HRDL   N+L+++ +  K++DFG++R+ E D     T+R       + +PE
Sbjct: 135 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 191
Query: 499 YAMHGQYSVKSDVFSFGVLVLEIIS-GQR 526
              + +++  SDV+S+G+++ E++S G+R
Sbjct: 192 AIAYRKFTSASDVWSYGIVLWEVMSYGER 220

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 113/205 (55%), Gaps = 23/205 (11%)
Query: 332 LGQGGFGAVYKGRLYD--GAEI--AVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLVRLL 386
           +G+G FG VY G L D  G +I  AVK L+R +  G++ +F  E +++ +  H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 387 GFSL--EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIG---GIARGLLYLHE 441
           G  L  EG+  L++  ++ +  L +FI + T    +       +IG    +A+G+ +L  
Sbjct: 98  GICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKFL-- 149
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF---EMDETQGNTSRIVGTYGYMAPE 498
            +  + +HRDL   N +LD + T K+ADFG+AR     E D     T   +    +MA E
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALE 207
Query: 499 YAMHGQYSVKSDVFSFGVLVLEIIS 523
                +++ KSDV+SFGVL+ E+++
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 113/205 (55%), Gaps = 23/205 (11%)
Query: 332 LGQGGFGAVYKGRLYD--GAEI--AVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLVRLL 386
           +G+G FG VY G L D  G +I  AVK L+R +  G++ +F  E +++ +  H N++ LL
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 387 GFSL--EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIG---GIARGLLYLHE 441
           G  L  EG+  L++  ++ +  L +FI + T    +       +IG    +A+G+ +L  
Sbjct: 157 GICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKFL-- 208
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF---EMDETQGNTSRIVGTYGYMAPE 498
            +  + +HRDL   N +LD + T K+ADFG+AR     E D     T   +    +MA E
Sbjct: 209 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALE 266
Query: 499 YAMHGQYSVKSDVFSFGVLVLEIIS 523
                +++ KSDV+SFGVL+ E+++
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMT 291

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 113/205 (55%), Gaps = 23/205 (11%)
Query: 332 LGQGGFGAVYKGRLYD--GAEI--AVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLVRLL 386
           +G+G FG VY G L D  G +I  AVK L+R +  G++ +F  E +++ +  H N++ LL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 387 GFSL--EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIG---GIARGLLYLHE 441
           G  L  EG+  L++  ++ +  L +FI + T    +       +IG    +A+G+ +L  
Sbjct: 96  GICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKFL-- 147
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF---EMDETQGNTSRIVGTYGYMAPE 498
            +  + +HRDL   N +LD + T K+ADFG+AR     E D     T   +    +MA E
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALE 205
Query: 499 YAMHGQYSVKSDVFSFGVLVLEIIS 523
                +++ KSDV+SFGVL+ E+++
Sbjct: 206 SLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 109/209 (52%), Gaps = 12/209 (5%)
Query: 325 NFSDANKLGQGGFGAVYKGRLY--DGAEIAVKRLSRDSGQGDLE---FKNEVLLVANLQH 379
           N S    +G G FG V  GRL      EI+V   +   G  + +   F  E  ++    H
Sbjct: 34  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 93
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            N++RL G   +    +++ E++ N SLD F+      AQ    +   ++ GIA G+ YL
Sbjct: 94  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL 151
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT-YGYMAPE 498
              S +  +HRDL   N+L+++ +  K++DFG++R+ E D     T+R       + +PE
Sbjct: 152 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 208
Query: 499 YAMHGQYSVKSDVFSFGVLVLEIIS-GQR 526
              + +++  SDV+S+G+++ E++S G+R
Sbjct: 209 AIAYRKFTSASDVWSYGIVLWEVMSYGER 237

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 113/205 (55%), Gaps = 23/205 (11%)
Query: 332 LGQGGFGAVYKGRLYD--GAEI--AVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLVRLL 386
           +G+G FG VY G L D  G +I  AVK L+R +  G++ +F  E +++ +  H N++ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 387 GFSL--EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIG---GIARGLLYLHE 441
           G  L  EG+  L++  ++ +  L +FI + T    +       +IG    +A+G+ +L  
Sbjct: 99  GICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKFL-- 150
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF---EMDETQGNTSRIVGTYGYMAPE 498
            +  + +HRDL   N +LD + T K+ADFG+AR     E D     T   +    +MA E
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALE 208
Query: 499 YAMHGQYSVKSDVFSFGVLVLEIIS 523
                +++ KSDV+SFGVL+ E+++
Sbjct: 209 SLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 107/229 (46%), Gaps = 18/229 (7%)
Query: 313 QFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEV- 371
           + D + +R     F     +G G +G VYKGR     ++A  ++   +G  + E K E+ 
Sbjct: 13  EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEIN 72
Query: 372 LLVANLQHRNLVRLLGFSLEGN------ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERR 425
           +L     HRN+    G  ++ N      +  L+ EF    S+   I + T+   L  E  
Sbjct: 73  MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWI 131
Query: 426 YKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNT 485
             I   I RGL +LH+    ++IHRD+K  NVLL      K+ DFG++   ++D T G  
Sbjct: 132 AYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRR 186
Query: 486 SRIVGTYGYMAPEYAM-----HGQYSVKSDVFSFGVLVLEIISGQRNNC 529
           +  +GT  +MAPE           Y  KSD++S G+  +E+  G    C
Sbjct: 187 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 235

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 113/205 (55%), Gaps = 23/205 (11%)
Query: 332 LGQGGFGAVYKGRLYD--GAEI--AVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLVRLL 386
           +G+G FG VY G L D  G +I  AVK L+R +  G++ +F  E +++ +  H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 387 GFSL--EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIG---GIARGLLYLHE 441
           G  L  EG+  L++  ++ +  L +FI + T    +       +IG    +A+G+ +L  
Sbjct: 98  GICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKFL-- 149
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF---EMDETQGNTSRIVGTYGYMAPE 498
            +  + +HRDL   N +LD + T K+ADFG+AR     E D     T   +    +MA E
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALE 207
Query: 499 YAMHGQYSVKSDVFSFGVLVLEIIS 523
                +++ KSDV+SFGVL+ E+++
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 109/209 (52%), Gaps = 12/209 (5%)
Query: 325 NFSDANKLGQGGFGAVYKGRLY--DGAEIAVKRLSRDSGQGDLE---FKNEVLLVANLQH 379
           N S    +G G FG V  GRL      EI+V   +   G  + +   F  E  ++    H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            N++RL G   +    +++ E++ N SLD F+      AQ    +   ++ GIA G+ YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT-YGYMAPE 498
              S +  +HRDL   N+L+++ +  K++DFG++R+ E D     T+R       + +PE
Sbjct: 164 ---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 499 YAMHGQYSVKSDVFSFGVLVLEIIS-GQR 526
              + +++  SDV+S+G+++ E++S G+R
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 113/205 (55%), Gaps = 23/205 (11%)
Query: 332 LGQGGFGAVYKGRLYD--GAEI--AVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLVRLL 386
           +G+G FG VY G L D  G +I  AVK L+R +  G++ +F  E +++ +  H N++ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 387 GFSL--EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIG---GIARGLLYLHE 441
           G  L  EG+  L++  ++ +  L +FI + T    +       +IG    +A+G+ +L  
Sbjct: 99  GICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKFL-- 150
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF---EMDETQGNTSRIVGTYGYMAPE 498
            +  + +HRDL   N +LD + T K+ADFG+AR     E D     T   +    +MA E
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPV-KWMALE 208
Query: 499 YAMHGQYSVKSDVFSFGVLVLEIIS 523
                +++ KSDV+SFGVL+ E+++
Sbjct: 209 SLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 113/205 (55%), Gaps = 23/205 (11%)
Query: 332 LGQGGFGAVYKGRLYD--GAEI--AVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLVRLL 386
           +G+G FG VY G L D  G +I  AVK L+R +  G++ +F  E +++ +  H N++ LL
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 387 GFSL--EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIG---GIARGLLYLHE 441
           G  L  EG+  L++  ++ +  L +FI + T    +       +IG    +A+G+ +L  
Sbjct: 103 GICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKFL-- 154
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF---EMDETQGNTSRIVGTYGYMAPE 498
            +  + +HRDL   N +LD + T K+ADFG+AR     E D     T   +    +MA E
Sbjct: 155 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALE 212
Query: 499 YAMHGQYSVKSDVFSFGVLVLEIIS 523
                +++ KSDV+SFGVL+ E+++
Sbjct: 213 SLQTQKFTTKSDVWSFGVLLWELMT 237

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 84/333 (25%), Positives = 153/333 (45%), Gaps = 51/333 (15%)
Query: 321 VATDNFSDANKLGQGGFGAVY----KGRLYDGAE--IAVKRLSRDSGQGD-LEFKNEVLL 373
           VA +  + + +LGQG FG VY    KG + D  E  +A+K ++  +   + +EF NE  +
Sbjct: 22  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI--FDPTRR-----AQLDWERRY 426
           +      ++VRLLG   +G   L+I E +    L  ++    P        A     +  
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 141
Query: 427 KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQGNT 485
           ++ G IA G+ YL+ +   + +HRDL   N ++  + T KI DFGM R ++E D  +   
Sbjct: 142 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 198
Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEI--ISGQRNNCFRNGETVEDLLSSA 543
             ++    +M+PE    G ++  SDV+SFGV++ EI  ++ Q      N + +  ++   
Sbjct: 199 KGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM--- 254
Query: 544 WKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTL 603
                EG  ++   P      + E++R      +C Q N   RP+   ++  +       
Sbjct: 255 -----EGGLLD--KPDNCPDMLFELMR------MCWQYNPKMRPSFLEIISSIKE----- 296
Query: 604 PVPSEPAFFMDSIIESDMSFSLAHDSRITETDQ 636
               EP F        ++SF  + ++++ E ++
Sbjct: 297 --EMEPGF-------REVSFYYSEENKLPEPEE 320

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 19/216 (8%)
Query: 321 VATDNFSDANKLGQGGFGAVY----KGRLYDGAE--IAVKRLSRDSGQGD-LEFKNEVLL 373
           VA +  + + +LGQG FG VY    KG + D  E  +A+K ++  +   + +EF NE  +
Sbjct: 15  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 74
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI--FDPTRR-----AQLDWERRY 426
           +      ++VRLLG   +G   L+I E +    L  ++    P        A     +  
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 427 KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQGNT 485
           ++ G IA G+ YL+ +   + +HRDL   N ++  + T KI DFGM R ++E D  +   
Sbjct: 135 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 191
Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEI 521
             ++    +M+PE    G ++  SDV+SFGV++ EI
Sbjct: 192 KGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/278 (27%), Positives = 136/278 (48%), Gaps = 35/278 (12%)
Query: 332 LGQGGFGAVYKGRLYDGAE----IAVKRLSRD-SGQGDLEFKNEVLLVANLQHRNLVRLL 386
           +G G  G V  GRL    +    +A+K L    + +   +F +E  ++    H N++RL 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 387 GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLR 446
           G    G   +++ E++ N SLD F+   T   Q    +   ++ G+  G+ YL   S L 
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLR--THDGQFTIMQLVGMLRGVGAGMRYL---SDLG 171
Query: 447 IIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG-----YMAPEYAM 501
            +HRDL   NVL+D+ +  K++DFG++R+ E D     T+    T G     + APE   
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTT----TGGKIPIRWTAPEAIA 227
Query: 502 HGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTL 560
              +S  SDV+SFGV++ E+++ G+R        T  D++SS  + +R      +  P  
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERPYW---NMTNRDVISSVEEGYR------LPAPMG 278
Query: 561 SSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS 598
              ++ +++      L C  ++ A RP  + +V +L++
Sbjct: 279 CPHALHQLM------LDCWHKDRAQRPRFSQIVSVLDA 310

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 112/204 (54%), Gaps = 21/204 (10%)
Query: 332 LGQGGFGAVYKGRLYD--GAEI--AVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLVRLL 386
           +G+G FG VY G L D  G +I  AVK L+R +  G++ +F  E +++ +  H N++ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 387 GFSL--EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIG---GIARGLLYLHE 441
           G  L  EG+  L++  ++ +  L +FI + T    +       +IG    +A+G+ YL  
Sbjct: 97  GICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKYL-- 148
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQG--NTSRIVGTYGYMAPEY 499
            +  + +HRDL   N +LD + T K+ADFG+AR     E     N +       +MA E 
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALES 207
Query: 500 AMHGQYSVKSDVFSFGVLVLEIIS 523
               +++ KSDV+SFGVL+ E+++
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 109/209 (52%), Gaps = 12/209 (5%)
Query: 325 NFSDANKLGQGGFGAVYKGRLY--DGAEIAVKRLSRDSGQGDLE---FKNEVLLVANLQH 379
           N S    +G G FG V  GRL      EI+V   +   G  + +   F  E  ++    H
Sbjct: 44  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 103
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            N++RL G   +    +++ E++ N SLD F+      AQ    +   ++ GIA G+ YL
Sbjct: 104 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIASGMKYL 161
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT-YGYMAPE 498
              S +  +HRDL   N+L+++ +  K++DFG++R+ E D     T+R       + +PE
Sbjct: 162 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 218
Query: 499 YAMHGQYSVKSDVFSFGVLVLEIIS-GQR 526
              + +++  SDV+S+G+++ E++S G+R
Sbjct: 219 AIAYRKFTSASDVWSYGIVLWEVMSYGER 247

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/333 (25%), Positives = 153/333 (45%), Gaps = 51/333 (15%)
Query: 321 VATDNFSDANKLGQGGFGAVY----KGRLYDGAE--IAVKRLSRDSGQGD-LEFKNEVLL 373
           VA +  + + +LGQG FG VY    KG + D  E  +A+K ++  +   + +EF NE  +
Sbjct: 22  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI--FDPTRR-----AQLDWERRY 426
           +      ++VRLLG   +G   L+I E +    L  ++    P        A     +  
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 427 KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQGNT 485
           ++ G IA G+ YL+ +   + +HRDL   N ++  + T KI DFGM R ++E D  +   
Sbjct: 142 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 198
Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEI--ISGQRNNCFRNGETVEDLLSSA 543
             ++    +M+PE    G ++  SDV+SFGV++ EI  ++ Q      N + +  ++   
Sbjct: 199 KGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM--- 254
Query: 544 WKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTL 603
                EG  ++   P      + E++R      +C Q N   RP+   ++  +       
Sbjct: 255 -----EGGLLD--KPDNCPDMLFELMR------MCWQYNPKMRPSFLEIISSIKE----- 296
Query: 604 PVPSEPAFFMDSIIESDMSFSLAHDSRITETDQ 636
               EP F        ++SF  + ++++ E ++
Sbjct: 297 --EMEPGF-------REVSFYYSEENKLPEPEE 320

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 107/207 (51%), Gaps = 23/207 (11%)
Query: 330 NKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
            +LG+G FG+V   R YD      G  +AVK+L   + +   +F+ E+ ++ +LQH N+V
Sbjct: 17  QQLGKGNFGSVEMCR-YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 75
Query: 384 RLLGFSLEGNER--LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           +  G       R   LI E++P  SL  ++     + ++D  +  +    I +G+ YL  
Sbjct: 76  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL-- 131
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE-----TQGNTSRIVGTYGYMA 496
               R IHR+L T N+L++ E   KI DFG+ ++   D+      +   S I     + A
Sbjct: 132 -GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF----WYA 186
Query: 497 PEYAMHGQYSVKSDVFSFGVLVLEIIS 523
           PE     ++SV SDV+SFGV++ E+ +
Sbjct: 187 PESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 19/216 (8%)
Query: 321 VATDNFSDANKLGQGGFGAVY----KGRLYDGAE--IAVKRLSRDSGQGD-LEFKNEVLL 373
           VA +  + + +LGQG FG VY    KG + D  E  +A+K ++  +   + +EF NE  +
Sbjct: 15  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 74
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI--FDPTRR-----AQLDWERRY 426
           +      ++VRLLG   +G   L+I E +    L  ++    P        A     +  
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 427 KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQGNT 485
           ++ G IA G+ YL+ +   + +HRDL   N ++  + T KI DFGM R ++E D  +   
Sbjct: 135 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 191
Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEI 521
             ++    +M+PE    G ++  SDV+SFGV++ EI
Sbjct: 192 KGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 109/209 (52%), Gaps = 12/209 (5%)
Query: 325 NFSDANKLGQGGFGAVYKGRLY--DGAEIAVKRLSRDSGQGDLE---FKNEVLLVANLQH 379
           N S    +G G FG V  GRL      EI+V   +   G  + +   F  E  ++    H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            N++RL G   +    +++ E++ N SLD F+      AQ    +   ++ GIA G+ YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT-YGYMAPE 498
              S +  +HRDL   N+L+++ +  K++DFG++R+ E D     T+R       + +PE
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 499 YAMHGQYSVKSDVFSFGVLVLEIIS-GQR 526
              + +++  SDV+S+G+++ E++S G+R
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 109/209 (52%), Gaps = 12/209 (5%)
Query: 325 NFSDANKLGQGGFGAVYKGRLY--DGAEIAVKRLSRDSGQGDLE---FKNEVLLVANLQH 379
           N S    +G G FG V  GRL      EI+V   +   G  + +   F  E  ++    H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            N++RL G   +    +++ E++ N SLD F+      AQ    +   ++ GIA G+ YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT-YGYMAPE 498
              S +  +HRDL   N+L+++ +  K++DFG++R+ E D     T+R       + +PE
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 499 YAMHGQYSVKSDVFSFGVLVLEIIS-GQR 526
              + +++  SDV+S+G+++ E++S G+R
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 109/209 (52%), Gaps = 12/209 (5%)
Query: 325 NFSDANKLGQGGFGAVYKGRLY--DGAEIAVKRLSRDSGQGDLE---FKNEVLLVANLQH 379
           N S    +G G FG V  GRL      EI+V   +   G  + +   F  E  ++    H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            N++RL G   +    +++ E++ N SLD F+      AQ    +   ++ GIA G+ YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT-YGYMAPE 498
              S +  +HRDL   N+L+++ +  K++DFG++R+ E D     T+R       + +PE
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 499 YAMHGQYSVKSDVFSFGVLVLEIIS-GQR 526
              + +++  SDV+S+G+++ E++S G+R
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 19/216 (8%)
Query: 321 VATDNFSDANKLGQGGFGAVY----KGRLYDGAE--IAVKRLSRDSGQGD-LEFKNEVLL 373
           VA +  + + +LGQG FG VY    KG + D  E  +A+K ++  +   + +EF NE  +
Sbjct: 9   VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 68
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI--FDPTRR-----AQLDWERRY 426
           +      ++VRLLG   +G   L+I E +    L  ++    P        A     +  
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 128
Query: 427 KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQGNT 485
           ++ G IA G+ YL+ +   + +HRDL   N ++  + T KI DFGM R ++E D  +   
Sbjct: 129 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 185
Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEI 521
             ++    +M+PE    G ++  SDV+SFGV++ EI
Sbjct: 186 KGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 19/216 (8%)
Query: 321 VATDNFSDANKLGQGGFGAVY----KGRLYDGAE--IAVKRLSRDSGQGD-LEFKNEVLL 373
           VA +  + + +LGQG FG VY    KG + D  E  +A+K ++  +   + +EF NE  +
Sbjct: 13  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 72
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI--FDPTRR-----AQLDWERRY 426
           +      ++VRLLG   +G   L+I E +    L  ++    P        A     +  
Sbjct: 73  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 132
Query: 427 KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQGNT 485
           ++ G IA G+ YL+ +   + +HRDL   N ++  + T KI DFGM R ++E D  +   
Sbjct: 133 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 189
Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEI 521
             ++    +M+PE    G ++  SDV+SFGV++ EI
Sbjct: 190 KGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEI 224

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 109/209 (52%), Gaps = 12/209 (5%)
Query: 325 NFSDANKLGQGGFGAVYKGRLY--DGAEIAVKRLSRDSGQGDLE---FKNEVLLVANLQH 379
           N S    +G G FG V  GRL      EI+V   +   G  + +   F  E  ++    H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            N++RL G   +    +++ E++ N SLD F+      AQ    +   ++ GIA G+ YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT-YGYMAPE 498
              S +  +HRDL   N+L+++ +  K++DFG++R+ E D     T+R       + +PE
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 499 YAMHGQYSVKSDVFSFGVLVLEIIS-GQR 526
              + +++  SDV+S+G+++ E++S G+R
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 19/216 (8%)
Query: 321 VATDNFSDANKLGQGGFGAVY----KGRLYDGAE--IAVKRLSRDSGQGD-LEFKNEVLL 373
           VA +  + + +LGQG FG VY    KG + D  E  +A+K ++  +   + +EF NE  +
Sbjct: 16  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 75
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI--FDPTRR-----AQLDWERRY 426
           +      ++VRLLG   +G   L+I E +    L  ++    P        A     +  
Sbjct: 76  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 135
Query: 427 KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQGNT 485
           ++ G IA G+ YL+ +   + +HRDL   N ++  + T KI DFGM R ++E D  +   
Sbjct: 136 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 192
Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEI 521
             ++    +M+PE    G ++  SDV+SFGV++ EI
Sbjct: 193 KGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 19/216 (8%)
Query: 321 VATDNFSDANKLGQGGFGAVY----KGRLYDGAE--IAVKRLSRDSGQGD-LEFKNEVLL 373
           VA +  + + +LGQG FG VY    KG + D  E  +A+K ++  +   + +EF NE  +
Sbjct: 12  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 71
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI--FDPTRR-----AQLDWERRY 426
           +      ++VRLLG   +G   L+I E +    L  ++    P        A     +  
Sbjct: 72  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 131
Query: 427 KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQGNT 485
           ++ G IA G+ YL+ +   + +HRDL   N ++  + T KI DFGM R ++E D  +   
Sbjct: 132 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 188
Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEI 521
             ++    +M+PE    G ++  SDV+SFGV++ EI
Sbjct: 189 KGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEI 223

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 119/236 (50%), Gaps = 15/236 (6%)
Query: 292 DNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGR-LYDGAE 350
           +N   +S     ++   A  +  D    R+  D++    K+G+G  G V   R  + G +
Sbjct: 16  ENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYV---KIGEGSTGIVCLAREKHSGRQ 72
Query: 351 IAVKRLS-RDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDH 409
           +AVK +  R   + +L F NEV+++ + QH N+V +    L G E  ++ EF+   +L  
Sbjct: 73  VAVKMMDLRKQQRRELLF-NEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT- 130
Query: 410 FIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIAD 469
              D   + +L+ E+   +   + + L YLH      +IHRD+K+ ++LL  +   K++D
Sbjct: 131 ---DIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSD 184
Query: 470 FGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           FG       D  +     +VGT  +MAPE      Y+ + D++S G++V+E++ G+
Sbjct: 185 FGFCAQISKDVPKRKX--LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 108/209 (51%), Gaps = 12/209 (5%)
Query: 325 NFSDANKLGQGGFGAVYKGRLY--DGAEIAVKRLSRDSGQGDLE---FKNEVLLVANLQH 379
           N S    +G G FG V  GRL      EI+V   +   G  + +   F  E  ++    H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            N++RL G   +    +++ E++ N SLD F+      AQ    +   ++ GIA G+ YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVG-TYGYMAPE 498
              S +  +HRDL   N+L+++ +  K++DFG+ R+ E D     T+R       + +PE
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 499 YAMHGQYSVKSDVFSFGVLVLEIIS-GQR 526
              + +++  SDV+S+G+++ E++S G+R
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 111/229 (48%), Gaps = 33/229 (14%)
Query: 324 DNFSDANKLGQGGFGAVYKGRL-----YDGAEIAVKRLSRDSGQGDLE--FKNEVLLVAN 376
           +N      +G+G FG V++ R      Y+   +   ++ ++    D++  F+ E  L+A 
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 377 LQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI-------------FDPTRRAQ---- 419
             + N+V+LLG    G    L++E++    L+ F+              D + RA+    
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 420 ----LDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR- 474
               L    +  I   +A G+ YL E    + +HRDL T N L+   M  KIADFG++R 
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 475 LFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
           ++  D  + + +  +    +M PE   + +Y+ +SDV+++GV++ EI S
Sbjct: 224 IYSADYYKADGNDAIPI-RWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 137/290 (47%), Gaps = 37/290 (12%)
Query: 321 VATDNFSDANKLGQGGFGAVY----KGRLYDGAE--IAVKRLSRDSGQGD-LEFKNEVLL 373
           VA +  + + +LGQG FG VY    KG + D  E  +A+K ++  +   + +EF NE  +
Sbjct: 44  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 103
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI--FDPTRR-----AQLDWERRY 426
           +      ++VRLLG   +G   L+I E +    L  ++    P        A     +  
Sbjct: 104 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 163
Query: 427 KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQGNT 485
           ++ G IA G+ YL+ +   + +HRDL   N ++  + T KI DFGM R ++E D  +   
Sbjct: 164 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 220
Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEI--ISGQRNNCFRNGETVEDLLSSA 543
             ++    +M+PE    G ++  SDV+SFGV++ EI  ++ Q      N + +  ++   
Sbjct: 221 KGLLPV-RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM--- 276
Query: 544 WKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVV 593
                EG  ++   P      + E++R      +C Q N   RP+   ++
Sbjct: 277 -----EGGLLD--KPDNCPDMLFELMR------MCWQYNPKMRPSFLEII 313

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/278 (27%), Positives = 136/278 (48%), Gaps = 35/278 (12%)
Query: 332 LGQGGFGAVYKGRLYDGAE----IAVKRLSRD-SGQGDLEFKNEVLLVANLQHRNLVRLL 386
           +G G  G V  GRL    +    +A+K L    + +   +F +E  ++    H N++RL 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 387 GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLR 446
           G    G   +++ E++ N SLD F+   T   Q    +   ++ G+  G+ YL   S L 
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLR--THDGQFTIMQLVGMLRGVGAGMRYL---SDLG 171
Query: 447 IIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG-----YMAPEYAM 501
            +HRDL   NVL+D+ +  K++DFG++R+ E D     T+    T G     + APE   
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT----TGGKIPIRWTAPEAIA 227
Query: 502 HGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTL 560
              +S  SDV+SFGV++ E+++ G+R        T  D++SS  + +R      +  P  
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERPYW---NMTNRDVISSVEEGYR------LPAPMG 278
Query: 561 SSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS 598
              ++ +++      L C  ++ A RP  + +V +L++
Sbjct: 279 CPHALHQLM------LDCWHKDRAQRPRFSQIVSVLDA 310

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 135/294 (45%), Gaps = 37/294 (12%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQGD-LEFKNEVLL 373
           V+ +  +   +LGQG FG VY+G   D         +AVK ++  +   + +EF NE  +
Sbjct: 14  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI--FDPTR-----RAQLDWERRY 426
           +      ++VRLLG   +G   L++ E + +  L  ++    P       R     +   
Sbjct: 74  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 133
Query: 427 KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQGNT 485
           ++   IA G+ YL+     + +HRDL   N ++  + T KI DFGM R ++E D  +   
Sbjct: 134 QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG 190
Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEI--ISGQRNNCFRNGETVEDLLSSA 543
             ++    +MAPE    G ++  SD++SFGV++ EI  ++ Q      N + ++ ++   
Sbjct: 191 KGLLPVR-WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 249
Query: 544 WKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN 597
           + +           P      +T+++R      +C Q N   RPT   +V +L 
Sbjct: 250 YLD----------QPDNCPERVTDLMR------MCWQFNPKMRPTFLEIVNLLK 287

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 113/204 (55%), Gaps = 21/204 (10%)
Query: 332 LGQGGFGAVYKGRLYD--GAEI--AVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLVRLL 386
           +G+G FG VY G L D  G +I  AVK L+R +  G++ +F  E +++ +  H N++ LL
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 387 GFSL--EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIG---GIARGLLYLHE 441
           G  L  EG+  L++  ++ +  L +FI + T    +       +IG    +A+G+ YL  
Sbjct: 117 GICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKYL-- 168
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE--TQGNTSRIVGTYGYMAPEY 499
            +  + +HRDL   N +LD + T K+ADFG+AR     E  +  N +       +MA E 
Sbjct: 169 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 227
Query: 500 AMHGQYSVKSDVFSFGVLVLEIIS 523
               +++ KSDV+SFGVL+ E+++
Sbjct: 228 LQTQKFTTKSDVWSFGVLLWELMT 251

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 109/216 (50%), Gaps = 19/216 (8%)
Query: 321 VATDNFSDANKLGQGGFGAVY----KGRLYDGAE--IAVKRLSRDSGQGD-LEFKNEVLL 373
           VA +  + + +LGQG FG VY    KG + D  E  +A+K ++  +   + +EF NE  +
Sbjct: 7   VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 66
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI--FDPTRR-----AQLDWERRY 426
           +      ++VRLLG   +G   L+I E +    L  ++    P        A     +  
Sbjct: 67  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 126
Query: 427 KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQGNT 485
           ++ G IA G+ YL+ +   + +HRDL   N ++  + T KI DFGM R + E D  +   
Sbjct: 127 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGG 183
Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEI 521
             ++    +M+PE    G ++  SDV+SFGV++ EI
Sbjct: 184 KGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEI 218

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 113/204 (55%), Gaps = 21/204 (10%)
Query: 332 LGQGGFGAVYKGRLYD--GAEI--AVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLVRLL 386
           +G+G FG VY G L D  G +I  AVK L+R +  G++ +F  E +++ +  H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 387 GFSL--EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIG---GIARGLLYLHE 441
           G  L  EG+  L++  ++ +  L +FI + T    +       +IG    +A+G+ YL  
Sbjct: 98  GICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKYL-- 149
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE--TQGNTSRIVGTYGYMAPEY 499
            +  + +HRDL   N +LD + T K+ADFG+AR     E  +  N +       +MA E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 500 AMHGQYSVKSDVFSFGVLVLEIIS 523
               +++ KSDV+SFGVL+ E+++
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 135/294 (45%), Gaps = 37/294 (12%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSG-QGDLEFKNEVLL 373
           V+ +  +   +LGQG FG VY+G   D         +AVK ++  +  +  +EF NE  +
Sbjct: 13  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 72
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI--FDPTR-----RAQLDWERRY 426
           +      ++VRLLG   +G   L++ E + +  L  ++    P       R     +   
Sbjct: 73  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 132
Query: 427 KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQGNT 485
           ++   IA G+ YL+     + +HRDL   N ++  + T KI DFGM R ++E D  +   
Sbjct: 133 QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG 189
Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEI--ISGQRNNCFRNGETVEDLLSSA 543
             ++    +MAPE    G ++  SD++SFGV++ EI  ++ Q      N + ++ ++   
Sbjct: 190 KGLLPVR-WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 248
Query: 544 WKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN 597
           +          +  P      +T+++R      +C Q N   RPT   +V +L 
Sbjct: 249 Y----------LDQPDNCPERVTDLMR------MCWQFNPKMRPTFLEIVNLLK 286

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 113/204 (55%), Gaps = 21/204 (10%)
Query: 332 LGQGGFGAVYKGRLYD--GAEI--AVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLVRLL 386
           +G+G FG VY G L D  G +I  AVK L+R +  G++ +F  E +++ +  H N++ LL
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 387 GFSL--EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIG---GIARGLLYLHE 441
           G  L  EG+  L++  ++ +  L +FI + T    +       +IG    +A+G+ YL  
Sbjct: 116 GICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKYL-- 167
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE--TQGNTSRIVGTYGYMAPEY 499
            +  + +HRDL   N +LD + T K+ADFG+AR     E  +  N +       +MA E 
Sbjct: 168 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 226
Query: 500 AMHGQYSVKSDVFSFGVLVLEIIS 523
               +++ KSDV+SFGVL+ E+++
Sbjct: 227 LQTQKFTTKSDVWSFGVLLWELMT 250

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 113/204 (55%), Gaps = 21/204 (10%)
Query: 332 LGQGGFGAVYKGRLYD--GAEI--AVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLVRLL 386
           +G+G FG VY G L D  G +I  AVK L+R +  G++ +F  E +++ +  H N++ LL
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 387 GFSL--EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIG---GIARGLLYLHE 441
           G  L  EG+  L++  ++ +  L +FI + T    +       +IG    +A+G+ YL  
Sbjct: 90  GICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKYL-- 141
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE--TQGNTSRIVGTYGYMAPEY 499
            +  + +HRDL   N +LD + T K+ADFG+AR     E  +  N +       +MA E 
Sbjct: 142 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 200
Query: 500 AMHGQYSVKSDVFSFGVLVLEIIS 523
               +++ KSDV+SFGVL+ E+++
Sbjct: 201 LQTQKFTTKSDVWSFGVLLWELMT 224

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 109/216 (50%), Gaps = 19/216 (8%)
Query: 321 VATDNFSDANKLGQGGFGAVY----KGRLYDGAE--IAVKRLSRDSGQGD-LEFKNEVLL 373
           VA +  + + +LGQG FG VY    KG + D  E  +A+K ++  +   + +EF NE  +
Sbjct: 16  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 75
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI--FDPTRR-----AQLDWERRY 426
           +      ++VRLLG   +G   L+I E +    L  ++    P        A     +  
Sbjct: 76  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 135
Query: 427 KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQGNT 485
           ++ G IA G+ YL+ +   + +HRDL   N ++  + T KI DFGM R + E D  +   
Sbjct: 136 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGG 192
Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEI 521
             ++    +M+PE    G ++  SDV+SFGV++ EI
Sbjct: 193 KGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 113/204 (55%), Gaps = 21/204 (10%)
Query: 332 LGQGGFGAVYKGRLYD--GAEI--AVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLVRLL 386
           +G+G FG VY G L D  G +I  AVK L+R +  G++ +F  E +++ +  H N++ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 387 GFSL--EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIG---GIARGLLYLHE 441
           G  L  EG+  L++  ++ +  L +FI + T    +       +IG    +A+G+ YL  
Sbjct: 97  GICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKYL-- 148
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE--TQGNTSRIVGTYGYMAPEY 499
            +  + +HRDL   N +LD + T K+ADFG+AR     E  +  N +       +MA E 
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 207
Query: 500 AMHGQYSVKSDVFSFGVLVLEIIS 523
               +++ KSDV+SFGVL+ E+++
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 113/204 (55%), Gaps = 21/204 (10%)
Query: 332 LGQGGFGAVYKGRLYD--GAEI--AVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLVRLL 386
           +G+G FG VY G L D  G +I  AVK L+R +  G++ +F  E +++ +  H N++ LL
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 387 GFSL--EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIG---GIARGLLYLHE 441
           G  L  EG+  L++  ++ +  L +FI + T    +       +IG    +A+G+ YL  
Sbjct: 95  GICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKYL-- 146
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE--TQGNTSRIVGTYGYMAPEY 499
            +  + +HRDL   N +LD + T K+ADFG+AR     E  +  N +       +MA E 
Sbjct: 147 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 205
Query: 500 AMHGQYSVKSDVFSFGVLVLEIIS 523
               +++ KSDV+SFGVL+ E+++
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMT 229

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 108/209 (51%), Gaps = 12/209 (5%)
Query: 325 NFSDANKLGQGGFGAVYKGRLY--DGAEIAVKRLSRDSGQGDLE---FKNEVLLVANLQH 379
           N S    +G G FG V  GRL      EI+V   +   G  + +   F  E  ++    H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            N++RL G   +    +++ E + N SLD F+      AQ    +   ++ GIA G+ YL
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL 134
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT-YGYMAPE 498
              S +  +HRDL   N+L+++ +  K++DFG++R+ E D     T+R       + +PE
Sbjct: 135 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 191
Query: 499 YAMHGQYSVKSDVFSFGVLVLEIIS-GQR 526
              + +++  SDV+S+G+++ E++S G+R
Sbjct: 192 AIAYRKFTSASDVWSYGIVLWEVMSYGER 220

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 113/204 (55%), Gaps = 21/204 (10%)
Query: 332 LGQGGFGAVYKGRLYD--GAEI--AVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLVRLL 386
           +G+G FG VY G L D  G +I  AVK L+R +  G++ +F  E +++ +  H N++ LL
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 387 GFSL--EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIG---GIARGLLYLHE 441
           G  L  EG+  L++  ++ +  L +FI + T    +       +IG    +A+G+ YL  
Sbjct: 93  GICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKYL-- 144
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE--TQGNTSRIVGTYGYMAPEY 499
            +  + +HRDL   N +LD + T K+ADFG+AR     E  +  N +       +MA E 
Sbjct: 145 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 203
Query: 500 AMHGQYSVKSDVFSFGVLVLEIIS 523
               +++ KSDV+SFGVL+ E+++
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMT 227

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 113/204 (55%), Gaps = 21/204 (10%)
Query: 332 LGQGGFGAVYKGRLYD--GAEI--AVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLVRLL 386
           +G+G FG VY G L D  G +I  AVK L+R +  G++ +F  E +++ +  H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 387 GFSL--EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIG---GIARGLLYLHE 441
           G  L  EG+  L++  ++ +  L +FI + T    +       +IG    +A+G+ YL  
Sbjct: 98  GICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKYL-- 149
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE--TQGNTSRIVGTYGYMAPEY 499
            +  + +HRDL   N +LD + T K+ADFG+AR     E  +  N +       +MA E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 500 AMHGQYSVKSDVFSFGVLVLEIIS 523
               +++ KSDV+SFGVL+ E+++
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 107/200 (53%), Gaps = 9/200 (4%)
Query: 329 ANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGF 388
           + ++G G FG VYKG+ +    + + ++   + +    F+NEV ++   +H N++  +G+
Sbjct: 41  STRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100
Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRII 448
             + N   ++ ++   +SL   +     + Q+   +   I    A+G+ YLH  +   II
Sbjct: 101 MTKDN-LAIVTQWCEGSSLYKHLHVQETKFQMF--QLIDIARQTAQGMDYLHAKN---II 154
Query: 449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM---HGQY 505
           HRD+K++N+ L   +T KI DFG+A +           +  G+  +MAPE      +  +
Sbjct: 155 HRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPF 214
Query: 506 SVKSDVFSFGVLVLEIISGQ 525
           S +SDV+S+G+++ E+++G+
Sbjct: 215 SFQSDVYSYGIVLYELMTGE 234

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 113/204 (55%), Gaps = 21/204 (10%)
Query: 332 LGQGGFGAVYKGRLYD--GAEI--AVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLVRLL 386
           +G+G FG VY G L D  G +I  AVK L+R +  G++ +F  E +++ +  H N++ LL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 387 GFSL--EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIG---GIARGLLYLHE 441
           G  L  EG+  L++  ++ +  L +FI + T    +       +IG    +A+G+ YL  
Sbjct: 96  GICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKYL-- 147
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE--TQGNTSRIVGTYGYMAPEY 499
            +  + +HRDL   N +LD + T K+ADFG+AR     E  +  N +       +MA E 
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 206
Query: 500 AMHGQYSVKSDVFSFGVLVLEIIS 523
               +++ KSDV+SFGVL+ E+++
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 103/202 (50%), Gaps = 10/202 (4%)
Query: 325 NFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
            ++   K+GQG  G VY    +  G E+A+++++           NE+L++   ++ N+V
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 384 RLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS 443
             L   L G+E  ++ E++   SL   + +      +D  +   +     + L +LH + 
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSN- 135
Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG 503
             ++IHRD+K+ N+LL  + + K+ DFG     ++   Q   S +VGT  +MAPE     
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSEMVGTPYWMAPEVVTRK 191
Query: 504 QYSVKSDVFSFGVLVLEIISGQ 525
            Y  K D++S G++ +E+I G+
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 103/202 (50%), Gaps = 10/202 (4%)
Query: 325 NFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
            ++   K+GQG  G VY    +  G E+A+++++           NE+L++   ++ N+V
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 384 RLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS 443
             L   L G+E  ++ E++   SL   + +      +D  +   +     + L +LH + 
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSN- 135
Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG 503
             ++IHRD+K+ N+LL  + + K+ DFG     ++   Q   S +VGT  +MAPE     
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSXMVGTPYWMAPEVVTRK 191
Query: 504 QYSVKSDVFSFGVLVLEIISGQ 525
            Y  K D++S G++ +E+I G+
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 136/290 (46%), Gaps = 37/290 (12%)
Query: 321 VATDNFSDANKLGQGGFGAVY----KGRLYDGAE--IAVKRLSRDSGQGD-LEFKNEVLL 373
           VA +  + + +LGQG FG VY    KG + D  E  +A+K ++  +   + +EF NE  +
Sbjct: 9   VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 68
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI--FDPTRR-----AQLDWERRY 426
           +      ++VRLLG   +G   L+I E +    L  ++    P        A     +  
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 128
Query: 427 KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQGNT 485
           ++ G IA G+ YL+ +   + +HRDL   N  +  + T KI DFGM R ++E D  +   
Sbjct: 129 QMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGG 185
Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEI--ISGQRNNCFRNGETVEDLLSSA 543
             ++    +M+PE    G ++  SDV+SFGV++ EI  ++ Q      N + +  ++   
Sbjct: 186 KGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM--- 241
Query: 544 WKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVV 593
                EG  ++   P      + E++R      +C Q N   RP+   ++
Sbjct: 242 -----EGGLLD--KPDNCPDMLLELMR------MCWQYNPKMRPSFLEII 278

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 103/202 (50%), Gaps = 10/202 (4%)
Query: 325 NFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
            ++   K+GQG  G VY    +  G E+A+++++           NE+L++   ++ N+V
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 384 RLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS 443
             L   L G+E  ++ E++   SL   + +      +D  +   +     + L +LH + 
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSN- 135
Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG 503
             ++IHRD+K+ N+LL  + + K+ DFG     ++   Q   S +VGT  +MAPE     
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRK 191
Query: 504 QYSVKSDVFSFGVLVLEIISGQ 525
            Y  K D++S G++ +E+I G+
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGE 213

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 134/294 (45%), Gaps = 37/294 (12%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQGD-LEFKNEVLL 373
           V+ +  +   +LGQG FG VY+G   D         +AVK ++  +   + +EF NE  +
Sbjct: 14  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI--FDPTR-----RAQLDWERRY 426
           +      ++VRLLG   +G   L++ E + +  L  ++    P       R     +   
Sbjct: 74  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 133
Query: 427 KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQGNT 485
           ++   IA G+ YL+     + +HRDL   N ++  + T KI DFGM R + E D  +   
Sbjct: 134 QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGG 190
Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEI--ISGQRNNCFRNGETVEDLLSSA 543
             ++    +MAPE    G ++  SD++SFGV++ EI  ++ Q      N + ++ ++   
Sbjct: 191 KGLLPVR-WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 249
Query: 544 WKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN 597
           + +           P      +T+++R      +C Q N   RPT   +V +L 
Sbjct: 250 YLD----------QPDNCPERVTDLMR------MCWQFNPKMRPTFLEIVNLLK 287

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 103/202 (50%), Gaps = 10/202 (4%)
Query: 325 NFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
            ++   K+GQG  G VY    +  G E+A+++++           NE+L++   ++ N+V
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 81
Query: 384 RLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS 443
             L   L G+E  ++ E++   SL   + +      +D  +   +     + L +LH + 
Sbjct: 82  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSN- 136
Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG 503
             ++IHRD+K+ N+LL  + + K+ DFG     ++   Q   S +VGT  +MAPE     
Sbjct: 137 --QVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSXMVGTPYWMAPEVVTRK 192
Query: 504 QYSVKSDVFSFGVLVLEIISGQ 525
            Y  K D++S G++ +E+I G+
Sbjct: 193 AYGPKVDIWSLGIMAIEMIEGE 214

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 134/294 (45%), Gaps = 37/294 (12%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQGD-LEFKNEVLL 373
           V+ +  +   +LGQG FG VY+G   D         +AVK ++  +   + +EF NE  +
Sbjct: 11  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 70
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI--FDPTR-----RAQLDWERRY 426
           +      ++VRLLG   +G   L++ E + +  L  ++    P       R     +   
Sbjct: 71  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 130
Query: 427 KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQGNT 485
           ++   IA G+ YL+     + +HRDL   N ++  + T KI DFGM R + E D  +   
Sbjct: 131 QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGG 187
Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEI--ISGQRNNCFRNGETVEDLLSSA 543
             ++    +MAPE    G ++  SD++SFGV++ EI  ++ Q      N + ++ ++   
Sbjct: 188 KGLLPVR-WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 246
Query: 544 WKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN 597
           + +           P      +T+++R      +C Q N   RPT   +V +L 
Sbjct: 247 YLD----------QPDNCPERVTDLMR------MCWQFNPKMRPTFLEIVNLLK 284

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 111/217 (51%), Gaps = 15/217 (6%)
Query: 314 FDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLE-FKNEVL 372
           ++ +   +  ++     KLG G FG V+        ++AVK +    G   +E F  E  
Sbjct: 5   WEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMK--PGSMSVEAFLAEAN 62
Query: 373 LVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI-FDPTRRAQLDWERRYKIIGG 431
           ++  LQH  LV+L    +      +I EF+   SL  F+  D   +  L   +       
Sbjct: 63  VMKTLQHDKLVKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQ 119
Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT 491
           IA G+ ++ + +    IHRDL+ +N+L+ A +  KIADFG+AR+ E +E    T+R    
Sbjct: 120 IAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAK 173
Query: 492 Y--GYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQR 526
           +   + APE    G +++KSDV+SFG+L++EI++  R
Sbjct: 174 FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 210

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 130/277 (46%), Gaps = 33/277 (11%)
Query: 332 LGQGGFGAVYKGRLY--DGAEIAVKRLSRDSGQGDLE---FKNEVLLVANLQHRNLVRLL 386
           +G G FG V  GRL      EI V   +  +G  D +   F +E  ++    H N++ L 
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 96
Query: 387 GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIG---GIARGLLYLHEDS 443
           G   +    ++I E++ N SLD F+     R  +      +++G   GI  G+ YL   S
Sbjct: 97  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV-----IQLVGMLRGIGSGMKYL---S 148
Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVG-TYGYMAPEYAMH 502
            +  +HRDL   N+L+++ +  K++DFGM+R+ E D     T+R       + APE   +
Sbjct: 149 DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 208
Query: 503 GQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLS 561
            +++  SDV+S+G+++ E++S G+R     + + V   +   ++          + P + 
Sbjct: 209 RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYR----------LPPPMD 258
Query: 562 SGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS 598
                  I    + L C Q+  + RP    +V ML+ 
Sbjct: 259 CP-----IALHQLMLDCWQKERSDRPKFGQIVNMLDK 290

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 108/209 (51%), Gaps = 12/209 (5%)
Query: 325 NFSDANKLGQGGFGAVYKGRLY--DGAEIAVKRLSRDSGQGDLE---FKNEVLLVANLQH 379
           N S    +G G FG V  GRL      EI+V   +   G  + +   F  E  ++    H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            N++RL G   +    +++ E + N SLD F+      AQ    +   ++ GIA G+ YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR--KHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT-YGYMAPE 498
              S +  +HRDL   N+L+++ +  K++DFG++R+ E D     T+R       + +PE
Sbjct: 164 ---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 499 YAMHGQYSVKSDVFSFGVLVLEIIS-GQR 526
              + +++  SDV+S+G+++ E++S G+R
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 134/294 (45%), Gaps = 37/294 (12%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQGD-LEFKNEVLL 373
           V+ +  +   +LGQG FG VY+G   D         +AVK ++  +   + +EF NE  +
Sbjct: 14  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI--FDPTR-----RAQLDWERRY 426
           +      ++VRLLG   +G   L++ E + +  L  ++    P       R     +   
Sbjct: 74  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 133
Query: 427 KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQGNT 485
           ++   IA G+ YL+     + +HRDL   N ++  + T KI DFGM R + E D  +   
Sbjct: 134 QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGG 190
Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEI--ISGQRNNCFRNGETVEDLLSSA 543
             ++    +MAPE    G ++  SD++SFGV++ EI  ++ Q      N + ++ ++   
Sbjct: 191 KGLLPVR-WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 249
Query: 544 WKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN 597
           + +           P      +T+++R      +C Q N   RPT   +V +L 
Sbjct: 250 YLD----------QPDNCPERVTDLMR------MCWQFNPNMRPTFLEIVNLLK 287

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 108/209 (51%), Gaps = 12/209 (5%)
Query: 325 NFSDANKLGQGGFGAVYKGRLY--DGAEIAVKRLSRDSGQGDLE---FKNEVLLVANLQH 379
           N S    +G G FG V  GRL      EI+V   +   G  + +   F  E  ++    H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            N++RL G   +    +++ E + N SLD F+      AQ    +   ++ GIA G+ YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR--KHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT-YGYMAPE 498
              S +  +HRDL   N+L+++ +  K++DFG++R+ E D     T+R       + +PE
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 499 YAMHGQYSVKSDVFSFGVLVLEIIS-GQR 526
              + +++  SDV+S+G+++ E++S G+R
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 130/277 (46%), Gaps = 33/277 (11%)
Query: 332 LGQGGFGAVYKGRLY--DGAEIAVKRLSRDSGQGDLE---FKNEVLLVANLQHRNLVRLL 386
           +G G FG V  GRL      EI V   +  +G  D +   F +E  ++    H N++ L 
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 387 GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIG---GIARGLLYLHEDS 443
           G   +    ++I E++ N SLD F+     R  +      +++G   GI  G+ YL   S
Sbjct: 76  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV-----IQLVGMLRGIGSGMKYL---S 127
Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT-YGYMAPEYAMH 502
            +  +HRDL   N+L+++ +  K++DFGM+R+ E D     T+R       + APE   +
Sbjct: 128 DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 187
Query: 503 GQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLS 561
            +++  SDV+S+G+++ E++S G+R     + + V   +   ++          + P + 
Sbjct: 188 RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYR----------LPPPMD 237
Query: 562 SGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS 598
                  I    + L C Q+  + RP    +V ML+ 
Sbjct: 238 CP-----IALHQLMLDCWQKERSDRPKFGQIVNMLDK 269

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 130/277 (46%), Gaps = 33/277 (11%)
Query: 332 LGQGGFGAVYKGRLY--DGAEIAVKRLSRDSGQGDLE---FKNEVLLVANLQHRNLVRLL 386
           +G G FG V  GRL      EI V   +  +G  D +   F +E  ++    H N++ L 
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 387 GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIG---GIARGLLYLHEDS 443
           G   +    ++I E++ N SLD F+     R  +      +++G   GI  G+ YL   S
Sbjct: 82  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV-----IQLVGMLRGIGSGMKYL---S 133
Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT-YGYMAPEYAMH 502
            +  +HRDL   N+L+++ +  K++DFGM+R+ E D     T+R       + APE   +
Sbjct: 134 DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 193
Query: 503 GQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLS 561
            +++  SDV+S+G+++ E++S G+R     + + V   +   ++          + P + 
Sbjct: 194 RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYR----------LPPPMD 243
Query: 562 SGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS 598
                  I    + L C Q+  + RP    +V ML+ 
Sbjct: 244 CP-----IALHQLMLDCWQKERSDRPKFGQIVNMLDK 275

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 329 ANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLE--FKNEVLLVANLQHRNLVRL 385
             ++G+G FG V+ GRL  D   +AVK   R++   DL+  F  E  ++    H N+VRL
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKS-CRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 386 LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRL 445
           +G   +     ++ E V     D   F  T  A+L  +   +++G  A G+ YL      
Sbjct: 178 IGVCTQKQPIYIVMELVQGG--DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC-- 233
Query: 446 RIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVG----TYGYMAPEYAM 501
             IHRDL   N L+  +   KI+DFGM+R    +E  G  +   G       + APE   
Sbjct: 234 -CIHRDLAARNCLVTEKNVLKISDFGMSR----EEADGVXAASGGLRQVPVKWTAPEALN 288
Query: 502 HGQYSVKSDVFSFGVLVLEIIS 523
           +G+YS +SDV+SFG+L+ E  S
Sbjct: 289 YGRYSSESDVWSFGILLWETFS 310

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 87/308 (28%), Positives = 140/308 (45%), Gaps = 57/308 (18%)
Query: 314 FDFNTIRVATDNFSDANKLGQGGFGAVYKGRLY-DGAEI--AVKRLSRDSGQGDL-EFKN 369
            D+N I+     F D   +G+G FG V K R+  DG  +  A+KR+   + + D  +F  
Sbjct: 12  LDWNDIK-----FQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG 64
Query: 370 EVLLVANL-QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI-------FDP------T 415
           E+ ++  L  H N++ LLG         L  E+ P+ +L  F+        DP      +
Sbjct: 65  ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 124
Query: 416 RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL 475
             + L  ++       +ARG+ YL   S+ + IHRDL   N+L+      KIADFG++R 
Sbjct: 125 TASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR- 180
Query: 476 FEMDETQGNTSRIVGTYG-----YMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNC 529
                  G    +  T G     +MA E   +  Y+  SDV+S+GVL+ EI+S G    C
Sbjct: 181 -------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 233
Query: 530 FRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTM 589
              G T  +L     + +R    +N  D       + +++R       C +E    RP+ 
Sbjct: 234 ---GMTCAELYEKLPQGYRLEKPLNCDD------EVYDLMR------QCWREKPYERPSF 278
Query: 590 ASVVLMLN 597
           A +++ LN
Sbjct: 279 AQILVSLN 286

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 87/308 (28%), Positives = 140/308 (45%), Gaps = 57/308 (18%)
Query: 314 FDFNTIRVATDNFSDANKLGQGGFGAVYKGRLY-DGAEI--AVKRLSRDSGQGDL-EFKN 369
            D+N I+     F D   +G+G FG V K R+  DG  +  A+KR+   + + D  +F  
Sbjct: 22  LDWNDIK-----FQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG 74
Query: 370 EVLLVANL-QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI-------FDP------T 415
           E+ ++  L  H N++ LLG         L  E+ P+ +L  F+        DP      +
Sbjct: 75  ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 134
Query: 416 RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL 475
             + L  ++       +ARG+ YL   S+ + IHRDL   N+L+      KIADFG++R 
Sbjct: 135 TASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR- 190
Query: 476 FEMDETQGNTSRIVGTYG-----YMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNC 529
                  G    +  T G     +MA E   +  Y+  SDV+S+GVL+ EI+S G    C
Sbjct: 191 -------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 243
Query: 530 FRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTM 589
              G T  +L     + +R    +N  D       + +++R       C +E    RP+ 
Sbjct: 244 ---GMTCAELYEKLPQGYRLEKPLNCDD------EVYDLMR------QCWREKPYERPSF 288
Query: 590 ASVVLMLN 597
           A +++ LN
Sbjct: 289 AQILVSLN 296

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 101/198 (51%), Gaps = 12/198 (6%)
Query: 332 LGQGGFGAVYKGRLYDGAE-----IAVKRLSRD-SGQGDLEFKNEVLLVANLQHRNLVRL 385
           LG G FG VYKG      E     +A+K L  + S + + E  +E  ++A +    + RL
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 386 LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRL 445
           LG  L    +L+         LDH       R +L  +        IA+G+ YL +   +
Sbjct: 85  LGICLTSTVQLVTQLMPYGCLLDHV---RENRGRLGSQDLLNWCMQIAKGMSYLED---V 138
Query: 446 RIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQY 505
           R++HRDL   NVL+ +    KI DFG+ARL ++DET+ +         +MA E  +  ++
Sbjct: 139 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRF 198
Query: 506 SVKSDVFSFGVLVLEIIS 523
           + +SDV+S+GV V E+++
Sbjct: 199 THQSDVWSYGVTVWELMT 216

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 137/275 (49%), Gaps = 29/275 (10%)
Query: 332 LGQGGFGAVYKGRLYDGAE----IAVKRLSRD-SGQGDLEFKNEVLLVANLQHRNLVRLL 386
           +G G FG V +GRL    +    +A+K L    + +   EF +E  ++   +H N++RL 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 387 GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLR 446
           G        +++ EF+ N +LD F+       Q    +   ++ GIA G+ YL E   + 
Sbjct: 84  GVVTNSMPVMILTEFMENGALDSFLR--LNDGQFTVIQLVGMLRGIASGMRYLAE---MS 138
Query: 447 IIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVG---TYGYMAPEYAMHG 503
            +HRDL   N+L+++ +  K++DFG++R  E + +    +  +G      + APE     
Sbjct: 139 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFR 198
Query: 504 QYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSS 562
           +++  SD +S+G+++ E++S G+R     +    +D++++  +++R      +  P    
Sbjct: 199 KFTSASDAWSYGIVMWEVMSFGERPYWDMSN---QDVINAIEQDYR------LPPPPDCP 249
Query: 563 GSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN 597
            S+ +++      L C Q++  +RP    VV  L+
Sbjct: 250 TSLHQLM------LDCWQKDRNARPRFPQVVSALD 278

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 113/220 (51%), Gaps = 21/220 (9%)
Query: 314 FDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLE-FKNEVL 372
           ++ +   +  ++     KLG G FG V+        ++AVK +    G   +E F  E  
Sbjct: 178 WEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMK--PGSMSVEAFLAEAN 235
Query: 373 LVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI-FDPTRRAQLDWERRYKII-- 429
           ++  LQH  LV+L    +      +I EF+   SL  F+  D   +  L      K+I  
Sbjct: 236 VMKTLQHDKLVKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP-----KLIDF 289
Query: 430 -GGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
              IA G+ ++ + +    IHRDL+ +N+L+ A +  KIADFG+AR+ E +E    T+R 
Sbjct: 290 SAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---TARE 343
Query: 489 VGTY--GYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQR 526
              +   + APE    G +++KSDV+SFG+L++EI++  R
Sbjct: 344 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 383

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 333 GQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEG 392
            +G FG V+K +L +   +AVK       Q   + + EV  +  ++H N+++ +G    G
Sbjct: 33  ARGRFGCVWKAQLLN-EYVAVKIFPIQDKQS-WQNEYEVYSLPGMKHENILQFIGAEKRG 90
Query: 393 N----ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED------ 442
                +  LI  F    SL  F+    +   + W     I   +ARGL YLHED      
Sbjct: 91  TSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIAETMARGLAYLHEDIPGLKD 146
Query: 443 -SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM 501
             +  I HRD+K+ NVLL   +T  IADFG+A  FE  ++ G+T   VGT  YMAPE  +
Sbjct: 147 GHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPE-VL 205
Query: 502 HGQYSVKSDVF------SFGVLVLEIIS 523
            G  + + D F      + G+++ E+ S
Sbjct: 206 EGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 329 ANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLE--FKNEVLLVANLQHRNLVRL 385
             ++G+G FG V+ GRL  D   +AVK   R++   DL+  F  E  ++    H N+VRL
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKS-CRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 386 LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRL 445
           +G   +     ++ E V     D   F  T  A+L  +   +++G  A G+ YL      
Sbjct: 178 IGVCTQKQPIYIVMELVQGG--DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC-- 233
Query: 446 RIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVG----TYGYMAPEYAM 501
             IHRDL   N L+  +   KI+DFGM+R    +E  G  +   G       + APE   
Sbjct: 234 -CIHRDLAARNCLVTEKNVLKISDFGMSR----EEADGVYAASGGLRQVPVKWTAPEALN 288
Query: 502 HGQYSVKSDVFSFGVLVLEIIS 523
           +G+YS +SDV+SFG+L+ E  S
Sbjct: 289 YGRYSSESDVWSFGILLWETFS 310

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 133/275 (48%), Gaps = 29/275 (10%)
Query: 332 LGQGGFGAVYKG--RLYDGAEIAVKRLSRDSGQGDLE---FKNEVLLVANLQHRNLVRLL 386
           +G G FG V  G  +L    EI V   +  SG  + +   F +E  ++    H N++ L 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 387 GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLR 446
           G   +    ++I EF+ N SLD F+       Q    +   ++ GIA G+ YL +   + 
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLAD---MN 155
Query: 447 IIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVG---TYGYMAPEYAMHG 503
            +HRDL   N+L+++ +  K++DFG++R  E D +    +  +G      + APE   + 
Sbjct: 156 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 215
Query: 504 QYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSS 562
           +++  SDV+S+G+++ E++S G+R        T +D++++  +++R       + P +  
Sbjct: 216 KFTSASDVWSYGIVMWEVMSYGERPYW---DMTNQDVINAIEQDYR-------LPPPMDC 265
Query: 563 GSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN 597
            S    +      L C Q++   RP    +V  L+
Sbjct: 266 PSALHQLM-----LDCWQKDRNHRPKFGQIVNTLD 295

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 76/243 (31%), Positives = 117/243 (48%), Gaps = 41/243 (16%)
Query: 298 SEAAAGDEINRAESLQFDFNTIRVATDN-FSDANKLGQGGFGAVYKGRLYDGAE-----I 351
           S  A+G+  N+A         +R+  +  F     LG G FG VYKG      E     +
Sbjct: 2   SHMASGEAPNQA--------LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV 53
Query: 352 AVKRLSR-DSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF 410
           A+K L    S + + E  +E  ++A++ + ++ RLLG  L    +L I + +P   L   
Sbjct: 54  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCL--- 109
Query: 411 IFDPTRRAQLDWERRYKI-IGG---------IARGLLYLHEDSRLRIIHRDLKTSNVLLD 460
                    LD+ R +K  IG          IA+G+ YL ED RL  +HRDL   NVL+ 
Sbjct: 110 ---------LDYVREHKDNIGSQYLLNWCVQIAKGMNYL-EDRRL--VHRDLAARNVLVK 157
Query: 461 AEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLE 520
                KI DFG+A+L   +E + +         +MA E  +H  Y+ +SDV+S+GV V E
Sbjct: 158 TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWE 217
Query: 521 IIS 523
           +++
Sbjct: 218 LMT 220

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 106/216 (49%), Gaps = 13/216 (6%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKG---RLYDGAEIAVKRLSRDSGQGDLEFKNEVLL 373
           N I    + F+   ++G+G FG V+KG   R      I +  L     + +   + E+ +
Sbjct: 16  NNIADPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDI-QQEITV 74
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA 433
           ++      + +  G  L+G++  +I E++   S      D  R    D  +   ++  I 
Sbjct: 75  LSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEIL 130
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
           +GL YLH + +   IHRD+K +NVLL  +   K+ADFG+A   ++ +TQ   +  VGT  
Sbjct: 131 KGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGTPF 185
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNC 529
           +MAPE      Y  K+D++S G+  +E+  G+  N 
Sbjct: 186 WMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNS 221

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 112/224 (50%), Gaps = 13/224 (5%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK--NEVLLVANL 377
           V  +NF    K+G+G +G VYK R    G  +A+K++  D+    +      E+ L+  L
Sbjct: 4   VDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
            H N+V+LL      N+  L++EF+ +  L  F+ D +    +        +  + +GL 
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 121
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           + H     R++HRDLK  N+L++ E   K+ADFG+AR F +   +  T  +V T  Y AP
Sbjct: 122 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAP 176
Query: 498 EYAMHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
           E  +  + YS   D++S G +  E+++  R   F     ++ L 
Sbjct: 177 EILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 218

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 105/215 (48%), Gaps = 32/215 (14%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-----IAVKRLSR-DSGQGDLEFKNEVLLVANLQ 378
            F     LG G FG VYKG      E     +A+K L    S + + E  +E  ++A++ 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI-IGG------ 431
           + ++ RLLG  L    +L I + +P   L            LD+ R +K  IG       
Sbjct: 80  NPHVCRLLGICLTSTVQL-IMQLMPFGCL------------LDYVREHKDNIGSQYLLNW 126
Query: 432 ---IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
              IA+G+ YL ED RL  +HRDL   NVL+      KI DFG+A+L   +E + +    
Sbjct: 127 CVQIAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 183
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
                +MA E  +H  Y+ +SDV+S+GV V E+++
Sbjct: 184 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 105/215 (48%), Gaps = 32/215 (14%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-----IAVKRLSR-DSGQGDLEFKNEVLLVANLQ 378
            F     LG G FG VYKG      E     +A+K L    S + + E  +E  ++A++ 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI-IGG------ 431
           + ++ RLLG  L    +L I + +P   L            LD+ R +K  IG       
Sbjct: 77  NPHVCRLLGICLTSTVQL-IMQLMPFGCL------------LDYVREHKDNIGSQYLLNW 123
Query: 432 ---IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
              IA+G+ YL ED RL  +HRDL   NVL+      KI DFG+A+L   +E + +    
Sbjct: 124 CVQIAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 180
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
                +MA E  +H  Y+ +SDV+S+GV V E+++
Sbjct: 181 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 124/265 (46%), Gaps = 23/265 (8%)
Query: 330 NKLGQGGFGAVYKGRLYDGA-EIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGF 388
           +KLG G FG VY+G     +  +AVK L  D+ + + EF  E  ++  ++H NLV+LLG 
Sbjct: 17  HKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 75
Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRII 448
                   +I EF+   +L  ++ +  R+        Y +   I+  + YL + +    I
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-MATQISSAMEYLEKKN---FI 131
Query: 449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVK 508
           HRDL   N L+      K+ADFG++RL   D    +         + APE   + ++S+K
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYNKFSIK 190
Query: 509 SDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITE 567
           SDV++FGVL+ EI + G       +   V +LL   ++  R         P      + E
Sbjct: 191 SDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMER---------PEGCPEKVYE 241
Query: 568 MIRCIHIGLLCVQENVASRPTMASV 592
           ++R       C Q N + RP+ A +
Sbjct: 242 LMRA------CWQWNPSDRPSFAEI 260

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 112/223 (50%), Gaps = 13/223 (5%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK--NEVLLVANLQ 378
           + +NF    K+G+G +G VYK R    G  +A+K++  D+    +      E+ L+  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           H N+V+LL      N+  L++EF+ +  L  F+ D +    +        +  + +GL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
            H     R++HRDLK  N+L++ E   K+ADFG+AR F +   +  T  +V T  Y APE
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPE 174
Query: 499 YAMHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
             +  + YS   D++S G +  E+++  R   F     ++ L 
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 215

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 105/215 (48%), Gaps = 32/215 (14%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-----IAVKRLSR-DSGQGDLEFKNEVLLVANLQ 378
            F     LG G FG VYKG      E     +A+K L    S + + E  +E  ++A++ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI-IGG------ 431
           + ++ RLLG  L    +L I + +P   L            LD+ R +K  IG       
Sbjct: 78  NPHVCRLLGICLTSTVQL-IMQLMPFGCL------------LDYVREHKDNIGSQYLLNW 124
Query: 432 ---IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
              IA+G+ YL ED RL  +HRDL   NVL+      KI DFG+A+L   +E + +    
Sbjct: 125 CVQIAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 181
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
                +MA E  +H  Y+ +SDV+S+GV V E+++
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 135/294 (45%), Gaps = 37/294 (12%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSG-QGDLEFKNEVLL 373
           V+ +  +   +LGQG FG VY+G   D         +AVK ++  +  +  +EF NE  +
Sbjct: 14  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI--FDPTR-----RAQLDWERRY 426
           +      ++VRLLG   +G   L++ E + +  L  ++    P       R     +   
Sbjct: 74  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 133
Query: 427 KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQGNT 485
           ++   IA G+ YL+     + +HR+L   N ++  + T KI DFGM R ++E D  +   
Sbjct: 134 QMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG 190
Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEI--ISGQRNNCFRNGETVEDLLSSA 543
             ++    +MAPE    G ++  SD++SFGV++ EI  ++ Q      N + ++ ++   
Sbjct: 191 KGLLPVR-WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 249
Query: 544 WKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN 597
           + +           P      +T+++R      +C Q N   RPT   +V +L 
Sbjct: 250 YLD----------QPDNCPERVTDLMR------MCWQFNPNMRPTFLEIVNLLK 287

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 105/215 (48%), Gaps = 32/215 (14%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-----IAVKRLSR-DSGQGDLEFKNEVLLVANLQ 378
            F     LG G FG VYKG      E     +A+K L    S + + E  +E  ++A++ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI-IGG------ 431
           + ++ RLLG  L    +L I + +P   L            LD+ R +K  IG       
Sbjct: 79  NPHVCRLLGICLTSTVQL-IMQLMPFGCL------------LDYVREHKDNIGSQYLLNW 125
Query: 432 ---IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
              IA+G+ YL ED RL  +HRDL   NVL+      KI DFG+A+L   +E + +    
Sbjct: 126 CVQIAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
                +MA E  +H  Y+ +SDV+S+GV V E+++
Sbjct: 183 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 105/215 (48%), Gaps = 32/215 (14%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-----IAVKRLSR-DSGQGDLEFKNEVLLVANLQ 378
            F     LG G FG VYKG      E     +A+K L    S + + E  +E  ++A++ 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI-IGG------ 431
           + ++ RLLG  L    +L I + +P   L            LD+ R +K  IG       
Sbjct: 77  NPHVCRLLGICLTSTVQL-IMQLMPFGXL------------LDYVREHKDNIGSQYLLNW 123
Query: 432 ---IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
              IA+G+ YL ED RL  +HRDL   NVL+      KI DFG+A+L   +E + +    
Sbjct: 124 CVQIAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 180
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
                +MA E  +H  Y+ +SDV+S+GV V E+++
Sbjct: 181 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 107/204 (52%), Gaps = 14/204 (6%)
Query: 332 LGQGGFGAVYKGRLYDGAE----IAVKRLSRD-SGQGDLEFKNEVLLVANLQHRNLVRLL 386
           +G G FG V +GRL    +    +A+K L    + +   EF +E  ++   +H N++RL 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 387 GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLR 446
           G        +++ EF+ N +LD F+       Q    +   ++ GIA G+ YL E   + 
Sbjct: 82  GVVTNSMPVMILTEFMENGALDSFLR--LNDGQFTVIQLVGMLRGIASGMRYLAE---MS 136
Query: 447 IIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVG---TYGYMAPEYAMHG 503
            +HRDL   N+L+++ +  K++DFG++R  E + +    +  +G      + APE     
Sbjct: 137 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFR 196
Query: 504 QYSVKSDVFSFGVLVLEIIS-GQR 526
           +++  SD +S+G+++ E++S G+R
Sbjct: 197 KFTSASDAWSYGIVMWEVMSFGER 220

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 105/215 (48%), Gaps = 32/215 (14%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-----IAVKRLSR-DSGQGDLEFKNEVLLVANLQ 378
            F     LG G FG VYKG      E     +A+K L    S + + E  +E  ++A++ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI-IGG------ 431
           + ++ RLLG  L    +L I + +P   L            LD+ R +K  IG       
Sbjct: 76  NPHVCRLLGICLTSTVQL-IMQLMPFGCL------------LDYVREHKDNIGSQYLLNW 122
Query: 432 ---IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
              IA+G+ YL ED RL  +HRDL   NVL+      KI DFG+A+L   +E + +    
Sbjct: 123 CVQIAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
                +MA E  +H  Y+ +SDV+S+GV V E+++
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 135/294 (45%), Gaps = 37/294 (12%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSG-QGDLEFKNEVLL 373
           V+ +  +   +LGQG FG VY+G   D         +AVK ++  +  +  +EF NE  +
Sbjct: 15  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 74
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI--FDPTR-----RAQLDWERRY 426
           +      ++VRLLG   +G   L++ E + +  L  ++    P       R     +   
Sbjct: 75  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 134
Query: 427 KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQGNT 485
           ++   IA G+ YL+     + +HR+L   N ++  + T KI DFGM R ++E D  +   
Sbjct: 135 QMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG 191
Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEI--ISGQRNNCFRNGETVEDLLSSA 543
             ++    +MAPE    G ++  SD++SFGV++ EI  ++ Q      N + ++ ++   
Sbjct: 192 KGLLPVR-WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 250
Query: 544 WKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN 597
           + +           P      +T+++R      +C Q N   RPT   +V +L 
Sbjct: 251 YLD----------QPDNCPERVTDLMR------MCWQFNPNMRPTFLEIVNLLK 288

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 131/280 (46%), Gaps = 23/280 (8%)
Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGA-EIAVKRLSRDSGQGDLEFKNEVLL 373
           +++   +   + +  +KLG G +G VY+G     +  +AVK L  D+ + + EF  E  +
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 67
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA 433
           +  ++H NLV+LLG         +I EF+   +L  ++ +   R +++      +   I+
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQIS 126
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             + YL + +    IHRDL   N L+      K+ADFG++RL   D    +         
Sbjct: 127 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-K 182
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTT 552
           + APE   + ++S+KSDV++FGVL+ EI + G       +   V +LL   ++  R    
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER---- 238
Query: 553 VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASV 592
                P      + E++R       C Q N + RP+ A +
Sbjct: 239 -----PEGCPEKVYELMRA------CWQWNPSDRPSFAEI 267

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 111/221 (50%), Gaps = 13/221 (5%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK--NEVLLVANLQHR 380
           +NF    K+G+G +G VYK R    G  +A+K++  D+    +      E+ L+  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH 440
           N+V+LL      N+  L++EF+ +  L  F+ D +    +        +  + +GL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 441 EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA 500
                R++HRDLK  N+L++ E   K+ADFG+AR F +   +  T  +V T  Y APE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 175
Query: 501 MHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
           +  + YS   D++S G +  E+++  R   F     ++ L 
Sbjct: 176 LGXKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 214

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 111/221 (50%), Gaps = 13/221 (5%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK--NEVLLVANLQHR 380
           +NF    K+G+G +G VYK R    G  +A+K++  D+    +      E+ L+  L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH 440
           N+V+LL      N+  L++EF+ +  L  F+ D +    +        +  + +GL + H
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 441 EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA 500
                R++HRDLK  N+L++ E   K+ADFG+AR F +   +  T  +V T  Y APE  
Sbjct: 128 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 182
Query: 501 MHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
           +  + YS   D++S G +  E+++  R   F     ++ L 
Sbjct: 183 LGXKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 221

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 111/221 (50%), Gaps = 13/221 (5%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK--NEVLLVANLQHR 380
           +NF    K+G+G +G VYK R    G  +A+K++  D+    +      E+ L+  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH 440
           N+V+LL      N+  L++EF+ +  L  F+ D +    +        +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 441 EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA 500
                R++HRDLK  N+L++ E   K+ADFG+AR F +   +  T  +V T  Y APE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 174
Query: 501 MHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
           +  + YS   D++S G +  E+++  R   F     ++ L 
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 213

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 131/280 (46%), Gaps = 23/280 (8%)
Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGA-EIAVKRLSRDSGQGDLEFKNEVLL 373
           +++   +   + +  +KLG G +G VY+G     +  +AVK L  D+ + + EF  E  +
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 63
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA 433
           +  ++H NLV+LLG         +I EF+   +L  ++ +   R +++      +   I+
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQIS 122
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             + YL + +    IHRDL   N L+      K+ADFG++RL   D    +         
Sbjct: 123 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-K 178
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTT 552
           + APE   + ++S+KSDV++FGVL+ EI + G       +   V +LL   ++  R    
Sbjct: 179 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER---- 234
Query: 553 VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASV 592
                P      + E++R       C Q N + RP+ A +
Sbjct: 235 -----PEGCPEKVYELMRA------CWQWNPSDRPSFAEI 263

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 105/215 (48%), Gaps = 32/215 (14%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-----IAVKRLSR-DSGQGDLEFKNEVLLVANLQ 378
            F     LG G FG VYKG      E     +A+K L    S + + E  +E  ++A++ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI-IGG------ 431
           + ++ RLLG  L    +L I + +P   L            LD+ R +K  IG       
Sbjct: 76  NPHVCRLLGICLTSTVQL-ITQLMPFGCL------------LDYVREHKDNIGSQYLLNW 122
Query: 432 ---IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
              IA+G+ YL ED RL  +HRDL   NVL+      KI DFG+A+L   +E + +    
Sbjct: 123 CVQIAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
                +MA E  +H  Y+ +SDV+S+GV V E+++
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 111/221 (50%), Gaps = 13/221 (5%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK--NEVLLVANLQHR 380
           +NF    K+G+G +G VYK R    G  +A+K++  D+    +      E+ L+  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH 440
           N+V+LL      N+  L++EF+ +  L  F+ D +    +        +  + +GL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 441 EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA 500
                R++HRDLK  N+L++ E   K+ADFG+AR F +   +  T  +V T  Y APE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 175
Query: 501 MHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
           +  + YS   D++S G +  E+++  R   F     ++ L 
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 214

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 105/215 (48%), Gaps = 32/215 (14%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-----IAVKRLSR-DSGQGDLEFKNEVLLVANLQ 378
            F     LG G FG VYKG      E     +A+K L    S + + E  +E  ++A++ 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI-IGG------ 431
           + ++ RLLG  L    +L I + +P   L            LD+ R +K  IG       
Sbjct: 70  NPHVCRLLGICLTSTVQL-ITQLMPFGCL------------LDYVREHKDNIGSQYLLNW 116
Query: 432 ---IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
              IA+G+ YL ED RL  +HRDL   NVL+      KI DFG+A+L   +E + +    
Sbjct: 117 CVQIAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 173
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
                +MA E  +H  Y+ +SDV+S+GV V E+++
Sbjct: 174 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 111/221 (50%), Gaps = 13/221 (5%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK--NEVLLVANLQHR 380
           +NF    K+G+G +G VYK R    G  +A+K++  D+    +      E+ L+  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH 440
           N+V+LL      N+  L++EF+ +  L  F+ D +    +        +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 441 EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA 500
                R++HRDLK  N+L++ E   K+ADFG+AR F +   +  T  +V T  Y APE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 174
Query: 501 MHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
           +  + YS   D++S G +  E+++  R   F     ++ L 
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 213

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 105/215 (48%), Gaps = 32/215 (14%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-----IAVKRLSR-DSGQGDLEFKNEVLLVANLQ 378
            F     LG G FG VYKG      E     +A+K L    S + + E  +E  ++A++ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI-IGG------ 431
           + ++ RLLG  L    +L I + +P   L            LD+ R +K  IG       
Sbjct: 79  NPHVCRLLGICLTSTVQL-ITQLMPFGCL------------LDYVREHKDNIGSQYLLNW 125
Query: 432 ---IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
              IA+G+ YL ED RL  +HRDL   NVL+      KI DFG+A+L   +E + +    
Sbjct: 126 CVQIAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
                +MA E  +H  Y+ +SDV+S+GV V E+++
Sbjct: 183 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 105/215 (48%), Gaps = 32/215 (14%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-----IAVKRLSR-DSGQGDLEFKNEVLLVANLQ 378
            F     LG G FG VYKG      E     +A+K L    S + + E  +E  ++A++ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI-IGG------ 431
           + ++ RLLG  L    +L I + +P   L            LD+ R +K  IG       
Sbjct: 78  NPHVCRLLGICLTSTVQL-ITQLMPFGCL------------LDYVREHKDNIGSQYLLNW 124
Query: 432 ---IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
              IA+G+ YL ED RL  +HRDL   NVL+      KI DFG+A+L   +E + +    
Sbjct: 125 CVQIAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 181
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
                +MA E  +H  Y+ +SDV+S+GV V E+++
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 105/215 (48%), Gaps = 32/215 (14%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-----IAVKRLSR-DSGQGDLEFKNEVLLVANLQ 378
            F     LG G FG VYKG      E     +A+K L    S + + E  +E  ++A++ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI-IGG------ 431
           + ++ RLLG  L    +L I + +P   L            LD+ R +K  IG       
Sbjct: 79  NPHVCRLLGICLTSTVQL-ITQLMPFGCL------------LDYVREHKDNIGSQYLLNW 125
Query: 432 ---IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
              IA+G+ YL ED RL  +HRDL   NVL+      KI DFG+A+L   +E + +    
Sbjct: 126 CVQIAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
                +MA E  +H  Y+ +SDV+S+GV V E+++
Sbjct: 183 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 131/280 (46%), Gaps = 23/280 (8%)
Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGA-EIAVKRLSRDSGQGDLEFKNEVLL 373
           +++   +   + +  +KLG G +G VY+G     +  +AVK L  D+ + + EF  E  +
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 67
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA 433
           +  ++H NLV+LLG         +I EF+   +L  ++ +   R +++      +   I+
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQIS 126
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             + YL + +    IHRDL   N L+      K+ADFG++RL   D    +         
Sbjct: 127 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-K 182
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTT 552
           + APE   + ++S+KSDV++FGVL+ EI + G       +   V +LL   ++  R    
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER---- 238
Query: 553 VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASV 592
                P      + E++R       C Q N + RP+ A +
Sbjct: 239 -----PEGCPEKVYELMRA------CWQWNPSDRPSFAEI 267

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 111/221 (50%), Gaps = 13/221 (5%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK--NEVLLVANLQHR 380
           +NF    K+G+G +G VYK R    G  +A+K++  D+    +      E+ L+  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH 440
           N+V+LL      N+  L++EF+ +  L  F+ D +    +        +  + +GL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 441 EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA 500
                R++HRDLK  N+L++ E   K+ADFG+AR F +   +  T  +V T  Y APE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 175
Query: 501 MHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
           +  + YS   D++S G +  E+++  R   F     ++ L 
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 214

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 105/215 (48%), Gaps = 32/215 (14%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-----IAVKRLSR-DSGQGDLEFKNEVLLVANLQ 378
            F     LG G FG VYKG      E     +A+K L    S + + E  +E  ++A++ 
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI-IGG------ 431
           + ++ RLLG  L    +L I + +P   L            LD+ R +K  IG       
Sbjct: 86  NPHVCRLLGICLTSTVQL-ITQLMPFGCL------------LDYVREHKDNIGSQYLLNW 132
Query: 432 ---IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
              IA+G+ YL ED RL  +HRDL   NVL+      KI DFG+A+L   +E + +    
Sbjct: 133 CVQIAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 189
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
                +MA E  +H  Y+ +SDV+S+GV V E+++
Sbjct: 190 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLS-RDSGQGDLEFKNEVLLVANLQHRNLV 383
           F+  +++G+G FG VYKG      E+ A+K +   ++     + + E+ +++      + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 384 RLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS 443
           R  G  L+  +  +I E++   S      D  +   L+      I+  I +GL YLH + 
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHSE- 135
Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG 503
             R IHRD+K +NVLL  +   K+ADFG+A   ++ +TQ   +  VGT  +MAPE     
Sbjct: 136 --RKIHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNXFVGTPFWMAPEVIKQS 191
Query: 504 QYSVKSDVFSFGVLVLEIISGQRNNC 529
            Y  K+D++S G+  +E+  G+  N 
Sbjct: 192 AYDFKADIWSLGITAIELAKGEPPNS 217

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 103/202 (50%), Gaps = 10/202 (4%)
Query: 325 NFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
            ++   K+GQG  G VY    +  G E+A+++++           NE+L++   ++ N+V
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 81
Query: 384 RLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS 443
             L   L G+E  ++ E++   SL   + +      +D  +   +     + L +LH + 
Sbjct: 82  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSN- 136
Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG 503
             ++IHR++K+ N+LL  + + K+ DFG     ++   Q   S +VGT  +MAPE     
Sbjct: 137 --QVIHRNIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRK 192
Query: 504 QYSVKSDVFSFGVLVLEIISGQ 525
            Y  K D++S G++ +E+I G+
Sbjct: 193 AYGPKVDIWSLGIMAIEMIEGE 214

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 105/215 (48%), Gaps = 32/215 (14%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-----IAVKRLSR-DSGQGDLEFKNEVLLVANLQ 378
            F     LG G FG VYKG      E     +A+K L    S + + E  +E  ++A++ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI-IGG------ 431
           + ++ RLLG  L    +L I + +P   L            LD+ R +K  IG       
Sbjct: 76  NPHVCRLLGICLTSTVQL-ITQLMPFGXL------------LDYVREHKDNIGSQYLLNW 122
Query: 432 ---IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
              IA+G+ YL ED RL  +HRDL   NVL+      KI DFG+A+L   +E + +    
Sbjct: 123 CVQIAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
                +MA E  +H  Y+ +SDV+S+GV V E+++
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 111/221 (50%), Gaps = 13/221 (5%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK--NEVLLVANLQHR 380
           +NF    K+G+G +G VYK R    G  +A+K++  D+    +      E+ L+  L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH 440
           N+V+LL      N+  L++EF+ +  L  F+ D +    +        +  + +GL + H
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 441 EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA 500
                R++HRDLK  N+L++ E   K+ADFG+AR F +   +  T  +V T  Y APE  
Sbjct: 128 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 182
Query: 501 MHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
           +  + YS   D++S G +  E+++  R   F     ++ L 
Sbjct: 183 LGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 221

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 105/215 (48%), Gaps = 32/215 (14%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-----IAVKRLSR-DSGQGDLEFKNEVLLVANLQ 378
            F     LG G FG VYKG      E     +A+K L    S + + E  +E  ++A++ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI-IGG------ 431
           + ++ RLLG  L    +L I + +P   L            LD+ R +K  IG       
Sbjct: 76  NPHVCRLLGICLTSTVQL-ITQLMPFGCL------------LDYVREHKDNIGSQYLLNW 122
Query: 432 ---IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
              IA+G+ YL ED RL  +HRDL   NVL+      KI DFG+A+L   +E + +    
Sbjct: 123 CVQIAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
                +MA E  +H  Y+ +SDV+S+GV V E+++
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 117/235 (49%), Gaps = 19/235 (8%)
Query: 320 RVATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRL---SRDSGQGDLEFKNEVLLVA 375
           ++  + +   +KLG GG   VY         ++A+K +    R+  +    F+ EV   +
Sbjct: 7   KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSS 66
Query: 376 NLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARG 435
            L H+N+V ++    E +   L+ E++   +L  +I        L  +        I  G
Sbjct: 67  QLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDG 123
Query: 436 LLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQGNTSRIVGTYGY 494
           + + H+   +RI+HRD+K  N+L+D+  T KI DFG+A+ L E   TQ  T+ ++GT  Y
Sbjct: 124 IKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ--TNHVLGTVQY 178
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWRE 549
            +PE A        +D++S G+++ E++ G+      NGET    +S A K+ ++
Sbjct: 179 FSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP---FNGETA---VSIAIKHIQD 227

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 105/215 (48%), Gaps = 32/215 (14%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-----IAVKRLSR-DSGQGDLEFKNEVLLVANLQ 378
            F     LG G FG VYKG      E     +A+K L    S + + E  +E  ++A++ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI-IGG------ 431
           + ++ RLLG  L    +L I + +P   L            LD+ R +K  IG       
Sbjct: 79  NPHVCRLLGICLTSTVQL-ITQLMPFGCL------------LDYVREHKDNIGSQYLLNW 125
Query: 432 ---IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
              IA+G+ YL ED RL  +HRDL   NVL+      KI DFG+A+L   +E + +    
Sbjct: 126 CVQIAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
                +MA E  +H  Y+ +SDV+S+GV V E+++
Sbjct: 183 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 134/294 (45%), Gaps = 37/294 (12%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQGD-LEFKNEVLL 373
           V+ +  +   +LGQG FG VY+G   D         +AVK ++  +   + +EF NE  +
Sbjct: 14  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI--FDPTR-----RAQLDWERRY 426
           +      ++VRLLG   +G   L++ E + +  L  ++    P       R     +   
Sbjct: 74  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 133
Query: 427 KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQGNT 485
           ++   IA G+ YL+     + +HRDL   N ++  + T KI DFGM R ++E    +   
Sbjct: 134 QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGG 190
Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEI--ISGQRNNCFRNGETVEDLLSSA 543
             ++    +MAPE    G ++  SD++SFGV++ EI  ++ Q      N + ++ ++   
Sbjct: 191 KGLLPVR-WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 249
Query: 544 WKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN 597
           + +           P      +T+++R      +C Q N   RPT   +V +L 
Sbjct: 250 YLD----------QPDNCPERVTDLMR------MCWQFNPKMRPTFLEIVNLLK 287

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 124/265 (46%), Gaps = 23/265 (8%)
Query: 330 NKLGQGGFGAVYKGRLYDGA-EIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGF 388
           +KLG G +G VY+G     +  +AVK L  D+ + + EF  E  ++  ++H NLV+LLG 
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 75
Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRII 448
                   +I EF+   +L  ++ +  R+        Y +   I+  + YL + +    I
Sbjct: 76  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLY-MATQISSAMEYLEKKN---FI 131
Query: 449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVK 508
           HRDL   N L+      K+ADFG++RL   D    +         + APE   + ++S+K
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYNKFSIK 190
Query: 509 SDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITE 567
           SDV++FGVL+ EI + G       +   V +LL   ++  R         P      + E
Sbjct: 191 SDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMER---------PEGCPEKVYE 241
Query: 568 MIRCIHIGLLCVQENVASRPTMASV 592
           ++R       C Q N + RP+ A +
Sbjct: 242 LMRA------CWQWNPSDRPSFAEI 260

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 105/215 (48%), Gaps = 32/215 (14%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-----IAVKRLSR-DSGQGDLEFKNEVLLVANLQ 378
            F     LG G FG VYKG      E     +A+K L    S + + E  +E  ++A++ 
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 100
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI-IGG------ 431
           + ++ RLLG  L    +L I + +P   L            LD+ R +K  IG       
Sbjct: 101 NPHVCRLLGICLTSTVQL-ITQLMPFGCL------------LDYVREHKDNIGSQYLLNW 147
Query: 432 ---IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
              IA+G+ YL ED RL  +HRDL   NVL+      KI DFG+A+L   +E + +    
Sbjct: 148 CVQIAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 204
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
                +MA E  +H  Y+ +SDV+S+GV V E+++
Sbjct: 205 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 105/215 (48%), Gaps = 32/215 (14%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-----IAVKRLSR-DSGQGDLEFKNEVLLVANLQ 378
            F     LG G FG VYKG      E     +A+K L    S + + E  +E  ++A++ 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI-IGG------ 431
           + ++ RLLG  L    +L I + +P   L            LD+ R +K  IG       
Sbjct: 83  NPHVCRLLGICLTSTVQL-ITQLMPFGCL------------LDYVREHKDNIGSQYLLNW 129
Query: 432 ---IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
              IA+G+ YL ED RL  +HRDL   NVL+      KI DFG+A+L   +E + +    
Sbjct: 130 CVQIAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
                +MA E  +H  Y+ +SDV+S+GV V E+++
Sbjct: 187 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 131/280 (46%), Gaps = 23/280 (8%)
Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGA-EIAVKRLSRDSGQGDLEFKNEVLL 373
           +++   +   + +  +KLG G +G VY+G     +  +AVK L  D+ + + EF  E  +
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 67
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA 433
           +  ++H NLV+LLG         +I EF+   +L  ++ +   R +++      +   I+
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQIS 126
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             + YL + +    IHRDL   N L+      K+ADFG++RL   D    +         
Sbjct: 127 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-K 182
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTT 552
           + APE   + ++S+KSDV++FGVL+ EI + G       +   V +LL   ++  R    
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER---- 238
Query: 553 VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASV 592
                P      + E++R       C Q N + RP+ A +
Sbjct: 239 -----PEGCPEKVYELMRA------CWQWNPSDRPSFAEI 267

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 131/280 (46%), Gaps = 23/280 (8%)
Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGA-EIAVKRLSRDSGQGDLEFKNEVLL 373
           +++   +   + +  +KLG G +G VY+G     +  +AVK L  D+ + + EF  E  +
Sbjct: 8   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 66
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA 433
           +  ++H NLV+LLG         +I EF+   +L  ++ +   R +++      +   I+
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQIS 125
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             + YL + +    IHRDL   N L+      K+ADFG++RL   D    +         
Sbjct: 126 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-K 181
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTT 552
           + APE   + ++S+KSDV++FGVL+ EI + G       +   V +LL   ++  R    
Sbjct: 182 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER---- 237
Query: 553 VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASV 592
                P      + E++R       C Q N + RP+ A +
Sbjct: 238 -----PEGCPEKVYELMRA------CWQWNPSDRPSFAEI 266

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 131/280 (46%), Gaps = 23/280 (8%)
Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGA-EIAVKRLSRDSGQGDLEFKNEVLL 373
           +++   +   + +  +KLG G +G VY+G     +  +AVK L  D+ + + EF  E  +
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 62
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA 433
           +  ++H NLV+LLG         +I EF+   +L  ++ +   R +++      +   I+
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQIS 121
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             + YL + +    IHRDL   N L+      K+ADFG++RL   D    +         
Sbjct: 122 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-K 177
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTT 552
           + APE   + ++S+KSDV++FGVL+ EI + G       +   V +LL   ++  R    
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER---- 233
Query: 553 VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASV 592
                P      + E++R       C Q N + RP+ A +
Sbjct: 234 -----PEGCPEKVYELMRA------CWQWNPSDRPSFAEI 262

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 131/280 (46%), Gaps = 23/280 (8%)
Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGA-EIAVKRLSRDSGQGDLEFKNEVLL 373
           +++   +   + +  +KLG G +G VY+G     +  +AVK L  D+ + + EF  E  +
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 62
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA 433
           +  ++H NLV+LLG         +I EF+   +L  ++ +   R +++      +   I+
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQIS 121
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             + YL + +    IHRDL   N L+      K+ADFG++RL   D    +         
Sbjct: 122 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-K 177
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTT 552
           + APE   + ++S+KSDV++FGVL+ EI + G       +   V +LL   ++  R    
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER---- 233
Query: 553 VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASV 592
                P      + E++R       C Q N + RP+ A +
Sbjct: 234 -----PEGCPEKVYELMRA------CWQWNPSDRPSFAEI 262

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 111/212 (52%), Gaps = 19/212 (8%)
Query: 321 VATDNFSDANKLGQGGFGAVY--KGRLYDGAEIAVKRLSRDSGQGDLEFKN---EVLLVA 375
           + +D +     LG+G FG V   K ++  G E AVK +S+   +   + ++   EV L+ 
Sbjct: 29  IFSDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLK 87
Query: 376 NLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARG 435
            L H N+++L  F  +     L+ E      L   I    R +++D  R   II  +  G
Sbjct: 88  QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSG 144
Query: 436 LLYLHEDSRLRIIHRDLKTSNVLLDAEMTP---KIADFGMARLFEMDETQGNTSRIVGTY 492
           + Y+H++   +I+HRDLK  N+LL+++      +I DFG++  FE  +   +    +GT 
Sbjct: 145 ITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---IGTA 198
Query: 493 GYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
            Y+APE  +HG Y  K DV+S GV++  ++SG
Sbjct: 199 YYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 111/221 (50%), Gaps = 13/221 (5%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK--NEVLLVANLQHR 380
           +NF    K+G+G +G VYK R    G  +A+K++  D+    +      E+ L+  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH 440
           N+V+LL      N+  L++EF+ +  L  F+ D +    +        +  + +GL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLSFCH 120
Query: 441 EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA 500
                R++HRDLK  N+L++ E   K+ADFG+AR F +   +  T  +V T  Y APE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 175
Query: 501 MHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
           +  + YS   D++S G +  E+++  R   F     ++ L 
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 214

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 110/211 (52%), Gaps = 14/211 (6%)
Query: 322 ATDNFSDANKLGQGGFGAVYKG-RLYDGAEIAVKRLSRDSGQGDLEFK-NEVLLVANLQH 379
           ++  F    KLG G +  VYKG     G  +A+K +  DS +G       E+ L+  L+H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHF----IFDPTRRAQLDWERRYKIIGGIARG 435
            N+VRL       N+  L++EF+ N    +     + +  R  +L+  + ++    + +G
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQ--WQLLQG 120
Query: 436 LLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYM 495
           L + HE+   +I+HRDLK  N+L++     K+ DFG+AR F +      +S +V T  Y 
Sbjct: 121 LAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGI-PVNTFSSEVV-TLWYR 175
Query: 496 APEYAMHGQ-YSVKSDVFSFGVLVLEIISGQ 525
           AP+  M  + YS   D++S G ++ E+I+G+
Sbjct: 176 APDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 131/280 (46%), Gaps = 23/280 (8%)
Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGA-EIAVKRLSRDSGQGDLEFKNEVLL 373
           +++   +   + +  +KLG G +G VY+G     +  +AVK L  D+ + + EF  E  +
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 67
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA 433
           +  ++H NLV+LLG         +I EF+   +L  ++ +   R +++      +   I+
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQIS 126
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             + YL + +    IHRDL   N L+      K+ADFG++RL   D    +         
Sbjct: 127 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-K 182
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTT 552
           + APE   + ++S+KSDV++FGVL+ EI + G       +   V +LL   ++  R    
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER---- 238
Query: 553 VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASV 592
                P      + E++R       C Q N + RP+ A +
Sbjct: 239 -----PEGCPEKVYELMRA------CWQWNPSDRPSFAEI 267

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 101/199 (50%), Gaps = 14/199 (7%)
Query: 332 LGQGGFGAVYKGRLYDGAE-----IAVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLVRL 385
           LG G FG V+KG      E     + +K +   SG+   +   + +L + +L H ++VRL
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 386 LGFSLEGNERLLIYEFVPNTSL-DHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSR 444
           LG    G+   L+ +++P  SL DH       R  L  +        IA+G+ YL E   
Sbjct: 99  LGLC-PGSSLQLVTQYLPLGSLLDHVR---QHRGALGPQLLLNWGVQIAKGMYYLEEHG- 153
Query: 445 LRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQ 504
             ++HR+L   NVLL +    ++ADFG+A L   D+ Q   S       +MA E    G+
Sbjct: 154 --MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 211
Query: 505 YSVKSDVFSFGVLVLEIIS 523
           Y+ +SDV+S+GV V E+++
Sbjct: 212 YTHQSDVWSYGVTVWELMT 230

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSR---DSGQGDLEFKNEVLLVANL 377
           A ++F     LG+G FG VY  R      I A+K L +   +    + + + EV + ++L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           +H N++RL G+  +     LI E+ P   L     +  + ++ D +R    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           Y H     R+IHRD+K  N+LL +    KIADFG    + +       + + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTELCGTLDYLPP 175
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           E      +  K D++S GVL  E + G+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 131/280 (46%), Gaps = 23/280 (8%)
Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGA-EIAVKRLSRDSGQGDLEFKNEVLL 373
           +++   +   + +  +KLG G +G VY+G     +  +AVK L  D+ + + EF  E  +
Sbjct: 17  NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 75
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA 433
           +  ++H NLV+LLG         +I EF+   +L  ++ +   R +++      +   I+
Sbjct: 76  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQIS 134
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             + YL + +    IHRDL   N L+      K+ADFG++RL   D    +         
Sbjct: 135 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-K 190
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTT 552
           + APE   + ++S+KSDV++FGVL+ EI + G       +   V +LL   ++  R    
Sbjct: 191 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER---- 246
Query: 553 VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASV 592
                P      + E++R       C Q N + RP+ A +
Sbjct: 247 -----PEGCPEKVYELMRA------CWQWNPSDRPSFAEI 275

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSR---DSGQGDLEFKNEVLLVANL 377
           A ++F     LG+G FG VY  R      I A+K L +   +    + + + EV + ++L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           +H N++RL G+  +     LI E+ P   L     +  + ++ D +R    I  +A  L 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           Y H     R+IHRD+K  N+LL +    KIADFG    + +       + + GT  Y+ P
Sbjct: 149 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 201
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           E      +  K D++S GVL  E + G+
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 132/280 (47%), Gaps = 23/280 (8%)
Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGA-EIAVKRLSRDSGQGDLEFKNEVLL 373
           +++   +   + +  +KLG G +G VY+G     +  +AVK L  D+ + + EF  E  +
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 63
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA 433
           +  ++H NLV+LLG         +I EF+   +L  ++ +   R +++      +   I+
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQIS 122
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             + YL + +    IHRDL   N L+      K+ADFG++RL   D T    +       
Sbjct: 123 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAPAGAKFPIK 178
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTT 552
           + APE   + ++S+KSDV++FGVL+ EI + G       +   V +LL   ++  R    
Sbjct: 179 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER---- 234
Query: 553 VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASV 592
                P      + E++R       C Q N + RP+ A +
Sbjct: 235 -----PEGCPEKVYELMRA------CWQWNPSDRPSFAEI 263

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 86/308 (27%), Positives = 140/308 (45%), Gaps = 57/308 (18%)
Query: 314 FDFNTIRVATDNFSDANKLGQGGFGAVYKGRLY-DGAEI--AVKRLSRDSGQGDL-EFKN 369
            D+N I+     F D   +G+G FG V K R+  DG  +  A+KR+   + + D  +F  
Sbjct: 19  LDWNDIK-----FQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG 71
Query: 370 EVLLVANL-QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI-------FDP------T 415
           E+ ++  L  H N++ LLG         L  E+ P+ +L  F+        DP      +
Sbjct: 72  ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 131
Query: 416 RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL 475
             + L  ++       +ARG+ YL   S+ + IHR+L   N+L+      KIADFG++R 
Sbjct: 132 TASTLSSQQLLHFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR- 187
Query: 476 FEMDETQGNTSRIVGTYG-----YMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNC 529
                  G    +  T G     +MA E   +  Y+  SDV+S+GVL+ EI+S G    C
Sbjct: 188 -------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 240
Query: 530 FRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTM 589
              G T  +L     + +R    +N  D       + +++R       C +E    RP+ 
Sbjct: 241 ---GMTCAELYEKLPQGYRLEKPLNCDD------EVYDLMR------QCWREKPYERPSF 285
Query: 590 ASVVLMLN 597
           A +++ LN
Sbjct: 286 AQILVSLN 293

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 28/206 (13%)
Query: 332 LGQGGFGAVYKGRLYDGAE-----IAVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLVRL 385
           LG G FG V+KG      E     + +K +   SG+   +   + +L + +L H ++VRL
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 386 LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQ--------LDWERRYKIIGGIARGLL 437
           LG    G+   L+ +++P  SL     D  R+ +        L+W  +      IA+G+ 
Sbjct: 81  LGLC-PGSSLQLVTQYLPLGSL----LDHVRQHRGALGPQLLLNWGVQ------IAKGMY 129
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           YL E     ++HR+L   NVLL +    ++ADFG+A L   D+ Q   S       +MA 
Sbjct: 130 YLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIIS 523
           E    G+Y+ +SDV+S+GV V E+++
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 131/280 (46%), Gaps = 23/280 (8%)
Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGA-EIAVKRLSRDSGQGDLEFKNEVLL 373
           +++   +   + +  +KLG G +G VY+G     +  +AVK L  D+ + + EF  E  +
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 64
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA 433
           +  ++H NLV+LLG         +I EF+   +L  ++ +   R +++      +   I+
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQIS 123
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             + YL + +    IHRDL   N L+      K+ADFG++RL   D    +         
Sbjct: 124 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-K 179
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTT 552
           + APE   + ++S+KSDV++FGVL+ EI + G       +   V +LL   ++  R    
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER---- 235
Query: 553 VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASV 592
                P      + E++R       C Q N + RP+ A +
Sbjct: 236 -----PEGCPEKVYELMRA------CWQWNPSDRPSFAEI 264

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 25/209 (11%)
Query: 333 GQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEG 392
            +G FG V+K +L +   +AVK       Q   + + E+     ++H NL++ +     G
Sbjct: 24  ARGRFGCVWKAQLMNDF-VAVKIFPLQDKQ-SWQSEREIFSTPGMKHENLLQFIAAEKRG 81
Query: 393 N----ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED------ 442
           +    E  LI  F    SL  ++    +   + W     +   ++RGL YLHED      
Sbjct: 82  SNLEVELWLITAFHDKGSLTDYL----KGNIITWNELCHVAETMSRGLSYLHEDVPWCRG 137
Query: 443 --SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA 500
              +  I HRD K+ NVLL +++T  +ADFG+A  FE  +  G+T   VGT  YMAPE  
Sbjct: 138 EGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPE-V 196
Query: 501 MHGQYSVKSDVF------SFGVLVLEIIS 523
           + G  + + D F      + G+++ E++S
Sbjct: 197 LEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 133/274 (48%), Gaps = 27/274 (9%)
Query: 332 LGQGGFGAVYKGRLYDGAE----IAVKRLSRD-SGQGDLEFKNEVLLVANLQHRNLVRLL 386
           +G G FG V  GRL    +    +A+K L    + +   +F  E  ++    H N++ L 
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLE 89
Query: 387 GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLR 446
           G   +    +++ E++ N SLD F+       Q    +   ++ GI+ G+ YL   S + 
Sbjct: 90  GVVTKSKPVMIVTEYMENGSLDTFL--KKNDGQFTVIQLVGMLRGISAGMKYL---SDMG 144
Query: 447 IIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVG-TYGYMAPEYAMHGQY 505
            +HRDL   N+L+++ +  K++DFG++R+ E D     T+R       + APE     ++
Sbjct: 145 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKF 204
Query: 506 SVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGS 564
           +  SDV+S+G+++ E++S G+R        T +D++ +  + +R      +  P     +
Sbjct: 205 TSASDVWSYGIVMWEVVSYGERPYW---EMTNQDVIKAVEEGYR------LPSPMDCPAA 255
Query: 565 ITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS 598
           + +++      L C Q+   SRP    +V ML+ 
Sbjct: 256 LYQLM------LDCWQKERNSRPKFDEIVNMLDK 283

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 130/280 (46%), Gaps = 23/280 (8%)
Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGA-EIAVKRLSRDSGQGDLEFKNEVLL 373
           +++   +   + +  +KLG G +G VY+G     +  +AVK L  D+ + + EF  E  +
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 62
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA 433
           +  ++H NLV+LLG         +I EF+   +L  ++ +  R+        Y +   I+
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLY-MATQIS 121
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             + YL + +    IHRDL   N L+      K+ADFG++RL   D    +         
Sbjct: 122 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-K 177
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTT 552
           + APE   + ++S+KSDV++FGVL+ EI + G       +   V +LL   ++  R    
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER---- 233
Query: 553 VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASV 592
                P      + E++R       C Q N + RP+ A +
Sbjct: 234 -----PEGCPEKVYELMRA------CWQWNPSDRPSFAEI 262

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 130/280 (46%), Gaps = 23/280 (8%)
Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGA-EIAVKRLSRDSGQGDLEFKNEVLL 373
           +++   +   + +  +KLG G +G VY+G     +  +AVK L  D+ + + EF  E  +
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 67
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA 433
           +  ++H NLV+LLG         +I EF+   +L  ++ +   R ++       +   I+
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQIS 126
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             + YL + +    IHRDL   N L+      K+ADFG++RL   D    +         
Sbjct: 127 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-K 182
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTT 552
           + APE   + ++S+KSDV++FGVL+ EI + G       +   V +LL   ++  R    
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER---- 238
Query: 553 VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASV 592
                P      + E++R       C Q N + RP+ A +
Sbjct: 239 -----PEGCPEKVYELMRA------CWQWNPSDRPSFAEI 267

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSR---DSGQGDLEFKNEVLLVANL 377
           A ++F     LG+G FG VY  R      I A+K L +   +    + + + EV + ++L
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           +H N++RL G+  +     LI E+ P   L     +  + ++ D +R    I  +A  L 
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 139
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           Y H     R+IHRD+K  N+LL +    KIADFG    + +       + + GT  Y+ P
Sbjct: 140 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 192
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           E      +  K D++S GVL  E + G+
Sbjct: 193 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 131/280 (46%), Gaps = 23/280 (8%)
Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGA-EIAVKRLSRDSGQGDLEFKNEVLL 373
           +++   +   + +  +KLG G +G VY+G     +  +AVK L  D+ + + EF  E  +
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 64
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA 433
           +  ++H NLV+LLG         +I EF+   +L  ++ +   R +++      +   I+
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQIS 123
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             + YL + +    IHRDL   N L+      K+ADFG++RL   D    +         
Sbjct: 124 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-K 179
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTT 552
           + APE   + ++S+KSDV++FGVL+ EI + G       +   V +LL   ++  R    
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER---- 235
Query: 553 VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASV 592
                P      + E++R       C Q N + RP+ A +
Sbjct: 236 -----PEGCPEKVYELMRA------CWQWNPSDRPSFAEI 264

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/203 (33%), Positives = 105/203 (51%), Gaps = 19/203 (9%)
Query: 332 LGQGGFGAVYKGRLYDGAE----IAVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLVRLL 386
           +G+G FG VY G   D A+     A+K LSR +    +E F  E LL+  L H N++ L+
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 387 GFSL--EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSR 444
           G  L  EG   +L+  ++ +  L  FI  P R   +     + +   +ARG+ YL E   
Sbjct: 89  GIMLPPEGLPHVLL-PYMCHGDLLQFIRSPQRNPTVKDLISFGL--QVARGMEYLAEQ-- 143
Query: 445 LRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE----TQGNTSRIVGTYGYMAPEYA 500
            + +HRDL   N +LD   T K+ADFG+AR     E     Q   +R+     + A E  
Sbjct: 144 -KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL--PVKWTALESL 200
Query: 501 MHGQYSVKSDVFSFGVLVLEIIS 523
              +++ KSDV+SFGVL+ E+++
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLT 223

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 113/216 (52%), Gaps = 19/216 (8%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVY--KGRLYDGAEIAVKRLSRDSGQGDLEFKN---EV 371
           ++  + +D +     LG+G FG V   K ++  G E AVK +S+   +   + ++   EV
Sbjct: 19  HSTAIFSDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREV 77
Query: 372 LLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG 431
            L+  L H N+++L  F  +     L+ E      L   I    R +++D  R   II  
Sbjct: 78  QLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQ 134
Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP---KIADFGMARLFEMDETQGNTSRI 488
           +  G+ Y+H++   +I+HRDLK  N+LL+++      +I DFG++  FE  +   +    
Sbjct: 135 VLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK--- 188
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +GT  Y+APE  +HG Y  K DV+S GV++  ++SG
Sbjct: 189 IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 132/280 (47%), Gaps = 23/280 (8%)
Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGA-EIAVKRLSRDSGQGDLEFKNEVLL 373
           +++   +   + +  +KLG G +G VY+G     +  +AVK L  D+ + + EF  E  +
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 64
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA 433
           +  ++H NLV+LLG         +I EF+   +L  ++ +   R +++      +   I+
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQIS 123
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             + YL + +    IHRDL   N L+      K+ADFG++RL   D T    +       
Sbjct: 124 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAPAGAKFPIK 179
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTT 552
           + APE   + ++S+KSDV++FGVL+ EI + G       +   V +LL   ++  R    
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER---- 235
Query: 553 VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASV 592
                P      + E++R       C Q N + RP+ A +
Sbjct: 236 -----PEGCPEKVYELMRA------CWQWNPSDRPSFAEI 264

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 119/230 (51%), Gaps = 20/230 (8%)
Query: 303 GDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVY--KGRLYDGAEIAVKRLSRDS 360
           GD ++    + F  ++  + +D +     LG+G FG V   K ++  G E AVK +S+  
Sbjct: 29  GDHLHATPGM-FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQ 86
Query: 361 GQGDLEFKN---EVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRR 417
            +   + ++   EV L+  L H N+++L  F  +     L+ E      L   I    R 
Sbjct: 87  VKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF 146
Query: 418 AQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP---KIADFGMAR 474
           +++D  R   II  +  G+ Y+H++   +I+HRDLK  N+LL+++      +I DFG++ 
Sbjct: 147 SEVDAAR---IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST 200
Query: 475 LFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
            FE  +   +    +GT  Y+APE  +HG Y  K DV+S GV++  ++SG
Sbjct: 201 HFEASKKMKDK---IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 104/215 (48%), Gaps = 32/215 (14%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-----IAVKRLSR-DSGQGDLEFKNEVLLVANLQ 378
            F     LG G FG VYKG      E     +A+K L    S + + E  +E  ++A++ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI-IGG------ 431
           + ++ RLLG  L    +L I + +P   L            LD+ R +K  IG       
Sbjct: 78  NPHVCRLLGICLTSTVQL-IMQLMPFGCL------------LDYVREHKDNIGSQYLLNW 124
Query: 432 ---IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
              IA+G+ YL ED RL  +HRDL   NVL+      KI DFG A+L   +E + +    
Sbjct: 125 CVQIAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
                +MA E  +H  Y+ +SDV+S+GV V E+++
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 130/280 (46%), Gaps = 23/280 (8%)
Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGA-EIAVKRLSRDSGQGDLEFKNEVLL 373
           +++   +   + +  +KLG G +G VY+G     +  +AVK L  D+ + + EF  E  +
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 62
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA 433
           +  ++H NLV+LLG         +I EF+   +L  ++ +  R+        Y +   I+
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLY-MATQIS 121
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             + YL + +    IHRDL   N L+      K+ADFG++RL   D    +         
Sbjct: 122 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-K 177
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTT 552
           + APE   + ++S+KSDV++FGVL+ EI + G       +   V +LL   ++  R    
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER---- 233
Query: 553 VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASV 592
                P      + E++R       C Q N + RP+ A +
Sbjct: 234 -----PEGCPEKVYELMRA------CWQWNPSDRPSFAEI 262

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSR---DSGQGDLEFKNEVLLVANL 377
           A ++F     LG+G FG VY  R      I A+K L +   +    + + + EV + ++L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           +H N++RL G+  +     LI E+ P   L     +  + ++ D +R    I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           Y H     R+IHRD+K  N+LL +    KIADFG    + +       + + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           E      +  K D++S GVL  E + G+
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 120/235 (51%), Gaps = 20/235 (8%)
Query: 298 SEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVY--KGRLYDGAEIAVKR 355
           +    GD ++    + F  ++  + +D +     LG+G FG V   K ++  G E AVK 
Sbjct: 25  TSGGPGDHLHATPGM-FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKV 82
Query: 356 LSRDSGQGDLEFKN---EVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIF 412
           +S+   +   + ++   EV L+  L H N+++L  F  +     L+ E      L   I 
Sbjct: 83  ISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII 142
Query: 413 DPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP---KIAD 469
              R +++D  R   II  +  G+ Y+H++   +I+HRDLK  N+LL+++      +I D
Sbjct: 143 SRKRFSEVDAAR---IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIID 196
Query: 470 FGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           FG++  FE  +   +    +GT  Y+APE  +HG Y  K DV+S GV++  ++SG
Sbjct: 197 FGLSTHFEASKKMKDK---IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 130/280 (46%), Gaps = 23/280 (8%)
Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGA-EIAVKRLSRDSGQGDLEFKNEVLL 373
           +++   +   + +  +KLG G +G VY+G     +  +AVK L  D+ + + EF  E  +
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 62
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA 433
           +  ++H NLV+LLG         +I EF+   +L  ++ +  R+        Y +   I+
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-MATQIS 121
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             + YL + +    IHRDL   N L+      K+ADFG++RL   D    +         
Sbjct: 122 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-K 177
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTT 552
           + APE   + ++S+KSDV++FGVL+ EI + G       +   V +LL   ++  R    
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER---- 233
Query: 553 VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASV 592
                P      + E++R       C Q N + RP+ A +
Sbjct: 234 -----PEGCPEKVYELMRA------CWQWNPSDRPSFAEI 262

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSR---DSGQGDLEFKNEVLLVANL 377
           A ++F     LG+G FG VY  R      I A+K L +   +    + + + EV + ++L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           +H N++RL G+  +     LI E+ P   L     +  + ++ D +R    I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           Y H     R+IHRD+K  N+LL +    KIADFG    + +       + + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           E      +  K D++S GVL  E + G+
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSR---DSGQGDLEFKNEVLLVANL 377
           A ++F     LG+G FG VY  R      I A+K L +   +    + + + EV + ++L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           +H N++RL G+  +     LI E+ P   L     +  + ++ D +R    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           Y H     R+IHRD+K  N+LL +    KIADFG    + +       + + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 175
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           E      +  K D++S GVL  E + G+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 104/215 (48%), Gaps = 32/215 (14%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-----IAVKRLSR-DSGQGDLEFKNEVLLVANLQ 378
            F     LG G FG VYKG      E     +A+K L    S + + E  +E  ++A++ 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI-IGG------ 431
           + ++ RLLG  L    +L I + +P   L            LD+ R +K  IG       
Sbjct: 80  NPHVCRLLGICLTSTVQL-IMQLMPFGCL------------LDYVREHKDNIGSQYLLNW 126
Query: 432 ---IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
              IA+G+ YL ED RL  +HRDL   NVL+      KI DFG A+L   +E + +    
Sbjct: 127 CVQIAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 183
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
                +MA E  +H  Y+ +SDV+S+GV V E+++
Sbjct: 184 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 130/280 (46%), Gaps = 23/280 (8%)
Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGA-EIAVKRLSRDSGQGDLEFKNEVLL 373
           +++   +   + +  +KLG G +G VY+G     +  +AVK L  D+ + + EF  E  +
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 62
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA 433
           +  ++H NLV+LLG         +I EF+   +L  ++ +  R+        Y +   I+
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-MATQIS 121
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             + YL + +    IHRDL   N L+      K+ADFG++RL   D    +         
Sbjct: 122 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-K 177
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTT 552
           + APE   + ++S+KSDV++FGVL+ EI + G       +   V +LL   ++  R    
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER---- 233
Query: 553 VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASV 592
                P      + E++R       C Q N + RP+ A +
Sbjct: 234 -----PEGCPEKVYELMRA------CWQWNPSDRPSFAEI 262

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 104/215 (48%), Gaps = 32/215 (14%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-----IAVKRLSR-DSGQGDLEFKNEVLLVANLQ 378
            F     LG G FG VYKG      E     +A+K L    S + + E  +E  ++A++ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI-IGG------ 431
           + ++ RLLG  L    +L I + +P   L            LD+ R +K  IG       
Sbjct: 78  NPHVCRLLGICLTSTVQL-IMQLMPFGCL------------LDYVREHKDNIGSQYLLNW 124
Query: 432 ---IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
              IA+G+ YL ED RL  +HRDL   NVL+      KI DFG A+L   +E + +    
Sbjct: 125 CVQIAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
                +MA E  +H  Y+ +SDV+S+GV V E+++
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSR---DSGQGDLEFKNEVLLVANL 377
           A ++F     LG+G FG VY  R      I A+K L +   +    + + + EV + ++L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           +H N++RL G+  +     LI E+ P   +   +    + ++ D +R    I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL---QKLSKFDEQRTATYITELANALS 127
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           Y H     R+IHRD+K  N+LL +    KIADFG    + +       + + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           E      +  K D++S GVL  E + G+
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSR---DSGQGDLEFKNEVLLVANL 377
           A ++F     LG+G FG VY  R      I A+K L +   +    + + + EV + ++L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           +H N++RL G+  +     LI E+ P   L     +  + ++ D +R    I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           Y H     R+IHRD+K  N+LL +    KIADFG    + +       + + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 178
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           E      +  K D++S GVL  E + G+
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 104/215 (48%), Gaps = 32/215 (14%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-----IAVKRLSR-DSGQGDLEFKNEVLLVANLQ 378
            F     LG G FG VYKG      E     +A+K L    S + + E  +E  ++A++ 
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI-IGG------ 431
           + ++ RLLG  L    +L I + +P   L            LD+ R +K  IG       
Sbjct: 73  NPHVCRLLGICLTSTVQL-ITQLMPFGCL------------LDYVREHKDNIGSQYLLNW 119
Query: 432 ---IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
              IA G+ YL ED RL  +HRDL   NVL+      KI DFG+A+L   +E + +    
Sbjct: 120 CVQIAEGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 176
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
                +MA E  +H  Y+ +SDV+S+GV V E+++
Sbjct: 177 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 124/265 (46%), Gaps = 23/265 (8%)
Query: 330 NKLGQGGFGAVYKGRLYDGA-EIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGF 388
           +KLG G +G VY+G     +  +AVK L  D+ + + EF  E  ++  ++H NLV+LLG 
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 75
Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRII 448
                   +I EF+   +L  ++ +  R+        Y +   I+  + YL + +    I
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-MATQISSAMEYLEKKN---FI 131
Query: 449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVK 508
           HRDL   N L+      K+ADFG++RL   D    +         + APE   + ++S+K
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPI-KWTAPESLAYNKFSIK 190
Query: 509 SDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITE 567
           SDV++FGVL+ EI + G       +   V +LL   ++  R         P      + E
Sbjct: 191 SDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMER---------PEGCPEKVYE 241
Query: 568 MIRCIHIGLLCVQENVASRPTMASV 592
           ++R       C Q N + RP+ A +
Sbjct: 242 LMRA------CWQWNPSDRPSFAEI 260

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 104/215 (48%), Gaps = 32/215 (14%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-----IAVKRLSR-DSGQGDLEFKNEVLLVANLQ 378
            F     LG G FG VYKG      E     +A+K L    S + + E  +E  ++A++ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI-IGG------ 431
           + ++ RLLG  L    +L I + +P   L            LD+ R +K  IG       
Sbjct: 76  NPHVCRLLGICLTSTVQL-ITQLMPFGCL------------LDYVREHKDNIGSQYLLNW 122
Query: 432 ---IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
              IA+G+ YL ED RL  +HRDL   NVL+      KI DFG A+L   +E + +    
Sbjct: 123 CVQIAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 179
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
                +MA E  +H  Y+ +SDV+S+GV V E+++
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 111/223 (49%), Gaps = 13/223 (5%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK--NEVLLVANLQ 378
           + +NF    K+G+G +G VYK R    G  +A+K++  D+    +      E+ L+  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           H N+V+LL      N+  L++EF+ +  L  F+ D +    +        +  + +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
            H     R++HRDLK  N+L++ E   K+ADFG+AR F +   +     +V T  Y APE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 173
Query: 499 YAMHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
             +  + YS   D++S G +  E+++  R   F     ++ L 
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 214

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSR---DSGQGDLEFKNEVLLVANL 377
           A ++F     LG+G FG VY  R      I A+K L +   +    + + + EV + ++L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           +H N++RL G+  +     LI E+ P   L     +  + ++ D +R    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           Y H     R+IHRD+K  N+LL +    KIADFG    + +       + + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 175
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           E      +  K D++S GVL  E + G+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 111/223 (49%), Gaps = 13/223 (5%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK--NEVLLVANLQ 378
           + +NF    K+G+G +G VYK R    G  +A+K++  D+    +      E+ L+  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           H N+V+LL      N+  L++EF+ +  L  F+ D +    +        +  + +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
            H     R++HRDLK  N+L++ E   K+ADFG+AR F +   +     +V T  Y APE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 173
Query: 499 YAMHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
             +  + YS   D++S G +  E+++  R   F     ++ L 
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 214

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSR---DSGQGDLEFKNEVLLVANL 377
           A ++F     LG+G FG VY  R      I A+K L +   +    + + + EV + ++L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           +H N++RL G+  +     LI E+ P   L     +  + ++ D +R    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           Y H     R+IHRD+K  N+LL +    KIADFG    + +       + + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 175
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           E      +  K D++S GVL  E + G+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 105/197 (53%), Gaps = 12/197 (6%)
Query: 331 KLGQGGFGAV-YKGRLYDGAEIAVKRLS-RDSGQGDLEFKNEVLLVANLQHRNLVRLLGF 388
           K+G+G  G V      + G ++AVK++  R   + +L F NEV+++ +  H N+V +   
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF-NEVVIMRDYHHDNVVDMYSS 110
Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRII 448
            L G+E  ++ EF+   +L     D     +++ E+   +   + R L YLH      +I
Sbjct: 111 YLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VI 163
Query: 449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVK 508
           HRD+K+ ++LL ++   K++DFG     ++ +       +VGT  +MAPE      Y  +
Sbjct: 164 HRDIKSDSILLTSDGRIKLSDFGFCA--QVSKEVPKRKXLVGTPYWMAPEVISRLPYGTE 221
Query: 509 SDVFSFGVLVLEIISGQ 525
            D++S G++V+E+I G+
Sbjct: 222 VDIWSLGIMVIEMIDGE 238

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 111/223 (49%), Gaps = 13/223 (5%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK--NEVLLVANLQ 378
           + +NF    K+G+G +G VYK R    G  +A+K++  D+    +      E+ L+  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           H N+V+LL      N+  L++EF+ +  L  F+ D +    +        +  + +GL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
            H     R++HRDLK  N+L++ E   K+ADFG+AR F +   +     +V T  Y APE
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 175
Query: 499 YAMHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
             +  + YS   D++S G +  E+++  R   F     ++ L 
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 216

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSR---DSGQGDLEFKNEVLLVANL 377
           A ++F     LG+G FG VY  R      I A+K L +   +    + + + EV + ++L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           +H N++RL G+  +     LI E+ P   L     +  + ++ D +R    I  +A  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           Y H     R+IHRD+K  N+LL +    KIADFG    + +       + + GT  Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 176
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           E      +  K D++S GVL  E + G+
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSR---DSGQGDLEFKNEVLLVANL 377
           A ++F     LG+G FG VY  R      I A+K L +   +    + + + EV + ++L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           +H N++RL G+  +     LI E+ P   L     +  + ++ D +R    I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           Y H     R+IHRD+K  N+LL +    KIADFG    + +       + + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           E      +  K D++S GVL  E + G+
Sbjct: 181 EXIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSR---DSGQGDLEFKNEVLLVANL 377
           A ++F     LG+G FG VY  R      I A+K L +   +    + + + EV + ++L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           +H N++RL G+  +     LI E+ P   L     +  + ++ D +R    I  +A  L 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           Y H     R+IHRD+K  N+LL +    KIADFG    + +         + GT  Y+ P
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 177
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           E      +  K D++S GVL  E + G+
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 104/215 (48%), Gaps = 32/215 (14%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-----IAVKRLSR-DSGQGDLEFKNEVLLVANLQ 378
            F     LG G FG VYKG      E     +A+K L    S + + E  +E  ++A++ 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI-IGG------ 431
           + ++ RLLG  L    +L I + +P   L            LD+ R +K  IG       
Sbjct: 83  NPHVCRLLGICLTSTVQL-ITQLMPFGCL------------LDYVREHKDNIGSQYLLNW 129
Query: 432 ---IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
              IA+G+ YL ED RL  +HRDL   NVL+      KI DFG A+L   +E + +    
Sbjct: 130 CVQIAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 186
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
                +MA E  +H  Y+ +SDV+S+GV V E+++
Sbjct: 187 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 111/223 (49%), Gaps = 13/223 (5%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK--NEVLLVANLQ 378
           + +NF    K+G+G +G VYK R    G  +A+K++  D+    +      E+ L+  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           H N+V+LL      N+  L++EF+ +  L  F+ D +    +        +  + +GL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
            H     R++HRDLK  N+L++ E   K+ADFG+AR F +   +     +V T  Y APE
Sbjct: 121 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 175
Query: 499 YAMHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
             +  + YS   D++S G +  E+++  R   F     ++ L 
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 216

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 104/215 (48%), Gaps = 32/215 (14%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-----IAVKRLSR-DSGQGDLEFKNEVLLVANLQ 378
            F     LG G FG VYKG      E     +A+K L    S + + E  +E  ++A++ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI-IGG------ 431
           + ++ RLLG  L    +L I + +P   L            LD+ R +K  IG       
Sbjct: 78  NPHVCRLLGICLTSTVQL-ITQLMPFGCL------------LDYVREHKDNIGSQYLLNW 124
Query: 432 ---IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
              IA+G+ YL ED RL  +HRDL   NVL+      KI DFG A+L   +E + +    
Sbjct: 125 CVQIAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
                +MA E  +H  Y+ +SDV+S+GV V E+++
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSR---DSGQGDLEFKNEVLLVANL 377
           A ++F     LG+G FG VY  R      I A+K L +   +    + + + EV + ++L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           +H N++RL G+  +     LI E+ P   L     +  + ++ D +R    I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           Y H     R+IHRD+K  N+LL +    KIADFG    + +       + + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 180
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           E      +  K D++S GVL  E + G+
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 111/223 (49%), Gaps = 13/223 (5%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK--NEVLLVANLQ 378
           + +NF    K+G+G +G VYK R    G  +A+K++  D+    +      E+ L+  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           H N+V+LL      N+  L++EF+ +  L  F+ D +    +        +  + +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
            H     R++HRDLK  N+L++ E   K+ADFG+AR F +   +     +V T  Y APE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 176
Query: 499 YAMHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
             +  + YS   D++S G +  E+++  R   F     ++ L 
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 217

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 111/223 (49%), Gaps = 13/223 (5%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK--NEVLLVANLQ 378
           + +NF    K+G+G +G VYK R    G  +A+K++  D+    +      E+ L+  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           H N+V+LL      N+  L++EF+ +  L  F+ D +    +        +  + +GL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
            H     R++HRDLK  N+L++ E   K+ADFG+AR F +   +     +V T  Y APE
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 175
Query: 499 YAMHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
             +  + YS   D++S G +  E+++  R   F     ++ L 
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 216

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 111/223 (49%), Gaps = 13/223 (5%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK--NEVLLVANLQ 378
           + +NF    K+G+G +G VYK R    G  +A+K++  D+    +      E+ L+  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           H N+V+LL      N+  L++EF+ +  L  F+ D +    +        +  + +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
            H     R++HRDLK  N+L++ E   K+ADFG+AR F +   +     +V T  Y APE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 173
Query: 499 YAMHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
             +  + YS   D++S G +  E+++  R   F     ++ L 
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 214

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 111/223 (49%), Gaps = 13/223 (5%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK--NEVLLVANLQ 378
           + +NF    K+G+G +G VYK R    G  +A+K++  D+    +      E+ L+  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           H N+V+LL      N+  L++EF+ +  L  F+ D +    +        +  + +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
            H     R++HRDLK  N+L++ E   K+ADFG+AR F +   +     +V T  Y APE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 176
Query: 499 YAMHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
             +  + YS   D++S G +  E+++  R   F     ++ L 
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 217

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 111/223 (49%), Gaps = 13/223 (5%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK--NEVLLVANLQ 378
           + +NF    K+G+G +G VYK R    G  +A+K++  D+    +      E+ L+  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           H N+V+LL      N+  L++EF+ +  L  F+ D +    +        +  + +GL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
            H     R++HRDLK  N+L++ E   K+ADFG+AR F +   +     +V T  Y APE
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 174
Query: 499 YAMHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
             +  + YS   D++S G +  E+++  R   F     ++ L 
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 215

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 111/223 (49%), Gaps = 13/223 (5%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK--NEVLLVANLQ 378
           + +NF    K+G+G +G VYK R    G  +A+K++  D+    +      E+ L+  L 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           H N+V+LL      N+  L++EF+ +  L  F+ D +    +        +  + +GL +
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 122
Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
            H     R++HRDLK  N+L++ E   K+ADFG+AR F +   +     +V T  Y APE
Sbjct: 123 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 177
Query: 499 YAMHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
             +  + YS   D++S G +  E+++  R   F     ++ L 
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 218

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 111/223 (49%), Gaps = 13/223 (5%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK--NEVLLVANLQ 378
           + +NF    K+G+G +G VYK R    G  +A+K++  D+    +      E+ L+  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           H N+V+LL      N+  L++EF+ +  L  F+ D +    +        +  + +GL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
            H     R++HRDLK  N+L++ E   K+ADFG+AR F +   +     +V T  Y APE
Sbjct: 120 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 174
Query: 499 YAMHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
             +  + YS   D++S G +  E+++  R   F     ++ L 
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 215

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 20/211 (9%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSR---DSGQGDLEFKNEVLLVANL 377
           A ++F     LG+G FG VY  R      I A+K L +   +    + + + EV + ++L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           +H N++RL G+  +     LI E+ P   L     +  + ++ D +R    I  +A  L 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSR---IVGTYGY 494
           Y H     R+IHRD+K  N+LL +    KIADFG +           +SR   + GT  Y
Sbjct: 149 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDDLCGTLDY 198
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           + PE      +  K D++S GVL  E + G+
Sbjct: 199 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 111/223 (49%), Gaps = 13/223 (5%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK--NEVLLVANLQ 378
           + +NF    K+G+G +G VYK R    G  +A+K++  D+    +      E+ L+  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           H N+V+LL      N+  L++EF+ +  L  F+ D +    +        +  + +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
            H     R++HRDLK  N+L++ E   K+ADFG+AR F +   +     +V T  Y APE
Sbjct: 122 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 176
Query: 499 YAMHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
             +  + YS   D++S G +  E+++  R   F     ++ L 
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 217

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 110/221 (49%), Gaps = 13/221 (5%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK--NEVLLVANLQHR 380
           +NF    K+G+G +G VYK R    G  +A+K++  D+    +      E+ L+  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH 440
           N+V+LL      N+  L++EF+ +  L  F+ D +    +        +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 441 EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA 500
                R++HRDLK  N+L++ E   K+ADFG+AR F +   +     +V T  Y APE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPEIL 174
Query: 501 MHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
           +  + YS   D++S G +  E+++  R   F     ++ L 
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 213

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 111/223 (49%), Gaps = 13/223 (5%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK--NEVLLVANLQ 378
           + +NF    K+G+G +G VYK R    G  +A+K++  D+    +      E+ L+  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           H N+V+LL      N+  L++EF+ +  L  F+ D +    +        +  + +GL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
            H     R++HRDLK  N+L++ E   K+ADFG+AR F +   +     +V T  Y APE
Sbjct: 120 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 174
Query: 499 YAMHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
             +  + YS   D++S G +  E+++  R   F     ++ L 
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 215

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 111/223 (49%), Gaps = 13/223 (5%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK--NEVLLVANLQ 378
           + +NF    K+G+G +G VYK R    G  +A+K++  D+    +      E+ L+  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           H N+V+LL      N+  L++EF+ +  L  F+ D +    +        +  + +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
            H     R++HRDLK  N+L++ E   K+ADFG+AR F +   +     +V T  Y APE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 173
Query: 499 YAMHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
             +  + YS   D++S G +  E+++  R   F     ++ L 
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 214

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 110/221 (49%), Gaps = 13/221 (5%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK--NEVLLVANLQHR 380
           +NF    K+G+G +G VYK R    G  +A+K++  D+    +      E+ L+  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH 440
           N+V+LL      N+  L++EF+ +  L  F+ D +    +        +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 441 EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA 500
                R++HRDLK  N+L++ E   K+ADFG+AR F +   +     +V T  Y APE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPEIL 174
Query: 501 MHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
           +  + YS   D++S G +  E+++  R   F     ++ L 
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 213

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 110/221 (49%), Gaps = 13/221 (5%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK--NEVLLVANLQHR 380
           +NF    K+G+G +G VYK R    G  +A+K++  D+    +      E+ L+  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH 440
           N+V+LL      N+  L++E V +  L  F+ D +    +        +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHV-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 441 EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA 500
                R++HRDLK  N+L++ E   K+ADFG+AR F +   +  T  +V T  Y APE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 174
Query: 501 MHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
           +  + YS   D++S G +  E+++  R   F     ++ L 
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 213

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 124/270 (45%), Gaps = 33/270 (12%)
Query: 330 NKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFS 389
            +LG G FG V  G+     ++AVK +   S   D EF  E   +  L H  LV+  G  
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED-EFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 390 LEGNERLLIYEFVPNTSLDHFI------FDPTRRAQLDWERRYKIIGGIARGLLYLHEDS 443
            +     ++ E++ N  L +++       +P++  ++ ++        +  G+ +L    
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYD--------VCEGMAFLESH- 123
Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG 503
             + IHRDL   N L+D ++  K++DFGM R + +D+   ++        + APE   + 
Sbjct: 124 --QFIHRDLAARNCLVDRDLCVKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAPEVFHYF 180
Query: 504 QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSG 563
           +YS KSDV++FG+L+ E+        F  G+   DL +++    +      +  P L+S 
Sbjct: 181 KYSSKSDVWAFGILMWEV--------FSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASD 232
Query: 564 SITEMIRCIHIGLLCVQENVASRPTMASVV 593
           +I +++        C  E    RPT   ++
Sbjct: 233 TIYQIMYS------CWHELPEKRPTFQQLL 256

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSR---DSGQGDLEFKNEVLLVANL 377
           A ++F     LG+G FG VY  R      I A+K L +   +    + + + EV + ++L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           +H N++RL G+  +     LI E+ P   L     +  + ++ D +R    I  +A  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           Y H     R+IHRD+K  N+LL +    KIADFG    + +         + GT  Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDTLCGTLDYLPP 176
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           E      +  K D++S GVL  E + G+
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 110/221 (49%), Gaps = 13/221 (5%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK--NEVLLVANLQHR 380
           +NF    K+G+G +G VYK R    G  +A+K++  D+    +      E+ L+  L H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH 440
           N+V+LL      N+  L++EF+ +  L  F+ D +    +        +  + +GL + H
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 441 EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA 500
                R++HRDLK  N+L++ E   K+ADFG+AR F +   +     +V T  Y APE  
Sbjct: 122 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPEIL 176
Query: 501 MHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
           +  + YS   D++S G +  E+++  R   F     ++ L 
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 215

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSR---DSGQGDLEFKNEVLLVANL 377
           A ++F     LG+G FG VY  R      I A+K L +   +    + + + EV + ++L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           +H N++RL G+  +     LI E+ P   L     +  + ++ D +R    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           Y H     R+IHRD+K  N+LL +    KIADFG    + +       + + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTXLCGTLDYLPP 175
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           E      +  K D++S GVL  E + G+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 110/221 (49%), Gaps = 13/221 (5%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK--NEVLLVANLQHR 380
           +NF    K+G+G +G VYK R    G  +A+ ++  D+    +      E+ L+  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH 440
           N+V+LL      N+  L++EF+ +  L  F+ D +    +        +  + +GL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 441 EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA 500
                R++HRDLK  N+L++ E   K+ADFG+AR F +   +  T  +V T  Y APE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 175
Query: 501 MHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
           +  + YS   D++S G +  E+++  R   F     ++ L 
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 214

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 110/221 (49%), Gaps = 13/221 (5%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK--NEVLLVANLQHR 380
           +NF    K+G+G +G VYK R    G  +A+ ++  D+    +      E+ L+  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH 440
           N+V+LL      N+  L++EF+ +  L  F+ D +    +        +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 441 EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA 500
                R++HRDLK  N+L++ E   K+ADFG+AR F +   +  T  +V T  Y APE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 174
Query: 501 MHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
           +  + YS   D++S G +  E+++  R   F     ++ L 
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 213

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 111/223 (49%), Gaps = 13/223 (5%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK--NEVLLVANLQ 378
           + +NF    K+G+G +G VYK R    G  +A+K++  D+    +      E+ L+  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           H N+V+LL      N+  L++EF+ +  L  F+ D +    +        +  + +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
            H     R++HRDLK  N+L++ E   K+ADFG+AR F +   +     +V T  Y APE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 176
Query: 499 YAMHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
             +  + YS   D++S G +  E+++  R   F     ++ L 
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 217

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 111/223 (49%), Gaps = 13/223 (5%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK--NEVLLVANLQ 378
           + +NF    K+G+G +G VYK R    G  +A+K++  D+    +      E+ L+  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           H N+V+LL      N+  L++EF+ +  L  F+ D +    +        +  + +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
            H     R++HRDLK  N+L++ E   K+ADFG+AR F +   +     +V T  Y APE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 176
Query: 499 YAMHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
             +  + YS   D++S G +  E+++  R   F     ++ L 
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 217

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSR---DSGQGDLEFKNEVLLVANL 377
           A ++F     LG+G FG VY  R      I A+K L +   +    + + + EV + ++L
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           +H N++RL G+  +     LI E+ P   L     +  + ++ D +R    I  +A  L 
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 121
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           Y H     R+IHRD+K  N+LL +    KIADFG    + +       + + GT  Y+ P
Sbjct: 122 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 174
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           E      +  K D++S GVL  E + G+
Sbjct: 175 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSR---DSGQGDLEFKNEVLLVANL 377
           A ++F     LG+G FG VY  R      I A+K L +   +    + + + EV + ++L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           +H N++RL G+  +     LI E+ P   +   +    + ++ D +R    I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL---QKLSKFDEQRTATYITELANALS 127
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           Y H     R+IHRD+K  N+LL +    KIADFG    + +         + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLXGTLDYLPP 180
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           E      +  K D++S GVL  E + G+
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 104/215 (48%), Gaps = 32/215 (14%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-----IAVKRLSR-DSGQGDLEFKNEVLLVANLQ 378
            F     L  G FG VYKG      E     +A+K L    S + + E  +E  ++A++ 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI-IGG------ 431
           + ++ RLLG  L    +L I + +P   L            LD+ R +K  IG       
Sbjct: 83  NPHVCRLLGICLTSTVQL-IMQLMPFGCL------------LDYVREHKDNIGSQYLLNW 129
Query: 432 ---IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
              IA+G+ YL ED RL  +HRDL   NVL+      KI DFG+A+L   +E + +    
Sbjct: 130 CVQIAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
                +MA E  +H  Y+ +SDV+S+GV V E+++
Sbjct: 187 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 111/223 (49%), Gaps = 13/223 (5%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK--NEVLLVANLQ 378
           + +NF    K+G+G +G VYK R    G  +A+K++  D+    +      E+ L+  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           H N+V+LL      N+  L++EF+ +  L  F+ D +    +        +  + +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
            H     R++HRDLK  N+L++ E   K+ADFG+AR F +   +     +V T  Y APE
Sbjct: 119 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 173
Query: 499 YAMHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
             +  + YS   D++S G +  E+++  R   F     ++ L 
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 214

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSR---DSGQGDLEFKNEVLLVANL 377
           A ++F     LG+G FG VY  R      I A+K L +   +    + + + EV + ++L
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           +H N++RL G+  +     LI E+ P   L     +  + ++ D +R    I  +A  L 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 126
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           Y H     R+IHRD+K  N+LL +    KIADFG    + +       + + GT  Y+ P
Sbjct: 127 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 179
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           E      +  K D++S GVL  E + G+
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSR---DSGQGDLEFKNEVLLVANL 377
           A ++F     LG+G FG VY  R      I A+K L +   +    + + + EV + ++L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           +H N++RL G+  +     LI E+ P   L     +  + ++ D +R    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           Y H     R+IHRD+K  N+LL +    KIADFG    + +       + + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 175
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           E      +  K D++S GVL  E + G+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 120/254 (47%), Gaps = 41/254 (16%)
Query: 287 RRKPRDNSKVKSEAAAGDEINRAESLQFDFNTIRVATDN-FSDANKLGQGGFGAVYKGRL 345
           RR  ++   V+    +G+  N+A         +R+  +  F     LG G FG VYKG  
Sbjct: 19  RRLLQERELVEPLTPSGEAPNQA--------LLRILKETEFKKIKVLGSGAFGTVYKGLW 70
Query: 346 YDGAE-----IAVKRLSR-DSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY 399
               E     +A+  L    S + + E  +E  ++A++ + ++ RLLG  L    +L I 
Sbjct: 71  IPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-IT 129
Query: 400 EFVPNTSLDHFIFDPTRRAQLDWERRYKI-IGG---------IARGLLYLHEDSRLRIIH 449
           + +P   L            LD+ R +K  IG          IA+G+ YL ED RL  +H
Sbjct: 130 QLMPFGCL------------LDYVREHKDNIGSQYLLNWCVQIAKGMNYL-EDRRL--VH 174
Query: 450 RDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKS 509
           RDL   NVL+      KI DFG+A+L   +E + +         +MA E  +H  Y+ +S
Sbjct: 175 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 234
Query: 510 DVFSFGVLVLEIIS 523
           DV+S+GV V E+++
Sbjct: 235 DVWSYGVTVWELMT 248

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSR---DSGQGDLEFKNEVLLVANL 377
           A ++F     LG+G FG VY  R      I A+K L +   +    + + + EV + ++L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           +H N++RL G+  +     LI E+ P   L     +  + ++ D +R    I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           Y H     R+IHRD+K  N+LL +    KIADFG    + +       + + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           E      +  K D++S GVL  E + G+
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 104/215 (48%), Gaps = 32/215 (14%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-----IAVKRLSR-DSGQGDLEFKNEVLLVANLQ 378
            F     L  G FG VYKG      E     +A+K L    S + + E  +E  ++A++ 
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI-IGG------ 431
           + ++ RLLG  L    +L I + +P   L            LD+ R +K  IG       
Sbjct: 76  NPHVCRLLGICLTSTVQL-ITQLMPFGCL------------LDYVREHKDNIGSQYLLNW 122
Query: 432 ---IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
              IA+G+ YL ED RL  +HRDL   NVL+      KI DFG+A+L   +E + +    
Sbjct: 123 CVQIAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
                +MA E  +H  Y+ +SDV+S+GV V E+++
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 111/223 (49%), Gaps = 13/223 (5%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK--NEVLLVANLQ 378
           + +NF    K+G+G +G VYK R    G  +A+K++  D+    +      E+ L+  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           H N+V+LL      N+  L++EF+ +  L  F+ D +    +        +  + +GL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
            H     R++HRDLK  N+L++ E   K+ADFG+AR F +   +     +V T  Y APE
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 175
Query: 499 YAMHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
             +  + YS   D++S G +  E+++  R   F     ++ L 
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 216

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 132/275 (48%), Gaps = 29/275 (10%)
Query: 332 LGQGGFGAVYKG--RLYDGAEIAVKRLSRDSGQGDLE---FKNEVLLVANLQHRNLVRLL 386
           +G G FG V  G  +L    EI V   +  SG  + +   F +E  ++    H N++ L 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 387 GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLR 446
           G   +    ++I EF+ N SLD F+       Q    +   ++ GIA G+ YL +   + 
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLAD---MN 129
Query: 447 IIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVG---TYGYMAPEYAMHG 503
            +HR L   N+L+++ +  K++DFG++R  E D +    +  +G      + APE   + 
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 189
Query: 504 QYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSS 562
           +++  SDV+S+G+++ E++S G+R        T +D++++  +++R       + P +  
Sbjct: 190 KFTSASDVWSYGIVMWEVMSYGERPYW---DMTNQDVINAIEQDYR-------LPPPMDC 239
Query: 563 GSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN 597
            S         + L C Q++   RP    +V  L+
Sbjct: 240 PSALH-----QLMLDCWQKDRNHRPKFGQIVNTLD 269

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 104/215 (48%), Gaps = 32/215 (14%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-----IAVKRLSR-DSGQGDLEFKNEVLLVANLQ 378
            F     L  G FG VYKG      E     +A+K L    S + + E  +E  ++A++ 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI-IGG------ 431
           + ++ RLLG  L    +L I + +P   L            LD+ R +K  IG       
Sbjct: 83  NPHVCRLLGICLTSTVQL-ITQLMPFGCL------------LDYVREHKDNIGSQYLLNW 129
Query: 432 ---IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
              IA+G+ YL ED RL  +HRDL   NVL+      KI DFG+A+L   +E + +    
Sbjct: 130 CVQIAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
                +MA E  +H  Y+ +SDV+S+GV V E+++
Sbjct: 187 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 105/205 (51%), Gaps = 11/205 (5%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFK--NEVLLVANLQHRN 381
           + +    K+G+G +G VYK +   G  +A+KR+  D+    +      E+ L+  L H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           +V L+          L++EF+        + D  +    D + +  +   + RG+ + H+
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEKDLKK--VLDENKTGLQDSQIKIYLYQ-LLRGVAHCHQ 137
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM 501
               RI+HRDLK  N+L++++   K+ADFG+AR F +   +  T  +V T  Y AP+  M
Sbjct: 138 H---RILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVV-TLWYRAPDVLM 192
Query: 502 -HGQYSVKSDVFSFGVLVLEIISGQ 525
              +YS   D++S G +  E+I+G+
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 105/205 (51%), Gaps = 11/205 (5%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFK--NEVLLVANLQHRN 381
           + +    K+G+G +G VYK +   G  +A+KR+  D+    +      E+ L+  L H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           +V L+          L++EF+        + D  +    D + +  +   + RG+ + H+
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEKDLKK--VLDENKTGLQDSQIKIYLYQ-LLRGVAHCHQ 137
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM 501
               RI+HRDLK  N+L++++   K+ADFG+AR F +   +  T  +V T  Y AP+  M
Sbjct: 138 H---RILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVV-TLWYRAPDVLM 192
Query: 502 -HGQYSVKSDVFSFGVLVLEIISGQ 525
              +YS   D++S G +  E+I+G+
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 111/216 (51%), Gaps = 19/216 (8%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVY--KGRLYDGAEIAVKRLSRDSGQGDLEFKN---EV 371
           ++  + +D +     LG+G FG V   K ++  G E AVK +S+   +   + ++   EV
Sbjct: 19  HSTAIFSDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREV 77
Query: 372 LLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG 431
            L+  L H N+ +L  F  +     L+ E      L   I    R +++D  R   II  
Sbjct: 78  QLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQ 134
Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP---KIADFGMARLFEMDETQGNTSRI 488
           +  G+ Y H++   +I+HRDLK  N+LL+++      +I DFG++  FE  +   +    
Sbjct: 135 VLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDK--- 188
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +GT  Y+APE  +HG Y  K DV+S GV++  ++SG
Sbjct: 189 IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSR---DSGQGDLEFKNEVLLVANL 377
           A ++F     LG+G FG VY  R      I A+K L +   +    + + + EV + ++L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           +H N++RL G+  +     LI E+ P   L     +  + ++ D +R    I  +A  L 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           Y H     R+IHRD+K  N+LL +    KIA+FG    + +       + + GT  Y+ P
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPP 177
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           E      +  K D++S GVL  E + G+
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 103/202 (50%), Gaps = 12/202 (5%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLV 383
           F    KLG+G +G+VYK    +  +I A+K++  +S   DL E   E+ ++      ++V
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVV 87
Query: 384 RLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS 443
           +  G   +  +  ++ E+    S+   I    R   L  +    I+    +GL YLH   
Sbjct: 88  KYYGSYFKNTDLWIVMEYCGAGSVSDIIR--LRNKTLTEDEIATILQSTLKGLEYLH--- 142
Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG 503
            +R IHRD+K  N+LL+ E   K+ADFG+A   ++ +     + ++GT  +MAPE     
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAG--QLTDXMAKRNXVIGTPFWMAPEVIQEI 200
Query: 504 QYSVKSDVFSFGVLVLEIISGQ 525
            Y+  +D++S G+  +E+  G+
Sbjct: 201 GYNCVADIWSLGITAIEMAEGK 222

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSR---DSGQGDLEFKNEVLLVANL 377
           A ++F     LG+G FG VY  R      I A+K L +   +    + + + EV + ++L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           +H N++RL G+  +     LI E+ P   L     +  + ++ D +R    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           Y H     R+IHRD+K  N+LL +    KIADFG    + +         + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 175
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           E      +  K D++S GVL  E + G+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 322 ATDNFSDANKLGQGGFGAVY----KGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANL 377
           A ++F     LG+G FG VY    K R +  A   + +   +    + + + EV + ++L
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           +H N++RL G+  +     LI E+ P   L     +  + ++ D +R    I  +A  L 
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 119
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           Y H     R+IHRD+K  N+LL +    KIADFG    + +       + + GT  Y+ P
Sbjct: 120 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 172
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           E      +  K D++S GVL  E + G+
Sbjct: 173 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSR---DSGQGDLEFKNEVLLVANL 377
           A ++F     LG+G FG VY  R      I A+K L +   +    + + + EV + ++L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           +H N++RL G+  +     LI E+ P   L     +  + ++ D +R    I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           Y H     R+IHRD+K  N+LL +    KIADFG    + +         + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 178
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           E      +  K D++S GVL  E + G+
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 130/274 (47%), Gaps = 27/274 (9%)
Query: 332 LGQGGFGAVYKGRLYDGAE----IAVKRLSRD-SGQGDLEFKNEVLLVANLQHRNLVRLL 386
           +G G FG V  GRL    +    +A+K L    + +   +F  E  ++    H N+V L 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 387 GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLR 446
           G    G   +++ EF+ N +LD F+       Q    +   ++ GIA G+ YL +   + 
Sbjct: 111 GVVTRGKPVMIVIEFMENGALDAFL--RKHDGQFTVIQLVGMLRGIAAGMRYLAD---MG 165
Query: 447 IIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD-ETQGNTSRIVGTYGYMAPEYAMHGQY 505
            +HRDL   N+L+++ +  K++DFG++R+ E D E    T+       + APE   + ++
Sbjct: 166 YVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKF 225
Query: 506 SVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGS 564
           +  SDV+S+G+++ E++S G+R     + + V   +   ++         +  P      
Sbjct: 226 TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYR---------LPAPMDCPAG 276
Query: 565 ITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS 598
           + +++      L C Q+  A RP    +V +L+ 
Sbjct: 277 LHQLM------LDCWQKERAERPKFEQIVGILDK 304

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 121/263 (46%), Gaps = 23/263 (8%)
Query: 330 NKLGQGGFGAVYKGRLYDGA-EIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGF 388
           +KLG G +G VY G     +  +AVK L  D+ + + EF  E  ++  ++H NLV+LLG 
Sbjct: 38  HKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 96
Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRII 448
                   ++ E++P  +L  ++ +  R         Y +   I+  + YL + +    I
Sbjct: 97  CTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLY-MATQISSAMEYLEKKN---FI 152
Query: 449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVK 508
           HRDL   N L+      K+ADFG++RL   D    +         + APE   +  +S+K
Sbjct: 153 HRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNTFSIK 211
Query: 509 SDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITE 567
           SDV++FGVL+ EI + G       +   V DLL   ++         +  P      + E
Sbjct: 212 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEKGYR---------MEQPEGCPPKVYE 262
Query: 568 MIRCIHIGLLCVQENVASRPTMA 590
           ++R       C + + A RP+ A
Sbjct: 263 LMRA------CWKWSPADRPSFA 279

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSR---DSGQGDLEFKNEVLLVANL 377
           A ++F     LG+G FG VY  R      I A+K L +   +    + + + EV + ++L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           +H N++RL G+  +     LI E+ P   L     +  + ++ D +R    I  +A  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           Y H     R+IHRD+K  N+LL +    KIADFG    +         + + GT  Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSCHAPSSRRTTLSGTLDYLPP 176
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           E      +  K D++S GVL  E + G+
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 131/280 (46%), Gaps = 23/280 (8%)
Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGA-EIAVKRLSRDSGQGDLEFKNEVLL 373
           +++   +   + +  +KLG G +G VY+G     +  +AVK L  D+ + + EF  E  +
Sbjct: 250 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 308
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA 433
           +  ++H NLV+LLG         +I EF+   +L  ++ +   R +++      +   I+
Sbjct: 309 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQIS 367
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             + YL + +    IHR+L   N L+      K+ADFG++RL   D    +         
Sbjct: 368 SAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-K 423
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTT 552
           + APE   + ++S+KSDV++FGVL+ EI + G       +   V +LL   ++  R    
Sbjct: 424 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER---- 479
Query: 553 VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASV 592
                P      + E++R       C Q N + RP+ A +
Sbjct: 480 -----PEGCPEKVYELMRA------CWQWNPSDRPSFAEI 508

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 110/223 (49%), Gaps = 13/223 (5%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK--NEVLLVANLQ 378
           + +NF    K+G+G +G VYK R    G  +A+K++  D+    +      E+ L+  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           H N+V+LL      N+  L++E V +  L  F+ D +    +        +  + +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
            H     R++HRDLK  N+L++ E   K+ADFG+AR F +   +     +V T  Y APE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 176
Query: 499 YAMHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
             +  + YS   D++S G +  E+++  R   F     ++ L 
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 217

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 130/280 (46%), Gaps = 23/280 (8%)
Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGA-EIAVKRLSRDSGQGDLEFKNEVLL 373
           +++   +   + +  +KLG G +G VY+G     +  +AVK L  D+ + + EF  E  +
Sbjct: 211 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 269
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA 433
           +  ++H NLV+LLG         +I EF+   +L  ++ +   R ++       +   I+
Sbjct: 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQIS 328
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             + YL + +    IHR+L   N L+      K+ADFG++RL   D    +         
Sbjct: 329 SAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-K 384
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTT 552
           + APE   + ++S+KSDV++FGVL+ EI + G       +   V +LL   ++  R    
Sbjct: 385 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER---- 440
Query: 553 VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASV 592
                P      + E++R       C Q N + RP+ A +
Sbjct: 441 -----PEGCPEKVYELMRA------CWQWNPSDRPSFAEI 469

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSR---DSGQGDLEFKNEVLLVANL 377
           A ++F     LG+G FG VY  R  +   I A+K L +   +    + + + EV + ++L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           +H N++RL G+  +     LI E+ P   L     +  + ++ D +R    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           Y H     ++IHRD+K  N+LL +    KIADFG    + +       + + GT  Y+ P
Sbjct: 123 YCHSK---KVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 175
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           E      +  K D++S GVL  E + G+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 20/211 (9%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSR---DSGQGDLEFKNEVLLVANL 377
           A ++F     LG+G FG VY  R      I A+K L +   +    + + + EV + ++L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           +H N++RL G+  +     LI E+ P   L     +  + ++ D +R    I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSR---IVGTYGY 494
           Y H     R+IHRD+K  N+LL +    KIADFG +           +SR   + GT  Y
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDDLCGTLDY 175
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           + PE      +  K D++S GVL  E + G+
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 107/228 (46%), Gaps = 40/228 (17%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
           DN      +G+G +GAVYKG L D   +AVK  S  + Q  +  KN +  V  ++H N+ 
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKN-IYRVPLMEHDNIA 70
Query: 384 RLLGFSLEGNER---------LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
           R +     G+ER         LL+ E+ PN SL  ++   T     DW    ++   + R
Sbjct: 71  RFIV----GDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS----DWVSSCRLAHSVTR 122
Query: 435 GLLYLH------EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMA------RLFEMDETQ 482
           GL YLH      +  +  I HRDL + NVL+  + T  I+DFG++      RL    E  
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 483 GNTSRIVGTYGYMAPEYAMHGQYSVKS--------DVFSFGVLVLEII 522
                 VGT  YMAPE  + G  +++         D+++ G++  EI 
Sbjct: 183 NAAISEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSR---DSGQGDLEFKNEVLLVANL 377
           A ++F     LG+G FG VY  R      I A+K L +   +    + + + EV + ++L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           +H N++RL G+  +     LI E+ P   L     +  + ++ D +R    I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           Y H     R+IHRD+K  N+LL +    KIA+FG    + +       + + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           E      +  K D++S GVL  E + G+
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 100/198 (50%), Gaps = 15/198 (7%)
Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLVRLLGFS 389
           +LG G FG VYK +  +   +A  ++     + +LE +  E+ ++A   H  +V+LLG  
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 390 LEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKII-GGIARGLLYLHEDSRLRII 448
               +  ++ EF P  ++D  + +  R      E + +++   +   L +LH     RII
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVVCRQMLEALNFLHSK---RII 131
Query: 449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM-----HG 503
           HRDLK  NVL+  E   ++ADFG++   +  +T       +GT  +MAPE  M       
Sbjct: 132 HRDLKAGNVLMTLEGDIRLADFGVSA--KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDT 189
Query: 504 QYSVKSDVFSFGVLVLEI 521
            Y  K+D++S G+ ++E+
Sbjct: 190 PYDYKADIWSLGITLIEM 207

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 124/279 (44%), Gaps = 24/279 (8%)
Query: 332 LGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLE 391
           +G+G FG V K + +   ++A+K++  +S +    F  E+  ++ + H N+V+L G  L 
Sbjct: 17  VGRGAFGVVCKAK-WRAKDVAIKQIESESERK--AFIVELRQLSRVNHPNIVKLYGACL- 72
Query: 392 GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRD 451
            N   L+ E+    SL + +                     ++G+ YLH      +IHRD
Sbjct: 73  -NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 131
Query: 452 LKTSNVLLDAEMTP-KIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSD 510
           LK  N+LL A  T  KI DFG A      + Q + +   G+  +MAPE      YS K D
Sbjct: 132 LKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCD 186
Query: 511 VFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIR 570
           VFS+G+++ E+I+ +R      G     ++ +     R     N+  P  S      M R
Sbjct: 187 VFSWGIILWEVIT-RRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESL-----MTR 240
Query: 571 CIHIGLLCVQENVASRPTMASVVLMLNSYSLTLPVPSEP 609
           C         ++ + RP+M  +V ++       P   EP
Sbjct: 241 CW-------SKDPSQRPSMEEIVKIMTHLMRYFPGADEP 272

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 124/279 (44%), Gaps = 24/279 (8%)
Query: 332 LGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLE 391
           +G+G FG V K + +   ++A+K++  +S +    F  E+  ++ + H N+V+L G  L 
Sbjct: 16  VGRGAFGVVCKAK-WRAKDVAIKQIESESERK--AFIVELRQLSRVNHPNIVKLYGACL- 71
Query: 392 GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRD 451
            N   L+ E+    SL + +                     ++G+ YLH      +IHRD
Sbjct: 72  -NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 452 LKTSNVLLDAEMTP-KIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSD 510
           LK  N+LL A  T  KI DFG A      + Q + +   G+  +MAPE      YS K D
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCD 185
Query: 511 VFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIR 570
           VFS+G+++ E+I+ +R      G     ++ +     R     N+  P  S      M R
Sbjct: 186 VFSWGIILWEVIT-RRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESL-----MTR 239
Query: 571 CIHIGLLCVQENVASRPTMASVVLMLNSYSLTLPVPSEP 609
           C         ++ + RP+M  +V ++       P   EP
Sbjct: 240 CW-------SKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 115/230 (50%), Gaps = 22/230 (9%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGR-LYDGAE-IAVKRLSRDSGQGDLEFKN--EVLLVANL 377
           A   +    ++G+G +G V+K R L +G   +A+KR+   +G+  +      EV ++ +L
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 378 Q---HRNLVRLLGF-SLEGNER----LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKII 429
           +   H N+VRL    ++   +R     L++E V +  L  ++ D      +  E    ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIV 489
             + RGL +LH     R++HRDLK  N+L+ +    K+ADFG+AR++     Q   + +V
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVV 180
Query: 490 GTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDL 539
            T  Y APE  +   Y+   D++S G +  E+   +R   FR    V+ L
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF--RRKPLFRGSSDVDQL 228

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 109/223 (48%), Gaps = 24/223 (10%)
Query: 312 LQFDFNTIRVATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNE 370
           L++D+       D   D   LG+G +G VY GR L +   IA+K +     +       E
Sbjct: 15  LEYDYEY-----DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEE 69
Query: 371 VLLVANLQHRNLVRLLG-FSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKII 429
           + L  +L+H+N+V+ LG FS  G  ++ + E VP  SL   +    R      +   + I
Sbjct: 70  IALHKHLKHKNIVQYLGSFSENGFIKIFM-EQVPGGSLSALL----RSKWGPLKDNEQTI 124
Query: 430 G----GIARGLLYLHEDSRLRIIHRDLKTSNVLLDA-EMTPKIADFGMARLFEMDETQGN 484
           G     I  GL YLH++   +I+HRD+K  NVL++      KI+DFG ++   +      
Sbjct: 125 GFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSK--RLAGINPC 179
Query: 485 TSRIVGTYGYMAPEYAMHGQ--YSVKSDVFSFGVLVLEIISGQ 525
           T    GT  YMAPE    G   Y   +D++S G  ++E+ +G+
Sbjct: 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 108/218 (49%), Gaps = 27/218 (12%)
Query: 314 FDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLE-FKNEVL 372
           ++ +   +  ++     KLG G FG V+        ++AVK +    G   +E F  E  
Sbjct: 172 WEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMK--PGSMSVEAFLAEAN 229
Query: 373 LVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI-FDPTRRAQLDWERRYKII-- 429
           ++  LQH  LV+L    +      +I EF+   SL  F+  D   +  L      K+I  
Sbjct: 230 VMKTLQHDKLVKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP-----KLIDF 283
Query: 430 -GGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
              IA G+ ++ + +    IHRDL+ +N+L+ A +  KIADFG+AR+       G    I
Sbjct: 284 SAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARV-------GAKFPI 333
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQR 526
             T    APE    G +++KSDV+SFG+L++EI++  R
Sbjct: 334 KWT----APEAINFGSFTIKSDVWSFGILLMEIVTYGR 367

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 106/223 (47%), Gaps = 26/223 (11%)
Query: 324 DNFSDANKLGQGGFGAVY--------KGRLYDGAEIAVKRLSRDSGQGDL-EFKNEVLLV 374
           D  +    LG+G FG V         K +  +   +AVK L  D+ + DL +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 375 ANL-QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI-----------FDPTR--RAQL 420
             + +H+N++ LLG   +     +I E+    +L  ++           +D  R    Q+
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 421 DWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE 480
            ++        +ARG+ YL   +  + IHRDL   NVL+      KIADFG+AR     +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
              NT+       +MAPE      Y+ +SDV+SFGVL+ EI +
Sbjct: 212 YYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 100/198 (50%), Gaps = 15/198 (7%)
Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLVRLLGFS 389
           +LG G FG VYK +  +   +A  ++     + +LE +  E+ ++A   H  +V+LLG  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 390 LEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKII-GGIARGLLYLHEDSRLRII 448
               +  ++ EF P  ++D  + +  R      E + +++   +   L +LH     RII
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVVCRQMLEALNFLHSK---RII 139
Query: 449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM-----HG 503
           HRDLK  NVL+  E   ++ADFG++   +  +T       +GT  +MAPE  M       
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVSA--KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDT 197
Query: 504 QYSVKSDVFSFGVLVLEI 521
            Y  K+D++S G+ ++E+
Sbjct: 198 PYDYKADIWSLGITLIEM 215

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 114/236 (48%), Gaps = 21/236 (8%)
Query: 323 TDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGD---LEFKNEVLLVANLQ 378
           +D +     LG GG   V+  R L D  ++AVK L  D  +     L F+ E    A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 379 HRNLVRLL----GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
           H  +V +       +  G    ++ E+V   +L   +        +  +R  ++I    +
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 127
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQGNTSRIVGTYG 493
            L + H++    IIHRD+K +N+L+ A    K+ DFG+AR + +   +   T+ ++GT  
Sbjct: 128 ALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQ 184
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWRE 549
           Y++PE A       +SDV+S G ++ E+++G+    F    T +  +S A+++ RE
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE--PPF----TGDSPVSVAYQHVRE 234

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 118/238 (49%), Gaps = 16/238 (6%)
Query: 290 PRDNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYD-G 348
           PR   + + +  + ++   A  L  D    R   DNF    K+G+G  G V    +   G
Sbjct: 121 PRSPQR-EPQRVSHEQFRAALQLVVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSG 176
Query: 349 AEIAVKRLS-RDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSL 407
             +AVK++  R   + +L F NEV+++ + QH N+V +    L G+E  ++ EF+   +L
Sbjct: 177 KLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 235
Query: 408 DHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKI 467
              +       +++ E+   +   + + L  LH      +IHRD+K+ ++LL  +   K+
Sbjct: 236 TDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKL 288
Query: 468 ADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           +DFG     ++ +       +VGT  +MAPE      Y  + D++S G++V+E++ G+
Sbjct: 289 SDFGFC--AQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 344

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 115/230 (50%), Gaps = 22/230 (9%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGR-LYDGAE-IAVKRLSRDSGQGDLEFKN--EVLLVANL 377
           A   +    ++G+G +G V+K R L +G   +A+KR+   +G+  +      EV ++ +L
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 378 Q---HRNLVRLLGF-SLEGNER----LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKII 429
           +   H N+VRL    ++   +R     L++E V +  L  ++ D      +  E    ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIV 489
             + RGL +LH     R++HRDLK  N+L+ +    K+ADFG+AR++     Q   + +V
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVV 180
Query: 490 GTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDL 539
            T  Y APE  +   Y+   D++S G +  E+   +R   FR    V+ L
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF--RRKPLFRGSSDVDQL 228

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 14/205 (6%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSR---DSGQGDLEFKNEVLLVANLQH 379
           ++F     LG+G FG VY  R      I A+K L +   +    + + + EV + ++L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            N++RL G+  +     LI E+ P   L     +  + ++ D +R    I  +A  L Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSRFDEQRTATYITELANALSYC 128
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
           H     R+IHRD+K  N+LL +    KIADFG    + +       + + GT  Y+ PE 
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 181
Query: 500 AMHGQYSVKSDVFSFGVLVLEIISG 524
                +  K D++S GVL  E + G
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 115/230 (50%), Gaps = 22/230 (9%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGR-LYDGAE-IAVKRLSRDSGQGDLEFKN--EVLLVANL 377
           A   +    ++G+G +G V+K R L +G   +A+KR+   +G+  +      EV ++ +L
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 378 Q---HRNLVRLLGF-SLEGNER----LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKII 429
           +   H N+VRL    ++   +R     L++E V +  L  ++ D      +  E    ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIV 489
             + RGL +LH     R++HRDLK  N+L+ +    K+ADFG+AR++     Q   + +V
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVV 180
Query: 490 GTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDL 539
            T  Y APE  +   Y+   D++S G +  E+   +R   FR    V+ L
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF--RRKPLFRGSSDVDQL 228

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 13/203 (6%)
Query: 326 FSDANKLGQGGFGAVYKG---RLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNL 382
           F+   K+G+G FG V+KG   R      I +  L     + +   + E+ +++      +
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDSPYV 87
Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
            +  G  L+  +  +I E++   S      D      LD  +   I+  I +GL YLH +
Sbjct: 88  TKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSE 143
Query: 443 SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMH 502
            +   IHRD+K +NVLL      K+ADFG+A   ++ +TQ   +  VGT  +MAPE    
Sbjct: 144 KK---IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIKQ 198
Query: 503 GQYSVKSDVFSFGVLVLEIISGQ 525
             Y  K+D++S G+  +E+  G+
Sbjct: 199 SAYDSKADIWSLGITAIELARGE 221

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 13/203 (6%)
Query: 326 FSDANKLGQGGFGAVYKG---RLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNL 382
           F+   K+G+G FG V+KG   R      I +  L     +   + + E+ +++      +
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYV 82
Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
            +  G  L+  +  +I E++   S      D      LD  +   I+  I +GL YLH +
Sbjct: 83  TKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSE 138
Query: 443 SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMH 502
            +   IHRD+K +NVLL      K+ADFG+A   ++ +TQ   +  VGT  +MAPE    
Sbjct: 139 KK---IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNXFVGTPFWMAPEVIKQ 193
Query: 503 GQYSVKSDVFSFGVLVLEIISGQ 525
             Y  K+D++S G+  +E+  G+
Sbjct: 194 SAYDSKADIWSLGITAIELARGE 216

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 115/231 (49%), Gaps = 15/231 (6%)
Query: 297 KSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKR 355
           + +  + ++   A  L  D    R   DNF    K+G+G  G V    +   G  +AVK+
Sbjct: 5   EPQRVSHEQFRAALQLVVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKK 61
Query: 356 LS-RDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDP 414
           +  R   + +L F NEV+++ + QH N+V +    L G+E  ++ EF+   +L     D 
Sbjct: 62  MDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT----DI 116
Query: 415 TRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR 474
               +++ E+   +   + + L  LH      +IHRD+K+ ++LL  +   K++DFG   
Sbjct: 117 VTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCA 173
Query: 475 LFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
             ++ +       +VGT  +MAPE      Y  + D++S G++V+E++ G+
Sbjct: 174 --QVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 222

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 13/203 (6%)
Query: 326 FSDANKLGQGGFGAVYKG---RLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNL 382
           F+   K+G+G FG V+KG   R      I +  L     + +   + E+ +++      +
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDSPYV 67
Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
            +  G  L+  +  +I E++   S      D      LD  +   I+  I +GL YLH +
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSE 123
Query: 443 SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMH 502
            +   IHRD+K +NVLL      K+ADFG+A   ++ +TQ   +  VGT  +MAPE    
Sbjct: 124 KK---IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNXFVGTPFWMAPEVIKQ 178
Query: 503 GQYSVKSDVFSFGVLVLEIISGQ 525
             Y  K+D++S G+  +E+  G+
Sbjct: 179 SAYDSKADIWSLGITAIELARGE 201

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 13/203 (6%)
Query: 326 FSDANKLGQGGFGAVYKG---RLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNL 382
           F+   K+G+G FG V+KG   R      I +  L     + +   + E+ +++      +
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDSPYV 67
Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
            +  G  L+  +  +I E++   S      D      LD  +   I+  I +GL YLH +
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSE 123
Query: 443 SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMH 502
            +   IHRD+K +NVLL      K+ADFG+A   ++ +TQ   +  VGT  +MAPE    
Sbjct: 124 KK---IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIKQ 178
Query: 503 GQYSVKSDVFSFGVLVLEIISGQ 525
             Y  K+D++S G+  +E+  G+
Sbjct: 179 SAYDSKADIWSLGITAIELARGE 201

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 109/223 (48%), Gaps = 24/223 (10%)
Query: 312 LQFDFNTIRVATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNE 370
           L++D+       D   D   LG+G +G VY GR L +   IA+K +     +       E
Sbjct: 1   LEYDYEY-----DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEE 55
Query: 371 VLLVANLQHRNLVRLLG-FSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKII 429
           + L  +L+H+N+V+ LG FS  G  ++ + E VP  SL   +    R      +   + I
Sbjct: 56  IALHKHLKHKNIVQYLGSFSENGFIKIFM-EQVPGGSLSALL----RSKWGPLKDNEQTI 110
Query: 430 G----GIARGLLYLHEDSRLRIIHRDLKTSNVLLDA-EMTPKIADFGMARLFEMDETQGN 484
           G     I  GL YLH++   +I+HRD+K  NVL++      KI+DFG ++   +      
Sbjct: 111 GFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSK--RLAGINPC 165
Query: 485 TSRIVGTYGYMAPEYAMHGQ--YSVKSDVFSFGVLVLEIISGQ 525
           T    GT  YMAPE    G   Y   +D++S G  ++E+ +G+
Sbjct: 166 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 76/260 (29%), Positives = 120/260 (46%), Gaps = 32/260 (12%)
Query: 287 RRKPRDNSKVKS-EAAAGDEINRAESLQFDFN-TIRVATDNFSDANKLGQGGFGAVYKGR 344
           ++KP+   + K  E+  G+     +  Q  +N       +N      LG G FG V +  
Sbjct: 7   KQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEAT 66
Query: 345 LYD-GAE-----IAVKRLSRDSGQGDLE-FKNEVLLVANL-QHRNLVRLLGFSLEGNERL 396
            +  G E     +AVK L   +   + E   +E+ ++++L QH N+V LLG    G   L
Sbjct: 67  AFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVL 126
Query: 397 LIYEFVPNTSLDHFIFDPTRRAQLDWERR----------YKIIGGIARGLLYLHEDSRLR 446
           +I E+     L +F+    R+A+ D ++                 +A+G+ +L   +   
Sbjct: 127 VITEYCCYGDLLNFL---RRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKN--- 180
Query: 447 IIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE---TQGNTSRIVGTYGYMAPEYAMHG 503
            IHRD+   NVLL      KI DFG+AR    D     +GN    V    +MAPE     
Sbjct: 181 CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK---WMAPESIFDC 237
Query: 504 QYSVKSDVFSFGVLVLEIIS 523
            Y+V+SDV+S+G+L+ EI S
Sbjct: 238 VYTVQSDVWSYGILLWEIFS 257

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 115/231 (49%), Gaps = 15/231 (6%)
Query: 297 KSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKR 355
           + +  + ++   A  L  D    R   DNF    K+G+G  G V    +   G  +AVK+
Sbjct: 7   EPQRVSHEQFRAALQLVVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKK 63
Query: 356 LS-RDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDP 414
           +  R   + +L F NEV+++ + QH N+V +    L G+E  ++ EF+   +L     D 
Sbjct: 64  MDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT----DI 118
Query: 415 TRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR 474
               +++ E+   +   + + L  LH      +IHRD+K+ ++LL  +   K++DFG   
Sbjct: 119 VTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC- 174
Query: 475 LFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
             ++ +       +VGT  +MAPE      Y  + D++S G++V+E++ G+
Sbjct: 175 -AQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 224

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 112/224 (50%), Gaps = 15/224 (6%)
Query: 304 DEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLS-RDSG 361
           ++   A  L  D    R   DNF    K+G+G  G V    +   G  +AVK++  R   
Sbjct: 7   EQFRAALQLVVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ 63
Query: 362 QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLD 421
           + +L F NEV+++ + QH N+V +    L G+E  ++ EF+   +L     D     +++
Sbjct: 64  RRELLF-NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMN 118
Query: 422 WERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET 481
            E+   +   + + L  LH      +IHRD+K+ ++LL  +   K++DFG     ++ + 
Sbjct: 119 EEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCA--QVSKE 173
Query: 482 QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
                 +VGT  +MAPE      Y  + D++S G++V+E++ G+
Sbjct: 174 VPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 217

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 112/224 (50%), Gaps = 15/224 (6%)
Query: 304 DEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLS-RDSG 361
           ++   A  L  D    R   DNF    K+G+G  G V    +   G  +AVK++  R   
Sbjct: 3   EQFRAALQLVVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ 59
Query: 362 QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLD 421
           + +L F NEV+++ + QH N+V +    L G+E  ++ EF+   +L     D     +++
Sbjct: 60  RRELLF-NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMN 114
Query: 422 WERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET 481
            E+   +   + + L  LH      +IHRD+K+ ++LL  +   K++DFG     ++ + 
Sbjct: 115 EEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCA--QVSKE 169
Query: 482 QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
                 +VGT  +MAPE      Y  + D++S G++V+E++ G+
Sbjct: 170 VPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 213

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 103/199 (51%), Gaps = 17/199 (8%)
Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLVRLL-GF 388
           +LG G FG VYK +  + + +A  ++     + +LE +  E+ ++A+  H N+V+LL  F
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKII-GGIARGLLYLHEDSRLRI 447
             E N  +LI EF    ++D  + +  R      E + +++       L YLH++   +I
Sbjct: 104 YYENNLWILI-EFCAGGAVDAVMLELERPLT---ESQIQVVCKQTLDALNYLHDN---KI 156
Query: 448 IHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM-----H 502
           IHRDLK  N+L   +   K+ADFG++   +   T       +GT  +MAPE  M      
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 503 GQYSVKSDVFSFGVLVLEI 521
             Y  K+DV+S G+ ++E+
Sbjct: 215 RPYDYKADVWSLGITLIEM 233

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 26/223 (11%)
Query: 324 DNFSDANKLGQGGFGAVY--------KGRLYDGAEIAVKRLSRDSGQGDL-EFKNEVLLV 374
           D  +    LG+G FG V         K +  +   +AVK L  D+ + DL +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 375 ANL-QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI-----------FDPTR--RAQL 420
             + +H+N++ LLG   +     +I E+    +L  ++           +D  R    Q+
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQM 154
Query: 421 DWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE 480
            ++        +ARG+ YL   +  + IHRDL   NVL+      KIADFG+AR     +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
               T+       +MAPE      Y+ +SDV+SFGVL+ EI +
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 131/293 (44%), Gaps = 40/293 (13%)
Query: 324 DNFSDANKLGQGGFGAVY--------KGRLYDGAEIAVKRLSRDSGQGDL-EFKNEVLLV 374
           D       LG+G FG V         K +     ++AVK L  D+ + DL +  +E+ ++
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 375 ANL-QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI-----------FDPTR--RAQL 420
             + +H+N++ LLG   +     +I E+    +L  ++           F+P+     QL
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQL 147
Query: 421 DWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE 480
             +        +ARG+ YL   +  + IHRDL   NVL+  +   KIADFG+AR     +
Sbjct: 148 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
               T+       +MAPE      Y+ +SDV+SFGVL+ EI +         G  VE+L 
Sbjct: 205 XXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGGSPYPGVPVEEL- 261
Query: 541 SSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVV 593
              +K  +EG  ++   P+  +  +  M+R       C     + RPT   +V
Sbjct: 262 ---FKLLKEGHRMD--KPSNCTNELYMMMRD------CWHAVPSQRPTFKQLV 303

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSR---DSGQGDLEFKNEVLLVANLQH 379
           ++F     LG+G FG VY  R      I A+K L +   +    + + + EV + ++L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            N++RL G+  +     LI E+ P   L     +  + ++ D +R    I  +A  L Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSRFDEQRTATYITELANALSYC 128
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
           H     R+IHRD+K  N+LL +    KIADFG    + +         + GT  Y+ PE 
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRDTLCGTLDYLPPEM 181
Query: 500 AMHGQYSVKSDVFSFGVLVLEIISG 524
                +  K D++S GVL  E + G
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 118/238 (49%), Gaps = 16/238 (6%)
Query: 290 PRDNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYD-G 348
           PR   + + +  + ++   A  L  D    R   DNF    K+G+G  G V    +   G
Sbjct: 44  PRSPQR-EPQRVSHEQFRAALQLVVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSG 99
Query: 349 AEIAVKRLS-RDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSL 407
             +AVK++  R   + +L F NEV+++ + QH N+V +    L G+E  ++ EF+   +L
Sbjct: 100 KLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 158
Query: 408 DHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKI 467
                D     +++ E+   +   + + L  LH      +IHRD+K+ ++LL  +   K+
Sbjct: 159 T----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKL 211
Query: 468 ADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           +DFG     ++ +       +VGT  +MAPE      Y  + D++S G++V+E++ G+
Sbjct: 212 SDFGFC--AQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 267

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 26/223 (11%)
Query: 324 DNFSDANKLGQGGFGAVY--------KGRLYDGAEIAVKRLSRDSGQGDL-EFKNEVLLV 374
           D  +    LG+G FG V         K +  +   +AVK L  D+ + DL +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 375 ANL-QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI-----------FDPTR--RAQL 420
             + +H+N++ LLG   +     +I E+    +L  ++           +D  R    Q+
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 421 DWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE 480
            ++        +ARG+ YL   +  + IHRDL   NVL+      KIADFG+AR     +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
               T+       +MAPE      Y+ +SDV+SFGVL+ EI +
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 114/236 (48%), Gaps = 21/236 (8%)
Query: 323 TDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGD---LEFKNEVLLVANLQ 378
           +D +     LG GG   V+  R L D  ++AVK L  D  +     L F+ E    A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 379 HRNLVRLL----GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
           H  +V +       +  G    ++ E+V   +L   +        +  +R  ++I    +
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 127
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQGNTSRIVGTYG 493
            L + H++    IIHRD+K +N+++ A    K+ DFG+AR + +   +   T+ ++GT  
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWRE 549
           Y++PE A       +SDV+S G ++ E+++G+    F    T +  +S A+++ RE
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE--PPF----TGDSPVSVAYQHVRE 234

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 118/258 (45%), Gaps = 32/258 (12%)
Query: 289 KPRDNSKVKS-EAAAGDEINRAESLQFDFN-TIRVATDNFSDANKLGQGGFGAVYKGRLY 346
           KP+   + K  E+  G+     +  Q  +N       +N      LG G FG V +   +
Sbjct: 1   KPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAF 60
Query: 347 D-GAE-----IAVKRLSRDSGQGDLE-FKNEVLLVANL-QHRNLVRLLGFSLEGNERLLI 398
             G E     +AVK L   +   + E   +E+ ++++L QH N+V LLG    G   L+I
Sbjct: 61  GLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVI 120
Query: 399 YEFVPNTSLDHFIFDPTRRAQLDWERR----------YKIIGGIARGLLYLHEDSRLRII 448
            E+     L +F+    R+A+ D ++                 +A+G+ +L   +    I
Sbjct: 121 TEYCCYGDLLNFL---RRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKN---CI 174
Query: 449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDE---TQGNTSRIVGTYGYMAPEYAMHGQY 505
           HRD+   NVLL      KI DFG+AR    D     +GN    V    +MAPE      Y
Sbjct: 175 HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK---WMAPESIFDCVY 231
Query: 506 SVKSDVFSFGVLVLEIIS 523
           +V+SDV+S+G+L+ EI S
Sbjct: 232 TVQSDVWSYGILLWEIFS 249

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 19/220 (8%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKN--EVLLVANL 377
           +AT  +    ++G G +G VYK R  + G  +A+K +   +G+  L      EV L+  L
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 378 Q---HRNLVRLLGFSLEGN-----ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKII 429
           +   H N+VRL+            +  L++E V +  L  ++ D      L  E    ++
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLM 118
Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIV 489
               RGL +LH +    I+HRDLK  N+L+ +  T K+ADFG+AR++     Q   + +V
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALAPVV 172
Query: 490 GTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNC 529
            T  Y APE  +   Y+   D++S G +  E+   +   C
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 212

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 113/265 (42%), Gaps = 28/265 (10%)
Query: 320 RVATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDS--GQGDLE--FKNEVLLV 374
           R+  DNF     LG+G FG V   R+ +  ++ AVK L +D      D+E     + +L 
Sbjct: 19  RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS 78
Query: 375 ANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
               H  L +L       +    + EFV    L   +F   +  + D  R       I  
Sbjct: 79  LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEIIS 135
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
            L++LH+     II+RDLK  NVLLD E   K+ADFGM +  E       T+   GT  Y
Sbjct: 136 ALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDY 190
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSS------AWKNWR 548
           +APE      Y    D ++ GVL+ E++ G         E  +DL  +       +  W 
Sbjct: 191 IAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP---FEAENEDDLFEAILNDEVVYPTWL 247
Query: 549 EGTTVNII------DPTLSSGSITE 567
                 I+      +PT+  GS+T+
Sbjct: 248 HEDATGILKSFMTKNPTMRLGSLTQ 272

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 29/205 (14%)
Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLVRLL-GF 388
           +LG G FG VYK +  + + +A  ++     + +LE +  E+ ++A+  H N+V+LL  F
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKII-GGIARGLLYLHEDSRLRI 447
             E N  +LI EF    ++D  + +  R      E + +++       L YLH++   +I
Sbjct: 104 YYENNLWILI-EFCAGGAVDAVMLELERPLT---ESQIQVVCKQTLDALNYLHDN---KI 156
Query: 448 IHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI------VGTYGYMAPEYAM 501
           IHRDLK  N+L   +   K+ADFG+        +  NT  I      +GT  +MAPE  M
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGV--------SAKNTRXIQRRDSFIGTPYWMAPEVVM 208
Query: 502 -----HGQYSVKSDVFSFGVLVLEI 521
                   Y  K+DV+S G+ ++E+
Sbjct: 209 CETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 26/223 (11%)
Query: 324 DNFSDANKLGQGGFGAVY--------KGRLYDGAEIAVKRLSRDSGQGDL-EFKNEVLLV 374
           D  +    LG+G FG V         K +  +   +AVK L  D+ + DL +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 375 ANL-QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI-----------FDPTR--RAQL 420
             + +H+N++ LLG   +     +I E+    +L  ++           +D  R    Q+
Sbjct: 95  KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 421 DWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE 480
            ++        +ARG+ YL   +  + IHRDL   NVL+      KIADFG+AR     +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
               T+       +MAPE      Y+ +SDV+SFGVL+ EI +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 15/212 (7%)
Query: 323 TDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGD---LEFKNEVLLVANLQ 378
           +D +     LG GG   V+  R L D  ++AVK L  D  +     L F+ E    A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 379 HRNLVRLL----GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
           H  +V +       +  G    ++ E+V   +L   +        +  +R  ++I    +
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 127
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQGNTSRIVGTYG 493
            L + H++    IIHRD+K +N+++ A    K+ DFG+AR + +   +   T+ ++GT  
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           Y++PE A       +SDV+S G ++ E+++G+
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 117/260 (45%), Gaps = 28/260 (10%)
Query: 287 RRKPRDNSKVKS-EAAAGDEINRAESLQFDFN-TIRVATDNFSDANKLGQGGFGAVYKGR 344
           ++KP+   + K  E+  G+     +  Q  +N       +N      LG G FG V +  
Sbjct: 7   KQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEAT 66
Query: 345 LYD-GAE-----IAVKRLSRDSGQGDLE-FKNEVLLVANL-QHRNLVRLLGFSLEGNERL 396
            +  G E     +AVK L   +   + E   +E+ ++++L QH N+V LLG    G   L
Sbjct: 67  AFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVL 126
Query: 397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRL----------R 446
           +I E+     L +F+   +R  + D    + I    A     LH  S++           
Sbjct: 127 VITEYCCYGDLLNFLRRKSRVLETD--PAFAIANSTASTRDLLHFSSQVAQGMAFLASKN 184
Query: 447 IIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE---TQGNTSRIVGTYGYMAPEYAMHG 503
            IHRD+   NVLL      KI DFG+AR    D     +GN    V    +MAPE     
Sbjct: 185 CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK---WMAPESIFDC 241
Query: 504 QYSVKSDVFSFGVLVLEIIS 523
            Y+V+SDV+S+G+L+ EI S
Sbjct: 242 VYTVQSDVWSYGILLWEIFS 261

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 29/205 (14%)
Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLVRLL-GF 388
           +LG G FG VYK +  + + +A  ++     + +LE +  E+ ++A+  H N+V+LL  F
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKII-GGIARGLLYLHEDSRLRI 447
             E N  +LI EF    ++D  + +  R      E + +++       L YLH++   +I
Sbjct: 104 YYENNLWILI-EFCAGGAVDAVMLELERPLT---ESQIQVVCKQTLDALNYLHDN---KI 156
Query: 448 IHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI------VGTYGYMAPEYAM 501
           IHRDLK  N+L   +   K+ADFG+        +  NT  I      +GT  +MAPE  M
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGV--------SAKNTRXIQRRDXFIGTPYWMAPEVVM 208
Query: 502 -----HGQYSVKSDVFSFGVLVLEI 521
                   Y  K+DV+S G+ ++E+
Sbjct: 209 CETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 119/263 (45%), Gaps = 32/263 (12%)
Query: 287 RRKPRDNSKVKS-EAAAGDEINRAESLQFDFN-TIRVATDNFSDANKLGQGGFGAVYKGR 344
           ++KP+   + K  E+  G+     +  Q  +N       +N      LG G FG V +  
Sbjct: 7   KQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEAT 66
Query: 345 LYD-GAE-----IAVKRLSRDSGQGDLE-FKNEVLLVANL-QHRNLVRLLGFSLEGNERL 396
            +  G E     +AVK L   +   + E   +E+ ++++L QH N+V LLG    G   L
Sbjct: 67  AFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVL 126
Query: 397 LIYEFVPNTSLDHFI-----------FDPTR--RAQLDWERRYKIIGGIARGLLYLHEDS 443
           +I E+     L +F+           ++P+     QL           +A+G+ +L   +
Sbjct: 127 VITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKN 186
Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE---TQGNTSRIVGTYGYMAPEYA 500
               IHRD+   NVLL      KI DFG+AR    D     +GN    V    +MAPE  
Sbjct: 187 ---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK---WMAPESI 240
Query: 501 MHGQYSVKSDVFSFGVLVLEIIS 523
               Y+V+SDV+S+G+L+ EI S
Sbjct: 241 FDCVYTVQSDVWSYGILLWEIFS 263

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 26/223 (11%)
Query: 324 DNFSDANKLGQGGFGAVY--------KGRLYDGAEIAVKRLSRDSGQGDL-EFKNEVLLV 374
           D  +    LG+G FG V         K +  +   +AVK L  D+ + DL +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 375 ANL-QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI-----------FDPTR--RAQL 420
             + +H+N++ LLG   +     +I E+    +L  ++           +D  R    Q+
Sbjct: 95  KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 421 DWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE 480
            ++        +ARG+ YL   +  + IHRDL   NVL+      KIADFG+AR     +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
               T+       +MAPE      Y+ +SDV+SFGVL+ EI +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 105/220 (47%), Gaps = 19/220 (8%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKN--EVLLVANL 377
           +AT  +    ++G G +G VYK R  + G  +A+K +   +G+  L      EV L+  L
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 378 Q---HRNLVRLLGFSLEGN-----ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKII 429
           +   H N+VRL+            +  L++E V +  L  ++ D      L  E    ++
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLM 118
Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIV 489
               RGL +LH +    I+HRDLK  N+L+ +  T K+ADFG+AR++     Q     +V
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALDPVV 172
Query: 490 GTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNC 529
            T  Y APE  +   Y+   D++S G +  E+   +   C
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 212

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 26/223 (11%)
Query: 324 DNFSDANKLGQGGFGAVY--------KGRLYDGAEIAVKRLSRDSGQGDL-EFKNEVLLV 374
           D  +    LG+G FG V         K +  +   +AVK L  D+ + DL +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 375 ANL-QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI-----------FDPTR--RAQL 420
             + +H+N++ LLG   +     +I E+    +L  ++           +D  R    Q+
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 421 DWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE 480
            ++        +ARG+ YL   +  + IHRDL   NVL+      KIADFG+AR     +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
               T+       +MAPE      Y+ +SDV+SFGVL+ EI +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 26/223 (11%)
Query: 324 DNFSDANKLGQGGFGAVY--------KGRLYDGAEIAVKRLSRDSGQGDL-EFKNEVLLV 374
           D  +    LG+G FG V         K +  +   +AVK L  D+ + DL +  +E+ ++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 375 ANL-QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI-----------FDPTR--RAQL 420
             + +H+N++ LLG   +     +I E+    +L  ++           +D  R    Q+
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 421 DWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE 480
            ++        +ARG+ YL   +  + IHRDL   NVL+      KIADFG+AR     +
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
               T+       +MAPE      Y+ +SDV+SFGVL+ EI +
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 26/223 (11%)
Query: 324 DNFSDANKLGQGGFGAVY--------KGRLYDGAEIAVKRLSRDSGQGDL-EFKNEVLLV 374
           D  +    LG+G FG V         K +  +   +AVK L  D+ + DL +  +E+ ++
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 375 ANL-QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI-----------FDPTR--RAQL 420
             + +H+N++ LLG   +     +I E+    +L  ++           +D  R    Q+
Sbjct: 82  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 141
Query: 421 DWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE 480
            ++        +ARG+ YL   +  + IHRDL   NVL+      KIADFG+AR     +
Sbjct: 142 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNID 198
Query: 481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
               T+       +MAPE      Y+ +SDV+SFGVL+ EI +
Sbjct: 199 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 130/293 (44%), Gaps = 40/293 (13%)
Query: 324 DNFSDANKLGQGGFGAVY--------KGRLYDGAEIAVKRLSRDSGQGDL-EFKNEVLLV 374
           D       LG+G FG V         K +     ++AVK L  D+ + DL +  +E+ ++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 375 ANL-QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI-----------FDPTR--RAQL 420
             + +H+N++ LLG   +     +I E+    +L  ++           ++P+     QL
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 132
Query: 421 DWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE 480
             +        +ARG+ YL   +  + IHRDL   NVL+  +   KIADFG+AR     +
Sbjct: 133 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
               T+       +MAPE      Y+ +SDV+SFGVL+ EI +         G  VE+L 
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGGSPYPGVPVEELF 247
Query: 541 SSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVV 593
               K  +EG  ++   P+  +  +  M+R       C     + RPT   +V
Sbjct: 248 ----KLLKEGHRMD--KPSNCTNELYMMMRD------CWHAVPSQRPTFKQLV 288

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 26/223 (11%)
Query: 324 DNFSDANKLGQGGFGAVY--------KGRLYDGAEIAVKRLSRDSGQGDL-EFKNEVLLV 374
           D  +    LG+G FG V         K +  +   +AVK L  D+ + DL +  +E+ ++
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 375 ANL-QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI-----------FDPTR--RAQL 420
             + +H+N++ LLG   +     +I E+    +L  ++           +D  R    Q+
Sbjct: 84  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 143
Query: 421 DWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE 480
            ++        +ARG+ YL   +  + IHRDL   NVL+      KIADFG+AR     +
Sbjct: 144 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 200
Query: 481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
               T+       +MAPE      Y+ +SDV+SFGVL+ EI +
Sbjct: 201 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 39/220 (17%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-IAVKRLSRDSGQGDLEFKN-EVLLVANLQHRNL 382
           +++D   +G G FG VY+ +L D  E +A+K++ +D       FKN E+ ++  L H N+
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 103
Query: 383 VRLLGFSLEGNERL------LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA--- 433
           VRL  F     E+       L+ ++VP T           R    + R  + +  I    
Sbjct: 104 VRLRYFFYSSGEKKDEVYLNLVLDYVPET---------VYRVARHYSRAKQTLPVIYVKL 154
Query: 434 ------RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP-KIADFGMARLFEMDETQGNTS 486
                 R L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++   + N S
Sbjct: 155 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS 209
Query: 487 RIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
            I   Y Y APE       Y+   DV+S G ++ E++ GQ
Sbjct: 210 YICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 39/220 (17%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-IAVKRLSRDSGQGDLEFKN-EVLLVANLQHRNL 382
           +++D   +G G FG VY+ +L D  E +A+K++ +D       FKN E+ ++  L H N+
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 109
Query: 383 VRLLGFSLEGNERL------LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA--- 433
           VRL  F     E+       L+ ++VP T           R    + R  + +  I    
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPET---------VYRVARHYSRAKQTLPVIYVKL 160
Query: 434 ------RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP-KIADFGMARLFEMDETQGNTS 486
                 R L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++   + N S
Sbjct: 161 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS 215
Query: 487 RIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
            I   Y Y APE       Y+   DV+S G ++ E++ GQ
Sbjct: 216 XICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 130/293 (44%), Gaps = 40/293 (13%)
Query: 324 DNFSDANKLGQGGFGAVY--------KGRLYDGAEIAVKRLSRDSGQGDL-EFKNEVLLV 374
           D       LG+G FG V         K +     ++AVK L  D+ + DL +  +E+ ++
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 375 ANL-QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI-----------FDPTR--RAQL 420
             + +H+N++ LLG   +     +I E+    +L  ++           ++P+     QL
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 147
Query: 421 DWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE 480
             +        +ARG+ YL   +  + IHRDL   NVL+  +   KIADFG+AR     +
Sbjct: 148 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
               T+       +MAPE      Y+ +SDV+SFGVL+ EI +         G  VE+L 
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGGSPYPGVPVEELF 262
Query: 541 SSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVV 593
               K  +EG  ++   P+  +  +  M+R       C     + RPT   +V
Sbjct: 263 ----KLLKEGHRMD--KPSNCTNELYMMMRD------CWHAVPSQRPTFKQLV 303

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 26/223 (11%)
Query: 324 DNFSDANKLGQGGFGAVY--------KGRLYDGAEIAVKRLSRDSGQGDL-EFKNEVLLV 374
           D  +    LG+G FG V         K +  +   +AVK L  D+ + DL +  +E+ ++
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 375 ANL-QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI-----------FDPTR--RAQL 420
             + +H+N++ LLG   +     +I E+    +L  ++           +D  R    Q+
Sbjct: 87  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 146
Query: 421 DWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE 480
            ++        +ARG+ YL   +  + IHRDL   NVL+      KIADFG+AR     +
Sbjct: 147 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 203
Query: 481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
               T+       +MAPE      Y+ +SDV+SFGVL+ EI +
Sbjct: 204 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 130/293 (44%), Gaps = 40/293 (13%)
Query: 324 DNFSDANKLGQGGFGAVY--------KGRLYDGAEIAVKRLSRDSGQGDL-EFKNEVLLV 374
           D       LG+G FG V         K +     ++AVK L  D+ + DL +  +E+ ++
Sbjct: 21  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 80
Query: 375 ANL-QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI-----------FDPTR--RAQL 420
             + +H+N++ LLG   +     +I E+    +L  ++           ++P+     QL
Sbjct: 81  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 140
Query: 421 DWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE 480
             +        +ARG+ YL   +  + IHRDL   NVL+  +   KIADFG+AR     +
Sbjct: 141 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 197
Query: 481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
               T+       +MAPE      Y+ +SDV+SFGVL+ EI +         G  VE+L 
Sbjct: 198 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGGSPYPGVPVEELF 255
Query: 541 SSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVV 593
               K  +EG  ++   P+  +  +  M+R       C     + RPT   +V
Sbjct: 256 ----KLLKEGHRMD--KPSNCTNELYMMMRD------CWHAVPSQRPTFKQLV 296

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 130/293 (44%), Gaps = 40/293 (13%)
Query: 324 DNFSDANKLGQGGFGAVY--------KGRLYDGAEIAVKRLSRDSGQGDL-EFKNEVLLV 374
           D       LG+G FG V         K +     ++AVK L  D+ + DL +  +E+ ++
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 375 ANL-QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI-----------FDPTR--RAQL 420
             + +H+N++ LLG   +     +I E+    +L  ++           ++P+     QL
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQL 147
Query: 421 DWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE 480
             +        +ARG+ YL   +  + IHRDL   NVL+  +   KIADFG+AR     +
Sbjct: 148 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
               T+       +MAPE      Y+ +SDV+SFGVL+ EI +         G  VE+L 
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGGSPYPGVPVEELF 262
Query: 541 SSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVV 593
               K  +EG  ++   P+  +  +  M+R       C     + RPT   +V
Sbjct: 263 ----KLLKEGHRMD--KPSNCTNELYMMMRD------CWHAVPSQRPTFKQLV 303

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 130/293 (44%), Gaps = 40/293 (13%)
Query: 324 DNFSDANKLGQGGFGAVY--------KGRLYDGAEIAVKRLSRDSGQGDL-EFKNEVLLV 374
           D       LG+G FG V         K +     ++AVK L  D+ + DL +  +E+ ++
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 375 ANL-QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI-----------FDPTR--RAQL 420
             + +H+N++ LLG   +     +I E+    +L  ++           ++P+     QL
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 147
Query: 421 DWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE 480
             +        +ARG+ YL   +  + IHRDL   NVL+  +   KIADFG+AR     +
Sbjct: 148 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
               T+       +MAPE      Y+ +SDV+SFGVL+ EI +         G  VE+L 
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGGSPYPGVPVEELF 262
Query: 541 SSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVV 593
               K  +EG  ++   P+  +  +  M+R       C     + RPT   +V
Sbjct: 263 ----KLLKEGHRMD--KPSNCTNELYMMMRD------CWHAVPSQRPTFKQLV 303

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 130/293 (44%), Gaps = 40/293 (13%)
Query: 324 DNFSDANKLGQGGFGAVY--------KGRLYDGAEIAVKRLSRDSGQGDL-EFKNEVLLV 374
           D       LG+G FG V         K +     ++AVK L  D+ + DL +  +E+ ++
Sbjct: 17  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 76
Query: 375 ANL-QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI-----------FDPTR--RAQL 420
             + +H+N++ LLG   +     +I E+    +L  ++           ++P+     QL
Sbjct: 77  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 136
Query: 421 DWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE 480
             +        +ARG+ YL   +  + IHRDL   NVL+  +   KIADFG+AR     +
Sbjct: 137 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 193
Query: 481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
               T+       +MAPE      Y+ +SDV+SFGVL+ EI +         G  VE+L 
Sbjct: 194 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGGSPYPGVPVEELF 251
Query: 541 SSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVV 593
               K  +EG  ++   P+  +  +  M+R       C     + RPT   +V
Sbjct: 252 ----KLLKEGHRMD--KPSNCTNELYMMMRD------CWHAVPSQRPTFKQLV 292

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 39/220 (17%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-IAVKRLSRDSGQGDLEFKN-EVLLVANLQHRNL 382
           +++D   +G G FG VY+ +L D  E +A+K++ +D       FKN E+ ++  L H N+
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 111
Query: 383 VRLLGFSLEGNERL------LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA--- 433
           VRL  F     E+       L+ ++VP T           R    + R  + +  I    
Sbjct: 112 VRLRYFFYSSGEKKDEVYLNLVLDYVPET---------VYRVARHYSRAKQTLPVIYVKL 162
Query: 434 ------RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP-KIADFGMARLFEMDETQGNTS 486
                 R L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++   + N S
Sbjct: 163 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS 217
Query: 487 RIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
            I   Y Y APE       Y+   DV+S G ++ E++ GQ
Sbjct: 218 YICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 39/220 (17%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-IAVKRLSRDSGQGDLEFKN-EVLLVANLQHRNL 382
           +++D   +G G FG VY+ +L D  E +A+K++ +D       FKN E+ ++  L H N+
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 109
Query: 383 VRLLGFSLEGNERL------LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA--- 433
           VRL  F     E+       L+ ++VP T           R    + R  + +  I    
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPET---------VYRVARHYSRAKQTLPVIYVKL 160
Query: 434 ------RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP-KIADFGMARLFEMDETQGNTS 486
                 R L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++   + N S
Sbjct: 161 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS 215
Query: 487 RIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
            I   Y Y APE       Y+   DV+S G ++ E++ GQ
Sbjct: 216 YICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 131/293 (44%), Gaps = 40/293 (13%)
Query: 324 DNFSDANKLGQGGFGAVY--------KGRLYDGAEIAVKRLSRDSGQGDL-EFKNEVLLV 374
           D       LG+G FG V         K +     ++AVK L  D+ + DL +  +E+ ++
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 375 ANL-QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI-----------FDPTR--RAQL 420
             + +H+N++ LLG   +     +I E+    +L  ++           ++P+     QL
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 421 DWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE 480
             +        +ARG+ YL   +  + IHRDL   NVL+  +   KIADFG+AR     +
Sbjct: 189 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
Query: 481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
               T+       +MAPE      Y+ +SDV+SFGVL+ EI +         G  VE+L 
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGGSPYPGVPVEEL- 302
Query: 541 SSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVV 593
              +K  +EG  ++   P+  +  +  M+R       C     + RPT   +V
Sbjct: 303 ---FKLLKEGHRMD--KPSNCTNELYMMMRD------CWHAVPSQRPTFKQLV 344

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 130/293 (44%), Gaps = 40/293 (13%)
Query: 324 DNFSDANKLGQGGFGAVY--------KGRLYDGAEIAVKRLSRDSGQGDL-EFKNEVLLV 374
           D       LG+G FG V         K +     ++AVK L  D+ + DL +  +E+ ++
Sbjct: 20  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 79
Query: 375 ANL-QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI-----------FDPTR--RAQL 420
             + +H+N++ LLG   +     +I E+    +L  ++           ++P+     QL
Sbjct: 80  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 139
Query: 421 DWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE 480
             +        +ARG+ YL   +  + IHRDL   NVL+  +   KIADFG+AR     +
Sbjct: 140 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 196
Query: 481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
               T+       +MAPE      Y+ +SDV+SFGVL+ EI +         G  VE+L 
Sbjct: 197 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGGSPYPGVPVEELF 254
Query: 541 SSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVV 593
               K  +EG  ++   P+  +  +  M+R       C     + RPT   +V
Sbjct: 255 ----KLLKEGHRMD--KPSNCTNELYMMMRD------CWHAVPSQRPTFKQLV 295

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 39/220 (17%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-IAVKRLSRDSGQGDLEFKN-EVLLVANLQHRNL 382
           +++D   +G G FG VY+ +L D  E +A+K++ +D       FKN E+ ++  L H N+
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 113
Query: 383 VRLLGFSLEGNERL------LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA--- 433
           VRL  F     E+       L+ ++VP T           R    + R  + +  I    
Sbjct: 114 VRLRYFFYSSGEKKDEVYLNLVLDYVPET---------VYRVARHYSRAKQTLPVIYVKL 164
Query: 434 ------RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP-KIADFGMARLFEMDETQGNTS 486
                 R L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++   + N S
Sbjct: 165 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS 219
Query: 487 RIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
            I   Y Y APE       Y+   DV+S G ++ E++ GQ
Sbjct: 220 YICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 103/207 (49%), Gaps = 11/207 (5%)
Query: 323 TDNFSDANKLGQGGFGAVYKG--RLYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQH 379
            +++     LG+G +G V     R+ + A +AVK +         E  K E+ + A L H
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINAMLNH 64
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            N+V+  G   EGN + L  E+     L   I       + D +R +     +  G++YL
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYL 121
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
           H    + I HRD+K  N+LLD     KI+DFG+A +F  +  +   +++ GT  Y+APE 
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 500 AMHGQYSVKS-DVFSFGVLVLEIISGQ 525
               ++  +  DV+S G+++  +++G+
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 105/220 (47%), Gaps = 19/220 (8%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKN--EVLLVANL 377
           +AT  +    ++G G +G VYK R  + G  +A+K +   +G+  L      EV L+  L
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 378 Q---HRNLVRLLGFSLEGN-----ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKII 429
           +   H N+VRL+            +  L++E V +  L  ++ D      L  E    ++
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLM 118
Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIV 489
               RGL +LH +    I+HRDLK  N+L+ +  T K+ADFG+AR++     Q     +V
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALFPVV 172
Query: 490 GTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNC 529
            T  Y APE  +   Y+   D++S G +  E+   +   C
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 212

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 119/263 (45%), Gaps = 34/263 (12%)
Query: 287 RRKPRDNSKVKS-EAAAGDEINRAESLQFDFN-TIRVATDNFSDANKLGQGGFGAVYKGR 344
           ++KP+   + K  E+  G+     +  Q  +N       +N      LG G FG V +  
Sbjct: 7   KQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEAT 66
Query: 345 LYD-GAE-----IAVKRLSRDSGQGDLE-FKNEVLLVANL-QHRNLVRLLGFSLEGNERL 396
            +  G E     +AVK L   +   + E   +E+ ++++L QH N+V LLG    G   L
Sbjct: 67  AFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVL 126
Query: 397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-------------IARGLLYLHEDS 443
           +I E+     L +F+   +R  + D    + I                +A+G+ +L   +
Sbjct: 127 VITEYCCYGDLLNFLRRKSRVLETD--PAFAIANSTLSTRDLLHFSSQVAQGMAFLASKN 184
Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE---TQGNTSRIVGTYGYMAPEYA 500
               IHRD+   NVLL      KI DFG+AR    D     +GN    V    +MAPE  
Sbjct: 185 ---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK---WMAPESI 238
Query: 501 MHGQYSVKSDVFSFGVLVLEIIS 523
               Y+V+SDV+S+G+L+ EI S
Sbjct: 239 FDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 105/223 (47%), Gaps = 26/223 (11%)
Query: 324 DNFSDANKLGQGGFGAVY--------KGRLYDGAEIAVKRLSRDSGQGDL-EFKNEVLLV 374
           D  +    LG+G FG V         K +  +   +AVK L  D+ + DL +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 375 ANL-QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI-----------FDPTR--RAQL 420
             + +H+N++ LLG   +     +I E+    +L  ++           +D  R    Q+
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 421 DWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE 480
            ++        +ARG+ YL   +  + IHRDL   NVL+      +IADFG+AR     +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNID 211
Query: 481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
               T+       +MAPE      Y+ +SDV+SFGVL+ EI +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 39/220 (17%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-IAVKRLSRDSGQGDLEFKN-EVLLVANLQHRNL 382
           +++D   +G G FG VY+ +L D  E +A+K++ +D       FKN E+ ++  L H N+
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 94
Query: 383 VRLLGFSLEGNERL------LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA--- 433
           VRL  F     E+       L+ ++VP T           R    + R  + +  I    
Sbjct: 95  VRLRYFFYSSGEKKDEVYLNLVLDYVPET---------VYRVARHYSRAKQTLPVIYVKL 145
Query: 434 ------RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP-KIADFGMARLFEMDETQGNTS 486
                 R L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++   + N S
Sbjct: 146 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS 200
Query: 487 RIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
            I   Y Y APE       Y+   DV+S G ++ E++ GQ
Sbjct: 201 XICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 39/220 (17%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-IAVKRLSRDSGQGDLEFKN-EVLLVANLQHRNL 382
           +++D   +G G FG VY+ +L D  E +A+K++ +D       FKN E+ ++  L H N+
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 87
Query: 383 VRLLGFSLEGNERL------LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA--- 433
           VRL  F     E+       L+ ++VP T           R    + R  + +  I    
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPET---------VYRVARHYSRAKQTLPVIYVKL 138
Query: 434 ------RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP-KIADFGMARLFEMDETQGNTS 486
                 R L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++   + N S
Sbjct: 139 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS 193
Query: 487 RIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
            I   Y Y APE       Y+   DV+S G ++ E++ GQ
Sbjct: 194 XICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 39/220 (17%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-IAVKRLSRDSGQGDLEFKN-EVLLVANLQHRNL 382
           +++D   +G G FG VY+ +L D  E +A+K++ +D       FKN E+ ++  L H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 75
Query: 383 VRLLGFSLEGNERL------LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA--- 433
           VRL  F     E+       L+ ++VP T           R    + R  + +  I    
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPET---------VYRVARHYSRAKQTLPVIYVKL 126
Query: 434 ------RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP-KIADFGMARLFEMDETQGNTS 486
                 R L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++   + N S
Sbjct: 127 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS 181
Query: 487 RIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
            I   Y Y APE       Y+   DV+S G ++ E++ GQ
Sbjct: 182 XICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 39/220 (17%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-IAVKRLSRDSGQGDLEFKN-EVLLVANLQHRNL 382
           +++D   +G G FG VY+ +L D  E +A+K++ +D       FKN E+ ++  L H N+
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 83
Query: 383 VRLLGFSLEGNERL------LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA--- 433
           VRL  F     E+       L+ ++VP T           R    + R  + +  I    
Sbjct: 84  VRLRYFFYSSGEKKDEVYLNLVLDYVPET---------VYRVARHYSRAKQTLPVIYVKL 134
Query: 434 ------RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP-KIADFGMARLFEMDETQGNTS 486
                 R L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++   + N S
Sbjct: 135 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS 189
Query: 487 RIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
            I   Y Y APE       Y+   DV+S G ++ E++ GQ
Sbjct: 190 XICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 39/220 (17%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-IAVKRLSRDSGQGDLEFKN-EVLLVANLQHRNL 382
           +++D   +G G FG VY+ +L D  E +A+K++ +D       FKN E+ ++  L H N+
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 154
Query: 383 VRLLGFSLEGNERL------LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA--- 433
           VRL  F     E+       L+ ++VP T           R    + R  + +  I    
Sbjct: 155 VRLRYFFYSSGEKKDEVYLNLVLDYVPET---------VYRVARHYSRAKQTLPVIYVKL 205
Query: 434 ------RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP-KIADFGMARLFEMDETQGNTS 486
                 R L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++   + N S
Sbjct: 206 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS 260
Query: 487 RIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
            I   Y Y APE       Y+   DV+S G ++ E++ GQ
Sbjct: 261 YICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 39/220 (17%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-IAVKRLSRDSGQGDLEFKN-EVLLVANLQHRNL 382
           +++D   +G G FG VY+ +L D  E +A+K++ +D       FKN E+ ++  L H N+
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 87
Query: 383 VRLLGFSLEGNERL------LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA--- 433
           VRL  F     E+       L+ ++VP T           R    + R  + +  I    
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPET---------VYRVARHYSRAKQTLPVIYVKL 138
Query: 434 ------RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP-KIADFGMARLFEMDETQGNTS 486
                 R L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++   + N S
Sbjct: 139 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS 193
Query: 487 RIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
            I   Y Y APE       Y+   DV+S G ++ E++ GQ
Sbjct: 194 XICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 39/220 (17%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-IAVKRLSRDSGQGDLEFKN-EVLLVANLQHRNL 382
           +++D   +G G FG VY+ +L D  E +A+K++ +D       FKN E+ ++  L H N+
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 80
Query: 383 VRLLGFSLEGNERL------LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA--- 433
           VRL  F     E+       L+ ++VP T           R    + R  + +  I    
Sbjct: 81  VRLRYFFYSSGEKKDEVYLNLVLDYVPET---------VYRVARHYSRAKQTLPVIYVKL 131
Query: 434 ------RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP-KIADFGMARLFEMDETQGNTS 486
                 R L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++   + N S
Sbjct: 132 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS 186
Query: 487 RIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
            I   Y Y APE       Y+   DV+S G ++ E++ GQ
Sbjct: 187 YICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 39/220 (17%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-IAVKRLSRDSGQGDLEFKN-EVLLVANLQHRNL 382
           +++D   +G G FG VY+ +L D  E +A+K++ +D       FKN E+ ++  L H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 75
Query: 383 VRLLGFSLEGNERL------LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA--- 433
           VRL  F     E+       L+ ++VP T           R    + R  + +  I    
Sbjct: 76  VRLRYFFYSSGEKKDVVYLNLVLDYVPET---------VYRVARHYSRAKQTLPVIYVKL 126
Query: 434 ------RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP-KIADFGMARLFEMDETQGNTS 486
                 R L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++   + N S
Sbjct: 127 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS 181
Query: 487 RIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
            I   Y Y APE       Y+   DV+S G ++ E++ GQ
Sbjct: 182 XICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 12/204 (5%)
Query: 332 LGQGGFGAVYKGRL--YDGAEI--AVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLVRLL 386
           LG+G FG VY+G    + G +I  AVK   +D    + E F +E +++ NL H ++V+L+
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 387 GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLR 446
           G  +E     +I E  P   L H++       ++     Y +   I + + YL     + 
Sbjct: 92  GI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL--QICKAMAYLES---IN 145
Query: 447 IIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYS 506
            +HRD+   N+L+ +    K+ DFG++R  E DE     S       +M+PE     +++
Sbjct: 146 CVHRDIAVRNILVASPECVKLGDFGLSRYIE-DEDYYKASVTRLPIKWMSPESINFRRFT 204
Query: 507 VKSDVFSFGVLVLEIISGQRNNCF 530
             SDV+ F V + EI+S  +   F
Sbjct: 205 TASDVWMFAVCMWEILSFGKQPFF 228

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 39/220 (17%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-IAVKRLSRDSGQGDLEFKN-EVLLVANLQHRNL 382
           +++D   +G G FG VY+ +L D  E +A+K++ +D       FKN E+ ++  L H N+
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 88
Query: 383 VRLLGFSLEGNERL------LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA--- 433
           VRL  F     E+       L+ ++VP T           R    + R  + +  I    
Sbjct: 89  VRLRYFFYSSGEKKDEVYLNLVLDYVPET---------VYRVARHYSRAKQTLPVIYVKL 139
Query: 434 ------RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP-KIADFGMARLFEMDETQGNTS 486
                 R L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++   + N S
Sbjct: 140 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS 194
Query: 487 RIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
            I   Y Y APE       Y+   DV+S G ++ E++ GQ
Sbjct: 195 YICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 39/220 (17%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-IAVKRLSRDSGQGDLEFKN-EVLLVANLQHRNL 382
           +++D   +G G FG VY+ +L D  E +A+K++ +D       FKN E+ ++  L H N+
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 76
Query: 383 VRLLGFSLEGNERL------LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA--- 433
           VRL  F     E+       L+ ++VP T           R    + R  + +  I    
Sbjct: 77  VRLRYFFYSSGEKKDEVYLNLVLDYVPET---------VYRVARHYSRAKQTLPVIYVKL 127
Query: 434 ------RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP-KIADFGMARLFEMDETQGNTS 486
                 R L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++   + N S
Sbjct: 128 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS 182
Query: 487 RIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
            I   Y Y APE       Y+   DV+S G ++ E++ GQ
Sbjct: 183 XICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 85/319 (26%), Positives = 146/319 (45%), Gaps = 40/319 (12%)
Query: 290 PRDNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKG--RLYD 347
           P D    +S  A  +EI R + +  D   + +      +  +LG G FG V KG  ++  
Sbjct: 342 PMDTEVFESPFADPEEI-RPKEVYLDRKLLTL------EDKELGSGNFGTVKKGYYQMKK 394
Query: 348 GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHR----NLVRLLGFSLEGNERLLIYEFVP 403
             +    ++ ++    D   K+E+L  AN+  +     +VR++G   E    +L+ E   
Sbjct: 395 VVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAE 452
Query: 404 NTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM 463
              L+ ++    +   +  +   +++  ++ G+ YL E +    +HRDL   NVLL  + 
Sbjct: 453 LGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQH 506
Query: 464 TPKIADFGMARLFEMDETQGNTSRIVGTY--GYMAPEYAMHGQYSVKSDVFSFGVLVLEI 521
             KI+DFG+++    DE     ++  G +   + APE   + ++S KSDV+SFGVL+ E 
Sbjct: 507 YAKISDFGLSKALRADENY-YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEA 565
Query: 522 IS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQ 580
            S GQ+      G  V  +L    K  R G           +G   EM   ++   LC  
Sbjct: 566 FSYGQKPYRGMKGSEVTAMLE---KGERMGC---------PAGCPREMYDLMN---LCWT 610
Query: 581 ENVASRPTMASVVLMLNSY 599
            +V +RP  A+V L L +Y
Sbjct: 611 YDVENRPGFAAVELRLRNY 629

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 39/220 (17%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-IAVKRLSRDSGQGDLEFKN-EVLLVANLQHRNL 382
           +++D   +G G FG VY+ +L D  E +A+K++ +D       FKN E+ ++  L H N+
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 79
Query: 383 VRLLGFSLEGNERL------LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA--- 433
           VRL  F     E+       L+ ++VP T           R    + R  + +  I    
Sbjct: 80  VRLRYFFYSSGEKKDEVYLNLVLDYVPET---------VYRVARHYSRAKQTLPVIYVKL 130
Query: 434 ------RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP-KIADFGMARLFEMDETQGNTS 486
                 R L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++   + N S
Sbjct: 131 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS 185
Query: 487 RIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
            I   Y Y APE       Y+   DV+S G ++ E++ GQ
Sbjct: 186 XICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 12/204 (5%)
Query: 332 LGQGGFGAVYKGRL--YDGAEI--AVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLVRLL 386
           LG+G FG VY+G    + G +I  AVK   +D    + E F +E +++ NL H ++V+L+
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 387 GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLR 446
           G  +E     +I E  P   L H++       ++     Y +   I + + YL     + 
Sbjct: 76  GI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL--QICKAMAYLES---IN 129
Query: 447 IIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYS 506
            +HRD+   N+L+ +    K+ DFG++R  E DE     S       +M+PE     +++
Sbjct: 130 CVHRDIAVRNILVASPECVKLGDFGLSRYIE-DEDYYKASVTRLPIKWMSPESINFRRFT 188
Query: 507 VKSDVFSFGVLVLEIISGQRNNCF 530
             SDV+ F V + EI+S  +   F
Sbjct: 189 TASDVWMFAVCMWEILSFGKQPFF 212

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 39/220 (17%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-IAVKRLSRDSGQGDLEFKN-EVLLVANLQHRNL 382
           +++D   +G G FG VY+ +L D  E +A+K++ +D       FKN E+ ++  L H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 75
Query: 383 VRLLGFSLEGNERL------LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA--- 433
           VRL  F     E+       L+ ++VP T           R    + R  + +  I    
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPET---------VYRVARHYSRAKQTLPVIYVKL 126
Query: 434 ------RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP-KIADFGMARLFEMDETQGNTS 486
                 R L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++   + N S
Sbjct: 127 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS 181
Query: 487 RIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
            I   Y Y APE       Y+   DV+S G ++ E++ GQ
Sbjct: 182 XICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 85/319 (26%), Positives = 146/319 (45%), Gaps = 40/319 (12%)
Query: 290 PRDNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKG--RLYD 347
           P D    +S  A  +EI R + +  D   + +      +  +LG G FG V KG  ++  
Sbjct: 343 PMDTEVYESPYADPEEI-RPKEVYLDRKLLTL------EDKELGSGNFGTVKKGYYQMKK 395
Query: 348 GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHR----NLVRLLGFSLEGNERLLIYEFVP 403
             +    ++ ++    D   K+E+L  AN+  +     +VR++G   E    +L+ E   
Sbjct: 396 VVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAE 453
Query: 404 NTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM 463
              L+ ++    +   +  +   +++  ++ G+ YL E +    +HRDL   NVLL  + 
Sbjct: 454 LGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQH 507
Query: 464 TPKIADFGMARLFEMDETQGNTSRIVGTY--GYMAPEYAMHGQYSVKSDVFSFGVLVLEI 521
             KI+DFG+++    DE     ++  G +   + APE   + ++S KSDV+SFGVL+ E 
Sbjct: 508 YAKISDFGLSKALRADENY-YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEA 566
Query: 522 IS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQ 580
            S GQ+      G  V  +L    K  R G           +G   EM   ++   LC  
Sbjct: 567 FSYGQKPYRGMKGSEVTAMLE---KGERMGC---------PAGCPREMYDLMN---LCWT 611
Query: 581 ENVASRPTMASVVLMLNSY 599
            +V +RP  A+V L L +Y
Sbjct: 612 YDVENRPGFAAVELRLRNY 630

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 12/204 (5%)
Query: 332 LGQGGFGAVYKGRL--YDGAEI--AVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLVRLL 386
           LG+G FG VY+G    + G +I  AVK   +D    + E F +E +++ NL H ++V+L+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 387 GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLR 446
           G  +E     +I E  P   L H++       ++     Y +   I + + YL     + 
Sbjct: 80  GI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL--QICKAMAYLES---IN 133
Query: 447 IIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYS 506
            +HRD+   N+L+ +    K+ DFG++R  E DE     S       +M+PE     +++
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIE-DEDYYKASVTRLPIKWMSPESINFRRFT 192
Query: 507 VKSDVFSFGVLVLEIISGQRNNCF 530
             SDV+ F V + EI+S  +   F
Sbjct: 193 TASDVWMFAVCMWEILSFGKQPFF 216

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 39/220 (17%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-IAVKRLSRDSGQGDLEFKN-EVLLVANLQHRNL 382
           +++D   +G G FG VY+ +L D  E +A+K++ +D       FKN E+ ++  L H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 75
Query: 383 VRLLGFSLEGNERL------LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA--- 433
           VRL  F     E+       L+ ++VP T           R    + R  + +  I    
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPET---------VYRVARHYSRAKQTLPVIYVKL 126
Query: 434 ------RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP-KIADFGMARLFEMDETQGNTS 486
                 R L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++   + N S
Sbjct: 127 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS 181
Query: 487 RIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
            I   Y Y APE       Y+   DV+S G ++ E++ GQ
Sbjct: 182 YICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 107/232 (46%), Gaps = 34/232 (14%)
Query: 318 TIRVATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVAN 376
           ++R A+D F +   LGQG FG V K R   D    A+K++ R + +      +EV+L+A+
Sbjct: 1   SLRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLAS 58
Query: 377 LQHRNLVRLLGFSLE------------GNERLLI-YEFVPNTSLDHFIFDPTRRAQLDWE 423
           L H+ +VR     LE                L I  E+  N +L   I       Q D  
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRD-- 116
Query: 424 RRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-------LF 476
             +++   I   L Y+H      IIHRDLK  N+ +D     KI DFG+A+       + 
Sbjct: 117 EYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 477 EMDE-----TQGNTSRIVGTYGYMAPEYA-MHGQYSVKSDVFSFGVLVLEII 522
           ++D      +  N +  +GT  Y+A E     G Y+ K D++S G++  E+I
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 12/208 (5%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRL--SRDSGQGDLEFKNEVLLVANLQ 378
           + + + +   +G+G +G V K R  D G  +A+K+   S D          E+ L+  L+
Sbjct: 23  SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           H NLV LL    +     L++EFV +T LD     P     LD++   K +  I  G+ +
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGF 139
Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
            H  +   IIHRD+K  N+L+      K+ DFG AR         +    V T  Y APE
Sbjct: 140 CHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE--VATRWYRAPE 194
Query: 499 YAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
             +   +Y    DV++ G LV E+  G+
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 102/207 (49%), Gaps = 17/207 (8%)
Query: 331 KLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLV--RLL 386
           +LG GGFG V +    D G ++A+K+  ++    + E +  E+ ++  L H N+V  R +
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 387 GFSLE----GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
              L+     +  LL  E+     L  ++        L       ++  I+  L YLHE+
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 443 SRLRIIHRDLKTSNVLLDA---EMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
              RIIHRDLK  N++L      +  KI D G A+  E+D+ +  T   VGT  Y+APE 
Sbjct: 141 ---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGELCTE-FVGTLQYLAPEL 194
Query: 500 AMHGQYSVKSDVFSFGVLVLEIISGQR 526
               +Y+V  D +SFG L  E I+G R
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFR 221

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 107/232 (46%), Gaps = 34/232 (14%)
Query: 318 TIRVATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVAN 376
           ++R A+D F +   LGQG FG V K R   D    A+K++ R + +      +EV+L+A+
Sbjct: 1   SLRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLAS 58
Query: 377 LQHRNLVRLLGFSLE------------GNERLLI-YEFVPNTSLDHFIFDPTRRAQLDWE 423
           L H+ +VR     LE                L I  E+  N +L   I       Q D  
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD-- 116
Query: 424 RRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-------LF 476
             +++   I   L Y+H      IIHRDLK  N+ +D     KI DFG+A+       + 
Sbjct: 117 EYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 477 EMDE-----TQGNTSRIVGTYGYMAPEYA-MHGQYSVKSDVFSFGVLVLEII 522
           ++D      +  N +  +GT  Y+A E     G Y+ K D++S G++  E+I
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 104/223 (46%), Gaps = 26/223 (11%)
Query: 324 DNFSDANKLGQGGFGAVY--------KGRLYDGAEIAVKRLSRDSGQGDL-EFKNEVLLV 374
           D  +    LG+G FG V         K +  +   +AVK L  D+ + DL +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 375 ANL-QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI-----------FDPTR--RAQL 420
             + +H+N++ LLG   +     +I  +    +L  ++           +D  R    Q+
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 421 DWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE 480
            ++        +ARG+ YL   +  + IHRDL   NVL+      KIADFG+AR     +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
               T+       +MAPE      Y+ +SDV+SFGVL+ EI +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 108/229 (47%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + +   + +G G +G+V     YD   G +IAVK+LSR   Q  +  K    E
Sbjct: 44  KTIWEVPERYQTLSPVGSGAYGSVCSS--YDVKSGLKIAVKKLSR-PFQSIIHAKRTYRE 100
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P TSL+ F  ++  T     D     K 
Sbjct: 101 LRLLKHMKHENVIGLLDV------------FTPATSLEEFNDVYLVTHLMGADLNNIVKC 148
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 149 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 202
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y++  D++S G ++ E+++G+
Sbjct: 203 --HTDDEMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 102/207 (49%), Gaps = 17/207 (8%)
Query: 331 KLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLV--RLL 386
           +LG GGFG V +    D G ++A+K+  ++    + E +  E+ ++  L H N+V  R +
Sbjct: 22  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 81
Query: 387 GFSLE----GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
              L+     +  LL  E+     L  ++        L       ++  I+  L YLHE+
Sbjct: 82  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 141
Query: 443 SRLRIIHRDLKTSNVLLDA---EMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
              RIIHRDLK  N++L      +  KI D G A+  E+D+ +  T   VGT  Y+APE 
Sbjct: 142 ---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGELCTE-FVGTLQYLAPEL 195
Query: 500 AMHGQYSVKSDVFSFGVLVLEIISGQR 526
               +Y+V  D +SFG L  E I+G R
Sbjct: 196 LEQKKYTVTVDYWSFGTLAFECITGFR 222

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 100/199 (50%), Gaps = 16/199 (8%)
Query: 332 LGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGD--LEFKNEVLLVANLQHRNLVRLLGF 388
           LG+G FG V K +      E AVK +++ S +         EV L+  L H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRII 448
             + +   ++ E      L   I    R ++ D  R   II  +  G+ Y+H+ +   I+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKHN---IV 143
Query: 449 HRDLKTSNVLLDAEMTP---KIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQY 505
           HRDLK  N+LL+++      KI DFG++  F+ +    +    +GT  Y+APE  + G Y
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IGTAYYIAPE-VLRGTY 199
Query: 506 SVKSDVFSFGVLVLEIISG 524
             K DV+S GV++  ++SG
Sbjct: 200 DEKCDVWSAGVILYILLSG 218

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 107/239 (44%), Gaps = 25/239 (10%)
Query: 307 NRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAE------IAVKRLSRDS 360
             AE L +D +      D       LG+G FG V +   +   +      +AVK L   +
Sbjct: 1   EHAERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 60
Query: 361 GQGDLE-FKNEVLLVANL-QHRNLVRLLGFSLE-GNERLLIYEFVPNTSLDHFI------ 411
              +     +E+ ++ ++  H N+V LLG   + G   ++I EF    +L  ++      
Sbjct: 61  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE 120
Query: 412 FDPTRRAQLDWERRYKIIGG-------IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMT 464
           F P + A  D  + +  +         +A+G+ +L   +  + IHRDL   N+LL  +  
Sbjct: 121 FVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNV 177
Query: 465 PKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
            KI DFG+AR    D              +MAPE      Y+++SDV+SFGVL+ EI S
Sbjct: 178 VKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 100/199 (50%), Gaps = 16/199 (8%)
Query: 332 LGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGD--LEFKNEVLLVANLQHRNLVRLLGF 388
           LG+G FG V K +      E AVK +++ S +         EV L+  L H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRII 448
             + +   ++ E      L   I    R ++ D  R   II  +  G+ Y+H+ +   I+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKHN---IV 143
Query: 449 HRDLKTSNVLLDAEMTP---KIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQY 505
           HRDLK  N+LL+++      KI DFG++  F+ +    +    +GT  Y+APE  + G Y
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IGTAYYIAPE-VLRGTY 199
Query: 506 SVKSDVFSFGVLVLEIISG 524
             K DV+S GV++  ++SG
Sbjct: 200 DEKCDVWSAGVILYILLSG 218

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 332 LGQGGFGAVYKG--RLYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLVRLLGF 388
           LG+G +G V     R+ + A +AVK +         E  K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRII 448
             EGN + L  E+     L   I       + D +R +     +  G++YLH    + I 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH---GIGIT 126
Query: 449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVK 508
           HRD+K  N+LLD     KI+DFG+A +F  +  +   +++ GT  Y+APE     ++  +
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 509 S-DVFSFGVLVLEIISGQ 525
             DV+S G+++  +++G+
Sbjct: 187 PVDVWSCGIVLTAMLAGE 204

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 130/281 (46%), Gaps = 37/281 (13%)
Query: 330 NKLGQGGFGAVYKG--RLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHR----NLV 383
            +LG G FG V KG  ++    +    ++ ++    D   K+E+L  AN+  +     +V
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIV 91
Query: 384 RLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS 443
           R++G   E    +L+ E      L+ ++    +   +  +   +++  ++ G+ YL E +
Sbjct: 92  RMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN 147
Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE----TQGNTSRIVGTYGYMAPEY 499
               +HRDL   NVLL  +   KI+DFG+++    DE     Q +    V  Y   APE 
Sbjct: 148 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APEC 201
Query: 500 AMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP 558
             + ++S KSDV+SFGVL+ E  S GQ+      G  V  +L    K  R G        
Sbjct: 202 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE---KGERMGC------- 251
Query: 559 TLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY 599
              +G   EM   ++   LC   +V +RP  A+V L L +Y
Sbjct: 252 --PAGCPREMYDLMN---LCWTYDVENRPGFAAVELRLRNY 287

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 130/281 (46%), Gaps = 37/281 (13%)
Query: 330 NKLGQGGFGAVYKG--RLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHR----NLV 383
            +LG G FG V KG  ++    +    ++ ++    D   K+E+L  AN+  +     +V
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIV 91
Query: 384 RLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS 443
           R++G   E    +L+ E      L+ ++    +   +  +   +++  ++ G+ YL E +
Sbjct: 92  RMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN 147
Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE----TQGNTSRIVGTYGYMAPEY 499
               +HRDL   NVLL  +   KI+DFG+++    DE     Q +    V  Y   APE 
Sbjct: 148 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APEC 201
Query: 500 AMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP 558
             + ++S KSDV+SFGVL+ E  S GQ+      G  V  +L    K  R G        
Sbjct: 202 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE---KGERMGC------- 251
Query: 559 TLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY 599
              +G   EM   ++   LC   +V +RP  A+V L L +Y
Sbjct: 252 --PAGCPREMYDLMN---LCWTYDVENRPGFAAVELRLRNY 287

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 113/236 (47%), Gaps = 21/236 (8%)
Query: 323 TDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGD---LEFKNEVLLVANLQ 378
           +D +     LG GG   V+  R L    ++AVK L  D  +     L F+ E    A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 379 HRNLVRLLGF----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
           H  +V +       +  G    ++ E+V   +L   +        +  +R  ++I    +
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQ 127
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQGNTSRIVGTYG 493
            L + H++    IIHRD+K +N+++ A    K+ DFG+AR + +   +   T+ ++GT  
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWRE 549
           Y++PE A       +SDV+S G ++ E+++G+    F    T +  +S A+++ RE
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE--PPF----TGDSPVSVAYQHVRE 234

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 107/239 (44%), Gaps = 25/239 (10%)
Query: 307 NRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAE------IAVKRLSRDS 360
             AE L +D +      D       LG+G FG V +   +   +      +AVK L   +
Sbjct: 1   EHAERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 60
Query: 361 GQGDLE-FKNEVLLVANL-QHRNLVRLLGFSLE-GNERLLIYEFVPNTSLDHFI------ 411
              +     +E+ ++ ++  H N+V LLG   + G   ++I EF    +L  ++      
Sbjct: 61  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNE 120
Query: 412 FDPTRRAQLDWERRYKIIGG-------IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMT 464
           F P + A  D  + +  +         +A+G+ +L   +  + IHRDL   N+LL  +  
Sbjct: 121 FVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNV 177
Query: 465 PKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
            KI DFG+AR    D              +MAPE      Y+++SDV+SFGVL+ EI S
Sbjct: 178 VKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 323 TDNFSDANKLGQGGFGAVYKG--RLYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQH 379
            +++     LG+G +G V     R+ + A +AVK +         E  K E+ +   L H
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            N+V+  G   EGN + L  E+     L   I       + D +R +     +  G++YL
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYL 120
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
           H    + I HRD+K  N+LLD     KI+DFG+A +F  +  +   +++ GT  Y+APE 
Sbjct: 121 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 500 AMHGQYSVKS-DVFSFGVLVLEIISGQ 525
               ++  +  DV+S G+++  +++G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 323 TDNFSDANKLGQGGFGAVYKG--RLYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQH 379
            +++     LG+G +G V     R+ + A +AVK +         E  K E+ +   L H
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            N+V+  G   EGN + L  E+     L   I       + D +R +     +  G++YL
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYL 121
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
           H    + I HRD+K  N+LLD     KI+DFG+A +F  +  +   +++ GT  Y+APE 
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 500 AMHGQYSVKS-DVFSFGVLVLEIISGQ 525
               ++  +  DV+S G+++  +++G+
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 323 TDNFSDANKLGQGGFGAVYKG--RLYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQH 379
            +++     LG+G +G V     R+ + A +AVK +         E  K E+ +   L H
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            N+V+  G   EGN + L  E+     L   I       + D +R +     +  G++YL
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYL 120
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
           H    + I HRD+K  N+LLD     KI+DFG+A +F  +  +   +++ GT  Y+APE 
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 500 AMHGQYSVKS-DVFSFGVLVLEIISGQ 525
               ++  +  DV+S G+++  +++G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 323 TDNFSDANKLGQGGFGAVYKG--RLYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQH 379
            +++     LG+G +G V     R+ + A +AVK +         E  K E+ +   L H
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            N+V+  G   EGN + L  E+     L   I       + D +R +     +  G++YL
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYL 120
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
           H    + I HRD+K  N+LLD     KI+DFG+A +F  +  +   +++ GT  Y+APE 
Sbjct: 121 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 500 AMHGQYSVKS-DVFSFGVLVLEIISGQ 525
               ++  +  DV+S G+++  +++G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 77/278 (27%), Positives = 131/278 (47%), Gaps = 33/278 (11%)
Query: 331 KLGQGGFGAVYKG--RLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHR----NLVR 384
           +LG G FG V KG  ++    +    ++ ++    D   K+E+L  AN+  +     +VR
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVR 76
Query: 385 LLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSR 444
           ++G   E    +L+ E      L+ ++    +   +  +   +++  ++ G+ YL E + 
Sbjct: 77  MIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN- 131
Query: 445 LRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY--GYMAPEYAMH 502
              +HRDL   NVLL  +   KI+DFG+++    DE     ++  G +   + APE   +
Sbjct: 132 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENX-YKAQTHGKWPVKWYAPECINY 188
Query: 503 GQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLS 561
            ++S KSDV+SFGVL+ E  S GQ+      G  V  +L    K  R G           
Sbjct: 189 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE---KGERMGC---------P 236
Query: 562 SGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY 599
           +G   EM   ++   LC   +V +RP  A+V L L +Y
Sbjct: 237 AGCPREMYDLMN---LCWTYDVENRPGFAAVELRLRNY 271

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 323 TDNFSDANKLGQGGFGAVYKG--RLYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQH 379
            +++     LG+G +G V     R+ + A +AVK +         E  K E+ +   L H
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNH 62
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            N+V+  G   EGN + L  E+     L   I       + D +R +     +  G++YL
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYL 119
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
           H    + I HRD+K  N+LLD     KI+DFG+A +F  +  +   +++ GT  Y+APE 
Sbjct: 120 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 500 AMHGQYSVKS-DVFSFGVLVLEIISGQ 525
               ++  +  DV+S G+++  +++G+
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGE 203

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 100/228 (43%), Gaps = 30/228 (13%)
Query: 320 RVATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANL 377
           R  TD F     LG+GGFG V++ +   D    A+KR+   + +   E    EV  +A L
Sbjct: 2   RYLTD-FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 60
Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQL-DW-------ERRYK-- 427
           +H  +VR     LE N    +    P   L +      R+  L DW       E R +  
Sbjct: 61  EHPGIVRYFNAWLEKNTTEKLQPSSPKVYL-YIQMQLCRKENLKDWMNGRCTIEERERSV 119
Query: 428 ---IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ-- 482
              I   IA  + +LH      ++HRDLK SN+    +   K+ DFG+    + DE +  
Sbjct: 120 CLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176
Query: 483 --------GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEII 522
                      +  VGT  YM+PE      YS K D+FS G+++ E++
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 323 TDNFSDANKLGQGGFGAVYKG--RLYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQH 379
            +++     LG+G +G V     R+ + A +AVK +         E  K E+ +   L H
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            N+V+  G   EGN + L  E+     L   I       + D +R +     +  G++YL
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYL 120
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
           H    + I HRD+K  N+LLD     KI+DFG+A +F  +  +   +++ GT  Y+APE 
Sbjct: 121 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 500 AMHGQYSVKS-DVFSFGVLVLEIISGQ 525
               ++  +  DV+S G+++  +++G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 323 TDNFSDANKLGQGGFGAVYKG--RLYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQH 379
            +++     LG+G +G V     R+ + A +AVK +         E  K E+ +   L H
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            N+V+  G   EGN + L  E+     L   I       + D +R +     +  G++YL
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYL 121
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
           H    + I HRD+K  N+LLD     KI+DFG+A +F  +  +   +++ GT  Y+APE 
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 500 AMHGQYSVKS-DVFSFGVLVLEIISGQ 525
               ++  +  DV+S G+++  +++G+
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 332 LGQGGFGAVYKGRLYDGAE-----IAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLL 386
           LG+GGF   ++    D  E     I  K L     Q + +   E+ +  +L H+++V   
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISIHRSLAHQHVVGFH 87
Query: 387 GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLR 446
           GF  + +   ++ E     SL        R+A  + E RY  +  I  G  YLH   R R
Sbjct: 88  GFFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNR 141
Query: 447 IIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYS 506
           +IHRDLK  N+ L+ ++  KI DFG+A   E D  +  T  + GT  Y+APE      +S
Sbjct: 142 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHS 199
Query: 507 VKSDVFSFGVLVLEIISGQ 525
            + DV+S G ++  ++ G+
Sbjct: 200 FEVDVWSIGCIMYTLLVGK 218

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 104/223 (46%), Gaps = 26/223 (11%)
Query: 324 DNFSDANKLGQGGFGAVY--------KGRLYDGAEIAVKRLSRDSGQGDL-EFKNEVLLV 374
           D  +    LG+G FG V         K +  +   +AVK L  D+ + DL +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 375 ANL-QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI-----------FDPTR--RAQL 420
             + +H+N++ LLG   +     +I  +    +L  ++           +D  R    Q+
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 421 DWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE 480
            ++        +ARG+ YL   +  + IHRDL   NVL+      KIADFG+AR     +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
               T+       +MAPE      Y+ +SDV+SFGVL+ EI +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 323 TDNFSDANKLGQGGFGAVYKG--RLYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQH 379
            +++     LG+G +G V     R+ + A +AVK +         E  K E+ +   L H
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            N+V+  G   EGN + L  E+     L   I       + D +R +     +  G++YL
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYL 121
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
           H    + I HRD+K  N+LLD     KI+DFG+A +F  +  +   +++ GT  Y+APE 
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 500 AMHGQYSVKS-DVFSFGVLVLEIISGQ 525
               ++  +  DV+S G+++  +++G+
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 323 TDNFSDANKLGQGGFGAVYKG--RLYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQH 379
            +++     LG+G +G V     R+ + A +AVK +         E  K E+ +   L H
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            N+V+  G   EGN + L  E+     L   I       + D +R +     +  G++YL
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYL 121
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
           H    + I HRD+K  N+LLD     KI+DFG+A +F  +  +   +++ GT  Y+APE 
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 500 AMHGQYSVKS-DVFSFGVLVLEIISGQ 525
               ++  +  DV+S G+++  +++G+
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 323 TDNFSDANKLGQGGFGAVYKG--RLYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQH 379
            +++     LG+G +G V     R+ + A +AVK +         E  K E+ +   L H
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            N+V+  G   EGN + L  E+     L   I       + D +R +     +  G++YL
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYL 121
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
           H    + I HRD+K  N+LLD     KI+DFG+A +F  +  +   +++ GT  Y+APE 
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 500 AMHGQYSVKS-DVFSFGVLVLEIISGQ 525
               ++  +  DV+S G+++  +++G+
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 100/199 (50%), Gaps = 16/199 (8%)
Query: 332 LGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGD--LEFKNEVLLVANLQHRNLVRLLGF 388
           LG+G FG V K +      E AVK +++ S +         EV L+  L H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRII 448
             + +   ++ E      L   I    R ++ D  R   II  +  G+ Y+H+ +   I+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKHN---IV 143
Query: 449 HRDLKTSNVLLDAEMTP---KIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQY 505
           HRDLK  N+LL+++      KI DFG++  F+ +    +    +GT  Y+APE  + G Y
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IGTAYYIAPE-VLRGTY 199
Query: 506 SVKSDVFSFGVLVLEIISG 524
             K DV+S GV++  ++SG
Sbjct: 200 DEKCDVWSAGVILYILLSG 218

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 130/281 (46%), Gaps = 37/281 (13%)
Query: 330 NKLGQGGFGAVYKG--RLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHR----NLV 383
            +LG G FG V KG  ++    +    ++ ++    D   K+E+L  AN+  +     +V
Sbjct: 31  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIV 89
Query: 384 RLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS 443
           R++G   E    +L+ E      L+ ++    +   +  +   +++  ++ G+ YL E +
Sbjct: 90  RMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN 145
Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE----TQGNTSRIVGTYGYMAPEY 499
               +HRDL   NVLL  +   KI+DFG+++    DE     Q +    V  Y   APE 
Sbjct: 146 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APEC 199
Query: 500 AMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP 558
             + ++S KSDV+SFGVL+ E  S GQ+      G  V  +L    K  R G        
Sbjct: 200 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE---KGERMGC------- 249
Query: 559 TLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY 599
              +G   EM   ++   LC   +V +RP  A+V L L +Y
Sbjct: 250 --PAGCPREMYDLMN---LCWTYDVENRPGFAAVELRLRNY 285

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 323 TDNFSDANKLGQGGFGAVYKG--RLYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQH 379
            +++     LG+G +G V     R+ + A +AVK +         E  K E+ +   L H
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            N+V+  G   EGN + L  E+     L   I       + D +R +     +  G++YL
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYL 120
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
           H    + I HRD+K  N+LLD     KI+DFG+A +F  +  +   +++ GT  Y+APE 
Sbjct: 121 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 500 AMHGQYSVKS-DVFSFGVLVLEIISGQ 525
               ++  +  DV+S G+++  +++G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 323 TDNFSDANKLGQGGFGAVYKG--RLYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQH 379
            +++     LG+G +G V     R+ + A +AVK +         E  K E+ +   L H
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEIXINKMLNH 63
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            N+V+  G   EGN + L  E+     L   I       + D +R +     +  G++YL
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYL 120
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
           H    + I HRD+K  N+LLD     KI+DFG+A +F  +  +   +++ GT  Y+APE 
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 500 AMHGQYSVKS-DVFSFGVLVLEIISGQ 525
               ++  +  DV+S G+++  +++G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 332 LGQGGFGAVYKGRLYDGAE-----IAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLL 386
           LG+GGF   ++    D  E     I  K L     Q + +   E+ +  +L H+++V   
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISIHRSLAHQHVVGFH 83
Query: 387 GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLR 446
           GF  + +   ++ E     SL        R+A  + E RY  +  I  G  YLH   R R
Sbjct: 84  GFFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNR 137
Query: 447 IIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYS 506
           +IHRDLK  N+ L+ ++  KI DFG+A   E D  +  T  + GT  Y+APE      +S
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHS 195
Query: 507 VKSDVFSFGVLVLEIISGQ 525
            + DV+S G ++  ++ G+
Sbjct: 196 FEVDVWSIGCIMYTLLVGK 214

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 323 TDNFSDANKLGQGGFGAVYKG--RLYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQH 379
            +++     LG+G +G V     R+ + A +AVK +         E  K E+ +   L H
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            N+V+  G   EGN + L  E+     L   I       + D +R +     +  G++YL
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYL 121
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
           H    + I HRD+K  N+LLD     KI+DFG+A +F  +  +   +++ GT  Y+APE 
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 500 AMHGQYSVKS-DVFSFGVLVLEIISGQ 525
               ++  +  DV+S G+++  +++G+
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 113/236 (47%), Gaps = 21/236 (8%)
Query: 323 TDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGD---LEFKNEVLLVANLQ 378
           +D +     LG GG   V+  R L    ++AVK L  D  +     L F+ E    A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 379 HRNLVRLL----GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
           H  +V +       +  G    ++ E+V   +L   +        +  +R  ++I    +
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQ 127
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQGNTSRIVGTYG 493
            L + H++    IIHRD+K +N+++ A    K+ DFG+AR + +   +   T+ ++GT  
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWRE 549
           Y++PE A       +SDV+S G ++ E+++G+    F    T +  +S A+++ RE
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE--PPF----TGDSPVSVAYQHVRE 234

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 332 LGQGGFGAVYKGRLYDGAE-----IAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLL 386
           LG+GGF   ++    D  E     I  K L     Q + +   E+ +  +L H+++V   
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISIHRSLAHQHVVGFH 83
Query: 387 GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLR 446
           GF  + +   ++ E     SL        R+A  + E RY  +  I  G  YLH   R R
Sbjct: 84  GFFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNR 137
Query: 447 IIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYS 506
           +IHRDLK  N+ L+ ++  KI DFG+A   E D  +  T  + GT  Y+APE      +S
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHS 195
Query: 507 VKSDVFSFGVLVLEIISGQ 525
            + DV+S G ++  ++ G+
Sbjct: 196 FEVDVWSIGCIMYTLLVGK 214

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 323 TDNFSDANKLGQGGFGAVYKG--RLYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQH 379
            +++     LG+G +G V     R+ + A +AVK +         E  K E+ +   L H
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            N+V+  G   EGN + L  E+     L   I       + D +R +     +  G++YL
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYL 120
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
           H    + I HRD+K  N+LLD     KI+DFG+A +F  +  +   +++ GT  Y+APE 
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 500 AMHGQYSVKS-DVFSFGVLVLEIISGQ 525
               ++  +  DV+S G+++  +++G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 130/280 (46%), Gaps = 37/280 (13%)
Query: 331 KLGQGGFGAVYKG--RLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHR----NLVR 384
           +LG G FG V KG  ++    +    ++ ++    D   K+E+L  AN+  +     +VR
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVR 76
Query: 385 LLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSR 444
           ++G   E    +L+ E      L+ ++    +   +  +   +++  ++ G+ YL E + 
Sbjct: 77  MIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN- 131
Query: 445 LRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE----TQGNTSRIVGTYGYMAPEYA 500
              +HRDL   NVLL  +   KI+DFG+++    DE     Q +    V  Y   APE  
Sbjct: 132 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECI 186
Query: 501 MHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT 559
            + ++S KSDV+SFGVL+ E  S GQ+      G  V  +L    K  R G         
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE---KGERMGC-------- 235
Query: 560 LSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY 599
             +G   EM   ++   LC   +V +RP  A+V L L +Y
Sbjct: 236 -PAGCPREMYDLMN---LCWTYDVENRPGFAAVELRLRNY 271

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 130/280 (46%), Gaps = 37/280 (13%)
Query: 331 KLGQGGFGAVYKG--RLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHR----NLVR 384
           +LG G FG V KG  ++    +    ++ ++    D   K+E+L  AN+  +     +VR
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVR 72
Query: 385 LLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSR 444
           ++G   E    +L+ E      L+ ++    +   +  +   +++  ++ G+ YL E + 
Sbjct: 73  MIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN- 127
Query: 445 LRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE----TQGNTSRIVGTYGYMAPEYA 500
              +HRDL   NVLL  +   KI+DFG+++    DE     Q +    V  Y   APE  
Sbjct: 128 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECI 182
Query: 501 MHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT 559
            + ++S KSDV+SFGVL+ E  S GQ+      G  V  +L    K  R G         
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE---KGERMGC-------- 231
Query: 560 LSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY 599
             +G   EM   ++   LC   +V +RP  A+V L L +Y
Sbjct: 232 -PAGCPREMYDLMN---LCWTYDVENRPGFAAVELRLRNY 267

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 102/196 (52%), Gaps = 13/196 (6%)
Query: 332 LGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLE 391
           +G+G FG V  G  Y G ++AVK +  D+      F  E  ++  L+H NLV+LLG  +E
Sbjct: 201 IGKGEFGDVMLGD-YRGNKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 392 GNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHR 450
               L ++ E++   SL  ++     R+ L  +   K    +   + YL  ++    +HR
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 313
Query: 451 DLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSD 510
           DL   NVL+  +   K++DFG+ +  E   TQ +T ++     + APE     ++S KSD
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTK--EASSTQ-DTGKL--PVKWTAPEALREKKFSTKSD 368
Query: 511 VFSFGVLVLEIISGQR 526
           V+SFG+L+ EI S  R
Sbjct: 369 VWSFGILLWEIYSFGR 384

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 130/280 (46%), Gaps = 37/280 (13%)
Query: 331 KLGQGGFGAVYKG--RLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHR----NLVR 384
           +LG G FG V KG  ++    +    ++ ++    D   K+E+L  AN+  +     +VR
Sbjct: 12  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVR 70
Query: 385 LLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSR 444
           ++G   E    +L+ E      L+ ++    +   +  +   +++  ++ G+ YL E + 
Sbjct: 71  MIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN- 125
Query: 445 LRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE----TQGNTSRIVGTYGYMAPEYA 500
              +HRDL   NVLL  +   KI+DFG+++    DE     Q +    V  Y   APE  
Sbjct: 126 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECI 180
Query: 501 MHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT 559
            + ++S KSDV+SFGVL+ E  S GQ+      G  V  +L    K  R G         
Sbjct: 181 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE---KGERMGC-------- 229
Query: 560 LSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY 599
             +G   EM   ++   LC   +V +RP  A+V L L +Y
Sbjct: 230 -PAGCPREMYDLMN---LCWTYDVENRPGFAAVELRLRNY 265

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 102/196 (52%), Gaps = 13/196 (6%)
Query: 332 LGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLE 391
           +G+G FG V  G  Y G ++AVK +  D+      F  E  ++  L+H NLV+LLG  +E
Sbjct: 14  IGKGEFGDVMLGD-YRGNKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 392 GNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHR 450
               L ++ E++   SL  ++     R+ L  +   K    +   + YL  ++    +HR
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 126
Query: 451 DLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSD 510
           DL   NVL+  +   K++DFG+ +  E   TQ +T ++     + APE     ++S KSD
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK--EASSTQ-DTGKL--PVKWTAPEALREKKFSTKSD 181
Query: 511 VFSFGVLVLEIISGQR 526
           V+SFG+L+ EI S  R
Sbjct: 182 VWSFGILLWEIYSFGR 197

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 323 TDNFSDANKLGQGGFGAVYKG--RLYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQH 379
            +++     LG+G +G V     R+ + A +AVK +         E  K E+ +   L H
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEIXINKMLNH 63
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            N+V+  G   EGN + L  E+     L   I       + D +R +     +  G++YL
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYL 120
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
           H    + I HRD+K  N+LLD     KI+DFG+A +F  +  +   +++ GT  Y+APE 
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 500 AMHGQYSVKS-DVFSFGVLVLEIISGQ 525
               ++  +  DV+S G+++  +++G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 107/239 (44%), Gaps = 25/239 (10%)
Query: 307 NRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAE------IAVKRLSRDS 360
             AE L +D +      D       LG+G FG V +   +   +      +AVK L   +
Sbjct: 1   EHAERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 60
Query: 361 GQGDLE-FKNEVLLVANL-QHRNLVRLLGFSLE-GNERLLIYEFVPNTSLDHFI------ 411
              +     +E+ ++ ++  H N+V LLG   + G   ++I EF    +L  ++      
Sbjct: 61  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNE 120
Query: 412 FDPTRRAQLDWERRYKIIGG-------IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMT 464
           F P + A  D  + +  +         +A+G+ +L   +  + IHRDL   N+LL  +  
Sbjct: 121 FVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNV 177
Query: 465 PKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
            KI DFG+AR    D              +MAPE      Y+++SDV+SFGVL+ EI S
Sbjct: 178 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 323 TDNFSDANKLGQGGFGAVYKG--RLYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQH 379
            +++     LG+G +G V     R+ + A +AVK +         E  K E+ +   L H
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            N+V+  G   EGN + L  E+     L   I       + D +R +     +  G++YL
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYL 120
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
           H    + I HRD+K  N+LLD     KI+DFG+A +F  +  +   +++ GT  Y+APE 
Sbjct: 121 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 500 AMHGQYSVKS-DVFSFGVLVLEIISGQ 525
               ++  +  DV+S G+++  +++G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 130/281 (46%), Gaps = 37/281 (13%)
Query: 330 NKLGQGGFGAVYKG--RLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHR----NLV 383
            +LG G FG V KG  ++    +    ++ ++    D   K+E+L  AN+  +     +V
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIV 81
Query: 384 RLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS 443
           R++G   E    +L+ E      L+ ++    +   +  +   +++  ++ G+ YL E +
Sbjct: 82  RMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN 137
Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE----TQGNTSRIVGTYGYMAPEY 499
               +HRDL   NVLL  +   KI+DFG+++    DE     Q +    V  Y   APE 
Sbjct: 138 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APEC 191
Query: 500 AMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP 558
             + ++S KSDV+SFGVL+ E  S GQ+      G  V  +L    K  R G        
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE---KGERMGC------- 241
Query: 559 TLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY 599
              +G   EM   ++   LC   +V +RP  A+V L L +Y
Sbjct: 242 --PAGCPREMYDLMN---LCWTYDVENRPGFAAVELRLRNY 277

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 102/196 (52%), Gaps = 13/196 (6%)
Query: 332 LGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLE 391
           +G+G FG V  G  Y G ++AVK +  D+      F  E  ++  L+H NLV+LLG  +E
Sbjct: 29  IGKGEFGDVMLGD-YRGNKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 392 GNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHR 450
               L ++ E++   SL  ++     R+ L  +   K    +   + YL  ++    +HR
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 141
Query: 451 DLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSD 510
           DL   NVL+  +   K++DFG+ +  E   TQ +T ++     + APE     ++S KSD
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTK--EASSTQ-DTGKL--PVKWTAPEALREKKFSTKSD 196
Query: 511 VFSFGVLVLEIISGQR 526
           V+SFG+L+ EI S  R
Sbjct: 197 VWSFGILLWEIYSFGR 212

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 14/214 (6%)
Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRL--SRDSGQG-DLEFKNE 370
           D  T     D+F     LG+G FG VY  R      I A+K L  S+   +G + + + E
Sbjct: 14  DILTRHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRRE 73
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIG 430
           + + A+L H N++RL  +  +     LI E+ P   L   +    +    D +R   I+ 
Sbjct: 74  IEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKEL---QKSCTFDEQRTATIME 130
Query: 431 GIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVG 490
            +A  L+Y H     ++IHRD+K  N+LL  +   KIADFG    + +         + G
Sbjct: 131 ELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFG----WSVHAPSLRRKTMCG 183
Query: 491 TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           T  Y+ PE      ++ K D++  GVL  E++ G
Sbjct: 184 TLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 332 LGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLE 391
           +G+G FG V  G  Y G ++AVK +  D+      F  E  ++  L+H NLV+LLG  +E
Sbjct: 20  IGKGEFGDVMLGD-YRGNKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 392 GNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHR 450
               L ++ E++   SL  ++     R+ L  +   K    +   + YL  ++    +HR
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 132
Query: 451 DLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSD 510
           DL   NVL+  +   K++DFG+ +  E   TQ +T ++     + APE      +S KSD
Sbjct: 133 DLAARNVLVSEDNVAKVSDFGLTK--EASSTQ-DTGKL--PVKWTAPEALREAAFSTKSD 187
Query: 511 VFSFGVLVLEIISGQR 526
           V+SFG+L+ EI S  R
Sbjct: 188 VWSFGILLWEIYSFGR 203

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 106/236 (44%), Gaps = 25/236 (10%)
Query: 310 ESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAE------IAVKRLSRDSGQG 363
           E L +D +      D       LG+G FG V +   +   +      +AVK L   +   
Sbjct: 13  ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 72
Query: 364 DLE-FKNEVLLVANL-QHRNLVRLLGFSLE-GNERLLIYEFVPNTSLDHFI------FDP 414
           +     +E+ ++ ++  H N+V LLG   + G   ++I EF    +L  ++      F P
Sbjct: 73  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132
Query: 415 TRRAQLDWERRYKIIGG-------IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKI 467
            + A  D  + +  +         +A+G+ +L   +  + IHRDL   N+LL  +   KI
Sbjct: 133 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 189
Query: 468 ADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
            DFG+AR    D              +MAPE      Y+++SDV+SFGVL+ EI S
Sbjct: 190 CDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 106/236 (44%), Gaps = 25/236 (10%)
Query: 310 ESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAE------IAVKRLSRDSGQG 363
           E L +D +      D       LG+G FG V +   +   +      +AVK L   +   
Sbjct: 15  ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 74
Query: 364 DLE-FKNEVLLVANL-QHRNLVRLLGFSLE-GNERLLIYEFVPNTSLDHFI------FDP 414
           +     +E+ ++ ++  H N+V LLG   + G   ++I EF    +L  ++      F P
Sbjct: 75  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 134
Query: 415 TRRAQLDWERRYKIIGG-------IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKI 467
            + A  D  + +  +         +A+G+ +L   +  + IHRDL   N+LL  +   KI
Sbjct: 135 YKEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 191
Query: 468 ADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
            DFG+AR    D              +MAPE      Y+++SDV+SFGVL+ EI S
Sbjct: 192 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 323 TDNFSDANKLGQGGFGAVYKG--RLYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQH 379
            +++     LG+G +G V     R+ + A +AVK +         E  K E+ +   L H
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEIXINKMLNH 64
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            N+V+  G   EGN + L  E+     L   I       + D +R +     +  G++YL
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYL 121
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
           H    + I HRD+K  N+LLD     KI+DFG+A +F  +  +   +++ GT  Y+APE 
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 178
Query: 500 AMHGQYSVKS-DVFSFGVLVLEIISGQ 525
               ++  +  DV+S G+++  +++G+
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 323 TDNFSDANKLGQGGFGAVYKG--RLYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQH 379
            +++     LG+G +G V     R+ + A +AVK +         E  K E+ +   L H
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            N+V+  G   EGN + L  E+     L   I       + D +R +     +  G++YL
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYL 120
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
           H    + I HRD+K  N+LLD     KI+DFG+A +F  +  +   +++ GT  Y+APE 
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 500 AMHGQYSVKS-DVFSFGVLVLEIISGQ 525
               ++  +  DV+S G+++  +++G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 117/238 (49%), Gaps = 24/238 (10%)
Query: 304 DEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLY--DGA--EIAVKRLSRD 359
           D +  ++ L+     + +    F+    LG+G FG+V + +L   DG+  ++AVK L  D
Sbjct: 3   DSLGISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKAD 62
Query: 360 S-GQGDLE-FKNEVLLVANLQHRNLVRLLGFSLEGNER------LLIYEFVPNTSLDHFI 411
                D+E F  E   +    H ++ +L+G SL    +      ++I  F+ +  L  F+
Sbjct: 63  IIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL 122
Query: 412 FDPTRRAQ----LDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKI 467
              +R  +    L  +   + +  IA G+ YL   S    IHRDL   N +L  +MT  +
Sbjct: 123 L-ASRIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCV 178
Query: 468 ADFGMAR-LFEMD-ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
           ADFG++R ++  D   QG  S++     ++A E      Y+V SDV++FGV + EI++
Sbjct: 179 ADFGLSRKIYSGDYYRQGCASKL--PVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 113/236 (47%), Gaps = 21/236 (8%)
Query: 323 TDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGD---LEFKNEVLLVANLQ 378
           +D +     LG GG   V+  R L    ++AVK L  D  +     L F+ E    A L 
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 379 HRNLVRLL----GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
           H  +V +       +  G    ++ E+V   +L   +        +  +R  ++I    +
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQ 144
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQGNTSRIVGTYG 493
            L + H++    IIHRD+K +N+++ A    K+ DFG+AR + +   +   T+ ++GT  
Sbjct: 145 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 201
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWRE 549
           Y++PE A       +SDV+S G ++ E+++G+    F    T +  +S A+++ RE
Sbjct: 202 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE--PPF----TGDSPVSVAYQHVRE 251

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 332 LGQGGFGAVYKGRLYDGAEIAVKRLSRDS----GQGDLEFKNEVLLVANLQHRNLVRLLG 387
           LG+GGF   Y+    D  E+   ++   S         +   E+ +  +L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 388 FSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRI 447
           F  + +   ++ E     SL        R+A  + E RY +   I +G+ YLH +   R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 163
Query: 448 IHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSV 507
           IHRDLK  N+ L+ +M  KI DFG+A   E D  +  T  + GT  Y+APE      +S 
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT--LCGTPNYIAPEVLCKKGHSF 221
Query: 508 KSDVFSFGVLVLEIISGQ 525
           + D++S G ++  ++ G+
Sbjct: 222 EVDIWSLGCILYTLLVGK 239

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 41/228 (17%)
Query: 325 NFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
           +F +   +G GGFG V+K +   DG    ++R+  ++ + +     EV  +A L H N+V
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAE----REVKALAKLDHVNIV 68
Query: 384 RLLGF-------------SLEGNER----------------LLIYEFVPNTSLDHFIFDP 414
              G              SLE ++                  +  EF    +L+ +I + 
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EK 127
Query: 415 TRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR 474
            R  +LD     ++   I +G+ Y+H     ++IHRDLK SN+ L      KI DFG+  
Sbjct: 128 RRGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVT 184
Query: 475 LFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEII 522
             + D   G  +R  GT  YM+PE      Y  + D+++ G+++ E++
Sbjct: 185 SLKND---GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 28/215 (13%)
Query: 325 NFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
           +F +   +G GGFG V+K +   DG    +KR+  ++ + +     EV  +A L H N+V
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE----REVKALAKLDHVNIV 67
Query: 384 RLLG------FSLEGNER----------LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYK 427
              G      +  E + +           +  EF    +L+ +I +  R  +LD     +
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALE 126
Query: 428 IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSR 487
           +   I +G+ Y+H     ++I+RDLK SN+ L      KI DFG+    + D   G   R
Sbjct: 127 LFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKRXR 180
Query: 488 IVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEII 522
             GT  YM+PE      Y  + D+++ G+++ E++
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 39/220 (17%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-IAVKRLSRDSGQGDLEFKN-EVLLVANLQHRNL 382
           +++D   +G G FG VY+ +L D  E +A+K++ +        FKN E+ ++  L H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKA-----FKNRELQIMRKLDHCNI 75
Query: 383 VRLLGFSLEGNERL------LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA--- 433
           VRL  F     E+       L+ ++VP T           R    + R  + +  I    
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPET---------VYRVARHYSRAKQTLPVIYVKL 126
Query: 434 ------RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP-KIADFGMARLFEMDETQGNTS 486
                 R L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++   + N S
Sbjct: 127 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS 181
Query: 487 RIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
            I   Y Y APE       Y+   DV+S G ++ E++ GQ
Sbjct: 182 YICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 106/236 (44%), Gaps = 25/236 (10%)
Query: 310 ESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAE------IAVKRLSRDSGQG 363
           E L +D +      D       LG+G FG V +   +   +      +AVK L   +   
Sbjct: 13  ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 72
Query: 364 DLE-FKNEVLLVANL-QHRNLVRLLGFSLE-GNERLLIYEFVPNTSLDHFI------FDP 414
           +     +E+ ++ ++  H N+V LLG   + G   ++I EF    +L  ++      F P
Sbjct: 73  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132
Query: 415 TRRAQLDWERRYKIIGG-------IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKI 467
            + A  D  + +  +         +A+G+ +L   +  + IHRDL   N+LL  +   KI
Sbjct: 133 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 189
Query: 468 ADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
            DFG+AR    D              +MAPE      Y+++SDV+SFGVL+ EI S
Sbjct: 190 CDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 39/220 (17%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-IAVKRLSRDSGQGDLEFKN-EVLLVANLQHRNL 382
           +++D   +G G FG VY+ +L D  E +A+K++ +        FKN E+ ++  L H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKA-----FKNRELQIMRKLDHCNI 75
Query: 383 VRLLGFSLEGNERL------LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA--- 433
           VRL  F     E+       L+ ++VP T           R    + R  + +  I    
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPET---------VYRVARHYSRAKQTLPVIYVKL 126
Query: 434 ------RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP-KIADFGMARLFEMDETQGNTS 486
                 R L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++   + N S
Sbjct: 127 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS 181
Query: 487 RIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
            I   Y Y APE       Y+   DV+S G ++ E++ GQ
Sbjct: 182 YICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 39/220 (17%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE-IAVKRLSRDSGQGDLEFKN-EVLLVANLQHRNL 382
           +++D   +G G FG VY+ +L D  E +A+K++ +        FKN E+ ++  L H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKA-----FKNRELQIMRKLDHCNI 75
Query: 383 VRLLGFSLEGNERL------LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA--- 433
           VRL  F     E+       L+ ++VP T           R    + R  + +  I    
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPAT---------VYRVARHYSRAKQTLPVIYVKL 126
Query: 434 ------RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP-KIADFGMARLFEMDETQGNTS 486
                 R L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++   + N S
Sbjct: 127 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS 181
Query: 487 RIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
            I   Y Y APE       Y+   DV+S G ++ E++ GQ
Sbjct: 182 XICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 106/236 (44%), Gaps = 25/236 (10%)
Query: 310 ESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAE------IAVKRLSRDSGQG 363
           E L +D +      D       LG+G FG V +   +   +      +AVK L   +   
Sbjct: 13  ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 72
Query: 364 DLE-FKNEVLLVANL-QHRNLVRLLGFSLE-GNERLLIYEFVPNTSLDHFI------FDP 414
           +     +E+ ++ ++  H N+V LLG   + G   ++I EF    +L  ++      F P
Sbjct: 73  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132
Query: 415 TRRAQLDWERRYKIIGG-------IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKI 467
            + A  D  + +  +         +A+G+ +L   +  + IHRDL   N+LL  +   KI
Sbjct: 133 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 189
Query: 468 ADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
            DFG+AR    D              +MAPE      Y+++SDV+SFGVL+ EI S
Sbjct: 190 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/236 (30%), Positives = 113/236 (47%), Gaps = 18/236 (7%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQGDLEFK---NEVL 372
           N  RV   +F+    LG+G FG V         E+ A+K L +D    D + +    E  
Sbjct: 12  NLDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKR 71
Query: 373 LVANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG 431
           ++A L     +  L    +  +RL  + E+V    L + I    +  +    +       
Sbjct: 72  VLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI---QQVGKFKEPQAVFYAAE 128
Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSR-IVG 490
           I+ GL +LH+     II+RDLK  NV+LD+E   KIADFGM +   MD   G T+R   G
Sbjct: 129 ISIGLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMD---GVTTREFCG 182
Query: 491 TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKN 546
           T  Y+APE   +  Y    D +++GVL+ E+++GQ      +GE  ++L  S  ++
Sbjct: 183 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPF---DGEDEDELFQSIMEH 235

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 97/200 (48%), Gaps = 16/200 (8%)
Query: 332 LGQGGFGAVYKGRLYDGAE-----IAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLL 386
           LG+GGF   ++    D  E     I  K L     Q + +   E+ +  +L H+++V   
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISIHRSLAHQHVVGFH 105
Query: 387 GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLR 446
           GF  + +   ++ E     SL        R+A  + E RY  +  I  G  YLH   R R
Sbjct: 106 GFFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNR 159
Query: 447 IIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIV-GTYGYMAPEYAMHGQY 505
           +IHRDLK  N+ L+ ++  KI DFG+A   E D   G   +++ GT  Y+APE      +
Sbjct: 160 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD---GERKKVLCGTPNYIAPEVLSKKGH 216
Query: 506 SVKSDVFSFGVLVLEIISGQ 525
           S + DV+S G ++  ++ G+
Sbjct: 217 SFEVDVWSIGCIMYTLLVGK 236

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 11/207 (5%)
Query: 323 TDNFSDANKLGQGGFGAVYKG--RLYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQH 379
            +++     LG+G  G V     R+ + A +AVK +         E  K E+ +   L H
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            N+V+  G   EGN + L  E+     L   I       + D +R +     +  G++YL
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYL 120
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
           H    + I HRD+K  N+LLD     KI+DFG+A +F  +  +   +++ GT  Y+APE 
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 500 AMHGQYSVKS-DVFSFGVLVLEIISGQ 525
               ++  +  DV+S G+++  +++G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 97/200 (48%), Gaps = 16/200 (8%)
Query: 332 LGQGGFGAVYKGRLYDGAE-----IAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLL 386
           LG+GGF   ++    D  E     I  K L     Q + +   E+ +  +L H+++V   
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISIHRSLAHQHVVGFH 107
Query: 387 GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLR 446
           GF  + +   ++ E     SL        R+A  + E RY  +  I  G  YLH   R R
Sbjct: 108 GFFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNR 161
Query: 447 IIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIV-GTYGYMAPEYAMHGQY 505
           +IHRDLK  N+ L+ ++  KI DFG+A   E D   G   +++ GT  Y+APE      +
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD---GERKKVLCGTPNYIAPEVLSKKGH 218
Query: 506 SVKSDVFSFGVLVLEIISGQ 525
           S + DV+S G ++  ++ G+
Sbjct: 219 SFEVDVWSIGCIMYTLLVGK 238

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 106/236 (44%), Gaps = 25/236 (10%)
Query: 310 ESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAE------IAVKRLSRDSGQG 363
           E L +D +      D       LG+G FG V +   +   +      +AVK L   +   
Sbjct: 4   ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 63
Query: 364 DLE-FKNEVLLVANL-QHRNLVRLLGFSLE-GNERLLIYEFVPNTSLDHFI------FDP 414
           +     +E+ ++ ++  H N+V LLG   + G   ++I EF    +L  ++      F P
Sbjct: 64  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVP 123
Query: 415 TRRAQLDWERRYKIIGG-------IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKI 467
            + A  D  + +  +         +A+G+ +L   +  + IHRDL   N+LL  +   KI
Sbjct: 124 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 180
Query: 468 ADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
            DFG+AR    D              +MAPE      Y+++SDV+SFGVL+ EI S
Sbjct: 181 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 105/214 (49%), Gaps = 30/214 (14%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKN-EVLLVANLQHRNLVR 384
           +++   +G G FG V++ +L +  E+A+K++ +D       FKN E+ ++  ++H N+V 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK-----RFKNRELQIMRIVKHPNVVD 96
Query: 385 LLGFSLEGNERL------LIYEFVPNTSLDHFIFDPTRR-AQLDWERRYKIIG----GIA 433
           L  F     ++       L+ E+VP T     ++  +R  A+L       +I      + 
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPET-----VYRASRHYAKLKQTMPMLLIKLYMYQLL 151
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEM-TPKIADFGMARLFEMDETQGNTSRIVGTY 492
           R L Y+H    + I HRD+K  N+LLD      K+ DFG A++    E   N S I   Y
Sbjct: 152 RSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP--NVSXICSRY 206
Query: 493 GYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
            Y APE       Y+   D++S G ++ E++ GQ
Sbjct: 207 -YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 97/200 (48%), Gaps = 16/200 (8%)
Query: 332 LGQGGFGAVYKGRLYDGAE-----IAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLL 386
           LG+GGF   ++    D  E     I  K L     Q + +   E+ +  +L H+++V   
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISIHRSLAHQHVVGFH 81
Query: 387 GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLR 446
           GF  + +   ++ E     SL        R+A  + E RY  +  I  G  YLH   R R
Sbjct: 82  GFFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNR 135
Query: 447 IIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIV-GTYGYMAPEYAMHGQY 505
           +IHRDLK  N+ L+ ++  KI DFG+A   E D   G   +++ GT  Y+APE      +
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD---GERKKVLCGTPNYIAPEVLSKKGH 192
Query: 506 SVKSDVFSFGVLVLEIISGQ 525
           S + DV+S G ++  ++ G+
Sbjct: 193 SFEVDVWSIGCIMYTLLVGK 212

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 106/236 (44%), Gaps = 25/236 (10%)
Query: 310 ESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAE------IAVKRLSRDSGQG 363
           E L +D +      D       LG+G FG V +   +   +      +AVK L   +   
Sbjct: 50  ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 109
Query: 364 DLE-FKNEVLLVANL-QHRNLVRLLGFSLE-GNERLLIYEFVPNTSLDHFI------FDP 414
           +     +E+ ++ ++  H N+V LLG   + G   ++I EF    +L  ++      F P
Sbjct: 110 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 169
Query: 415 TRRAQLDWERRYKIIGG-------IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKI 467
            + A  D  + +  +         +A+G+ +L   +  + IHRDL   N+LL  +   KI
Sbjct: 170 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 226
Query: 468 ADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
            DFG+AR    D              +MAPE      Y+++SDV+SFGVL+ EI S
Sbjct: 227 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 105/212 (49%), Gaps = 23/212 (10%)
Query: 323 TDNFSDANKLGQGGFGAVY--KGRLYDGAEIAVKRLSRDS-----GQGDLEFKNEVLLVA 375
           +D +    KLG G +G V   K +L  GAE A+K + + S       G L   +EV ++ 
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKL-TGAERAIKIIKKSSVTTTSNSGAL--LDEVAVLK 76
Query: 376 NLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARG 435
            L H N+++L  F  +     L+ E      L   I    + +++D      I+  +  G
Sbjct: 77  QLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV---IMKQVLSG 133
Query: 436 LLYLHEDSRLRIIHRDLKTSNVLLDA---EMTPKIADFGMARLFEMDETQGNTSRIVGTY 492
             YLH+ +   I+HRDLK  N+LL++   +   KI DFG++  FE+    G     +GT 
Sbjct: 134 TTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG---GKMKERLGTA 187
Query: 493 GYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
            Y+APE  +  +Y  K DV+S GV++  ++ G
Sbjct: 188 YYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 218

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 320 RVATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRL--SRDSGQG-DLEFKNEVLLVA 375
           +   D+F     LG+G FG VY  R      I A+K L  S+   +G + + + E+ + +
Sbjct: 11  KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 70
Query: 376 NLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARG 435
           +L+H N++R+  +  +     L+ EF P   L   +    +  + D +R    +  +A  
Sbjct: 71  HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADA 127
Query: 436 LLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYM 495
           L Y HE    ++IHRD+K  N+L+  +   KIADFG    + +         + GT  Y+
Sbjct: 128 LHYCHER---KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYL 180
Query: 496 APEYAMHGQYSVKSDVFSFGVLVLEIISG 524
            PE      +  K D++  GVL  E + G
Sbjct: 181 PPEMIEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 320 RVATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRL--SRDSGQG-DLEFKNEVLLVA 375
           +   D+F     LG+G FG VY  R      I A+K L  S+   +G + + + E+ + +
Sbjct: 10  KFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 69
Query: 376 NLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARG 435
           +L+H N++R+  +  +     L+ EF P   L   +    +  + D +R    +  +A  
Sbjct: 70  HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADA 126
Query: 436 LLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYM 495
           L Y HE    ++IHRD+K  N+L+  +   KIADFG    + +         + GT  Y+
Sbjct: 127 LHYCHER---KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYL 179
Query: 496 APEYAMHGQYSVKSDVFSFGVLVLEIISG 524
            PE      +  K D++  GVL  E + G
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-----LYDGAEIAVKRLSRDSGQG----DLEFKNEVLLV 374
           D +    +LG G F  V K R     L   A+   KR ++ S +G    D+E   EV ++
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSIL 68
Query: 375 ANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
             +QH N++ L        + +LI E V    L  F+     +  L  E   + +  I  
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILN 125
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPK----IADFGMARLFEMDETQGNTSR-IV 489
           G+ YLH    L+I H DLK  N++L     PK    I DFG+A   +     GN  + I 
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF----GNEFKNIF 178
Query: 490 GTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           GT  ++APE   +    +++D++S GV+   ++SG
Sbjct: 179 GTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 16/211 (7%)
Query: 320 RVATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQG-DL--EFKNEVLLVA 375
           RV   ++   + LG G FG V  G+    G ++AVK L+R   +  D+  + + E+  + 
Sbjct: 12  RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLK 71
Query: 376 NLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARG 435
             +H ++++L       ++  ++ E+V    L  +I    +  +LD +   ++   I  G
Sbjct: 72  LFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYI---CKNGRLDEKESRRLFQQILSG 128
Query: 436 LLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI-VGTYGY 494
           + Y H   R  ++HRDLK  NVLLDA M  KIADFG++ +     + G   R   G+  Y
Sbjct: 129 VDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM----SDGEFLRXSCGSPNY 181
Query: 495 MAPEYAMHGQYS-VKSDVFSFGVLVLEIISG 524
            APE      Y+  + D++S GV++  ++ G
Sbjct: 182 AAPEVISGRLYAGPEVDIWSSGVILYALLCG 212

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 103/211 (48%), Gaps = 20/211 (9%)
Query: 322 ATDNFSDANKLGQGGFGAVYKG-RLYDGAEIAVKRLSRDSGQGDLEFK--NEVLLVANLQ 378
           + D +    KLG+G +G VYK         +A+KR+  +  +  +      EV L+  LQ
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ 91
Query: 379 HRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           HRN++ L    +  N RL LI+E+  N    +   +P    ++     Y++I G+     
Sbjct: 92  HRNIIELKSV-IHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVN---- 146
Query: 438 YLHEDSRLRIIHRDLKTSNVLL---DAEMTP--KIADFGMARLFEMDETQGNTSRIVGTY 492
           + H  SR R +HRDLK  N+LL   DA  TP  KI DFG+AR F +   Q  T  I+ T 
Sbjct: 147 FCH--SR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ-FTHEII-TL 201
Query: 493 GYMAPEYAMHG-QYSVKSDVFSFGVLVLEII 522
            Y  PE  +    YS   D++S   +  E++
Sbjct: 202 WYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 105/212 (49%), Gaps = 23/212 (10%)
Query: 323 TDNFSDANKLGQGGFGAVY--KGRLYDGAEIAVKRLSRDS-----GQGDLEFKNEVLLVA 375
           +D +    KLG G +G V   K +L  GAE A+K + + S       G L   +EV ++ 
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKL-TGAERAIKIIKKSSVTTTSNSGAL--LDEVAVLK 59
Query: 376 NLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARG 435
            L H N+++L  F  +     L+ E      L   I    + +++D      I+  +  G
Sbjct: 60  QLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVD---AAVIMKQVLSG 116
Query: 436 LLYLHEDSRLRIIHRDLKTSNVLLDA---EMTPKIADFGMARLFEMDETQGNTSRIVGTY 492
             YLH+ +   I+HRDLK  N+LL++   +   KI DFG++  FE+    G     +GT 
Sbjct: 117 TTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG---GKMKERLGTA 170
Query: 493 GYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
            Y+APE  +  +Y  K DV+S GV++  ++ G
Sbjct: 171 YYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 201

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 71/247 (28%), Positives = 114/247 (46%), Gaps = 32/247 (12%)
Query: 323 TDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVK--RLSRDSGQGDLEFKNEVLLVANLQH 379
           ++ +    KLG G +G V   R      E A+K  R +  S   + +   EV ++  L H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPT-RRAQLDWERRYKIIGGIARGLLY 438
            N+++L  F  +     L+ E      L    FD    R + +      II  +  G+ Y
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEIIHRMKFNEVDAAVIIKQVLSGVTY 151
Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTP---KIADFGMARLFEMDETQGNTSRIVGTYGYM 495
           LH+ +   I+HRDLK  N+LL+++      KI DFG++ +F   E Q      +GT  Y+
Sbjct: 152 LHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQKKMKERLGTAYYI 205
Query: 496 APEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL-----------SSAW 544
           APE  +  +Y  K DV+S GV++  +++G        G+T +++L           S  W
Sbjct: 206 APE-VLRKKYDEKCDVWSIGVILFILLAGYPP---FGGQTDQEILRKVEKGKYTFDSPEW 261
Query: 545 KNWREGT 551
           KN  EG 
Sbjct: 262 KNVSEGA 268

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 325 NFSDANKLGQGGFGAVYKGR-LYDGAEIAVK-----RLSRDSGQGDLEFKNEVLLVANLQ 378
           N+     +G+G F  V   R +  G E+A+K     +L+  S Q   +   EV ++  L 
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQ---KLFREVRIMKILN 72
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           H N+V+L           LI E+     +  ++    R  + +   +++    I   + Y
Sbjct: 73  HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR---QIVSAVQY 129
Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
            H+    RI+HRDLK  N+LLDA+M  KIADFG +  F +    G      G   Y APE
Sbjct: 130 CHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---GKLDAFCGAPPYAAPE 183
Query: 499 YAMHGQY-SVKSDVFSFGVLVLEIISG 524
                +Y   + DV+S GV++  ++SG
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 106/219 (48%), Gaps = 16/219 (7%)
Query: 332 LGQGGFGAVYK-GRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSL 390
           LG G FG V+K      G ++A K +     +   E KNE+ ++  L H NL++L     
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 391 EGNERLLIYEFVPNTSL-DHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIH 449
             N+ +L+ E+V    L D  I +     +LD       +  I  G+ ++H+   + I+H
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIIDESYNLTELD---TILFMKQICEGIRHMHQ---MYILH 210
Query: 450 RDLKTSNVLL---DAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYS 506
            DLK  N+L    DA+   KI DFG+AR ++  E         GT  ++APE   +   S
Sbjct: 211 LDLKPENILCVNRDAKQI-KIIDFGLARRYKPREKLKVN---FGTPEFLAPEVVNYDFVS 266
Query: 507 VKSDVFSFGVLVLEIISGQRNNCFRN-GETVEDLLSSAW 544
             +D++S GV+   ++SG       N  ET+ ++L+  W
Sbjct: 267 FPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRW 305

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 325 NFSDANKLGQGGFGAVYKGR-LYDGAEIAVK-----RLSRDSGQGDLEFKNEVLLVANLQ 378
           N+     +G+G F  V   R +  G E+A+K     +L+  S Q   +   EV ++  L 
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQ---KLFREVRIMKILN 69
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           H N+V+L           LI E+     +  ++    R  + +   +++    I   + Y
Sbjct: 70  HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR---QIVSAVQY 126
Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
            H+    RI+HRDLK  N+LLDA+M  KIADFG +  F +    G      G+  Y APE
Sbjct: 127 CHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---GKLDTFCGSPPYAAPE 180
Query: 499 YAMHGQY-SVKSDVFSFGVLVLEIISG 524
                +Y   + DV+S GV++  ++SG
Sbjct: 181 LFQGKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 105/232 (45%), Gaps = 21/232 (9%)
Query: 310 ESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRDSGQG 363
           E L +D +      D  +    LG+G FG V +   +          +AVK L   +   
Sbjct: 13  ERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHS 72
Query: 364 DLE-FKNEVLLVANL-QHRNLVRLLGFSLE-GNERLLIYEFVPNTSLDHFI------FDP 414
           +     +E+ ++ ++  H N+V LLG   + G   ++I EF    +L  ++      F P
Sbjct: 73  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132
Query: 415 TRRAQLDWERRYKIIG---GIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFG 471
            +    D+     +I     +A+G+ +L   +  + IHRDL   N+LL  +   KI DFG
Sbjct: 133 YKDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFG 189
Query: 472 MARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
           +AR    D              +MAPE      Y+++SDV+SFGVL+ EI S
Sbjct: 190 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 104/230 (45%), Gaps = 18/230 (7%)
Query: 319 IRVATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDS--GQGDLE---FKNEVL 372
           I++  ++F     LG+G FG V+        +  A+K L +D      D+E    +  VL
Sbjct: 13  IKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 72
Query: 373 LVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGI 432
            +A  +H  L  +            + E++    L + I       + D  R       I
Sbjct: 73  SLA-WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAEI 128
Query: 433 ARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY 492
             GL +LH      I++RDLK  N+LLD +   KIADFGM +  E       T+   GT 
Sbjct: 129 ILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNEFCGTP 183
Query: 493 GYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSS 542
            Y+APE  +  +Y+   D +SFGVL+ E++ GQ      +G+  E+L  S
Sbjct: 184 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP---FHGQDEEELFHS 230

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 12/198 (6%)
Query: 332 LGQGGFGAVYKGRLYDGAEIAVKRLSRDS----GQGDLEFKNEVLLVANLQHRNLVRLLG 387
           LG+GGF   Y+    D  E+   ++   S         +   E+ +  +L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 388 FSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRI 447
           F  + +   ++ E     SL        R+A  + E RY +   I +G+ YLH +   R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 163
Query: 448 IHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSV 507
           IHRDLK  N+ L+ +M  KI DFG+A   E D  +     + GT  Y+APE      +S 
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKX--LCGTPNYIAPEVLCKKGHSF 221
Query: 508 KSDVFSFGVLVLEIISGQ 525
           + D++S G ++  ++ G+
Sbjct: 222 EVDIWSLGCILYTLLVGK 239

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 104/232 (44%), Gaps = 34/232 (14%)
Query: 318 TIRVATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVAN 376
           ++R A+D F +   LGQG FG V K R   D    A+K++ R + +      +EV L+A+
Sbjct: 1   SLRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVXLLAS 58
Query: 377 LQHRNLVRLLGFSLE------------GNERLLI-YEFVPNTSLDHFIFDPTRRAQLDWE 423
           L H+ +VR     LE                L I  E+  N +L   I       Q D  
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRD-- 116
Query: 424 RRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-------LF 476
             +++   I   L Y+H      IIHR+LK  N+ +D     KI DFG+A+       + 
Sbjct: 117 EYWRLFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 477 EMDE-----TQGNTSRIVGTYGYMAPEYA-MHGQYSVKSDVFSFGVLVLEII 522
           ++D      +  N +  +GT  Y+A E     G Y+ K D +S G++  E I
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 105/235 (44%), Gaps = 24/235 (10%)
Query: 310 ESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAE------IAVKRLSRDSGQG 363
           E L +D +      D  +    LG+G FG V +   +   +      +AVK L   +   
Sbjct: 14  ERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 73
Query: 364 DLE-FKNEVLLVANL-QHRNLVRLLGFSLE-GNERLLIYEFVPNTSLDHFI------FDP 414
           +     +E+ ++ ++  H N+V LLG   + G   ++I EF    +L  ++      F P
Sbjct: 74  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 133
Query: 415 TRRAQ------LDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIA 468
            +  +      L  E        +A+G+ +L   +  + IHRDL   N+LL  +   KI 
Sbjct: 134 YKTPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKIC 190
Query: 469 DFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
           DFG+AR    D              +MAPE      Y+++SDV+SFGVL+ EI S
Sbjct: 191 DFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 110/211 (52%), Gaps = 15/211 (7%)
Query: 324 DNFSDAN-KLGQGGFGAVYKG--RLYDGA-EIAVKRLSRDSGQGDLE-FKNEVLLVANLQ 378
           DN   A+ +LG G FG+V +G  R+     ++A+K L + + + D E    E  ++  L 
Sbjct: 9   DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 68
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           +  +VRL+G   +    +L+ E      L  F+    +R ++      +++  ++ G+ Y
Sbjct: 69  NPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKY 125
Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY--GYMA 496
           L E +    +HRDL   NVLL      KI+DFG+++    D++   T+R  G +   + A
Sbjct: 126 LEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY-YTARSAGKWPLKWYA 181
Query: 497 PEYAMHGQYSVKSDVFSFGVLVLEIIS-GQR 526
           PE     ++S +SDV+S+GV + E +S GQ+
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALSYGQK 212

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 22/201 (10%)
Query: 332 LGQGGFGAVY--KGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFS 389
           LG G F  V+  K RL  G   A+K + +     D   +NE+ ++  ++H N+V L    
Sbjct: 17  LGSGAFSEVFLVKQRL-TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 390 LEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIH 449
                  L+ + V    L   I +     + D      +I  +   + YLHE+    I+H
Sbjct: 76  ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL---VIQQVLSAVKYLHENG---IVH 129
Query: 450 RDLKTSNVLLDAEMTPK------IADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG 503
           RDLK  N+L    +TP+      I DFG++++    E  G  S   GT GY+APE     
Sbjct: 130 RDLKPENLLY---LTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVAPEVLAQK 182
Query: 504 QYSVKSDVFSFGVLVLEIISG 524
            YS   D +S GV+   ++ G
Sbjct: 183 PYSKAVDCWSIGVITYILLCG 203

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 101/205 (49%), Gaps = 13/205 (6%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRL---SRDSGQGDLEFKNEVLLVANLQHR 380
           + +    K+G+G +G VYK +   G   A+K++     D G      + E+ ++  L+H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHS 60
Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH 440
           N+V+L          +L++E + +  L   +        L+       +  +  G+ Y H
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHL-DQDLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 441 EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA 500
           +    R++HRDLK  N+L++ E   KIADFG+AR F +   +  T  IV T  Y AP+  
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIV-TLWYRAPDVL 172
Query: 501 M-HGQYSVKSDVFSFGVLVLEIISG 524
           M   +YS   D++S G +  E+++G
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-----LYDGAEIAVKRLSRDSGQG----DLEFKNEVLLV 374
           D +    +LG G F  V K R     L   A+   KR ++ S +G    D+E   EV ++
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSIL 68
Query: 375 ANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
             +QH N++ L        + +LI E V    L  F+     +  L  E   + +  I  
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILN 125
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPK----IADFGMARLFEMDETQGNTSR-IV 489
           G+ YLH    L+I H DLK  N++L     PK    I DFG+A   +     GN  + I 
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF----GNEFKNIF 178
Query: 490 GTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           GT  ++APE   +    +++D++S GV+   ++SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 12/198 (6%)
Query: 332 LGQGGFGAVYKGRLYDGAEIAVKRLSRDS----GQGDLEFKNEVLLVANLQHRNLVRLLG 387
           LG+GGF   Y+    D  E+   ++   S         +   E+ +  +L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 388 FSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRI 447
           F  + +   ++ E     SL        R+A  + E RY +   I +G+ YLH +   R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 163
Query: 448 IHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSV 507
           IHRDLK  N+ L+ +M  KI DFG+A   E D  +     + GT  Y+APE      +S 
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKD--LCGTPNYIAPEVLCKKGHSF 221
Query: 508 KSDVFSFGVLVLEIISGQ 525
           + D++S G ++  ++ G+
Sbjct: 222 EVDIWSLGCILYTLLVGK 239

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 106/223 (47%), Gaps = 22/223 (9%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQG-----DLEFKNEVLLV 374
           +AT  +    ++G G +G VYK R  + G  +A+K +   +G G      +    EV L+
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 375 ANLQ---HRNLVRLLGFSLEGN-----ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRY 426
             L+   H N+VRL+            +  L++E V +  L  ++ D      L  E   
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIK 123
Query: 427 KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTS 486
            ++    RGL +LH +    I+HRDLK  N+L+ +  T K+ADFG+AR++     Q   +
Sbjct: 124 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALT 177
Query: 487 RIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNC 529
            +V T  Y APE  +   Y+   D++S G +  E+   +   C
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 220

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 110/221 (49%), Gaps = 27/221 (12%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGHRVAVKKLSR-PFQSIIHAKRTYRE 67
Query: 371 VLLVANLQHRNLVRLLGF-----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERR 425
           + L+ +++H N++ LL       SLE    + +   +    L++ +    + A+L  +  
Sbjct: 68  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCAKLTDDHV 123
Query: 426 YKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNT 485
             +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T    
Sbjct: 124 QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEM 175
Query: 486 SRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
           +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-----LYDGAEIAVKRLSRDSGQG----DLEFKNEVLLV 374
           D +    +LG G F  V K R     L   A+   KR ++ S +G    D+E   EV ++
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSIL 67
Query: 375 ANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
             +QH N++ L        + +LI E V    L  F+     +  L  E   + +  I  
Sbjct: 68  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILN 124
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPK----IADFGMARLFEMDETQGNTSR-IV 489
           G+ YLH    L+I H DLK  N++L     PK    I DFG+A   +     GN  + I 
Sbjct: 125 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF----GNEFKNIF 177
Query: 490 GTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           GT  ++APE   +    +++D++S GV+   ++SG
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 108/227 (47%), Gaps = 19/227 (8%)
Query: 321 VATDNFSDANKLGQGGFGAVYK------GRLYDGAEIAVKRLSRDSG-QGDLEFKNEVLL 373
           +  D F D   LG+GGFG V+       G+LY   ++  KRL +  G QG +  K    +
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK---I 238
Query: 374 VANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTR-RAQLDWERRYKIIGG 431
           +A +  R +V L  ++ E    L L+   +    + + I++           R       
Sbjct: 239 LAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297
Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT 491
           I  GL +LH+ +   II+RDLK  NVLLD +   +I+D G+A   E+   Q  T    GT
Sbjct: 298 IVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGT 352
Query: 492 YGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVED 538
            G+MAPE  +  +Y    D F+ GV + E+I+  R      GE VE+
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAA-RGPFRARGEKVEN 398

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-----LYDGAEIAVKRLSRDSGQG----DLEFKNEVLLV 374
           D +    +LG G F  V K R     L   A+   KR ++ S +G    D+E   EV ++
Sbjct: 11  DYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSIL 68
Query: 375 ANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
             +QH N++ L        + +LI E V    L  F+     +  L  E   + +  I  
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILN 125
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPK----IADFGMARLFEMDETQGNTSR-IV 489
           G+ YLH    L+I H DLK  N++L     PK    I DFG+A   +     GN  + I 
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF----GNEFKNIF 178
Query: 490 GTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           GT  ++APE   +    +++D++S GV+   ++SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 93/198 (46%), Gaps = 10/198 (5%)
Query: 332 LGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFK---NEVLLVANLQHRNLVRLLGF 388
           +G G +G   K R     +I V +        + E +   +EV L+  L+H N+VR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 389 SLEGNERLL--IYEFVPNTSLDHFIFDPTRRAQ-LDWERRYKIIGGIARGLLYLHE--DS 443
            ++     L  + E+     L   I   T+  Q LD E   +++  +   L   H   D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG 503
              ++HRDLK +NV LD +   K+ DFG+AR+   D +   T   VGT  YM+PE     
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMSPEQMNRM 191
Query: 504 QYSVKSDVFSFGVLVLEI 521
            Y+ KSD++S G L+ E+
Sbjct: 192 SYNEKSDIWSLGCLLYEL 209

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-----LYDGAEIAVKRLSRDSGQG----DLEFKNEVLLV 374
           D +    +LG G F  V K R     L   A+   KR ++ S +G    D+E   EV ++
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSIL 67
Query: 375 ANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
             +QH N++ L        + +LI E V    L  F+     +  L  E   + +  I  
Sbjct: 68  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILN 124
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPK----IADFGMARLFEMDETQGNTSR-IV 489
           G+ YLH    L+I H DLK  N++L     PK    I DFG+A   +     GN  + I 
Sbjct: 125 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF----GNEFKNIF 177
Query: 490 GTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           GT  ++APE   +    +++D++S GV+   ++SG
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-----LYDGAEIAVKRLSRDSGQG----DLEFKNEVLLV 374
           D +    +LG G F  V K R     L   A+   KR ++ S +G    D+E   EV ++
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSIL 68
Query: 375 ANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
             +QH N++ L        + +LI E V    L  F+     +  L  E   + +  I  
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILN 125
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPK----IADFGMARLFEMDETQGNTSR-IV 489
           G+ YLH    L+I H DLK  N++L     PK    I DFG+A   +     GN  + I 
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF----GNEFKNIF 178
Query: 490 GTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           GT  ++APE   +    +++D++S GV+   ++SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-----LYDGAEIAVKRLSRDSGQG----DLEFKNEVLLV 374
           D +    +LG G F  V K R     L   A+   KR ++ S +G    D+E   EV ++
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSIL 68
Query: 375 ANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
             +QH N++ L        + +LI E V    L  F+     +  L  E   + +  I  
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILN 125
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPK----IADFGMARLFEMDETQGNTSR-IV 489
           G+ YLH    L+I H DLK  N++L     PK    I DFG+A   +     GN  + I 
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF----GNEFKNIF 178
Query: 490 GTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           GT  ++APE   +    +++D++S GV+   ++SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 12/198 (6%)
Query: 332 LGQGGFGAVYKGRLYDGAEIAVKRLSRDS----GQGDLEFKNEVLLVANLQHRNLVRLLG 387
           LG+GGF   Y+    D  E+   ++   S         +   E+ +  +L + ++V   G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 388 FSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRI 447
           F  + +   ++ E     SL        R+A  + E RY +   I +G+ YLH +   R+
Sbjct: 94  FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 147
Query: 448 IHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSV 507
           IHRDLK  N+ L+ +M  KI DFG+A   E D  +     + GT  Y+APE      +S 
Sbjct: 148 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKD--LCGTPNYIAPEVLCKKGHSF 205
Query: 508 KSDVFSFGVLVLEIISGQ 525
           + D++S G ++  ++ G+
Sbjct: 206 EVDIWSLGCILYTLLVGK 223

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-----LYDGAEIAVKRLSRDSGQG----DLEFKNEVLLV 374
           D +    +LG G F  V K R     L   A+   KR ++ S +G    D+E   EV ++
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSIL 68
Query: 375 ANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
             +QH N++ L        + +LI E V    L  F+     +  L  E   + +  I  
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILN 125
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPK----IADFGMARLFEMDETQGNTSR-IV 489
           G+ YLH    L+I H DLK  N++L     PK    I DFG+A   +     GN  + I 
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF----GNEFKNIF 178
Query: 490 GTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           GT  ++APE   +    +++D++S GV+   ++SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 112/257 (43%), Gaps = 38/257 (14%)
Query: 299 EAAAGDEINRAESLQFDFN-TIRVATDNFSDANKLGQGGFGAVYKGRLYD-GAE-----I 351
           E+  G+     +  Q  +N       +N      LG G FG V +   +  G E     +
Sbjct: 5   ESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKV 64
Query: 352 AVKRLSRDSGQGDLE-FKNEVLLVANL-QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDH 409
           AVK L   +   + E   +E+ ++++L QH N+V LLG    G   L+I E+     L +
Sbjct: 65  AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 124
Query: 410 FI-------FDPTRRAQLDWERRYKIIG-------------GIARGLLYLHEDSRLRIIH 449
           F+         P+     D E   K  G              +A+G+ +L   +    IH
Sbjct: 125 FLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKN---CIH 181
Query: 450 RDLKTSNVLLDAEMTPKIADFGMARLFEMDE---TQGNTSRIVGTYGYMAPEYAMHGQYS 506
           RD+   NVLL      KI DFG+AR    D     +GN    V    +MAPE      Y+
Sbjct: 182 RDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV---KWMAPESIFDCVYT 238
Query: 507 VKSDVFSFGVLVLEIIS 523
           V+SDV+S+G+L+ EI S
Sbjct: 239 VQSDVWSYGILLWEIFS 255

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 108/227 (47%), Gaps = 19/227 (8%)
Query: 321 VATDNFSDANKLGQGGFGAVYK------GRLYDGAEIAVKRLSRDSG-QGDLEFKNEVLL 373
           +  D F D   LG+GGFG V+       G+LY   ++  KRL +  G QG +  K    +
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK---I 238
Query: 374 VANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTR-RAQLDWERRYKIIGG 431
           +A +  R +V L  ++ E    L L+   +    + + I++           R       
Sbjct: 239 LAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297
Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT 491
           I  GL +LH+ +   II+RDLK  NVLLD +   +I+D G+A   E+   Q  T    GT
Sbjct: 298 IVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGT 352
Query: 492 YGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVED 538
            G+MAPE  +  +Y    D F+ GV + E+I+  R      GE VE+
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAA-RGPFRARGEKVEN 398

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 79/302 (26%), Positives = 131/302 (43%), Gaps = 34/302 (11%)
Query: 310 ESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRDSGQG 363
           E L +D +      D  +    LG+G FG V +   +          +AVK L   +   
Sbjct: 13  ERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHS 72
Query: 364 DLE-FKNEVLLVANL-QHRNLVRLLGF-SLEGNERLLIYEFVPNTSLDHFI------FDP 414
           +     +E+ ++ ++  H N+V LLG  +  G   ++I EF    +L  ++      F P
Sbjct: 73  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132
Query: 415 TRRAQLDWERRYKIIG---GIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFG 471
            +    D+     +I     +A+G+ +L   +  + IHRDL   N+LL  +   KI DFG
Sbjct: 133 YKDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFG 189
Query: 472 MARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFR 531
           +AR    D              +MAPE      Y+++SDV+SFGVL+ EI S   +    
Sbjct: 190 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-- 247
Query: 532 NGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMAS 591
            G  +++      +  +EGT +   D T       EM + +   L C     + RPT + 
Sbjct: 248 PGVKIDEEFX---RRLKEGTRMRAPDYT-----TPEMYQTM---LDCWHGEPSQRPTFSE 296
Query: 592 VV 593
           +V
Sbjct: 297 LV 298

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-----LYDGAEIAVKRLSRDSGQG----DLEFKNEVLLV 374
           D +    +LG G F  V K R     L   A+   KR ++ S +G    D+E   EV ++
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSIL 68
Query: 375 ANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
             +QH N++ L        + +LI E V    L  F+     +  L  E   + +  I  
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILN 125
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPK----IADFGMARLFEMDETQGNTSR-IV 489
           G+ YLH    L+I H DLK  N++L     PK    I DFG+A   +     GN  + I 
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF----GNEFKNIF 178
Query: 490 GTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           GT  ++APE   +    +++D++S GV+   ++SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 13/205 (6%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRL---SRDSGQGDLEFKNEVLLVANLQHR 380
           + +    K+G+G +G VYK +   G   A+K++     D G      + E+ ++  L+H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHS 60
Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH 440
           N+V+L          +L++E + +  L   +        L+       +  +  G+ Y H
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHL-DQDLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 441 EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA 500
           +    R++HRDLK  N+L++ E   KIADFG+AR F +   +  T  +V T  Y AP+  
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEVV-TLWYRAPDVL 172
Query: 501 M-HGQYSVKSDVFSFGVLVLEIISG 524
           M   +YS   D++S G +  E+++G
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 108/227 (47%), Gaps = 19/227 (8%)
Query: 321 VATDNFSDANKLGQGGFGAVYK------GRLYDGAEIAVKRLSRDSG-QGDLEFKNEVLL 373
           +  D F D   LG+GGFG V+       G+LY   ++  KRL +  G QG +  K    +
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK---I 238
Query: 374 VANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTR-RAQLDWERRYKIIGG 431
           +A +  R +V L  ++ E    L L+   +    + + I++           R       
Sbjct: 239 LAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297
Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT 491
           I  GL +LH+ +   II+RDLK  NVLLD +   +I+D G+A   E+   Q  T    GT
Sbjct: 298 IVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGT 352
Query: 492 YGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVED 538
            G+MAPE  +  +Y    D F+ GV + E+I+  R      GE VE+
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAA-RGPFRARGEKVEN 398

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 106/221 (47%), Gaps = 34/221 (15%)
Query: 331 KLGQGGFGAVYKG-RLYDGAEIAVKRLS---RDSGQGDLEFKNEVLLVANLQHRNLVRLL 386
           KLG+G +G V+K      G  +AVK++    ++S      F+  ++L     H N+V LL
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLL 75
Query: 387 GFSLEGNER--LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSR 444
                 N+R   L+++++  T L   I    R   L+   +  ++  + + + YLH    
Sbjct: 76  NVLRADNDRDVYLVFDYM-ETDLHAVI----RANILEPVHKQYVVYQLIKVIKYLHSGG- 129
Query: 445 LRIIHRDLKTSNVLLDAEMTPKIADFGMARLF-------------------EMDETQGNT 485
             ++HRD+K SN+LL+AE   K+ADFG++R F                     D+ Q   
Sbjct: 130 --LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL 187
Query: 486 SRIVGTYGYMAPEYAM-HGQYSVKSDVFSFGVLVLEIISGQ 525
           +  V T  Y APE  +   +Y+   D++S G ++ EI+ G+
Sbjct: 188 TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 105/234 (44%), Gaps = 23/234 (9%)
Query: 310 ESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRDSGQG 363
           E L +D +      D       LG+G FG V +   +          +AVK L   +   
Sbjct: 15  ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHS 74
Query: 364 DLE-FKNEVLLVANL-QHRNLVRLLGF-SLEGNERLLIYEFVPNTSLDHFI------FDP 414
           +     +E+ ++ ++  H N+V LLG  +  G   ++I EF    +L  ++      F P
Sbjct: 75  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 134
Query: 415 TRRAQL--DWERRYKIIG---GIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIAD 469
            +   L  D+     +I     +A+G+ +L   +  + IHRDL   N+LL  +   KI D
Sbjct: 135 YKPEDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICD 191
Query: 470 FGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
           FG+AR    D              +MAPE      Y+++SDV+SFGVL+ EI S
Sbjct: 192 FGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 13/205 (6%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRL---SRDSGQGDLEFKNEVLLVANLQHR 380
           + +    K+G+G +G VYK +   G   A+K++     D G      + E+ ++  L+H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHS 60
Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH 440
           N+V+L          +L++E + +  L   +        L+       +  +  G+ Y H
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHL-DQDLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 441 EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA 500
           +    R++HRDLK  N+L++ E   KIADFG+AR F +   +  T  +V T  Y AP+  
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEVV-TLWYRAPDVL 172
Query: 501 M-HGQYSVKSDVFSFGVLVLEIISG 524
           M   +YS   D++S G +  E+++G
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 108/227 (47%), Gaps = 19/227 (8%)
Query: 321 VATDNFSDANKLGQGGFGAVYK------GRLYDGAEIAVKRLSRDSG-QGDLEFKNEVLL 373
           +  D F D   LG+GGFG V+       G+LY   ++  KRL +  G QG +  K    +
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK---I 238
Query: 374 VANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTR-RAQLDWERRYKIIGG 431
           +A +  R +V L  ++ E    L L+   +    + + I++           R       
Sbjct: 239 LAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297
Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT 491
           I  GL +LH+ +   II+RDLK  NVLLD +   +I+D G+A   E+   Q  T    GT
Sbjct: 298 IVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGT 352
Query: 492 YGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVED 538
            G+MAPE  +  +Y    D F+ GV + E+I+  R      GE VE+
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAA-RGPFRARGEKVEN 398

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 107/231 (46%), Gaps = 47/231 (20%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 71
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 72  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 119
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 173
Query: 478 MDETQGNTSRIVGTYGYMAPEY---AMHGQYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE    AMH  Y+   D++S G ++ E+++G+
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNAMH--YNQTVDIWSVGCIMAELLTGR 220

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-----LYDGAEIAVKRLSRDSGQG----DLEFKNEVLLV 374
           D +    +LG G F  V K R     L   A+   KR ++ S +G    D+E   EV ++
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSIL 68
Query: 375 ANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
             +QH N++ L        + +LI E V    L  F+     +  L  E   + +  I  
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILN 125
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPK----IADFGMARLFEMDETQGNTSR-IV 489
           G+ YLH    L+I H DLK  N++L     PK    I DFG+A   +     GN  + I 
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF----GNEFKNIF 178
Query: 490 GTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           GT  ++APE   +    +++D++S GV+   ++SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 99/231 (42%), Gaps = 37/231 (16%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQGDLE-FKNEVLLVAN 376
           +N      LG G FG V     Y         ++AVK L   +   + E   +E+ ++  
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 377 L-QHRNLVRLLGFSLEGNERLLIYEFV-------------PNTSLDHFIFDPTRRAQ--- 419
           L  H N+V LLG         LI+E+                 S D   ++  +R +   
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 420 ----LDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL 475
               L +E        +A+G+ +L   S    +HRDL   NVL+      KI DFG+AR 
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 476 FEMDE---TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
              D     +GN    V    +MAPE    G Y++KSDV+S+G+L+ EI S
Sbjct: 222 IMSDSNYVVRGNARLPVK---WMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-----LYDGAEIAVKRLSRDSGQG----DLEFKNEVLLV 374
           D +    +LG G F  V K R     L   A+   KR ++ S +G    D+E   EV ++
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSIL 68
Query: 375 ANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
             +QH N++ L        + +LI E V    L  F+     +  L  E   + +  I  
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILN 125
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPK----IADFGMARLFEMDETQGNTSR-IV 489
           G+ YLH    L+I H DLK  N++L     PK    I DFG+A   +     GN  + I 
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF----GNEFKNIF 178
Query: 490 GTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           GT  ++APE   +    +++D++S GV+   ++SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 332 LGQGGFGAVYK-GRLYDGAEIAVKRL---SRDSGQGDLEFKNEVLLVANLQHRNLVRLLG 387
           +G G +G   K  R  DG  +  K L   S    +  +   +EV L+  L+H N+VR   
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQM-LVSEVNLLRELKHPNIVRYYD 72
Query: 388 FSLEGNERLL--IYEFVPNTSLDHFIFDPTRRAQ-LDWERRYKIIGGIARGLLYLHE--D 442
             ++     L  + E+     L   I   T+  Q LD E   +++  +   L   H   D
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 443 SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMH 502
               ++HRDLK +NV LD +   K+ DFG+AR+   DE        VGT  YM+PE    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDE--DFAKEFVGTPYYMSPEQMNR 190
Query: 503 GQYSVKSDVFSFGVLVLEI 521
             Y+ KSD++S G L+ E+
Sbjct: 191 MSYNEKSDIWSLGCLLYEL 209

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 104/230 (45%), Gaps = 18/230 (7%)
Query: 319 IRVATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDS--GQGDLE---FKNEVL 372
           I++  ++F     LG+G FG V+        +  A+K L +D      D+E    +  VL
Sbjct: 12  IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 71
Query: 373 LVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGI 432
            +A  +H  L  +            + E++    L + I       + D  R       I
Sbjct: 72  SLA-WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAEI 127
Query: 433 ARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY 492
             GL +LH      I++RDLK  N+LLD +   KIADFGM +  E       T+   GT 
Sbjct: 128 ILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNXFCGTP 182
Query: 493 GYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSS 542
            Y+APE  +  +Y+   D +SFGVL+ E++ GQ      +G+  E+L  S
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP---FHGQDEEELFHS 229

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-----LYDGAEIAVKRLSRDSGQG----DLEFKNEVLLV 374
           D +    +LG G F  V K R     L   A+   KR ++ S +G    D+E   EV ++
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSIL 68
Query: 375 ANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
             +QH N++ L        + +LI E V    L  F+     +  L  E   + +  I  
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILN 125
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPK----IADFGMARLFEMDETQGNTSR-IV 489
           G+ YLH    L+I H DLK  N++L     PK    I DFG+A   +     GN  + I 
Sbjct: 126 GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF----GNEFKNIF 178
Query: 490 GTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           GT  ++APE   +    +++D++S GV+   ++SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-----LYDGAEIAVKRLSRDSGQG----DLEFKNEVLLV 374
           D +    +LG G F  V K R     L   A+   KR ++ S +G    D+E   EV ++
Sbjct: 11  DYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSIL 68
Query: 375 ANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
             +QH N++ L        + +LI E V    L  F+     +  L  E   + +  I  
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILN 125
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPK----IADFGMARLFEMDETQGNTSR-IV 489
           G+ YLH    L+I H DLK  N++L     PK    I DFG+A   +     GN  + I 
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF----GNEFKNIF 178
Query: 490 GTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           GT  ++APE   +    +++D++S GV+   ++SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/258 (26%), Positives = 124/258 (48%), Gaps = 23/258 (8%)
Query: 287 RRKPRDNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDAN-KLGQGGFGAVYKG-- 343
           R  P D S  +S  +  +E+            + +  DN   A+ +LG G FG+V +G  
Sbjct: 306 RPMPMDTSVFESPFSDPEELKD--------KKLFLKRDNLLIADIELGCGNFGSVRQGVY 357
Query: 344 RLYDGA-EIAVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF 401
           R+     ++A+K L + + + D E    E  ++  L +  +VRL+G   +    +L+ E 
Sbjct: 358 RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEM 416
Query: 402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDA 461
                L  F+    +R ++      +++  ++ G+ YL E +    +HR+L   NVLL  
Sbjct: 417 AGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVN 471
Query: 462 EMTPKIADFGMARLFEMDETQGNTSRIVGTY--GYMAPEYAMHGQYSVKSDVFSFGVLVL 519
               KI+DFG+++    D++   T+R  G +   + APE     ++S +SDV+S+GV + 
Sbjct: 472 RHYAKISDFGLSKALGADDSY-YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMW 530
Query: 520 EIIS-GQRNNCFRNGETV 536
           E +S GQ+      G  V
Sbjct: 531 EALSYGQKPYKKMKGPEV 548

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 110/225 (48%), Gaps = 14/225 (6%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQGDLEFK--NEVLLVANLQHRN 381
            +    K+G+G +G V+K +  +  EI A+KR+  D     +      E+ L+  L+H+N
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           +VRL        +  L++EF  +  L  + FD +    LD E     +  + +GL + H 
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFC-DQDLKKY-FD-SCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM 501
            +   ++HRDLK  N+L++     K+ADFG+AR F +   +  ++ +V T  Y  P+   
Sbjct: 120 RN---VLHRDLKPQNLLINRNGELKLADFGLARAFGI-PVRCYSAEVV-TLWYRPPDVLF 174
Query: 502 HGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWK 545
             + YS   D++S G +  E+ +  R      G  V+D L   ++
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAARP--LFPGNDVDDQLKRIFR 217

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 20  KTIWEVPERYQNLSPIGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 76
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 77  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 124
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 125 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR--- 178
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 179 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 109/221 (49%), Gaps = 27/221 (12%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 71
Query: 371 VLLVANLQHRNLVRLLGF-----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERR 425
           + L+ +++H N++ LL       SLE    + +   +    L++ +    +  +L  +  
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KXQKLTDDHV 127
Query: 426 YKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNT 485
             +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T    
Sbjct: 128 QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEM 179
Query: 486 SRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
           +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGHRVAVKKLSR-PFQSIIHAKRTYRE 71
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 72  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 119
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 173
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 174 --HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGHRVAVKKLSR-PFQSIIHAKRTYRE 71
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 72  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 119
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 173
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 174 --HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 114/229 (49%), Gaps = 21/229 (9%)
Query: 309 AESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLY--DGA--EIAVKRLSRD-SGQG 363
           +E LQ     + +  +       LG+G FG+V +G L   DG   ++AVK +  D S Q 
Sbjct: 19  SEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQR 78
Query: 364 DLE-FKNEVLLVANLQHRNLVRLLGFSLEGNER-----LLIYEFVPNTSLDHFIFD---P 414
           ++E F +E   + +  H N++RLLG  +E + +     ++I  F+    L  ++      
Sbjct: 79  EIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLE 138
Query: 415 TRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMA- 473
           T    +  +   K +  IA G+ YL   S    +HRDL   N +L  +MT  +ADFG++ 
Sbjct: 139 TGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195
Query: 474 RLFEMD-ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEI 521
           +++  D   QG  +++     ++A E      Y+ KSDV++FGV + EI
Sbjct: 196 KIYSGDYYRQGRIAKM--PVKWIAIESLADRVYTSKSDVWAFGVTMWEI 242

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 97/222 (43%), Gaps = 27/222 (12%)
Query: 330 NKLGQGGFGAVYKGRLYDG-----AEIAVKRLSRD---SGQGDLEFKNEVLLVANLQHRN 381
            KLG G FG V +G  +D        +AVK L  D     +   +F  EV  + +L HRN
Sbjct: 14  EKLGDGSFGVVRRGE-WDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72
Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQ----LDWERRYKIIGGIARGLL 437
           L+RL G  L    ++ + E  P  SL     D  R+ Q    L    RY +   +A G+ 
Sbjct: 73  LIRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QVAEGMG 125
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM--DETQGNTSRIVGTYGYM 495
           YL      R IHRDL   N+LL      KI DFG+ R      D       R V  + + 
Sbjct: 126 YLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFAWC 181
Query: 496 APEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETV 536
           APE      +S  SD + FGV + E+ + GQ      NG  +
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI 223

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 97/222 (43%), Gaps = 27/222 (12%)
Query: 330 NKLGQGGFGAVYKGRLYDG-----AEIAVKRLSRD---SGQGDLEFKNEVLLVANLQHRN 381
            KLG G FG V +G  +D        +AVK L  D     +   +F  EV  + +L HRN
Sbjct: 18  EKLGDGSFGVVRRGE-WDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 76
Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQ----LDWERRYKIIGGIARGLL 437
           L+RL G  L    ++ + E  P  SL     D  R+ Q    L    RY +   +A G+ 
Sbjct: 77  LIRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QVAEGMG 129
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM--DETQGNTSRIVGTYGYM 495
           YL      R IHRDL   N+LL      KI DFG+ R      D       R V  + + 
Sbjct: 130 YLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWC 185
Query: 496 APEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETV 536
           APE      +S  SD + FGV + E+ + GQ      NG  +
Sbjct: 186 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI 227

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 97/222 (43%), Gaps = 27/222 (12%)
Query: 330 NKLGQGGFGAVYKGRLYDG-----AEIAVKRLSRD---SGQGDLEFKNEVLLVANLQHRN 381
            KLG G FG V +G  +D        +AVK L  D     +   +F  EV  + +L HRN
Sbjct: 24  EKLGDGSFGVVRRGE-WDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQ----LDWERRYKIIGGIARGLL 437
           L+RL G  L    ++ + E  P  SL     D  R+ Q    L    RY +   +A G+ 
Sbjct: 83  LIRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QVAEGMG 135
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM--DETQGNTSRIVGTYGYM 495
           YL      R IHRDL   N+LL      KI DFG+ R      D       R V  + + 
Sbjct: 136 YLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFAWC 191
Query: 496 APEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETV 536
           APE      +S  SD + FGV + E+ + GQ      NG  +
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI 233

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 107/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 78
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 79  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 126
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 127 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HT 182
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
            DE  G     V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 183 ADEMTG----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-----LYDGAEIAVKRLSRDSGQG----DLEFKNEVLLV 374
           D +    +LG G F  V K R     L   A+   KR ++ S +G    D+E   EV ++
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSIL 68
Query: 375 ANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
             +QH N++ L        + +LI E V    L  F+     +  L  E   + +  I  
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFL---AEKESLTEEEATEFLKQILN 125
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPK----IADFGMARLFEMDETQGNTSR-IV 489
           G+ YLH    L+I H DLK  N++L     PK    I DFG+A   +     GN  + I 
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF----GNEFKNIF 178
Query: 490 GTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           GT  ++APE   +    +++D++S GV+   ++SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 109/221 (49%), Gaps = 27/221 (12%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 71
Query: 371 VLLVANLQHRNLVRLLGF-----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERR 425
           + L+ +++H N++ LL       SLE    + +   +    L++ +    +  +L  +  
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KXQKLTDDHV 127
Query: 426 YKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNT 485
             +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T    
Sbjct: 128 QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEM 179
Query: 486 SRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
           +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 135/302 (44%), Gaps = 41/302 (13%)
Query: 320 RVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQH 379
           R          ++G+G +G V+ G+ + G ++AVK +   + +     + E+     ++H
Sbjct: 33  RTIAKQIQMVKQIGKGRYGEVWMGK-WRGEKVAVK-VFFTTEEASWFRETEIYQTVLMRH 90
Query: 380 RNLVRLLGFSLEGN----ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARG 435
            N++  +   ++G     +  LI ++  N SL    +D  +   LD +   K+      G
Sbjct: 91  ENILGFIAADIKGTGSWTQLYLITDYHENGSL----YDYLKSTTLDAKSMLKLAYSSVSG 146
Query: 436 LLYLHED-----SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF--EMDETQGNTSRI 488
           L +LH +      +  I HRDLK+ N+L+    T  IAD G+A  F  + +E     +  
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR 206
Query: 489 VGTYGYMAPEYA------MHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVE----- 537
           VGT  YM PE         H Q  + +D++SFG+++ E+       C   G   E     
Sbjct: 207 VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA----RRCVSGGIVEEYQLPY 262
Query: 538 -DLLSS--AWKNWREGTTVNIIDPTLSS-GSITEMIRCIHIGLL---CVQENVASRPTMA 590
            DL+ S  ++++ RE   +  + P+  +  S  E +R   +G L   C   N ASR T  
Sbjct: 263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLR--QMGKLMTECWAHNPASRLTAL 320
Query: 591 SV 592
            V
Sbjct: 321 RV 322

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 20/215 (9%)
Query: 318 TIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQGDLEFKNEVLLVAN 376
           ++ V  D+     +LG+G +G V K R     +I AVKR+       +   +  +L+  +
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE---QKRLLMDLD 57
Query: 377 LQHRNL-----VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRY-KIIG 430
           +  R +     V   G      +  +  E + +TSLD F      + Q   E    KI  
Sbjct: 58  ISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAV 116
Query: 431 GIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVG 490
            I + L +LH  S+L +IHRD+K SNVL++A    K+ DFG++  + +D+   +     G
Sbjct: 117 SIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISG-YLVDDVAKDID--AG 171
Query: 491 TYGYMAPEYA----MHGQYSVKSDVFSFGVLVLEI 521
              YMAPE          YSVKSD++S G+ ++E+
Sbjct: 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 76
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 77  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 124
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 125 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR--- 178
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 179 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 113/240 (47%), Gaps = 23/240 (9%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFK----NEVLLVANLQH 379
           D+F   ++LG G  G V K +      I  ++L        LE K    N+++    + H
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIH------LEIKPAIRNQIIRELQVLH 69
Query: 380 R----NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARG 435
                 +V   G      E  +  E +   SLD  + +  R   +  E   K+   + RG
Sbjct: 70  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR---IPEEILGKVSIAVLRG 126
Query: 436 LLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYM 495
           L YL E  + +I+HRD+K SN+L+++    K+ DFG++   ++ ++  N+   VGT  YM
Sbjct: 127 LAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRSYM 180
Query: 496 APEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNI 555
           APE      YSV+SD++S G+ ++E+  G+      + + +E +      +  EG   +I
Sbjct: 181 APERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSI 240

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 107/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 78
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 79  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 126
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 127 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HT 182
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
            DE  G     V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 183 ADEMTG----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGHRVAVKKLSR-PFQSIIHAKRTYRE 67
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 68  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 115
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 116 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 169
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 170 --HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 71
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 72  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 119
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 173
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 97/222 (43%), Gaps = 27/222 (12%)
Query: 330 NKLGQGGFGAVYKGRLYDG-----AEIAVKRLSRD---SGQGDLEFKNEVLLVANLQHRN 381
            KLG G FG V +G  +D        +AVK L  D     +   +F  EV  + +L HRN
Sbjct: 14  EKLGDGSFGVVRRGE-WDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72
Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQ----LDWERRYKIIGGIARGLL 437
           L+RL G  L    ++ + E  P  SL     D  R+ Q    L    RY +   +A G+ 
Sbjct: 73  LIRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QVAEGMG 125
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM--DETQGNTSRIVGTYGYM 495
           YL      R IHRDL   N+LL      KI DFG+ R      D       R V  + + 
Sbjct: 126 YLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWC 181
Query: 496 APEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETV 536
           APE      +S  SD + FGV + E+ + GQ      NG  +
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI 223

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 71
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 72  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 119
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 173
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 82
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 83  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 130
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 131 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR--- 184
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 185 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 76
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 77  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 124
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 125 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 178
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 179 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 71
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 72  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 119
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 173
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 14  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 70
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 71  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 118
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 119 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 172
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 173 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 71
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 72  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 119
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 173
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 71
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 72  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 119
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 173
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGHRVAVKKLSR-PFQSIIHAKRTYRE 71
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 72  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 119
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 173
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 76
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 77  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 124
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 125 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 178
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 179 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 73
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 74  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 121
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 122 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 175
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 176 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 27/218 (12%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYDG-AEIAVKRLSR---DSG----------QGDLEFKN 369
           +++    KLG G +G V   +  +G +E A+K + +   D G          +   E  N
Sbjct: 36  ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 370 EVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKII 429
           E+ L+ +L H N+++L     +     L+ EF     L   I +   R + D      I+
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIM 152
Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE---MTPKIADFGMARLFEMDETQGNTS 486
             I  G+ YLH+ +   I+HRD+K  N+LL+ +   +  KI DFG++  F  D    +  
Sbjct: 153 KQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR- 208
Query: 487 RIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
             +GT  Y+APE  +  +Y+ K DV+S GV++  ++ G
Sbjct: 209 --LGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 71
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 72  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 119
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 173
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 174 --HTDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 71
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 72  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 119
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 173
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 78
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 79  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 126
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 127 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 180
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 181 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 67
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 68  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 115
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 116 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 169
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 170 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 73
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 74  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 121
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 122 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 175
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 176 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 13  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 69
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 70  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 117
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 118 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 171
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 172 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 107/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 78
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 79  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 126
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 127 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HT 182
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
            DE  G     V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 183 ADEMTG----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 97/222 (43%), Gaps = 27/222 (12%)
Query: 330 NKLGQGGFGAVYKGRLYDG-----AEIAVKRLSRD---SGQGDLEFKNEVLLVANLQHRN 381
            KLG G FG V +G  +D        +AVK L  D     +   +F  EV  + +L HRN
Sbjct: 24  EKLGDGSFGVVRRGE-WDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQ----LDWERRYKIIGGIARGLL 437
           L+RL G  L    ++ + E  P  SL     D  R+ Q    L    RY +   +A G+ 
Sbjct: 83  LIRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QVAEGMG 135
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM--DETQGNTSRIVGTYGYM 495
           YL      R IHRDL   N+LL      KI DFG+ R      D       R V  + + 
Sbjct: 136 YLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWC 191
Query: 496 APEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETV 536
           APE      +S  SD + FGV + E+ + GQ      NG  +
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI 233

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGHRVAVKKLSR-PFQSIIHAKRTYRE 67
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 68  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 115
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 116 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 169
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 170 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 112/234 (47%), Gaps = 45/234 (19%)
Query: 326 FSDANKLGQGGFGAV---YKGRLYDGAEIAVKRLSRDSGQGDLEFKN---EVLLVANLQH 379
           + D   +G G +GAV     GR   GA++A+K+L R   Q +L  K    E+ L+ +++H
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRT--GAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMRH 83
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHF----IFDP---------TRRAQLDWERRY 426
            N++ LL              F P+ +LD F    +  P          +  +L  +R  
Sbjct: 84  ENVIGLLDV------------FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQ 131
Query: 427 KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTS 486
            ++  + +GL Y+H      IIHRDLK  N+ ++ +   KI DFG+AR     +      
Sbjct: 132 FLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMX 183
Query: 487 RIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDL 539
             V T  Y APE  ++  +Y+   D++S G ++ E+I+G+    F+  + ++ L
Sbjct: 184 GXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK--TLFKGSDHLDQL 235

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 97/222 (43%), Gaps = 27/222 (12%)
Query: 330 NKLGQGGFGAVYKGRLYDG-----AEIAVKRLSRD---SGQGDLEFKNEVLLVANLQHRN 381
            KLG G FG V +G  +D        +AVK L  D     +   +F  EV  + +L HRN
Sbjct: 18  EKLGDGSFGVVRRGE-WDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 76
Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQ----LDWERRYKIIGGIARGLL 437
           L+RL G  L    ++ + E  P  SL     D  R+ Q    L    RY +   +A G+ 
Sbjct: 77  LIRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QVAEGMG 129
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM--DETQGNTSRIVGTYGYM 495
           YL      R IHRDL   N+LL      KI DFG+ R      D       R V  + + 
Sbjct: 130 YLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWC 185
Query: 496 APEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETV 536
           APE      +S  SD + FGV + E+ + GQ      NG  +
Sbjct: 186 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI 227

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 77
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 78  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 125
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 126 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 179
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 180 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 68
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 69  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 116
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 117 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 170
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 171 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 73
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 74  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 121
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 122 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 175
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 176 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 71
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 72  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 119
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 173
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 103/213 (48%), Gaps = 29/213 (13%)
Query: 322 ATDNFSDANKLGQGGFG-AVYKGRLYDGAEIAVKRL--SRDSGQGDLEFKNEVLLVANLQ 378
           + + +    K+G+G FG A+      DG +  +K +  SR S +   E + EV ++AN++
Sbjct: 22  SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMK 81
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQ----------LDWERRYKI 428
           H N+V+      E     ++ ++     L   I      AQ          LDW      
Sbjct: 82  HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI-----NAQKGVLFQEDQILDW------ 130
Query: 429 IGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
              I   L ++H+    +I+HRD+K+ N+ L  + T ++ DFG+AR+  ++ T       
Sbjct: 131 FVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARAC 185
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEI 521
           +GT  Y++PE   +  Y+ KSD+++ G ++ E+
Sbjct: 186 IGTPYYLSPEICENKPYNNKSDIWALGCVLYEL 218

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 83
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 84  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 131
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 132 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 185
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 186 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 73
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 74  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 121
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 122 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR--- 175
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 176 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 83
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 84  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 131
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 132 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 185
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 186 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 68
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 69  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 116
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 117 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 170
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 171 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 108/229 (47%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGHRVAVKKLSR-PFQSIIHAKRTYRE 91
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 92  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 139
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR  +
Sbjct: 140 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD 196
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
            DE  G     V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 197 -DEMXGX----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 97/222 (43%), Gaps = 27/222 (12%)
Query: 330 NKLGQGGFGAVYKGRLYDG-----AEIAVKRLSRD---SGQGDLEFKNEVLLVANLQHRN 381
            KLG G FG V +G  +D        +AVK L  D     +   +F  EV  + +L HRN
Sbjct: 14  EKLGDGSFGVVRRGE-WDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72
Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQ----LDWERRYKIIGGIARGLL 437
           L+RL G  L    ++ + E  P  SL     D  R+ Q    L    RY +   +A G+ 
Sbjct: 73  LIRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QVAEGMG 125
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM--DETQGNTSRIVGTYGYM 495
           YL      R IHRDL   N+LL      KI DFG+ R      D       R V  + + 
Sbjct: 126 YLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWC 181
Query: 496 APEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETV 536
           APE      +S  SD + FGV + E+ + GQ      NG  +
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI 223

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 77
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 78  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 125
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 126 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR--- 179
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 180 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGHRVAVKKLSR-PFQSIIHAKRTYRE 91
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 92  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 139
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 140 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 193
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 194 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 82
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 83  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 130
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 131 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 184
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 185 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 103/222 (46%), Gaps = 27/222 (12%)
Query: 317 NTIRVATD------NFSDANKLGQGGFGAVYKGR-LYDGAEIAVK-----RLSRDSGQGD 364
           N+I  ATD      N+     +G+G F  V   R +  G E+AVK     +L+  S Q  
Sbjct: 2   NSITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQ-- 59
Query: 365 LEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWER 424
            +   EV ++  L H N+V+L           L+ E+     +  ++    R  + +   
Sbjct: 60  -KLFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA 118
Query: 425 RYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN 484
           +++    I   + Y H+     I+HRDLK  N+LLD +M  KIADFG +  F    T GN
Sbjct: 119 KFR---QIVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEF----TVGN 168
Query: 485 T-SRIVGTYGYMAPEYAMHGQYS-VKSDVFSFGVLVLEIISG 524
                 G+  Y APE     +Y   + DV+S GV++  ++SG
Sbjct: 169 KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 34  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGHRVAVKKLSR-PFQSIIHAKRTYRE 90
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 91  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 138
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 139 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 192
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 193 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 108/229 (47%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 38  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 94
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 95  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 142
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR  +
Sbjct: 143 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD 199
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
            DE  G     V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 200 -DEMXG----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 38  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 94
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 95  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 142
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 143 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 196
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 197 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 91
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 92  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 139
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 140 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 193
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 194 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 17/212 (8%)
Query: 321 VATDNFSDANKLGQGGFGAV------YKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLV 374
           V  + F     LG+GGFG V        G++Y  A   +++      +G+    NE  ++
Sbjct: 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMY--ACKKLEKKRIKKRKGEAMALNEKQIL 238
Query: 375 ANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA 433
             +  R +V L  ++ E  + L L+   +    L   I+    +A     R       I 
Sbjct: 239 EKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYH-MGQAGFPEARAVFYAAEIC 296
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
            GL  LH   R RI++RDLK  N+LLD     +I+D G+A    + E Q    R VGT G
Sbjct: 297 CGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGR-VGTVG 350
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           YMAPE   + +Y+   D ++ G L+ E+I+GQ
Sbjct: 351 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 34  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 90
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 91  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 138
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 139 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 192
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 193 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 21/202 (10%)
Query: 325 NFSDANKLGQGGFGAVYKG-RLYDGAEIAVK-----RLSRDSGQGDLEFKNEVLLVANLQ 378
           N+     LG+G FG V        G ++A+K      L++   QG +E   E+  +  L+
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 71
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           H ++++L       +E +++ E+  N   D+ +    +R ++  +   +    I   + Y
Sbjct: 72  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEY 127
Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI-VGTYGYMAP 497
            H   R +I+HRDLK  N+LLD  +  KIADFG++ +     T GN  +   G+  Y AP
Sbjct: 128 CH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAAP 180
Query: 498 EYAMHGQYS-VKSDVFSFGVLV 518
           E      Y+  + DV+S GV++
Sbjct: 181 EVISGKLYAGPEVDVWSCGVIL 202

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 96/206 (46%), Gaps = 26/206 (12%)
Query: 332 LGQGGFGAVYKGRLYD------GAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVR 384
           LG+G FG V     YD      G  +AVK L  D G Q    +K E+ ++  L H ++++
Sbjct: 22  LGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIK 80
Query: 385 LLGFSLEGNER--LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
             G   +  E+   L+ E+VP  SL  ++     R  +   +       I  G+ YLH  
Sbjct: 81  YKGCCEDQGEKSLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHSQ 136
Query: 443 SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG-----YMAP 497
                IHR+L   NVLLD +   KI DFG+A+       +G+    V   G     + AP
Sbjct: 137 ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAV----PEGHEYYRVREDGDSPVFWYAP 189
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIIS 523
           E     ++   SDV+SFGV + E+++
Sbjct: 190 ECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGHRVAVKKLSR-PFQSIIHAKRTYRE 77
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 78  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 125
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 126 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 179
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 180 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 21/202 (10%)
Query: 325 NFSDANKLGQGGFGAVYKG-RLYDGAEIAVK-----RLSRDSGQGDLEFKNEVLLVANLQ 378
           N+     LG+G FG V        G ++A+K      L++   QG +E   E+  +  L+
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 72
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           H ++++L       +E +++ E+  N   D+ +    +R ++  +   +    I   + Y
Sbjct: 73  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEY 128
Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI-VGTYGYMAP 497
            H   R +I+HRDLK  N+LLD  +  KIADFG++ +     T GN  +   G+  Y AP
Sbjct: 129 CH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAAP 181
Query: 498 EYAMHGQYS-VKSDVFSFGVLV 518
           E      Y+  + DV+S GV++
Sbjct: 182 EVISGKLYAGPEVDVWSCGVIL 203

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 33/214 (15%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDLEFKN---EVLLVANLQH 379
           + +   +G G  G V     YD      +A+K+LSR   Q     K    E++L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVVAA--YDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKVVNH 82
Query: 380 RNLVRLLGF-----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
           +N++ LL       SLE  + + I   + + +L   I     + +LD ER   ++  +  
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVI-----QMELDHERMSYLLYQMLV 137
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN----TSRIVG 490
           G+ +LH      IIHRDLK SN+++ ++ T KI DFG+AR      T G     T  +V 
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR------TAGTSFMMTPYVVT 188
Query: 491 TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
            Y Y APE  +   Y    D++S GV++ E+I G
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 77
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 78  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 125
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 126 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 179
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 180 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 21/202 (10%)
Query: 325 NFSDANKLGQGGFGAVYKG-RLYDGAEIAVK-----RLSRDSGQGDLEFKNEVLLVANLQ 378
           N+     LG+G FG V        G ++A+K      L++   QG +E   E+  +  L+
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 62
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           H ++++L       +E +++ E+  N   D+ +    +R ++  +   +    I   + Y
Sbjct: 63  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEY 118
Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI-VGTYGYMAP 497
            H   R +I+HRDLK  N+LLD  +  KIADFG++ +     T GN  +   G+  Y AP
Sbjct: 119 CH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAAP 171
Query: 498 EYAMHGQYS-VKSDVFSFGVLV 518
           E      Y+  + DV+S GV++
Sbjct: 172 EVISGKLYAGPEVDVWSCGVIL 193

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 92/198 (46%), Gaps = 10/198 (5%)
Query: 332 LGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFK---NEVLLVANLQHRNLVRLLGF 388
           +G G +G   K R     +I V +        + E +   +EV L+  L+H N+VR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 389 SLEGNERLL--IYEFVPNTSLDHFIFDPTRRAQ-LDWERRYKIIGGIARGLLYLHE--DS 443
            ++     L  + E+     L   I   T+  Q LD E   +++  +   L   H   D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG 503
              ++HRDLK +NV LD +   K+ DFG+AR+   D +       VGT  YM+PE     
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMSPEQMNRM 191
Query: 504 QYSVKSDVFSFGVLVLEI 521
            Y+ KSD++S G L+ E+
Sbjct: 192 SYNEKSDIWSLGCLLYEL 209

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDS--GQGDLEF-KNEVLLVANLQH 379
           ++F     LG+G F  V   R L    E A+K L +     +  + +   E  +++ L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 380 RNLVRLLGFSLEGNERLLI-YEFVPNTSLDHFI-----FDPTRRAQLDWERRYKIIGGIA 433
              V+L  F+ + +E+L     +  N  L  +I     FD T        R Y     I 
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDET------CTRFY--TAEIV 142
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             L YLH      IIHRDLK  N+LL+ +M  +I DFG A++   +  Q   +  VGT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 199
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           Y++PE       S  SD+++ G ++ ++++G
Sbjct: 200 YVSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 96/206 (46%), Gaps = 26/206 (12%)
Query: 332 LGQGGFGAVYKGRLYD------GAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVR 384
           LG+G FG V     YD      G  +AVK L  D G Q    +K E+ ++  L H ++++
Sbjct: 22  LGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIK 80
Query: 385 LLGFSLEGNER--LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
             G   +  E+   L+ E+VP  SL  ++     R  +   +       I  G+ YLH  
Sbjct: 81  YKGCCEDQGEKSLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHAQ 136
Query: 443 SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG-----YMAP 497
                IHR+L   NVLLD +   KI DFG+A+       +G+    V   G     + AP
Sbjct: 137 ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAV----PEGHEYYRVREDGDSPVFWYAP 189
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIIS 523
           E     ++   SDV+SFGV + E+++
Sbjct: 190 ECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 21/202 (10%)
Query: 325 NFSDANKLGQGGFGAVYKG-RLYDGAEIAVK-----RLSRDSGQGDLEFKNEVLLVANLQ 378
           N+     LG+G FG V        G ++A+K      L++   QG +E   E+  +  L+
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 66
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           H ++++L       +E +++ E+  N   D+ +    +R ++  +   +    I   + Y
Sbjct: 67  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEY 122
Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI-VGTYGYMAP 497
            H   R +I+HRDLK  N+LLD  +  KIADFG++ +     T GN  +   G+  Y AP
Sbjct: 123 CH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAAP 175
Query: 498 EYAMHGQYS-VKSDVFSFGVLV 518
           E      Y+  + DV+S GV++
Sbjct: 176 EVISGKLYAGPEVDVWSCGVIL 197

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 325 NFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSR---DSGQGDLEFKNEVLLVANLQHR 380
           N+     +G+G F  V   R +  G E+AVK + +   +S      F+ EV ++  L H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 73
Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH 440
           N+V+L           L+ E+     +  ++    R  + +   +++    I   + Y H
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQYCH 130
Query: 441 EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNT-SRIVGTYGYMAPEY 499
           +     I+HRDLK  N+LLDA+M  KIADFG +  F    T GN      G+  Y APE 
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF----TFGNKLDTFCGSPPYAAPEL 183
Query: 500 AMHGQY-SVKSDVFSFGVLVLEIISG 524
               +Y   + DV+S GV++  ++SG
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 105/229 (45%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + +   +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 25  KTIWEVPERYQNLAPVGSGAYGSVCAA--FDTKTGHRVAVKKLSR-PFQSIIHAKRTYRE 81
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 82  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 129
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 130 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 183
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 184 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 17/212 (8%)
Query: 321 VATDNFSDANKLGQGGFGAV------YKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLV 374
           V  + F     LG+GGFG V        G++Y  A   +++      +G+    NE  ++
Sbjct: 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMY--ACKKLEKKRIKKRKGEAMALNEKQIL 238
Query: 375 ANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA 433
             +  R +V L  ++ E  + L L+   +    L   I+    +A     R       I 
Sbjct: 239 EKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYH-MGQAGFPEARAVFYAAEIC 296
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
            GL  LH   R RI++RDLK  N+LLD     +I+D G+A    + E Q    R VGT G
Sbjct: 297 CGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGR-VGTVG 350
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           YMAPE   + +Y+   D ++ G L+ E+I+GQ
Sbjct: 351 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 332 LGQGGFGAVYKGRLYDGAE-----IAVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLVRL 385
           +G+G FG V++G +Y   E     +A+K     +     E F  E L +    H ++V+L
Sbjct: 18  IGEGQFGDVHQG-IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 386 LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRL 445
           +G   E N   +I E      L  F+    R+  LD          ++  L YL      
Sbjct: 77  IGVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK--- 130
Query: 446 RIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQY 505
           R +HRD+   NVL+ A    K+ DFG++R  E D T    S+      +MAPE     ++
Sbjct: 131 RFVHRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 506 SVKSDVFSFGVLVLEII 522
           +  SDV+ FGV + EI+
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 13/207 (6%)
Query: 324 DNFSDANKLGQGGFGAVY-KGRLYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQHRN 381
           D F    KLG G FG V+       G E  +K +++D  Q  +E  + E+ ++ +L H N
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQ-LDWERRYKIIGGIARGLLYLH 440
           ++++     + +   ++ E      L   I     R + L      +++  +   L Y H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 441 EDSRLRIIHRDLKTSNVLLD--AEMTP-KIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
                 ++H+DLK  N+L    +  +P KI DFG+A LF+ DE   N +   GT  YMAP
Sbjct: 142 SQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA---GTALYMAP 195
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISG 524
           E       + K D++S GV++  +++G
Sbjct: 196 E-VFKRDVTFKCDIWSAGVVMYFLLTG 221

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 130/290 (44%), Gaps = 38/290 (13%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYDGAE-IAVKRLSRDSGQGDL-EFKNEVLLVANLQHRN 381
           D++     +G G    V         E +A+KR++ +  Q  + E   E+  ++   H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 382 LVRLLGFSLEGNERLLIYEFVPNTS----LDHFIFDPTRRAQ-LDWERRYKIIGGIARGL 436
           +V      +  +E  L+ + +   S    + H +     ++  LD      I+  +  GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSR------IVG 490
            YLH++ +   IHRD+K  N+LL  + + +IADFG++       T G+ +R       VG
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFL---ATGGDITRNKVRKTFVG 188
Query: 491 TYGYMAPEYAMHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWRE 549
           T  +MAPE     + Y  K+D++SFG+  +E+ +G     +     ++ L+         
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP--YHKYPPMKVLM--------- 237
Query: 550 GTTVNIIDPTLSSG-SITEMIRCIHIGL-----LCVQENVASRPTMASVV 593
             T+    P+L +G    EM++           LC+Q++   RPT A ++
Sbjct: 238 -LTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 325 NFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSR---DSGQGDLEFKNEVLLVANLQHR 380
           N+     +G+G F  V   R +  G E+AVK + +   +S      F+ EV ++  L H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 73
Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH 440
           N+V+L           L+ E+     +  ++    R  + +   +++    I   + Y H
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQYCH 130
Query: 441 EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNT-SRIVGTYGYMAPEY 499
           +     I+HRDLK  N+LLDA+M  KIADFG +  F    T GN      G+  Y APE 
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF----TFGNKLDTFCGSPPYAAPEL 183
Query: 500 AMHGQY-SVKSDVFSFGVLVLEIISG 524
               +Y   + DV+S GV++  ++SG
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 332 LGQGGFGAVYKGRLYDGAE-----IAVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLVRL 385
           +G+G FG V++G +Y   E     +A+K     +     E F  E L +    H ++V+L
Sbjct: 18  IGEGQFGDVHQG-IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 386 LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRL 445
           +G   E N   +I E      L  F+    R+  LD          ++  L YL      
Sbjct: 77  IGVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK--- 130
Query: 446 RIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQY 505
           R +HRD+   NVL+ +    K+ DFG++R  E D T    S+      +MAPE     ++
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTXXKASKGKLPIKWMAPESINFRRF 189
Query: 506 SVKSDVFSFGVLVLEII 522
           +  SDV+ FGV + EI+
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 130/290 (44%), Gaps = 38/290 (13%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYDGAE-IAVKRLSRDSGQGDL-EFKNEVLLVANLQHRN 381
           D++     +G G    V         E +A+KR++ +  Q  + E   E+  ++   H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 382 LVRLLGFSLEGNERLLIYEFVPNTS----LDHFIFDPTRRAQ-LDWERRYKIIGGIARGL 436
           +V      +  +E  L+ + +   S    + H +     ++  LD      I+  +  GL
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSR------IVG 490
            YLH++ +   IHRD+K  N+LL  + + +IADFG++       T G+ +R       VG
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFL---ATGGDITRNKVRKTFVG 183
Query: 491 TYGYMAPEYAMHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWRE 549
           T  +MAPE     + Y  K+D++SFG+  +E+ +G     +     ++ L+         
Sbjct: 184 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP--YHKYPPMKVLM--------- 232
Query: 550 GTTVNIIDPTLSSG-SITEMIRCIHIGL-----LCVQENVASRPTMASVV 593
             T+    P+L +G    EM++           LC+Q++   RPT A ++
Sbjct: 233 -LTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 281

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 71
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 72  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 119
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI D+G+AR   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLAR--- 173
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 33/214 (15%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDLEFKN---EVLLVANLQH 379
           + +   +G G  G V     YD      +A+K+LSR   Q     K    E++L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAA--YDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKVVNH 82
Query: 380 RNLVRLLGF-----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
           +N++ LL       SLE  + + I   + + +L   I     + +LD ER   ++  +  
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVI-----QMELDHERMSYLLYQMLV 137
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN----TSRIVG 490
           G+ +LH      IIHRDLK SN+++ ++ T KI DFG+AR      T G     T  +V 
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR------TAGTSFMMTPYVVT 188
Query: 491 TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
            Y Y APE  +   Y    D++S GV++ E+I G
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 100/212 (47%), Gaps = 20/212 (9%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQGDLEFKNEVLLVANLQH 379
           V  D+     +LG+G +G V K R     +I AVKR+       +   +  +L+  ++  
Sbjct: 48  VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE---QKRLLMDLDISM 104
Query: 380 RNL-----VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRY-KIIGGIA 433
           R +     V   G      +  +  E + +TSLD F      + Q   E    KI   I 
Sbjct: 105 RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 163
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
           + L +LH  S+L +IHRD+K SNVL++A    K+ DFG++  + +D          G   
Sbjct: 164 KALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISG-YLVDSVAKTID--AGCKP 218
Query: 494 YMAPEYA----MHGQYSVKSDVFSFGVLVLEI 521
           YMAPE          YSVKSD++S G+ ++E+
Sbjct: 219 YMAPERINPELNQKGYSVKSDIWSLGITMIEL 250

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 104/213 (48%), Gaps = 28/213 (13%)
Query: 325 NFSDANKLGQGGFGAVY---------KGRLYDGAEIAVKRLSRDSGQ--GDLEFKNEVLL 373
           +F     LGQG FG V+          G LY     A+K L + + +    +  K E  +
Sbjct: 29  HFELLKVLGQGSFGKVFLVRKVTRPDSGHLY-----AMKVLKKATLKVRDRVRTKMERDI 83
Query: 374 VANLQHRNLVRL-LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI-IGG 431
           +A++ H  +V+L   F  EG +  LI +F+    L    F    +  +  E   K  +  
Sbjct: 84  LADVNHPFVVKLHYAFQTEG-KLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAE 138
Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT 491
           +A GL +LH    L II+RDLK  N+LLD E   K+ DFG+++  E  + +       GT
Sbjct: 139 LALGLDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK--EAIDHEKKAYSFCGT 193
Query: 492 YGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
             YMAPE      +S  +D +S+GVL+ E+++G
Sbjct: 194 VEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LS+   Q  +  K    E
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSK-PFQSIIHAKRTYRE 83
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 84  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 131
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR   
Sbjct: 132 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 185
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 186 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 17/206 (8%)
Query: 325 NFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSR---DSGQGDLEFKNEVLLVANLQHR 380
           N+     +G+G F  V   R +  G E+AVK + +   +S      F+ EV ++  L H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 73
Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH 440
           N+V+L           L+ E+     +  ++    R  + +   +++    I   + Y H
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQYCH 130
Query: 441 EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNT-SRIVGTYGYMAPEY 499
           +     I+HRDLK  N+LLDA+M  KIADFG +  F    T GN      G   Y APE 
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF----TFGNKLDAFCGAPPYAAPEL 183
Query: 500 AMHGQY-SVKSDVFSFGVLVLEIISG 524
               +Y   + DV+S GV++  ++SG
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 23/210 (10%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFK----NEVLLVANLQH 379
           D+F   ++LG G  G V+K        +  ++L        LE K    N+++    + H
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPAIRNQIIRELQVLH 121
Query: 380 R----NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARG 435
                 +V   G      E  +  E +   SLD  +    +  ++  +   K+   + +G
Sbjct: 122 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKG 178
Query: 436 LLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYM 495
           L YL E  + +I+HRD+K SN+L+++    K+ DFG++   ++ ++  N+   VGT  YM
Sbjct: 179 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRSYM 232
Query: 496 APEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           +PE      YSV+SD++S G+ ++E+  G+
Sbjct: 233 SPERLQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 97/206 (47%), Gaps = 26/206 (12%)
Query: 332 LGQGGFGAVYKGRLYD------GAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVR 384
           LG+G FG V     YD      G  +AVK L  D+G Q    +K E+ ++  L H ++++
Sbjct: 39  LGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 385 LLGFSLE-GNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
             G   + G   L L+ E+VP  SL  ++     R  +   +       I  G+ YLH  
Sbjct: 98  YKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHAQ 153
Query: 443 SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG-----YMAP 497
                IHRDL   NVLLD +   KI DFG+A+       +G+    V   G     + AP
Sbjct: 154 ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV----PEGHEXYRVREDGDSPVFWYAP 206
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIIS 523
           E     ++   SDV+SFGV + E+++
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 17/210 (8%)
Query: 320 RVATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRD--SGQGDLEFKN-EVLLVA 375
           + +  +F     LG G FG V+  R  ++G   A+K L ++       +E  N E L+++
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 376 NLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
            + H  ++R+ G   +  +  +I +++    L    F   R++Q       K     +  
Sbjct: 62  IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL----FSLLRKSQRFPNPVAKFYAAEVCL 117
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
            L YLH      II+RDLK  N+LLD     KI DFG A+          T  + GT  Y
Sbjct: 118 ALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKY-----VPDVTYXLCGTPDY 169
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE      Y+   D +SFG+L+ E+++G
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 325 NFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSR---DSGQGDLEFKNEVLLVANLQHR 380
           N+     +G+G F  V   R +  G E+AV+ + +   +S      F+ EV ++  L H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 73
Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH 440
           N+V+L           L+ E+     +  ++    R  + +   +++    I   + Y H
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQYCH 130
Query: 441 EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNT-SRIVGTYGYMAPEY 499
           +     I+HRDLK  N+LLDA+M  KIADFG +  F    T GN      G+  Y APE 
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF----TFGNKLDEFCGSPPYAAPEL 183
Query: 500 AMHGQY-SVKSDVFSFGVLVLEIISG 524
               +Y   + DV+S GV++  ++SG
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 108/221 (48%), Gaps = 27/221 (12%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 71
Query: 371 VLLVANLQHRNLVRLLGF-----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERR 425
           + L+ +++H N++ LL       SLE    + +   +    L++ +    +  +L  +  
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KSQKLTDDHV 127
Query: 426 YKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNT 485
             +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+ R      T    
Sbjct: 128 QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCR-----HTDDEM 179
Query: 486 SRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
           +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 14/210 (6%)
Query: 320 RVATDNFSDANKLGQGGFGAVYKG-RLYDGAEIAVKRLSRDSGQG-DL--EFKNEVLLVA 375
           RV   ++   + LG G FG V  G     G ++AVK L+R   +  D+  + K E+  + 
Sbjct: 7   RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK 66
Query: 376 NLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARG 435
             +H ++++L        +  ++ E+V    L  +I    R  +++  R ++    I   
Sbjct: 67  LFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ---QILSA 123
Query: 436 LLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYM 495
           + Y H   R  ++HRDLK  NVLLDA M  KIADFG++ +    E   ++    G+  Y 
Sbjct: 124 VDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC---GSPNYA 177
Query: 496 APEYAMHGQYS-VKSDVFSFGVLVLEIISG 524
           APE      Y+  + D++S GV++  ++ G
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 319 IRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFK----NEVLLV 374
           + +  D+F   ++LG G  G V+K        +  ++L        LE K    N+++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPAIRNQIIRE 54
Query: 375 ANLQHR----NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIG 430
             + H      +V   G      E  +  E +   SLD  +    +  ++  +   K+  
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSI 111
Query: 431 GIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVG 490
            + +GL YL E  + +I+HRD+K SN+L+++    K+ DFG++   ++ ++  N+   VG
Sbjct: 112 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVG 165
Query: 491 TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           T  YM+PE      YSV+SD++S G+ ++E+  G+
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 332 LGQGGFGAVYKGRLYDGAE-----IAVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLVRL 385
           +G+G FG V++G +Y   E     +A+K     +     E F  E L +    H ++V+L
Sbjct: 46  IGEGQFGDVHQG-IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 104
Query: 386 LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRL 445
           +G   E N   +I E      L  F+    R+  LD          ++  L YL      
Sbjct: 105 IGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK--- 158
Query: 446 RIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQY 505
           R +HRD+   NVL+ +    K+ DFG++R  E D T    S+      +MAPE     ++
Sbjct: 159 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRRF 217
Query: 506 SVKSDVFSFGVLVLEII 522
           +  SDV+ FGV + EI+
Sbjct: 218 TSASDVWMFGVCMWEIL 234

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 319 IRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFK----NEVLLV 374
           + +  D+F   ++LG G  G V+K        +  ++L        LE K    N+++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPAIRNQIIRE 54
Query: 375 ANLQHR----NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIG 430
             + H      +V   G      E  +  E +   SLD  +    +  ++  +   K+  
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSI 111
Query: 431 GIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVG 490
            + +GL YL E  + +I+HRD+K SN+L+++    K+ DFG++   ++ ++  N+   VG
Sbjct: 112 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVG 165
Query: 491 TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           T  YM+PE      YSV+SD++S G+ ++E+  G+
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 319 IRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFK----NEVLLV 374
           + +  D+F   ++LG G  G V+K        +  ++L        LE K    N+++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPAIRNQIIRE 54
Query: 375 ANLQHR----NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIG 430
             + H      +V   G      E  +  E +   SLD  +    +  ++  +   K+  
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSI 111
Query: 431 GIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVG 490
            + +GL YL E  + +I+HRD+K SN+L+++    K+ DFG++   ++ ++  N+   VG
Sbjct: 112 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVG 165
Query: 491 TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           T  YM+PE      YSV+SD++S G+ ++E+  G+
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 332 LGQGGFGAVYKGRLYDGAE-----IAVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLVRL 385
           +G+G FG V++G +Y   E     +A+K     +     E F  E L +    H ++V+L
Sbjct: 23  IGEGQFGDVHQG-IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 386 LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRL 445
           +G   E N   +I E      L  F+    R+  LD          ++  L YL      
Sbjct: 82  IGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK--- 135
Query: 446 RIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQY 505
           R +HRD+   NVL+ +    K+ DFG++R  E D T    S+      +MAPE     ++
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 506 SVKSDVFSFGVLVLEII 522
           +  SDV+ FGV + EI+
Sbjct: 195 TSASDVWMFGVCMWEIL 211

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 332 LGQGGFGAVYKGRLYDGAE-----IAVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLVRL 385
           +G+G FG V++G +Y   E     +A+K     +     E F  E L +    H ++V+L
Sbjct: 20  IGEGQFGDVHQG-IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 78
Query: 386 LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRL 445
           +G   E N   +I E      L  F+    R+  LD          ++  L YL      
Sbjct: 79  IGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK--- 132
Query: 446 RIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQY 505
           R +HRD+   NVL+ +    K+ DFG++R  E D T    S+      +MAPE     ++
Sbjct: 133 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRRF 191
Query: 506 SVKSDVFSFGVLVLEII 522
           +  SDV+ FGV + EI+
Sbjct: 192 TSASDVWMFGVCMWEIL 208

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 332 LGQGGFGAVYKGRLYDGAE-----IAVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLVRL 385
           +G+G FG V++G +Y   E     +A+K     +     E F  E L +    H ++V+L
Sbjct: 18  IGEGQFGDVHQG-IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 386 LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRL 445
           +G   E N   +I E      L  F+    R+  LD          ++  L YL      
Sbjct: 77  IGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK--- 130
Query: 446 RIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQY 505
           R +HRD+   NVL+ +    K+ DFG++R  E D T    S+      +MAPE     ++
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 506 SVKSDVFSFGVLVLEII 522
           +  SDV+ FGV + EI+
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 332 LGQGGFGAVYKGRLYDGAE-----IAVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLVRL 385
           +G+G FG V++G +Y   E     +A+K     +     E F  E L +    H ++V+L
Sbjct: 21  IGEGQFGDVHQG-IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 79
Query: 386 LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRL 445
           +G   E N   +I E      L  F+    R+  LD          ++  L YL      
Sbjct: 80  IGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK--- 133
Query: 446 RIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQY 505
           R +HRD+   NVL+ +    K+ DFG++R  E D T    S+      +MAPE     ++
Sbjct: 134 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRRF 192
Query: 506 SVKSDVFSFGVLVLEII 522
           +  SDV+ FGV + EI+
Sbjct: 193 TSASDVWMFGVCMWEIL 209

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 332 LGQGGFGAVYKGRLYDGAE-----IAVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLVRL 385
           +G+G FG V++G +Y   E     +A+K     +     E F  E L +    H ++V+L
Sbjct: 18  IGEGQFGDVHQG-IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 386 LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRL 445
           +G   E N   +I E      L  F+    R+  LD          ++  L YL      
Sbjct: 77  IGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK--- 130
Query: 446 RIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQY 505
           R +HRD+   NVL+ +    K+ DFG++R  E D T    S+      +MAPE     ++
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 506 SVKSDVFSFGVLVLEII 522
           +  SDV+ FGV + EI+
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 106/237 (44%), Gaps = 53/237 (22%)
Query: 316 FNTIRVATDNFS------DANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLE 366
           F ++ VA   F+          +G G  G V     +D   G  +AVK+LSR   Q    
Sbjct: 10  FYSVEVADSTFTVLKRYQQLKPIGSGAQGIVCAA--FDTVLGINVAVKKLSR-PFQNQTH 66
Query: 367 FKN---EVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--------IFDP- 414
            K    E++L+  + H+N++ LL              F P  +L+ F        + D  
Sbjct: 67  AKRAYRELVLLKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDAN 114
Query: 415 ---TRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFG 471
                  +LD ER   ++  +  G+ +LH      IIHRDLK SN+++ ++ T KI DFG
Sbjct: 115 LCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171
Query: 472 MARL----FEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +AR     F M      T  +V  Y Y APE  +   Y+   D++S G ++ E++ G
Sbjct: 172 LARTACTNFMM------TPYVVTRY-YRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 319 IRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFK----NEVLLV 374
           + +  D+F   ++LG G  G V+K        +  ++L        LE K    N+++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPAIRNQIIRE 54
Query: 375 ANLQHR----NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIG 430
             + H      +V   G      E  +  E +   SLD  +    +  ++  +   K+  
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSI 111
Query: 431 GIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVG 490
            + +GL YL E  + +I+HRD+K SN+L+++    K+ DFG++   ++ ++  N+   VG
Sbjct: 112 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVG 165
Query: 491 TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           T  YM+PE      YSV+SD++S G+ ++E+  G+
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 319 IRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFK----NEVLLV 374
           + +  D+F   ++LG G  G V+K        +  ++L        LE K    N+++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPAIRNQIIRE 54
Query: 375 ANLQHR----NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIG 430
             + H      +V   G      E  +  E +   SLD  +    +  ++  +   K+  
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSI 111
Query: 431 GIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVG 490
            + +GL YL E  + +I+HRD+K SN+L+++    K+ DFG++   ++ ++  N+   VG
Sbjct: 112 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVG 165
Query: 491 TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           T  YM+PE      YSV+SD++S G+ ++E+  G+
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDS--GQGDLEF-KNEVLLVANLQH 379
           ++F     LG+G F  V   R L    E A+K L +     +  + +   E  +++ L H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 380 RNLVRLLGFSLEGNERLLI-YEFVPNTSLDHFI-----FDPTRRAQLDWERRYKIIGGIA 433
              V+L  F+ + +E+L     +  N  L  +I     FD T        R Y     I 
Sbjct: 69  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFY--TAEIV 119
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             L YLH      IIHRDLK  N+LL+ +M  +I DFG A++   +  Q   +  VGT  
Sbjct: 120 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 176
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           Y++PE          SD+++ G ++ ++++G
Sbjct: 177 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDS--GQGDLEF-KNEVLLVANLQH 379
           ++F     LG+G F  V   R L    E A+K L +     +  + +   E  +++ L H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 380 RNLVRLLGFSLEGNERLLI-YEFVPNTSLDHFI-----FDPTRRAQLDWERRYKIIGGIA 433
              V+L  F+ + +E+L     +  N  L  +I     FD T        R Y     I 
Sbjct: 70  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFY--TAEIV 120
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             L YLH      IIHRDLK  N+LL+ +M  +I DFG A++   +  Q   +  VGT  
Sbjct: 121 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 177
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           Y++PE          SD+++ G ++ ++++G
Sbjct: 178 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 332 LGQGGFGAVYKGRLYDGAE-----IAVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLVRL 385
           +G+G FG V++G +Y   E     +A+K     +     E F  E L +    H ++V+L
Sbjct: 15  IGEGQFGDVHQG-IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 386 LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRL 445
           +G   E N   +I E      L  F+    R+  LD          ++  L YL      
Sbjct: 74  IGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK--- 127
Query: 446 RIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQY 505
           R +HRD+   NVL+ +    K+ DFG++R  E D T    S+      +MAPE     ++
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 506 SVKSDVFSFGVLVLEII 522
           +  SDV+ FGV + EI+
Sbjct: 187 TSASDVWMFGVCMWEIL 203

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 14/210 (6%)
Query: 320 RVATDNFSDANKLGQGGFGAVYKG-RLYDGAEIAVKRLSRDSGQG-DL--EFKNEVLLVA 375
           RV   ++   + LG G FG V  G     G ++AVK L+R   +  D+  + K E+  + 
Sbjct: 7   RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK 66
Query: 376 NLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARG 435
             +H ++++L        +  ++ E+V    L  +I    R  +++  R ++    I   
Sbjct: 67  LFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ---QILSA 123
Query: 436 LLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYM 495
           + Y H   R  ++HRDLK  NVLLDA M  KIADFG++ +    E    +    G+  Y 
Sbjct: 124 VDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYA 177
Query: 496 APEYAMHGQYS-VKSDVFSFGVLVLEIISG 524
           APE      Y+  + D++S GV++  ++ G
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDS--GQGDLEF-KNEVLLVANLQH 379
           ++F     LG+G F  V   R L    E A+K L +     +  + +   E  +++ L H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 380 RNLVRLLGFSLEGNERLLI-YEFVPNTSLDHFI-----FDPTRRAQLDWERRYKIIGGIA 433
              V+L  F+ + +E+L     +  N  L  +I     FD T        R Y     I 
Sbjct: 67  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFY--TAEIV 117
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             L YLH      IIHRDLK  N+LL+ +M  +I DFG A++   +  Q   +  VGT  
Sbjct: 118 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 174
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           Y++PE          SD+++ G ++ ++++G
Sbjct: 175 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 325 NFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSR---DSGQGDLEFKNEVLLVANLQHR 380
           N+     +G+G F  V   R +  G E+AV+ + +   +S      F+ EV ++  L H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 73
Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH 440
           N+V+L           L+ E+     +  ++    R  + +   +++    I   + Y H
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQYCH 130
Query: 441 EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNT-SRIVGTYGYMAPEY 499
           +     I+HRDLK  N+LLDA+M  KIADFG +  F    T GN      G+  Y APE 
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF----TFGNKLDTFCGSPPYAAPEL 183
Query: 500 AMHGQY-SVKSDVFSFGVLVLEIISG 524
               +Y   + DV+S GV++  ++SG
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDS--GQGDLEF-KNEVLLVANLQH 379
           ++F     LG+G F  V   R L    E A+K L +     +  + +   E  +++ L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 380 RNLVRLLGFSLEGNERLLI-YEFVPNTSLDHFI-----FDPTRRAQLDWERRYKIIGGIA 433
              V+L  F+ + +E+L     +  N  L  +I     FD T        R Y     I 
Sbjct: 68  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFY--TAEIV 118
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             L YLH      IIHRDLK  N+LL+ +M  +I DFG A++   +  Q   +  VGT  
Sbjct: 119 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 175
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           Y++PE          SD+++ G ++ ++++G
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDS--GQGDLEF-KNEVLLVANLQH 379
           ++F     LG+G F  V   R L    E A+K L +     +  + +   E  +++ L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 380 RNLVRLLGFSLEGNERLLI-YEFVPNTSLDHFI-----FDPTRRAQLDWERRYKIIGGIA 433
              V+L  F+ + +E+L     +  N  L  +I     FD T        R Y     I 
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFY--TAEIV 142
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             L YLH      IIHRDLK  N+LL+ +M  +I DFG A++   +  Q   +  VGT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           Y++PE          SD+++ G ++ ++++G
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDS--GQGDLEF-KNEVLLVANLQH 379
           ++F     LG+G F  V   R L    E A+K L +     +  + +   E  +++ L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 380 RNLVRLLGFSLEGNERLLI-YEFVPNTSLDHFI-----FDPTRRAQLDWERRYKIIGGIA 433
              V+L  F+ + +E+L     +  N  L  +I     FD T        R Y     I 
Sbjct: 93  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFY--TAEIV 143
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             L YLH      IIHRDLK  N+LL+ +M  +I DFG A++   +  Q   +  VGT  
Sbjct: 144 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 200
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           Y++PE          SD+++ G ++ ++++G
Sbjct: 201 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDS--GQGDLEF-KNEVLLVANLQH 379
           ++F     LG+G F  V   R L    E A+K L +     +  + +   E  +++ L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 380 RNLVRLLGFSLEGNERLLI-YEFVPNTSLDHFI-----FDPTRRAQLDWERRYKIIGGIA 433
              V+L  F+ + +E+L     +  N  L  +I     FD T        R Y     I 
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFY--TAEIV 140
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             L YLH      IIHRDLK  N+LL+ +M  +I DFG A++   +  Q   +  VGT  
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           Y++PE          SD+++ G ++ ++++G
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 110/225 (48%), Gaps = 14/225 (6%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQGDLEFK--NEVLLVANLQHRN 381
            +    K+G+G +G V+K +  +  EI A+KR+  D     +      E+ L+  L+H+N
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           +VRL        +  L++EF  +  L  + FD +    LD E     +  + +GL + H 
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFC-DQDLKKY-FD-SCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM 501
            +   ++HRDLK  N+L++     K+A+FG+AR F +   +  ++ +V T  Y  P+   
Sbjct: 120 RN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVV-TLWYRPPDVLF 174
Query: 502 HGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWK 545
             + YS   D++S G +  E+ +  R      G  V+D L   ++
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRP--LFPGNDVDDQLKRIFR 217

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDS--GQGDLEF-KNEVLLVANLQH 379
           ++F     LG+G F  V   R L    E A+K L +     +  + +   E  +++ L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 380 RNLVRLLGFSLEGNERLLI-YEFVPNTSLDHFI-----FDPTRRAQLDWERRYKIIGGIA 433
              V+L  F+ + +E+L     +  N  L  +I     FD T        R Y     I 
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFY--TAEIV 140
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             L YLH      IIHRDLK  N+LL+ +M  +I DFG A++   +  Q   +  VGT  
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQ 197
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           Y++PE          SD+++ G ++ ++++G
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDS--GQGDLEF-KNEVLLVANLQH 379
           ++F     LG+G F  V   R L    E A+K L +     +  + +   E  +++ L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 380 RNLVRLLGFSLEGNERLLI-YEFVPNTSLDHFI-----FDPTRRAQLDWERRYKIIGGIA 433
              V+L  F+ + +E+L     +  N  L  +I     FD T        R Y     I 
Sbjct: 93  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFY--TAEIV 143
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             L YLH      IIHRDLK  N+LL+ +M  +I DFG A++   +  Q   +  VGT  
Sbjct: 144 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 200
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           Y++PE          SD+++ G ++ ++++G
Sbjct: 201 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDS--GQGDLEF-KNEVLLVANLQH 379
           ++F     LG+G F  V   R L    E A+K L +     +  + +   E  +++ L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 380 RNLVRLLGFSLEGNERLLI-YEFVPNTSLDHFI-----FDPTRRAQLDWERRYKIIGGIA 433
              V+L  F+ + +E+L     +  N  L  +I     FD T        R Y     I 
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFY--TAEIV 140
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             L YLH      IIHRDLK  N+LL+ +M  +I DFG A++   +  Q   +  VGT  
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           Y++PE          SD+++ G ++ ++++G
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 332 LGQGGFGAVYKGRLYDGAE-----IAVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLVRL 385
           +G+G FG V++G +Y   E     +A+K     +     E F  E L +    H ++V+L
Sbjct: 398 IGEGQFGDVHQG-IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 386 LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRL 445
           +G   E N   +I E      L  F+    R+  LD          ++  L YL      
Sbjct: 457 IGVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK--- 510
Query: 446 RIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQY 505
           R +HRD+   NVL+ A    K+ DFG++R  E D T    S+      +MAPE     ++
Sbjct: 511 RFVHRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 506 SVKSDVFSFGVLVLEII 522
           +  SDV+ FGV + EI+
Sbjct: 570 TSASDVWMFGVCMWEIL 586

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDS--GQGDLEF-KNEVLLVANLQH 379
           ++F     LG+G F  V   R L    E A+K L +     +  + +   E  +++ L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 380 RNLVRLLGFSLEGNERLLI-YEFVPNTSLDHFI-----FDPTRRAQLDWERRYKIIGGIA 433
              V+L  F+ + +E+L     +  N  L  +I     FD T        R Y     I 
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFY--TAEIV 142
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             L YLH      IIHRDLK  N+LL+ +M  +I DFG A++   +  Q   +  VGT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           Y++PE          SD+++ G ++ ++++G
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDS--GQGDLEF-KNEVLLVANLQH 379
           ++F     LG+G F  V   R L    E A+K L +     +  + +   E  +++ L H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 380 RNLVRLLGFSLEGNERLLI-YEFVPNTSLDHFI-----FDPTRRAQLDWERRYKIIGGIA 433
              V+L  F+ + +E+L     +  N  L  +I     FD T        R Y     I 
Sbjct: 74  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFY--TAEIV 124
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             L YLH      IIHRDLK  N+LL+ +M  +I DFG A++   +  Q   +  VGT  
Sbjct: 125 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 181
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           Y++PE          SD+++ G ++ ++++G
Sbjct: 182 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDS--GQGDLEF-KNEVLLVANLQH 379
           ++F     LG+G F  V   R L    E A+K L +     +  + +   E  +++ L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 380 RNLVRLLGFSLEGNERLLI-YEFVPNTSLDHFI-----FDPTRRAQLDWERRYKIIGGIA 433
              V+L  F+ + +E+L     +  N  L  +I     FD T        R Y     I 
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFY--TAEIV 142
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             L YLH      IIHRDLK  N+LL+ +M  +I DFG A++   +  Q   +  VGT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           Y++PE          SD+++ G ++ ++++G
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDS--GQGDLEF-KNEVLLVANLQH 379
           ++F     LG+G F  V   R L    E A+K L +     +  + +   E  +++ L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 380 RNLVRLLGFSLEGNERLLI-YEFVPNTSLDHFI-----FDPTRRAQLDWERRYKIIGGIA 433
              V+L  F+ + +E+L     +  N  L  +I     FD T        R Y     I 
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFY--TAEIV 142
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             L YLH      IIHRDLK  N+LL+ +M  +I DFG A++   +  Q   +  VGT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           Y++PE          SD+++ G ++ ++++G
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDS--GQGDLEF-KNEVLLVANLQH 379
           ++F     LG+G F  V   R L    E A+K L +     +  + +   E  +++ L H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 380 RNLVRLLGFSLEGNERLLI-YEFVPNTSLDHFI-----FDPTRRAQLDWERRYKIIGGIA 433
              V+L  F+ + +E+L     +  N  L  +I     FD T        R Y     I 
Sbjct: 95  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFY--TAEIV 145
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             L YLH      IIHRDLK  N+LL+ +M  +I DFG A++   +  Q   +  VGT  
Sbjct: 146 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 202
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           Y++PE          SD+++ G ++ ++++G
Sbjct: 203 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFK----NEVLLVANLQH 379
           D+F   ++LG G  G V+K        +  ++L        LE K    N+++    + H
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPAIRNQIIRELQVLH 62
Query: 380 R----NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARG 435
                 +V   G      E  +  E +   SLD  +    +  ++  +   K+   + +G
Sbjct: 63  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKG 119
Query: 436 LLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYM 495
           L YL E  + +I+HRD+K SN+L+++    K+ DFG++    +DE     +  VGT  YM
Sbjct: 120 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDEM---ANEFVGTRSYM 173
Query: 496 APEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           +PE      YSV+SD++S G+ ++E+  G+
Sbjct: 174 SPERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDS--GQGDLEF-KNEVLLVANLQH 379
           ++F     LG+G F  V   R L    E A+K L +     +  + +   E  +++ L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 380 RNLVRLLGFSLEGNERLLI-YEFVPNTSLDHFI-----FDPTRRAQLDWERRYKIIGGIA 433
              V+L  F+ + +E+L     +  N  L  +I     FD T        R Y     I 
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFY--TAEIV 142
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             L YLH      IIHRDLK  N+LL+ +M  +I DFG A++   +  Q   +  VGT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           Y++PE          SD+++ G ++ ++++G
Sbjct: 200 YVSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDS--GQGDLEF-KNEVLLVANLQH 379
           ++F     LG+G F  V   R L    E A+K L +     +  + +   E  +++ L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 380 RNLVRLLGFSLEGNERLLI-YEFVPNTSLDHFI-----FDPTRRAQLDWERRYKIIGGIA 433
              V+L  F+ + +E+L     +  N  L  +I     FD T        R Y     I 
Sbjct: 89  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFY--TAEIV 139
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             L YLH      IIHRDLK  N+LL+ +M  +I DFG A++   +  Q   +  VGT  
Sbjct: 140 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 196
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           Y++PE          SD+++ G ++ ++++G
Sbjct: 197 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDS--GQGDLEF-KNEVLLVANLQH 379
           ++F     LG+G F  V   R L    E A+K L +     +  + +   E  +++ L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 380 RNLVRLLGFSLEGNERLLI-YEFVPNTSLDHFI-----FDPTRRAQLDWERRYKIIGGIA 433
              V+L  F+ + +E+L     +  N  L  +I     FD T        R Y     I 
Sbjct: 89  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFY--TAEIV 139
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             L YLH      IIHRDLK  N+LL+ +M  +I DFG A++   +  Q   +  VGT  
Sbjct: 140 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 196
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           Y++PE          SD+++ G ++ ++++G
Sbjct: 197 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 104/233 (44%), Gaps = 45/233 (19%)
Query: 316 FNTIRVATDNFS------DANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLE 366
           F +++VA   F+          +G G  G V     +D   G  +AVK+LSR   Q    
Sbjct: 8   FYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAA--FDTVLGINVAVKKLSR-PFQNQTH 64
Query: 367 FKN---EVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--------IFDP- 414
            K    E++L+  + H+N++ LL              F P  +L+ F        + D  
Sbjct: 65  AKRAYRELVLLKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDAN 112
Query: 415 ---TRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFG 471
                  +LD ER   ++  +  G+ +LH      IIHRDLK SN+++ ++ T KI DFG
Sbjct: 113 LCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 169
Query: 472 MARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +AR      T    +  V T  Y APE  +   Y    D++S G ++ E++ G
Sbjct: 170 LAR---TASTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 23/210 (10%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFK----NEVLLVANLQH 379
           D+F   ++LG G  G V+K        +  ++L        LE K    N+++    + H
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPAIRNQIIRELQVLH 86
Query: 380 R----NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARG 435
                 +V   G      E  +  E +   SLD  +    +  ++  +   K+   + +G
Sbjct: 87  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKG 143
Query: 436 LLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYM 495
           L YL E  + +I+HRD+K SN+L+++    K+ DFG++   ++ ++  N+   VGT  YM
Sbjct: 144 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRSYM 197
Query: 496 APEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           +PE      YSV+SD++S G+ ++E+  G+
Sbjct: 198 SPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 326 FSDANKLGQGGFGAVY------KGRLYDGAEIAVKRLSRDSGQG-DLEFKNEVLLVANLQ 378
           F     LG G F  V        G+L+     AVK + + + +G +   +NE+ ++  ++
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLF-----AVKCIPKKALKGKESSIENEIAVLRKIK 78
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           H N+V L       N   L+ + V    L   I +     + D      +I  +   + Y
Sbjct: 79  HENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKD---ASTLIRQVLDAVYY 135
Query: 439 LHEDSRLRIIHRDLKTSNVLL---DAEMTPKIADFGMARLFEMDETQGNT-SRIVGTYGY 494
           LH   R+ I+HRDLK  N+L    D E    I+DFG++++    E +G+  S   GT GY
Sbjct: 136 LH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM----EGKGDVMSTACGTPGY 188
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE      YS   D +S GV+   ++ G
Sbjct: 189 VAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 321 VATDNFSDANKLGQGGFGAVYK------GRLYDGAEIAVKRLSRDS-GQGDLEFKNEVLL 373
           +  D++    +LG G F  V K      G+ Y    I  +RLS    G    E + EV +
Sbjct: 2   MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA 433
           +  ++H N++ L        + +LI E V    L  F+     +  L  +   + +  I 
Sbjct: 62  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQIL 118
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP----KIADFGMARLFEMDETQGNTSR-I 488
            G+ YLH     RI H DLK  N++L  +  P    K+ DFG+A   E     GN  + I
Sbjct: 119 DGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA----GNEFKNI 171
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
            GT  ++APE   +    +++D++S GV+   ++SG
Sbjct: 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 105/229 (45%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 71
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 72  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 119
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI  FG+AR   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLAR--- 173
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 33/214 (15%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDLEFKN---EVLLVANLQH 379
           + +   +G G  G V     YD      +A+K+LSR   Q     K    E++L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAA--YDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 82
Query: 380 RNLVRLLGF-----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
           +N++ LL       SLE  + + I   + + +L   I     + +LD ER   ++  +  
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI-----QMELDHERMSYLLYQMLC 137
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN----TSRIVG 490
           G+ +LH      IIHRDLK SN+++ ++ T KI DFG+AR      T G     T  +V 
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFMMTPEVVT 188
Query: 491 TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
            Y Y APE  +   Y    D++S G ++ E+I G
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDS--GQGDLEF-KNEVLLVANLQH 379
           ++F     LG+G F  V   R L    E A+K L +     +  + +   E  +++ L H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 380 RNLVRLLGFSLEGNERLLI-YEFVPNTSLDHFI-----FDPTRRAQLDWERRYKIIGGIA 433
              V+L  F  + +E+L     +  N  L  +I     FD T        R Y     I 
Sbjct: 97  PFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFY--TAEIV 147
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             L YLH      IIHRDLK  N+LL+ +M  +I DFG A++   +  Q   +  VGT  
Sbjct: 148 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 204
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           Y++PE          SD+++ G ++ ++++G
Sbjct: 205 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 105/229 (45%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGHRVAVKKLSR-PFQSIIHAKRTYRE 71
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 72  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 119
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLAR--- 173
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 22/213 (10%)
Query: 324 DNFSDANKLGQGGFGAVYK------GRLYDGAEIAVKRLSRDS-GQGDLEFKNEVLLVAN 376
           D++    +LG G F  V K      G+ Y    I  +RLS    G    E + EV ++  
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 71
Query: 377 LQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGL 436
           ++H N++ L        + +LI E V    L  F+     +  L  +   + +  I  G+
Sbjct: 72  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGV 128
Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEMTP----KIADFGMARLFEMDETQGNTSR-IVGT 491
            YLH     RI H DLK  N++L  +  P    K+ DFG+A   E     GN  + I GT
Sbjct: 129 HYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA----GNEFKNIFGT 181
Query: 492 YGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
             ++APE   +    +++D++S GV+   ++SG
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 33/214 (15%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDLEFKN---EVLLVANLQH 379
           + +   +G G  G V     YD      +A+K+LSR   Q     K    E++L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAA--YDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKVVNH 82
Query: 380 RNLVRLLGF-----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
           +N++ LL       SLE  + + I   + + +L   I     + +LD ER   ++  +  
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVI-----QMELDHERMSYLLYQMLV 137
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN----TSRIVG 490
           G+ +LH      IIHRDLK SN+++ ++ T KI DFG+AR      T G     T  +V 
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR------TAGTSFMMTPYVVT 188
Query: 491 TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
            Y Y APE  +   Y    D++S G ++ E+I G
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 105/229 (45%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 71
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 72  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 119
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI D G+AR   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLAR--- 173
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 23/210 (10%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFK----NEVLLVANLQH 379
           D+F   ++LG G  G V+K        +  ++L        LE K    N+++    + H
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPAIRNQIIRELQVLH 78
Query: 380 R----NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARG 435
                 +V   G      E  +  E +   SLD  +    +  ++  +   K+   + +G
Sbjct: 79  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKG 135
Query: 436 LLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYM 495
           L YL E  + +I+HRD+K SN+L+++    K+ DFG++   ++ ++  N+   VGT  YM
Sbjct: 136 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRSYM 189
Query: 496 APEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           +PE      YSV+SD++S G+ ++E+  G+
Sbjct: 190 SPERLQGTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 89/178 (50%), Gaps = 13/178 (7%)
Query: 351 IAVKRLSRDSGQG-DLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDH 409
           +A+K +++++ +G +   +NE+ ++  ++H N+V L      G    LI + V    L  
Sbjct: 46  VAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFD 105
Query: 410 FIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVL---LDAEMTPK 466
            I +     + D  R   +I  +   + YLH+   L I+HRDLK  N+L   LD +    
Sbjct: 106 RIVEKGFYTERDASR---LIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIM 159
Query: 467 IADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           I+DFG+++   M++     S   GT GY+APE      YS   D +S GV+   ++ G
Sbjct: 160 ISDFGLSK---MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 89/178 (50%), Gaps = 13/178 (7%)
Query: 351 IAVKRLSRDSGQG-DLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDH 409
           +A+K +++++ +G +   +NE+ ++  ++H N+V L      G    LI + V    L  
Sbjct: 46  VAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFD 105
Query: 410 FIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVL---LDAEMTPK 466
            I +     + D  R   +I  +   + YLH+   L I+HRDLK  N+L   LD +    
Sbjct: 106 RIVEKGFYTERDASR---LIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIM 159
Query: 467 IADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           I+DFG+++   M++     S   GT GY+APE      YS   D +S GV+   ++ G
Sbjct: 160 ISDFGLSK---MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 105/231 (45%), Gaps = 23/231 (9%)
Query: 303 GDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYK------GRLYDGAEIAVKRL 356
           G ++ R    +F  N     +DN+    +LG+G F  V +      G  +    I  K+L
Sbjct: 10  GQQMGRGS--EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL 67
Query: 357 SRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTR 416
           S    Q   + + E  +   LQH N+VRL     E +   L+++ V    L   I     
Sbjct: 68  SARDFQ---KLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 124
Query: 417 RAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM---TPKIADFGMA 473
            ++ D       I  I   + Y H +    I+HR+LK  N+LL ++      K+ADFG+A
Sbjct: 125 YSEADASH---CIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA 178
Query: 474 RLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
              E+++++       GT GY++PE      YS   D+++ GV++  ++ G
Sbjct: 179 --IEVNDSEAWHG-FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 332 LGQGGFGAVYKGRLYDGAE-----IAVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLVRL 385
           +G+G FG V++G +Y   E     +A+K     +     E F  E L +    H ++V+L
Sbjct: 398 IGEGQFGDVHQG-IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 386 LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRL 445
           +G   E N   +I E      L  F+    R+  LD          ++  L YL      
Sbjct: 457 IGVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK--- 510
Query: 446 RIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQY 505
           R +HRD+   NVL+ +    K+ DFG++R  E D T    S+      +MAPE     ++
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 506 SVKSDVFSFGVLVLEII 522
           +  SDV+ FGV + EI+
Sbjct: 570 TSASDVWMFGVCMWEIL 586

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 89/178 (50%), Gaps = 13/178 (7%)
Query: 351 IAVKRLSRDSGQG-DLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDH 409
           +A+K +++++ +G +   +NE+ ++  ++H N+V L      G    LI + V    L  
Sbjct: 46  VAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFD 105
Query: 410 FIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVL---LDAEMTPK 466
            I +     + D  R   +I  +   + YLH+   L I+HRDLK  N+L   LD +    
Sbjct: 106 RIVEKGFYTERDASR---LIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIM 159
Query: 467 IADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           I+DFG+++   M++     S   GT GY+APE      YS   D +S GV+   ++ G
Sbjct: 160 ISDFGLSK---MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 40/94 (42%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT 491
           IA GL +L       II+RDLK  NV+LD+E   KIADFGM +    D     T    GT
Sbjct: 451 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKXFCGT 505
Query: 492 YGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
             Y+APE   +  Y    D ++FGVL+ E+++GQ
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 33/214 (15%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDLEFKN---EVLLVANLQH 379
           + +   +G G  G V     YD      +A+K+LSR   Q     K    E++L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAA--YDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKVVNH 82
Query: 380 RNLVRLLGF-----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
           +N++ LL       SLE  + + I   + + +L   I     + +LD ER   ++  +  
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVI-----QMELDHERMSYLLYQMLC 137
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN----TSRIVG 490
           G+ +LH      IIHRDLK SN+++ ++ T KI DFG+AR      T G     T  +V 
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR------TAGTSFMMTPYVVT 188
Query: 491 TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
            Y Y APE  +   Y    D++S G ++ E+I G
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 130/299 (43%), Gaps = 45/299 (15%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLY-----DGA-EIAVKRLSRDSGQGDLE-FKNEVLLVAN 376
           +  S    LG G FG V +   Y     D A  +AVK L   +   + E   +E+ +++ 
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 377 L-QHRNLVRLLGFSLEGNERLLIYEFVPNTSL--------DHFIFDPTRRAQLDWERRYK 427
           L  H N+V LLG    G   L+I E+     L        D FI   T  A ++ +    
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 428 IIGG-------IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE 480
            +         +A+G+ +L   +    IHRDL   N+LL      KI DFG+AR  + D 
Sbjct: 166 DLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARHIKNDS 222
Query: 481 ---TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVE 537
               +GN    V    +MAPE   +  Y+ +SDV+S+G+ + E+ S    +    G  V+
Sbjct: 223 NYVVKGNARLPV---KWMAPESIFNCVYTFESDVWSYGIFLWELFS--LGSSPYPGMPVD 277
Query: 538 DLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLML 596
              S  +K  +EG    ++ P  +   + ++++       C   +   RPT   +V ++
Sbjct: 278 ---SKFYKMIKEG--FRMLSPEHAPAEMYDIMKT------CWDADPLKRPTFKQIVQLI 325

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 33/214 (15%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDLEFKN---EVLLVANLQH 379
           + +   +G G  G V     YD      +A+K+LSR   Q     K    E++L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAA--YDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 82
Query: 380 RNLVRLLGF-----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
           +N++ LL       SLE  + + I   + + +L   I     + +LD ER   ++  +  
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVI-----QMELDHERMSYLLYQMLC 137
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN----TSRIVG 490
           G+ +LH      IIHRDLK SN+++ ++ T KI DFG+AR      T G     T  +V 
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR------TAGTSFMMTPYVVT 188
Query: 491 TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
            Y Y APE  +   Y    D++S G ++ E+I G
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 33/214 (15%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDLEFKN---EVLLVANLQH 379
           + +   +G G  G V     YD      +A+K+LSR   Q     K    E++L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAA--YDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 82
Query: 380 RNLVRLLGF-----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
           +N++ LL       SLE  + + I   + + +L   I     + +LD ER   ++  +  
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVI-----QMELDHERMSYLLYQMLC 137
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN----TSRIVG 490
           G+ +LH      IIHRDLK SN+++ ++ T KI DFG+AR      T G     T  +V 
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFMMTPYVVT 188
Query: 491 TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
            Y Y APE  +   Y    D++S G ++ E+I G
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 130/299 (43%), Gaps = 45/299 (15%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLY-----DGA-EIAVKRLSRDSGQGDLE-FKNEVLLVAN 376
           +  S    LG G FG V +   Y     D A  +AVK L   +   + E   +E+ +++ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 377 L-QHRNLVRLLGFSLEGNERLLIYEFVPNTSL--------DHFIFDPTRRAQLDWERRYK 427
           L  H N+V LLG    G   L+I E+     L        D FI   T  A ++ +    
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 428 IIGG-------IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE 480
            +         +A+G+ +L   +    IHRDL   N+LL      KI DFG+AR  + D 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 481 ---TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVE 537
               +GN    V    +MAPE   +  Y+ +SDV+S+G+ + E+ S    +    G  V+
Sbjct: 200 NYVVKGNARLPV---KWMAPESIFNCVYTFESDVWSYGIFLWELFS--LGSSPYPGMPVD 254
Query: 538 DLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLML 596
              S  +K  +EG    ++ P  +   + ++++       C   +   RPT   +V ++
Sbjct: 255 ---SKFYKMIKEG--FRMLSPEHAPAEMYDIMKT------CWDADPLKRPTFKQIVQLI 302

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 114/241 (47%), Gaps = 37/241 (15%)
Query: 300 AAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSR 358
           AAA DE +R E             D F      GQG FG V  G+    G  +A+K++ +
Sbjct: 11  AAAADERSRKE------------MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ 58
Query: 359 DSGQGDLEFKNEVLLV----ANLQHRNLVRLLG--FSLEGNERLLIY-----EFVPNTSL 407
           D       F+N  L +    A L H N+V+L    ++L   +R  IY     E+VP+T L
Sbjct: 59  DP-----RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDT-L 112
Query: 408 DHFIFDPTRRAQLDWERRYKI-IGGIARGLLYLHEDSRLRIIHRDLKTSNVLL-DAEMTP 465
                +  RR         K+ +  + R +  LH  S + + HRD+K  NVL+ +A+ T 
Sbjct: 113 HRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTL 171
Query: 466 KIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQ-YSVKSDVFSFGVLVLEIISG 524
           K+ DFG A+  ++  ++ N + I   Y Y APE     Q Y+   D++S G +  E++ G
Sbjct: 172 KLCDFGSAK--KLSPSEPNVAYICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228
Query: 525 Q 525
           +
Sbjct: 229 E 229

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 105/229 (45%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 71
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 72  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 119
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI D G+AR   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLAR--- 173
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 321 VATDNFSDANKLGQGGFGAVYK------GRLYDGAEIAVKRL-SRDSGQGDLEFKNEVLL 373
           +  D++    +LG G F  V K      G+ Y    I  +RL S   G    E + EV +
Sbjct: 23  MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNI 82
Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA 433
           +  ++H N++ L        + +LI E V    L  F+     +  L  +   + +  I 
Sbjct: 83  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQIL 139
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP----KIADFGMARLFEMDETQGNTSR-I 488
            G+ YLH     RI H DLK  N++L  +  P    K+ DFG+A   E     GN  + I
Sbjct: 140 DGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA----GNEFKNI 192
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
            GT  ++APE   +    +++D++S GV+   ++SG
Sbjct: 193 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 43/214 (20%)
Query: 332 LGQGGFGAV---YKGRLYDGAEIAVKRLSRDSGQGDLEFKN---EVLLVANLQHRNLVRL 385
           +G G +G+V   Y  RL    ++AVK+LSR   Q  +  +    E+ L+ +L+H N++ L
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVKKLSR-PFQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 386 LGFSLEGNERLLIYEFVPNTSLDHF-------------IFDPTRRAQLDWERRYKIIGGI 432
           L              F P TS++ F             + +  +   L  E    ++  +
Sbjct: 93  LDV------------FTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQL 140
Query: 433 ARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY 492
            RGL Y+H      IIHRDLK SNV ++ +   +I DFG+AR  + DE     +  V T 
Sbjct: 141 LRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR--QADE---EMTGYVATR 192
Query: 493 GYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
            Y APE  ++   Y+   D++S G ++ E++ G+
Sbjct: 193 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 112/225 (49%), Gaps = 20/225 (8%)
Query: 319 IRVATDNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDS---GQGDLEFKNEVLLV 374
           I +  ++FS    +G+GGFG VY  R  D G   A+K L +      QG+    NE +++
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 375 ANLQHRN--LVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG 431
           + +   +   +  + ++    ++L  I + +    L + +      ++ D  R Y     
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM-RFY--AAE 300
Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT 491
           I  GL ++H  +R  +++RDLK +N+LLD     +I+D G+A     D ++      VGT
Sbjct: 301 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGT 353
Query: 492 YGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGET 535
           +GYMAPE    G  Y   +D FS G ++ +++ G  ++ FR  +T
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG--HSPFRQHKT 396

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 112/225 (49%), Gaps = 20/225 (8%)
Query: 319 IRVATDNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDS---GQGDLEFKNEVLLV 374
           I +  ++FS    +G+GGFG VY  R  D G   A+K L +      QG+    NE +++
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 375 ANLQHRN--LVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG 431
           + +   +   +  + ++    ++L  I + +    L + +      ++ D  R Y     
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM-RFY--AAE 300
Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT 491
           I  GL ++H  +R  +++RDLK +N+LLD     +I+D G+A     D ++      VGT
Sbjct: 301 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGT 353
Query: 492 YGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGET 535
           +GYMAPE    G  Y   +D FS G ++ +++ G  ++ FR  +T
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG--HSPFRQHKT 396

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 105/229 (45%), Gaps = 43/229 (18%)
Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---E 370
            TI    + + + + +G G +G+V     +D   G  +AVK+LSR   Q  +  K    E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 71
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--IFDPTRRAQLDWERRYK- 427
           + L+ +++H N++ LL              F P  SL+ F  ++  T     D     K 
Sbjct: 72  LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 119
Query: 428 ----------IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
                     +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI D G+AR   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLAR--- 173
Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
              T    +  V T  Y APE  ++   Y+   D++S G ++ E+++G+
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 33/214 (15%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDLEFKN---EVLLVANLQH 379
           + +   +G G  G V     YD      +A+K+LSR   Q     K    E++L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAA--YDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 82
Query: 380 RNLVRLLGF-----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
           +N++ LL       SLE  + + I   + + +L   I     + +LD ER   ++  +  
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI-----QMELDHERMSYLLYQMLC 137
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN----TSRIVG 490
           G+ +LH      IIHRDLK SN+++ ++ T KI DFG+AR      T G     T  +V 
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFMMTPYVVT 188
Query: 491 TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
            Y Y APE  +   Y    D++S G ++ E+I G
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDS--GQGDLEF-KNEVLLVANLQH 379
           ++F     LG+G F      R L    E A+K L +     +  + +   E  +++ L H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 380 RNLVRLLGFSLEGNERLLI-YEFVPNTSLDHFI-----FDPTRRAQLDWERRYKIIGGIA 433
              V+L  F+ + +E+L     +  N  L  +I     FD T        R Y     I 
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFY--TAEIV 140
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             L YLH      IIHRDLK  N+LL+ +M  +I DFG A++   +  Q   +  VGT  
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           Y++PE          SD+++ G ++ ++++G
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 130/299 (43%), Gaps = 45/299 (15%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLY-----DGA-EIAVKRLSRDSGQGDLE-FKNEVLLVAN 376
           +  S    LG G FG V +   Y     D A  +AVK L   +   + E   +E+ +++ 
Sbjct: 39  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 98
Query: 377 L-QHRNLVRLLGFSLEGNERLLIYEFVPNTSL--------DHFIFDPTRRAQLDWERRYK 427
           L  H N+V LLG    G   L+I E+     L        D FI   T  A ++ +    
Sbjct: 99  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 158
Query: 428 IIGG-------IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE 480
            +         +A+G+ +L   +    IHRDL   N+LL      KI DFG+AR  + D 
Sbjct: 159 DLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDS 215
Query: 481 ---TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVE 537
               +GN    V    +MAPE   +  Y+ +SDV+S+G+ + E+ S    +    G  V+
Sbjct: 216 NYVVKGNARLPV---KWMAPESIFNCVYTFESDVWSYGIFLWELFS--LGSSPYPGMPVD 270
Query: 538 DLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLML 596
              S  +K  +EG    ++ P  +   + ++++       C   +   RPT   +V ++
Sbjct: 271 ---SKFYKMIKEG--FRMLSPEHAPAEMYDIMKT------CWDADPLKRPTFKQIVQLI 318

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 112/225 (49%), Gaps = 20/225 (8%)
Query: 319 IRVATDNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDS---GQGDLEFKNEVLLV 374
           I +  ++FS    +G+GGFG VY  R  D G   A+K L +      QG+    NE +++
Sbjct: 183 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 242
Query: 375 ANLQHRN--LVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG 431
           + +   +   +  + ++    ++L  I + +    L + +      ++ D  R Y     
Sbjct: 243 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM-RFY--AAE 299
Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT 491
           I  GL ++H  +R  +++RDLK +N+LLD     +I+D G+A     D ++      VGT
Sbjct: 300 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGT 352
Query: 492 YGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGET 535
           +GYMAPE    G  Y   +D FS G ++ +++ G  ++ FR  +T
Sbjct: 353 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG--HSPFRQHKT 395

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 130/299 (43%), Gaps = 45/299 (15%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLY-----DGA-EIAVKRLSRDSGQGDLE-FKNEVLLVAN 376
           +  S    LG G FG V +   Y     D A  +AVK L   +   + E   +E+ +++ 
Sbjct: 41  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 100
Query: 377 L-QHRNLVRLLGFSLEGNERLLIYEFVPNTSL--------DHFIFDPTRRAQLDWERRYK 427
           L  H N+V LLG    G   L+I E+     L        D FI   T  A ++ +    
Sbjct: 101 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 160
Query: 428 IIGG-------IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE 480
            +         +A+G+ +L   +    IHRDL   N+LL      KI DFG+AR  + D 
Sbjct: 161 DLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDS 217
Query: 481 ---TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVE 537
               +GN    V    +MAPE   +  Y+ +SDV+S+G+ + E+ S    +    G  V+
Sbjct: 218 NYVVKGNARLPV---KWMAPESIFNCVYTFESDVWSYGIFLWELFS--LGSSPYPGMPVD 272
Query: 538 DLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLML 596
              S  +K  +EG    ++ P  +   + ++++       C   +   RPT   +V ++
Sbjct: 273 ---SKFYKMIKEG--FRMLSPEHAPAEMYDIMKT------CWDADPLKRPTFKQIVQLI 320

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 31/213 (14%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDLEFKN---EVLLVANLQH 379
           + +   +G G  G V     YD      +A+K+LSR   Q     K    E++L+  + H
Sbjct: 28  YQNLKPIGSGAQGIVCAA--YDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 84
Query: 380 RNLVRLLGF-----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
           +N++ LL       SLE  + + I   + + +L   I     + +LD ER   ++  +  
Sbjct: 85  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI-----QMELDHERMSYLLYQMLC 139
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVG---T 491
           G+ +LH      IIHRDLK SN+++ ++ T KI DFG+AR      T G +  +V    T
Sbjct: 140 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFMMVPFVVT 190
Query: 492 YGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
             Y APE  +   Y    D++S G ++ E+I G
Sbjct: 191 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 130/299 (43%), Gaps = 45/299 (15%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLY-----DGA-EIAVKRLSRDSGQGDLE-FKNEVLLVAN 376
           +  S    LG G FG V +   Y     D A  +AVK L   +   + E   +E+ +++ 
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 377 L-QHRNLVRLLGFSLEGNERLLIYEFVPNTSL--------DHFIFDPTRRAQLDWERRYK 427
           L  H N+V LLG    G   L+I E+     L        D FI   T  A ++ +    
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 428 IIGG-------IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE 480
            +         +A+G+ +L   +    IHRDL   N+LL      KI DFG+AR  + D 
Sbjct: 166 DLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDS 222
Query: 481 ---TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVE 537
               +GN    V    +MAPE   +  Y+ +SDV+S+G+ + E+ S    +    G  V+
Sbjct: 223 NYVVKGNARLPV---KWMAPESIFNCVYTFESDVWSYGIFLWELFS--LGSSPYPGMPVD 277
Query: 538 DLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLML 596
              S  +K  +EG    ++ P  +   + ++++       C   +   RPT   +V ++
Sbjct: 278 ---SKFYKMIKEG--FRMLSPEHAPAEMYDIMKT------CWDADPLKRPTFKQIVQLI 325

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 107/229 (46%), Gaps = 35/229 (15%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQGDL-EFKNEVLLVANL 377
           N      LG+G FG V K   +          +AVK L  ++   +L +  +E  ++  +
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV 83
Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTR-------------RAQLDWER 424
            H ++++L G   +    LLI E+    SL  F+ +  +              + LD   
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 425 RYKIIGG--------IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-L 475
              +  G        I++G+ YL E   ++++HRDL   N+L+      KI+DFG++R +
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 476 FEMDE-TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
           +E D   + +  RI     +MA E      Y+ +SDV+SFGVL+ EI++
Sbjct: 201 YEEDSXVKRSQGRI--PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 112/225 (49%), Gaps = 20/225 (8%)
Query: 319 IRVATDNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDS---GQGDLEFKNEVLLV 374
           I +  ++FS    +G+GGFG VY  R  D G   A+K L +      QG+    NE +++
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 375 ANLQHRN--LVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG 431
           + +   +   +  + ++    ++L  I + +    L + +      ++ D  R Y     
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM-RFY--AAE 300
Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT 491
           I  GL ++H  +R  +++RDLK +N+LLD     +I+D G+A     D ++      VGT
Sbjct: 301 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGT 353
Query: 492 YGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGET 535
           +GYMAPE    G  Y   +D FS G ++ +++ G  ++ FR  +T
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG--HSPFRQHKT 396

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 88/178 (49%), Gaps = 13/178 (7%)
Query: 351 IAVKRLSRDSGQG-DLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDH 409
           +A+K +++ + +G +   +NE+ ++  ++H N+V L      G    LI + V    L  
Sbjct: 46  VAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFD 105
Query: 410 FIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVL---LDAEMTPK 466
            I +     + D  R   +I  +   + YLH+   L I+HRDLK  N+L   LD +    
Sbjct: 106 RIVEKGFYTERDASR---LIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIM 159
Query: 467 IADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           I+DFG+++   M++     S   GT GY+APE      YS   D +S GV+   ++ G
Sbjct: 160 ISDFGLSK---MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 33/214 (15%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDLEFKN---EVLLVANLQH 379
           + +   +G G  G V     YD      +A+K+LSR   Q     K    E++L+  + H
Sbjct: 27  YQNLKPIGSGAQGIVCAA--YDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 83
Query: 380 RNLVRLLGF-----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
           +N++ LL       SLE  + + I   + + +L   I     + +LD ER   ++  +  
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI-----QMELDHERMSYLLYQMLC 138
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN----TSRIVG 490
           G+ +LH      IIHRDLK SN+++ ++ T KI DFG+AR      T G     T  +V 
Sbjct: 139 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFMMTPYVVT 189
Query: 491 TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
            Y Y APE  +   Y    D++S G ++ E+I G
Sbjct: 190 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 120/296 (40%), Gaps = 32/296 (10%)
Query: 332 LGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLE 391
           +G+G FG VY GR +    I +  + RD+      FK EV+     +H N+V  +G  + 
Sbjct: 41  IGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100
Query: 392 GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRD 451
                +I       +L   + D   +  LD  +  +I   I +G+ YLH      I+H+D
Sbjct: 101 PPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKD 155
Query: 452 LKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIV---GTYGYMAPEYAMHGQ---- 504
           LK+ NV  D      I DFG+  +  + +      ++    G   ++APE          
Sbjct: 156 LKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTE 214
Query: 505 -----YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT 559
                +S  SDVF+ G +  E+ +  R   F+  +  E ++      W+ GT +    P 
Sbjct: 215 EDKLPFSKHSDVFALGTIWYELHA--REWPFKT-QPAEAII------WQMGTGMK---PN 262
Query: 560 LSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTLPVPSEPAFFMDS 615
           LS   + + I    I L C       RPT   ++ ML          S P  F  S
Sbjct: 263 LSQIGMGKEIS--DILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWKS 316

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 323 TDNFSDANKLGQGGFGAVYK------GRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVAN 376
           +DN+    +LG+G F  V +      G  +    I  K+LS    Q   + + E  +   
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ---KLEREARICRK 61
Query: 377 LQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGL 436
           LQH N+VRL     E +   L+++ V    L   I      ++ D       I  I   +
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH---CIQQILESI 118
Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEM---TPKIADFGMARLFEMDETQGNTSRIVGTYG 493
            Y H +    I+HR+LK  N+LL ++      K+ADFG+A   E+++++       GT G
Sbjct: 119 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHG-FAGTPG 172
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           Y++PE      YS   D+++ GV++  ++ G
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVY-KGRLYDGAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     +G G FG V     +  G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 97
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+VP   +    F   RR     E   +     I  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   K+ADFG A+       +G T  + GT  Y
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEY 204
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/111 (39%), Positives = 59/111 (53%), Gaps = 8/111 (7%)
Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT 491
           IA GL +L       II+RDLK  NV+LD+E   KIADFGM +    D     T    GT
Sbjct: 130 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKXFCGT 184
Query: 492 YGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSS 542
             Y+APE   +  Y    D ++FGVL+ E+++GQ       GE  ++L  S
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP---FEGEDEDELFQS 232

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 323 TDNFSDANKLGQGGFGAVYK------GRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVAN 376
           +DN+    +LG+G F  V +      G  +    I  K+LS    Q   + + E  +   
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ---KLEREARICRK 60
Query: 377 LQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGL 436
           LQH N+VRL     E +   L+++ V    L   I      ++ D       I  I   +
Sbjct: 61  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH---CIQQILESI 117
Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEM---TPKIADFGMARLFEMDETQGNTSRIVGTYG 493
            Y H +    I+HR+LK  N+LL ++      K+ADFG+A   E+++++       GT G
Sbjct: 118 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHG-FAGTPG 171
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           Y++PE      YS   D+++ GV++  ++ G
Sbjct: 172 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 107/229 (46%), Gaps = 35/229 (15%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQGDL-EFKNEVLLVANL 377
           N      LG+G FG V K   +          +AVK L  ++   +L +  +E  ++  +
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV 83
Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTR-------------RAQLDWER 424
            H ++++L G   +    LLI E+    SL  F+ +  +              + LD   
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 425 RYKIIGG--------IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-L 475
              +  G        I++G+ YL E   ++++HRDL   N+L+      KI+DFG++R +
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 476 FEMDE-TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
           +E D   + +  RI     +MA E      Y+ +SDV+SFGVL+ EI++
Sbjct: 201 YEEDSYVKRSQGRI--PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 17/206 (8%)
Query: 325 NFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSR---DSGQGDLEFKNEVLLVANLQHR 380
           N+     +G+G F  V   R +  G E+AVK + +   +S      F+ EV ++  L H 
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 66
Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH 440
           N+V+L           L+ E+     +  ++       + +   +++    I   + Y H
Sbjct: 67  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR---QIVSAVQYCH 123
Query: 441 EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNT-SRIVGTYGYMAPEY 499
           +     I+HRDLK  N+LLDA+M  KIADFG +  F    T GN      G+  Y APE 
Sbjct: 124 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF----TFGNKLDTFCGSPPYAAPEL 176
Query: 500 AMHGQY-SVKSDVFSFGVLVLEIISG 524
               +Y   + DV+S GV++  ++SG
Sbjct: 177 FQGKKYDGPEVDVWSLGVILYTLVSG 202

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 43/214 (20%)
Query: 332 LGQGGFGAV---YKGRLYDGAEIAVKRLSRDSGQGDLEFKN---EVLLVANLQHRNLVRL 385
           +G G +G+V   Y  RL    ++AVK+LSR   Q  +  +    E+ L+ +L+H N++ L
Sbjct: 28  VGSGAYGSVCSAYDARLRQ--KVAVKKLSR-PFQSLIHARRTYRELRLLKHLKHENVIGL 84
Query: 386 LGFSLEGNERLLIYEFVPNTSLDHF-------------IFDPTRRAQLDWERRYKIIGGI 432
           L              F P TS++ F             + +  +   L  E    ++  +
Sbjct: 85  LDV------------FTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQL 132
Query: 433 ARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY 492
            RGL Y+H      IIHRDLK SNV ++ +   +I DFG+AR  + DE     +  V T 
Sbjct: 133 LRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR--QADE---EMTGYVATR 184
Query: 493 GYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
            Y APE  ++   Y+   D++S G ++ E++ G+
Sbjct: 185 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 33/214 (15%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDLEFKN---EVLLVANLQH 379
           + +   +G G  G V     YD      +A+K+LSR   Q     K    E++L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAA--YDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 82
Query: 380 RNLVRLLGF-----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
           +N++ LL       SLE  + + I   + + +L   I     + +LD ER   ++  +  
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI-----QMELDHERMSYLLYQMLC 137
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN----TSRIVG 490
           G+ +LH      IIHRDLK SN+++ ++ T KI DFG+AR      T G     T  +V 
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFMMTPYVVT 188
Query: 491 TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
            Y Y APE  +   Y    D++S G ++ E+I G
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 323 TDNFSDANKLGQGGFGAVYK------GRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVAN 376
           +DN+    +LG+G F  V +      G  +    I  K+LS    Q   + + E  +   
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ---KLEREARICRK 61
Query: 377 LQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGL 436
           LQH N+VRL     E +   L+++ V    L   I      ++ D       I  I   +
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH---CIQQILESI 118
Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEM---TPKIADFGMARLFEMDETQGNTSRIVGTYG 493
            Y H +    I+HR+LK  N+LL ++      K+ADFG+A   E+++++       GT G
Sbjct: 119 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHG-FAGTPG 172
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           Y++PE      YS   D+++ GV++  ++ G
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 108/232 (46%), Gaps = 28/232 (12%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRN- 381
           ++  +  ++G G  G V+K R    G  IAVK++ R    G+ E    +L+  ++  ++ 
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR---SGNKEENKRILMDLDVVLKSH 81
Query: 382 ----LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRY--KIIGGIARG 435
               +V+  G  +   +  +  E +  T  +       +R Q     R   K+   I + 
Sbjct: 82  DCPYIVQCFGTFITNTDVFIAMELM-GTCAEKL----KKRMQGPIPERILGKMTVAIVKA 136
Query: 436 LLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYM 495
           L YL E  +  +IHRD+K SN+LLD     K+ DFG++     D+ +    R  G   YM
Sbjct: 137 LYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAGCAAYM 191
Query: 496 APEY-----AMHGQYSVKSDVFSFGVLVLEIISGQ--RNNCFRNGETVEDLL 540
           APE           Y +++DV+S G+ ++E+ +GQ    NC  + E +  +L
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL 243

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 17/206 (8%)
Query: 325 NFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSR---DSGQGDLEFKNEVLLVANLQHR 380
           N+     +G+G F  V   R +  G E+AVK + +   +S      F+ EV +   L H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIXKVLNHP 73
Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH 440
           N+V+L           L+ E+     +  ++    R  + +   +++    I   + Y H
Sbjct: 74  NIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR---QIVSAVQYCH 130
Query: 441 EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNT-SRIVGTYGYMAPEY 499
           +     I+HRDLK  N+LLDA+   KIADFG +  F    T GN      G   Y APE 
Sbjct: 131 QKF---IVHRDLKAENLLLDADXNIKIADFGFSNEF----TFGNKLDAFCGAPPYAAPEL 183
Query: 500 AMHGQY-SVKSDVFSFGVLVLEIISG 524
               +Y   + DV+S GV++  ++SG
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 43/214 (20%)
Query: 332 LGQGGFGAV---YKGRLYDGAEIAVKRLSRDSGQGDLEFKN---EVLLVANLQHRNLVRL 385
           +G G +G+V   Y  RL    ++AVK+LSR   Q  +  +    E+ L+ +L+H N++ L
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVKKLSR-PFQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 386 LGFSLEGNERLLIYEFVPNTSLDHF-------------IFDPTRRAQLDWERRYKIIGGI 432
           L              F P TS++ F             + +  +   L  E    ++  +
Sbjct: 93  LDV------------FTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQL 140
Query: 433 ARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY 492
            RGL Y+H      IIHRDLK SNV ++ +   +I DFG+AR  + DE     +  V T 
Sbjct: 141 LRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR--QADE---EMTGYVATR 192
Query: 493 GYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
            Y APE  ++   Y+   D++S G ++ E++ G+
Sbjct: 193 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 332 LGQGGFGAVYKGRLYDGAE----IAVKRLSRDSGQ--GDLEFKNEVLLVANLQHRNLVRL 385
           LGQG FG V+  +   G++     A+K L + + +    +  K E  ++  + H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 386 -LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI-IGGIARGLLYLHEDS 443
              F  EG +  LI +F+    L    F    +  +  E   K  +  +A  L +LH   
Sbjct: 92  HYAFQTEG-KLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLHS-- 144
Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG 503
            L II+RDLK  N+LLD E   K+ DFG+++  E  + +       GT  YMAPE     
Sbjct: 145 -LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRR 201
Query: 504 QYSVKSDVFSFGVLVLEIISG 524
            ++  +D +SFGVL+ E+++G
Sbjct: 202 GHTQSADWWSFGVLMFEMLTG 222

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 14/206 (6%)
Query: 323 TDNFSDANKLGQGGFGAVYKGRLYDGAE-IAVKRLSRDSGQGDLEFKNEVLLVANLQHRN 381
           +D +     +G G FG     R     E +AVK + R +   D   + E++   +L+H N
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPN 77
Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           +VR     L      +I E+     L   I +  R ++ D  R +     +  G+ Y H 
Sbjct: 78  IVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSE-DEARFF--FQQLLSGVSYCHS 134
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTP--KIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
              ++I HRDLK  N LLD    P  KI DFG ++   +     +T   VGT  Y+APE 
Sbjct: 135 ---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEV 188
Query: 500 AMHGQYSVK-SDVFSFGVLVLEIISG 524
            +  +Y  K +DV+S GV +  ++ G
Sbjct: 189 LLRQEYDGKIADVWSCGVTLYVMLVG 214

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 18/208 (8%)
Query: 323 TDNFSDANKLGQGGFGAVYKGRLYDGAE-IAVKRLSRDSGQGDLEFKNEVLLVANLQHRN 381
           +D +     +G G FG     R     E +AVK + R   + D   K E++   +L+H N
Sbjct: 18  SDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGE-KIDENVKREIINHRSLRHPN 76
Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRY--KIIGGIARGLLYL 439
           +VR     L      ++ E+     L   I +  R ++ D  R +  ++I G++    Y 
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE-DEARFFFQQLISGVS----YA 131
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTP--KIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           H    +++ HRDLK  N LLD    P  KIADFG ++   +          VGT  Y+AP
Sbjct: 132 HA---MQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVL---HSQPKSAVGTPAYIAP 185
Query: 498 EYAMHGQYSVK-SDVFSFGVLVLEIISG 524
           E  +  +Y  K +DV+S GV +  ++ G
Sbjct: 186 EVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 332 LGQGGFGAVYKGRLYDGAEI--AVKRLSRDSGQGDLEFKNEV----LLVANLQHRNLVRL 385
           +G+G FG V   R +   E+  AVK L + +     E K+ +    +L+ N++H  LV L
Sbjct: 46  IGKGSFGKVLLAR-HKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 386 LGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IARGLLYLHEDS 443
             FS +  ++L  + +++    L    F   +R +   E R +     IA  L YLH   
Sbjct: 105 -HFSFQTADKLYFVLDYINGGEL----FYHLQRERCFLEPRARFYAAEIASALGYLHS-- 157
Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG 503
            L I++RDLK  N+LLD++    + DFG+ +  E  E    TS   GT  Y+APE     
Sbjct: 158 -LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAPEVLHKQ 214
Query: 504 QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVED 538
            Y    D +  G ++ E++ G      RN   + D
Sbjct: 215 PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 249

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-----LYDGAEIAVKRLSRDSGQG--DLEFKNEVLLVAN 376
           D +    +LG G F  V K R     L   A+   KR SR S +G    E + EV ++  
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 377 LQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGL 436
           + H N++ L        + +LI E V    L  F+    ++  L  E     I  I  G+
Sbjct: 72  VLHPNIITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGV 128
Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEMTP----KIADFGMARLFEMDETQGNTSRIVGTY 492
            YLH     +I H DLK  N++L  +  P    K+ DFG+A   E      N   I GT 
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTP 182
Query: 493 GYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
            ++APE   +    +++D++S GV+   ++SG
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 111/222 (50%), Gaps = 18/222 (8%)
Query: 324 DNFSDANKLGQGGFGAVYKGR--LYDGAEIAVK--RLSRDSGQGDLEFKNEVLLVANLQH 379
           + +   +KLG+G +  VYKG+  L D   +A+K  RL  + G      + EV L+ +L+H
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIR-EVSLLKDLKH 59
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            N+V L           L++E++ +  L  ++ D      +   + +  +  + RGL Y 
Sbjct: 60  ANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLF--LFQLLRGLAYC 116
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
           H   R +++HRDLK  N+L++     K+ADFG+AR   +  T+   + +V T  Y  P+ 
Sbjct: 117 H---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYDNEVV-TLWYRPPDI 171
Query: 500 AMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
            +    YS + D++  G +  E+ +G+       G TVE+ L
Sbjct: 172 LLGSTDYSTQIDMWGVGCIFYEMATGR---PLFPGSTVEEQL 210

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 323 TDNFSDANKLGQGGFGAVYK------GRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVAN 376
           T+ +    +LG+G F  V +      G+ Y    I  K+LS    Q   + + E  +   
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQ---KLEREARICRL 66
Query: 377 LQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGL 436
           L+H N+VRL     E     LI++ V    L   I      ++ D       I  I   +
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEAD---ASHCIQQILEAV 123
Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEM---TPKIADFGMARLFEMDETQGNTSRIVGTYG 493
           L+ H+   + ++HR+LK  N+LL +++     K+ADFG+A   E++  Q       GT G
Sbjct: 124 LHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAGTPG 178
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           Y++PE      Y    D+++ GV++  ++ G
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 18/208 (8%)
Query: 323 TDNFSDANKLGQGGFGAVYKGRLYDGAE-IAVKRLSRDSGQGDLEFKNEVLLVANLQHRN 381
           +D +     +G G FG     R     E +AVK + R   + D   K E++   +L+H N
Sbjct: 17  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE-KIDENVKREIINHRSLRHPN 75
Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRY--KIIGGIARGLLYL 439
           +VR     L      ++ E+     L   I +  R ++ D  R +  ++I G++    Y 
Sbjct: 76  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE-DEARFFFQQLISGVS----YC 130
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTP--KIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           H    +++ HRDLK  N LLD    P  KI DFG ++   +     +T   VGT  Y+AP
Sbjct: 131 HA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAP 184
Query: 498 EYAMHGQYSVK-SDVFSFGVLVLEIISG 524
           E  +  +Y  K +DV+S GV +  ++ G
Sbjct: 185 EVLLKKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 106/229 (46%), Gaps = 35/229 (15%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQGDL-EFKNEVLLVANL 377
           N      LG+G FG V K   +          +AVK L  ++   +L +  +E  ++  +
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV 83
Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTR-------------RAQLDWER 424
            H ++++L G   +    LLI E+    SL  F+ +  +              + LD   
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 425 RYKIIGG--------IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-L 475
              +  G        I++G+ YL E S   ++HRDL   N+L+      KI+DFG++R +
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 476 FEMDE-TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
           +E D   + +  RI     +MA E      Y+ +SDV+SFGVL+ EI++
Sbjct: 201 YEEDSXVKRSQGRI--PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 21/202 (10%)
Query: 332 LGQGGFGAVYKGRLYDGAE-IAVKRLSRD---SGQGDLEFKNEVLLVANLQHRNLVRLLG 387
           LG+G FG V     Y   + +A+K +SR         +  + E+  +  L+H ++++L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 388 FSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRY--KIIGGIARGLLYLHEDSRL 445
                 + +++ E+      D+ +    +R   D  RR+  +II  I     Y H   R 
Sbjct: 77  VITTPTDIVMVIEYAGGELFDYIV--EKKRMTEDEGRRFFQQIICAIE----YCH---RH 127
Query: 446 RIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI-VGTYGYMAPEYAMHGQ 504
           +I+HRDLK  N+LLD  +  KIADFG++ +     T GN  +   G+  Y APE      
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAAPEVINGKL 183
Query: 505 YS-VKSDVFSFGVLVLEIISGQ 525
           Y+  + DV+S G+++  ++ G+
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGR 205

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 319 IRVATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLS---RDSGQGDLEFK--NEVL 372
           ++     +   + LG+G F  VYK R  +  +I A+K++    R   +  +      E+ 
Sbjct: 5   VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 373 LVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGI 432
           L+  L H N++ LL      +   L+++F+  T L+  I D +        + Y ++   
Sbjct: 65  LLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLM--T 121
Query: 433 ARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI---- 488
            +GL YLH+     I+HRDLK +N+LLD     K+ADFG+A+ F      G+ +R     
Sbjct: 122 LQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF------GSPNRAYXHQ 172
Query: 489 VGTYGYMAPEYAMHGQ-YSVKSDVFSFGVLVLEII 522
           V T  Y APE     + Y V  D+++ G ++ E++
Sbjct: 173 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 15/203 (7%)
Query: 332 LGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLE 391
           +G+G FG V++G+ + G E+AVK  S    +     + E+     L+H N++  +    +
Sbjct: 12  IGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADNK 69
Query: 392 GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED-----SRLR 446
            N        V +      +FD   R  +  E   K+    A GL +LH +      +  
Sbjct: 70  DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA 129
Query: 447 IIHRDLKTSNVLLDAEMTPKIADFGMARLFE--MDETQGNTSRIVGTYGYMAPEY----- 499
           I HRDLK+ N+L+    T  IAD G+A   +   D      +  VGT  YMAPE      
Sbjct: 130 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI 189
Query: 500 -AMHGQYSVKSDVFSFGVLVLEI 521
              H +   ++D+++ G++  EI
Sbjct: 190 NMKHFESFKRADIYAMGLVFWEI 212

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 332 LGQGGFGAVYKGRLYDGAE----IAVKRLSRDSGQ--GDLEFKNEVLLVANLQHRNLVRL 385
           LGQG FG V+  +   G++     A+K L + + +    +  K E  ++  + H  +V+L
Sbjct: 33  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 92
Query: 386 -LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI-IGGIARGLLYLHEDS 443
              F  EG +  LI +F+    L    F    +  +  E   K  +  +A  L +LH   
Sbjct: 93  HYAFQTEG-KLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLHS-- 145
Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG 503
            L II+RDLK  N+LLD E   K+ DFG+++  E  + +       GT  YMAPE     
Sbjct: 146 -LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRR 202
Query: 504 QYSVKSDVFSFGVLVLEIISG 524
            ++  +D +SFGVL+ E+++G
Sbjct: 203 GHTQSADWWSFGVLMFEMLTG 223

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 332 LGQGGFGAVYKGRLYDGAE----IAVKRLSRDSGQ--GDLEFKNEVLLVANLQHRNLVRL 385
           LGQG FG V+  +   G++     A+K L + + +    +  K E  ++  + H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 386 -LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI-IGGIARGLLYLHEDS 443
              F  EG +  LI +F+    L    F    +  +  E   K  +  +A  L +LH   
Sbjct: 92  HYAFQTEG-KLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLHS-- 144
Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG 503
            L II+RDLK  N+LLD E   K+ DFG+++  E  + +       GT  YMAPE     
Sbjct: 145 -LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRR 201
Query: 504 QYSVKSDVFSFGVLVLEIISG 524
            ++  +D +SFGVL+ E+++G
Sbjct: 202 GHTQSADWWSFGVLMFEMLTG 222

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 107/232 (46%), Gaps = 40/232 (17%)
Query: 325 NFSDANKLGQGGFGAVYKG-RLYDGAEIAVKRLSRDSGQGDLEFKN---EVLLVANLQHR 380
            +     +G G +G+V        G ++A+K+LSR   Q ++  K    E+LL+ ++QH 
Sbjct: 25  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-PFQSEIFAKRAYRELLLLKHMQHE 83
Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSL----DHFIFDPTRRAQLDW--------ERRYKI 428
           N++ LL              F P +SL    D ++  P  +  L          E+   +
Sbjct: 84  NVIGLLDV------------FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYL 131
Query: 429 IGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
           +  + +GL Y+H      ++HRDLK  N+ ++ +   KI DFG+AR           +  
Sbjct: 132 VYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGY 183
Query: 489 VGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDL 539
           V T  Y APE  +    Y+   D++S G ++ E+++G+    F+  + ++ L
Sbjct: 184 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK--TLFKGKDYLDQL 233

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 20/204 (9%)
Query: 330 NKLGQGGFGAVYK------GRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
            +LG+G F  V +      G+ Y    I  K+LS    Q   + + E  +   L+H N+V
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQ---KLEREARICRLLKHPNIV 84
Query: 384 RLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS 443
           RL     E     LI++ V    L   I      ++ D       I  I   +L+ H+  
Sbjct: 85  RLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASH---CIQQILEAVLHCHQ-- 139
Query: 444 RLRIIHRDLKTSNVLLDAEM---TPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA 500
            + ++HRDLK  N+LL +++     K+ADFG+A   E++  Q       GT GY++PE  
Sbjct: 140 -MGVVHRDLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAGTPGYLSPEVL 196
Query: 501 MHGQYSVKSDVFSFGVLVLEIISG 524
               Y    D+++ GV++  ++ G
Sbjct: 197 RKDPYGKPVDLWACGVILYILLVG 220

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVY-KGRLYDGAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     +G G FG V     +  G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 97
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E++P   +    F   RR     E   +     I  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYMPGGDM----FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   K+ADFG A+       +G T  + GT  Y
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEY 204
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 15/203 (7%)
Query: 332 LGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLE 391
           +G+G FG V++G+ + G E+AVK  S    +     + E+     L+H N++  +    +
Sbjct: 17  IGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADNK 74
Query: 392 GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED-----SRLR 446
            N        V +      +FD   R  +  E   K+    A GL +LH +      +  
Sbjct: 75  DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA 134
Query: 447 IIHRDLKTSNVLLDAEMTPKIADFGMARLFE--MDETQGNTSRIVGTYGYMAPEY----- 499
           I HRDLK+ N+L+    T  IAD G+A   +   D      +  VGT  YMAPE      
Sbjct: 135 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI 194
Query: 500 -AMHGQYSVKSDVFSFGVLVLEI 521
              H +   ++D+++ G++  EI
Sbjct: 195 NMKHFESFKRADIYAMGLVFWEI 217

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 33/212 (15%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDLEFKN---EVLLVANLQH 379
           + +   +G G  G V     YD      +A+K+LSR   Q     K    E++L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAA--YDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKXVNH 82
Query: 380 RNLVRLLGF-----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
           +N++ LL       +LE  + + +   + + +L   I     + +LD ER   ++  +  
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVI-----QMELDHERMSYLLYQMLX 137
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN----TSRIVG 490
           G+ +LH      IIHRDLK SN+++ ++ T KI DFG+AR      T G     T  +V 
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR------TAGTSFMMTPYVVT 188
Query: 491 TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEII 522
            Y Y APE  +   Y    D++S G ++ E++
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 103/211 (48%), Gaps = 21/211 (9%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGAE---IAVKRLSRDSGQGDLEFK-NEVLLVANLQHRN 381
           ++    +G+G +G V     YD      +A+K++S    Q   +    E+ ++   +H N
Sbjct: 45  YTQLQYIGEGAYGMVSSA--YDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHEN 102
Query: 382 LVR----LLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           ++     L   +LE    + I + +  T L   +    +  QL  +     +  I RGL 
Sbjct: 103 VIGIRDILRASTLEAMRDVYIVQDLMETDLYKLL----KSQQLSNDHICYFLYQILRGLK 158
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF--EMDETQGNTSRIVGTYGYM 495
           Y+H  +   ++HRDLK SN+L++     KI DFG+AR+   E D T G  +  V T  Y 
Sbjct: 159 YIHSAN---VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHT-GFLTEXVATRWYR 214
Query: 496 APEYAMHGQ-YSVKSDVFSFGVLVLEIISGQ 525
           APE  ++ + Y+   D++S G ++ E++S +
Sbjct: 215 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 15/203 (7%)
Query: 332 LGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLE 391
           +G+G FG V++G+ + G E+AVK  S    +     + E+     L+H N++  +    +
Sbjct: 37  IGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADNK 94
Query: 392 GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED-----SRLR 446
            N        V +      +FD   R  +  E   K+    A GL +LH +      +  
Sbjct: 95  DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA 154
Query: 447 IIHRDLKTSNVLLDAEMTPKIADFGMARLFE--MDETQGNTSRIVGTYGYMAPEY----- 499
           I HRDLK+ N+L+    T  IAD G+A   +   D      +  VGT  YMAPE      
Sbjct: 155 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI 214
Query: 500 -AMHGQYSVKSDVFSFGVLVLEI 521
              H +   ++D+++ G++  EI
Sbjct: 215 NMKHFESFKRADIYAMGLVFWEI 237

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 94/206 (45%), Gaps = 26/206 (12%)
Query: 332 LGQGGFGAVYKGRLYD------GAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVR 384
           LG+G FG V     YD      G  +AVK L    G Q    ++ E+ ++  L H ++V+
Sbjct: 17  LGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVK 75
Query: 385 LLGFSLEGNER--LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
             G   +  E+   L+ E+VP  SL  ++     R  +   +       I  G+ YLH  
Sbjct: 76  YKGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICEGMAYLHAQ 131
Query: 443 SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG-----YMAP 497
                IHR L   NVLLD +   KI DFG+A+       +G+    V   G     + AP
Sbjct: 132 ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAV----PEGHEYYRVREDGDSPVFWYAP 184
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIIS 523
           E     ++   SDV+SFGV + E+++
Sbjct: 185 ECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 15/203 (7%)
Query: 332 LGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLE 391
           +G+G FG V++G+ + G E+AVK  S    +     + E+     L+H N++  +    +
Sbjct: 50  IGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADNK 107
Query: 392 GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED-----SRLR 446
            N        V +      +FD   R  +  E   K+    A GL +LH +      +  
Sbjct: 108 DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA 167
Query: 447 IIHRDLKTSNVLLDAEMTPKIADFGMARLFE--MDETQGNTSRIVGTYGYMAPEY----- 499
           I HRDLK+ N+L+    T  IAD G+A   +   D      +  VGT  YMAPE      
Sbjct: 168 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI 227
Query: 500 -AMHGQYSVKSDVFSFGVLVLEI 521
              H +   ++D+++ G++  EI
Sbjct: 228 NMKHFESFKRADIYAMGLVFWEI 250

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-----LYDGAEIAVKRLSRDSGQG--DLEFKNEVLLVAN 376
           D +    +LG G F  V K R     L   A+   KR SR S +G    E + EV ++  
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 377 LQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGL 436
           + H N++ L        + +LI E V    L  F+    ++  L  E     I  I  G+
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGV 128
Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEMTP----KIADFGMARLFEMDETQGNTSRIVGTY 492
            YLH     +I H DLK  N++L  +  P    K+ DFG+A   E      N   I GT 
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTP 182
Query: 493 GYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
            ++APE   +    +++D++S GV+   ++SG
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 107/232 (46%), Gaps = 40/232 (17%)
Query: 325 NFSDANKLGQGGFGAVYKG-RLYDGAEIAVKRLSRDSGQGDLEFKN---EVLLVANLQHR 380
            +     +G G +G+V        G ++A+K+LSR   Q ++  K    E+LL+ ++QH 
Sbjct: 43  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-PFQSEIFAKRAYRELLLLKHMQHE 101
Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSL----DHFIFDPTRRAQLDW--------ERRYKI 428
           N++ LL              F P +SL    D ++  P  +  L          E+   +
Sbjct: 102 NVIGLLDV------------FTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYL 149
Query: 429 IGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
           +  + +GL Y+H      ++HRDLK  N+ ++ +   KI DFG+AR           +  
Sbjct: 150 VYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGY 201
Query: 489 VGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDL 539
           V T  Y APE  +    Y+   D++S G ++ E+++G+    F+  + ++ L
Sbjct: 202 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK--TLFKGKDYLDQL 251

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 15/203 (7%)
Query: 332 LGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLE 391
           +G+G FG V++G+ + G E+AVK  S    +     + E+     L+H N++  +    +
Sbjct: 11  IGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADNK 68
Query: 392 GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED-----SRLR 446
            N        V +      +FD   R  +  E   K+    A GL +LH +      +  
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA 128
Query: 447 IIHRDLKTSNVLLDAEMTPKIADFGMARLFE--MDETQGNTSRIVGTYGYMAPEY----- 499
           I HRDLK+ N+L+    T  IAD G+A   +   D      +  VGT  YMAPE      
Sbjct: 129 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI 188
Query: 500 -AMHGQYSVKSDVFSFGVLVLEI 521
              H +   ++D+++ G++  EI
Sbjct: 189 NMKHFESFKRADIYAMGLVFWEI 211

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 15/203 (7%)
Query: 332 LGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLE 391
           +G+G FG V++G+ + G E+AVK  S    +     + E+     L+H N++  +    +
Sbjct: 14  IGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADNK 71
Query: 392 GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED-----SRLR 446
            N        V +      +FD   R  +  E   K+    A GL +LH +      +  
Sbjct: 72  DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA 131
Query: 447 IIHRDLKTSNVLLDAEMTPKIADFGMARLFE--MDETQGNTSRIVGTYGYMAPEY----- 499
           I HRDLK+ N+L+    T  IAD G+A   +   D      +  VGT  YMAPE      
Sbjct: 132 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI 191
Query: 500 -AMHGQYSVKSDVFSFGVLVLEI 521
              H +   ++D+++ G++  EI
Sbjct: 192 NMKHFESFKRADIYAMGLVFWEI 214

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVY-KGRLYDGAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     +G G FG V     +  G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 97
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E++P   +    F   RR     E   +     I  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYMPGGDM----FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   K+ADFG A+       +G T  + GT  Y
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEY 204
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 99/219 (45%), Gaps = 47/219 (21%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDLEFKN---EVLLVANLQH 379
           + +   +G G  G V     YD      +A+K+LSR   Q     K    E++L+  + H
Sbjct: 64  YQNLKPIGSGAQGIVCAA--YDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 120
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--------IFDPTR----RAQLDWERRYK 427
           +N++ LL              F P  +L+ F        + D       + +LD ER   
Sbjct: 121 KNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY 168
Query: 428 IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN--- 484
           ++  +  G+ +LH      IIHRDLK SN+++ ++ T KI DFG+AR      T G    
Sbjct: 169 LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFM 219
Query: 485 -TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEII 522
            T  +V  Y Y APE  +   Y    D++S G ++ E++
Sbjct: 220 MTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 94/206 (45%), Gaps = 26/206 (12%)
Query: 332 LGQGGFGAVYKGRLYD------GAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVR 384
           LG+G FG V     YD      G  +AVK L    G Q    ++ E+ ++  L H ++V+
Sbjct: 16  LGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVK 74
Query: 385 LLGFSLEGNER--LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
             G   +  E+   L+ E+VP  SL  ++     R  +   +       I  G+ YLH  
Sbjct: 75  YKGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICEGMAYLHAQ 130
Query: 443 SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG-----YMAP 497
                IHR L   NVLLD +   KI DFG+A+       +G+    V   G     + AP
Sbjct: 131 ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAV----PEGHEYYRVREDGDSPVFWYAP 183
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIIS 523
           E     ++   SDV+SFGV + E+++
Sbjct: 184 ECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-----LYDGAEIAVKRLSRDSGQG--DLEFKNEVLLVAN 376
           D +    +LG G F  V K R     L   A+   KR SR S +G    E + EV ++  
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 377 LQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGL 436
           + H N++ L        + +LI E V    L  F+    ++  L  E     I  I  G+
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGV 128
Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEMTP----KIADFGMARLFEMDETQGNTSRIVGTY 492
            YLH     +I H DLK  N++L  +  P    K+ DFG+A   E      N   I GT 
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTP 182
Query: 493 GYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
            ++APE   +    +++D++S GV+   ++SG
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-----LYDGAEIAVKRLSRDSGQG--DLEFKNEVLLVAN 376
           D +    +LG G F  V K R     L   A+   KR SR S +G    E + EV ++  
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 377 LQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGL 436
           + H N++ L        + +LI E V    L  F+    ++  L  E     I  I  G+
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGV 128
Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEMTP----KIADFGMARLFEMDETQGNTSRIVGTY 492
            YLH     +I H DLK  N++L  +  P    K+ DFG+A   E      N   I GT 
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTP 182
Query: 493 GYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
            ++APE   +    +++D++S GV+   ++SG
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 102/229 (44%), Gaps = 22/229 (9%)
Query: 306 INRAESLQFD--FNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQ 362
           I   E+L F        V  D+     +LG+G +G V K R     +I AVKR+      
Sbjct: 14  IPTTENLYFQGAXENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNS 73
Query: 363 GDLEFKNEVLLVANLQHRNL-----VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRR 417
            +   +  +L   ++  R +     V   G      +  +  E   +TSLD F      +
Sbjct: 74  QE---QKRLLXDLDISXRTVDCPFTVTFYGALFREGDVWICXELX-DTSLDKFYKQVIDK 129
Query: 418 AQLDWERRY-KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF 476
            Q   E    KI   I + L +LH  S+L +IHRD+K SNVL++A    K  DFG++  +
Sbjct: 130 GQTIPEDILGKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGISG-Y 186
Query: 477 EMDETQGNTSRIVGTYGYMAPEYA----MHGQYSVKSDVFSFGVLVLEI 521
            +D+   +     G   Y APE          YSVKSD++S G+  +E+
Sbjct: 187 LVDDVAKDID--AGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIEL 233

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-----LYDGAEIAVKRLSRDSGQG--DLEFKNEVLLVAN 376
           D +    +LG G F  V K R     L   A+   KR SR S +G    E + EV ++  
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 377 LQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGL 436
           + H N++ L        + +LI E V    L  F+    ++  L  E     I  I  G+
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGV 128
Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEMTP----KIADFGMARLFEMDETQGNTSRIVGTY 492
            YLH     +I H DLK  N++L  +  P    K+ DFG+A   E      N   I GT 
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTP 182
Query: 493 GYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
            ++APE   +    +++D++S GV+   ++SG
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 20/211 (9%)
Query: 323 TDNFSDANKLGQGGFGAVYK------GRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVAN 376
           TD +     +G+G F  V +      G  Y    I  K+LS    Q   + + E  +   
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQ---KLEREARICRL 59
Query: 377 LQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGL 436
           L+H N+VRL     E     L+++ V    L   I      ++ D       I  I   +
Sbjct: 60  LKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASH---CIQQILEAV 116
Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAE---MTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
           L+ H+   + ++HRDLK  N+LL ++      K+ADFG+A   E+   Q       GT G
Sbjct: 117 LHCHQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPG 171
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           Y++PE      Y    D+++ GV++  ++ G
Sbjct: 172 YLSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 33/212 (15%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDLEFKN---EVLLVANLQH 379
           + +   +G G  G V     YD      +A+K+LSR   Q     K    E++L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAA--YDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 82
Query: 380 RNLVRLLGF-----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
           +N++ LL       +LE  + + +   + + +L   I     + +LD ER   ++  +  
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVI-----QMELDHERMSYLLYQMLX 137
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN----TSRIVG 490
           G+ +LH      IIHRDLK SN+++ ++ T KI DFG+AR      T G     T  +V 
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR------TAGTSFMMTPYVVT 188
Query: 491 TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEII 522
            Y Y APE  +   Y    D++S G ++ E++
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   + +  G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 98
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+VP   +    F   RR     E   +     I  
Sbjct: 99  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQIVL 153
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   ++ DFG A+       +G T  + GT  Y
Sbjct: 154 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 205
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   + +  G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 97
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+VP   +    F   RR     E   +     I  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQIVL 152
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   ++ DFG A+       +G T  + GT  Y
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   +  + G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 90
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+VP   +    F   RR     E   +     I  
Sbjct: 91  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQIVL 145
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   ++ DFG A+       +G T  + GT  Y
Sbjct: 146 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 197
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 198 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 324 DNFSDANKLGQGGFGAVY-KGRLYDGAEIAVKRLSRDSGQGDLEFK---NEVLLVANLQH 379
           D F     LG G FG V     +  G   A+K L +       E +   NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 380 RNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IARGLL 437
             LV+L  FS + N  L ++ E+ P   +    F   RR     E   +     I     
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           YLH    L +I+RDLK  N+++D +   K+ DFG+A+       +G T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAK-----RVKGRTWXLCGTPEYLAP 207
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISG 524
           E  +   Y+   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 33/212 (15%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDLEFKN---EVLLVANLQH 379
           + +   +G G  G V     YD      +A+K+LSR   Q     K    E++L+  + H
Sbjct: 19  YQNLKPIGSGAQGIVCAA--YDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 75
Query: 380 RNLVRLLGF-----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
           +N++ LL       +LE  + + +   + + +L   I     + +LD ER   ++  +  
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVI-----QMELDHERMSYLLYQMLX 130
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN----TSRIVG 490
           G+ +LH      IIHRDLK SN+++ ++ T KI DFG+AR      T G     T  +V 
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR------TAGTSFMMTPYVVT 181
Query: 491 TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEII 522
            Y Y APE  +   Y    D++S G ++ E++
Sbjct: 182 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDLEFK-NEVLLVANLQHRN 381
           +++ + +G+G +G V     YD      +A+K++S    Q   +    E+ ++   +H N
Sbjct: 25  YTNLSYIGEGAYGMVCSA--YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 382 LVRLLGF----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           ++ +       ++E  + + I + +  T L    +   +   L  +     +  I RGL 
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDL----YKLLKTQHLSNDHICYFLYQILRGLK 138
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ-GNTSRIVGTYGYMA 496
           Y+H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y A
Sbjct: 139 YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 497 PEYAMHGQ-YSVKSDVFSFGVLVLEIISGQ 525
           PE  ++ + Y+   D++S G ++ E++S +
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   + +  G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 97
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+VP   +    F   RR     E   +     I  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQIVL 152
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   ++ DFG A+       +G T  + GT  Y
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDLEFK-NEVLLVANLQHRN 381
           +++ + +G+G +G V     YD      +A+K++S    Q   +    E+ ++   +H N
Sbjct: 27  YTNLSYIGEGAYGMVCSA--YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 84
Query: 382 LVRLLGF----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           ++ +       ++E  + + I + +  T L    +   +   L  +     +  I RGL 
Sbjct: 85  IIGINDIIRAPTIEQMKDVYIVQDLMETDL----YKLLKTQHLSNDHICYFLYQILRGLK 140
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ-GNTSRIVGTYGYMA 496
           Y+H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y A
Sbjct: 141 YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 497 PEYAMHGQ-YSVKSDVFSFGVLVLEIISGQ 525
           PE  ++ + Y+   D++S G ++ E++S +
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   + +  G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 97
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+VP   +    F   RR     E   +     I  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   ++ DFG A+       +G T  + GT  Y
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 99/219 (45%), Gaps = 47/219 (21%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDLEFKN---EVLLVANLQH 379
           + +   +G G  G V     YD      +A+K+LSR   Q     K    E++L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAA--YDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKXVNH 82
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--------IFDPTR----RAQLDWERRYK 427
           +N++ LL              F P  +L+ F        + D       + +LD ER   
Sbjct: 83  KNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY 130
Query: 428 IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN--- 484
           ++  +  G+ +LH      IIHRDLK SN+++ ++ T KI DFG+AR      T G    
Sbjct: 131 LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR------TAGTSFM 181
Query: 485 -TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEII 522
            T  +V  Y Y APE  +   Y    D++S G ++ E++
Sbjct: 182 MTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDLEFK-NEVLLVANLQHRN 381
           +++ + +G+G +G V     YD      +A+K++S    Q   +    E+ ++   +H N
Sbjct: 25  YTNLSYIGEGAYGMVCSA--YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 382 LVRLLGF----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           ++ +       ++E  + + I + +  T L    +   +   L  +     +  I RGL 
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDL----YKLLKTQHLSNDHICYFLYQILRGLK 138
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ-GNTSRIVGTYGYMA 496
           Y+H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y A
Sbjct: 139 YIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 497 PEYAMHGQ-YSVKSDVFSFGVLVLEIISGQ 525
           PE  ++ + Y+   D++S G ++ E++S +
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 25/208 (12%)
Query: 332 LGQGGFGAVYKGRLYDGAEIAVKRLS-RDSGQG--DLEFKNEVLLVANLQHRNLVRLLGF 388
           +G+G +G V++G  + G  +AVK  S RD      + E  N V+L    +H N++  +  
Sbjct: 45  VGKGRYGEVWRGS-WQGENVAVKIFSSRDEKSWFRETELYNTVML----RHENILGFIAS 99
Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH-----EDS 443
            +           + +      ++D  +   LD     +I+  IA GL +LH        
Sbjct: 100 DMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQG 159
Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ---GNTSRIVGTYGYMAPEYA 500
           +  I HRDLK+ N+L+       IAD G+A +      Q   GN  R VGT  YMAPE  
Sbjct: 160 KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR-VGTKRYMAPE-V 217
Query: 501 MHGQYSV-------KSDVFSFGVLVLEI 521
           +     V       + D+++FG+++ E+
Sbjct: 218 LDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-----LYDGAEIAVKRLSRDSGQG--DLEFKNEVLLVAN 376
           D +    +LG G F  V K R     L   A+   KR SR S +G    E + EV ++  
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 377 LQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGL 436
           + H N++ L        + +LI E V    L  F+    ++  L  E     I  I  G+
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGV 128
Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEMTP----KIADFGMARLFEMDETQGNTSRIVGTY 492
            YLH     +I H DLK  N++L  +  P    K+ DFG+A   E      N   I GT 
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTP 182
Query: 493 GYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
            ++APE   +    +++D++S GV+   ++SG
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   + +  G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 98
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+VP   +    F   RR     E   +     I  
Sbjct: 99  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVL 153
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   ++ DFG A+       +G T  + GT  Y
Sbjct: 154 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 205
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   + +  G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 97
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+VP   +    F   RR     E   +     I  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   ++ DFG A+       +G T  + GT  Y
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDG---AEIAVKRLSRDSGQGDLEFK-NEVLLVANLQHRN 381
           +++ + +G+G +G V     YD      +A+K++S    Q   +    E+ ++   +H N
Sbjct: 29  YTNLSYIGEGAYGMVCSA--YDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 382 LVRLLGF----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           ++ +       ++E  + + I + +  T L    +   +   L  +     +  I RGL 
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDL----YKLLKTQHLSNDHICYFLYQILRGLK 142
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ-GNTSRIVGTYGYMA 496
           Y+H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y A
Sbjct: 143 YIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 497 PEYAMHGQ-YSVKSDVFSFGVLVLEIISGQ 525
           PE  ++ + Y+   D++S G ++ E++S +
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   + +  G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 98
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+VP   +    F   RR     E   +     I  
Sbjct: 99  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVL 153
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   ++ DFG A+       +G T  + GT  Y
Sbjct: 154 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEY 205
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDG---AEIAVKRLSRDSGQGDLEFK-NEVLLVANLQHRN 381
           +++ + +G+G +G V     YD      +A+K++S    Q   +    E+ ++   +H N
Sbjct: 30  YTNLSYIGEGAYGMVCSA--YDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 87
Query: 382 LVRLLGF----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           ++ +       ++E  + + I + +  T L    +   +   L  +     +  I RGL 
Sbjct: 88  IIGINDIIRAPTIEQMKDVYIVQDLMETDL----YKLLKTQHLSNDHICYFLYQILRGLK 143
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ-GNTSRIVGTYGYMA 496
           Y+H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y A
Sbjct: 144 YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 200
Query: 497 PEYAMHGQ-YSVKSDVFSFGVLVLEIISGQ 525
           PE  ++ + Y+   D++S G ++ E++S +
Sbjct: 201 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 33/212 (15%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDLEFKN---EVLLVANLQH 379
           + +   +G G  G V     YD      +A+K+LSR   Q     K    E++L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAA--YDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKXVNH 82
Query: 380 RNLVRLLGF-----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
           +N++ LL       +LE  + + +   + + +L   I     + +LD ER   ++  +  
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVI-----QMELDHERMSYLLYQMLC 137
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN----TSRIVG 490
           G+ +LH      IIHRDLK SN+++ ++ T KI DFG+AR      T G     T  +V 
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR------TAGTSFMMTPYVVT 188
Query: 491 TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEII 522
            Y Y APE  +   Y    D++S G ++ E++
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDG---AEIAVKRLSRDSGQGDLEFK-NEVLLVANLQHRN 381
           +++ + +G+G +G V     YD      +A+K++S    Q   +    E+ ++   +H N
Sbjct: 31  YTNLSYIGEGAYGMVCSA--YDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 88
Query: 382 LVRLLGF----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           ++ +       ++E  + + I + +  T L    +   +   L  +     +  I RGL 
Sbjct: 89  IIGINDIIRAPTIEQMKDVYIVQDLMETDL----YKLLKTQHLSNDHICYFLYQILRGLK 144
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ-GNTSRIVGTYGYMA 496
           Y+H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y A
Sbjct: 145 YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 201
Query: 497 PEYAMHGQ-YSVKSDVFSFGVLVLEIISGQ 525
           PE  ++ + Y+   D++S G ++ E++S +
Sbjct: 202 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDG---AEIAVKRLSRDSGQGDLEFK-NEVLLVANLQHRN 381
           +++ + +G+G +G V     YD      +A+K++S    Q   +    E+ ++   +H N
Sbjct: 22  YTNLSYIGEGAYGMVCSA--YDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 79
Query: 382 LVRLLGF----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           ++ +       ++E  + + I + +  T L    +   +   L  +     +  I RGL 
Sbjct: 80  IIGINDIIRAPTIEQMKDVYIVQDLMETDL----YKLLKTQHLSNDHICYFLYQILRGLK 135
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ-GNTSRIVGTYGYMA 496
           Y+H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y A
Sbjct: 136 YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 192
Query: 497 PEYAMHGQ-YSVKSDVFSFGVLVLEIISGQ 525
           PE  ++ + Y+   D++S G ++ E++S +
Sbjct: 193 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDG---AEIAVKRLSRDSGQGDLEFK-NEVLLVANLQHRN 381
           +++ + +G+G +G V     YD      +A+K++S    Q   +    E+ ++   +H N
Sbjct: 29  YTNLSYIGEGAYGMVCSA--YDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 382 LVRLLGF----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           ++ +       ++E  + + I + +  T L    +   +   L  +     +  I RGL 
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDL----YKLLKTQHLSNDHICYFLYQILRGLK 142
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ-GNTSRIVGTYGYMA 496
           Y+H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y A
Sbjct: 143 YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 497 PEYAMHGQ-YSVKSDVFSFGVLVLEIISGQ 525
           PE  ++ + Y+   D++S G ++ E++S +
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   +  + G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 90
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+VP   +    F   RR     E   +     I  
Sbjct: 91  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVL 145
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   ++ DFG A+       +G T  + GT  Y
Sbjct: 146 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 197
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 198 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 102/225 (45%), Gaps = 12/225 (5%)
Query: 324 DNFSDANKLGQGGFGAVYK-GRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNL 382
           D++    +LG G FG V++      G   A K +           + E+  ++ L+H  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           V L     + NE ++IYEF+    L   + D   +   D    Y  +  + +GL ++HE+
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY--MRQVCKGLCHMHEN 274
Query: 443 SRLRIIHRDLKTSNVLLDAEMTP--KIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA 500
           +    +H DLK  N++   + +   K+ DFG+    +  ++   T+   GT  + APE A
Sbjct: 275 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVA 328
Query: 501 MHGQYSVKSDVFSFGVLVLEIISGQRNNCFRN-GETVEDLLSSAW 544
                   +D++S GVL   ++SG       N  ET+ ++ S  W
Sbjct: 329 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW 373

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   + +  G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 83
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+VP   +    F   RR     E   +     I  
Sbjct: 84  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVL 138
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   ++ DFG A+       +G T  + GT  Y
Sbjct: 139 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEY 190
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 191 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDG---AEIAVKRLSRDSGQGDLEFK-NEVLLVANLQHRN 381
           +++ + +G+G +G V     YD      +A+K++S    Q   +    E+ ++   +H N
Sbjct: 23  YTNLSYIGEGAYGMVCSA--YDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 80
Query: 382 LVRLLGF----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           ++ +       ++E  + + I + +  T L    +   +   L  +     +  I RGL 
Sbjct: 81  IIGINDIIRAPTIEQMKDVYIVQDLMETDL----YKLLKTQHLSNDHICYFLYQILRGLK 136
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ-GNTSRIVGTYGYMA 496
           Y+H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y A
Sbjct: 137 YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 193
Query: 497 PEYAMHGQ-YSVKSDVFSFGVLVLEIISGQ 525
           PE  ++ + Y+   D++S G ++ E++S +
Sbjct: 194 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDLEFK-NEVLLVANLQHRN 381
           +++ + +G+G +G V     YD      +A+K++S    Q   +    E+ ++   +H N
Sbjct: 33  YTNLSYIGEGAYGMVCSA--YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 90
Query: 382 LVRLLGF----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           ++ +       ++E  + + I + +  T L    +   +   L  +     +  I RGL 
Sbjct: 91  IIGINDIIRAPTIEQMKDVYIVQDLMETDL----YKLLKTQHLSNDHICYFLYQILRGLK 146
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ-GNTSRIVGTYGYMA 496
           Y+H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y A
Sbjct: 147 YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 203
Query: 497 PEYAMHGQ-YSVKSDVFSFGVLVLEIISGQ 525
           PE  ++ + Y+   D++S G ++ E++S +
Sbjct: 204 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDLEFK-NEVLLVANLQHRN 381
           +++ + +G+G +G V     YD      +A+K++S    Q   +    E+ ++   +H N
Sbjct: 25  YTNLSYIGEGAYGMVCSA--YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 382 LVRLLGF----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           ++ +       ++E  + + I + +  T L    +   +   L  +     +  I RGL 
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDL----YKLLKTQHLSNDHICYFLYQILRGLK 138
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ-GNTSRIVGTYGYMA 496
           Y+H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y A
Sbjct: 139 YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 497 PEYAMHGQ-YSVKSDVFSFGVLVLEIISGQ 525
           PE  ++ + Y+   D++S G ++ E++S +
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDLEFK-NEVLLVANLQHRN 381
           +++ + +G+G +G V     YD      +A+K++S    Q   +    E+ ++   +H N
Sbjct: 27  YTNLSYIGEGAYGMVCSA--YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHEN 84
Query: 382 LVRLLGF----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           ++ +       ++E  + + I + +  T L    +   +   L  +     +  I RGL 
Sbjct: 85  IIGINDIIRAPTIEQMKDVYIVQDLMETDL----YKLLKTQHLSNDHICYFLYQILRGLK 140
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ-GNTSRIVGTYGYMA 496
           Y+H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y A
Sbjct: 141 YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 497 PEYAMHGQ-YSVKSDVFSFGVLVLEIISGQ 525
           PE  ++ + Y+   D++S G ++ E++S +
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 96/216 (44%), Gaps = 23/216 (10%)
Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLV 374
           DF+ +RV          +G+G +  V   RL     I   R+ +     D E  + V   
Sbjct: 53  DFDLLRV----------IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTE 102
Query: 375 ANL--QHRNLVRLLGFS--LEGNERLL-IYEFVPNTSLDHFIFDPTRRAQLDWERRYKII 429
            ++  Q  N   L+G     +   RL  + E+V    L   +F   R+ +L  E      
Sbjct: 103 KHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYS 159
Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIV 489
             I+  L YLHE     II+RDLK  NVLLD+E   K+ D+GM +  E       TS   
Sbjct: 160 AEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFC 214
Query: 490 GTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           GT  Y+APE      Y    D ++ GVL+ E+++G+
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDG---AEIAVKRLSRDSGQGDLEFK-NEVLLVANLQHRN 381
           +++ + +G+G +G V     YD      +A+K++S    Q   +    E+ ++   +H N
Sbjct: 23  YTNLSYIGEGAYGMVCSA--YDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 80
Query: 382 LVRLLGF----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           ++ +       ++E  + + I + +  T L    +   +   L  +     +  I RGL 
Sbjct: 81  IIGINDIIRAPTIEQMKDVYIVQDLMETDL----YKLLKTQHLSNDHICYFLYQILRGLK 136
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ-GNTSRIVGTYGYMA 496
           Y+H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y A
Sbjct: 137 YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 193
Query: 497 PEYAMHGQ-YSVKSDVFSFGVLVLEIISGQ 525
           PE  ++ + Y+   D++S G ++ E++S +
Sbjct: 194 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   + +  G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 97
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+VP   +    F   RR     E   +     I  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   ++ DFG A+       +G T  + GT  Y
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDLEFK-NEVLLVANLQHRN 381
           +++ + +G+G +G V     YD      +A+K++S    Q   +    E+ ++   +H N
Sbjct: 25  YTNLSYIGEGAYGMVCSA--YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 382 LVRLLGF----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           ++ +       ++E  + + I + +  T L    +   +   L  +     +  I RGL 
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDL----YKLLKTQHLSNDHICYFLYQILRGLK 138
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ-GNTSRIVGTYGYMA 496
           Y+H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y A
Sbjct: 139 YIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 497 PEYAMHGQ-YSVKSDVFSFGVLVLEIISGQ 525
           PE  ++ + Y+   D++S G ++ E++S +
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDLEFK-NEVLLVANLQHRN 381
           +++ + +G+G +G V     YD      +A+K++S    Q   +    E+ ++   +H N
Sbjct: 45  YTNLSYIGEGAYGMVCSA--YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 102
Query: 382 LVRLLGF----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           ++ +       ++E  + + I + +  T L    +   +   L  +     +  I RGL 
Sbjct: 103 IIGINDIIRAPTIEQMKDVYIVQDLMETDL----YKLLKTQHLSNDHICYFLYQILRGLK 158
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ-GNTSRIVGTYGYMA 496
           Y+H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y A
Sbjct: 159 YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 215
Query: 497 PEYAMHGQ-YSVKSDVFSFGVLVLEIISGQ 525
           PE  ++ + Y+   D++S G ++ E++S +
Sbjct: 216 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 33/212 (15%)
Query: 332 LGQGGFGAVYKGRLYDGAEIAVKRLS-RDSGQG--DLEFKNEVLLVANLQHRNLVRLLGF 388
           +G+G +G V++G  + G  +AVK  S RD      + E  N V+L    +H N++  +  
Sbjct: 16  VGKGRYGEVWRGS-WQGENVAVKIFSSRDEKSWFRETELYNTVML----RHENILGFIAS 70
Query: 389 SL----EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH---- 440
            +       +  LI  +    SL    +D  +   LD     +I+  IA GL +LH    
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 441 -EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ---GNTSRIVGTYGYMA 496
               +  I HRDLK+ N+L+       IAD G+A +      Q   GN  R VGT  YMA
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR-VGTKRYMA 185
Query: 497 PEYAMHGQYSV-------KSDVFSFGVLVLEI 521
           PE  +     V       + D+++FG+++ E+
Sbjct: 186 PE-VLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDG---AEIAVKRLSRDSGQGDLEFK-NEVLLVANLQHRN 381
           +++ + +G+G +G V     YD      +A+K++S    Q   +    E+ ++   +H N
Sbjct: 29  YTNLSYIGEGAYGMVCSA--YDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHEN 86
Query: 382 LVRLLGF----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           ++ +       ++E  + + I + +  T L    +   +   L  +     +  I RGL 
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDL----YKLLKTQHLSNDHICYFLYQILRGLK 142
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ-GNTSRIVGTYGYMA 496
           Y+H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y A
Sbjct: 143 YIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 497 PEYAMHGQ-YSVKSDVFSFGVLVLEIISGQ 525
           PE  ++ + Y+   D++S G ++ E++S +
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 99/219 (45%), Gaps = 47/219 (21%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDLEFKN---EVLLVANLQH 379
           + +   +G G  G V     YD      +A+K+LSR   Q     K    E++L+  + H
Sbjct: 64  YQNLKPIGSGAQGIVCAA--YDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 120
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--------IFDPTR----RAQLDWERRYK 427
           +N++ LL              F P  +L+ F        + D       + +LD ER   
Sbjct: 121 KNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY 168
Query: 428 IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN--- 484
           ++  +  G+ +LH      IIHRDLK SN+++ ++ T KI DFG+AR      T G    
Sbjct: 169 LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFM 219
Query: 485 -TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEII 522
            T  +V  Y Y APE  +   Y    D++S G ++ E++
Sbjct: 220 MTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   +  + G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 98
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+VP   +    F   RR     E   +     I  
Sbjct: 99  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVL 153
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   ++ DFG A+       +G T  + GT  Y
Sbjct: 154 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 205
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 25/208 (12%)
Query: 332 LGQGGFGAVYKGRLYDGAEIAVKRLS-RDSGQG--DLEFKNEVLLVANLQHRNLVRLLGF 388
           +G+G +G V++G  + G  +AVK  S RD      + E  N V+L    +H N++  +  
Sbjct: 16  VGKGRYGEVWRGS-WQGENVAVKIFSSRDEKSWFRETELYNTVML----RHENILGFIAS 70
Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH-----EDS 443
            +           + +      ++D  +   LD     +I+  IA GL +LH        
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQG 130
Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ---GNTSRIVGTYGYMAPEYA 500
           +  I HRDLK+ N+L+       IAD G+A +      Q   GN  R VGT  YMAPE  
Sbjct: 131 KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR-VGTKRYMAPE-V 188
Query: 501 MHGQYSV-------KSDVFSFGVLVLEI 521
           +     V       + D+++FG+++ E+
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/167 (32%), Positives = 78/167 (46%), Gaps = 20/167 (11%)
Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR--LFEMDETQGNTSRIV 489
           +ARG+ +L   S  + IHRDL   N+LL      KI DFG+AR      D  +   +R+ 
Sbjct: 208 VARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRL- 263
Query: 490 GTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWRE 549
               +MAPE      YS KSDV+S+GVL+ EI S    + +   +  ED  S      RE
Sbjct: 264 -PLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS-LGGSPYPGVQMDEDFCSRL----RE 317
Query: 550 GTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLML 596
           G  +    P  S+  I +++      L C   +   RP  A +V  L
Sbjct: 318 GMRMRA--PEYSTPEIYQIM------LDCWHRDPKERPRFAELVEKL 356

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 45/218 (20%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDLEFKN---EVLLVANLQH 379
           + +   +G G  G V     YD      +A+K+LSR   Q     K    E++L+  + H
Sbjct: 27  YQNLKPIGSGAQGIVCAA--YDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 83
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--------IFDPTR----RAQLDWERRYK 427
           +N++ LL              F P  +L+ F        + D       + +LD ER   
Sbjct: 84  KNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY 131
Query: 428 IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNT-- 485
           ++  +  G+ +LH      IIHRDLK SN+++ ++ T KI DFG+AR      T G +  
Sbjct: 132 LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFM 182
Query: 486 -SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEII 522
            +  V T  Y APE  +   Y    D++S G ++ E++
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   +  + G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 98
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+VP   +    F   RR     E   +     I  
Sbjct: 99  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVL 153
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   ++ DFG A+       +G T  + GT  Y
Sbjct: 154 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 205
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDG---AEIAVKRLSRDSGQGDLEFK-NEVLLVANLQHRN 381
           +++ + +G+G +G V     YD      +A+K++S    Q   +    E+ ++   +H N
Sbjct: 29  YTNLSYIGEGAYGMVCSA--YDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 382 LVRLLGF----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           ++ +       ++E  + + I + +  T L    +   +   L  +     +  I RGL 
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDL----YKLLKCQHLSNDHICYFLYQILRGLK 142
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ-GNTSRIVGTYGYMA 496
           Y+H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y A
Sbjct: 143 YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 497 PEYAMHGQ-YSVKSDVFSFGVLVLEIISGQ 525
           PE  ++ + Y+   D++S G ++ E++S +
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 45/218 (20%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDLEFKN---EVLLVANLQH 379
           + +   +G G  G V     YD      +A+K+LSR   Q     K    E++L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAA--YDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 82
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--------IFDPTR----RAQLDWERRYK 427
           +N++ LL              F P  +L+ F        + D       + +LD ER   
Sbjct: 83  KNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY 130
Query: 428 IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNT-- 485
           ++  +  G+ +LH      IIHRDLK SN+++ ++ T KI DFG+AR      T G +  
Sbjct: 131 LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFM 181
Query: 486 -SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEII 522
            +  V T  Y APE  +   Y    D++S G ++ E++
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 99/219 (45%), Gaps = 47/219 (21%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDLEFKN---EVLLVANLQH 379
           + +   +G G  G V     YD      +A+K+LSR   Q     K    E++L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAA--YDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 82
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--------IFDPTR----RAQLDWERRYK 427
           +N++ LL              F P  +L+ F        + D       + +LD ER   
Sbjct: 83  KNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY 130
Query: 428 IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN--- 484
           ++  +  G+ +LH      IIHRDLK SN+++ ++ T KI DFG+AR      T G    
Sbjct: 131 LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFM 181
Query: 485 -TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEII 522
            T  +V  Y Y APE  +   Y    D++S G ++ E++
Sbjct: 182 MTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 31/211 (14%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDLEFKN---EVLLVANLQH 379
           + +   +G G  G V     YD      +A+K+LSR   Q     K    E++L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAA--YDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 82
Query: 380 RNLVRLLGF-----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
           +N++ LL       SLE  + + I   + + +L   I     + +LD ER   ++  +  
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI-----QMELDHERMSYLLYQMLC 137
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI---VGT 491
           G+ +LH      IIHRDLK SN+++ ++ T KI DFG+AR      T G +  +   V T
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFMMEPEVVT 188
Query: 492 YGYMAPEYAMHGQYSVKSDVFSFGVLVLEII 522
             Y APE  +   Y    D++S G ++ E++
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   +  + G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 98
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+VP   +    F   RR     E   +     I  
Sbjct: 99  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVL 153
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   ++ DFG A+       +G T  + GT  Y
Sbjct: 154 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 205
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 99/219 (45%), Gaps = 47/219 (21%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDLEFKN---EVLLVANLQH 379
           + +   +G G  G V     YD      +A+K+LSR   Q     K    E++L+  + H
Sbjct: 25  YQNLKPIGSGAQGIVCAA--YDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 81
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--------IFDPTR----RAQLDWERRYK 427
           +N++ LL              F P  +L+ F        + D       + +LD ER   
Sbjct: 82  KNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY 129
Query: 428 IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN--- 484
           ++  +  G+ +LH      IIHRDLK SN+++ ++ T KI DFG+AR      T G    
Sbjct: 130 LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFM 180
Query: 485 -TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEII 522
            T  +V  Y Y APE  +   Y    D++S G ++ E++
Sbjct: 181 MTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 218

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 16/207 (7%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRL--SRDSGQGDLEFKNEVLLVANLQHR 380
           + +    K+G+G +G V+K R  D G  +A+K+   S D          E+ ++  L+H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRY--KIIGGIARGLLY 438
           NLV LL          L++E+      DH +     R Q          I     + + +
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYC-----DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
            H+ +    IHRD+K  N+L+      K+ DFG ARL        +    V T  Y +PE
Sbjct: 118 CHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE--VATRWYRSPE 172
Query: 499 YAM-HGQYSVKSDVFSFGVLVLEIISG 524
             +   QY    DV++ G +  E++SG
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   +  + G   A+K L +   Q  ++ K      NE  +   
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDK---QKVVKLKQIEHTLNEKRIQQA 98
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+ P   +    F   RR     E   +     I  
Sbjct: 99  VNFPFLVKL-EFSFKDNSNLYMVLEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVL 153
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   K+ADFG A+       +G T  + GT  Y
Sbjct: 154 TFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEY 205
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 99/219 (45%), Gaps = 47/219 (21%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDLEFKN---EVLLVANLQH 379
           + +   +G G  G V     YD      +A+K+LSR   Q     K    E++L+  + H
Sbjct: 27  YQNLKPIGSGAQGIVCAA--YDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 83
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--------IFDPTR----RAQLDWERRYK 427
           +N++ LL              F P  +L+ F        + D       + +LD ER   
Sbjct: 84  KNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY 131
Query: 428 IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN--- 484
           ++  +  G+ +LH      IIHRDLK SN+++ ++ T KI DFG+AR      T G    
Sbjct: 132 LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFM 182
Query: 485 -TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEII 522
            T  +V  Y Y APE  +   Y    D++S G ++ E++
Sbjct: 183 MTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 103/210 (49%), Gaps = 19/210 (9%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDG---AEIAVKRLSRDSGQGDLEFK-NEVLLVANLQHRN 381
           +++ + +G+G +G V     YD      +A+K++S    Q   +    E+ ++   +H N
Sbjct: 29  YTNLSYIGEGAYGMVCSA--YDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 382 LVRLLGF----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           ++ +       ++E  + + I + +  T L    +   +   L  +     +  I RGL 
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDL----YKLLKTQHLSNDHICYFLYQILRGLK 142
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ-GNTSRIVGTYGYMA 496
           Y+H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G     V T  Y A
Sbjct: 143 YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRA 199
Query: 497 PEYAMHGQ-YSVKSDVFSFGVLVLEIISGQ 525
           PE  ++ + Y+   D++S G ++ E++S +
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 103/210 (49%), Gaps = 19/210 (9%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDG---AEIAVKRLSRDSGQGDLEFK-NEVLLVANLQHRN 381
           +++ + +G+G +G V     YD      +A+K++S    Q   +    E+ ++   +H N
Sbjct: 30  YTNLSYIGEGAYGMVCSA--YDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 87
Query: 382 LVRLLGF----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           ++ +       ++E  + + I + +  T L    +   +   L  +     +  I RGL 
Sbjct: 88  IIGINDIIRAPTIEQMKDVYIVQDLMETDL----YKLLKTQHLSNDHICYFLYQILRGLK 143
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ-GNTSRIVGTYGYMA 496
           Y+H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G     V T  Y A
Sbjct: 144 YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRA 200
Query: 497 PEYAMHGQ-YSVKSDVFSFGVLVLEIISGQ 525
           PE  ++ + Y+   D++S G ++ E++S +
Sbjct: 201 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   + +  G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 97
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+ P   +    F   RR     E   +     I  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFXEPHARFYAAQIVL 152
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+++D +   K+ DFG A+       +G T  + GT  Y
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 99/219 (45%), Gaps = 47/219 (21%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDLEFKN---EVLLVANLQH 379
           + +   +G G  G V     YD      +A+K+LSR   Q     K    E++L+  + H
Sbjct: 20  YQNLKPIGSGAQGIVCAA--YDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 76
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--------IFDPTR----RAQLDWERRYK 427
           +N++ LL              F P  +L+ F        + D       + +LD ER   
Sbjct: 77  KNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY 124
Query: 428 IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN--- 484
           ++  +  G+ +LH      IIHRDLK SN+++ ++ T KI DFG+AR      T G    
Sbjct: 125 LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFM 175
Query: 485 -TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEII 522
            T  +V  Y Y APE  +   Y    D++S G ++ E++
Sbjct: 176 MTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDLEFK-NEVLLVANLQHRN 381
           +++ + +G+G +G V     YD      +A+K++S    Q   +    E+ ++   +H N
Sbjct: 25  YTNLSYIGEGAYGMVCSA--YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 382 LVRLLGF----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           ++ +       ++E  + + I + +  T L    +   +   L  +     +  I RGL 
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDL----YKLLKTQHLSNDHICYFLYQILRGLK 138
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ-GNTSRIVGTYGYMA 496
           Y+H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y A
Sbjct: 139 YIHSAN---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 497 PEYAMHGQ-YSVKSDVFSFGVLVLEIISGQ 525
           PE  ++ + Y+   D++S G ++ E++S +
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 99/219 (45%), Gaps = 47/219 (21%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDLEFKN---EVLLVANLQH 379
           + +   +G G  G V     YD      +A+K+LSR   Q     K    E++L+  + H
Sbjct: 20  YQNLKPIGSGAQGIVCAA--YDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 76
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--------IFDPTR----RAQLDWERRYK 427
           +N++ LL              F P  +L+ F        + D       + +LD ER   
Sbjct: 77  KNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY 124
Query: 428 IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN--- 484
           ++  +  G+ +LH      IIHRDLK SN+++ ++ T KI DFG+AR      T G    
Sbjct: 125 LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFM 175
Query: 485 -TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEII 522
            T  +V  Y Y APE  +   Y    D++S G ++ E++
Sbjct: 176 MTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 99/219 (45%), Gaps = 47/219 (21%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDLEFKN---EVLLVANLQH 379
           + +   +G G  G V     YD      +A+K+LSR   Q     K    E++L+  + H
Sbjct: 19  YQNLKPIGSGAQGIVCAA--YDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 75
Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHF--------IFDPTR----RAQLDWERRYK 427
           +N++ LL              F P  +L+ F        + D       + +LD ER   
Sbjct: 76  KNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY 123
Query: 428 IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN--- 484
           ++  +  G+ +LH      IIHRDLK SN+++ ++ T KI DFG+AR      T G    
Sbjct: 124 LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFM 174
Query: 485 -TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEII 522
            T  +V  Y Y APE  +   Y    D++S G ++ E++
Sbjct: 175 MTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 323 TDNFSDANKLGQGGFGAVYKGRLYDGAE-IAVKRLSRDSGQGDLEFKNEVLLVANLQHRN 381
           +D +     +G G FG     R     E +AVK + R         K E++   +L+H N
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIA-ANVKREIINHRSLRHPN 76
Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRY--KIIGGIARGLLYL 439
           +VR     L      ++ E+     L   I +  R ++ D  R +  ++I G++    Y 
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE-DEARFFFQQLISGVS----YC 131
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTP--KIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           H    +++ HRDLK  N LLD    P  KI DFG ++   +     +T   VGT  Y+AP
Sbjct: 132 HA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAP 185
Query: 498 EYAMHGQYSVK-SDVFSFGVLVLEIISG 524
           E  +  +Y  K +DV+S GV +  ++ G
Sbjct: 186 EVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 91/216 (42%), Gaps = 23/216 (10%)
Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYD-----GAEIAVKRLSRDSGQGDLEFKN 369
           DF+ +RV          +G+G +  V   RL         ++  K L  D    D     
Sbjct: 21  DFDLLRV----------IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTE 70
Query: 370 EVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKII 429
           + +      H  LV L       +    + E+V    L   +F   R+ +L  E      
Sbjct: 71  KHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYS 127
Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIV 489
             I+  L YLHE     II+RDLK  NVLLD+E   K+ D+GM +  E       TS   
Sbjct: 128 AEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFC 182
Query: 490 GTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           GT  Y+APE      Y    D ++ GVL+ E+++G+
Sbjct: 183 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 218

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   +  + G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 118
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+VP   +    F   RR     E   +     I  
Sbjct: 119 VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVL 173
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   ++ DFG A+       +G T  + GT  Y
Sbjct: 174 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 225
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 226 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 109/217 (50%), Gaps = 25/217 (11%)
Query: 323 TDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQGDLEFKNEVLLVANLQHRN 381
            ++  D  ++G+G +G+V K       +I AVKR+     + +   + ++L+  ++  R+
Sbjct: 21  AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE---QKQLLMDLDVVMRS 77
Query: 382 -----LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGI---- 432
                +V+  G      +  +  E + +TS D F       + LD     +I+G I    
Sbjct: 78  SDCPYIVQFYGALFREGDCWICMELM-STSFDKFY--KYVYSVLDDVIPEEILGKITLAT 134
Query: 433 ARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY 492
            + L +L E+  L+IIHRD+K SN+LLD     K+ DFG++   ++ ++   T R  G  
Sbjct: 135 VKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISG--QLVDSIAKT-RDAGCR 189
Query: 493 GYMAPEY----AMHGQYSVKSDVFSFGVLVLEIISGQ 525
            YMAPE     A    Y V+SDV+S G+ + E+ +G+
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 103/229 (44%), Gaps = 16/229 (6%)
Query: 321 VATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQGDLEFKN---EVLLVAN 376
           V  D+F     +G+G FG V   +  D  ++ A+K +++       E +N   E+ ++  
Sbjct: 12  VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQG 71
Query: 377 LQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGL 436
           L+H  LV L     +  +  ++ + +    L + +    +      E     I  +   L
Sbjct: 72  LEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL---QQNVHFKEETVKLFICELVMAL 128
Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMA 496
            YL      RIIHRD+K  N+LLD      I DF +A +    ETQ  T  + GT  YMA
Sbjct: 129 DYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR-ETQITT--MAGTKPYMA 182
Query: 497 PEYAMHGQ---YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSS 542
           PE     +   YS   D +S GV   E++ G+R    R+  + ++++ +
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT 231

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDLEFK-NEVLLVANLQHRN 381
           +++ + +G+G +G V     YD      +A+K++S    Q   +    E+ ++   +H N
Sbjct: 27  YTNLSYIGEGAYGMVCSA--YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHEN 84
Query: 382 LVRLLGF----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           ++ +       ++E  + + I + +  T L    +   +   L  +     +  I RGL 
Sbjct: 85  IIGINDIIRAPTIEQMKDVYIVQDLMETDL----YKLLKTQHLSNDHICYFLYQILRGLK 140
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ-GNTSRIVGTYGYMA 496
           Y+H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y A
Sbjct: 141 YIHSAN---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 497 PEYAMHGQ-YSVKSDVFSFGVLVLEIISGQ 525
           PE  ++ + Y+   D++S G ++ E++S +
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 33/212 (15%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDLEFKN---EVLLVANLQH 379
           + +   +G G  G V     YD      +A+K+LSR   Q     K    E++L+  + H
Sbjct: 20  YQNLKPIGSGAQGIVCAA--YDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 76
Query: 380 RNLVRLLGF-----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
           +N++ LL       SLE  + + I   + + +L   I     + +LD ER   ++  +  
Sbjct: 77  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI-----QMELDHERMSYLLYQMLC 131
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN----TSRIVG 490
           G+ +LH      IIHRDLK SN+++ ++ T KI DFG+AR      T G     T  +V 
Sbjct: 132 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFMMTPYVVT 182
Query: 491 TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEII 522
            Y Y APE  +   Y    D++S G ++ E++
Sbjct: 183 RY-YRAPEVILGMGYKENVDLWSVGCIMGEMV 213

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 33/212 (15%)
Query: 332 LGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQG---DLEFKNEVLLVANLQHRNLVRLLGF 388
           +G+G +G V++G L+ G  +AVK  S    Q    + E  N VLL    +H N++  +  
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRETEIYNTVLL----RHDNILGFIAS 70
Query: 389 SL----EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED-- 442
            +       +  LI  +  + SL    +D  +R  L+     ++    A GL +LH +  
Sbjct: 71  DMTSRNSSTQLWLITHYHEHGSL----YDFLQRQTLEPHLALRLAVSAACGLAHLHVEIF 126
Query: 443 ---SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ---GNTSRIVGTYGYMA 496
               +  I HRD K+ NVL+ + +   IAD G+A +          GN  R VGT  YMA
Sbjct: 127 GTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPR-VGTKRYMA 185
Query: 497 PEYAMHGQYSVK-------SDVFSFGVLVLEI 521
           PE  +  Q           +D+++FG+++ EI
Sbjct: 186 PE-VLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 94/210 (44%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVY-KGRLYDGAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V     +  G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 97
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+ P   +    F   RR     E   +     I  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+++D +   K+ DFG A+       +G T  + GT  Y
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDG---AEIAVKRLSRDSGQGDLEFK-NEVLLVANLQHRN 381
           +++ + +G+G +G V     YD      +A++++S    Q   +    E+ ++   +H N
Sbjct: 29  YTNLSYIGEGAYGMVCSA--YDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 382 LVRLLGF----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           ++ +       ++E  + + I + +  T L    +   +   L  +     +  I RGL 
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDL----YKLLKTQHLSNDHICYFLYQILRGLK 142
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ-GNTSRIVGTYGYMA 496
           Y+H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y A
Sbjct: 143 YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 497 PEYAMHGQ-YSVKSDVFSFGVLVLEIISGQ 525
           PE  ++ + Y+   D++S G ++ E++S +
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 102/225 (45%), Gaps = 12/225 (5%)
Query: 324 DNFSDANKLGQGGFGAVYK-GRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNL 382
           D++    +LG G FG V++      G   A K +           + E+  ++ L+H  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           V L     + NE ++IYEF+    L   + D   +   D    Y  +  + +GL ++HE+
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY--MRQVCKGLCHMHEN 168
Query: 443 SRLRIIHRDLKTSNVLLDAEMTP--KIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA 500
           +    +H DLK  N++   + +   K+ DFG+    +  ++   T+   GT  + APE A
Sbjct: 169 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVA 222
Query: 501 MHGQYSVKSDVFSFGVLVLEIISGQRNNCFRN-GETVEDLLSSAW 544
                   +D++S GVL   ++SG       N  ET+ ++ S  W
Sbjct: 223 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW 267

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 33/212 (15%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDLEFKN---EVLLVANLQH 379
           + +   +G G  G V     YD      +A+K+LSR   Q     K    E++L+  + H
Sbjct: 31  YQNLKPIGSGAQGIVCAA--YDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 87
Query: 380 RNLVRLLGF-----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
           +N++ LL       SLE  + + I   + + +L   I     + +LD ER   ++  +  
Sbjct: 88  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI-----QMELDHERMSYLLYQMLC 142
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN----TSRIVG 490
           G+ +LH      IIHRDLK SN+++ ++ T KI DFG+AR      T G     T  +V 
Sbjct: 143 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFMMTPYVVT 193
Query: 491 TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEII 522
            Y Y APE  +   Y    D++S G ++ E++
Sbjct: 194 RY-YRAPEVILGMGYKENVDLWSVGCIMGEMV 224

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   +  + G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDK---QKVVKLKQIEHTLNEKRILQA 97
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  +S + N  L ++ E+VP   +    F   RR     E   +     I  
Sbjct: 98  VNFPFLVKL-EYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   ++ DFG A+       +G T  + GT  Y
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 31/211 (14%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDLEFKN---EVLLVANLQH 379
           + +   +G G  G V     YD      +A+K+LSR   Q     K    E++L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAA--YDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 82
Query: 380 RNLVRLLGF-----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
           +N++ LL       SLE  + + I   + + +L   I     + +LD ER   ++  +  
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI-----QMELDHERMSYLLYQMLC 137
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI---VGT 491
           G+ +LH      IIHRDLK SN+++ ++ T KI DFG+AR      T G +  +   V T
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFMMEPEVVT 188
Query: 492 YGYMAPEYAMHGQYSVKSDVFSFGVLVLEII 522
             Y APE  +   Y    D++S G ++ E++
Sbjct: 189 RYYRAPEVILGMGYKENVDLWSVGCIMGEMV 219

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 324 DNFSDANKLGQGGFGAVY-KGRLYDGAEIAVKRLSRDSGQGDLEFK---NEVLLVANLQH 379
           D F     LG G FG V     +  G   A+K L +       E +   NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 380 RNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IARGLL 437
             LV+L  FS + N  L ++ E+ P   +    F   RR     E   +     I     
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           YLH    L +I+RDLK  N+++D +   ++ DFG+A+       +G T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAK-----RVKGRTWXLCGTPEYLAP 207
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISG 524
           E  +   Y+   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   +  + G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDK---QKVVKLKQIEHTLNEKRILQA 97
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  +S + N  L ++ E+VP   +    F   RR     E   +     I  
Sbjct: 98  VNFPFLVKL-EYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   ++ DFG A+       +G T  + GT  Y
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   +  + G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDK---QKVVKLKQIEHTLNEKRILQA 97
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  +S + N  L ++ E+VP   +    F   RR     E   +     I  
Sbjct: 98  VNFPFLVKL-EYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   ++ DFG A+       +G T  + GT  Y
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 108/228 (47%), Gaps = 19/228 (8%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
           + +  A  LG+G FG V++       +  + +  +  G   +  K E+ ++   +HRN++
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 384 RLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
            L   S E  E L +I+EF+  + LD F    T   +L+       +  +   L +LH  
Sbjct: 65  HLHE-SFESMEELVMIFEFI--SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 443 SRLRIIHRDLKTSNVLLDAEM--TPKIADFGMARLFEMDETQGNTSRIVGTY-GYMAPEY 499
           +   I H D++  N++       T KI +FG AR  +     G+  R++ T   Y APE 
Sbjct: 122 N---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK----PGDNFRLLFTAPEYYAPEV 174
Query: 500 AMHGQYSVKSDVFSFGVLVLEIISGQRNNCF---RNGETVEDLLSSAW 544
             H   S  +D++S G LV  ++SG   N F    N + +E+++++ +
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSG--INPFLAETNQQIIENIMNAEY 220

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 102/217 (47%), Gaps = 20/217 (9%)
Query: 320 RVATDNFSDANKLGQGGFGAVYKGRLYDGAEI----AVKRLSR----DSGQGDLEFKNEV 371
           +V  +NF     LG G +G V+  R   G +     A+K L +       +     + E 
Sbjct: 50  KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 109
Query: 372 LLVANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI-I 429
            ++ +++    +  L ++ +   +L LI +++    L    F    + +   E   +I +
Sbjct: 110 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGEL----FTHLSQRERFTEHEVQIYV 165
Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIV 489
           G I   L +LH   +L II+RD+K  N+LLD+     + DFG+++ F  DET+       
Sbjct: 166 GEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFC 221
Query: 490 GTYGYMAPEYAMHGQ--YSVKSDVFSFGVLVLEIISG 524
           GT  YMAP+    G   +    D +S GVL+ E+++G
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 91/216 (42%), Gaps = 23/216 (10%)
Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYD-----GAEIAVKRLSRDSGQGDLEFKN 369
           DF+ +RV          +G+G +  V   RL         ++  K L  D    D     
Sbjct: 6   DFDLLRV----------IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTE 55
Query: 370 EVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKII 429
           + +      H  LV L       +    + E+V    L   +F   R+ +L  E      
Sbjct: 56  KHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYS 112
Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIV 489
             I+  L YLHE     II+RDLK  NVLLD+E   K+ D+GM +  E       TS   
Sbjct: 113 AEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFC 167
Query: 490 GTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           GT  Y+APE      Y    D ++ GVL+ E+++G+
Sbjct: 168 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 203

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   +  + G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 98
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+ P   +    F   RR     E   +     I  
Sbjct: 99  VNFPFLVKL-EFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVL 153
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+++D +   K+ DFG A+       +G T  + GT  Y
Sbjct: 154 TFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEY 205
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 18/208 (8%)
Query: 323 TDNFSDANKLGQGGFGAVYKGRLYDGAE-IAVKRLSRDSGQGDLEFKNEVLLVANLQHRN 381
           +D +     +G G FG     R     E +AVK + R   + D   K E++   +L+H N
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE-KIDENVKREIINHRSLRHPN 76
Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRY--KIIGGIARGLLYL 439
           +VR     L      ++ E+     L   I +  R ++ D  R +  ++I G++    Y 
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE-DEARFFFQQLISGVS----YC 131
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTP--KIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           H    +++ HRDLK  N LLD    P  KI  FG ++   +     +T   VGT  Y+AP
Sbjct: 132 HA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDT---VGTPAYIAP 185
Query: 498 EYAMHGQYSVK-SDVFSFGVLVLEIISG 524
           E  +  +Y  K +DV+S GV +  ++ G
Sbjct: 186 EVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 17/207 (8%)
Query: 323 TDNFSDANKLGQGGFGAVYKGRLYDGAE-IAVKRLSRDSGQGDLEFKNEVLLVANLQHRN 381
           +D F   ++LG+G    VY+ +     +  A+K L +   +  +  + E+ ++  L H N
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIV--RTEIGVLLRLSHPN 109
Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           +++L        E  L+ E V    L   I +    ++ D     K    I   + YLHE
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVK---QILEAVAYLHE 166
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTP----KIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           +    I+HRDLK  N LL A   P    KIADFG++++ E    Q     + GT GY AP
Sbjct: 167 NG---IVHRDLKPEN-LLYATPAPDAPLKIADFGLSKIVEH---QVLMKTVCGTPGYCAP 219
Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISG 524
           E      Y  + D++S G++   ++ G
Sbjct: 220 EILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 91/206 (44%), Gaps = 17/206 (8%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNL 382
           D F     LG G FG V   + +  G   A+K L +       + ++ +     LQ  N 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 383 VRL--LGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IARGLLY 438
             L  L FS + N  L ++ E+ P   +    F   RR     E   +     I     Y
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFXEPHARFYAAQIVLTFEY 157
Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
           LH    L +I+RDLK  N+++D +   K+ DFG A+       +G T  + GT  Y+APE
Sbjct: 158 LHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPE 209
Query: 499 YAMHGQYSVKSDVFSFGVLVLEIISG 524
             +   Y+   D ++ GVL+ E+ +G
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 18/208 (8%)
Query: 323 TDNFSDANKLGQGGFGAVYKGRLYDGAE-IAVKRLSRDSGQGDLEFKNEVLLVANLQHRN 381
           +D +     +G G FG     R     E +AVK + R   + D   K E++   +L+H N
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE-KIDENVKREIINHRSLRHPN 76
Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRY--KIIGGIARGLLYL 439
           +VR     L      ++ E+     L   I +  R ++ D  R +  ++I G++    Y 
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE-DEARFFFQQLISGVS----YC 131
Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTP--KIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           H    +++ HRDLK  N LLD    P  KI  FG ++   +     +T   VGT  Y+AP
Sbjct: 132 HA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKST---VGTPAYIAP 185
Query: 498 EYAMHGQYSVK-SDVFSFGVLVLEIISG 524
           E  +  +Y  K +DV+S GV +  ++ G
Sbjct: 186 EVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 91/216 (42%), Gaps = 23/216 (10%)
Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYD-----GAEIAVKRLSRDSGQGDLEFKN 369
           DF+ +RV          +G+G +  V   RL         ++  K L  D    D     
Sbjct: 10  DFDLLRV----------IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTE 59
Query: 370 EVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKII 429
           + +      H  LV L       +    + E+V    L   +F   R+ +L  E      
Sbjct: 60  KHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYS 116
Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIV 489
             I+  L YLHE     II+RDLK  NVLLD+E   K+ D+GM +  E       TS   
Sbjct: 117 AEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFC 171
Query: 490 GTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           GT  Y+APE      Y    D ++ GVL+ E+++G+
Sbjct: 172 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 320 RVATDNFSDANKLGQGGFGAVYKGRLYDGAE----IAVKRLSR----DSGQGDLEFKNEV 371
           ++  + F     LG+GG+G V++ R   GA      A+K L +     + +     K E 
Sbjct: 13  KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER 72
Query: 372 LLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG 431
            ++  ++H  +V L+     G +  LI E++    L        R      +     +  
Sbjct: 73  NILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL---FMQLEREGIFMEDTACFYLAE 129
Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT 491
           I+  L +LH+     II+RDLK  N++L+ +   K+ DFG+ +    D T  +T    GT
Sbjct: 130 ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGT 184
Query: 492 YGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
             YMAPE  M   ++   D +S G L+ ++++G
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 20/211 (9%)
Query: 323 TDNFSDANKLGQGGFGAVYK------GRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVAN 376
           TD++    +LG+G F  V +       + Y    I  K+LS    Q   + + E  +   
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQ---KLEREARICRL 86
Query: 377 LQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGL 436
           L+H N+VRL     E     L+++ V    L   I      ++ D       I  I   +
Sbjct: 87  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASH---CIHQILESV 143
Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAE---MTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
            ++H+     I+HRDLK  N+LL ++      K+ADFG+A   E+   Q       GT G
Sbjct: 144 NHIHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGEQQAWFGFAGTPG 198
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           Y++PE      Y    D+++ GV++  ++ G
Sbjct: 199 YLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 91/206 (44%), Gaps = 17/206 (8%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNL 382
           D F     LG G FG V   + +  G   A+K L +       + ++ +     LQ  N 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 383 VRL--LGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IARGLLY 438
             L  L FS + N  L ++ E+ P   +    F   RR     E   +     I     Y
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
           LH    L +I+RDLK  N+++D +   K+ DFG A+       +G T  + GT  Y+APE
Sbjct: 158 LHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPE 209
Query: 499 YAMHGQYSVKSDVFSFGVLVLEIISG 524
             +   Y+   D ++ GVL+ E+ +G
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 90/206 (43%), Gaps = 17/206 (8%)
Query: 324 DNFSDANKLGQGGFGAVY-KGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNL 382
           D F     LG G FG V     +  G   A+K L +       + ++ +     LQ  N 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 383 VRL--LGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IARGLLY 438
             L  L FS + N  L ++ E+ P   +    F   RR     E   +     I     Y
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
           LH    L +I+RDLK  N+++D +   K+ DFG A+       +G T  + GT  Y+APE
Sbjct: 158 LHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPE 209
Query: 499 YAMHGQYSVKSDVFSFGVLVLEIISG 524
             +   Y+   D ++ GVL+ E+ +G
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 20/201 (9%)
Query: 331 KLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLG 387
           +LG+G FG V+  R+ D   G + AVK++  +  + +     E++  A L    +V L G
Sbjct: 100 RLGRGSFGEVH--RMEDKQTGFQCAVKKVRLEVFRAE-----ELMACAGLTSPRIVPLYG 152
Query: 388 FSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRI 447
              EG    +  E +   SL   + +   +  L  +R    +G    GL YLH  SR RI
Sbjct: 153 AVREGPWVNIFMELLEGGSLGQLVKE---QGCLPEDRALYYLGQALEGLEYLH--SR-RI 206
Query: 448 IHRDLKTSNVLLDAEMT-PKIADFGMARLFEMD---ETQGNTSRIVGTYGYMAPEYAMHG 503
           +H D+K  NVLL ++ +   + DFG A   + D   ++      I GT  +MAPE  +  
Sbjct: 207 LHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGR 266
Query: 504 QYSVKSDVFSFGVLVLEIISG 524
               K DV+S   ++L +++G
Sbjct: 267 SCDAKVDVWSSCCMMLHMLNG 287

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 57/96 (59%), Gaps = 5/96 (5%)
Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ-GNTSRIVG 490
           I RGL Y+H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V 
Sbjct: 153 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 491 TYGYMAPEYAMHGQ-YSVKSDVFSFGVLVLEIISGQ 525
           T  Y APE  ++ + Y+   D++S G ++ E++S +
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 107/212 (50%), Gaps = 22/212 (10%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYD-GAEIAVKR-LSRDSGQG-DLEFKNEVLLVANLQHRN 381
            +    K+GQG FG V+K R    G ++A+K+ L  +  +G  +    E+ ++  L+H N
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 78
Query: 382 LVRLL--------GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA 433
           +V L+         ++       L+++F  +  L   + +   +  L   +R  ++  + 
Sbjct: 79  VVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLL 135
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE-TQGN--TSRIVG 490
            GL Y+H   R +I+HRD+K +NVL+  +   K+ADFG+AR F + + +Q N   +R+V 
Sbjct: 136 NGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV- 191
Query: 491 TYGYMAPEYAM-HGQYSVKSDVFSFGVLVLEI 521
           T  Y  PE  +    Y    D++  G ++ E+
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVY-KGRLYDGAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V     +  G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 97
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+ P   +    F   RR     E   +     I  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+++D +   ++ DFG A+       +G T  + GT  Y
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 16/213 (7%)
Query: 320 RVATDNFSDANKLGQGGFGAVYKGRLYDGAE----IAVKRLSR----DSGQGDLEFKNEV 371
           ++  + F     LG+GG+G V++ R   GA      A+K L +     + +     K E 
Sbjct: 13  KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER 72
Query: 372 LLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG 431
            ++  ++H  +V L+     G +  LI E++    L        R      +     +  
Sbjct: 73  NILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL---FMQLEREGIFMEDTACFYLAE 129
Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT 491
           I+  L +LH+     II+RDLK  N++L+ +   K+ DFG+ +    D T   T    GT
Sbjct: 130 ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV--THXFCGT 184
Query: 492 YGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
             YMAPE  M   ++   D +S G L+ ++++G
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 107/212 (50%), Gaps = 22/212 (10%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYD-GAEIAVKR-LSRDSGQG-DLEFKNEVLLVANLQHRN 381
            +    K+GQG FG V+K R    G ++A+K+ L  +  +G  +    E+ ++  L+H N
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 78
Query: 382 LVRLL--------GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA 433
           +V L+         ++       L+++F  +  L   + +   +  L   +R  ++  + 
Sbjct: 79  VVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLL 135
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE-TQGN--TSRIVG 490
            GL Y+H   R +I+HRD+K +NVL+  +   K+ADFG+AR F + + +Q N   +R+V 
Sbjct: 136 NGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV- 191
Query: 491 TYGYMAPEYAM-HGQYSVKSDVFSFGVLVLEI 521
           T  Y  PE  +    Y    D++  G ++ E+
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 104/209 (49%), Gaps = 17/209 (8%)
Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQG-DLEFKNEVLLVANLQHRNLVRLLGFS 389
           K+G+G +G VYK +  DG +     L +  G G  +    E+ L+  L+H N++ L    
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 390 LEGNER--LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY-----LHED 442
           L   +R   L++++  +  L H I     RA    ++  ++  G+ + LLY     +H  
Sbjct: 88  LSHADRKVWLLFDYAEH-DLWHII--KFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 443 SRLRIIHRDLKTSNVLLDAEMTP----KIADFGMARLFEMD-ETQGNTSRIVGTYGYMAP 497
               ++HRDLK +N+L+  E       KIAD G ARLF    +   +   +V T+ Y AP
Sbjct: 145 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 204
Query: 498 EYAMHGQYSVKS-DVFSFGVLVLEIISGQ 525
           E  +  ++  K+ D+++ G +  E+++ +
Sbjct: 205 ELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 21/206 (10%)
Query: 332 LGQGGFGAVYK------GRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRL 385
           +G+G F  V +      G+ +    + V + +   G    + K E  +   L+H ++V L
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 386 LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL----YLHE 441
           L          +++EF+    L    F+  +RA   +     +     R +L    Y H+
Sbjct: 92  LETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 442 DSRLRIIHRDLKTSNVLLDAE---MTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
           ++   IIHRD+K  NVLL ++      K+ DFG+A   ++ E+       VGT  +MAPE
Sbjct: 149 NN---IIHRDVKPENVLLASKENSAPVKLGDFGVA--IQLGESGLVAGGRVGTPHFMAPE 203
Query: 499 YAMHGQYSVKSDVFSFGVLVLEIISG 524
                 Y    DV+  GV++  ++SG
Sbjct: 204 VVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 20/201 (9%)
Query: 331 KLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLG 387
           +LG+G FG V+  R+ D   G + AVK++  +  + +     E++  A L    +V L G
Sbjct: 81  RLGRGSFGEVH--RMEDKQTGFQCAVKKVRLEVFRAE-----ELMACAGLTSPRIVPLYG 133
Query: 388 FSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRI 447
              EG    +  E +   SL   + +   +  L  +R    +G    GL YLH  SR RI
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLVKE---QGCLPEDRALYYLGQALEGLEYLH--SR-RI 187
Query: 448 IHRDLKTSNVLLDAEMT-PKIADFGMARLFEMDETQGNT---SRIVGTYGYMAPEYAMHG 503
           +H D+K  NVLL ++ +   + DFG A   + D    +      I GT  +MAPE  +  
Sbjct: 188 LHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGR 247
Query: 504 QYSVKSDVFSFGVLVLEIISG 524
               K DV+S   ++L +++G
Sbjct: 248 SCDAKVDVWSSCCMMLHMLNG 268

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 94/208 (45%), Gaps = 29/208 (13%)
Query: 332 LGQGGFGAV---------YKGRLYDGAEIAVKRLSRDSGQGDL-------EFKNEVLLVA 375
           L QG F  +         Y  + Y+ + +  KR    S    +       +FKNE+ ++ 
Sbjct: 39  LNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 376 NLQHRNLVRLLGFSLEGNERLLIYEFVPNTSL-----DHFIFDPTRRAQLDWERRYKIIG 430
           ++++   +   G     +E  +IYE++ N S+       F+ D      +  +    II 
Sbjct: 99  DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIK 158
Query: 431 GIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVG 490
            +     Y+H +    I HRD+K SN+L+D     K++DFG +      + +G  SR  G
Sbjct: 159 SVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKG--SR--G 212
Query: 491 TYGYMAPE-YAMHGQYS-VKSDVFSFGV 516
           TY +M PE ++    Y+  K D++S G+
Sbjct: 213 TYEFMPPEFFSNESSYNGAKVDIWSLGI 240

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT 491
           +A+G+ +L   +  + IHRDL   N+LL  +   KI DFG+AR    D            
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 492 YGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
             +MAPE      Y+++SDV+SFGVL+ EI S
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT 491
           +A+G+ +L   +  + IHRDL   N+LL  +   KI DFG+AR    D            
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 492 YGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
             +MAPE      Y+++SDV+SFGVL+ EI S
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 22/202 (10%)
Query: 331 KLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKNEVLLV-ANLQHRNLVRLL 386
           +LG+G FG V+  R+ D   G + AVK++  +       F+ E L+  A L    +V L 
Sbjct: 79  RLGRGSFGEVH--RMKDKQTGFQCAVKKVRLEV------FRVEELVACAGLSSPRIVPLY 130
Query: 387 GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLR 446
           G   EG    +  E +   SL   I    +   L  +R    +G    GL YLH     R
Sbjct: 131 GAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR---R 184
Query: 447 IIHRDLKTSNVLLDAEMT-PKIADFGMARLFEMD---ETQGNTSRIVGTYGYMAPEYAMH 502
           I+H D+K  NVLL ++ +   + DFG A   + D   ++      I GT  +MAPE  M 
Sbjct: 185 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 244
Query: 503 GQYSVKSDVFSFGVLVLEIISG 524
                K D++S   ++L +++G
Sbjct: 245 KPCDAKVDIWSSCCMMLHMLNG 266

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT 491
           +A+G+ +L   +  + IHRDL   N+LL  +   KI DFG+AR    D            
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 492 YGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
             +MAPE      Y+++SDV+SFGVL+ EI S
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 22/206 (10%)
Query: 332 LGQGGFGAVYKG-RLYDGAEIAVKRLSRDSGQGDLEFKNEV---LLVANLQ-------HR 380
           LG+GGFG V+ G RL D  ++A+K + R+   G     + V   L VA L        H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH 440
            ++RLL +  E  E  ++    P  + D F +  T +  L         G +   + + H
Sbjct: 99  GVIRLLDW-FETQEGFMLVLERPLPAQDLFDYI-TEKGPLGEGPSRCFFGQVVAAIQHCH 156
Query: 441 EDSRLRIIHRDLKTSNVLLDAEM-TPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
                 ++HRD+K  N+L+D      K+ DFG   L   DE   +     GT  Y  PE+
Sbjct: 157 SRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH-DEPYTDFD---GTRVYSPPEW 209
Query: 500 AMHGQY-SVKSDVFSFGVLVLEIISG 524
               QY ++ + V+S G+L+ +++ G
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVCG 235

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT 491
           +A+G+ +L   +  + IHRDL   N+LL  +   KI DFG+AR    D            
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 492 YGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
             +MAPE      Y+++SDV+SFGVL+ EI S
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 107/212 (50%), Gaps = 22/212 (10%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYD-GAEIAVKR-LSRDSGQG-DLEFKNEVLLVANLQHRN 381
            +    K+GQG FG V+K R    G ++A+K+ L  +  +G  +    E+ ++  L+H N
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 78
Query: 382 LVRLL--------GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA 433
           +V L+         ++       L+++F  +  L   + +   +  L   +R  ++  + 
Sbjct: 79  VVNLIEICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLL 135
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE-TQGN--TSRIVG 490
            GL Y+H   R +I+HRD+K +NVL+  +   K+ADFG+AR F + + +Q N   +R+V 
Sbjct: 136 NGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV- 191
Query: 491 TYGYMAPEYAM-HGQYSVKSDVFSFGVLVLEI 521
           T  Y  PE  +    Y    D++  G ++ E+
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 107/212 (50%), Gaps = 22/212 (10%)
Query: 325 NFSDANKLGQGGFGAVYKGRLYD-GAEIAVKR-LSRDSGQG-DLEFKNEVLLVANLQHRN 381
            +    K+GQG FG V+K R    G ++A+K+ L  +  +G  +    E+ ++  L+H N
Sbjct: 18  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 77
Query: 382 LVRLL--------GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA 433
           +V L+         ++       L+++F  +  L   + +   +  L   +R  ++  + 
Sbjct: 78  VVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLL 134
Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE-TQGN--TSRIVG 490
            GL Y+H   R +I+HRD+K +NVL+  +   K+ADFG+AR F + + +Q N   +R+V 
Sbjct: 135 NGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV- 190
Query: 491 TYGYMAPEYAM-HGQYSVKSDVFSFGVLVLEI 521
           T  Y  PE  +    Y    D++  G ++ E+
Sbjct: 191 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 222

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 20/211 (9%)
Query: 323 TDNFSDANKLGQGGFGAVYK------GRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVAN 376
           TD +    +LG+G F  V +      G+ Y    I  K+LS    Q   + + E  +   
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQ---KLEREARICRL 59
Query: 377 LQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGL 436
           L+H N+VRL     E     L+++ V    L   I      ++ D       I  I   +
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASH---CIQQILESV 116
Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAE---MTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
            + H +    I+HRDLK  N+LL ++      K+ADFG+A   E+   Q       GT G
Sbjct: 117 NHCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPG 171
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           Y++PE      Y    D+++ GV++  ++ G
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   +  + G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 97
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+V    +    F   RR     E   +     I  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFYAAQIVL 152
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   ++ DFG A+       +G T  + GT  Y
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 94/210 (44%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVY-KGRLYDGAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V     +  G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 97
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+V    +    F   RR     E   +     I  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   ++ DFG A+       +G T  + GT  Y
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   +  + G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 97
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+V    +    F   RR     E   +     I  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFYAAQIVL 152
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   ++ DFG A+       +G T  + GT  Y
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 20/211 (9%)
Query: 323 TDNFSDANKLGQGGFGAVYK------GRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVAN 376
           TD +    +LG+G F  V +      G+ Y    I  K+LS    Q   + + E  +   
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQ---KLEREARICRL 59
Query: 377 LQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGL 436
           L+H N+VRL     E     L+++ V    L   I      ++ D       I  I   +
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASH---CIQQILESV 116
Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAE---MTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
            + H +    I+HRDLK  N+LL ++      K+ADFG+A   E+   Q       GT G
Sbjct: 117 NHCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPG 171
Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           Y++PE      Y    D+++ GV++  ++ G
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   +  + G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 97
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+V    +    F   RR     E   +     I  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFYAAQIVL 152
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   ++ DFG A+       +G T  + GT  Y
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   +  + G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 92
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+V    +    F   RR     E   +     I  
Sbjct: 93  VNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFYAAQIVL 147
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   ++ DFG A+       +G T  + GT  Y
Sbjct: 148 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 199
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 200 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   +  + G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 97
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+V    +    F   RR     E   +     I  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   ++ DFG A+       +G T  + GT  Y
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 22/202 (10%)
Query: 331 KLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFK-NEVLLVANLQHRNLVRLL 386
           ++G+G FG V+  R+ D   G + AVK++  +       F+  E++  A L    +V L 
Sbjct: 65  RVGRGSFGEVH--RMKDKQTGFQCAVKKVRLEV------FRVEELVACAGLSSPRIVPLY 116
Query: 387 GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLR 446
           G   EG    +  E +   SL   I    +   L  +R    +G    GL YLH     R
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR---R 170
Query: 447 IIHRDLKTSNVLLDAEMT-PKIADFGMARLFEMD---ETQGNTSRIVGTYGYMAPEYAMH 502
           I+H D+K  NVLL ++ +   + DFG A   + D   ++      I GT  +MAPE  M 
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 503 GQYSVKSDVFSFGVLVLEIISG 524
                K D++S   ++L +++G
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNG 252

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   +  + G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 97
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+V    +    F   RR     E   +     I  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   ++ DFG A+       +G T  + GT  Y
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLAGTPEY 204
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   +  + G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 118
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+V    +    F   RR     E   +     I  
Sbjct: 119 VNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFYAAQIVL 173
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   ++ DFG A+       +G T  + GT  Y
Sbjct: 174 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 225
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 226 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   +  + G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 97
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+V    +    F   RR     E   +     I  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFAEPHARFYAAQIVL 152
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   ++ DFG A+       +G T  + GT  Y
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   +  + G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 97
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+V    +    F   RR     E   +     I  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   ++ DFG A+       +G T  + GT  Y
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   +  + G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 97
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+V    +    F   RR     E   +     I  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   ++ DFG A+       +G T  + GT  Y
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   +  + G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 98
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+V    +    F   RR     E   +     I  
Sbjct: 99  VNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVL 153
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   ++ DFG A+       +G T  + GT  Y
Sbjct: 154 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 205
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   +  + G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 97
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+V    +    F   RR     E   +     I  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   ++ DFG A+       +G T  + GT  Y
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 113/253 (44%), Gaps = 23/253 (9%)
Query: 298 SEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRL 356
           S AA    + +A S    F+      D +     +G G +G V   R    G ++A+K++
Sbjct: 33  SVAAKNLALLKARSFDVTFDV----GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKI 88
Query: 357 SR--DSGQGDLEFKNEVLLVANLQHRNLVRL---LGFSLEGNERLLIYEFVPNTSLD-HF 410
               D          E+ ++ + +H N++ +   L  ++   E   +Y  +     D H 
Sbjct: 89  PNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQ 148
Query: 411 IFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADF 470
           I   ++   L+  R +  +  + RGL Y+H     ++IHRDLK SN+L++     KI DF
Sbjct: 149 IIHSSQPLTLEHVRYF--LYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDF 203
Query: 471 GMARLF--EMDETQGNTSRIVGTYGYMAPE--YAMHGQYSVKSDVFSFGVLVLEIISGQR 526
           GMAR       E Q   +  V T  Y APE   ++H +Y+   D++S G +  E+++  R
Sbjct: 204 GMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLH-EYTQAIDLWSVGCIFGEMLA--R 260
Query: 527 NNCFRNGETVEDL 539
              F     V  L
Sbjct: 261 RQLFPGKNYVHQL 273

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   +  + G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 97
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+V    +    F   RR     E   +     I  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   ++ DFG A+       +G T  + GT  Y
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   +  + G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 97
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+V    +    F   RR     E   +     I  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   ++ DFG A+       +G T  + GT  Y
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLXGTPEY 204
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   +  + G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 84
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+V    +    F   RR     E   +     I  
Sbjct: 85  VNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVL 139
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   ++ DFG A+       +G T  + GT  Y
Sbjct: 140 TFEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 191
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 192 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 22/202 (10%)
Query: 331 KLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKNEVLLV-ANLQHRNLVRLL 386
           ++G+G FG V+  R+ D   G + AVK++  +       F+ E L+  A L    +V L 
Sbjct: 81  RVGRGSFGEVH--RMKDKQTGFQCAVKKVRLEV------FRVEELVACAGLSSPRIVPLY 132
Query: 387 GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLR 446
           G   EG    +  E +   SL   I    +   L  +R    +G    GL YLH     R
Sbjct: 133 GAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR---R 186
Query: 447 IIHRDLKTSNVLLDAEMT-PKIADFGMARLFEMD---ETQGNTSRIVGTYGYMAPEYAMH 502
           I+H D+K  NVLL ++ +   + DFG A   + D   ++      I GT  +MAPE  M 
Sbjct: 187 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 246
Query: 503 GQYSVKSDVFSFGVLVLEIISG 524
                K D++S   ++L +++G
Sbjct: 247 KPCDAKVDIWSSCCMMLHMLNG 268

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 26/216 (12%)
Query: 323 TDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSR-DSGQGDLEFKNEVLLVANLQHR 380
           + +F   + LG+G +G V         EI A+K++   D     L    E+ ++ + +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 381 NLVRLLGF----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGL 436
           N++ +       S E    + I + +  T L   I   + +   D   +Y I   + R +
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI---STQMLSDDHIQYFIYQTL-RAV 125
Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET----------QGNTS 486
             LH  +   +IHRDLK SN+L+++    K+ DFG+AR+  +DE+          Q   +
Sbjct: 126 KVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI--IDESAADNSEPTGQQSGMT 180
Query: 487 RIVGTYGYMAPEYAM-HGQYSVKSDVFSFGVLVLEI 521
             V T  Y APE  +   +YS   DV+S G ++ E+
Sbjct: 181 EXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 332 LGQGGFGAVYKG-RLYDGAEIAVKRLSRD--SGQGDL----EFKNEVLLVANLQ--HRNL 382
           LG GGFG+VY G R+ D   +A+K + +D  S  G+L        EV+L+  +      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           +RLL +    +  +LI E  P    D F F  T R  L  E        +   + + H  
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHNC 161
Query: 443 SRLRIIHRDLKTSNVLLD---AEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
               ++HRD+K  N+L+D    E+  K+ DFG   L + D    +     GT  Y  PE+
Sbjct: 162 G---VLHRDIKDENILIDLNRGEL--KLIDFGSGALLK-DTVYTDFD---GTRVYSPPEW 212
Query: 500 AMHGQYSVKS-DVFSFGVLVLEIISG 524
             + +Y  +S  V+S G+L+ +++ G
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 103/221 (46%), Gaps = 18/221 (8%)
Query: 310 ESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEI--AVKRLSRDSGQGDLEF 367
           E+L F  +T       ++  N +G+G +G V K  +  G  I  A K++ +   +    F
Sbjct: 12  ENLYFQGSTKGDINQYYTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRF 70
Query: 368 KNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYK 427
           K E+ ++ +L H N++RL     +  +  L+ E      L   +       + D  R   
Sbjct: 71  KQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR--- 127
Query: 428 IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLL--DAEMTP-KIADFGMARLFEMDETQGN 484
           I+  +   + Y H   +L + HRDLK  N L   D+  +P K+ DFG+A  F+     G 
Sbjct: 128 IMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK----PGK 180
Query: 485 TSRI-VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
             R  VGT  Y++P+  + G Y  + D +S GV++  ++ G
Sbjct: 181 MMRTKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 220

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 332 LGQGGFGAVYKG-RLYDGAEIAVKRLSRD--SGQGDL----EFKNEVLLVANLQ--HRNL 382
           LG GGFG+VY G R+ D   +A+K + +D  S  G+L        EV+L+  +      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           +RLL +    +  +LI E  P    D F F  T R  L  E        +   + + H  
Sbjct: 91  IRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHNC 148
Query: 443 SRLRIIHRDLKTSNVLLD---AEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
               ++HRD+K  N+L+D    E+  K+ DFG   L + D    +     GT  Y  PE+
Sbjct: 149 G---VLHRDIKDENILIDLNRGEL--KLIDFGSGALLK-DTVYTDFD---GTRVYSPPEW 199
Query: 500 AMHGQYSVKS-DVFSFGVLVLEIISG 524
             + +Y  +S  V+S G+L+ +++ G
Sbjct: 200 IRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   +  + G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 118
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+V    +    F   RR     E   +     I  
Sbjct: 119 VNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVL 173
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   ++ DFG A+       +G T  + GT  Y
Sbjct: 174 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGATWTLCGTPEY 225
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 226 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 26/216 (12%)
Query: 323 TDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSR-DSGQGDLEFKNEVLLVANLQHR 380
           + +F   + LG+G +G V         EI A+K++   D     L    E+ ++ + +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 381 NLVRLLGF----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGL 436
           N++ +       S E    + I + +  T L   I   + +   D   +Y I   + R +
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI---STQMLSDDHIQYFIYQTL-RAV 125
Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET----------QGNTS 486
             LH  +   +IHRDLK SN+L+++    K+ DFG+AR+  +DE+          Q   +
Sbjct: 126 KVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI--IDESAADNSEPTGQQSGMT 180
Query: 487 RIVGTYGYMAPEYAM-HGQYSVKSDVFSFGVLVLEI 521
             V T  Y APE  +   +YS   DV+S G ++ E+
Sbjct: 181 EYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 31/210 (14%)
Query: 331 KLGQGGFGAVYKGRLYDGA------EIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVR 384
           ++G+G F  VYKG   +        E+  ++L++   Q    FK E   +  LQH N+VR
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ---RFKEEAEXLKGLQHPNIVR 89
Query: 385 LLGFSLEGNER-----LLIYEFVPNTSLDHFI--FDPTRRAQL-DWERRYKIIGGIARGL 436
               S E   +     +L+ E   + +L  ++  F   +   L  W R+      I +GL
Sbjct: 90  FYD-SWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQ------ILKGL 142
Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEM-TPKIADFGMARLFEMDETQGNTSRIVGTYGYM 495
            +LH  +   IIHRDLK  N+ +     + KI D G+A L    +       ++GT  + 
Sbjct: 143 QFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFX 197
Query: 496 APEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           APE     +Y    DV++FG   LE  + +
Sbjct: 198 APE-XYEEKYDESVDVYAFGXCXLEXATSE 226

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 332 LGQGGFGAVYKG-RLYDGAEIAVKRLSRD--SGQGDL----EFKNEVLLVANLQ--HRNL 382
           LG GGFG+VY G R+ D   +A+K + +D  S  G+L        EV+L+  +      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           +RLL +    +  +LI E  P    D F F  T R  L  E        +   + + H  
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHNC 162
Query: 443 SRLRIIHRDLKTSNVLLD---AEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
               ++HRD+K  N+L+D    E+  K+ DFG   L + D    +     GT  Y  PE+
Sbjct: 163 G---VLHRDIKDENILIDLNRGEL--KLIDFGSGALLK-DTVYTDFD---GTRVYSPPEW 213
Query: 500 AMHGQYSVKS-DVFSFGVLVLEIISG 524
             + +Y  +S  V+S G+L+ +++ G
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 332 LGQGGFGAVYKG-RLYDGAEIAVKRLSRD--SGQGDL----EFKNEVLLVANLQ--HRNL 382
           LG GGFG+VY G R+ D   +A+K + +D  S  G+L        EV+L+  +      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           +RLL +    +  +LI E  P    D F F  T R  L  E        +   + + H  
Sbjct: 91  IRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHNC 148
Query: 443 SRLRIIHRDLKTSNVLLD---AEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
               ++HRD+K  N+L+D    E+  K+ DFG   L + D    +     GT  Y  PE+
Sbjct: 149 G---VLHRDIKDENILIDLNRGEL--KLIDFGSGALLK-DTVYTDFD---GTRVYSPPEW 199
Query: 500 AMHGQYSVKS-DVFSFGVLVLEIISG 524
             + +Y  +S  V+S G+L+ +++ G
Sbjct: 200 IRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 26/216 (12%)
Query: 323 TDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSR-DSGQGDLEFKNEVLLVANLQHR 380
           + +F   + LG+G +G V         EI A+K++   D     L    E+ ++ + +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 381 NLVRLLGF----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGL 436
           N++ +       S E    + I + +  T L   I   + +   D   +Y I   + R +
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI---STQMLSDDHIQYFIYQTL-RAV 125
Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTS---------- 486
             LH  +   +IHRDLK SN+L+++    K+ DFG+AR+  +DE+  + S          
Sbjct: 126 KVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI--IDESAADNSEPTGQQSGMV 180
Query: 487 RIVGTYGYMAPEYAM-HGQYSVKSDVFSFGVLVLEI 521
             V T  Y APE  +   +YS   DV+S G ++ E+
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 332 LGQGGFGAVYKG-RLYDGAEIAVKRLSRD--SGQGDL----EFKNEVLLVANLQ--HRNL 382
           LG GGFG+VY G R+ D   +A+K + +D  S  G+L        EV+L+  +      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           +RLL +    +  +LI E  P    D F F  T R  L  E        +   + + H  
Sbjct: 92  IRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHN- 148
Query: 443 SRLRIIHRDLKTSNVLLD---AEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
               ++HRD+K  N+L+D    E+  K+ DFG   L + D    +     GT  Y  PE+
Sbjct: 149 --CGVLHRDIKDENILIDLNRGEL--KLIDFGSGALLK-DTVYTDFD---GTRVYSPPEW 200
Query: 500 AMHGQYSVKS-DVFSFGVLVLEIISG 524
             + +Y  +S  V+S G+L+ +++ G
Sbjct: 201 IRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 332 LGQGGFGAVYKG-RLYDGAEIAVKRLSRD--SGQGDL----EFKNEVLLVANLQ--HRNL 382
           LG GGFG+VY G R+ D   +A+K + +D  S  G+L        EV+L+  +      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           +RLL +    +  +LI E  P    D F F  T R  L  E        +   + + H  
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHNC 162
Query: 443 SRLRIIHRDLKTSNVLLD---AEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
               ++HRD+K  N+L+D    E+  K+ DFG   L + D    +     GT  Y  PE+
Sbjct: 163 G---VLHRDIKDENILIDLNRGEL--KLIDFGSGALLK-DTVYTDFD---GTRVYSPPEW 213
Query: 500 AMHGQYSVKS-DVFSFGVLVLEIISG 524
             + +Y  +S  V+S G+L+ +++ G
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 332 LGQGGFGAVYKG-RLYDGAEIAVKRLSRD--SGQGDL----EFKNEVLLVANLQ--HRNL 382
           LG GGFG+VY G R+ D   +A+K + +D  S  G+L        EV+L+  +      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           +RLL +    +  +LI E  P    D F F  T R  L  E        +   + + H  
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHNC 161
Query: 443 SRLRIIHRDLKTSNVLLD---AEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
               ++HRD+K  N+L+D    E+  K+ DFG   L + D    +     GT  Y  PE+
Sbjct: 162 G---VLHRDIKDENILIDLNRGEL--KLIDFGSGALLK-DTVYTDFD---GTRVYSPPEW 212
Query: 500 AMHGQYSVKS-DVFSFGVLVLEIISG 524
             + +Y  +S  V+S G+L+ +++ G
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 332 LGQGGFGAVYKG-RLYDGAEIAVKRLSRD--SGQGDL----EFKNEVLLVANLQ--HRNL 382
           LG GGFG+VY G R+ D   +A+K + +D  S  G+L        EV+L+  +      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           +RLL +    +  +LI E  P    D F F  T R  L  E        +   + + H  
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHNC 162
Query: 443 SRLRIIHRDLKTSNVLLD---AEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
               ++HRD+K  N+L+D    E+  K+ DFG   L + D    +     GT  Y  PE+
Sbjct: 163 G---VLHRDIKDENILIDLNRGEL--KLIDFGSGALLK-DTVYTDFD---GTRVYSPPEW 213
Query: 500 AMHGQYSVKS-DVFSFGVLVLEIISG 524
             + +Y  +S  V+S G+L+ +++ G
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 332 LGQGGFGAVYKG-RLYDGAEIAVKRLSRD--SGQGDL----EFKNEVLLVANLQ--HRNL 382
           LG GGFG+VY G R+ D   +A+K + +D  S  G+L        EV+L+  +      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           +RLL +    +  +LI E  P    D F F  T R  L  E        +   + + H  
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHNC 162
Query: 443 SRLRIIHRDLKTSNVLLD---AEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
               ++HRD+K  N+L+D    E+  K+ DFG   L + D    +     GT  Y  PE+
Sbjct: 163 G---VLHRDIKDENILIDLNRGEL--KLIDFGSGALLK-DTVYTDFD---GTRVYSPPEW 213
Query: 500 AMHGQYSVKS-DVFSFGVLVLEIISG 524
             + +Y  +S  V+S G+L+ +++ G
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 332 LGQGGFGAVYKG-RLYDGAEIAVKRLSRD--SGQGDL----EFKNEVLLVANLQ--HRNL 382
           LG GGFG+VY G R+ D   +A+K + +D  S  G+L        EV+L+  +      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           +RLL +    +  +LI E  P    D F F  T R  L  E        +   + + H  
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHNC 161
Query: 443 SRLRIIHRDLKTSNVLLD---AEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
               ++HRD+K  N+L+D    E+  K+ DFG   L + D    +     GT  Y  PE+
Sbjct: 162 G---VLHRDIKDENILIDLNRGEL--KLIDFGSGALLK-DTVYTDFD---GTRVYSPPEW 212
Query: 500 AMHGQYSVKS-DVFSFGVLVLEIISG 524
             + +Y  +S  V+S G+L+ +++ G
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 332 LGQGGFGAVYKG-RLYDGAEIAVKRLSRD--SGQGDL----EFKNEVLLVANLQ--HRNL 382
           LG GGFG+VY G R+ D   +A+K + +D  S  G+L        EV+L+  +      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           +RLL +    +  +LI E  P    D F F  T R  L  E        +   + + H  
Sbjct: 92  IRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHN- 148
Query: 443 SRLRIIHRDLKTSNVLLD---AEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
               ++HRD+K  N+L+D    E+  K+ DFG   L + D    +     GT  Y  PE+
Sbjct: 149 --CGVLHRDIKDENILIDLNRGEL--KLIDFGSGALLK-DTVYTDFD---GTRVYSPPEW 200
Query: 500 AMHGQYSVKS-DVFSFGVLVLEIISG 524
             + +Y  +S  V+S G+L+ +++ G
Sbjct: 201 IRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 66/252 (26%), Positives = 111/252 (44%), Gaps = 21/252 (8%)
Query: 298 SEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRL 356
           S AA    + +A S    F+      D +     +G G +G V   R    G ++A+K++
Sbjct: 32  SVAAKNLALLKARSFDVTFDV----GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKI 87
Query: 357 SR--DSGQGDLEFKNEVLLVANLQHRNLVRL---LGFSLEGNERLLIYEFVPNTSLD-HF 410
               D          E+ ++ + +H N++ +   L  ++   E   +Y  +     D H 
Sbjct: 88  PNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQ 147
Query: 411 IFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADF 470
           I   ++   L+  R +  +  + RGL Y+H     ++IHRDLK SN+L++     KI DF
Sbjct: 148 IIHSSQPLTLEHVRYF--LYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDF 202
Query: 471 GMARLF--EMDETQGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRN 527
           GMAR       E Q   +  V T  Y APE  +   +Y+   D++S G +  E+++  R 
Sbjct: 203 GMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA--RR 260
Query: 528 NCFRNGETVEDL 539
             F     V  L
Sbjct: 261 QLFPGKNYVHQL 272

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 332 LGQGGFGAVYKG-RLYDGAEIAVKRLSRD--SGQGDL----EFKNEVLLVANLQ--HRNL 382
           LG GGFG+VY G R+ D   +A+K + +D  S  G+L        EV+L+  +      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           +RLL +    +  +LI E  P    D F F  T R  L  E        +   + + H  
Sbjct: 72  IRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHNX 129
Query: 443 SRLRIIHRDLKTSNVLLDAEMTP-KIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM 501
               ++HRD+K  N+L+D      K+ DFG   L + D    +     GT  Y  PE+  
Sbjct: 130 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSPPEWIR 182
Query: 502 HGQYSVKS-DVFSFGVLVLEIISG 524
           + +Y  +S  V+S G+L+ +++ G
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 332 LGQGGFGAVYKG-RLYDGAEIAVKRLSRD--SGQGDL----EFKNEVLLVANLQ--HRNL 382
           LG GGFG+VY G R+ D   +A+K + +D  S  G+L        EV+L+  +      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           +RLL +    +  +LI E  P    D F F  T R  L  E        +   + + H  
Sbjct: 119 IRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHNC 176
Query: 443 SRLRIIHRDLKTSNVLLD---AEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
               ++HRD+K  N+L+D    E+  K+ DFG   L + D    +     GT  Y  PE+
Sbjct: 177 G---VLHRDIKDENILIDLNRGEL--KLIDFGSGALLK-DTVYTDFD---GTRVYSPPEW 227
Query: 500 AMHGQYSVKS-DVFSFGVLVLEIISG 524
             + +Y  +S  V+S G+L+ +++ G
Sbjct: 228 IRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 332 LGQGGFGAVYKG-RLYDGAEIAVKRLSRD--SGQGDL----EFKNEVLLVANLQ--HRNL 382
           LG GGFG+VY G R+ D   +A+K + +D  S  G+L        EV+L+  +      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           +RLL +    +  +LI E  P    D F F  T R  L  E        +   + + H  
Sbjct: 119 IRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHNC 176
Query: 443 SRLRIIHRDLKTSNVLLDAEMTP-KIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM 501
               ++HRD+K  N+L+D      K+ DFG   L + D    +     GT  Y  PE+  
Sbjct: 177 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSPPEWIR 229
Query: 502 HGQYSVKS-DVFSFGVLVLEIISG 524
           + +Y  +S  V+S G+L+ +++ G
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 332 LGQGGFGAVYKG-RLYDGAEIAVKRLSRD--SGQGDL----EFKNEVLLVANLQ--HRNL 382
           LG GGFG+VY G R+ D   +A+K + +D  S  G+L        EV+L+  +      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           +RLL +    +  +LI E  P    D F F  T R  L  E        +   + + H  
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHNC 161
Query: 443 SRLRIIHRDLKTSNVLLD---AEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
               ++HRD+K  N+L+D    E+  K+ DFG   L + D    +     GT  Y  PE+
Sbjct: 162 G---VLHRDIKDENILIDLNRGEL--KLIDFGSGALLK-DTVYTDFD---GTRVYSPPEW 212
Query: 500 AMHGQYSVKS-DVFSFGVLVLEIISG 524
             + +Y  +S  V+S G+L+ +++ G
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 332 LGQGGFGAVYKG-RLYDGAEIAVKRLSRD--SGQGDL----EFKNEVLLVANLQ--HRNL 382
           LG GGFG+VY G R+ D   +A+K + +D  S  G+L        EV+L+  +      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           +RLL +    +  +LI E  P    D F F  T R  L  E        +   + + H  
Sbjct: 92  IRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHNC 149
Query: 443 SRLRIIHRDLKTSNVLLD---AEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
               ++HRD+K  N+L+D    E+  K+ DFG   L + D    +     GT  Y  PE+
Sbjct: 150 G---VLHRDIKDENILIDLNRGEL--KLIDFGSGALLK-DTVYTDFD---GTRVYSPPEW 200
Query: 500 AMHGQYSVKS-DVFSFGVLVLEIISG 524
             + +Y  +S  V+S G+L+ +++ G
Sbjct: 201 IRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   +  + G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 97
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+V    +    F   RR     E   +     I  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   ++ DFG A+       +G T  + GT  Y
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ ++ +G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   +  + G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 97
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+V    +    F   RR     E   +     I  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+++D +   ++ DFG A+       +G T  + GT  Y
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 205 LAPEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 332 LGQGGFGAVYKG-RLYDGAEIAVKRLSRD--SGQGDL----EFKNEVLLVANLQ--HRNL 382
           LG GGFG+VY G R+ D   +A+K + +D  S  G+L        EV+L+  +      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           +RLL +    +  +LI E  P    D F F  T R  L  E        +   + + H  
Sbjct: 76  IRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHNC 133
Query: 443 SRLRIIHRDLKTSNVLLDAEMTP-KIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM 501
               ++HRD+K  N+L+D      K+ DFG   L + D    +     GT  Y  PE+  
Sbjct: 134 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSPPEWIR 186
Query: 502 HGQYSVKS-DVFSFGVLVLEIISG 524
           + +Y  +S  V+S G+L+ +++ G
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 332 LGQGGFGAVYKG-RLYDGAEIAVKRLSRD--SGQGDL----EFKNEVLLVANLQ--HRNL 382
           LG GGFG+VY G R+ D   +A+K + +D  S  G+L        EV+L+  +      +
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 123
Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           +RLL +    +  +LI E  P    D F F  T R  L  E        +   + + H  
Sbjct: 124 IRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHNC 181
Query: 443 SRLRIIHRDLKTSNVLLD---AEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
               ++HRD+K  N+L+D    E+  K+ DFG   L + D    +     GT  Y  PE+
Sbjct: 182 G---VLHRDIKDENILIDLNRGEL--KLIDFGSGALLK-DTVYTDFD---GTRVYSPPEW 232
Query: 500 AMHGQYSVKS-DVFSFGVLVLEIISG 524
             + +Y  +S  V+S G+L+ +++ G
Sbjct: 233 IRYHRYHGRSAAVWSLGILLYDMVCG 258

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 332 LGQGGFGAVYKG-RLYDGAEIAVKRLSRD--SGQGDL----EFKNEVLLVANLQ--HRNL 382
           LG GGFG+VY G R+ D   +A+K + +D  S  G+L        EV+L+  +      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           +RLL +    +  +LI E  P    D F F  T R  L  E        +   + + H  
Sbjct: 111 IRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHNC 168
Query: 443 SRLRIIHRDLKTSNVLLD---AEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
               ++HRD+K  N+L+D    E+  K+ DFG   L + D    +     GT  Y  PE+
Sbjct: 169 G---VLHRDIKDENILIDLNRGEL--KLIDFGSGALLK-DTVYTDFD---GTRVYSPPEW 219
Query: 500 AMHGQYSVKS-DVFSFGVLVLEIISG 524
             + +Y  +S  V+S G+L+ +++ G
Sbjct: 220 IRYHRYHGRSAAVWSLGILLYDMVCG 245

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 22/205 (10%)
Query: 332 LGQGGFGAVYKG-RLYDGAEIAVKRLSRD--SGQGDL----EFKNEVLLVANLQ--HRNL 382
           LG GGFG+VY G R+ D   +A+K + +D  S  G+L        EV+L+  +      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 383 VRLLGFSLEGNERLLIYEFV-PNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           +RLL +    +  +LI E + P   L  FI   T R  L  E        +   + + H 
Sbjct: 76  IRLLDWFERPDSFVLILERMEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCHN 132
Query: 442 DSRLRIIHRDLKTSNVLLDAEMTP-KIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA 500
                ++HRD+K  N+L+D      K+ DFG   L + D    +     GT  Y  PE+ 
Sbjct: 133 CG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSPPEWI 185
Query: 501 MHGQYSVKS-DVFSFGVLVLEIISG 524
            + +Y  +S  V+S G+L+ +++ G
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 332 LGQGGFGAVYKG-RLYDGAEIAVKRLSRD--SGQGDL----EFKNEVLLVANLQ--HRNL 382
           LG GGFG+VY G R+ D   +A+K + +D  S  G+L        EV+L+  +      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           +RLL +    +  +LI E  P    D F F  T R  L  E        +   + + H  
Sbjct: 77  IRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHNC 134
Query: 443 SRLRIIHRDLKTSNVLLDAEMTP-KIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM 501
               ++HRD+K  N+L+D      K+ DFG   L + D    +     GT  Y  PE+  
Sbjct: 135 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSPPEWIR 187
Query: 502 HGQYSVKS-DVFSFGVLVLEIISG 524
           + +Y  +S  V+S G+L+ +++ G
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 332 LGQGGFGAVYKG-RLYDGAEIAVKRLSRD--SGQGDL----EFKNEVLLVANLQ--HRNL 382
           LG GGFG+VY G R+ D   +A+K + +D  S  G+L        EV+L+  +      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           +RLL +    +  +LI E  P    D F F  T R  L  E        +   + + H  
Sbjct: 77  IRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCH-- 132
Query: 443 SRLRIIHRDLKTSNVLLDAEMTP-KIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM 501
               ++HRD+K  N+L+D      K+ DFG   L + D    +     GT  Y  PE+  
Sbjct: 133 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSPPEWIR 187
Query: 502 HGQYSVKS-DVFSFGVLVLEIISG 524
           + +Y  +S  V+S G+L+ +++ G
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 332 LGQGGFGAVYKG-RLYDGAEIAVKRLSRD--SGQGDL----EFKNEVLLVANLQ--HRNL 382
           LG GGFG+VY G R+ D   +A+K + +D  S  G+L        EV+L+  +      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           +RLL +    +  +LI E  P    D F F  T R  L  E        +   + + H  
Sbjct: 77  IRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHNC 134
Query: 443 SRLRIIHRDLKTSNVLLDAEMTP-KIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM 501
               ++HRD+K  N+L+D      K+ DFG   L + D    +     GT  Y  PE+  
Sbjct: 135 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSPPEWIR 187
Query: 502 HGQYSVKS-DVFSFGVLVLEIISG 524
           + +Y  +S  V+S G+L+ +++ G
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 85/163 (52%), Gaps = 16/163 (9%)
Query: 369 NEVLLVANLQHRNLVRLLGFSLEGNERLL--IYEFVPNTSLDHFIFDPTRRAQLDWERRY 426
            E+ ++  L H N+V+L+    + NE  L  ++E V    +      PT +   + + R+
Sbjct: 85  QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV---PTLKPLSEDQARF 141
Query: 427 KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE-MDETQGNT 485
                + +G+ YLH     +IIHRD+K SN+L+  +   KIADFG++  F+  D    NT
Sbjct: 142 -YFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNT 197
Query: 486 SRIVGTYGYMAPEYAMHGQ--YSVKS-DVFSFGVLVLEIISGQ 525
              VGT  +MAPE     +  +S K+ DV++ GV +   + GQ
Sbjct: 198 ---VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 332 LGQGGFGAVYKG-RLYDGAEIAVKRLSRD--SGQGDL----EFKNEVLLVANLQ--HRNL 382
           LG GGFG+VY G R+ D   +A+K + +D  S  G+L        EV+L+  +      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           +RLL +    +  +LI E  P    D F F  T R  L  E        +   + + H  
Sbjct: 72  IRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHNC 129
Query: 443 SRLRIIHRDLKTSNVLLDAEMTP-KIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM 501
               ++HRD+K  N+L+D      K+ DFG   L + D    +     GT  Y  PE+  
Sbjct: 130 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSPPEWIR 182
Query: 502 HGQYSVKS-DVFSFGVLVLEIISG 524
           + +Y  +S  V+S G+L+ +++ G
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 332 LGQGGFGAVYKG-RLYDGAEIAVKRLSRD--SGQGDL----EFKNEVLLVANLQ--HRNL 382
           LG GGFG+VY G R+ D   +A+K + +D  S  G+L        EV+L+  +      +
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 74
Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           +RLL +    +  +LI E  P    D F F  T R  L  E        +   + + H  
Sbjct: 75  IRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHNC 132
Query: 443 SRLRIIHRDLKTSNVLLDAEMTP-KIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM 501
               ++HRD+K  N+L+D      K+ DFG   L + D    +     GT  Y  PE+  
Sbjct: 133 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSPPEWIR 185
Query: 502 HGQYSVKS-DVFSFGVLVLEIISG 524
           + +Y  +S  V+S G+L+ +++ G
Sbjct: 186 YHRYHGRSAAVWSLGILLYDMVCG 209

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 18/205 (8%)
Query: 326 FSDANKLGQGGFGAVYKGRLYDGAEI--AVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
           ++  N +G+G +G V K  +  G  I  A K++ +   +    FK E+ ++ +L H N++
Sbjct: 11  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 384 RLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS 443
           RL     +  +  L+ E      L   +       + D  R   I+  +   + Y H   
Sbjct: 70  RLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR---IMKDVLSAVAYCH--- 123
Query: 444 RLRIIHRDLKTSNVLL--DAEMTP-KIADFGMARLFEMDETQGNTSRI-VGTYGYMAPEY 499
           +L + HRDLK  N L   D+  +P K+ DFG+A  F+     G   R  VGT  Y++P+ 
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK----PGKMMRTKVGTPYYVSPQ- 178
Query: 500 AMHGQYSVKSDVFSFGVLVLEIISG 524
            + G Y  + D +S GV++  ++ G
Sbjct: 179 VLEGLYGPECDEWSAGVMMYVLLCG 203

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 332 LGQGGFGAVYKG-RLYDGAEIAVKRLSRD--SGQGDL----EFKNEVLLVANLQ--HRNL 382
           LG GGFG+VY G R+ D   +A+K + +D  S  G+L        EV+L+  +      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           +RLL +    +  +LI E  P    D F F  T R  L  E        +   + + H  
Sbjct: 72  IRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHNC 129
Query: 443 SRLRIIHRDLKTSNVLLDAEMTP-KIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM 501
               ++HRD+K  N+L+D      K+ DFG   L + D    +     GT  Y  PE+  
Sbjct: 130 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSPPEWIR 182
Query: 502 HGQYSVKS-DVFSFGVLVLEIISG 524
           + +Y  +S  V+S G+L+ +++ G
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 111/243 (45%), Gaps = 15/243 (6%)
Query: 292 DNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEI 351
           +NS ++ E    + +  A+        +R+  ++F     +G+G FG V   +L +  ++
Sbjct: 42  NNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKV 101
Query: 352 -AVKRLSRDSGQGDLE---FKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSL 407
            A+K L++       E   F+ E  ++ N   + +  L     + N   L+ ++     L
Sbjct: 102 FAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDL 161
Query: 408 DHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKI 467
              +     R   +  R Y     +A  ++ +    +L  +HRD+K  N+L+D     ++
Sbjct: 162 LTLLSKFEDRLPEEMARFY-----LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRL 216
Query: 468 ADFGMARLFEMDETQGNTSRIVGTYGYMAPEY--AMH---GQYSVKSDVFSFGVLVLEII 522
           ADFG   L  M++    +S  VGT  Y++PE   AM    G+Y  + D +S GV + E++
Sbjct: 217 ADFGSC-LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEML 275
Query: 523 SGQ 525
            G+
Sbjct: 276 YGE 278

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 332 LGQGGFGAVYKG-RLYDGAEIAVKRLSRD--SGQGDL----EFKNEVLLVANLQ--HRNL 382
           LG GGFG+VY G R+ D   +A+K + +D  S  G+L        EV+L+  +      +
Sbjct: 39  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 98
Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           +RLL +    +  +LI E  P    D F F  T R  L  E        +   + + H  
Sbjct: 99  IRLLDWFERPDSFVLILE-RPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHNC 156
Query: 443 SRLRIIHRDLKTSNVLLD---AEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
               ++HRD+K  N+L+D    E+  K+ DFG   L + D    +     GT  Y  PE+
Sbjct: 157 G---VLHRDIKDENILIDLNRGEL--KLIDFGSGALLK-DTVYTDFD---GTRVYSPPEW 207
Query: 500 AMHGQYSVKS-DVFSFGVLVLEIISG 524
             + +Y  +S  V+S G+L+ +++ G
Sbjct: 208 IRYHRYHGRSAAVWSLGILLYDMVCG 233

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 25/217 (11%)
Query: 320 RVATDNFSDANKLGQGGFGAVY------KGRLYDGAEIAVKRLSRDSGQGDLEFKN---E 370
           RV  + F     LG+G FG V        GR Y     A+K L ++      E  +   E
Sbjct: 5   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYY-----AMKILKKEVIVAKDEVAHTLTE 59
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKII 429
             ++ N +H  L   L +S + ++RL  + E+     L    F    R ++  E R +  
Sbjct: 60  NRVLQNSRHPFLT-ALKYSFQTHDRLCFVMEYANGGEL----FFHLSRERVFSEDRARFY 114
Query: 430 GG-IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
           G  I   L YLH  S   +++RDLK  N++LD +   KI DFG+ +  E  +        
Sbjct: 115 GAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXF 170
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
            GT  Y+APE      Y    D +  GV++ E++ G+
Sbjct: 171 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 25/217 (11%)
Query: 320 RVATDNFSDANKLGQGGFGAVY------KGRLYDGAEIAVKRLSRDSGQGDLEFKN---E 370
           RV  + F     LG+G FG V        GR Y     A+K L ++      E  +   E
Sbjct: 6   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYY-----AMKILKKEVIVAKDEVAHTLTE 60
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKII 429
             ++ N +H  L   L +S + ++RL  + E+     L    F    R ++  E R +  
Sbjct: 61  NRVLQNSRHPFLT-ALKYSFQTHDRLCFVMEYANGGEL----FFHLSRERVFSEDRARFY 115
Query: 430 GG-IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
           G  I   L YLH  S   +++RDLK  N++LD +   KI DFG+ +  E  +        
Sbjct: 116 GAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXF 171
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
            GT  Y+APE      Y    D +  GV++ E++ G+
Sbjct: 172 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 25/217 (11%)
Query: 320 RVATDNFSDANKLGQGGFGAVY------KGRLYDGAEIAVKRLSRDSGQGDLEFKN---E 370
           RV  + F     LG+G FG V        GR Y     A+K L ++      E  +   E
Sbjct: 4   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYY-----AMKILKKEVIVAKDEVAHTLTE 58
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKII 429
             ++ N +H  L   L +S + ++RL  + E+     L    F    R ++  E R +  
Sbjct: 59  NRVLQNSRHPFLT-ALKYSFQTHDRLCFVMEYANGGEL----FFHLSRERVFSEDRARFY 113
Query: 430 GG-IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
           G  I   L YLH  S   +++RDLK  N++LD +   KI DFG+ +  E  +        
Sbjct: 114 GAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXF 169
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
            GT  Y+APE      Y    D +  GV++ E++ G+
Sbjct: 170 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 25/217 (11%)
Query: 320 RVATDNFSDANKLGQGGFGAVY------KGRLYDGAEIAVKRLSRDSGQGDLEFKN---E 370
           RV  + F     LG+G FG V        GR Y     A+K L ++      E  +   E
Sbjct: 147 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYY-----AMKILKKEVIVAKDEVAHTLTE 201
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKII 429
             ++ N +H  L   L +S + ++RL  + E+     L    F    R ++  E R +  
Sbjct: 202 NRVLQNSRHPFLT-ALKYSFQTHDRLCFVMEYANGGEL----FFHLSRERVFSEDRARFY 256
Query: 430 GG-IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
           G  I   L YLH  S   +++RDLK  N++LD +   KI DFG+ +  E  +        
Sbjct: 257 GAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTF 312
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
            GT  Y+APE      Y    D +  GV++ E++ G+
Sbjct: 313 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 25/217 (11%)
Query: 320 RVATDNFSDANKLGQGGFGAVY------KGRLYDGAEIAVKRLSRDSGQGDLEFKN---E 370
           RV  + F     LG+G FG V        GR Y     A+K L ++      E  +   E
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYY-----AMKILKKEVIVAKDEVAHTLTE 198
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKII 429
             ++ N +H  L   L +S + ++RL  + E+     L    F    R ++  E R +  
Sbjct: 199 NRVLQNSRHPFLT-ALKYSFQTHDRLCFVMEYANGGEL----FFHLSRERVFSEDRARFY 253
Query: 430 GG-IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
           G  I   L YLH  S   +++RDLK  N++LD +   KI DFG+ +  E  +        
Sbjct: 254 GAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTF 309
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
            GT  Y+APE      Y    D +  GV++ E++ G+
Sbjct: 310 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   +  + G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 97
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+V    +    F   RR     E   +     I  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   ++ DFG A+       +G T  + GT  Y
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +AP   +   Y+   D ++ GVL+ E+ +G
Sbjct: 205 LAPAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 106/227 (46%), Gaps = 23/227 (10%)
Query: 323 TDNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFKN--------EVLL 373
           +  +S  + LG G FG V+     +   E+ VK + ++    D   ++        E+ +
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 374 VANLQHRNLVRLLG-FSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGI 432
           ++ ++H N++++L  F  +G  +L++ +    + LD F F   R  +LD      I   +
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKH--GSGLDLFAFI-DRHPRLDEPLASYIFRQL 139
Query: 433 ARGLLYLHEDSRLR-IIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT 491
              + YL    RL+ IIHRD+K  N+++  + T K+ DFG A   E  +         GT
Sbjct: 140 VSAVGYL----RLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGT 192
Query: 492 YGYMAPEYAMHGQY-SVKSDVFSFGVLVLEIISGQRNNCFRNGETVE 537
             Y APE  M   Y   + +++S GV +  ++  +   C    ETVE
Sbjct: 193 IEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC-ELEETVE 238

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 15/152 (9%)
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           H N+++L           L+++ +    L  ++   T +  L  +   KI+  +   +  
Sbjct: 70  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALLEVICA 126
Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
           LH   +L I+HRDLK  N+LLD +M  K+ DFG +   +  E       + GT  Y+APE
Sbjct: 127 LH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPE 180
Query: 499 YAM------HGQYSVKSDVFSFGVLVLEIISG 524
                    H  Y  + D++S GV++  +++G
Sbjct: 181 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 50/105 (47%), Gaps = 13/105 (12%)
Query: 428 IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ----- 482
           I   IA  + +LH      ++HRDLK SN+    +   K+ DFG+    + DE +     
Sbjct: 169 IFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225
Query: 483 -----GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEII 522
                      VGT  YM+PE      YS K D+FS G+++ E++
Sbjct: 226 PMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 22/230 (9%)
Query: 306 INRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDS--GQ 362
           +NR E +      +++  +++     +G+G FG V   R     ++ A+K LS+     +
Sbjct: 57  LNRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKR 116
Query: 363 GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFI--FDPTRRAQ 419
            D  F  E   +    +   V  L  + + ++ L ++ E++P   L + +  +D   +  
Sbjct: 117 SDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK-- 174
Query: 420 LDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD 479
             W + Y      A  +L L     + +IHRD+K  N+LLD     K+ADFG     +MD
Sbjct: 175 --WAKFY-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC--MKMD 225
Query: 480 ET-QGNTSRIVGTYGYMAPEY----AMHGQYSVKSDVFSFGVLVLEIISG 524
           ET   +    VGT  Y++PE        G Y  + D +S GV + E++ G
Sbjct: 226 ETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 15/152 (9%)
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           H N+++L           L+++ +    L  ++   T +  L  +   KI+  +   +  
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALLEVICA 139
Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
           LH   +L I+HRDLK  N+LLD +M  K+ DFG +   +  E       + GT  Y+APE
Sbjct: 140 LH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPE 193
Query: 499 YAM------HGQYSVKSDVFSFGVLVLEIISG 524
                    H  Y  + D++S GV++  +++G
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 25/210 (11%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFK------NEVLLVAN 376
           D F     LG G FG V   +  + G   A+K L +   Q  ++ K      NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQA 97
Query: 377 LQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IAR 434
           +    LV+L  FS + N  L ++ E+V    +    F   RR     E   +     I  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
              YLH    L +I+RDLK  N+L+D +   ++ DFG A+       +G T  + GT   
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEA 204
Query: 495 MAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           +APE  +   Y+   D ++ GVL+ E+ +G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 110/246 (44%), Gaps = 23/246 (9%)
Query: 310 ESLQFDFNTIRVATDNFSDANKLGQGGFGAV--YKGRLYDGAEIAVKRLSRDSGQGDLEF 367
           E+L F  + + +   ++    KLG+GGF  V   +G L+DG   A+KR+     Q   E 
Sbjct: 15  ENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEA 73
Query: 368 KNEVLLVANLQHRNLVRLLGFSLE----GNERLLIYEFVPNTSLDHFIFDPTRRAQ-LDW 422
           + E  +     H N++RL+ + L      +E  L+  F    +L + I     +   L  
Sbjct: 74  QREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTE 133
Query: 423 ERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFG---MARLFEMD 479
           ++   ++ GI RGL  +H        HRDLK +N+LL  E  P + D G    A +    
Sbjct: 134 DQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190
Query: 480 ETQGNTSRIVG----TYGYMAPEY---AMHGQYSVKSDVFSFGVLVLEIISGQ--RNNCF 530
             Q  T +       T  Y APE      H     ++DV+S G ++  ++ G+   +  F
Sbjct: 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF 250
Query: 531 RNGETV 536
           + G++V
Sbjct: 251 QKGDSV 256

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 29/213 (13%)
Query: 324 DNFSDANKLGQGGFGAVYK------GRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANL 377
           D +    +LG G FG V++      GR++       K ++          KNE+ ++  L
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKATGRVF-----VAKFINTPYPLDKYTVKNEISIMNQL 105
Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR--- 434
            H  L+ L     +  E +LI EF+    L    FD  R A  D++     +    R   
Sbjct: 106 HHPKLINLHDAFEDKYEMVLILEFLSGGEL----FD--RIAAEDYKMSEAEVINYMRQAC 159
Query: 435 -GLLYLHEDSRLRIIHRDLKTSNVLLDAEM--TPKIADFGMARLFEMDETQGNTSRIVGT 491
            GL ++HE S   I+H D+K  N++ + +   + KI DFG+A     DE    T+    T
Sbjct: 160 EGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---AT 213
Query: 492 YGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
             + APE          +D+++ GVL   ++SG
Sbjct: 214 AEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 15/152 (9%)
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           H N+++L           L+++ +    L  ++   T +  L  +   KI+  +   +  
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALLEVICA 139
Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
           LH   +L I+HRDLK  N+LLD +M  K+ DFG +   +  E       + GT  Y+APE
Sbjct: 140 LH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLRSVCGTPSYLAPE 193
Query: 499 YAM------HGQYSVKSDVFSFGVLVLEIISG 524
                    H  Y  + D++S GV++  +++G
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 332 LGQGGFGAVYKG-RLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQ-HRNLVRLLGFS 389
           LG+G +  V     L +G E AVK + + +G        EV  +   Q ++N++ L+ F 
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFF 80
Query: 390 LEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIH 449
            +     L++E +   S+   I    ++   +     +++  +A  L +LH      I H
Sbjct: 81  EDDTRFYLVFEKLQGGSILAHI---QKQKHFNEREASRVVRDVAAALDFLHTKG---IAH 134
Query: 450 RDLKTSNVLLDA--EMTP-KIADFGMARLFEMDE-----TQGNTSRIVGTYGYMAPEYA- 500
           RDLK  N+L ++  +++P KI DF +    +++      T    +   G+  YMAPE   
Sbjct: 135 RDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVE 194
Query: 501 ----MHGQYSVKSDVFSFGVLVLEIISG 524
                   Y  + D++S GV++  ++SG
Sbjct: 195 VFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 109/238 (45%), Gaps = 25/238 (10%)
Query: 313 QFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGA--EIAVKRLSRDSGQGDLEFKNE 370
           Q   N+I+  TD +     +G G + +V K  ++     E AVK +  D  + D   + E
Sbjct: 12  QLHRNSIQF-TDGYEVKEDIGVGSY-SVCKRCIHKATNMEFAVKII--DKSKRDPTEEIE 67
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYK-II 429
           +LL    QH N++ L     +G    ++ E +    L     D   R +   ER    ++
Sbjct: 68  ILLRYG-QHPNIITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQKFFSEREASAVL 122
Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVL-LDAEMTP---KIADFGMARLFEMDETQGNT 485
             I + + YLH      ++HRDLK SN+L +D    P   +I DFG A+  ++    G  
Sbjct: 123 FTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK--QLRAENGLL 177
Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNG--ETVEDLLS 541
                T  ++APE      Y    D++S GVL+  +++G     F NG  +T E++L+
Sbjct: 178 MTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGY--TPFANGPDDTPEEILA 233

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/116 (29%), Positives = 59/116 (50%), Gaps = 12/116 (10%)
Query: 415 TRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR 474
           T +  L  +    I+  +   + +LH ++   I+HRDLK  N+LLD  M  +++DFG + 
Sbjct: 192 TEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSC 248
Query: 475 LFEMDETQGNTSRIVGTYGYMAPEY------AMHGQYSVKSDVFSFGVLVLEIISG 524
             E  E       + GT GY+APE         H  Y  + D+++ GV++  +++G
Sbjct: 249 HLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 126/293 (43%), Gaps = 46/293 (15%)
Query: 323 TDNFSDANKLGQGGFGAVYK--GRLYDGAEIAVKRLSRDSGQGDLEFKN---EVLLVANL 377
           T  F +  K+G G FG+V+K   RL DG   A+KR S+    G ++ +N   EV   A L
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVL 65
Query: 378 -QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYK-IIGGIARG 435
            QH ++VR      E +  L+  E+    SL   I +  R      E   K ++  + RG
Sbjct: 66  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 125
Query: 436 LLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIA-------DFGMARLFEMDETQGNTSRI 488
           L Y+H    + ++H D+K SN+ +     P  A       D+   ++       G+ +RI
Sbjct: 126 LRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 182
Query: 489 V------GTYGYMAPEYAMHGQYS--VKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
                  G   ++A E  +   Y+   K+D+F+  + V  + +       RNG+      
Sbjct: 183 SSPQVEEGDSRFLANE-VLQENYTHLPKADIFALALTV--VCAAGAEPLPRNGDQ----- 234
Query: 541 SSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVV 593
              W   R+G    I  P + S   TE+++ +      +  +   RP+  ++V
Sbjct: 235 ---WHEIRQGRLPRI--PQVLSQEFTELLKVM------IHPDPERRPSAMALV 276

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 104/250 (41%), Gaps = 30/250 (12%)
Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANL----Q 378
            +F   ++LG G +G V+K R   DG   AVKR S    +G  +   ++  V +     Q
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKDRARKLAEVGSHEKVGQ 115
Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           H   VRL     EG    L  E    +   H        A L   + +  +      L +
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELCGPSLQQHC---EAWGASLPEAQVWGYLRDTLLALAH 172
Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
           LH      ++H D+K +N+ L      K+ DFG+  L E+  T G      G   YMAPE
Sbjct: 173 LHSQG---LVHLDVKPANIFLGPRGRCKLGDFGL--LVELG-TAGAGEVQEGDPRYMAPE 226
Query: 499 YAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP 558
             + G Y   +DVFS G+ +LE+     N    +G          W+  R+G     + P
Sbjct: 227 L-LQGSYGTAADVFSLGLTILEVAC---NMELPHG-------GEGWQQLRQG----YLPP 271
Query: 559 TLSSGSITEM 568
             ++G  +E+
Sbjct: 272 EFTAGLSSEL 281

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 92/199 (46%), Gaps = 21/199 (10%)
Query: 350 EIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDH 409
           E AVK +  D  + D   + E+LL    QH N++ L     +G    L+ E +    L  
Sbjct: 54  EYAVKVI--DKSKRDPSEEIEILLRYG-QHPNIITLKDVYDDGKHVYLVTELMRGGEL-- 108
Query: 410 FIFDPTRRAQLDWERRYK-IIGGIARGLLYLHEDSRLRIIHRDLKTSNVL-LDAEMTP-- 465
              D   R +   ER    ++  I + + YLH      ++HRDLK SN+L +D    P  
Sbjct: 109 --LDKILRQKFFSEREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPEC 163
Query: 466 -KIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
            +I DFG A+  ++    G       T  ++APE      Y    D++S G+L+  +++G
Sbjct: 164 LRICDFGFAK--QLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221
Query: 525 QRNNCFRNG--ETVEDLLS 541
                F NG  +T E++L+
Sbjct: 222 Y--TPFANGPSDTPEEILT 238

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 125/292 (42%), Gaps = 44/292 (15%)
Query: 323 TDNFSDANKLGQGGFGAVYKG-RLYDGAEIAVKRLSRDSGQGDLEFKN---EVLLVANL- 377
           T  F +  K+G G FG+V+K  +  DG   A+KR S+    G ++ +N   EV   A L 
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLG 66
Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYK-IIGGIARGL 436
           QH ++VR      E +  L+  E+    SL   I +  R      E   K ++  + RGL
Sbjct: 67  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 126
Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIA-------DFGMARLFEMDETQGNTSRIV 489
            Y+H    + ++H D+K SN+ +     P  A       D+   ++       G+ +RI 
Sbjct: 127 RYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 183
Query: 490 ------GTYGYMAPEYAMHGQYS--VKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLS 541
                 G   ++A E  +   Y+   K+D+F+  + V  + +       RNG+       
Sbjct: 184 SPQVEEGDSRFLANE-VLQENYTHLPKADIFALALTV--VCAAGAEPLPRNGDQ------ 234
Query: 542 SAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVV 593
             W   R+G    I  P + S   TE+++ +      +  +   RP+  ++V
Sbjct: 235 --WHEIRQGRLPRI--PQVLSQEFTELLKVM------IHPDPERRPSAMALV 276

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 92/199 (46%), Gaps = 21/199 (10%)
Query: 350 EIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDH 409
           E AVK +  D  + D   + E+LL    QH N++ L     +G    L+ E +    L  
Sbjct: 54  EYAVKVI--DKSKRDPSEEIEILLRYG-QHPNIITLKDVYDDGKHVYLVTELMRGGEL-- 108
Query: 410 FIFDPTRRAQLDWERRYK-IIGGIARGLLYLHEDSRLRIIHRDLKTSNVL-LDAEMTP-- 465
              D   R +   ER    ++  I + + YLH      ++HRDLK SN+L +D    P  
Sbjct: 109 --LDKILRQKFFSEREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPEC 163
Query: 466 -KIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
            +I DFG A+  ++    G       T  ++APE      Y    D++S G+L+  +++G
Sbjct: 164 LRICDFGFAK--QLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221
Query: 525 QRNNCFRNG--ETVEDLLS 541
                F NG  +T E++L+
Sbjct: 222 Y--TPFANGPSDTPEEILT 238

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 75/173 (43%), Gaps = 14/173 (8%)
Query: 313 QFDF--NTIRVATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKN 369
           Q DF   T+ +          L +GGF  VY+ + +  G E A+KRL  +  + +     
Sbjct: 15  QSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQ 74
Query: 370 EVLLVANLQ-HRNLVRLLGFSLEGNER--------LLIYEFVPNTSLDHFIFDPTRRAQL 420
           EV  +  L  H N+V+    +  G E         LL+ E      L  F+     R  L
Sbjct: 75  EVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPL 133
Query: 421 DWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMA 473
             +   KI     R + ++H   +  IIHRDLK  N+LL  + T K+ DFG A
Sbjct: 134 SCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 126/293 (43%), Gaps = 46/293 (15%)
Query: 323 TDNFSDANKLGQGGFGAVYK--GRLYDGAEIAVKRLSRDSGQGDLEFKN---EVLLVANL 377
           T  F +  K+G G FG+V+K   RL DG   A+KR S+    G ++ +N   EV   A L
Sbjct: 6   TTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVL 63
Query: 378 -QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYK-IIGGIARG 435
            QH ++VR      E +  L+  E+    SL   I +  R      E   K ++  + RG
Sbjct: 64  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 123
Query: 436 LLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIA-------DFGMARLFEMDETQGNTSRI 488
           L Y+H    + ++H D+K SN+ +     P  A       D+   ++       G+ +RI
Sbjct: 124 LRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 180
Query: 489 V------GTYGYMAPEYAMHGQYS--VKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
                  G   ++A E  +   Y+   K+D+F+  + V  + +       RNG+      
Sbjct: 181 SSPQVEEGDSRFLANE-VLQENYTHLPKADIFALALTV--VXAAGAEPLPRNGDQ----- 232
Query: 541 SSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVV 593
              W   R+G    I  P + S   TE+++ +      +  +   RP+  ++V
Sbjct: 233 ---WHEIRQGRLPRI--PQVLSQEFTELLKVM------IHPDPERRPSAMALV 274

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 125/292 (42%), Gaps = 44/292 (15%)
Query: 323 TDNFSDANKLGQGGFGAVYKG-RLYDGAEIAVKRLSRDSGQGDLEFKN---EVLLVANL- 377
           T  F +  K+G G FG+V+K  +  DG   A+KR S+    G ++ +N   EV   A L 
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLG 68
Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYK-IIGGIARGL 436
           QH ++VR      E +  L+  E+    SL   I +  R      E   K ++  + RGL
Sbjct: 69  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIA-------DFGMARLFEMDETQGNTSRIV 489
            Y+H    + ++H D+K SN+ +     P  A       D+   ++       G+ +RI 
Sbjct: 129 RYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 490 ------GTYGYMAPEYAMHGQYS--VKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLS 541
                 G   ++A E  +   Y+   K+D+F+  + V  + +       RNG+       
Sbjct: 186 SPQVEEGDSRFLANE-VLQENYTHLPKADIFALALTV--VCAAGAEPLPRNGDQ------ 236
Query: 542 SAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVV 593
             W   R+G    I  P + S   TE+++ +      +  +   RP+  ++V
Sbjct: 237 --WHEIRQGRLPRI--PQVLSQEFTELLKVM------IHPDPERRPSAMALV 278

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 102/218 (46%), Gaps = 26/218 (11%)
Query: 326 FSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVR 384
           + D   LG GG G V+     D    +A+K++     Q       E+ ++  L H N+V+
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 385 L--------------LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIG 430
           +              +G   E N   ++ E++  T L + +     +  L  E     + 
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVL----EQGPLLEEHARLFMY 127
Query: 431 GIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE-MTPKIADFGMARLFEMDET-QGNTSRI 488
            + RGL Y+H  +   ++HRDLK +N+ ++ E +  KI DFG+AR+ +   + +G+ S  
Sbjct: 128 QLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 489 VGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQ 525
           + T  Y +P   +    Y+   D+++ G +  E+++G+
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 93/214 (43%), Gaps = 21/214 (9%)
Query: 324 DNFSDANKLGQGGFGAVYK------GRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANL 377
           D +     +G+G F  V +      G+ +    + V + +   G    + K E  +   L
Sbjct: 24  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           +H ++V LL          +++EF+    L    F+  +RA   +     +     R +L
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 438 ----YLHEDSRLRIIHRDLKTSNVLLDAE---MTPKIADFGMARLFEMDETQGNTSRIVG 490
               Y H+++   IIHRD+K   VLL ++      K+  FG+A   ++ E+       VG
Sbjct: 141 EALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA--IQLGESGLVAGGRVG 195
Query: 491 TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           T  +MAPE      Y    DV+  GV++  ++SG
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 93/214 (43%), Gaps = 21/214 (9%)
Query: 324 DNFSDANKLGQGGFGAVYK------GRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANL 377
           D +     +G+G F  V +      G+ +    + V + +   G    + K E  +   L
Sbjct: 26  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 85
Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
           +H ++V LL          +++EF+    L    F+  +RA   +     +     R +L
Sbjct: 86  KHPHIVELLETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQIL 142
Query: 438 ----YLHEDSRLRIIHRDLKTSNVLLDAE---MTPKIADFGMARLFEMDETQGNTSRIVG 490
               Y H+++   IIHRD+K   VLL ++      K+  FG+A   ++ E+       VG
Sbjct: 143 EALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA--IQLGESGLVAGGRVG 197
Query: 491 TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           T  +MAPE      Y    DV+  GV++  ++SG
Sbjct: 198 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 100/253 (39%), Gaps = 36/253 (14%)
Query: 295 KVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVK 354
           + K EAA  D I    ++Q  +   R           +  G +GAV  G   +G  +A+K
Sbjct: 3   QAKGEAAMRDLIAELHAMQSPYTVQRF----------ISSGSYGAVCAGVDSEGIPVAIK 52
Query: 355 RLSRDSGQGDL-----------EFKNEVLLVANLQHRNLVRL----LGFSLEGNERLLIY 399
           R+      G                 E+ L+ +  H N++ L    + F      +L + 
Sbjct: 53  RVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLV 112
Query: 400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLL 459
             +  T L   I D  +R  +  +     +  I  GL  LHE     ++HRDL   N+LL
Sbjct: 113 TELMRTDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL 167
Query: 460 DAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQ-YSVKSDVFSFGVLV 518
                  I DF +AR    D    N +  V    Y APE  M  + ++   D++S G ++
Sbjct: 168 ADNNDITICDFNLAR---EDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVM 224
Query: 519 LEIISGQRNNCFR 531
            E+ +  R   FR
Sbjct: 225 AEMFN--RKALFR 235

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 100/253 (39%), Gaps = 36/253 (14%)
Query: 295 KVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVK 354
           + K EAA  D I    ++Q  +   R           +  G +GAV  G   +G  +A+K
Sbjct: 3   QAKGEAAMRDLIAELHAMQSPYTVQRF----------ISSGSYGAVCAGVDSEGIPVAIK 52
Query: 355 RLSRDSGQGDL-----------EFKNEVLLVANLQHRNLVRL----LGFSLEGNERLLIY 399
           R+      G                 E+ L+ +  H N++ L    + F      +L + 
Sbjct: 53  RVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLV 112
Query: 400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLL 459
             +  T L   I D  +R  +  +     +  I  GL  LHE     ++HRDL   N+LL
Sbjct: 113 TELMRTDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL 167
Query: 460 DAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQ-YSVKSDVFSFGVLV 518
                  I DF +AR    D    N +  V    Y APE  M  + ++   D++S G ++
Sbjct: 168 ADNNDITICDFNLAR---EDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVM 224
Query: 519 LEIISGQRNNCFR 531
            E+ +  R   FR
Sbjct: 225 AEMFN--RKALFR 235

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 26/217 (11%)
Query: 320 RVATDNFSDANKLGQGGFGAVY------KGRLYDGAEIAVKRLSRDSGQGDLEFKNEVL- 372
           +V  ++F     LG+G FG V        GR Y     A+K L ++      E  + V  
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYY-----AMKILRKEVIIAKDEVAHTVTE 55
Query: 373 --LVANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKII 429
             ++ N +H  L   L ++ + ++RL  + E+     L    F    R ++  E R +  
Sbjct: 56  SRVLQNTRHPFLT-ALKYAFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFY 110
Query: 430 GG-IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
           G  I   L YLH      +++RD+K  N++LD +   KI DFG+ +  E           
Sbjct: 111 GAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTF 165
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
            GT  Y+APE      Y    D +  GV++ E++ G+
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 26/217 (11%)
Query: 320 RVATDNFSDANKLGQGGFGAVY------KGRLYDGAEIAVKRLSRDSGQGDLEFKNEVL- 372
           +V  ++F     LG+G FG V        GR Y     A+K L ++      E  + V  
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYY-----AMKILRKEVIIAKDEVAHTVTE 55
Query: 373 --LVANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKII 429
             ++ N +H  L   L ++ + ++RL  + E+     L    F    R ++  E R +  
Sbjct: 56  SRVLQNTRHPFLT-ALKYAFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFY 110
Query: 430 GG-IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
           G  I   L YLH      +++RD+K  N++LD +   KI DFG+ +  E           
Sbjct: 111 GAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTF 165
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
            GT  Y+APE      Y    D +  GV++ E++ G+
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 107/238 (44%), Gaps = 25/238 (10%)
Query: 313 QFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGA--EIAVKRLSRDSGQGDLEFKNE 370
           Q   N+I+  TD +     +G G + +V K  ++     E AVK +  D  + D   + E
Sbjct: 12  QLHRNSIQF-TDGYEVKEDIGVGSY-SVCKRCIHKATNXEFAVKII--DKSKRDPTEEIE 67
Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYK-II 429
           +LL    QH N++ L     +G    ++ E      L     D   R +   ER    ++
Sbjct: 68  ILLRYG-QHPNIITLKDVYDDGKYVYVVTELXKGGEL----LDKILRQKFFSEREASAVL 122
Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVL-LDAEMTP---KIADFGMARLFEMDETQGNT 485
             I + + YLH      ++HRDLK SN+L +D    P   +I DFG A+  ++    G  
Sbjct: 123 FTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK--QLRAENGLL 177
Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNG--ETVEDLLS 541
                T  ++APE      Y    D++S GVL+   ++G     F NG  +T E++L+
Sbjct: 178 XTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGY--TPFANGPDDTPEEILA 233

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 26/217 (11%)
Query: 320 RVATDNFSDANKLGQGGFGAVY------KGRLYDGAEIAVKRLSRDSGQGDLEFKNEVL- 372
           +V  ++F     LG+G FG V        GR Y     A+K L ++      E  + V  
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYY-----AMKILRKEVIIAKDEVAHTVTE 55
Query: 373 --LVANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKII 429
             ++ N +H  L   L ++ + ++RL  + E+     L    F    R ++  E R +  
Sbjct: 56  SRVLQNTRHPFLT-ALKYAFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFY 110
Query: 430 GG-IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
           G  I   L YLH      +++RD+K  N++LD +   KI DFG+ +  E           
Sbjct: 111 GAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXF 165
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
            GT  Y+APE      Y    D +  GV++ E++ G+
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 26/217 (11%)
Query: 320 RVATDNFSDANKLGQGGFGAVY------KGRLYDGAEIAVKRLSRDSGQGDLEFKNEVL- 372
           +V  ++F     LG+G FG V        GR Y     A+K L ++      E  + V  
Sbjct: 4   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYY-----AMKILRKEVIIAKDEVAHTVTE 58
Query: 373 --LVANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKII 429
             ++ N +H  L   L ++ + ++RL  + E+     L    F    R ++  E R +  
Sbjct: 59  SRVLQNTRHPFLT-ALKYAFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFY 113
Query: 430 GG-IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
           G  I   L YLH      +++RD+K  N++LD +   KI DFG+ +  E           
Sbjct: 114 GAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTF 168
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
            GT  Y+APE      Y    D +  GV++ E++ G+
Sbjct: 169 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 26/217 (11%)
Query: 320 RVATDNFSDANKLGQGGFGAVY------KGRLYDGAEIAVKRLSRDSGQGDLEFKNEVL- 372
           +V  ++F     LG+G FG V        GR Y     A+K L ++      E  + V  
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYY-----AMKILRKEVIIAKDEVAHTVTE 55
Query: 373 --LVANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKII 429
             ++ N +H  L   L ++ + ++RL  + E+     L    F    R ++  E R +  
Sbjct: 56  SRVLQNTRHPFLT-ALKYAFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFY 110
Query: 430 GG-IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
           G  I   L YLH      +++RD+K  N++LD +   KI DFG+ +  E           
Sbjct: 111 GAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXF 165
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
            GT  Y+APE      Y    D +  GV++ E++ G+
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 26/217 (11%)
Query: 320 RVATDNFSDANKLGQGGFGAVY------KGRLYDGAEIAVKRLSRDSGQGDLEFKNEVL- 372
           +V  ++F     LG+G FG V        GR Y     A+K L ++      E  + V  
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYY-----AMKILRKEVIIAKDEVAHTVTE 55
Query: 373 --LVANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKII 429
             ++ N +H  L   L ++ + ++RL  + E+     L    F    R ++  E R +  
Sbjct: 56  SRVLQNTRHPFLT-ALKYAFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFY 110
Query: 430 GG-IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
           G  I   L YLH      +++RD+K  N++LD +   KI DFG+ +  E           
Sbjct: 111 GAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXF 165
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
            GT  Y+APE      Y    D +  GV++ E++ G+
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 26/217 (11%)
Query: 320 RVATDNFSDANKLGQGGFGAVY------KGRLYDGAEIAVKRLSRDSGQGDLEFKNEVL- 372
           +V  ++F     LG+G FG V        GR Y     A+K L ++      E  + V  
Sbjct: 6   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYY-----AMKILRKEVIIAKDEVAHTVTE 60
Query: 373 --LVANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKII 429
             ++ N +H  L   L ++ + ++RL  + E+     L    F    R ++  E R +  
Sbjct: 61  SRVLQNTRHPFLT-ALKYAFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFY 115
Query: 430 GG-IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
           G  I   L YLH      +++RD+K  N++LD +   KI DFG+ +  E           
Sbjct: 116 GAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXF 170
Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
            GT  Y+APE      Y    D +  GV++ E++ G+
Sbjct: 171 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 101/230 (43%), Gaps = 45/230 (19%)
Query: 317 NTIRVATDNFSDANKLGQGGFGA-VYKGRLYDGAEIAVKRLSRDSGQ-GDLEFKNEVLLV 374
           + + V   +F   + LG G  G  VY+G ++D  ++AVKR+  +     D E +   LL 
Sbjct: 17  SVVIVGKISFCPKDVLGHGAEGTIVYRG-MFDNRDVAVKRILPECFSFADREVQ---LLR 72
Query: 375 ANLQHRNLVRLLGFSLEGNERL----------LIYEFVPNTSLDHFIFDPTRRAQLDWER 424
            + +H N++R   F  E + +            + E+V      H   +P          
Sbjct: 73  ESDEHPNVIRY--FCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPI--------- 121
Query: 425 RYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLL-----DAEMTPKIADFGMARLFEMD 479
              ++     GL +LH    L I+HRDLK  N+L+       ++   I+DFG+ +   + 
Sbjct: 122 --TLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176
Query: 480 -ETQGNTSRIVGTYGYMAPEY-----AMHGQYSVKSDVFSFGVLVLEIIS 523
             +    S + GT G++APE        +  Y+V  D+FS G +   +IS
Sbjct: 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTV--DIFSAGCVFYYVIS 224

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 15/216 (6%)
Query: 319 IRVATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQGDLE---FKNEVLLV 374
           +++  ++F     +G+G FG V   ++ +   I A+K L++       E   F+ E  ++
Sbjct: 85  MQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVL 144
Query: 375 ANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
            N   + +  L     + N   L+ ++     L   +     +   D  R Y  IG +  
Sbjct: 145 VNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFY--IGEMVL 202
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
            +  +H+   L  +HRD+K  NVLLD     ++ADFG   L   D+    +S  VGT  Y
Sbjct: 203 AIDSIHQ---LHYVHRDIKPDNVLLDVNGHIRLADFGSC-LKMNDDGTVQSSVAVGTPDY 258
Query: 495 MAPEY--AMH---GQYSVKSDVFSFGVLVLEIISGQ 525
           ++PE   AM    G+Y  + D +S GV + E++ G+
Sbjct: 259 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 294

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 15/216 (6%)
Query: 319 IRVATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQGDLE---FKNEVLLV 374
           +++  ++F     +G+G FG V   ++ +   I A+K L++       E   F+ E  ++
Sbjct: 69  MQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVL 128
Query: 375 ANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
            N   + +  L     + N   L+ ++     L   +     +   D  R Y  IG +  
Sbjct: 129 VNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFY--IGEMVL 186
Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
            +  +H+   L  +HRD+K  NVLLD     ++ADFG   L   D+    +S  VGT  Y
Sbjct: 187 AIDSIHQ---LHYVHRDIKPDNVLLDVNGHIRLADFGSC-LKMNDDGTVQSSVAVGTPDY 242
Query: 495 MAPEY--AMH---GQYSVKSDVFSFGVLVLEIISGQ 525
           ++PE   AM    G+Y  + D +S GV + E++ G+
Sbjct: 243 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 278

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 58/105 (55%), Gaps = 19/105 (18%)
Query: 427 KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP----KIADFGMARLF----EM 478
           ++I  I  G+ YLH+++   I+H DLK  N+LL + + P    KI DFGM+R      E+
Sbjct: 135 RLIKQILEGVYYLHQNN---IVHLDLKPQNILLSS-IYPLGDIKIVDFGMSRKIGHACEL 190
Query: 479 DETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
            E       I+GT  Y+APE   +   +  +D+++ G++   +++
Sbjct: 191 RE-------IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLT 228

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 20/216 (9%)
Query: 319 IRVATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDS--GQGDLEFKNEVLLVA 375
           +R+  +++     +G+G FG V   R     ++ A+K LS+     + D  F  E   + 
Sbjct: 64  LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM 123
Query: 376 NLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFI--FDPTRRAQLDWERRYKIIGGI 432
              +   V  L ++ + +  L ++ E++P   L + +  +D   +    W R Y      
Sbjct: 124 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFY-----T 174
Query: 433 ARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY 492
           A  +L L     +  IHRD+K  N+LLD     K+ADFG        E        VGT 
Sbjct: 175 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK-EGMVRCDTAVGTP 233
Query: 493 GYMAPEYAM----HGQYSVKSDVFSFGVLVLEIISG 524
            Y++PE        G Y  + D +S GV + E++ G
Sbjct: 234 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 102/230 (44%), Gaps = 36/230 (15%)
Query: 322 ATDNFS---------DANKLGQGGFGAVYKG-RLYDGAEIAVKRLSRDSGQGDLEFKNEV 371
           +TD+FS           + LG+G    V     L    E AVK + +  G        EV
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 372 LLVANLQ-HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIG 430
            ++   Q HRN++ L+ F  E +   L++E +   S+   I    +R   +      ++ 
Sbjct: 62  EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIH---KRRHFNELEASVVVQ 118
Query: 431 GIARGLLYLHEDSRLRIIHRDLKTSNVLLDA--EMTP-KIADFGMARLFEMDETQGNTSR 487
            +A  L +LH      I HRDLK  N+L +   +++P KI DFG+    +++   G+ S 
Sbjct: 119 DVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLN---GDCSP 172
Query: 488 I--------VGTYGYMAPEYA-----MHGQYSVKSDVFSFGVLVLEIISG 524
           I         G+  YMAPE           Y  + D++S GV++  ++SG
Sbjct: 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 103/221 (46%), Gaps = 20/221 (9%)
Query: 316 FNTIRVATDNFSDANKLGQGGFGAVYKG---------RLYDGAEIAVKRLSRDSGQGDLE 366
           F+ IR     F+++  LGQG F  ++KG         +L++  E+ +K L +        
Sbjct: 2   FHKIRNEDLIFNES--LGQGTFTKIFKGVRREVGDYGQLHE-TEVLLKVLDKAHRNYSES 58
Query: 367 FKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRY 426
           F     +++ L H++LV   G  + G+E +L+ EFV   SLD ++        + W  + 
Sbjct: 59  FFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KL 116
Query: 427 KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE--MDETQGN 484
           ++   +A  + +L E++   +IH ++   N+LL  E   K  +    +L +  +  T   
Sbjct: 117 EVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP 173
Query: 485 TSRIVGTYGYMAPEYAMHGQ-YSVKSDVFSFGVLVLEIISG 524
              +     ++ PE   + +  ++ +D +SFG  + EI SG
Sbjct: 174 KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 20/216 (9%)
Query: 319 IRVATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDS--GQGDLEFKNEVLLVA 375
           +R+  +++     +G+G FG V   R     ++ A+K LS+     + D  F  E   + 
Sbjct: 69  LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM 128
Query: 376 NLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFI--FDPTRRAQLDWERRYKIIGGI 432
              +   V  L ++ + +  L ++ E++P   L + +  +D   +    W R Y      
Sbjct: 129 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFY-----T 179
Query: 433 ARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY 492
           A  +L L     +  IHRD+K  N+LLD     K+ADFG        E        VGT 
Sbjct: 180 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN-KEGMVRCDTAVGTP 238
Query: 493 GYMAPEYAM----HGQYSVKSDVFSFGVLVLEIISG 524
            Y++PE        G Y  + D +S GV + E++ G
Sbjct: 239 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 20/216 (9%)
Query: 319 IRVATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDS--GQGDLEFKNEVLLVA 375
           +R+  +++     +G+G FG V   R     ++ A+K LS+     + D  F  E   + 
Sbjct: 69  LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM 128
Query: 376 NLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFI--FDPTRRAQLDWERRYKIIGGI 432
              +   V  L ++ + +  L ++ E++P   L + +  +D   +    W R Y      
Sbjct: 129 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFY-----T 179
Query: 433 ARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY 492
           A  +L L     +  IHRD+K  N+LLD     K+ADFG        E        VGT 
Sbjct: 180 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN-KEGMVRCDTAVGTP 238
Query: 493 GYMAPEYAM----HGQYSVKSDVFSFGVLVLEIISG 524
            Y++PE        G Y  + D +S GV + E++ G
Sbjct: 239 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 50/101 (49%), Gaps = 8/101 (7%)
Query: 428 IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE---MTPKIADFGMARLFEMDETQGN 484
           I+  +   + ++H+   + ++HRDLK  N+L   E   +  KI DFG ARL   D     
Sbjct: 111 IMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK 167
Query: 485 TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           T     T  Y APE      Y    D++S GV++  ++SGQ
Sbjct: 168 TPCF--TLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQ 206

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 102/221 (46%), Gaps = 20/221 (9%)
Query: 316 FNTIRVATDNFSDANKLGQGGFGAVYKG---------RLYDGAEIAVKRLSRDSGQGDLE 366
           F+ IR     F+++  LGQG F  ++KG         +L++  E+ +K L +        
Sbjct: 2   FHKIRNEDLIFNES--LGQGTFTKIFKGVRREVGDYGQLHE-TEVLLKVLDKAHRNYSES 58
Query: 367 FKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRY 426
           F     +++ L H++LV   G    G+E +L+ EFV   SLD ++        + W  + 
Sbjct: 59  FFEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KL 116
Query: 427 KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE--MDETQGN 484
           ++   +A  + +L E++   +IH ++   N+LL  E   K  +    +L +  +  T   
Sbjct: 117 EVAKQLAWAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP 173
Query: 485 TSRIVGTYGYMAPEYAMHGQ-YSVKSDVFSFGVLVLEIISG 524
              +     ++ PE   + +  ++ +D +SFG  + EI SG
Sbjct: 174 KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 83/191 (43%), Gaps = 20/191 (10%)
Query: 316 FNTIRVATDNFSDANKLGQGGFGAVY-----KGRLYDGAEIAVKRLSRDSGQGDLEFKNE 370
           F ++ V    +S   ++G GG   V+     K ++Y    I    L     Q    ++NE
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIY---AIKYVNLEEADNQTLDSYRNE 76
Query: 371 VLLVANLQHRN--LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLD-WERRYK 427
           +  +  LQ  +  ++RL  + +      ++ E   N  L+ ++    ++  +D WER+  
Sbjct: 77  IAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWL---KKKKSIDPWERK-- 130
Query: 428 IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSR 487
                   L  +H   +  I+H DLK +N L+   M  K+ DFG+A   + D T      
Sbjct: 131 --SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDS 187
Query: 488 IVGTYGYMAPE 498
            VGT  YM PE
Sbjct: 188 QVGTVNYMPPE 198

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 105/234 (44%), Gaps = 42/234 (17%)
Query: 322 ATDNFSDANKLGQGGFGAVYKGRLYDG---AEIAVKRLSRDSGQGDLEFKN---EVLLVA 375
             DN+   + +G+G +G VY    YD      +A+K+++R   +  ++ K    E+ ++ 
Sbjct: 24  VPDNYIIKHLIGRGSYGYVYLA--YDKNTEKNVAIKKVNR-MFEDLIDCKRILREITILN 80
Query: 376 NLQHRNLVRLLGFSLEGN----ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG 431
            L+   ++RL    +  +    + L I   + ++ L      P    +   E    I+  
Sbjct: 81  RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTE---EHIKTILYN 137
Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL------------FEMD 479
           +  G  ++HE     IIHRDLK +N LL+ + + K+ DFG+AR              E +
Sbjct: 138 LLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194
Query: 480 ETQGN---------TSRIVGTYGYMAPEYAMHGQYSVKS-DVFSFGVLVLEIIS 523
           E  G          TS +V T  Y APE  +  +   KS D++S G +  E+++
Sbjct: 195 EEPGPHNKNLKKQLTSHVV-TRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 50/96 (52%), Gaps = 18/96 (18%)
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTP---KIADFGMARLFEMDETQGNTS---RIVGT 491
           YLHE+    IIHRDLK  NVLL ++      KI DFG +++       G TS    + GT
Sbjct: 129 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL------GETSLMRTLCGT 179
Query: 492 YGYMAPEYAMH---GQYSVKSDVFSFGVLVLEIISG 524
             Y+APE  +      Y+   D +S GV++   +SG
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 50/96 (52%), Gaps = 18/96 (18%)
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTP---KIADFGMARLFEMDETQGNTS---RIVGT 491
           YLHE+    IIHRDLK  NVLL ++      KI DFG +++       G TS    + GT
Sbjct: 128 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL------GETSLMRTLCGT 178
Query: 492 YGYMAPEYAMH---GQYSVKSDVFSFGVLVLEIISG 524
             Y+APE  +      Y+   D +S GV++   +SG
Sbjct: 179 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 50/96 (52%), Gaps = 18/96 (18%)
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTP---KIADFGMARLFEMDETQGNTS---RIVGT 491
           YLHE+    IIHRDLK  NVLL ++      KI DFG +++       G TS    + GT
Sbjct: 129 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL------GETSLMRTLCGT 179
Query: 492 YGYMAPEYAMH---GQYSVKSDVFSFGVLVLEIISG 524
             Y+APE  +      Y+   D +S GV++   +SG
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 50/96 (52%), Gaps = 18/96 (18%)
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTP---KIADFGMARLFEMDETQGNTS---RIVGT 491
           YLHE+    IIHRDLK  NVLL ++      KI DFG +++       G TS    + GT
Sbjct: 135 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL------GETSLMRTLCGT 185
Query: 492 YGYMAPEYAMH---GQYSVKSDVFSFGVLVLEIISG 524
             Y+APE  +      Y+   D +S GV++   +SG
Sbjct: 186 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 221

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 50/96 (52%), Gaps = 18/96 (18%)
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTP---KIADFGMARLFEMDETQGNTS---RIVGT 491
           YLHE+    IIHRDLK  NVLL ++      KI DFG +++       G TS    + GT
Sbjct: 129 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL------GETSLMRTLCGT 179
Query: 492 YGYMAPEYAMH---GQYSVKSDVFSFGVLVLEIISG 524
             Y+APE  +      Y+   D +S GV++   +SG
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 50/96 (52%), Gaps = 18/96 (18%)
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTP---KIADFGMARLFEMDETQGNTS---RIVGT 491
           YLHE+    IIHRDLK  NVLL ++      KI DFG +++       G TS    + GT
Sbjct: 254 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL------GETSLMRTLCGT 304
Query: 492 YGYMAPEYAMH---GQYSVKSDVFSFGVLVLEIISG 524
             Y+APE  +      Y+   D +S GV++   +SG
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 50/96 (52%), Gaps = 18/96 (18%)
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTP---KIADFGMARLFEMDETQGNTS---RIVGT 491
           YLHE+    IIHRDLK  NVLL ++      KI DFG +++       G TS    + GT
Sbjct: 268 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL------GETSLMRTLCGT 318
Query: 492 YGYMAPEYAMH---GQYSVKSDVFSFGVLVLEIISG 524
             Y+APE  +      Y+   D +S GV++   +SG
Sbjct: 319 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/241 (23%), Positives = 108/241 (44%), Gaps = 47/241 (19%)
Query: 324 DNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLEFKN---EVLLVANL 377
           DN+   + +G+G +G VY    YD      +A+K+++R   +  ++ K    E+ ++  L
Sbjct: 28  DNYEIKHLIGRGSYGYVYLA--YDKNANKNVAIKKVNR-MFEDLIDCKRILREITILNRL 84
Query: 378 QHRNLVRLLGFS-----LEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGI 432
           +   ++RL         L+ +E  ++ E + ++ L      P    +   +    I+  +
Sbjct: 85  KSDYIIRLHDLIIPEDLLKFDELYIVLE-IADSDLKKLFKTPIFLTE---QHVKTILYNL 140
Query: 433 ARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE------------ 480
             G  ++HE     IIHRDLK +N LL+ + + KI DFG+AR    D+            
Sbjct: 141 LLGEKFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKE 197
Query: 481 ------------TQGNTSRIVGTYGYMAPEYA-MHGQYSVKSDVFSFGVLVLEIISGQRN 527
                        +  TS +V T  Y APE   +   Y+   D++S G +  E+++  ++
Sbjct: 198 ENEEPGPHNKNLKKQLTSHVV-TRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKS 256
Query: 528 N 528
           +
Sbjct: 257 H 257

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 104/243 (42%), Gaps = 17/243 (6%)
Query: 294 SKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEI-A 352
           S++  +    D +  AE +      +R+  D+F     +G+G F  V   ++    ++ A
Sbjct: 31  SELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYA 90
Query: 353 VKRLSRDS--GQGDLE-FKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDH 409
           +K +++     +G++  F+ E  ++ N   R + +L     + N   L+ E+     L  
Sbjct: 91  MKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLT 150
Query: 410 FIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIAD 469
            +     R   +  R Y     +A  ++ +    RL  +HRD+K  N+LLD     ++AD
Sbjct: 151 LLSKFGERIPAEMARFY-----LAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLAD 205
Query: 470 FGMARLFEMDETQGNTSRIVGTYGYMAPE-------YAMHGQYSVKSDVFSFGVLVLEII 522
           FG       D T   +   VGT  Y++PE           G Y  + D ++ GV   E+ 
Sbjct: 206 FGSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF 264
Query: 523 SGQ 525
            GQ
Sbjct: 265 YGQ 267

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 79/181 (43%), Gaps = 20/181 (11%)
Query: 326 FSDANKLGQGGFGAVY-----KGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHR 380
           +S   ++G GG   V+     K ++Y    I    L     Q    ++NE+  +  LQ  
Sbjct: 14  YSILKQIGSGGSSKVFQVLNEKKQIY---AIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 70
Query: 381 N--LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLD-WERRYKIIGGIARGLL 437
           +  ++RL  + +      ++ E   N  L+ ++    ++  +D WER+          L 
Sbjct: 71  SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWL---KKKKSIDPWERK----SYWKNMLE 122
Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
            +H   +  I+H DLK +N L+   M  K+ DFG+A   + D T       VGT  YM P
Sbjct: 123 AVHTIHQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 181
Query: 498 E 498
           E
Sbjct: 182 E 182
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	658
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-153
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-143
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-124
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-94
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-75
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-68
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-66
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-60
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-60
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-59
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	8e-59
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-57
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-57
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-56
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-53
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-52
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	9e-52
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-50
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-44
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-44
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-43
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-43
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-43
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	5e-43
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-42
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	6e-42
3pls_A	298	Macrophage-stimulating protein receptor; protein k	8e-42
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	9e-42
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-41
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-41
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-41
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-41
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-41
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-41
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	6e-41
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	7e-41
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	9e-41
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-40
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-40
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-40
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-40
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	5e-40
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	6e-40
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	9e-40
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	9e-40
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	9e-40
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-39
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-39
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-39
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-39
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-39
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-39
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	6e-39
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	7e-39
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	9e-39
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	9e-39
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-38
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-38
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-38
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-38
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-38
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-38
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-38
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-38
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-38
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-38
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	8e-38
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	8e-38
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-37
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-37
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-37
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-37
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-37
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-37
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-37
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-37
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	6e-37
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	9e-37
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-36
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-36
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-36
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	8e-36
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-35
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-34
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-34
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-34
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-34
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-33
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-33
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-33
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	5e-33
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	5e-33
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-33
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	8e-33
3fme_A	290	Dual specificity mitogen-activated protein kinase;	8e-33
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	8e-33
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-32
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-32
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-32
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-32
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-32
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	9e-32
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-31
3ork_A	311	Serine/threonine protein kinase; structural genomi	5e-31
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-30
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-30
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-30
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-30
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	8e-30
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-29
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-29
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	9e-29
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	9e-29
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-28
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	6e-28
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	9e-28
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-27
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-27
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-27
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	5e-27
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	5e-27
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	7e-27
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	9e-27
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-26
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-26
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	6e-26
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	7e-26
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	8e-26
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	8e-26
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	9e-26
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-25
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-25
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-25
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-25
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-25
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-25
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	9e-25
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-24
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-24
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-24
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-24
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-24
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-24
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-24
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-24
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-24
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-24
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-24
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-24
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	9e-24
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-23
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-23
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-23
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-23
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-23
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-23
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-23
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-23
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-23
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-23
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-23
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	7e-23
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	7e-23
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	7e-23
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	8e-23
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	8e-23
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	9e-23
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-22
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-22
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-22
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-22
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-22
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-22
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-22
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	6e-22
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	6e-22
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-21
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-21
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-21
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-21
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-21
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-21
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-21
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-21
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-21
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-20
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-20
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-20
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-20
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	7e-20
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	8e-20
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-19
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-19
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-19
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-19
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-19
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-19
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-19
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-19
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-19
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-19
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-19
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-19
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-19
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	5e-19
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-19
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	6e-19
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	8e-19
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-09
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-18
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-18
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-18
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	7e-18
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	8e-18
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-17
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-17
3rp9_A	458	Mitogen-activated protein kinase; structural genom	6e-17
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	8e-17
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-16
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-14
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	8e-14
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	7e-13
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	9e-13
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-11
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-04
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-09
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-08
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	5e-08
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	6e-08
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	6e-08
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-07
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-07
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-07
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	6e-07
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	7e-06
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-05
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-05

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  443 bits (1143), Expect = e-153
 Identities = 107/313 (34%), Positives = 164/313 (52%), Gaps = 21/313 (6%)

Query: 304 DEINRAESLQ---FDFNTIRVATDNFSD------ANKLGQGGFGAVYKGRLYDGAEIAVK 354
           ++       +   F F  ++  T+NF +       NK+G+GGFG VYKG + +   +AVK
Sbjct: 2   NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60

Query: 355 RLS----RDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF 410
           +L+      + +   +F  E+ ++A  QH NLV LLGFS +G++  L+Y ++PN SL   
Sbjct: 61  KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120

Query: 411 IFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADF 470
           +        L W  R KI  G A G+ +LHE+     IHRD+K++N+LLD   T KI+DF
Sbjct: 121 LSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDF 177

Query: 471 GMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCF 530
           G+AR  E       TSRIVGT  YMAPE  + G+ + KSD++SFGV++LEII+G      
Sbjct: 178 GLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDE 236

Query: 531 RNGETVEDLLSSAWKNWREGTTV-NIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTM 589
                 + LL    +   E  T+ + ID  ++    T +     +   C+ E    RP +
Sbjct: 237 HREP--QLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDI 294

Query: 590 ASVVLMLNSYSLT 602
             V  +L   + +
Sbjct: 295 KKVQQLLQEMTAS 307

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  418 bits (1078), Expect = e-143
 Identities = 118/288 (40%), Positives = 171/288 (59%), Gaps = 6/288 (2%)

Query: 314 FDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQG-DLEFKNEVL 372
           F    ++VA+DNFS+ N LG+GGFG VYKGRL DG  +AVKRL  +  QG +L+F+ EV 
Sbjct: 20  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79

Query: 373 LVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTR-RAQLDWERRYKIIGG 431
           +++   HRNL+RL GF +   ERLL+Y ++ N S+   + +    +  LDW +R +I  G
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139

Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT 491
            ARGL YLH+    +IIHRD+K +N+LLD E    + DFG+A+L +  +T   T  + GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGT 198

Query: 492 YGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRN--GETVEDLLSSAWKNWRE 549
            G++APEY   G+ S K+DVF +GV++LE+I+GQR         +    LL       +E
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258

Query: 550 GTTVNIIDPTLSSG-SITEMIRCIHIGLLCVQENVASRPTMASVVLML 596
                ++D  L       E+ + I + LLC Q +   RP M+ VV ML
Sbjct: 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  368 bits (948), Expect = e-124
 Identities = 104/306 (33%), Positives = 169/306 (55%), Gaps = 7/306 (2%)

Query: 294 SKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAV 353
           +   ++A +   +   ES +     +  AT+NF     +G G FG VYKG L DGA++A+
Sbjct: 9   TNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVAL 68

Query: 354 KRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFD 413
           KR + +S QG  EF+ E+  ++  +H +LV L+GF  E NE +LIY+++ N +L   ++ 
Sbjct: 69  KRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYG 128

Query: 414 PTR-RAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGM 472
                  + WE+R +I  G ARGL YLH  +   IIHRD+K+ N+LLD    PKI DFG+
Sbjct: 129 SDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI 185

Query: 473 ARLF-EMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFR 531
           ++   E+D+T  +T  + GT GY+ PEY + G+ + KSDV+SFGV++ E++  +      
Sbjct: 186 SKKGTELDQTHLST-VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS 244

Query: 532 NGETVEDLLSSAWKNWREGTTVNIIDPTLSSG-SITEMIRCIHIGLLCVQENVASRPTMA 590
               + +L   A ++   G    I+DP L+       + +     + C+  +   RP+M 
Sbjct: 245 LPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMG 304

Query: 591 SVVLML 596
            V+  L
Sbjct: 305 DVLWKL 310

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  293 bits (751), Expect = 2e-94
 Identities = 71/313 (22%), Positives = 120/313 (38%), Gaps = 29/313 (9%)

Query: 309 AESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFK 368
           +  +      +   +          +G FG V+K +      +AVK       Q   + +
Sbjct: 9   SSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQS-WQNE 66

Query: 369 NEVLLVANLQHRNLVRLLGFSLEGN----ERLLIYEFVPNTSLDHFIFDPTRRAQLDWER 424
            EV  +  ++H N+++ +G    G     +  LI  F    SL  F+    +   + W  
Sbjct: 67  YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNE 122

Query: 425 RYKIIGGIARGLLYLHED-------SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
              I   +ARGL YLHED        +  I HRD+K+ NVLL   +T  IADFG+A  FE
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182

Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHG-----QYSVKSDVFSFGVLVLEIISGQRNNCFRN 532
             ++ G+T   VGT  YMAPE             ++ D+++ G+++ E+ S         
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242

Query: 533 GETVEDLLSSAWKNW-----REGTTVNIIDPTL-SSGSITEMIRCI-HIGLLCVQENVAS 585
            E +        ++      +E        P L         +  +      C   +  +
Sbjct: 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302

Query: 586 RPTMASVVLMLNS 598
           R +   V   +  
Sbjct: 303 RLSAGCVGERITQ 315

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  244 bits (624), Expect = 2e-75
 Identities = 75/337 (22%), Positives = 125/337 (37%), Gaps = 48/337 (14%)

Query: 312 LQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNE- 370
           ++   +   +  DN      +G+G +GAVYKG   D   +AVK  S  + Q    F NE 
Sbjct: 1   MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGS-LDERPVAVKVFSFANRQ---NFINEK 56

Query: 371 -VLLVANLQHRNLVRLLGFSLEGN-----ERLLIYEFVPNTSLDHFIFDPTRRAQLDWER 424
            +  V  ++H N+ R +            E LL+ E+ PN SL  ++   T     DW  
Sbjct: 57  NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVS 112

Query: 425 RYKIIGGIARGLLYLHED------SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF-- 476
             ++   + RGL YLH +       +  I HRDL + NVL+  + T  I+DFG++     
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172

Query: 477 ----EMDETQGNTSRIVGTYGYMAPEYAM-------HGQYSVKSDVFSFGVLVLEIISGQ 525
                  E        VGT  YMAPE                + D+++ G++  EI    
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM-- 230

Query: 526 RNNCFRNGETVEDL-LSSAWKNWREGTTVNIID--------PTLSSGSITEMIRCIHIGL 576
           R      GE+V +  ++   +     T  ++          P          +    +  
Sbjct: 231 RCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKE 290

Query: 577 L---CVQENVASRPTMASVVLMLNSYSLTLPVPSEPA 610
               C  ++  +R T       +    +        +
Sbjct: 291 TIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVS 327

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  224 bits (572), Expect = 4e-68
 Identities = 78/328 (23%), Positives = 142/328 (43%), Gaps = 28/328 (8%)

Query: 287 RRKPRDNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLY 346
                D     +E          + +   +  + +         K+G G FG V++   +
Sbjct: 7   HHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIK-------EKIGAGSFGTVHRAE-W 58

Query: 347 DGAEIAVKRLSRDSGQGDL--EFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPN 404
            G+++AVK L       +   EF  EV ++  L+H N+V  +G   +     ++ E++  
Sbjct: 59  HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR 118

Query: 405 TSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMT 464
            SL   +     R QLD  RR  +   +A+G+ YLH      I+HR+LK+ N+L+D + T
Sbjct: 119 GSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYT 177

Query: 465 PKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
            K+ DFG++R      T  ++    GT  +MAPE       + KSDV+SFGV++ E+ + 
Sbjct: 178 VKVCDFGLSR--LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATL 235

Query: 525 QRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVA 584
           Q+   + N    + + +  +K  R           +      ++   I     C      
Sbjct: 236 QQP--WGNLNPAQVVAAVGFKCKR---------LEIPRNLNPQVAAIIE---GCWTNEPW 281

Query: 585 SRPTMASVVLMLNSYSLT-LPVPSEPAF 611
            RP+ A+++ +L     + +P P+    
Sbjct: 282 KRPSFATIMDLLRPLIKSAVPPPNRSDL 309

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  218 bits (558), Expect = 4e-66
 Identities = 73/291 (25%), Positives = 124/291 (42%), Gaps = 32/291 (10%)

Query: 324 DNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
                   +G+G FG V K + +   ++A+K++  +S +    F  E+  ++ + H N+V
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAK-WRAKDVAIKQIESESERK--AFIVELRQLSRVNHPNIV 64

Query: 384 RLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS 443
           +L G  L  N   L+ E+    SL + +                     ++G+ YLH   
Sbjct: 65  KLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 444 RLRIIHRDLKTSNVLLDAEMT-PKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMH 502
              +IHRDLK  N+LL A  T  KI DFG A      + Q + +   G+  +MAPE    
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEG 177

Query: 503 GQYSVKSDVFSFGVLVLEIISGQRNNCFRN-GETVEDLLSSAWKNWREGTTVNIIDPTLS 561
             YS K DVFS+G+++ E+I+ ++   F   G     ++ +     R         P L 
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRK--PFDEIGGPAFRIMWAVHNGTR---------PPLI 226

Query: 562 SG---SITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTLPVPSEP 609
                 I  ++        C  ++ + RP+M  +V ++       P   EP
Sbjct: 227 KNLPKPIESLMTR------CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  203 bits (518), Expect = 1e-60
 Identities = 76/281 (27%), Positives = 123/281 (43%), Gaps = 35/281 (12%)

Query: 330 NKLGQGGFGAVYKGRLYDGAEIAVKRL----SRDSGQGDLEFKNEVLLVANLQHRNLVRL 385
             +G GGFG VY+   + G E+AVK        D  Q     + E  L A L+H N++ L
Sbjct: 13  EIIGIGGFGKVYRAF-WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 386 LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRL 445
            G  L+     L+ EF     L+  +       ++  +        IARG+ YLH+++ +
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIV 127

Query: 446 RIIHRDLKTSNVLLDAEMTP--------KIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
            IIHRDLK+SN+L+  ++          KI DFG+AR +             G Y +MAP
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA----GAYAWMAP 183

Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID 557
           E      +S  SDV+S+GVL+ E+++G+    FR  + +      A              
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVP--FRGIDGLAVAYGVAMNKLA--------- 232

Query: 558 PTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS 598
             + S       + +     C   +  SRP+  +++  L +
Sbjct: 233 LPIPSTCPEPFAKLME---DCWNPDPHSRPSFTNILDQLTT 270

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  203 bits (518), Expect = 2e-60
 Identities = 79/314 (25%), Positives = 144/314 (45%), Gaps = 44/314 (14%)

Query: 300 AAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSR 358
           A  G E  ++       N I           ++G+GGFG V+KGR + D + +A+K L  
Sbjct: 2   AMGGSEFPKSRLPTLADNEIEYE-------KQIGKGGFGLVHKGRLVKDKSVVAIKSLIL 54

Query: 359 DSGQGDL-------EFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI 411
              +G+        EF+ EV +++NL H N+V+L G         ++ EFVP   L H +
Sbjct: 55  GDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRL 112

Query: 412 FDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLD-----AEMTPK 466
            D      + W  + +++  IA G+ Y+  +    I+HRDL++ N+ L      A +  K
Sbjct: 113 LDKAH--PIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAK 169

Query: 467 IADFGMARLFEMDETQGNTSRIVGTYGYMAPE--YAMHGQYSVKSDVFSFGVLVLEIISG 524
           +ADFG+++     ++  + S ++G + +MAPE   A    Y+ K+D +SF +++  I++G
Sbjct: 170 VADFGLSQ-----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

Query: 525 QRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVA 584
           +      +   ++ +     +  R         PT+       +   I    LC   +  
Sbjct: 225 EGPFDEYSYGKIKFINMIREEGLR---------PTIPEDCPPRLRNVIE---LCWSGDPK 272

Query: 585 SRPTMASVVLMLNS 598
            RP  + +V  L+ 
Sbjct: 273 KRPHFSYIVKELSE 286

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  201 bits (512), Expect = 2e-59
 Identities = 72/300 (24%), Positives = 112/300 (37%), Gaps = 43/300 (14%)

Query: 330 NKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGF 388
             LG+G FG   K    + G  + +K L R   +    F  EV ++  L+H N+++ +G 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRII 448
             +      I E++   +L   I       Q  W +R      IA G+ YLH    + II
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHS---MNII 130

Query: 449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSR------------IVGTYGYMA 496
           HRDL + N L+       +ADFG+ARL   ++TQ    R            +VG   +MA
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190

Query: 497 PEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNII 556
           PE      Y  K DVFSFG+++ EII                    A  ++   T    +
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVN----------------ADPDYLPRTMDFGL 234

Query: 557 D------PTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTLPVPSEPA 610
           +                        + C   +   RP+   +   L +  + L       
Sbjct: 235 NVRGFLDRYCPPNCPPSFFPIT---VRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLG 291

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  198 bits (505), Expect = 8e-59
 Identities = 62/276 (22%), Positives = 114/276 (41%), Gaps = 31/276 (11%)

Query: 330 NKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDL--EFKNEVLLVANLQHRNLVRLLG 387
            KL +   G ++KGR + G +I VK L           +F  E   +    H N++ +LG
Sbjct: 16  TKLNENHSGELWKGR-WQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74

Query: 388 FSLEGNERLL--IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRL 445
                       I  ++P  SL + + + T    +D  +  K    +ARG+ +LH    L
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF-VVDQSQAVKFALDMARGMAFLHTLEPL 133

Query: 446 RIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQY 505
            I    L + +V++D +MT +I+   +   F+           +    ++APE       
Sbjct: 134 -IPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR-------MYAPAWVAPEALQKKPE 185

Query: 506 SV---KSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSS 562
                 +D++SF VL+ E+++ +    F +   +E  +  A +  R         PT+  
Sbjct: 186 DTNRRSADMWSFAVLLWELVTREVP--FADLSNMEIGMKVALEGLR---------PTIPP 234

Query: 563 GSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS 598
           G    + + + I   C+ E+ A RP    +V +L  
Sbjct: 235 GISPHVSKLMKI---CMNEDPAKRPKFDMIVPILEK 267

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  194 bits (495), Expect = 3e-57
 Identities = 67/274 (24%), Positives = 128/274 (46%), Gaps = 23/274 (8%)

Query: 330 NKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDL--EFKNEVLLVANLQHRNLVRLLG 387
            ++G G FG VYKG+ + G ++AVK L+  +        FKNEV ++   +H N++  +G
Sbjct: 30  QRIGSGSFGTVYKGK-WHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 388 FSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRI 447
           +S       ++ ++   +SL H +       + + ++   I    ARG+ YLH      I
Sbjct: 88  YSTAPQ-LAIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLH---AKSI 141

Query: 448 IHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE---YAMHGQ 504
           IHRDLK++N+ L  + T KI DFG+A             ++ G+  +MAPE         
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201

Query: 505 YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGS 564
           YS +SDV++FG+++ E+++GQ    + N    + ++    +         +   +     
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQIIEMVGRGSLSPDLSKV--RSNCPKR 257

Query: 565 ITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS 598
           +  ++        C+++    RP+   ++  +  
Sbjct: 258 MKRLMA------ECLKKKRDERPSFPRILAEIEE 285

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  193 bits (493), Expect = 1e-56
 Identities = 72/300 (24%), Positives = 119/300 (39%), Gaps = 36/300 (12%)

Query: 330 NKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDL--EFKNEVLLVANLQHRNLVRLLG 387
             +G+G FG VY GR + G E+A++ +  +    D    FK EV+     +H N+V  +G
Sbjct: 39  ELIGKGRFGQVYHGR-WHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 388 FSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRI 447
             +      +I       +L   + D   +  LD  +  +I   I +G+ YLH      I
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLH---AKGI 151

Query: 448 IHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI---VGTYGYMAPE------ 498
           +H+DLK+ NV  D      I DFG+  +  + +      ++    G   ++APE      
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210

Query: 499 ---YAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNI 555
                    +S  SDVF+ G +  E+ + +    F+  +  E ++       +       
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWP--FK-TQPAEAIIWQMGTGMK------- 260

Query: 556 IDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTLPVPSEPAFFMDS 615
             P LS   + + I    I L C       RPT   ++ ML          S P  F  S
Sbjct: 261 --PNLSQIGMGKEIS--DILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWKS 316

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  186 bits (474), Expect = 1e-53
 Identities = 72/301 (23%), Positives = 122/301 (40%), Gaps = 43/301 (14%)

Query: 330 NKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNE--VLLVANLQHRNLVRLLG 387
            ++G+G +G V+ G+ + G ++AVK         +  +  E  +     ++H N++  + 
Sbjct: 43  KQIGKGRYGEVWMGK-WRGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIA 98

Query: 388 FSLEGNER----LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS 443
             ++G        LI ++  N SL  ++    +   LD +   K+      GL +LH + 
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEI 154

Query: 444 RLR-----IIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI--VGTYGYMA 496
                   I HRDLK+ N+L+    T  IAD G+A  F  D  + +      VGT  YM 
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214

Query: 497 PE------YAMHGQYSVKSDVFSFGVLVL-EIISGQRNNCFRNGETVEDLLSSAWKNWRE 549
           PE         H Q  + +D++SFG L+L E+       C   G   E  L        +
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFG-LILWEVARR----CVSGGIVEEYQLPYHDLVPSD 269

Query: 550 GTTVNIID--------PTLSSGSITEMIRCIHIGLL--CVQENVASRPTMASVVLMLNSY 599
            +  ++ +        P+  +   ++        L+  C   N ASR T   V   L   
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329

Query: 600 S 600
           S
Sbjct: 330 S 330

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  181 bits (462), Expect = 2e-52
 Identities = 53/214 (24%), Positives = 92/214 (42%), Gaps = 27/214 (12%)

Query: 330 NKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNE--VLLVANLQHRNLVRLLG 387
             +G+G +G V++G  + G  +AVK  S    + +  +  E  +     L+H N++  + 
Sbjct: 14  ECVGKGRYGEVWRGS-WQGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69

Query: 388 FSLEGN----ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS 443
             +       +  LI  +    SL  ++    +   LD     +I+  IA GL +LH + 
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125

Query: 444 RLR-----IIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI--VGTYGYMA 496
                   I HRDLK+ N+L+       IAD G+A +      Q +      VGT  YMA
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185

Query: 497 PE------YAMHGQYSVKSDVFSFGVLVLEIISG 524
           PE               + D+++FG+++ E+   
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  177 bits (451), Expect = 2e-50
 Identities = 65/306 (21%), Positives = 118/306 (38%), Gaps = 57/306 (18%)

Query: 330 NKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNE--VLLVANLQHRNLVRLLG 387
             +G+G FG V++G+ + G E+AVK  S    + +  +  E  +     L+H N++  + 
Sbjct: 48  ESIGKGRFGEVWRGK-WRGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIA 103

Query: 388 ----FSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED- 442
                +    +  L+ ++  + SL  ++     R  +  E   K+    A GL +LH + 
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEI 159

Query: 443 ----SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE---MDETQGNTSRIVGTYGYM 495
                +  I HRDLK+ N+L+    T  IAD G+A   +            R VGT  YM
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR-VGTKRYM 218

Query: 496 APE------YAMHGQYSVKSDVFSFGVLVLEIISGQRN------------NCFRNGETVE 537
           APE         H +   ++D+++ G++  EI                  +   +  +VE
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278

Query: 538 DLLSS-AWKNWR----EGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASV 592
           ++      +  R               ++      M  C +        N A+R T   +
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAK----IMRECWY-------ANGAARLTALRI 327

Query: 593 VLMLNS 598
              L+ 
Sbjct: 328 KKTLSQ 333

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  158 bits (403), Expect = 3e-44
 Identities = 72/289 (24%), Positives = 127/289 (43%), Gaps = 34/289 (11%)

Query: 330 NKLGQGGFGAVYKGRLY-----DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVR 384
            +LG+G FG+V   R        G  +AVK+L   + +   +F+ E+ ++ +LQH N+V+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 385 LLGFSLEGNER--LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
             G       R   LI E++P  SL  ++     + ++D  +  +    I +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT- 132

Query: 443 SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE-----TQGNTSRIVGTYGYMAP 497
              R IHRDL T N+L++ E   KI DFG+ ++   D+      +   S I     + AP
Sbjct: 133 --KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI----FWYAP 186

Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID 557
           E     ++SV SDV+SFGV++ E+ +    +     E +  + +           + ++ 
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246

Query: 558 -------PTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY 599
                  P      I  ++        C   NV  RP+   + L ++  
Sbjct: 247 NNGRLPRPDGCPDEIYMIM------TECWNNNVNQRPSFRDLALRVDQI 289

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  159 bits (405), Expect = 5e-44
 Identities = 72/289 (24%), Positives = 127/289 (43%), Gaps = 34/289 (11%)

Query: 330 NKLGQGGFGAVYKGRLY-----DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVR 384
            +LG+G FG+V   R        G  +AVK+L   + +   +F+ E+ ++ +LQH N+V+
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 385 LLGFSLEGNER--LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
             G       R   LI E++P  SL  ++     + ++D  +  +    I +G+ YL   
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT- 163

Query: 443 SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE-----TQGNTSRIVGTYGYMAP 497
              R IHRDL T N+L++ E   KI DFG+ ++   D+      +   S I     + AP
Sbjct: 164 --KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI----FWYAP 217

Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID 557
           E     ++SV SDV+SFGV++ E+ +    +     E +  + +           + ++ 
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277

Query: 558 -------PTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY 599
                  P      I  ++        C   NV  RP+   + L ++  
Sbjct: 278 NNGRLPRPDGCPDEIYMIM------TECWNNNVNQRPSFRDLALRVDQI 320

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  160 bits (406), Expect = 1e-43
 Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 11/197 (5%)

Query: 331 KLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLVRLLGF 388
           ++G+G FG V+ GRL  D   +AVK            +F  E  ++    H N+VRL+G 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180

Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRII 448
             +     ++ E V       F+   T  A+L  +   +++G  A G+ YL        I
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYLES---KCCI 235

Query: 449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDE--TQGNTSRIVGTYGYMAPEYAMHGQYS 506
           HRDL   N L+  +   KI+DFGM+R          G   ++     + APE   +G+YS
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV--PVKWTAPEALNYGRYS 293

Query: 507 VKSDVFSFGVLVLEIIS 523
            +SDV+SFG+L+ E  S
Sbjct: 294 SESDVWSFGILLWETFS 310

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  157 bits (399), Expect = 2e-43
 Identities = 64/207 (30%), Positives = 106/207 (51%), Gaps = 22/207 (10%)

Query: 330 NKLGQGGFGAVYKGRL-----YDGAEIAVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLV 383
             LG+G FG V   R        G ++AVK L  +SG   + + K E+ ++ NL H N+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 384 RLLGFSLEGNER--LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           +  G   E       LI EF+P+ SL  ++  P  + +++ +++ K    I +G+ YL  
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGS 144

Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE-----TQGNTSRIVGTYGYMA 496
               + +HRDL   NVL+++E   KI DFG+ +  E D+          S +     + A
Sbjct: 145 ---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPV----FWYA 197

Query: 497 PEYAMHGQYSVKSDVFSFGVLVLEIIS 523
           PE  M  ++ + SDV+SFGV + E+++
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLT 224

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  157 bits (400), Expect = 2e-43
 Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 21/206 (10%)

Query: 330 NKLGQGGFGAVYKGRLY-----DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVR 384
           ++LG+G FG+V   R        GA +AVK+L         +F+ E+ ++  L    +V+
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 385 LLGFSLEGNER--LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
             G S     +   L+ E++P+  L  F+     RA+LD  R       I +G+ YL   
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS- 145

Query: 443 SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE-----TQGNTSRIVGTYGYMAP 497
              R +HRDL   N+L+++E   KIADFG+A+L  +D+      +   S I     + AP
Sbjct: 146 --RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI----FWYAP 199

Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIIS 523
           E      +S +SDV+SFGV++ E+ +
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFT 225

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  156 bits (397), Expect = 5e-43
 Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 24/207 (11%)

Query: 330 NKLGQGGFGAVYKGRL-----YDGAEIAVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLV 383
             LG+G FG V            G  +AVK L  D+G      +K E+ ++  L H +++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 384 RLLGFSLEGNER--LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           +  G   +       L+ E+VP  SL  ++     R  +   +       I  G+ YLH 
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHA 152

Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE-----TQGNTSRIVGTYGYMA 496
                 IHRDL   NVLLD +   KI DFG+A+            +   S +     + A
Sbjct: 153 ---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV----FWYA 205

Query: 497 PEYAMHGQYSVKSDVFSFGVLVLEIIS 523
           PE     ++   SDV+SFGV + E+++
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLT 232

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  154 bits (391), Expect = 4e-42
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 23/209 (11%)

Query: 330 NKLGQGGFGAVYKGRLYDGAE-----IAVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLV 383
             LG G FG VYKG      E     +A+K L   +      E  +E  ++A++ + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 384 RLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS 443
           RLLG  L  +   LI + +P   L  ++ +   +  +  +        IA+G+ YL    
Sbjct: 81  RLLGICLT-STVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL---E 134

Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG-----YMAPE 498
             R++HRDL   NVL+      KI DFG+A+L   +E + +        G     +MA E
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMALE 189

Query: 499 YAMHGQYSVKSDVFSFGVLVLEIIS-GQR 526
             +H  Y+ +SDV+S+GV V E+++ G +
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  152 bits (387), Expect = 6e-42
 Identities = 57/197 (28%), Positives = 99/197 (50%), Gaps = 13/197 (6%)

Query: 330 NKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFS 389
            +LG G FG V  G+     ++A+K +   S   D EF  E  ++ NL H  LV+L G  
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 390 LEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIH 449
            +     +I E++ N  L +++     R +   ++  ++   +   + YL      + +H
Sbjct: 89  TKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLH 143

Query: 450 RDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT---YGYMAPEYAMHGQYS 506
           RDL   N L++ +   K++DFG++R    DE     +  VG+     +  PE  M+ ++S
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDE----YTSSVGSKFPVRWSPPEVLMYSKFS 199

Query: 507 VKSDVFSFGVLVLEIIS 523
            KSD+++FGVL+ EI S
Sbjct: 200 SKSDIWAFGVLMWEIYS 216

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  152 bits (387), Expect = 8e-42
 Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 19/205 (9%)

Query: 330 NKLGQGGFGAVYKGRLYDGAE----IAVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLVR 384
             +G+G FG VY G   D A+     A+K LSR +    +  F  E LL+  L H N++ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 385 LLGFSLEGNERLLI-YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS 443
           L+G  L       +   ++ +  L  FI  P  +     +        +ARG+ YL   +
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYL---A 141

Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG-----YMAPE 498
             + +HRDL   N +LD   T K+ADFG+AR     E     S     +      + A E
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY---YSVQQHRHARLPVKWTALE 198

Query: 499 YAMHGQYSVKSDVFSFGVLVLEIIS 523
                +++ KSDV+SFGVL+ E+++
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLT 223

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  151 bits (384), Expect = 9e-42
 Identities = 59/196 (30%), Positives = 93/196 (47%), Gaps = 11/196 (5%)

Query: 330 NKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFS 389
            ++G G FG V+ G   +  ++A+K +   +   + +F  E  ++  L H  LV+L G  
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 390 LEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIH 449
           LE     L+ EF+ +  L  ++   T+R     E    +   +  G+ YL       +IH
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIH 127

Query: 450 RDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY--MAPEYAMHGQYSV 507
           RDL   N L+      K++DFGM R    D+    TS     +     +PE     +YS 
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQY---TSSTGTKFPVKWASPEVFSFSRYSS 184

Query: 508 KSDVFSFGVLVLEIIS 523
           KSDV+SFGVL+ E+ S
Sbjct: 185 KSDVWSFGVLMWEVFS 200

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  152 bits (386), Expect = 1e-41
 Identities = 61/219 (27%), Positives = 107/219 (48%), Gaps = 34/219 (15%)

Query: 330 NKLGQGGFGAVYKGRLYDGAE------IAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
            +LG+G FG V+    Y+ +       +AVK L   +     +F+ E  L+ NLQH ++V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 384 RLLGFSLEGNERLLIYEFVPNTSLDHF-------------IFDPTRRAQLDWERRYKIIG 430
           +  G   +G+  ++++E++ +  L+ F                   + +L   +   I  
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 431 GIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQGNTS--- 486
            IA G++YL   +    +HRDL T N L+ A +  KI DFGM+R ++  D  +       
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197

Query: 487 --RIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
             R      +M PE  M+ +++ +SDV+SFGV++ EI +
Sbjct: 198 PIR------WMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  152 bits (385), Expect = 2e-41
 Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 21/206 (10%)

Query: 330 NKLGQGGFGAVYKGRLYDGAE----IAVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLVR 384
             +G+G FG VY G L D        AVK L+R +  G++ +F  E +++ +  H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 385 LLGFSLEGNE-RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS 443
           LLG  L      L++  ++ +  L +FI +         +        +A+G+ YL    
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLAS-- 146

Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG------YMAP 497
             + +HRDL   N +LD + T K+ADFG+AR     E       +    G      +MA 
Sbjct: 147 -KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY----SVHNKTGAKLPVKWMAL 201

Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIIS 523
           E     +++ KSDV+SFGVL+ E+++
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMT 227

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  150 bits (382), Expect = 2e-41
 Identities = 58/196 (29%), Positives = 96/196 (48%), Gaps = 13/196 (6%)

Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSL 390
           +LG G FG V  G+     ++AVK +   S   D EF  E   +  L H  LV+  G   
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED-EFFQEAQTMMKLSHPKLVKFYGVCS 73

Query: 391 EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHR 450
           +     ++ E++ N  L +++   +    L+  +  ++   +  G+ +L      + IHR
Sbjct: 74  KEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHR 128

Query: 451 DLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT---YGYMAPEYAMHGQYSV 507
           DL   N L+D ++  K++DFGM R    D+        VGT     + APE   + +YS 
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQ----YVSSVGTKFPVKWSAPEVFHYFKYSS 184

Query: 508 KSDVFSFGVLVLEIIS 523
           KSDV++FG+L+ E+ S
Sbjct: 185 KSDVWAFGILMWEVFS 200

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  152 bits (385), Expect = 3e-41
 Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 34/215 (15%)

Query: 330 NKLGQGGFGAVYKGRLYDGAE----IAVKRLSRDSGQGD-LEFKNEVLLVANLQHRNLVR 384
             +G G  G V  GRL    +    +A+K L     +    +F +E  ++    H N++R
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114

Query: 385 LLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSR 444
           L G    G   +++ E++ N SLD F+       Q    +   ++ G+  G+ YL   S 
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYL---SD 169

Query: 445 LRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY---------- 494
           L  +HRDL   NVL+D+ +  K++DFG++R+ E D                         
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP-----------DAAYTTTGGKIPI 218

Query: 495 --MAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQR 526
              APE      +S  SDV+SFGV++ E+++ G+R
Sbjct: 219 RWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  152 bits (385), Expect = 3e-41
 Identities = 61/218 (27%), Positives = 105/218 (48%), Gaps = 33/218 (15%)

Query: 330 NKLGQGGFGAVYKGRLYDGAE------IAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
            +LG+G FG V+    ++         +AVK L   S     +F+ E  L+  LQH+++V
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 384 RLLGFSLEGNERLLIYEFVPNTSLDHF------------IFDPTRRAQLDWERRYKIIGG 431
           R  G   EG   L+++E++ +  L+ F              +      L   +   +   
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQGNTSRIVG 490
           +A G++YL   + L  +HRDL T N L+   +  KI DFGM+R ++  D  +      VG
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR------VG 217

Query: 491 TYG-----YMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
                   +M PE  ++ +++ +SDV+SFGV++ EI +
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  152 bits (385), Expect = 3e-41
 Identities = 58/209 (27%), Positives = 109/209 (52%), Gaps = 23/209 (11%)

Query: 331 KLGQGGFGAVYKGRLYDGAE-----IAVKRLSRDSGQGD-LEFKNEVLLVANLQHRNLVR 384
            +G G FG VYKG L   +      +A+K L     +   ++F  E  ++    H N++R
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110

Query: 385 LLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSR 444
           L G   +    ++I E++ N +LD F+    +  +    +   ++ GIA G+ YL   + 
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYL---AN 165

Query: 445 LRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG------YMAPE 498
           +  +HRDL   N+L+++ +  K++DFG++R+ E D     T+      G      + APE
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----GGKIPIRWTAPE 220

Query: 499 YAMHGQYSVKSDVFSFGVLVLEIIS-GQR 526
              + +++  SDV+SFG+++ E+++ G+R
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGER 249

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  150 bits (382), Expect = 6e-41
 Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 29/214 (13%)

Query: 330 NKLGQGGFGAVYKGRLYDGAE------IAVKRLSRDSGQGDL-EFKNEVLLVANLQHRNL 382
            +LGQG FG VY+G      +      +A+K ++  +   +  EF NE  ++      ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHF-------IFDPTRRAQLDWERRYKIIGGIARG 435
           VRLLG   +G   L+I E +    L  +       + +    A     +  ++ G IA G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 436 LLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQGNTSRIVGTYGY 494
           + YL+     + +HRDL   N ++  + T KI DFGM R ++E D  +       G  G 
Sbjct: 151 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR------KGGKGL 201

Query: 495 -----MAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
                M+PE    G ++  SDV+SFGV++ EI +
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  149 bits (379), Expect = 7e-41
 Identities = 67/220 (30%), Positives = 109/220 (49%), Gaps = 35/220 (15%)

Query: 330 NKLGQGGFGAVYKGRLYDGAE------IAVKRLSRDSGQGDL-EFKNEVLLVANLQHRNL 382
            +LG+  FG VYKG L+  A       +A+K L   +      EF++E +L A LQH N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHF-------------IFDPTRRAQLDWERRYKII 429
           V LLG   +     +I+ +  +  L  F               D T ++ L+      ++
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE---TQGNTS 486
             IA G+ YL   S   ++H+DL T NVL+  ++  KI+D G+ R     +     GN+ 
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191

Query: 487 ---RIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
              R      +MAPE  M+G++S+ SD++S+GV++ E+ S
Sbjct: 192 LPIR------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  150 bits (381), Expect = 9e-41
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 23/209 (11%)

Query: 330 NKLGQGGFGAVYKGRLYDGAE-----IAVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLV 383
             LG G FG V+KG      E     + +K +   SG+       + +L + +L H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 384 RLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS 443
           RLLG     +   L+ +++P  SL   +     R  L  +        IA+G+ YL    
Sbjct: 79  RLLGLCPG-SSLQLVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYL---E 132

Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG-----YMAPE 498
              ++HR+L   NVLL +    ++ADFG+A L   D+ Q   S            +MA E
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-----AKTPIKWMALE 187

Query: 499 YAMHGQYSVKSDVFSFGVLVLEIIS-GQR 526
               G+Y+ +SDV+S+GV V E+++ G  
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMTFGAE 216

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  148 bits (377), Expect = 2e-40
 Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 9/196 (4%)

Query: 330 NKLGQGGFGAVYKGRLYDGA-EIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGF 388
           +KLG G +G VY+G     +  +AVK L  D+ + + EF  E  ++  ++H NLV+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 77

Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRII 448
                   +I EF+   +L  ++ +   R ++       +   I+  + YL    +   I
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL---EKKNFI 133

Query: 449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDE-TQGNTSRIVGTYGYMAPEYAMHGQYSV 507
           HRDL   N L+      K+ADFG++RL   D  T    ++      + APE   + ++S+
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSI 191

Query: 508 KSDVFSFGVLVLEIIS 523
           KSDV++FGVL+ EI +
Sbjct: 192 KSDVWAFGVLLWEIAT 207

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  149 bits (378), Expect = 3e-40
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 23/209 (11%)

Query: 330 NKLGQGGFGAVYKGRLYDGAE-----IAVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLV 383
             LG G FG VYKG      E     +A+K L   +      E  +E  ++A++ + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 384 RLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS 443
           RLLG  L  +   LI + +P   L  ++ +   +  +  +        IA+G+ YL    
Sbjct: 81  RLLGICLT-STVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL---E 134

Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG-----YMAPE 498
             R++HRDL   NVL+      KI DFG+A+L   +E + +        G     +MA E
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMALE 189

Query: 499 YAMHGQYSVKSDVFSFGVLVLEIIS-GQR 526
             +H  Y+ +SDV+S+GV V E+++ G +
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  148 bits (375), Expect = 3e-40
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 22/207 (10%)

Query: 331 KLGQGGFGAVYKGRLYDGAE---IAVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLVRLL 386
           +LG G FG+V +G      +   +A+K L + + + D  E   E  ++  L +  +VRL+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 387 GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLR 446
           G        +L+ E      L  F+    +R ++      +++  ++ G+ YL       
Sbjct: 77  GVCQA-EALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EEKN 130

Query: 447 IIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG------YMAPEYA 500
            +HRDL   NVLL      KI+DFG+++    D++                  + APE  
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLKWYAPECI 185

Query: 501 MHGQYSVKSDVFSFGVLVLEIIS-GQR 526
              ++S +SDV+S+GV + E +S GQ+
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQK 212

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  150 bits (380), Expect = 3e-40
 Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 19/205 (9%)

Query: 330 NKLGQGGFGAVYKGRLYDGAE----IAVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLVR 384
             +G+G FG VY G L D        AVK L+R +  G++ +F  E +++ +  H N++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 385 LLGFSLEGNE-RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS 443
           LLG  L      L++  ++ +  L +FI +         +        +A+G+ +L   +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFL---A 209

Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG-----YMAPE 498
             + +HRDL   N +LD + T K+ADFG+AR     E     ++   T       +MA E
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK---TGAKLPVKWMALE 266

Query: 499 YAMHGQYSVKSDVFSFGVLVLEIIS 523
                +++ KSDV+SFGVL+ E+++
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMT 291

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  149 bits (379), Expect = 5e-40
 Identities = 60/206 (29%), Positives = 108/206 (52%), Gaps = 16/206 (7%)

Query: 330 NKLGQGGFGAVYKGRLYDGAE----IAVKRLSRDSGQGD-LEFKNEVLLVANLQHRNLVR 384
             +G G FG V  GRL   ++    +A+K L     +    +F  E  ++    H N++R
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 385 LLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSR 444
           L G   +    +++ E++ N SLD F+      AQ    +   ++ GIA G+ YL   S 
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL---SD 165

Query: 445 LRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT---YGYMAPEYAM 501
           +  +HRDL   N+L+++ +  K++DFG+ R+ E D     T+R  G      + +PE   
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIRWTSPEAIA 223

Query: 502 HGQYSVKSDVFSFGVLVLEIIS-GQR 526
           + +++  SDV+S+G+++ E++S G+R
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGER 249

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  147 bits (374), Expect = 6e-40
 Identities = 62/211 (29%), Positives = 104/211 (49%), Gaps = 23/211 (10%)

Query: 330 NKLGQGGFGAVYKGRLYDGAE----IAVKRLSRD--SGQGDLEFKNEVLLVANLQHRNLV 383
             LG+G FG+V +G L         +AVK +  D  S +   EF +E   + +  H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 384 RLLGFSLEGN-----ERLLIYEFVPNTSLDHFI---FDPTRRAQLDWERRYKIIGGIARG 435
           RLLG  +E +     + ++I  F+    L  ++      T    +  +   K +  IA G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 436 LLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDE-TQGNTSRI-VGTY 492
           + YL   S    +HRDL   N +L  +MT  +ADFG+++ ++  D   QG  +++ V   
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV--- 213

Query: 493 GYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
            ++A E      Y+ KSDV++FGV + EI +
Sbjct: 214 KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  146 bits (371), Expect = 9e-40
 Identities = 72/221 (32%), Positives = 112/221 (50%), Gaps = 26/221 (11%)

Query: 305 EINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGD 364
           E+ R E+L+                 +LG G FG V+ G      ++AVK L + S   D
Sbjct: 9   EVPR-ETLKLV--------------ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD 53

Query: 365 LEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWER 424
             F  E  L+  LQH+ LVRL     +     +I E++ N SL  F+  P    +L   +
Sbjct: 54  -AFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINK 110

Query: 425 RYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN 484
              +   IA G+ ++        IHRDL+ +N+L+   ++ KIADFG+ARL E +E    
Sbjct: 111 LLDMAAQIAEGMAFI---EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY--- 164

Query: 485 TSRIVGTYGY--MAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
           T+R    +     APE   +G +++KSDV+SFG+L+ EI++
Sbjct: 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  148 bits (375), Expect = 9e-40
 Identities = 49/206 (23%), Positives = 99/206 (48%), Gaps = 9/206 (4%)

Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVK--RLSRDSGQGDLEFKNEVLLVANLQHR 380
           + +    K+G+G FG     +   DG +  +K   +SR S +   E + EV ++AN++H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH 440
           N+V+      E     ++ ++     L   I +  +      ++       I   L ++H
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVH 142

Query: 441 EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA 500
           +    +I+HRD+K+ N+ L  + T ++ DFG+AR+             +GT  Y++PE  
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEIC 197

Query: 501 MHGQYSVKSDVFSFGVLVLEIISGQR 526
            +  Y+ KSD+++ G ++ E+ + + 
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKH 223

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  147 bits (374), Expect = 9e-40
 Identities = 65/214 (30%), Positives = 96/214 (44%), Gaps = 29/214 (13%)

Query: 330 NKLGQGGFGAVYKGRLYDGA------EIAVKRLSRDSGQGDL-EFKNEVLLVANLQHRNL 382
             LG G FG VY+G++          ++AVK L     + D  +F  E L+++   H+N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFI----FDPTRRAQLDWERRYKIIGGIARGLLY 438
           VR +G SL+   R ++ E +    L  F+      P++ + L       +   IA G  Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 439 LHEDSRLRIIHRDLKTSNVLLDAE---MTPKIADFGMAR-LFEMDETQGNTSRIVGTYGY 494
           L        IHRD+   N LL         KI DFGMAR ++     +       G    
Sbjct: 156 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR------KGGCAM 206

Query: 495 -----MAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
                M PE  M G ++ K+D +SFGVL+ EI S
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  146 bits (370), Expect = 2e-39
 Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 12/209 (5%)

Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRL---SRDSGQGDLEFKNEVLLVANLQH 379
            NF    K+G+G F  VY+   L DG  +A+K++        +   +   E+ L+  L H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 380 RNLVRLLGFSLEGNERLLIY-EFVPNTSLDHFIFDPTRRAQLDWERR-YKIIGGIARGLL 437
            N+++     +E NE L I  E      L   I    ++ +L  ER  +K    +   L 
Sbjct: 92  PNVIKYYASFIEDNE-LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150

Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           ++H     R++HRD+K +NV + A    K+ D G+ R F    T  ++  +VGT  YM+P
Sbjct: 151 HMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSP 205

Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQR 526
           E      Y+ KSD++S G L+ E+ + Q 
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQS 234

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  147 bits (374), Expect = 2e-39
 Identities = 65/214 (30%), Positives = 96/214 (44%), Gaps = 29/214 (13%)

Query: 330 NKLGQGGFGAVYKGRLYDGA------EIAVKRLSRDSGQGDL-EFKNEVLLVANLQHRNL 382
             LG G FG VY+G++          ++AVK L     + D  +F  E L+++   H+N+
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFI----FDPTRRAQLDWERRYKIIGGIARGLLY 438
           VR +G SL+   R ++ E +    L  F+      P++ + L       +   IA G  Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 439 LHEDSRLRIIHRDLKTSNVLLDAE---MTPKIADFGMAR-LFEMDETQGNTSRIVGTYGY 494
           L        IHRD+   N LL         KI DFGMAR ++     +       G    
Sbjct: 197 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR------KGGCAM 247

Query: 495 -----MAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
                M PE  M G ++ K+D +SFGVL+ EI S
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  145 bits (367), Expect = 3e-39
 Identities = 49/241 (20%), Positives = 93/241 (38%), Gaps = 53/241 (21%)

Query: 305 EINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGA--------EIAVKRL 356
           +I   E L F+                LGQG F  ++KG   +          E+ +K L
Sbjct: 4   KIRN-EDLIFN--------------ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL 48

Query: 357 SRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTR 416
            +        F     +++ L H++LV   G  + G+E +L+ EFV   SLD ++     
Sbjct: 49  DKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK--N 106

Query: 417 RAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP--------KIA 468
           +  ++   + ++   +A  + +L       +IH ++   N+LL  E           K++
Sbjct: 107 KNCINILWKLEVAKQLAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163

Query: 469 DFGMARLFEMDETQGNTSRIVGTYGY-----MAPEYAMHG-QYSVKSDVFSFGVLVLEII 522
           D G++      +                   + PE   +    ++ +D +SFG  + EI 
Sbjct: 164 DPGISITVLPKD-----------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEIC 212

Query: 523 S 523
           S
Sbjct: 213 S 213

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  145 bits (367), Expect = 3e-39
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 28/220 (12%)

Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNL 382
            +F +   +G GGFG V+K +   DG    +KR+  ++     + + EV  +A L H N+
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66

Query: 383 VRLLGF---------------SLEGNERLLIY-EFVPNTSLDHFIFDPTRRAQLDWERRY 426
           V   G                S    + L I  EF    +L+ +I +  R  +LD     
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125

Query: 427 KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTS 486
           ++   I +G+ Y+H     ++I+RDLK SN+ L      KI DFG+    + D   G  +
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKRT 179

Query: 487 RIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQR 526
           R  GT  YM+PE      Y  + D+++ G+++ E++    
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  145 bits (367), Expect = 3e-39
 Identities = 60/207 (28%), Positives = 85/207 (41%), Gaps = 19/207 (9%)

Query: 331 KLGQGGFGAVYKGRL--YDGAEI--AVKRL---SRDSGQGDLEFKNEVLLVANLQHRNLV 383
           KLG G FG V +G      G  +  AVK L        +   +F  EV  + +L HRNL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 384 RLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS 443
           RL G  L      ++ E  P  SL   +     +         +    +A G+ YL    
Sbjct: 85  RLYGVVLT-PPMKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYL---E 138

Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT---YGYMAPEYA 500
             R IHRDL   N+LL      KI DFG+ R    ++              + + APE  
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPESL 196

Query: 501 MHGQYSVKSDVFSFGVLVLEIIS-GQR 526
               +S  SD + FGV + E+ + GQ 
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQE 223

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  145 bits (369), Expect = 4e-39
 Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 24/212 (11%)

Query: 330 NKLGQGGFGAVYKGRLYDGAE----IAVKRLSRD-SGQGDLE-FKNEVLLVANLQHRNLV 383
             LG+G FG+V + +L         +AVK L  D     D+E F  E   +    H ++ 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 384 RLLGFSLEGNER------LLIYEFVPNTSLDHFIFD---PTRRAQLDWERRYKIIGGIAR 434
           +L+G SL    +      ++I  F+ +  L  F+           L  +   + +  IA 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDE-TQGNTSRI-VGT 491
           G+ YL   S    IHRDL   N +L  +MT  +ADFG++R ++  D   QG  S++ V  
Sbjct: 149 GMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPV-- 203

Query: 492 YGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
             ++A E      Y+V SDV++FGV + EI++
Sbjct: 204 -KWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  144 bits (365), Expect = 6e-39
 Identities = 54/205 (26%), Positives = 88/205 (42%), Gaps = 19/205 (9%)

Query: 331 KLGQGGFGAVYKGRL--YDGAEI--AVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLVRL 385
            +G+G FG V++G     +   +  A+K     +      +F  E L +    H ++V+L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 386 LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRL 445
           +G   E N   +I E      L  F+    R+  LD          ++  L YL      
Sbjct: 82  IGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYL---ESK 135

Query: 446 RIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE---TQGNTSRIVGTYGYMAPEYAMH 502
           R +HRD+   NVL+ +    K+ DFG++R  E             I     +MAPE    
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI----KWMAPESINF 191

Query: 503 GQYSVKSDVFSFGVLVLEIIS-GQR 526
            +++  SDV+ FGV + EI+  G +
Sbjct: 192 RRFTSASDVWMFGVCMWEILMHGVK 216

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  144 bits (365), Expect = 7e-39
 Identities = 63/268 (23%), Positives = 118/268 (44%), Gaps = 34/268 (12%)

Query: 331 KLGQGGFGAVYKGR-LYDGAEIAVKRLS-RDSGQGDLE-FKNEVLLVANLQHRNLVRLLG 387
           ++G+G F  VYKG       E+A   L  R   + + + FK E  ++  LQH N+VR   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 388 F---SLEGNERLLIY-EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS 443
               +++G + +++  E + + +L  ++    R   +  +        I +GL +LH  +
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRT 149

Query: 444 RLRIIHRDLKTSNVLLDAEM-TPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMH 502
              IIHRDLK  N+ +     + KI D G+A L    +       ++GT  +MAPE    
Sbjct: 150 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMAPEM-YE 203

Query: 503 GQYSVKSDVFSFGVLVLEIISGQR--NNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTL 560
            +Y    DV++FG+ +LE+ + +   + C           +  ++    G         +
Sbjct: 204 EKYDESVDVYAFGMCMLEMATSEYPYSEC--------QNAAQIYRRVTSGVKPASF-DKV 254

Query: 561 SSGSITEMIRCIHIGLLCVQENVASRPT 588
           +   + E+I        C+++N   R +
Sbjct: 255 AIPEVKEIIE------GCIRQNKDERYS 276

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  143 bits (363), Expect = 9e-39
 Identities = 56/204 (27%), Positives = 103/204 (50%), Gaps = 17/204 (8%)

Query: 331 KLGQGGFGAVYKGRL--YDGAEI--AVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLVRL 385
            LG+G FG VY+G    + G +I  AVK   +D    +  +F +E +++ NL H ++V+L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 386 LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRL 445
           +G   E     +I E  P   L H++     +  L           I + + YL     +
Sbjct: 79  IGIIEE-EPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYL---ESI 132

Query: 446 RIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE-TQGNTSRI-VGTYGYMAPEYAMHG 503
             +HRD+   N+L+ +    K+ DFG++R  E ++  + + +R+ +    +M+PE     
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPI---KWMSPESINFR 189

Query: 504 QYSVKSDVFSFGVLVLEIIS-GQR 526
           +++  SDV+ F V + EI+S G++
Sbjct: 190 RFTTASDVWMFAVCMWEILSFGKQ 213

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  144 bits (364), Expect = 9e-39
 Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 27/223 (12%)

Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQHRN 381
            +F     LG+GGFG V++ +   D    A+KR+   + +   E    EV  +A L+H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 382 LVRLLGFSLEGNE---------RLLIY---EFVPNTSLDHFIFDPTRRAQLDWERRYKII 429
           +VR     LE N          ++ +Y   +     +L  ++       + +      I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNT---- 485
             IA  + +LH      ++HRDLK SN+    +   K+ DFG+    + DE +       
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 486 ------SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEII 522
                 +  VGT  YM+PE      YS K D+FS G+++ E++
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  147 bits (374), Expect = 1e-38
 Identities = 63/220 (28%), Positives = 102/220 (46%), Gaps = 28/220 (12%)

Query: 305 EINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGD 364
            +N  + L+                  +G+G FG V  G  Y G ++AVK +  D+    
Sbjct: 189 ALNM-KELKLL--------------QTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATAQA 232

Query: 365 LEFKNEVLLVANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWE 423
             F  E  ++  L+H NLV+LLG  +E    L ++ E++   SL  ++     R+ L  +
Sbjct: 233 --FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGD 289

Query: 424 RRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQG 483
              K    +   + YL        +HRDL   NVL+  +   K++DFG+ +  E   TQ 
Sbjct: 290 CLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQD 344

Query: 484 NTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
              ++     + APE     ++S KSDV+SFG+L+ EI S
Sbjct: 345 TG-KL--PVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  147 bits (374), Expect = 1e-38
 Identities = 68/221 (30%), Positives = 108/221 (48%), Gaps = 26/221 (11%)

Query: 305 EINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGD 364
           EI R ESL+ +               KLG G FG V+        ++AVK +   S   +
Sbjct: 184 EIPR-ESLKLE--------------KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE 228

Query: 365 LEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWER 424
             F  E  ++  LQH  LV+L     +     +I EF+   SL  F+      ++    +
Sbjct: 229 -AFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSD-EGSKQPLPK 285

Query: 425 RYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN 484
                  IA G+ ++    +   IHRDL+ +N+L+ A +  KIADFG+AR+ E +E    
Sbjct: 286 LIDFSAQIAEGMAFI---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY--- 339

Query: 485 TSRIVGTYGY--MAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
           T+R    +     APE    G +++KSDV+SFG+L++EI++
Sbjct: 340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  143 bits (362), Expect = 1e-38
 Identities = 60/211 (28%), Positives = 92/211 (43%), Gaps = 10/211 (4%)

Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVK--RLSRDSGQGDLEFKNEVLLVANLQHR 380
           +++     +G G +G   K R   DG  +  K       +        +EV L+  L+H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 381 NLVRLLG-FSLEGNERLLIY-EFVPNTSLDHFIFDPTRRAQLDWERR-YKIIGGIARGLL 437
           N+VR         N  L I  E+     L   I   T+  Q   E    +++  +   L 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 438 YLHE--DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYM 495
             H   D    ++HRDLK +NV LD +   K+ DFG+AR+   D +   T   VGT  YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183

Query: 496 APEYAMHGQYSVKSDVFSFGVLVLEIISGQR 526
           +PE      Y+ KSD++S G L+ E+ +   
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMP 214

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  144 bits (364), Expect = 1e-38
 Identities = 65/273 (23%), Positives = 102/273 (37%), Gaps = 39/273 (14%)

Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRD--SGQGDLEFKNEVLLVANL-QH 379
            +F   ++LG G +G V+K R   DG   AVKR        +       EV     + QH
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116

Query: 380 RNLVRLLGFSLEGNERLLIY-EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
              VRL   + E    L +  E     SL          A L   + +  +      L +
Sbjct: 117 PCCVRLEQ-AWEEGGILYLQTELC-GPSLQQHCEA--WGASLPEAQVWGYLRDTLLALAH 172

Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
           LH      ++H D+K +N+ L      K+ DFG+    E+           G   YMAPE
Sbjct: 173 LHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLV--ELGTAGAGEV-QEGDPRYMAPE 226

Query: 499 YAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP 558
             + G Y   +DVFS G+ +LE+           GE         W+  R+G     + P
Sbjct: 227 -LLQGSYGTAADVFSLGLTILEVACNMEL--PHGGEG--------WQQLRQG----YLPP 271

Query: 559 TLS---SGSITEMIRCIHIGLLCVQENVASRPT 588
             +   S  +  ++       + ++ +   R T
Sbjct: 272 EFTAGLSSELRSVLV------MMLEPDPKLRAT 298

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  144 bits (366), Expect = 2e-38
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 43/228 (18%)

Query: 330 NKLGQGGFGAVYKGRLYDGAE------IAVKRLSRDSGQGDL-EFKNEVLLVANLQHRNL 382
             +G+G FG V++ R            +AVK L  ++      +F+ E  L+A   + N+
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHF---------------------IFDPTRRAQLD 421
           V+LLG    G    L++E++    L+ F                              L 
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 422 WERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMD- 479
              +  I   +A G+ YL   S  + +HRDL T N L+   M  KIADFG++R ++  D 
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229

Query: 480 -ETQGNTS---RIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
            +  GN +   R      +M PE   + +Y+ +SDV+++GV++ EI S
Sbjct: 230 YKADGNDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  148 bits (375), Expect = 2e-38
 Identities = 62/221 (28%), Positives = 104/221 (47%), Gaps = 24/221 (10%)

Query: 305 EINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQG 363
           E+ R   +                 +KLG G +G VY+G        +AVK L  D+ + 
Sbjct: 216 EMER-TDITMK--------------HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV 260

Query: 364 DLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWE 423
           + EF  E  ++  ++H NLV+LLG         +I EF+   +L  ++ +   R ++   
Sbjct: 261 E-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAV 318

Query: 424 RRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE-TQ 482
               +   I+  + YL    +   IHR+L   N L+      K+ADFG++RL   D  T 
Sbjct: 319 VLLYMATQISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 375

Query: 483 GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
              ++      + APE   + ++S+KSDV++FGVL+ EI +
Sbjct: 376 HAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  142 bits (361), Expect = 3e-38
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 24/208 (11%)

Query: 331 KLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDL--EFKNEVLLVANLQHRNLVRL 385
           +LG G FG V KG          +AVK L  ++    L  E   E  ++  L +  +VR+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 386 LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRL 445
           +G        +L+ E      L+ ++    +   +  +   +++  ++ G+ YL      
Sbjct: 84  IGICE-AESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---EES 136

Query: 446 RIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG------YMAPEY 499
             +HRDL   NVLL  +   KI+DFG+++    DE                   + APE 
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVKWYAPEC 191

Query: 500 AMHGQYSVKSDVFSFGVLVLEIIS-GQR 526
             + ++S KSDV+SFGVL+ E  S GQ+
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQK 219

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  141 bits (359), Expect = 3e-38
 Identities = 61/226 (26%), Positives = 98/226 (43%), Gaps = 40/226 (17%)

Query: 305 EINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGD 364
            +N  + L+                  +G+G FG V  G  Y G ++AVK +  D+    
Sbjct: 17  ALNM-KELKLL--------------QTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATAQA 60

Query: 365 LEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLI-YEFVPNTSLDHFIFDPTRRAQLDWE 423
             F  E  ++  L+H NLV+LLG  +E    L I  E++   SL  ++     R+ L  +
Sbjct: 61  --FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGD 117

Query: 424 RRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQG 483
              K    +   + YL        +HRDL   NVL+  +   K++DFG+ +    + +  
Sbjct: 118 CLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EAS-- 168

Query: 484 NTSRIVGTYG------YMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
                           + APE     ++S KSDV+SFG+L+ EI S
Sbjct: 169 -----STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  149 bits (377), Expect = 3e-38
 Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 16/204 (7%)

Query: 331 KLGQGGFGAVYKGRL-YDGAEI--AVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLVRLL 386
           +LG G FG+V +G       +I  A+K L + + + D  E   E  ++  L +  +VRL+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 387 GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLR 446
           G        +L+ E      L  F+    +R ++      +++  ++ G+ YL       
Sbjct: 403 GVCQA-EALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL---EEKN 456

Query: 447 IIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT---YGYMAPEYAMHG 503
            +HR+L   NVLL      KI+DFG+++    D++               + APE     
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR--SAGKWPLKWYAPECINFR 514

Query: 504 QYSVKSDVFSFGVLVLEIIS-GQR 526
           ++S +SDV+S+GV + E +S GQ+
Sbjct: 515 KFSSRSDVWSYGVTMWEALSYGQK 538

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  142 bits (360), Expect = 6e-38
 Identities = 57/228 (25%), Positives = 98/228 (42%), Gaps = 43/228 (18%)

Query: 330 NKLGQGGFGAVYKGRLYDGAE------IAVKRLSRDSGQGDL-EFKNEVLLVANLQHRNL 382
             LG+G FG V K   +          +AVK L  ++   +L +  +E  ++  + H ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88

Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHF---------------------IFDPTRRAQLD 421
           ++L G   +    LLI E+    SL  F                       D      L 
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 422 WERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDE 480
                     I++G+ YL   + ++++HRDL   N+L+      KI+DFG++R ++E D 
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205

Query: 481 TQGNTS-----RIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
               +      +      +MA E      Y+ +SDV+SFGVL+ EI++
Sbjct: 206 YVKRSQGRIPVK------WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  142 bits (360), Expect = 8e-38
 Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 36/222 (16%)

Query: 330 NKLGQGGFGAVYKGRLYDGAE--------IAVKRLSRDSGQGDL-EFKNEVLLVANL-QH 379
             LG+G FG V         +        +AVK L  D+ + DL +  +E+ ++  + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHF-------------IFDPTRRAQLDWERRY 426
           +N++ LLG   +     +I E+    +L  +               +     Q+ ++   
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 427 KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTS 486
                +ARG+ YL   +  + IHRDL   NVL+      KIADFG+AR     +      
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY---- 213

Query: 487 RIVGTYG-----YMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
               T G     +MAPE      Y+ +SDV+SFGVL+ EI +
Sbjct: 214 -KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  142 bits (360), Expect = 8e-38
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 28/214 (13%)

Query: 330 NKLGQGGFGAVYKGRLYDGAE---IAVKRLSRDSGQGDL-EFKNEVLLVANL-QHRNLVR 384
           + +G+G FG V K R+         A+KR+   + + D  +F  E+ ++  L  H N++ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 385 LLGFSLEGNERLLIYEFVPNTSLDHF-------------IFDPTRRAQLDWERRYKIIGG 431
           LLG         L  E+ P+ +L  F                 +  + L  ++       
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150

Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE-TQGNTSRI-V 489
           +ARG+ YL   S+ + IHRDL   N+L+      KIADFG++R    +   +    R+ V
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPV 205

Query: 490 GTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
               +MA E   +  Y+  SDV+S+GVL+ EI+S
Sbjct: 206 ---RWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  141 bits (358), Expect = 1e-37
 Identities = 58/218 (26%), Positives = 91/218 (41%), Gaps = 28/218 (12%)

Query: 330 NKLGQGGFGAVYKGRLYDGAE------IAVKRLSRDSGQGDL-EFKNEVLLVANL-QHRN 381
             LG G FG V +   Y   +      +AVK L   +   +     +E+ +++ L  H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHF---------------IFDPTRRAQLDWERRY 426
           +V LLG    G   L+I E+     L +F                        LD E   
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 427 KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQGNT 485
                +A+G+ +L   +    IHRDL   N+LL      KI DFG+AR +          
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205

Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
           +  +    +MAPE   +  Y+ +SDV+S+G+ + E+ S
Sbjct: 206 NARL-PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  142 bits (360), Expect = 2e-37
 Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 36/222 (16%)

Query: 330 NKLGQGGFGAVYKGRLYDGAE--------IAVKRLSRDSGQGDL-EFKNEVLLVANL-QH 379
             LG+G FG V         +        +AVK L  D+ + DL +  +E+ ++  + +H
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146

Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHF-------------IFDPTRRAQLDWERRY 426
           +N++ LLG   +     +I E+    +L  +               +     Q+ ++   
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206

Query: 427 KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTS 486
                +ARG+ YL   +  + IHRDL   NVL+      KIADFG+AR     +      
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY---- 259

Query: 487 RIVGTYG-----YMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
               T G     +MAPE      Y+ +SDV+SFGVL+ EI +
Sbjct: 260 -KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  141 bits (357), Expect = 2e-37
 Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 31/219 (14%)

Query: 330 NKLGQGGFGAVYKGRLYDGAE------IAVKRLSRDSGQGDL-EFKNEVLLVANL-QHRN 381
             LG+G FG V +   +   +      +AVK L   +   +     +E+ ++ ++  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 382 LVRLLGF-SLEGNERLLIYEFVPNTSLDHF-------------IFDPTRRAQLDWERRYK 427
           +V LLG  +  G   ++I EF    +L  +               +   +  L  E    
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 428 IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDE-TQGNT 485
               +A+G+ +L   +  + IHRDL   N+LL  +   KI DFG+AR +++  +  +   
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209

Query: 486 SRI-VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
           +R+ +    +MAPE      Y+++SDV+SFGVL+ EI S
Sbjct: 210 ARLPL---KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  140 bits (354), Expect = 3e-37
 Identities = 69/293 (23%), Positives = 114/293 (38%), Gaps = 47/293 (16%)

Query: 323 TDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRN 381
             +F +   LGQG FG V K R   D    A+K++     +      +EV+L+A+L H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVMLLASLNHQY 63

Query: 382 LVRLLGFSLEGNERLL----------IY---EFVPNTSLDHFIFDPTRRAQLDWERRYKI 428
           +VR     LE    +           ++   E+  N +L   I   +       +  +++
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQRDEYWRL 121

Query: 429 IGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE----------- 477
              I   L Y+H      IIHRDLK  N+ +D     KI DFG+A+              
Sbjct: 122 FRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178

Query: 478 -MDETQGNTSRIVGTYGYMAPE-YAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGET 535
            +  +  N +  +GT  Y+A E     G Y+ K D++S G++  E+I       F  G  
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP-----FSTGME 233

Query: 536 VEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPT 588
             ++     K  R  +      P      +    + I    L +  +   RP 
Sbjct: 234 RVNI----LKKLRSVSI--EFPPDFDDNKMKVEKKIIR---LLIDHDPNKRPG 277

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  143 bits (363), Expect = 3e-37
 Identities = 70/238 (29%), Positives = 115/238 (48%), Gaps = 24/238 (10%)

Query: 288 RKPRDNSKVKSEAAAGD--EINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRL 345
                 SK +++  A D  EI R ESL+ +               KLGQG FG V+ G  
Sbjct: 161 TTVCPTSKPQTQGLAKDAWEIPR-ESLRLE--------------VKLGQGCFGEVWMGTW 205

Query: 346 YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNT 405
                +A+K L   +   +  F  E  ++  L+H  LV+L     E     ++ E++   
Sbjct: 206 NGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKG 263

Query: 406 SLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP 465
           SL  F+        L   +   +   IA G+ Y+    R+  +HRDL+ +N+L+   +  
Sbjct: 264 SLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVC 319

Query: 466 KIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
           K+ADFG+ARL E +E             + APE A++G++++KSDV+SFG+L+ E+ +
Sbjct: 320 KVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 376

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  139 bits (353), Expect = 3e-37
 Identities = 66/234 (28%), Positives = 110/234 (47%), Gaps = 16/234 (6%)

Query: 298 SEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRL 356
           S  +  +    ++ L++D+       D   D   LG+G +G VY GR L +   IA+K +
Sbjct: 1   SMRSTEEGDCESDLLEYDYEY-----DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI 55

Query: 357 SRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY-EFVPNTSLDHFIFDPT 415
                +       E+ L  +L+H+N+V+ LG   E    + I+ E VP  SL   +    
Sbjct: 56  PERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG-FIKIFMEQVPGGSLSALLRSKW 114

Query: 416 RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM-TPKIADFGMAR 474
              + + +        I  GL YLH++   +I+HRD+K  NVL++      KI+DFG ++
Sbjct: 115 GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSK 171

Query: 475 LFEMDETQGNTSRIVGTYGYMAPEYAMHGQ--YSVKSDVFSFGVLVLEIISGQR 526
              +      T    GT  YMAPE    G   Y   +D++S G  ++E+ +G+ 
Sbjct: 172 --RLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKP 223

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  140 bits (355), Expect = 4e-37
 Identities = 71/283 (25%), Positives = 111/283 (39%), Gaps = 64/283 (22%)

Query: 282 ICFFLRRKPRDNSKVKS-EAAAGD----------------EINRAESLQFDFNTIRVATD 324
           + +  ++KP+   + K  E+  G+                E  R  +LQF          
Sbjct: 2   VDYKYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPR-NNLQFG--------- 51

Query: 325 NFSDANKLGQGGFGAVYKGRLYDGAE------IAVKRLSRDSGQGDL-EFKNEVLLVANL 377
                  LG G FG V +   +   +      +AVK L   +   +     +E+ ++++L
Sbjct: 52  -----KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 106

Query: 378 -QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHF-----------IFDPTRRAQLDWERR 425
            QH N+V LLG    G   L+I E+     L +F                  +       
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166

Query: 426 YKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNT 485
                 +A+G+ +L   +    IHRD+   NVLL      KI DFG+AR    D      
Sbjct: 167 LHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY--- 220

Query: 486 SRIVGTYG-----YMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
             IV         +MAPE      Y+V+SDV+S+G+L+ EI S
Sbjct: 221 --IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  140 bits (354), Expect = 6e-37
 Identities = 60/245 (24%), Positives = 101/245 (41%), Gaps = 16/245 (6%)

Query: 287 RRKPRDNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGR-L 345
                   ++  E    + +   E L+      R      +   ++G+G FG V++ +  
Sbjct: 21  SSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDK 80

Query: 346 YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNT 405
             G + AVK++  +  +       E++  A L    +V L G   EG    +  E +   
Sbjct: 81  QTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG 135

Query: 406 SLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP 465
           SL   I    +   L  +R    +G    GL YLH     RI+H D+K  NVLL ++ + 
Sbjct: 136 SLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSR 189

Query: 466 -KIADFGMARLFEMDETQGNTSR---IVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEI 521
             + DFG A   + D    +      I GT  +MAPE  M      K D++S   ++L +
Sbjct: 190 AALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHM 249

Query: 522 ISGQR 526
           ++G  
Sbjct: 250 LNGCH 254

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  144 bits (364), Expect = 6e-37
 Identities = 68/234 (29%), Positives = 112/234 (47%), Gaps = 22/234 (9%)

Query: 290 PRDNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGA 349
           P    + +  A    EI R ESL+ +               KLGQG FG V+ G      
Sbjct: 248 PTSKPQTQGLAKDAWEIPR-ESLRLE--------------VKLGQGCFGEVWMGTWNGTT 292

Query: 350 EIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDH 409
            +A+K L   +   +  F  E  ++  L+H  LV+L     E     ++ E++   SL  
Sbjct: 293 RVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLD 350

Query: 410 FIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIAD 469
           F+        L   +   +   IA G+ Y+    R+  +HRDL+ +N+L+   +  K+AD
Sbjct: 351 FLKGE-TGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVAD 406

Query: 470 FGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
           FG+ARL E +E             + APE A++G++++KSDV+SFG+L+ E+ +
Sbjct: 407 FGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 459

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  138 bits (351), Expect = 9e-37
 Identities = 50/233 (21%), Positives = 95/233 (40%), Gaps = 23/233 (9%)

Query: 308 RAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDL-- 365
              +    F ++ V    +S   ++G GG   V++         A+K ++ +        
Sbjct: 12  DLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD 71

Query: 366 EFKNEVLLVANLQHRNL--VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWE 423
            ++NE+  +  LQ  +   +RL  + +      ++ E   N  L+ ++    ++  +D  
Sbjct: 72  SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPW 127

Query: 424 RRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQG 483
            R      +   +  +H+     I+H DLK +N L+  +   K+ DFG+A   + D T  
Sbjct: 128 ERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 183

Query: 484 NTSRIVGTYGYMAPE-----------YAMHGQYSVKSDVFSFGVLVLEIISGQ 525
                VGT  YM PE                + S KSDV+S G ++  +  G+
Sbjct: 184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  140 bits (354), Expect = 1e-36
 Identities = 62/222 (27%), Positives = 97/222 (43%), Gaps = 36/222 (16%)

Query: 330 NKLGQGGFGAVYKGRLYDGA--------EIAVKRLSRDSGQGDL-EFKNEVLLVANL-QH 379
             LG+G FG V                 ++AVK L  D+ + DL +  +E+ ++  + +H
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134

Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHF-------------IFDPTRRAQLDWERRY 426
           +N++ LLG   +     +I E+    +L  +                     QL  +   
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 427 KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTS 486
                +ARG+ YL   +  + IHRDL   NVL+  +   KIADFG+AR     +      
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY---- 247

Query: 487 RIVGTYG-----YMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
               T G     +MAPE      Y+ +SDV+SFGVL+ EI +
Sbjct: 248 -KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  137 bits (348), Expect = 4e-36
 Identities = 50/224 (22%), Positives = 92/224 (41%), Gaps = 23/224 (10%)

Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDL--EFKNEVLLV 374
             I V    +S   ++G GG   V++         A+K ++ +         ++NE+  +
Sbjct: 2   ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 61

Query: 375 ANLQHRNL--VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGI 432
             LQ  +   +RL  + +      ++ E   N  L+ ++    ++  +D   R      +
Sbjct: 62  NKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKNM 117

Query: 433 ARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY 492
              +  +H+     I+H DLK +N L+  +   K+ DFG+A   + D T       VGT 
Sbjct: 118 LEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTV 173

Query: 493 GYMAPE-----------YAMHGQYSVKSDVFSFGVLVLEIISGQ 525
            YM PE                + S KSDV+S G ++  +  G+
Sbjct: 174 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  143 bits (361), Expect = 4e-36
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 14/199 (7%)

Query: 331 KLGQGGFGAVYKGRL--YDGAEI--AVKRLSRDSGQGDL-EFKNEVLLVANLQHRNLVRL 385
            +G+G FG V++G     +   +  A+K     +      +F  E L +    H ++V+L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456

Query: 386 LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRL 445
           +G   E N   +I E      L  F+    R+  LD          ++  L YL      
Sbjct: 457 IGVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYL---ESK 510

Query: 446 RIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE-TQGNTSRIVGTYGYMAPEYAMHGQ 504
           R +HRD+   NVL+ +    K+ DFG++R  E     + +  ++     +MAPE     +
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRR 568

Query: 505 YSVKSDVFSFGVLVLEIIS 523
           ++  SDV+ FGV + EI+ 
Sbjct: 569 FTSASDVWMFGVCMWEILM 587

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  137 bits (346), Expect = 8e-36
 Identities = 58/228 (25%), Positives = 92/228 (40%), Gaps = 43/228 (18%)

Query: 330 NKLGQGGFGAVYKGRLYDGAE------IAVKRLSRDSGQGDL-EFKNEVLLVANL-QHRN 381
             LG G FG V     Y  ++      +AVK L   +   +     +E+ ++  L  H N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110

Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHF--------------------IFDPTRRAQLD 421
           +V LLG         LI+E+     L ++                    + +      L 
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170

Query: 422 WERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDE 480
           +E        +A+G+ +L        +HRDL   NVL+      KI DFG+AR +     
Sbjct: 171 FEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227

Query: 481 TQGNTS-----RIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
                +     +      +MAPE    G Y++KSDV+S+G+L+ EI S
Sbjct: 228 YVVRGNARLPVK------WMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  136 bits (345), Expect = 3e-35
 Identities = 52/254 (20%), Positives = 99/254 (38%), Gaps = 24/254 (9%)

Query: 287 RRKPRDNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLY 346
               +   +       G + +   S       I V    +S   ++G GG   V++    
Sbjct: 20  TAAAKFERQHMDSPDLGTDDDDKASSS-ANECISVKGRIYSILKQIGSGGSSKVFQVLNE 78

Query: 347 DGAEIAVKRLSRDS-GQGDLE-FKNEVLLVANLQHRNL--VRLLGFSLEGNERLLIYEFV 402
                A+K ++ +      L+ ++NE+  +  LQ  +   +RL  + +      ++ E  
Sbjct: 79  KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG 138

Query: 403 PNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE 462
            N  L+ ++    ++  +D   R      +   +  +H+     I+H DLK +N L+  +
Sbjct: 139 -NIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-D 190

Query: 463 MTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE-----------YAMHGQYSVKSDV 511
              K+ DFG+A   + D T       VG   YM PE                + S KSDV
Sbjct: 191 GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDV 250

Query: 512 FSFGVLVLEIISGQ 525
           +S G ++  +  G+
Sbjct: 251 WSLGCILYYMTYGK 264

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  133 bits (336), Expect = 1e-34
 Identities = 67/310 (21%), Positives = 122/310 (39%), Gaps = 38/310 (12%)

Query: 318 TIRVATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVAN 376
            + +   ++    KLG+GGF  V     L+DG   A+KR+     Q   E + E  +   
Sbjct: 23  MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRL 82

Query: 377 LQHRNLVRLLGFSLE----GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERR-YKIIGG 431
             H N++RL+ + L      +E  L+  F    +L + I     +     E +   ++ G
Sbjct: 83  FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLG 142

Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIV-- 489
           I RGL  +H        HRDLK +N+LL  E  P + D G      +       +  +  
Sbjct: 143 ICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQD 199

Query: 490 -----GTYGYMAPE---YAMHGQYSVKSDVFSFGVLVLEIISGQR--NNCFRNGETVEDL 539
                 T  Y APE      H     ++DV+S G ++  ++ G+   +  F+ G++V   
Sbjct: 200 WAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259

Query: 540 LSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY 599
           + +            I      S ++ +++         +  +   RP +  ++  L   
Sbjct: 260 VQNQLS---------IPQSPRHSSALWQLLNS------MMTVDPHQRPHIPLLLSQLE-- 302

Query: 600 SLTLPVPSEP 609
           +L  P P + 
Sbjct: 303 ALQPPAPGQH 312

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  132 bits (334), Expect = 1e-34
 Identities = 67/292 (22%), Positives = 113/292 (38%), Gaps = 54/292 (18%)

Query: 323 TDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSR-DSGQGDLEFK-NEVLLVANL-Q 378
           T  F +  K+G G FG+V+K     DG   A+KR  +  +G  D +    EV   A L Q
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 379 HRNLVRLLGFSLEGNERLLIY-EFVPNTSLDHFIFDPTRRAQLDWERR-YKIIGGIARGL 436
           H ++VR      E +  +LI  E+    SL   I +  R      E     ++  + RGL
Sbjct: 70  HSHVVRYFSAWAEDD-HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128

Query: 437 LYLHEDSRLRIIHRDLKTSNVLLD-------------------AEMTPKIADFGMARLFE 477
            Y+H      ++H D+K SN+ +                     ++  KI D G      
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185

Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETV 536
             + +       G   ++A E       +  K+D+F+  + V+     +     RNG+  
Sbjct: 186 SPQVE------EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP--LPRNGD-- 235

Query: 537 EDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPT 588
                  W   R+G    I  P + S   TE+++      + +  +   RP+
Sbjct: 236 ------QWHEIRQGRLPRI--PQVLSQEFTELLK------VMIHPDPERRPS 273

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  132 bits (334), Expect = 2e-34
 Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 22/221 (9%)

Query: 321 VATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQ 378
            +   +  ++ LGQG    V++GR    G   A+K  +  S    ++    E  ++  L 
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65

Query: 379 HRNLVRLLGF--SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGL 436
           H+N+V+L           ++LI EF P  SL   + +P+    L       ++  +  G+
Sbjct: 66  HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125

Query: 437 LYLHEDSRLRIIHRDLKTSNVLL----DAEMTPKIADFGMARLFEMDETQGNTSRIVGTY 492
            +L E     I+HR++K  N++     D +   K+ DFG AR  E D+ Q  +  + GT 
Sbjct: 126 NHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--LYGTE 179

Query: 493 GYMAPE--------YAMHGQYSVKSDVFSFGVLVLEIISGQ 525
            Y+ P+             +Y    D++S GV      +G 
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  134 bits (340), Expect = 2e-34
 Identities = 52/219 (23%), Positives = 93/219 (42%), Gaps = 21/219 (9%)

Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEF-KNEV-LLV 374
           + + V   +F   + LG G  G +    ++D  ++AVKR+  +       F   EV LL 
Sbjct: 17  SVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE----CFSFADREVQLLR 72

Query: 375 ANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
            + +H N++R      +   + +  E    T  ++          L+      ++     
Sbjct: 73  ESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLE---PITLLQQTTS 129

Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLL-----DAEMTPKIADFGMARLFEMDE-TQGNTSRI 488
           GL +LH    L I+HRDLK  N+L+       ++   I+DFG+ +   +   +    S +
Sbjct: 130 GLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV 186

Query: 489 VGTYGYMAPEY---AMHGQYSVKSDVFSFGVLVLEIISG 524
            GT G++APE          +   D+FS G +   +IS 
Sbjct: 187 PGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  130 bits (328), Expect = 1e-33
 Identities = 54/201 (26%), Positives = 97/201 (48%), Gaps = 13/201 (6%)

Query: 331 KLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLE----FKNEVLLVANLQHRNLVRL 385
           KLG GG   VY         ++A+K +     +   E    F+ EV   + L H+N+V +
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAI-FIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76

Query: 386 LGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRL 445
           +    E +   L+ E++   +L  +I        L  +        I  G+ + H    +
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH---DM 130

Query: 446 RIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQY 505
           RI+HRD+K  N+L+D+  T KI DFG+A+    + +   T+ ++GT  Y +PE A     
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEAT 189

Query: 506 SVKSDVFSFGVLVLEIISGQR 526
              +D++S G+++ E++ G+ 
Sbjct: 190 DECTDIYSIGIVLYEMLVGEP 210

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  131 bits (330), Expect = 2e-33
 Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 22/221 (9%)

Query: 321 VATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQ 378
            +   +  ++ LGQG    V++GR    G   A+K  +  S    ++    E  ++  L 
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65

Query: 379 HRNLVRLLGF--SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGL 436
           H+N+V+L           ++LI EF P  SL   + +P+    L       ++  +  G+
Sbjct: 66  HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125

Query: 437 LYLHEDSRLRIIHRDLKTSNVLL----DAEMTPKIADFGMARLFEMDETQGNTSRIVGTY 492
            +L E     I+HR++K  N++     D +   K+ DFG AR  E D+ Q  +  + GT 
Sbjct: 126 NHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--LYGTE 179

Query: 493 GYMAPE--------YAMHGQYSVKSDVFSFGVLVLEIISGQ 525
            Y+ P+             +Y    D++S GV      +G 
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  134 bits (337), Expect = 5e-33
 Identities = 60/207 (28%), Positives = 91/207 (43%), Gaps = 17/207 (8%)

Query: 331 KLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLVRLL-- 386
           +LG GGFG V +      G ++A+K+  ++    + E +  E+ ++  L H N+V     
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80

Query: 387 ----GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
                     +  LL  E+     L  ++        L       ++  I+  L YLHE 
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE- 139

Query: 443 SRLRIIHRDLKTSNVLLDAE---MTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
              RIIHRDLK  N++L      +  KI D G A+  +           VGT  Y+APE 
Sbjct: 140 --NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEF--VGTLQYLAPEL 194

Query: 500 AMHGQYSVKSDVFSFGVLVLEIISGQR 526
               +Y+V  D +SFG L  E I+G R
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFR 221

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  127 bits (322), Expect = 5e-33
 Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 10/204 (4%)

Query: 323 TDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRN 381
              ++   K+GQG  G VY    +  G E+A+++++           NE+L++   ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           +V  L   L G+E  ++ E++   SL     D      +D  +   +     + L +LH 
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHS 134

Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM 501
           +   ++IHRD+K+ N+LL  + + K+ DFG     ++   Q   S +VGT  +MAPE   
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVT 189

Query: 502 HGQYSVKSDVFSFGVLVLEIISGQ 525
              Y  K D++S G++ +E+I G+
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGE 213

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  129 bits (326), Expect = 5e-33
 Identities = 57/222 (25%), Positives = 101/222 (45%), Gaps = 19/222 (8%)

Query: 310 ESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEF- 367
             L        +  D+F   ++LG G  G V+K      G  +A K +  +         
Sbjct: 19  AFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI 78

Query: 368 KNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYK 427
             E+ ++       +V   G      E  +  E +   SLD  +    R  +       +
Sbjct: 79  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-------Q 131

Query: 428 IIGGIAR----GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQG 483
           I+G ++     GL YL E    +I+HRD+K SN+L+++    K+ DFG++   ++ ++  
Sbjct: 132 ILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMA 187

Query: 484 NTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           N+   VGT  YM+PE      YSV+SD++S G+ ++E+  G+
Sbjct: 188 NS--FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  127 bits (322), Expect = 8e-33
 Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 10/204 (4%)

Query: 323 TDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRN 381
                   K+G+G  G V   R  + G ++AVK +     Q      NEV+++ + QH N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           +V +    L G E  ++ EF+   +L     D   + +L+ E+   +   + + L YLH 
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHA 159

Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM 501
                +IHRD+K+ ++LL  +   K++DFG     ++ +       +VGT  +MAPE   
Sbjct: 160 Q---GVIHRDIKSDSILLTLDGRVKLSDFGFCA--QISKDVPKRKSLVGTPYWMAPEVIS 214

Query: 502 HGQYSVKSDVFSFGVLVLEIISGQ 525
              Y+ + D++S G++V+E++ G+
Sbjct: 215 RSLYATEVDIWSLGIMVIEMVDGE 238

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  126 bits (320), Expect = 8e-33
 Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 28/223 (12%)

Query: 318 TIRVATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVL---- 372
           ++ V  D+     +LG+G +G V K R +  G  +AVKR+       + + +  +L    
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV---NSQEQKRLLMDLD 57

Query: 373 -LVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG 431
             +  +     V   G      +  +  E + +TSLD F      + Q   E    I+G 
Sbjct: 58  ISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPE---DILGK 113

Query: 432 IAR----GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET-QGNTS 486
           IA      L +LH  S+L +IHRD+K SNVL++A    K+ DFG++    + +    +  
Sbjct: 114 IAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISG--YLVDDVAKDID 169

Query: 487 RIVGTYGYMAPE----YAMHGQYSVKSDVFSFGVLVLEIISGQ 525
              G   YMAPE          YSVKSD++S G+ ++E+   +
Sbjct: 170 --AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  127 bits (321), Expect = 8e-33
 Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 19/209 (9%)

Query: 323 TDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQHR 380
            + F+   K+G+G FG V+KG        +A+K +  +  + ++E  + E+ +++     
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR----GL 436
            + +  G  L+  +  +I E++   S    +        LD E     I  I R    GL
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLD-E---TQIATILREILKGL 132

Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMA 496
            YLH +   + IHRD+K +NVLL      K+ADFG+A   ++ +TQ   +  VGT  +MA
Sbjct: 133 DYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMA 187

Query: 497 PEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           PE      Y  K+D++S G+  +E+  G+
Sbjct: 188 PEVIKQSAYDSKADIWSLGITAIELARGE 216

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  126 bits (318), Expect = 1e-32
 Identities = 58/198 (29%), Positives = 104/198 (52%), Gaps = 13/198 (6%)

Query: 332 LGQGGFGAVYKGR-LYDGAEIAVKRLSRDS-GQGDLE--FKNEVLLVANLQHRNLVRLLG 387
           LG+G F  VY+   ++ G E+A+K + + +  +  +    +NEV +   L+H +++ L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 388 FSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLR 446
           +  E +  + L+ E   N  ++ ++ +  +    +  R +  +  I  G+LYLH      
Sbjct: 79  Y-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF--MHQIITGMLYLH---SHG 132

Query: 447 IIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYS 506
           I+HRDL  SN+LL   M  KIADFG+A   +M   +  T  + GT  Y++PE A    + 
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIATRSAHG 190

Query: 507 VKSDVFSFGVLVLEIISG 524
           ++SDV+S G +   ++ G
Sbjct: 191 LESDVWSLGCMFYTLLIG 208

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  127 bits (321), Expect = 2e-32
 Identities = 62/237 (26%), Positives = 109/237 (45%), Gaps = 30/237 (12%)

Query: 306 INRAESLQFDFN-TIRVATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQG 363
           I  +  L+           ++  D  ++G+G +G+V K      G  +AVKR+       
Sbjct: 3   IESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--- 59

Query: 364 DLEFKNEVL-----LVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRA 418
           D + + ++L     ++ +     +V+  G      +  +  E + +TS D F     +  
Sbjct: 60  DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFY----KYV 114

Query: 419 QLDWERRY--KIIGGIAR----GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGM 472
               +     +I+G I       L +L E+  L+IIHRD+K SN+LLD     K+ DFG+
Sbjct: 115 YSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGI 172

Query: 473 ARLFEMDETQGNTSRIVGTYGYMAPE----YAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           +   ++ ++   T R  G   YMAPE     A    Y V+SDV+S G+ + E+ +G+
Sbjct: 173 SG--QLVDSIAKT-RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  127 bits (320), Expect = 2e-32
 Identities = 59/199 (29%), Positives = 92/199 (46%), Gaps = 16/199 (8%)

Query: 332 LGQGGFGAVYKGR-LYDGAEIAVKRLSRDS-GQGDLE--FKNEVLLVANLQHRNLVRLLG 387
           LG+GGF   ++          A K + +    +         E+ +  +L H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 388 FSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLD-WERRYKIIGGIARGLLYLHEDSRL 445
           F  E N+ + ++ E     SL        RR  L   E RY +   I  G  YLH   R 
Sbjct: 109 F-FEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQ-IVLGCQYLH---RN 160

Query: 446 RIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQY 505
           R+IHRDLK  N+ L+ ++  KI DFG+A   E D  +     + GT  Y+APE      +
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGH 218

Query: 506 SVKSDVFSFGVLVLEIISG 524
           S + DV+S G ++  ++ G
Sbjct: 219 SFEVDVWSIGCIMYTLLVG 237

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  125 bits (317), Expect = 3e-32
 Identities = 59/199 (29%), Positives = 92/199 (46%), Gaps = 16/199 (8%)

Query: 332 LGQGGFGAVYKGR-LYDGAEIAVKRLSRDS-GQGDLE--FKNEVLLVANLQHRNLVRLLG 387
           LG+GGF   ++          A K + +    +         E+ +  +L H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 388 FSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLD-WERRYKIIGGIARGLLYLHEDSRL 445
           F  E N+ + ++ E     SL        RR  L   E RY +   I  G  YLH   R 
Sbjct: 83  F-FEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQ-IVLGCQYLH---RN 134

Query: 446 RIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQY 505
           R+IHRDLK  N+ L+ ++  KI DFG+A   E D  +     + GT  Y+APE      +
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGH 192

Query: 506 SVKSDVFSFGVLVLEIISG 524
           S + DV+S G ++  ++ G
Sbjct: 193 SFEVDVWSIGCIMYTLLVG 211

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  125 bits (317), Expect = 4e-32
 Identities = 48/203 (23%), Positives = 80/203 (39%), Gaps = 17/203 (8%)

Query: 331 KLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDLE----FKNEVLLVANLQHRNLV 383
            +G+GG G VY+    D      +A+K +S      D       + E      LQ  ++V
Sbjct: 41  LVGRGGMGDVYEAE--DTVRERIVALKLMSETL-SSDPVFRTRMQREARTAGRLQEPHVV 97

Query: 384 RLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS 443
            +  F     +  +    +    L   +    R+  L   R   I+  I   L   H   
Sbjct: 98  PIHDFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAHAA- 153

Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG 503
                HRD+K  N+L+ A+    + DFG+A     DE        VGT  YMAPE     
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFSES 210

Query: 504 QYSVKSDVFSFGVLVLEIISGQR 526
             + ++D+++   ++ E ++G  
Sbjct: 211 HATYRADIYALTCVLYECLTGSP 233

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  124 bits (313), Expect = 9e-32
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 14/213 (6%)

Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQHRN 381
           D++     +G G    V          ++A+KR++ +  Q  ++    E+  ++   H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWER-RYKIIGGIAR----GL 436
           +V      +  +E  L+ + +   S+   I     + +          I  I R    GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGM-ARLFEMDETQGNTSR--IVGTYG 493
            YLH++     IHRD+K  N+LL  + + +IADFG+ A L    +   N  R   VGT  
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 494 YMAPEYAMHGQ-YSVKSDVFSFGVLVLEIISGQ 525
           +MAPE     + Y  K+D++SFG+  +E+ +G 
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  129 bits (326), Expect = 1e-31
 Identities = 46/217 (21%), Positives = 81/217 (37%), Gaps = 27/217 (12%)

Query: 331 KLGQGGFGAVYKGR--LYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLVRLLG 387
            +  GG G +Y       +G  + +K L              E   +A + H ++V++  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 388 FSLEGNERL-----LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           F    +        ++ E+V   SL           +L        +  I   L YLH  
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSYLH-- 199

Query: 443 SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMH 502
             + +++ DLK  N++L  E   K+ D G            +   + GT G+ APE    
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS------RINSFGYLYGTPGFQAPEIVRT 251

Query: 503 GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDL 539
           G  +V +D+++ G  +  +         RNG  V+ L
Sbjct: 252 GP-TVATDIYTVGRTLAALTLDLP---TRNGRYVDGL 284

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  122 bits (308), Expect = 5e-31
 Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 23/209 (11%)

Query: 331 KLGQGGFGAVYKG---RLYDGAEIAVKRLSRDSGQGDLE----FKNEVLLVANLQHRNLV 383
            LG GG   V+     R     ++AVK L R     D      F+ E    A L H  +V
Sbjct: 19  ILGFGGMSEVHLARDLRD--HRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIV 75

Query: 384 RLL--GFSLEGNERLLIY---EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
            +   G + E     L Y   E+V   +L   +        +  +R  ++I    + L +
Sbjct: 76  AVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNF 131

Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR-LFEMDETQGNTSRIVGTYGYMAP 497
            H   +  IIHRD+K +N+++ A    K+ DFG+AR + +   +   T+ ++GT  Y++P
Sbjct: 132 SH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQR 526
           E A       +SDV+S G ++ E+++G+ 
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  122 bits (309), Expect = 2e-30
 Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 24/222 (10%)

Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKN-EVLL 373
           D  T       +++   +G G FG V++ +L +  E+A+K++ +D       FKN E+ +
Sbjct: 31  DGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK-----RFKNRELQI 85

Query: 374 VANLQHRNLVRLLGFSLEGNERL------LIYEFVPNTSLDHFIFDPTRRAQLDWERRYK 427
           +  ++H N+V L  F     ++       L+ E+VP  ++        +  Q       K
Sbjct: 86  MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRASRHYAKLKQTMPMLLIK 144

Query: 428 IIG-GIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP-KIADFGMARLFEMDETQGNT 485
           +    + R L Y+H    + I HRD+K  N+LLD      K+ DFG A++    E   N 
Sbjct: 145 LYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP--NV 199

Query: 486 SRIVGTYGYMAPEYAMHG--QYSVKSDVFSFGVLVLEIISGQ 525
           S I   Y Y APE  + G   Y+   D++S G ++ E++ GQ
Sbjct: 200 SYICSRY-YRAPE-LIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  120 bits (303), Expect = 3e-30
 Identities = 54/236 (22%), Positives = 98/236 (41%), Gaps = 22/236 (9%)

Query: 301 AAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRD 359
           ++G    +   L       +   ++  +  ++G G  G V+K R    G  IAVK++ R 
Sbjct: 2   SSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS 61

Query: 360 SGQGDLEFKNEVL-----LVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDP 414
               + E    +L     ++ +     +V+  G  +   +  +  E +  T  +      
Sbjct: 62  G---NKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRM 117

Query: 415 TRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR 474
                       K+   I + L YL E     +IHRD+K SN+LLD     K+ DFG++ 
Sbjct: 118 QGPIPERILG--KMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISG 173

Query: 475 LFEMDETQGNTSRIVGTYGYMAPE-----YAMHGQYSVKSDVFSFGVLVLEIISGQ 525
              + + +       G   YMAPE           Y +++DV+S G+ ++E+ +GQ
Sbjct: 174 --RLVDDKAKDR-SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  120 bits (302), Expect = 3e-30
 Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 10/204 (4%)

Query: 323 TDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRN 381
            + F    KLG+G +G+VYK      G  +A+K++  +S   ++    E+ ++      +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEII--KEISIMQQCDSPH 85

Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           +V+  G   +  +  ++ E+    S+   I    R   L  +    I+    +GL YLH 
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLHF 143

Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM 501
               R IHRD+K  N+LL+ E   K+ADFG+A   ++ +T    + ++GT  +MAPE   
Sbjct: 144 M---RKIHRDIKAGNILLNTEGHAKLADFGVAG--QLTDTMAKRNTVIGTPFWMAPEVIQ 198

Query: 502 HGQYSVKSDVFSFGVLVLEIISGQ 525
              Y+  +D++S G+  +E+  G+
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEGK 222

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  122 bits (307), Expect = 6e-30
 Identities = 52/228 (22%), Positives = 84/228 (36%), Gaps = 34/228 (14%)

Query: 324 DNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEV-LLVANLQHRNL 382
           +       LG G  G V     + G  +AVKR+  D          E+ LL  +  H N+
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD---IALMEIKLLTESDDHPNV 71

Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFI----FDPTRRAQLDWERRYKIIGGIARGLLY 438
           +R            +  E   N +L   +                    ++  IA G+ +
Sbjct: 72  IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTP-------------KIADFGMARLFEMDET--QG 483
           LH    L+IIHRDLK  N+L+                    I+DFG+ +  +  ++  + 
Sbjct: 131 LHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187

Query: 484 NTSRIVGTYGYMAPE-------YAMHGQYSVKSDVFSFGVLVLEIISG 524
           N +   GT G+ APE            + +   D+FS G +   I+S 
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  118 bits (297), Expect = 8e-30
 Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 20/212 (9%)

Query: 320 RVATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRD----SGQGDLEFKNEVLLV 374
           + A ++F     LG+G FG VY  R       +A+K L +     +G    + + EV + 
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQ 63

Query: 375 ANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQ-LDWERRYKIIGGI 432
           ++L+H N++RL G+      R+ LI E+ P  ++    +   ++    D +R    I  +
Sbjct: 64  SHLRHPNILRLYGY-FHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITEL 118

Query: 433 ARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY 492
           A  L Y H     R+IHRD+K  N+LL +    KIADFG +       ++     + GT 
Sbjct: 119 ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTD--LCGTL 171

Query: 493 GYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
            Y+ PE      +  K D++S GVL  E + G
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 203

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  118 bits (298), Expect = 1e-29
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 21/213 (9%)

Query: 323 TDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRN 381
            + +    +LG G FG VYK +    GA  A K +   S +   ++  E+ ++A   H  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR----GLL 437
           +V+LLG      +  ++ EF P  ++D  + +  R            I  + R     L 
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ------IQVVCRQMLEALN 131

Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           +LH     RIIHRDLK  NVL+  E   ++ADFG++   +  +T       +GT  +MAP
Sbjct: 132 FLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGTPYWMAP 186

Query: 498 E-----YAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           E           Y  K+D++S G+ ++E+   +
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  117 bits (295), Expect = 5e-29
 Identities = 66/322 (20%), Positives = 113/322 (35%), Gaps = 53/322 (16%)

Query: 318 TIRVATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVAN 376
           T+ +          L +GGF  VY+ + +  G E A+KRL  +  + +     EV  +  
Sbjct: 22  TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKK 81

Query: 377 LQ-HRNLVRLLGFSLEGNER-------LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI 428
           L  H N+V+    +  G E         L+   +    L  F+     R  L  +   KI
Sbjct: 82  LSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKI 141

Query: 429 IGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
                R + ++H   +  IIHRDLK  N+LL  + T K+ DFG A           +++ 
Sbjct: 142 FYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQR 200

Query: 489 ----------VGTYGYMAPE---YAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFR---- 531
                       T  Y  PE      +     K D+++ G ++  +       CFR    
Sbjct: 201 RALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL-------CFRQHPF 253

Query: 532 NGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMAS 591
                  +++            +I            +IR        +Q N   R ++A 
Sbjct: 254 EDGAKLRIVNG---------KYSIPPHDTQYTVFHSLIRA------MLQVNPEERLSIAE 298

Query: 592 VV----LMLNSYSLTLPVPSEP 609
           VV     +  + ++    P   
Sbjct: 299 VVHQLQEIAAARNVNPKSPITE 320

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  118 bits (297), Expect = 9e-29
 Identities = 68/221 (30%), Positives = 105/221 (47%), Gaps = 25/221 (11%)

Query: 317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFKN-EVLLV 374
              R    +++D   +G G FG VY+ +L D G  +A+K++ +D       FKN E+ ++
Sbjct: 47  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIM 101

Query: 375 ANLQHRNLVRLLGFSLEGNERL------LIYEFVPNTSLDHFIFDPTRRAQLDWERRYK- 427
             L H N+VRL  F     E+       L+ ++VP  ++       +R  Q       K 
Sbjct: 102 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKL 160

Query: 428 IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP-KIADFGMARLFEMDETQGNTS 486
            +  + R L Y+H      I HRD+K  N+LLD +    K+ DFG A+     E   N S
Sbjct: 161 YMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVS 215

Query: 487 RIVGTYGYMAPEYAMHG--QYSVKSDVFSFGVLVLEIISGQ 525
            I   Y Y APE  + G   Y+   DV+S G ++ E++ GQ
Sbjct: 216 YICSRY-YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  116 bits (293), Expect = 9e-29
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 21/211 (9%)

Query: 323 TDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK---NEVLLVANLQ 378
              FSD  ++G G FGAVY  R + +   +A+K++S    Q + +++    EV  +  L+
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           H N ++  G  L  +   L+ E+   ++ D        +  L       +  G  +GL Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASD---LLEVHKKPLQEVEIAAVTHGALQGLAY 169

Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGM-ARLFEMDETQGNTSRIVGTYGYMAP 497
           LH      +IHRD+K  N+LL      K+ DFG  + +        N+   VGT  +MAP
Sbjct: 170 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANS--FVGTPYWMAP 219

Query: 498 EYAMH---GQYSVKSDVFSFGVLVLEIISGQ 525
           E  +    GQY  K DV+S G+  +E+   +
Sbjct: 220 EVILAMDEGQYDGKVDVWSLGITCIELAERK 250

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  115 bits (290), Expect = 3e-28
 Identities = 32/227 (14%), Positives = 69/227 (30%), Gaps = 22/227 (9%)

Query: 318 TIRVATDNFSDANKLGQGGFGAVYKGRLYDGAE------IAVKRLSRDSGQGDLEFKNEV 371
             ++ +      + LG+G F  VY+    D  +        +K     +          +
Sbjct: 59  EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118

Query: 372 LLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI--FDPTRRAQLDWERRYKII 429
             +        ++     L  N  +L+ E     +L + I  +  T    +         
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178

Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP-----------KIADFGMARLFEM 478
             +   +  +H+     IIH D+K  N +L                  + D G +   ++
Sbjct: 179 MRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235

Query: 479 DETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
                  +    T G+   E   +  ++ + D F     V  ++ G 
Sbjct: 236 FPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  114 bits (286), Expect = 6e-28
 Identities = 70/233 (30%), Positives = 108/233 (46%), Gaps = 21/233 (9%)

Query: 307 NRAESLQ-FDFNTIRVATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGD 364
           + A SL   D + +R     F     +G G +G VYKGR +  G   A+K +    G  +
Sbjct: 6   SPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEE 64

Query: 365 LEFKNEVLLVANL-QHRNLVRLLG-----FSLEGNERL-LIYEFVPNTSLDHFIFDPTRR 417
            E K E+ ++     HRN+    G          +++L L+ EF    S+   +   T+ 
Sbjct: 65  EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKG 123

Query: 418 AQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
             L  E    I   I RGL +LH+    ++IHRD+K  NVLL      K+ DFG++   +
Sbjct: 124 NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA--Q 178

Query: 478 MDETQGNTSRIVGTYGYMAPE-----YAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           +D T G  +  +GT  +MAPE           Y  KSD++S G+  +E+  G 
Sbjct: 179 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  114 bits (286), Expect = 9e-28
 Identities = 48/222 (21%), Positives = 91/222 (40%), Gaps = 39/222 (17%)

Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEF-----------------KNEVLL 373
            L QG F  +      D    A+K+  +   +   +F                 KNE+ +
Sbjct: 38  TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96

Query: 374 VANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSL-----DHFIFDPTRRAQLDWERRYK 427
           + ++++   +   G  +   + + +IYE++ N S+       F+ D      +  +    
Sbjct: 97  ITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155

Query: 428 IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSR 487
           II  +     Y+H  +   I HRD+K SN+L+D     K++DFG +      + +   S 
Sbjct: 156 IIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK--GS- 210

Query: 488 IVGTYGYMAPE-----YAMHGQYSVKSDVFSFGVLVLEIISG 524
             GTY +M PE      + +G    K D++S G+ +  +   
Sbjct: 211 -RGTYEFMPPEFFSNESSYNGA---KVDIWSLGICLYVMFYN 248

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  111 bits (280), Expect = 2e-27
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 18/211 (8%)

Query: 320 RVATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDS-GQGDLE--FKNEVLLVA 375
           +   D+F     LG+G FG VY  R   +   +A+K L +    +  +E   + E+ + +
Sbjct: 10  KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 69

Query: 376 NLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQ-LDWERRYKIIGGIA 433
           +L+H N++R+  +     +R+ L+ EF P   L    +   ++    D +R    +  +A
Sbjct: 70  HLRHPNILRMYNY-FHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEELA 124

Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
             L Y H     ++IHRD+K  N+L+  +   KIADFG +           T    GT  
Sbjct: 125 DALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR--RTM--CGTLD 177

Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
           Y+ PE      +  K D++  GVL  E + G
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  113 bits (283), Expect = 2e-27
 Identities = 21/229 (9%), Positives = 47/229 (20%), Gaps = 43/229 (18%)

Query: 332 LGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLE---FKNEVLLVANLQHRNLVRLLG 387
           L  G    V+  R +    + A+K  +  +     E           A L   +      
Sbjct: 70  LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129

Query: 388 F--------------------------SLEGNERLLIYEFVP---NTSLDHFIFDPTRRA 418
                                             LL+                F    R 
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189

Query: 419 QLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM 478
                  + +   + R    L       ++H      N+ +  +    + D         
Sbjct: 190 DEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW---- 242

Query: 479 DETQGNTSRIVGTYGYMAPEYAMHG--QYSVKSDVFSFGVLVLEIISGQ 525
            +             Y   E+       ++   + +  G+ +  +    
Sbjct: 243 -KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  112 bits (281), Expect = 3e-27
 Identities = 34/133 (25%), Positives = 56/133 (42%), Gaps = 13/133 (9%)

Query: 400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLL 459
           +     +L  ++         +      I   IA  + +LH      ++HRDLK SN+  
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFF 197

Query: 460 DAEMTPKIADFGMARLFEMDETQGNTS----------RIVGTYGYMAPEYAMHGQYSVKS 509
             +   K+ DFG+    + DE +                VGT  YM+PE      YS K 
Sbjct: 198 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKV 257

Query: 510 DVFSFGVLVLEII 522
           D+FS G+++ E++
Sbjct: 258 DIFSLGLILFELL 270

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  114 bits (287), Expect = 5e-27
 Identities = 64/257 (24%), Positives = 108/257 (42%), Gaps = 38/257 (14%)

Query: 286 LRRKPRDNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDA----NKLGQGGFGAVY 341
           +      +S  ++    GD              I     + S+      KLG G +G V 
Sbjct: 1   MHHHHHHSSGRENLYFQGDLQATPGMF------ITSKKGHLSEMYQRVKKLGSGAYGEVL 54

Query: 342 KGR-LYDGAEIAVKRLSRD--SGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLI 398
             R      E A+K + +   S   + +   EV ++  L H N+++L  F  +     L+
Sbjct: 55  LCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114

Query: 399 YEFVPNTSLDHFIFDPTRRAQLDWERRY------KIIGGIARGLLYLHEDSRLRIIHRDL 452
            E      L    FD     ++    ++       II  +  G+ YLH+     I+HRDL
Sbjct: 115 MECYKGGEL----FD-----EIIHRMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDL 162

Query: 453 KTSNVLL---DAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKS 509
           K  N+LL   + +   KI DFG++ +FE  +        +GT  Y+APE  +  +Y  K 
Sbjct: 163 KPENLLLESKEKDALIKIVDFGLSAVFENQKKM---KERLGTAYYIAPE-VLRKKYDEKC 218

Query: 510 DVFSFGVLVLEIISGQR 526
           DV+S GV++  +++G  
Sbjct: 219 DVWSIGVILFILLAGYP 235

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  111 bits (280), Expect = 9e-27
 Identities = 38/220 (17%), Positives = 80/220 (36%), Gaps = 26/220 (11%)

Query: 323 TDNFSDANKLGQG--GFGAVYKGR-LYDGAEIAVKRLSRDSGQGDL--EFKNEVLLVANL 377
              +     +G+G      V   R    G  + V+R++ ++   ++    + E+ +    
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR--- 434
            H N+V      +  NE  ++  F+   S    +        ++ E     I  I +   
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKD-LICTHFMDGMN-E---LAIAYILQGVL 138

Query: 435 -GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNT-----SRI 488
             L Y+H       +HR +K S++L+  +    ++             +           
Sbjct: 139 KALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195

Query: 489 VGTYGYMAPE---YAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           V    +++PE     + G Y  KSD++S G+   E+ +G 
Sbjct: 196 VKVLPWLSPEVLQQNLQG-YDAKSDIYSVGITACELANGH 234

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  108 bits (272), Expect = 2e-26
 Identities = 55/200 (27%), Positives = 89/200 (44%), Gaps = 13/200 (6%)

Query: 323 TDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQHR 380
            D F    KLG G FG V+       G E  +K +++D  Q  +E  + E+ ++ +L H 
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERR-YKIIGGIARGLLYL 439
           N++++     + +   ++ E      L   I     R +   E    +++  +   L Y 
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140

Query: 440 HEDSRLRIIHRDLKTSNVLL---DAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMA 496
           H      ++H+DLK  N+L          KI DFG+A LF+ DE     +   GT  YMA
Sbjct: 141 HS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGTALYMA 194

Query: 497 PEYAMHGQYSVKSDVFSFGV 516
           PE       + K D++S GV
Sbjct: 195 PE-VFKRDVTFKCDIWSAGV 213

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  112 bits (282), Expect = 2e-26
 Identities = 69/223 (30%), Positives = 108/223 (48%), Gaps = 33/223 (14%)

Query: 319 IRVATDNFSDA----NKLGQGGFGAVYKGR-LYDGAEIAVKRLSRD--SGQGDLE-FKNE 370
           ++ +T  FSD       LG+G FG V   +    G E AVK +S+     + D E    E
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76

Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRY---- 426
           V L+  L H N+++L  F  +     L+ E      L    FD     ++   +R+    
Sbjct: 77  VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FD-----EIISRKRFSEVD 127

Query: 427 --KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLL---DAEMTPKIADFGMARLFEMDET 481
             +II  +  G+ Y+H+    +I+HRDLK  N+LL     +   +I DFG++  FE  + 
Sbjct: 128 AARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184

Query: 482 QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
                  +GT  Y+APE  +HG Y  K DV+S GV++  ++SG
Sbjct: 185 M---KDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  108 bits (273), Expect = 6e-26
 Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 29/227 (12%)

Query: 316 FNTIRVATDNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFKN----E 370
               R   D F      GQG FG V  G+    G  +A+K++ +D       F+N     
Sbjct: 15  DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-----RFRNRELQI 69

Query: 371 VLLVANLQHRNLVRLLGFSLEGNER-------LLIYEFVPNTSLDHFIFDPTRRAQL--D 421
           +  +A L H N+V+L  +     ER        ++ E+VP  +L     +  RR      
Sbjct: 70  MQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPP 128

Query: 422 WERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM-TPKIADFGMARLFEMDE 480
              +   +  + R +  LH  S + + HRD+K  NVL++    T K+ DFG A+     E
Sbjct: 129 ILIKV-FLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE 186

Query: 481 TQGNTSRIVGTYGYMAPEYAMHG--QYSVKSDVFSFGVLVLEIISGQ 525
              N + I   Y Y APE  + G   Y+   D++S G +  E++ G+
Sbjct: 187 P--NVAYICSRY-YRAPEL-IFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  111 bits (278), Expect = 7e-26
 Identities = 59/221 (26%), Positives = 98/221 (44%), Gaps = 30/221 (13%)

Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQGDLEFKNEVLL 373
            F   RV          LG+GGFG V+  ++    ++ A K+L++      L+ +     
Sbjct: 186 WFLDFRV----------LGRGGFGEVFACQMKATGKLYACKKLNKK----RLKKRKGYQG 231

Query: 374 V-------ANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERR 425
                   A +  R +V L  ++ E    L L+   +    + + I++         E R
Sbjct: 232 AMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPR 290

Query: 426 YKI-IGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN 484
                  I  GL +LH+     II+RDLK  NVLLD +   +I+D G+A   +  +T+  
Sbjct: 291 AIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK 347

Query: 485 TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
                GT G+MAPE  +  +Y    D F+ GV + E+I+ +
Sbjct: 348 GY--AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  110 bits (277), Expect = 8e-26
 Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 32/218 (14%)

Query: 323 TDNFSDA----NKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDS-GQGDLE-FKNEVLLVA 375
              F++       LG+G FG V K +      E AVK +++ S    D      EV L+ 
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76

Query: 376 NLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRY------KII 429
            L H N+++L     + +   ++ E      L    FD     ++   +R+      +II
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FD-----EIIKRKRFSEHDAARII 127

Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVLL---DAEMTPKIADFGMARLFEMDETQGNTS 486
             +  G+ Y+H+     I+HRDLK  N+LL   + +   KI DFG++  F+ +       
Sbjct: 128 KQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---K 181

Query: 487 RIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISG 524
             +GT  Y+APE  + G Y  K DV+S GV++  ++SG
Sbjct: 182 DRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  109 bits (273), Expect = 8e-26
 Identities = 52/239 (21%), Positives = 87/239 (36%), Gaps = 21/239 (8%)

Query: 289 KPRDNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSD----ANKLGQGGFGAVYKGR 344
                     +    D+       ++    + V   +  D      +LG G FG V++  
Sbjct: 12  SKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCV 71

Query: 345 -LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVP 403
               G     K ++          KNE+ ++  L H  L+ L     +  E +LI EF+ 
Sbjct: 72  EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131

Query: 404 NTSLDHFIFD--PTRRAQLDWERR-YKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLD 460
              L    FD       ++  E      +     GL ++HE     I+H D+K  N++ +
Sbjct: 132 GGEL----FDRIAAEDYKMS-EAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCE 183

Query: 461 AEMTP--KIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVL 517
            +     KI DFG+A     DE          T  + APE          +D+++ GVL
Sbjct: 184 TKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVL 239

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  109 bits (273), Expect = 9e-26
 Identities = 31/233 (13%), Positives = 61/233 (26%), Gaps = 43/233 (18%)

Query: 332 LGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGD---LEFKNEVLLVANLQ--------- 378
           LGQ    A  +      G    V               + K EVL +  L+         
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 379 -------------HRNLVRLLGFSLEGNERLLIYEFV----PNTSLDHFIFDPTRRAQ-- 419
                             +++   L+  +  ++  F       ++L  F       +   
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 420 --LDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
             L    R ++   + R L  LH      ++H  L+  +++LD      +  F      +
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR-D 261

Query: 478 MDETQGNTSRIVGTYGYMAPE-----YAMHGQYSVKSDVFSFGVLVLEIISGQ 525
                    R        A              +   D ++ G+ +  I    
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  108 bits (270), Expect = 1e-25
 Identities = 32/238 (13%), Positives = 62/238 (26%), Gaps = 54/238 (22%)

Query: 332 LGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGD-------------------------- 364
           LGQ    A  +      G    V                                     
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 365 --LEFKNEVLLVANLQHRNLVRLLGF--SLEGNERLLIYEFVPNTSLDHF--IFD-PTRR 417
             L F     LV + Q + ++R+      +    R  +Y  + +        +    +  
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 418 AQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
             L    R ++   + R L  LH      ++H  L+  +++LD      +  F       
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 256

Query: 478 MDETQGNTSRIVGTYGYMAPEY-----------AMHGQYSVKSDVFSFGVLVLEIISG 524
                G       + G+  PE                  +   D ++ G+++  I   
Sbjct: 257 -----GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  109 bits (273), Expect = 3e-25
 Identities = 63/262 (24%), Positives = 113/262 (43%), Gaps = 42/262 (16%)

Query: 286 LRRKPRDNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGR- 344
           +      +S  ++    G  IN    ++     I    +++    KLG G +G V   + 
Sbjct: 1   MHHHHHHSSGRENLYFQGIAINPGMYVRKKEGKIG---ESYFKVRKLGSGAYGEVLLCKE 57

Query: 345 LYDGAEIAVKRLSR------------DSGQGDLE-FKNEVLLVANLQHRNLVRLLGFSLE 391
               +E A+K + +             + +   E   NE+ L+ +L H N+++L     +
Sbjct: 58  KNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFED 117

Query: 392 GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRY------KIIGGIARGLLYLHEDSRL 445
                L+ EF     L    F+     Q+    ++       I+  I  G+ YLH+    
Sbjct: 118 KKYFYLVTEFYEGGEL----FE-----QIINRHKFDECDAANIMKQILSGICYLHK---H 165

Query: 446 RIIHRDLKTSNVLL---DAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMH 502
            I+HRD+K  N+LL   ++ +  KI DFG++  F  D         +GT  Y+APE  + 
Sbjct: 166 NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL---RDRLGTAYYIAPE-VLK 221

Query: 503 GQYSVKSDVFSFGVLVLEIISG 524
            +Y+ K DV+S GV++  ++ G
Sbjct: 222 KKYNEKCDVWSCGVIMYILLCG 243

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  109 bits (274), Expect = 3e-25
 Identities = 51/238 (21%), Positives = 97/238 (40%), Gaps = 15/238 (6%)

Query: 288 RKPRDNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSD----ANKLGQGGFGAVYKG 343
            + +      + ++  D        Q+    + +  D+  D      +LG G FG V++ 
Sbjct: 117 EQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRV 176

Query: 344 R-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFV 402
                G   A K +           + E+  ++ L+H  LV L     + NE ++IYEF+
Sbjct: 177 TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236

Query: 403 PNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE 462
               L   + D     ++  +   + +  + +GL ++HE      +H DLK  N++   +
Sbjct: 237 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTK 291

Query: 463 MTP--KIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLV 518
            +   K+ DFG+    +  +   +     GT  + APE A        +D++S GVL 
Sbjct: 292 RSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  109 bits (275), Expect = 3e-25
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 32/221 (14%)

Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRD---SGQGDLEFKNE 370
           DF+  R+          +G+GGFG VY  R  D  ++ A+K L +      QG+    NE
Sbjct: 190 DFSVHRI----------IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE 239

Query: 371 --VL-LVANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRY 426
             +L LV+      +V +  ++    ++L  I + +    L + +     +  +  E   
Sbjct: 240 RIMLSLVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADM 294

Query: 427 KI-IGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNT 485
           +     I  GL ++H      +++RDLK +N+LLD     +I+D G+A  F   +     
Sbjct: 295 RFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-- 349

Query: 486 SRIVGTYGYMAPEYAMHGQ-YSVKSDVFSFGVLVLEIISGQ 525
              VGT+GYMAPE    G  Y   +D FS G ++ +++ G 
Sbjct: 350 --SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  105 bits (264), Expect = 4e-25
 Identities = 55/212 (25%), Positives = 84/212 (39%), Gaps = 28/212 (13%)

Query: 323 TDNFSDA----NKLGQGGFGAVYK------GRLYDGAEIAVKRLSRDSGQGDLE-FKNEV 371
                D      +LG G F  V K      G  Y    I  ++          E  + EV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66

Query: 372 LLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDP-TRRAQLDWERR-YKII 429
            ++  + H N++ L        + +LI E V    L    FD   ++  L  E      I
Sbjct: 67  SILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLS-EEEATSFI 121

Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP----KIADFGMARLFEMDETQGNT 485
             I  G+ YLH     +I H DLK  N++L  +  P    K+ DFG+A   E        
Sbjct: 122 KQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---F 175

Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVL 517
             I GT  ++APE   +    +++D++S GV+
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  106 bits (266), Expect = 5e-25
 Identities = 55/212 (25%), Positives = 84/212 (39%), Gaps = 28/212 (13%)

Query: 323 TDNFSDA----NKLGQGGFGAVYK------GRLYDGAEIAVKRLSRDSGQGDLE-FKNEV 371
                D      +LG G F  V K      G  Y    I  ++          E  + EV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66

Query: 372 LLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDP-TRRAQLDWERR-YKII 429
            ++  + H N++ L        + +LI E V    L    FD   ++  L  E      I
Sbjct: 67  SILRQVLHPNIITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLS-EEEATSFI 121

Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP----KIADFGMARLFEMDETQGNT 485
             I  G+ YLH     +I H DLK  N++L  +  P    K+ DFG+A   E        
Sbjct: 122 KQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---F 175

Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVL 517
             I GT  ++APE   +    +++D++S GV+
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  105 bits (264), Expect = 9e-25
 Identities = 63/242 (26%), Positives = 100/242 (41%), Gaps = 22/242 (9%)

Query: 287 RRKPRDNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSD------ANKLGQGGFGAV 340
               R   K K  +A   +I    +  FD   +       +          LG G FG V
Sbjct: 47  DLTERMPVKSKRTSALAVDIPAPPA-PFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQV 105

Query: 341 YKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY 399
           +K      G ++A K +     +   E KNE+ ++  L H NL++L       N+ +L+ 
Sbjct: 106 HKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVM 165

Query: 400 EFVPNTSL-DHFIFDPTRRAQLDWERR-YKIIGGIARGLLYLHEDSRLRIIHRDLKTSNV 457
           E+V    L D  I        L  E      +  I  G+ ++H+   + I+H DLK  N+
Sbjct: 166 EYVDGGELFDRII---DESYNLT-ELDTILFMKQICEGIRHMHQ---MYILHLDLKPENI 218

Query: 458 LLDAEMTP--KIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFG 515
           L         KI DFG+AR ++  E         GT  ++APE   +   S  +D++S G
Sbjct: 219 LCVNRDAKQIKIIDFGLARRYKPREKL---KVNFGTPEFLAPEVVNYDFVSFPTDMWSVG 275

Query: 516 VL 517
           V+
Sbjct: 276 VI 277

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  103 bits (260), Expect = 1e-24
 Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 22/218 (10%)

Query: 322 ATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKN-----EVLLVA 375
           AT  +    ++G G +G VYK R  + G  +A+K +   +G G           EV L+ 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66

Query: 376 NLQ---HRNLVRLL----GFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYK 427
            L+   H N+VRL+        +   ++ L++E V +  L  ++ D      L  E    
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124

Query: 428 IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSR 487
           ++    RGL +LH +    I+HRDLK  N+L+ +  T K+ADFG+AR++        T  
Sbjct: 125 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--TPV 179

Query: 488 IVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           +V T  Y APE  +   Y+   D++S G +  E+   +
Sbjct: 180 VV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  102 bits (257), Expect = 1e-24
 Identities = 56/193 (29%), Positives = 88/193 (45%), Gaps = 19/193 (9%)

Query: 332 LGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLVRLLGFS 389
           LG+G +G V           +AVK +         E  K E+ +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 390 LEGNERLLIYEFVPNTSLDHFIFD---PTRRAQLDWERRY--KIIGGIARGLLYLHEDSR 444
            EGN + L  E+     L    FD   P         +R+  +++ G+     YLH    
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 123

Query: 445 LRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQ 504
           + I HRD+K  N+LLD     KI+DFG+A +F  +  +   +++ GT  Y+APE     +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 505 YS-VKSDVFSFGV 516
           +     DV+S G+
Sbjct: 184 FHAEPVDVWSCGI 196

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  104 bits (261), Expect = 2e-24
 Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 21/212 (9%)

Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKN--------EVLLV 374
             +   + LG+G F  VYK R       +A+K++         E K+        E+ L+
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGH---RSEAKDGINRTALREIKLL 66

Query: 375 ANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
             L H N++ LL      +   L+++F+  T L+  I D      L        +    +
Sbjct: 67  QELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDN--SLVLTPSHIKAYMLMTLQ 123

Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
           GL YLH+     I+HRDLK +N+LLD     K+ADFG+A+ F     +  T ++V T  Y
Sbjct: 124 GLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVV-TRWY 178

Query: 495 MAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
            APE       Y V  D+++ G ++ E++   
Sbjct: 179 RAPELLFGARMYGVGVDMWAVGCILAELLLRV 210

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  106 bits (267), Expect = 2e-24
 Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 25/217 (11%)

Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQGDLEF---KNE 370
            F   RV          LG+GGFG V   ++    ++ A K+L +   +         NE
Sbjct: 185 TFRQYRV----------LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNE 234

Query: 371 VLLVANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRA-QLDWERRYKI 428
             ++  +  R +V L  ++ E  + L L+   +    L   I+   +          Y  
Sbjct: 235 KQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY-- 291

Query: 429 IGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
              I  GL  LH     RI++RDLK  N+LLD     +I+D G+A    + E Q    R 
Sbjct: 292 AAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAV--HVPEGQTIKGR- 345

Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           VGT GYMAPE   + +Y+   D ++ G L+ E+I+GQ
Sbjct: 346 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  104 bits (262), Expect = 3e-24
 Identities = 59/248 (23%), Positives = 106/248 (42%), Gaps = 23/248 (9%)

Query: 292 DNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEI 351
             S++  +    D +  AE +      +R+  D+F     +G+G F  V   ++    ++
Sbjct: 29  GASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQV 88

Query: 352 -AVKRLSRDS--GQGDLE-FKNE--VLLVANLQHRNLVRLLGFSLEGNERL-LIYEFVPN 404
            A+K +++     +G++  F+ E  VL+  +   R + +L  F+ +    L L+ E+   
Sbjct: 89  YAMKIMNKWDMLKRGEVSCFREERDVLVNGD--RRWITQLH-FAFQDENYLYLVMEYYVG 145

Query: 405 TSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMT 464
             L   +     R   +  R Y  +  I   +  +H    L  +HRD+K  N+LLD    
Sbjct: 146 GDLLTLLSKFGERIPAEMARFY--LAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGH 200

Query: 465 PKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE-------YAMHGQYSVKSDVFSFGVL 517
            ++ADFG       D T   +   VGT  Y++PE           G Y  + D ++ GV 
Sbjct: 201 IRLADFGSCLKLRADGTVR-SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVF 259

Query: 518 VLEIISGQ 525
             E+  GQ
Sbjct: 260 AYEMFYGQ 267

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  103 bits (258), Expect = 3e-24
 Identities = 57/211 (27%), Positives = 87/211 (41%), Gaps = 26/211 (12%)

Query: 323 TDNFSDA----NKLGQGGFGAVYK------GRLYDGAEIAVKRLSRDSGQGDLE-FKNEV 371
            +N  D      +LG G F  V K      G  Y    I  +R          E  + EV
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65

Query: 372 LLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERR-YKIIG 430
            ++  +QH N++ L        + +LI E V    L  F+     +  L  E    + + 
Sbjct: 66  SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLT-EEEATEFLK 121

Query: 431 GIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP----KIADFGMARLFEMDETQGNTS 486
            I  G+ YLH    L+I H DLK  N++L     P    KI DFG+A   +         
Sbjct: 122 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FK 175

Query: 487 RIVGTYGYMAPEYAMHGQYSVKSDVFSFGVL 517
            I GT  ++APE   +    +++D++S GV+
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  102 bits (256), Expect = 3e-24
 Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 22/207 (10%)

Query: 323 TDNFSDANKLGQGGFGAVYK------GRLYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVA 375
            D++    +LG G F  V K      G+ Y    I  +RLS        E  + EV ++ 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 376 NLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERR-YKIIGGIAR 434
            ++H N++ L        + +LI E V    L  F+     +  L  E    + +  I  
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLT-EDEATQFLKQILD 119

Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP----KIADFGMARLFEMDETQGNTSRIVG 490
           G+ YLH     RI H DLK  N++L  +  P    K+ DFG+A   E          I G
Sbjct: 120 GVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFG 173

Query: 491 TYGYMAPEYAMHGQYSVKSDVFSFGVL 517
           T  ++APE   +    +++D++S GV+
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVI 200

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  102 bits (256), Expect = 3e-24
 Identities = 60/194 (30%), Positives = 93/194 (47%), Gaps = 20/194 (10%)

Query: 331 KLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQG-DLE-FKNEVLLVANLQHRNLVRLLG 387
            LG+G FG V K +      E AVK +++ S +  D      EV L+  L H N+++L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88

Query: 388 FSLEGNERLLIYEFVPNTSLDHFIFDP-TRRAQLDWERR-YKIIGGIARGLLYLHEDSRL 445
              + +   ++ E      L    FD   +R +   E    +II  +  G+ Y+H+    
Sbjct: 89  ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFS-EHDAARIIKQVFSGITYMHK---H 140

Query: 446 RIIHRDLKTSNVLL---DAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMH 502
            I+HRDLK  N+LL   + +   KI DFG++  F+ +         +GT  Y+APE  + 
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPE-VLR 196

Query: 503 GQYSVKSDVFSFGV 516
           G Y  K DV+S GV
Sbjct: 197 GTYDEKCDVWSAGV 210

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  102 bits (257), Expect = 4e-24
 Identities = 59/211 (27%), Positives = 103/211 (48%), Gaps = 23/211 (10%)

Query: 324 DNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKN--------EVLLVA 375
           + +    K+G+G +G VYK +   G  +A+KR+  D+                 E+ L+ 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDA------EDEGIPSTAIREISLLK 74

Query: 376 NLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARG 435
            L H N+V L+          L++EF+    L   + +   +  L   +    +  + RG
Sbjct: 75  ELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDE--NKTGLQDSQIKIYLYQLLRG 131

Query: 436 LLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYM 495
           + + H+    RI+HRDLK  N+L++++   K+ADFG+AR F     +  T  +V T  Y 
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG-IPVRSYTHEVV-TLWYR 186

Query: 496 APEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
           AP+  M   +YS   D++S G +  E+I+G+
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  103 bits (258), Expect = 4e-24
 Identities = 51/197 (25%), Positives = 77/197 (39%), Gaps = 15/197 (7%)

Query: 331 KLGQGGFGAVYKGR-LYDGAEIAVK-----RLSRDSGQGDLEFKNEVLLVANLQHRNLVR 384
            +G+G F  V +      G + AVK     + +   G    + K E  +   L+H ++V 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 385 LLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERR-YKIIGGIARGLLYLHEDS 443
           LL          +++EF+    L   I        +  E      +  I   L Y H+  
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-- 148

Query: 444 RLRIIHRDLKTSNVLL---DAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA 500
              IIHRD+K   VLL   +     K+  FG+A      E+       VGT  +MAPE  
Sbjct: 149 -NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRVGTPHFMAPEVV 205

Query: 501 MHGQYSVKSDVFSFGVL 517
               Y    DV+  GV+
Sbjct: 206 KREPYGKPVDVWGCGVI 222

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  102 bits (256), Expect = 5e-24
 Identities = 56/193 (29%), Positives = 88/193 (45%), Gaps = 19/193 (9%)

Query: 332 LGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQHRNLVRLLGFS 389
           LG+G +G V           +AVK +         E  K E+ +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 390 LEGNERLLIYEFVPNTSLDHFIFD---PTRRAQLDWERRY--KIIGGIARGLLYLHEDSR 444
            EGN + L  E+     L    FD   P         +R+  +++ G+     YLH    
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 123

Query: 445 LRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQ 504
           + I HRD+K  N+LLD     KI+DFG+A +F  +  +   +++ GT  Y+APE     +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 505 YS-VKSDVFSFGV 516
           +     DV+S G+
Sbjct: 184 FHAEPVDVWSCGI 196

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  100 bits (252), Expect = 9e-24
 Identities = 46/202 (22%), Positives = 83/202 (41%), Gaps = 18/202 (8%)

Query: 323 TDNFSDA----NKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANL 377
             + +      N +G+G +G V            A K++ +   +    FK E+ ++ +L
Sbjct: 4   KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL 63

Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
            H N++RL     +  +  L+ E      L   +     +         +I+  +   + 
Sbjct: 64  DHPNIIRLYETFEDNTDIYLVMELCTGGELFERV---VHKRVFRESDAARIMKDVLSAVA 120

Query: 438 YLHEDSRLRIIHRDLKTSNVLL---DAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
           Y H+   L + HRDLK  N L      +   K+ DFG+A  F+  +        VGT  Y
Sbjct: 121 YCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGTPYY 174

Query: 495 MAPEYAMHGQYSVKSDVFSFGV 516
           ++P+  + G Y  + D +S GV
Sbjct: 175 VSPQ-VLEGLYGPECDEWSAGV 195

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  101 bits (253), Expect = 1e-23
 Identities = 58/222 (26%), Positives = 92/222 (41%), Gaps = 51/222 (22%)

Query: 332 LGQGGFGAVYKGR-LYDGAEIAVKRLSRD-------------------------SGQGDL 365
           +G+G +G V       D    A+K LS+                            +G +
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 366 EF-KNEVLLVANLQHRNLVRLLGFSLEGNERLLIY---EFVPNTSLDHFIFDPTRRAQLD 421
           E    E+ ++  L H N+V+L+   L+      +Y   E V    +     +      L 
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEV-LDDPNEDHLYMVFELVNQGPV----MEVPTLKPLS 135

Query: 422 WE--RRY--KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
            +  R Y   +I GI     YLH     +IIHRD+K SN+L+  +   KIADFG++  F+
Sbjct: 136 EDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188

Query: 478 MDETQGNTSRIVGTYGYMAPE--YAMHGQYS-VKSDVFSFGV 516
             +   + +  VGT  +MAPE        +S    DV++ GV
Sbjct: 189 GSDALLSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGV 228

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  101 bits (253), Expect = 1e-23
 Identities = 53/196 (27%), Positives = 82/196 (41%), Gaps = 26/196 (13%)

Query: 331 KLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFS 389
            LG G F  V+  +    G   A+K + +     D   +NE+ ++  ++H N+V L    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 390 LEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRY------KIIGGIARGLLYLHEDS 443
                  L+ + V    L    FD     ++     Y       +I  +   + YLHE  
Sbjct: 76  ESTTHYYLVMQLVSGGEL----FD-----RILERGVYTEKDASLVIQQVLSAVKYLHE-- 124

Query: 444 RLRIIHRDLKTSNVLL---DAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA 500
              I+HRDLK  N+L    +      I DFG++++ +     G  S   GT GY+APE  
Sbjct: 125 -NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIMSTACGTPGYVAPEVL 179

Query: 501 MHGQYSVKSDVFSFGV 516
               YS   D +S GV
Sbjct: 180 AQKPYSKAVDCWSIGV 195

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  100 bits (252), Expect = 1e-23
 Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 20/205 (9%)

Query: 332 LGQGGFGAVYKGR-LYDGAEIAVKRLSRDS----GQGDLEFKNEVLLVANLQHRNLVRLL 386
           LG+G +G V +          AVK L +        G+   K E+ L+  L+H+N+++L+
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 387 GFSLEGNERLLIY---EFVPNTSLDHFIFDPTRRAQLDWERRY--KIIGGIARGLLYLHE 441
              L   E+  +Y   E+      +     P +R  +     Y  ++I G+     YLH 
Sbjct: 73  DV-LYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH- 126

Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM 501
                I+H+D+K  N+LL    T KI+  G+A                G+  +  PE A 
Sbjct: 127 --SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184

Query: 502 -HGQYS-VKSDVFSFGVLVLEIISG 524
               +S  K D++S GV +  I +G
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTG 209

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  101 bits (253), Expect = 1e-23
 Identities = 53/208 (25%), Positives = 100/208 (48%), Gaps = 17/208 (8%)

Query: 324 DNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQGDLEFKN----EVLLVANLQ 378
           + +   +KLG+G +  VYKG+      + A+K +  +  +G          EV L+ +L+
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG---APCTAIREVSLLKDLK 58

Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           H N+V L           L++E++ +  L  ++ D      +   + +  +  + RGL Y
Sbjct: 59  HANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLF--LFQLLRGLAY 115

Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
            H     +++HRDLK  N+L++     K+ADFG+AR      T+   + +V T  Y  P+
Sbjct: 116 CHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKS-IPTKTYDNEVV-TLWYRPPD 170

Query: 499 YAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
             +    YS + D++  G +  E+ +G+
Sbjct: 171 ILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  100 bits (252), Expect = 1e-23
 Identities = 56/217 (25%), Positives = 96/217 (44%), Gaps = 24/217 (11%)

Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDS--GQGDLEF-KNE 370
           DF   ++          LG+G F  V   R    +   A+K L +     +  + +   E
Sbjct: 31  DFKFGKI----------LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRE 80

Query: 371 VLLVANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKII 429
             +++ L H   V+L  F+ + +E+L     +  N  L  +I    R+     E   +  
Sbjct: 81  RDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFY 135

Query: 430 GG-IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
              I   L YLH      IIHRDLK  N+LL+ +M  +I DFG A++   +  Q   +  
Sbjct: 136 TAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 192

Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           VGT  Y++PE          SD+++ G ++ ++++G 
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  102 bits (257), Expect = 1e-23
 Identities = 55/244 (22%), Positives = 111/244 (45%), Gaps = 17/244 (6%)

Query: 292 DNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEI 351
           +NS ++ E    + +  A+        +R+  ++F     +G+G FG V   +L +  ++
Sbjct: 42  NNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKV 101

Query: 352 -AVKRLSRDS--GQGDLE-FKNEVLLVANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTS 406
            A+K L++     + +   F+ E  ++ N   + +  L  ++ + +  L L+ ++     
Sbjct: 102 FAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGD 160

Query: 407 LDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPK 466
           L   +     R   +  R Y  +  +   +  +H+   L  +HRD+K  N+L+D     +
Sbjct: 161 LLTLLSKFEDRLPEEMARFY--LAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIR 215

Query: 467 IADFGMARLFEMDETQGNTSRIVGTYGYMAPE-----YAMHGQYSVKSDVFSFGVLVLEI 521
           +ADFG       D T   +S  VGT  Y++PE         G+Y  + D +S GV + E+
Sbjct: 216 LADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEM 274

Query: 522 ISGQ 525
           + G+
Sbjct: 275 LYGE 278

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  100 bits (251), Expect = 1e-23
 Identities = 56/211 (26%), Positives = 97/211 (45%), Gaps = 23/211 (10%)

Query: 324 DNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKN--------EVLLVA 375
           + +    K+G+G +G VYK +   G   A+K++  +                  E+ ++ 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEK------EDEGIPSTTIREISILK 55

Query: 376 NLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARG 435
            L+H N+V+L          +L++E +    L   +        L+       +  +  G
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDV--CEGGLESVTAKSFLLQLLNG 112

Query: 436 LLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYM 495
           + Y H+    R++HRDLK  N+L++ E   KIADFG+AR F     +  T  IV T  Y 
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFG-IPVRKYTHEIV-TLWYR 167

Query: 496 APEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
           AP+  M   +YS   D++S G +  E+++G 
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  100 bits (251), Expect = 2e-23
 Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 24/213 (11%)

Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKN--------EVLLV 374
             +    K+G+G +G V+K +       +A+KR+  D                  E+ L+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD------DDEGVPSSALREICLL 55

Query: 375 ANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
             L+H+N+VRL        +  L++EF     L  +         LD E     +  + +
Sbjct: 56  KELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDS--CNGDLDPEIVKSFLFQLLK 112

Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
           GL + H      ++HRDLK  N+L++     K+A+FG+AR F     +  ++ +V T  Y
Sbjct: 113 GLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAEVV-TLWY 167

Query: 495 MAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQR 526
             P+       YS   D++S G +  E+ +  R
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  100 bits (252), Expect = 2e-23
 Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 18/213 (8%)

Query: 322 ATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKN----EVLLVAN 376
           ++  F    KLG G +  VYKG     G  +A+K +  DS +G     +    E+ L+  
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG---TPSTAIREISLMKE 59

Query: 377 LQHRNLVRLLGFSLEGNERLLIYEFVPN---TSLDHFIFDPTRRAQLDWERRYKIIGGIA 433
           L+H N+VRL       N+  L++EF+ N     +D      T R       +      + 
Sbjct: 60  LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK-YFQWQLL 118

Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYG 493
           +GL + HE+   +I+HRDLK  N+L++     K+ DFG+AR F        +S +V T  
Sbjct: 119 QGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG-IPVNTFSSEVV-TLW 173

Query: 494 YMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
           Y AP+  M    YS   D++S G ++ E+I+G+
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  101 bits (252), Expect = 2e-23
 Identities = 52/244 (21%), Positives = 82/244 (33%), Gaps = 54/244 (22%)

Query: 331 KLGQGGFGAVYKGR-LYDGAEIAVK-----RLSRDSGQGDLEFKNEVLLVANLQHRNLVR 384
            +GQG +G V         A  A+K     ++ + + +     K EV L+  L H N+ R
Sbjct: 33  AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92

Query: 385 LLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRY----------------- 426
           L     E  + + L+ E      L   +      +                         
Sbjct: 93  LYEV-YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151

Query: 427 --------------------KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLL--DAEMT 464
                                I+  I   L YLH      I HRD+K  N L   +    
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFE 208

Query: 465 PKIADFGMARLFEMDETQGNT--SRIVGTYGYMAPE--YAMHGQYSVKSDVFSFGVLVLE 520
            K+ DFG+++ F           +   GT  ++APE     +  Y  K D +S GVL+  
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268

Query: 521 IISG 524
           ++ G
Sbjct: 269 LLMG 272

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =   99 bits (250), Expect = 3e-23
 Identities = 58/220 (26%), Positives = 103/220 (46%), Gaps = 32/220 (14%)

Query: 324 DNFSDANKLGQGGFGAVYKGR--LYDGAEIAVKRLSRDSGQGDLEFKN--------EVLL 373
             +    ++G+G +G V+K R     G  +A+KR+   +       +         EV +
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT------GEEGMPLSTIREVAV 64

Query: 374 VANLQ---HRNLVRLL----GFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERR 425
           + +L+   H N+VRL         +   +L L++E V +  L  ++ D      +  E  
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETI 122

Query: 426 YKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNT 485
             ++  + RGL +LH     R++HRDLK  N+L+ +    K+ADFG+AR++        T
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--T 177

Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           S +V T  Y APE  +   Y+   D++S G +  E+   +
Sbjct: 178 SVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 99.8 bits (249), Expect = 7e-23
 Identities = 63/309 (20%), Positives = 113/309 (36%), Gaps = 41/309 (13%)

Query: 226 KPSCNFRFETERFYNPTANSPPPSPPPPAEGNGSDTARTVIIILIPTVGFVILIIFICFF 285
               + +F  ER                      +  R  I  L         ++     
Sbjct: 8   SSGVDNKFNKER-------RRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLA---- 56

Query: 286 LRRKPRDNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGR- 344
              K  ++++ K       +    E    D+   +     +   + +G+G    V +   
Sbjct: 57  -EAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVH 115

Query: 345 LYDGAEIAVK-------RLSRDSGQGDLE-FKNEVLLVANL-QHRNLVRLLGFSLEGNER 395
              G E AVK       RLS +  +   E  + E  ++  +  H +++ L+      +  
Sbjct: 116 RATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM 175

Query: 396 LLIYEFVPNTSLDHFIFDP-TRRAQLDWERR-YKIIGGIARGLLYLHEDSRLRIIHRDLK 453
            L+++ +    L    FD  T +  L  E+    I+  +   + +LH      I+HRDLK
Sbjct: 176 FLVFDLMRKGEL----FDYLTEKVALS-EKETRSIMRSLLEAVSFLHA---NNIVHRDLK 227

Query: 454 TSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE------YAMHGQYSV 507
             N+LLD  M  +++DFG +   E  E       + GT GY+APE         H  Y  
Sbjct: 228 PENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGK 284

Query: 508 KSDVFSFGV 516
           + D+++ GV
Sbjct: 285 EVDLWACGV 293

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 98.8 bits (247), Expect = 7e-23
 Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 20/210 (9%)

Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVK--RLSRDSGQGDLEFKN----EVLLVAN 376
           + +    K+G+G +G V+K R    G  +A+K    S D    D   K     E+ ++  
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED----DPVIKKIALREIRMLKQ 58

Query: 377 LQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGL 436
           L+H NLV LL          L++E+  +T + H +     +  +       I     + +
Sbjct: 59  LKHPNLVNLLEVFRRKRRLHLVFEYCDHT-VLHELDR--YQRGVPEHLVKSITWQTLQAV 115

Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMA 496
            + H   +   IHRD+K  N+L+      K+ DFG ARL     +      +  T  Y +
Sbjct: 116 NFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLT-GPSDYYDDEVA-TRWYRS 170

Query: 497 PEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
           PE  +   QY    DV++ G +  E++SG 
Sbjct: 171 PELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 98.9 bits (247), Expect = 7e-23
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 36/213 (16%)

Query: 332 LGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKN------EV----LLVANLQHR 380
           LG+GGFG V+ G  L D  ++A+K + R+   G     +      EV     + A   H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 381 NLVRLLGFSLEGNERL-LIYEF-VPNTSLDHFIFDPTRRAQLDWE---RRY--KIIGGIA 433
            ++RLL +  E  E   L+ E  +P   L  +I   T +  L  E   R +  +++  I 
Sbjct: 99  GVIRLLDW-FETQEGFMLVLERPLPAQDLFDYI---TEKGPLG-EGPSRCFFGQVVAAIQ 153

Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEM-TPKIADFGMARLFEMDETQGNTSRIVGTY 492
               + H      ++HRD+K  N+L+D      K+ DFG   L  + +         GT 
Sbjct: 154 ----HCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL--LHDEPYTDF--DGTR 202

Query: 493 GYMAPEYAMHGQYS-VKSDVFSFGVLVLEIISG 524
            Y  PE+    QY  + + V+S G+L+ +++ G
Sbjct: 203 VYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 98.0 bits (245), Expect = 8e-23
 Identities = 58/204 (28%), Positives = 84/204 (41%), Gaps = 19/204 (9%)

Query: 323 TDNFSDA----NKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQG-DLE-FKNEVLLVA 375
           +  FSD      +LG+G F  V +      G E A K ++       D +  + E  +  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 376 NLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARG 435
            LQH N+VRL     E +   L+++ V    L   I     R           I  I   
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQQILES 117

Query: 436 LLYLHEDSRLRIIHRDLKTSNVLLD--AEMTP-KIADFGMARLFEMDETQGNTSRIVGTY 492
           + Y H      I+HR+LK  N+LL   A+    K+ADFG+A      E         GT 
Sbjct: 118 IAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTP 171

Query: 493 GYMAPEYAMHGQYSVKSDVFSFGV 516
           GY++PE      YS   D+++ GV
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGV 195

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 99.0 bits (247), Expect = 8e-23
 Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 34/204 (16%)

Query: 332 LGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKN------EVLLVANLQHR--NL 382
           LG GGFG+VY G  + D   +A+K + +D      E  N      EV+L+  +      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 383 VRLLGFSLEGNERL-LIYEFV-PNTSLDHFIFDPTRRAQLDWE---RRY--KIIGGIARG 435
           +RLL +  E  +   LI E   P   L  FI   T R  L  E   R +  +++  +   
Sbjct: 111 IRLLDW-FERPDSFVLILERPEPVQDLFDFI---TERGALQ-EELARSFFWQVLEAVR-- 163

Query: 436 LLYLHEDSRLRIIHRDLKTSNVLLDAE-MTPKIADFGMARLFEMDETQGNTSRIVGTYGY 494
             + H      ++HRD+K  N+L+D      K+ DFG   L  + +T        GT  Y
Sbjct: 164 --HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL--LKDTVYTDF--DGTRVY 214

Query: 495 MAPEYAMHGQYS-VKSDVFSFGVL 517
             PE+  + +Y    + V+S G+L
Sbjct: 215 SPPEWIRYHRYHGRSAAVWSLGIL 238

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  100 bits (250), Expect = 9e-23
 Identities = 52/243 (21%), Positives = 89/243 (36%), Gaps = 38/243 (15%)

Query: 303 GDEINRAESLQFDF-------NTIRVATDNFSD----ANKLGQGGFGAVYKGR-LYDGAE 350
             EI  + S    F       +   V      D    +  LG G  G V          +
Sbjct: 103 NSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKK 162

Query: 351 IAVKRLSRDSGQGDLE--------FKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFV 402
           +A++ +S+                 + E+ ++  L H  ++++  F  +  +  ++ E +
Sbjct: 163 VAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELM 221

Query: 403 PNTSLDHFIFDPTRRAQLDWERR-YKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLL-- 459
               L   +       +L  E         +   + YLHE     IIHRDLK  NVLL  
Sbjct: 222 EGGELFDKV---VGNKRLK-EATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSS 274

Query: 460 -DAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE---YAMHGQYSVKSDVFSFG 515
            + +   KI DFG +++            + GT  Y+APE         Y+   D +S G
Sbjct: 275 QEEDCLIKITDFGHSKIL---GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG 331

Query: 516 VLV 518
           V++
Sbjct: 332 VIL 334

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 98.5 bits (246), Expect = 1e-22
 Identities = 47/201 (23%), Positives = 83/201 (41%), Gaps = 18/201 (8%)

Query: 323 TDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRN 381
            + +  A  LG+G FG V++            K +    G   +  K E+ ++   +HRN
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRN 62

Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFD--PTRRAQLDWERR-YKIIGGIARGLLY 438
           ++ L        E ++I+EF+    +    F+   T   +L+ ER     +  +   L +
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLDI----FERINTSAFELN-EREIVSYVHQVCEALQF 117

Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTP--KIADFGMARLFEMDETQGNTSRIVGTYGYMA 496
           LH      I H D++  N++     +   KI +FG AR  +  +       +     Y A
Sbjct: 118 LHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYA 171

Query: 497 PEYAMHGQYSVKSDVFSFGVL 517
           PE   H   S  +D++S G L
Sbjct: 172 PEVHQHDVVSTATDMWSLGTL 192

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 98.4 bits (246), Expect = 1e-22
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 20/210 (9%)

Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVK--RLSRDSGQGDLEFKN----EVLLVAN 376
           + + +   +G+G +G V K R    G  +A+K    S D    D   K     E+ L+  
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD----DKMVKKIAMREIKLLKQ 80

Query: 377 LQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGL 436
           L+H NLV LL    +     L++EFV +T +   +        LD++   K +  I  G+
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFVDHT-ILDDLEL--FPNGLDYQVVQKYLFQIINGI 137

Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMA 496
            + H      IIHRD+K  N+L+      K+ DFG AR       +     +  T  Y A
Sbjct: 138 GFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYDDEVA-TRWYRA 192

Query: 497 PEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
           PE  +   +Y    DV++ G LV E+  G+
Sbjct: 193 PELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 99.0 bits (247), Expect = 1e-22
 Identities = 50/248 (20%), Positives = 96/248 (38%), Gaps = 55/248 (22%)

Query: 321 VATDNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFKN-EVLLVANLQ 378
            ++  +S    LG G FG V +    + G   A+K++ +D       +KN E+ ++  L 
Sbjct: 4   TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVLD 58

Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERR------------- 425
           H N+++L+ +     +        P+        +                         
Sbjct: 59  HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118

Query: 426 ------YKIIGG-------------------IARGLLYLHEDSRLRIIHRDLKTSNVLLD 460
                 +K++                     + R + ++H    L I HRD+K  N+L++
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVN 175

Query: 461 AEMTP-KIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG--QYSVKSDVFSFGVL 517
           ++    K+ DFG A+     E   + + I   + Y APE  M G  +Y+   D++S G +
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSEP--SVAYICSRF-YRAPEL-MLGATEYTPSIDLWSIGCV 231

Query: 518 VLEIISGQ 525
             E+I G+
Sbjct: 232 FGELILGK 239

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 97.3 bits (243), Expect = 2e-22
 Identities = 55/218 (25%), Positives = 89/218 (40%), Gaps = 34/218 (15%)

Query: 322 ATDNFSDA----NKLGQGGFGAVYKGR-LYDGAEIAVKRLSR---------DSGQGDLEF 367
           +T  F +       LG+G    V +        E AVK +           +  +     
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70

Query: 368 KNEVLLVANL-QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDP-TRRAQLDWERR 425
             EV ++  +  H N+++L           L+++ +    L    FD  T +  L  E+ 
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLS-EKE 125

Query: 426 -YKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN 484
             KI+  +   +  LH+   L I+HRDLK  N+LLD +M  K+ DFG +   +  E    
Sbjct: 126 TRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--- 179

Query: 485 TSRIVGTYGYMAPE------YAMHGQYSVKSDVFSFGV 516
              + GT  Y+APE         H  Y  + D++S GV
Sbjct: 180 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 217

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 98.2 bits (245), Expect = 3e-22
 Identities = 55/194 (28%), Positives = 80/194 (41%), Gaps = 19/194 (9%)

Query: 331 KLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQG-DLE-FKNEVLLVANLQHRNLVRLLG 387
           +LG+G F  V +      G E A K ++       D +  + E  +   LQH N+VRL  
Sbjct: 36  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95

Query: 388 FSLEGNERLLIYEFVPNTSLDHFIFDP-TRRAQLDWERR-YKIIGGIARGLLYLHEDSRL 445
              E +   L+++ V    L    F+    R     E      I  I   + Y H     
Sbjct: 96  SIQEESFHYLVFDLVTGGEL----FEDIVAREFYS-EADASHCIQQILESIAYCHS---N 147

Query: 446 RIIHRDLKTSNVLL---DAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMH 502
            I+HR+LK  N+LL         K+ADFG+A      E         GT GY++PE    
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKK 204

Query: 503 GQYSVKSDVFSFGV 516
             YS   D+++ GV
Sbjct: 205 DPYSKPVDIWACGV 218

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 98.7 bits (246), Expect = 3e-22
 Identities = 57/244 (23%), Positives = 112/244 (45%), Gaps = 33/244 (13%)

Query: 304 DEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDS 360
           D+++    ++      RV      +  K+G+G +G VYK +  D     + A+K++    
Sbjct: 1   DKMDYDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG 60

Query: 361 GQGDLEFKNEVLLVANLQHRNLVRLLG-FSLEGNERL-LIYEFVPNTSLDH---FIFDPT 415
               +    E+ L+  L+H N++ L   F    + ++ L++++      +H    I    
Sbjct: 61  I--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY-----AEHDLWHIIKFH 113

Query: 416 RRAQLDWERRY-------KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP--- 465
           R ++ + +           ++  I  G+ YLH +    ++HRDLK +N+L+  E      
Sbjct: 114 RASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGR 170

Query: 466 -KIADFGMARLF-EMDETQGNTSRIVGTYGYMAPEYAMHG--QYSVKSDVFSFGVLVLEI 521
            KIAD G ARLF    +   +   +V T+ Y APE  + G   Y+   D+++ G +  E+
Sbjct: 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLL-GARHYTKAIDIWAIGCIFAEL 229

Query: 522 ISGQ 525
           ++ +
Sbjct: 230 LTSE 233

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 96.9 bits (242), Expect = 4e-22
 Identities = 52/230 (22%), Positives = 92/230 (40%), Gaps = 32/230 (13%)

Query: 307 NRAESLQFDFNTIRVA-TDNFSD-----ANKLGQGGFGAVYKGR-LYDGAEIAVKRLS-R 358
           + +  +      +     +NF++     + +LG+G F  V +      G E A K L  R
Sbjct: 6   HHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKR 65

Query: 359 DSGQGDLE-FKNEVLLVANLQHR-NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTR 416
             GQ       +E+ ++   +    ++ L       +E +LI E+     +    F    
Sbjct: 66  RRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI----FS--- 118

Query: 417 RAQLDWERRY------KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLL---DAEMTPKI 467
               +           ++I  I  G+ YLH+     I+H DLK  N+LL         KI
Sbjct: 119 LCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKI 175

Query: 468 ADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVL 517
            DFGM+R             I+GT  Y+APE   +   +  +D+++ G++
Sbjct: 176 VDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGII 222

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 96.7 bits (241), Expect = 6e-22
 Identities = 52/209 (24%), Positives = 87/209 (41%), Gaps = 30/209 (14%)

Query: 332 LGQGGFGAVYKGR-LYDGAEIAVKRLSRD--SGQGDLEFKN------EVLLVANLQHRNL 382
           LG G FG V+         E+ VK + ++       +E         E+ +++ ++H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 383 VRLLGFSLEGNERL-LIYEF-VPNTSLDHFIFDPTRRAQLD-WERRYK---IIGGIARGL 436
           +++L    E      L+ E       L  FI    R  +LD     Y    ++  +    
Sbjct: 92  IKVLDI-FENQGFFQLVMEKHGSGLDLFAFI---DRHPRLDEPLASYIFRQLVSAVG--- 144

Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMA 496
            YL       IIHRD+K  N+++  + T K+ DFG A   E  +    T    GT  Y A
Sbjct: 145 -YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF-YTF--CGTIEYCA 197

Query: 497 PEYAMHGQYS-VKSDVFSFGVLVLEIISG 524
           PE  M   Y   + +++S GV +  ++  
Sbjct: 198 PEVLMGNPYRGPELEMWSLGVTLYTLVFE 226

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 96.2 bits (240), Expect = 6e-22
 Identities = 55/217 (25%), Positives = 88/217 (40%), Gaps = 30/217 (13%)

Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKN--------EVLLV 374
           D +    KLG+G +G VYK         +A+KR+  +        +         EV L+
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH------EEEGVPGTAIREVSLL 87

Query: 375 ANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
             LQHRN++ L       +   LI+E+     L  ++    +   +        +  +  
Sbjct: 88  KELQHRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYM---DKNPDVSMRVIKSFLYQLIN 143

Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP-----KIADFGMARLFEMDETQGNTSRIV 489
           G+ + H     R +HRDLK  N+LL           KI DFG+AR F     +  T  I+
Sbjct: 144 GVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG-IPIRQFTHEII 199

Query: 490 GTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
            T  Y  PE  +    YS   D++S   +  E++   
Sbjct: 200 -TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 95.4 bits (238), Expect = 1e-21
 Identities = 55/223 (24%), Positives = 87/223 (39%), Gaps = 42/223 (18%)

Query: 323 TDNFSD-----ANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVAN 376
           +  F D      + LG+G    V     L    E AVK + +  G        EV ++  
Sbjct: 7   SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQ 66

Query: 377 LQ-HRNLVRLLGFSLEGNERLLIYEFVPNTSL-DHFIFDPTRRAQLDWERRY-------K 427
            Q HRN++ L+ F  E +   L++E +   S+  H             +RR+        
Sbjct: 67  CQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIH-----------KRRHFNELEASV 115

Query: 428 IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLL---DAEMTPKIADFGMARLFEMDETQGN 484
           ++  +A  L +LH      I HRDLK  N+L    +     KI DF +    +++     
Sbjct: 116 VVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP 172

Query: 485 TSR-----IVGTYGYMAPE-----YAMHGQYSVKSDVFSFGVL 517
            S        G+  YMAPE           Y  + D++S GV+
Sbjct: 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 97.4 bits (243), Expect = 1e-21
 Identities = 53/208 (25%), Positives = 87/208 (41%), Gaps = 22/208 (10%)

Query: 321 VATDNFSDA----NKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQG-DLE-FKNEVLL 373
           +    F++      +LG+G F  V +   +  G E A   ++       D +  + E  +
Sbjct: 4   ITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARI 63

Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDP-TRRAQLDWERR-YKIIGG 431
              L+H N+VRL     E     LI++ V    L    F+    R     E      I  
Sbjct: 64  CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYYS-EADASHCIQQ 118

Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLL---DAEMTPKIADFGMARLFEMDETQGNTSRI 488
           I   +L+ H+   + ++HR+LK  N+LL         K+ADFG+A   E ++        
Sbjct: 119 ILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--F 173

Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGV 516
            GT GY++PE      Y    D+++ GV
Sbjct: 174 AGTPGYLSPEVLRKDPYGKPVDLWACGV 201

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 95.8 bits (239), Expect = 1e-21
 Identities = 56/224 (25%), Positives = 104/224 (46%), Gaps = 36/224 (16%)

Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLE-FKN----EVLLVANL 377
             +    K+GQG FG V+K R    G ++A+K++  ++   + E F      E+ ++  L
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN---EKEGFPITALREIKILQLL 73

Query: 378 QHRNLVRLLG-----FSLEGNERLLIY---EFVPNTSLDH----FIFDPTRRAQLDWERR 425
           +H N+V L+       S     +  IY   +F      +H     + +     +      
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDF-----CEHDLAGLLSNV--LVKFTLSEI 126

Query: 426 YKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN- 484
            +++  +  GL Y+H +   +I+HRD+K +NVL+  +   K+ADFG+AR F + +     
Sbjct: 127 KRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 183

Query: 485 --TSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ 525
             T+R+V T  Y  PE  +    Y    D++  G ++ E+ +  
Sbjct: 184 RYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 95.4 bits (238), Expect = 1e-21
 Identities = 60/196 (30%), Positives = 91/196 (46%), Gaps = 25/196 (12%)

Query: 332 LGQGGFGAVYKGR-LYDGAEIAVKRLSRDS-GQGDLE-FKNEVLLVANLQHRNLVRLLGF 388
           +G+G F  V   R +  G E+A+K + +       L+    EV ++  L H N+V+L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 389 SLEGNERL-LIYEFVPNTSLDHFIFD---PTRRAQLDWERRY--KIIGGIARGLLYLHED 442
            +E  + L LI E+     +    FD      R +    R    +I+  +     Y H  
Sbjct: 83  -IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFRQIVSAVQ----YCH-- 131

Query: 443 SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMH 502
            + RI+HRDLK  N+LLDA+M  KIADFG +  F +     +     G   Y APE    
Sbjct: 132 -QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL-DAF--CGAPPYAAPELFQG 187

Query: 503 GQYS-VKSDVFSFGVL 517
            +Y   + DV+S GV+
Sbjct: 188 KKYDGPEVDVWSLGVI 203

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 95.5 bits (238), Expect = 2e-21
 Identities = 59/246 (23%), Positives = 93/246 (37%), Gaps = 41/246 (16%)

Query: 290 PRDNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDA----NKLGQGGFGAVYKGRL 345
             +       +          SL  D+       D  SD     ++LG+G    VY+ + 
Sbjct: 15  TENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQ 74

Query: 346 YD-GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPN 404
                  A+K L +   +  +  + E+ ++  L H N+++L        E  L+ E V  
Sbjct: 75  KGTQKPYALKVLKKTVDKKIV--RTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTG 132

Query: 405 TSLDHFIFDPTRRAQLDWER-----RY------KIIGGIARGLLYLHEDSRLRIIHRDLK 453
             L    FD          R      Y        +  I   + YLHE     I+HRDLK
Sbjct: 133 GEL----FD----------RIVEKGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLK 175

Query: 454 TSNVLL---DAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSD 510
             N+L      +   KIADFG++++ E          + GT GY APE      Y  + D
Sbjct: 176 PENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVD 232

Query: 511 VFSFGV 516
           ++S G+
Sbjct: 233 MWSVGI 238

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 95.1 bits (237), Expect = 2e-21
 Identities = 46/212 (21%), Positives = 82/212 (38%), Gaps = 36/212 (16%)

Query: 323 TDNFSDA----NKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEV-LLVAN 376
           +  F+D       +G G +    +        E AVK + +       +   E+ +L+  
Sbjct: 17  SIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRY 72

Query: 377 LQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRY-------KII 429
            QH N++ L     +G    ++ E +    L     D   +      +++        ++
Sbjct: 73  GQHPNIITLKDVYDDGKYVYVVTELMKGGEL----LD---KIL---RQKFFSEREASAVL 122

Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVLL----DAEMTPKIADFGMARLFEMDETQGNT 485
             I + + YLH      ++HRDLK SN+L         + +I DFG A+    +     T
Sbjct: 123 FTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT 179

Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVL 517
                T  ++APE      Y    D++S GVL
Sbjct: 180 --PCYTANFVAPEVLERQGYDAACDIWSLGVL 209

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 94.7 bits (236), Expect = 3e-21
 Identities = 50/231 (21%), Positives = 82/231 (35%), Gaps = 39/231 (16%)

Query: 307 NRAESLQFDFNTIRVATDNFSD-----ANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDS 360
           + +  L+  F          +D        LG G  G V +      G + A+K L    
Sbjct: 7   HHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP 66

Query: 361 GQGDLEFKNEV-LLVANLQHRNLVRLLGF----SLEGNERLLIYEFVPNTSLDHFIFDPT 415
                + + EV          ++V +L             L+I E +    L    F   
Sbjct: 67  -----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGEL----FS-- 115

Query: 416 RRAQLDWERRY------KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLL---DAEMTPK 466
            R Q   ++ +      +I+  I   + +LH      I HRD+K  N+L    + +   K
Sbjct: 116 -RIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLK 171

Query: 467 IADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVL 517
           + DFG A+       Q        T  Y+APE     +Y    D++S GV+
Sbjct: 172 LTDFGFAKETT----QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 218

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 94.3 bits (235), Expect = 3e-21
 Identities = 49/203 (24%), Positives = 79/203 (38%), Gaps = 29/203 (14%)

Query: 331 KLGQGGFGAVYKGR-LYDGAEIAVKRLSR-------DSGQGDLE-FKNEVLLVANLQHRN 381
            LG G  G V          ++A+K +S+                 + E+ ++  L H  
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76

Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDP-TRRAQLDWERR-YKIIGGIARGLLYL 439
           ++++  F  +  +  ++ E +    L    FD      +L  E         +   + YL
Sbjct: 77  IIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLK-EATCKLYFYQMLLAVQYL 130

Query: 440 HEDSRLRIIHRDLKTSNVLL---DAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMA 496
           HE     IIHRDLK  NVLL   + +   KI DFG +++            + GT  Y+A
Sbjct: 131 HE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLA 184

Query: 497 PE---YAMHGQYSVKSDVFSFGV 516
           PE         Y+   D +S GV
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGV 207

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 95.5 bits (238), Expect = 3e-21
 Identities = 56/243 (23%), Positives = 100/243 (41%), Gaps = 18/243 (7%)

Query: 292 DNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEI 351
           D   ++      + ++R +        +R+  +++     +G+G FG V   R     ++
Sbjct: 37  DFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKV 96

Query: 352 -AVKRLSRDS--GQGDLE-FKNEVLLVANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTS 406
            A+K LS+     + D   F  E  ++A      +V+L  ++ + +  L ++ E++P   
Sbjct: 97  YAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGD 155

Query: 407 LDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPK 466
           L              W R Y     +   L  +H    +  IHRD+K  N+LLD     K
Sbjct: 156 L--VNLMSNYDVPEKWARFY--TAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLK 208

Query: 467 IADFGMARLFEMDETQGNTSRIVGTYGYMAPE----YAMHGQYSVKSDVFSFGVLVLEII 522
           +ADFG       +         VGT  Y++PE        G Y  + D +S GV + E++
Sbjct: 209 LADFGTCMKMNKEGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 267

Query: 523 SGQ 525
            G 
Sbjct: 268 VGD 270

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 94.4 bits (235), Expect = 1e-20
 Identities = 62/246 (25%), Positives = 106/246 (43%), Gaps = 34/246 (13%)

Query: 290 PRDNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGA 349
           P DNS  +    +  +     ++  +F  +++          LG+G FG V   +     
Sbjct: 125 PSDNSGAEEMEVSLAKPKHRVTMN-EFEYLKL----------LGKGTFGKVILVKEKATG 173

Query: 350 EI-AVKRLSRDSGQGDLEFKNEV-------LLVANLQHRNLVRLLGFSLEGNERL-LIYE 400
              A+K L ++     +  K+EV        ++ N +H  L  L  +S + ++RL  + E
Sbjct: 174 RYYAMKILKKE----VIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVME 228

Query: 401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGG-IARGLLYLHEDSRLRIIHRDLKTSNVLL 459
           +     L   +     R ++  E R +  G  I   L YLH  S   +++RDLK  N++L
Sbjct: 229 YANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLML 282

Query: 460 DAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVL 519
           D +   KI DFG+ +    D     T    GT  Y+APE      Y    D +  GV++ 
Sbjct: 283 DKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 340

Query: 520 EIISGQ 525
           E++ G+
Sbjct: 341 EMMCGR 346

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 92.8 bits (231), Expect = 2e-20
 Identities = 56/221 (25%), Positives = 97/221 (43%), Gaps = 30/221 (13%)

Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDS--GQGDLEF-KNE 370
            F  +R           +G+G FG V   +  D  ++ A+K +++     + ++     E
Sbjct: 16  HFEILRA----------IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKE 65

Query: 371 VLLVANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI- 428
           + ++  L+H  LV L  +S +  E + ++ + +    L + +    ++     E   K+ 
Sbjct: 66  LQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL----QQNVHFKEETVKLF 120

Query: 429 IGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
           I  +   L YL      RIIHRD+K  N+LLD      I DF +A +   +      + +
Sbjct: 121 ICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTM 174

Query: 489 VGTYGYMAPE---YAMHGQYSVKSDVFSFGVLVLEIISGQR 526
            GT  YMAPE         YS   D +S GV   E++ G+R
Sbjct: 175 AGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 91.2 bits (227), Expect = 3e-20
 Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 30/199 (15%)

Query: 331 KLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQ-HRNLVRLLGF 388
            LG+G F    K          AVK +S+   + + +   E+  +   + H N+V+L   
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKIISK-RMEANTQ--KEITALKLCEGHPNIVKLHEV 74

Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRY-------KIIGGIARGLLYLHE 441
             +     L+ E +    L    F+   R +   ++++        I+  +   + ++H+
Sbjct: 75  FHDQLHTFLVMELLNGGEL----FE---RIK---KKKHFSETEASYIMRKLVSAVSHMHD 124

Query: 442 DSRLRIIHRDLKTSNVLL---DAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
              + ++HRDLK  N+L    +  +  KI DFG ARL   D     T     T  Y APE
Sbjct: 125 ---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPE 179

Query: 499 YAMHGQYSVKSDVFSFGVL 517
                 Y    D++S GV+
Sbjct: 180 LLNQNGYDESCDLWSLGVI 198

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 90.0 bits (224), Expect = 3e-20
 Identities = 60/197 (30%), Positives = 90/197 (45%), Gaps = 26/197 (13%)

Query: 332 LGQGGFGAVYKGR-LYDGAEIAVKRLSRDS--GQGDLE-FKNEVLLVANLQHRNLVRLLG 387
           LG G FG V  G     G ++AVK L+R        +   K E+  +   +H ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 388 FSLEGNERL-LIYEFVPNTSLDHFIFD---PTRRAQLDWERRY--KIIGGIARGLLYLHE 441
             +       ++ E+V    L    FD      R +    RR   +I+  +     Y H 
Sbjct: 79  V-ISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQILSAVD----YCH- 128

Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM 501
             R  ++HRDLK  NVLLDA M  KIADFG++ +    E    TS   G+  Y APE   
Sbjct: 129 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL-RTS--CGSPNYAAPEVIS 183

Query: 502 HGQYS-VKSDVFSFGVL 517
              Y+  + D++S GV+
Sbjct: 184 GRLYAGPEVDIWSCGVI 200

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 90.9 bits (226), Expect = 7e-20
 Identities = 55/194 (28%), Positives = 88/194 (45%), Gaps = 24/194 (12%)

Query: 332 LGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSL 390
           +G G FG     R       +AVK + R +   +   + E++   +L+H N+VR     L
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE-NVQREIINHRSLRHPNIVRFKEVIL 86

Query: 391 EGNERLLIYEFVPNTSLDHFIFD---PTRRAQLDWERRY--KIIGGIARGLLYLHEDSRL 445
                 +I E+     L    ++      R   D  R +  +++ G++    Y H    +
Sbjct: 87  TPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSGVS----YCH---SM 135

Query: 446 RIIHRDLKTSNVLLDAEMTP--KIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG 503
           +I HRDLK  N LLD    P  KI DFG ++   +   Q  ++  VGT  Y+APE  +  
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKST--VGTPAYIAPEVLLRQ 192

Query: 504 QYS-VKSDVFSFGV 516
           +Y    +DV+S GV
Sbjct: 193 EYDGKIADVWSCGV 206

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 92.8 bits (230), Expect = 8e-20
 Identities = 74/381 (19%), Positives = 125/381 (32%), Gaps = 37/381 (9%)

Query: 159 RRLRGTAASGNSQKKFATGDTTASFRTIYALEQCTPDLSELQCSDCLDRAIGEIPNCCSG 218
           + L     +G S                    +        + ++     + E       
Sbjct: 182 KNLVPMDPNGLSDPYVKLKLIPDPKSESKQKTKTIKSSLNPEWNETFRFQLKESDKDRRL 241

Query: 219 KIGGRVLKPSCNFRFETERFYNPTANSPPPSPPPPAEGNGSDTARTVIIILIPTVGFVIL 278
            +       +    F     +  +              +  +     + +          
Sbjct: 242 SVEIWDWDLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEE 301

Query: 279 IIFICFFLRRKPRDNSKVKSEAAAGDEINRAESLQF----DFNTIRVATDNFSDANKLGQ 334
           +       +      +  +  A    + +   +       DFN + V          LG+
Sbjct: 302 LRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMV----------LGK 351

Query: 335 GGFGAVYKGRLYDGAEI-AVKRLSRDSGQGDLEFKNEV--------LLVANLQHRNLVRL 385
           G FG V         E+ AVK L +D     +   ++V        +L    +   L +L
Sbjct: 352 GSFGKVMLSERKGTDELYAVKILKKD----VVIQDDDVECTMVEKRVLALPGKPPFLTQL 407

Query: 386 LGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSR 444
                +  +RL  + E+V    L + I     R +      Y     IA GL +L     
Sbjct: 408 H-SCFQTMDRLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVFY--AAEIAIGLFFLQS--- 460

Query: 445 LRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQ 504
             II+RDLK  NV+LD+E   KIADFGM +    D     T    GT  Y+APE   +  
Sbjct: 461 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDYIAPEIIAYQP 518

Query: 505 YSVKSDVFSFGVLVLEIISGQ 525
           Y    D ++FGVL+ E+++GQ
Sbjct: 519 YGKSVDWWAFGVLLYEMLAGQ 539

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 89.6 bits (223), Expect = 1e-19
 Identities = 57/242 (23%), Positives = 107/242 (44%), Gaps = 25/242 (10%)

Query: 293 NSKVKSEAAAGDEINRAESLQF-DFNTIRVA---TDNFSDANKLGQGGFGAVYKGR-LYD 347
           +  V S A    ++N     ++ D+ +  V     D++    KLG+G +  V++   + +
Sbjct: 1   SGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITN 60

Query: 348 GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQ-HRNLVRLLG-FSLEGNERL-LIYEFVPN 404
             ++ VK L     +   + K E+ ++ NL+   N++ L        +    L++E V N
Sbjct: 61  NEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN 117

Query: 405 TSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE-M 463
           T         T     D++ R+  +  I + L Y H  S   I+HRD+K  NV++D E  
Sbjct: 118 TDFKQLYQTLT-----DYDIRF-YMYEILKALDYCH--SM-GIMHRDVKPHNVMIDHEHR 168

Query: 464 TPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQ-YSVKSDVFSFGVLVLEII 522
             ++ D+G+A  +     Q    R+   Y +  PE  +  Q Y    D++S G ++  +I
Sbjct: 169 KLRLIDWGLAEFY--HPGQEYNVRVASRY-FKGPELLVDYQMYDYSLDMWSLGCMLASMI 225

Query: 523 SG 524
             
Sbjct: 226 FR 227

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 90.0 bits (224), Expect = 1e-19
 Identities = 68/221 (30%), Positives = 97/221 (43%), Gaps = 33/221 (14%)

Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQGDLEFKNEV-- 371
           +F  IRV          LG+G FG V   R+ +  ++ AVK L +D     +   ++V  
Sbjct: 24  NFEFIRV----------LGKGSFGKVMLARVKETGDLYAVKVLKKD----VILQDDDVEC 69

Query: 372 ------LLVANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWER 424
                 +L     H  L +L     +  +RL  + EFV    L   I   +RR      R
Sbjct: 70  TMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHI-QKSRRFDEARAR 127

Query: 425 RYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN 484
            Y     I   L++LH+     II+RDLK  NVLLD E   K+ADFGM +    +     
Sbjct: 128 FY--AAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTA 182

Query: 485 TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           T    GT  Y+APE      Y    D ++ GVL+ E++ G 
Sbjct: 183 T--FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 90.0 bits (224), Expect = 1e-19
 Identities = 67/221 (30%), Positives = 98/221 (44%), Gaps = 33/221 (14%)

Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQGDLEFKNEV-- 371
           DFN + V          LG+G FG V         E+ AVK L +D     +   ++V  
Sbjct: 21  DFNFLMV----------LGKGSFGKVMLSERKGTDELYAVKILKKD----VVIQDDDVEC 66

Query: 372 ------LLVANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWER 424
                 +L    +   L +L     +  +RL  + E+V    L + I     R +     
Sbjct: 67  TMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHI-QQVGRFKEPHAV 124

Query: 425 RYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN 484
            Y     IA GL +L       II+RDLK  NV+LD+E   KIADFGM +   + +    
Sbjct: 125 FY--AAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVT- 177

Query: 485 TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           T    GT  Y+APE   +  Y    D ++FGVL+ E+++GQ
Sbjct: 178 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 89.7 bits (223), Expect = 1e-19
 Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 38/227 (16%)

Query: 316 FNTIRVATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKN----- 369
             T       +     +G G +G+V        G ++A+K+LSR        F++     
Sbjct: 16  NKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-------PFQSEIFAK 68

Query: 370 ----EVLLVANLQHRNLVRLL-----GFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQ 419
               E+LL+ ++QH N++ LL       SL       L+  F+  T L   +       +
Sbjct: 69  RAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIM-----GLK 122

Query: 420 LDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD 479
              E+   ++  + +GL Y+H      ++HRDLK  N+ ++ +   KI DFG+AR  + +
Sbjct: 123 FSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179

Query: 480 ETQGNTSRIVGTYGYMAPEYAM-HGQYSVKSDVFSFGVLVLEIISGQ 525
            T       V T  Y APE  +    Y+   D++S G ++ E+++G+
Sbjct: 180 MTG-----YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 91.0 bits (226), Expect = 2e-19
 Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 26/197 (13%)

Query: 332 LGQGGFGAVYKGR-LYDGAEIAVKRLSRDS--GQGDLE-FKNEVLLVANLQHRNLVRLLG 387
           LG G FG V  G+    G ++AVK L+R        +   + E+  +   +H ++++L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 388 FSLEGNERL-LIYEFVPNTSLDHFIFD---PTRRAQLDWERRY--KIIGGIARGLLYLHE 441
             +     + ++ E+V    L    FD      R      RR   +I+ G+     Y H 
Sbjct: 84  V-ISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQILSGVD----YCH- 133

Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM 501
             R  ++HRDLK  NVLLDA M  KIADFG++ +    E    TS   G+  Y APE   
Sbjct: 134 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL-RTS--CGSPNYAAPEVIS 188

Query: 502 HGQYS-VKSDVFSFGVL 517
              Y+  + D++S GV+
Sbjct: 189 GRLYAGPEVDIWSSGVI 205

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 89.2 bits (222), Expect = 2e-19
 Identities = 56/226 (24%), Positives = 93/226 (41%), Gaps = 44/226 (19%)

Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQGDLEFKNEVL- 372
           DF+ +++          LG+G FG V   R        A+K L ++     +  K+EV  
Sbjct: 6   DFDYLKL----------LGKGTFGKVILVREKATGRYYAMKILRKE----VIIAKDEVAH 51

Query: 373 ------LVANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERR 425
                 ++ N +H  L  L  ++ + ++RL  + E+     L            L  ER 
Sbjct: 52  TVTESRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFF---------HLSRERV 101

Query: 426 YKI------IGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD 479
           +           I   L YLH      +++RD+K  N++LD +   KI DFG+ +    D
Sbjct: 102 FTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158

Query: 480 ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
                T    GT  Y+APE      Y    D +  GV++ E++ G+
Sbjct: 159 GATMKT--FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 89.6 bits (223), Expect = 2e-19
 Identities = 62/251 (24%), Positives = 103/251 (41%), Gaps = 36/251 (14%)

Query: 286 LRRKPRDNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRL 345
           +   P        +   G   N       DF+ ++V          +G+G FG V   R 
Sbjct: 11  MNANPAPPPAPSQQINLGPSSNPHAKPS-DFHFLKV----------IGKGSFGKVLLARH 59

Query: 346 YDGAEI-AVKRLSRDSGQGDLEFKNEV--------LLVANLQHRNLVRLLGFSLEGNERL 396
                  AVK L +      +  K E         +L+ N++H  LV L  FS +  ++L
Sbjct: 60  KAEEVFYAVKVLQKK----AILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKL 114

Query: 397 -LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI-IGGIARGLLYLHEDSRLRIIHRDLKT 454
             + +++    L + +    +R +   E R +     IA  L YLH    L I++RDLK 
Sbjct: 115 YFVLDYINGGELFYHL----QRERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKP 167

Query: 455 SNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSF 514
            N+LLD++    + DFG+ +      +  +T    GT  Y+APE      Y    D +  
Sbjct: 168 ENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGTPEYLAPEVLHKQPYDRTVDWWCL 225

Query: 515 GVLVLEIISGQ 525
           G ++ E++ G 
Sbjct: 226 GAVLYEMLYGL 236

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 89.2 bits (222), Expect = 2e-19
 Identities = 60/221 (27%), Positives = 94/221 (42%), Gaps = 33/221 (14%)

Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQGDLEFKNEV-- 371
           DF+ +RV          +G+G +  V   RL     I A+K + ++     +    ++  
Sbjct: 10  DFDLLRV----------IGRGSYAKVLLVRLKKTDRIYAMKVVKKE----LVNDDEDIDW 55

Query: 372 ------LLVANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWER 424
                 +      H  LV L     +   RL  + E+V    L   +    R+   +  R
Sbjct: 56  VQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHAR 113

Query: 425 RYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN 484
            Y     I+  L YLHE     II+RDLK  NVLLD+E   K+ D+GM +         +
Sbjct: 114 FY--SAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS 168

Query: 485 TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           T    GT  Y+APE      Y    D ++ GVL+ E+++G+
Sbjct: 169 T--FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 89.7 bits (223), Expect = 2e-19
 Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 35/219 (15%)

Query: 323 TDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKN---------EVL 372
              + +   +G G  G V           +A+K+LSR        F+N         E++
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-------PFQNQTHAKRAYRELV 76

Query: 373 LVANLQHRNLVRLL-----GFSLEG-NERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRY 426
           L+  + H+N++ LL       SLE   +  ++ E +   +L   I     + +LD ER  
Sbjct: 77  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVI-----QMELDHERMS 130

Query: 427 KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTS 486
            ++  +  G+ +LH      IIHRDLK SN+++ ++ T KI DFG+AR      T    +
Sbjct: 131 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMT 184

Query: 487 RIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
             V T  Y APE  +   Y    D++S G ++ E+I G 
Sbjct: 185 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 88.4 bits (220), Expect = 3e-19
 Identities = 64/226 (28%), Positives = 105/226 (46%), Gaps = 42/226 (18%)

Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVY---------KGRLYDGAEIAVKRLSRDS--GQG 363
            F  ++V          LGQG FG V+           +LY     A+K L + +   + 
Sbjct: 25  QFELLKV----------LGQGSFGKVFLVKKISGSDARQLY-----AMKVLKKATLKVRD 69

Query: 364 DLEFKNE--VLLVANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQL 420
            +  K E  +L+  N  H  +V+L  ++ +   +L LI +F+    L   +     +  +
Sbjct: 70  RVRTKMERDILVEVN--HPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRL----SKEVM 122

Query: 421 DWERRYKI-IGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD 479
             E   K  +  +A  L +LH    L II+RDLK  N+LLD E   K+ DFG+++     
Sbjct: 123 FTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179

Query: 480 ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           E +  +    GT  YMAPE      ++  +D +SFGVL+ E+++G 
Sbjct: 180 EKKAYS--FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 88.9 bits (221), Expect = 3e-19
 Identities = 53/227 (23%), Positives = 89/227 (39%), Gaps = 26/227 (11%)

Query: 316 FNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLE--FKN---- 369
              +      ++    +  G +GAV  G   +G  +A+KR+      G       +    
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73

Query: 370 -----EVLLVANLQHRNLVRLLG----FSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQ 419
                E+ L+ +  H N++ L      F      +L L+ E +  T L   I    +R  
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVI--HDQRIV 130

Query: 420 LDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD 479
           +  +     +  I  GL  LHE     ++HRDL   N+LL       I DF +AR    D
Sbjct: 131 ISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTAD 187

Query: 480 ETQGNTSRIVGTYGYMAPEYAM-HGQYSVKSDVFSFGVLVLEIISGQ 525
               N +  V    Y APE  M    ++   D++S G ++ E+ + +
Sbjct: 188 A---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 88.5 bits (220), Expect = 3e-19
 Identities = 55/194 (28%), Positives = 93/194 (47%), Gaps = 21/194 (10%)

Query: 332 LGQGGFGAVYKGR-LYDGAEIAVKRLSRDS-GQGDLEFK--NEVLLVANLQHRNLVRLLG 387
           LG+G FG V          ++A+K +SR    + D+  +   E+  +  L+H ++++L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 388 FSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRY--KIIGGIARGLLYLHEDSR 444
             +     + ++ E+      D+ +    +R   D  RR+  +II  I     Y H   R
Sbjct: 77  V-ITTPTDIVMVIEYAGGELFDYIV--EKKRMTEDEGRRFFQQIICAIE----YCH---R 126

Query: 445 LRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQ 504
            +I+HRDLK  N+LLD  +  KIADFG++ +         TS   G+  Y APE      
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLKTS--CGSPNYAAPEVINGKL 183

Query: 505 YS-VKSDVFSFGVL 517
           Y+  + DV+S G++
Sbjct: 184 YAGPEVDVWSCGIV 197

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 88.9 bits (221), Expect = 4e-19
 Identities = 62/248 (25%), Positives = 101/248 (40%), Gaps = 34/248 (13%)

Query: 288 RKPRDNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYD 347
               +  K         + + +  LQ DF+ +RV          +G+G +  V   RL  
Sbjct: 27  GSGIEEEKEAMNTRESGKASSSLGLQ-DFDLLRV----------IGRGSYAKVLLVRLKK 75

Query: 348 GAEI-AVKRLSRDSGQGDLEFKNEV--------LLVANLQHRNLVRLLGFSLEGNERL-L 397
              I A++ + ++     +    ++        +      H  LV L     +   RL  
Sbjct: 76  TDRIYAMRVVKKE----LVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFF 130

Query: 398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNV 457
           + E+V    L   +    R+   +  R Y     I+  L YLHE     II+RDLK  NV
Sbjct: 131 VIEYVNGGDLMFHMQR-QRKLPEEHARFY--SAEISLALNYLHE---RGIIYRDLKLDNV 184

Query: 458 LLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVL 517
           LLD+E   K+ D+GM +         +T    GT  Y+APE      Y    D ++ GVL
Sbjct: 185 LLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIAPEILRGEDYGFSVDWWALGVL 242

Query: 518 VLEIISGQ 525
           + E+++G+
Sbjct: 243 MFEMMAGR 250

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 89.5 bits (222), Expect = 5e-19
 Identities = 59/226 (26%), Positives = 102/226 (45%), Gaps = 35/226 (15%)

Query: 316 FNTIRVATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKN----- 369
            ++       + +   +G G  G V           +A+K+LSR        F+N     
Sbjct: 54  GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-------PFQNQTHAK 106

Query: 370 ----EVLLVANLQHRNLVRLL-----GFSLEG-NERLLIYEFVPNTSLDHFIFDPTRRAQ 419
               E++L+  + H+N++ LL       +LE   +  L+ E +   +L   I     + +
Sbjct: 107 RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVI-----QME 160

Query: 420 LDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD 479
           LD ER   ++  +  G+ +LH      IIHRDLK SN+++ ++ T KI DFG+AR     
Sbjct: 161 LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--- 214

Query: 480 ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
            T    +  V T  Y APE  +   Y    D++S G ++ E++  +
Sbjct: 215 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 87.7 bits (218), Expect = 6e-19
 Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 35/222 (15%)

Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDSGQGDLEFKNEV-- 371
           DF   ++          LG+G FG V+        +  A+K L +D     +   ++V  
Sbjct: 18  DFILHKM----------LGKGSFGKVFLAEFKKTNQFFAIKALKKD----VVLMDDDVEC 63

Query: 372 ------LLVANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWER 424
                 +L    +H  L  +   + +  E L  + E++    L + I    +        
Sbjct: 64  TMVEKRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHI----QSCHKFDLS 118

Query: 425 RYKIIGG-IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQG 483
           R       I  GL +LH      I++RDLK  N+LLD +   KIADFGM +   + + + 
Sbjct: 119 RATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT 175

Query: 484 NTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           NT    GT  Y+APE  +  +Y+   D +SFGVL+ E++ GQ
Sbjct: 176 NT--FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 88.2 bits (219), Expect = 8e-19
 Identities = 58/294 (19%), Positives = 98/294 (33%), Gaps = 64/294 (21%)

Query: 240 NPTANSPPPSPPPPAEGNGSDTARTVIIILIPTVGFVILIIFICFFLRRKPRDNSKVKSE 299
             +   P P+P PP +                                            
Sbjct: 7   GQSPPVPFPAPAPPPQPPTPALPH---------------------------PPAQPPPPP 39

Query: 300 AAAGDEINRAESLQFDFNTIRVATDNFSDANK-LGQGGFGAVYKGR-LYDGAEIAVKRLS 357
                + +    LQ   N I    D++   ++ LG G  G V +        + A+K L 
Sbjct: 40  PQQFPQFHVKSGLQIKKNAI---IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ 96

Query: 358 RDSGQGDLEFKNEV-LLVANLQHRNLVRLLGF---SLEGNERL-LIYEFVPNTSLDHFIF 412
                   + + EV L     Q  ++VR++        G + L ++ E +    L    F
Sbjct: 97  DCP-----KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL----F 147

Query: 413 DPTRRAQLDWERRY------KIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLL---DAEM 463
               R Q   ++ +      +I+  I   + YLH    + I HRD+K  N+L        
Sbjct: 148 S---RIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNA 201

Query: 464 TPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVL 517
             K+ DFG A+      +    +    T  Y+APE     +Y    D++S GV+
Sbjct: 202 ILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 252

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 87.0 bits (216), Expect = 1e-18
 Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 29/217 (13%)

Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDS--GQGDLE-FKNE 370
            F+ I+           LG G FG V   +  +     A+K L +        +E   NE
Sbjct: 42  QFDRIKT----------LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91

Query: 371 VLLVANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKII 429
             ++  +    LV+L  FS + N  L ++ E+V    +    F   RR     E   +  
Sbjct: 92  KRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFY 146

Query: 430 GG-IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
              I     YLH    L +I+RDLK  N+L+D +   ++ DFG A+       +G T  +
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTL 198

Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
            GT   +APE  +   Y+   D ++ GVL+ E+ +G 
Sbjct: 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 86.5 bits (214), Expect = 2e-18
 Identities = 36/94 (38%), Positives = 54/94 (57%), Gaps = 7/94 (7%)

Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE--TQGNTSRIV 489
           +A+G+ +L   +  + IHRDL   N+LL  +   KI DFG+AR    D    +   +R+ 
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL- 257

Query: 490 GTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
               +MAPE      Y+++SDV+SFGVL+ EI S
Sbjct: 258 -PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 57.2 bits (138), Expect = 7e-09
 Identities = 35/182 (19%), Positives = 65/182 (35%), Gaps = 19/182 (10%)

Query: 308 RAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSG 361
             E L +D +      D       LG+G FG V +   +          +AVK L   + 
Sbjct: 6   HCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT 65

Query: 362 QGDL-EFKNEV-LLVANLQHRNLVRLLG-FSLEGNERLLIYEFVPNTSLDHFIFDPTRRA 418
             +     +E+ +L+    H N+V LLG  +  G   ++I EF    +L  ++       
Sbjct: 66  HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL------- 118

Query: 419 QLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM 478
                +R + +    +G  +      +  I  DLK     + +  +   + F   +    
Sbjct: 119 ---RSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175

Query: 479 DE 480
            E
Sbjct: 176 VE 177

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 84.8 bits (210), Expect = 3e-18
 Identities = 21/202 (10%), Positives = 51/202 (25%), Gaps = 45/202 (22%)

Query: 331 KLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDL---EFKNEVLLVANLQHRNLVR 384
             G       ++    D     ++A+  +       D    E  +  L ++ +    + R
Sbjct: 38  FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 385 LLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSR 444
           +L         L++ E++   SL                   + +  +A      H   R
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAH---R 147

Query: 445 LRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQ 504
             +       S V +  +    +A                          M         
Sbjct: 148 AGVALSIDHPSRVRVSIDGDVVLAYP----------------------ATMPDA------ 179

Query: 505 YSVKSDVFSFGVLVLEIISGQR 526
            + + D+   G  +  ++  + 
Sbjct: 180 -NPQDDIRGIGASLYALLVNRW 200

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 85.5 bits (212), Expect = 4e-18
 Identities = 60/227 (26%), Positives = 107/227 (47%), Gaps = 37/227 (16%)

Query: 316 FNTIRVATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKN----- 369
             T       + D   +G G +GAV        GA++A+K+L R        F++     
Sbjct: 17  TKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-------PFQSELFAK 69

Query: 370 ----EVLLVANLQHRNLVRLL-----GFSLEG-NERLLIYEFVPNTSLDHFIFDPTRRAQ 419
               E+ L+ +++H N++ LL       +L+   +  L+  F+  T L   +    +  +
Sbjct: 70  RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM----KHEK 124

Query: 420 LDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD 479
           L  +R   ++  + +GL Y+H      IIHRDLK  N+ ++ +   KI DFG+AR  + +
Sbjct: 125 LGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181

Query: 480 ETQGNTSRIVGTYGYMAPEYAM-HGQYSVKSDVFSFGVLVLEIISGQ 525
            T       V T  Y APE  +   +Y+   D++S G ++ E+I+G+
Sbjct: 182 MTG-----YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 84.9 bits (211), Expect = 5e-18
 Identities = 58/226 (25%), Positives = 102/226 (45%), Gaps = 40/226 (17%)

Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVY---------KGRLYDGAEIAVKRLSRDS---GQ 362
            F  +RV          LG+GG+G V+          G+++     A+K L +       
Sbjct: 18  CFELLRV----------LGKGGYGKVFQVRKVTGANTGKIF-----AMKVLKKAMIVRNA 62

Query: 363 GDLEF-KNEVLLVANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQL 420
            D    K E  ++  ++H  +V L+ ++ +   +L LI E++    L   +     R  +
Sbjct: 63  KDTAHTKAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQL----EREGI 117

Query: 421 DWERRYKI-IGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD 479
             E      +  I+  L +LH+     II+RDLK  N++L+ +   K+ DFG+ +    D
Sbjct: 118 FMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD 174

Query: 480 ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
            T  +T    GT  YMAPE  M   ++   D +S G L+ ++++G 
Sbjct: 175 GTVTHT--FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 84.1 bits (209), Expect = 7e-18
 Identities = 58/217 (26%), Positives = 97/217 (44%), Gaps = 29/217 (13%)

Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEI-AVKRLSRDS--GQGDLE-FKNE 370
           DF  +R           LG G FG V+  R        A+K L ++       +E   +E
Sbjct: 7   DFQILRT----------LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDE 56

Query: 371 VLLVANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI- 428
            L+++ + H  ++R+   + +  +++ +I +++    L   +    R++Q       K  
Sbjct: 57  RLMLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLL----RKSQRFPNPVAKFY 111

Query: 429 IGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
              +   L YLH      II+RDLK  N+LLD     KI DFG A+          T  +
Sbjct: 112 AAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTL 163

Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
            GT  Y+APE      Y+   D +SFG+L+ E+++G 
Sbjct: 164 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 200

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 84.6 bits (210), Expect = 8e-18
 Identities = 51/234 (21%), Positives = 105/234 (44%), Gaps = 33/234 (14%)

Query: 309 AESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEF 367
           A   +     +      +++ + +G+G +G V       +   +A+K++S         F
Sbjct: 12  AAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------F 63

Query: 368 KN---------EVLLVANLQHRNLVRLLGF----SLEGNERL-LIYEFVPNTSLDHFIFD 413
           ++         E+ ++   +H N++ +       ++E  + + ++ + +  T L   +  
Sbjct: 64  EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLL-- 120

Query: 414 PTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMA 473
             +   L  +     +  I RGL Y+H  +   ++HRDLK SN+LL+     KI DFG+A
Sbjct: 121 --KTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA 175

Query: 474 RLFEMDETQGNT-SRIVGTYGYMAPEYAM-HGQYSVKSDVFSFGVLVLEIISGQ 525
           R+ + D       +  V T  Y APE  +    Y+   D++S G ++ E++S +
Sbjct: 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 84.3 bits (209), Expect = 1e-17
 Identities = 64/232 (27%), Positives = 103/232 (44%), Gaps = 48/232 (20%)

Query: 315 DFNTIRVATDNFSDANKLGQGGFGAVY---------KGRLYDGAEIAVKRLSRD---SGQ 362
           +F  ++V          LG G +G V+          G+LY     A+K L +       
Sbjct: 55  NFELLKV----------LGTGAYGKVFLVRKISGHDTGKLY-----AMKVLKKATIVQKA 99

Query: 363 GDLEF-KNE--VLLVANLQHRNLVRLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRA 418
              E  + E  VL     Q   LV L  ++ +   +L LI +++    L   +     + 
Sbjct: 100 KTTEHTRTERQVLEHIR-QSPFLVTLH-YAFQTETKLHLILDYINGGELFTHL----SQR 153

Query: 419 QLDWERRYKI-IGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE 477
           +   E   +I +G I   L +LH+   L II+RD+K  N+LLD+     + DFG+++ F 
Sbjct: 154 ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210

Query: 478 MDETQGNTSRIVGTYGYMAPEYAMHGQY----SVKSDVFSFGVLVLEIISGQ 525
            DET+       GT  YMAP+    G      +V  D +S GVL+ E+++G 
Sbjct: 211 ADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAV--DWWSLGVLMYELLTGA 259

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 83.5 bits (207), Expect = 2e-17
 Identities = 62/227 (27%), Positives = 107/227 (47%), Gaps = 37/227 (16%)

Query: 316 FNTIRVATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKN----- 369
             TI    + + + + +G G +G+V        G  +AVK+LSR        F++     
Sbjct: 21  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-------PFQSIIHAK 73

Query: 370 ----EVLLVANLQHRNLVRLL-----GFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQ 419
               E+ L+ +++H N++ LL       SLE    + L+   +    L++ +    +  +
Sbjct: 74  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV----KCQK 128

Query: 420 LDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD 479
           L  +    +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR    +
Sbjct: 129 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185

Query: 480 ETQGNTSRIVGTYGYMAPEYAM-HGQYSVKSDVFSFGVLVLEIISGQ 525
            T       V T  Y APE  +    Y+   D++S G ++ E+++G+
Sbjct: 186 MTG-----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 82.9 bits (205), Expect = 6e-17
 Identities = 41/239 (17%), Positives = 93/239 (38%), Gaps = 33/239 (13%)

Query: 287 RRKPRDNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGR-L 345
            +     S+ + +       ++  +     ++     D +   + +G G +G V +    
Sbjct: 16  TQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDK 75

Query: 346 YDGAEIAVKRLSRDSGQGDLEFKN---------EVLLVANLQHRNLVRLL----GFSLEG 392
            +   +A+K++ R        F++         E+ ++  L H ++V++L       +E 
Sbjct: 76  LEKRVVAIKKILR-------VFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK 128

Query: 393 NERL-LIYEFVPNTSLDHFIFDPTRRAQL--DWERRYKIIGGIARGLLYLHEDSRLRIIH 449
            + L ++ E    +          R      +   +  ++  +  G+ Y+H  S   I+H
Sbjct: 129 FDELYVVLEIAD-SDFKKLF----RTPVYLTELHIKT-LLYNLLVGVKYVH--SA-GILH 179

Query: 450 RDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVK 508
           RDLK +N L++ + + K+ DFG+AR  +  E   +   I      M      H +   +
Sbjct: 180 RDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKR 238

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 80.8 bits (200), Expect = 8e-17
 Identities = 50/230 (21%), Positives = 97/230 (42%), Gaps = 44/230 (19%)

Query: 323 TDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKN---------EVL 372
              + D   LG GG G V+          +A+K++            +         E+ 
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60

Query: 373 LVANLQHRNLVRLL--------------GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRA 418
           ++  L H N+V++               G   E N   ++ E++  T L + +     + 
Sbjct: 61  IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVL----EQG 115

Query: 419 QLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE-MTPKIADFGMARLFE 477
            L  E     +  + RGL Y+H  +   ++HRDLK +N+ ++ E +  KI DFG+AR+ +
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172

Query: 478 MDETQGNT-SRIVGTYGYMAPEYAMHGQ-YSVKSDVFSFGVLVLEIISGQ 525
              +     S  + T  Y +P   +    Y+   D+++ G +  E+++G+
Sbjct: 173 PHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 79.6 bits (197), Expect = 4e-16
 Identities = 53/227 (23%), Positives = 93/227 (40%), Gaps = 40/227 (17%)

Query: 323 TDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKN---------EVL 372
           + +F   + LG+G +G V        G  +A+K++          F           E+ 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61

Query: 373 LVANLQHRNLVRLLGF----SLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYK 427
           ++ + +H N++ +       S E    + +I E +  T L   I        L  +    
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVI----STQMLSDDHIQY 116

Query: 428 IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSR 487
            I    R +  LH  +   +IHRDLK SN+L+++    K+ DFG+AR+ +      +   
Sbjct: 117 FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173

Query: 488 I--------VGTYGYMAPEYAM-HGQYSVKSDVFSFGVLVLEIISGQ 525
                    V T  Y APE  +   +YS   DV+S G ++ E+   +
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 75.6 bits (186), Expect = 1e-14
 Identities = 52/244 (21%), Positives = 101/244 (41%), Gaps = 52/244 (21%)

Query: 323 TDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKN---------EVL 372
            DN+   + +G+G +G VY          +A+K+++R        F++         E+ 
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-------MFEDLIDCKRILREIT 77

Query: 373 LVANLQHRNLVRLL-----GFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYK 427
           ++  L+   ++RL         L+ +E  ++ E    + L        +      E   K
Sbjct: 78  ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLF----KTPIFLTEEHIK 132

Query: 428 -IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTS 486
            I+  +  G  ++HE     IIHRDLK +N LL+ + + K+ DFG+AR    ++     +
Sbjct: 133 TILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVN 189

Query: 487 RI--------------------VGTYGYMAPEYAM-HGQYSVKSDVFSFGVLVLEIISGQ 525
            +                    V T  Y APE  +    Y+   D++S G +  E+++  
Sbjct: 190 DLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML 249

Query: 526 RNNC 529
           +++ 
Sbjct: 250 QSHI 253

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 72.8 bits (179), Expect = 8e-14
 Identities = 62/238 (26%), Positives = 109/238 (45%), Gaps = 52/238 (21%)

Query: 323 TDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKN---------EVL 372
              +    KLG+G +G V+K      G  +AVK++          F+N         E++
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD-------AFQNSTDAQRTFREIM 60

Query: 373 LVANLQ-HRNLVRLLG-FSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQL--DWERRYK 427
           ++  L  H N+V LL     + +  + L+++++  T L   I     RA +     ++Y 
Sbjct: 61  ILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVI-----RANILEPVHKQY- 113

Query: 428 IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSR 487
           ++  + + + YLH  S   ++HRD+K SN+LL+AE   K+ADFG++R F       N   
Sbjct: 114 VVYQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170

Query: 488 I-------------------VGTYGYMAPEYAM-HGQYSVKSDVFSFGVLVLEIISGQ 525
           +                   V T  Y APE  +   +Y+   D++S G ++ EI+ G+
Sbjct: 171 LSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 69.7 bits (171), Expect = 7e-13
 Identities = 53/217 (24%), Positives = 96/217 (44%), Gaps = 32/217 (14%)

Query: 331 KLGQGGFGAVYKGR-LYDGAEIAVKRL---SRDSGQGDLEFK-------NEVLLVANLQH 379
           KLG G F  V+  + + +   +A+K +      +   + E K        +     ++  
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85

Query: 380 RNLVRLLG-FSLEGNERL---LIYEFVPNTSLDHFIFD-PTRRAQLDWERRYKIIGGIAR 434
            ++++LL  F+ +G   +   +++E V   +L   I     R   L + +  +I   +  
Sbjct: 86  NHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVK--QISKQLLL 142

Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP------KIADFGMARLFEMDETQGNTSRI 488
           GL Y+H   R  IIH D+K  NVL++   +P      KIAD G A        +  T+ I
Sbjct: 143 GLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDEHYTNSI 196

Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
             T  Y +PE  +   +   +D++S   L+ E+I+G 
Sbjct: 197 Q-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 69.1 bits (168), Expect = 9e-13
 Identities = 35/255 (13%), Positives = 69/255 (27%), Gaps = 65/255 (25%)

Query: 321 VATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDS--------GQGDLEFKNEVL 372
           + T+      K+G+G FG V++    D   +A+K ++ +          +   E   E++
Sbjct: 17  LPTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75

Query: 373 L---------VANLQHRNLVRLLGFSL------------------------------EGN 393
           +             +    + L                                   + +
Sbjct: 76  ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135

Query: 394 ERLLIYEFVPN-TSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDL 452
           +  ++ EF      L+                   I+  +   L        LR  HRDL
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKL-----SSLATAKSILHQLTASLAVAEA--SLRFEHRDL 188

Query: 453 KTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVF 512
              NVLL      K+      +   +     +    V    Y        G       VF
Sbjct: 189 HWGNVLLKKTSLKKLHYTLNGKSSTI----PSCGLQVSIIDYTLSRLERDGIV-----VF 239

Query: 513 SFGVLVLEIISGQRN 527
               +  ++ +G  +
Sbjct: 240 CDVSMDEDLFTGDGD 254

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 43/208 (20%), Positives = 68/208 (32%), Gaps = 66/208 (31%)

Query: 331 KLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEV-LLVANLQHRNLVRLLGF 388
            LG G  G V +        + A+K L         + + EV L     Q  ++VR++  
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIVD- 78

Query: 389 SLEGNERLLIYEFVPNTSLDHFI----------FDPTRRAQLDWERRY------KIIGGI 432
                    +YE +        I          F    R Q   ++ +      +I+  I
Sbjct: 79  ---------VYENLYAGRKCLLIVMECLDGGELFS---RIQDRGDQAFTEREASEIMKSI 126

Query: 433 ARGLLYLHEDSRLRIIHRDLKTSNVLL---DAEMTPKIADFGMARLFEMDETQGNTSRIV 489
              + YLH    + I HRD+K  N+L          K+ DFG                  
Sbjct: 127 GEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFG------------------ 165

Query: 490 GTYGYMAPEYAMHGQYSVKSDVFSFGVL 517
                 A E     +Y    D++S GV+
Sbjct: 166 -----FAKE-TTGEKYDKSCDMWSLGVI 187

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 61.3 bits (149), Expect = 3e-10
 Identities = 53/220 (24%), Positives = 85/220 (38%), Gaps = 48/220 (21%)

Query: 330 NKLGQGGFGAVYKGR-LYDGAEIAVK---RLSRDSGQGDLEFK--------------NEV 371
           + +G+G FG V K     +   +A+K          Q  +E +                V
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119

Query: 372 LLVANLQHRN---LV-RLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYK 427
            L  +   RN   LV  +L ++L        Y+ + NT+      + TR          K
Sbjct: 120 HLKRHFMFRNHLCLVFEMLSYNL--------YDLLRNTNFRGVSLNLTR----------K 161

Query: 428 IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP--KIADFGMARLFEMDETQGNT 485
               +   LL+L     L IIH DLK  N+LL        KI DFG +        Q   
Sbjct: 162 FAQQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS----CQLGQRIY 216

Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
             I   + Y +PE  +   Y +  D++S G +++E+ +G+
Sbjct: 217 QYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 60.3 bits (145), Expect = 2e-09
 Identities = 63/432 (14%), Positives = 124/432 (28%), Gaps = 102/432 (23%)

Query: 259 SDTARTVI-------IILIPTVGFVILIIFICFFLRRKPRDNSKVKSEAAAGDEINR--- 308
            D  ++++       II+        L +F    L  K      V+        IN    
Sbjct: 39  QDMPKSILSKEEIDHIIMSKDAVSGTLRLFWT--LLSKQ--EEMVQKFVEEVLRINYKFL 94

Query: 309 AESLQFDFNTIRVATDNFSDA-NKLGQGG--F--GAVYKGRLYDGAEIAVKRLSRDSG-- 361
              ++ +     + T  + +  ++L      F    V + + Y     A+  L       
Sbjct: 95  MSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVL 154

Query: 362 -QGDLEFKNEVLLVANLQHRNLVRLLGF-----SLEGN--------ERL--LIYEFVPNT 405
             G L      + +       +   + F     +L  N        E L  L+Y+  PN 
Sbjct: 155 IDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNL-KNCNSPETVLEMLQKLLYQIDPNW 213

Query: 406 S--LDHFIFDPTRRAQL-DWERRYKIIGGIARGLLYLHED--------------SRLRII 448
           +   DH      R   +    RR          LL L                  ++ + 
Sbjct: 214 TSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVL--LNVQNAKAWNAFNLSCKILLT 271

Query: 449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVK 508
            R  + ++ L  A  T  I+    +     DE +    + +       P   +       
Sbjct: 272 TRFKQVTDFL-SAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTT----- 325

Query: 509 SDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTT---VNIIDPTLSSGSI 565
                     L II           E++ D L++ W NW+         II+ +L+    
Sbjct: 326 ------NPRRLSII----------AESIRDGLAT-WDNWKHVNCDKLTTIIESSLNVLEP 368

Query: 566 TEMIRCIHIGLLCV-QENVASRPTMASVVLMLNSYSLTLPVPSEPAFFMD-----SIIES 619
            E  +      L V   +         ++ ++        + S+    ++     S++E 
Sbjct: 369 AEYRKMFD--RLSVFPPSA---HIPTILLSLIWFDV----IKSDVMVVVNKLHKYSLVEK 419

Query: 620 D---MSFSLAHD 628
                + S+   
Sbjct: 420 QPKESTISI-PS 430

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.5 bits (104), Expect = 1e-04
 Identities = 41/323 (12%), Positives = 93/323 (28%), Gaps = 107/323 (33%)

Query: 364 DLEFKN------EVLLVANLQH-------RNLVRLLGFSLEGNERLLIYEFVPNTSLD-- 408
           + + K+       +L    + H        +    L ++L   +  ++ +FV    L   
Sbjct: 32  NFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFV-EEVLRIN 90

Query: 409 -HFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKI 467
             F+  P +  Q       +         +Y+ +  RL   + D    N +       ++
Sbjct: 91  YKFLMSPIKTEQRQPSMMTR---------MYIEQRDRL---YND----NQVFAKYNVSRL 134

Query: 468 ADFGMAR--LFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
             +   R  L E+   +      V   G       + G  S K+       + L++    
Sbjct: 135 QPYLKLRQALLELRPAKN-----VLIDG-------VLG--SGKT------WVALDVCLSY 174

Query: 526 RNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQ--ENV 583
           +  C  + +         W N +   +           ++ EM++      L  Q   N 
Sbjct: 175 KVQCKMDFKI-------FWLNLKNCNSPE---------TVLEMLQ-----KLLYQIDPNW 213

Query: 584 ASRPTMASVVLMLNSYSLTLPVPSEPA------FFMDS------IIESDMSFSLAHDSRI 631
            SR            +S  + +                      ++  ++      +++ 
Sbjct: 214 TSRS----------DHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQ-----NAKA 258

Query: 632 TETDQPGCENLLLSGNNEISITD 654
                  C+ LL +      +TD
Sbjct: 259 WNAFNLSCKILLTTRF--KQVTD 279

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 59.4 bits (144), Expect = 2e-09
 Identities = 54/218 (24%), Positives = 84/218 (38%), Gaps = 50/218 (22%)

Query: 332 LGQGGFGAVYKGR-LYDGAEIAVKRL---SRDSGQGDLEFK--------------NEVLL 373
           +G+G FG V K         +A+K +    R   Q   E +              N + +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164

Query: 374 VANLQHRN---LV-RLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKII 429
           + N   RN   +   LL  +L        YE +       F     R          K  
Sbjct: 165 LENFTFRNHICMTFELLSMNL--------YELIKKNKFQGFSLPLVR----------KFA 206

Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP--KIADFGMARLFEMDETQGNTSR 487
             I + L  LH   + RIIH DLK  N+LL  +     K+ DFG +      E Q   + 
Sbjct: 207 HSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTY 259

Query: 488 IVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           I   + Y APE  +  +Y +  D++S G ++ E+++G 
Sbjct: 260 IQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 51/268 (19%), Positives = 87/268 (32%), Gaps = 92/268 (34%)

Query: 331 KLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEV-----LLVANLQHRN--- 381
           KLG G F  V+    +     +A+K +       +    +E+     +  ++    N   
Sbjct: 44  KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREM 102

Query: 382 LVRLLG-FSLEGNERLLIYEFVPNTSLDH--FIFDPTRRAQLDWERRYK----------- 427
           +V+LL  F + G           N +  H   +F+      L W  +             
Sbjct: 103 VVQLLDDFKISG----------VNGT--HICMVFEVLGHHLLKWIIKSNYQGLPLPCVKK 150

Query: 428 IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE------------------------- 462
           II  + +GL YLH  ++ RIIH D+K  N+LL                            
Sbjct: 151 IIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208

Query: 463 ------------------------MTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
                                   +  KIAD G A       T+      + T  Y + E
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE-----DIQTRQYRSLE 263

Query: 499 YAMHGQYSVKSDVFSFGVLVLEIISGQR 526
             +   Y+  +D++S   +  E+ +G  
Sbjct: 264 VLIGSGYNTPADIWSTACMAFELATGDY 291

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 54.3 bits (131), Expect = 5e-08
 Identities = 38/162 (23%), Positives = 62/162 (38%), Gaps = 23/162 (14%)

Query: 331 KLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFS 389
           K+G G FG +  G+ LY    +A+K     S    L  +             + ++  F 
Sbjct: 16  KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQ-LGSGDGIPQVYYFG 74

Query: 390 LEGNERLLIYEFV-PNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL----YLHEDSR 444
             G    ++ E + P  SL+       R   L      K +  IA  L+    Y+H  + 
Sbjct: 75  PCGKYNAMVLELLGP--SLEDLFDLCDRTFSL------KTVLMIAIQLISRMEYVHSKN- 125

Query: 445 LRIIHRDLKTSNVLLDAEMTPK-----IADFGMARLFEMDET 481
             +I+RD+K  N L+            I DF +A+ +   ET
Sbjct: 126 --LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET 165

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 53.9 bits (130), Expect = 6e-08
 Identities = 34/161 (21%), Positives = 69/161 (42%), Gaps = 21/161 (13%)

Query: 331 KLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFS 389
           ++G+G FG +++G  L +  ++A+K   R S    L  +     +       +  +  F 
Sbjct: 17  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKL-LAGCTGIPNVYYFG 75

Query: 390 LEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL----YLHEDSRL 445
            EG   +L+ + +   SL+  +    R+  +      K +   A+ +L     +HE S  
Sbjct: 76  QEGLHNVLVIDLLGP-SLEDLLDLCGRKFSV------KTVAMAAKQMLARVQSIHEKS-- 126

Query: 446 RIIHRDLKTSNVLLDAEMTPK-----IADFGMARLFEMDET 481
            +++RD+K  N L+    +       + DFGM + +    T
Sbjct: 127 -LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 166

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 53.9 bits (130), Expect = 6e-08
 Identities = 39/161 (24%), Positives = 68/161 (42%), Gaps = 23/161 (14%)

Query: 331 KLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQH-RNLVRLLGF 388
           K+G G FG +Y G  +  G E+A+K     +    L    E  +   +Q    +  +   
Sbjct: 16  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVGIPTIRWC 73

Query: 389 SLEGNERLLIYEFV-PNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL----YLHEDS 443
             EG+  +++ E + P  SL+      +R+  L      K +  +A  ++    Y+H  +
Sbjct: 74  GAEGDYNVMVMELLGP--SLEDLFNFCSRKFSL------KTVLLLADQMISRIEYIHSKN 125

Query: 444 RLRIIHRDLKTSNVLLDAEMTPK---IADFGMARLFEMDET 481
               IHRD+K  N L+          I DFG+A+ +    T
Sbjct: 126 ---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 52.8 bits (127), Expect = 2e-07
 Identities = 38/197 (19%), Positives = 69/197 (35%), Gaps = 42/197 (21%)

Query: 331 KLGQGGFGAVYKGRLYDG------AEIAVKRLSRDSGQGDLEFK-----------NEVLL 373
            +GQGGFG +Y   +         A   VK    D+G    E K            + + 
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 374 VANLQHRNLVRLLGFSLEGNE----RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKII 429
              L++  + +  G  L        R +I +    + L        +R         K +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSR------KTV 154

Query: 430 GGIARGLL----YLHEDSRLRIIHRDLKTSNVLLDAEMTPKI--ADFGMARLFEMDET-- 481
             ++  +L    Y+HE      +H D+K SN+LL+ +   ++   D+G+A  +  +    
Sbjct: 155 LQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211

Query: 482 ---QGNTSRIVGTYGYM 495
                      GT  + 
Sbjct: 212 AYAADPKRCHDGTIEFT 228

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 35/195 (17%), Positives = 67/195 (34%), Gaps = 41/195 (21%)

Query: 331 KLGQGGFGAVYKGR----LYDGAEIAVKRLSRDSGQGDLEFK-----NEVLLVANLQHRN 381
           K+G GGFG +Y           A   VK   +++G    E K      +   +     R 
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 382 LVRLLGF----------SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG 431
            +  LG               + R ++ E +    L   I       +         +  
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQK-ISGQNGTFKK------STVLQ 155

Query: 432 IARGLL----YLHEDSRLRIIHRDLKTSNVLLDAEMTPKI--ADFGMARLFEMDET---- 481
           +   +L    Y+HE+     +H D+K +N+LL  +   ++  AD+G++  +  +      
Sbjct: 156 LGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQY 212

Query: 482 -QGNTSRIVGTYGYM 495
            +       GT  + 
Sbjct: 213 QENPRKGHNGTIEFT 227

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 38/160 (23%), Positives = 70/160 (43%), Gaps = 21/160 (13%)

Query: 331 KLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV-RLLGF 388
           K+G G FG +Y G  +    E+A+K  +  +    L +  E  +   LQ    +  +  F
Sbjct: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTGIPNVRWF 71

Query: 389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL----YLHEDSR 444
            +EG+  +L+ + +   SL+      +R+  L      K +  +A  ++    ++H  S 
Sbjct: 72  GVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSL------KTVLMLADQMINRVEFVHSKS- 123

Query: 445 LRIIHRDLKTSNVLLDAEMTPK---IADFGMARLFEMDET 481
              +HRD+K  N L+          I DFG+A+ +    T
Sbjct: 124 --FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 50.9 bits (122), Expect = 6e-07
 Identities = 29/174 (16%), Positives = 57/174 (32%), Gaps = 37/174 (21%)

Query: 330 NKLGQGGFGAVYKGR---------LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHR 380
           +   +   G +Y+                + ++K L    G+   E          LQ  
Sbjct: 48  SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVN 106

Query: 381 NLVRL-----LGF-------SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI 428
              +L     L           +   R L+   +   SL     D + +  L      + 
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-ALDVSPKHVLS----ERS 160

Query: 429 IGGIARGLL----YLHEDSRLRIIHRDLKTSNVLLDAEMTPKI--ADFGMARLF 476
           +  +A  LL    +LHE+     +H ++   N+ +D E   ++  A +G A  +
Sbjct: 161 VLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 47.7 bits (114), Expect = 7e-06
 Identities = 46/237 (19%), Positives = 81/237 (34%), Gaps = 68/237 (28%)

Query: 331 KLGQGGFGAVYKG--RLYDGAEIAVK-----RLSRDSGQ---GDLEFKNE---------V 371
            LG+G FG V +        +++A+K        R++ +     L+   E         V
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCV 85

Query: 372 LLVANLQHRN---LV-RLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYK 427
           L+           +   LLG +         +EF+   +   +     R           
Sbjct: 86  LMSDWFNFHGHMCIAFELLGKNT--------FEFLKENNFQPYPLPHVR----------H 127

Query: 428 IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP-------------------KIA 468
           +   +   L +LHE    ++ H DLK  N+L                          ++A
Sbjct: 128 MAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184

Query: 469 DFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           DFG A      + + + + IV T  Y  PE  +   ++   DV+S G ++ E   G 
Sbjct: 185 DFGSA----TFDHE-HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 47.3 bits (113), Expect = 1e-05
 Identities = 52/245 (21%), Positives = 85/245 (34%), Gaps = 80/245 (32%)

Query: 331 KLGQGGFGAVYKGR-LYDGAEIAVK--------------------RLSRDSGQGDLEFKN 369
           K+G G FG V   + + +    AVK                    ++  D    D+   N
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQND----DINNNN 97

Query: 370 EVLLVANLQHRN---LV-RLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERR 425
            V       + +   L+   LG SL        YE +   + + F  +  +         
Sbjct: 98  IVKYHGKFMYYDHMCLIFEPLGPSL--------YEIITRNNYNGFHIEDIK--------- 140

Query: 426 YKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP-------------------- 465
                 I + L YL +   + + H DLK  N+LLD                         
Sbjct: 141 -LYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRT 196

Query: 466 -----KIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLE 520
                K+ DFG A      ++      I+ T  Y APE  ++  + V SD++SFG ++ E
Sbjct: 197 KSTGIKLIDFGCA----TFKSD-YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251

Query: 521 IISGQ 525
           + +G 
Sbjct: 252 LYTGS 256

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 46.5 bits (111), Expect = 2e-05
 Identities = 51/237 (21%), Positives = 83/237 (35%), Gaps = 68/237 (28%)

Query: 331 KLGQGGFGAVYKG-------------------RLYDGAEIAVKRLSRDSGQGDLEFKNEV 371
            LG+G FG V +                    R  + A   ++ L   +          V
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCV 80

Query: 372 LLVANLQHRN---LV-RLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYK 427
            ++   +H     +V  LLG S         Y+F+       F  D  R          K
Sbjct: 81  QMLEWFEHHGHICIVFELLGLST--------YDFIKENGFLPFRLDHIR----------K 122

Query: 428 IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLL-DAEMTP------------------KIA 468
           +   I + + +LH     ++ H DLK  N+L   ++ T                   K+ 
Sbjct: 123 MAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVV 179

Query: 469 DFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           DFG A      + + + S +V T  Y APE  +   +S   DV+S G +++E   G 
Sbjct: 180 DFGSA----TYDDE-HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGF 231

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	658
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
3a2e_A	108	Ginkbilobin-2; domain 26 unknown function (DUF26),	99.93
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	99.92
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.88
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	99.82
3a2e_A	108	Ginkbilobin-2; domain 26 unknown function (DUF26),	99.82
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.77
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.66
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.26
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.15
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.96
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.85
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.56
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.51
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.35
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.28
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.24
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.18
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.98
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.89
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.87
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.73
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.55
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.28
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.17
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.11
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.09
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.99
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.95
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.81
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.62
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.29
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.92
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.15
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	94.11
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	88.62
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	88.13
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	85.58
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	82.59

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.9e-55  Score=453.95  Aligned_cols=261  Identities=26%  Similarity=0.444  Sum_probs=214.6

Q ss_pred             hccCCcccCcccccCceEEEEeEec------CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCce
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNER  395 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  395 (658)
                      ..++|...++||+|+||+||+|++.      ++..||||+++........+|.+|+.+|++++|||||+++|++.+++..
T Consensus        11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~   90 (299)
T 4asz_A           11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   90 (299)
T ss_dssp             CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence            3467888999999999999999853      4678999999877666677899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCc----------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCe
Q 006155          396 LLIYEFVPNTSLDHFIFDP----------TRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP  465 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~  465 (658)
                      +||||||++|+|.++|+..          .....++|..+++|+.||++||.|||+++   ||||||||+||||++++.+
T Consensus        91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~  167 (299)
T 4asz_A           91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLV  167 (299)
T ss_dssp             EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcE
Confidence            9999999999999999642          22457999999999999999999999987   9999999999999999999


Q ss_pred             EEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHH
Q 006155          466 KIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAW  544 (658)
Q Consensus       466 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~  544 (658)
                      ||+|||+++...............||+.|||||++.++.|+.|+|||||||++|||+| |+.||...   ...+++....
T Consensus       168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~---~~~~~~~~i~  244 (299)
T 4asz_A          168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL---SNNEVIECIT  244 (299)
T ss_dssp             EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS---CHHHHHHHHH
T ss_pred             EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---CHHHHHHHHH
Confidence            9999999987655444333445679999999999999999999999999999999999 89998532   2334444433


Q ss_pred             HhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 006155          545 KNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYS  600 (658)
Q Consensus       545 ~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~  600 (658)
                      ..    ...     .......+   .+.+++..||+.||++||||++|+++|+...
T Consensus       245 ~~----~~~-----~~p~~~~~---~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~  288 (299)
T 4asz_A          245 QG----RVL-----QRPRTCPQ---EVYELMLGCWQREPHMRKNIKGIHTLLQNLA  288 (299)
T ss_dssp             HT----CCC-----CCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cC----CCC-----CCCccchH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            32    111     11122223   3456788999999999999999999998653

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.1e-54  Score=449.99  Aligned_cols=258  Identities=27%  Similarity=0.450  Sum_probs=211.6

Q ss_pred             cCCcccCcccccCceEEEEeEec------CCcceeEEEeccCC-cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRDS-GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERL  396 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  396 (658)
                      ++++..++||+|+||+||+|++.      +++.||||+++... .....+|.+|+.++++++|||||+++|+|.+++..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            45566789999999999999863      46789999997653 334567999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCcC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCC
Q 006155          397 LIYEFVPNTSLDHFIFDPT-------------RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM  463 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~  463 (658)
                      ||||||++|+|.++|....             ....++|..+++|+.|||+||.|||+++   ||||||||+||||++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence            9999999999999996432             1346999999999999999999999987   99999999999999999


Q ss_pred             CeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHH
Q 006155          464 TPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSS  542 (658)
Q Consensus       464 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~  542 (658)
                      ++||+|||+++.+.............||+.|||||++.++.|+.++|||||||++|||+| |+.||...   ...+++..
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~---~~~~~~~~  259 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY---SNQDVVEM  259 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC---CHHHHHHH
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC---CHHHHHHH
Confidence            999999999997765544444556789999999999999999999999999999999999 88898532   23344444


Q ss_pred             HHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          543 AWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       543 ~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      +..    +....     .....+++   +.+++..||+.||++||||.||++.|+..
T Consensus       260 i~~----~~~~~-----~p~~~~~~---~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          260 IRN----RQVLP-----CPDDCPAW---VYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HHT----TCCCC-----CCTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HHc----CCCCC-----CcccchHH---HHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            332    22111     12222333   45678899999999999999999999863

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=8.9e-55  Score=454.99  Aligned_cols=261  Identities=26%  Similarity=0.401  Sum_probs=207.1

Q ss_pred             hccCCcccCcccccCceEEEEeEec------CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCce
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNER  395 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  395 (658)
                      ..++|...++||+|+||+||+|++.      ++..||||+++........+|.+|+.+|++++|||||+++|+|.+++..
T Consensus        39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~  118 (329)
T 4aoj_A           39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL  118 (329)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            3467788889999999999999854      4778999999877666677899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCcC------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCC
Q 006155          396 LLIYEFVPNTSLDHFIFDPT------------RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM  463 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~  463 (658)
                      +||||||++|+|.++|+...            ....++|.++++|+.||++||.|||+.+   ||||||||+||||++++
T Consensus       119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~  195 (329)
T 4aoj_A          119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGL  195 (329)
T ss_dssp             EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTT
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCC
Confidence            99999999999999996532            2346999999999999999999999987   99999999999999999


Q ss_pred             CeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHH
Q 006155          464 TPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSS  542 (658)
Q Consensus       464 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~  542 (658)
                      .+||+|||+++.+.............||+.|||||++.+..|+.++|||||||++|||+| |+.||...   ...+++..
T Consensus       196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~---~~~~~~~~  272 (329)
T 4aoj_A          196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL---SNTEAIDC  272 (329)
T ss_dssp             EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS---CHHHHHHH
T ss_pred             cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCC---CHHHHHHH
Confidence            999999999997765544444456789999999999999999999999999999999999 89998532   23344443


Q ss_pred             HHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 006155          543 AWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYS  600 (658)
Q Consensus       543 ~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~  600 (658)
                      +....+         +.......++   +.+|+.+||+.||++||||.||+++|+...
T Consensus       273 i~~g~~---------~~~p~~~~~~---~~~li~~cl~~dP~~RPs~~ei~~~L~~l~  318 (329)
T 4aoj_A          273 ITQGRE---------LERPRACPPE---VYAIMRGCWQREPQQRHSIKDVHARLQALA  318 (329)
T ss_dssp             HHHTCC---------CCCCTTCCHH---HHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred             HHcCCC---------CCCcccccHH---HHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence            332211         1122222333   456778999999999999999999998753

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.3e-54  Score=446.09  Aligned_cols=267  Identities=24%  Similarity=0.425  Sum_probs=204.4

Q ss_pred             hhhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEE
Q 006155          320 RVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       320 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  397 (658)
                      ++..+++...++||+|+||+||+|++.  ..||||+++...  .+...+|.+|+.++++++|||||+++|++.+ +..+|
T Consensus        32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i  108 (307)
T 3omv_A           32 EIEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI  108 (307)
T ss_dssp             BCCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred             EEcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence            445678888999999999999999864  359999986543  2344579999999999999999999999865 56899


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE  477 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~  477 (658)
                      |||||++|+|.++|+..  ...++|..+++|+.|||+||+|||+++   ||||||||+||||++++++||+|||+|+...
T Consensus       109 VmEy~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  183 (307)
T 3omv_A          109 VTQWCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKS  183 (307)
T ss_dssp             EEECCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred             EEEcCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence            99999999999999643  356999999999999999999999987   9999999999999999999999999998765


Q ss_pred             cCCCccccccccccccccCcccccc---CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          478 MDETQGNTSRIVGTYGYMAPEYAMH---GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      ...........+||+.|||||++.+   +.|+.|+|||||||++|||+||+.||.....  ...+.............  
T Consensus       184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~--~~~~~~~~~~~~~~p~~--  259 (307)
T 3omv_A          184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN--RDQIIFMVGRGYASPDL--  259 (307)
T ss_dssp             ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--HHHHHHHHHTTCCCCCS--
T ss_pred             cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh--HHHHHHHHhcCCCCCCc--
Confidence            4443344556789999999999864   4699999999999999999999999853221  12222222222211111  


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCCC
Q 006155          555 IIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTLP  604 (658)
Q Consensus       555 ~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~~~~~  604 (658)
                         +.+.....++   +.+++..||+.||++||||.||++.|+.+.-++|
T Consensus       260 ---~~~~~~~~~~---l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp  303 (307)
T 3omv_A          260 ---SKLYKNCPKA---MKRLVADCVKKVKEERPLFPQILSSIELLQHSLP  303 (307)
T ss_dssp             ---TTSCTTSCHH---HHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred             ---ccccccchHH---HHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence               1112222333   4467789999999999999999999986554444

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=6.6e-52  Score=436.79  Aligned_cols=272  Identities=27%  Similarity=0.368  Sum_probs=218.6

Q ss_pred             ccccchhhhhhhccCCcccCcccccCceEEEEeEecC------CcceeEEEeccCCcc-cHHHHHHHHHHHHhcCC-CCc
Q 006155          311 SLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQ-GDLEFKNEVLLVANLQH-RNL  382 (658)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H-~ni  382 (658)
                      .+.++.+.+++..++|+..++||+|+||+||+|+...      ++.||||++...... ...+|.+|+.+|.+++| |||
T Consensus        51 ~lp~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnI  130 (353)
T 4ase_A           51 RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV  130 (353)
T ss_dssp             GSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             cCCCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcE
Confidence            3455666778888999999999999999999998543      357999999765443 34569999999999965 899


Q ss_pred             eeeeeeeccC-CceEEEEEecCCCChhhhhcCcC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEE
Q 006155          383 VRLLGFSLEG-NERLLIYEFVPNTSLDHFIFDPT-------------RRAQLDWERRYKIIGGIARGLLYLHEDSRLRII  448 (658)
Q Consensus       383 v~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv  448 (658)
                      |+++|+|.+. +..+||||||++|+|.++|+...             ....++|..++.|+.|||+||.|||+++   ||
T Consensus       131 V~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---ii  207 (353)
T 4ase_A          131 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CI  207 (353)
T ss_dssp             CCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred             EEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---ee
Confidence            9999998764 56899999999999999996432             1346899999999999999999999987   99


Q ss_pred             EeccCCCceeeCCCCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCC
Q 006155          449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRN  527 (658)
Q Consensus       449 HrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p  527 (658)
                      ||||||+||||++++.+||+|||+|+.+..+..........||+.|||||++.++.|+.++|||||||++|||+| |+.|
T Consensus       208 HRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~P  287 (353)
T 4ase_A          208 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP  287 (353)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             cCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCC
Confidence            999999999999999999999999998765554444556789999999999999999999999999999999998 8999


Q ss_pred             CccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          528 NCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       528 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      |.....  ...+......    +..     +.......++   +.+++..||+.||++|||+.||++.|+..
T Consensus       288 f~~~~~--~~~~~~~i~~----g~~-----~~~p~~~~~~---~~~li~~c~~~dP~~RPt~~eil~~L~~l  345 (353)
T 4ase_A          288 YPGVKI--DEEFCRRLKE----GTR-----MRAPDYTTPE---MYQTMLDCWHGEPSQRPTFSELVEHLGNL  345 (353)
T ss_dssp             STTCCC--SHHHHHHHHH----TCC-----CCCCTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCH--HHHHHHHHHc----CCC-----CCCCccCCHH---HHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            853321  1222222222    211     1122222333   45677899999999999999999998753

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.4e-52  Score=433.03  Aligned_cols=266  Identities=24%  Similarity=0.317  Sum_probs=201.4

Q ss_pred             cCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCC----ceEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGN----ERLLIY  399 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~lv~  399 (658)
                      ++|...++||+|+||+||+|++ +|+.||||+++.... ....++.|+..+.+++|||||+++|++.+++    ..+|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            4577888999999999999986 689999999965422 2223345666677899999999999998654    579999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhc-----CCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED-----SRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      |||++|+|.++|+    ...++|+.+++++.|+++||+|||++     ..++||||||||+||||+.++++||+|||+++
T Consensus        81 Ey~~~gsL~~~l~----~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           81 DYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCCCCcHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            9999999999994    34699999999999999999999986     23459999999999999999999999999998


Q ss_pred             ccccCCCc--cccccccccccccCccccccC------CCCcccccccccchHhHHHhCCCCCccCCCCCc--------ch
Q 006155          475 LFEMDETQ--GNTSRIVGTYGYMAPEYAMHG------QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETV--------ED  538 (658)
Q Consensus       475 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~--------~~  538 (658)
                      ........  ......+||+.|||||++.+.      .++.|+|||||||++|||+||+.|+........        ..
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~  236 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence            77544322  223346899999999998754      478899999999999999999887643222110        00


Q ss_pred             HHHHHHHhccCCCcccccCCCCCCC--CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          539 LLSSAWKNWREGTTVNIIDPTLSSG--SITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       539 l~~~~~~~~~~~~~~~~~dp~l~~~--~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      ..........    .+.++|.+...  ..+....+.+++.+||+.||++||||.||+++|+.+
T Consensus       237 ~~~~~~~~~~----~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l  295 (303)
T 3hmm_A          237 SVEEMRKVVC----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             CHHHHHHHHT----TSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             hHHHHHHHHh----cccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            1111111111    12233444332  334455677899999999999999999999999764

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=9.5e-51  Score=423.12  Aligned_cols=254  Identities=22%  Similarity=0.264  Sum_probs=202.9

Q ss_pred             hccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      ..+.|...++||+|+||.||+|+. .+|+.||||+++....     ..+|+.++++++|||||++++++.+++..+||||
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE  130 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME  130 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            346788889999999999999985 4589999999976432     2479999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCC-CeEEeccccccccccC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM-TPKIADFGMARLFEMD  479 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~-~~kl~DFGla~~~~~~  479 (658)
                      |+++|+|.++|.   +...+++..+..|+.||+.||+|||+++   ||||||||+||||+.++ ++||+|||+|+.+..+
T Consensus       131 y~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~  204 (336)
T 4g3f_A          131 LLEGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD  204 (336)
T ss_dssp             CCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred             ccCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence            999999999994   3457999999999999999999999988   99999999999999987 6999999999987643


Q ss_pred             CCc---cccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccccc
Q 006155          480 ETQ---GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNII  556 (658)
Q Consensus       480 ~~~---~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  556 (658)
                      ...   ......+||+.|||||++.+..|+.++|||||||++|||++|+.||......   .+.......   .....  
T Consensus       205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~~i~~~---~~~~~--  276 (336)
T 4g3f_A          205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG---PLCLKIASE---PPPIR--  276 (336)
T ss_dssp             ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS---CCHHHHHHS---CCGGG--
T ss_pred             CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH---HHHHHHHcC---CCCch--
Confidence            321   1233468999999999999999999999999999999999999999644332   233322221   11111  


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          557 DPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       557 dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                        .+.....++   +.+++..||+.||++|||+.|+++.|...
T Consensus       277 --~~~~~~s~~---~~~li~~~L~~dP~~R~sa~el~~~l~~~  314 (336)
T 4g3f_A          277 --EIPPSCAPL---TAQAIQEGLRKEPVHRASAMELRRKVGKA  314 (336)
T ss_dssp             --GSCTTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --hcCccCCHH---HHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence              111222223   34567799999999999999999888653

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=8.3e-51  Score=424.78  Aligned_cols=248  Identities=24%  Similarity=0.365  Sum_probs=206.3

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      .+.|+..++||+|+||+||+|+.. +|+.||||++..........+.+|+.+|++++|||||++++++.+++..+|||||
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  152 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  152 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            356889999999999999999854 6899999999776555666789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      +++|+|.+++.    ...+++..+..|+.||+.||+|||+++   ||||||||+||||+.++++||+|||+++.+.....
T Consensus       153 ~~gg~L~~~l~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  225 (346)
T 4fih_A          153 LEGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  225 (346)
T ss_dssp             CTTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred             CCCCcHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence            99999999984    246999999999999999999999998   99999999999999999999999999987654322


Q ss_pred             ccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCC
Q 006155          482 QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLS  561 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~  561 (658)
                        .....+||+.|||||++.+..|+.++|||||||++|||++|+.||...   ...+++.......    .     +.+.
T Consensus       226 --~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~i~~~~----~-----~~~~  291 (346)
T 4fih_A          226 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---PPLKAMKMIRDNL----P-----PRLK  291 (346)
T ss_dssp             --CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHHHHHSS----C-----CCCS
T ss_pred             --cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHHcCC----C-----CCCC
Confidence              344579999999999999999999999999999999999999998532   2233333322211    1     1111


Q ss_pred             C--CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          562 S--GSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       562 ~--~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .  ...+   .+.+++..||+.||++|||+.|+++
T Consensus       292 ~~~~~s~---~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          292 NLHKVSP---SLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             CGGGSCH---HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccccCCH---HHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1  1112   3446778999999999999999874

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=5.5e-51  Score=426.82  Aligned_cols=250  Identities=21%  Similarity=0.344  Sum_probs=200.3

Q ss_pred             cCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      ++|+..++||+|+||+||+++. .+|+.||||++....  ......+.+|+.+|++++|||||++++++.+++..+||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            6899999999999999999985 468999999997653  2334568999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      |+++|+|.++|.. .+...+++..++.|+.||+.||.|||+++   ||||||||+||||+.++.+||+|||+++.+....
T Consensus       104 y~~gg~L~~~i~~-~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          104 YCEGGDLFKRINA-QKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             CCTTCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             CCCCCcHHHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            9999999999953 23456789999999999999999999998   9999999999999999999999999998764322


Q ss_pred             CccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCC
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTL  560 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l  560 (658)
                        ......+||+.|||||++.+..|+.++|||||||++|||++|+.||..   .+..+++......    ..     |.+
T Consensus       180 --~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~---~~~~~~~~~i~~~----~~-----~~~  245 (350)
T 4b9d_A          180 --ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA---GSMKNLVLKIISG----SF-----PPV  245 (350)
T ss_dssp             --HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC---SSHHHHHHHHHHT----CC-----CCC
T ss_pred             --ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC---cCHHHHHHHHHcC----CC-----CCC
Confidence              123446899999999999999999999999999999999999999953   2333443333321    11     112


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          561 SSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       561 ~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .....++   +.+++..||+.||++|||+.|+++
T Consensus       246 ~~~~s~~---~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          246 SLHYSYD---LRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             CTTSCHH---HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CccCCHH---HHHHHHHHccCChhHCcCHHHHhc
Confidence            2222223   446778999999999999999985

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2e-50  Score=415.70  Aligned_cols=248  Identities=22%  Similarity=0.295  Sum_probs=208.2

Q ss_pred             cCCcccCcccccCceEEEEeEe-cCCcceeEEEeccC---CcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRD---SGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ++|+..++||+|+||+||+++. .+|+.||||++.+.   .......+.+|+.+|++++|||||++++++.+++..+|||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5799999999999999999984 46899999999753   2334567899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ||+++|+|.++|.   +...+++..+..++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+.+...
T Consensus       112 Ey~~gG~L~~~i~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            9999999999994   3457999999999999999999999998   999999999999999999999999999987655


Q ss_pred             CCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCC
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT  559 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~  559 (658)
                      .........+||+.|||||++.+..|+.++||||+||++|||++|+.||..   .+..+++......    .      +.
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~---~~~~~~~~~i~~~----~------~~  252 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA---GNEGLIFAKIIKL----E------YD  252 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHHT----C------CC
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHcC----C------CC
Confidence            444455668999999999999999999999999999999999999999953   2333444433321    1      11


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 006155          560 LSSGSITEMIRCIHIGLLCVQENVASRPTMASVV  593 (658)
Q Consensus       560 l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv  593 (658)
                      +.....++   +.+++..||+.||++|||+.|++
T Consensus       253 ~p~~~s~~---~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          253 FPEKFFPK---ARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             CCTTCCHH---HHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             CCcccCHH---HHHHHHHHccCCHhHCcChHHHc
Confidence            22222222   45677899999999999999863

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=5e-50  Score=410.66  Aligned_cols=246  Identities=25%  Similarity=0.366  Sum_probs=193.7

Q ss_pred             cccCcccccCceEEEEeEec-CCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeecc----CCceEEEE
Q 006155          327 SDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLE----GNERLLIY  399 (658)
Q Consensus       327 ~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lv~  399 (658)
                      ...++||+|+||+||+|+.. ++..||||++....  ......|.+|+.++++++|||||++++++.+    ++..+|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            55678999999999999854 58899999986542  2334568999999999999999999999864    34579999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeC-CCCCeEEecccccccccc
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLD-AEMTPKIADFGMARLFEM  478 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~-~~~~~kl~DFGla~~~~~  478 (658)
                      |||++|+|.++|.   +...+++..+..|+.||+.||+|||+++ ++||||||||+||||+ .++.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            9999999999994   3457999999999999999999999875 4599999999999998 479999999999986432


Q ss_pred             CCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCC
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP  558 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp  558 (658)
                          ......+||+.|||||++. ++|+.++|||||||++|||+||+.||...  .....+...    ...+......  
T Consensus       185 ----~~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~--~~~~~~~~~----i~~~~~~~~~--  251 (290)
T 3fpq_A          185 ----SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSEC--QNAAQIYRR----VTSGVKPASF--  251 (290)
T ss_dssp             ----TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTC--SSHHHHHHH----HTTTCCCGGG--
T ss_pred             ----CccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCC--CcHHHHHHH----HHcCCCCCCC--
Confidence                2334578999999999886 46999999999999999999999998432  122222222    2222111111  


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          559 TLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       559 ~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                        .....++   +.+++..||+.||++|||+.|+++
T Consensus       252 --~~~~~~~---~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          252 --DKVAIPE---VKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             --GGCCCHH---HHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --CccCCHH---HHHHHHHHccCChhHCcCHHHHhc
Confidence              1112223   456778999999999999999974

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.4e-49  Score=425.50  Aligned_cols=250  Identities=23%  Similarity=0.341  Sum_probs=207.1

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      .+.|+..++||+|+||.||+|+.. +|+.||||++..........+.+|+.+|++++|||||++++++.+++..+|||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            467999999999999999999854 5899999999876666666789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      |++|+|.+++.    ...+++..+..|+.||+.||+|||+++   ||||||||+||||+.++.+||+|||+++.+.... 
T Consensus       230 ~~gG~L~~~i~----~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-  301 (423)
T 4fie_A          230 LEGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-  301 (423)
T ss_dssp             CTTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-
T ss_pred             CCCCcHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC-
Confidence            99999999984    345999999999999999999999998   9999999999999999999999999998765432 


Q ss_pred             ccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCC
Q 006155          482 QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLS  561 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~  561 (658)
                       ......+||+.|||||++.+..|+.++|||||||++|||++|+.||...   ...+++......    ....+-.   .
T Consensus       302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~i~~~----~~~~~~~---~  370 (423)
T 4fie_A          302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---PPLKAMKMIRDN----LPPRLKN---L  370 (423)
T ss_dssp             -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHHHHHS----CCCCCSC---T
T ss_pred             -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHHcC----CCCCCcc---c
Confidence             2344578999999999999999999999999999999999999998432   223333332221    1111111   0


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          562 SGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       562 ~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ....+   .+.+++..||+.||++|||+.|+++
T Consensus       371 ~~~s~---~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          371 HKVSP---SLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             TSSCH---HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccCCH---HHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11122   2446777999999999999999874

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.4e-48  Score=396.60  Aligned_cols=245  Identities=22%  Similarity=0.346  Sum_probs=188.6

Q ss_pred             cCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ++|+..+.||+|+||+||+++. .+|+.||||++.+..   ......+.+|+.++++++|||||++++++.+++..++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            6899999999999999999984 468999999997542   233456899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ||+ +|+|.+++.   ++..+++..+..++.||+.||+|||+++   |+||||||+||||++++++||+|||+|+.....
T Consensus        93 Ey~-~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           93 EYA-GNELFDYIV---QRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             ECC-CEEHHHHHH---HSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999 689988884   3457999999999999999999999998   999999999999999999999999999875432


Q ss_pred             CCccccccccccccccCccccccCCC-CcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCC
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMHGQY-SVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP  558 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp  558 (658)
                      .   .....+||+.|||||++.+..+ +.++||||+||++|||++|+.||..   .+...+.......    .      +
T Consensus       166 ~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~---~~~~~~~~~i~~~----~------~  229 (275)
T 3hyh_A          166 N---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD---ESIPVLFKNISNG----V------Y  229 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHHT----C------C
T ss_pred             C---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC---CCHHHHHHHHHcC----C------C
Confidence            2   2334689999999999998876 5799999999999999999999953   2333333333221    1      1


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          559 TLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       559 ~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .+.....++   +.+++..||+.||++|||+.|+++
T Consensus       230 ~~p~~~s~~---~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          230 TLPKFLSPG---AAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             CCCTTSCHH---HHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCHH---HHHHHHHHccCChhHCcCHHHHHc
Confidence            111221222   446778999999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.9e-49  Score=405.31  Aligned_cols=247  Identities=25%  Similarity=0.279  Sum_probs=194.6

Q ss_pred             ccCCcccCcccccCceEEEEeEec----CCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY----DGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERL  396 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  396 (658)
                      .++|+..+.||+|+||+||+++..    .++.||||++....  ......+.+|+.++++++|||||++++++.+++..+
T Consensus        23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  102 (304)
T 3ubd_A           23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY  102 (304)
T ss_dssp             GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred             ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            467999999999999999999742    36789999986542  223346789999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccc
Q 006155          397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF  476 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~  476 (658)
                      |||||+++|+|.++|.   +...+++..+..++.||+.||+|||+++   ||||||||+|||++.++++||+|||+|+..
T Consensus       103 ivmEy~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          103 LILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             EEECCCTTCEEHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             EEEEcCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            9999999999999994   3457999999999999999999999998   999999999999999999999999999865


Q ss_pred             ccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccccc
Q 006155          477 EMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNII  556 (658)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  556 (658)
                      .....  .....+||+.|||||++.+..|+.++|||||||++|||++|+.||..   .+..+++....+.    .     
T Consensus       177 ~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~---~~~~~~~~~i~~~----~-----  242 (304)
T 3ubd_A          177 IDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG---KDRKETMTMILKA----K-----  242 (304)
T ss_dssp             ----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHHC----C-----
T ss_pred             cCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC---cCHHHHHHHHHcC----C-----
Confidence            43322  23457899999999999999999999999999999999999999953   2333444433321    1     


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHH
Q 006155          557 DPTLSSGSITEMIRCIHIGLLCVQENVASRPTM-----ASVV  593 (658)
Q Consensus       557 dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm-----~evv  593 (658)
                       +.+.....++   +.+++..||+.||++|||+     +|++
T Consensus       243 -~~~p~~~s~~---~~~li~~~L~~dP~~R~ta~~~~~~eil  280 (304)
T 3ubd_A          243 -LGMPQFLSPE---AQSLLRMLFKRNPANRLGAGPDGVEEIK  280 (304)
T ss_dssp             -CCCCTTSCHH---HHHHHHHHTCSSGGGSTTCSTTTHHHHH
T ss_pred             -CCCCCcCCHH---HHHHHHHHcccCHHHCCCCCcCCHHHHH
Confidence             1111222223   4467789999999999984     5665

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.6e-48  Score=400.08  Aligned_cols=251  Identities=24%  Similarity=0.363  Sum_probs=187.6

Q ss_pred             cCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcc-cHHHHHHHHHHHHhcCCCCceeeeeeeccCC--------
Q 006155          324 DNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQ-GDLEFKNEVLLVANLQHRNLVRLLGFSLEGN--------  393 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--------  393 (658)
                      ++|+..+.||+|+||+||+|+. .+|+.||||++.....+ ....+.+|+.+|++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            4688999999999999999985 46899999999765433 3456899999999999999999999987544        


Q ss_pred             ----ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEec
Q 006155          394 ----ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIAD  469 (658)
Q Consensus       394 ----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~D  469 (658)
                          ..++||||+++|+|.+++.........++..++.|+.||++||+|||+++   ||||||||+||||+.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence                36899999999999999976554456778889999999999999999998   99999999999999999999999


Q ss_pred             cccccccccCCCcc----------ccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchH
Q 006155          470 FGMARLFEMDETQG----------NTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDL  539 (658)
Q Consensus       470 FGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l  539 (658)
                      ||+|+.+..+....          .....+||+.|||||++.+..|+.++|||||||++|||++   ||..     ..+.
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~-----~~~~  233 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST-----QMER  233 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS-----HHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC-----ccHH
Confidence            99999876443211          2234689999999999999999999999999999999996   5521     1111


Q ss_pred             HHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          540 LSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       540 ~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .. .....+.......        .......+.+++.+||+.||++|||+.|+++
T Consensus       234 ~~-~~~~~~~~~~p~~--------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          234 VR-TLTDVRNLKFPPL--------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HH-HHHHHHTTCCCHH--------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HH-HHHHHhcCCCCCC--------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11 1111122111110        0111123446788999999999999999986

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=4.1e-46  Score=390.20  Aligned_cols=284  Identities=34%  Similarity=0.585  Sum_probs=244.2

Q ss_pred             ccchhhhhhhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccC
Q 006155          313 QFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEG  392 (658)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~  392 (658)
                      .+.+.++...+++|...+.||+|+||.||+|+..+|+.||||++..........+.+|+.++..++||||+++++++.++
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  107 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER  107 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            34555667788999999999999999999999888999999998877666677899999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhhhhcCcC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccc
Q 006155          393 NERLLIYEFVPNTSLDHFIFDPT-RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFG  471 (658)
Q Consensus       393 ~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFG  471 (658)
                      +..++||||+++|+|.+++.... ....++|..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg  184 (321)
T 2qkw_B          108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFG  184 (321)
T ss_dssp             TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCT
T ss_pred             CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecc
Confidence            99999999999999999996532 2346999999999999999999999987   9999999999999999999999999


Q ss_pred             cccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCC
Q 006155          472 MARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGT  551 (658)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  551 (658)
                      +++...............||+.|+|||++.++.++.++||||||+++|||++|+.|+.............+.......+.
T Consensus       185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  264 (321)
T 2qkw_B          185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ  264 (321)
T ss_dssp             TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred             cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence            99865433333333445789999999999999999999999999999999999999976666666666666666666667


Q ss_pred             cccccCCCCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          552 TVNIIDPTLSSG-SITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       552 ~~~~~dp~l~~~-~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      ...++++.+... .......+.+++..||+.||++|||+.||++.|+..
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  313 (321)
T 2qkw_B          265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA  313 (321)
T ss_dssp             CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            777788877665 666677888999999999999999999999999854

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.9e-45  Score=384.44  Aligned_cols=290  Identities=41%  Similarity=0.689  Sum_probs=242.7

Q ss_pred             ccccchhhhhhhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcc-cHHHHHHHHHHHHhcCCCCceeeeeee
Q 006155          311 SLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQ-GDLEFKNEVLLVANLQHRNLVRLLGFS  389 (658)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~  389 (658)
                      ...+++.++....++|...+.||+|+||.||+|+..+|+.||||++...... ....+.+|+.++..++||||+++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            3467888999999999999999999999999999878999999998765322 333689999999999999999999999


Q ss_pred             ccCCceEEEEEecCCCChhhhhcCcC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEe
Q 006155          390 LEGNERLLIYEFVPNTSLDHFIFDPT-RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIA  468 (658)
Q Consensus       390 ~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~  468 (658)
                      ...+..++||||+++|+|.+++.... ....++|..++.++.||+.||.|||+....+|+||||||+|||++.++.+||+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~  176 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG  176 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence            99999999999999999999996543 34469999999999999999999999822239999999999999999999999


Q ss_pred             ccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccC--CCCCcchHHHHHHHh
Q 006155          469 DFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFR--NGETVEDLLSSAWKN  546 (658)
Q Consensus       469 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~--~~~~~~~l~~~~~~~  546 (658)
                      |||+++.+..... .......||+.|+|||++.++.++.++||||||+++|||++|+.||...  ..........+....
T Consensus       177 Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  255 (326)
T 3uim_A          177 DFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL  255 (326)
T ss_dssp             CCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred             cCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence            9999987654322 2233456999999999999999999999999999999999999998532  122333455555555


Q ss_pred             ccCCCcccccCCCCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 006155          547 WREGTTVNIIDPTLSSG-SITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSL  601 (658)
Q Consensus       547 ~~~~~~~~~~dp~l~~~-~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~~  601 (658)
                      ........+.++.+... ...+...+.+++.+||+.||++|||+.||+++|+....
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  311 (326)
T 3uim_A          256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL  311 (326)
T ss_dssp             TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred             hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence            66666677777777665 67777888999999999999999999999999987544

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.5e-45  Score=390.54  Aligned_cols=262  Identities=22%  Similarity=0.309  Sum_probs=199.2

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeecc------CC
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLE------GN  393 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~  393 (658)
                      .++|+..++||+|+||+||+|+. .+|+.||||++.....  .....+.+|+.+|+.++|||||++++++..      .+
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            36799999999999999999985 4689999999975432  233467899999999999999999998653      46


Q ss_pred             ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccc
Q 006155          394 ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMA  473 (658)
Q Consensus       394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla  473 (658)
                      ..+||||||+ |+|.+++.   ....+++..+..++.||+.||.|||+++   ||||||||+|||++.++.+||+|||++
T Consensus       133 ~~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence            7899999996 67999884   3457999999999999999999999998   999999999999999999999999999


Q ss_pred             cccccCC--CccccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCC
Q 006155          474 RLFEMDE--TQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREG  550 (658)
Q Consensus       474 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  550 (658)
                      +.+....  ........+||+.|||||++.+. .++.++||||+||++|||++|+.||...+   ..+.+..........
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~---~~~~l~~I~~~~g~p  282 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN---YVHQLQLIMMVLGTP  282 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS---HHHHHHHHHHHHCCC
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC---HHHHHHHHHHhcCCC
Confidence            8765432  12234457999999999998875 46999999999999999999999995432   223333322221111


Q ss_pred             Ccccc-----------c--CCCCCCCCHHHH-----HHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          551 TTVNI-----------I--DPTLSSGSITEM-----IRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       551 ~~~~~-----------~--dp~l~~~~~~e~-----~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .....           +  .|.........+     ..+++++..||+.||++|||+.|+++
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            10000           0  000000111111     23557788999999999999999875

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.8e-44  Score=379.87  Aligned_cols=200  Identities=22%  Similarity=0.337  Sum_probs=171.3

Q ss_pred             hhhhccCCcccCcccccCceEEEEeEec----CCcceeEEEeccCCcccHHHHHHHHHHHHhc-CCCCceeeeeeeccCC
Q 006155          319 IRVATDNFSDANKLGQGGFGAVYKGRLY----DGAEIAVKRLSRDSGQGDLEFKNEVLLVANL-QHRNLVRLLGFSLEGN  393 (658)
Q Consensus       319 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~  393 (658)
                      +....++|++.++||+|+||+||+|+..    .++.||||++....  ....+.+|+.+|..+ +|||||++++++.+.+
T Consensus        16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~   93 (361)
T 4f9c_A           16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND   93 (361)
T ss_dssp             SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred             cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence            3345688999999999999999999743    46789999986543  345678999999998 6999999999999999


Q ss_pred             ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCC-CCeEEecccc
Q 006155          394 ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE-MTPKIADFGM  472 (658)
Q Consensus       394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~-~~~kl~DFGl  472 (658)
                      ..++||||+++|+|.+++      ..+++..+..++.||+.||+|||+++   ||||||||+|||++.+ +.+||+|||+
T Consensus        94 ~~~lvmE~~~g~~L~~~~------~~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGl  164 (361)
T 4f9c_A           94 HVVIAMPYLEHESFLDIL------NSLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGL  164 (361)
T ss_dssp             EEEEEEECCCCCCHHHHH------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEEeCCCcccHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence            999999999999999998      24899999999999999999999998   9999999999999877 7999999999


Q ss_pred             ccccccCCCc--------------------------cccccccccccccCccccccC-CCCcccccccccchHhHHHhCC
Q 006155          473 ARLFEMDETQ--------------------------GNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQ  525 (658)
Q Consensus       473 a~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~  525 (658)
                      |+........                          ......+||+.|||||++.+. .|+.++||||+||++|||++|+
T Consensus       165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~  244 (361)
T 4f9c_A          165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR  244 (361)
T ss_dssp             CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred             CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence            9865432110                          112335799999999999876 4899999999999999999999


Q ss_pred             CCCc
Q 006155          526 RNNC  529 (658)
Q Consensus       526 ~p~~  529 (658)
                      .||.
T Consensus       245 ~Pf~  248 (361)
T 4f9c_A          245 YPFY  248 (361)
T ss_dssp             SSSS
T ss_pred             CCCC
Confidence            9984

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=5.3e-43  Score=363.91  Aligned_cols=283  Identities=37%  Similarity=0.568  Sum_probs=230.9

Q ss_pred             ccccchhhhhhhccCCccc------CcccccCceEEEEeEecCCcceeEEEeccCC----cccHHHHHHHHHHHHhcCCC
Q 006155          311 SLQFDFNTIRVATDNFSDA------NKLGQGGFGAVYKGRLYDGAEIAVKRLSRDS----GQGDLEFKNEVLLVANLQHR  380 (658)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~------~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~  380 (658)
                      ...|.+.++..++++|...      ++||+|+||.||+|+. +++.||||++....    ......+.+|+.++.+++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            3557888888888888877      8999999999999985 78899999986542    23345689999999999999


Q ss_pred             CceeeeeeeccCCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeC
Q 006155          381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLD  460 (658)
Q Consensus       381 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~  460 (658)
                      ||+++++++.+.+..++||||+++++|.+++........++|..++.++.||+.||.|||+.+   |+||||||+|||++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~  167 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD  167 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence            999999999999999999999999999999976555567999999999999999999999988   99999999999999


Q ss_pred             CCCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHH
Q 006155          461 AEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL  540 (658)
Q Consensus       461 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~  540 (658)
                      .++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|||++|+.|+...........+
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~  246 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI  246 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH
T ss_pred             CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH
Confidence            999999999999987654333333445679999999998764 5899999999999999999999998654433222211


Q ss_pred             HHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          541 SSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       541 ~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      ..... .......+.+++.+..........+.+++..||+.||.+|||+.+|++.|+..
T Consensus       247 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l  304 (307)
T 2nru_A          247 KEEIE-DEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM  304 (307)
T ss_dssp             HHHHH-TTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHhh-hhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            11111 11223345566666555666667788899999999999999999999999864

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.4e-44  Score=402.80  Aligned_cols=252  Identities=23%  Similarity=0.314  Sum_probs=206.7

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      .++|++.+.||+|+||.||+++. .+|+.||||++..........+.+|+.+|+.++|||||++++++.+++..+|||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            46899999999999999999985 46899999999876655666789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCC--CCeEEeccccccccccC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE--MTPKIADFGMARLFEMD  479 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~--~~~kl~DFGla~~~~~~  479 (658)
                      |++|+|.++|..  ....+++..+..++.||+.||.|||+++   |+||||||+|||++.+  +.+||+|||+++.+...
T Consensus       236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            999999999853  3356999999999999999999999998   9999999999999854  89999999999987543


Q ss_pred             CCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCC
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT  559 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~  559 (658)
                      .   .....+||+.|||||++.+..|+.++||||+||++|||++|+.||...   ...+.+......    .. . +++.
T Consensus       311 ~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~---~~~~~~~~i~~~----~~-~-~~~~  378 (573)
T 3uto_A          311 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE---NDDETLRNVKSC----DW-N-MDDS  378 (573)
T ss_dssp             S---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHHHHTT----CC-C-CCSG
T ss_pred             C---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHHhC----CC-C-CCcc
Confidence            2   234468999999999999999999999999999999999999998532   233333332221    10 0 0111


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          560 LSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       560 l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ......+   .+.+++..||+.||++|||+.|+++
T Consensus       379 ~~~~~s~---~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          379 AFSGISE---DGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             GGTTSCH---HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cccCCCH---HHHHHHHHHccCChhHCcCHHHHhc
Confidence            1111112   2446778999999999999999987

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=8.3e-44  Score=397.56  Aligned_cols=249  Identities=24%  Similarity=0.285  Sum_probs=198.4

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHH---HHHHHHHhcCCCCceeeeeeeccCCc
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFK---NEVLLVANLQHRNLVRLLGFSLEGNE  394 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~---~E~~~l~~l~H~niv~l~~~~~~~~~  394 (658)
                      .-++|++.++||+|+||+||+++.. +|+.||||++.+..   ......+.   .++.++..++|||||++++++.+.+.
T Consensus       187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~  266 (689)
T 3v5w_A          187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK  266 (689)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence            3478999999999999999999854 58999999986431   12222233   34666777899999999999999999


Q ss_pred             eEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          395 RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      .+|||||++||+|.++|.   +...+++..+..++.||+.||+|||+++   ||||||||+||||+.+|++||+|||+|+
T Consensus       267 lylVmEy~~GGdL~~~l~---~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~  340 (689)
T 3v5w_A          267 LSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC  340 (689)
T ss_dssp             EEEEECCCCSCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceee
Confidence            999999999999999994   3456999999999999999999999998   9999999999999999999999999998


Q ss_pred             ccccCCCccccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcc
Q 006155          475 LFEMDETQGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTV  553 (658)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  553 (658)
                      .+....    ....+||+.|||||++.+ ..|+.++|||||||++|||++|+.||......+...+.......       
T Consensus       341 ~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~-------  409 (689)
T 3v5w_A          341 DFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-------  409 (689)
T ss_dssp             ECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC-------
T ss_pred             ecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC-------
Confidence            765432    345699999999999975 47999999999999999999999999654433333333322221       


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHH
Q 006155          554 NIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPT-----MASVV  593 (658)
Q Consensus       554 ~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPt-----m~evv  593 (658)
                         .+.+.....++   +.+++..||+.||.+|++     +.||.
T Consensus       410 ---~~~~p~~~S~~---a~dLI~~lL~~dP~~Rl~~~~~ga~ei~  448 (689)
T 3v5w_A          410 ---AVELPDSFSPE---LRSLLEGLLQRDVNRRLGCLGRGAQEVK  448 (689)
T ss_dssp             ---CCCCCTTSCHH---HHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred             ---CCCCCccCCHH---HHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence               01111221222   446777999999999998     67776

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3.7e-43  Score=365.94  Aligned_cols=270  Identities=27%  Similarity=0.395  Sum_probs=204.6

Q ss_pred             chhhhhhhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeeccC
Q 006155          315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLEG  392 (658)
Q Consensus       315 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~  392 (658)
                      +...+.+..++|++.++||+|+||+||+++. +|+.||||++.....  ....++.+|+.++.+++||||+++++++.+.
T Consensus        28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  106 (309)
T 3p86_A           28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP  106 (309)
T ss_dssp             ----CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             CcccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence            3444556678999999999999999999985 788999999876542  2335688999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccc
Q 006155          393 NERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGM  472 (658)
Q Consensus       393 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGl  472 (658)
                      +..++||||+++|+|.+++........+++..++.++.||++||.|||+.+ .+|+||||||+|||++.++.+||+|||+
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~  185 (309)
T 3p86_A          107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGL  185 (309)
T ss_dssp             TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred             CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCC
Confidence            999999999999999999965443445999999999999999999999875 3499999999999999999999999999


Q ss_pred             ccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCc
Q 006155          473 ARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTT  552 (658)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  552 (658)
                      ++......  .......||+.|+|||++.+..++.++||||||+++|||++|+.||....   ..+...........   
T Consensus       186 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~---~~~~~~~~~~~~~~---  257 (309)
T 3p86_A          186 SRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN---PAQVVAAVGFKCKR---  257 (309)
T ss_dssp             ------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC---HHHHHHHHHHSCCC---
T ss_pred             Cccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhcCCC---
Confidence            98644322  12334679999999999999999999999999999999999999985322   22222222111110   


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCC
Q 006155          553 VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLT  602 (658)
Q Consensus       553 ~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~~~  602 (658)
                           ..+......   .+.+++..||+.||++|||+.+|++.|+.....
T Consensus       258 -----~~~~~~~~~---~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          258 -----LEIPRNLNP---QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             -----CCCCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             -----CCCCccCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                 111112222   345677899999999999999999999875433

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=9.6e-44  Score=372.56  Aligned_cols=269  Identities=26%  Similarity=0.368  Sum_probs=209.6

Q ss_pred             hhhhhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCC----
Q 006155          318 TIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGN----  393 (658)
Q Consensus       318 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----  393 (658)
                      ++....++|+..++||+|+||+||+|+. .++.||||++.... .....+..|+.++.+++||||+++++++.+..    
T Consensus        18 n~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (322)
T 3soc_A           18 NLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDV   95 (322)
T ss_dssp             CEEETTEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred             ccccchhhchhhheecccCceEEEEEEE-CCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCc
Confidence            3445568899999999999999999985 48999999996543 23345667899999999999999999998754    


Q ss_pred             ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhc----------CCCcEEEeccCCCceeeCCCC
Q 006155          394 ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED----------SRLRIIHRDLKTSNVLLDAEM  463 (658)
Q Consensus       394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------~~~~ivHrDlk~~NILl~~~~  463 (658)
                      ..++||||+++|+|.+++..    ..++|..++.++.||++||.|||+.          +   |+||||||+|||++.++
T Consensus        96 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~  168 (322)
T 3soc_A           96 DLWLITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNL  168 (322)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTC
T ss_pred             eEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCC
Confidence            36999999999999999943    4599999999999999999999987          6   99999999999999999


Q ss_pred             CeEEeccccccccccCCCccccccccccccccCccccccC-----CCCcccccccccchHhHHHhCCCCCccCCCCCcch
Q 006155          464 TPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG-----QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVED  538 (658)
Q Consensus       464 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~  538 (658)
                      .+||+|||+++.+.............||+.|+|||++.+.     .++.++||||||+++|||++|+.||..........
T Consensus       169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~  248 (322)
T 3soc_A          169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP  248 (322)
T ss_dssp             CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred             eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence            9999999999877655444444556899999999999863     56678999999999999999999986543322111


Q ss_pred             HHH---------HHHHhccCCCcccccCCCCCCC--CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          539 LLS---------SAWKNWREGTTVNIIDPTLSSG--SITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       539 l~~---------~~~~~~~~~~~~~~~dp~l~~~--~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      ...         .........    ...|.+...  .......+.+++..||+.||++|||+.||++.|+.+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l  316 (322)
T 3soc_A          249 FEEEIGQHPSLEDMQEVVVHK----KKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM  316 (322)
T ss_dssp             THHHHCSSCCHHHHHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhhhhccCCchhhhhhhhhcc----cCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            111         011111111    111222211  223344577888999999999999999999999764

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.4e-42  Score=370.83  Aligned_cols=261  Identities=27%  Similarity=0.377  Sum_probs=210.9

Q ss_pred             hhccCCcccCcccccCceEEEEeEec--------CCcceeEEEeccCCc-ccHHHHHHHHHHHHhc-CCCCceeeeeeec
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLY--------DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANL-QHRNLVRLLGFSL  390 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~  390 (658)
                      ...++|...+.||+|+||.||+|+..        ++..||||++..... .....+.+|+.++.++ +||||+++++++.
T Consensus        78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  157 (370)
T 2psq_A           78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  157 (370)
T ss_dssp             CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred             ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence            44678999999999999999999742        345699999976533 2345689999999999 8999999999999


Q ss_pred             cCCceEEEEEecCCCChhhhhcCcC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCce
Q 006155          391 EGNERLLIYEFVPNTSLDHFIFDPT-------------RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNV  457 (658)
Q Consensus       391 ~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NI  457 (658)
                      +.+..++||||+++|+|.+++....             ....+++..++.++.||++||.|||+.+   |+||||||+||
T Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NI  234 (370)
T 2psq_A          158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNV  234 (370)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGE
T ss_pred             cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhE
Confidence            9999999999999999999986432             1245899999999999999999999988   99999999999


Q ss_pred             eeCCCCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCc
Q 006155          458 LLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETV  536 (658)
Q Consensus       458 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~  536 (658)
                      |++.++.+||+|||+++.+.............||+.|+|||++.+..++.++||||||+++|||++ |+.|+...   ..
T Consensus       235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~---~~  311 (370)
T 2psq_A          235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI---PV  311 (370)
T ss_dssp             EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC---CG
T ss_pred             EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC---CH
Confidence            999999999999999987655443334445677899999999999999999999999999999999 88888543   23


Q ss_pred             chHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          537 EDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       537 ~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      .++........+         +.......+   .+.+++..||+.||++||++.|+++.|+..
T Consensus       312 ~~~~~~~~~~~~---------~~~~~~~~~---~l~~li~~~l~~dP~~Rpt~~ell~~L~~i  362 (370)
T 2psq_A          312 EELFKLLKEGHR---------MDKPANCTN---ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  362 (370)
T ss_dssp             GGHHHHHHTTCC---------CCCCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHhcCCC---------CCCCCCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            333333222211         111112222   345677899999999999999999999764

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=4.3e-42  Score=357.74  Aligned_cols=258  Identities=27%  Similarity=0.414  Sum_probs=208.7

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      .++|...++||+|+||+||+++.. +++.||+|++..........+.+|+.++.+++||||+++++++.+++..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            578889999999999999999854 5889999999776666677899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      +++++|.+++..  ....++|..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.....
T Consensus        89 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           89 IKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             CTTCBHHHHHHH--CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            999999999954  2456999999999999999999999998   99999999999999999999999999987654322


Q ss_pred             cc------------ccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcc--hHHHHHHHhc
Q 006155          482 QG------------NTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVE--DLLSSAWKNW  547 (658)
Q Consensus       482 ~~------------~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~--~l~~~~~~~~  547 (658)
                      ..            ......||+.|+|||++.+..++.++||||||+++|||++|..|+.........  ......... 
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~-  242 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR-  242 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH-
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc-
Confidence            11            111467999999999999999999999999999999999999987543322111  111111111 


Q ss_pred             cCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 006155          548 REGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYS  600 (658)
Q Consensus       548 ~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~  600 (658)
                                 .......+   .+.+++..||+.||++|||+.++++.|+...
T Consensus       243 -----------~~~~~~~~---~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~  281 (310)
T 3s95_A          243 -----------YCPPNCPP---SFFPITVRCCDLDPEKRPSFVKLEHWLETLR  281 (310)
T ss_dssp             -----------TCCTTCCT---THHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----------cCCCCCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                       00111111   2456778999999999999999999998754

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=6.9e-42  Score=354.25  Aligned_cols=251  Identities=25%  Similarity=0.411  Sum_probs=205.7

Q ss_pred             hccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      ..++|...++||+|+||+||+++. .+|+.||||++..........+.+|+.++++++||||+++++++..++..++|||
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            457899999999999999999984 5688999999977666667778999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      |+++++|.+++..    ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+....
T Consensus        98 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (297)
T 3fxz_A           98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (297)
T ss_dssp             CCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             CCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence            9999999999843    35899999999999999999999998   9999999999999999999999999998765432


Q ss_pred             CccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCC
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTL  560 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l  560 (658)
                      .  ......||+.|+|||++.+..++.++||||||+++|||++|+.||....   ...........   +. .....+  
T Consensus       171 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~~~~~---~~-~~~~~~--  239 (297)
T 3fxz_A          171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN---PLRALYLIATN---GT-PELQNP--  239 (297)
T ss_dssp             C--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHH---CS-CCCSCG--
T ss_pred             c--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhC---CC-CCCCCc--
Confidence            2  2334689999999999999999999999999999999999999984322   11222111111   11 011011  


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          561 SSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       561 ~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                       ....   ..+.+++..||+.||++|||+.|+++
T Consensus       240 -~~~~---~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          240 -EKLS---AIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             -GGSC---HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -cccC---HHHHHHHHHHccCChhHCcCHHHHhh
Confidence             0111   23456778999999999999999975

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2e-42  Score=367.77  Aligned_cols=271  Identities=27%  Similarity=0.370  Sum_probs=214.3

Q ss_pred             cccchhhhhhhccCCcccCcccccCceEEEEeEe------cCCcceeEEEeccCCcc-cHHHHHHHHHHHHhc-CCCCce
Q 006155          312 LQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRL------YDGAEIAVKRLSRDSGQ-GDLEFKNEVLLVANL-QHRNLV  383 (658)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l-~H~niv  383 (658)
                      +.++...++...++|...+.||+|+||.||+|+.      .+++.||||++...... ....+.+|+.++.++ +||||+
T Consensus        10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv   89 (359)
T 3vhe_A           10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV   89 (359)
T ss_dssp             SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence            4456667778889999999999999999999973      24578999999765332 335689999999999 799999


Q ss_pred             eeeeeeccCCc-eEEEEEecCCCChhhhhcCcCC----------------------------------------------
Q 006155          384 RLLGFSLEGNE-RLLIYEFVPNTSLDHFIFDPTR----------------------------------------------  416 (658)
Q Consensus       384 ~l~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------  416 (658)
                      ++++++.+.+. .++||||+++|+|.+++.....                                              
T Consensus        90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (359)
T 3vhe_A           90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE  169 (359)
T ss_dssp             CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred             eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence            99999887554 8999999999999999965332                                              


Q ss_pred             -----------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          417 -----------------RAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       417 -----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                                       ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  246 (359)
T 3vhe_A          170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKD  246 (359)
T ss_dssp             --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred             ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence                             122899999999999999999999998   999999999999999999999999999876544


Q ss_pred             CCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccCC
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP  558 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp  558 (658)
                      ..........||+.|+|||++.+..++.++||||||+++|||++ |+.||......   ..+......   +..     +
T Consensus       247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~~~~~---~~~-----~  315 (359)
T 3vhe_A          247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---EEFCRRLKE---GTR-----M  315 (359)
T ss_dssp             TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS---HHHHHHHHH---TCC-----C
T ss_pred             ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh---HHHHHHHHc---CCC-----C
Confidence            43334445678999999999999999999999999999999998 99998543221   222221111   111     1


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          559 TLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       559 ~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      .......+   .+.+++..||+.||++|||+.||++.|+..
T Consensus       316 ~~~~~~~~---~l~~li~~~l~~dP~~Rps~~ell~~L~~~  353 (359)
T 3vhe_A          316 RAPDYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHLGNL  353 (359)
T ss_dssp             CCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCH---HHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence            11111222   345677899999999999999999999753

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.4e-42  Score=360.40  Aligned_cols=259  Identities=28%  Similarity=0.462  Sum_probs=206.1

Q ss_pred             hhccCCcccCcccccCceEEEEeEec----CCcceeEEEeccCC-cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCce
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLY----DGAEIAVKRLSRDS-GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNER  395 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  395 (658)
                      +..++|...+.||+|+||.||+|+..    .+..||||++.... ......+.+|+.++.+++||||+++++++.+++..
T Consensus        46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  125 (325)
T 3kul_A           46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA  125 (325)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred             cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence            34578899999999999999999864    34459999997653 33445689999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ++||||+++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       126 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          126 MIVTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             EEEEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEEeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccc
Confidence            999999999999999954  2346999999999999999999999998   99999999999999999999999999987


Q ss_pred             cccCCCc-cccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcc
Q 006155          476 FEMDETQ-GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTV  553 (658)
Q Consensus       476 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  553 (658)
                      +...... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...   ...++.........     
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~---~~~~~~~~~~~~~~-----  272 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM---TNRDVISSVEEGYR-----  272 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS---CHHHHHHHHHTTCC-----
T ss_pred             cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC---CHHHHHHHHHcCCC-----
Confidence            6543322 12233456889999999999999999999999999999999 99998432   22233333222211     


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          554 NIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       554 ~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                          +.......+   .+.+++..||+.||++|||+.+|+++|+..
T Consensus       273 ----~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~eil~~L~~l  311 (325)
T 3kul_A          273 ----LPAPMGCPH---ALHQLMLDCWHKDRAQRPRFSQIVSVLDAL  311 (325)
T ss_dssp             ----CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCCCcCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                111111222   355677899999999999999999999875

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.3e-42  Score=368.21  Aligned_cols=259  Identities=26%  Similarity=0.454  Sum_probs=196.7

Q ss_pred             hhccCCcccCcccccCceEEEEeEec----CCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCce
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLY----DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNER  395 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  395 (658)
                      +..++|...+.||+|+||.||+|+..    ++..||||++..... ....+|.+|+.++.+++||||+++++++.+++..
T Consensus        42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  121 (373)
T 2qol_A           42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV  121 (373)
T ss_dssp             CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence            34578999999999999999999864    577899999976532 3345689999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ++||||+++|+|.+++..  ....+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       122 ~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  196 (373)
T 2qol_A          122 MIVTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRV  196 (373)
T ss_dssp             EEEEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             EEEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccc
Confidence            999999999999999954  3346999999999999999999999987   99999999999999999999999999987


Q ss_pred             cccCCCcc-ccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcc
Q 006155          476 FEMDETQG-NTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTV  553 (658)
Q Consensus       476 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  553 (658)
                      +....... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.|+...   ...++........+..   
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~---~~~~~~~~i~~~~~~~---  270 (373)
T 2qol_A          197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM---SNQDVIKAVDEGYRLP---  270 (373)
T ss_dssp             -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC---CHHHHHHHHHTTEECC---
T ss_pred             cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHHcCCCCC---
Confidence            65433221 2223346788999999999999999999999999999998 99998432   2233333322221111   


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          554 NIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       554 ~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                            ......   ..+.+++..||+.||++||++.+|+++|+..
T Consensus       271 ------~~~~~~---~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~  307 (373)
T 2qol_A          271 ------PPMDCP---AALYQLMLDCWQKDRNNRPKFEQIVSILDKL  307 (373)
T ss_dssp             ------CCTTCB---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------CCcccc---HHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence                  111112   2355778899999999999999999999754

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.2e-42  Score=363.03  Aligned_cols=256  Identities=27%  Similarity=0.436  Sum_probs=198.1

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcc----eeEEEeccCC-cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAE----IAVKRLSRDS-GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERL  396 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~----vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  396 (658)
                      .++|...++||+|+||+||+|+.. +++.    ||+|.+.... .....++.+|+.++.+++||||+++++++.++. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            567999999999999999999843 4544    5888775432 345567999999999999999999999998754 78


Q ss_pred             EEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccc
Q 006155          397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF  476 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~  476 (658)
                      +|+||+++|+|.+++..  ....+++..++.|+.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus        93 ~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           93 LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEECCTTCBHHHHHHH--STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             EEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            99999999999999854  3356999999999999999999999987   999999999999999999999999999887


Q ss_pred             ccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccc
Q 006155          477 EMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNI  555 (658)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  555 (658)
                      .............||+.|+|||++.+..++.++||||||+++|||++ |+.||.....   ..+.........       
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~~~~~~~-------  237 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSILEKGER-------  237 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHHHTTCC-------
T ss_pred             cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH---HHHHHHHHcCCC-------
Confidence            65544444445677889999999999999999999999999999999 9999854332   222222221111       


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          556 IDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       556 ~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                        +......   ...+.+++..||+.||++||++.+|++.|+..
T Consensus       238 --~~~~~~~---~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~  276 (327)
T 3poz_A          238 --LPQPPIC---TIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             --CCCCTTB---CHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred             --CCCCccC---CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence              0011111   12456788899999999999999999998653

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.6e-41  Score=353.91  Aligned_cols=245  Identities=24%  Similarity=0.383  Sum_probs=203.0

Q ss_pred             CcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecCC
Q 006155          326 FSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPN  404 (658)
Q Consensus       326 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  404 (658)
                      |...++||+|+||.||+|+.. +|+.||||++..........+.+|+.++.+++||||+++++++..++..++||||+++
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  126 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG  126 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence            666779999999999999865 6999999999877767777899999999999999999999999999999999999999


Q ss_pred             CChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCccc
Q 006155          405 TSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN  484 (658)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~  484 (658)
                      ++|.+++.    ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+.....  .
T Consensus       127 ~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~  197 (321)
T 2c30_A          127 GALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--K  197 (321)
T ss_dssp             CBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--C
T ss_pred             CCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--c
Confidence            99999984    346999999999999999999999987   99999999999999999999999999987654322  2


Q ss_pred             cccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCC--
Q 006155          485 TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSS--  562 (658)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~--  562 (658)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||....   ..+.......    ..     .+.+..  
T Consensus       198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~---~~~~~~~~~~----~~-----~~~~~~~~  265 (321)
T 2c30_A          198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS---PVQAMKRLRD----SP-----PPKLKNSH  265 (321)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHH----SS-----CCCCTTGG
T ss_pred             cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhc----CC-----CCCcCccc
Confidence            334689999999999999999999999999999999999999985322   2222222211    11     111111  


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          563 GSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       563 ~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ....   .+.+++..||+.||++|||+.++++
T Consensus       266 ~~~~---~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          266 KVSP---VLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             GSCH---HHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCCH---HHHHHHHHHccCChhhCcCHHHHhc
Confidence            1112   3446777999999999999999986

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.1e-42  Score=370.46  Aligned_cols=260  Identities=26%  Similarity=0.366  Sum_probs=207.4

Q ss_pred             hhhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcc-cHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEE
Q 006155          320 RVATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQ-GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       320 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  397 (658)
                      .+..++|...+.||+|+||.||+|+.. +++.||||++...... ...+|.+|+.++.+++||||+++++++.+++..++
T Consensus       110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  189 (377)
T 3cbl_A          110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI  189 (377)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence            455678999999999999999999975 6889999998754322 23458899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE  477 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~  477 (658)
                      ||||+++|+|.+++..  ....+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       190 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~  264 (377)
T 3cbl_A          190 VMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEA  264 (377)
T ss_dssp             EEECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred             EEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence            9999999999999953  2345899999999999999999999998   9999999999999999999999999998654


Q ss_pred             cCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCccccc
Q 006155          478 MDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNII  556 (658)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  556 (658)
                      ............+++.|+|||.+..+.++.++||||||+++|||++ |+.|+....   ..+.......    +..    
T Consensus       265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~---~~~~~~~~~~----~~~----  333 (377)
T 3cbl_A          265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS---NQQTREFVEK----GGR----  333 (377)
T ss_dssp             TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC---HHHHHHHHHT----TCC----
T ss_pred             CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHc----CCC----
Confidence            3322212222345788999999999999999999999999999998 888885322   2222222221    111    


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          557 DPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       557 dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                       +.......+   .+.+++..||+.||++|||+.+|++.|+..
T Consensus       334 -~~~~~~~~~---~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  372 (377)
T 3cbl_A          334 -LPCPELCPD---AVFRLMEQCWAYEPGQRPSFSTIYQELQSI  372 (377)
T ss_dssp             -CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CCCCCCCCH---HHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence             111111223   344677899999999999999999999763

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=7.2e-42  Score=375.40  Aligned_cols=263  Identities=26%  Similarity=0.418  Sum_probs=213.4

Q ss_pred             hhhhhhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceE
Q 006155          317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERL  396 (658)
Q Consensus       317 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  396 (658)
                      ..+++..++|...++||+|+||.||+|+..++..||||++.... ....+|.+|+.++++++||||+++++++. .+..+
T Consensus       181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~  258 (454)
T 1qcf_A          181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY  258 (454)
T ss_dssp             TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred             cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence            44566778899999999999999999998888899999997654 45678999999999999999999999986 56789


Q ss_pred             EEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccc
Q 006155          397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF  476 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~  476 (658)
                      +||||+++|+|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus       259 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  334 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI  334 (454)
T ss_dssp             EEECCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred             EEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence            999999999999999542 2236899999999999999999999988   999999999999999999999999999876


Q ss_pred             ccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccc
Q 006155          477 EMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNI  555 (658)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  555 (658)
                      ..... .......+|..|+|||++..+.++.++||||||+++|||++ |+.|+...   ...++........+..     
T Consensus       335 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~---~~~~~~~~i~~~~~~~-----  405 (454)
T 1qcf_A          335 EDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM---SNPEVIRALERGYRMP-----  405 (454)
T ss_dssp             CCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC---CHHHHHHHHHHTCCCC-----
T ss_pred             CCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC---CHHHHHHHHHcCCCCC-----
Confidence            43221 11223456889999999999999999999999999999999 99998532   2233333332222111     


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 006155          556 IDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSL  601 (658)
Q Consensus       556 ~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~~  601 (658)
                          ......+   .+.+++..||+.||++|||+.+|+++|+....
T Consensus       406 ----~~~~~~~---~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          406 ----RPENCPE---ELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             ----CCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             ----CCCCCCH---HHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence                1111222   34567789999999999999999999998643

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.2e-42  Score=366.58  Aligned_cols=263  Identities=27%  Similarity=0.368  Sum_probs=212.0

Q ss_pred             hhhccCCcccCcccccCceEEEEeEec--------CCcceeEEEeccCCc-ccHHHHHHHHHHHHhc-CCCCceeeeeee
Q 006155          320 RVATDNFSDANKLGQGGFGAVYKGRLY--------DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANL-QHRNLVRLLGFS  389 (658)
Q Consensus       320 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~  389 (658)
                      ++..++|...++||+|+||.||+|+..        .+..||||++..... .....+.+|+.++.++ +||||+++++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            455688999999999999999999842        235699999976533 2335688999999999 899999999999


Q ss_pred             ccCCceEEEEEecCCCChhhhhcCcCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCc
Q 006155          390 LEGNERLLIYEFVPNTSLDHFIFDPTR-------------RAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSN  456 (658)
Q Consensus       390 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~N  456 (658)
                      .+++..++||||+++|+|.+++.....             ...+++..++.++.||+.||.|||+.+   |+||||||+|
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N  221 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN  221 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcce
Confidence            999999999999999999999864321             245999999999999999999999987   9999999999


Q ss_pred             eeeCCCCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCC
Q 006155          457 VLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGET  535 (658)
Q Consensus       457 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~  535 (658)
                      ||++.++.+||+|||+++.+.............||+.|+|||++.+..++.++||||||+++|||++ |+.|+...   .
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~---~  298 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV---P  298 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC---C
T ss_pred             EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---C
Confidence            9999999999999999987655443344445678899999999999999999999999999999999 98888432   2


Q ss_pred             cchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 006155          536 VEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYS  600 (658)
Q Consensus       536 ~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~  600 (658)
                      ..++......    +..     +.......+   .+.+++..||+.||++|||+.||++.|+...
T Consensus       299 ~~~~~~~~~~----~~~-----~~~~~~~~~---~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  351 (382)
T 3tt0_A          299 VEELFKLLKE----GHR-----MDKPSNCTN---ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  351 (382)
T ss_dssp             HHHHHHHHHT----TCC-----CCCCSSCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHc----CCC-----CCCCccCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            2233332222    111     111112222   3456778999999999999999999998753

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-41  Score=358.19  Aligned_cols=267  Identities=25%  Similarity=0.350  Sum_probs=210.0

Q ss_pred             hhhhccCCcccCcccccCceEEEEeEec------CCcceeEEEeccCC-cccHHHHHHHHHHHHhc-CCCCceeeeeeec
Q 006155          319 IRVATDNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRDS-GQGDLEFKNEVLLVANL-QHRNLVRLLGFSL  390 (658)
Q Consensus       319 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~  390 (658)
                      .+...++|...+.||+|+||.||+|+..      .+..||||++.... ......+.+|+.++.++ +||||+++++++.
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            4566789999999999999999999852      35679999997543 23446789999999999 8999999999999


Q ss_pred             cCCceEEEEEecCCCChhhhhcCcCC--------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEe
Q 006155          391 EGNERLLIYEFVPNTSLDHFIFDPTR--------------------RAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHR  450 (658)
Q Consensus       391 ~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHr  450 (658)
                      ..+..++||||+++|+|.+++.....                    ...+++..++.++.||+.||.|||+.+   |+||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~  196 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR  196 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence            99999999999999999999965322                    134899999999999999999999988   9999


Q ss_pred             ccCCCceeeCCCCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCc
Q 006155          451 DLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNC  529 (658)
Q Consensus       451 Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~  529 (658)
                      ||||+|||++.++.+||+|||+++.+.............||+.|+|||++.++.++.++||||||+++|||++ |+.||.
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            9999999999999999999999987765443333445678899999999999999999999999999999998 999985


Q ss_pred             cCCCCCcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCC
Q 006155          530 FRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLT  602 (658)
Q Consensus       530 ~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~~~  602 (658)
                      .....  ..+....    ..+.     .+.......+   .+.+++..||+.||.+|||+.+|++.|+.....
T Consensus       277 ~~~~~--~~~~~~~----~~~~-----~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  335 (344)
T 1rjb_A          277 GIPVD--ANFYKLI----QNGF-----KMDQPFYATE---EIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD  335 (344)
T ss_dssp             TCCCS--HHHHHHH----HTTC-----CCCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             cCCcH--HHHHHHH----hcCC-----CCCCCCCCCH---HHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            43221  1111111    1111     1111111222   345677899999999999999999999875443

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.2e-41  Score=344.62  Aligned_cols=259  Identities=25%  Similarity=0.401  Sum_probs=210.7

Q ss_pred             hhhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          320 RVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       320 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ++..++|...+.||+|+||.||+++..++..||||++.... ....++.+|+.++.+++||||+++++++.+++..++||
T Consensus         4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (268)
T 3sxs_A            4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT   82 (268)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             EechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence            44568899999999999999999998888899999997654 34567899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ||+++++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        83 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A           83 EYISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             ECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred             EccCCCcHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchh
Confidence            99999999999854  2345999999999999999999999988   999999999999999999999999999876543


Q ss_pred             CCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccCC
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP  558 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp  558 (658)
                      ... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+....   ..+.......    +.  ....|
T Consensus       158 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~~~~----~~--~~~~~  227 (268)
T 3sxs_A          158 QYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT---NSEVVLKVSQ----GH--RLYRP  227 (268)
T ss_dssp             CEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC---HHHHHHHHHT----TC--CCCCC
T ss_pred             hhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC---hHHHHHHHHc----CC--CCCCC
Confidence            221 2233456788999999999999999999999999999999 998984322   2222222211    11  11111


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 006155          559 TLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYS  600 (658)
Q Consensus       559 ~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~  600 (658)
                      ..   ..+   .+.+++..||+.||++|||+.++++.|+...
T Consensus       228 ~~---~~~---~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (268)
T 3sxs_A          228 HL---ASD---TIYQIMYSCWHELPEKRPTFQQLLSSIEPLR  263 (268)
T ss_dssp             TT---SCH---HHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred             Cc---ChH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            11   122   3556778999999999999999999998753

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.1e-42  Score=366.12  Aligned_cols=261  Identities=29%  Similarity=0.441  Sum_probs=208.9

Q ss_pred             hhccCCcccCcccccCceEEEEeEec------CCcceeEEEeccCC-cccHHHHHHHHHHHHhcCCCCceeeeeeeccCC
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRDS-GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGN  393 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  393 (658)
                      +..++|...+.||+|+||.||+|+..      .+..||||++.... ......+.+|+.++.+++||||+++++++.++.
T Consensus        68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  147 (367)
T 3l9p_A           68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  147 (367)
T ss_dssp             CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            34578999999999999999999843      35689999996543 334456889999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhhhhcCcC----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCC---CeE
Q 006155          394 ERLLIYEFVPNTSLDHFIFDPT----RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM---TPK  466 (658)
Q Consensus       394 ~~~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~---~~k  466 (658)
                      ..++||||+++|+|.+++....    ....+++..++.++.||++||.|||+.+   |+||||||+|||++.++   .+|
T Consensus       148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~k  224 (367)
T 3l9p_A          148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK  224 (367)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEE
Confidence            9999999999999999996432    2246999999999999999999999998   99999999999999555   599


Q ss_pred             EeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHH
Q 006155          467 IADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWK  545 (658)
Q Consensus       467 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~  545 (658)
                      |+|||+++.+.............||+.|+|||++.++.++.++||||||+++|||++ |+.||...   ...++......
T Consensus       225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~---~~~~~~~~i~~  301 (367)
T 3l9p_A          225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK---SNQEVLEFVTS  301 (367)
T ss_dssp             ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC---CHHHHHHHHHT
T ss_pred             ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHHc
Confidence            999999986654433334445678999999999999999999999999999999998 88888432   22333333222


Q ss_pred             hccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          546 NWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       546 ~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      ..+         +........   .+.+++..||+.||++|||+.+|++.|+..
T Consensus       302 ~~~---------~~~~~~~~~---~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          302 GGR---------MDPPKNCPG---PVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             TCC---------CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCC---------CCCCccCCH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            111         111111222   345677899999999999999999999754

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=6.8e-42  Score=354.20  Aligned_cols=262  Identities=24%  Similarity=0.323  Sum_probs=200.4

Q ss_pred             hhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHh--cCCCCceeeeeeecc----CCc
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVAN--LQHRNLVRLLGFSLE----GNE  394 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~----~~~  394 (658)
                      ...++|...+.||+|+||+||+|+. +|+.||||++...   ....+..|.+++..  ++||||+++++++..    ...
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~   80 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ   80 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence            3567899999999999999999986 7899999998653   34456667777666  789999999998654    345


Q ss_pred             eEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhh--------hcCCCcEEEeccCCCceeeCCCCCeE
Q 006155          395 RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH--------EDSRLRIIHRDLKTSNVLLDAEMTPK  466 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivHrDlk~~NILl~~~~~~k  466 (658)
                      .++||||+++|+|.+++.    ...+++..+++++.||+.||.|||        +.+   |+||||||+|||++.++.+|
T Consensus        81 ~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~k  153 (301)
T 3q4u_A           81 LWLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCC  153 (301)
T ss_dssp             EEEEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEE
T ss_pred             eEEehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEE
Confidence            789999999999999993    346999999999999999999999        665   99999999999999999999


Q ss_pred             EeccccccccccCCCcc--ccccccccccccCccccccC------CCCcccccccccchHhHHHhC----------CCCC
Q 006155          467 IADFGMARLFEMDETQG--NTSRIVGTYGYMAPEYAMHG------QYSVKSDVFSFGVLVLEIISG----------QRNN  528 (658)
Q Consensus       467 l~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~ksDV~S~Gvll~elltG----------~~p~  528 (658)
                      |+|||+++.........  ......||+.|+|||++.+.      .++.++||||||+++|||++|          +.||
T Consensus       154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf  233 (301)
T 3q4u_A          154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF  233 (301)
T ss_dssp             ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence            99999998765433221  12335899999999999877      456799999999999999999          6776


Q ss_pred             ccCCCCCcchHHHHHHHhccCCCcccccCCCCCCC--CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          529 CFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSG--SITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       529 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~--~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      .........  ...........    ...+.+...  .......+.+++..||+.||++|||+.+|+++|+.+
T Consensus       234 ~~~~~~~~~--~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          234 YDVVPNDPS--FEDMRKVVCVD----QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TTTSCSSCC--HHHHHHHHTTS----CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccCCCCcc--hhhhhHHHhcc----CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            432222111  11111111111    111222111  123345567888999999999999999999999763

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.2e-41  Score=373.31  Aligned_cols=265  Identities=26%  Similarity=0.414  Sum_probs=208.0

Q ss_pred             hhhhhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEE
Q 006155          318 TIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       318 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  397 (658)
                      .+++..++|...++||+|+||.||+|+..++..||||++.... ....+|.+|+.++++++||||+++++++.+ +..++
T Consensus       178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i  255 (452)
T 1fmk_A          178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI  255 (452)
T ss_dssp             CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             ccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence            3455678899999999999999999998877889999997654 345679999999999999999999999876 67899


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE  477 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~  477 (658)
                      ||||+++|+|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       256 v~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  331 (452)
T 1fmk_A          256 VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE  331 (452)
T ss_dssp             EECCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             EehhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecC
Confidence            99999999999999532 2346899999999999999999999988   9999999999999999999999999998765


Q ss_pred             cCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCccccc
Q 006155          478 MDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNII  556 (658)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  556 (658)
                      .... .......+|..|+|||.+..+.++.++||||||+++|||++ |+.|+...   ...+++.......+.       
T Consensus       332 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~---~~~~~~~~i~~~~~~-------  400 (452)
T 1fmk_A          332 DNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQVERGYRM-------  400 (452)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC---CHHHHHHHHHTTCCC-------
T ss_pred             CCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC---CHHHHHHHHHcCCCC-------
Confidence            3321 12233457889999999999999999999999999999999 88888432   222333333222111       


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCCC
Q 006155          557 DPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTLP  604 (658)
Q Consensus       557 dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~~~~~  604 (658)
                        .......+   .+.+++..||+.||++|||+.+|+++|+......+
T Consensus       401 --~~~~~~~~---~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~  443 (452)
T 1fmk_A          401 --PCPPECPE---SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  443 (452)
T ss_dssp             --CCCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             --CCCCCCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence              11112222   34567789999999999999999999998755443

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.4e-41  Score=346.45  Aligned_cols=257  Identities=26%  Similarity=0.447  Sum_probs=209.7

Q ss_pred             hhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      +..++|...+.||+|+||.||+++..+++.||||++.... ....++.+|+.++.+++||||+++++++.+++..++|||
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (269)
T 4hcu_A            7 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE   85 (269)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             eChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence            4457899999999999999999998788999999997653 345679999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      |+++++|.+++..  ....+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        86 ~~~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  160 (269)
T 4hcu_A           86 FMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  160 (269)
T ss_dssp             CCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             eCCCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc
Confidence            9999999999954  3346899999999999999999999988   9999999999999999999999999998654332


Q ss_pred             CccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccCCC
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT  559 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~  559 (658)
                      . .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...   ...+..........      ...|.
T Consensus       161 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~---~~~~~~~~~~~~~~------~~~~~  230 (269)
T 4hcu_A          161 Y-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR---SNSEVVEDISTGFR------LYKPR  230 (269)
T ss_dssp             H-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHHHHHHTTCC------CCCCT
T ss_pred             c-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC---CHHHHHHHHhcCcc------CCCCC
Confidence            1 12233467889999999999999999999999999999999 88888532   22233322222111      11111


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          560 LSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       560 l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                         ...+   .+.+++..||+.||++|||+.++++.|+..
T Consensus       231 ---~~~~---~~~~li~~~l~~~p~~Rps~~~ll~~l~~l  264 (269)
T 4hcu_A          231 ---LAST---HVYQIMNHCWRERPEDRPAFSRLLRQLAEI  264 (269)
T ss_dssp             ---TSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---cCCH---HHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence               1122   345677899999999999999999999753

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1e-41  Score=359.74  Aligned_cols=266  Identities=26%  Similarity=0.441  Sum_probs=212.6

Q ss_pred             hhhhhccCCcccCcccccCceEEEEeEec------CCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeec
Q 006155          318 TIRVATDNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSL  390 (658)
Q Consensus       318 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~  390 (658)
                      .+....++|...+.||+|+||.||+++..      +++.||||++..... .....+.+|+.++.+++||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            34556789999999999999999999864      347899999976543 23456899999999999999999999999


Q ss_pred             cCCceEEEEEecCCCChhhhhcCcCC---------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEE
Q 006155          391 EGNERLLIYEFVPNTSLDHFIFDPTR---------------------RAQLDWERRYKIIGGIARGLLYLHEDSRLRIIH  449 (658)
Q Consensus       391 ~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH  449 (658)
                      +++..++||||+++++|.+++.....                     ...+++..++.++.||++||.|||+.+   |+|
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH  197 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH  197 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence            99999999999999999999864211                     257999999999999999999999998   999


Q ss_pred             eccCCCceeeCCCCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCC
Q 006155          450 RDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNN  528 (658)
Q Consensus       450 rDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~  528 (658)
                      |||||+|||++.++.+||+|||+++.+.............||+.|+|||++.+..++.++||||||+++|||++ |+.||
T Consensus       198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  277 (343)
T 1luf_A          198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  277 (343)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence            99999999999999999999999987654433333344678999999999999999999999999999999999 98888


Q ss_pred             ccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 006155          529 CFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSL  601 (658)
Q Consensus       529 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~~  601 (658)
                      ...   ...++....    ..+....     .......   .+.+++..||+.||++||++.+|++.|+....
T Consensus       278 ~~~---~~~~~~~~~----~~~~~~~-----~~~~~~~---~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          278 YGM---AHEEVIYYV----RDGNILA-----CPENCPL---ELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             TTS---CHHHHHHHH----HTTCCCC-----CCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             CCC---ChHHHHHHH----hCCCcCC-----CCCCCCH---HHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence            432   222222222    2222111     1112222   35567789999999999999999999988643

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=6.7e-42  Score=372.17  Aligned_cols=274  Identities=19%  Similarity=0.246  Sum_probs=212.2

Q ss_pred             cccchhhhhhhccCCcccCcccccCceEEEEeEecC-CcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeee
Q 006155          312 LQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLG  387 (658)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~  387 (658)
                      ..+.+.+++...++|+..++||+|+||+||+++..+ ++.||||++....   ......+.+|+.++..++||||+++++
T Consensus        62 ~~~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~  141 (437)
T 4aw2_A           62 FTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY  141 (437)
T ss_dssp             HHHHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEE
T ss_pred             ccchhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence            344566778889999999999999999999998654 7889999986531   112223789999999999999999999


Q ss_pred             eeccCCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEE
Q 006155          388 FSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKI  467 (658)
Q Consensus       388 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl  467 (658)
                      ++.+++..+|||||+++|+|.+++..  ....+++..++.++.||+.||.|||+.+   ||||||||+||||+.++.+||
T Consensus       142 ~~~~~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL  216 (437)
T 4aw2_A          142 AFQDDNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRL  216 (437)
T ss_dssp             EEECSSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEE
T ss_pred             EEeeCCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEE
Confidence            99999999999999999999999954  2356999999999999999999999988   999999999999999999999


Q ss_pred             eccccccccccCCCccccccccccccccCccccc-----cCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHH
Q 006155          468 ADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM-----HGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSS  542 (658)
Q Consensus       468 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~  542 (658)
                      +|||+++.+..... ......+||+.|+|||++.     .+.++.++|||||||++|||++|+.||...   +..+....
T Consensus       217 ~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~---~~~~~~~~  292 (437)
T 4aw2_A          217 ADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE---SLVETYGK  292 (437)
T ss_dssp             CCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHH
T ss_pred             cchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC---ChhHHHHh
Confidence            99999986654322 1233468999999999987     567999999999999999999999998532   22233332


Q ss_pred             HHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHH--HhccCCCC
Q 006155          543 AWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVAS--RPTMASVVL--MLNSYSLT  602 (658)
Q Consensus       543 ~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~--RPtm~evv~--~L~~~~~~  602 (658)
                      ......     ...-|.......++   +.+++..||+.+|++  ||+++|+++  .+++..+.
T Consensus       293 i~~~~~-----~~~~p~~~~~~s~~---~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~  348 (437)
T 4aw2_A          293 IMNHKE-----RFQFPTQVTDVSEN---AKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWD  348 (437)
T ss_dssp             HHTHHH-----HCCCCSSCCCSCHH---HHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTT
T ss_pred             hhhccc-----cccCCcccccCCHH---HHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHH
Confidence            221110     01112221122223   335556778777777  999999985  45554443

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.2e-41  Score=354.74  Aligned_cols=254  Identities=24%  Similarity=0.372  Sum_probs=201.8

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      .++|+..+.||+|+||.||+++.. +++.||||++..... .....+.+|+.++..++||||+++++++.+++..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999855 688999999865432 223558899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      |+++++|.+++.   ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+....
T Consensus        86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            999999999984   3456999999999999999999999988   9999999999999999999999999998765444


Q ss_pred             CccccccccccccccCccccccCCC-CcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCC
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMHGQY-SVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT  559 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~  559 (658)
                      .........||+.|+|||++.+..+ +.++||||||+++|||++|+.||........   ....+..   ...  ...+ 
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~~~~~---~~~--~~~~-  230 (323)
T 3tki_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ---EYSDWKE---KKT--YLNP-  230 (323)
T ss_dssp             EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH---HHHHHHT---TCT--TSTT-
T ss_pred             cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH---HHHHHhc---ccc--cCCc-
Confidence            3334445789999999999988775 7899999999999999999999964332211   1111111   110  0000 


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          560 LSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       560 l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                      . ....   ..+.+++..||+.||++|||+.|+++.
T Consensus       231 ~-~~~~---~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          231 W-KKID---SAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             G-GGSC---HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             c-ccCC---HHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            0 0111   234567789999999999999999753

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.2e-41  Score=356.45  Aligned_cols=267  Identities=24%  Similarity=0.397  Sum_probs=194.6

Q ss_pred             chhhhhhhccCCcccCcccccCceEEEEeEecCCc----ceeEEEeccC--CcccHHHHHHHHHHHHhcCCCCceeeeee
Q 006155          315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGA----EIAVKRLSRD--SGQGDLEFKNEVLLVANLQHRNLVRLLGF  388 (658)
Q Consensus       315 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~----~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~  388 (658)
                      .++.+.+..++|...+.||+|+||.||+|+.....    .||||++...  .......+.+|+.++++++||||++++++
T Consensus        14 ~~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   93 (323)
T 3qup_A           14 KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGV   93 (323)
T ss_dssp             --CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEE
T ss_pred             HhhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhce
Confidence            34455667789999999999999999999855432    7999998765  33445678999999999999999999999


Q ss_pred             eccCCce------EEEEEecCCCChhhhhcCcC---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceee
Q 006155          389 SLEGNER------LLIYEFVPNTSLDHFIFDPT---RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLL  459 (658)
Q Consensus       389 ~~~~~~~------~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl  459 (658)
                      +...+..      ++||||+++|+|.+++....   ....+++..++.++.||++||.|||+.+   |+||||||+|||+
T Consensus        94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli  170 (323)
T 3qup_A           94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCML  170 (323)
T ss_dssp             EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEE
Confidence            9877655      99999999999999985422   2236999999999999999999999998   9999999999999


Q ss_pred             CCCCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcch
Q 006155          460 DAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVED  538 (658)
Q Consensus       460 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~  538 (658)
                      +.++.+||+|||+++.+.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....   ..+
T Consensus       171 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~---~~~  247 (323)
T 3qup_A          171 AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE---NAE  247 (323)
T ss_dssp             CTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---GGG
T ss_pred             cCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC---hHH
Confidence            9999999999999987655443333344567889999999999999999999999999999999 888885432   223


Q ss_pred             HHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          539 LLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       539 l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      +.........         +.......+   .+.+++..||+.||++|||+.++++.|+..
T Consensus       248 ~~~~~~~~~~---------~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  296 (323)
T 3qup_A          248 IYNYLIGGNR---------LKQPPECME---EVYDLMYQCWSADPKQRPSFTCLRMELENI  296 (323)
T ss_dssp             HHHHHHTTCC---------CCCCTTCCH---HHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHhcCCC---------CCCCCccCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            3332222111         111111122   355778899999999999999999999865

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.8e-41  Score=376.04  Aligned_cols=261  Identities=26%  Similarity=0.398  Sum_probs=212.5

Q ss_pred             hhhhhccCCcccCcccccCceEEEEeEecC-CcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceE
Q 006155          318 TIRVATDNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERL  396 (658)
Q Consensus       318 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  396 (658)
                      ..++..++|...++||+|+||.||+|+... +..||||++.... ....+|.+|+.+|.+++||||+++++++.+.+..+
T Consensus       214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  292 (495)
T 1opk_A          214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY  292 (495)
T ss_dssp             CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEE
Confidence            344556789999999999999999998764 7889999997653 34678999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccc
Q 006155          397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF  476 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~  476 (658)
                      +||||+++|+|.+++... ....+++..++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++.+
T Consensus       293 lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  368 (495)
T 1opk_A          293 IITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLM  368 (495)
T ss_dssp             EEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred             EEEEccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceec
Confidence            999999999999999542 2356899999999999999999999988   999999999999999999999999999876


Q ss_pred             ccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccc
Q 006155          477 EMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNI  555 (658)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  555 (658)
                      ..... .......+|..|+|||++..+.++.++||||||+++|||++ |+.|+....   ..++.......++.      
T Consensus       369 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~---~~~~~~~~~~~~~~------  438 (495)
T 1opk_A          369 TGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRM------  438 (495)
T ss_dssp             TTCCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC---GGGHHHHHHTTCCC------
T ss_pred             cCCce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCCC------
Confidence            53321 12233456789999999999999999999999999999999 888885432   23333332222111      


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          556 IDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       556 ~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                         .......+   .+.+++..||+.||++|||+.+|+++|+..
T Consensus       439 ---~~~~~~~~---~l~~li~~cl~~dP~~RPs~~el~~~L~~~  476 (495)
T 1opk_A          439 ---ERPEGCPE---KVYELMRACWQWNPSDRPSFAEIHQAFETM  476 (495)
T ss_dssp             ---CCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             ---CCCCCCCH---HHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence               11112222   345677899999999999999999999875

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.8e-41  Score=353.29  Aligned_cols=264  Identities=25%  Similarity=0.339  Sum_probs=211.9

Q ss_pred             hhhhhccCCcccCcccccCceEEEEeEe------cCCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeec
Q 006155          318 TIRVATDNFSDANKLGQGGFGAVYKGRL------YDGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSL  390 (658)
Q Consensus       318 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~  390 (658)
                      +++...++|...+.||+|+||.||+++.      .++..||||++..... .....+.+|+.++.+++||||+++++++.
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   96 (314)
T 2ivs_A           17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS   96 (314)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence            3455678899999999999999999974      2357899999976532 33456889999999999999999999999


Q ss_pred             cCCceEEEEEecCCCChhhhhcCcCC---------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEE
Q 006155          391 EGNERLLIYEFVPNTSLDHFIFDPTR---------------------RAQLDWERRYKIIGGIARGLLYLHEDSRLRIIH  449 (658)
Q Consensus       391 ~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH  449 (658)
                      +.+..++||||+++++|.+++.....                     ...+++..++.++.||++||.|||+.+   |+|
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH  173 (314)
T 2ivs_A           97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVH  173 (314)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred             cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccc
Confidence            99999999999999999999964322                     234899999999999999999999988   999


Q ss_pred             eccCCCceeeCCCCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCC
Q 006155          450 RDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNN  528 (658)
Q Consensus       450 rDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~  528 (658)
                      |||||+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+
T Consensus       174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  253 (314)
T 2ivs_A          174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY  253 (314)
T ss_dssp             CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999987655443333444567899999999999999999999999999999999 99998


Q ss_pred             ccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          529 CFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       529 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      .....   ..+.......    ..     +.......+   .+.+++..||+.||++||++.+|++.|+..
T Consensus       254 ~~~~~---~~~~~~~~~~----~~-----~~~~~~~~~---~~~~li~~~l~~dp~~Rps~~~l~~~l~~~  309 (314)
T 2ivs_A          254 PGIPP---ERLFNLLKTG----HR-----MERPDNCSE---EMYRLMLQCWKQEPDKRPVFADISKDLEKM  309 (314)
T ss_dssp             TTCCG---GGHHHHHHTT----CC-----CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCH---HHHHHHhhcC----Cc-----CCCCccCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            54332   2332222211    11     111112222   345677899999999999999999999763

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.5e-41  Score=354.88  Aligned_cols=248  Identities=25%  Similarity=0.379  Sum_probs=203.5

Q ss_pred             hccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  398 (658)
                      ..++|...+.||+|+||.||+|+. .+|+.||||++....  ......+.+|+.+++.++||||+++++++...+..++|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            457899999999999999999985 578999999987643  23345688999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccccc
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~  478 (658)
                      |||+++++|.+++..   ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++++||+|||+++.+..
T Consensus        93 ~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  166 (328)
T 3fe3_A           93 MEYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV  166 (328)
T ss_dssp             ECCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred             EECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence            999999999999843   356999999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCCccccccccccccccCccccccCCCC-cccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccC
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAMHGQYS-VKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID  557 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  557 (658)
                      ..   .....+||+.|+|||++.+..++ .++||||||+++|||++|+.||...   ...++.......    .      
T Consensus       167 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~~~~i~~~----~------  230 (328)
T 3fe3_A          167 GG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ---NLKELRERVLRG----K------  230 (328)
T ss_dssp             SC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHC----C------
T ss_pred             CC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC---CHHHHHHHHHhC----C------
Confidence            32   23456899999999999988875 7999999999999999999998532   223333332221    1      


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          558 PTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       558 p~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ..+......   .+.+++..||+.||.+|||+.|+++
T Consensus       231 ~~~p~~~s~---~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          231 YRIPFYMST---DCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             CCCCTTSCH---HHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             CCCCCCCCH---HHHHHHHHHCCCChhHCcCHHHHhc
Confidence            011111112   3456777999999999999999985

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.8e-41  Score=356.58  Aligned_cols=265  Identities=26%  Similarity=0.360  Sum_probs=210.1

Q ss_pred             hhhhhccCCcccCcccccCceEEEEeEecC-C-----cceeEEEeccCCc-ccHHHHHHHHHHHHhc-CCCCceeeeeee
Q 006155          318 TIRVATDNFSDANKLGQGGFGAVYKGRLYD-G-----AEIAVKRLSRDSG-QGDLEFKNEVLLVANL-QHRNLVRLLGFS  389 (658)
Q Consensus       318 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-g-----~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~  389 (658)
                      .++...++|...+.||+|+||.||+|+... +     ..||||.+..... .....+.+|+.++.++ +||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            456677899999999999999999998532 2     3699999976543 2345688999999999 899999999999


Q ss_pred             ccCCceEEEEEecCCCChhhhhcCcC-----------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCcee
Q 006155          390 LEGNERLLIYEFVPNTSLDHFIFDPT-----------RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVL  458 (658)
Q Consensus       390 ~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIL  458 (658)
                      .+++..++||||+++|+|.+++....           ....+++..++.++.||+.||.|||+.+   |+||||||+|||
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl  196 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL  196 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence            99999999999999999999985421           1346899999999999999999999987   999999999999


Q ss_pred             eCCCCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcc
Q 006155          459 LDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVE  537 (658)
Q Consensus       459 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~  537 (658)
                      ++.++.+||+|||+++.+.............||+.|+|||++.+..++.++||||||+++|||++ |..|+......  .
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~  274 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN--S  274 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS--H
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh--H
Confidence            99999999999999987654433333344567889999999999999999999999999999999 88888533221  1


Q ss_pred             hHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          538 DLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       538 ~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      .+.........         +.......+   .+.+++..||+.||.+|||+.+|++.|+..
T Consensus       275 ~~~~~~~~~~~---------~~~~~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          275 KFYKLVKDGYQ---------MAQPAFAPK---NIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             HHHHHHHHTCC---------CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHhcCCC---------CCCCCCCCH---HHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence            11111111111         111111122   345677899999999999999999999753

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.4e-41  Score=351.15  Aligned_cols=265  Identities=25%  Similarity=0.402  Sum_probs=203.3

Q ss_pred             hccCCcccCcccccCceEEEEeEe-----cCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeecc--CCc
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRL-----YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLE--GNE  394 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~  394 (658)
                      ..++|+..++||+|+||+||+++.     .+++.||||++..........+.+|+.++.+++||||+++++++..  ...
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   87 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   87 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence            457899999999999999999973     3578999999987666666779999999999999999999999854  456


Q ss_pred             eEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          395 RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      .++||||+++++|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           88 LKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             CEEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             eEEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence            89999999999999999542  345999999999999999999999987   9999999999999999999999999998


Q ss_pred             ccccCCCc-cccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCC---------CCCcchHHHHHH
Q 006155          475 LFEMDETQ-GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRN---------GETVEDLLSSAW  544 (658)
Q Consensus       475 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~---------~~~~~~l~~~~~  544 (658)
                      .+...... .......+|..|+|||.+.+..++.++||||||+++|||++|..|+....         ............
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  242 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence            76543322 22333467888999999999999999999999999999999998874211         011111111111


Q ss_pred             HhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          545 KNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       545 ~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      .....+..     +.......+   .+.+++..||+.||++|||+.||++.|+..
T Consensus       243 ~~~~~~~~-----~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~el~~~L~~l  289 (295)
T 3ugc_A          243 ELLKNNGR-----LPRPDGCPD---EIYMIMTECWNNNVNQRPSFRDLALRVDQI  289 (295)
T ss_dssp             HHHHTTCC-----CCCCTTCCH---HHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHhccCc-----CCCCcCcCH---HHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            22221111     111112222   345677899999999999999999999864

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.1e-41  Score=346.35  Aligned_cols=261  Identities=24%  Similarity=0.397  Sum_probs=209.3

Q ss_pred             hhhhhhhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCce
Q 006155          316 FNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNER  395 (658)
Q Consensus       316 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  395 (658)
                      ....++..++|...+.||+|+||.||+++..++..||||++.... ....++.+|+.++.+++||||+++++++.+++..
T Consensus        16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   94 (283)
T 3gen_A           16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI   94 (283)
T ss_dssp             CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             CCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCe
Confidence            344556678999999999999999999998888899999997653 3456789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ++||||+++++|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        95 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~  169 (283)
T 3gen_A           95 FIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRY  169 (283)
T ss_dssp             EEEECCCTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGG
T ss_pred             EEEEeccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccc
Confidence            9999999999999999542  346999999999999999999999988   99999999999999999999999999986


Q ss_pred             cccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          476 FEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      ...... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....   ..+..........      
T Consensus       170 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~---~~~~~~~~~~~~~------  239 (283)
T 3gen_A          170 VLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT---NSETAEHIAQGLR------  239 (283)
T ss_dssp             BCCHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC---HHHHHHHHHTTCC------
T ss_pred             cccccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC---hhHHHHHHhcccC------
Confidence            643321 12223457889999999999999999999999999999998 999985332   2222222221111      


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          555 IIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       555 ~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      ...+   ....+   .+.+++..||+.||++|||+.++++.|..
T Consensus       240 ~~~~---~~~~~---~l~~li~~~l~~~p~~Rps~~~ll~~L~~  277 (283)
T 3gen_A          240 LYRP---HLASE---KVYTIMYSCWHEKADERPTFKILLSNILD  277 (283)
T ss_dssp             CCCC---TTCCH---HHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCC---CcCCH---HHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence            1111   11122   35567789999999999999999999975

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-40  Score=346.78  Aligned_cols=273  Identities=21%  Similarity=0.287  Sum_probs=214.3

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCC--ceEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGN--ERLL  397 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~l  397 (658)
                      ..++|...++||+|+||+||+|+.. +|+.||||++..... .....+.+|+.++.+++||||+++++++....  ..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence            4578999999999999999999865 488999999976432 34566889999999999999999999987655  7799


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceee----CCCCCeEEeccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLL----DAEMTPKIADFGMA  473 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl----~~~~~~kl~DFGla  473 (658)
                      ||||+++++|.+++........+++..++.++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            9999999999999976555556999999999999999999999998   9999999999999    78888999999999


Q ss_pred             cccccCCCccccccccccccccCccccc--------cCCCCcccccccccchHhHHHhCCCCCccCCC-CCcchHHHHHH
Q 006155          474 RLFEMDETQGNTSRIVGTYGYMAPEYAM--------HGQYSVKSDVFSFGVLVLEIISGQRNNCFRNG-ETVEDLLSSAW  544 (658)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~-~~~~~l~~~~~  544 (658)
                      +.+.....   .....||+.|+|||++.        +..++.++||||||+++|||++|+.||..... ....+.+....
T Consensus       164 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  240 (319)
T 4euu_A          164 RELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (319)
T ss_dssp             EECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred             eecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence            87654332   23457999999999986        57899999999999999999999999864333 22333333333


Q ss_pred             HhccCCCccccc---------CCCCCC--C-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 006155          545 KNWREGTTVNII---------DPTLSS--G-SITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYS  600 (658)
Q Consensus       545 ~~~~~~~~~~~~---------dp~l~~--~-~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~  600 (658)
                      .......+..+.         .+.+..  . ....-..+.+++..||+.||++|||+.|+++..+...
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            322221111110         011111  1 3333445568889999999999999999999987643

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4.9e-41  Score=342.46  Aligned_cols=254  Identities=29%  Similarity=0.409  Sum_probs=194.7

Q ss_pred             hccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCc----ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSG----QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  397 (658)
                      ..++|+..+.||+|+||.||+++. .|+.||||++.....    .....+.+|+.++..++||||+++++++.+++..++
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            5 DFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             CTTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred             chhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence            457899999999999999999985 588999999865432    234568899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCC--------CCCeEEec
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDA--------EMTPKIAD  469 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~--------~~~~kl~D  469 (658)
                      ||||+++++|.+++.    ...+++..++.++.|++.||.|||+.+..+|+||||||+|||++.        ++.+||+|
T Consensus        84 v~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           84 VMEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             EEECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             EEEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            999999999999983    356999999999999999999999987566999999999999986        67899999


Q ss_pred             cccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccC
Q 006155          470 FGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWRE  549 (658)
Q Consensus       470 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  549 (658)
                      ||+++.+....    .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....   ........   ...
T Consensus       160 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~---~~~  229 (271)
T 3dtc_A          160 FGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID---GLAVAYGV---AMN  229 (271)
T ss_dssp             CCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC---HHHHHHHH---HTS
T ss_pred             CCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHhh---hcC
Confidence            99998654332    223578999999999999999999999999999999999999985322   11111111   111


Q ss_pred             CCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          550 GTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       550 ~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      ..     .+.......+   .+.+++..||+.||++|||+.|+++.|+.
T Consensus       230 ~~-----~~~~~~~~~~---~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          230 KL-----ALPIPSTCPE---PFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             CC-----CCCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             CC-----CCCCCcccCH---HHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence            11     1111122222   34567789999999999999999999975

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.4e-40  Score=344.97  Aligned_cols=263  Identities=23%  Similarity=0.326  Sum_probs=200.8

Q ss_pred             hhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcc--cHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEE
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQ--GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  398 (658)
                      ...++|+..++||+|+||+||+++..+|+.||||++......  ....+.+|+.++.+++||||+++++++.+++..++|
T Consensus        18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   97 (311)
T 3niz_A           18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV   97 (311)
T ss_dssp             CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred             chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence            345789999999999999999999888999999998754322  235688999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccccc
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~  478 (658)
                      |||+++ +|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        98 ~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A           98 FEFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI  171 (311)
T ss_dssp             EECCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred             EcCCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence            999985 77777743  3346899999999999999999999988   99999999999999999999999999987643


Q ss_pred             CCCccccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcc---c
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTV---N  554 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~---~  554 (658)
                      ..  .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+   .+.............   .
T Consensus       172 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~  246 (311)
T 3niz_A          172 PV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD---QLPKIFSILGTPNPREWPQ  246 (311)
T ss_dssp             CC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT---HHHHHHHHHCCCCTTTSGG
T ss_pred             Cc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHHCCCChHHhhh
Confidence            32  22334578999999999876 568999999999999999999999986544332   222222211111100   0


Q ss_pred             cc---------CCCCCCCCHHH-----HHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          555 II---------DPTLSSGSITE-----MIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       555 ~~---------dp~l~~~~~~e-----~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ..         ...........     ...+.+++..||+.||++|||+.|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            00         00000111111     124567888999999999999999985

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.1e-41  Score=348.30  Aligned_cols=265  Identities=26%  Similarity=0.407  Sum_probs=202.9

Q ss_pred             ccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEec
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFV  402 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  402 (658)
                      .++|+..+.||+|+||.||+++. .++.||||++...  .....+.+|+.++.+++||||+++++++.+  ..++||||+
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~   81 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA   81 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred             HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence            46788899999999999999985 5788999998643  345678999999999999999999999874  479999999


Q ss_pred             CCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCC-eEEeccccccccccCCC
Q 006155          403 PNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMT-PKIADFGMARLFEMDET  481 (658)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~-~kl~DFGla~~~~~~~~  481 (658)
                      ++++|.+++........+++..++.++.||++||.|||+.+..+|+||||||+|||++.++. +||+|||++......  
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--  159 (307)
T 2eva_A           82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--  159 (307)
T ss_dssp             TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred             CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence            99999999976554456899999999999999999999943234999999999999998887 799999999765322  


Q ss_pred             ccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCC
Q 006155          482 QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLS  561 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~  561 (658)
                         .....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ....   .+.. ..+..     +.+.
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~---~~~~-~~~~~-----~~~~  226 (307)
T 2eva_A          160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP-AFRI---MWAV-HNGTR-----PPLI  226 (307)
T ss_dssp             --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS-HHHH---HHHH-HTTCC-----CCCB
T ss_pred             ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc-HHHH---HHHH-hcCCC-----CCcc
Confidence               22346899999999999999999999999999999999999998543221 1111   1111 11111     1111


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCCCCCCCCC
Q 006155          562 SGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTLPVPSEPA  610 (658)
Q Consensus       562 ~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~~~~~~p~~p~  610 (658)
                      .....   .+.+++..||+.||++|||+.+|+++|+.....++.+..|.
T Consensus       227 ~~~~~---~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~  272 (307)
T 2eva_A          227 KNLPK---PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL  272 (307)
T ss_dssp             TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCC
T ss_pred             cccCH---HHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCcc
Confidence            12222   34567789999999999999999999987765555554444

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=6.2e-41  Score=349.02  Aligned_cols=264  Identities=25%  Similarity=0.358  Sum_probs=211.0

Q ss_pred             hhhhccCCcccCcccccCceEEEEeEe------cCCcceeEEEeccCCc-ccHHHHHHHHHHHHhc-CCCCceeeeeeec
Q 006155          319 IRVATDNFSDANKLGQGGFGAVYKGRL------YDGAEIAVKRLSRDSG-QGDLEFKNEVLLVANL-QHRNLVRLLGFSL  390 (658)
Q Consensus       319 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~  390 (658)
                      .+...++|...+.||+|+||.||+++.      .+++.||||++..... .....+.+|+.++.++ +||||+++++++.
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   97 (313)
T 1t46_A           18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (313)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence            345567899999999999999999974      2467899999976543 2345689999999999 8999999999999


Q ss_pred             cCCceEEEEEecCCCChhhhhcCcCC---------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCC
Q 006155          391 EGNERLLIYEFVPNTSLDHFIFDPTR---------------RAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTS  455 (658)
Q Consensus       391 ~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~  455 (658)
                      +++..++||||+++|+|.+++.....               ...+++..++.++.||++||.|||+.+   |+||||||+
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~  174 (313)
T 1t46_A           98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR  174 (313)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred             cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccc
Confidence            99999999999999999999864321               225899999999999999999999988   999999999


Q ss_pred             ceeeCCCCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCC
Q 006155          456 NVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGE  534 (658)
Q Consensus       456 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~  534 (658)
                      |||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |+.|+......
T Consensus       175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  254 (313)
T 1t46_A          175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (313)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence            99999999999999999987765443333444567889999999999999999999999999999999 88888543221


Q ss_pred             CcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          535 TVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       535 ~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                        ..+........+         +........   .+.+++..||+.||.+|||+.+|+++|++.
T Consensus       255 --~~~~~~~~~~~~---------~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~ell~~L~~~  305 (313)
T 1t46_A          255 --SKFYKMIKEGFR---------MLSPEHAPA---EMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (313)
T ss_dssp             --HHHHHHHHHTCC---------CCCCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --hHHHHHhccCCC---------CCCcccCCH---HHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence              112121111111         111111222   345677899999999999999999999763

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=8.8e-41  Score=366.21  Aligned_cols=254  Identities=26%  Similarity=0.395  Sum_probs=205.4

Q ss_pred             hhhhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCC-ceEE
Q 006155          319 IRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGN-ERLL  397 (658)
Q Consensus       319 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~l  397 (658)
                      +.+..++|...++||+|+||.||+|+. .|+.||||+++...  ....|.+|+.++.+++||||+++++++.+.+ ..++
T Consensus       188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i  264 (450)
T 1k9a_A          188 WALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI  264 (450)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred             cccChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence            445667899999999999999999986 58899999997653  4567999999999999999999999987665 7899


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE  477 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~  477 (658)
                      ||||+++|+|.+++... ....+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       265 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          265 VTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  340 (450)
T ss_dssp             EEECCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence            99999999999999642 2334799999999999999999999998   9999999999999999999999999998543


Q ss_pred             cCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCccccc
Q 006155          478 MDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNII  556 (658)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  556 (658)
                      ..     .....+++.|+|||++.+..++.++||||||+++|||++ |+.|+.....   .++........+        
T Consensus       341 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~--------  404 (450)
T 1k9a_A          341 ST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVEKGYK--------  404 (450)
T ss_dssp             -----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT---TTHHHHHHTTCC--------
T ss_pred             cc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCC--------
Confidence            22     122367889999999999999999999999999999998 9999854332   233333222211        


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          557 DPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       557 dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                       +.......+   .+.+++..||+.||++|||+.+|++.|+..
T Consensus       405 -~~~p~~~~~---~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i  443 (450)
T 1k9a_A          405 -MDAPDGCPP---AVYDVMKNCWHLDAATRPTFLQLREQLEHI  443 (450)
T ss_dssp             -CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CCCCCcCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence             111112223   344677899999999999999999999763

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=9.7e-41  Score=351.45  Aligned_cols=263  Identities=27%  Similarity=0.375  Sum_probs=210.0

Q ss_pred             hhhhccCCcccCcccccCceEEEEeEec--------CCcceeEEEeccCCc-ccHHHHHHHHHHHHhc-CCCCceeeeee
Q 006155          319 IRVATDNFSDANKLGQGGFGAVYKGRLY--------DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANL-QHRNLVRLLGF  388 (658)
Q Consensus       319 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~  388 (658)
                      +....++|...+.||+|+||.||+++..        ++..||||++..... .....+.+|+.++.++ +||||++++++
T Consensus        30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  109 (334)
T 2pvf_A           30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA  109 (334)
T ss_dssp             TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence            3455689999999999999999999852        467899999976533 3345688999999999 89999999999


Q ss_pred             eccCCceEEEEEecCCCChhhhhcCcCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCC
Q 006155          389 SLEGNERLLIYEFVPNTSLDHFIFDPTR-------------RAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTS  455 (658)
Q Consensus       389 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~  455 (658)
                      +.+.+..++||||+++|+|.+++.....             ...+++..++.++.||++||.|||+.+   |+||||||+
T Consensus       110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~  186 (334)
T 2pvf_A          110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAAR  186 (334)
T ss_dssp             ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG
T ss_pred             EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccc
Confidence            9999999999999999999999965321             235899999999999999999999988   999999999


Q ss_pred             ceeeCCCCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCC
Q 006155          456 NVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGE  534 (658)
Q Consensus       456 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~  534 (658)
                      |||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+...   
T Consensus       187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~---  263 (334)
T 2pvf_A          187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI---  263 (334)
T ss_dssp             GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC---
T ss_pred             eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC---
Confidence            99999999999999999987654433333344567889999999999999999999999999999999 99888432   


Q ss_pred             CcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          535 TVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       535 ~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      ...++.........         +........   .+.+++..||+.||++|||+.+|++.|+..
T Consensus       264 ~~~~~~~~~~~~~~---------~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~ell~~L~~l  316 (334)
T 2pvf_A          264 PVEELFKLLKEGHR---------MDKPANCTN---ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  316 (334)
T ss_dssp             CHHHHHHHHHHTCC---------CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CHHHHHHHHhcCCC---------CCCCccCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            22333332222211         111112222   345677899999999999999999999764

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=7.1e-41  Score=346.01  Aligned_cols=264  Identities=16%  Similarity=0.230  Sum_probs=211.2

Q ss_pred             hhccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhc-CCCCceeeeeeeccCCceEEE
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANL-QHRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv  398 (658)
                      +..++|...+.||+|+||.||+|+. .+|+.||||++.....  ...+.+|+.++..+ +|+|++++++++.++...++|
T Consensus         7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   84 (298)
T 1csn_A            7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   84 (298)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence            3457899999999999999999984 5789999999865432  33578999999999 799999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCC-----eEEeccccc
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMT-----PKIADFGMA  473 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~-----~kl~DFGla  473 (658)
                      |||+ +++|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.     +||+|||++
T Consensus        85 ~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~  158 (298)
T 1csn_A           85 IDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  158 (298)
T ss_dssp             EECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             EEec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence            9999 99999999532  345999999999999999999999987   999999999999987776     999999999


Q ss_pred             cccccCCCc-----cccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhcc
Q 006155          474 RLFEMDETQ-----GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWR  548 (658)
Q Consensus       474 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~  548 (658)
                      +.+......     .......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  238 (298)
T 1csn_A          159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ  238 (298)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred             cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence            876544322     123456799999999999999999999999999999999999999976544444443333322211


Q ss_pred             CCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 006155          549 EGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYS  600 (658)
Q Consensus       549 ~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~  600 (658)
                      .....++     .....   ..+.+++..||+.||++||++.+|++.|+...
T Consensus       239 ~~~~~~~-----~~~~~---~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~  282 (298)
T 1csn_A          239 STPLREL-----CAGFP---EEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  282 (298)
T ss_dssp             HSCHHHH-----TTTSC---HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             CccHHHH-----HhhCc---HHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence            1111111     11111   23556778999999999999999999998653

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=6.9e-41  Score=351.98  Aligned_cols=261  Identities=18%  Similarity=0.237  Sum_probs=209.6

Q ss_pred             hccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhc-CCCCceeeeeeeccCCceEEEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANL-QHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ..++|...+.||+|+||.||+|+. .+|+.||||++.....  ...+.+|+.++.++ +||||+++++++..++..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~   84 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL   84 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence            357899999999999999999984 5688999999875533  23578999999999 8999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCC-----eEEecccccc
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMT-----PKIADFGMAR  474 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~-----~kl~DFGla~  474 (658)
                      ||+ +++|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.     +||+|||+++
T Consensus        85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~  158 (330)
T 2izr_A           85 ELL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK  158 (330)
T ss_dssp             ECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred             EeC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence            999 99999998532  457999999999999999999999998   999999999999998887     9999999998


Q ss_pred             ccccCCCcc-----ccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccC
Q 006155          475 LFEMDETQG-----NTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWRE  549 (658)
Q Consensus       475 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  549 (658)
                      .+.......     ......||+.|+|||++.+..++.++||||||+++|||++|+.||.........+.+......-..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~  238 (330)
T 2izr_A          159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA  238 (330)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred             eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence            765433211     124568999999999999999999999999999999999999999765444443333332221111


Q ss_pred             CCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          550 GTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       550 ~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      .. .+.    +....+    .+.+++..||+.||.+||++.+|++.|+..
T Consensus       239 ~~-~~~----~~~~~p----~~~~li~~~l~~~p~~RP~~~~l~~~l~~~  279 (330)
T 2izr_A          239 TP-IEV----LCENFP----EMATYLRYVRRLDFFEKPDYDYLRKLFTDL  279 (330)
T ss_dssp             SC-HHH----HTTTCH----HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             CC-HHH----HhccCh----HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence            00 000    011122    456777899999999999999999999643

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1e-40  Score=350.01  Aligned_cols=252  Identities=23%  Similarity=0.338  Sum_probs=198.4

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCc------
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNE------  394 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------  394 (658)
                      .++|+..+.||+|+||.||+|+.. +|+.||||++..... .....+.+|+.++++++||||+++++++.+...      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            467899999999999999999865 689999999975443 344678999999999999999999998865432      


Q ss_pred             ---------------------------------------------------eEEEEEecCCCChhhhhcCcCCCCCCCHH
Q 006155          395 ---------------------------------------------------RLLIYEFVPNTSLDHFIFDPTRRAQLDWE  423 (658)
Q Consensus       395 ---------------------------------------------------~~lv~e~~~~gsL~~~l~~~~~~~~l~~~  423 (658)
                                                                         .++||||+++++|.+++.........++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                               78999999999999999776666667888


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCc----------ccccccccccc
Q 006155          424 RRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ----------GNTSRIVGTYG  493 (658)
Q Consensus       424 ~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~~  493 (658)
                      .++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+......          .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            89999999999999999988   999999999999999999999999999876543211          12234579999


Q ss_pred             ccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHH
Q 006155          494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIH  573 (658)
Q Consensus       494 y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~  573 (658)
                      |+|||++.+..++.++||||||+++|||++|..|+..     ...    ............        ........+.+
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~----~~~~~~~~~~~~--------~~~~~~~~~~~  304 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVR----IITDVRNLKFPL--------LFTQKYPQEHM  304 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHH----HHHHHHTTCCCH--------HHHHHCHHHHH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHH----HHHHhhccCCCc--------ccccCChhHHH
Confidence            9999999999999999999999999999998765410     111    111111111100        01111234467


Q ss_pred             HHHHhcCCCCCCCCCHHHHHH
Q 006155          574 IGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       574 i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ++..||+.||++|||+.|+++
T Consensus       305 li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          305 MVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCCCCcCCCHHHHhh
Confidence            888999999999999999985

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.5e-41  Score=351.30  Aligned_cols=276  Identities=25%  Similarity=0.378  Sum_probs=202.9

Q ss_pred             ccccccccchhhhhhhccCCcccCcccccCceEEEEeEecC----CcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCC
Q 006155          307 NRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYD----GAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHR  380 (658)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~  380 (658)
                      ...+.++..+..+....++|...+.||+|+||.||+|+...    +..||||++.....  .....+.+|+.++.+++||
T Consensus        17 ~~~eel~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~   96 (313)
T 3brb_A           17 RGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP   96 (313)
T ss_dssp             -------CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCT
T ss_pred             CchHhhhhhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCC
Confidence            34455667777888888999999999999999999997542    44799999875532  2345688999999999999


Q ss_pred             CceeeeeeeccCC-----ceEEEEEecCCCChhhhhcCc---CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEecc
Q 006155          381 NLVRLLGFSLEGN-----ERLLIYEFVPNTSLDHFIFDP---TRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDL  452 (658)
Q Consensus       381 niv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl  452 (658)
                      ||+++++++.+.+     ..++||||+++++|.+++...   .....+++..++.++.||++||.|||+.+   |+||||
T Consensus        97 ~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~di  173 (313)
T 3brb_A           97 NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDL  173 (313)
T ss_dssp             TBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCC
T ss_pred             CeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence            9999999987755     349999999999999998432   23456999999999999999999999987   999999


Q ss_pred             CCCceeeCCCCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccC
Q 006155          453 KTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFR  531 (658)
Q Consensus       453 k~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~  531 (658)
                      ||+|||++.++.+||+|||+++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |+.|+...
T Consensus       174 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  253 (313)
T 3brb_A          174 AARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV  253 (313)
T ss_dssp             SGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccC
Confidence            99999999999999999999987654433333344567889999999999999999999999999999999 88887533


Q ss_pred             CCCCcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 006155          532 NGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYS  600 (658)
Q Consensus       532 ~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~  600 (658)
                      .   ...+.........         +.......+   .+.+++..||+.||++|||+.++++.|+...
T Consensus       254 ~---~~~~~~~~~~~~~---------~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~  307 (313)
T 3brb_A          254 Q---NHEMYDYLLHGHR---------LKQPEDCLD---ELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL  307 (313)
T ss_dssp             C---GGGHHHHHHTTCC---------CCCBTTCCH---HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             C---HHHHHHHHHcCCC---------CCCCccccH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            2   2233333222211         111111222   3556778999999999999999999998653

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.2e-41  Score=353.85  Aligned_cols=257  Identities=27%  Similarity=0.398  Sum_probs=201.6

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcc----eeEEEeccCC-cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAE----IAVKRLSRDS-GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERL  396 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~----vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  396 (658)
                      .++|...+.||+|+||.||+|+.. +++.    ||+|.+.... ......+.+|+.++.+++||||+++++++. ++..+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            467889999999999999999853 4554    7777775443 233345788999999999999999999986 46688


Q ss_pred             EEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccc
Q 006155          397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF  476 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~  476 (658)
                      +||||+++|+|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus        91 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             EEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             EEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence            999999999999998542  356899999999999999999999998   999999999999999999999999999987


Q ss_pred             ccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccc
Q 006155          477 EMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNI  555 (658)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  555 (658)
                      .............||..|+|||++.++.++.++||||||+++|||++ |+.||......   ++..........      
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~~~~~------  236 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA---EVPDLLEKGERL------  236 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT---HHHHHHHTTCBC------
T ss_pred             CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH---HHHHHHHcCCCC------
Confidence            65544444455678899999999999999999999999999999999 99998643322   222222221110      


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 006155          556 IDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYS  600 (658)
Q Consensus       556 ~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~  600 (658)
                      ..+....   .   .+.+++..||+.||++||++.++++.|+...
T Consensus       237 ~~~~~~~---~---~~~~li~~~l~~dp~~Rps~~el~~~l~~~~  275 (325)
T 3kex_A          237 AQPQICT---I---DVYMVMVKCWMIDENIRPTFKELANEFTRMA  275 (325)
T ss_dssp             CCCTTBC---T---TTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred             CCCCcCc---H---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            0111111   1   2346777999999999999999999997653

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=4.7e-41  Score=376.04  Aligned_cols=264  Identities=26%  Similarity=0.421  Sum_probs=212.7

Q ss_pred             hhhhhhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceE
Q 006155          317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERL  396 (658)
Q Consensus       317 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  396 (658)
                      ..+++..++|...++||+|+||.||+|+..++..||||++.... ....+|.+|+.+|++++||||+++++++.+ +..+
T Consensus       260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~  337 (535)
T 2h8h_A          260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY  337 (535)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence            34556678899999999999999999998877889999997654 345679999999999999999999999876 6789


Q ss_pred             EEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccc
Q 006155          397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF  476 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~  476 (658)
                      |||||+++|+|.++|... ....+++..++.|+.||++||.|||+++   |+||||||+||||+.++.+||+|||+++.+
T Consensus       338 lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  413 (535)
T 2h8h_A          338 IVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI  413 (535)
T ss_dssp             EEECCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred             EeeehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence            999999999999999532 2345899999999999999999999988   999999999999999999999999999876


Q ss_pred             ccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccc
Q 006155          477 EMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNI  555 (658)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  555 (658)
                      ..... .......++..|+|||++..+.++.++||||||+++|||++ |+.|+...   ...+++.......+.      
T Consensus       414 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~---~~~~~~~~i~~~~~~------  483 (535)
T 2h8h_A          414 EDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQVERGYRM------  483 (535)
T ss_dssp             CCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC---CHHHHHHHHHTTCCC------
T ss_pred             CCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHHcCCCC------
Confidence            43221 11223457889999999999999999999999999999999 88888432   223333333222111      


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCC
Q 006155          556 IDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLT  602 (658)
Q Consensus       556 ~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~~~  602 (658)
                         .......+   .+.+++..||+.||++|||+.+|+++|+.....
T Consensus       484 ---~~~~~~~~---~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          484 ---PCPPECPE---SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             ---CCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             ---CCCCCCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence               11112222   345677899999999999999999999986443

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.2e-40  Score=344.29  Aligned_cols=261  Identities=23%  Similarity=0.366  Sum_probs=202.6

Q ss_pred             hccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcc---cHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQ---GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  397 (658)
                      ..++|+..+.||+|+||.||+++. ..+..||+|++......   ....+.+|+.++.+++||||+++++++.+++..++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l   88 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL   88 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence            457899999999999999999984 36889999998654332   23468899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE  477 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~  477 (658)
                      ||||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        89 v~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           89 VMEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             EEECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred             EEeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence            9999999999999843   356999999999999999999999988   9999999999999999999999999998764


Q ss_pred             cCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccC
Q 006155          478 MDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID  557 (658)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  557 (658)
                      .... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....   ....   ......... ... .
T Consensus       163 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~---~~~~---~~~~~~~~~-~~~-~  233 (294)
T 4eqm_A          163 ETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET---AVSI---AIKHIQDSV-PNV-T  233 (294)
T ss_dssp             -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC---HHHH---HHHHHSSCC-CCH-H
T ss_pred             cccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC---hHHH---HHHHhhccC-CCc-c
Confidence            3321 22334679999999999999999999999999999999999999984322   1111   111111111 110 0


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHhccCC
Q 006155          558 PTLSSGSITEMIRCIHIGLLCVQENVASRP-TMASVVLMLNSYS  600 (658)
Q Consensus       558 p~l~~~~~~e~~~~~~i~~~Cl~~~p~~RP-tm~evv~~L~~~~  600 (658)
                      +.......+   .+.+++.+|++.||++|| ++.++.+.|....
T Consensus       234 ~~~~~~~~~---~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          234 TDVRKDIPQ---SLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             HHSCTTSCH---HHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             hhcccCCCH---HHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence            011111122   345677899999999998 9999999998753

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=6.1e-41  Score=350.79  Aligned_cols=268  Identities=25%  Similarity=0.416  Sum_probs=214.0

Q ss_pred             chhhhhhhccCCcccCcccccCceEEEEeEec------CCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeee
Q 006155          315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLG  387 (658)
Q Consensus       315 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~  387 (658)
                      ...++++..++|...+.||+|+||.||+|+..      .++.||||++..... .....+.+|+.++.+++||||+++++
T Consensus        16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   95 (322)
T 1p4o_A           16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG   95 (322)
T ss_dssp             CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence            34456677889999999999999999999754      367899999976533 33446889999999999999999999


Q ss_pred             eeccCCceEEEEEecCCCChhhhhcCcC-------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeC
Q 006155          388 FSLEGNERLLIYEFVPNTSLDHFIFDPT-------RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLD  460 (658)
Q Consensus       388 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~  460 (658)
                      ++.+++..++||||+++|+|.+++....       ....+++..+++++.||+.||.|||+.+   |+||||||+|||++
T Consensus        96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~  172 (322)
T 1p4o_A           96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVA  172 (322)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEEC
T ss_pred             EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEc
Confidence            9999999999999999999999985421       1246799999999999999999999998   99999999999999


Q ss_pred             CCCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchH
Q 006155          461 AEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDL  539 (658)
Q Consensus       461 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l  539 (658)
                      .++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |+.|+...   ...++
T Consensus       173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~---~~~~~  249 (322)
T 1p4o_A          173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNEQV  249 (322)
T ss_dssp             TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS---CHHHH
T ss_pred             CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC---CHHHH
Confidence            999999999999987654433333344567899999999999999999999999999999999 78887432   22222


Q ss_pred             HHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 006155          540 LSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYS  600 (658)
Q Consensus       540 ~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~  600 (658)
                      ......    +....     ......+   .+.+++..||+.||++|||+.|+++.|+...
T Consensus       250 ~~~~~~----~~~~~-----~~~~~~~---~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~  298 (322)
T 1p4o_A          250 LRFVME----GGLLD-----KPDNCPD---MLFELMRMCWQYNPKMRPSFLEIISSIKEEM  298 (322)
T ss_dssp             HHHHHT----TCCCC-----CCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             HHHHHc----CCcCC-----CCCCCCH---HHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence            222221    11111     1112222   3456778999999999999999999998753

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=5.9e-41  Score=356.50  Aligned_cols=252  Identities=25%  Similarity=0.313  Sum_probs=203.4

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcc------cHHHHHHHHHHHHhcCCCCceeeeeeeccCCc
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQ------GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNE  394 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  394 (658)
                      ..+.|...+.||+|+||.||+++.. +|+.||||++......      ....+.+|+.++.+++||||+++++++.+.+.
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            4578999999999999999999854 5889999998765322      34678999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCC----CeEEecc
Q 006155          395 RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM----TPKIADF  470 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~----~~kl~DF  470 (658)
                      .++||||+++|+|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++    .+||+||
T Consensus        90 ~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            9999999999999999943   456999999999999999999999988   99999999999998877    7999999


Q ss_pred             ccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCC
Q 006155          471 GMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREG  550 (658)
Q Consensus       471 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  550 (658)
                      |+++.+....   ......||+.|+|||++.+..++.++|||||||++|||++|+.||...   ...+++.....    +
T Consensus       164 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~---~~~~~~~~i~~----~  233 (361)
T 2yab_A          164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANITA----V  233 (361)
T ss_dssp             SSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHHHHT----T
T ss_pred             CCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHh----c
Confidence            9998765432   233467999999999999999999999999999999999999998432   22233322211    1


Q ss_pred             CcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          551 TTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       551 ~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ...  +++.......   ..+.+++..||+.||++|||+.|+++
T Consensus       234 ~~~--~~~~~~~~~s---~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          234 SYD--FDEEFFSQTS---ELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             CCC--CCHHHHTTSC---HHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCC--CCchhccCCC---HHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            100  0000001111   13456778999999999999999884

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=9.6e-41  Score=348.04  Aligned_cols=273  Identities=27%  Similarity=0.370  Sum_probs=215.4

Q ss_pred             cccccchhhhhhhccCCcccCcccccCceEEEEeEe------cCCcceeEEEeccCCcc-cHHHHHHHHHHHHhc-CCCC
Q 006155          310 ESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRL------YDGAEIAVKRLSRDSGQ-GDLEFKNEVLLVANL-QHRN  381 (658)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l-~H~n  381 (658)
                      +.+.++........++|...+.||+|+||.||+++.      .+++.||||++...... ....+.+|+.++.++ +|||
T Consensus        13 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~   92 (316)
T 2xir_A           13 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN   92 (316)
T ss_dssp             GGSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred             hhccccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCC
Confidence            344566667777889999999999999999999973      34678999999765432 335688999999999 6999


Q ss_pred             ceeeeeeeccCC-ceEEEEEecCCCChhhhhcCcCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcE
Q 006155          382 LVRLLGFSLEGN-ERLLIYEFVPNTSLDHFIFDPTR-------------RAQLDWERRYKIIGGIARGLLYLHEDSRLRI  447 (658)
Q Consensus       382 iv~l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i  447 (658)
                      |+++++++...+ ..++||||+++++|.+++.....             ...+++..++.++.||++||.|||+.+   |
T Consensus        93 iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i  169 (316)
T 2xir_A           93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---C  169 (316)
T ss_dssp             BCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred             eeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence            999999987654 58999999999999999965332             223899999999999999999999987   9


Q ss_pred             EEeccCCCceeeCCCCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCC
Q 006155          448 IHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQR  526 (658)
Q Consensus       448 vHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~  526 (658)
                      +||||||+|||++.++.+||+|||+++.+.............||+.|+|||++.+..++.++||||||+++|||++ |+.
T Consensus       170 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~  249 (316)
T 2xir_A          170 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS  249 (316)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             ccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999987655443333445678999999999999999999999999999999998 998


Q ss_pred             CCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          527 NNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       527 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      |+......  ..+......    +..     +........   .+.+++..||+.||++|||+.+|++.|+..
T Consensus       250 p~~~~~~~--~~~~~~~~~----~~~-----~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~ell~~L~~~  308 (316)
T 2xir_A          250 PYPGVKID--EEFCRRLKE----GTR-----MRAPDYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHLGNL  308 (316)
T ss_dssp             SSTTCCCS--HHHHHHHHH----TCC-----CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCcccchh--HHHHHHhcc----Ccc-----CCCCCCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            88543221  122222111    111     111111222   345677899999999999999999999763

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.2e-40  Score=348.93  Aligned_cols=248  Identities=22%  Similarity=0.258  Sum_probs=202.5

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccC---CcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRD---SGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  398 (658)
                      .++|+..+.||+|+||.||+++.. +|+.||||++...   .......+.+|+.++..++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            468999999999999999999854 5889999999654   233455688999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccccc
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~  478 (658)
                      |||+++|+|..++.   ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        84 ~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           84 MEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            99999999999984   3456899999999999999999999988   99999999999999999999999999985432


Q ss_pred             CCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCC
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP  558 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp  558 (658)
                      ..  ......+||+.|+|||++.+..++.++||||||+++|||++|+.||...   +...+......    +.      .
T Consensus       158 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~~~~i~~----~~------~  222 (337)
T 1o6l_A          158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ---DHERLFELILM----EE------I  222 (337)
T ss_dssp             TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHH----CC------C
T ss_pred             CC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC---CHHHHHHHHHc----CC------C
Confidence            21  2234568999999999999999999999999999999999999998432   22233322221    11      1


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 006155          559 TLSSGSITEMIRCIHIGLLCVQENVASRP-----TMASVVL  594 (658)
Q Consensus       559 ~l~~~~~~e~~~~~~i~~~Cl~~~p~~RP-----tm~evv~  594 (658)
                      .+.....+   .+.+++..||+.||++||     ++.||++
T Consensus       223 ~~p~~~s~---~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          223 RFPRTLSP---EAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CCCTTSCH---HHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCCCCCCH---HHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            11112122   244667799999999999     8999975

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.7e-40  Score=342.30  Aligned_cols=264  Identities=27%  Similarity=0.462  Sum_probs=195.3

Q ss_pred             hhhhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceE
Q 006155          319 IRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERL  396 (658)
Q Consensus       319 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  396 (658)
                      .++..++|...++||+|+||.||+|+.  ...||||++.....  .....+.+|+.++++++||||++++++. .....+
T Consensus        19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~   95 (289)
T 3og7_A           19 WEIPDGQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA   95 (289)
T ss_dssp             CBCCTTSCEEEEEEEECSSEEEEEEES--SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred             CccCccceeeeeEecCCCCeEEEEEEE--cCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence            345678899999999999999999984  34599999876532  3345689999999999999999999965 455689


Q ss_pred             EEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccc
Q 006155          397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF  476 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~  476 (658)
                      +||||+++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        96 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  170 (289)
T 3og7_A           96 IVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEK  170 (289)
T ss_dssp             EEEECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred             EEEEecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccc
Confidence            99999999999999854  3456999999999999999999999988   999999999999999999999999999866


Q ss_pred             ccCCCccccccccccccccCccccc---cCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcc
Q 006155          477 EMDETQGNTSRIVGTYGYMAPEYAM---HGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTV  553 (658)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  553 (658)
                      .............||+.|+|||++.   +..++.++||||||+++|||++|+.||....  ....+............. 
T Consensus       171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~-  247 (289)
T 3og7_A          171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN--NRDQIIEMVGRGSLSPDL-  247 (289)
T ss_dssp             -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC--CHHHHHHHHHHTSCCCCT-
T ss_pred             ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc--hHHHHHHHhcccccCcch-
Confidence            5433333344567999999999986   6678999999999999999999999985332  222232222221111110 


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 006155          554 NIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYS  600 (658)
Q Consensus       554 ~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~  600 (658)
                          +.+.....+   .+.+++..||+.||++|||+.+++++|+...
T Consensus       248 ----~~~~~~~~~---~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          248 ----SKVRSNCPK---RMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             ----TSSCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             ----hhccccCCH---HHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence                111112222   3556778999999999999999999998753

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.9e-41  Score=350.28  Aligned_cols=252  Identities=24%  Similarity=0.322  Sum_probs=203.0

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcc------cHHHHHHHHHHHHhcCCCCceeeeeeeccCCc
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQ------GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNE  394 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  394 (658)
                      ..++|...+.||+|+||.||+++.. +|+.||||++......      ....+.+|+.++.+++||||+++++++.+.+.
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   88 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   88 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            3467899999999999999999854 5889999998764322      35678999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCC----CeEEecc
Q 006155          395 RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM----TPKIADF  470 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~----~~kl~DF  470 (658)
                      .++||||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++    .+||+||
T Consensus        89 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           89 VILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             EEEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            9999999999999999943   456999999999999999999999988   99999999999999887    8999999


Q ss_pred             ccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCC
Q 006155          471 GMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREG  550 (658)
Q Consensus       471 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  550 (658)
                      |+++.+....   ......||+.|+|||++.+..++.++||||||+++|||++|+.||...   ...+.+........ .
T Consensus       163 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~~~~~~~-~  235 (326)
T 2y0a_A          163 GLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSAVNY-E  235 (326)
T ss_dssp             TTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHHHHHTCC-C
T ss_pred             CCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC---CHHHHHHHHHhcCC-C
Confidence            9998765332   223457999999999999999999999999999999999999998432   22222222221100 0


Q ss_pred             CcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          551 TTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       551 ~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      . .    +.......   ..+.+++..||+.||++|||+.|+++
T Consensus       236 ~-~----~~~~~~~~---~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          236 F-E----DEYFSNTS---ALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             C-C----HHHHTTSC---HHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             c-C----ccccccCC---HHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0 0    00000111   23456778999999999999999986

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.9e-40  Score=341.94  Aligned_cols=249  Identities=24%  Similarity=0.317  Sum_probs=193.6

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcc--------------------------cHHHHHHHHHHHH
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQ--------------------------GDLEFKNEVLLVA  375 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~--------------------------~~~~~~~E~~~l~  375 (658)
                      .++|...+.||+|+||.||+++. .+|+.||||++......                          ....+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            47899999999999999999985 45889999998654311                          1245889999999


Q ss_pred             hcCCCCceeeeeeecc--CCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccC
Q 006155          376 NLQHRNLVRLLGFSLE--GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLK  453 (658)
Q Consensus       376 ~l~H~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk  453 (658)
                      +++||||+++++++.+  ++..++||||+++++|.+++    ....+++..++.++.||++||.|||+.+   |+|||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence            9999999999999876  56789999999999998876    3357999999999999999999999998   9999999


Q ss_pred             CCceeeCCCCCeEEeccccccccccCCCccccccccccccccCccccccCC---CCcccccccccchHhHHHhCCCCCcc
Q 006155          454 TSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQ---YSVKSDVFSFGVLVLEIISGQRNNCF  530 (658)
Q Consensus       454 ~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDV~S~Gvll~elltG~~p~~~  530 (658)
                      |+|||++.++.+||+|||+++.+.....  ......||+.|+|||++.+..   ++.++||||||+++|||++|+.||..
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            9999999999999999999987654322  233457999999999997765   47889999999999999999999843


Q ss_pred             CCCCCcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          531 RNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       531 ~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .   ....+......    ... ..  |. .....+   .+.+++.+||+.||++|||+.|+++
T Consensus       243 ~---~~~~~~~~~~~----~~~-~~--~~-~~~~~~---~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          243 E---RIMCLHSKIKS----QAL-EF--PD-QPDIAE---DLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             S---SHHHHHHHHHH----CCC-CC--CS-SSCCCH---HHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             c---cHHHHHHHHhc----ccC-CC--CC-ccccCH---HHHHHHHHHhhcChhhCCCHHHHhc
Confidence            2   22222222111    110 00  11 111122   3456778999999999999999864

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=4.1e-41  Score=358.73  Aligned_cols=268  Identities=17%  Similarity=0.206  Sum_probs=203.5

Q ss_pred             hhccCCcccCcccccCceEEEEeEecC------CcceeEEEeccCCcccH-----------HHHHHHHHHHHhcCCCCce
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQGD-----------LEFKNEVLLVANLQHRNLV  383 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~l~~~~~~~~-----------~~~~~E~~~l~~l~H~niv  383 (658)
                      ...++|...++||+|+||.||+|+...      ++.||||++........           ..+..|+..+..++||||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            456789999999999999999998654      47899999876542211           1233455667778899999


Q ss_pred             eeeeeeccC----CceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceee
Q 006155          384 RLLGFSLEG----NERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLL  459 (658)
Q Consensus       384 ~l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl  459 (658)
                      ++++++...    ...+|||||+ +++|.+++..  ....+++..++.|+.||+.||.|||+.+   |+||||||+|||+
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill  185 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLL  185 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEE
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEE
Confidence            999998764    4479999999 9999999854  3356999999999999999999999997   9999999999999


Q ss_pred             C--CCCCeEEeccccccccccCCCcc-----ccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCC
Q 006155          460 D--AEMTPKIADFGMARLFEMDETQG-----NTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRN  532 (658)
Q Consensus       460 ~--~~~~~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~  532 (658)
                      +  .++.+||+|||+++.+.......     ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus       186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~  265 (364)
T 3op5_A          186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL  265 (364)
T ss_dssp             ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence            9  88999999999998765432211     1233569999999999999999999999999999999999999996432


Q ss_pred             CCCcchHHHHHHHhccCCCcccccCCCCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 006155          533 GETVEDLLSSAWKNWREGTTVNIIDPTLSSG-SITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYS  600 (658)
Q Consensus       533 ~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~-~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~  600 (658)
                      ..  ..........+. ....+++++.+... ..++   +.+++..||+.+|++||++.+|+++|+...
T Consensus       266 ~~--~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~---~~~li~~cl~~~p~~RP~~~~l~~~l~~~~  328 (364)
T 3op5_A          266 KD--PKYVRDSKIRYR-ENIASLMDKCFPAANAPGE---IAKYMETVKLLDYTEKPLYENLRDILLQGL  328 (364)
T ss_dssp             TC--HHHHHHHHHHHH-HCHHHHHHHHSCTTCCCHH---HHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             cC--HHHHHHHHHHhh-hhHHHHHHHhcccccCHHH---HHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence            21  122222222221 12233333333222 2333   445677899999999999999999997643

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.3e-41  Score=351.53  Aligned_cols=251  Identities=22%  Similarity=0.271  Sum_probs=203.1

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      .++|...+.||+|+||.||+++.. +++.+|+|.+.... .....+.+|+.++..++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            578999999999999999999854 57889999987543 3445688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCC--CCCeEEeccccccccccC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDA--EMTPKIADFGMARLFEMD  479 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~--~~~~kl~DFGla~~~~~~  479 (658)
                      +++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.  ++.+||+|||+++.+...
T Consensus        83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            999999999843  2346999999999999999999999998   999999999999987  789999999999876543


Q ss_pred             CCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCC
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT  559 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~  559 (658)
                      .   ......||+.|+|||++.+..++.++||||||+++|||++|+.||...   ...+.+..........      ++.
T Consensus       158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i~~~~~~~------~~~  225 (321)
T 1tki_A          158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE---TNQQIIENIMNAEYTF------DEE  225 (321)
T ss_dssp             C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHHTCCCC------CHH
T ss_pred             C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC---CHHHHHHHHHcCCCCC------Chh
Confidence            2   233467999999999999988999999999999999999999998532   2223333322211100      000


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          560 LSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       560 l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ......   ..+.+++..||+.||++|||+.|+++
T Consensus       226 ~~~~~s---~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          226 AFKEIS---IEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHTTSC---HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhccCC---HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            000111   23557788999999999999999986

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=352.16  Aligned_cols=256  Identities=21%  Similarity=0.297  Sum_probs=195.7

Q ss_pred             hhhhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCC--CCceeeeeeeccCCc
Q 006155          319 IRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQH--RNLVRLLGFSLEGNE  394 (658)
Q Consensus       319 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~  394 (658)
                      +.+..++|+..+.||+|+||.||++...+++.||||++.....  .....+.+|+.++.+++|  |||+++++++.+++.
T Consensus         4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~   83 (343)
T 3dbq_A            4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY   83 (343)
T ss_dssp             EESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             eeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence            3455678999999999999999999988899999999875432  334568999999999986  999999999999999


Q ss_pred             eEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          395 RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      .++||| +.+++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++ ++.+||+|||+++
T Consensus        84 ~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~  155 (343)
T 3dbq_A           84 IYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIAN  155 (343)
T ss_dssp             EEEEEC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSC
T ss_pred             EEEEEe-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeeccccc
Confidence            999999 568899999853   456899999999999999999999988   99999999999997 5789999999998


Q ss_pred             ccccCCCccccccccccccccCcccccc-----------CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHH
Q 006155          475 LFEMDETQGNTSRIVGTYGYMAPEYAMH-----------GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSA  543 (658)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~  543 (658)
                      .+.............||+.|+|||++.+           ..++.++||||||+++|||++|+.||....     +.....
T Consensus       156 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~  230 (343)
T 3dbq_A          156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----NQISKL  230 (343)
T ss_dssp             CC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-----SHHHHH
T ss_pred             ccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh-----hHHHHH
Confidence            7765444334445689999999999865           678999999999999999999999984321     111111


Q ss_pred             HHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          544 WKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       544 ~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                      .........     .........   .+.+++..||+.||.+|||+.|+++.
T Consensus       231 ~~~~~~~~~-----~~~~~~~~~---~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          231 HAIIDPNHE-----IEFPDIPEK---DLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             HHHHCTTSC-----CCCCCCSCH---HHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHhcCCcc-----cCCcccCCH---HHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            111111110     111111222   34567789999999999999999853

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.1e-40  Score=343.18  Aligned_cols=253  Identities=22%  Similarity=0.355  Sum_probs=202.2

Q ss_pred             hccCCcccCcccccCceEEEEeEecC-C-------cceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCC
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLYD-G-------AEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGN  393 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-g-------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  393 (658)
                      ..++|...+.||+|+||.||+|+... +       ..||+|++..........+.+|+.++.+++||||+++++++.+++
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD   85 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence            45788999999999999999998543 3       469999998776667778999999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCC--------e
Q 006155          394 ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMT--------P  465 (658)
Q Consensus       394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~--------~  465 (658)
                      ..++||||+++++|.+++..  ....+++..++.++.||++||.|||+.+   |+||||||+|||++.++.        +
T Consensus        86 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           86 ENILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             CCEEEEECCTTCBHHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             CCEEEEECCCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccccee
Confidence            99999999999999999954  2334899999999999999999999998   999999999999998887        9


Q ss_pred             EEeccccccccccCCCccccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHH
Q 006155          466 KIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAW  544 (658)
Q Consensus       466 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~  544 (658)
                      ||+|||++.....      .....||+.|+|||++.+ ..++.++||||||+++|||++|..|+....  ........ .
T Consensus       161 kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~--~~~~~~~~-~  231 (289)
T 4fvq_A          161 KLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL--DSQRKLQF-Y  231 (289)
T ss_dssp             EECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS--CHHHHHHH-H
T ss_pred             eeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc--chHHHHHH-h
Confidence            9999999875432      223468899999999987 779999999999999999999766542211  11111111 1


Q ss_pred             HhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 006155          545 KNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSL  601 (658)
Q Consensus       545 ~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~~  601 (658)
                      ..  ...        +......   .+.+++..||+.||++|||+.++++.|+....
T Consensus       232 ~~--~~~--------~~~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          232 ED--RHQ--------LPAPKAA---ELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             HT--TCC--------CCCCSSC---TTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             hc--cCC--------CCCCCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            11  000        1011111   24467779999999999999999999987643

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=360.22  Aligned_cols=284  Identities=20%  Similarity=0.229  Sum_probs=215.0

Q ss_pred             cccchhhhhhhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeee
Q 006155          312 LQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLG  387 (658)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~  387 (658)
                      ..+.+++++...++|+..+.||+|+||.||+++.. +|+.||||++.+..   ......+.+|..++..++||||+++++
T Consensus        49 ~~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~  128 (412)
T 2vd5_A           49 IVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF  128 (412)
T ss_dssp             HHHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEE
T ss_pred             hhhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEE
Confidence            34556677788899999999999999999999864 68999999986532   112234789999999999999999999


Q ss_pred             eeccCCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEE
Q 006155          388 FSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKI  467 (658)
Q Consensus       388 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl  467 (658)
                      ++.+.+..+|||||+++|+|.+++...  ...+++..++.++.||+.||+|||+.+   |+||||||+||||+.++++||
T Consensus       129 ~~~~~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL  203 (412)
T 2vd5_A          129 AFQDENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRL  203 (412)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEE
T ss_pred             EEeeCCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEE
Confidence            999999999999999999999999532  246999999999999999999999988   999999999999999999999


Q ss_pred             eccccccccccCCCccccccccccccccCccccc-------cCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHH
Q 006155          468 ADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM-------HGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL  540 (658)
Q Consensus       468 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~  540 (658)
                      +|||+++.+..... ......+||+.|+|||++.       .+.++.++|||||||++|||++|+.||....   ..+..
T Consensus       204 ~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~  279 (412)
T 2vd5_A          204 ADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS---TAETY  279 (412)
T ss_dssp             CCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHH
T ss_pred             eechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC---HHHHH
Confidence            99999987654322 1223468999999999987       3578999999999999999999999985332   22222


Q ss_pred             HHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCC---CCHHHHHH--HhccCCCCCCCCCCCCccc
Q 006155          541 SSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASR---PTMASVVL--MLNSYSLTLPVPSEPAFFM  613 (658)
Q Consensus       541 ~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~R---Ptm~evv~--~L~~~~~~~~~p~~p~~~~  613 (658)
                      ........     ....|........+   +.+++..||+ +|++|   |+++||++  .+.+..+..-....|+|..
T Consensus       280 ~~i~~~~~-----~~~~p~~~~~~s~~---~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~~~~~p~~p  348 (412)
T 2vd5_A          280 GKIVHYKE-----HLSLPLVDEGVPEE---ARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPFTP  348 (412)
T ss_dssp             HHHHTHHH-----HCCCC----CCCHH---HHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTSTTSCCSCCC
T ss_pred             HHHHhccc-----CcCCCccccCCCHH---HHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHhhcCCCCCC
Confidence            22221100     01112111122223   4456678998 99998   69999974  4555544433334455543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4.3e-40  Score=338.54  Aligned_cols=256  Identities=29%  Similarity=0.553  Sum_probs=201.6

Q ss_pred             hhccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccH-------HHHHHHHHHHHhcCCCCceeeeeeeccC
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGD-------LEFKNEVLLVANLQHRNLVRLLGFSLEG  392 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~-------~~~~~E~~~l~~l~H~niv~l~~~~~~~  392 (658)
                      ...++|...+.||+|+||.||+++. .+++.||||++........       ..+.+|+.++.+++||||+++++++.+.
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP   95 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence            3457899999999999999999985 4688999999865433222       5688999999999999999999998765


Q ss_pred             CceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCC-----eEE
Q 006155          393 NERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMT-----PKI  467 (658)
Q Consensus       393 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~-----~kl  467 (658)
                      .  ++||||+++++|.+++..  ....+++..++.++.|++.||.|||+.+ .+|+||||||+|||++.++.     +||
T Consensus        96 ~--~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           96 P--RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             T--EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             C--eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEe
Confidence            5  799999999999888854  3457999999999999999999999875 34999999999999988776     999


Q ss_pred             eccccccccccCCCccccccccccccccCcccc--ccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHH
Q 006155          468 ADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA--MHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWK  545 (658)
Q Consensus       468 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~  545 (658)
                      +|||+++....     ......||+.|+|||++  ....++.++||||||+++|||++|+.||........ ........
T Consensus       171 ~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~  244 (287)
T 4f0f_A          171 ADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI-KFINMIRE  244 (287)
T ss_dssp             CCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH-HHHHHHHH
T ss_pred             CCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH-HHHHHHhc
Confidence            99999975332     23346799999999998  455678999999999999999999999854332221 11121111


Q ss_pred             hccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          546 NWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       546 ~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      .   +     ..+.+.....+   .+.+++..||+.||++|||+.+|++.|+.
T Consensus       245 ~---~-----~~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          245 E---G-----LRPTIPEDCPP---RLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             S---C-----CCCCCCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             c---C-----CCCCCCcccCH---HHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            1   1     11222222222   34567789999999999999999999975

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.9e-40  Score=339.71  Aligned_cols=260  Identities=30%  Similarity=0.467  Sum_probs=208.7

Q ss_pred             hhhhhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEE
Q 006155          318 TIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       318 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  397 (658)
                      +.++..++|...+.||+|+||.||+|+..++..||||++.... .....+.+|+.++.+++||||+++++++.+ +..++
T Consensus         7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   84 (279)
T 1qpc_A            7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI   84 (279)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence            3455668899999999999999999998778899999997643 345678999999999999999999999864 56899


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE  477 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~  477 (658)
                      ||||+++++|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        85 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  160 (279)
T 1qpc_A           85 ITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE  160 (279)
T ss_dssp             EEECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEecCCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence            99999999999998532 1236999999999999999999999988   9999999999999999999999999998765


Q ss_pred             cCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCccccc
Q 006155          478 MDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNII  556 (658)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  556 (658)
                      .... .......++..|+|||.+.++.++.++||||||+++|||++ |+.|+...   ...++.........        
T Consensus       161 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~---~~~~~~~~~~~~~~--------  228 (279)
T 1qpc_A          161 DNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQNLERGYR--------  228 (279)
T ss_dssp             SSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC---CHHHHHHHHHTTCC--------
T ss_pred             Cccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc---CHHHHHHHHhcccC--------
Confidence            4321 12233467889999999999999999999999999999999 88887432   22233332222111        


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          557 DPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       557 dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                       +.......+   .+.+++..|++.||++|||+.+++++|+..
T Consensus       229 -~~~~~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  267 (279)
T 1qpc_A          229 -MVRPDNCPE---ELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (279)
T ss_dssp             -CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CCCcccccH---HHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence             111112222   345677899999999999999999999864

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.6e-40  Score=340.24  Aligned_cols=261  Identities=24%  Similarity=0.329  Sum_probs=199.0

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcc--cHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQ--GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      ++|+..++||+|+||+||+++.. +|+.||||++......  ....+.+|+.++.+++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57889999999999999999864 5888999999765332  23568899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      |++++.+..+. .  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+....
T Consensus        82 ~~~~~l~~~~~-~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           82 FCDQDLKKYFD-S--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHH-H--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             cCCCCHHHHHH-h--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            99864444443 2  2456999999999999999999999998   9999999999999999999999999998764332


Q ss_pred             CccccccccccccccCccccccCC-CCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccc----
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNI----  555 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~----  555 (658)
                        .......||+.|+|||++.+.. ++.++||||||+++|||++|..|+..  ..+..+.+...............    
T Consensus       156 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~--~~~~~~~~~~i~~~~~~~~~~~~~~~~  231 (292)
T 3o0g_A          156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP--GNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             --SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC--CSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             --ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcC--CCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence              2233457899999999998766 89999999999999999999988632  22333444443332221111000    


Q ss_pred             --cC----------CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          556 --ID----------PTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       556 --~d----------p~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                        .+          ..+.......-..+.+++..||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence              00          0000000011123457778999999999999999985

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.6e-40  Score=343.69  Aligned_cols=246  Identities=25%  Similarity=0.301  Sum_probs=191.4

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc--ccHHHHHHHHHHHHhc-CCCCceeeeeeeccCCceEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG--QGDLEFKNEVLLVANL-QHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l  397 (658)
                      ..++|+..++||+|+||+||+|+.. +|+.||||++.....  .....+..|+..+.++ +||||+++++++.+++..++
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l  134 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL  134 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence            4478999999999999999999865 689999999865432  2233455566666555 89999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE  477 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~  477 (658)
                      ||||+ +++|.+++...  ...++|..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       135 v~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~  208 (311)
T 3p1a_A          135 QTELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG  208 (311)
T ss_dssp             EEECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred             EEecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence            99999 67888887542  346999999999999999999999987   9999999999999999999999999998654


Q ss_pred             cCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccC
Q 006155          478 MDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID  557 (658)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  557 (658)
                      ...   ......||++|+|||++.+ .++.++||||||+++|||++|..++...          ..+..+..+.....+.
T Consensus       209 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----------~~~~~~~~~~~~~~~~  274 (311)
T 3p1a_A          209 TAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----------EGWQQLRQGYLPPEFT  274 (311)
T ss_dssp             ---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----------HHHHHHTTTCCCHHHH
T ss_pred             cCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----------cHHHHHhccCCCcccc
Confidence            322   2334579999999998875 7999999999999999999997765211          1122222222111111


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          558 PTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       558 p~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                          ....   ..+.+++..||+.||++|||+.|+++
T Consensus       275 ----~~~~---~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          275 ----AGLS---SELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             ----TTSC---HHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ----cCCC---HHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                1111   23557778999999999999999985

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.7e-40  Score=337.45  Aligned_cols=257  Identities=26%  Similarity=0.437  Sum_probs=208.6

Q ss_pred             hhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      +..++|...+.||+|+||.||+++..+++.||+|++.... ....++.+|+.++.+++||||+++++++.+++..++|||
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (267)
T 3t9t_A            5 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE   83 (267)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred             EchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence            3457889999999999999999998788899999997654 344678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      |+++++|.+++..  ....+++..++.++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||+++......
T Consensus        84 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  158 (267)
T 3t9t_A           84 FMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  158 (267)
T ss_dssp             CCTTCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             CCCCCcHHHHHhh--CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc
Confidence            9999999999853  2356899999999999999999999998   9999999999999999999999999998654321


Q ss_pred             CccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccCCC
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT  559 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~  559 (658)
                      . .......||..|+|||++.+..++.++||||||+++|||++ |+.|+....   ..+..........      ...|.
T Consensus       159 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~i~~~~~------~~~~~  228 (267)
T 3t9t_A          159 Y-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVEDISTGFR------LYKPR  228 (267)
T ss_dssp             H-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHHTTCC------CCCCT
T ss_pred             c-cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC---HHHHHHHHhcCCc------CCCCc
Confidence            1 12223467889999999999999999999999999999999 888874322   2222222222111      01111


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          560 LSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       560 l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                         ....   .+.+++..||+.||++||++.++++.|+..
T Consensus       229 ---~~~~---~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (267)
T 3t9t_A          229 ---LAST---HVYQIMNHCWRERPEDRPAFSRLLRQLAEI  262 (267)
T ss_dssp             ---TSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---cCcH---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence               1122   345677899999999999999999999764

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.8e-40  Score=352.43  Aligned_cols=256  Identities=14%  Similarity=0.145  Sum_probs=205.8

Q ss_pred             hhhhhhccCCcccCcccccCceEEEEeE------ecCCcceeEEEeccCCcccHHHHHHHHHHHHhcC---CCCceeeee
Q 006155          317 NTIRVATDNFSDANKLGQGGFGAVYKGR------LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQ---HRNLVRLLG  387 (658)
Q Consensus       317 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~------~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~  387 (658)
                      .+++...++|...++||+|+||.||+|+      ...++.||||++...   ...++..|+.++..++   |+||+++++
T Consensus        58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~  134 (365)
T 3e7e_A           58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYS  134 (365)
T ss_dssp             CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred             eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence            4456677899999999999999999993      456889999999654   3456788888888887   999999999


Q ss_pred             eeccCCceEEEEEecCCCChhhhhcCcC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCC----
Q 006155          388 FSLEGNERLLIYEFVPNTSLDHFIFDPT--RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDA----  461 (658)
Q Consensus       388 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~----  461 (658)
                      ++..++..++||||+++|+|.+++....  ....++|..++.|+.||++||+|||+.+   ||||||||+||||+.    
T Consensus       135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~  211 (365)
T 3e7e_A          135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLE  211 (365)
T ss_dssp             EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTC
T ss_pred             eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccC
Confidence            9999999999999999999999995321  3456999999999999999999999987   999999999999998    


Q ss_pred             -------CCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCC
Q 006155          462 -------EMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGE  534 (658)
Q Consensus       462 -------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~  534 (658)
                             ++.+||+|||+++.+............+||++|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~  291 (365)
T 3e7e_A          212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG  291 (365)
T ss_dssp             C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred             ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence                   8999999999998665333333445578999999999999999999999999999999999999998432211


Q ss_pred             CcchHHHHHHHhccCCCcccccCCCCCCC-CHHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHhccC
Q 006155          535 TVEDLLSSAWKNWREGTTVNIIDPTLSSG-SITEMIRCIHIGLLCVQENVASR-PTMASVVLMLNSY  599 (658)
Q Consensus       535 ~~~~l~~~~~~~~~~~~~~~~~dp~l~~~-~~~e~~~~~~i~~~Cl~~~p~~R-Ptm~evv~~L~~~  599 (658)
                      .           +.       +...+... ..+.+   .++...|++.+|.+| |++.++.+.|+..
T Consensus       292 ~-----------~~-------~~~~~~~~~~~~~~---~~~~~~~l~~~p~~r~~~~~~l~~~l~~~  337 (365)
T 3e7e_A          292 E-----------CK-------PEGLFRRLPHLDMW---NEFFHVMLNIPDCHHLPSLDLLRQKLKKV  337 (365)
T ss_dssp             E-----------EE-------ECSCCTTCSSHHHH---HHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred             c-----------ee-------echhccccCcHHHH---HHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence            0           00       11111111 22333   356668899999988 6888888888653

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3.2e-40  Score=341.99  Aligned_cols=263  Identities=25%  Similarity=0.412  Sum_probs=203.8

Q ss_pred             ccCCcccCcccccCceEEEEeEe-----cCCcceeEEEeccCC-cccHHHHHHHHHHHHhcCCCCceeeeeeeccC--Cc
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-----YDGAEIAVKRLSRDS-GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEG--NE  394 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~  394 (658)
                      .+.|+..++||+|+||.||+++.     .+++.||||++.... ......+.+|+.++.+++||||+++++++.+.  +.
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            46688899999999999999983     468899999997543 33456789999999999999999999999876  66


Q ss_pred             eEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          395 RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      .++||||+++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       100 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence            8999999999999999843  2346999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccccCCCc-cccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCC--------CCCcchHHHHHHH
Q 006155          475 LFEMDETQ-GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRN--------GETVEDLLSSAWK  545 (658)
Q Consensus       475 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~--------~~~~~~l~~~~~~  545 (658)
                      .+...... .......||..|+|||++.+..++.++||||||+++|||++|+.|+....        .............
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN  254 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence            76544322 22334578889999999999999999999999999999999998753210        0011111111112


Q ss_pred             hccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          546 NWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       546 ~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      .+..+...     .......+   .+.+++..||+.||++|||+.+++++|+.
T Consensus       255 ~~~~~~~~-----~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~~L~~  299 (302)
T 4e5w_A          255 TLKEGKRL-----PCPPNCPD---EVYQLMRKCWEFQPSNRTSFQNLIEGFEA  299 (302)
T ss_dssp             HHHTTCCC-----CCCTTCCH---HHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHhccCCC-----CCCCCCCH---HHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence            22221111     11112222   35567789999999999999999999975

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.4e-40  Score=354.11  Aligned_cols=254  Identities=24%  Similarity=0.307  Sum_probs=202.5

Q ss_pred             hhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEE
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  397 (658)
                      ...++|...+.||+|+||.||+++.. +|+.||||++.....  .....+.+|+.++.+++||||+++++++.+++..++
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            34578999999999999999999854 588999999976432  234568899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCC---CeEEecccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM---TPKIADFGMAR  474 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~---~~kl~DFGla~  474 (658)
                      ||||+++|+|.+++..   ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++   .+||+|||+++
T Consensus       106 v~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             EECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             EEecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            9999999999998843   456899999999999999999999998   99999999999998654   59999999998


Q ss_pred             ccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          475 LFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      .+....   ......||+.|+|||++.+..++.++|||||||++|||++|+.||...   +...+.......    ... 
T Consensus       180 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~---~~~~~~~~i~~~----~~~-  248 (362)
T 2bdw_A          180 EVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE---DQHRLYAQIKAG----AYD-  248 (362)
T ss_dssp             CCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHT----CCC-
T ss_pred             EecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHhC----CCC-
Confidence            765332   223468999999999999999999999999999999999999998432   222333222221    110 


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          555 IIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       555 ~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                      ...+.. ....+   .+.+++..||+.||++|||+.++++.
T Consensus       249 ~~~~~~-~~~~~---~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          249 YPSPEW-DTVTP---EAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             CCTTGG-GGSCH---HHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             CCcccc-cCCCH---HHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000100 01112   34567789999999999999999753

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.1e-40  Score=349.26  Aligned_cols=269  Identities=17%  Similarity=0.206  Sum_probs=199.6

Q ss_pred             hccCCcccCcccccCceEEEEeEec----CCcceeEEEeccCCcc-----------cHHHHHHHHHHHHhcCCCCceeee
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY----DGAEIAVKRLSRDSGQ-----------GDLEFKNEVLLVANLQHRNLVRLL  386 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~  386 (658)
                      ..++|...+.||+|+||.||+|+..    .+..+|||++......           ....+.+|+..+..++||||++++
T Consensus        35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~  114 (345)
T 2v62_A           35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY  114 (345)
T ss_dssp             TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred             cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence            3478999999999999999999864    5778999998765332           112356788889999999999999


Q ss_pred             eeecc----CCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCC
Q 006155          387 GFSLE----GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE  462 (658)
Q Consensus       387 ~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~  462 (658)
                      +++..    ....++||||+ +++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.+
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESS
T ss_pred             cccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccC
Confidence            99887    67889999999 9999999853   237999999999999999999999987   9999999999999988


Q ss_pred             C--CeEEeccccccccccCCCc-----cccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCC
Q 006155          463 M--TPKIADFGMARLFEMDETQ-----GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGET  535 (658)
Q Consensus       463 ~--~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~  535 (658)
                      +  .+||+|||+++.+......     .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... 
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-  266 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD-  266 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC-
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc-
Confidence            7  9999999999876543221     1124468999999999999999999999999999999999999999532221 


Q ss_pred             cchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCC
Q 006155          536 VEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLT  602 (658)
Q Consensus       536 ~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~~~  602 (658)
                      . .........+.......+....-.....+   .+.+++..||+.||++||++.+|++.|+.....
T Consensus       267 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  329 (345)
T 2v62_A          267 P-VAVQTAKTNLLDELPQSVLKWAPSGSSCC---EIAQFLVCAHSLAYDEKPNYQALKKILNPHGIP  329 (345)
T ss_dssp             H-HHHHHHHHHHHHTTTHHHHHHSCTTSCCH---HHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCC
T ss_pred             c-HHHHHHHHhhcccccHHHHhhccccccHH---HHHHHHHHHhhcCcccCCCHHHHHHHHhccCCc
Confidence            1 11111111111111111100000001122   355677899999999999999999999986553

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.6e-40  Score=340.19  Aligned_cols=262  Identities=27%  Similarity=0.402  Sum_probs=212.5

Q ss_pred             hhhhhhccCCcccCcccccCceEEEEeEecC-CcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCce
Q 006155          317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNER  395 (658)
Q Consensus       317 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  395 (658)
                      ...+...++|...+.||+|+||.||+++... +..||||++.... .....+.+|+.++.+++||||+++++++.+++..
T Consensus         6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   84 (288)
T 3kfa_A            6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   84 (288)
T ss_dssp             CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence            3455677899999999999999999998654 7889999997543 3456789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ++||||+++++|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus        85 ~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~  160 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRL  160 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred             EEEEEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCcccee
Confidence            9999999999999998542 3456999999999999999999999998   99999999999999999999999999987


Q ss_pred             cccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          476 FEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      ...... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.|+....   .............      
T Consensus       161 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~---~~~~~~~~~~~~~------  230 (288)
T 3kfa_A          161 MTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYR------  230 (288)
T ss_dssp             SCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---GGGHHHHHHTTCC------
T ss_pred             ccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHhccCC------
Confidence            654322 22334567889999999999999999999999999999999 888885432   2233222222111      


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          555 IIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       555 ~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                         +.......+   .+.+++..||+.||++|||+.+|+++|+..
T Consensus       231 ---~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~~~~~l~~~  269 (288)
T 3kfa_A          231 ---MERPEGCPE---KVYELMRACWQWNPSDRPSFAEIHQAFETM  269 (288)
T ss_dssp             ---CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCCCCCCCH---HHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence               111111222   355677899999999999999999999753

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.8e-41  Score=355.99  Aligned_cols=266  Identities=27%  Similarity=0.405  Sum_probs=208.1

Q ss_pred             ccCCcccCcccccCceEEEEeEe-----cCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeec--cCCce
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-----YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSL--EGNER  395 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~  395 (658)
                      .++|...+.||+|+||.||+++.     .+++.||||++..........+.+|+.++.+++||||+++++++.  +.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            57899999999999999999983     357889999998776666667999999999999999999999886  45668


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ++||||+++++|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       102 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             EEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence            8999999999999998532  345999999999999999999999988   99999999999999999999999999987


Q ss_pred             cccCCCc-cccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCC--------CcchHHHHHHHh
Q 006155          476 FEMDETQ-GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGE--------TVEDLLSSAWKN  546 (658)
Q Consensus       476 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~--------~~~~l~~~~~~~  546 (658)
                      +...... .......||+.|+|||++.+..++.++||||||+++|||++|+.|+......        ............
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL  256 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            6543322 1233456888999999999999999999999999999999999987422110        000111111111


Q ss_pred             ccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 006155          547 WREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSL  601 (658)
Q Consensus       547 ~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~~  601 (658)
                      ...+..     +.......+   .+.+++..||+.||++|||+.+|++.|+....
T Consensus       257 ~~~~~~-----~~~~~~~~~---~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  303 (327)
T 3lxl_A          257 LEEGQR-----LPAPPACPA---EVHELMKLCWAPSPQDRPSFSALGPQLDMLWS  303 (327)
T ss_dssp             HHTTCC-----CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred             hhcccC-----CCCCCcccH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            111111     111111222   34567789999999999999999999987644

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2e-40  Score=341.52  Aligned_cols=257  Identities=23%  Similarity=0.366  Sum_probs=197.6

Q ss_pred             cCCcccCcccccCceEEEEeEecCCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      ++|...+.||+|+||.||+++..+|+.||||++.....  .....+.+|+.++.+++||||+++++++.+++..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            57889999999999999999987799999999865432  2345788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      +++ +|.+++..  ....+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.....
T Consensus        82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (288)
T ss_dssp             CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence            985 88888853  2356899999999999999999999988   99999999999999999999999999986643221


Q ss_pred             ccccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCc--------
Q 006155          482 QGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTT--------  552 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~--------  552 (658)
                        ......||+.|+|||++.+. .++.++||||||+++|||++|+.||....   ..+.+............        
T Consensus       156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T 1ob3_A          156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS---EADQLMRIFRILGTPNSKNWPNVTE  230 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             --ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHHCCCChhhchhhhc
Confidence              22345789999999998764 58999999999999999999999985332   22223322222111100        


Q ss_pred             ccccCCCCC-----------CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          553 VNIIDPTLS-----------SGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       553 ~~~~dp~l~-----------~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ....++.+.           ....+   .+.+++..||+.||++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          231 LPKYDPNFTVYEPLPWESFLKGLDE---SGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCH---HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccCccHHHHhhhcCH---HHHHHHHHHcCCCcccCCCHHHHhc
Confidence            001111111           11112   3457778999999999999999974

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.2e-40  Score=339.84  Aligned_cols=258  Identities=22%  Similarity=0.332  Sum_probs=194.2

Q ss_pred             hhhccCCcccCcccccCceEEEEeEecC----CcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCc
Q 006155          320 RVATDNFSDANKLGQGGFGAVYKGRLYD----GAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNE  394 (658)
Q Consensus       320 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  394 (658)
                      ++..++|+..+.||+|+||.||+|+...    +..||+|++..... .....+.+|+.++.+++||||+++++++. ++.
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~   89 (281)
T 1mp8_A           11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP   89 (281)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred             EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence            4456789999999999999999998543    44699999876433 33456889999999999999999999984 467


Q ss_pred             eEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          395 RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      .++||||+++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        90 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           90 VWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR  164 (281)
T ss_dssp             CEEEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             cEEEEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccc
Confidence            8999999999999999953  2346899999999999999999999988   9999999999999999999999999998


Q ss_pred             ccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcc
Q 006155          475 LFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTV  553 (658)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  553 (658)
                      .+..... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....   ..+........    .. 
T Consensus       165 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~---~~~~~~~i~~~----~~-  235 (281)
T 1mp8_A          165 YMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK---NNDVIGRIENG----ER-  235 (281)
T ss_dssp             ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC---GGGHHHHHHTT----CC-
T ss_pred             ccCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCC---HHHHHHHHHcC----CC-
Confidence            7654322 12233467889999999999999999999999999999997 888885432   22333322211    11 


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          554 NIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       554 ~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                          +.+.....+   .+.+++..||+.||++|||+.++++.|+..
T Consensus       236 ----~~~~~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  274 (281)
T 1mp8_A          236 ----LPMPPNCPP---TLYSLMTKCWAYDPSRRPRFTELKAQLSTI  274 (281)
T ss_dssp             ----CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCCCCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                111122222   344677899999999999999999999753

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.2e-40  Score=361.44  Aligned_cols=254  Identities=23%  Similarity=0.288  Sum_probs=202.2

Q ss_pred             hhccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEE
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  397 (658)
                      ...++|+..+.||+|+||.||+++. .+|+.+|+|++.....  .....+.+|+.+++.++||||+++++++.+++..++
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            3467899999999999999999974 4688999999876532  234568899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeC---CCCCeEEecccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLD---AEMTPKIADFGMAR  474 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~---~~~~~kl~DFGla~  474 (658)
                      ||||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++   .++.+||+|||+++
T Consensus        88 v~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           88 IFDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             EECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             EEEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            9999999999998853   356999999999999999999999998   99999999999998   46789999999998


Q ss_pred             ccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          475 LFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      .+.....  ......||+.|+|||++.+..++.++||||||+++|||++|+.||...   ....+.......    .. .
T Consensus       162 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~----~~-~  231 (444)
T 3soa_A          162 EVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE---DQHRLYQQIKAG----AY-D  231 (444)
T ss_dssp             CCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHT----CC-C
T ss_pred             EecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc---cHHHHHHHHHhC----CC-C
Confidence            7654322  223468999999999999999999999999999999999999998432   223333322221    11 1


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          555 IIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       555 ~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ...+... ...+   .+.+++..||+.||++|||+.|+++
T Consensus       232 ~~~~~~~-~~s~---~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          232 FPSPEWD-TVTP---EAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             CCTTTTT-TSCH---HHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCccccc-cCCH---HHHHHHHHHcCCChhHCCCHHHHhc
Confidence            1111111 1122   3446778999999999999999986

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-40  Score=355.40  Aligned_cols=253  Identities=23%  Similarity=0.259  Sum_probs=204.6

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      .++|...+.||+|+||.||+|+.. +|+.||+|++..........+.+|+.++..++||||+++++++.++...++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            468999999999999999999854 5888999999776555566789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCC--CCCeEEeccccccccccC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDA--EMTPKIADFGMARLFEMD  479 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~--~~~~kl~DFGla~~~~~~  479 (658)
                      +++|+|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.  ++.+||+|||+++.+...
T Consensus       130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            999999999853  2346899999999999999999999988   999999999999974  578999999999876543


Q ss_pred             CCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCC
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT  559 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~  559 (658)
                      .   ......||+.|+|||++.+..++.++||||||+++|||++|+.||...   ...+.+......    ..  ..++.
T Consensus       205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~---~~~~~~~~i~~~----~~--~~~~~  272 (387)
T 1kob_A          205 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE---DDLETLQNVKRC----DW--EFDED  272 (387)
T ss_dssp             S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHHHHHC----CC--CCCSS
T ss_pred             c---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC---CHHHHHHHHHhC----CC--CCCcc
Confidence            2   223457999999999999999999999999999999999999998532   222222222211    10  01111


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          560 LSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       560 l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                      ......+   .+.+++..||+.||++|||+.|+++.
T Consensus       273 ~~~~~s~---~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          273 AFSSVSP---EAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             TTTTSCH---HHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ccccCCH---HHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            1112122   34567789999999999999999863

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.1e-40  Score=359.97  Aligned_cols=266  Identities=20%  Similarity=0.248  Sum_probs=207.9

Q ss_pred             chhhhhhhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeec
Q 006155          315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSL  390 (658)
Q Consensus       315 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~  390 (658)
                      .+..++...++|...++||+|+||+||+++.. +++.||+|++....   ......+.+|+.++..++||||+++++++.
T Consensus        60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~  139 (410)
T 3v8s_A           60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ  139 (410)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            34556777899999999999999999999865 47889999986521   122334789999999999999999999999


Q ss_pred             cCCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecc
Q 006155          391 EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADF  470 (658)
Q Consensus       391 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DF  470 (658)
                      +++..++||||+++|+|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+||
T Consensus       140 ~~~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DF  212 (410)
T 3v8s_A          140 DDRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADF  212 (410)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             ECCEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEecc
Confidence            99999999999999999999843    45899999999999999999999988   999999999999999999999999


Q ss_pred             ccccccccCCCccccccccccccccCccccccCC----CCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHh
Q 006155          471 GMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQ----YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKN  546 (658)
Q Consensus       471 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~  546 (658)
                      |+++.+..... ......+||+.|+|||++.+..    ++.++|||||||++|||++|+.||...   +...........
T Consensus       213 G~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~  288 (410)
T 3v8s_A          213 GTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD---SLVGTYSKIMNH  288 (410)
T ss_dssp             TTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHTH
T ss_pred             ceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC---ChhhHHHHHHhc
Confidence            99987653321 1233568999999999998665    889999999999999999999998532   222333322221


Q ss_pred             ccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH--hccCC
Q 006155          547 WREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVAS--RPTMASVVLM--LNSYS  600 (658)
Q Consensus       547 ~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~--RPtm~evv~~--L~~~~  600 (658)
                      ..     .+.-|.. .....+   +.+++..||+.+|.+  ||++.||++.  +.+..
T Consensus       289 ~~-----~~~~p~~-~~~s~~---~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~  337 (410)
T 3v8s_A          289 KN-----SLTFPDD-NDISKE---AKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  337 (410)
T ss_dssp             HH-----HCCCCTT-CCCCHH---HHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred             cc-----cccCCCc-ccccHH---HHHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence            00     0001111 111222   345667899999988  9999999853  44443

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=7.5e-40  Score=347.21  Aligned_cols=255  Identities=24%  Similarity=0.286  Sum_probs=201.8

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccC-----CcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCce
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRD-----SGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNER  395 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  395 (658)
                      ..++|+..+.||+|+||.||+++.. +|+.||||++...     .......+.+|+.++..++||||+++++++.+++..
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            3467999999999999999999854 6889999998542     122456789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCcC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCC---eEEeccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPT-RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMT---PKIADFG  471 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~---~kl~DFG  471 (658)
                      ++||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.   +||+|||
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCc
Confidence            99999999999988875422 2345899999999999999999999998   999999999999987655   9999999


Q ss_pred             cccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCC
Q 006155          472 MARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGT  551 (658)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  551 (658)
                      +++.+.....  ......||+.|+|||++.+..++.++||||||+++|||++|+.||...    ...+......    +.
T Consensus       179 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~~~~i~~----~~  248 (351)
T 3c0i_A          179 VAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT----KERLFEGIIK----GK  248 (351)
T ss_dssp             TCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS----HHHHHHHHHH----TC
T ss_pred             ceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc----HHHHHHHHHc----CC
Confidence            9987654321  233467999999999999999999999999999999999999998532    1222222221    11


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          552 TVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       552 ~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ..  .++.......   ..+.+++..||+.||++|||+.|+++
T Consensus       249 ~~--~~~~~~~~~s---~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          249 YK--MNPRQWSHIS---ESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             CC--CCHHHHTTSC---HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CC--CCccccccCC---HHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            00  0000000111   23456778999999999999999985

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=7.6e-40  Score=351.45  Aligned_cols=252  Identities=22%  Similarity=0.265  Sum_probs=196.9

Q ss_pred             hhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc---ccHHHHHHHHHHHHhc-CCCCceeeeeeeccCCce
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG---QGDLEFKNEVLLVANL-QHRNLVRLLGFSLEGNER  395 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~  395 (658)
                      ...++|...++||+|+||.||+++.. +++.||||++.....   .....+..|..++.++ +||||+++++++.+.+..
T Consensus        49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~  128 (396)
T 4dc2_A           49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL  128 (396)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence            34578999999999999999999865 477899999976432   2233478899999887 899999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ++||||+++|+|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.
T Consensus       129 ~lV~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~  202 (396)
T 4dc2_A          129 FFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE  202 (396)
T ss_dssp             EEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeee
Confidence            999999999999999843   356999999999999999999999998   99999999999999999999999999985


Q ss_pred             cccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCc--chHHHHHHHhccCCCcc
Q 006155          476 FEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETV--EDLLSSAWKNWREGTTV  553 (658)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~--~~l~~~~~~~~~~~~~~  553 (658)
                      ....  .......+||+.|+|||++.+..++.++|||||||++|||++|+.||........  ...............  
T Consensus       203 ~~~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--  278 (396)
T 4dc2_A          203 GLRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--  278 (396)
T ss_dssp             CCCT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC--
T ss_pred             cccC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc--
Confidence            3222  1234457899999999999999999999999999999999999999964322111  111111111111111  


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 006155          554 NIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTM  589 (658)
Q Consensus       554 ~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm  589 (658)
                          +.+......   .+.+++..||+.||++||++
T Consensus       279 ----~~~p~~~s~---~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          279 ----IRIPRSLSV---KAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             ----CCCCTTSCH---HHHHHHHHHTCSCTTTSTTC
T ss_pred             ----cCCCCcCCH---HHHHHHHHHhcCCHhHcCCC
Confidence                111112112   34567779999999999995

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.1e-40  Score=345.04  Aligned_cols=258  Identities=27%  Similarity=0.424  Sum_probs=197.5

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcce----eEEEeccC-CcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCce
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEI----AVKRLSRD-SGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNER  395 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~v----avK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  395 (658)
                      ..++|...++||+|+||.||+|+.. +++.+    |+|.+... .......+.+|+.++.+++||||+++++++..+. .
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~   91 (327)
T 3lzb_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V   91 (327)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred             CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence            3578999999999999999999843 45554    77776543 3345677999999999999999999999998765 7


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ++|+||+++|+|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        92 ~~v~~~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~  166 (327)
T 3lzb_A           92 QLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEEECCCSSCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred             eEEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence            899999999999999854  2356999999999999999999999998   99999999999999999999999999987


Q ss_pred             cccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          476 FEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      +.............||+.|+|||.+.+..++.++||||||+++|||++ |+.||.....   .++.........      
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~---~~~~~~~~~~~~------  237 (327)
T 3lzb_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSILEKGER------  237 (327)
T ss_dssp             -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHHHTTCC------
T ss_pred             ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH---HHHHHHHHcCCC------
Confidence            755444334444567889999999999999999999999999999999 9999854332   223222222111      


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 006155          555 IIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYS  600 (658)
Q Consensus       555 ~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~  600 (658)
                         +........   .+.+++..||+.||++||++.|+++.|+...
T Consensus       238 ---~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  277 (327)
T 3lzb_A          238 ---LPQPPICTI---DVYMIMRKCWMIDADSRPKFRELIIEFSKMA  277 (327)
T ss_dssp             ---CCCCTTBCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CCCCccCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence               011111112   3556778999999999999999999998753

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.4e-40  Score=353.84  Aligned_cols=210  Identities=27%  Similarity=0.320  Sum_probs=182.4

Q ss_pred             cccccchhhhhhhccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhcC-----CCCce
Q 006155          310 ESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQ-----HRNLV  383 (658)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----H~niv  383 (658)
                      +...+.+.......++|...++||+|+||.||+++. .+++.||||++... ......+..|+.++..++     ||||+
T Consensus        21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv   99 (360)
T 3llt_A           21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIV   99 (360)
T ss_dssp             GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred             cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence            345667777788889999999999999999999985 46888999998643 233456788999999996     99999


Q ss_pred             eeeeeeccCCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCC--
Q 006155          384 RLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDA--  461 (658)
Q Consensus       384 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~--  461 (658)
                      ++++++...+..++||||+ +++|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.  
T Consensus       100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~  174 (360)
T 3llt_A          100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPY  174 (360)
T ss_dssp             CEEEEEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTT
T ss_pred             cccceeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccc
Confidence            9999999999999999999 99999998542 2335899999999999999999999988   999999999999975  


Q ss_pred             -----------------------CCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchH
Q 006155          462 -----------------------EMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLV  518 (658)
Q Consensus       462 -----------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll  518 (658)
                                             ++.+||+|||+++.....     .....||+.|+|||++.+..++.++||||||+++
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il  249 (360)
T 3llt_A          175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL  249 (360)
T ss_dssp             CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred             ccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence                                   789999999999864322     2346789999999999999999999999999999


Q ss_pred             hHHHhCCCCCcc
Q 006155          519 LEIISGQRNNCF  530 (658)
Q Consensus       519 ~elltG~~p~~~  530 (658)
                      |||++|+.||..
T Consensus       250 ~ell~g~~pf~~  261 (360)
T 3llt_A          250 AELYTGSLLFRT  261 (360)
T ss_dssp             HHHHHSSCSCCC
T ss_pred             HHHHHCCCCCCC
Confidence            999999999854

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.2e-40  Score=372.97  Aligned_cols=258  Identities=24%  Similarity=0.400  Sum_probs=200.6

Q ss_pred             hhccCCcccC-cccccCceEEEEeEec---CCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCce
Q 006155          321 VATDNFSDAN-KLGQGGFGAVYKGRLY---DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNER  395 (658)
Q Consensus       321 ~~~~~~~~~~-~lG~G~fg~Vy~~~~~---~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  395 (658)
                      ...+++...+ +||+|+||.||+|...   ++..||||+++.... ....+|.+|+.+|.+++|||||++++++.. +..
T Consensus       332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~  410 (613)
T 2ozo_A          332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL  410 (613)
T ss_dssp             CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSE
T ss_pred             ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCe
Confidence            3344555555 7999999999999754   456799999976533 356779999999999999999999999976 568


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ++||||+++|+|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.
T Consensus       411 ~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~  485 (613)
T 2ozo_A          411 MLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKA  485 (613)
T ss_dssp             EEEEECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred             EEEEEeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence            999999999999999954  3456999999999999999999999988   99999999999999999999999999987


Q ss_pred             cccCCCc-cccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcc
Q 006155          476 FEMDETQ-GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTV  553 (658)
Q Consensus       476 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  553 (658)
                      +...... .......+|+.|+|||++.++.++.++|||||||++|||++ |+.||.....   .++......    +...
T Consensus       486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~~~~~~i~~----~~~~  558 (613)
T 2ozo_A          486 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFIEQ----GKRM  558 (613)
T ss_dssp             CC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS---HHHHHHHHT----TCCC
T ss_pred             ccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH---HHHHHHHHc----CCCC
Confidence            6543221 11223456789999999999999999999999999999998 9999854332   233333222    2111


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          554 NIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       554 ~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      .     ......+   .+.+++..||+.||++||++.+|++.|+..
T Consensus       559 ~-----~p~~~~~---~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          559 E-----CPPECPP---ELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             C-----CCTTCCH---HHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             C-----CCCcCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            1     1112223   345677899999999999999999999864

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.5e-40  Score=344.96  Aligned_cols=269  Identities=24%  Similarity=0.321  Sum_probs=199.3

Q ss_pred             hhhhhhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHh--cCCCCceeeeeeeccC--
Q 006155          317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVAN--LQHRNLVRLLGFSLEG--  392 (658)
Q Consensus       317 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~--  392 (658)
                      ...+...++|+..++||+|+||.||+|+. .|+.||||++...   ....+..|.+++..  ++||||+++++++...  
T Consensus        30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~  105 (337)
T 3mdy_A           30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTG  105 (337)
T ss_dssp             HHHTTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred             ccccccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence            33455668999999999999999999986 5899999998543   23344555555554  4899999999998877  


Q ss_pred             --CceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcC-----CCcEEEeccCCCceeeCCCCCe
Q 006155          393 --NERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS-----RLRIIHRDLKTSNVLLDAEMTP  465 (658)
Q Consensus       393 --~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDlk~~NILl~~~~~~  465 (658)
                        ...++||||+++|+|.+++..    ..+++..++.++.|++.||.|||+..     ..+|+||||||+|||++.++.+
T Consensus       106 ~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  181 (337)
T 3mdy_A          106 SWTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC  181 (337)
T ss_dssp             GGCEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred             CCCceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence              678999999999999999942    46999999999999999999999871     1139999999999999999999


Q ss_pred             EEeccccccccccCCCcc--ccccccccccccCccccccCCCCcc------cccccccchHhHHHhC----------CCC
Q 006155          466 KIADFGMARLFEMDETQG--NTSRIVGTYGYMAPEYAMHGQYSVK------SDVFSFGVLVLEIISG----------QRN  527 (658)
Q Consensus       466 kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~k------sDV~S~Gvll~elltG----------~~p  527 (658)
                      ||+|||+++.+.......  ......||+.|+|||++.+...+.+      +||||||+++|||++|          +.|
T Consensus       182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p  261 (337)
T 3mdy_A          182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP  261 (337)
T ss_dssp             EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence            999999998765433221  1234579999999999988776665      9999999999999999          445


Q ss_pred             CccCCCCCcchHHHHHHHhccCCCcccccCCCCCCC--CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          528 NCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSG--SITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       528 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~--~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      +.........  ...........    ...+.+...  .......+.+++..||+.||++|||+.+|++.|+..
T Consensus       262 ~~~~~~~~~~--~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l  329 (337)
T 3mdy_A          262 YHDLVPSDPS--YEDMREIVCIK----KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM  329 (337)
T ss_dssp             TTTTSCSSCC--HHHHHHHHTTS----CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhhhcCCCCc--hhhhHHHHhhh----ccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence            4322211111  11111111111    111222211  113344567888999999999999999999999864

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-40  Score=340.24  Aligned_cols=261  Identities=25%  Similarity=0.391  Sum_probs=207.0

Q ss_pred             hhhccCCcccC-cccccCceEEEEeEec---CCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCc
Q 006155          320 RVATDNFSDAN-KLGQGGFGAVYKGRLY---DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNE  394 (658)
Q Consensus       320 ~~~~~~~~~~~-~lG~G~fg~Vy~~~~~---~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  394 (658)
                      ....++|...+ .||+|+||.||+|+..   ++..||||++..... .....+.+|+.++.+++||||+++++++ ..+.
T Consensus         5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~   83 (287)
T 1u59_A            5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEA   83 (287)
T ss_dssp             BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSS
T ss_pred             cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCC
Confidence            34456677766 8999999999999743   577899999977533 3445689999999999999999999999 5567


Q ss_pred             eEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          395 RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      .++||||+++++|.+++..  ....+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        84 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~  158 (287)
T 1u59_A           84 LMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSK  158 (287)
T ss_dssp             EEEEEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             cEEEEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECccccee
Confidence            8999999999999999853  3456999999999999999999999998   9999999999999999999999999998


Q ss_pred             ccccCCCc-cccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCc
Q 006155          475 LFEMDETQ-GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTT  552 (658)
Q Consensus       475 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~  552 (658)
                      .+...... .......||+.|+|||++.+..++.++||||||+++|||++ |+.||.....   .++......    +..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~i~~----~~~  231 (287)
T 1u59_A          159 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFIEQ----GKR  231 (287)
T ss_dssp             ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHHHHT----TCC
T ss_pred             eeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHhc----CCc
Confidence            76543321 12233467899999999998999999999999999999998 9999854322   223222221    111


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 006155          553 VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSL  601 (658)
Q Consensus       553 ~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~~  601 (658)
                           +.......+   .+.+++..||+.||++||++.+|++.|+....
T Consensus       232 -----~~~~~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  272 (287)
T 1u59_A          232 -----MECPPECPP---ELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  272 (287)
T ss_dssp             -----CCCCTTCCH---HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCCCCcCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                 111122222   34567789999999999999999999987543

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1e-39  Score=349.14  Aligned_cols=251  Identities=23%  Similarity=0.323  Sum_probs=203.9

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  397 (658)
                      ..++|...+.||+|+||.||+++.. +++.||+|++....   ......+.+|+.++..++||||+++++++.+.+..++
T Consensus        13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   92 (384)
T 4fr4_A           13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM   92 (384)
T ss_dssp             CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            3578999999999999999999854 47889999986532   2344568899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE  477 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~  477 (658)
                      ||||+++|+|..++..   ...+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+.
T Consensus        93 v~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  166 (384)
T 4fr4_A           93 VVDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLP  166 (384)
T ss_dssp             EECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence            9999999999999953   456999999999999999999999998   9999999999999999999999999998764


Q ss_pred             cCCCccccccccccccccCcccccc---CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          478 MDETQGNTSRIVGTYGYMAPEYAMH---GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      ...   ......||+.|+|||++..   ..++.++|||||||++|||++|+.||..........+........       
T Consensus       167 ~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~-------  236 (384)
T 4fr4_A          167 RET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV-------  236 (384)
T ss_dssp             TTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC-------
T ss_pred             CCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc-------
Confidence            332   2345689999999999864   458999999999999999999999996555444444333322211       


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHH
Q 006155          555 IIDPTLSSGSITEMIRCIHIGLLCVQENVASRPT-MASVVL  594 (658)
Q Consensus       555 ~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPt-m~evv~  594 (658)
                         .........   .+.+++..||+.||++||+ +.+|..
T Consensus       237 ---~~~p~~~s~---~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          237 ---VTYPSAWSQ---EMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             ---CCCCTTSCH---HHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             ---cCCCCcCCH---HHHHHHHHHhcCCHhHhcccHHHHHc
Confidence               111111112   3456778999999999998 777764

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.9e-40  Score=354.53  Aligned_cols=248  Identities=25%  Similarity=0.299  Sum_probs=194.9

Q ss_pred             cccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecCCC
Q 006155          327 SDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNT  405 (658)
Q Consensus       327 ~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g  405 (658)
                      ...+.||+|+||.||+++. .+|+.||||++.........++.+|+.++.+++||||+++++++.+.+..+|||||++++
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~  171 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG  171 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            3356899999999999985 468899999998766566678999999999999999999999999999999999999999


Q ss_pred             ChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceee--CCCCCeEEeccccccccccCCCcc
Q 006155          406 SLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLL--DAEMTPKIADFGMARLFEMDETQG  483 (658)
Q Consensus       406 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl--~~~~~~kl~DFGla~~~~~~~~~~  483 (658)
                      +|.+++..  ....+++..++.++.||++||.|||+.+   |+||||||+|||+  +.++.+||+|||+++.+.....  
T Consensus       172 ~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--  244 (373)
T 2x4f_A          172 ELFDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--  244 (373)
T ss_dssp             EEHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred             cHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence            99988853  2346899999999999999999999988   9999999999999  6778999999999987654322  


Q ss_pred             ccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCC
Q 006155          484 NTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSG  563 (658)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~  563 (658)
                       .....||+.|+|||++.+..++.++||||||+++|||++|+.||....   ..+.+........     ...++.. ..
T Consensus       245 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~i~~~~~-----~~~~~~~-~~  314 (373)
T 2x4f_A          245 -LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN---DAETLNNILACRW-----DLEDEEF-QD  314 (373)
T ss_dssp             -CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCC-----CSCSGGG-TT
T ss_pred             -cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhccC-----CCChhhh-cc
Confidence             233579999999999999999999999999999999999999985322   2222222222100     0000000 11


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          564 SITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       564 ~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ..+   .+.+++..||+.||++|||+.|+++
T Consensus       315 ~~~---~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          315 ISE---EAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             SCH---HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCH---HHHHHHHHHcCCChhhCCCHHHHhc
Confidence            112   3456778999999999999999986

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.3e-39  Score=340.49  Aligned_cols=260  Identities=27%  Similarity=0.349  Sum_probs=187.6

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      .++|+..++||+|+||.||+|+.. +|+.||||++..... .....+.+|+.++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            467899999999999999999854 588999999876533 334678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCc---CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccc
Q 006155          401 FVPNTSLDHFIFDP---TRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE  477 (658)
Q Consensus       401 ~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~  477 (658)
                      |++ ++|.+++...   .....+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 5898888532   12245899999999999999999999988   9999999999999999999999999998764


Q ss_pred             cCCCccccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCC---Ccc
Q 006155          478 MDETQGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREG---TTV  553 (658)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~  553 (658)
                      ....  ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.....   .+.+..........   ...
T Consensus       160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~  234 (317)
T 2pmi_A          160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND---EEQLKLIFDIMGTPNESLWP  234 (317)
T ss_dssp             SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCSCCTTTCG
T ss_pred             CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCChhHhh
Confidence            3321  2234578999999999876 4689999999999999999999999854322   22222222211100   000


Q ss_pred             c-----ccCCC----------------CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          554 N-----IIDPT----------------LSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       554 ~-----~~dp~----------------l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .     ...+.                ......   ..+.+++..||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLD---GNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCC---HHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhhcccccccccchhHHHhhcccccccCC---HHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            0     00011                111111   23567888999999999999999874

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.5e-40  Score=344.64  Aligned_cols=259  Identities=26%  Similarity=0.462  Sum_probs=199.5

Q ss_pred             hhccCCcccCcccccCceEEEEeEecC-----CcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCc
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLYD-----GAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNE  394 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~-----g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  394 (658)
                      +..++|...+.||+|+||.||+|+...     +..||||++..... .....+.+|+.++.+++||||+++++++.+.+.
T Consensus        41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  120 (333)
T 1mqb_A           41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP  120 (333)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence            345678888999999999999998543     23599999976533 234568899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          395 RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      .++||||+++++|.+++..  ....+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       121 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          121 MMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSR  195 (333)
T ss_dssp             EEEEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             cEEEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcch
Confidence            9999999999999999853  2356999999999999999999999998   9999999999999999999999999998


Q ss_pred             ccccCCCc-cccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCc
Q 006155          475 LFEMDETQ-GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTT  552 (658)
Q Consensus       475 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~  552 (658)
                      .+...... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....   ..++........+    
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~---~~~~~~~~~~~~~----  268 (333)
T 1mqb_A          196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS---NHEVMKAINDGFR----  268 (333)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHHTTCC----
T ss_pred             hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC---HHHHHHHHHCCCc----
Confidence            76543221 12223456889999999999999999999999999999999 999984322   2233322222111    


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          553 VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       553 ~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                           +........   .+.+++..||+.||++||++.+|+++|+..
T Consensus       269 -----~~~~~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  307 (333)
T 1mqb_A          269 -----LPTPMDCPS---AIYQLMMQCWQQERARRPKFADIVSILDKL  307 (333)
T ss_dssp             -----CCCCTTCBH---HHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -----CCCcccCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                 111111222   345677899999999999999999999764

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2e-40  Score=348.98  Aligned_cols=268  Identities=25%  Similarity=0.343  Sum_probs=194.9

Q ss_pred             hhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHH--HHhcCCCCceeeeeeec-----cCC
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLL--VANLQHRNLVRLLGFSL-----EGN  393 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~--l~~l~H~niv~l~~~~~-----~~~  393 (658)
                      ...++|...+.||+|+||.||+|+. +++.||||++....   ...+..|.++  +..++||||+++++.+.     ...
T Consensus        10 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   85 (336)
T 3g2f_A           10 LDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM   85 (336)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred             cChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence            3457899999999999999999975 78999999986542   2334444444  45689999999997542     233


Q ss_pred             ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhc---------CCCcEEEeccCCCceeeCCCCC
Q 006155          394 ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED---------SRLRIIHRDLKTSNVLLDAEMT  464 (658)
Q Consensus       394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------~~~~ivHrDlk~~NILl~~~~~  464 (658)
                      ..++||||+++|+|.+++..    ...+|..+++++.||++||.|||+.         +   |+||||||+|||++.++.
T Consensus        86 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~  158 (336)
T 3g2f_A           86 EYLLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGT  158 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSC
T ss_pred             eEEEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCc
Confidence            56899999999999999943    3458999999999999999999998         6   999999999999999999


Q ss_pred             eEEeccccccccccCCC------ccccccccccccccCcccccc-------CCCCcccccccccchHhHHHhCCCCCccC
Q 006155          465 PKIADFGMARLFEMDET------QGNTSRIVGTYGYMAPEYAMH-------GQYSVKSDVFSFGVLVLEIISGQRNNCFR  531 (658)
Q Consensus       465 ~kl~DFGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDV~S~Gvll~elltG~~p~~~~  531 (658)
                      +||+|||+++.+.....      ........||+.|+|||++.+       ..++.++||||||+++|||++|+.|+...
T Consensus       159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~  238 (336)
T 3g2f_A          159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG  238 (336)
T ss_dssp             EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred             EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence            99999999987654321      112234579999999999976       45678999999999999999998776332


Q ss_pred             CC-CCcchHHHH----------HHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 006155          532 NG-ETVEDLLSS----------AWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYS  600 (658)
Q Consensus       532 ~~-~~~~~l~~~----------~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~  600 (658)
                      .. .........          .............+ |............+.+++..||+.||++|||+.||++.|+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll  317 (336)
T 3g2f_A          239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKF-PEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM  317 (336)
T ss_dssp             SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCC-CTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCC-CcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence            22 111111110          00001111111111 1111112223345678889999999999999999999998753

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.2e-41  Score=353.99  Aligned_cols=263  Identities=24%  Similarity=0.349  Sum_probs=202.3

Q ss_pred             hccCC-cccCcccccCceEEEEeEe-----cCCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeecc--C
Q 006155          322 ATDNF-SDANKLGQGGFGAVYKGRL-----YDGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLE--G  392 (658)
Q Consensus       322 ~~~~~-~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~  392 (658)
                      ..++| ...++||+|+||+||++..     .+++.||||++..... .....+.+|+.++.+++||||+++++++.+  .
T Consensus        28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (318)
T 3lxp_A           28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA  107 (318)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred             ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence            34445 8999999999999988863     2578899999976543 334568999999999999999999999987  4


Q ss_pred             CceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccc
Q 006155          393 NERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGM  472 (658)
Q Consensus       393 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGl  472 (658)
                      ...++||||+++++|.+++..    ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~  180 (318)
T 3lxp_A          108 ASLQLVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGL  180 (318)
T ss_dssp             TEEEEEECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGG
T ss_pred             ceEEEEEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccc
Confidence            577999999999999999943    34999999999999999999999998   99999999999999999999999999


Q ss_pred             ccccccCCCc-cccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCC--------CcchHHHHH
Q 006155          473 ARLFEMDETQ-GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGE--------TVEDLLSSA  543 (658)
Q Consensus       473 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~--------~~~~l~~~~  543 (658)
                      ++.+...... .......||..|+|||++.+..++.++||||||+++|||++|+.|+......        ....-....
T Consensus       181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  260 (318)
T 3lxp_A          181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL  260 (318)
T ss_dssp             CEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHH
T ss_pred             cccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHH
Confidence            9876543321 1233456888999999999999999999999999999999999987432100        000000011


Q ss_pred             HHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          544 WKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       544 ~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      ......+..     +........   .+.+++..||+.||++|||+.++++.|+..
T Consensus       261 ~~~~~~~~~-----~~~~~~~~~---~l~~li~~~l~~dP~~Rps~~ell~~L~~l  308 (318)
T 3lxp_A          261 TELLERGER-----LPRPDKCPA---EVYHLMKNCWETEASFRPTFENLIPILKTV  308 (318)
T ss_dssp             HHHHHTTCC-----CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHhcccC-----CCCCccccH---HHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            111111111     111111222   355677899999999999999999999865

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.2e-40  Score=349.90  Aligned_cols=250  Identities=27%  Similarity=0.330  Sum_probs=196.8

Q ss_pred             hhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccC---CcccHHHHHHHHHHHHhc-CCCCceeeeeeeccCCce
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRD---SGQGDLEFKNEVLLVANL-QHRNLVRLLGFSLEGNER  395 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~  395 (658)
                      ...++|+..++||+|+||.||+++.. +|+.||||++...   .......+.+|..++..+ +||||+++++++.+.+..
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~   99 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL   99 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence            44578999999999999999999854 5889999998754   223345578899999988 699999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ++||||+++|+|..++..   ...+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.
T Consensus       100 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~  173 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE  173 (353)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceee
Confidence            999999999999999843   356999999999999999999999998   99999999999999999999999999985


Q ss_pred             cccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccc
Q 006155          476 FEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNI  555 (658)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  555 (658)
                      .....  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...   ...++.......    .    
T Consensus       174 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~---~~~~~~~~i~~~----~----  240 (353)
T 3txo_A          174 GICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE---NEDDLFEAILND----E----  240 (353)
T ss_dssp             SCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHC----C----
T ss_pred             cccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC---CHHHHHHHHHcC----C----
Confidence            33221  2334568999999999999999999999999999999999999998533   223333333221    1    


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHH
Q 006155          556 IDPTLSSGSITEMIRCIHIGLLCVQENVASRPTM------ASVVL  594 (658)
Q Consensus       556 ~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm------~evv~  594 (658)
                        ..+......   .+.+++..||+.||++||++      .++++
T Consensus       241 --~~~p~~~~~---~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          241 --VVYPTWLHE---DATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             --CCCCTTSCH---HHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             --CCCCCCCCH---HHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence              111111112   24467779999999999998      67764

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=8.6e-40  Score=346.44  Aligned_cols=252  Identities=23%  Similarity=0.319  Sum_probs=187.3

Q ss_pred             hhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ...++|...+.||+|+||.||+++.. +++.||||++....  ....+.+|+.++.+++||||+++++++.+.+..++||
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  127 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL  127 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence            45678999999999999999999865 47789999997643  3456789999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCC---CCCeEEecccccccc
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDA---EMTPKIADFGMARLF  476 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~---~~~~kl~DFGla~~~  476 (658)
                      ||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||+++..
T Consensus       128 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          128 ELVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             CCCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             EeCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            99999999999843   356899999999999999999999988   999999999999975   889999999999865


Q ss_pred             ccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccccc
Q 006155          477 EMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNII  556 (658)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  556 (658)
                      ....   ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....  ...+......    ... ...
T Consensus       202 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~~i~~----~~~-~~~  271 (349)
T 2w4o_A          202 EHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG--DQFMFRRILN----CEY-YFI  271 (349)
T ss_dssp             --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC--HHHHHHHHHT----TCC-CCC
T ss_pred             Cccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc--cHHHHHHHHh----CCC-ccC
Confidence            4322   22346799999999999999999999999999999999999999843221  1112222211    111 111


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          557 DPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       557 dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .+ .......   .+.+++..||+.||++|||+.|+++
T Consensus       272 ~~-~~~~~~~---~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          272 SP-WWDEVSL---NAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             TT-TTTTSCH---HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             Cc-hhhhCCH---HHHHHHHHHccCChhhCcCHHHHhc
Confidence            11 1111122   3456778999999999999999986

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.5e-40  Score=347.12  Aligned_cols=246  Identities=20%  Similarity=0.291  Sum_probs=198.6

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  398 (658)
                      .++|...+.||+|+||.||+|+. .+|+.||||++....   ......+.+|+.+++.++||||+++++++...+..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            46899999999999999999985 568899999986531   22345688999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccccc
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~  478 (658)
                      |||+ +|+|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+..
T Consensus        88 ~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           88 IEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             ECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             EECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            9999 7888888743   356999999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCCccccccccccccccCccccccCCC-CcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccC
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAMHGQY-SVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID  557 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  557 (658)
                      ..   .....+||+.|+|||++.+..+ +.++||||||+++|||++|+.||...........       ...+      .
T Consensus       161 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~-------i~~~------~  224 (336)
T 3h4j_B          161 GN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK-------VNSC------V  224 (336)
T ss_dssp             SB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC-------CCSS------C
T ss_pred             Cc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH-------HHcC------C
Confidence            32   2334579999999999988776 6899999999999999999999864332211100       0000      0


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          558 PTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       558 p~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ..+.....+   .+.+++..||+.||.+|||+.|+++
T Consensus       225 ~~~p~~~s~---~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          225 YVMPDFLSP---GAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             CCCCTTSCH---HHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             CCCcccCCH---HHHHHHHHHcCCChhHCcCHHHHHh
Confidence            111111122   2456778999999999999999974

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-39  Score=340.41  Aligned_cols=244  Identities=23%  Similarity=0.306  Sum_probs=200.6

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  398 (658)
                      .++|+..+.||+|+||.||+++.. +|+.||+|++....   ......+.+|+.++..++||||+++++++.+.+..++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            467899999999999999999854 68899999986542   23445678999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccccc
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~  478 (658)
                      |||+++|+|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        85 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           85 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            999999999999943   356899999999999999999999988   99999999999999999999999999986542


Q ss_pred             CCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCC
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP  558 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp  558 (658)
                           .....+||+.|+|||++.+..++.++||||||+++|||++|+.||...   ...........    +.      .
T Consensus       159 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~~~~i~~----~~------~  220 (318)
T 1fot_A          159 -----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS---NTMKTYEKILN----AE------L  220 (318)
T ss_dssp             -----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHH----CC------C
T ss_pred             -----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC---CHHHHHHHHHh----CC------C
Confidence                 223468999999999999999999999999999999999999998432   22222222222    11      1


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHH
Q 006155          559 TLSSGSITEMIRCIHIGLLCVQENVASRP-----TMASVV  593 (658)
Q Consensus       559 ~l~~~~~~e~~~~~~i~~~Cl~~~p~~RP-----tm~evv  593 (658)
                      .+.....+   .+.+++..|++.||++||     ++.+++
T Consensus       221 ~~p~~~~~---~~~~li~~lL~~dp~~R~~~~~~~~~~i~  257 (318)
T 1fot_A          221 RFPPFFNE---DVKDLLSRLITRDLSQRLGNLQNGTEDVK  257 (318)
T ss_dssp             CCCTTSCH---HHHHHHHHHTCSCTTTCTTSSTTTTHHHH
T ss_pred             CCCCCCCH---HHHHHHHHHhccCHHHcCCCcCCCHHHHh
Confidence            11112122   344667799999999999     888887

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=8e-40  Score=332.99  Aligned_cols=254  Identities=23%  Similarity=0.335  Sum_probs=202.1

Q ss_pred             hccCCcccCcccccCceEEEEeEecCCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeeccC--CceEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEG--NERLL  397 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~l  397 (658)
                      ..++|...+.||+|+||.||+|+. +++.||||++....  ......+.+|+.++.+++||||+++++++.+.  +..++
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL   86 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence            356889999999999999999986 58899999997653  23345689999999999999999999999877  77899


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE  477 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~  477 (658)
                      ||||+++|+|.+++... ....+++..++.++.||++||.|||+.+ ..++||||||+|||++.++.++|+|||++....
T Consensus        87 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           87 ITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EEECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             eecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            99999999999999652 2336899999999999999999999864 349999999999999999999999999875422


Q ss_pred             cCCCccccccccccccccCccccccCCCCc---ccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          478 MDETQGNTSRIVGTYGYMAPEYAMHGQYSV---KSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      .       ....||+.|+|||.+.+..++.   ++||||||+++|||++|+.||....   ..+.......   .+.   
T Consensus       165 ~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~~~~~~---~~~---  228 (271)
T 3kmu_A          165 S-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS---NMEIGMKVAL---EGL---  228 (271)
T ss_dssp             C-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC---HHHHHHHHHH---SCC---
T ss_pred             c-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC---hHHHHHHHHh---cCC---
Confidence            1       2347899999999998765554   8999999999999999999985322   2222222221   111   


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          555 IIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       555 ~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                        .+.+.....++   +.+++..||+.||++|||+.++++.|+..
T Consensus       229 --~~~~~~~~~~~---~~~li~~~l~~~p~~Rps~~~il~~L~~l  268 (271)
T 3kmu_A          229 --RPTIPPGISPH---VSKLMKICMNEDPAKRPKFDMIVPILEKM  268 (271)
T ss_dssp             --CCCCCTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --CCCCCCCCCHH---HHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence              12222222223   45677799999999999999999999864

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.4e-40  Score=344.29  Aligned_cols=271  Identities=23%  Similarity=0.281  Sum_probs=207.5

Q ss_pred             hhhhhhccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeec----c
Q 006155          317 NTIRVATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSL----E  391 (658)
Q Consensus       317 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~----~  391 (658)
                      +.+.+..++|...+.||+|+||.||+++. .+|+.||||++..........+.+|+.++..++||||+++++++.    .
T Consensus        22 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (317)
T 2buj_A           22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA  101 (317)
T ss_dssp             EEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred             cEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence            33445678999999999999999999985 568999999987766566677899999999999999999999986    3


Q ss_pred             CCceEEEEEecCCCChhhhhcCc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecc
Q 006155          392 GNERLLIYEFVPNTSLDHFIFDP-TRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADF  470 (658)
Q Consensus       392 ~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DF  470 (658)
                      ....++||||+++++|.+++... .....+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus       102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~df  178 (317)
T 2buj_A          102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDL  178 (317)
T ss_dssp             EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred             CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEec
Confidence            44778999999999999998542 13457999999999999999999999997   999999999999999999999999


Q ss_pred             ccccccccCCCc-------cccccccccccccCccccccCC---CCcccccccccchHhHHHhCCCCCccCCCCCcchHH
Q 006155          471 GMARLFEMDETQ-------GNTSRIVGTYGYMAPEYAMHGQ---YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL  540 (658)
Q Consensus       471 Gla~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~  540 (658)
                      |++.........       .......||+.|+|||++....   ++.++||||||+++|||++|+.||....... ..+.
T Consensus       179 g~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~  257 (317)
T 2buj_A          179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-DSVA  257 (317)
T ss_dssp             SSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT-SCHH
T ss_pred             CcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc-chhh
Confidence            998765321111       0112346799999999987554   7899999999999999999999985311111 1111


Q ss_pred             HHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCC
Q 006155          541 SSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTL  603 (658)
Q Consensus       541 ~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~~~~  603 (658)
                       .....   ..  ..  |. ......   .+.+++..||+.||.+|||+.+|++.|+....+.
T Consensus       258 -~~~~~---~~--~~--~~-~~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  308 (317)
T 2buj_A          258 -LAVQN---QL--SI--PQ-SPRHSS---ALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA  308 (317)
T ss_dssp             -HHHHC---C----C--CC-CTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred             -HHhhc---cC--CC--Cc-cccCCH---HHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence             11111   00  00  11 111112   3556778999999999999999999999865443

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.7e-40  Score=345.84  Aligned_cols=265  Identities=22%  Similarity=0.211  Sum_probs=201.4

Q ss_pred             chhhhhhhccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccC-----CcccHHHHHHHHHHHHhcCCCCceeeeee
Q 006155          315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRD-----SGQGDLEFKNEVLLVANLQHRNLVRLLGF  388 (658)
Q Consensus       315 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~  388 (658)
                      .-.++....++|...+.||+|+||.||+++. .++..||+|++...     .......+.+|+.++.+++||||++++++
T Consensus        17 q~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~   96 (345)
T 3hko_A           17 QGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEV   96 (345)
T ss_dssp             CCBCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cCchhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehh
Confidence            3345566778999999999999999999985 35778999998653     23445678999999999999999999999


Q ss_pred             eccCCceEEEEEecCCCChhhhhcCcC-------------------------------------CCCCCCHHHHHHHHHH
Q 006155          389 SLEGNERLLIYEFVPNTSLDHFIFDPT-------------------------------------RRAQLDWERRYKIIGG  431 (658)
Q Consensus       389 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~  431 (658)
                      +.+++..++||||+++|+|.+++....                                     ....+++..++.++.|
T Consensus        97 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q  176 (345)
T 3hko_A           97 YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQ  176 (345)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHH
T ss_pred             hccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHH
Confidence            999999999999999999999884210                                     0122467788899999


Q ss_pred             HHHHHHHhhhcCCCcEEEeccCCCceeeCCCC--CeEEeccccccccccCCCc--cccccccccccccCcccccc--CCC
Q 006155          432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM--TPKIADFGMARLFEMDETQ--GNTSRIVGTYGYMAPEYAMH--GQY  505 (658)
Q Consensus       432 ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~--~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~  505 (658)
                      |+.||.|||+.+   |+||||||+|||++.++  .+||+|||+++.+......  .......||+.|+|||++.+  ..+
T Consensus       177 i~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  253 (345)
T 3hko_A          177 IFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY  253 (345)
T ss_dssp             HHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCC
T ss_pred             HHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCC
Confidence            999999999998   99999999999998776  8999999999876432221  12345679999999999875  678


Q ss_pred             CcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCC
Q 006155          506 SVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVAS  585 (658)
Q Consensus       506 s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~  585 (658)
                      +.++||||||+++|||++|+.||....   ..+...........     ...+... ...   ..+.+++..||+.||++
T Consensus       254 ~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~~~~~~~~-----~~~~~~~-~~~---~~~~~li~~~l~~~p~~  321 (345)
T 3hko_A          254 GPKCDAWSAGVLLHLLLMGAVPFPGVN---DADTISQVLNKKLC-----FENPNYN-VLS---PLARDLLSNLLNRNVDE  321 (345)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCC-----TTSGGGG-GSC---HHHHHHHHHHSCSCTTT
T ss_pred             CcHHHHHHHHHHHHHHHHCCCCCCCCC---hHHHHHHHHhcccc-----cCCcccc-cCC---HHHHHHHHHHcCCChhH
Confidence            999999999999999999999984322   22232222221110     0011100 011   23456778999999999


Q ss_pred             CCCHHHHHH
Q 006155          586 RPTMASVVL  594 (658)
Q Consensus       586 RPtm~evv~  594 (658)
                      ||++.++++
T Consensus       322 Rps~~~~l~  330 (345)
T 3hko_A          322 RFDAMRALQ  330 (345)
T ss_dssp             SCCHHHHHH
T ss_pred             CCCHHHHhc
Confidence            999999986

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=6.8e-40  Score=352.43  Aligned_cols=255  Identities=20%  Similarity=0.286  Sum_probs=195.8

Q ss_pred             hhhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCC--cccHHHHHHHHHHHHhcC--CCCceeeeeeeccCCce
Q 006155          320 RVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQ--HRNLVRLLGFSLEGNER  395 (658)
Q Consensus       320 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~  395 (658)
                      ....++|...+.||+|+||.||++...+++.||||++....  ......+.+|+.++.+++  ||||+++++++..++..
T Consensus        52 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~  131 (390)
T 2zmd_A           52 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI  131 (390)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             cccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence            34456799999999999999999998779999999986543  233456899999999996  59999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ++||| +.+++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++ ++.+||+|||+++.
T Consensus       132 ~lv~E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~  203 (390)
T 2zmd_A          132 YMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQ  203 (390)
T ss_dssp             EEEEE-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCC
T ss_pred             EEEEe-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCcccc
Confidence            99999 678999999853   347899999999999999999999987   99999999999996 58999999999987


Q ss_pred             cccCCCccccccccccccccCcccccc-----------CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHH
Q 006155          476 FEMDETQGNTSRIVGTYGYMAPEYAMH-----------GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAW  544 (658)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~  544 (658)
                      +............+||+.|+|||++.+           ..++.++|||||||++|||++|+.||.....  ....+....
T Consensus       204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--~~~~~~~~~  281 (390)
T 2zmd_A          204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLHAII  281 (390)
T ss_dssp             C---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC--HHHHHHHHH
T ss_pred             ccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH--HHHHHHHHh
Confidence            765443333445689999999999865           4689999999999999999999999843211  111111111


Q ss_pred             HhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          545 KNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       545 ~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                         .....     .........   .+.+++..||+.||++|||+.||++.
T Consensus       282 ---~~~~~-----~~~~~~~~~---~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          282 ---DPNHE-----IEFPDIPEK---DLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             ---CTTSC-----CCCCCCSCH---HHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ---Ccccc-----CCCCccchH---HHHHHHHHHcccChhhCCCHHHHhhC
Confidence               11100     111111222   34567789999999999999999853

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.9e-39  Score=331.54  Aligned_cols=253  Identities=24%  Similarity=0.380  Sum_probs=202.6

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      .++|+..+.||+|+||.||+++.. +++.||||++..... .....+.+|+.++..++||||+++++++.+++..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            467889999999999999999864 688999999865432 334678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      |+++++|.+++.   ....+++..++.++.||++||.|||+.+   ++||||||+||+++.++.+||+|||++..+....
T Consensus        86 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            999999999984   3356999999999999999999999988   9999999999999999999999999998765443


Q ss_pred             CccccccccccccccCccccccCCC-CcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCC
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMHGQY-SVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT  559 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~  559 (658)
                      .........||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........ ..  ..+   ......  . +.
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~--~~~---~~~~~~--~-~~  230 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EY--SDW---KEKKTY--L-NP  230 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HH--HHH---HTTCTT--S-TT
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HH--HHh---hhcccc--c-Cc
Confidence            3333445679999999999987775 7899999999999999999999864332211 11  111   111100  0 00


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          560 LSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       560 l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      . ....+   .+.+++..||+.||++|||+.|+++
T Consensus       231 ~-~~~~~---~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          231 W-KKIDS---APLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             G-GGSCH---HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             h-hhcCH---HHHHHHHHHCCCCchhCCCHHHHhc
Confidence            0 01112   3456778999999999999999975

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=351.08  Aligned_cols=272  Identities=21%  Similarity=0.291  Sum_probs=212.5

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCC--ceEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGN--ERLL  397 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~l  397 (658)
                      ..++|...++||+|+||.||+|+.. +|+.||||++..... .....+.+|+.++.+++||||+++++++...+  ..++
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l   86 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence            4578999999999999999999865 488999999976432 34456789999999999999999999987655  6799


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceee----CCCCCeEEeccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLL----DAEMTPKIADFGMA  473 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl----~~~~~~kl~DFGla  473 (658)
                      ||||+++|+|.+++........+++..++.++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            9999999999999976555555999999999999999999999998   9999999999999    77888999999999


Q ss_pred             cccccCCCccccccccccccccCcccccc--------CCCCcccccccccchHhHHHhCCCCCccCCC-CCcchHHHHHH
Q 006155          474 RLFEMDETQGNTSRIVGTYGYMAPEYAMH--------GQYSVKSDVFSFGVLVLEIISGQRNNCFRNG-ETVEDLLSSAW  544 (658)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~ksDV~S~Gvll~elltG~~p~~~~~~-~~~~~l~~~~~  544 (658)
                      +.+....   ......||+.|+|||++.+        ..++.++||||||+++|||++|+.||..... ....+.+....
T Consensus       164 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  240 (396)
T 4eut_A          164 RELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (396)
T ss_dssp             EECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred             eEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence            8765432   2234579999999999865        5678899999999999999999999864332 23333433333


Q ss_pred             HhccCCCccccc---------CCCCCC--C-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          545 KNWREGTTVNII---------DPTLSS--G-SITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       545 ~~~~~~~~~~~~---------dp~l~~--~-~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      .......+..+.         ...+..  . ....-..+..++..||+.||++||++.++++.|+..
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i  307 (396)
T 4eut_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (396)
T ss_dssp             HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence            322211111110         001111  1 334444566888999999999999999999888654

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4.9e-40  Score=347.26  Aligned_cols=250  Identities=25%  Similarity=0.336  Sum_probs=201.0

Q ss_pred             hhhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHhc-CCCCceeeeeeeccCCc
Q 006155          320 RVATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANL-QHRNLVRLLGFSLEGNE  394 (658)
Q Consensus       320 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~  394 (658)
                      ....++|...+.||+|+||.||+++.. +|+.||||++....   ......+..|..++..+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            345688999999999999999999864 58899999997542   23445678899999877 89999999999999999


Q ss_pred             eEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          395 RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      .++||||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        93 ~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~  166 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK  166 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence            9999999999999999843   356999999999999999999999998   9999999999999999999999999998


Q ss_pred             ccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          475 LFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      ......  ......+||+.|+|||++.+..++.++||||||+++|||++|+.||...   +..++......    +.   
T Consensus       167 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~~~~i~~----~~---  234 (345)
T 1xjd_A          167 ENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ---DEEELFHSIRM----DN---  234 (345)
T ss_dssp             CCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHH----CC---
T ss_pred             hcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC---CHHHHHHHHHh----CC---
Confidence            543222  2244578999999999999999999999999999999999999998532   22333332221    11   


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHH-HHH
Q 006155          555 IIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMA-SVV  593 (658)
Q Consensus       555 ~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~-evv  593 (658)
                         +.+......   .+.+++..||+.||++||++. +|.
T Consensus       235 ---~~~p~~~s~---~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          235 ---PFYPRWLEK---EAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             ---CCCCTTSCH---HHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             ---CCCCcccCH---HHHHHHHHHhcCCHhHcCCChHHHH
Confidence               111112122   344677899999999999997 664

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.1e-39  Score=334.60  Aligned_cols=262  Identities=17%  Similarity=0.258  Sum_probs=206.4

Q ss_pred             hccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeee-ccCCceEEEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFS-LEGNERLLIY  399 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~-~~~~~~~lv~  399 (658)
                      ..++|...+.||+|+||.||+|+. .+|+.||||++......  .++.+|+.++..++|++++..+.++ ..++..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            357899999999999999999985 57899999998765432  3588999999999998877766655 5667789999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceee---CCCCCeEEecccccccc
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLL---DAEMTPKIADFGMARLF  476 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl---~~~~~~kl~DFGla~~~  476 (658)
                      ||+ +++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+|||+++.+
T Consensus        85 e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           85 ELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Eec-CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence            999 9999999853  2346999999999999999999999998   9999999999999   48899999999999876


Q ss_pred             ccCCCcc-----ccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCC
Q 006155          477 EMDETQG-----NTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGT  551 (658)
Q Consensus       477 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  551 (658)
                      .......     ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+...........
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence            5443211     12446899999999999999999999999999999999999999976544443333333322111111


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          552 TVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       552 ~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      . ..+    .....   ..+.+++..||+.||++|||+.+|++.|+..
T Consensus       239 ~-~~~----~~~~~---~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  278 (296)
T 3uzp_A          239 I-EVL----CKGYP---SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             H-HHH----TTTSC---HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             h-HHH----HhhCC---HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence            0 000    11111   2355677899999999999999999999864

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=6.3e-40  Score=344.16  Aligned_cols=261  Identities=29%  Similarity=0.448  Sum_probs=203.2

Q ss_pred             hhccCCcccCcccccCceEEEEeEe------cCCcceeEEEeccCC-cccHHHHHHHHHHHHhcCCCCceeeeeeeccCC
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRL------YDGAEIAVKRLSRDS-GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGN  393 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  393 (658)
                      +..++|...+.||+|+||.||+|+.      .++..||||++.... .....++.+|+.++.+++||||+++++++.+..
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  106 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence            4568899999999999999999983      246789999997543 334456889999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhhhhcCcC----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCC---CCCeE
Q 006155          394 ERLLIYEFVPNTSLDHFIFDPT----RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDA---EMTPK  466 (658)
Q Consensus       394 ~~~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~---~~~~k  466 (658)
                      ..++||||+++++|.+++....    ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.   +..+|
T Consensus       107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEE
Confidence            9999999999999999996432    1245899999999999999999999988   999999999999984   45699


Q ss_pred             EeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHH
Q 006155          467 IADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWK  545 (658)
Q Consensus       467 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~  545 (658)
                      |+|||+++...............||+.|+|||++.++.++.++||||||+++|||++ |+.|+...   ...++......
T Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~---~~~~~~~~~~~  260 (327)
T 2yfx_A          184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK---SNQEVLEFVTS  260 (327)
T ss_dssp             ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC---CHHHHHHHHHT
T ss_pred             ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc---CHHHHHHHHhc
Confidence            999999986654433333344678999999999999999999999999999999998 88887432   22233322222


Q ss_pred             hccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          546 NWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       546 ~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                          +..     +........   .+.+++..||+.||.+||++.+|++.|...
T Consensus       261 ----~~~-----~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          261 ----GGR-----MDPPKNCPG---PVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             ----TCC-----CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCC-----CCCCCCCCH---HHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence                111     111112222   345677899999999999999999999754

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=8.7e-40  Score=344.86  Aligned_cols=266  Identities=25%  Similarity=0.312  Sum_probs=206.0

Q ss_pred             hhhhhhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHh--cCCCCceeeeeeeccCC-
Q 006155          317 NTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVAN--LQHRNLVRLLGFSLEGN-  393 (658)
Q Consensus       317 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~-  393 (658)
                      ...+...++|...+.||+|+||.||+|+. +|+.||||++...   ....+.+|++++..  ++||||+++++++.... 
T Consensus        35 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~  110 (342)
T 1b6c_B           35 LVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNG  110 (342)
T ss_dssp             HHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred             eecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence            33455678999999999999999999986 6899999998643   34567888888887  78999999999998776 


Q ss_pred             ---ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhh--------hcCCCcEEEeccCCCceeeCCC
Q 006155          394 ---ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH--------EDSRLRIIHRDLKTSNVLLDAE  462 (658)
Q Consensus       394 ---~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivHrDlk~~NILl~~~  462 (658)
                         ..++||||+++|+|.+++..    ..+++..++.++.||+.||.|||        +.+   |+||||||+|||++.+
T Consensus       111 ~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~  183 (342)
T 1b6c_B          111 TWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKN  183 (342)
T ss_dssp             SCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTT
T ss_pred             ccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCC
Confidence               78999999999999999943    46899999999999999999999        555   9999999999999999


Q ss_pred             CCeEEeccccccccccCCCcc--ccccccccccccCccccccC------CCCcccccccccchHhHHHhC----------
Q 006155          463 MTPKIADFGMARLFEMDETQG--NTSRIVGTYGYMAPEYAMHG------QYSVKSDVFSFGVLVLEIISG----------  524 (658)
Q Consensus       463 ~~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~ksDV~S~Gvll~elltG----------  524 (658)
                      +.+||+|||+++.........  ......||+.|+|||++.+.      .++.++||||||+++|||++|          
T Consensus       184 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~  263 (342)
T 1b6c_B          184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY  263 (342)
T ss_dssp             SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccc
Confidence            999999999998765433211  23345799999999998776      344789999999999999999          


Q ss_pred             CCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCC--CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          525 QRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSG--SITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       525 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~--~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      +.||........  ............    ...+.+...  ..+....+.+++..||+.||++|||+.+|++.|+.+
T Consensus       264 ~~p~~~~~~~~~--~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i  334 (342)
T 1b6c_B          264 QLPYYDLVPSDP--SVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  334 (342)
T ss_dssp             CCTTTTTSCSSC--CHHHHHHHHTTS----CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccCccccCcCcc--cHHHHHHHHHHH----HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence            556643222111  111111111111    112222221  234445677888999999999999999999999864

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.5e-39  Score=346.23  Aligned_cols=252  Identities=24%  Similarity=0.332  Sum_probs=191.5

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      ..++|...+.||+|+||.||+++.. +++.||||++..... ....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence            4578999999999999999999865 688999999976533 34568899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCC--eEEecccccccccc
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMT--PKIADFGMARLFEM  478 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~--~kl~DFGla~~~~~  478 (658)
                      |+++|+|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.  +||+|||+++....
T Consensus        97 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~  170 (361)
T 3uc3_A           97 YASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  170 (361)
T ss_dssp             CCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred             eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence            9999999999843   346999999999999999999999988   999999999999987765  99999999974332


Q ss_pred             CCCccccccccccccccCccccccCCCCcc-cccccccchHhHHHhCCCCCccCCCCC-cchHHHHHHHhccCCCccccc
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAMHGQYSVK-SDVFSFGVLVLEIISGQRNNCFRNGET-VEDLLSSAWKNWREGTTVNII  556 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k-sDV~S~Gvll~elltG~~p~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~  556 (658)
                      .   .......||+.|+|||++.+..++.+ +||||||+++|||++|+.||....... ....+.....    ... .. 
T Consensus       171 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~----~~~-~~-  241 (361)
T 3uc3_A          171 H---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS----VKY-SI-  241 (361)
T ss_dssp             -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHT----TCC-CC-
T ss_pred             c---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhc----CCC-CC-
Confidence            2   12234579999999999988888766 899999999999999999986433221 1222221111    110 00 


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          557 DPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       557 dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                       |.. .....   .+.+++.+||+.||++|||+.|+++
T Consensus       242 -~~~-~~~s~---~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          242 -PDD-IRISP---ECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             -CTT-SCCCH---HHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             -CCc-CCCCH---HHHHHHHHHccCChhHCcCHHHHHh
Confidence             000 01112   3456778999999999999999985

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-39  Score=334.34  Aligned_cols=256  Identities=27%  Similarity=0.335  Sum_probs=201.9

Q ss_pred             CCcccCcccccCceEEEEeEecC-C---cceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCce-EEE
Q 006155          325 NFSDANKLGQGGFGAVYKGRLYD-G---AEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNER-LLI  398 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~~-g---~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~-~lv  398 (658)
                      .|...++||+|+||+||+|+..+ +   ..+|+|++..... .....+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            45667899999999999998543 2   2699999976443 3345688999999999999999999999876665 999


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccccc
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~  478 (658)
                      |||+.+++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            999999999999954  3456899999999999999999999998   99999999999999999999999999986644


Q ss_pred             CCC--ccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccccc
Q 006155          479 DET--QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNII  556 (658)
Q Consensus       479 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  556 (658)
                      ...  ........+|+.|+|||.+.+..++.++||||||+++|||++|..|+..  .....++.........        
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~--~~~~~~~~~~~~~~~~--------  246 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYR--HIDPFDLTHFLAQGRR--------  246 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTT--TSCGGGHHHHHHTTCC--------
T ss_pred             CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCc--cCCHHHHHHHhhcCCC--------
Confidence            321  2233345789999999999999999999999999999999997766522  2222333333222211        


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          557 DPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       557 dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                       +.......+   .+.+++..||+.||.+|||+.+++++|+..
T Consensus       247 -~~~~~~~~~---~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  285 (298)
T 3pls_A          247 -LPQPEYCPD---SLYQVMQQCWEADPAVRPTFRVLVGEVEQI  285 (298)
T ss_dssp             -CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CCCCccchH---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence             111111122   355677899999999999999999999865

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.6e-39  Score=341.29  Aligned_cols=249  Identities=24%  Similarity=0.300  Sum_probs=192.9

Q ss_pred             hccCCcccCcccccCceEEEEeEe----cCCcceeEEEeccCC----cccHHHHHHHHHHHHhcCCCCceeeeeeeccCC
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRL----YDGAEIAVKRLSRDS----GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGN  393 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  393 (658)
                      ..++|...+.||+|+||.||+++.    .+|+.||||++....    ......+.+|+.++.+++||||+++++++..++
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   94 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG   94 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence            457899999999999999999986    468899999997642    223345788999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccc
Q 006155          394 ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMA  473 (658)
Q Consensus       394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla  473 (658)
                      ..++||||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~  168 (327)
T 3a62_A           95 KLYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLC  168 (327)
T ss_dssp             CEEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred             EEEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcc
Confidence            99999999999999999843   356899999999999999999999998   999999999999999999999999999


Q ss_pred             cccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcc
Q 006155          474 RLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTV  553 (658)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  553 (658)
                      +......  .......||+.|+|||++.+..++.++||||||+++|||++|+.||...   .....+......    .  
T Consensus       169 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~---~~~~~~~~i~~~----~--  237 (327)
T 3a62_A          169 KESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE---NRKKTIDKILKC----K--  237 (327)
T ss_dssp             ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHT----C--
T ss_pred             cccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC---CHHHHHHHHHhC----C--
Confidence            7543222  1233467999999999999999999999999999999999999998532   222333332221    1  


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 006155          554 NIIDPTLSSGSITEMIRCIHIGLLCVQENVASRP-----TMASVVL  594 (658)
Q Consensus       554 ~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RP-----tm~evv~  594 (658)
                          ..+......   .+.+++..||+.||++||     ++.|+++
T Consensus       238 ----~~~p~~~~~---~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          238 ----LNLPPYLTQ---EARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             ----CCCCTTSCH---HHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             ----CCCCCCCCH---HHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                111111122   345677799999999999     7778774

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.7e-39  Score=338.90  Aligned_cols=261  Identities=23%  Similarity=0.310  Sum_probs=196.5

Q ss_pred             ccCCccc-CcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhc-CCCCceeeeeeeccCCceEEEE
Q 006155          323 TDNFSDA-NKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANL-QHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       323 ~~~~~~~-~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      .+.|.+. +.||+|+||.||+++. .+++.||||++..........+.+|+.++.++ +||||+++++++.+++..++||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            4677774 7899999999999984 46889999999877666677899999999985 7999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCC---eEEecccccccc
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMT---PKIADFGMARLF  476 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~---~kl~DFGla~~~  476 (658)
                      ||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.   +||+|||+++.+
T Consensus        91 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           91 EKMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             EcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            99999999999853   356899999999999999999999998   999999999999998776   999999999765


Q ss_pred             ccCCC-----ccccccccccccccCcccccc-----CCCCcccccccccchHhHHHhCCCCCccCCCCCcc--------h
Q 006155          477 EMDET-----QGNTSRIVGTYGYMAPEYAMH-----GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVE--------D  538 (658)
Q Consensus       477 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~--------~  538 (658)
                      .....     ........||+.|+|||++.+     ..++.++||||||+++|||++|+.||......+..        .
T Consensus       165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  244 (316)
T 2ac3_A          165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA  244 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred             ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence            43211     112223569999999999875     56889999999999999999999998654322100        0


Q ss_pred             HHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          539 LLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       539 l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ...........+.. ...++.. ....   ..+.+++.+||+.||++|||+.|+++
T Consensus       245 ~~~~~~~~i~~~~~-~~~~~~~-~~~~---~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          245 CQNMLFESIQEGKY-EFPDKDW-AHIS---CAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHHHHCCC-CCCHHHH-TTSC---HHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHhccCc-ccCchhc-ccCC---HHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            00111111111111 0000000 0011   23557888999999999999999986

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.8e-39  Score=349.10  Aligned_cols=206  Identities=18%  Similarity=0.252  Sum_probs=177.0

Q ss_pred             hhccCCcccCccccc--CceEEEEeEec-CCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCce
Q 006155          321 VATDNFSDANKLGQG--GFGAVYKGRLY-DGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNER  395 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G--~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  395 (658)
                      ...++|+..++||+|  +||.||+++.. +|+.||||++....  ......+.+|+.+++.++||||+++++++.+++..
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  101 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL  101 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence            345789999999999  99999999865 68999999997653  22335678899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ++||||+++|+|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus       102 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~  177 (389)
T 3gni_B          102 WVVTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLS  177 (389)
T ss_dssp             EEEEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccccccee
Confidence            9999999999999998542 2346999999999999999999999998   99999999999999999999999999865


Q ss_pred             cccCCC-----ccccccccccccccCcccccc--CCCCcccccccccchHhHHHhCCCCCcc
Q 006155          476 FEMDET-----QGNTSRIVGTYGYMAPEYAMH--GQYSVKSDVFSFGVLVLEIISGQRNNCF  530 (658)
Q Consensus       476 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~S~Gvll~elltG~~p~~~  530 (658)
                      ......     ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||..
T Consensus       178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  239 (389)
T 3gni_B          178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD  239 (389)
T ss_dssp             CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            432211     112233578999999999987  6799999999999999999999999854

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.1e-39  Score=337.33  Aligned_cols=263  Identities=22%  Similarity=0.299  Sum_probs=195.4

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcc--cHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQ--GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      ++|...++||+|+||+||+++.. +|+.||||++......  ....+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            67889999999999999999864 4889999998665332  23457899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      |+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+....
T Consensus        83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            9999999998743   356899999999999999999999998   9999999999999999999999999998765332


Q ss_pred             CccccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHH--------HhccCCC
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAW--------KNWREGT  551 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~--------~~~~~~~  551 (658)
                      .  ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+....        ..+....
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (311)
T 4agu_A          157 D--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ  234 (311)
T ss_dssp             -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred             c--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence            2  2234578999999999876 678999999999999999999999985433221111111110        0001010


Q ss_pred             c---ccccCCCCCCCC----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          552 T---VNIIDPTLSSGS----ITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       552 ~---~~~~dp~l~~~~----~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .   ..+.++......    ...-..+.+++..||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0   011111110000    001123567888999999999999999984

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=4.2e-40  Score=345.32  Aligned_cols=248  Identities=22%  Similarity=0.265  Sum_probs=176.3

Q ss_pred             cCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcC-CCCceeeeeeeccCCceEEEEEecCCCC
Q 006155          329 ANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQ-HRNLVRLLGFSLEGNERLLIYEFVPNTS  406 (658)
Q Consensus       329 ~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~gs  406 (658)
                      .+.||+|+||.||+++.. +|+.||||++...   ....+.+|+.++..++ ||||+++++++.++...++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            378999999999999864 5889999998643   3456789999999997 9999999999999999999999999999


Q ss_pred             hhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCC---CeEEeccccccccccCCCcc
Q 006155          407 LDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM---TPKIADFGMARLFEMDETQG  483 (658)
Q Consensus       407 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~---~~kl~DFGla~~~~~~~~~~  483 (658)
                      |.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++   .+||+|||+++.......  
T Consensus        93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--  164 (325)
T 3kn6_A           93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--  164 (325)
T ss_dssp             HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred             HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--
Confidence            9999953   456999999999999999999999988   99999999999997665   899999999986543322  


Q ss_pred             ccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCC
Q 006155          484 NTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSG  563 (658)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~  563 (658)
                      ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....................+...      ....
T Consensus       165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~------~~~~  238 (325)
T 3kn6_A          165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS------FEGE  238 (325)
T ss_dssp             -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC------CCSH
T ss_pred             cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC------CCcc
Confidence            2334578999999999999999999999999999999999999996443321111111222222222110      0000


Q ss_pred             C-HHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 006155          564 S-ITEMIRCIHIGLLCVQENVASRPTMASVV  593 (658)
Q Consensus       564 ~-~~e~~~~~~i~~~Cl~~~p~~RPtm~evv  593 (658)
                      . ...-..+.+++..||+.||++|||+.|++
T Consensus       239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell  269 (325)
T 3kn6_A          239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR  269 (325)
T ss_dssp             HHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred             cccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence            0 00012355778899999999999999987

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.7e-39  Score=333.69  Aligned_cols=262  Identities=17%  Similarity=0.254  Sum_probs=202.6

Q ss_pred             hccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeee-ccCCceEEEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFS-LEGNERLLIY  399 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~-~~~~~~~lv~  399 (658)
                      ..++|...+.||+|+||.||+|+. .+++.||||++......  ..+.+|+.++..++|++++..++.+ ..++..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            457899999999999999999985 56889999987654322  3478899999999988877777665 5677789999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceee---CCCCCeEEecccccccc
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLL---DAEMTPKIADFGMARLF  476 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl---~~~~~~kl~DFGla~~~  476 (658)
                      ||+ +++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+|||+++.+
T Consensus        85 e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           85 ELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Ecc-CCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            999 9999999853  2346999999999999999999999998   9999999999999   78899999999999876


Q ss_pred             ccCCCc-----cccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCC
Q 006155          477 EMDETQ-----GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGT  551 (658)
Q Consensus       477 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  551 (658)
                      ......     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+...........
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence            544321     123356899999999999999999999999999999999999999976554444444333322211111


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          552 TVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       552 ~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      . ..+.    ....   ..+.+++..||+.||++|||+.+|++.|+..
T Consensus       239 ~-~~~~----~~~~---~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~  278 (296)
T 4hgt_A          239 I-EVLC----KGYP---SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             H-HHHT----TTSC---HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             h-hhhh----ccCC---HHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence            0 0000    1111   2355777899999999999999999999764

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.2e-39  Score=335.73  Aligned_cols=263  Identities=25%  Similarity=0.381  Sum_probs=196.9

Q ss_pred             hhccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCC-----cccHHHHHHHHHHHHhcC---CCCceeeeeeecc
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDS-----GQGDLEFKNEVLLVANLQ---HRNLVRLLGFSLE  391 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~  391 (658)
                      ...++|+..++||+|+||+||+++. .+|+.||||++....     ......+.+|+.+++.++   ||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            3467999999999999999999984 468899999986432     122345677888777765   9999999999877


Q ss_pred             CC-----ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeE
Q 006155          392 GN-----ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPK  466 (658)
Q Consensus       392 ~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~k  466 (658)
                      ..     ..++||||+. ++|.+++.... ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+|
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k  160 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK  160 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence            55     4789999997 59999985432 234999999999999999999999998   99999999999999999999


Q ss_pred             EeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHh
Q 006155          467 IADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKN  546 (658)
Q Consensus       467 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~  546 (658)
                      |+|||+++.+....   ......||+.|+|||++.+..++.++||||||+++|||++|+.||....   ..+.+......
T Consensus       161 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---~~~~~~~i~~~  234 (308)
T 3g33_A          161 LADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS---EADQLGKIFDL  234 (308)
T ss_dssp             ECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS---HHHHHHHHHHH
T ss_pred             EeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHH
Confidence            99999998664322   2344689999999999999999999999999999999999999985432   22333333222


Q ss_pred             ccCCCcccc---c------CCCCCCCCHHH-----HHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          547 WREGTTVNI---I------DPTLSSGSITE-----MIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       547 ~~~~~~~~~---~------dp~l~~~~~~e-----~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ........+   .      -+.........     -..+.+++..||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            111100000   0      00000001111     124557788999999999999999984

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.1e-39  Score=331.64  Aligned_cols=251  Identities=19%  Similarity=0.244  Sum_probs=202.0

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      ..++|...++||+|+||.||+|+.. ++..||+|++..........+.+|+.++.+++||||+++++++.+++..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            3567999999999999999999854 467899999987766677789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceee---CCCCCeEEeccccccccc
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLL---DAEMTPKIADFGMARLFE  477 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl---~~~~~~kl~DFGla~~~~  477 (658)
                      |+++++|.+++..   ...+++..++.++.|++.||.|||+.+   |+||||||+|||+   +.++.+||+|||++..+.
T Consensus        87 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           87 LCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             CCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             ccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            9999999998843   356899999999999999999999998   9999999999999   788999999999998765


Q ss_pred             cCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccC
Q 006155          478 MDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID  557 (658)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  557 (658)
                      ...   ......||+.|+|||++.+ .++.++||||||+++|||++|+.||....   ..+..........  ...... 
T Consensus       161 ~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~--~~~~~~-  230 (277)
T 3f3z_A          161 PGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPT---DSEVMLKIREGTF--TFPEKD-  230 (277)
T ss_dssp             TTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCC--CCCHHH-
T ss_pred             Ccc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCCC--CCCchh-
Confidence            432   2234579999999998765 49999999999999999999999985322   2222222211100  000000 


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          558 PTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       558 p~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                        . ....   ..+.+++..||+.||++|||+.++++
T Consensus       231 --~-~~~~---~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          231 --W-LNVS---PQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             --H-TTSC---HHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             --h-hcCC---HHHHHHHHHHccCChhhCcCHHHHhc
Confidence              0 0011   23557778999999999999999974

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=7.3e-40  Score=335.83  Aligned_cols=250  Identities=25%  Similarity=0.406  Sum_probs=202.4

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeecc---------
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLE---------  391 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~---------  391 (658)
                      ..++|+..+.||+|+||.||+++.. +|+.||||++....    ..+.+|+.++.+++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            4567899999999999999999865 68999999997543    246789999999999999999998754         


Q ss_pred             -------CCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCC
Q 006155          392 -------GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMT  464 (658)
Q Consensus       392 -------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~  464 (658)
                             ....++||||+++++|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence                   34578999999999999999542 2356999999999999999999999988   999999999999999999


Q ss_pred             eEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHH
Q 006155          465 PKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAW  544 (658)
Q Consensus       465 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~  544 (658)
                      +||+|||++..+....   ......||+.|+|||++.+..++.++||||||+++|||++|..|+...         ...+
T Consensus       161 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---------~~~~  228 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---------SKFF  228 (284)
T ss_dssp             EEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---------HHHH
T ss_pred             EEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---------HHHH
Confidence            9999999998765432   223357899999999999999999999999999999999999876210         1112


Q ss_pred             HhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCC
Q 006155          545 KNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLT  602 (658)
Q Consensus       545 ~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~~~  602 (658)
                      .....+...        .....   .+.+++..||+.||++|||+.|+++.|......
T Consensus       229 ~~~~~~~~~--------~~~~~---~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~  275 (284)
T 2a19_B          229 TDLRDGIIS--------DIFDK---KEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS  275 (284)
T ss_dssp             HHHHTTCCC--------TTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred             HHhhccccc--------ccCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence            222222211        11112   244677899999999999999999999876443

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8e-40  Score=349.58  Aligned_cols=257  Identities=26%  Similarity=0.395  Sum_probs=191.6

Q ss_pred             cCCcccCcccccCceEEEEeEecC----CcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeecc-CCceEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLYD----GAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLE-GNERLL  397 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~l  397 (658)
                      ..|...+.||+|+||.||+|+..+    +..||||.+..... .....+.+|+.++.+++||||+++++++.+ ++..++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            356777899999999999998543    23589999876433 344678999999999999999999998754 457899


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE  477 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~  477 (658)
                      ||||+++|+|.+++..  ....+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       169 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EEECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence            9999999999999954  3356899999999999999999999998   9999999999999999999999999998664


Q ss_pred             cCCCc--cccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          478 MDETQ--GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       478 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      .....  .......+|+.|+|||++.+..++.++||||||+++|||++ |..|+.....   .+........    ..  
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~---~~~~~~~~~~----~~--  314 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITVYLLQG----RR--  314 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS---SCHHHHHHTT----CC--
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH---HHHHHHHHcC----CC--
Confidence            33221  12234567889999999999999999999999999999999 5556643322   2232222221    11  


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 006155          555 IIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYS  600 (658)
Q Consensus       555 ~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~  600 (658)
                      ...|   ....+   .+.+++..||+.||++|||+.+|++.|+...
T Consensus       315 ~~~p---~~~~~---~l~~li~~cl~~dp~~RPs~~ell~~L~~i~  354 (373)
T 3c1x_A          315 LLQP---EYCPD---PLYEVMLKCWHPKAEMRPSFSELVSRISAIF  354 (373)
T ss_dssp             CCCC---TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCC---CCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1111   11222   3456778999999999999999999998753

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.5e-40  Score=344.80  Aligned_cols=258  Identities=24%  Similarity=0.371  Sum_probs=192.6

Q ss_pred             hccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCccc---HHHHHHHHHHHHhcCCCCceeeeeeeccCCce--
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQG---DLEFKNEVLLVANLQHRNLVRLLGFSLEGNER--  395 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~--  395 (658)
                      ..++|+..+.||+|+||.||+++. .+++.||||++.......   ...+.+|+.++.+++||||+++++++......  
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            457899999999999999999984 568899999997653332   34688999999999999999999998765543  


Q ss_pred             --EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccc
Q 006155          396 --LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMA  473 (658)
Q Consensus       396 --~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla  473 (658)
                        ++||||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA  163 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred             ccEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence              999999999999999853   346999999999999999999999988   999999999999999999999999999


Q ss_pred             cccccCCCc-cccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCc
Q 006155          474 RLFEMDETQ-GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTT  552 (658)
Q Consensus       474 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  552 (658)
                      +.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....   ..+..   +........
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~---~~~~~---~~~~~~~~~  237 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS---PVSVA---YQHVREDPI  237 (311)
T ss_dssp             ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHH---HHHHHCCCC
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC---hHHHH---HHHhcCCCC
Confidence            876543221 22334679999999999999999999999999999999999999984322   12221   111111111


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH-HHhc
Q 006155          553 VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVV-LMLN  597 (658)
Q Consensus       553 ~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv-~~L~  597 (658)
                      ....   ......   ..+.+++..||+.||++||+..+++ ..|.
T Consensus       238 ~~~~---~~~~~~---~~l~~li~~~l~~dP~~R~~~~~~l~~~l~  277 (311)
T 3ork_A          238 PPSA---RHEGLS---ADLDAVVLKALAKNPENRYQTAAEMRADLV  277 (311)
T ss_dssp             CHHH---HSTTCC---HHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             Cccc---ccCCCC---HHHHHHHHHHHhcCHhhChhhHHHHHHHHH
Confidence            1000   001111   2345677899999999999766655 4443

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.4e-39  Score=335.61  Aligned_cols=258  Identities=27%  Similarity=0.403  Sum_probs=201.4

Q ss_pred             hhhccCCcccC-cccccCceEEEEeEe---cCCcceeEEEeccCCcc--cHHHHHHHHHHHHhcCCCCceeeeeeeccCC
Q 006155          320 RVATDNFSDAN-KLGQGGFGAVYKGRL---YDGAEIAVKRLSRDSGQ--GDLEFKNEVLLVANLQHRNLVRLLGFSLEGN  393 (658)
Q Consensus       320 ~~~~~~~~~~~-~lG~G~fg~Vy~~~~---~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  393 (658)
                      ....++|...+ .||+|+||.||+|..   ..++.||||++......  ...++.+|+.++..++||||+++++++ ..+
T Consensus        12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~   90 (291)
T 1xbb_A           12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE   90 (291)
T ss_dssp             BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred             eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence            34457788887 999999999999953   24678999999765322  245789999999999999999999999 567


Q ss_pred             ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccc
Q 006155          394 ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMA  473 (658)
Q Consensus       394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla  473 (658)
                      ..++||||+++++|.+++..   ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        91 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~  164 (291)
T 1xbb_A           91 SWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLS  164 (291)
T ss_dssp             SEEEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             CcEEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcc
Confidence            78999999999999999953   346999999999999999999999998   999999999999999999999999999


Q ss_pred             cccccCCCc-cccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCC
Q 006155          474 RLFEMDETQ-GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGT  551 (658)
Q Consensus       474 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~  551 (658)
                      +.+...... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+....   ..++.....    .+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~~~----~~~  237 (291)
T 1xbb_A          165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK---GSEVTAMLE----KGE  237 (291)
T ss_dssp             EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHHHH----TTC
T ss_pred             eeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHH----cCC
Confidence            876543322 12223456789999999999899999999999999999999 999985322   222222221    111


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          552 TVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       552 ~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      .     +.......+   .+.+++..||+.||++||++.+|++.|+..
T Consensus       238 ~-----~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  277 (291)
T 1xbb_A          238 R-----MGCPAGCPR---EMYDLMNLCWTYDVENRPGFAAVELRLRNY  277 (291)
T ss_dssp             C-----CCCCTTCCH---HHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             C-----CCCCCCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1     111112222   345677899999999999999999999764

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.6e-39  Score=342.66  Aligned_cols=245  Identities=21%  Similarity=0.245  Sum_probs=201.6

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  398 (658)
                      .++|...+.||+|+||.||+++.. +|+.||||++....   ......+.+|+.++..++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            478999999999999999999854 58899999986542   23445688999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccccc
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~  478 (658)
                      |||+++|+|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       120 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence            999999999999843   346899999999999999999999988   99999999999999999999999999986543


Q ss_pred             CCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCC
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP  558 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp  558 (658)
                      .     ....+||+.|+|||++.+..++.++||||||+++|||++|+.||...   ...++......    +.      .
T Consensus       194 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~~~~i~~----~~------~  255 (350)
T 1rdq_E          194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD---QPIQIYEKIVS----GK------V  255 (350)
T ss_dssp             C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHH----CC------C
T ss_pred             C-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC---CHHHHHHHHHc----CC------C
Confidence            2     23468999999999999999999999999999999999999998532   22233222222    11      1


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 006155          559 TLSSGSITEMIRCIHIGLLCVQENVASRPT-----MASVVL  594 (658)
Q Consensus       559 ~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPt-----m~evv~  594 (658)
                      .+......   .+.+++..||+.||++||+     +.+|++
T Consensus       256 ~~p~~~~~---~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          256 RFPSHFSS---DLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CCCTTCCH---HHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCCCCH---HHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            11112122   3456778999999999998     888874

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.6e-40  Score=346.57  Aligned_cols=267  Identities=24%  Similarity=0.260  Sum_probs=192.9

Q ss_pred             hhhhhhhccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhcC-CCCceeeeeeec---
Q 006155          316 FNTIRVATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQ-HRNLVRLLGFSL---  390 (658)
Q Consensus       316 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~---  390 (658)
                      ...+.....+|...++||+|+||.||+++. .+|+.||||++..........+.+|+.++.++. ||||+++++++.   
T Consensus        20 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~   99 (337)
T 3ll6_A           20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK   99 (337)
T ss_dssp             TCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred             cceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence            345566678999999999999999999985 368899999997766666677899999999996 999999999983   


Q ss_pred             -----cCCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCe
Q 006155          391 -----EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP  465 (658)
Q Consensus       391 -----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~  465 (658)
                           .....++||||+. |+|.+++........+++..++.++.||+.||.|||+.+ ++|+||||||+|||++.++.+
T Consensus       100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~  177 (337)
T 3ll6_A          100 EESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTI  177 (337)
T ss_dssp             TTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCE
T ss_pred             cccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCE
Confidence                 3345789999996 789888855444567999999999999999999999874 349999999999999999999


Q ss_pred             EEeccccccccccCCCcc----------ccccccccccccCcccc---ccCCCCcccccccccchHhHHHhCCCCCccCC
Q 006155          466 KIADFGMARLFEMDETQG----------NTSRIVGTYGYMAPEYA---MHGQYSVKSDVFSFGVLVLEIISGQRNNCFRN  532 (658)
Q Consensus       466 kl~DFGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~  532 (658)
                      ||+|||+++.+.......          ......||+.|+|||++   .+..++.++||||||+++|||++|+.||....
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  257 (337)
T 3ll6_A          178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA  257 (337)
T ss_dssp             EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence            999999998765432211          11235689999999998   56778999999999999999999999984322


Q ss_pred             CCCcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCC
Q 006155          533 GETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLT  602 (658)
Q Consensus       533 ~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~~~  602 (658)
                      ..   ....   ..+.         .........   .+.+++..||+.||++|||+.|+++.|+.....
T Consensus       258 ~~---~~~~---~~~~---------~~~~~~~~~---~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~  309 (337)
T 3ll6_A          258 KL---RIVN---GKYS---------IPPHDTQYT---VFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA  309 (337)
T ss_dssp             --------------CC---------CCTTCCSSG---GGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HH---Hhhc---Cccc---------CCcccccch---HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            11   1110   0000         000011111   244677899999999999999999999875443

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1e-39  Score=345.54  Aligned_cols=246  Identities=29%  Similarity=0.418  Sum_probs=196.7

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcc---cHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQ---GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  398 (658)
                      .+.|...+.||+|+||.||+|+. .+|+.||||++......   ...++.+|+.++.+++||||+++++++.+++..++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            35688889999999999999984 57889999999754332   234688999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccccc
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~  478 (658)
                      |||++ |+|.+++..  ....+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       133 ~e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          133 MEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             EECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            99997 677777743  2356999999999999999999999998   99999999999999999999999999986543


Q ss_pred             CCCccccccccccccccCccccc---cCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccc
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAM---HGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNI  555 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  555 (658)
                      .      ....||+.|+|||++.   .+.++.++||||||+++|||++|+.|+....   ....+.....   ..     
T Consensus       207 ~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~---~~~~~~~~~~---~~-----  269 (348)
T 1u5q_A          207 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSALYHIAQ---NE-----  269 (348)
T ss_dssp             B------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHH---SC-----
T ss_pred             C------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHh---cC-----
Confidence            2      2357999999999984   5779999999999999999999999984322   1122211111   11     


Q ss_pred             cCCCCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          556 IDPTLSSG-SITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       556 ~dp~l~~~-~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                       .+.+... ..++   +.+++..||+.||++|||+.++++.
T Consensus       270 -~~~~~~~~~~~~---l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          270 -SPALQSGHWSEY---FRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             -CCCCCCTTSCHH---HHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             -CCCCCCCCCCHH---HHHHHHHHcccChhhCcCHHHHhhC
Confidence             1111111 2222   4467789999999999999999853

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3e-39  Score=341.57  Aligned_cols=250  Identities=23%  Similarity=0.262  Sum_probs=196.5

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc---ccHHHHHHHHHHHHhc-CCCCceeeeeeeccCCceEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG---QGDLEFKNEVLLVANL-QHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l  397 (658)
                      .++|...+.||+|+||.||+++.. +|+.||||++.....   .....+.+|..++.++ +||||+++++++.+.+..++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            467899999999999999999865 588899999976532   2234578899999988 89999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE  477 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~  477 (658)
                      ||||+++|+|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++++||+|||+++...
T Consensus        88 v~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  161 (345)
T ss_dssp             EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred             EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence            9999999999999843   356999999999999999999999998   9999999999999999999999999998533


Q ss_pred             cCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcc--hHHHHHHHhccCCCcccc
Q 006155          478 MDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVE--DLLSSAWKNWREGTTVNI  555 (658)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~--~l~~~~~~~~~~~~~~~~  555 (658)
                      ...  ......+||+.|+|||++.+..++.++||||||+++|||++|+.||.........  ............+.    
T Consensus       162 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~----  235 (345)
T 3a8x_A          162 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----  235 (345)
T ss_dssp             CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC----
T ss_pred             CCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC----
Confidence            221  2234568999999999999999999999999999999999999999542221100  11111111111111    


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 006155          556 IDPTLSSGSITEMIRCIHIGLLCVQENVASRPTM  589 (658)
Q Consensus       556 ~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm  589 (658)
                        ..+......   .+.+++..||+.||++||++
T Consensus       236 --~~~p~~~s~---~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          236 --IRIPRSLSV---KAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             --CCCCTTSCH---HHHHHHHHHTCSSTTTSTTC
T ss_pred             --CCCCCCCCH---HHHHHHHHHhcCCHhHCCCC
Confidence              111112122   34567779999999999995

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.5e-39  Score=333.52  Aligned_cols=258  Identities=24%  Similarity=0.380  Sum_probs=201.8

Q ss_pred             hhhccCCcccCcccccCceEEEEeEecC----CcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCc
Q 006155          320 RVATDNFSDANKLGQGGFGAVYKGRLYD----GAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNE  394 (658)
Q Consensus       320 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  394 (658)
                      ....++|...+.||+|+||.||+|+..+    +..||||.+..... .....+.+|+.++.+++||||+++++++.+ +.
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~   86 (281)
T 3cc6_A            8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EP   86 (281)
T ss_dssp             SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SS
T ss_pred             eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CC
Confidence            3456889999999999999999998543    23599999876532 344568999999999999999999999865 45


Q ss_pred             eEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          395 RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      .++||||+++++|.+++..  ....+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        87 ~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  161 (281)
T 3cc6_A           87 TWIIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSR  161 (281)
T ss_dssp             CEEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred             CEEEEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCc
Confidence            6899999999999999953  2346899999999999999999999988   9999999999999999999999999998


Q ss_pred             ccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcc
Q 006155          475 LFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTV  553 (658)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  553 (658)
                      ....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.....   .+..........     
T Consensus       162 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~---~~~~~~~~~~~~-----  232 (281)
T 3cc6_A          162 YIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN---KDVIGVLEKGDR-----  232 (281)
T ss_dssp             CC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG---GGHHHHHHHTCC-----
T ss_pred             ccccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh---HHHHHHHhcCCC-----
Confidence            7654322 12233567889999999999999999999999999999998 9999854332   223322222111     


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          554 NIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       554 ~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                          +.......+   .+.+++..||+.||++|||+.|+++.|+..
T Consensus       233 ----~~~~~~~~~---~l~~li~~~l~~~p~~Rps~~ell~~L~~~  271 (281)
T 3cc6_A          233 ----LPKPDLCPP---VLYTLMTRCWDYDPSDRPRFTELVCSLSDV  271 (281)
T ss_dssp             ----CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCCCCCH---HHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence                011111122   345677899999999999999999999753

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.9e-39  Score=361.67  Aligned_cols=255  Identities=25%  Similarity=0.337  Sum_probs=205.0

Q ss_pred             hhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccC---CcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceE
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRD---SGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERL  396 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  396 (658)
                      +..++|...+.||+|+||.||+++.. +|+.||||++...   .......+.+|+.++..++||||+++++++.+.+..+
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence            44678999999999999999999864 6899999998653   2234456889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccc
Q 006155          397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF  476 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~  476 (658)
                      +||||+++|+|.+++.... ...+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+
T Consensus       261 lVmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~  336 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHV  336 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceec
Confidence            9999999999999986432 345999999999999999999999998   999999999999999999999999999876


Q ss_pred             ccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccccc
Q 006155          477 EMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNII  556 (658)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  556 (658)
                      ....   .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+........        
T Consensus       337 ~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~--------  405 (576)
T 2acx_A          337 PEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP--------  405 (576)
T ss_dssp             CTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC--------
T ss_pred             ccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc--------
Confidence            5432   22345899999999999999999999999999999999999999965433222222221111111        


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 006155          557 DPTLSSGSITEMIRCIHIGLLCVQENVASRP-----TMASVVL  594 (658)
Q Consensus       557 dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RP-----tm~evv~  594 (658)
                       +.+......   .+.+++..||+.||++||     ++.||++
T Consensus       406 -~~~p~~~s~---~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          406 -EEYSERFSP---QARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             -CCCCTTSCH---HHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             -ccCCccCCH---HHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence             111111122   344677799999999999     7888874

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.8e-39  Score=334.30  Aligned_cols=259  Identities=27%  Similarity=0.394  Sum_probs=199.9

Q ss_pred             hccCCcccCcccccCceEEEEeEecCC----cceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeec-cCCce
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLYDG----AEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSL-EGNER  395 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g----~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~-~~~~~  395 (658)
                      ...+|...++||+|+||.||+|+..++    ..+|||.+..... .....+.+|+.++++++||||+++++++. .++..
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (298)
T 3f66_A           23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  102 (298)
T ss_dssp             GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence            345688889999999999999985432    2589999876443 33456889999999999999999999864 45678


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ++||||+++++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       103 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~  177 (298)
T 3f66_A          103 LVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD  177 (298)
T ss_dssp             EEEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred             EEEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence            999999999999999954  3456899999999999999999999998   99999999999999999999999999987


Q ss_pred             cccCCC--ccccccccccccccCccccccCCCCcccccccccchHhHHHhCCC-CCccCCCCCcchHHHHHHHhccCCCc
Q 006155          476 FEMDET--QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQR-NNCFRNGETVEDLLSSAWKNWREGTT  552 (658)
Q Consensus       476 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~-p~~~~~~~~~~~l~~~~~~~~~~~~~  552 (658)
                      +.....  ........||+.|+|||.+.+..++.++||||||+++|||++|.. |+....   ..+..........    
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~~~~~~~~~~----  250 (298)
T 3f66_A          178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYLLQGRR----  250 (298)
T ss_dssp             CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC---TTTHHHHHHTTCC----
T ss_pred             ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCC---HHHHHHHHhcCCC----
Confidence            654322  122334567889999999999999999999999999999999555 443222   2222222222111    


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 006155          553 VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYS  600 (658)
Q Consensus       553 ~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~  600 (658)
                        ...|   ....+   .+.+++..||+.||++|||+.++++.|+...
T Consensus       251 --~~~~---~~~~~---~l~~li~~~l~~~p~~Rps~~ell~~L~~~~  290 (298)
T 3f66_A          251 --LLQP---EYCPD---PLYEVMLKCWHPKAEMRPSFSELVSRISAIF  290 (298)
T ss_dssp             --CCCC---TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --CCCC---ccCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence              0111   11122   3556778999999999999999999998753

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.4e-39  Score=334.03  Aligned_cols=252  Identities=24%  Similarity=0.318  Sum_probs=201.3

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  398 (658)
                      ..++|+..+.||+|+||.||+++.. +|+.||+|++....  ......+.+|+.++.+++||||+++++++.+++..++|
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            3578999999999999999999854 58899999986543  22345688999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCC---eEEeccccccc
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMT---PKIADFGMARL  475 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~---~kl~DFGla~~  475 (658)
                      |||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.   +||+|||++..
T Consensus        84 ~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~  157 (284)
T 3kk8_A           84 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE  157 (284)
T ss_dssp             ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence            999999999888843   356899999999999999999999998   999999999999987655   99999999976


Q ss_pred             cccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccc
Q 006155          476 FEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNI  555 (658)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  555 (658)
                      ......   .....||+.|+|||++.+..++.++||||||+++|||++|+.||...   ..............     ..
T Consensus       158 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~---~~~~~~~~~~~~~~-----~~  226 (284)
T 3kk8_A          158 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE---DQHRLYAQIKAGAY-----DY  226 (284)
T ss_dssp             CCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCC-----CC
T ss_pred             cccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC---chhHHHHHHHhccc-----cC
Confidence            553322   23467999999999999999999999999999999999999998432   22222222221110     01


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          556 IDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       556 ~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ..+.. ....+   .+.+++..||+.||++|||+.|+++
T Consensus       227 ~~~~~-~~~~~---~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          227 PSPEW-DTVTP---EAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             CTTTT-TTSCH---HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             Cchhh-cccCH---HHHHHHHHHcccChhhCCCHHHHhc
Confidence            11111 11122   2456778999999999999999985

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=4.5e-39  Score=353.48  Aligned_cols=252  Identities=25%  Similarity=0.365  Sum_probs=204.7

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  397 (658)
                      ..++|...+.||+|+||.||+|+.. +|+.||||++....   ......+.+|+.+++.++||||+++++++...+..++
T Consensus        14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l   93 (476)
T 2y94_A           14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM   93 (476)
T ss_dssp             EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            3468999999999999999999864 68999999986542   2234568899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE  477 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~  477 (658)
                      ||||+++|+|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        94 v~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~  167 (476)
T 2y94_A           94 VMEYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS  167 (476)
T ss_dssp             EEECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence            9999999999999943   456999999999999999999999988   9999999999999999999999999998765


Q ss_pred             cCCCccccccccccccccCccccccCCC-CcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccccc
Q 006155          478 MDETQGNTSRIVGTYGYMAPEYAMHGQY-SVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNII  556 (658)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  556 (658)
                      ...   .....+||+.|+|||++.+..+ +.++||||||+++|||++|+.||...   ....+......    +..    
T Consensus       168 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~---~~~~~~~~i~~----~~~----  233 (476)
T 2y94_A          168 DGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD---HVPTLFKKICD----GIF----  233 (476)
T ss_dssp             TTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS---SSHHHHHHHHT----TCC----
T ss_pred             ccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC---CHHHHHHHHhc----CCc----
Confidence            432   2334589999999999988776 68999999999999999999998532   22233332222    111    


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--Hhcc
Q 006155          557 DPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL--MLNS  598 (658)
Q Consensus       557 dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~--~L~~  598 (658)
                        .......+   .+.+++..||+.||++|||+.|+++  .+..
T Consensus       234 --~~p~~~s~---~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~  272 (476)
T 2y94_A          234 --YTPQYLNP---SVISLLKHMLQVDPMKRATIKDIREHEWFKQ  272 (476)
T ss_dssp             --CCCTTCCH---HHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred             --CCCccCCH---HHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence              01111112   3456778999999999999999986  4544

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.3e-39  Score=340.90  Aligned_cols=252  Identities=25%  Similarity=0.316  Sum_probs=203.2

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcc------cHHHHHHHHHHHHhcCCCCceeeeeeeccCCc
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQ------GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNE  394 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  394 (658)
                      ..++|...+.||+|+||.||+++.. +|+.||||++......      ...++.+|+.++.+++||||+++++++.+++.
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD   89 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            3567999999999999999999854 5889999998765322      35678999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCC----CeEEecc
Q 006155          395 RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM----TPKIADF  470 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~----~~kl~DF  470 (658)
                      .++||||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++    .+||+||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence            9999999999999999953   356899999999999999999999988   99999999999999888    7999999


Q ss_pred             ccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCC
Q 006155          471 GMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREG  550 (658)
Q Consensus       471 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  550 (658)
                      |+++......   ......||+.|+|||++.+..++.++||||||+++|||++|+.||...   ...+.+.....    .
T Consensus       164 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~---~~~~~~~~i~~----~  233 (321)
T 2a2a_A          164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANITS----V  233 (321)
T ss_dssp             TTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHHHHT----T
T ss_pred             ccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHh----c
Confidence            9998765432   223457999999999999999999999999999999999999998432   22222222211    1


Q ss_pred             CcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          551 TTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       551 ~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ..  ..++.......   ..+.+++..||+.||++|||+.|+++
T Consensus       234 ~~--~~~~~~~~~~~---~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          234 SY--DFDEEFFSHTS---ELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             CC--CCCHHHHTTCC---HHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             cc--ccChhhhcccC---HHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            00  00000001111   23457788999999999999999986

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.3e-39  Score=339.74  Aligned_cols=265  Identities=25%  Similarity=0.407  Sum_probs=206.2

Q ss_pred             hccCCcccCcccccCceEEEEeEe-----cCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCC--c
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRL-----YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGN--E  394 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~  394 (658)
                      ..++|...+.||+|+||.||+++.     .+|+.||||++..........+.+|+.++.+++||||+++++++...+  .
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN  118 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence            456788999999999999999973     358899999998776666678999999999999999999999987654  7


Q ss_pred             eEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          395 RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      .++||||+++++|.+++..  ....+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       119 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          119 LKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             CEEEECCCTTCBHHHHHHH--STTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             eEEEEECCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence            8999999999999999954  2346899999999999999999999987   9999999999999999999999999998


Q ss_pred             ccccCCCc-cccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCC---------CCCcchHHHHHH
Q 006155          475 LFEMDETQ-GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRN---------GETVEDLLSSAW  544 (658)
Q Consensus       475 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~---------~~~~~~l~~~~~  544 (658)
                      .+...... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+....         ............
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  273 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence            76544321 11233467888999999999999999999999999999999998874210         000011111111


Q ss_pred             HhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          545 KNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       545 ~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      .....+..     +.......+   .+.+++..||+.||++|||+.+|++.|+..
T Consensus       274 ~~~~~~~~-----~~~~~~~~~---~l~~li~~cl~~dP~~Rps~~el~~~L~~l  320 (326)
T 2w1i_A          274 ELLKNNGR-----LPRPDGCPD---EIYMIMTECWNNNVNQRPSFRDLALRVDQI  320 (326)
T ss_dssp             HHHHTTCC-----CCCCTTCCH---HHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHhhcCCC-----CCCCCcccH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11111111     111112222   345677899999999999999999999764

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.3e-39  Score=370.62  Aligned_cols=247  Identities=28%  Similarity=0.412  Sum_probs=194.3

Q ss_pred             CcccccCceEEEEeEec---CCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecCC
Q 006155          330 NKLGQGGFGAVYKGRLY---DGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPN  404 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~~---~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  404 (658)
                      ++||+|+||.||+|...   .++.||||+++....  ....++.+|+.++.+++|||||++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999643   467899999976533  335679999999999999999999999864 568899999999


Q ss_pred             CChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCc-c
Q 006155          405 TSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ-G  483 (658)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~-~  483 (658)
                      |+|.+++.   ....+++..++.|+.||+.||.|||+.+   ||||||||+||||+.++.+||+|||+++.+...... .
T Consensus       454 g~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          454 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CCHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            99999994   3456999999999999999999999988   999999999999999999999999999877544322 2


Q ss_pred             ccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCC
Q 006155          484 NTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSS  562 (658)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~  562 (658)
                      ......||+.|+|||++.+..++.++|||||||++|||++ |+.||....   ..++......    +...     ....
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~---~~~~~~~i~~----~~~~-----~~p~  595 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK---GSEVTAMLEK----GERM-----GCPA  595 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHHHHT----TCCC-----CCCT
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHc----CCCC-----CCCC
Confidence            2333467889999999999999999999999999999998 999985332   2233332222    2111     1111


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          563 GSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       563 ~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      ...+   .+.+++..||+.||++||++.+|+++|+.
T Consensus       596 ~~~~---~l~~li~~cl~~dP~~RPs~~~l~~~L~~  628 (635)
T 4fl3_A          596 GCPR---EMYDLMNLCWTYDVENRPGFAAVELRLRN  628 (635)
T ss_dssp             TCCH---HHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCCH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            2223   34567789999999999999999999975

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.3e-39  Score=347.03  Aligned_cols=202  Identities=29%  Similarity=0.448  Sum_probs=162.0

Q ss_pred             hhccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccC--CcccHHHHHHHHHHHHhcC-CCCceeeeeeeccCC--c
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRD--SGQGDLEFKNEVLLVANLQ-HRNLVRLLGFSLEGN--E  394 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~--~  394 (658)
                      ...++|...+.||+|+||.||+|+. .+|+.||||++...  .......+.+|+.++..+. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            3457899999999999999999984 46889999998654  2233455788999999997 999999999987544  6


Q ss_pred             eEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          395 RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      .++||||++ ++|..++..    ..+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            899999997 689888842    46899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccccCC-------------------CccccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCcc
Q 006155          475 LFEMDE-------------------TQGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCF  530 (658)
Q Consensus       475 ~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~  530 (658)
                      .+....                   ........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  233 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG  233 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence            764311                   1112234689999999999976 6799999999999999999999999854

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=8.3e-40  Score=341.56  Aligned_cols=277  Identities=24%  Similarity=0.348  Sum_probs=202.4

Q ss_pred             chhhhhhhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeeccC
Q 006155          315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEG  392 (658)
Q Consensus       315 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~  392 (658)
                      ...+..+..++|...+.||+|+||.||+|+..  ..+|+|++....  ......+.+|+.++.+++||||+++++++.+.
T Consensus        24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  101 (319)
T 2y4i_B           24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP  101 (319)
T ss_dssp             CGGGSSSCCSCEECCCBCCCSSSSEEEEEEES--SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred             ccccccCCHHHeEEeeEeccCCceEEEEEEEc--CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence            34555667789999999999999999999853  469999987542  22334578899999999999999999999999


Q ss_pred             CceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccc
Q 006155          393 NERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGM  472 (658)
Q Consensus       393 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGl  472 (658)
                      +..++||||+++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++ ++.+||+|||+
T Consensus       102 ~~~~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~  175 (319)
T 2y4i_B          102 PHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGL  175 (319)
T ss_dssp             SCEEEECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSC
T ss_pred             CceEEEeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCC
Confidence            999999999999999999954  2346899999999999999999999998   99999999999998 67999999999


Q ss_pred             ccccccCC---CccccccccccccccCcccccc---------CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHH
Q 006155          473 ARLFEMDE---TQGNTSRIVGTYGYMAPEYAMH---------GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL  540 (658)
Q Consensus       473 a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~  540 (658)
                      ++......   .........||+.|+|||++..         ..++.++||||||+++|||++|+.||....   .....
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~  252 (319)
T 2y4i_B          176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP---AEAII  252 (319)
T ss_dssp             CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC---HHHHH
T ss_pred             ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHH
Confidence            87653221   1122334568999999999864         457899999999999999999999985322   22222


Q ss_pred             HHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCCCCCCCCCccc
Q 006155          541 SSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTLPVPSEPAFFM  613 (658)
Q Consensus       541 ~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~~~~~~p~~p~~~~  613 (658)
                      ....    .+.........+    ..   .+.+++..||+.||++|||+.+|+++|+...........|+.++
T Consensus       253 ~~~~----~~~~~~~~~~~~----~~---~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~  314 (319)
T 2y4i_B          253 WQMG----TGMKPNLSQIGM----GK---EISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFW  314 (319)
T ss_dssp             HHHH----TTCCCCCCCSSC----CT---THHHHHHHHHCSSTTTSCCHHHHHHHHTTC--------------
T ss_pred             HHhc----cCCCCCCCcCCC----CH---HHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCcccc
Confidence            2221    111111111111    11   24567789999999999999999999998876666656665544

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.5e-39  Score=341.84  Aligned_cols=250  Identities=26%  Similarity=0.275  Sum_probs=200.4

Q ss_pred             hhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccC---CcccHHHHHHHHHHHHhc-CCCCceeeeeeeccCCce
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRD---SGQGDLEFKNEVLLVANL-QHRNLVRLLGFSLEGNER  395 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~  395 (658)
                      ...++|...+.||+|+||.||+++.. +|+.||||++...   .......+..|..++..+ +||||+++++++.+.+..
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   96 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL   96 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence            44678999999999999999999865 4788999998754   223445678899999888 799999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ++||||+++|+|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        97 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~  170 (353)
T 2i0e_A           97 YFVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE  170 (353)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence            999999999999999843   346999999999999999999999998   99999999999999999999999999985


Q ss_pred             cccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccc
Q 006155          476 FEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNI  555 (658)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  555 (658)
                      .....  ......+||+.|+|||++.+..++.++||||||+++|||++|+.||...   ...++......    +.    
T Consensus       171 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~---~~~~~~~~i~~----~~----  237 (353)
T 2i0e_A          171 NIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE---DEDELFQSIME----HN----  237 (353)
T ss_dssp             CCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHH----CC----
T ss_pred             cccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC---CHHHHHHHHHh----CC----
Confidence            43221  2334568999999999999999999999999999999999999998532   22333333222    11    


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 006155          556 IDPTLSSGSITEMIRCIHIGLLCVQENVASRPT-----MASVVL  594 (658)
Q Consensus       556 ~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPt-----m~evv~  594 (658)
                        +.+......   .+.+++..||+.||++||+     +.+|++
T Consensus       238 --~~~p~~~s~---~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          238 --VAYPKSMSK---EAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             --CCCCTTSCH---HHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             --CCCCCCCCH---HHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence              111112122   3456777999999999995     466653

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.3e-39  Score=333.07  Aligned_cols=253  Identities=24%  Similarity=0.358  Sum_probs=196.3

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC-cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS-GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ..++|...++||+|+||.||+++.. ++..||+|++.... ......+.+|+.++.+++||||+++++++.+.+..++||
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   99 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM   99 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence            3478999999999999999999854 58899999987653 334567899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceee---CCCCCeEEeccccccc
Q 006155          400 EFVPNTSLDHFIFDP-TRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLL---DAEMTPKIADFGMARL  475 (658)
Q Consensus       400 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl---~~~~~~kl~DFGla~~  475 (658)
                      ||+++++|.+++... .....+++..++.++.||++||.|||+.+   |+||||||+|||+   +.++.+||+|||+++.
T Consensus       100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~  176 (285)
T 3is5_A          100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL  176 (285)
T ss_dssp             CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred             EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence            999999999988542 23357999999999999999999999988   9999999999999   4568899999999987


Q ss_pred             cccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccc
Q 006155          476 FEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNI  555 (658)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  555 (658)
                      +....   ......||+.|+|||++. +.++.++||||||+++|||++|+.||....   ..+........  .... ..
T Consensus       177 ~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~---~~~~~~~~~~~--~~~~-~~  246 (285)
T 3is5_A          177 FKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS---LEEVQQKATYK--EPNY-AV  246 (285)
T ss_dssp             -------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHC--CCCC-CC
T ss_pred             cCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC---HHHHHhhhccC--Cccc-cc
Confidence            65432   223457899999999875 578999999999999999999999985322   22222222111  1000 00


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          556 IDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       556 ~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                         . .....+   .+.+++..||+.||++|||+.||++
T Consensus       247 ---~-~~~~~~---~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          247 ---E-CRPLTP---QAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             ------CCCCH---HHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ---c-cCcCCH---HHHHHHHHHccCChhhCcCHHHHhc
Confidence               0 001112   3446778999999999999999984

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=5.9e-39  Score=346.25  Aligned_cols=251  Identities=22%  Similarity=0.247  Sum_probs=187.9

Q ss_pred             cCCccc-CcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHh-cCCCCceeeeeeecc----CCceE
Q 006155          324 DNFSDA-NKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVAN-LQHRNLVRLLGFSLE----GNERL  396 (658)
Q Consensus       324 ~~~~~~-~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~----~~~~~  396 (658)
                      ++|... +.||+|+||+||+++.. +|+.||||++..     ...+.+|+.++.+ .+||||+++++++..    +...+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            456655 68999999999999854 588899999853     2356788888744 589999999998765    56789


Q ss_pred             EEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCC---CCCeEEeccccc
Q 006155          397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDA---EMTPKIADFGMA  473 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~---~~~~kl~DFGla  473 (658)
                      |||||+++|+|.+++... ....+++..++.|+.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||++
T Consensus       136 lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence            999999999999999652 2346999999999999999999999987   999999999999997   789999999999


Q ss_pred             cccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcc-hHHHHHHHhccCCCc
Q 006155          474 RLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVE-DLLSSAWKNWREGTT  552 (658)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~  552 (658)
                      +......   .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ........    +..
T Consensus       212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~----~~~  284 (400)
T 1nxk_A          212 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM----GQY  284 (400)
T ss_dssp             EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH----TCC
T ss_pred             cccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc----Ccc
Confidence            8654322   233568899999999999999999999999999999999999999654433221 12121111    110


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          553 VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       553 ~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                       ....+.. ....+   .+.+++..||+.||++|||+.|+++.
T Consensus       285 -~~~~~~~-~~~s~---~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          285 -EFPNPEW-SEVSE---EVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             -CCCTTTT-TTSCH---HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -cCCCccc-ccCCH---HHHHHHHHHCCCChhHCcCHHHHhcC
Confidence             0111111 11122   34567789999999999999999863

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=5.4e-39  Score=352.94  Aligned_cols=258  Identities=23%  Similarity=0.285  Sum_probs=192.5

Q ss_pred             hccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccC--CcccHHHHHHHHHHHHhcCCCCceeeeeeeccC------
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRD--SGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEG------  392 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------  392 (658)
                      ..++|+..++||+|+||.||+++. .+|+.||||++...  .......+.+|+.+++.++||||+++++++...      
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            357899999999999999999974 45889999999754  223345688999999999999999999998654      


Q ss_pred             CceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccc
Q 006155          393 NERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGM  472 (658)
Q Consensus       393 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGl  472 (658)
                      ...++||||++++ |.+.+.     ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+
T Consensus       140 ~~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~  210 (464)
T 3ttj_A          140 QDVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  210 (464)
T ss_dssp             CEEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred             CeEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEe
Confidence            3569999999865 555552     24899999999999999999999998   99999999999999999999999999


Q ss_pred             ccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCC-
Q 006155          473 ARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGT-  551 (658)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-  551 (658)
                      ++.....   ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....   ..+.+........... 
T Consensus       211 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~---~~~~~~~i~~~lg~p~~  284 (464)
T 3ttj_A          211 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD---YIDQWNKVIEQLGTPCP  284 (464)
T ss_dssp             C-----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHHCSCCH
T ss_pred             eeecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHhcCCCCH
Confidence            9865432   22344689999999999999999999999999999999999999985432   2222222211111000 


Q ss_pred             ------------------------cccccCCCC-CCCC---HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          552 ------------------------TVNIIDPTL-SSGS---ITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       552 ------------------------~~~~~dp~l-~~~~---~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                                              ....+...+ ....   ...-..+.+++..||+.||++|||+.|+++
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                                    000000000 0011   111234678889999999999999999985

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.2e-39  Score=357.12  Aligned_cols=251  Identities=22%  Similarity=0.253  Sum_probs=194.1

Q ss_pred             hhhccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccC---CcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCce
Q 006155          320 RVATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRD---SGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNER  395 (658)
Q Consensus       320 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  395 (658)
                      +...++|+..++||+|+||.||+++. .+|+.||||++...   .......+.+|+.++..++||||+++++++.+.+..
T Consensus       144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~  223 (446)
T 4ejn_A          144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL  223 (446)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred             CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence            34557899999999999999999984 46889999998753   223344578899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE-DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      ++||||+++|+|.+++..   ...+++..+..++.||+.||.|||+ .+   |+||||||+||||+.++.+||+|||+++
T Consensus       224 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~  297 (446)
T 4ejn_A          224 CFVMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCK  297 (446)
T ss_dssp             EEEECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCC
T ss_pred             EEEEeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCce
Confidence            999999999999999843   4569999999999999999999998 76   9999999999999999999999999998


Q ss_pred             ccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          475 LFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      ......  ......+||+.|+|||++.+..++.++||||||+++|||++|+.||...   ....+.......    .   
T Consensus       298 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~~~~i~~~----~---  365 (446)
T 4ejn_A          298 EGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ---DHEKLFELILME----E---  365 (446)
T ss_dssp             TTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHC----C---
T ss_pred             eccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC---CHHHHHHHHHhC----C---
Confidence            543222  2234468999999999999999999999999999999999999998432   222333322221    0   


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 006155          555 IIDPTLSSGSITEMIRCIHIGLLCVQENVASRP-----TMASVVL  594 (658)
Q Consensus       555 ~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RP-----tm~evv~  594 (658)
                         ..+.....+   .+.+++..||+.||.+||     ++.|+++
T Consensus       366 ---~~~p~~~~~---~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          366 ---IRFPRTLGP---EAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             ---CCCCTTSCH---HHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ---CCCCccCCH---HHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence               111111122   345677899999999999     9999985

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.9e-39  Score=337.66  Aligned_cols=261  Identities=23%  Similarity=0.363  Sum_probs=195.4

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  398 (658)
                      .++|...+.||+|+||.||+++. .+|+.||||++....   ......+.+|+.++.+++||||+++++++..++..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            35788999999999999999985 468999999997533   23345688999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccc
Q 006155          399 YEFVPNTSLDHFIFDP-TRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE  477 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~  477 (658)
                      |||+++++|.+++... .....+++..++.++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||+++.+.
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            9999999999998532 23456899999999999999999999998   9999999999999999999999999998654


Q ss_pred             cCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccC
Q 006155          478 MDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID  557 (658)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  557 (658)
                      ....  ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ....+...    .......... 
T Consensus       188 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~----~~~~~~~~~~-  259 (310)
T 2wqm_A          188 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKK----IEQCDYPPLP-  259 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C-CHHHHHHH----HHTTCSCCCC-
T ss_pred             CCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-hHHHHHHH----hhcccCCCCc-
Confidence            3321  22345789999999999999999999999999999999999999853221 11122221    1111111111 


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 006155          558 PTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYS  600 (658)
Q Consensus       558 p~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~  600 (658)
                         .....+   .+.+++..||+.||++|||+.+|+++|+...
T Consensus       260 ---~~~~~~---~l~~li~~~l~~dp~~Rps~~~il~~l~~l~  296 (310)
T 2wqm_A          260 ---SDHYSE---ELRQLVNMCINPDPEKRPDVTYVYDVAKRMH  296 (310)
T ss_dssp             ---TTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---ccccCH---HHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence               111222   3456778999999999999999999998753

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=5.5e-39  Score=331.34  Aligned_cols=254  Identities=26%  Similarity=0.389  Sum_probs=199.2

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      .++|.....||+|+||.||+|+. .++..||||.+..........+.+|+.++..++||||+++++++.+.+..++||||
T Consensus        21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  100 (295)
T 2clq_A           21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ  100 (295)
T ss_dssp             BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence            45566677999999999999984 46788999999877666667899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCC-CCCeEEeccccccccccCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDA-EMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~-~~~~kl~DFGla~~~~~~~  480 (658)
                      +++++|.+++........+++..+..++.||+.||.|||+.+   |+||||||+|||++. ++.+||+|||+++.+....
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~  177 (295)
T 2clq_A          101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN  177 (295)
T ss_dssp             CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred             CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence            999999999965444456789999999999999999999987   999999999999987 8999999999998654322


Q ss_pred             CccccccccccccccCccccccCC--CCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCC
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMHGQ--YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP  558 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp  558 (658)
                        .......||+.|+|||++.++.  ++.++||||||+++|||++|+.||....... .........         ...+
T Consensus       178 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~---------~~~~  245 (295)
T 2clq_A          178 --PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ-AAMFKVGMF---------KVHP  245 (295)
T ss_dssp             -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH-HHHHHHHHH---------CCCC
T ss_pred             --CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh-HHHHhhccc---------cccc
Confidence              1223457899999999997654  8899999999999999999999985322111 111111110         0112


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          559 TLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       559 ~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .+......   .+.+++..||+.||++||++.++++
T Consensus       246 ~~~~~~~~---~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          246 EIPESMSA---EAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CCCTTSCH---HHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             cccccCCH---HHHHHHHHHccCChhhCCCHHHHhc
Confidence            22222222   3446778999999999999999984

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.2e-39  Score=338.91  Aligned_cols=261  Identities=20%  Similarity=0.268  Sum_probs=202.8

Q ss_pred             chhhhhhhccCCccc-CcccccCceEEEEeEec-CCcceeEEEeccCC--cccHHHHHHHHHHHHhcC-CCCceeeeeee
Q 006155          315 DFNTIRVATDNFSDA-NKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQ-HRNLVRLLGFS  389 (658)
Q Consensus       315 ~~~~~~~~~~~~~~~-~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~~~~  389 (658)
                      .+...+...+.|... +.||+|+||.||+++.. +|+.||||++....  .....++.+|+.++..++ ||||+++++++
T Consensus        19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~   98 (327)
T 3lm5_A           19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY   98 (327)
T ss_dssp             CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            344556667778877 88999999999999854 58899999987542  334567899999999995 69999999999


Q ss_pred             ccCCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCC---CCCeE
Q 006155          390 LEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDA---EMTPK  466 (658)
Q Consensus       390 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~---~~~~k  466 (658)
                      .+.+..++||||+++|+|.+++.. .....+++..++.++.||+.||.|||+.+   |+||||||+|||++.   ++.+|
T Consensus        99 ~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~k  174 (327)
T 3lm5_A           99 ENTSEIILILEYAAGGEIFSLCLP-ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIK  174 (327)
T ss_dssp             ECSSEEEEEEECCTTEEGGGGGSS-CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEE
T ss_pred             EeCCeEEEEEEecCCCcHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEE
Confidence            999999999999999999999854 23456999999999999999999999998   999999999999998   78999


Q ss_pred             EeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHh
Q 006155          467 IADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKN  546 (658)
Q Consensus       467 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~  546 (658)
                      |+|||+++.+....   ......||+.|+|||++.+..++.++||||||+++|||++|+.||....   ..+........
T Consensus       175 L~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~  248 (327)
T 3lm5_A          175 IVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED---NQETYLNISQV  248 (327)
T ss_dssp             ECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHT
T ss_pred             EeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---chHHHHHHHhc
Confidence            99999998764332   2234679999999999999999999999999999999999999984322   22222222111


Q ss_pred             ccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          547 WREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       547 ~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                       ...    .. +........   .+.+++..||+.||++|||+.++++
T Consensus       249 -~~~----~~-~~~~~~~~~---~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          249 -NVD----YS-EETFSSVSQ---LATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             -CCC----CC-TTTTTTSCH---HHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             -ccc----cC-chhhcccCH---HHHHHHHHHcCCChhhCcCHHHHhC
Confidence             100    00 111111112   3456778999999999999999985

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-39  Score=345.23  Aligned_cols=255  Identities=24%  Similarity=0.316  Sum_probs=201.3

Q ss_pred             hccCCcccCcccccCceEEEEeEe----cCCcceeEEEeccCC----cccHHHHHHHHHHHHhc-CCCCceeeeeeeccC
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRL----YDGAEIAVKRLSRDS----GQGDLEFKNEVLLVANL-QHRNLVRLLGFSLEG  392 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~  392 (658)
                      ..++|...+.||+|+||.||+++.    .+|+.||||++....    ......+.+|+.++.++ +||||+++++++..+
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  131 (355)
T 1vzo_A           52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  131 (355)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence            457899999999999999999986    368899999986532    12334567899999999 699999999999999


Q ss_pred             CceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccc
Q 006155          393 NERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGM  472 (658)
Q Consensus       393 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGl  472 (658)
                      +..++||||+++++|.+++..   ...+++..++.++.||++||.|||+.+   |+||||||+||||+.++.+||+|||+
T Consensus       132 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~  205 (355)
T 1vzo_A          132 TKLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL  205 (355)
T ss_dssp             TEEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             ceEEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCC
Confidence            999999999999999999953   346899999999999999999999987   99999999999999999999999999


Q ss_pred             ccccccCCCccccccccccccccCccccccC--CCCcccccccccchHhHHHhCCCCCccCCCCCcc-hHHHHHHHhccC
Q 006155          473 ARLFEMDETQGNTSRIVGTYGYMAPEYAMHG--QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVE-DLLSSAWKNWRE  549 (658)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~  549 (658)
                      ++.+..... .......||+.|+|||++.++  .++.++||||||+++|||++|+.||......... .+.......   
T Consensus       206 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~---  281 (355)
T 1vzo_A          206 SKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS---  281 (355)
T ss_dssp             EEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC---
T ss_pred             CeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc---
Confidence            987643322 223346799999999999863  4789999999999999999999998644332222 222221111   


Q ss_pred             CCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHh
Q 006155          550 GTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRP-----TMASVVLML  596 (658)
Q Consensus       550 ~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RP-----tm~evv~~L  596 (658)
                             .+.+......   .+.+++..||+.||++||     ++.|+++..
T Consensus       282 -------~~~~~~~~~~---~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          282 -------EPPYPQEMSA---LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             -------CCCCCTTSCH---HHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             -------CCCCCcccCH---HHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence                   1111112112   345677899999999999     999998644

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.3e-39  Score=342.03  Aligned_cols=252  Identities=21%  Similarity=0.300  Sum_probs=199.6

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhc-CCCCceeeeeeeccCCceEEEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANL-QHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ..++|...+.||+|+||.||+++.. +|+.||||++......    ..+|++++.++ +||||+++++++.+++..++||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            4578999999999999999999854 5889999999765432    35688888888 7999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCC----CCeEEeccccccc
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE----MTPKIADFGMARL  475 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~----~~~kl~DFGla~~  475 (658)
                      ||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||+..+    +.+||+|||+++.
T Consensus        96 E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           96 ELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             CCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            99999999999853   356999999999999999999999998   9999999999998443    3599999999987


Q ss_pred             cccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccc
Q 006155          476 FEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNI  555 (658)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  555 (658)
                      +.....  ......||+.|+|||++.+..++.++||||||+++|||++|+.||.........++......    +... .
T Consensus       170 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~----~~~~-~  242 (342)
T 2qr7_A          170 LRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS----GKFS-L  242 (342)
T ss_dssp             CBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH----CCCC-C
T ss_pred             CcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc----CCcc-c
Confidence            644322  23346889999999999888899999999999999999999999965444444444433322    1111 0


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          556 IDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       556 ~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                       .........+   .+.+++..||+.||++|||+.++++
T Consensus       243 -~~~~~~~~s~---~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          243 -SGGYWNSVSD---TAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             -CSTTTTTSCH---HHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -CccccccCCH---HHHHHHHHHCCCChhHCcCHHHHhc
Confidence             0111111122   2446777999999999999999974

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.1e-38  Score=330.79  Aligned_cols=249  Identities=26%  Similarity=0.397  Sum_probs=203.5

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCC-cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDS-GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      .+.|...+.||+|+||.||+|+. .+++.||||++.... ......+.+|+.++.+++||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            45688899999999999999985 458899999987654 3345678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      |+++++|.+++.    ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+....
T Consensus       101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A          101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            999999999984    356999999999999999999999998   9999999999999999999999999998765432


Q ss_pred             CccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCC
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTL  560 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l  560 (658)
                      .  ......||+.|+|||++.+..++.++||||||+++|||++|+.|+....   ...........    .     .+.+
T Consensus       174 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~----~-----~~~~  239 (303)
T 3a7i_A          174 I--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH---PMKVLFLIPKN----N-----PPTL  239 (303)
T ss_dssp             C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHS----C-----CCCC
T ss_pred             c--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC---HHHHHHHhhcC----C-----CCCC
Confidence            1  2334678999999999999999999999999999999999999985322   12222221111    1     1122


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          561 SSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       561 ~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                      ......   .+.+++..||+.||++|||+.++++.
T Consensus       240 ~~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          240 EGNYSK---PLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             CSSCCH---HHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             ccccCH---HHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            222222   24567789999999999999999853

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=8.5e-39  Score=332.91  Aligned_cols=258  Identities=18%  Similarity=0.242  Sum_probs=195.3

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCccc---HHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQG---DLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  398 (658)
                      .++|...+.||+|+||.||+++.. +++.||||++.......   ...+.+|+.++.+++||||+++++++..++..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            478999999999999999999854 68899999987653322   35688999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccccc
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~  478 (658)
                      |||+++++|.+++..   ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       113 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          113 MRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             EECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             EEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            999999999999853   356999999999999999999999998   99999999999999999999999999986543


Q ss_pred             CCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCC
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP  558 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp  558 (658)
                      ... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....    ...+......  .........+
T Consensus       187 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~~~~~~~--~~~~~~~~~~  259 (309)
T 2h34_A          187 EKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ----LSVMGAHINQ--AIPRPSTVRP  259 (309)
T ss_dssp             -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH----HHHHHHHHHS--CCCCGGGTST
T ss_pred             ccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch----HHHHHHHhcc--CCCCccccCC
Confidence            321 12234578999999999999999999999999999999999999985321    1111111111  0000111111


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHhccCC
Q 006155          559 TLSSGSITEMIRCIHIGLLCVQENVASRP-TMASVVLMLNSYS  600 (658)
Q Consensus       559 ~l~~~~~~e~~~~~~i~~~Cl~~~p~~RP-tm~evv~~L~~~~  600 (658)
                      .+    ..   .+.+++..||+.||++|| ++.++++.|+...
T Consensus       260 ~~----~~---~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l  295 (309)
T 2h34_A          260 GI----PV---AFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL  295 (309)
T ss_dssp             TC----CT---HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred             CC----CH---HHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence            11    12   344677899999999999 9999999998753

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2e-39  Score=332.78  Aligned_cols=251  Identities=24%  Similarity=0.327  Sum_probs=198.9

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc------ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCce
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG------QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNER  395 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  395 (658)
                      .++|...+.||+|+||.||+++.. +|+.||||.+.....      .....+.+|+.++.+++||||+++++++.+++..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            467889999999999999999865 588999999875432      2356789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCC----CeEEeccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM----TPKIADFG  471 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~----~~kl~DFG  471 (658)
                      ++||||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+||+++.++    .+||+|||
T Consensus        84 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            999999999999999843   356899999999999999999999988   99999999999998877    89999999


Q ss_pred             cccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCC
Q 006155          472 MARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGT  551 (658)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  551 (658)
                      ++..+....   ......||+.|+|||++.+..++.++||||||+++|||++|+.||....   ..+......    ...
T Consensus       158 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~----~~~  227 (283)
T 3bhy_A          158 IAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET---KQETLTNIS----AVN  227 (283)
T ss_dssp             TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHH----TTC
T ss_pred             cceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc---hHHHHHHhH----hcc
Confidence            998764332   2234578999999999999999999999999999999999999985322   222222211    111


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          552 TVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       552 ~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ..  .++.......   ..+.+++..||+.||++|||+.++++
T Consensus       228 ~~--~~~~~~~~~~---~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          228 YD--FDEEYFSNTS---ELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             CC--CCHHHHTTCC---HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cC--CcchhcccCC---HHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            00  0000001111   23557788999999999999999986

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.5e-39  Score=328.71  Aligned_cols=249  Identities=27%  Similarity=0.420  Sum_probs=180.4

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  398 (658)
                      .++|...+.||+|+||.||+++. .+|+.||||++....   ......+.+|+.++.+++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            46789999999999999999985 468999999986532   22345689999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccccc
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~  478 (658)
                      |||+++++|.+++..  ....+++..++.++.||++||.|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           90 LEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            999999999999854  2356899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCC
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP  558 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp  558 (658)
                      ...  ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+.......   .+.    ....      .+.
T Consensus       165 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~----~~~~------~~~  229 (278)
T 3cok_A          165 PHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN---TLN----KVVL------ADY  229 (278)
T ss_dssp             -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CCS------SCC
T ss_pred             CCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH---HHH----HHhh------ccc
Confidence            221  1223578999999999999999999999999999999999999985433211   110    0000      011


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          559 TLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       559 ~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .+......   .+.+++.+||+.||++|||+.++++
T Consensus       230 ~~~~~~~~---~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          230 EMPSFLSI---EAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             CCCTTSCH---HHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCccccCH---HHHHHHHHHcccCHhhCCCHHHHhc
Confidence            11112122   3456778999999999999999874

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.8e-39  Score=337.05  Aligned_cols=251  Identities=23%  Similarity=0.339  Sum_probs=200.3

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      ..++|...+.||+|+||.||+++.. +|+.||||++..........+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            3468899999999999999999854 688999999987655555678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceee---CCCCCeEEeccccccccc
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLL---DAEMTPKIADFGMARLFE  477 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl---~~~~~~kl~DFGla~~~~  477 (658)
                      |+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+|||+++...
T Consensus        87 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           87 LVSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             CCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             cCCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            9999999998843   346899999999999999999999988   9999999999999   788999999999987543


Q ss_pred             cCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccC
Q 006155          478 MDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID  557 (658)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  557 (658)
                      ..    ......||+.|+|||++.+..++.++||||||+++|||++|+.||...   ....+.........     .. .
T Consensus       161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~---~~~~~~~~i~~~~~-----~~-~  227 (304)
T 2jam_A          161 NG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE---TESKLFEKIKEGYY-----EF-E  227 (304)
T ss_dssp             CB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHHHHHCCC-----CC-C
T ss_pred             CC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHcCCC-----CC-C
Confidence            22    223457899999999999999999999999999999999999998432   22223322222111     00 1


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          558 PTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       558 p~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ........+   .+.+++..||+.||++|||+.++++
T Consensus       228 ~~~~~~~~~---~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          228 SPFWDDISE---SAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             TTTTTTSCH---HHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ccccccCCH---HHHHHHHHHcCCChhHCcCHHHHhc
Confidence            111111122   3456778999999999999999985

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.4e-39  Score=336.97  Aligned_cols=266  Identities=23%  Similarity=0.343  Sum_probs=186.3

Q ss_pred             hhhccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCC-cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEE
Q 006155          320 RVATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDS-GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       320 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  397 (658)
                      .+..++|...+.||+|+||.||+++. .+++.||||++.... .....++.+|+.++.+++||||+++++++...+..++
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   90 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL   90 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence            45568999999999999999999984 368899999886543 2334568899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCc-----CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccc
Q 006155          398 IYEFVPNTSLDHFIFDP-----TRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGM  472 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGl  472 (658)
                      ||||+++++|.+++...     .....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence            99999999999998531     12456899999999999999999999988   99999999999999999999999999


Q ss_pred             ccccccCCC---ccccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhcc
Q 006155          473 ARLFEMDET---QGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWR  548 (658)
Q Consensus       473 a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~  548 (658)
                      +..+.....   ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||.....   ............
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~  244 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP---MKVLMLTLQNDP  244 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCG---GGHHHHHHTSSC
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCch---hhHHHHHhccCC
Confidence            986643321   112234579999999999876 5689999999999999999999999854332   222222222111


Q ss_pred             CCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          549 EGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       549 ~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ........++.+......+   +.+++..||+.||++|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~---~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          245 PSLETGVQDKEMLKKYGKS---FRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             CCTTC-----CCCCCCCHH---HHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CccccccccchhhhhhhHH---HHHHHHHHccCChhhCcCHHHHhh
Confidence            1111112222222222233   446778999999999999999985

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.2e-39  Score=333.84  Aligned_cols=247  Identities=26%  Similarity=0.382  Sum_probs=197.6

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  397 (658)
                      ..++|...+.||+|+||.||+++.. ++..||||++....   ......+.+|+.++.+++||||+++++++.+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            4578999999999999999999854 46789999986532   2234568899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE  477 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~  477 (658)
                      ||||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        87 v~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~  160 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP  160 (279)
T ss_dssp             EECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred             EEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence            9999999999999843   356899999999999999999999987   9999999999999999999999999986543


Q ss_pred             cCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccC
Q 006155          478 MDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID  557 (658)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  557 (658)
                      ..    ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...   ...+........          .
T Consensus       161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~---~~~~~~~~~~~~----------~  223 (279)
T 3fdn_A          161 SS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---TYQETYKRISRV----------E  223 (279)
T ss_dssp             -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHHT----------C
T ss_pred             cc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC---cHHHHHHHHHhC----------C
Confidence            22    223457899999999999999999999999999999999999998532   222222222111          0


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          558 PTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       558 p~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ..+.....+   .+.+++..||+.||++|||+.|+++
T Consensus       224 ~~~~~~~~~---~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          224 FTFPDFVTE---GARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             CCCCTTSCH---HHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CCCCCcCCH---HHHHHHHHHhccChhhCCCHHHHhh
Confidence            111111122   2446778999999999999999995

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=8.5e-39  Score=338.92  Aligned_cols=266  Identities=21%  Similarity=0.331  Sum_probs=198.7

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeecc--------
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLE--------  391 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------  391 (658)
                      .++|...++||+|+||.||+++. .+|+.||||++.....  .....+.+|+.++..++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            46899999999999999999986 4688999998865532  234567899999999999999999999876        


Q ss_pred             CCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccc
Q 006155          392 GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFG  471 (658)
Q Consensus       392 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFG  471 (658)
                      ++..++||||+++ +|.+.+..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence            4468999999985 66666643  2345999999999999999999999998   9999999999999999999999999


Q ss_pred             cccccccCCC--ccccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhcc
Q 006155          472 MARLFEMDET--QGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWR  548 (658)
Q Consensus       472 la~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~  548 (658)
                      +++.+.....  ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........+........
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  249 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            9987653322  222344678999999999876 4589999999999999999999999854332211111111111111


Q ss_pred             CCCcccc-----c---CC-CCCCCCH-HHH------HHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          549 EGTTVNI-----I---DP-TLSSGSI-TEM------IRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       549 ~~~~~~~-----~---dp-~l~~~~~-~e~------~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .......     .   .. ....... ..+      ..+.+++..||+.||++|||+.|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            1111100     0   00 0000111 111      12568889999999999999999985

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.6e-40  Score=355.88  Aligned_cols=244  Identities=14%  Similarity=0.115  Sum_probs=187.1

Q ss_pred             hhccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccC---CcccHHHHHHHH---HHHHhcCCCCceeee-------
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRD---SGQGDLEFKNEV---LLVANLQHRNLVRLL-------  386 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~---~~l~~l~H~niv~l~-------  386 (658)
                      ...++|...+.||+|+||.||+|+. .+|+.||||++...   .......+.+|+   .++++++|||||+++       
T Consensus        70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~  149 (377)
T 3byv_A           70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  149 (377)
T ss_dssp             CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred             CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence            3467899999999999999999985 46899999999743   233446788999   555666899999998       


Q ss_pred             eeeccCC-----------------ceEEEEEecCCCChhhhhcCcC----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 006155          387 GFSLEGN-----------------ERLLIYEFVPNTSLDHFIFDPT----RRAQLDWERRYKIIGGIARGLLYLHEDSRL  445 (658)
Q Consensus       387 ~~~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~  445 (658)
                      +++.+.+                 ..++||||+ +|+|.+++....    ....++|..++.|+.||++||.|||+.+  
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--  226 (377)
T 3byv_A          150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--  226 (377)
T ss_dssp             EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence            4444432                 278999999 689999985421    1223556889999999999999999998  


Q ss_pred             cEEEeccCCCceeeCCCCCeEEeccccccccccCCCccccccccccccccCccccccC-----------CCCcccccccc
Q 006155          446 RIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG-----------QYSVKSDVFSF  514 (658)
Q Consensus       446 ~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDV~S~  514 (658)
                       |+||||||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++|||||
T Consensus       227 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSl  299 (377)
T 3byv_A          227 -LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWAL  299 (377)
T ss_dssp             -EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHH
T ss_pred             -eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHH
Confidence             99999999999999999999999999985322     2334577 999999999887           89999999999


Q ss_pred             cchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          515 GVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       515 Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      |+++|||++|+.||...........               +.. .. ....+   .+.+++..||+.||++|||+.++++
T Consensus       300 G~il~elltg~~Pf~~~~~~~~~~~---------------~~~-~~-~~~~~---~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          300 GLVIYWIWCADLPITKDAALGGSEW---------------IFR-SC-KNIPQ---PVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHHHHSSCCC------CCSGG---------------GGS-SC-CCCCH---HHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHHHHCCCCCcccccccchhh---------------hhh-hc-cCCCH---HHHHHHHHHcCCCchhCCCHHHHhh
Confidence            9999999999999854332211110               100 00 11122   3456778999999999999999985

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=9e-40  Score=343.43  Aligned_cols=265  Identities=21%  Similarity=0.294  Sum_probs=192.6

Q ss_pred             hhhhhccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcc--cHHHHHHHHHHHHhcCCCCceeeeeeeccCCc
Q 006155          318 TIRVATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQ--GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNE  394 (658)
Q Consensus       318 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  394 (658)
                      ......++|...++||+|+||+||+++. .+|+.||||++......  ....+.+|+.++.+++||||+++++++.+++.
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (329)
T 3gbz_A           28 PSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR  107 (329)
T ss_dssp             ----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred             CcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence            3345567899999999999999999984 46889999999755332  23457899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeC-----CCCCeEEec
Q 006155          395 RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLD-----AEMTPKIAD  469 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~-----~~~~~kl~D  469 (658)
                      .++||||++ |+|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++     .++.+||+|
T Consensus       108 ~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~D  180 (329)
T 3gbz_A          108 LHLIFEYAE-NDLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGD  180 (329)
T ss_dssp             EEEEEECCS-EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred             EEEEEecCC-CCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECc
Confidence            999999998 499988843   346999999999999999999999998   99999999999994     455699999


Q ss_pred             cccccccccCCCccccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhcc
Q 006155          470 FGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWR  548 (658)
Q Consensus       470 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~  548 (658)
                      ||+++.+.....  ......||+.|+|||++.+. .++.++||||||+++|||++|+.||....   ..+.+........
T Consensus       181 fg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~~~~~~~  255 (329)
T 3gbz_A          181 FGLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS---EIDQLFKIFEVLG  255 (329)
T ss_dssp             TTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHHC
T ss_pred             CCCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC---HHHHHHHHHHHhC
Confidence            999987643322  23345789999999999875 48999999999999999999999985332   2222222222111


Q ss_pred             CCC---ccc--------ccCCCCCCCCHHHH------HHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          549 EGT---TVN--------IIDPTLSSGSITEM------IRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       549 ~~~---~~~--------~~dp~l~~~~~~e~------~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ...   ...        ...+..........      ..+.+++..||+.||++|||+.|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          256 LPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             CCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            000   000        00011111111111      24567888999999999999999985

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.5e-39  Score=340.93  Aligned_cols=243  Identities=23%  Similarity=0.306  Sum_probs=198.4

Q ss_pred             hccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcc--------cHHHHHHHHHHHHhcCCCCceeeeeeeccC
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQ--------GDLEFKNEVLLVANLQHRNLVRLLGFSLEG  392 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~  392 (658)
                      ..++|...+.||+|+||.||+++. .+++.||||++......        ....+.+|+.++.+++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            457899999999999999999984 56889999998765321        223467899999999999999999999999


Q ss_pred             CceEEEEEecCCC-ChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccc
Q 006155          393 NERLLIYEFVPNT-SLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFG  471 (658)
Q Consensus       393 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFG  471 (658)
                      +..++||||+.+| +|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence            9999999999777 99999843   346999999999999999999999998   9999999999999999999999999


Q ss_pred             cccccccCCCccccccccccccccCccccccCCC-CcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCC
Q 006155          472 MARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQY-SVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREG  550 (658)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  550 (658)
                      +++.+....   ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||....     +.       .. .
T Consensus       176 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~-------~~-~  239 (335)
T 3dls_A          176 SAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE-----ET-------VE-A  239 (335)
T ss_dssp             TCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG-----GG-------TT-T
T ss_pred             cceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH-----HH-------Hh-h
Confidence            998765432   2234679999999999988887 789999999999999999999984211     00       00 0


Q ss_pred             CcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          551 TTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       551 ~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                         ....|.   ...+   .+.+++..||+.||++|||+.++++.
T Consensus       240 ---~~~~~~---~~~~---~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          240 ---AIHPPY---LVSK---ELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ---CCCCSS---CCCH---HHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ---ccCCCc---ccCH---HHHHHHHHHccCChhhCcCHHHHhcC
Confidence               000011   1122   34567789999999999999999874

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-39  Score=345.17  Aligned_cols=262  Identities=16%  Similarity=0.181  Sum_probs=202.5

Q ss_pred             ccCCcccCcccccCceEEEEeEecC---------CcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCcee---------
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLYD---------GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVR---------  384 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~---------  384 (658)
                      .++|...+.||+|+||.||+|+...         ++.||||++...     ..+.+|+.++.+++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            4789999999999999999998653         789999998654     35789999999999999998         


Q ss_pred             ------eeeeecc-CCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCce
Q 006155          385 ------LLGFSLE-GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNV  457 (658)
Q Consensus       385 ------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NI  457 (658)
                            +++++.. +...++||||+ +++|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI  190 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI  190 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence                  5566655 67889999999 99999999542 2357999999999999999999999998   99999999999


Q ss_pred             eeCCCC--CeEEeccccccccccCCCc-----cccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCcc
Q 006155          458 LLDAEM--TPKIADFGMARLFEMDETQ-----GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCF  530 (658)
Q Consensus       458 Ll~~~~--~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~  530 (658)
                      |++.++  .+||+|||+++.+......     .......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999998  9999999999876543221     122345899999999999999999999999999999999999999865


Q ss_pred             CCCCCcchHHHHHHHhccCCCcccccCCCCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 006155          531 RNGETVEDLLSSAWKNWREGTTVNIIDPTLSS-GSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYS  600 (658)
Q Consensus       531 ~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~-~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~  600 (658)
                      .... ...+.. ....+.. ....+.++.... ....   .+.+++..||+.||++||++.+|+++|+...
T Consensus       271 ~~~~-~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  335 (352)
T 2jii_A          271 CLPN-TEDIMK-QKQKFVD-KPGPFVGPCGHWIRPSE---TLQKYLKVVMALTYEEKPPYAMLRNNLEALL  335 (352)
T ss_dssp             GTTC-HHHHHH-HHHHHHH-SCCCEECTTSCEECCCH---HHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             CCcC-HHHHHH-HHHhccC-ChhhhhhhccccCCCcH---HHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence            4321 122222 2221111 111222211111 1122   3456777999999999999999999997653

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=6.2e-39  Score=348.31  Aligned_cols=253  Identities=22%  Similarity=0.300  Sum_probs=189.4

Q ss_pred             hhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc--------ccHHHHHHHHHHHHhcCCCCceeeeeeecc
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG--------QGDLEFKNEVLLVANLQHRNLVRLLGFSLE  391 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~  391 (658)
                      ...++|...+.||+|+||.||+|... +++.||||++.....        .....+.+|+.++.+++||||+++++++. 
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            45688999999999999999999854 578999999865321        11224789999999999999999999975 


Q ss_pred             CCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCC---CeEEe
Q 006155          392 GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM---TPKIA  468 (658)
Q Consensus       392 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~---~~kl~  468 (658)
                      .+..++||||+++|+|.+++.   ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++   .+||+
T Consensus       211 ~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          211 AEDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             SSEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             cCceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence            455799999999999999884   3456999999999999999999999988   99999999999997544   59999


Q ss_pred             ccccccccccCCCccccccccccccccCcccccc---CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHH
Q 006155          469 DFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMH---GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWK  545 (658)
Q Consensus       469 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~  545 (658)
                      |||+++.+....   ......||+.|+|||++.+   ..++.++||||||+++|||++|+.||.....  ...+......
T Consensus       285 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~--~~~~~~~i~~  359 (419)
T 3i6u_A          285 DFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT--QVSLKDQITS  359 (419)
T ss_dssp             CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS--SCCHHHHHHT
T ss_pred             ecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc--hHHHHHHHhc
Confidence            999998764322   2334689999999999853   6788999999999999999999999854322  1222222211


Q ss_pred             hccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          546 NWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       546 ~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                          +.....  +.......   ..+.+++..||+.||++|||+.|+++
T Consensus       360 ----~~~~~~--~~~~~~~~---~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          360 ----GKYNFI--PEVWAEVS---EKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             ----TCCCCC--HHHHTTSC---HHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ----CCCCCC--chhhcccC---HHHHHHHHHHccCChhHCcCHHHHhC
Confidence                110000  00000111   23557788999999999999999986

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.1e-38  Score=354.61  Aligned_cols=251  Identities=25%  Similarity=0.351  Sum_probs=202.3

Q ss_pred             hhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceE
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERL  396 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  396 (658)
                      ...++|...+.||+|+||.||+++.. +|+.||||++....   ......+.+|+.++.+++||||+++++++.+.+..+
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  261 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC  261 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence            34578999999999999999999864 58999999996542   233456889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCcC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          397 LIYEFVPNTSLDHFIFDPT-RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      +||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.
T Consensus       262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~  338 (543)
T 3c4z_A          262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVE  338 (543)
T ss_dssp             EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeee
Confidence            9999999999999986532 2456999999999999999999999988   99999999999999999999999999987


Q ss_pred             cccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCC-CcchHHHHHHHhccCCCccc
Q 006155          476 FEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGE-TVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~-~~~~l~~~~~~~~~~~~~~~  554 (658)
                      +.....  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....+.......    .   
T Consensus       339 ~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~----~---  409 (543)
T 3c4z_A          339 LKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ----A---  409 (543)
T ss_dssp             CCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC----C---
T ss_pred             ccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc----c---
Confidence            654322  233458999999999999999999999999999999999999999654322 222222222211    1   


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 006155          555 IIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTM  589 (658)
Q Consensus       555 ~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm  589 (658)
                         ..+......   .+.+++..||+.||++||++
T Consensus       410 ---~~~p~~~s~---~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          410 ---VTYPDKFSP---ASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             ---CCCCTTSCH---HHHHHHHHHSCSSGGGSCCC
T ss_pred             ---cCCCcccCH---HHHHHHHHhccCCHhHCCCC
Confidence               111112122   34466779999999999976

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-38  Score=337.48  Aligned_cols=263  Identities=24%  Similarity=0.299  Sum_probs=196.3

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCccc-----HHHHHHHHHHHHhcCCCCceeeeeeeccCCce
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQG-----DLEFKNEVLLVANLQHRNLVRLLGFSLEGNER  395 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~-----~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  395 (658)
                      ..++|...+.||+|+||.||+++.. +|+.||||++.......     ...+.+|+.++.+++||||+++++++.+.+..
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            4578999999999999999999864 58899999987542211     23578999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ++||||+++ +|..++..  ....+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        88 ~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS  161 (346)
T ss_dssp             EEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             EEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence            999999986 88888743  3356899999999999999999999998   99999999999999999999999999987


Q ss_pred             cccCCCccccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          476 FEMDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      +....  .......||+.|+|||++.+. .++.++||||||+++|||++|..|+...   ...+.+..............
T Consensus       162 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~---~~~~~~~~i~~~~~~~~~~~  236 (346)
T 1ua2_A          162 FGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD---SDLDQLTRIFETLGTPTEEQ  236 (346)
T ss_dssp             TTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHHHCCCCTTT
T ss_pred             ccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC---CHHHHHHHHHHHcCCCChhh
Confidence            64332  223346789999999998764 5899999999999999999999887432   22333333333221111111


Q ss_pred             cc------C----CCCCCCCHHH-----HHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          555 II------D----PTLSSGSITE-----MIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       555 ~~------d----p~l~~~~~~e-----~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                      ..      +    .........+     -..+.+++..||+.||++|||+.|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            00      0    0000001111     1345678889999999999999999864

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4.6e-39  Score=337.54  Aligned_cols=256  Identities=28%  Similarity=0.435  Sum_probs=200.2

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcc--eeEEEeccCC-cccHHHHHHHHHHHHhc-CCCCceeeeeeeccCCceEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAE--IAVKRLSRDS-GQGDLEFKNEVLLVANL-QHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~--vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l  397 (658)
                      .++|...+.||+|+||.||+++.. +|..  +|||++.... ......+.+|+.++.++ +||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            478999999999999999999854 4554  4999887542 23345688999999999 89999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCC
Q 006155          398 IYEFVPNTSLDHFIFDPT-------------RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMT  464 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~  464 (658)
                      ||||+++++|.+++....             ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  180 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence            999999999999996532             2347999999999999999999999988   999999999999999999


Q ss_pred             eEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHH
Q 006155          465 PKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSA  543 (658)
Q Consensus       465 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~  543 (658)
                      +||+|||+++.....   .......+++.|+|||++.+..++.++||||||+++|||++ |+.||....   ..++..  
T Consensus       181 ~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~---~~~~~~--  252 (327)
T 1fvr_A          181 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYE--  252 (327)
T ss_dssp             EEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHH--
T ss_pred             EEEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc---HHHHHH--
Confidence            999999999743321   12223467889999999999999999999999999999998 999984322   222222  


Q ss_pred             HHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          544 WKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       544 ~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                        ....+..     +.......+   .+.+++..||+.||++|||+.++++.|+..
T Consensus       253 --~~~~~~~-----~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~ell~~L~~~  298 (327)
T 1fvr_A          253 --KLPQGYR-----LEKPLNCDD---EVYDLMRQCWREKPYERPSFAQILVSLNRM  298 (327)
T ss_dssp             --HGGGTCC-----CCCCTTBCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --HhhcCCC-----CCCCCCCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence              1222111     111111122   355677899999999999999999999764

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.8e-39  Score=338.87  Aligned_cols=260  Identities=23%  Similarity=0.346  Sum_probs=192.3

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCccc-HHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQG-DLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      ++|...++||+|+||+||+|+.. +++.||||++....... ...+.+|+.++.+++||||+++++++.+++..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57889999999999999999865 68899999986543221 12355799999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      ++ |+|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-  154 (324)
T 3mtl_A           82 LD-KDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-  154 (324)
T ss_dssp             CS-EEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence            97 588888753  2346899999999999999999999998   9999999999999999999999999998654322 


Q ss_pred             ccccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCC---ccccc-
Q 006155          482 QGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGT---TVNII-  556 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~-  556 (658)
                       .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....   ..+.+...........   ..... 
T Consensus       155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~  230 (324)
T 3mtl_A          155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST---VEEQLHFIFRILGTPTEETWPGILS  230 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhCCCChHhchhhhc
Confidence             12234578999999999876 568999999999999999999999985432   2233333332211111   11100 


Q ss_pred             --------CCCCCCCCHH-----HHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          557 --------DPTLSSGSIT-----EMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       557 --------dp~l~~~~~~-----e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                              .+........     .-..+.+++..||+.||++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                    0111000000     0123557888999999999999999985

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.7e-39  Score=343.95  Aligned_cols=200  Identities=27%  Similarity=0.383  Sum_probs=175.1

Q ss_pred             hhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEE
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  398 (658)
                      ...++|...+.||+|+||.||+++.. +|..||+|++..... .....+.+|+.++.+++||||+++++++.+++..++|
T Consensus        30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  109 (360)
T 3eqc_A           30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC  109 (360)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence            44678999999999999999999865 588999999876533 3345688999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCcEEEeccCCCceeeCCCCCeEEeccccccccc
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED-SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE  477 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~  477 (658)
                      |||+++++|.+++..   ...+++..+..++.+++.||.|||+. +   |+||||||+|||++.++.+||+|||++..+.
T Consensus       110 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  183 (360)
T 3eqc_A          110 MEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  183 (360)
T ss_dssp             ECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             EECCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence            999999999999943   34689999999999999999999986 6   9999999999999999999999999997653


Q ss_pred             cCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCcc
Q 006155          478 MDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCF  530 (658)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~  530 (658)
                      ..    ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       184 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  232 (360)
T 3eqc_A          184 DS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP  232 (360)
T ss_dssp             HH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred             cc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            22    22345799999999999999999999999999999999999999854

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.8e-38  Score=349.34  Aligned_cols=262  Identities=18%  Similarity=0.269  Sum_probs=206.1

Q ss_pred             hccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhcCC-CCceeeeeeeccCCceEEEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQH-RNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lv~  399 (658)
                      ..++|.+.++||+|+||.||+|+. .+++.||||++......  .++..|+.++..++| ++|..+..++..++..+|||
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm   82 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM   82 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence            357899999999999999999984 56899999988655432  347899999999987 55666666677888889999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceee---CCCCCeEEecccccccc
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLL---DAEMTPKIADFGMARLF  476 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl---~~~~~~kl~DFGla~~~  476 (658)
                      ||+ +++|.+++..  ....+++..++.|+.||+.||.|||+.+   ||||||||+||||   +.++.+||+|||+++.+
T Consensus        83 e~~-g~sL~~ll~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~  156 (483)
T 3sv0_A           83 DLL-GPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY  156 (483)
T ss_dssp             ECC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             ECC-CCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence            999 9999999853  2356999999999999999999999998   9999999999999   68899999999999877


Q ss_pred             ccCCCc-----cccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCC
Q 006155          477 EMDETQ-----GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGT  551 (658)
Q Consensus       477 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  551 (658)
                      ......     .......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+...........
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (483)
T 3sv0_A          157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS  236 (483)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred             cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence            544322     122356899999999999999999999999999999999999999976554444443333322211111


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          552 TVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       552 ~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      ...+.     ....   ..+.+++..||+.+|++||++.+|+++|+..
T Consensus       237 ~~~l~-----~~~p---~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          237 IEALC-----RGYP---TEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             HHHHH-----TTSC---HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             HHHHh-----cCCc---HHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            11111     0111   2456778899999999999999999988653

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3.1e-39  Score=330.67  Aligned_cols=253  Identities=26%  Similarity=0.396  Sum_probs=196.4

Q ss_pred             hhhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccC-CceEEE
Q 006155          320 RVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEG-NERLLI  398 (658)
Q Consensus       320 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lv  398 (658)
                      ....++|...+.||+|+||.||+++. .|+.||||++....  ....+.+|+.++.+++||||+++++++.+. +..++|
T Consensus        17 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv   93 (278)
T 1byg_A           17 ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   93 (278)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred             cCChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence            34467899999999999999999985 58899999987543  456789999999999999999999987654 478999


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccccc
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~  478 (658)
                      |||+++++|.+++... ....+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++....
T Consensus        94 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           94 TEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             ECCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             EecCCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            9999999999998532 1234899999999999999999999988   99999999999999999999999999875433


Q ss_pred             CCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccC
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID  557 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  557 (658)
                      .     .....+++.|+|||.+.+..++.++||||||+++|||++ |+.|+....   ..++.....    .+.     .
T Consensus       170 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~---~~~~~~~~~----~~~-----~  232 (278)
T 1byg_A          170 T-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPRVE----KGY-----K  232 (278)
T ss_dssp             -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC---GGGHHHHHT----TTC-----C
T ss_pred             c-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHh----cCC-----C
Confidence            2     123467889999999999999999999999999999998 998885432   223322221    111     1


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          558 PTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       558 p~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      +.......+   .+.+++..||+.||++|||+.++++.|+..
T Consensus       233 ~~~~~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~L~~i  271 (278)
T 1byg_A          233 MDAPDGCPP---AVYEVMKNCWHLDAAMRPSFLQLREQLEHI  271 (278)
T ss_dssp             CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCcccCCH---HHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence            111122223   344677799999999999999999999764

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.6e-39  Score=332.01  Aligned_cols=246  Identities=24%  Similarity=0.336  Sum_probs=196.3

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC--cccHHHHHHHHHHHHhc-CCCCceeeeeeeccCCceEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS--GQGDLEFKNEVLLVANL-QHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l  397 (658)
                      ..++|...+.||+|+||.||+++.. +++.||||++....  .....++.+|+..+..+ +||||+++++++.+++..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            4578999999999999999999865 68999999987642  33455688999999999 89999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCC--------------
Q 006155          398 IYEFVPNTSLDHFIFDPT-RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE--------------  462 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~--------------  462 (658)
                      ||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence            999999999999995422 1256899999999999999999999998   9999999999999844              


Q ss_pred             -----CCeEEeccccccccccCCCccccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCc
Q 006155          463 -----MTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETV  536 (658)
Q Consensus       463 -----~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~  536 (658)
                           ..+||+|||++.......      ...||+.|+|||++.+. .++.++||||||+++|||++|+.++...     
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----  234 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG-----  234 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-----
T ss_pred             ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch-----
Confidence                 479999999998754322      23589999999999776 6678999999999999999998765211     


Q ss_pred             chHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          537 EDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       537 ~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                       +.    +.....+..     +.+.....+   .+.+++..||+.||++|||+.++++
T Consensus       235 -~~----~~~~~~~~~-----~~~~~~~~~---~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          235 -DQ----WHEIRQGRL-----PRIPQVLSQ---EFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             -HH----HHHHHTTCC-----CCCSSCCCH---HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -hH----HHHHHcCCC-----CCCCcccCH---HHHHHHHHHhCCCcccCCCHHHHhh
Confidence             11    122222222     122222222   3456777999999999999999975

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3e-39  Score=330.71  Aligned_cols=258  Identities=25%  Similarity=0.331  Sum_probs=200.7

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeec--cCCceEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSL--EGNERLL  397 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~~l  397 (658)
                      .++|+..+.||+|+||.||+++.. +|+.||+|++.....  .....+.+|+.++.+++||||+++++++.  .+...++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            468899999999999999999864 688999999976432  33456889999999999999999999874  4678899


Q ss_pred             EEEecCCCChhhhhcCcC-CCCCCCHHHHHHHHHHHHHHHHHhhhcC--CCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          398 IYEFVPNTSLDHFIFDPT-RRAQLDWERRYKIIGGIARGLLYLHEDS--RLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      ||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+  ..+|+||||||+|||++.++.+||+|||+++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            999999999999986432 2345999999999999999999999975  2349999999999999999999999999998


Q ss_pred             ccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          475 LFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      .......  ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+....   ..++......    +... 
T Consensus       165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~i~~----~~~~-  234 (279)
T 2w5a_A          165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAGKIRE----GKFR-  234 (279)
T ss_dssp             HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHH----TCCC-
T ss_pred             eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC---HHHHHHHHhh----cccc-
Confidence            7543221  1233578999999999999999999999999999999999999985332   2222222222    2111 


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 006155          555 IIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN  597 (658)
Q Consensus       555 ~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~  597 (658)
                          .+.....+   .+.+++..||+.||++||++.||++.+.
T Consensus       235 ----~~~~~~~~---~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          235 ----RIPYRYSD---ELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             ----CCCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             ----cCCcccCH---HHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence                11112222   3456778999999999999999998764

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.6e-38  Score=337.09  Aligned_cols=254  Identities=20%  Similarity=0.334  Sum_probs=201.5

Q ss_pred             hhhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcc--------cHHHHHHHHHHHHhc-CCCCceeeeeee
Q 006155          320 RVATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQ--------GDLEFKNEVLLVANL-QHRNLVRLLGFS  389 (658)
Q Consensus       320 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l-~H~niv~l~~~~  389 (658)
                      ....++|...+.||+|+||.||+++.. +|+.||||++......        ....+.+|+.++.++ +||||+++++++
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  169 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY  169 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence            345578999999999999999999875 6899999998765321        133578899999999 799999999999


Q ss_pred             ccCCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEec
Q 006155          390 LEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIAD  469 (658)
Q Consensus       390 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~D  469 (658)
                      ......++||||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus       170 ~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~D  243 (365)
T 2y7j_A          170 ESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSD  243 (365)
T ss_dssp             EBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred             eeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEe
Confidence            999999999999999999999853   356999999999999999999999988   99999999999999999999999


Q ss_pred             cccccccccCCCccccccccccccccCcccccc------CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHH
Q 006155          470 FGMARLFEMDETQGNTSRIVGTYGYMAPEYAMH------GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSA  543 (658)
Q Consensus       470 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~  543 (658)
                      ||++..+....   ......||+.|+|||++.+      ..++.++||||||+++|||++|+.||...   .....+...
T Consensus       244 fG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~---~~~~~~~~i  317 (365)
T 2y7j_A          244 FGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR---RQILMLRMI  317 (365)
T ss_dssp             CTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHH
T ss_pred             cCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC---CHHHHHHHH
Confidence            99998765432   2234689999999999863      35889999999999999999999998432   222222222


Q ss_pred             HHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          544 WKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       544 ~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ......     ...+... ...   ..+.+++..||+.||++|||+.++++
T Consensus       318 ~~~~~~-----~~~~~~~-~~~---~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          318 MEGQYQ-----FSSPEWD-DRS---STVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHTCCC-----CCHHHHS-SSC---HHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HhCCCC-----CCCcccc-cCC---HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            211100     0000000 111   23557788999999999999999986

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-38  Score=339.00  Aligned_cols=258  Identities=24%  Similarity=0.345  Sum_probs=193.1

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeeccCC------
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGN------  393 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------  393 (658)
                      .++|...+.||+|+||.||+|+. .+|+.||||++.....  .....+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            57899999999999999999985 4689999999865422  23456889999999999999999999987653      


Q ss_pred             ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccc
Q 006155          394 ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMA  473 (658)
Q Consensus       394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla  473 (658)
                      ..++||||+ +++|.+++..    ..+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            469999999 8899999843    46899999999999999999999998   999999999999999999999999999


Q ss_pred             cccccCCCccccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCC-
Q 006155          474 RLFEMDETQGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGT-  551 (658)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-  551 (658)
                      +.....     .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||....   ..+.+........... 
T Consensus       176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~l~~i~~~~g~~~~  247 (367)
T 1cm8_A          176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD---HLDQLKEIMKVTGTPPA  247 (367)
T ss_dssp             EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHHCCCCH
T ss_pred             cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHhcCCCCH
Confidence            875432     234578999999999887 679999999999999999999999985332   2222222111110000 


Q ss_pred             ----------c-------ccccCC---CCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HhccC
Q 006155          552 ----------T-------VNIIDP---TLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL--MLNSY  599 (658)
Q Consensus       552 ----------~-------~~~~dp---~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~--~L~~~  599 (658)
                                .       ......   .+.....+   .+.+++.+||+.||++|||+.|+++  .++..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~  314 (367)
T 1cm8_A          248 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASP---LAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  314 (367)
T ss_dssp             HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCH---HHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCH---HHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence                      0       000000   01111112   3456778999999999999999987  35443

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.1e-38  Score=348.35  Aligned_cols=195  Identities=24%  Similarity=0.397  Sum_probs=154.1

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeecc-----CCc
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLE-----GNE  394 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-----~~~  394 (658)
                      .++|...++||+|+||.||+++.. +|+.||||++....  ......+.+|+.++.+++||||+++++++..     ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            478999999999999999999844 68899999986542  2234568899999999999999999999843     357


Q ss_pred             eEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          395 RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      .++||||+ +++|.+++..   ...+++..+..++.||+.||.|||+.+   ||||||||+||||+.++.+||+|||+++
T Consensus       132 ~~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence            89999998 5789888843   456999999999999999999999998   9999999999999999999999999998


Q ss_pred             ccccCCCc-------------------------cccccccccccccCcccc-ccCCCCcccccccccchHhHHHhC
Q 006155          475 LFEMDETQ-------------------------GNTSRIVGTYGYMAPEYA-MHGQYSVKSDVFSFGVLVLEIISG  524 (658)
Q Consensus       475 ~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~ksDV~S~Gvll~elltG  524 (658)
                      .+......                         ......+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            76532211                         123346889999999976 566799999999999999999994

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4.7e-39  Score=343.23  Aligned_cols=247  Identities=22%  Similarity=0.273  Sum_probs=190.7

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc---ccHHHHHHHHHH-HHhcCCCCceeeeeeeccCCceEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG---QGDLEFKNEVLL-VANLQHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~l  397 (658)
                      .++|+..+.||+|+||.||+++.. +++.||||++.....   .....+..|..+ ++.++||||+++++++.+.+..++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            467899999999999999999865 477899999976532   223345666665 567899999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE  477 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~  477 (658)
                      ||||+++|+|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++++||+|||+++...
T Consensus       117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            9999999999999843   356899999999999999999999988   9999999999999999999999999998643


Q ss_pred             cCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccC
Q 006155          478 MDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID  557 (658)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  557 (658)
                      ..  .......+||+.|+|||++.+..++.++||||||+++|||++|+.||...   ...++.......    .      
T Consensus       191 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~---~~~~~~~~i~~~----~------  255 (373)
T 2r5t_A          191 EH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR---NTAEMYDNILNK----P------  255 (373)
T ss_dssp             CC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS---BHHHHHHHHHHS----C------
T ss_pred             cC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHhc----c------
Confidence            22  12344578999999999999999999999999999999999999998432   222333322221    1      


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 006155          558 PTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVV  593 (658)
Q Consensus       558 p~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv  593 (658)
                      ..+......   .+.+++..||+.||++||++.+.+
T Consensus       256 ~~~~~~~~~---~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          256 LQLKPNITN---SARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             CCCCSSSCH---HHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             cCCCCCCCH---HHHHHHHHHcccCHHhCCCCCCCH
Confidence            011111122   244677799999999999986443

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.8e-39  Score=344.01  Aligned_cols=269  Identities=21%  Similarity=0.266  Sum_probs=197.5

Q ss_pred             cchhhhhhhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCccc-----------HHHHHHHHHHHHhcCCCCc
Q 006155          314 FDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQG-----------DLEFKNEVLLVANLQHRNL  382 (658)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~-----------~~~~~~E~~~l~~l~H~ni  382 (658)
                      ....++....++|...+.||+|+||.||+|+..+|..||||++.......           ...+.+|+.++.+++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            34566778889999999999999999999998889999999986543221           2578999999999999999


Q ss_pred             eeeeeeecc-----CCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCce
Q 006155          383 VRLLGFSLE-----GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNV  457 (658)
Q Consensus       383 v~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NI  457 (658)
                      +++++++..     ....++||||++ |+|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+||
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI  165 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNI  165 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHE
Confidence            999999843     346799999998 678777753  3456999999999999999999999998   99999999999


Q ss_pred             eeCCCCCeEEeccccccccccCCCccccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCc
Q 006155          458 LLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETV  536 (658)
Q Consensus       458 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~  536 (658)
                      |++.++.+||+|||+++......   ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....   .
T Consensus       166 l~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---~  239 (362)
T 3pg1_A          166 LLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST---F  239 (362)
T ss_dssp             EECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS---H
T ss_pred             EEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC---H
Confidence            99999999999999997543322   2334578999999999877 679999999999999999999999985332   2


Q ss_pred             chHHHHHHHhccCCCcc-----------cccCCCC---CCCCHHH-----HHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          537 EDLLSSAWKNWREGTTV-----------NIIDPTL---SSGSITE-----MIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       537 ~~l~~~~~~~~~~~~~~-----------~~~dp~l---~~~~~~e-----~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .+.+.............           +.+...+   .......     -..+.+++..||+.||++|||+.|+++
T Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          240 YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            22222222111111100           0000000   0001100     123567888999999999999999985

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.2e-39  Score=340.69  Aligned_cols=261  Identities=26%  Similarity=0.372  Sum_probs=196.7

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcc--cHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQ--GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      .++|+..+.||+|+||.||+++.. +|+.||||++......  ....+.+|+.++.+++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            467899999999999999999865 4889999998655332  2345789999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus       104 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          104 EFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             ECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             ecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            99999999988743   346999999999999999999999998   999999999999999999999999999865433


Q ss_pred             CCccccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHH-----------hc
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWK-----------NW  547 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~-----------~~  547 (658)
                      ..  ......||+.|+|||++.+. .++.++||||||+++|||++|+.||.....   .+.+.....           .+
T Consensus       178 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~  252 (331)
T 4aaa_A          178 GE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD---IDQLYHIMMCLGNLIPRHQELF  252 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCSCCHHHHHHH
T ss_pred             cc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCCCChhhhhHh
Confidence            22  22345789999999999875 789999999999999999999999854322   111111111           00


Q ss_pred             cCC-CcccccCCCCCCC-CHH-----HHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          548 REG-TTVNIIDPTLSSG-SIT-----EMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       548 ~~~-~~~~~~dp~l~~~-~~~-----e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ... .......+.+... ...     .-..+.+++..||+.||++|||+.|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            000 0011111111111 111     1134667888999999999999999874

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.8e-38  Score=327.77  Aligned_cols=249  Identities=22%  Similarity=0.331  Sum_probs=201.6

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc---ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG---QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  397 (658)
                      ..++|...+.||+|+||.||+++.. +++.+|+|++.....   .....+.+|+.+++.++||||+++++++.+++..++
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV   92 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence            3467889999999999999999865 477899999865432   234568899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE  477 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~  477 (658)
                      ||||+++++|.+++.   ....+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        93 v~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           93 VLELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             EEECCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence            999999999999884   3356999999999999999999999998   9999999999999999999999999998764


Q ss_pred             cCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccC
Q 006155          478 MDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID  557 (658)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  557 (658)
                      ....  ......||+.|+|||++.+..++.++||||||+++|||++|+.|+....   ..+....    ...+.      
T Consensus       167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~----~~~~~------  231 (294)
T 2rku_A          167 YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC---LKETYLR----IKKNE------  231 (294)
T ss_dssp             STTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHH----HHTTC------
T ss_pred             cCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHH----Hhhcc------
Confidence            3222  2334578999999999999999999999999999999999999985322   1122111    11111      


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          558 PTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       558 p~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ..+......   .+.+++..||+.||++|||+.++++
T Consensus       232 ~~~~~~~~~---~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          232 YSIPKHINP---VAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             CCCCTTSCH---HHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             CCCccccCH---HHHHHHHHHcccChhhCcCHHHHhh
Confidence            111111112   3456778999999999999999985

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2e-38  Score=332.91  Aligned_cols=252  Identities=20%  Similarity=0.271  Sum_probs=196.5

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhcC-CCCceeeeeeecc--CCceEEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQ-HRNLVRLLGFSLE--GNERLLI  398 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~--~~~~~lv  398 (658)
                      .++|+..++||+|+||.||+++. .+++.||||++...   ....+.+|+.++.+++ ||||+++++++.+  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            47899999999999999999974 56889999998643   3567899999999997 9999999999987  6678999


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCC-CeEEeccccccccc
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM-TPKIADFGMARLFE  477 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~-~~kl~DFGla~~~~  477 (658)
                      |||+++++|.+++.      .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++ .+||+|||+++.+.
T Consensus       112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            99999999999882      3899999999999999999999988   99999999999999776 89999999998765


Q ss_pred             cCCCccccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhc---------
Q 006155          478 MDETQGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNW---------  547 (658)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~---------  547 (658)
                      ....   .....||..|+|||++.+ ..++.++||||||+++|||++|+.||.....  ..+.+.......         
T Consensus       183 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~--~~~~l~~~~~~~~~~~~~~~~  257 (330)
T 3nsz_A          183 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD--NYDQLVRIAKVLGTEDLYDYI  257 (330)
T ss_dssp             TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS--HHHHHHHHHHHHCHHHHHHHH
T ss_pred             CCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCc--hHHHHHHHHHhcCCchhhhHH
Confidence            4332   234578999999999877 6799999999999999999999999843221  111111111100         


Q ss_pred             ------------------cCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          548 ------------------REGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       548 ------------------~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                                        ......+...........   ..+.+++..||+.||++|||++|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVS---PEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCC---HHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHhccccccchhhhhhhccccchhhhccccccccCC---HHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                              000111111111110011   23557788999999999999999985

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.8e-38  Score=326.99  Aligned_cols=251  Identities=24%  Similarity=0.348  Sum_probs=195.5

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeecc----CCc
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLE----GNE  394 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~  394 (658)
                      ..+.|...+.||+|+||.||+|... ++..||+|++....  ......+.+|+.++.+++||||+++++++..    +..
T Consensus        24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  103 (290)
T 1t4h_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence            3455788889999999999999854 57789999986542  2334568899999999999999999998764    456


Q ss_pred             eEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeC-CCCCeEEeccccc
Q 006155          395 RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLD-AEMTPKIADFGMA  473 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~-~~~~~kl~DFGla  473 (658)
                      .++||||+++++|.+++..   ...+++..++.++.||+.||.|||+.+ .+|+||||||+|||++ .++.+||+|||++
T Consensus       104 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~  179 (290)
T 1t4h_A          104 IVLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEEEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence            7999999999999999943   356899999999999999999999875 3499999999999997 7899999999999


Q ss_pred             cccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcc
Q 006155          474 RLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTV  553 (658)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  553 (658)
                      ......    ......||+.|+|||++. +.++.++||||||+++|||++|+.||....  ........    ...+...
T Consensus       180 ~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--~~~~~~~~----~~~~~~~  248 (290)
T 1t4h_A          180 TLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQ--NAAQIYRR----VTSGVKP  248 (290)
T ss_dssp             GGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS--SHHHHHHH----HTTTCCC
T ss_pred             cccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcC--cHHHHHHH----HhccCCc
Confidence            754332    223457999999999876 569999999999999999999999984322  22222221    1111111


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          554 NIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       554 ~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ...+.    ...+   .+.+++..||+.||++|||+.++++
T Consensus       249 ~~~~~----~~~~---~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          249 ASFDK----VAIP---EVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             GGGGG----CCCH---HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccCC----CCCH---HHHHHHHHHccCChhhCCCHHHHhh
Confidence            11111    1112   3557778999999999999999985

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=6.7e-39  Score=330.02  Aligned_cols=259  Identities=27%  Similarity=0.361  Sum_probs=195.2

Q ss_pred             hccCCcccCcccccCceEEEEeEec--CCc--ceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCc
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY--DGA--EIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNE  394 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~g~--~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  394 (658)
                      ..++|+..+.||+|+||.||+|+..  ++.  .||||++....   ......+.+|+.++.+++||||+++++++.... 
T Consensus        16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   94 (291)
T 1u46_A           16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-   94 (291)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence            4578999999999999999999853  233  58999887542   234457899999999999999999999998765 


Q ss_pred             eEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          395 RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      .++|+||+++++|.+++...  ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        95 ~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           95 MKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             CEEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             ceeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccc
Confidence            88999999999999998542  346899999999999999999999988   9999999999999999999999999998


Q ss_pred             ccccCCCc-cccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCc
Q 006155          475 LFEMDETQ-GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTT  552 (658)
Q Consensus       475 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~  552 (658)
                      .+...... .......+|..|+|||++.+..++.++||||||+++|||++ |+.||....   ..++.......   ...
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~~~~~---~~~  243 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN---GSQILHKIDKE---GER  243 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHHTS---CCC
T ss_pred             cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC---HHHHHHHHHcc---CCC
Confidence            76543321 12334567889999999999999999999999999999999 999985332   22222222111   100


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 006155          553 VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYS  600 (658)
Q Consensus       553 ~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~  600 (658)
                           +........   .+.+++..||+.||++|||+.++++.|+...
T Consensus       244 -----~~~~~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  283 (291)
T 1u46_A          244 -----LPRPEDCPQ---DIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  283 (291)
T ss_dssp             -----CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             -----CCCCcCcCH---HHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence                 111111222   3556778999999999999999999998653

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.3e-38  Score=329.77  Aligned_cols=253  Identities=25%  Similarity=0.382  Sum_probs=196.4

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      ..++|+..+.||+|+||.||+|+.. +|+.||+|++..........+.+|+.++..++||||+++++++..++..++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            4578999999999999999999865 488999999987766677889999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      |+++++|.+++..  ....+++..++.++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||++.......
T Consensus        97 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  171 (302)
T 2j7t_A           97 FCPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL  171 (302)
T ss_dssp             CCTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred             eCCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence            9999999998853  2356999999999999999999999988   9999999999999999999999999976432211


Q ss_pred             CccccccccccccccCcccc-----ccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccc
Q 006155          481 TQGNTSRIVGTYGYMAPEYA-----MHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNI  555 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~-----~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  555 (658)
                        .......||+.|+|||++     ....++.++||||||+++|||++|+.|+....   ...........    .....
T Consensus       172 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~----~~~~~  242 (302)
T 2j7t_A          172 --QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN---PMRVLLKIAKS----DPPTL  242 (302)
T ss_dssp             --HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHS----CCCCC
T ss_pred             --cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC---HHHHHHHHhcc----CCccc
Confidence              112335789999999998     36778999999999999999999999985322   12222221111    11111


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          556 IDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       556 ~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ..+.   ...   ..+.+++..||+.||++|||+.++++
T Consensus       243 ~~~~---~~~---~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          243 LTPS---KWS---VEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             SSGG---GSC---HHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             CCcc---ccC---HHHHHHHHHHcccChhhCCCHHHHhc
Confidence            1110   111   23456778999999999999999874

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=4.5e-39  Score=338.99  Aligned_cols=248  Identities=23%  Similarity=0.320  Sum_probs=201.3

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc---ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG---QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  398 (658)
                      .++|...+.||+|+||.||+++.. +++.+|+|++.....   .....+.+|+.++..++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            467888999999999999999865 477899999865422   2345688999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccccc
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~  478 (658)
                      |||+++++|.+++..   ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       120 ~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          120 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             ECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            999999999998843   356999999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCC
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP  558 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp  558 (658)
                      ...  ......||+.|+|||++.+..++.++||||||+++|||++|+.||....   ..+.......    +.      .
T Consensus       194 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~~~~----~~------~  258 (335)
T 2owb_A          194 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC---LKETYLRIKK----NE------Y  258 (335)
T ss_dssp             TTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHH----TC------C
T ss_pred             Ccc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC---HHHHHHHHhc----CC------C
Confidence            322  2334679999999999999999999999999999999999999985322   1222221111    11      1


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          559 TLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       559 ~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .+......   .+.+++..||+.||++|||+.|+++
T Consensus       259 ~~~~~~~~---~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          259 SIPKHINP---VAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             CCCTTSCH---HHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             CCCccCCH---HHHHHHHHHccCChhHCcCHHHHhc
Confidence            11111112   2446778999999999999999985

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.1e-38  Score=353.90  Aligned_cols=251  Identities=26%  Similarity=0.371  Sum_probs=196.3

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  398 (658)
                      ..++|...++||+|+||+||+++.. ++..||||++....  ......+.+|+.+++.++||||+++++++.+....++|
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3567999999999999999999854 57889999987643  33456789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCC---CCeEEeccccccc
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE---MTPKIADFGMARL  475 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~---~~~kl~DFGla~~  475 (658)
                      |||+++|+|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++..   +.+||+|||+++.
T Consensus       115 ~e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          115 MECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            999999999988843   356899999999999999999999988   9999999999999764   4599999999987


Q ss_pred             cccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccc
Q 006155          476 FEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNI  555 (658)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  555 (658)
                      +....   ......||+.|+|||++. +.++.++|||||||++|||++|+.||...   ...+++.........     .
T Consensus       189 ~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i~~~~~~-----~  256 (494)
T 3lij_A          189 FENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQ---TDQEILRKVEKGKYT-----F  256 (494)
T ss_dssp             CBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCCC-----C
T ss_pred             CCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCC-----C
Confidence            65432   233467999999999876 57999999999999999999999998532   223333333221110     0


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          556 IDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       556 ~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ..+... ...+   .+.+++..||+.||.+|||+.|+++
T Consensus       257 ~~~~~~-~~s~---~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          257 DSPEWK-NVSE---GAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             CSGGGT-TSCH---HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             Cchhcc-cCCH---HHHHHHHHHCCCChhhCccHHHHhc
Confidence            011111 1112   3456778999999999999999984

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.8e-38  Score=346.17  Aligned_cols=200  Identities=25%  Similarity=0.409  Sum_probs=166.5

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeeccC-----C
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEG-----N  393 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~  393 (658)
                      ..++|...+.||+|+||.||+++.. +|+.||||++....  ......+.+|+.++.+++||||+++++++...     +
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            3578999999999999999999854 57889999997642  23345688999999999999999999998766     5


Q ss_pred             ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccc
Q 006155          394 ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMA  473 (658)
Q Consensus       394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla  473 (658)
                      ..++||||++ ++|.+++..   ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla  176 (432)
T 3n9x_A          104 ELYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA  176 (432)
T ss_dssp             CEEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence            7899999986 599999843   456999999999999999999999998   999999999999999999999999999


Q ss_pred             cccccCCCc--------------------cccccccccccccCcccc-ccCCCCcccccccccchHhHHHhCCCCC
Q 006155          474 RLFEMDETQ--------------------GNTSRIVGTYGYMAPEYA-MHGQYSVKSDVFSFGVLVLEIISGQRNN  528 (658)
Q Consensus       474 ~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~s~ksDV~S~Gvll~elltG~~p~  528 (658)
                      +........                    ......+||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            876543211                    123456899999999986 5667999999999999999999865554

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.1e-38  Score=324.22  Aligned_cols=247  Identities=23%  Similarity=0.325  Sum_probs=200.6

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  397 (658)
                      ..++|...+.||+|+||.||+++.. ++..||||++....   ......+.+|+.++.+++||||+++++++.+++..++
T Consensus        12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   91 (284)
T 2vgo_A           12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL   91 (284)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence            3468999999999999999999864 47789999986532   2234578999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE  477 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~  477 (658)
                      ||||+++++|.+++..   ...+++..++.++.||++||.|||+.+   |+||||||+||+++.++.+||+|||++....
T Consensus        92 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~  165 (284)
T 2vgo_A           92 MLEFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP  165 (284)
T ss_dssp             EECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred             EEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence            9999999999999843   346899999999999999999999987   9999999999999999999999999987543


Q ss_pred             cCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccC
Q 006155          478 MDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID  557 (658)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  557 (658)
                      ..    ......||+.|+|||++.+..++.++||||||+++|||++|+.||....   ..+......    ..      +
T Consensus       166 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~~~----~~------~  228 (284)
T 2vgo_A          166 SL----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS---HTETHRRIV----NV------D  228 (284)
T ss_dssp             SS----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHH----TT------C
T ss_pred             cc----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC---HhHHHHHHh----cc------c
Confidence            32    2234578999999999999999999999999999999999999985322   122221111    11      1


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          558 PTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       558 p~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ..+......   .+.+++..||+.||++||++.++++
T Consensus       229 ~~~~~~~~~---~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          229 LKFPPFLSD---GSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             CCCCTTSCH---HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCCCCcCCH---HHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            111122122   3456778999999999999999985

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3e-38  Score=336.53  Aligned_cols=261  Identities=21%  Similarity=0.313  Sum_probs=198.2

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcc-cHHHHHHHHHHHHhcCCCCceeeeeeeccC-----Cce
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQ-GDLEFKNEVLLVANLQHRNLVRLLGFSLEG-----NER  395 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~  395 (658)
                      .++|...+.||+|+||.||+++.. ++..||||++...... ....+.+|+.++.+++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            468999999999999999999854 5788999999754332 335688999999999999999999998654     367


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ++||||++ ++|.+++.    ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       106 ~iv~e~~~-~~L~~~l~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EEEEECCS-EEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcccC-cCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            99999997 58988883    345999999999999999999999998   99999999999999999999999999987


Q ss_pred             cccCCCc-cccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcc
Q 006155          476 FEMDETQ-GNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTV  553 (658)
Q Consensus       476 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  553 (658)
                      ....... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.....   .+.+.............
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~  254 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY---LDQLNHILGILGSPSQE  254 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG---GGHHHHHHHHHCSCCHH
T ss_pred             cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh---HHHHHHHHHHhCCCCHH
Confidence            6543322 12344689999999998765 4589999999999999999999999854332   22222222111110000


Q ss_pred             cc-----------c--CCCCCCCCHHH-----HHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          554 NI-----------I--DPTLSSGSITE-----MIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       554 ~~-----------~--dp~l~~~~~~e-----~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .+           .  .+........+     -..+.+++..||+.||++|||+.|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00           0  00000001111     123567888999999999999999985

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.5e-38  Score=333.50  Aligned_cols=256  Identities=22%  Similarity=0.313  Sum_probs=202.9

Q ss_pred             hhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCccc-----------------HHHHHHHHHHHHhcCCCCce
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQG-----------------DLEFKNEVLLVANLQHRNLV  383 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~-----------------~~~~~~E~~~l~~l~H~niv  383 (658)
                      ...++|...+.||+|+||.||+++. +|+.||||++.......                 ...+.+|+.++.+++||||+
T Consensus        28 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~  106 (348)
T 2pml_X           28 KYINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL  106 (348)
T ss_dssp             EEETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred             cccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence            3457899999999999999999997 89999999986542211                 16789999999999999999


Q ss_pred             eeeeeeccCCceEEEEEecCCCChhhh------hcCcCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCcEEEeccCCCc
Q 006155          384 RLLGFSLEGNERLLIYEFVPNTSLDHF------IFDPTRRAQLDWERRYKIIGGIARGLLYLHE-DSRLRIIHRDLKTSN  456 (658)
Q Consensus       384 ~l~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~N  456 (658)
                      ++++++.+.+..++||||+++++|.++      +.. .....+++..++.++.||+.||.|||+ .+   |+||||||+|
T Consensus       107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~N  182 (348)
T 2pml_X          107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSN  182 (348)
T ss_dssp             CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGG
T ss_pred             eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHh
Confidence            999999999999999999999999998      432 225679999999999999999999998 77   9999999999


Q ss_pred             eeeCCCCCeEEeccccccccccCCCccccccccccccccCccccccC-CCCc-ccccccccchHhHHHhCCCCCccCCCC
Q 006155          457 VLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG-QYSV-KSDVFSFGVLVLEIISGQRNNCFRNGE  534 (658)
Q Consensus       457 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-ksDV~S~Gvll~elltG~~p~~~~~~~  534 (658)
                      ||++.++.+||+|||++......    ......||+.|+|||++.+. .++. ++||||||+++|||++|+.||......
T Consensus       183 il~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  258 (348)
T 2pml_X          183 ILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL  258 (348)
T ss_dssp             EEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred             EEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence            99999999999999999875433    23346789999999999887 6766 999999999999999999998543321


Q ss_pred             CcchHHHHHHHhccCCCcccc------cCCCCC-------CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          535 TVEDLLSSAWKNWREGTTVNI------IDPTLS-------SGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       535 ~~~~l~~~~~~~~~~~~~~~~------~dp~l~-------~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                        .++....    ..+.....      ..+...       ....   ..+.+++..||+.||++|||+.|+++
T Consensus       259 --~~~~~~i----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          259 --VELFNNI----RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLS---NEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             --HHHHHHH----TSCCCCCCCSSSSSTTTTCC--------CCC---HHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             --HHHHHHH----hccCcCCccchhhhhccccccccccchhhcC---HHHHHHHHHHccCChhhCCCHHHHhc
Confidence              2222222    11111000      000000       1111   23557788999999999999999985

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3.8e-38  Score=342.18  Aligned_cols=258  Identities=24%  Similarity=0.336  Sum_probs=191.7

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccC----C--ce
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEG----N--ER  395 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~----~--~~  395 (658)
                      ..+|...+.||+|+||.||+|+.. +|+.||||++.....    .+.+|++++++++||||+++++++...    +  ..
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            456888999999999999999864 589999999865432    234799999999999999999988532    2  35


Q ss_pred             EEEEEecCCCChhhhhcC-cCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCC-CCeEEeccccc
Q 006155          396 LLIYEFVPNTSLDHFIFD-PTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE-MTPKIADFGMA  473 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~-~~~kl~DFGla  473 (658)
                      ++||||+++ +|.+++.. ......+++..++.++.||++||.|||+.+   |+||||||+||||+.+ +.+||+|||++
T Consensus       129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence            799999986 55555432 123467999999999999999999999987   9999999999999965 56899999999


Q ss_pred             cccccCCCccccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccC---
Q 006155          474 RLFEMDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWRE---  549 (658)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---  549 (658)
                      +.+.....   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||....   ..+.+....+....   
T Consensus       205 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~---~~~~l~~i~~~lg~p~~  278 (420)
T 1j1b_A          205 KQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS---GVDQLVEIIKVLGTPTR  278 (420)
T ss_dssp             EECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHHCSCCH
T ss_pred             hhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhCCCCH
Confidence            87644322   2335789999999998765 79999999999999999999999985432   22222222221111   


Q ss_pred             -------CCcccccCCCCCCCCHHHH------HHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          550 -------GTTVNIIDPTLSSGSITEM------IRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       550 -------~~~~~~~dp~l~~~~~~e~------~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                             ....+...|.+........      ..+.+++.+||+.||++|||+.|+++
T Consensus       279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence                   1111111222222221111      34567888999999999999999984

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=9.3e-39  Score=333.29  Aligned_cols=266  Identities=21%  Similarity=0.336  Sum_probs=193.4

Q ss_pred             ccCCcccCcccccCceEEEEeEecC-CcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeec-----------
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSL-----------  390 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~-----------  390 (658)
                      .++|...+.||+|+||.||+|+... |+.||||++..........+.+|+.++.+++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            4789999999999999999998654 8899999998766566677899999999999999999998873           


Q ss_pred             ---cCCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeC-CCCCeE
Q 006155          391 ---EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLD-AEMTPK  466 (658)
Q Consensus       391 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~-~~~~~k  466 (658)
                         +....++||||++ |+|.+++.    ...+++..++.++.||++||.|||+.+   |+||||||+|||++ +++.+|
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence               3467799999998 69999983    356899999999999999999999988   99999999999997 567999


Q ss_pred             EeccccccccccCCC-ccccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHH
Q 006155          467 IADFGMARLFEMDET-QGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAW  544 (658)
Q Consensus       467 l~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~  544 (658)
                      |+|||+++....... ........+|..|+|||.+.+ ..++.++||||||+++|||++|+.||.....   .+......
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~~~~~~~~  238 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE---LEQMQLIL  238 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH---HHHHHHHH
Confidence            999999987643221 122334567999999998865 6799999999999999999999999854322   12222211


Q ss_pred             HhccCCC---cccccC-------CCC--CCCCHHH-----HHHHHHHHHHhcCCCCCCCCCHHHHHH--HhccC
Q 006155          545 KNWREGT---TVNIID-------PTL--SSGSITE-----MIRCIHIGLLCVQENVASRPTMASVVL--MLNSY  599 (658)
Q Consensus       545 ~~~~~~~---~~~~~d-------p~l--~~~~~~e-----~~~~~~i~~~Cl~~~p~~RPtm~evv~--~L~~~  599 (658)
                      .......   ..++..       ...  ......+     -..+.+++..||+.||++|||+.|+++  .++..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  312 (320)
T 2i6l_A          239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY  312 (320)
T ss_dssp             HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence            1110000   000000       000  0000000     123567888999999999999999985  45443

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.4e-38  Score=352.40  Aligned_cols=252  Identities=25%  Similarity=0.339  Sum_probs=199.7

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccC--CcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRD--SGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  398 (658)
                      ..++|...++||+|+||+||+++.. +++.||||++...  .......+.+|+.++.+++||||+++++++.+....++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            4578999999999999999999854 6889999998643  233456789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeC---CCCCeEEeccccccc
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLD---AEMTPKIADFGMARL  475 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~---~~~~~kl~DFGla~~  475 (658)
                      |||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++   .++.+||+|||+++.
T Consensus       100 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A          100 GELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             EEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            999999999988843   356999999999999999999999998   99999999999995   456799999999987


Q ss_pred             cccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccc
Q 006155          476 FEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNI  555 (658)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  555 (658)
                      +....   ......||+.|+|||++.+ .++.++|||||||++|||++|+.||...   ...+++......    .... 
T Consensus       174 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i~~~----~~~~-  241 (486)
T 3mwu_A          174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK---NEYDILKRVETG----KYAF-  241 (486)
T ss_dssp             BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHT----CCCS-
T ss_pred             CCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhC----CCCC-
Confidence            65432   2334579999999999865 6999999999999999999999998432   222333332221    1100 


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          556 IDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       556 ~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                      ..|... ...+   .+.+++..||+.||++|||+.++++.
T Consensus       242 ~~~~~~-~~s~---~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          242 DLPQWR-TISD---DAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             CSGGGG-GSCH---HHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             CCcccC-CCCH---HHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            001000 1112   34567789999999999999999863

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.6e-38  Score=362.48  Aligned_cols=250  Identities=26%  Similarity=0.286  Sum_probs=201.0

Q ss_pred             hhhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccC---CcccHHHHHHHHHHHHhc-CCCCceeeeeeeccCCc
Q 006155          320 RVATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRD---SGQGDLEFKNEVLLVANL-QHRNLVRLLGFSLEGNE  394 (658)
Q Consensus       320 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~  394 (658)
                      +...++|...++||+|+||.||+++.. +++.||||++...   .......+..|..++..+ +||||+++++++.+.+.
T Consensus       337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~  416 (674)
T 3pfq_A          337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR  416 (674)
T ss_dssp             ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred             cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence            345678999999999999999999854 5778999998753   223445678899999887 69999999999999999


Q ss_pred             eEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          395 RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      .+|||||+++|+|.+++..   ...+++..++.++.||+.||+|||+.+   ||||||||+||||+.++++||+|||+++
T Consensus       417 ~~lV~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~  490 (674)
T 3pfq_A          417 LYFVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK  490 (674)
T ss_dssp             EEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred             EEEEEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceee
Confidence            9999999999999999953   356999999999999999999999998   9999999999999999999999999998


Q ss_pred             ccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          475 LFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      ......  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...   +..++......    +.   
T Consensus       491 ~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~---~~~~~~~~i~~----~~---  558 (674)
T 3pfq_A          491 ENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE---DEDELFQSIME----HN---  558 (674)
T ss_dssp             ECCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHS----SC---
T ss_pred             ccccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC---CHHHHHHHHHh----CC---
Confidence            643222  2344578999999999999999999999999999999999999998532   23333333322    11   


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHH
Q 006155          555 IIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTM-----ASVV  593 (658)
Q Consensus       555 ~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm-----~evv  593 (658)
                         ..+......   .+.+++..||+.||++||++     .||+
T Consensus       559 ---~~~p~~~s~---~~~~li~~lL~~dP~~R~~~~~~~~~ei~  596 (674)
T 3pfq_A          559 ---VAYPKSMSK---EAVAICKGLMTKHPGKRLGCGPEGERDIK  596 (674)
T ss_dssp             ---CCCCTTSCH---HHHHHHHHHSCSSSTTCTTCSTTHHHHHH
T ss_pred             ---CCCCccCCH---HHHHHHHHHccCCHHHCCCCCCCcHHHHh
Confidence               111112122   34567779999999999997     6666

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.8e-38  Score=330.87  Aligned_cols=260  Identities=21%  Similarity=0.293  Sum_probs=196.5

Q ss_pred             cchhhhhhhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCC--cccHHHHHHHHHHHHhcC--CCCceeeeeee
Q 006155          314 FDFNTIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQ--HRNLVRLLGFS  389 (658)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~--H~niv~l~~~~  389 (658)
                      +.+..+....++|...+.||+|+||.||+++..+++.||||++....  ......+.+|+.++.+++  ||||+++++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~   97 (313)
T 3cek_A           18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE   97 (313)
T ss_dssp             --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred             CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence            44555667778999999999999999999998889999999986543  233456899999999997  59999999999


Q ss_pred             ccCCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEec
Q 006155          390 LEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIAD  469 (658)
Q Consensus       390 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~D  469 (658)
                      ..++..++||| +.+++|.+++..   ...+++..++.++.||++||.|||+.+   |+||||||+|||+++ +.+||+|
T Consensus        98 ~~~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~D  169 (313)
T 3cek_A           98 ITDQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLID  169 (313)
T ss_dssp             ECSSEEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECC
T ss_pred             ecCCEEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEee
Confidence            99999999999 678899999853   356899999999999999999999997   999999999999964 8999999


Q ss_pred             cccccccccCCCccccccccccccccCcccccc-----------CCCCcccccccccchHhHHHhCCCCCccCCCCCcch
Q 006155          470 FGMARLFEMDETQGNTSRIVGTYGYMAPEYAMH-----------GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVED  538 (658)
Q Consensus       470 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~  538 (658)
                      ||+++.+.............||+.|+|||++.+           ..++.++||||||+++|||++|+.||.....  ...
T Consensus       170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~~  247 (313)
T 3cek_A          170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QIS  247 (313)
T ss_dssp             CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS--HHH
T ss_pred             ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH--HHH
Confidence            999987654433333345679999999999875           4788999999999999999999999843221  111


Q ss_pred             HHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          539 LLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       539 l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .+   ........     ...+......   .+.+++..||+.||++||++.|+++
T Consensus       248 ~~---~~~~~~~~-----~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          248 KL---HAIIDPNH-----EIEFPDIPEK---DLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             HH---HHHHCTTS-----CCCCCCCSCH---HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HH---HHHHhccc-----ccCCcccchH---HHHHHHHHHccCCcccCcCHHHHhc
Confidence            11   11111111     0111111222   3456777999999999999999985

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.1e-38  Score=328.32  Aligned_cols=254  Identities=27%  Similarity=0.353  Sum_probs=185.2

Q ss_pred             hhhccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCccc-H-HHHHHHHHHHHhcCCCCceeeeeeeccCCceE
Q 006155          320 RVATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQG-D-LEFKNEVLLVANLQHRNLVRLLGFSLEGNERL  396 (658)
Q Consensus       320 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~-~-~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  396 (658)
                      ++..++|+..+.||+|+||.||+++. .+|+.||||++....... . ..+.++...++.++||||+++++++.+++..+
T Consensus         3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~   82 (290)
T 3fme_A            3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW   82 (290)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred             cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence            45568899999999999999999985 468899999997653222 2 23445555678889999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCc-CCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          397 LIYEFVPNTSLDHFIFDP-TRRAQLDWERRYKIIGGIARGLLYLHED-SRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      +||||++ |+|.+++... .....+++..++.++.||+.||.|||++ +   |+||||||+|||++.++.+||+|||+++
T Consensus        83 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T 3fme_A           83 ICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISG  158 (290)
T ss_dssp             EEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC----
T ss_pred             EEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcc
Confidence            9999997 5887776431 2345799999999999999999999997 7   9999999999999999999999999998


Q ss_pred             ccccCCCccccccccccccccCcccc----ccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCC
Q 006155          475 LFEMDETQGNTSRIVGTYGYMAPEYA----MHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREG  550 (658)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  550 (658)
                      .+....   ......||+.|+|||++    .+..++.++||||||+++|||++|+.|+....  .....+.....   ..
T Consensus       159 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~---~~  230 (290)
T 3fme_A          159 YLVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG--TPFQQLKQVVE---EP  230 (290)
T ss_dssp             --------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS--CHHHHHHHHHH---SC
T ss_pred             cccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC--chHHHHHHHhc---cC
Confidence            764432   22234789999999996    56678999999999999999999999985322  11112222111   11


Q ss_pred             CcccccCCCCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          551 TTVNIIDPTLSS-GSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       551 ~~~~~~dp~l~~-~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .      +.... ....   .+.+++..||+.||++|||+.|+++
T Consensus       231 ~------~~~~~~~~~~---~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          231 S------PQLPADKFSA---EFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             C------CCCCTTTSCH---HHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             C------CCcccccCCH---HHHHHHHHHhhcChhhCcCHHHHHh
Confidence            1      11111 1122   3456778999999999999999975

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=6.7e-39  Score=354.85  Aligned_cols=252  Identities=26%  Similarity=0.341  Sum_probs=202.5

Q ss_pred             hhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceE
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERL  396 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  396 (658)
                      ...++|...++||+|+||.||+++.. +|+.||||++....   ......+.+|+.++.+++||||+++++++.+.+..+
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  102 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY  102 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            34578999999999999999999854 68899999986542   345567899999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceee---CCCCCeEEeccccc
Q 006155          397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLL---DAEMTPKIADFGMA  473 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl---~~~~~~kl~DFGla  473 (658)
                      +||||+.+|+|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+|||++
T Consensus       103 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a  176 (484)
T 3nyv_A          103 LVGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS  176 (484)
T ss_dssp             EEECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred             EEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence            99999999999998853   356999999999999999999999998   9999999999999   56789999999999


Q ss_pred             cccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcc
Q 006155          474 RLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTV  553 (658)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  553 (658)
                      +.+....   ......||+.|+|||++.+ .++.++||||||+++|||++|+.||...   ...+++......    ...
T Consensus       177 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i~~~----~~~  245 (484)
T 3nyv_A          177 THFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA---NEYDILKKVEKG----KYT  245 (484)
T ss_dssp             HHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHC----CCC
T ss_pred             EEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHcC----CCC
Confidence            8765432   2334579999999998865 7999999999999999999999998532   223333332221    110


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          554 NIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       554 ~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      . ..|... ...   ..+.+++..||+.||++|||+.|+++
T Consensus       246 ~-~~~~~~-~~s---~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          246 F-ELPQWK-KVS---ESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             C-CSGGGG-GSC---HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             C-CCcccc-cCC---HHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            0 001000 111   23456778999999999999999984

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.4e-37  Score=322.52  Aligned_cols=252  Identities=21%  Similarity=0.271  Sum_probs=195.9

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC----cccHHHHHHHHHHHHhcCCCCceeeeeee--ccCCce
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS----GQGDLEFKNEVLLVANLQHRNLVRLLGFS--LEGNER  395 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~--~~~~~~  395 (658)
                      .++|...+.||+|+||.||+++.. +++.||||++....    ......+.+|+.++.+++||||+++++++  .+.+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            468999999999999999999853 57899999986542    23456789999999999999999999998  445678


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ++||||++++ |.+++... ....+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence            9999999887 66666432 3456999999999999999999999998   99999999999999999999999999987


Q ss_pred             cccCCCccccccccccccccCccccccCC--CCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcc
Q 006155          476 FEMDETQGNTSRIVGTYGYMAPEYAMHGQ--YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTV  553 (658)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  553 (658)
                      ..............||+.|+|||++.+..  ++.++||||||+++|||++|+.|+...   ....+......    +.  
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~---~~~~~~~~i~~----~~--  229 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD---NIYKLFENIGK----GS--  229 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHH----CC--
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc---hHHHHHHHHhc----CC--
Confidence            65433333334567999999999987654  478999999999999999999998532   22222222211    11  


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          554 NIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       554 ~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                          ..+.....+   .+.+++.+||+.||++|||+.|+++.
T Consensus       230 ----~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          230 ----YAIPGDCGP---PLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             ----CCCCSSSCH---HHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ----CCCCCccCH---HHHHHHHHHccCChhhCCCHHHHhcC
Confidence                111122222   34467789999999999999999953

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=8.9e-39  Score=326.64  Aligned_cols=248  Identities=24%  Similarity=0.351  Sum_probs=193.7

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  397 (658)
                      ..++|...+.||+|+||.||+|+.. +|+.||||++....   ......+.+|+.++..++||||+++++++.+.+..++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM   88 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence            4578999999999999999999865 68999999986542   2334578899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE  477 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~  477 (658)
                      ||||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        89 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  162 (276)
T 2h6d_A           89 VMEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS  162 (276)
T ss_dssp             EEECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred             EEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccC
Confidence            9999999999999843   346899999999999999999999998   9999999999999999999999999998764


Q ss_pred             cCCCccccccccccccccCccccccCCC-CcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccccc
Q 006155          478 MDETQGNTSRIVGTYGYMAPEYAMHGQY-SVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNII  556 (658)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  556 (658)
                      ...   ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.|+...   ....+......    +.     
T Consensus       163 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~---~~~~~~~~~~~----~~-----  227 (276)
T 2h6d_A          163 DGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE---HVPTLFKKIRG----GV-----  227 (276)
T ss_dssp             C----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHH----CC-----
T ss_pred             CCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC---cHHHHHHHhhc----Cc-----
Confidence            332   1234578999999999988765 68999999999999999999998432   22222222211    11     


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          557 DPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       557 dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                       ..+......   .+.+++..||+.||++|||+.++++
T Consensus       228 -~~~~~~~~~---~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          228 -FYIPEYLNR---SVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             -CCCCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -ccCchhcCH---HHHHHHHHHccCChhhCCCHHHHHh
Confidence             011111112   3456778999999999999999986

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=4.3e-39  Score=344.03  Aligned_cols=253  Identities=10%  Similarity=0.032  Sum_probs=178.2

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc---ccHHHHHHHHHHHHhc--CCCCceeee-------ee
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG---QGDLEFKNEVLLVANL--QHRNLVRLL-------GF  388 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l--~H~niv~l~-------~~  388 (658)
                      ...+|...+.||+|+||.||+|+.. +|+.||||++.....   .....+.+|+.++..+  +||||++++       ++
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred             CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence            3456899999999999999999854 688999999987543   2334577886555555  699988855       33


Q ss_pred             eccC-----------------CceEEEEEecCCCChhhhhcCcCCCCCCCHHHH------HHHHHHHHHHHHHhhhcCCC
Q 006155          389 SLEG-----------------NERLLIYEFVPNTSLDHFIFDPTRRAQLDWERR------YKIIGGIARGLLYLHEDSRL  445 (658)
Q Consensus       389 ~~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~  445 (658)
                      +...                 ...++||||++ |+|.+++...  ...+.+..+      +.++.||++||.|||+.+  
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--  214 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG--  214 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence            3222                 33799999999 8999999543  223566666      788899999999999988  


Q ss_pred             cEEEeccCCCceeeCCCCCeEEeccccccccccCCCccccccccccccccCcccccc--CCCCcccccccccchHhHHHh
Q 006155          446 RIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMH--GQYSVKSDVFSFGVLVLEIIS  523 (658)
Q Consensus       446 ~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~S~Gvll~ellt  523 (658)
                       |+||||||+|||++.++.+||+|||+++.....     .....+|+.|+|||++.+  ..++.++||||||+++|||++
T Consensus       215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt  288 (371)
T 3q60_A          215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC  288 (371)
T ss_dssp             -EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred             -CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence             999999999999999999999999999865321     113567799999999987  679999999999999999999


Q ss_pred             CCCCCccCCCCCcchHHHHHHHhc--cCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          524 GQRNNCFRNGETVEDLLSSAWKNW--REGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       524 G~~p~~~~~~~~~~~l~~~~~~~~--~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      |+.||..........     +...  ..........+.. ....+   .+.+++..||+.||++|||+.++++
T Consensus       289 g~~Pf~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~-~~~~~---~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          289 LFLPFGLVTPGIKGS-----WKRPSLRVPGTDSLAFGSC-TPLPD---FVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             SSCSTTBCCTTCTTC-----CCBCCTTSCCCCSCCCTTS-SCCCH---HHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCCCCcCcccccc-----hhhhhhhhccccccchhhc-cCCCH---HHHHHHHHHcCCChhhCCCHHHHhc
Confidence            999996543221110     0000  0000001111111 11122   3456778999999999999999973

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.1e-38  Score=337.99  Aligned_cols=257  Identities=25%  Similarity=0.335  Sum_probs=181.5

Q ss_pred             hccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeeccC------
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEG------  392 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------  392 (658)
                      ..++|...+.||+|+||.||+|+. .+|+.||||++....  ......+.+|+.+++.++||||+++++++...      
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            357899999999999999999984 468899999987642  23345688999999999999999999998654      


Q ss_pred             CceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccc
Q 006155          393 NERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGM  472 (658)
Q Consensus       393 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGl  472 (658)
                      ...++|+||+ +++|.+++..    ..+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       107 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~  178 (367)
T 2fst_X          107 NDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL  178 (367)
T ss_dssp             CCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred             CeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence            5679999999 7899888842    56999999999999999999999988   99999999999999999999999999


Q ss_pred             ccccccCCCccccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCC
Q 006155          473 ARLFEMDETQGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGT  551 (658)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  551 (658)
                      ++.....     .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||....   ..+.+....+......
T Consensus       179 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~l~~i~~~~g~p~  250 (367)
T 2fst_X          179 ARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---HIDQLKLILRLVGTPG  250 (367)
T ss_dssp             -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCSCC
T ss_pred             ccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhCCCC
Confidence            9865422     234578999999999877 679999999999999999999999985432   2222222222111100


Q ss_pred             c-----------ccccC--CCCCCCCHHHH-----HHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          552 T-----------VNIID--PTLSSGSITEM-----IRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       552 ~-----------~~~~d--p~l~~~~~~e~-----~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .           ...+.  +........++     ..+.+++.+||+.||++|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence            0           00000  00111111111     23567788999999999999999985

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=8.3e-38  Score=347.72  Aligned_cols=251  Identities=26%  Similarity=0.348  Sum_probs=198.0

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc-------------ccHHHHHHHHHHHHhcCCCCceeeee
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG-------------QGDLEFKNEVLLVANLQHRNLVRLLG  387 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l~~  387 (658)
                      ..++|...++||+|+||+||+++.. +++.||||++.....             .....+.+|+.++.+++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4578999999999999999999854 578899999875431             23456889999999999999999999


Q ss_pred             eeccCCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCC---C
Q 006155          388 FSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM---T  464 (658)
Q Consensus       388 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~---~  464 (658)
                      ++.++...++||||+++|+|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++   .
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence            99999999999999999999998843   356999999999999999999999998   99999999999998776   6


Q ss_pred             eEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHH
Q 006155          465 PKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAW  544 (658)
Q Consensus       465 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~  544 (658)
                      +||+|||+++.+....   ......||+.|+|||++. +.++.++||||||+++|||++|+.||...   ...+++....
T Consensus       188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i~  260 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQ---NDQDIIKKVE  260 (504)
T ss_dssp             EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHH
T ss_pred             EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHH
Confidence            9999999998765432   233457999999999876 57999999999999999999999998532   2233333332


Q ss_pred             HhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          545 KNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       545 ~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ..    ....  +........   ..+.+++..||+.||.+|||+.|+++
T Consensus       261 ~~----~~~~--~~~~~~~~s---~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          261 KG----KYYF--DFNDWKNIS---DEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HC----CCCC--CHHHHTTSC---HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cC----CCCC--CccccCCCC---HHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            21    1100  000000111   23557778999999999999999984

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.5e-38  Score=330.38  Aligned_cols=259  Identities=28%  Similarity=0.436  Sum_probs=197.7

Q ss_pred             cchhhhhhhccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhc-CCCCceeeeeeecc
Q 006155          314 FDFNTIRVATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANL-QHRNLVRLLGFSLE  391 (658)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~  391 (658)
                      +++..+....++|...+.||+|+||.||+|+. .+|+.||||++.... .....+.+|+.++.++ +||||+++++++..
T Consensus        14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   92 (326)
T 2x7f_A           14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK   92 (326)
T ss_dssp             --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred             ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence            45566677889999999999999999999985 468899999986543 3456789999999999 79999999999876


Q ss_pred             ------CCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCe
Q 006155          392 ------GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP  465 (658)
Q Consensus       392 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~  465 (658)
                            .+..++||||+++++|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~  168 (326)
T 2x7f_A           93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV  168 (326)
T ss_dssp             CC--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred             ccCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence                  46789999999999999998542 2356899999999999999999999988   9999999999999999999


Q ss_pred             EEeccccccccccCCCccccccccccccccCccccc-----cCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHH
Q 006155          466 KIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM-----HGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL  540 (658)
Q Consensus       466 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~  540 (658)
                      ||+|||++..+....  .......||+.|+|||++.     +..++.++||||||+++|||++|+.|+....   .....
T Consensus       169 kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~  243 (326)
T 2x7f_A          169 KLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH---PMRAL  243 (326)
T ss_dssp             EECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC---HHHHH
T ss_pred             EEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc---HHHHH
Confidence            999999998654322  1223457899999999987     5678999999999999999999999984322   11111


Q ss_pred             HHHHHhccCCCcccccCCCCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          541 SSAWKNWREGTTVNIIDPTLSSG-SITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       541 ~~~~~~~~~~~~~~~~dp~l~~~-~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .....    ...     +.+... ...   .+.+++..||+.||++||++.++++
T Consensus       244 ~~~~~----~~~-----~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          244 FLIPR----NPA-----PRLKSKKWSK---KFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHHHH----SCC-----CCCSCSCSCH---HHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHhhc----Ccc-----ccCCccccCH---HHHHHHHHHhccChhhCCCHHHHhh
Confidence            11111    111     111111 122   3456778999999999999999986

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.7e-38  Score=340.19  Aligned_cols=262  Identities=23%  Similarity=0.265  Sum_probs=198.9

Q ss_pred             hccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhcC--------CCCceeeeeeec--
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQ--------HRNLVRLLGFSL--  390 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~~~~~--  390 (658)
                      ..++|...++||+|+||.||+++. .+++.||||++... ......+.+|+.++..++        |+||+++++++.  
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~  113 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS  113 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence            457899999999999999999984 45889999999643 233456889999999986        788999999987  


Q ss_pred             --cCCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCcEEEeccCCCceeeCCCC----
Q 006155          391 --EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED-SRLRIIHRDLKTSNVLLDAEM----  463 (658)
Q Consensus       391 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlk~~NILl~~~~----  463 (658)
                        .+...++||||+ +++|.+++.. .....+++..++.++.||+.||.|||++ +   |+||||||+||||+.++    
T Consensus       114 ~~~~~~~~lv~e~~-~~~l~~~~~~-~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~  188 (397)
T 1wak_A          114 GVNGTHICMVFEVL-GHHLLKWIIK-SNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIR  188 (397)
T ss_dssp             ETTEEEEEEEECCC-CCBHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHH
T ss_pred             CCCCceEEEEEecc-CccHHHHHHh-cccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhh
Confidence              566889999999 5555555532 2235699999999999999999999998 7   99999999999999775    


Q ss_pred             ---------------------------------------------CeEEeccccccccccCCCccccccccccccccCcc
Q 006155          464 ---------------------------------------------TPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE  498 (658)
Q Consensus       464 ---------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE  498 (658)
                                                                   .+||+|||+++.....     .....||+.|+|||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE  263 (397)
T 1wak_A          189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLE  263 (397)
T ss_dssp             HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHH
T ss_pred             hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCCh
Confidence                                                         8999999999865432     23357899999999


Q ss_pred             ccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcc---hHHHHHHHhccC--------CC-cccccCC--------
Q 006155          499 YAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVE---DLLSSAWKNWRE--------GT-TVNIIDP--------  558 (658)
Q Consensus       499 ~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~---~l~~~~~~~~~~--------~~-~~~~~dp--------  558 (658)
                      ++.+..++.++|||||||++|||++|+.||.........   +.+.........        +. ..+....        
T Consensus       264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  343 (397)
T 1wak_A          264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT  343 (397)
T ss_dssp             HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred             hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence            999999999999999999999999999999654443321   111111111000        00 0000000        


Q ss_pred             CC------------CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          559 TL------------SSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       559 ~l------------~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ..            ..........+.+++.+||+.||++|||+.|+++
T Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            00            0113344456778999999999999999999985

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.3e-38  Score=327.36  Aligned_cols=252  Identities=23%  Similarity=0.310  Sum_probs=200.1

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc---------ccHHHHHHHHHHHHhcC-CCCceeeeeeec
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG---------QGDLEFKNEVLLVANLQ-HRNLVRLLGFSL  390 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---------~~~~~~~~E~~~l~~l~-H~niv~l~~~~~  390 (658)
                      ..++|...+.||+|+||.||+++.. +|+.||||++.....         .....+.+|+.++.+++ ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            4578999999999999999999864 588999999865431         12345788999999996 999999999999


Q ss_pred             cCCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecc
Q 006155          391 EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADF  470 (658)
Q Consensus       391 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DF  470 (658)
                      .++..++||||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   ++||||||+||+++.++.+||+||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence            99999999999999999999843   356999999999999999999999988   999999999999999999999999


Q ss_pred             ccccccccCCCccccccccccccccCccccc------cCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHH
Q 006155          471 GMARLFEMDETQGNTSRIVGTYGYMAPEYAM------HGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAW  544 (658)
Q Consensus       471 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~  544 (658)
                      |++..+....   ......||+.|+|||++.      ...++.++||||||+++|||++|+.|+....   .........
T Consensus       169 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~  242 (298)
T 1phk_A          169 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLMLRMIM  242 (298)
T ss_dssp             TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH
T ss_pred             cchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc---HHHHHHHHh
Confidence            9998765432   223457899999999985      4568999999999999999999999984322   222222221


Q ss_pred             HhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          545 KNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       545 ~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .    +... ...+... ...   ..+.+++..||+.||++|||+.|+++
T Consensus       243 ~----~~~~-~~~~~~~-~~~---~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          243 S----GNYQ-FGSPEWD-DYS---DTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             H----TCCC-CCTTTGG-GSC---HHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             c----CCcc-cCccccc-ccC---HHHHHHHHHHccCCcccCCCHHHHHh
Confidence            1    1110 0001100 111   23557778999999999999999975

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.7e-38  Score=335.95  Aligned_cols=257  Identities=23%  Similarity=0.278  Sum_probs=188.7

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeeccCC------
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGN------  393 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------  393 (658)
                      .++|...+.||+|+||.||+++. .+|+.||||++....  ......+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            47899999999999999999984 358899999997642  223456889999999999999999999987654      


Q ss_pred             ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccc
Q 006155          394 ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMA  473 (658)
Q Consensus       394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla  473 (658)
                      ..++||||+++ +|.+++.     ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence            67999999975 6777773     34899999999999999999999998   999999999999999999999999999


Q ss_pred             cccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCC--
Q 006155          474 RLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGT--  551 (658)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--  551 (658)
                      +......   ......||+.|+|||++.+..++.++||||||+++|||++|+.||....   ..+.+...........  
T Consensus       175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~~~~~~  248 (371)
T 2xrw_A          175 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD---HIDQWNKVIEQLGTPCPE  248 (371)
T ss_dssp             ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHC-CCCCCHH
T ss_pred             ccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhCCCCHH
Confidence            8654321   2234578999999999999999999999999999999999999985432   1122221111110000  


Q ss_pred             -----------------------cccccCCC-CCCCC---HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          552 -----------------------TVNIIDPT-LSSGS---ITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       552 -----------------------~~~~~dp~-l~~~~---~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                                             ..+..... .....   ...-..+.+++.+||+.||++|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence                                   00000000 00011   111345678889999999999999999985

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1e-37  Score=325.04  Aligned_cols=252  Identities=24%  Similarity=0.354  Sum_probs=196.7

Q ss_pred             hhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ...++|...+.||+|+||.||+|+.. +|+.||||++....  ...++.+|+.++.+++||||+++++++...+..++||
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            34578999999999999999999865 48899999997643  3467899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ||+++++|.+++..  ....+++..++.++.+|+.||.|||+.+   ++|+||||+||+++.++.+||+|||++..+...
T Consensus       104 e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          104 EYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             ECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             ecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            99999999999842  3456899999999999999999999988   999999999999999999999999999866433


Q ss_pred             CCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCC
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT  559 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~  559 (658)
                      ..  ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....   .........    ........+.
T Consensus       179 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~----~~~~~~~~~~  249 (314)
T 3com_A          179 MA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP---MRAIFMIPT----NPPPTFRKPE  249 (314)
T ss_dssp             BS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHH----SCCCCCSSGG
T ss_pred             cc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHhc----CCCcccCCcc
Confidence            21  23345789999999999999999999999999999999999999853221   111111111    1111111111


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          560 LSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       560 l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .   ..   ..+.+++..||+.||.+|||+.++++
T Consensus       250 ~---~~---~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          250 L---WS---DNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             G---SC---HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             c---CC---HHHHHHHHHHccCChhhCcCHHHHHh
Confidence            0   11   23456778999999999999999975

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.1e-38  Score=343.57  Aligned_cols=260  Identities=22%  Similarity=0.309  Sum_probs=194.7

Q ss_pred             hccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCC------ce
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGN------ER  395 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~  395 (658)
                      ...+|...+.||+|+||.||+++...+..||+|++......    ..+|+.+++.++||||+++++++....      ..
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~  113 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL  113 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence            34679999999999999999999877777999988654322    246999999999999999999985433      27


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeC-CCCCeEEecccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLD-AEMTPKIADFGMAR  474 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~-~~~~~kl~DFGla~  474 (658)
                      ++||||++++.+............+++..++.++.||++||.|||+.+   |+||||||+|||++ .++.+||+|||+++
T Consensus       114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~  190 (394)
T 4e7w_A          114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAK  190 (394)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence            899999987655544432233567999999999999999999999988   99999999999999 79999999999998


Q ss_pred             ccccCCCccccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCC--
Q 006155          475 LFEMDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGT--  551 (658)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--  551 (658)
                      .+.....   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||....   ..+.+....+......  
T Consensus       191 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~---~~~~l~~i~~~~g~p~~~  264 (394)
T 4e7w_A          191 ILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES---GIDQLVEIIKVLGTPSRE  264 (394)
T ss_dssp             ECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHHCCCCHH
T ss_pred             cccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhCCCCHH
Confidence            7644332   2345789999999998765 58999999999999999999999985432   2222222222111000  


Q ss_pred             --------cccccCCCCCCCCHHH------HHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          552 --------TVNIIDPTLSSGSITE------MIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       552 --------~~~~~dp~l~~~~~~e------~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                              ..+..-|.........      -..+.+++..||+.||++|||+.|+++
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence                    0001111111111111      124567888999999999999999986

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=5.1e-38  Score=328.84  Aligned_cols=252  Identities=21%  Similarity=0.287  Sum_probs=193.7

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc--------ccHHHHHHHHHHHHhcCCCCceeeeeeeccC
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG--------QGDLEFKNEVLLVANLQHRNLVRLLGFSLEG  392 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~  392 (658)
                      ..++|...+.||+|+||.||+++.. +++.||||++.....        .....+.+|+.++.+++||||+++++++..+
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            4578999999999999999999854 578999999865421        1223478999999999999999999998765


Q ss_pred             CceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCC---eEEec
Q 006155          393 NERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMT---PKIAD  469 (658)
Q Consensus       393 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~---~kl~D  469 (658)
                      + .++||||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.   +||+|
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             c-eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence            5 8999999999999998843   456899999999999999999999988   999999999999987665   99999


Q ss_pred             cccccccccCCCccccccccccccccCccccc---cCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHh
Q 006155          470 FGMARLFEMDETQGNTSRIVGTYGYMAPEYAM---HGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKN  546 (658)
Q Consensus       470 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~  546 (658)
                      ||+++......   ......||+.|+|||++.   ...++.++||||||+++|||++|+.||......  ..+.......
T Consensus       161 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~  235 (322)
T 2ycf_A          161 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VSLKDQITSG  235 (322)
T ss_dssp             CTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS--SCHHHHHHHT
T ss_pred             Cccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH--HHHHHHHHhC
Confidence            99998754321   123457899999999974   567899999999999999999999998543322  1222222111


Q ss_pred             ccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          547 WREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       547 ~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                          ....  .+.......   ..+.+++..||+.||++||++.++++
T Consensus       236 ----~~~~--~~~~~~~~~---~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          236 ----KYNF--IPEVWAEVS---EKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             ----CCCC--CHHHHTTSC---HHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ----cccc--CchhhhhcC---HHHHHHHHHHcccCHhhCCCHHHHhh
Confidence                1000  000001111   23557788999999999999999984

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6e-38  Score=336.62  Aligned_cols=261  Identities=21%  Similarity=0.270  Sum_probs=193.3

Q ss_pred             hhhccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeecc-------
Q 006155          320 RVATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLE-------  391 (658)
Q Consensus       320 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-------  391 (658)
                      +...++|...+.||+|+||.||+++. .+|+.||||++......    ..+|+.+++.++||||+++++++..       
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            45678899999999999999999985 56899999998654322    2479999999999999999999843       


Q ss_pred             -------------------------------CCceEEEEEecCCCChhhhhcCc-CCCCCCCHHHHHHHHHHHHHHHHHh
Q 006155          392 -------------------------------GNERLLIYEFVPNTSLDHFIFDP-TRRAQLDWERRYKIIGGIARGLLYL  439 (658)
Q Consensus       392 -------------------------------~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yL  439 (658)
                                                     ....++||||++ ++|.+.+... .....+++..+..++.||++||.||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                           234789999998 5777776431 2345799999999999999999999


Q ss_pred             hhcCCCcEEEeccCCCceeeC-CCCCeEEeccccccccccCCCccccccccccccccCccccccC-CCCcccccccccch
Q 006155          440 HEDSRLRIIHRDLKTSNVLLD-AEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVL  517 (658)
Q Consensus       440 H~~~~~~ivHrDlk~~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvl  517 (658)
                      |+.+   |+||||||+|||++ .++.+||+|||+++.+.....   .....||+.|+|||++.+. .++.++||||||++
T Consensus       158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            9988   99999999999998 688999999999987644322   2345789999999998775 48999999999999


Q ss_pred             HhHHHhCCCCCccCCCCCcchHHHHHHHhccCC----------CcccccCCCCCCCCHHH------HHHHHHHHHHhcCC
Q 006155          518 VLEIISGQRNNCFRNGETVEDLLSSAWKNWREG----------TTVNIIDPTLSSGSITE------MIRCIHIGLLCVQE  581 (658)
Q Consensus       518 l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~----------~~~~~~dp~l~~~~~~e------~~~~~~i~~~Cl~~  581 (658)
                      +|||++|+.||....   ..+.+..........          ...+..-|.+.......      -..+.+++..||+.
T Consensus       232 l~ell~g~~pf~~~~---~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  308 (383)
T 3eb0_A          232 FGELILGKPLFSGET---SIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY  308 (383)
T ss_dssp             HHHHHHSSCSSCCSS---HHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred             HHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence            999999999985432   222222222211111          01111111111111111      12356788899999


Q ss_pred             CCCCCCCHHHHHH
Q 006155          582 NVASRPTMASVVL  594 (658)
Q Consensus       582 ~p~~RPtm~evv~  594 (658)
                      ||++|||+.|+++
T Consensus       309 dP~~R~t~~e~l~  321 (383)
T 3eb0_A          309 EPDLRINPYEAMA  321 (383)
T ss_dssp             SGGGSCCHHHHHT
T ss_pred             ChhhCCCHHHHhc
Confidence            9999999999983

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.8e-38  Score=332.27  Aligned_cols=263  Identities=21%  Similarity=0.278  Sum_probs=200.4

Q ss_pred             hhccCCcccCcccccCceEEEEeEe--cCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCC------ceeeeeeeccC
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRL--YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRN------LVRLLGFSLEG  392 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~~  392 (658)
                      ...++|...+.||+|+||.||+++.  .+++.||||++... ......+.+|+.++..++|+|      ++++++++...
T Consensus        11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~   89 (339)
T 1z57_A           11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH   89 (339)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred             CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence            3457899999999999999999975  36889999998653 233456889999999987664      99999999999


Q ss_pred             CceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCC-----------
Q 006155          393 NERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDA-----------  461 (658)
Q Consensus       393 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~-----------  461 (658)
                      +..++||||+ +++|.+++... ....+++..++.++.||++||.|||+.+   |+||||||+|||++.           
T Consensus        90 ~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~  164 (339)
T 1z57_A           90 GHICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKI  164 (339)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC---
T ss_pred             CcEEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcc
Confidence            9999999999 89999988542 2346899999999999999999999988   999999999999987           


Q ss_pred             --------CCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCC
Q 006155          462 --------EMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNG  533 (658)
Q Consensus       462 --------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~  533 (658)
                              ++.+||+|||+++.....     .....||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus       165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  239 (339)
T 1z57_A          165 KRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS  239 (339)
T ss_dssp             -CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred             ccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence                    678999999999864322     2345789999999999999999999999999999999999999864332


Q ss_pred             CCcchHHHHHH--------HhccCCCccc------------------ccCC--CCCCCCHHHHHHHHHHHHHhcCCCCCC
Q 006155          534 ETVEDLLSSAW--------KNWREGTTVN------------------IIDP--TLSSGSITEMIRCIHIGLLCVQENVAS  585 (658)
Q Consensus       534 ~~~~~l~~~~~--------~~~~~~~~~~------------------~~dp--~l~~~~~~e~~~~~~i~~~Cl~~~p~~  585 (658)
                      ......+....        ..........                  ...+  .........-..+.+++..||+.||++
T Consensus       240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  319 (339)
T 1z57_A          240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK  319 (339)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence            21111111111        0000000000                  0000  000011223345678889999999999


Q ss_pred             CCCHHHHHH
Q 006155          586 RPTMASVVL  594 (658)
Q Consensus       586 RPtm~evv~  594 (658)
                      |||+.|+++
T Consensus       320 Rpt~~ell~  328 (339)
T 1z57_A          320 RITLREALK  328 (339)
T ss_dssp             SCCHHHHTT
T ss_pred             ccCHHHHhc
Confidence            999999974

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.7e-38  Score=341.94  Aligned_cols=203  Identities=28%  Similarity=0.459  Sum_probs=154.4

Q ss_pred             ccCCcc-cCcccccCceEEEEeEec---CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeec--cCCceE
Q 006155          323 TDNFSD-ANKLGQGGFGAVYKGRLY---DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSL--EGNERL  396 (658)
Q Consensus       323 ~~~~~~-~~~lG~G~fg~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~~  396 (658)
                      .+.|.. .++||+|+||+||+++..   +++.||||++....  ....+.+|+.++++++||||+++++++.  .+...+
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVW   96 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence            345555 558999999999999865   47889999997543  2346789999999999999999999994  467889


Q ss_pred             EEEEecCCCChhhhhcCc------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceee----CCCCCeE
Q 006155          397 LIYEFVPNTSLDHFIFDP------TRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLL----DAEMTPK  466 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl----~~~~~~k  466 (658)
                      +||||+++ +|.+++...      .....+++..++.|+.||+.||.|||+.+   |+||||||+||||    +.++.+|
T Consensus        97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~k  172 (405)
T 3rgf_A           97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK  172 (405)
T ss_dssp             EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred             EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEE
Confidence            99999974 777766421      12235999999999999999999999998   9999999999999    7789999


Q ss_pred             EeccccccccccCCC-ccccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccC
Q 006155          467 IADFGMARLFEMDET-QGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFR  531 (658)
Q Consensus       467 l~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~  531 (658)
                      |+|||+++.+..... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  239 (405)
T 3rgf_A          173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  239 (405)
T ss_dssp             ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred             EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence            999999987654322 1233456899999999999874 5899999999999999999999999543

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.5e-37  Score=329.34  Aligned_cols=262  Identities=24%  Similarity=0.318  Sum_probs=195.8

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccC-----Cc
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEG-----NE  394 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~  394 (658)
                      ..++|...+.||+|+||.||+|+.. +|+.||||++..... .....+.+|+.++.+++||||+++++++...     ..
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            4578999999999999999999854 588999999965432 2344678999999999999999999987654     67


Q ss_pred             eEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          395 RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      .++||||+. ++|.+++..    ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        89 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR  160 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence            899999997 689888843    46999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccccCCCcc--------ccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHH
Q 006155          475 LFEMDETQG--------NTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWK  545 (658)
Q Consensus       475 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~  545 (658)
                      .+.......        ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.....   .+.+.....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~  237 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY---RHQLLLIFG  237 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHH
T ss_pred             ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHH
Confidence            765332111        1223578999999998765 6799999999999999999999999854321   111111111


Q ss_pred             hccCCCccc---c---------c--CCCCCCCCHHH-----HHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          546 NWREGTTVN---I---------I--DPTLSSGSITE-----MIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       546 ~~~~~~~~~---~---------~--dp~l~~~~~~e-----~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .........   .         +  -+........+     -..+.+++..||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            111000000   0         0  00000001110     123557888999999999999999986

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.3e-37  Score=338.97  Aligned_cols=200  Identities=22%  Similarity=0.288  Sum_probs=171.1

Q ss_pred             hhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhc------CCCCceeeeeeeccCC
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANL------QHRNLVRLLGFSLEGN  393 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~~~~~~~~  393 (658)
                      ....+|+..++||+|+||.||+|+.. +++.||||++... ......+.+|+.++..+      .|+||+++++++...+
T Consensus        94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  172 (429)
T 3kvw_A           94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN  172 (429)
T ss_dssp             EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred             cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence            34568999999999999999999754 4889999999653 23345677888888887      5779999999999999


Q ss_pred             ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCC--eEEeccc
Q 006155          394 ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMT--PKIADFG  471 (658)
Q Consensus       394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~--~kl~DFG  471 (658)
                      ..++||||+. ++|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.  +||+|||
T Consensus       173 ~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          173 HICMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             EEEEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             eEEEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecc
Confidence            9999999996 6888888542 2345899999999999999999999998   999999999999999887  9999999


Q ss_pred             cccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccC
Q 006155          472 MARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFR  531 (658)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~  531 (658)
                      +++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       248 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          248 SSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             TCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            99754322     23458899999999999999999999999999999999999998543

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=5.4e-38  Score=358.70  Aligned_cols=260  Identities=22%  Similarity=0.329  Sum_probs=202.4

Q ss_pred             hhhhhccCCcccCcccccCceEEEEeEecC----CcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccC
Q 006155          318 TIRVATDNFSDANKLGQGGFGAVYKGRLYD----GAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEG  392 (658)
Q Consensus       318 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~  392 (658)
                      ..+...++|...+.||+|+||.||+|+...    +..||||++..... .....+.+|+.++.+++||||+++++++. +
T Consensus       384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~  462 (656)
T 2j0j_A          384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E  462 (656)
T ss_dssp             GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred             ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence            344556788999999999999999998542    45699999876433 23356899999999999999999999985 4


Q ss_pred             CceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccc
Q 006155          393 NERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGM  472 (658)
Q Consensus       393 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGl  472 (658)
                      +..++||||+++|+|.+++..  ....+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       463 ~~~~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~  537 (656)
T 2j0j_A          463 NPVWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL  537 (656)
T ss_dssp             SSCEEEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred             CceEEEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCC
Confidence            568999999999999999953  2346899999999999999999999988   99999999999999999999999999


Q ss_pred             ccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCC
Q 006155          473 ARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGT  551 (658)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~  551 (658)
                      ++.+..... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...   ...+.+.......+   
T Consensus       538 a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~---~~~~~~~~i~~~~~---  610 (656)
T 2j0j_A          538 SRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV---KNNDVIGRIENGER---  610 (656)
T ss_dssp             CCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHHHHHHHTCC---
T ss_pred             CeecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHcCCC---
Confidence            987644322 22234567889999999999999999999999999999997 88888432   22233333222111   


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          552 TVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       552 ~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                            +.+......   .+.+++..||+.||++|||+.+|++.|+..
T Consensus       611 ------~~~~~~~~~---~l~~li~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          611 ------LPMPPNCPP---TLYSLMTKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             ------CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------CCCCccccH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                  111112222   345677899999999999999999999753

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=6.2e-38  Score=333.21  Aligned_cols=266  Identities=23%  Similarity=0.256  Sum_probs=185.7

Q ss_pred             hhhhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCc---
Q 006155          319 IRVATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNE---  394 (658)
Q Consensus       319 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---  394 (658)
                      .....++|...+.||+|+||.||+|+.. +|+.||||++...... ...+.+|+..+..++||||+++++++.....   
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~   96 (360)
T 3e3p_A           18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR   96 (360)
T ss_dssp             HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC-CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred             chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc-cHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence            3455689999999999999999999864 5889999998654332 3356778888999999999999999865433   


Q ss_pred             ----eEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhh--hcCCCcEEEeccCCCceeeCC-CCCeEE
Q 006155          395 ----RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH--EDSRLRIIHRDLKTSNVLLDA-EMTPKI  467 (658)
Q Consensus       395 ----~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~ivHrDlk~~NILl~~-~~~~kl  467 (658)
                          .++||||++++.+..+.........+++..+..++.||+.||.|||  +.+   |+||||||+|||++. ++.+||
T Consensus        97 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl  173 (360)
T 3e3p_A           97 RDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKL  173 (360)
T ss_dssp             TCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEE
T ss_pred             cceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEE
Confidence                7899999987533322221234567899999999999999999999  776   999999999999997 899999


Q ss_pred             eccccccccccCCCccccccccccccccCccccccCC-CCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHh
Q 006155          468 ADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKN  546 (658)
Q Consensus       468 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~  546 (658)
                      +|||+++.+.....   .....||+.|+|||++.+.. ++.++||||||+++|||++|+.||....   ....+......
T Consensus       174 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~---~~~~~~~~~~~  247 (360)
T 3e3p_A          174 CDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN---SAGQLHEIVRV  247 (360)
T ss_dssp             CCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHH
T ss_pred             eeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC---hHHHHHHHHHH
Confidence            99999987654322   23457899999999987654 8999999999999999999999985432   22222222211


Q ss_pred             ccCCC------------cccccCCC-------CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          547 WREGT------------TVNIIDPT-------LSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       547 ~~~~~------------~~~~~dp~-------l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .....            .....+..       +..........+.+++..||+.||++|||+.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            11000            00000000       00001112234667888999999999999999984

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=7.5e-38  Score=327.78  Aligned_cols=260  Identities=25%  Similarity=0.358  Sum_probs=197.5

Q ss_pred             hhccCCcccCcccccCceEEEEeEe--cCCcceeEEEeccCCc--ccHHHHHHHHHHHHhc---CCCCceeeeeeec---
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRL--YDGAEIAVKRLSRDSG--QGDLEFKNEVLLVANL---QHRNLVRLLGFSL---  390 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~---  390 (658)
                      ...++|...+.||+|+||.||+++.  .+|+.||||++.....  .....+.+|+.+++.+   +||||+++++++.   
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            4568899999999999999999986  4578899998865422  1223466777777666   8999999999987   


Q ss_pred             --cCCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEe
Q 006155          391 --EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIA  468 (658)
Q Consensus       391 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~  468 (658)
                        .....++||||++ |+|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence              5567899999998 6999988542 2345899999999999999999999998   9999999999999999999999


Q ss_pred             ccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhcc
Q 006155          469 DFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWR  548 (658)
Q Consensus       469 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~  548 (658)
                      |||+++.+....   ......||+.|+|||++.+..++.++||||||+++|||++|+.||....   ..+.+........
T Consensus       163 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~i~~~~~  236 (326)
T 1blx_A          163 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS---DVDQLGKILDVIG  236 (326)
T ss_dssp             SCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHC
T ss_pred             cCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHHHcC
Confidence            999998654322   2334678999999999999999999999999999999999999985332   2222222222111


Q ss_pred             CCCcccc----------cC----C---CCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          549 EGTTVNI----------ID----P---TLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       549 ~~~~~~~----------~d----p---~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .......          ..    .   .+......   .+.+++..||+.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDE---LGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCH---HHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCcccCccccccchhhhcccCcchhhhccccCCH---HHHHHHHHHcCCCcccCCCHHHHhc
Confidence            1100000          00    0   00111112   3456778999999999999999984

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.8e-37  Score=332.69  Aligned_cols=207  Identities=23%  Similarity=0.287  Sum_probs=172.2

Q ss_pred             chhhhhhhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcC-CC-----Cceeeee
Q 006155          315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQ-HR-----NLVRLLG  387 (658)
Q Consensus       315 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~~  387 (658)
                      .........++|...+.||+|+||+||+|+.. +++.||||++... .....++..|+.++..++ |+     +|+++++
T Consensus        45 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~  123 (382)
T 2vx3_A           45 IVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR  123 (382)
T ss_dssp             CCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred             EeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence            33444556789999999999999999999854 5788999999753 233456778888888885 55     4999999


Q ss_pred             eeccCCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeC--CCCCe
Q 006155          388 FSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLD--AEMTP  465 (658)
Q Consensus       388 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~--~~~~~  465 (658)
                      ++...+..++||||++ ++|.+++... ....+++..++.++.||+.||.|||.. ..+|+||||||+|||++  .++.+
T Consensus       124 ~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~  200 (382)
T 2vx3_A          124 HFMFRNHLCLVFEMLS-YNLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAI  200 (382)
T ss_dssp             EEEETTEEEEEEECCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCE
T ss_pred             eeccCCceEEEEecCC-CCHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcE
Confidence            9999999999999996 5999988542 224589999999999999999999952 12399999999999994  57889


Q ss_pred             EEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCcc
Q 006155          466 KIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCF  530 (658)
Q Consensus       466 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~  530 (658)
                      ||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       201 kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~  260 (382)
T 2vx3_A          201 KIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG  260 (382)
T ss_dssp             EECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            99999999876432     2346789999999999999999999999999999999999999854

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=8.2e-38  Score=321.72  Aligned_cols=253  Identities=26%  Similarity=0.353  Sum_probs=200.3

Q ss_pred             hhhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceE
Q 006155          320 RVATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERL  396 (658)
Q Consensus       320 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  396 (658)
                      ....++|...+.||+|+||.||+++.. +++.||||++....  ......+.+|+.++.+++||||+++++++.+.+..+
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            345678999999999999999999864 68899999986542  344567899999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCC---CCeEEeccccc
Q 006155          397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE---MTPKIADFGMA  473 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~---~~~kl~DFGla  473 (658)
                      +|+||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   ++||||||+|||++.+   +.+||+|||++
T Consensus        98 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A           98 IVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             EEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             EEEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            99999999999988843   346899999999999999999999988   9999999999999764   47999999999


Q ss_pred             cccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcc
Q 006155          474 RLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTV  553 (658)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  553 (658)
                      ..+.....   .....||+.|+|||.+.+ .++.++||||||+++|||++|+.|+....   ..++......    +...
T Consensus       172 ~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~----~~~~  240 (287)
T 2wei_A          172 TCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN---EYDILKRVET----GKYA  240 (287)
T ss_dssp             GTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHH----CCCC
T ss_pred             eeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHc----CCCC
Confidence            87644322   223468999999998765 58999999999999999999999985322   2222222221    1110


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          554 NIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       554 ~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .. .+.. ....+   .+.+++..||+.||++|||+.++++
T Consensus       241 ~~-~~~~-~~~~~---~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          241 FD-LPQW-RTISD---DAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             CC-SGGG-TTSCH---HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CC-chhh-hhcCH---HHHHHHHHHcccChhhCcCHHHHhc
Confidence            00 0100 11112   3456778999999999999999986

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.5e-37  Score=330.34  Aligned_cols=255  Identities=24%  Similarity=0.365  Sum_probs=193.0

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcc--cHHHHHHHHHHHHhcCCCCceeeeeeeccCCce---
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQ--GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNER---  395 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~---  395 (658)
                      ..++|...+.||+|+||.||+|+.. +|+.||||++......  ....+.+|+.+++.++||||+++++++...+..   
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            3578999999999999999999854 5889999999764322  245688999999999999999999999877655   


Q ss_pred             ---EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccc
Q 006155          396 ---LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGM  472 (658)
Q Consensus       396 ---~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGl  472 (658)
                         ++||||+. ++|.+++.     ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       120 ~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~  190 (371)
T 4exu_A          120 YDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL  190 (371)
T ss_dssp             CCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred             eeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence               99999997 68888772     34899999999999999999999998   99999999999999999999999999


Q ss_pred             ccccccCCCccccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCC
Q 006155          473 ARLFEMDETQGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGT  551 (658)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  551 (658)
                      ++.....     .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||....   ..+.+...........
T Consensus       191 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~~~~  262 (371)
T 4exu_A          191 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD---YLDQLTQILKVTGVPG  262 (371)
T ss_dssp             C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCCC
T ss_pred             ccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCc
Confidence            9865432     234578999999999887 689999999999999999999999985322   2222222211110000


Q ss_pred             cccccC--------------CCCCCCCHHH-----HHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          552 TVNIID--------------PTLSSGSITE-----MIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       552 ~~~~~d--------------p~l~~~~~~e-----~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                       .+...              +........+     -..+.+++..||+.||++|||+.|+++
T Consensus       263 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          263 -TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             -HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             -HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence             00000              0000001111     124567888999999999999999984

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=4.6e-37  Score=325.96  Aligned_cols=255  Identities=23%  Similarity=0.319  Sum_probs=191.8

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCc-----
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNE-----  394 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-----  394 (658)
                      .++|...+.||+|+||.||+|+.. +|+.||||++.....  .....+.+|+.++..++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            468999999999999999999854 588999999976432  223568899999999999999999999987654     


Q ss_pred             -eEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccc
Q 006155          395 -RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMA  473 (658)
Q Consensus       395 -~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla  473 (658)
                       .++||||++ ++|.+++.     ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence             499999997 68888772     24899999999999999999999998   999999999999999999999999999


Q ss_pred             cccccCCCccccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCC-
Q 006155          474 RLFEMDETQGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGT-  551 (658)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-  551 (658)
                      +.....     .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.....   .+.+........... 
T Consensus       174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~~~  245 (353)
T 3coi_A          174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY---LDQLTQILKVTGVPGT  245 (353)
T ss_dssp             TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH---HHHHHHHHHHHCBCCH
T ss_pred             cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCH
Confidence            864322     234578999999999877 6789999999999999999999999854321   222222111100000 


Q ss_pred             -----------------cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          552 -----------------TVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       552 -----------------~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                                       ......+.+.......-..+.+++..||+.||++|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          246 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                             0000001111000011123456778999999999999999984

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.2e-37  Score=322.03  Aligned_cols=252  Identities=27%  Similarity=0.426  Sum_probs=188.2

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeecc----------
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLE----------  391 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----------  391 (658)
                      .++|+..+.||+|+||.||+|+. .+|+.||||++... ......+.+|+.++.+++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            46789999999999999999985 46889999998643 2344568899999999999999999998754          


Q ss_pred             ---CCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEe
Q 006155          392 ---GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIA  468 (658)
Q Consensus       392 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~  468 (658)
                         .+..++||||+++++|.+++..  ....+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence               3467899999999999999953  2346788999999999999999999998   9999999999999999999999


Q ss_pred             ccccccccccCCC------------ccccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCC
Q 006155          469 DFGMARLFEMDET------------QGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGET  535 (658)
Q Consensus       469 DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~  535 (658)
                      |||+++.......            ........||+.|+|||++.+. .++.++||||||+++|||++   |+..  ...
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~--~~~  233 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST--GME  233 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS--HHH
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC--chh
Confidence            9999986643211            1122345789999999998764 78999999999999999998   3311  111


Q ss_pred             cchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          536 VEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       536 ~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ..+..    ..+.....  .+.+.+......   .+.+++..||+.||.+|||+.++++
T Consensus       234 ~~~~~----~~~~~~~~--~~~~~~~~~~~~---~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          234 RVNIL----KKLRSVSI--EFPPDFDDNKMK---VEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHHHH----HHHHSTTC--CCCTTCCTTTSH---HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHH----Hhcccccc--ccCccccccchH---HHHHHHHHHHhcCcccCcCHHHHhC
Confidence            11111    11111110  111222222222   3456778999999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.6e-37  Score=324.19  Aligned_cols=257  Identities=24%  Similarity=0.342  Sum_probs=176.4

Q ss_pred             hhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc-ccHHHHHHHHH-HHHhcCCCCceeeeeeeccCCceEE
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG-QGDLEFKNEVL-LVANLQHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~l  397 (658)
                      ...++|...+.||+|+||.||+++.. +|+.||||++..... ....++..|+. +++.++||||+++++++.+.+..++
T Consensus        19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l   98 (327)
T 3aln_A           19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI   98 (327)
T ss_dssp             CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence            44678999999999999999999864 688999999976532 23334555655 6777899999999999999999999


Q ss_pred             EEEecCCCChhhhhcC--cCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          398 IYEFVPNTSLDHFIFD--PTRRAQLDWERRYKIIGGIARGLLYLHED-SRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      ||||+++ +|.+++..  ......+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||+++
T Consensus        99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~  174 (327)
T 3aln_A           99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISG  174 (327)
T ss_dssp             EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred             EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCce
Confidence            9999985 77777632  11245789999999999999999999998 7   9999999999999999999999999998


Q ss_pred             ccccCCCccccccccccccccCcccc----ccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCC
Q 006155          475 LFEMDETQGNTSRIVGTYGYMAPEYA----MHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREG  550 (658)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  550 (658)
                      .+....   ......||+.|+|||++    .+..++.++||||||+++|||++|+.||......  .   . .......+
T Consensus       175 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~---~-~~~~~~~~  245 (327)
T 3aln_A          175 QLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV--F---D-QLTQVVKG  245 (327)
T ss_dssp             C---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCS
T ss_pred             eccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH--H---H-HHHHHhcC
Confidence            664332   12234789999999998    4667899999999999999999999998532211  0   0 01111111


Q ss_pred             CcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          551 TTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       551 ~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ....+.. ........   .+.+++..||+.||++|||+.+|++
T Consensus       246 ~~~~~~~-~~~~~~~~---~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          246 DPPQLSN-SEEREFSP---SFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCCCCCC-CSSCCCCH---HHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCC-cccccCCH---HHHHHHHHHhhCChhhCcCHHHHHh
Confidence            1111111 11111222   3556778999999999999999974

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3.4e-37  Score=324.73  Aligned_cols=253  Identities=21%  Similarity=0.247  Sum_probs=169.8

Q ss_pred             hccCCcccC-cccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeecc----CCce
Q 006155          322 ATDNFSDAN-KLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLE----GNER  395 (658)
Q Consensus       322 ~~~~~~~~~-~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~  395 (658)
                      ..++|...+ .||+|+||.||+++.. +|+.||||++...    .....+....+..++||||+++++++..    +...
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            457788855 6999999999999865 5899999998643    2222333344667799999999999875    4457


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCC---CCCeEEecccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDA---EMTPKIADFGM  472 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~---~~~~kl~DFGl  472 (658)
                      ++||||+++|+|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||+
T Consensus       102 ~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence            9999999999999999643 2346999999999999999999999998   999999999999976   45599999999


Q ss_pred             ccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCc
Q 006155          473 ARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTT  552 (658)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  552 (658)
                      ++.....    ......||+.|+|||++.+..++.++||||||+++|||++|+.||............   ......+. 
T Consensus       178 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~-  249 (336)
T 3fhr_A          178 AKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM---KRRIRLGQ-  249 (336)
T ss_dssp             CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred             ceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH---HHhhhccc-
Confidence            9865432    223457899999999999889999999999999999999999998543322111100   00000000 


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          553 VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       553 ~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .....+.. ....+   .+.+++..||+.||++|||+.|+++
T Consensus       250 ~~~~~~~~-~~~~~---~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          250 YGFPNPEW-SEVSE---DAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             -CCCTTTS-TTCCH---HHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cccCchhh-ccCCH---HHHHHHHHHCCCChhHCcCHHHHhc
Confidence            00111111 11122   3456778999999999999999996

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3.3e-37  Score=326.41  Aligned_cols=261  Identities=18%  Similarity=0.261  Sum_probs=195.4

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CC-cceeEEEeccCCcccHHHHHHHHHHHHhcCCCC------ceeeeeeeccCC
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DG-AEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRN------LVRLLGFSLEGN  393 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~~~  393 (658)
                      ..++|...+.||+|+||.||+++.. ++ ..||||++... ......+.+|+.++.+++|++      ++.+++++...+
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~   95 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG   95 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence            4578999999999999999999854 34 68999998653 234456888999999998766      899999999999


Q ss_pred             ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceee--------------
Q 006155          394 ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLL--------------  459 (658)
Q Consensus       394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl--------------  459 (658)
                      ..++||||+ +++|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+|||+              
T Consensus        96 ~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           96 HMCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             eEEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence            999999999 56666665432 2346999999999999999999999987   9999999999999              


Q ss_pred             -----CCCCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCC
Q 006155          460 -----DAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGE  534 (658)
Q Consensus       460 -----~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~  534 (658)
                           +.++.+||+|||+++.....     .....||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus       171 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (355)
T 2eu9_A          171 CEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR  245 (355)
T ss_dssp             CCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             ccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence                 56789999999999864322     23457999999999999999999999999999999999999998543321


Q ss_pred             CcchHHHHHH--------HhccCCCcc---ccc---------------C--CCCCCCCHHHHHHHHHHHHHhcCCCCCCC
Q 006155          535 TVEDLLSSAW--------KNWREGTTV---NII---------------D--PTLSSGSITEMIRCIHIGLLCVQENVASR  586 (658)
Q Consensus       535 ~~~~l~~~~~--------~~~~~~~~~---~~~---------------d--p~l~~~~~~e~~~~~~i~~~Cl~~~p~~R  586 (658)
                      .....+....        ..+......   ...               .  +........+-..+.+++..||+.||++|
T Consensus       246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  325 (355)
T 2eu9_A          246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR  325 (355)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence            1111111110        000000000   000               0  00000112223456788899999999999


Q ss_pred             CCHHHHH
Q 006155          587 PTMASVV  593 (658)
Q Consensus       587 Ptm~evv  593 (658)
                      ||+.|++
T Consensus       326 pt~~e~l  332 (355)
T 2eu9_A          326 ITLAEAL  332 (355)
T ss_dssp             CCHHHHT
T ss_pred             cCHHHHh
Confidence            9999987

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=6e-37  Score=334.17  Aligned_cols=252  Identities=22%  Similarity=0.266  Sum_probs=183.7

Q ss_pred             cCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhc-CCCCceeeeeeeccCCceEEEEEec
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANL-QHRNLVRLLGFSLEGNERLLIYEFV  402 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~  402 (658)
                      +.|...+.||+|+||+||.+...+|+.||||++...   ....+.+|+.++.++ +||||+++++++.+++..++||||+
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            445556889999999998766678999999998653   234578899999887 8999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCCC----CCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCC-------------CCe
Q 006155          403 PNTSLDHFIFDPTRRA----QLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE-------------MTP  465 (658)
Q Consensus       403 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~-------------~~~  465 (658)
                      + |+|.+++.......    ..++..++.++.||+.||.|||+.+   |+||||||+|||++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence            5 69999996432211    1234456789999999999999988   9999999999999654             489


Q ss_pred             EEeccccccccccCCCcc--ccccccccccccCcccccc-------CCCCcccccccccchHhHHHh-CCCCCccCCCCC
Q 006155          466 KIADFGMARLFEMDETQG--NTSRIVGTYGYMAPEYAMH-------GQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGET  535 (658)
Q Consensus       466 kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~  535 (658)
                      ||+|||+++.+.......  ......||+.|+|||++.+       ..++.++|||||||++|||++ |+.||...... 
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-  246 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR-  246 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH-
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh-
Confidence            999999998775543221  2234689999999999975       678999999999999999999 88898432211 


Q ss_pred             cchHHHHHHHhccCCCcccccCCCCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          536 VEDLLSSAWKNWREGTTVNIIDPTLSS-GSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       536 ~~~l~~~~~~~~~~~~~~~~~dp~l~~-~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                         . .........  .     +.+.. ........+.+++..||+.||++|||+.+|++
T Consensus       247 ---~-~~i~~~~~~--~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          247 ---E-SNIIRGIFS--L-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             ---H-HHHHHTCCC--C-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---H-HHHhcCCCC--c-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence               1 111111100  0     11111 12223345668889999999999999999984

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3.3e-37  Score=329.12  Aligned_cols=261  Identities=21%  Similarity=0.275  Sum_probs=195.8

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhcC-----------CCCceeeeeeec
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQ-----------HRNLVRLLGFSL  390 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~  390 (658)
                      .++|...+.||+|+||.||+++. .+++.||||++... ......+.+|+.++.+++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            46899999999999999999985 46889999998643 233456788999998886           899999999987


Q ss_pred             cCC----ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCcEEEeccCCCceeeC-----
Q 006155          391 EGN----ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED-SRLRIIHRDLKTSNVLLD-----  460 (658)
Q Consensus       391 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlk~~NILl~-----  460 (658)
                      ..+    ..++||||+ +++|.+++... ....+++..++.++.||+.||.|||++ +   |+||||||+|||++     
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence            544    779999999 89999998542 234589999999999999999999997 7   99999999999994     


Q ss_pred             -CCCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCC---c
Q 006155          461 -AEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGET---V  536 (658)
Q Consensus       461 -~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~---~  536 (658)
                       ..+.+||+|||+++.....     .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......   .
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence             4458999999999865432     223578999999999999999999999999999999999999996443221   1


Q ss_pred             chHHHHHHHhccC-------------------CCcccccCCC----------CCCCCHHHHHHHHHHHHHhcCCCCCCCC
Q 006155          537 EDLLSSAWKNWRE-------------------GTTVNIIDPT----------LSSGSITEMIRCIHIGLLCVQENVASRP  587 (658)
Q Consensus       537 ~~l~~~~~~~~~~-------------------~~~~~~~dp~----------l~~~~~~e~~~~~~i~~~Cl~~~p~~RP  587 (658)
                      .+.+.........                   +....+....          ........-..+.+++..||+.||++||
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  326 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  326 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence            1111111111100                   0000000000          0001233445677889999999999999


Q ss_pred             CHHHHHH
Q 006155          588 TMASVVL  594 (658)
Q Consensus       588 tm~evv~  594 (658)
                      |+.|+++
T Consensus       327 t~~ell~  333 (373)
T 1q8y_A          327 DAGGLVN  333 (373)
T ss_dssp             CHHHHHT
T ss_pred             CHHHHhh
Confidence            9999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-37  Score=322.96  Aligned_cols=242  Identities=24%  Similarity=0.439  Sum_probs=188.1

Q ss_pred             hhccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCccc------HHHHHHHHHHHHhc----CCCCceeeeeee
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQG------DLEFKNEVLLVANL----QHRNLVRLLGFS  389 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~------~~~~~~E~~~l~~l----~H~niv~l~~~~  389 (658)
                      ...++|...+.||+|+||.||+|+. .+++.||||++.......      ...+.+|+.++.++    +||||+++++++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~  107 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF  107 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence            3457899999999999999999985 468899999997653321      22356799999998    899999999999


Q ss_pred             ccCCceEEEEEe-cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeC-CCCCeEE
Q 006155          390 LEGNERLLIYEF-VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLD-AEMTPKI  467 (658)
Q Consensus       390 ~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~-~~~~~kl  467 (658)
                      ...+..++|+|| +.+++|.+++..   ...+++..++.++.||++||.|||+.+   |+||||||+|||++ .++.+||
T Consensus       108 ~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl  181 (312)
T 2iwi_A          108 ETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKL  181 (312)
T ss_dssp             -----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEE
T ss_pred             ecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEE
Confidence            999999999999 789999999853   346999999999999999999999998   99999999999999 8899999


Q ss_pred             eccccccccccCCCccccccccccccccCccccccCCCC-cccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHh
Q 006155          468 ADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYS-VKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKN  546 (658)
Q Consensus       468 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~  546 (658)
                      +|||+++.+....    .....||..|+|||++.+..+. .++||||||+++|||++|+.||...     ...    ...
T Consensus       182 ~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~~~----~~~  248 (312)
T 2iwi_A          182 IDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD-----QEI----LEA  248 (312)
T ss_dssp             CCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----HHH----HHT
T ss_pred             EEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh-----HHH----hhh
Confidence            9999998765432    2345789999999999877764 5899999999999999999998421     111    110


Q ss_pred             ccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          547 WREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       547 ~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                          .      ..+......   .+.+++..||+.||++|||+.|+++
T Consensus       249 ----~------~~~~~~~~~---~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          249 ----E------LHFPAHVSP---DCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             ----C------CCCCTTSCH---HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ----c------cCCcccCCH---HHHHHHHHHccCChhhCcCHHHHhc
Confidence                0      011111122   3456778999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.7e-37  Score=336.24  Aligned_cols=255  Identities=21%  Similarity=0.306  Sum_probs=187.7

Q ss_pred             hhhhhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhc-CCCCceeeeeeeccCCceE
Q 006155          318 TIRVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANL-QHRNLVRLLGFSLEGNERL  396 (658)
Q Consensus       318 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~  396 (658)
                      .+.+...+|...+.||+|+||+||.....+|+.||||++......   .+.+|+.++.++ +||||+++++++.+.+..+
T Consensus        18 ~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~   94 (432)
T 3p23_A           18 VVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQY   94 (432)
T ss_dssp             CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEE
T ss_pred             cEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEE
Confidence            345566789999999999999966555578999999999764332   356899999999 7999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCC-----CCCeEEeccc
Q 006155          397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDA-----EMTPKIADFG  471 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~-----~~~~kl~DFG  471 (658)
                      +||||++ |+|.+++....  ..+.+..++.++.||++||.|||+.+   |+||||||+|||++.     ...+||+|||
T Consensus        95 lv~E~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG  168 (432)
T 3p23_A           95 IAIELCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFG  168 (432)
T ss_dssp             EEEECCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTT
T ss_pred             EEEECCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEeccc
Confidence            9999996 69999985432  33455567899999999999999998   999999999999943     3468899999


Q ss_pred             cccccccCCC-ccccccccccccccCccccc---cCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHh
Q 006155          472 MARLFEMDET-QGNTSRIVGTYGYMAPEYAM---HGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKN  546 (658)
Q Consensus       472 la~~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~  546 (658)
                      +++.+..... ........||+.|+|||++.   ...++.++|||||||++|||++ |+.|+.....    ......   
T Consensus       169 ~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~----~~~~~~---  241 (432)
T 3p23_A          169 LCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ----RQANIL---  241 (432)
T ss_dssp             EEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT----HHHHHH---
T ss_pred             ceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH----HHHHHH---
Confidence            9987654322 12334568999999999997   4678889999999999999999 8888742211    111111   


Q ss_pred             ccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          547 WREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       547 ~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                       ..........    .. ...-..+.+++..||+.||++|||+.+|++
T Consensus       242 -~~~~~~~~~~----~~-~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          242 -LGACSLDCLH----PE-KHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             -TTCCCCTTSC----TT-CHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -hccCCccccC----cc-ccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence             1111111111    11 112223457888999999999999999983

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.3e-36  Score=317.09  Aligned_cols=255  Identities=23%  Similarity=0.371  Sum_probs=179.2

Q ss_pred             hhhhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCccc-H-HHHHHHHHHHHhcCCCCceeeeeeeccCCce
Q 006155          319 IRVATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQG-D-LEFKNEVLLVANLQHRNLVRLLGFSLEGNER  395 (658)
Q Consensus       319 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~-~-~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  395 (658)
                      .....++|...+.||+|+||.||+++.. +|+.||||++....... . ..+.++..++..++||||+++++++.+++..
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~   99 (318)
T 2dyl_A           20 YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV   99 (318)
T ss_dssp             EECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Confidence            3445678999999999999999999864 68899999997653322 2 2344555677888999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED-SRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      ++||||+ ++.+..+...  ....+++..++.++.||++||.|||++ +   |+||||||+|||++.++.+||+|||++.
T Consensus       100 ~lv~e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~  173 (318)
T 2dyl_A          100 FIAMELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISG  173 (318)
T ss_dssp             EEEECCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred             EEEEecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCch
Confidence            9999999 4555555421  235689999999999999999999985 7   9999999999999999999999999997


Q ss_pred             ccccCCCccccccccccccccCccccc-----cCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccC
Q 006155          475 LFEMDETQGNTSRIVGTYGYMAPEYAM-----HGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWRE  549 (658)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  549 (658)
                      .+....   ......||+.|+|||++.     ...++.++||||||+++|||++|+.||....  ...+.+......   
T Consensus       174 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~---  245 (318)
T 2dyl_A          174 RLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK--TDFEVLTKVLQE---  245 (318)
T ss_dssp             ----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC--SHHHHHHHHHHS---
T ss_pred             hccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC--ccHHHHHHHhcc---
Confidence            654332   223457899999999984     5678999999999999999999999985321  222232222221   


Q ss_pred             CCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          550 GTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       550 ~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                       ....+  +.. .....   .+.+++..||+.||.+||++.++++
T Consensus       246 -~~~~~--~~~-~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          246 -EPPLL--PGH-MGFSG---DFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             -CCCCC--CSS-SCCCH---HHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -CCCCC--Ccc-CCCCH---HHHHHHHHHccCChhHCcCHHHHhh
Confidence             11111  000 01122   3446778999999999999999974

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.8e-37  Score=324.56  Aligned_cols=243  Identities=25%  Similarity=0.404  Sum_probs=195.9

Q ss_pred             hhhccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcc------cHHHHHHHHHHHHhcC--CCCceeeeeeec
Q 006155          320 RVATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQ------GDLEFKNEVLLVANLQ--HRNLVRLLGFSL  390 (658)
Q Consensus       320 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~--H~niv~l~~~~~  390 (658)
                      ....++|...+.||+|+||.||+|+. .+++.||||++......      ....+.+|+.++.+++  |+||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            44567899999999999999999984 46889999998765322      1234678999999996  599999999999


Q ss_pred             cCCceEEEEEecCC-CChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeC-CCCCeEEe
Q 006155          391 EGNERLLIYEFVPN-TSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLD-AEMTPKIA  468 (658)
Q Consensus       391 ~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~-~~~~~kl~  468 (658)
                      ..+..++|+|++.+ ++|.+++..   ...+++..++.++.||++||.|||+.+   |+||||||+|||++ +++.+||+
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence            99999999999976 899999843   456899999999999999999999988   99999999999999 78999999


Q ss_pred             ccccccccccCCCccccccccccccccCccccccCCC-CcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhc
Q 006155          469 DFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQY-SVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNW  547 (658)
Q Consensus       469 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~  547 (658)
                      |||+++.+...    ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||...     ..    ...  
T Consensus       193 Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~-----~~----~~~--  257 (320)
T 3a99_A          193 DFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-----EE----IIR--  257 (320)
T ss_dssp             CCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----HH----HHH--
T ss_pred             eCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh-----hh----hhc--
Confidence            99999876532    2234579999999999987776 68899999999999999999998421     11    111  


Q ss_pred             cCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          548 REGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       548 ~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                        +.   .   .+.....+   .+.+++.+||+.||++|||+.+|++
T Consensus       258 --~~---~---~~~~~~~~---~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          258 --GQ---V---FFRQRVSS---ECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             --CC---C---CCSSCCCH---HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --cc---c---cccccCCH---HHHHHHHHHccCChhhCcCHHHHhc
Confidence              00   0   01111122   3456778999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.1e-36  Score=342.72  Aligned_cols=263  Identities=24%  Similarity=0.307  Sum_probs=193.2

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCC-cccHHHHHHHHHHHHhcCCCCceeeeeeecc------CCc
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDS-GQGDLEFKNEVLLVANLQHRNLVRLLGFSLE------GNE  394 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~~  394 (658)
                      .++|...++||+|+||.||+++. .+|+.||||++.... ......+.+|+.++.+++||||+++++++..      ++.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            37899999999999999999985 458899999987643 2334568899999999999999999998765      667


Q ss_pred             eEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCC---eEEeccc
Q 006155          395 RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMT---PKIADFG  471 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~---~kl~DFG  471 (658)
                      .++||||+++|+|.+++........+++..++.++.+|+.||.|||+.+   |+||||||+|||++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence            8999999999999999976555557999999999999999999999988   999999999999997765   8999999


Q ss_pred             cccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCc--chHHHHHHHh-cc
Q 006155          472 MARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETV--EDLLSSAWKN-WR  548 (658)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~--~~l~~~~~~~-~~  548 (658)
                      ++..+....   ......||+.|+|||++.+..++.++||||||+++|||++|+.||........  ..+....... ..
T Consensus       170 ~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~  246 (676)
T 3qa8_A          170 YAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV  246 (676)
T ss_dssp             CCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred             ccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence            998765432   22346899999999999999999999999999999999999999843210000  0000000000 00


Q ss_pred             CCCcc-cc-cCCCC--CCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 006155          549 EGTTV-NI-IDPTL--SSG-SITEMIRCIHIGLLCVQENVASRPTMAS  591 (658)
Q Consensus       549 ~~~~~-~~-~dp~l--~~~-~~~e~~~~~~i~~~Cl~~~p~~RPtm~e  591 (658)
                      ..... .. ....+  ... .......+.+++..||+.||++|||+.+
T Consensus       247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e  294 (676)
T 3qa8_A          247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ  294 (676)
T ss_dssp             CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred             hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence            00000 00 00000  011 1222334567888999999999999966

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.5e-36  Score=344.26  Aligned_cols=238  Identities=19%  Similarity=0.280  Sum_probs=189.0

Q ss_pred             hhccCCcccCcccccCceEEEEeEec--CCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCc---
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLY--DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNE---  394 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~--~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---  394 (658)
                      ...++|.+.+.||+|+||.||+++..  +|+.||||++..... .....+.+|+.++.+++||||+++++++...+.   
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~  156 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD  156 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence            34578999999999999999999864  588999999865432 334468899999999999999999999987665   


Q ss_pred             --eEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccc
Q 006155          395 --RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGM  472 (658)
Q Consensus       395 --~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGl  472 (658)
                        .+|||||+++++|.+++..     .++|..++.|+.||++||.|||+.+   ||||||||+|||++.+ .+||+|||+
T Consensus       157 ~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~  227 (681)
T 2pzi_A          157 PVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGA  227 (681)
T ss_dssp             EEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTT
T ss_pred             ceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEeccc
Confidence              6999999999999887732     6999999999999999999999998   9999999999999986 899999999


Q ss_pred             ccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCc
Q 006155          473 ARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTT  552 (658)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  552 (658)
                      ++.....      ....||++|+|||++.++. +.++||||||+++|||++|..|+.........               
T Consensus       228 a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~---------------  285 (681)
T 2pzi_A          228 VSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP---------------  285 (681)
T ss_dssp             CEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC---------------
T ss_pred             chhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccc---------------
Confidence            9865432      3457999999999987664 89999999999999999998876421110000               


Q ss_pred             ccccCCCCCCC-CHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHhc
Q 006155          553 VNIIDPTLSSG-SITEMIRCIHIGLLCVQENVASRPT-MASVVLMLN  597 (658)
Q Consensus       553 ~~~~dp~l~~~-~~~e~~~~~~i~~~Cl~~~p~~RPt-m~evv~~L~  597 (658)
                              ... .......+.+++..||+.||++||+ ++++...|.
T Consensus       286 --------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~  324 (681)
T 2pzi_A          286 --------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT  324 (681)
T ss_dssp             --------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             --------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence                    000 0111134567888999999999995 555655554

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3.1e-36  Score=326.46  Aligned_cols=243  Identities=16%  Similarity=0.119  Sum_probs=177.9

Q ss_pred             hhccCCcccCcccccCceEEEEeE-ecCCcceeEEEeccCCc---ccHHHHHHHHHHHHhcCC-CCceeee---------
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSG---QGDLEFKNEVLLVANLQH-RNLVRLL---------  386 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H-~niv~l~---------  386 (658)
                      ....+|...+.||+|+||.||+|+ ..+|+.||||++.....   .....+.+|+.++..++| +|.....         
T Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~  154 (413)
T 3dzo_A           75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  154 (413)
T ss_dssp             SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred             CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence            344567788899999999999998 45689999999874432   235678999999999987 3221111         


Q ss_pred             ------------eeecc-----CCceEEEEEecCCCChhhhhcC----cCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 006155          387 ------------GFSLE-----GNERLLIYEFVPNTSLDHFIFD----PTRRAQLDWERRYKIIGGIARGLLYLHEDSRL  445 (658)
Q Consensus       387 ------------~~~~~-----~~~~~lv~e~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~  445 (658)
                                  .+...     ....+++|+++ +++|.+++..    ......++|..++.++.||++||.|||+.+  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--  231 (413)
T 3dzo_A          155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--  231 (413)
T ss_dssp             EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence                        11111     12345666654 6899988831    123456889999999999999999999988  


Q ss_pred             cEEEeccCCCceeeCCCCCeEEeccccccccccCCCccccccccccccccCcccc----------ccCCCCccccccccc
Q 006155          446 RIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA----------MHGQYSVKSDVFSFG  515 (658)
Q Consensus       446 ~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~ksDV~S~G  515 (658)
                       ||||||||+||||+.++.+||+|||+++.....     .....| +.|+|||++          ....++.++||||||
T Consensus       232 -iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlG  304 (413)
T 3dzo_A          232 -LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG  304 (413)
T ss_dssp             -EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHH
T ss_pred             -cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHH
Confidence             999999999999999999999999998865432     334577 999999999          555688999999999


Q ss_pred             chHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 006155          516 VLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVV  593 (658)
Q Consensus       516 vll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv  593 (658)
                      |++|||++|+.||..........               .++.. . ....+   .+.+++..||+.||++||++.+++
T Consensus       305 vil~elltg~~Pf~~~~~~~~~~---------------~~~~~-~-~~~~~---~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          305 LAIYWIWCADLPNTDDAALGGSE---------------WIFRS-C-KNIPQ---PVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHHHHHSSCCCCTTGGGSCSG---------------GGGSS-C-CCCCH---HHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHHHHHCCCCCCCcchhhhHH---------------HHHhh-c-ccCCH---HHHHHHHHHccCChhhCcCHHHHH
Confidence            99999999999985432211111               11110 0 01112   355677899999999999977765

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=8.9e-35  Score=299.11  Aligned_cols=231  Identities=10%  Similarity=0.025  Sum_probs=178.9

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCccc---HHHHHHHHHHHHhcCCCCceeeeeeeccCCceEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQG---DLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  397 (658)
                      ..++|...+.||+|+||.||+|+.. .|+.||||++.......   ...+.+|+..+.+++||||+++++++.+++..++
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  108 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV  108 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence            3467999999999999999999864 48899999997654332   3568999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE  477 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~  477 (658)
                      ||||+++++|.+++..    . ....+..+|+.||+.||.|||+.+   |+||||||+|||++.++.+||+++|      
T Consensus       109 v~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------  174 (286)
T 3uqc_A          109 VAEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------  174 (286)
T ss_dssp             EEECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred             EEEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc------
Confidence            9999999999999832    2 355678899999999999999998   9999999999999999999997443      


Q ss_pred             cCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccC
Q 006155          478 MDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID  557 (658)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  557 (658)
                                      |++|       ++.++||||||+++|||++|+.||...........   ...... +.....  
T Consensus       175 ----------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~---~~~~~~-~~~~~~--  225 (286)
T 3uqc_A          175 ----------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP---AERDTA-GQPIEP--  225 (286)
T ss_dssp             ----------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE---CCBCTT-SCBCCH--
T ss_pred             ----------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH---HHHHhc-cCCCCh--
Confidence                            3333       68899999999999999999999864332211100   000000 000000  


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          558 PTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       558 p~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      ..+.....+   .+.+++.+||+.||++| |+.|+++.|+..
T Consensus       226 ~~~~~~~~~---~l~~li~~~l~~dP~~R-s~~el~~~L~~~  263 (286)
T 3uqc_A          226 ADIDRDIPF---QISAVAARSVQGDGGIR-SASTLLNLMQQA  263 (286)
T ss_dssp             HHHCTTSCH---HHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred             hhcccCCCH---HHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence            000111112   34577789999999999 999999999864

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.2e-33  Score=292.63  Aligned_cols=227  Identities=21%  Similarity=0.238  Sum_probs=173.1

Q ss_pred             ccCCccc-CcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHH-HhcCCCCceeeeeeecc----CCce
Q 006155          323 TDNFSDA-NKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLV-ANLQHRNLVRLLGFSLE----GNER  395 (658)
Q Consensus       323 ~~~~~~~-~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~~~~~~----~~~~  395 (658)
                      .++|... +.||+|+||.||+++. .+++.||||++..     ...+.+|+.++ +.++||||+++++++..    +...
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            3556666 7799999999999985 4688999999854     24567888887 55689999999999876    6678


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCC---CCCeEEecccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDA---EMTPKIADFGM  472 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~---~~~~kl~DFGl  472 (658)
                      ++||||+++++|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||+
T Consensus        91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~  166 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  166 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence            9999999999999999542 2346999999999999999999999988   999999999999998   78999999999


Q ss_pred             ccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCc
Q 006155          473 ARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTT  552 (658)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  552 (658)
                      +....                        +..++.++||||||+++|||++|+.||.........       .    ...
T Consensus       167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-------~----~~~  211 (299)
T 3m2w_A          167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------P----GMK  211 (299)
T ss_dssp             CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------C----CSC
T ss_pred             ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-------H----HHH
Confidence            86432                        234678999999999999999999998533221100       0    000


Q ss_pred             ccccCCCCCCCCHH----HHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          553 VNIIDPTLSSGSIT----EMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       553 ~~~~dp~l~~~~~~----e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ..+...... ....    .-..+.+++..||+.||++|||+.|+++
T Consensus       212 ~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          212 TRIRMGQYE-FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             CSSCTTCCS-SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHhhcccc-CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            000000000 0100    0123556778999999999999999986

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=7.3e-35  Score=306.82  Aligned_cols=191  Identities=17%  Similarity=0.182  Sum_probs=159.3

Q ss_pred             hccCCcccCcccccCceEEEEeEecCCcceeEEEeccCC--------cccHHHHHHHHHHHHhcC---------CCCcee
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDS--------GQGDLEFKNEVLLVANLQ---------HRNLVR  384 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~---------H~niv~  384 (658)
                      ..++|...++||+|+||+||+|+. +|+.||||++....        ......+.+|+.++++++         ||||++
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            357789999999999999999986 78999999997653        223367899999999886         555555


Q ss_pred             eee-----------------eecc-------------CCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHH
Q 006155          385 LLG-----------------FSLE-------------GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR  434 (658)
Q Consensus       385 l~~-----------------~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~  434 (658)
                      +.+                 ++.+             .+..++||||+++|++.+.+..    ..+++..++.++.||+.
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTA  172 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHH
Confidence            544                 4443             6789999999999977666622    56899999999999999


Q ss_pred             HHHHhh-hcCCCcEEEeccCCCceeeCCCC--------------------CeEEeccccccccccCCCcccccccccccc
Q 006155          435 GLLYLH-EDSRLRIIHRDLKTSNVLLDAEM--------------------TPKIADFGMARLFEMDETQGNTSRIVGTYG  493 (658)
Q Consensus       435 gL~yLH-~~~~~~ivHrDlk~~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~  493 (658)
                      ||.||| +.+   |+||||||+||||+.++                    .+||+|||+++.....       ..+||+.
T Consensus       173 aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~  242 (336)
T 2vuw_A          173 SLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDV  242 (336)
T ss_dssp             HHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCC
T ss_pred             HHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeec
Confidence            999999 887   99999999999999887                    8999999999876432       3489999


Q ss_pred             ccCccccccCCCCcccccccccch-HhHHHhCCCCC
Q 006155          494 YMAPEYAMHGQYSVKSDVFSFGVL-VLEIISGQRNN  528 (658)
Q Consensus       494 y~aPE~~~~~~~s~ksDV~S~Gvl-l~elltG~~p~  528 (658)
                      |+|||++.+.. +.++||||+|++ .+++++|..|+
T Consensus       243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~  277 (336)
T 2vuw_A          243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPY  277 (336)
T ss_dssp             TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTH
T ss_pred             ccChhhhcCCC-ccceehhhhhCCCCcccccccCCC
Confidence            99999998666 899999998766 88899999887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=1.3e-29  Score=284.28  Aligned_cols=185  Identities=21%  Similarity=0.236  Sum_probs=131.7

Q ss_pred             cccccCceEEEEeE-ecCCcceeEEEeccCCc----------ccHHHHHHHHHHHHhc-CCCCceeeeeeeccCCceEEE
Q 006155          331 KLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSG----------QGDLEFKNEVLLVANL-QHRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       331 ~lG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~----------~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv  398 (658)
                      ..+.|++|.+..++ ..-|+.++||.+.....          ....+|.+|+++|+++ .|+||+++++++.+++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            46677777776654 44689999999875421          2234689999999999 699999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccccc
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~  478 (658)
                      |||++|++|.++|..   ...++..   +|+.||+.||+|||+++   ||||||||+||||++++++||+|||+++.+..
T Consensus       321 MEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          321 MEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             EECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             EecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            999999999999953   3456654   58999999999999998   99999999999999999999999999987654


Q ss_pred             CCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCC
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRN  527 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p  527 (658)
                      +..  .....+||++|||||++.+ ++..++|+||+|++++++.++..+
T Consensus       392 ~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          392 DCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             --C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            332  3345789999999998865 567789999999999998776544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=2.6e-27  Score=264.24  Aligned_cols=185  Identities=17%  Similarity=0.238  Sum_probs=146.3

Q ss_pred             cccCcccccCceEEEEeEecCCcceeEEEeccCCccc--------HHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEE
Q 006155          327 SDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQG--------DLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       327 ~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~--------~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  398 (658)
                      ...++||+|+||.||+++ ..+..+++|+........        ...+.+|+.++.+++||||+++..++...+..+||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS-YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEE-CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEE-ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            456789999999999995 568889999865432211        23478999999999999999777777778888999


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccccc
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~  478 (658)
                      |||+++++|.+++..           ++.++.||++||.|||+++   |+||||||+|||++.  ++||+|||+++.+..
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999999843           5689999999999999988   999999999999999  999999999998754


Q ss_pred             CCCcc-----ccccccccccccCcccccc--CCCCcccccccccchHhHHHhCCCCC
Q 006155          479 DETQG-----NTSRIVGTYGYMAPEYAMH--GQYSVKSDVFSFGVLVLEIISGQRNN  528 (658)
Q Consensus       479 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~S~Gvll~elltG~~p~  528 (658)
                      .....     ......||+.|||||++..  ..|+.++|+|+..+-.++-+.++.++
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            32211     1235689999999999977  56888999999998888888777654

>3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba}

Probab=99.93  E-value=5.2e-26  Score=195.80  Aligned_cols=98  Identities=23%  Similarity=0.510  Sum_probs=88.2

Q ss_pred             CCCCCCCccCCCchHHHHHHHHHHHhhhcccCCC-CcceeccCC-CCCeEEEEEeccCCCChhhhhHHHHHHHHHHHhhC
Q 006155           26 VCSNDVGNYTSNSAYKTNLNSVLSSIASNAAVDY-GFYNESAGQ-EPDKVNVFALCRGDIATDVCRGCLENATQEILRVC  103 (658)
Q Consensus        26 ~C~~~~~~~~~~s~~~~nl~~l~~~l~~~a~~~~-~~~~~~~g~-~~~~vygl~~C~~D~~~~~C~~Cl~~a~~~~~~~C  103 (658)
                      .|+  +++|+++++|++||+.||++|+++++.++ .|+++..|. ++++||||+|||||+++++|+.||+.|+++++++|
T Consensus         9 ~Cn--~~~~t~~s~f~~nl~~ll~~L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~~~~C   86 (108)
T 3a2e_A            9 ACN--TQKIPSGSPFNRNLRAMLADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRIFSIC   86 (108)
T ss_dssp             EEC--SSBCCTTCTHHHHHHHHHHHHHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTTHHHHT
T ss_pred             ecC--CCccCCCChHHHHHHHHHHHHHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHHHHHHC
Confidence            486  47999999999999999999999886543 366665554 56899999999999999999999999999999999


Q ss_pred             CCcccEEEEcceeEEEEccccc
Q 006155          104 PNQKQAIIWSAECMLRYSNKTI  125 (658)
Q Consensus       104 ~~~~~~~i~~~~C~~ry~~~~f  125 (658)
                      |++++|+||++.|+||||+++|
T Consensus        87 ~~~~g~~i~~~~C~lRY~~~~F  108 (108)
T 3a2e_A           87 NNAIGARVQLVDCFIQYEQRSF  108 (108)
T ss_dssp             TSBSSEEEEETTEEEEEESSCC
T ss_pred             CCCceEEEECCCEEEEEeCCcC
Confidence            9999999999999999999998

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.88  E-value=3.1e-23  Score=212.23  Aligned_cols=148  Identities=18%  Similarity=0.090  Sum_probs=118.8

Q ss_pred             hccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCc------------------ccHHHHHHHHHHHHhcCCCCce
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSG------------------QGDLEFKNEVLLVANLQHRNLV  383 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~H~niv  383 (658)
                      ....|...+.||+|+||.||+|+..+|+.||||.+.....                  .....+.+|+.++.+++  | +
T Consensus        88 ~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~  164 (282)
T 1zar_A           88 SGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-L  164 (282)
T ss_dssp             TTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-S
T ss_pred             CCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-C
Confidence            3455667799999999999999986799999999864321                  12346889999999999  4 6


Q ss_pred             eeeeeeccCCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCC
Q 006155          384 RLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM  463 (658)
Q Consensus       384 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~  463 (658)
                      ++.+++. .+..++||||+++++|.+ +..         .....++.||++||.|||+.+   |+||||||+|||++ ++
T Consensus       165 ~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~  229 (282)
T 1zar_A          165 AVPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EE  229 (282)
T ss_dssp             SSCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TT
T ss_pred             CcCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CC
Confidence            6666543 356799999999999988 411         224579999999999999988   99999999999999 99


Q ss_pred             CeEEeccccccccccCCCccccccccccccccCcccccc
Q 006155          464 TPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMH  502 (658)
Q Consensus       464 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  502 (658)
                      .+||+|||+++.               +..++|||++..
T Consensus       230 ~vkl~DFG~a~~---------------~~~~~a~e~l~r  253 (282)
T 1zar_A          230 GIWIIDFPQSVE---------------VGEEGWREILER  253 (282)
T ss_dssp             EEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred             cEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence            999999999863               335789998753

>3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba}

Probab=99.82  E-value=1.3e-20  Score=162.00  Aligned_cols=105  Identities=26%  Similarity=0.456  Sum_probs=91.4

Q ss_pred             CCCceeeecccCccCChHHHHHHHHHHHHHHHHHhcCCCCccceeecccc-CCccceeEEeccCCCCChHhHHHHHHHHH
Q 006155          131 TGPTYYMWNVNNVTDDVSLFNQALQDLLRRLRGTAASGNSQKKFATGDTT-ASFRTIYALEQCTPDLSELQCSDCLDRAI  209 (658)
Q Consensus       131 ~~~~~~~~~~~~~~~~~~~f~~~~~~l~~~l~~~a~~~~~~~~fa~g~~~-~~~~~~Y~laQCt~dls~~~C~~Cl~~~~  209 (658)
                      +...+..||..+++ +.+.|+.+++.||..|...|+.+  ..+|+++... .+.++||||+||+|||++.+|+.||+.++
T Consensus         3 t~~v~~~Cn~~~~t-~~s~f~~nl~~ll~~L~~~a~~s--~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~   79 (108)
T 3a2e_A            3 TAFVSSACNTQKIP-SGSPFNRNLRAMLADLRQNTAFS--GYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLV   79 (108)
T ss_dssp             CCEEEEEECSSBCC-TTCTHHHHHHHHHHHHHHHGGGT--TSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHH
T ss_pred             cceeeeecCCCccC-CCChHHHHHHHHHHHHHhhCccc--cCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHH
Confidence            34456789888877 35579999999999999888764  3567777655 56789999999999999999999999999


Q ss_pred             hcCCCccCCCccceEeCCccCCccccccc
Q 006155          210 GEIPNCCSGKIGGRVLKPSCNFRFETERF  238 (658)
Q Consensus       210 ~~~~~~c~~~~gg~v~~~~C~lrye~~~f  238 (658)
                      .+++.+|+++.||++++++|++|||.++|
T Consensus        80 ~~~~~~C~~~~g~~i~~~~C~lRY~~~~F  108 (108)
T 3a2e_A           80 NRIFSICNNAIGARVQLVDCFIQYEQRSF  108 (108)
T ss_dssp             TTHHHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred             HHHHHHCCCCceEEEECCCEEEEEeCCcC
Confidence            99999999999999999999999999887

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.77  E-value=3.6e-19  Score=179.69  Aligned_cols=136  Identities=17%  Similarity=0.206  Sum_probs=106.0

Q ss_pred             CcccCcccccCceEEEEeEe-cCCcc--eeEEEeccCCcc------------------------cHHHHHHHHHHHHhcC
Q 006155          326 FSDANKLGQGGFGAVYKGRL-YDGAE--IAVKRLSRDSGQ------------------------GDLEFKNEVLLVANLQ  378 (658)
Q Consensus       326 ~~~~~~lG~G~fg~Vy~~~~-~~g~~--vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l~  378 (658)
                      |...+.||+|+||.||+|+. .+|+.  ||||++......                        ....+.+|+..+.+++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56778999999999999986 68889  999987543111                        0125788999999998


Q ss_pred             CCCc--eeeeeeeccCCceEEEEEecCC-C----ChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhh-hcCCCcEEEe
Q 006155          379 HRNL--VRLLGFSLEGNERLLIYEFVPN-T----SLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH-EDSRLRIIHR  450 (658)
Q Consensus       379 H~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivHr  450 (658)
                      |+++  ..++++    +..+|||||+.+ |    +|.++...      .++.....++.||+.||.||| +.+   |+||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr  195 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHA  195 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence            8864  334432    356899999942 4    56655421      235567889999999999999 877   9999


Q ss_pred             ccCCCceeeCCCCCeEEecccccccc
Q 006155          451 DLKTSNVLLDAEMTPKIADFGMARLF  476 (658)
Q Consensus       451 Dlk~~NILl~~~~~~kl~DFGla~~~  476 (658)
                      ||||+|||++.  .++|+|||++...
T Consensus       196 Dlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          196 DLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCHHHEEEcC--cEEEEECcccccC
Confidence            99999999998  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.66  E-value=5.8e-17  Score=170.44  Aligned_cols=139  Identities=14%  Similarity=0.127  Sum_probs=98.1

Q ss_pred             CCcccCcccccCceEEEEeEecCCcceeEEEeccCCc--------------ccHHHHHHHHHHHHhcCCCCceeeeeeec
Q 006155          325 NFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSG--------------QGDLEFKNEVLLVANLQHRNLVRLLGFSL  390 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~--------------~~~~~~~~E~~~l~~l~H~niv~l~~~~~  390 (658)
                      -|++.+.||+|+||.||+|...+|+.||||+++....              ........++.+.....|+|++++.....
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            4888999999999999999988899999998753210              01112223333333333444444432221


Q ss_pred             c------CCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCC
Q 006155          391 E------GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMT  464 (658)
Q Consensus       391 ~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~  464 (658)
                      .      ....+|||||+++++|..+...         +....++.||+.+|.|||+.+   ||||||||.|||+++++.
T Consensus       176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd  243 (397)
T 4gyi_A          176 PVPEPIAQSRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKD  243 (397)
T ss_dssp             SCCCEEEEETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEEC
T ss_pred             CCCeeeeccCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCC
Confidence            1      1233799999999998765421         123568899999999999988   999999999999988763


Q ss_pred             ----------eEEeccccccc
Q 006155          465 ----------PKIADFGMARL  475 (658)
Q Consensus       465 ----------~kl~DFGla~~  475 (658)
                                +.|+||+-+..
T Consensus       244 ~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          244 AEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             SSCTTSEEEEEEECCCTTCEE
T ss_pred             cccccccccceEEEEeCCccc
Confidence                      89999997654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.26  E-value=9.7e-12  Score=125.14  Aligned_cols=143  Identities=16%  Similarity=0.117  Sum_probs=112.4

Q ss_pred             ccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcC-CCCceeeeeeeccCCceEEEEEe
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQ-HRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      .+.|.....++.|+.+.||+... +++.+++|+...........+.+|+.+++.+. |..+.+++++..+.+..++||||
T Consensus        13 l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~   91 (263)
T 3tm0_A           13 IEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             HTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             hccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence            34677777888889999999974 47889999986532223345889999999985 67788999999888889999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhc---------------------------------------
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED---------------------------------------  442 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------------------------------------  442 (658)
                      ++|.+|.+.+.        +......++.+++++|..||+.                                       
T Consensus        92 i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T 3tm0_A           92 ADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             CSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred             cCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence            99999987641        1122347889999999999981                                       


Q ss_pred             -----------------CCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          443 -----------------SRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       443 -----------------~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                                       ....++|+|+++.|||++++..+.|.||+.+.
T Consensus       164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                             11348999999999999876556799999774

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.15  E-value=7.6e-11  Score=118.03  Aligned_cols=136  Identities=18%  Similarity=0.130  Sum_probs=100.5

Q ss_pred             CCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCC--ceeeeeeeccCCceEEEEEec
Q 006155          325 NFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRN--LVRLLGFSLEGNERLLIYEFV  402 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~lv~e~~  402 (658)
                      ++......+.|..+.||+....+|..++||.....   ....+..|+.++..+.+.+  +.+++++...++..++||||+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            34433333455569999998777888999987654   2235788999999886545  556888888777889999999


Q ss_pred             CCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcC---------------------------------------
Q 006155          403 PNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS---------------------------------------  443 (658)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------  443 (658)
                      +|.+|.  ...      .+   ...++.++++.|..||+..                                       
T Consensus        98 ~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (264)
T 1nd4_A           98 PGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA  166 (264)
T ss_dssp             SSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred             CCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence            999884  211      11   2357788888888888743                                       


Q ss_pred             ----------------CCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          444 ----------------RLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       444 ----------------~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                                      ...++|+|++|.|||++++..+.|.|||.+.
T Consensus       167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                            1239999999999999877666799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.96  E-value=1.7e-09  Score=113.97  Aligned_cols=142  Identities=14%  Similarity=0.207  Sum_probs=107.3

Q ss_pred             ccCcccccCceEEEEeEecCCcceeEEEec--cCC-cccHHHHHHHHHHHHhcC--CCCceeeeeeeccC---CceEEEE
Q 006155          328 DANKLGQGGFGAVYKGRLYDGAEIAVKRLS--RDS-GQGDLEFKNEVLLVANLQ--HRNLVRLLGFSLEG---NERLLIY  399 (658)
Q Consensus       328 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~--~~~-~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~---~~~~lv~  399 (658)
                      ..+.|+.|.++.||+.... +..+++|+..  ... ......+.+|+.++..+.  +..+.+++.++.+.   ...++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            4567899999999998854 5678888775  322 122346788999999997  45688888888776   3479999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcC------------------------------------
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS------------------------------------  443 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------  443 (658)
                      ||++|..+.+..     ...++...+..++.++++.|..||+..                                    
T Consensus       121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            999998885422     134778889999999999999999731                                    


Q ss_pred             -------------------CCcEEEeccCCCceeeCCCCC--eEEeccccccc
Q 006155          444 -------------------RLRIIHRDLKTSNVLLDAEMT--PKIADFGMARL  475 (658)
Q Consensus       444 -------------------~~~ivHrDlk~~NILl~~~~~--~kl~DFGla~~  475 (658)
                                         ...++|+|+++.|||++.++.  +.|.||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               246999999999999997753  58999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.85  E-value=1.2e-09  Score=112.45  Aligned_cols=187  Identities=18%  Similarity=0.222  Sum_probs=122.3

Q ss_pred             cCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcC-CCC--ceeeeeeeccCC---ceEEEEEec
Q 006155          329 ANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQ-HRN--LVRLLGFSLEGN---ERLLIYEFV  402 (658)
Q Consensus       329 ~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~n--iv~l~~~~~~~~---~~~lv~e~~  402 (658)
                      .+.++.|....||+..    ..+++|+....  .....+.+|..++..+. +..  +.+++......+   ..++|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4568999999999863    56889975432  33456889999998884 333  445555544333   347899999


Q ss_pred             CCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhc----------------------------------------
Q 006155          403 PNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED----------------------------------------  442 (658)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------------  442 (658)
                      +|.+|.....     ..++..++..++.++++.|..||+.                                        
T Consensus        99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9998865331     2467777888888888888888861                                        


Q ss_pred             ---------------CCCcEEEeccCCCceeeCC--CCCeEEeccccccccccCCCcccc------------cccccccc
Q 006155          443 ---------------SRLRIIHRDLKTSNVLLDA--EMTPKIADFGMARLFEMDETQGNT------------SRIVGTYG  493 (658)
Q Consensus       443 ---------------~~~~ivHrDlk~~NILl~~--~~~~kl~DFGla~~~~~~~~~~~~------------~~~~gt~~  493 (658)
                                     ..+.++|+|+++.||++++  ...+.|.||+.+..-+........            ......++
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence                           1235899999999999998  456789999988643211000000            00001111


Q ss_pred             ccC-ccccccCCCCcccccccccchHhHHHhCCCCC
Q 006155          494 YMA-PEYAMHGQYSVKSDVFSFGVLVLEIISGQRNN  528 (658)
Q Consensus       494 y~a-PE~~~~~~~s~ksDV~S~Gvll~elltG~~p~  528 (658)
                      ... |+.....  ....+.|+++.++|++.+|..++
T Consensus       254 ~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          254 HKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence            122 2222111  12358899999999999998654

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.35  E-value=2.9e-06  Score=87.04  Aligned_cols=136  Identities=21%  Similarity=0.181  Sum_probs=94.0

Q ss_pred             cCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCC---Cceeeeeeec-cCCceEEEEEecCC
Q 006155          329 ANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHR---NLVRLLGFSL-EGNERLLIYEFVPN  404 (658)
Q Consensus       329 ~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~~~~~-~~~~~~lv~e~~~~  404 (658)
                      .+.++.|....||+.    |..++||+-..  ......+..|..+|..+.+.   .+.+.+.+.. ..+..++||||++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            456788888899987    67888997422  22345688999999999753   3556666663 44567899999999


Q ss_pred             CChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhc------------------------------------------
Q 006155          405 TSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED------------------------------------------  442 (658)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------  442 (658)
                      .+|.....     ..++...+..++.++++.|..||+.                                          
T Consensus        98 ~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           98 QILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             EECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             eECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            98866321     1234444555555555555555532                                          


Q ss_pred             ---------------CCCcEEEeccCCCceeeCC---CCCe-EEeccccccc
Q 006155          443 ---------------SRLRIIHRDLKTSNVLLDA---EMTP-KIADFGMARL  475 (658)
Q Consensus       443 ---------------~~~~ivHrDlk~~NILl~~---~~~~-kl~DFGla~~  475 (658)
                                     ..+.++|+|+++.|||++.   ++.+ .|.||+.+..
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                           2235799999999999987   4554 7999998754

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.28  E-value=1.9e-06  Score=90.35  Aligned_cols=81  Identities=5%  Similarity=0.018  Sum_probs=56.7

Q ss_pred             cCcc-cccCceEEEEeEec-------CCcceeEEEeccCC---cccHHHHHHHHHHHHhcC-C--CCceeeeeeeccC--
Q 006155          329 ANKL-GQGGFGAVYKGRLY-------DGAEIAVKRLSRDS---GQGDLEFKNEVLLVANLQ-H--RNLVRLLGFSLEG--  392 (658)
Q Consensus       329 ~~~l-G~G~fg~Vy~~~~~-------~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~--  392 (658)
                      .+.| +.|....+|+....       ++..+++|+.....   ......+.+|+.++..+. +  -.+.++++++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4567 78888999998754       26778888765432   111245788888888885 3  3567788877655  


Q ss_pred             -CceEEEEEecCCCChhh
Q 006155          393 -NERLLIYEFVPNTSLDH  409 (658)
Q Consensus       393 -~~~~lv~e~~~~gsL~~  409 (658)
                       ...++||||++|.++.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             35689999999987754

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.24  E-value=3e-06  Score=85.00  Aligned_cols=134  Identities=16%  Similarity=0.165  Sum_probs=94.5

Q ss_pred             cccccCce-EEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcC-CCCceeeeeeeccCCceEEEEEecCCCCh
Q 006155          331 KLGQGGFG-AVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQ-HRNLVRLLGFSLEGNERLLIYEFVPNTSL  407 (658)
Q Consensus       331 ~lG~G~fg-~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~gsL  407 (658)
                      .+..|..| .||+.... ++..+.||+-...   ...++..|...|+.+. +--+.++++++.+++..++|||++++.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            34445544 68987644 4667899976432   3456788999998885 33477888888888899999999999888


Q ss_pred             hhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcC--------------------------------------------
Q 006155          408 DHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS--------------------------------------------  443 (658)
Q Consensus       408 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------------------  443 (658)
                      .+....       .......+..++++.|.-||...                                            
T Consensus       108 ~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          108 FQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             HHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             cccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            665421       11223345566666666666421                                            


Q ss_pred             -----------CCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          444 -----------RLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       444 -----------~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                                 .+.++|+|+.+.|||+++++.+-|.||+.+.
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                       1238999999999999987777799999875

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.98  E-value=1.7e-05  Score=82.30  Aligned_cols=141  Identities=17%  Similarity=0.231  Sum_probs=81.3

Q ss_pred             cCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCC--CCceeeeee------eccCCceEEEEE
Q 006155          329 ANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQH--RNLVRLLGF------SLEGNERLLIYE  400 (658)
Q Consensus       329 ~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~------~~~~~~~~lv~e  400 (658)
                      .+.|+.|..+.||+....+| .+++|+....    ..++..|+.++..|..  -.+.+++..      ...++..++|||
T Consensus        37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EEECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            34566677889999886554 4889988652    2334455565555531  133444431      123556789999


Q ss_pred             ecCCCChh--------------hhhcCcCC-----------CCCCCHHHHH-----------------------------
Q 006155          401 FVPNTSLD--------------HFIFDPTR-----------RAQLDWERRY-----------------------------  426 (658)
Q Consensus       401 ~~~~gsL~--------------~~l~~~~~-----------~~~l~~~~~~-----------------------------  426 (658)
                      |++|.++.              ..+|....           .....|...+                             
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            99987653              01111000           0112343211                             


Q ss_pred             --HHHHHHHHHHHHhhh----------cCCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          427 --KIIGGIARGLLYLHE----------DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       427 --~i~~~ia~gL~yLH~----------~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                        .+...+.+++.+|++          .....++|+|+++.|||++.++.+.|.||+.+.
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence              111223446667763          123569999999999999888899999999774

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.89  E-value=5.4e-05  Score=76.67  Aligned_cols=80  Identities=24%  Similarity=0.306  Sum_probs=59.2

Q ss_pred             cCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCC---CceeeeeeeccCCceEEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHR---NLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~~~~~~~~~~~lv~e  400 (658)
                      ..+...+.+|.|..+.||+.++.+|+.+.||+-..........|..|...|+.|.-.   -+.+.+++.    ..++|||
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e   90 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME   90 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred             CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence            345566789999999999999999999999987655444445678899999888422   244555542    3478999


Q ss_pred             ecCCCCh
Q 006155          401 FVPNTSL  407 (658)
Q Consensus       401 ~~~~gsL  407 (658)
                      |++.+..
T Consensus        91 ~l~~~~~   97 (288)
T 3f7w_A           91 WVDERPP   97 (288)
T ss_dssp             CCCCCCC
T ss_pred             eecccCC
Confidence            9987654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.87  E-value=5.4e-05  Score=80.48  Aligned_cols=75  Identities=9%  Similarity=0.061  Sum_probs=49.3

Q ss_pred             cCcccccCceEEEEeEec-CCcceeEEEeccCCc-------ccHHHHHHHHHHHHhcCC--CC-ceeeeeeeccCCceEE
Q 006155          329 ANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG-------QGDLEFKNEVLLVANLQH--RN-LVRLLGFSLEGNERLL  397 (658)
Q Consensus       329 ~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~H--~n-iv~l~~~~~~~~~~~l  397 (658)
                      .+.||.|..+.||+++.. +++.++||.......       .....+..|..++..+.+  +. +.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            467999999999999754 468899997653221       122346778888887742  33 4455544  3445689


Q ss_pred             EEEecCCC
Q 006155          398 IYEFVPNT  405 (658)
Q Consensus       398 v~e~~~~g  405 (658)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.73  E-value=0.00016  Score=73.98  Aligned_cols=140  Identities=16%  Similarity=0.157  Sum_probs=93.3

Q ss_pred             cccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcC---CCCceeeeeeeccCCceEEEEEecC
Q 006155          327 SDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQ---HRNLVRLLGFSLEGNERLLIYEFVP  403 (658)
Q Consensus       327 ~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lv~e~~~  403 (658)
                      ...+.|+.|....+|+... ++..++||+....   ....+..|...|+.|.   ...+.+++++....+..++||||++
T Consensus        39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~  114 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN  114 (312)
T ss_dssp             CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred             eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence            4456789999999999875 5778889987542   3456888999888884   3568888888877788999999999


Q ss_pred             CCChhh-----------hhcCcCC-------------------CCCCCHHHHH---HHH----------------HHHHH
Q 006155          404 NTSLDH-----------FIFDPTR-------------------RAQLDWERRY---KII----------------GGIAR  434 (658)
Q Consensus       404 ~gsL~~-----------~l~~~~~-------------------~~~l~~~~~~---~i~----------------~~ia~  434 (658)
                      +..+..           .||....                   .-.-+|....   ++.                ..+..
T Consensus       115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~  194 (312)
T 3jr1_A          115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ  194 (312)
T ss_dssp             CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred             CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence            886521           1221110                   0012565432   111                11111


Q ss_pred             H-HHHhhh-cCCCcEEEeccCCCceeeCCCCCeEEeccc
Q 006155          435 G-LLYLHE-DSRLRIIHRDLKTSNVLLDAEMTPKIADFG  471 (658)
Q Consensus       435 g-L~yLH~-~~~~~ivHrDlk~~NILl~~~~~~kl~DFG  471 (658)
                      - ...|.. ...+.+||+|+.+.||+++.++ +.|.||.
T Consensus       195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            1 223421 2356799999999999999887 8898974

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.55  E-value=0.00029  Score=75.40  Aligned_cols=80  Identities=14%  Similarity=0.086  Sum_probs=47.2

Q ss_pred             CCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCccccccccccccccCccccccC---CCCcccccccccchHhH
Q 006155          444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG---QYSVKSDVFSFGVLVLE  520 (658)
Q Consensus       444 ~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDV~S~Gvll~e  520 (658)
                      ...++|+|+++.|||++.++ ++|.||+.+..-.........- ..-...|++|+.....   .-....++......+|+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYL-GNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHH-HHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHH-HHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            34599999999999998876 9999999886422110000000 0001346666654311   11223455577777888


Q ss_pred             HHhCC
Q 006155          521 IISGQ  525 (658)
Q Consensus       521 lltG~  525 (658)
                      .++++
T Consensus       309 ~y~~~  313 (420)
T 2pyw_A          309 LFNKR  313 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            77754

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.28  E-value=0.00088  Score=68.07  Aligned_cols=138  Identities=11%  Similarity=0.136  Sum_probs=76.7

Q ss_pred             cCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCc-eeeeeeeccCCceEEEEEec-CCCC
Q 006155          329 ANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNL-VRLLGFSLEGNERLLIYEFV-PNTS  406 (658)
Q Consensus       329 ~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~-~~gs  406 (658)
                      .+.|+.|....+|+.     ..+++|+....... ..+..+|+..+..+...++ .+++++.  .+.-++|+||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence            678889999999998     67888887653211 1234568877777753233 4555543  33457899999 6655


Q ss_pred             hhhh------------------hcCcCC--CCCCC-HHHHHHHHHH--------------HHHHHH----Hhhh-cCCCc
Q 006155          407 LDHF------------------IFDPTR--RAQLD-WERRYKIIGG--------------IARGLL----YLHE-DSRLR  446 (658)
Q Consensus       407 L~~~------------------l~~~~~--~~~l~-~~~~~~i~~~--------------ia~gL~----yLH~-~~~~~  446 (658)
                      |...                  +|....  ....+ +.....+...              +.+.+.    .|.. .....
T Consensus        95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~  174 (301)
T 3dxq_A           95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA  174 (301)
T ss_dssp             CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred             CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence            5320                  111100  00011 1111111110              111111    1111 22345


Q ss_pred             EEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          447 IIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       447 ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ++|+|+.+.||+ ..++.+.|.||..+..
T Consensus       175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          175 ACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            899999999999 5667789999988753

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.17  E-value=0.0011  Score=67.93  Aligned_cols=143  Identities=13%  Similarity=0.103  Sum_probs=80.4

Q ss_pred             cCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCC--ceeeeeee------ccCCceEEEEE
Q 006155          329 ANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRN--LVRLLGFS------LEGNERLLIYE  400 (658)
Q Consensus       329 ~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~------~~~~~~~lv~e  400 (658)
                      .+.|+.|....+|+....+| .+++|+.....  ...++..|+.++..|...+  +.+++...      ...+..+++++
T Consensus        27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~  103 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS  103 (322)
T ss_dssp             EEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred             eeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence            34577788889999886555 68899886531  2234566777777774222  33343221      12345689999


Q ss_pred             ecCCCChhhh--------------hcCc----CCC-----CCCCHHHHHHH------------HHHHHHHHHHhhhc---
Q 006155          401 FVPNTSLDHF--------------IFDP----TRR-----AQLDWERRYKI------------IGGIARGLLYLHED---  442 (658)
Q Consensus       401 ~~~~gsL~~~--------------l~~~----~~~-----~~l~~~~~~~i------------~~~ia~gL~yLH~~---  442 (658)
                      |++|..+...              +|..    ...     ....|...+.-            ...+.+.+.+|++.   
T Consensus       104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~  183 (322)
T 2ppq_A          104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK  183 (322)
T ss_dssp             CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred             eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence            9998764210              1110    000     01124331111            01234455555532   


Q ss_pred             -CCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          443 -SRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       443 -~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                       ....++|+|+++.|||++++..+.|.||+.+.
T Consensus       184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             SSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence             23459999999999999987656899999775

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.11  E-value=0.00096  Score=71.54  Aligned_cols=73  Identities=16%  Similarity=0.285  Sum_probs=49.9

Q ss_pred             cCcccccCceEEEEeEecC--------CcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCc-eeeeeeeccCCceEEEE
Q 006155          329 ANKLGQGGFGAVYKGRLYD--------GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNL-VRLLGFSLEGNERLLIY  399 (658)
Q Consensus       329 ~~~lG~G~fg~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~  399 (658)
                      .+.|+.|-...+|+....+        ++.+.+|+....  .....+..|..++..|...++ .++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            3567888889999988653        467888887432  111456689888888853333 567776543    3899


Q ss_pred             EecCCCCh
Q 006155          400 EFVPNTSL  407 (658)
Q Consensus       400 e~~~~gsL  407 (658)
                      ||++|.+|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99987554

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.09  E-value=0.0042  Score=63.65  Aligned_cols=141  Identities=15%  Similarity=0.167  Sum_probs=81.9

Q ss_pred             CcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCC--ceeeeee-----eccCCceEEEEEec
Q 006155          330 NKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRN--LVRLLGF-----SLEGNERLLIYEFV  402 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~-----~~~~~~~~lv~e~~  402 (658)
                      ..|+ |....||+....+|+.+++|+..... .....+..|..++..+....  +++++..     ...++..+++|||+
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            3466 77789999877677789999886432 23456777888888775222  4445543     11234557899999


Q ss_pred             CCCChhh-----h---------hcC----c--CCCCCCCHHHH----HHHH---------------HHHHHHHHHhhh--
Q 006155          403 PNTSLDH-----F---------IFD----P--TRRAQLDWERR----YKII---------------GGIARGLLYLHE--  441 (658)
Q Consensus       403 ~~gsL~~-----~---------l~~----~--~~~~~l~~~~~----~~i~---------------~~ia~gL~yLH~--  441 (658)
                      +|..+..     +         +|.    .  ......++...    ..++               ..+.+.+..+.+  
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            8865421     0         111    0  01112333221    0111               011112222221  


Q ss_pred             --cCCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          442 --DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       442 --~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                        .....++|+|+++.|||++ + .+.|.||+.+.
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence              1234589999999999999 4 89999998775

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.99  E-value=0.0036  Score=64.42  Aligned_cols=142  Identities=20%  Similarity=0.175  Sum_probs=72.2

Q ss_pred             cCcccccCceE-EEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCC--CCceeeeeeeccCCceEEEEEecCCC
Q 006155          329 ANKLGQGGFGA-VYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQH--RNLVRLLGFSLEGNERLLIYEFVPNT  405 (658)
Q Consensus       329 ~~~lG~G~fg~-Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lv~e~~~~g  405 (658)
                      .+.|+.|.... +|+....+|..+++|.......   .++..|+.++..+..  -.+.+++.+..+..  +++||++.+.
T Consensus        23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~   97 (333)
T 3csv_A           23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA   97 (333)
T ss_dssp             ECC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred             eeECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence            34565554444 6676543467777776543321   234556666666642  23556666643332  7899999876


Q ss_pred             Chhhhhc---------------------CcCC--CCCCCHHHHH-------HH-------------HHHHHHHHHHhh--
Q 006155          406 SLDHFIF---------------------DPTR--RAQLDWERRY-------KI-------------IGGIARGLLYLH--  440 (658)
Q Consensus       406 sL~~~l~---------------------~~~~--~~~l~~~~~~-------~i-------------~~~ia~gL~yLH--  440 (658)
                      .+.+++.                     ....  ...++.....       .+             ...+...+..|.  
T Consensus        98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~  177 (333)
T 3csv_A           98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA  177 (333)
T ss_dssp             BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence            6643331                     1000  0111111100       00             001112222221  


Q ss_pred             -hcCCCcEEEeccCCCceeeCCC----CCeEEeccccccc
Q 006155          441 -EDSRLRIIHRDLKTSNVLLDAE----MTPKIADFGMARL  475 (658)
Q Consensus       441 -~~~~~~ivHrDlk~~NILl~~~----~~~kl~DFGla~~  475 (658)
                       ......++|+|+.+.|||++.+    +.+.|.||+.+..
T Consensus       178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence             1123469999999999999875    6789999998764

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.95  E-value=0.0033  Score=67.85  Aligned_cols=74  Identities=15%  Similarity=0.130  Sum_probs=48.6

Q ss_pred             cCcccccCceEEEEeEecC-CcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCc-eeeeeeeccCCceEEEEEecCCCC
Q 006155          329 ANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNL-VRLLGFSLEGNERLLIYEFVPNTS  406 (658)
Q Consensus       329 ~~~lG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~~~gs  406 (658)
                      .+.|+.|-...+|+....+ +..+++|+..... ....+...|..++..|...++ .++++.+..    .+||||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence            4568888889999988654 4778888774432 222223688899988875555 567776632    35999999865


Q ss_pred             h
Q 006155          407 L  407 (658)
Q Consensus       407 L  407 (658)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            5

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.81  E-value=0.0043  Score=65.10  Aligned_cols=142  Identities=17%  Similarity=0.175  Sum_probs=84.9

Q ss_pred             cCcccccCceEEEEeEec--------CCcceeEEEeccCCcccHHHHHHHHHHHHhcC-CCCceeeeeeeccCCceEEEE
Q 006155          329 ANKLGQGGFGAVYKGRLY--------DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQ-HRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       329 ~~~lG~G~fg~Vy~~~~~--------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~  399 (658)
                      .+.|..|-...+|+....        +++.+.+|+.... ......+.+|..+++.|. +.-..++++++.+    .+||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            346777777888998754        2467888875332 234556778999988885 3334567776654    2999


Q ss_pred             EecCCCChhhh-----------------hcCc--CCCCCCC--HHHHHHHHHHHHH-------------------HHHHh
Q 006155          400 EFVPNTSLDHF-----------------IFDP--TRRAQLD--WERRYKIIGGIAR-------------------GLLYL  439 (658)
Q Consensus       400 e~~~~gsL~~~-----------------l~~~--~~~~~l~--~~~~~~i~~~ia~-------------------gL~yL  439 (658)
                      ||++|.+|..-                 ||..  .-.+...  |.++.++..++..                   .+..|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99998766421                 1111  1111222  4555556544422                   23333


Q ss_pred             h----hc-CCCcEEEeccCCCceeeCCC----CCeEEeccccccc
Q 006155          440 H----ED-SRLRIIHRDLKTSNVLLDAE----MTPKIADFGMARL  475 (658)
Q Consensus       440 H----~~-~~~~ivHrDlk~~NILl~~~----~~~kl~DFGla~~  475 (658)
                      .    .. ....++|+|+.+.|||++.+    +.+.|.||..+..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            2    21 23458999999999999876    7899999998753

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.62  E-value=0.0036  Score=65.47  Aligned_cols=73  Identities=11%  Similarity=0.074  Sum_probs=43.8

Q ss_pred             CcccccCceEEEEeEecCC---------cceeEEEeccCCcccHHHHHHHHHHHHhcCCCC-ceeeeeeeccCCceEEEE
Q 006155          330 NKLGQGGFGAVYKGRLYDG---------AEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRN-LVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~~~g---------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~lv~  399 (658)
                      +.|+.|..-.+|+....++         ..+++|+..... ....+...|..++..+...+ ..++++...    -++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEecC----CcEEE
Confidence            4677787888999875442         678888765432 11123467888888775333 446665542    37899


Q ss_pred             EecCCCCh
Q 006155          400 EFVPNTSL  407 (658)
Q Consensus       400 e~~~~gsL  407 (658)
                      ||++|.++
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99998654

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.29  E-value=0.029  Score=57.84  Aligned_cols=32  Identities=28%  Similarity=0.425  Sum_probs=27.7

Q ss_pred             CCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       444 ~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ...++|+|+.+.||++++++.+.|.||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            34699999999999999888899999987653

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.15  E-value=0.074  Score=56.48  Aligned_cols=141  Identities=14%  Similarity=0.141  Sum_probs=85.0

Q ss_pred             cCcccccCceEEEEeEecC--------CcceeEEEeccCCcccHHHHHHHHHHHHhcC-CCCceeeeeeeccCCceEEEE
Q 006155          329 ANKLGQGGFGAVYKGRLYD--------GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQ-HRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       329 ~~~lG~G~fg~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~  399 (658)
                      .+.|..|-.-.+|+....+        +..+++|+..... ....+..+|..+++.+. +.-..++++.+.    -++||
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            4567777778899987653        5778888864432 22234567888888775 332455565432    37899


Q ss_pred             EecCCCChhhh-----------------hcCc--------C--CCCCCCHHHHHHHHHHH-------------------H
Q 006155          400 EFVPNTSLDHF-----------------IFDP--------T--RRAQLDWERRYKIIGGI-------------------A  433 (658)
Q Consensus       400 e~~~~gsL~~~-----------------l~~~--------~--~~~~l~~~~~~~i~~~i-------------------a  433 (658)
                      ||++|.+|..-                 ||..        .  ...+.-|.++.++..++                   .
T Consensus       150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~  229 (424)
T 3mes_A          150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL  229 (424)
T ss_dssp             ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred             EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence            99998765210                 1110        0  11112355554444332                   2


Q ss_pred             HHHHHhhh---------------------cCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          434 RGLLYLHE---------------------DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       434 ~gL~yLH~---------------------~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ..+.+|.+                     .....++|+|+.+.||+ +.++.+.|.||..+..
T Consensus       230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            22333321                     12345899999999999 7888999999998753

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=94.11  E-value=0.16  Score=48.31  Aligned_cols=103  Identities=12%  Similarity=0.085  Sum_probs=65.8

Q ss_pred             CChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCccc
Q 006155          405 TSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN  484 (658)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~  484 (658)
                      -||.++|..  ...+++++++|.++.|.++.|.-+-.... + ..+=+.|..|+|..+|++.+.+ ..+.          
T Consensus        33 vSL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------   97 (229)
T 2yle_A           33 LSLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD----------   97 (229)
T ss_dssp             EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             ccHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc----------
Confidence            378888843  45789999999999999999877622110 1 1223457899999999988764 2111          


Q ss_pred             cccccccccccCccccccCCCCcccccccccchHhHHHhCCCC
Q 006155          485 TSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRN  527 (658)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p  527 (658)
                          .....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus        98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence                0122456888763 3456788999999999988764443

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=88.62  E-value=1.2  Score=46.85  Aligned_cols=30  Identities=23%  Similarity=0.388  Sum_probs=25.0

Q ss_pred             cEEEeccCCCceee------CCCCCeEEeccccccc
Q 006155          446 RIIHRDLKTSNVLL------DAEMTPKIADFGMARL  475 (658)
Q Consensus       446 ~ivHrDlk~~NILl------~~~~~~kl~DFGla~~  475 (658)
                      .++|+|+.+.|||+      +++..++++||..+..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      4567799999998753

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=88.13  E-value=0.085  Score=36.10  Aligned_cols=20  Identities=20%  Similarity=0.401  Sum_probs=8.6

Q ss_pred             hhHHHHHHhhhheeecccCC
Q 006155          272 TVGFVILIIFICFFLRRKPR  291 (658)
Q Consensus       272 v~~~vll~i~~~~~~rr~~~  291 (658)
                      +++++++++++++++|||++
T Consensus        21 v~~~~ii~~~~~~~~RRr~~   40 (44)
T 2ks1_B           21 LLLLLVVALGIGLFMRRRHI   40 (44)
T ss_dssp             HHHHHHHHHHHHHHHHTTTC
T ss_pred             HHHHHHHHHHHHHHhhhhHh
Confidence            33333344444445554443

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=85.58  E-value=0.081  Score=36.12  Aligned_cols=19  Identities=26%  Similarity=0.394  Sum_probs=8.2

Q ss_pred             HHHHHHhhhheeecccCCC
Q 006155          274 GFVILIIFICFFLRRKPRD  292 (658)
Q Consensus       274 ~~vll~i~~~~~~rr~~~~  292 (658)
                      +++++++++++++|||+++
T Consensus        22 ~v~ii~~~~~~~~RRRr~~   40 (44)
T 2l2t_A           22 ILVIVGLTFAVYVRRKSIK   40 (44)
T ss_dssp             HHHHHHHHHHHHHHTTCSS
T ss_pred             HHHHHHHHHHHHhhhhhhh
Confidence            3333344444455554443

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=82.59  E-value=0.23  Score=53.44  Aligned_cols=61  Identities=11%  Similarity=0.167  Sum_probs=18.2

Q ss_pred             cccCcccccCceEEEEeEecC-CcceeE------EEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeec
Q 006155          327 SDANKLGQGGFGAVYKGRLYD-GAEIAV------KRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSL  390 (658)
Q Consensus       327 ~~~~~lG~G~fg~Vy~~~~~~-g~~vav------K~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~  390 (658)
                      ...++||   ||.||+|.+.. ..+|||      |......  .+....|.+|..++..++|||+++.+++..
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            3455676   99999998754 368999      7665432  223345788889999999999999988754

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	658
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-74
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-69
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	8e-67
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-66
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	7e-65
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-64
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-64
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-63
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-63
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-63
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	7e-63
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-62
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-61
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-61
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	9e-61
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-60
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-60
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-60
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-59
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-59
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	6e-59
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-58
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-58
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-57
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-56
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-56
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-56
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	6e-56
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-55
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-54
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-54
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-50
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-49
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-48
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	9e-47
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-46
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	6e-46
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-45
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	8e-45
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-44
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-44
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	6e-44
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-43
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-43
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	8e-43
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-42
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-42
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-42
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-41
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-40
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	8e-40
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-39
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-38
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	8e-38
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-37
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-36
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	6e-35
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	7e-33
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-32
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-31
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	7e-30
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	8e-30
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-25

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  237 bits (607), Expect = 3e-74
 Identities = 68/284 (23%), Positives = 132/284 (46%), Gaps = 19/284 (6%)

Query: 324 DNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
              +   ++G G FG VYKG+ +    + +  ++  + Q    FKNEV ++   +H N++
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 384 RLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS 443
             +G+S    +  ++ ++   +SL H +       + +  +   I    A+G+ YLH  S
Sbjct: 68  LFMGYS-TAPQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS 124

Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMH- 502
              IIHRDLK++N+ L  ++T KI DFG+A +           ++ G+  +MAPE     
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 503 --GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTL 560
               YS +SDV++FG+++ E+++GQ    + N    + ++    + +          P L
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQIIFMVGRGYL--------SPDL 231

Query: 561 SSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTLP 604
           S            +   C+++    RP    ++  +   + +LP
Sbjct: 232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  224 bits (573), Expect = 3e-69
 Identities = 78/276 (28%), Positives = 128/276 (46%), Gaps = 21/276 (7%)

Query: 324 DNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
           +      +LG G FG V+ G      ++AVK L + S   D  F  E  L+  LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLV 71

Query: 384 RLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS 443
           RL     +     +I E++ N SL  F+  P    +L   +   +   IA G+ ++ E +
Sbjct: 72  RLYAVVTQEP-IYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN 129

Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG 503
               IHRDL+ +N+L+   ++ KIADFG+ARL E +E             + APE   +G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPIKWTAPEAINYG 185

Query: 504 QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSG 563
            +++KSDV+SFG+L+ EI++  R      G T  +++ +  + +R      +        
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRI--PYPGMTNPEVIQNLERGYRM-----VRPDNCPE- 237

Query: 564 SITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY 599
                     +  LC +E    RPT   +  +L  +
Sbjct: 238 ------ELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (555), Expect = 8e-67
 Identities = 66/273 (24%), Positives = 116/273 (42%), Gaps = 21/273 (7%)

Query: 324 DNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
              +   ++G G FG V+ G   +  ++A+K +   +   + +F  E  ++  L H  LV
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 63

Query: 384 RLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS 443
           +L G  LE     L++EF+ +  L  ++           E    +   +  G+ YL E  
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF--AAETLLGMCLDVCEGMAYLEE-- 119

Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG 503
              +IHRDL   N L+      K++DFGM R    D+   +++       + +PE     
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFS 177

Query: 504 QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSG 563
           +YS KSDV+SFGVL+ E+ S  +        +  +++      +R      +  P L+S 
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKI--PYENRSNSEVVEDISTGFR------LYKPRLAS- 228

Query: 564 SITEMIRCIHIGLLCVQENVASRPTMASVVLML 596
                     I   C +E    RP  + ++  L
Sbjct: 229 -----THVYQIMNHCWKERPEDRPAFSRLLRQL 256

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (555), Expect = 1e-66
 Identities = 71/287 (24%), Positives = 124/287 (43%), Gaps = 21/287 (7%)

Query: 324 DNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
           ++     KLGQG FG V+ G       +A+K L   +      F  E  ++  L+H  LV
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75

Query: 384 RLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS 443
           +L    +      ++ E++   SL  F+   T +      +   +   IA G+ Y+    
Sbjct: 76  QLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVE--- 130

Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG 503
           R+  +HRDL+ +N+L+   +  K+ADFG+ARL E +E             + APE A++G
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYG 189

Query: 504 QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSG 563
           ++++KSDV+SFG+L+ E+ +  R      G    ++L    + +R         P     
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGR--VPYPGMVNREVLDQVERGYRM-----PCPPECPE- 241

Query: 564 SITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTLPVPSEPA 610
                     +   C ++    RPT   +   L  Y  +     +P 
Sbjct: 242 ------SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  214 bits (545), Expect = 7e-65
 Identities = 70/313 (22%), Positives = 125/313 (39%), Gaps = 45/313 (14%)

Query: 312 LQFDFNTIRVATDNFSDANKLGQGGFGAVYKGRL------YDGAEIAVKRLSRDSGQGDL 365
           L     ++    +N      +G+G FG V++ R            +AVK L  ++     
Sbjct: 1   LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60

Query: 366 -EFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRR------- 417
            +F+ E  L+A   + N+V+LLG    G    L++E++    L+ F+   +         
Sbjct: 61  ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120

Query: 418 --------------AQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM 463
                           L    +  I   +A G+ YL E    + +HRDL T N L+   M
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENM 177

Query: 464 TPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS 523
             KIADFG++R     +             +M PE   + +Y+ +SDV+++GV++ EI S
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237

Query: 524 GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENV 583
                    G   E+++              + D  + +      +   ++  LC  +  
Sbjct: 238 YGLQ--PYYGMAHEEVIY------------YVRDGNILACPENCPLELYNLMRLCWSKLP 283

Query: 584 ASRPTMASVVLML 596
           A RP+  S+  +L
Sbjct: 284 ADRPSFCSIHRIL 296

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (544), Expect = 1e-64
 Identities = 66/291 (22%), Positives = 119/291 (40%), Gaps = 29/291 (9%)

Query: 331 KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSL 390
            +G+G FG V++G+   G E+AVK  S    +     + E+     L+H N++  +    
Sbjct: 10  SIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67

Query: 391 EGN----ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED---- 442
           + N    +  L+ ++  + SL  ++     R  +  E   K+    A GL +LH +    
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 443 -SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE--MDETQGNTSRIVGTYGYMAPEY 499
             +  I HRDLK+ N+L+    T  IAD G+A   +   D      +  VGT  YMAPE 
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183

Query: 500 ------AMHGQYSVKSDVFSFGVLVLEIISGQR----NNCFRNGETVEDLLSSAWKNWRE 549
                   H +   ++D+++ G++  EI         +  ++           + +  R+
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243

Query: 550 GTTVNIIDPTLSSG--SITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS 598
                 + P + +   S   +     I   C   N A+R T   +   L+ 
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (544), Expect = 2e-64
 Identities = 62/304 (20%), Positives = 116/304 (38%), Gaps = 39/304 (12%)

Query: 319 IRVATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVAN 376
           + +  D+F   ++LG G  G V+K      G  +A K +  +           E+ ++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 377 LQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGL 436
                +V   G      E  +  E +   SLD  +    +  ++  +   K+   + +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGL 117

Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMA 496
            YL    + +I+HRD+K SN+L+++    K+ DFG++            +  VGT  YM+
Sbjct: 118 TYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMS 171

Query: 497 PEYAMHGQYSVKSDVFSFGVLVLEIISGQR-------------NNCFRNGETVEDLLSSA 543
           PE      YSV+SD++S G+ ++E+  G+                C   G+  E      
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231

Query: 544 WKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLL---------------CVQENVASRPT 588
                  +      P ++   + + I       L               C+ +N A R  
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291

Query: 589 MASV 592
           +  +
Sbjct: 292 LKQL 295

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (534), Expect = 2e-63
 Identities = 64/300 (21%), Positives = 120/300 (40%), Gaps = 26/300 (8%)

Query: 319 IRVATDNFSDAN-KLGQGGFGAVYKGRLY---DGAEIAVKRLSRDSGQGDLE-FKNEVLL 373
           + +  DN   A+ +LG G FG+V +G         ++A+K L + + + D E    E  +
Sbjct: 3   LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 62

Query: 374 VANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIA 433
           +  L +  +VRL+G   +    +L+ E      L  F+    +R ++      +++  ++
Sbjct: 63  MHQLDNPYIVRLIGV-CQAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVS 119

Query: 434 RGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGN-TSRIVGTY 492
            G+ YL        +HRDL   NVLL      KI+DFG+++    D++     S      
Sbjct: 120 MGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176

Query: 493 GYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTT 552
            + APE     ++S +SDV+S+GV + E +S  +           ++++   +  R    
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK--PYKKMKGPEVMAFIEQGKRM--- 231

Query: 553 VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTLPVPSEPAFF 612
                P               +   C       RP   +V   + +   +L    E    
Sbjct: 232 --ECPPECPP-------ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHH 282

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (530), Expect = 2e-63
 Identities = 65/273 (23%), Positives = 120/273 (43%), Gaps = 21/273 (7%)

Query: 324 DNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
            + +   +LG G FG V  G+     ++A+K +   S   + EF  E  ++ NL H  LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62

Query: 384 RLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS 443
           +L G   +     +I E++ N  L +++ +   R +   ++  ++   +   + YL    
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK- 119

Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG 503
             + +HRDL   N L++ +   K++DFG++R    DE   ++        +  PE  M+ 
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYS 176

Query: 504 QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSG 563
           ++S KSD+++FGVL+ EI S  +        T  +      +  R      +  P L+S 
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKM--PYERFTNSETAEHIAQGLR------LYRPHLASE 228

Query: 564 SITEMIRCIHIGLLCVQENVASRPTMASVVLML 596
                 +   I   C  E    RPT   ++  +
Sbjct: 229 ------KVYTIMYSCWHEKADERPTFKILLSNI 255

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (529), Expect = 4e-63
 Identities = 68/274 (24%), Positives = 114/274 (41%), Gaps = 27/274 (9%)

Query: 324 DNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV 383
                   +G+G FG V  G  Y G ++AVK +  D+      F  E  ++  L+H NLV
Sbjct: 7   KELKLLQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLV 63

Query: 384 RLLGFSLEGNERL-LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           +LLG  +E    L ++ E++   SL  ++     R+ L  +   K    +   + YL   
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLE-- 120

Query: 443 SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMH 502
                +HRDL   NVL+  +   K++DFG+ +     +  G          + APE    
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-----LPVKWTAPEALRE 174

Query: 503 GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSS 562
            ++S KSDV+SFG+L+ EI S  R         ++D++    K ++              
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRV--PYPRIPLKDVVPRVEKGYK---------MDAPD 223

Query: 563 GSITEMIRCIHIGLLCVQENVASRPTMASVVLML 596
           G    +   +     C   + A RP+   +   L
Sbjct: 224 GCPPAVYEVM---KNCWHLDAAMRPSFLQLREQL 254

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  208 bits (531), Expect = 7e-63
 Identities = 68/301 (22%), Positives = 131/301 (43%), Gaps = 36/301 (11%)

Query: 314 FDFNTIRVATDNFSDA---------NKLGQGGFGAVYKGRLY----DGAEIAVKRLSRDS 360
           F F     A   F+             +G G FG V  G L         +A+K L    
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 361 GQGDL-EFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQ 419
            +    +F +E  ++    H N++ L G   +    ++I EF+ N SLD F+     +  
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 420 LDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD 479
               +   ++ GIA G+ YL     +  +HRDL   N+L+++ +  K++DFG++R  E D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 480 ETQGNTSRIVG---TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETV 536
            +    +  +G      + APE   + +++  SDV+S+G+++ E++S      +    T 
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW--DMTN 239

Query: 537 EDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLML 596
           +D++++  +++R    ++                   + L C Q++   RP    +V  L
Sbjct: 240 QDVINAIEQDYRLPPPMDCPS------------ALHQLMLDCWQKDRNHRPKFGQIVNTL 287

Query: 597 N 597
           +
Sbjct: 288 D 288

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  206 bits (524), Expect = 5e-62
 Identities = 69/276 (25%), Positives = 121/276 (43%), Gaps = 21/276 (7%)

Query: 324 DNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNL 382
            + +  +KLG G +G VY+G        +AVK L  D+ + + EF  E  ++  ++H NL
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 75

Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           V+LLG         +I EF+   +L  ++ +   R ++       +   I+  + YL   
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLE-- 132

Query: 443 SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMH 502
            +   IHRDL   N L+      K+ADFG++RL   D    +         + APE   +
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAY 190

Query: 503 GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSS 562
            ++S+KSDV++FGVL+ EI +   +     G  +  +     K++R        +     
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMS--PYPGIDLSQVYELLEKDYRMERPEGCPE----- 243

Query: 563 GSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS 598
                  +   +   C Q N + RP+ A +     +
Sbjct: 244 -------KVYELMRACWQWNPSDRPSFAEIHQAFET 272

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (520), Expect = 3e-61
 Identities = 67/282 (23%), Positives = 123/282 (43%), Gaps = 29/282 (10%)

Query: 325 NFSDANKLGQGGFGAVYKGRLYD----GAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQH 379
           +F+    +G+G FG VY G L D        AVK L+R +  G++  F  E +++ +  H
Sbjct: 30  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87

Query: 380 RNLVRLLGFSLEG-NERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
            N++ LLG  L      L++  ++ +  L +FI + T    +     + +          
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG----- 142

Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSR--IVGTYGYMA 496
           +   +  + +HRDL   N +LD + T K+ADFG+AR     E     ++        +MA
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202

Query: 497 PEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNII 556
            E     +++ KSDV+SFGVL+ E+++              D+     +  R      ++
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLLQGRR------LL 254

Query: 557 DPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS 598
            P      + E++      L C       RP+ + +V  +++
Sbjct: 255 QPEYCPDPLYEVM------LKCWHPKAEMRPSFSELVSRISA 290

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 4e-61
 Identities = 74/279 (26%), Positives = 120/279 (43%), Gaps = 29/279 (10%)

Query: 328 DANKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSGQGDL--EFKNEVLLVANLQHRNL 382
           +  +LG G FG V KG          +AVK L  ++    L  E   E  ++  L +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           VR++G   E    +L+ E      L+ ++    +   +  +   +++  ++ G+ YL   
Sbjct: 71  VRMIGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLE-- 124

Query: 443 SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTS-RIVGTYGYMAPEYAM 501
                +HRDL   NVLL  +   KI+DFG+++    DE              + APE   
Sbjct: 125 -ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183

Query: 502 HGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTL 560
           + ++S KSDV+SFGVL+ E  S GQ+      G  V  +L    +               
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER------------MGC 231

Query: 561 SSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY 599
            +G   EM   +    LC   +V +RP  A+V L L +Y
Sbjct: 232 PAGCPREMYDLM---NLCWTYDVENRPGFAAVELRLRNY 267

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 9e-61
 Identities = 63/272 (23%), Positives = 117/272 (43%), Gaps = 22/272 (8%)

Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQHRN 381
           +++     LG+G +G V           +AVK +         E  K E+ +   L H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           +V+  G   EGN + L  E+     L   I        +      +    +  G++YLH 
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM 501
              + I HRD+K  N+LLD     KI+DFG+A +F  +  +   +++ GT  Y+APE   
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 502 HGQY-SVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTL 560
             ++ +   DV+S G+++  +++G+      +    E      + +W+E  T       +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YSDWKEKKTYLNPWKKI 232

Query: 561 SSGSITEMIRCIHIGLLCVQENVASRPTMASV 592
            S  +  + + +        EN ++R T+  +
Sbjct: 233 DSAPLALLHKIL-------VENPSARITIPDI 257

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  202 bits (516), Expect = 1e-60
 Identities = 74/278 (26%), Positives = 116/278 (41%), Gaps = 33/278 (11%)

Query: 323 TDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGD---LEFKNEVLLVANLQ 378
              FSD  ++G G FGAVY  R + +   +A+K++S    Q +    +   EV  +  L+
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           H N ++  G  L  +   L+ E+   ++ D        +  L       +  G  +GL Y
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAY 130

Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
           LH      +IHRD+K  N+LL      K+ DFG A +          +  VGT  +MAPE
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANSFVGTPYWMAPE 181

Query: 499 YAM---HGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNI 555
             +    GQY  K DV+S G+  +E+   +      N   +  L                
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPP--LFNMNAMSALYH----------IAQN 229

Query: 556 IDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVV 593
             P L SG  +E  R  +    C+Q+    RPT   ++
Sbjct: 230 ESPALQSGHWSEYFR--NFVDSCLQKIPQDRPTSEVLL 265

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 2e-60
 Identities = 78/319 (24%), Positives = 132/319 (41%), Gaps = 40/319 (12%)

Query: 324 DNFSDANKLGQGGFGAVYKGRLYDGAE-----IAVKRLSR-DSGQGDLEFKNEVLLVANL 377
             F     LG G FG VYKG      E     +A+K L    S + + E  +E  ++A++
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68

Query: 378 QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLL 437
            + ++ RLLG  L    +L I + +P   L  ++ +   +  +  +        IA+G+ 
Sbjct: 69  DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMN 125

Query: 438 YLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAP 497
           YL      R++HRDL   NVL+      KI DFG+A+L   +E + +         +MA 
Sbjct: 126 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182

Query: 498 EYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID 557
           E  +H  Y+ +SDV+S+GV V E+++        +G    ++ S   K  R         
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGS--KPYDGIPASEISSILEKGERL-----PQP 235

Query: 558 PTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLML--------------NSYSLTL 603
           P  +            I + C   +  SRP    +++                    + L
Sbjct: 236 PICTI-------DVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHL 288

Query: 604 PVPSEPAFFMDSIIESDMS 622
           P P++  F+   + E DM 
Sbjct: 289 PSPTDSNFYRALMDEEDMD 307

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 4e-60
 Identities = 67/288 (23%), Positives = 131/288 (45%), Gaps = 26/288 (9%)

Query: 318 TIRVATDNFSDANKLGQGGFGAVYKGRLYDG-----AEIAVKRLSRDSGQGDL-EFKNEV 371
           T  +     +    +G G FG VYKG L          +A+K L     +    +F  E 
Sbjct: 1   TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60

Query: 372 LLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGG 431
            ++    H N++RL G   +    ++I E++ N +LD F+ +  +  +    +   ++ G
Sbjct: 61  GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRG 118

Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNT-SRIVG 490
           IA G+ YL     +  +HRDL   N+L+++ +  K++DFG++R+ E D     T S    
Sbjct: 119 IAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175

Query: 491 TYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREG 550
              + APE   + +++  SDV+SFG+++ E+++      +    +  +++ +    +R  
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW--ELSNHEVMKAINDGFRLP 233

Query: 551 TTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS 598
           T ++                   + + C Q+  A RP  A +V +L+ 
Sbjct: 234 TPMDCPS------------AIYQLMMQCWQQERARRPKFADIVSILDK 269

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 2e-59
 Identities = 70/303 (23%), Positives = 116/303 (38%), Gaps = 44/303 (14%)

Query: 324 DNFSDANKLGQGGFGAVYKGRLYD------GAEIAVKRLSRDSGQGDLE-FKNEVLLVAN 376
           +N      LG G FG V     Y         ++AVK L   +   + E   +E+ ++  
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 377 L-QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQ---------------- 419
           L  H N+V LLG         LI+E+     L +++     +                  
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 420 ----LDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL 475
               L +E        +A+G+ +L        +HRDL   NVL+      KI DFG+AR 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 476 FEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGET 535
              D              +MAPE    G Y++KSDV+S+G+L+ EI S    N +     
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV-NPYPGIPV 272

Query: 536 VEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM 595
             +     +K  + G  ++   P  ++  I  +++       C   +   RP+  ++   
Sbjct: 273 DANF----YKLIQNGFKMDQ--PFYATEEIYIIMQ------SCWAFDSRKRPSFPNLTSF 320

Query: 596 LNS 598
           L  
Sbjct: 321 LGC 323

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 3e-59
 Identities = 70/296 (23%), Positives = 108/296 (36%), Gaps = 39/296 (13%)

Query: 324 DNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRDSGQGDLE-FKNEVLLVAN 376
           +  S    LG G FG V +   Y          +AVK L   +   + E   +E+ +++ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 377 L-QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFD---------------PTRRAQL 420
           L  H N+V LLG    G   L+I E+     L +F+                       L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 421 DWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE 480
           D E        +A+G+ +L        IHRDL   N+LL      KI DFG+AR  + D 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
                        +MAPE   +  Y+ +SDV+S+G+ + E+ S   +     G  V+   
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP--GMPVDSKF 257

Query: 541 SSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLML 596
               K      +                     I   C   +   RPT   +V ++
Sbjct: 258 YKMIKEGFRMLSPEHAPA-----------EMYDIMKTCWDADPLKRPTFKQIVQLI 302

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (503), Expect = 6e-59
 Identities = 68/289 (23%), Positives = 124/289 (42%), Gaps = 30/289 (10%)

Query: 310 ESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFK 368
           E +  D N      D +    +LG G FG VYK +        A K +   S +   ++ 
Sbjct: 2   EHVTRDLN----PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYM 57

Query: 369 NEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKI 428
            E+ ++A+  H N+V+LL      N   ++ EF    ++D  + +  R   L   +   +
Sbjct: 58  VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVV 115

Query: 429 IGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRI 488
                  L YLH+    +IIHRDLK  N+L   +   K+ADFG++        + ++   
Sbjct: 116 CKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--F 170

Query: 489 VGTYGYMAPEYAM-----HGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSA 543
           +GT  +MAPE  M        Y  K+DV+S G+ ++E+   +      +      +L   
Sbjct: 171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP---PHHELNPMRVL--- 224

Query: 544 WKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASV 592
                +     +  P+  S +  + ++       C+++NV +R T + +
Sbjct: 225 -LKIAKSEPPTLAQPSRWSSNFKDFLKK------CLEKNVDARWTTSQL 266

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 2e-58
 Identities = 72/278 (25%), Positives = 116/278 (41%), Gaps = 25/278 (8%)

Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDL--EFKNEVLLVANLQHR 380
           +++     +G G +G   K R   DG  +  K L   S          +EV L+  L+H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 381 NLVRLLGFSLEGNERLL--IYEFVPNTSLDHFIFDPTR-RAQLDWERRYKIIGGIARGLL 437
           N+VR     ++     L  + E+     L   I   T+ R  LD E   +++  +   L 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 438 YLHE--DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYM 495
             H   D    ++HRDLK +NV LD +   K+ DFG+AR+   D +       VGT  YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYM 181

Query: 496 APEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNI 555
           +PE      Y+ KSD++S G L+ E+ +           + ++L        REG    I
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMP---PFTAFSQKELA----GKIREGKFRRI 234

Query: 556 IDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVV 593
             P   S  + E+I         +      RP++  ++
Sbjct: 235 --PYRYSDELNEIITR------MLNLKDYHRPSVEEIL 264

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 4e-58
 Identities = 72/305 (23%), Positives = 128/305 (41%), Gaps = 33/305 (10%)

Query: 324 DNFSDANKLGQGGFGAVYKGRL------YDGAEIAVKRLSRDSGQGDL-EFKNEVLLVAN 376
           +  + + +LGQG FG VY+G             +A+K ++  +   +  EF NE  ++  
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 377 LQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIF-------DPTRRAQLDWERRYKII 429
               ++VRLLG   +G   L+I E +    L  ++        +    A     +  ++ 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 430 GGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIV 489
           G IA G+ YL+ +   + +HRDL   N ++  + T KI DFGM R     +      + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 490 GTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWRE 549
               +M+PE    G ++  SDV+SFGV++ EI +         G + E +L    +   E
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ--PYQGLSNEQVL----RFVME 250

Query: 550 GTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTLPVPSEP 609
           G  ++  D                +  +C Q N   RP+   ++  +       P   E 
Sbjct: 251 GGLLDKPDNCPD--------MLFELMRMCWQYNPKMRPSFLEIISSIK--EEMEPGFREV 300

Query: 610 AFFMD 614
           +F+  
Sbjct: 301 SFYYS 305

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (495), Expect = 1e-57
 Identities = 72/292 (24%), Positives = 124/292 (42%), Gaps = 38/292 (13%)

Query: 324 DNFSDANKLGQGGFGAVYKGRLYDGA---EIAVKRLSRDSGQGDL-EFKNEVLLVANL-Q 378
           ++    + +G+G FG V K R+       + A+KR+   + + D  +F  E+ ++  L  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFI-------------FDPTRRAQLDWERR 425
           H N++ LLG         L  E+ P+ +L  F+                +  + L  ++ 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 426 YKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNT 485
                 +ARG+ YL +    + IHRDL   N+L+      KIADFG++R  E+       
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---K 183

Query: 486 SRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWK 545
           +       +MA E   +  Y+  SDV+S+GVL+ EI+S         G T  +L     +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--PYCGMTCAELYEKLPQ 241

Query: 546 NWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN 597
            +R    +N  D                +   C +E    RP+ A +++ LN
Sbjct: 242 GYRLEKPLNCDD------------EVYDLMRQCWREKPYERPSFAQILVSLN 281

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (485), Expect = 1e-56
 Identities = 68/274 (24%), Positives = 116/274 (42%), Gaps = 30/274 (10%)

Query: 324 DNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGD---LEFKNEVLLVANLQH 379
           ++F     LG+G FG VY  R       +A+K L +   +      + + EV + ++L+H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
            N++RL G+  +     LI E+ P  ++   +   ++    D +R    I  +A  L Y 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122

Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
           H     R+IHRD+K  N+LL +    KIADFG +              + GT  Y+ PE 
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLPPEM 175

Query: 500 AMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT 559
                +  K D++S GVL  E + G+    F    T ++      +       V    P 
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKP--PF-EANTYQETYKRISR-------VEFTFPD 225

Query: 560 LSSGSITEMIRCIHIGLLCVQENVASRPTMASVV 593
             +    ++I         ++ N + RP +  V+
Sbjct: 226 FVTEGARDLISR------LLKHNPSQRPMLREVL 253

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 2e-56
 Identities = 61/272 (22%), Positives = 108/272 (39%), Gaps = 30/272 (11%)

Query: 330 NKLGQGGFGAVYKGRL-YDGAEIAVKRLSRD--SGQGDLEFKNEVLLVANLQHRNLVRLL 386
            ++G+G F  VYKG       E+A   L     +      FK E  ++  LQH N+VR  
Sbjct: 15  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 387 GF----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
                        +L+ E + + +L  ++    R   +  +        I +GL +LH  
Sbjct: 75  DSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTR 131

Query: 443 SRLRIIHRDLKTSNVLLDAE-MTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM 501
           +   IIHRDLK  N+ +     + KI D G+A L            ++GT  +MAPE   
Sbjct: 132 TP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR----ASFAKAVIGTPEFMAPEM-Y 185

Query: 502 HGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLS 561
             +Y    DV++FG+ +LE+ + +    +   +    +    ++    G      D    
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSEYP--YSECQNAAQI----YRRVTSGVKPASFDKVAI 239

Query: 562 SGSITEMIRCIHIGLLCVQENVASRPTMASVV 593
                       I   C+++N   R ++  ++
Sbjct: 240 P-------EVKEIIEGCIRQNKDERYSIKDLL 264

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 3e-56
 Identities = 67/287 (23%), Positives = 102/287 (35%), Gaps = 27/287 (9%)

Query: 318 TIRVATDNFSDANKLGQGGFGAVYKGRLY----DGAEIAVKRLSRD---SGQGDLEFKNE 370
           T  +   +     KLG G FG V +G           +AVK L  D     +   +F  E
Sbjct: 2   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61

Query: 371 VLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIG 430
           V  + +L HRNL+RL G  L    ++ + E  P  SL   +     +         +   
Sbjct: 62  VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK--HQGHFLLGTLSRYAV 118

Query: 431 GIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQG-NTSRIV 489
            +A G+ YL      R IHRDL   N+LL      KI DFG+ R    ++          
Sbjct: 119 QVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175

Query: 490 GTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWRE 549
             + + APE      +S  SD + FGV + E+ +  +      G     +L    K    
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE--PWIGLNGSQILHKIDKEGER 233

Query: 550 GTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLML 596
                                  ++ + C       RPT  ++   L
Sbjct: 234 LPRPEDCPQ-----------DIYNVMVQCWAHKPEDRPTFVALRDFL 269

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 6e-56
 Identities = 62/271 (22%), Positives = 120/271 (44%), Gaps = 23/271 (8%)

Query: 323 TDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRN 381
              ++   K+GQG  G VY    +  G E+A+++++           NE+L++   ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           +V  L   L G+E  ++ E++   SL   + +       D  +   +     + L +LH 
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEFLHS 134

Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM 501
               ++IHRD+K+ N+LL  + + K+ DFG       ++++   S +VGT  +MAPE   
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVT 189

Query: 502 HGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLS 561
              Y  K D++S G++ +E+I G+    + N   +  L            T  + +P   
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPP--YLNENPLRAL-----YLIATNGTPELQNPEKL 242

Query: 562 SGSITEMIRCIHIGLLCVQENVASRPTMASV 592
           S    + +        C+  +V  R +   +
Sbjct: 243 SAIFRDFLNR------CLDMDVEKRGSAKEL 267

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 2e-55
 Identities = 73/297 (24%), Positives = 114/297 (38%), Gaps = 38/297 (12%)

Query: 324 DNFSDANKLGQGGFGAVYKGR------LYDGAEIAVKRLSRDSGQGDLE--FKNEVLLVA 375
           D       LG+G FG V +              +AVK L   +   +         +L+ 
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 376 NLQHRNLVRLLGFSLE-GNERLLIYEFVPNTSLDHFIF-------------DPTRRAQLD 421
              H N+V LLG   + G   ++I EF    +L  ++              +   +  L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 422 WERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET 481
            E        +A+G+ +L      + IHRDL   N+LL  +   KI DFG+AR    D  
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 482 QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLS 541
                       +MAPE      Y+++SDV+SFGVL+ EI S    + +   +  E+   
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-SPYPGVKIDEEF-- 246

Query: 542 SAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS 598
              +  +EGT +   D T                L C     + RPT + +V  L +
Sbjct: 247 --CRRLKEGTRMRAPDYTTP--------EMYQTMLDCWHGEPSQRPTFSELVEHLGN 293

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 1e-54
 Identities = 60/280 (21%), Positives = 101/280 (36%), Gaps = 26/280 (9%)

Query: 324 DNFSDANKLGQGGFGAVYKGRLYD----GAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQ 378
           +       +G+G FG V++G           +A+K     +     E F  E L +    
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           H ++V+L+G   E     +I E      L  F+        LD          ++  L Y
Sbjct: 67  HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 123

Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
           L      R +HRD+   NVL+ +    K+ DFG++R  E        S+      +MAPE
Sbjct: 124 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPE 179

Query: 499 YAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP 558
                +++  SDV+ FGV + EI+          G    D++       R       + P
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVK--PFQGVKNNDVIGRIENGERL-----PMPP 232

Query: 559 TLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS 598
                          +   C   + + RP    +   L++
Sbjct: 233 NCPP-------TLYSLMTKCWAYDPSRRPRFTELKAQLST 265

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 2e-54
 Identities = 75/297 (25%), Positives = 122/297 (41%), Gaps = 40/297 (13%)

Query: 324 DNFSDANKLGQGGFGAVYKGRL--------YDGAEIAVKRLSRDSGQGDL-EFKNEVLLV 374
           D       LG+G FG V                 ++AVK L  D+ + DL +  +E+ ++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 375 ANL-QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIF-------------DPTRRAQL 420
             + +H+N++ LLG   +     +I E+    +L  ++                    QL
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 421 DWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE 480
             +        +ARG+ YL      + IHRDL   NVL+  +   KIADFG+AR     +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
               T+       +MAPE      Y+ +SDV+SFGVL+ EI +   +     G  VE+L 
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS--PYPGVPVEEL- 246

Query: 541 SSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLN 597
              +K  +EG  ++      +            +   C     + RPT   +V  L+
Sbjct: 247 ---FKLLKEGHRMDKPSNCTN--------ELYMMMRDCWHAVPSQRPTFKQLVEDLD 292

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 1e-50
 Identities = 53/211 (25%), Positives = 87/211 (41%), Gaps = 10/211 (4%)

Query: 320 RVATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGD---LEFKNEVLLVA 375
           +   ++F     LG+G F  V   R L    E A+K L +     +        E  +++
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63

Query: 376 NLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARG 435
            L H   V+L     +  +      +  N  L  +I         D          I   
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSA 120

Query: 436 LLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYM 495
           L YLH      IIHRDLK  N+LL+ +M  +I DFG A++   +  Q   +  VGT  Y+
Sbjct: 121 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177

Query: 496 APEYAMHGQYSVKSDVFSFGVLVLEIISGQR 526
           +PE          SD+++ G ++ ++++G  
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLP 208

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  174 bits (443), Expect = 1e-49
 Identities = 64/318 (20%), Positives = 123/318 (38%), Gaps = 25/318 (7%)

Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNL 382
           D++    +LG G FG V++      G   A K +           + E+  ++ L+H  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           V L     + NE ++IYEF+    L   + D     ++  +   + +  + +GL ++HE 
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHE- 142

Query: 443 SRLRIIHRDLKTSNVLLDAEMTP--KIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA 500
                +H DLK  N++   + +   K+ DFG+    +  ++   T    GT  + APE A
Sbjct: 143 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT---TGTAEFAAPEVA 197

Query: 501 MHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTL 560
                   +D++S GVL   ++SG        GE  ++ L +      +    +     +
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLS---PFGGENDDETLRNVKSC--DWNMDDSAFSGI 252

Query: 561 SSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM--LNSYSLTLPVPSEPAFFMDSIIE 618
           S     + IR        +  +  +R T+   +    L   +        P+     I +
Sbjct: 253 SEDGK-DFIRK------LLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRD 305

Query: 619 SDMSFSLAHDSRITETDQ 636
           S  +   A    +    +
Sbjct: 306 SIKTKYDAWPEPLPPLGR 323

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  171 bits (435), Expect = 2e-48
 Identities = 63/303 (20%), Positives = 110/303 (36%), Gaps = 27/303 (8%)

Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNL 382
           D +    +LG G FG V++      G     K ++          KNE+ ++  L H  L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           + L     +  E +LI EF+    L   I       ++        +     GL ++HE 
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHE- 145

Query: 443 SRLRIIHRDLKTSNVLLDAEMTP--KIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA 500
               I+H D+K  N++ + +     KI DFG+A     DE          T  + APE  
Sbjct: 146 --HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIV 200

Query: 501 MHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTL 560
                   +D+++ GVL   ++SG        GE   + L +  +   +         ++
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLS---PFAGEDDLETLQNVKRC--DWEFDEDAFSSV 255

Query: 561 SSGSITEMIRCIHIGLLCVQENVASRPTMASVV----LMLNSYSLTLPVPSEPAFFMDSI 616
           S                 +Q+    R T+   +    L  +  +LT  +PS     +   
Sbjct: 256 SP-------EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQK 308

Query: 617 IES 619
           I+ 
Sbjct: 309 IKE 311

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  164 bits (416), Expect = 9e-47
 Identities = 63/281 (22%), Positives = 119/281 (42%), Gaps = 27/281 (9%)

Query: 323 TDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGD---LEFKNEVLLVANLQ 378
           +D +     LG GG   V+  R L    ++AVK L  D  +     L F+ E    A L 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 379 HRNLVRLLGF----SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIAR 434
           H  +V +       +  G    ++ E+V   +L   +        +  +R  ++I    +
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122

Query: 435 GLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQG-NTSRIVGTYG 493
            L + H+     IIHRD+K +N+++ A    K+ DFG+AR           T+ ++GT  
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 494 YMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTV 553
           Y++PE A       +SDV+S G ++ E+++G+       G++   +    +++ RE    
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP---PFTGDSPVSVA---YQHVREDPIP 233

Query: 554 NIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL 594
                   S  +  ++         + +N  +R   A+ + 
Sbjct: 234 PSARHEGLSADLDAVVLK------ALAKNPENRYQTAAEMR 268

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 5e-46
 Identities = 47/214 (21%), Positives = 98/214 (45%), Gaps = 7/214 (3%)

Query: 323 TDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQHR 380
              +++ + +G+G +G V       +   +A+K++S    Q   +    E+ ++   +H 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH 440
           N++ +           +   ++    +   ++   +   L  +     +  I RGL Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 441 EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNT-SRIVGTYGYMAPEY 499
                 ++HRDLK SN+LL+     KI DFG+AR+ + D       +  V T  Y APE 
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 500 AMHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRN 532
            ++ + Y+   D++S G ++ E++S +     ++
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 217

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  163 bits (412), Expect = 6e-46
 Identities = 51/303 (16%), Positives = 104/303 (34%), Gaps = 27/303 (8%)

Query: 319 IRVATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANL 377
           +RV  + +    K+G G FG +Y G  +  G E+A+K     +     +   E  +   +
Sbjct: 3   LRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP--QLHIESKIYKMM 59

Query: 378 QHRNLVRLLGFSL-EGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGL 436
           Q    +  + +   EG+  +++ E +  +  D F F      +   +    +   +   +
Sbjct: 60  QGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRI 116

Query: 437 LYLHEDSRLRIIHRDLKTSNVL---LDAEMTPKIADFGMARLFEMDETQGN-----TSRI 488
            Y+H       IHRD+K  N L           I DFG+A+ +    T  +        +
Sbjct: 117 EYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 173

Query: 489 VGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWR 548
            GT  Y +    +  + S + D+ S G +++    G          T            +
Sbjct: 174 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY-ERISEKK 232

Query: 549 EGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTLPVPSE 608
             T + ++     S    E    ++    C       +P  + +  +  +         +
Sbjct: 233 MSTPIEVLCKGYPS----EFATYLN---FCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 285

Query: 609 PAF 611
             F
Sbjct: 286 YVF 288

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  164 bits (415), Expect = 1e-45
 Identities = 61/276 (22%), Positives = 106/276 (38%), Gaps = 31/276 (11%)

Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRD---SGQGDLEFKNEVL---LVAN 376
           ++FS    +G+GGFG VY  R    G   A+K L +      QG+    NE +   LV+ 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 377 LQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGL 436
                +V +       ++   I + +    L + +    +               I  GL
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120

Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMA 496
            ++H      +++RDLK +N+LLD     +I+D G+A  F     +      VGT+GYMA
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMA 173

Query: 497 PEYAMHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNI 555
           PE    G  Y   +D FS G ++ +++ G         +   ++         E      
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE------ 227

Query: 556 IDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMAS 591
           +  + S    + +   +       Q +V  R     
Sbjct: 228 LPDSFSPELRSLLEGLL-------QRDVNRRLGCLG 256

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 8e-45
 Identities = 57/272 (20%), Positives = 104/272 (38%), Gaps = 24/272 (8%)

Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNL 382
           + +  A  LG+G FG V++            K +    G   +  K E+ ++   +HRN+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNI 63

Query: 383 VRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED 442
           + L        E ++I+EF+    +   I   T   +L+       +  +   L +LH  
Sbjct: 64  LHLHESFESMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFLHS- 120

Query: 443 SRLRIIHRDLKTSNVLLDA--EMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA 500
               I H D++  N++       T KI +FG AR  +  +   N   +     Y APE  
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVH 175

Query: 501 MHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTL 560
            H   S  +D++S G LV  ++SG         + + + + +A   + E     I     
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEI----- 230

Query: 561 SSGSITEMIRCIHIGLLCVQENVASRPTMASV 592
            S    + +         + +   SR T +  
Sbjct: 231 -SIEAMDFVDR------LLVKERKSRMTASEA 255

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 1e-44
 Identities = 66/276 (23%), Positives = 109/276 (39%), Gaps = 29/276 (10%)

Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKN----EVLLVANLQ 378
           ++F     LG+G FG V+           A+K L +D    D + +     + +L    +
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 379 HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
           H  L  +            + E++    L + I       + D  R       I  GL +
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118

Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
           LH      I++RDLK  N+LLD +   KIADFGM +   + + + NT    GT  Y+APE
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173

Query: 499 YAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP 558
             +  +Y+   D +SFGVL+ E++ GQ      +G+  E+L  S   +       N   P
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQS---PFHGQDEEELFHSIRMD-------NPFYP 223

Query: 559 TLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL 594
                   +++                R  +   + 
Sbjct: 224 RWLEKEAKDLLVK------LFVREPEKRLGVRGDIR 253

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  159 bits (404), Expect = 1e-44
 Identities = 53/272 (19%), Positives = 96/272 (35%), Gaps = 20/272 (7%)

Query: 323 TDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLE-FKNEVLLVANLQHR 380
            D +   + LG G F  V           +A+K +++ + +G     +NE+ ++  ++H 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH 440
           N+V L      G    LI + V    L   I     +         ++I  +   + YLH
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLH 124

Query: 441 EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA 500
           +   +    +        LD +    I+DFG++++ +        S   GT GY+APE  
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPEVL 181

Query: 501 MHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTL 560
               YS   D +S GV+   ++ G         E    L     K   E    +     +
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGYP---PFYDENDAKLFEQILKA--EYEFDSPYWDDI 236

Query: 561 SSGSITEMIRCIHIGLLCVQENVASRPTMASV 592
           S                 ++++   R T    
Sbjct: 237 SD-------SAKDFIRHLMEKDPEKRFTCEQA 261

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  156 bits (396), Expect = 6e-44
 Identities = 58/286 (20%), Positives = 108/286 (37%), Gaps = 38/286 (13%)

Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLE---------FKNEVLL 373
           +N+     LG+G    V +        E AVK +    G                 EV +
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 374 VANLQ-HRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGI 432
           +  +  H N+++L           L+++ +    L  ++   T +  L  +   KI+  +
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119

Query: 433 ARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTY 492
              +  LH+   L I+HRDLK  N+LLD +M  K+ DFG +   +  E       + GT 
Sbjct: 120 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTP 173

Query: 493 GYMAPEYAM------HGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKN 546
            Y+APE         H  Y  + D++S GV++  +++G      R    +  ++ S    
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233

Query: 547 WREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASV 592
           +      +       S ++ +++         +      R T    
Sbjct: 234 FGSPEWDDY------SDTVKDLVSR------FLVVQPQKRYTAEEA 267

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 1e-43
 Identities = 68/303 (22%), Positives = 124/303 (40%), Gaps = 28/303 (9%)

Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDL--EFKNEVLLVANLQHR 380
           +NF    K+G+G +G VYK R    G  +A+K++  D+    +      E+ L+  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH 440
           N+V+LL      N+  L++EF+                 +        +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 119

Query: 441 EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA 500
                R++HRDLK  N+L++ E   K+ADFG+AR F +          V T  Y APE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEIL 174

Query: 501 MHGQY-SVKSDVFSFGVLVLEIISGQR--------NNCFRNGETVEDLLSSAWKNWREGT 551
           +  +Y S   D++S G +  E+++ +         +  FR   T+       W       
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234

Query: 552 TVNIIDPTLSSGSITEMIRCIHIGLL-----CVQENVASRPTMASVVLMLNSY--SLTLP 604
                 P  +    ++++  +           +  +   R +  +   + + +   +T P
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKA--ALAHPFFQDVTKP 292

Query: 605 VPS 607
           VP 
Sbjct: 293 VPH 295

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  155 bits (391), Expect = 3e-43
 Identities = 61/285 (21%), Positives = 112/285 (39%), Gaps = 24/285 (8%)

Query: 324 DNFSDANKLGQGGFGAVYKGRLYDGAEIAVK--RLSRDSGQGDLEFKNEVLLVANLQHRN 381
           + +    K+G+G +G VYK +   G   A+K  RL ++          E+ ++  L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           +V+L          +L++E +                 L+       +  +  G+ Y H+
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 442 DSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAM 501
               R++HRDLK  N+L++ E   KIADFG+AR F +   +      + T  Y AP+  M
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLM 173

Query: 502 -HGQYSVKSDVFSFGVLVLEIISGQ--------RNNCFRNGETVEDLLSSAWKNWREGTT 552
              +YS   D++S G +  E+++G          +   R    +    S  W N  E   
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233

Query: 553 VNIIDPTLSSGSITEMIRCIHIGLL-----CVQENVASRPTMASV 592
            +              ++ +    +      ++ +   R T    
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  154 bits (391), Expect = 8e-43
 Identities = 52/207 (25%), Positives = 88/207 (42%), Gaps = 15/207 (7%)

Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGD---LEFKNEVLLVANLQH 379
            +F     LG G FG V+  R  ++G   A+K L ++            +E L+++ + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
             ++R+ G   +  +  +I +++    L   +    R      +     +       L L
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117

Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
                  II+RDLK  N+LLD     KI DFG A+             + GT  Y+APE 
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLCGTPDYIAPEV 172

Query: 500 AMHGQYSVKSDVFSFGVLVLEIISGQR 526
                Y+   D +SFG+L+ E+++G  
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 3e-42
 Identities = 65/304 (21%), Positives = 111/304 (36%), Gaps = 35/304 (11%)

Query: 330 NKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLE-----FKNEVLLVANLQHRNLV 383
           + LG+G F  VYK R       +A+K++         +        E+ L+  L H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 384 RLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS 443
            LL      +   L+++F+                 L        +    +GL YLH+  
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119

Query: 444 RLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHG 503
              I+HRDLK +N+LLD     K+ADFG+A+           +  V T  Y APE     
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRAPELLFGA 175

Query: 504 Q-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSS 562
           + Y V  D+++ G ++ E++       F  G++  D L+  ++     T     D     
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVP---FLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232

Query: 563 GSITEMIR---------------CIHIGLLCVQENVASRPTMASVVLM--LNSYSLTLPV 605
             +T                    + +       N  +R T    + M   ++     P 
Sbjct: 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG 292

Query: 606 PSEP 609
              P
Sbjct: 293 CQLP 296

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 4e-42
 Identities = 66/292 (22%), Positives = 123/292 (42%), Gaps = 27/292 (9%)

Query: 322 ATDNFSDANKLGQGGFGAVYKGR--LYDGAEIAVKRLSRDSGQGD--LEFKNEVLLVANL 377
           A   +    ++G+G +G V+K R     G  +A+KR+   +G+    L    EV ++ +L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 378 ---QHRNLVRLLGFSLEGNERLLIYEFVPNTSLDH---FIFDPTRRAQLDWERRYKIIGG 431
              +H N+VRL                +    +D       D      +  E    ++  
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 432 IARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGT 491
           + RGL +LH     R++HRDLK  N+L+ +    K+ADFG+AR++         + +V T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVT 178

Query: 492 YGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQR-----NNCFRNGETVEDLLSSAWKN 546
             Y APE  +   Y+   D++S G +  E+   +      ++  + G+ ++ +     ++
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238

Query: 547 W-REGTTVNIIDPTLSSGSITEMIRCIHIGLL-----CVQENVASRPTMASV 592
           W R+         + S+  I + +  I          C+  N A R +  S 
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  152 bits (384), Expect = 4e-42
 Identities = 41/279 (14%), Positives = 93/279 (33%), Gaps = 26/279 (9%)

Query: 331 KLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFS 389
           ++G+G FG +++G  L +  ++A+K   R S     + ++E      L     +  + + 
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 390 LEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIH 449
            +     ++   +   SL+  +    R+     +        +   +  +HE     +++
Sbjct: 70  GQEGLHNVLVIDLLGPSLEDLLDLCGRK--FSVKTVAMAAKQMLARVQSIHE---KSLVY 124

Query: 450 RDLKTSNVLLDAEMTP-----KIADFGMARLFEMDETQGN-----TSRIVGTYGYMAPEY 499
           RD+K  N L+    +       + DFGM + +    T+ +        + GT  YM+   
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184

Query: 500 AMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT 559
            +  + S + D+ + G + +  + G          T         K  R G         
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN------KQKYERIGEKKQSTPLR 238

Query: 560 LSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS 598
                  E                 + P    +  + + 
Sbjct: 239 ELCAGFPEEFY--KYMHYARNLAFDATPDYDYLQGLFSK 275

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 2e-41
 Identities = 58/215 (26%), Positives = 92/215 (42%), Gaps = 17/215 (7%)

Query: 320 RVATDNFSDANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRDSGQGDLEFKNEVLLVANLQ 378
           R    +++D   +G G FG VY+ +L D G  +A+K++ +D          E+ ++  L 
Sbjct: 16  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLD 71

Query: 379 HRNLVRLLGFSLEGNER------LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGI 432
           H N+VRL  F     E+       L+ ++VP T           +  L        +  +
Sbjct: 72  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 131

Query: 433 ARGLLYLHEDSRLRIIHRDLKTSNVLLDAE-MTPKIADFGMARLFEMDETQGNTSRIVGT 491
            R L Y+H      I HRD+K  N+LLD +    K+ DFG A+     E     S I   
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSR 186

Query: 492 YGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQR 526
           Y            Y+   DV+S G ++ E++ GQ 
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 3e-40
 Identities = 64/280 (22%), Positives = 110/280 (39%), Gaps = 32/280 (11%)

Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDL------EFKNEVLLVAN 376
           D +    +LG G F  V K R    G + A K + +   +         + + EV ++  
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 377 LQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGL 436
           +QH N++ L        + +LI E V    L  F+     +  L  E   + +  I  G+
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGV 126

Query: 437 LYLHEDSRLRIIHRDLKTSNVLLDAEMTP----KIADFGMARLFEMDETQGNTSRIVGTY 492
            YLH    L+I H DLK  N++L     P    KI DFG+A   +          I GT 
Sbjct: 127 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 180

Query: 493 GYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTT 552
            ++APE   +    +++D++S GV+   ++SG         +     +S+    + +   
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 240

Query: 553 VNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASV 592
            N       S    + IR        + ++   R T+   
Sbjct: 241 SNT------SALAKDFIRR------LLVKDPKKRMTIQDS 268

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 8e-40
 Identities = 59/273 (21%), Positives = 102/273 (37%), Gaps = 42/273 (15%)

Query: 331 KLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLE------FKNEVLLVANLQ--HRN 381
            LG GGFG+VY G  + D   +A+K + +D      E         EV+L+  +      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 382 LVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE 441
           ++RLL +    +  +LI E              T R  L  E        +   + + H 
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHCHN 128

Query: 442 DSRLRIIHRDLKTSNVLLDAE-MTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA 500
                ++HRD+K  N+L+D      K+ DFG   L +        +   GT  Y  PE+ 
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWI 181

Query: 501 MHGQY-SVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT 559
            + +Y    + V+S G+L+ +++ G                   +++  E     +    
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGD----------------IPFEHDEEIIRGQVFFRQ 225

Query: 560 LSSGSITEMIRCIHIGLLCVQENVASRPTMASV 592
             S     +IR       C+    + RPT   +
Sbjct: 226 RVSSECQHLIRW------CLALRPSDRPTFEEI 252

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 2e-39
 Identities = 55/231 (23%), Positives = 87/231 (37%), Gaps = 15/231 (6%)

Query: 320 RVATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLE---FKNEVLLVA 375
           +V  ++F     LG+G FG V   R    G   A+K L ++      E      E  ++ 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60

Query: 376 NLQHRNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARG 435
           N +H  L  L       +    + E+     L   +   +R      ER       I   
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSA 117

Query: 436 LLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYM 495
           L YLH      +++RD+K  N++LD +   KI DFG+ +    D          GT  Y+
Sbjct: 118 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYL 172

Query: 496 APEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKN 546
           APE      Y    D +  GV++ E++ G+        +  E L       
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF---YNQDHERLFELILME 220

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 1e-38
 Identities = 61/293 (20%), Positives = 109/293 (37%), Gaps = 37/293 (12%)

Query: 312 LQFDFNTIRVATDNFSDANK-LGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKN 369
           LQ   N I    D++   ++ LG G  G V +        + A+K L         + + 
Sbjct: 2   LQIKKNAI---IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARR 53

Query: 370 EVLLVANL-QHRNLVRLLG----FSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWER 424
           EV L     Q  ++VR++             L++ E +    L   I D   +A      
Sbjct: 54  EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTERE 112

Query: 425 RYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP---KIADFGMARLFEMDET 481
             +I+  I   + YLH    + I HRD+K  N+L  ++      K+ DFG A+      +
Sbjct: 113 ASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 169

Query: 482 QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLS 541
                    T  Y+APE     +Y    D++S GV++  ++ G       +G  +   + 
Sbjct: 170 LTTPCY---TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 226

Query: 542 SAWKNWREGTTVNIIDPTLS--SGSITEMIRCIHIGLLCVQENVASRPTMASV 592
           +  +  +        +P  S  S  +  +IR        ++     R T+   
Sbjct: 227 TRIRMGQ----YEFPNPEWSEVSEEVKMLIRN------LLKTEPTQRMTITEF 269

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 8e-38
 Identities = 59/319 (18%), Positives = 124/319 (38%), Gaps = 44/319 (13%)

Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDL--EFKNEVLLVANLQHR 380
             +    K+GQG FG V+K R    G ++A+K++  ++ +         E+ ++  L+H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 381 NLVRLLGFSLEGNER--------LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGI 432
           N+V L+                  L+++F  +              +       +++  +
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQML 126

Query: 433 ARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNT--SRIVG 490
             GL Y+H +   +I+HRD+K +NVL+  +   K+ADFG+AR F + +       +  V 
Sbjct: 127 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 491 TYGYMAPEYAMHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLS-------- 541
           T  Y  PE  +  + Y    D++  G ++ E+ +         G T +  L+        
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP---IMQGNTEQHQLALISQLCGS 240

Query: 542 ---------SAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLL--CVQENVASRPTMA 590
                      ++ + +   V      +       +     + L+   +  + A R    
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300

Query: 591 SVVLMLNSYSLTLPVPSEP 609
               + + +  + P+PS+ 
Sbjct: 301 D--ALNHDFFWSDPMPSDL 317

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 1e-37
 Identities = 62/288 (21%), Positives = 114/288 (39%), Gaps = 28/288 (9%)

Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDL--EFKNEVLLVANLQHR 380
             +    K+G+G +G V+K +       +A+KR+  D     +      E+ L+  L+H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 381 NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH 440
           N+VRL        +  L++EF       +F         LD E     +  + +GL + H
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 441 EDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYA 500
                 ++HRDLK  N+L++     K+A+FG+AR F +      ++ +V  +        
Sbjct: 119 ---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-YSAEVVTLWYRPPDVLF 174

Query: 501 MHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWK--------NWREGTT 552
               YS   D++S G +  E+ +  R      G  V+D L   ++         W   T 
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGR--PLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232

Query: 553 VNIIDPTLSSGSITEMIRCIH------IGLL--CVQENVASRPTMASV 592
           +    P     + T ++  +         LL   ++ N   R +    
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  137 bits (346), Expect = 2e-36
 Identities = 57/292 (19%), Positives = 105/292 (35%), Gaps = 28/292 (9%)

Query: 287 RRKPRDNSKVKSEAAAGDEINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGR-L 345
           +   +++ K     A  D + + E+   +   +    D F     LG G FG V   +  
Sbjct: 8   KGSEQESVKEFLAKAKEDFLKKWETPSQNTAQL----DQFDRIKTLGTGSFGRVMLVKHK 63

Query: 346 YDGAEIAVKRLSRDSGQGDLE---FKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFV 402
             G   A+K L +       +     NE  ++  +    LV+L     + +   ++ E+V
Sbjct: 64  ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123

Query: 403 PNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE 462
               +   +    R  +            I     YLH    L +I+RDLK  N+L+D +
Sbjct: 124 AGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQ 177

Query: 463 MTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEII 522
              ++ DFG A+       +G T  + GT   +APE  +   Y+   D ++ GVL+ E+ 
Sbjct: 178 GYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMA 232

Query: 523 SGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHI 574
           +G         +    +                     SS     +   + +
Sbjct: 233 AGYP---PFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQV 275

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 6e-35
 Identities = 67/342 (19%), Positives = 127/342 (37%), Gaps = 40/342 (11%)

Query: 305 EINRAESLQFDFNTIRVATDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQG 363
           E+ +     ++          + D   +G G +GAV        GA++A+K+L R     
Sbjct: 8   EVTKT---AWEVR------AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE 58

Query: 364 DL--EFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPNTSL-DHFIFDPTRRAQL 420
                   E+ L+ +++H N++ LL             +F          +    +  +L
Sbjct: 59  LFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKL 118

Query: 421 DWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE 480
             +R   ++  + +GL Y+H      IIHRDLK  N+ ++ +   KI DFG+AR     +
Sbjct: 119 GEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR-----Q 170

Query: 481 TQGNTSRIVGTYGYMAPEYAMHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDL 539
                +  V T  Y APE  ++   Y+   D++S G ++ E+I+G+      +       
Sbjct: 171 ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE 230

Query: 540 L--------SSAWKNWREGTTVNIID--PTLSSGSITEMIRCIH---IGLL--CVQENVA 584
           +        +   +  +     N +   P L       ++       + LL   +  +  
Sbjct: 231 IMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAE 290

Query: 585 SRPTMASVVLM--LNSYSLTLPVPSEPAFFMDSIIESDMSFS 624
            R T    +      S   T   P    +  DS  + D +  
Sbjct: 291 QRVTAGEALAHPYFESLHDTEDEPQVQKYD-DSFDDVDRTLD 331

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  127 bits (319), Expect = 7e-33
 Identities = 50/223 (22%), Positives = 96/223 (43%), Gaps = 23/223 (10%)

Query: 324 DNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQ-HRN 381
           D++    KLG+G +  V++   + +  ++ VK L     +   + K E+ ++ NL+   N
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPN 91

Query: 382 LVRLLGFSLEGNERL--LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
           ++ L     +   R   L++E V NT              L        +  I + L Y 
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYC 145

Query: 440 HEDSRLRIIHRDLKTSNVLLDAE-MTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
           H    + I+HRD+K  NV++D E    ++ D+G+A  +   +     +  V +  +  PE
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPE 199

Query: 499 YAM-HGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLL 540
             + +  Y    D++S G ++  +I  +    F +G    D L
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEP--FFHGHDNYDQL 240

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 1e-32
 Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 18/218 (8%)

Query: 320 RVATDNFSDANKLGQGGFGAVYKGRL----YDGAEIAVKRLSRDSGQGDLE----FKNEV 371
           +V  +NF     LG G +G V+  R       G   A+K L + +     +     + E 
Sbjct: 20  KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 79

Query: 372 LLVANLQHR-NLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIG 430
            ++ +++    LV L        +  LI +++    L   +    R            +G
Sbjct: 80  QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---FTEHEVQIYVG 136

Query: 431 GIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVG 490
            I   L +LH+   L II+RD+K  N+LLD+     + DFG+++ F  DET+       G
Sbjct: 137 EIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCG 192

Query: 491 TYGYMAPEYAMHGQ--YSVKSDVFSFGVLVLEIISGQR 526
           T  YMAP+    G   +    D +S GVL+ E+++G  
Sbjct: 193 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 2e-31
 Identities = 56/226 (24%), Positives = 97/226 (42%), Gaps = 27/226 (11%)

Query: 315 DFNTIRVATDNFSDANK------LGQGGFGAVYKGR-LYDGAEIAVKRLSRD--SGQGDL 365
            F ++ V    F+   +      +G G  G V           +A+K+LSR   +     
Sbjct: 2   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61

Query: 366 EFKNEVLLVANLQHRNLVRLLGFSL------EGNERLLIYEFVPNTSLDHFIFDPTRRAQ 419
               E++L+  + H+N++ LL          E  +  L+ E +              + +
Sbjct: 62  RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QME 115

Query: 420 LDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD 479
           LD ER   ++  +  G+ +LH      IIHRDLK SN+++ ++ T KI DFG+AR     
Sbjct: 116 LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172

Query: 480 ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
                 +  V T  Y APE  +   Y    D++S G ++ E++  +
Sbjct: 173 FM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 7e-30
 Identities = 50/207 (24%), Positives = 96/207 (46%), Gaps = 11/207 (5%)

Query: 323 TDNFSDANKLGQGGFGAVYKGR-LYDGAEIAVKRLSRD--SGQGDLEFKNEVLLVANLQH 379
            + + + + +G G +G+V        G  +AVK+LSR   S         E+ L+ +++H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 380 RNLVRLLG-FSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLY 438
            N++ LL  F+   +       ++    +   + +  +  +L  +    +I  I RGL Y
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136

Query: 439 LHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPE 498
           +H      IIHRDLK SN+ ++ +   KI DFG+AR  + +     T  +   +      
Sbjct: 137 IHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEI 189

Query: 499 YAMHGQYSVKSDVFSFGVLVLEIISGQ 525
                 Y+   D++S G ++ E+++G+
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGR 216

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  118 bits (297), Expect = 8e-30
 Identities = 46/222 (20%), Positives = 89/222 (40%), Gaps = 23/222 (10%)

Query: 324 DNFSDA-----NKLGQGGFGAVYKGR-LYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANL 377
           + + DA      KLG G F  V+  + + +   +A+K +  D    +   ++E+ L+  +
Sbjct: 8   EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE-AAEDEIKLLQRV 66

Query: 378 QHRNLVRLLGFSLEGNERLLIY--EFVPNTSLDHFIFDPTRRAQLDWERRYK-------- 427
              +  +          +LL +     PN      +F+      L   ++Y+        
Sbjct: 67  NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 126

Query: 428 ---IIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE-MTPKIADFGMARLFEMDETQG 483
              I   +  GL Y+H   R  IIH D+K  NVL++       +    +A L        
Sbjct: 127 VKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 184

Query: 484 NTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQ 525
           + +  + T  Y +PE  +   +   +D++S   L+ E+I+G 
Sbjct: 185 HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score =  101 bits (252), Expect = 3e-25
 Identities = 40/201 (19%), Positives = 66/201 (32%), Gaps = 25/201 (12%)

Query: 330 NKLGQGGFGAVYKGRLYDGAEIAVK--RLSRDSGQ--------GDLEFKNEVLLVANLQH 379
             +G+G   AV+        E  VK  ++   S +        GDL F    +  A  + 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 380 RNLVRLLGFSLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYL 439
           R L +L G ++        Y +  N  L   I               +++  I   +   
Sbjct: 66  RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKF 119

Query: 440 HEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEY 499
           +      I+H DL   NVL+  E    I DF  +     +  +    R V         Y
Sbjct: 120 YHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDV----RNIITY 171

Query: 500 AMHGQYSVKSDVFSFGVLVLE 520
                Y  + D+ S    +L+
Sbjct: 172 -FSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	658
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.87
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.48
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.89
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.15
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.96
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.27
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.81

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-52  Score=420.61  Aligned_cols=267  Identities=26%  Similarity=0.458  Sum_probs=205.0

Q ss_pred             hhhccCCcccCcccccCceEEEEeEecCCcceeEEEeccC--CcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEE
Q 006155          320 RVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRD--SGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       320 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  397 (658)
                      ++..++|...++||+|+||+||+|+..  ..||||++...  .......|.+|+.++.+++|||||+++|++.+ +..++
T Consensus         4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l   80 (276)
T d1uwha_           4 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI   80 (276)
T ss_dssp             BCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred             ccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence            445678999999999999999999853  35999998654  33445679999999999999999999999765 56899


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE  477 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~  477 (658)
                      ||||+++|+|.+++..  ....++|..+++|+.||++||+|||+++   ||||||||+||||+.++.+||+|||+++...
T Consensus        81 v~Ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~  155 (276)
T d1uwha_          81 VTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKS  155 (276)
T ss_dssp             EEECCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred             EEecCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecc
Confidence            9999999999999964  2346999999999999999999999987   9999999999999999999999999998776


Q ss_pred             cCCCccccccccccccccCcccccc---CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          478 MDETQGNTSRIVGTYGYMAPEYAMH---GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      ............||+.|||||++.+   +.|+.++|||||||++|||+||+.||....  ....+..............+
T Consensus       156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~--~~~~~~~~~~~~~~~p~~~~  233 (276)
T d1uwha_         156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN--NRDQIIFMVGRGYLSPDLSK  233 (276)
T ss_dssp             ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC--CHHHHHHHHHHTSCCCCGGG
T ss_pred             ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC--hHHHHHHHHhcCCCCCcchh
Confidence            5444444556789999999999864   458999999999999999999999985322  12222222222222211111


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCCC
Q 006155          555 IIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTLP  604 (658)
Q Consensus       555 ~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~~~~~  604 (658)
                           +.....++   +.+++.+||+.||++||||.||++.|+.....+|
T Consensus       234 -----~~~~~~~~---l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P  275 (276)
T d1uwha_         234 -----VRSNCPKA---MKRLMAECLKKKRDERPLFPQILASIELLARSLP  275 (276)
T ss_dssp             -----SCTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             -----ccccchHH---HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence                 11222233   4467789999999999999999999987654444

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-51  Score=413.13  Aligned_cols=256  Identities=26%  Similarity=0.445  Sum_probs=200.9

Q ss_pred             ccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEec
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFV  402 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  402 (658)
                      .++|+..++||+|+||+||+|++.+++.||||++... .....+|.+|+.++++++|||||+++|++.+++..++||||+
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence            4678889999999999999999888889999999764 345678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCc
Q 006155          403 PNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ  482 (658)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  482 (658)
                      ++|+|.+++..  ....++|..+++++.||++||.|||+.+   |+||||||+||||++++.+||+|||+++.+......
T Consensus        83 ~~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~  157 (263)
T d1sm2a_          83 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  157 (263)
T ss_dssp             TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred             CCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce
Confidence            99999999854  3456899999999999999999999987   999999999999999999999999999876543322


Q ss_pred             cccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCC
Q 006155          483 GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSS  562 (658)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~  562 (658)
                       ......||+.|||||++.++.++.|+|||||||++|||+|+..|+..  .....+++.......+      ...|..  
T Consensus       158 -~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~--~~~~~~~~~~i~~~~~------~~~p~~--  226 (263)
T d1sm2a_         158 -SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE--NRSNSEVVEDISTGFR------LYKPRL--  226 (263)
T ss_dssp             --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC--SCCHHHHHHHHHHTCC------CCCCTT--
T ss_pred             -eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCC--CCCHHHHHHHHHhcCC------CCCccc--
Confidence             23346789999999999999999999999999999999996555422  2223334443333221      111221  


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          563 GSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       563 ~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                       ..+   .+.+++..||+.||++||||+||++.|+++
T Consensus       227 -~~~---~l~~li~~cl~~~p~~Rps~~~il~~L~~i  259 (263)
T d1sm2a_         227 -AST---HVYQIMNHCWKERPEDRPAFSRLLRQLAEI  259 (263)
T ss_dssp             -SCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -cCH---HHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence             122   355778899999999999999999999763

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-51  Score=413.70  Aligned_cols=258  Identities=30%  Similarity=0.468  Sum_probs=209.2

Q ss_pred             hhhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          320 RVATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       320 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ++..++|+..++||+|+||+||+|++.+++.||||++.... ....+|.+|+.++.+++|||||+++|++.+ +..++||
T Consensus         9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~   86 (272)
T d1qpca_           9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT   86 (272)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             ecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence            44567899999999999999999998888899999997643 455679999999999999999999998865 5679999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ||+++|+|.+++... ....++|..+++|+.||++||.|||+.+   |+||||||+||||++++.+||+|||+++.+...
T Consensus        87 Ey~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~  162 (272)
T d1qpca_          87 EYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (272)
T ss_dssp             ECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             EeCCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCC
Confidence            999999999987542 2345999999999999999999999987   999999999999999999999999999987543


Q ss_pred             CCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCC
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT  559 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~  559 (658)
                      .. .......||+.|||||++.++.++.++|||||||++|||+||.+|+...  ....+++.......+         +.
T Consensus       163 ~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~--~~~~~~~~~i~~~~~---------~~  230 (272)
T d1qpca_         163 EY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG--MTNPEVIQNLERGYR---------MV  230 (272)
T ss_dssp             CE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT--CCHHHHHHHHHTTCC---------CC
T ss_pred             cc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC--CCHHHHHHHHHhcCC---------CC
Confidence            32 2233467899999999999999999999999999999999977665322  222333333322111         11


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          560 LSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       560 l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      ......++   +.+++.+||+.||++||||.+|+++|+.
T Consensus       231 ~p~~~~~~---l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         231 RPDNCPEE---LYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             CCTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CcccChHH---HHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence            12222233   4567789999999999999999999975

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.9e-50  Score=413.11  Aligned_cols=264  Identities=26%  Similarity=0.390  Sum_probs=215.1

Q ss_pred             hhhhhhhccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCc
Q 006155          316 FNTIRVATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNE  394 (658)
Q Consensus       316 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  394 (658)
                      +.++++..++|+..++||+|+||+||+|+.. +|+.||||+++... ....+|.+|+.+|++++|||||+++|++.+++.
T Consensus         9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (287)
T d1opja_           9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP   87 (287)
T ss_dssp             CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence            3455666788999999999999999999865 58889999987653 456679999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          395 RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      .++||||+++|+|.+++... ....++|..+++|+.||++||.|||+++   |+||||||+||||++++.+||+|||+++
T Consensus        88 ~~iv~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~  163 (287)
T d1opja_          88 FYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSR  163 (287)
T ss_dssp             CEEEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred             eEEEeecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEcccccee
Confidence            99999999999999998542 3457999999999999999999999987   9999999999999999999999999998


Q ss_pred             ccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          475 LFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      ....+.. .......||+.|||||++.++.++.|+|||||||++|||++|..|+...  .+...+.......++      
T Consensus       164 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~--~~~~~~~~~i~~~~~------  234 (287)
T d1opja_         164 LMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG--IDLSQVYELLEKDYR------  234 (287)
T ss_dssp             TCCSSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT--CCHHHHHHHHHTTCC------
T ss_pred             ecCCCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCc--chHHHHHHHHhcCCC------
Confidence            7654332 2233456899999999999999999999999999999999987776322  222333332222211      


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          555 IIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       555 ~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                         +.......+   .+.+++..||+.||++||||.||+++|+..
T Consensus       235 ---~~~~~~~~~---~l~~li~~cl~~dP~~Rps~~ei~~~L~~~  273 (287)
T d1opja_         235 ---MERPEGCPE---KVYELMRACWQWNPSDRPSFAEIHQAFETM  273 (287)
T ss_dssp             ---CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             ---CCCCccchH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence               112222223   355678899999999999999999999864

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-50  Score=405.92  Aligned_cols=253  Identities=25%  Similarity=0.358  Sum_probs=202.0

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      .++|+..++||+|+||+||+|+. .+|+.||||++..... .....+.+|+.++++++|||||++++++.+++..+||||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            46799999999999999999985 4689999999876532 234468999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      |+++|+|.++|.   ....+++..++.++.||++||.|||+.+   |+||||||+|||+++++++||+|||+++.+....
T Consensus        84 y~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          84 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ccCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence            999999999994   3457999999999999999999999988   9999999999999999999999999999876554


Q ss_pred             CccccccccccccccCccccccCCC-CcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCC
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMHGQY-SVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT  559 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~  559 (658)
                      ........+||+.|||||++.+..+ +.++|||||||++|||++|+.||.......  .... .+.   .........  
T Consensus       158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~~~-~~~---~~~~~~~~~--  229 (271)
T d1nvra_         158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEYS-DWK---EKKTYLNPW--  229 (271)
T ss_dssp             EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS--HHHH-HHH---TTCTTSTTG--
T ss_pred             ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH--HHHH-HHh---cCCCCCCcc--
Confidence            4444556789999999999988876 578999999999999999999995433221  1111 111   111000000  


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          560 LSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       560 l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                        ....+   .+.+++.+||+.||++|||++|+++
T Consensus       230 --~~~s~---~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         230 --KKIDS---APLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             --GGSCH---HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --ccCCH---HHHHHHHHHcCCChhHCcCHHHHhc
Confidence              01112   3446777999999999999999853

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.2e-50  Score=413.83  Aligned_cols=257  Identities=26%  Similarity=0.435  Sum_probs=196.1

Q ss_pred             ccCCcccCcccccCceEEEEeEecC-Cc---ceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLYD-GA---EIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~~-g~---~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  397 (658)
                      .++|+..++||+|+||+||+|+... |+   .||||++..... ....+|.+|+.+|++++|||||+++|++.+++..++
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i  104 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI  104 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            4678888999999999999998642 32   589998866533 344579999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE  477 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~  477 (658)
                      ||||+++|+|.+++..  ....++|..+++|+.||++||.|||+.+   |+||||||+||||+.++++||+|||+++.+.
T Consensus       105 v~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         105 ITEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             EEECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence            9999999999998854  3456999999999999999999999987   9999999999999999999999999998776


Q ss_pred             cCCCcc---ccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcc
Q 006155          478 MDETQG---NTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTV  553 (658)
Q Consensus       478 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  553 (658)
                      ......   ......||+.|||||++.++.++.++|||||||++|||+| |+.||...   ...+++.......+.    
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~---~~~~~~~~i~~~~~~----  252 (299)
T d1jpaa_         180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM---TNQDVINAIEQDYRL----  252 (299)
T ss_dssp             ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHHHHHHTTCCC----
T ss_pred             CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC---CHHHHHHHHHcCCCC----
Confidence            543322   1223468999999999999999999999999999999998 88888432   233444433322111    


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          554 NIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       554 ~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                           .......+   .+.+++.+||+.||++||||.||++.|+..
T Consensus       253 -----~~~~~~~~---~l~~li~~cl~~~P~~RPs~~ei~~~L~~~  290 (299)
T d1jpaa_         253 -----PPPMDCPS---ALHQLMLDCWQKDRNHRPKFGQIVNTLDKM  290 (299)
T ss_dssp             -----CCCTTCCH---HHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -----CCCccchH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                 11112223   345678899999999999999999999753

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-49  Score=398.48  Aligned_cols=254  Identities=25%  Similarity=0.398  Sum_probs=211.7

Q ss_pred             ccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEec
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFV  402 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  402 (658)
                      .++|+..++||+|+||+||+|+.++++.||||+++... ....+|.+|+.++.+++||||++++|++.+++..++||||+
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            46899999999999999999998888899999997654 45568999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCc
Q 006155          403 PNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ  482 (658)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  482 (658)
                      ++|+|..++..  ....++|..+++++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..... 
T Consensus        82 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-  155 (258)
T d1k2pa_          82 ANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-  155 (258)
T ss_dssp             TTEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-
T ss_pred             CCCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc-
Confidence            99999999754  3456899999999999999999999987   99999999999999999999999999987654432 


Q ss_pred             cccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCC
Q 006155          483 GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLS  561 (658)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~  561 (658)
                      .......||+.|+|||++.++.++.|+||||||+++|||+| |+.||....   ..++........+      ...|.  
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~---~~~~~~~i~~~~~------~~~p~--  224 (258)
T d1k2pa_         156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT---NSETAEHIAQGLR------LYRPH--  224 (258)
T ss_dssp             CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC---HHHHHHHHHTTCC------CCCCT--
T ss_pred             eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC---HHHHHHHHHhCCC------CCCcc--
Confidence            23334679999999999999999999999999999999998 788885332   3334333322211      11222  


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          562 SGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       562 ~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                       ...+   .+.+++..||+.||++|||+++|++.|..
T Consensus       225 -~~~~---~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         225 -LASE---KVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             -TCCH---HHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             -cccH---HHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence             1222   34567789999999999999999999854

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-50  Score=407.31  Aligned_cols=262  Identities=26%  Similarity=0.415  Sum_probs=206.1

Q ss_pred             hhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      +..++|+..+.||+|+||+||+|+..++..||||++... .....+|.+|+.++.+++|||||+++|++.+ ++.++|||
T Consensus        14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E   91 (285)
T d1fmka3          14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE   91 (285)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             cCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEE
Confidence            335789999999999999999999888889999999654 3456789999999999999999999999854 56899999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      |+++|+|..++... ....++|..+++++.||+.||.|||+++   |+||||||+||||+.++++||+|||+++.+....
T Consensus        92 y~~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~  167 (285)
T d1fmka3          92 YMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE  167 (285)
T ss_dssp             CCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             ecCCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence            99999999988542 2346999999999999999999999988   9999999999999999999999999998765433


Q ss_pred             CccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCC
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTL  560 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l  560 (658)
                      . .......||+.|+|||++..+.++.++||||||+++|||++|.+|+...  ....+++.......+         +..
T Consensus       168 ~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~--~~~~~~~~~i~~~~~---------~~~  235 (285)
T d1fmka3         168 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG--MVNREVLDQVERGYR---------MPC  235 (285)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT--CCHHHHHHHHHTTCC---------CCC
T ss_pred             c-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC--CCHHHHHHHHHhcCC---------CCC
Confidence            2 2233467899999999999999999999999999999999987776332  223334333322211         112


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCC
Q 006155          561 SSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSYSLTL  603 (658)
Q Consensus       561 ~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~~~~~  603 (658)
                      .....+   .+.+++.+||+.||++||+|.+|+++|+..-...
T Consensus       236 ~~~~~~---~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         236 PPECPE---SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             CTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             CcccCH---HHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            222223   3456788999999999999999999998864443

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-49  Score=412.50  Aligned_cols=262  Identities=26%  Similarity=0.357  Sum_probs=207.8

Q ss_pred             hhhccCCcccCcccccCceEEEEeEecCC------cceeEEEeccCC-cccHHHHHHHHHHHHhc-CCCCceeeeeeecc
Q 006155          320 RVATDNFSDANKLGQGGFGAVYKGRLYDG------AEIAVKRLSRDS-GQGDLEFKNEVLLVANL-QHRNLVRLLGFSLE  391 (658)
Q Consensus       320 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g------~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~  391 (658)
                      ++..++|+..++||+|+||+||+|+....      ..||||++.... ......+.+|+.++.++ +|||||++++++.+
T Consensus        33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~  112 (325)
T d1rjba_          33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL  112 (325)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence            45668899999999999999999985432      258999986543 33445789999999998 89999999999999


Q ss_pred             CCceEEEEEecCCCChhhhhcCcCC--------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEec
Q 006155          392 GNERLLIYEFVPNTSLDHFIFDPTR--------------------RAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRD  451 (658)
Q Consensus       392 ~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrD  451 (658)
                      .+..++||||+++|+|.++|.....                    ...++|..++.++.||++||.|||+++   |||||
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRD  189 (325)
T d1rjba_         113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRD  189 (325)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETT
T ss_pred             CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecc
Confidence            9999999999999999999965321                    245899999999999999999999987   99999


Q ss_pred             cCCCceeeCCCCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCcc
Q 006155          452 LKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCF  530 (658)
Q Consensus       452 lk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~  530 (658)
                      |||+|||++.++++||+|||+++...............||+.|||||++.++.++.++|||||||++|||+| |+.||..
T Consensus       190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~  269 (325)
T d1rjba_         190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  269 (325)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence            999999999999999999999987765544444455678999999999999999999999999999999998 8999853


Q ss_pred             CCCCCcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          531 RNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       531 ~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      ....  ..+......    +.     .+.......+   .+.+++..||+.||++||||+||+++|..
T Consensus       270 ~~~~--~~~~~~~~~----~~-----~~~~p~~~~~---~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         270 IPVD--ANFYKLIQN----GF-----KMDQPFYATE---EIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             CCCS--HHHHHHHHT----TC-----CCCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCHH--HHHHHHHhc----CC-----CCCCCCcCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence            3221  122222211    11     1112222223   34567789999999999999999999963

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-49  Score=405.90  Aligned_cols=259  Identities=25%  Similarity=0.450  Sum_probs=200.4

Q ss_pred             hccCCcccCcccccCceEEEEeEecCC-----cceeEEEeccCCcc-cHHHHHHHHHHHHhcCCCCceeeeeeeccCCce
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLYDG-----AEIAVKRLSRDSGQ-GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNER  395 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g-----~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  395 (658)
                      ..+.|+..++||+|+||+||+|++..+     ..||||++...... ...+|.+|+.++.+++|||||+++|++.+.+..
T Consensus         5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~   84 (283)
T d1mqba_           5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM   84 (283)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence            446788889999999999999986542     36999999765433 345689999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ++||||+.+++|.+++..  ....++|..+++++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.
T Consensus        85 ~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~  159 (283)
T d1mqba_          85 MIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV  159 (283)
T ss_dssp             EEEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEEEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhc
Confidence            999999999999988743  3456999999999999999999999987   99999999999999999999999999987


Q ss_pred             cccCCCc-cccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          476 FEMDETQ-GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       476 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      +...... .......||+.|||||++.++.++.++|||||||++|||++|..|+...  ....++........+      
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~--~~~~~~~~~i~~~~~------  231 (283)
T d1mqba_         160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE--LSNHEVMKAINDGFR------  231 (283)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT--CCHHHHHHHHHTTCC------
T ss_pred             ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcccc--CCHHHHHHHHhccCC------
Confidence            7554322 2333457899999999999999999999999999999999977765322  222333333322211      


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          555 IIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       555 ~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                         +........   .+.+++.+||+.||++||||.||+++|+..
T Consensus       232 ---~~~~~~~~~---~l~~li~~cl~~~p~~RPt~~eil~~L~~l  270 (283)
T d1mqba_         232 ---LPTPMDCPS---AIYQLMMQCWQQERARRPKFADIVSILDKL  270 (283)
T ss_dssp             ---CCCCTTCBH---HHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ---CCCchhhHH---HHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence               111222222   355788899999999999999999999764

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-49  Score=404.82  Aligned_cols=256  Identities=25%  Similarity=0.398  Sum_probs=205.7

Q ss_pred             hccCCcccC-cccccCceEEEEeEec---CCcceeEEEeccCCcc-cHHHHHHHHHHHHhcCCCCceeeeeeeccCCceE
Q 006155          322 ATDNFSDAN-KLGQGGFGAVYKGRLY---DGAEIAVKRLSRDSGQ-GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERL  396 (658)
Q Consensus       322 ~~~~~~~~~-~lG~G~fg~Vy~~~~~---~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  396 (658)
                      ..++|...+ +||+|+||+||+|+..   ++..||||+++..... ...+|.+|+.+|.+++|||||+++|++.+ +..+
T Consensus         6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~   84 (285)
T d1u59a_           6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM   84 (285)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred             cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEE
Confidence            345666666 4999999999999753   3457999999765433 34679999999999999999999999865 5689


Q ss_pred             EEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccc
Q 006155          397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF  476 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~  476 (658)
                      |||||+++|+|.+++..  .+..++|..+++++.||++||.|||+++   |+||||||+||||+.++.+||+|||+++.+
T Consensus        85 lvmE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          85 LVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL  159 (285)
T ss_dssp             EEEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcc
Confidence            99999999999999843  3457999999999999999999999987   999999999999999999999999999987


Q ss_pred             ccCCCc-cccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          477 EMDETQ-GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       477 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      ...... .......||+.|||||++.++.++.++|||||||++|||+| |+.||....   ..++.....    ++... 
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~---~~~~~~~i~----~~~~~-  231 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK---GPEVMAFIE----QGKRM-  231 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---THHHHHHHH----TTCCC-
T ss_pred             cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC---HHHHHHHHH----cCCCC-
Confidence            654322 23334578999999999999999999999999999999998 899985432   223333322    22211 


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          555 IIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       555 ~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                          .......++   +.+++..||+.||++||||.+|++.|+.
T Consensus       232 ----~~p~~~~~~---l~~li~~cl~~~p~~RPs~~~i~~~L~~  268 (285)
T d1u59a_         232 ----ECPPECPPE---LYALMSDCWIYKWEDRPDFLTVEQRMRA  268 (285)
T ss_dssp             ----CCCTTCCHH---HHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----CCCCcCCHH---HHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence                122222233   4467789999999999999999999975

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-49  Score=402.43  Aligned_cols=249  Identities=25%  Similarity=0.412  Sum_probs=205.3

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      .++|+..++||+|+||+||+|+. .+|+.||||++..........+.+|+.++++++|||||++++++.+++..++||||
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            35799999999999999999984 46899999999876666667899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      +++|+|.+++.    ...+++..++.++.||+.||.|||+++   ||||||||+|||++.++++||+|||+++.+.... 
T Consensus        99 ~~gg~L~~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-  170 (293)
T d1yhwa1          99 LAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-  170 (293)
T ss_dssp             CTTCBHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred             cCCCcHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc-
Confidence            99999999874    246999999999999999999999998   9999999999999999999999999998765432 


Q ss_pred             ccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCC
Q 006155          482 QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLS  561 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~  561 (658)
                       ......+||+.|||||++.++.++.++|||||||++|||++|+.||....   ..+.+......   +. ..+..|   
T Consensus       171 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~---~~~~~~~~~~~---~~-~~~~~~---  239 (293)
T d1yhwa1         171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN---PLRALYLIATN---GT-PELQNP---  239 (293)
T ss_dssp             -CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHH---CS-CCCSSG---
T ss_pred             -ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC---HHHHHHHHHhC---CC-CCCCCc---
Confidence             23345689999999999999999999999999999999999999984322   22222222221   11 011111   


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 006155          562 SGSITEMIRCIHIGLLCVQENVASRPTMASVV  593 (658)
Q Consensus       562 ~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv  593 (658)
                      ....+   .+.+++.+||+.||++|||+.|++
T Consensus       240 ~~~s~---~~~~li~~~L~~dP~~R~s~~eil  268 (293)
T d1yhwa1         240 EKLSA---IFRDFLNRCLDMDVEKRGSAKELL  268 (293)
T ss_dssp             GGSCH---HHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred             ccCCH---HHHHHHHHHccCChhHCcCHHHHh
Confidence            11112   345677899999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.4e-49  Score=406.31  Aligned_cols=265  Identities=26%  Similarity=0.417  Sum_probs=213.5

Q ss_pred             hhhhhhccCCcccCcccccCceEEEEeEec------CCcceeEEEeccCCcc-cHHHHHHHHHHHHhcCCCCceeeeeee
Q 006155          317 NTIRVATDNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRDSGQ-GDLEFKNEVLLVANLQHRNLVRLLGFS  389 (658)
Q Consensus       317 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~  389 (658)
                      .+++...++|+..++||+|+||+||+|+..      +++.||||++...... ...+|.+|+.++++++||||+++++++
T Consensus         6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            345667789999999999999999999853      3578999999765433 345699999999999999999999999


Q ss_pred             ccCCceEEEEEecCCCChhhhhcCcC---------------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEE
Q 006155          390 LEGNERLLIYEFVPNTSLDHFIFDPT---------------------RRAQLDWERRYKIIGGIARGLLYLHEDSRLRII  448 (658)
Q Consensus       390 ~~~~~~~lv~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv  448 (658)
                      .+.+..++||||+++|+|.++|....                     ....++|..+++|+.||+.||+|||+.+   ||
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iv  162 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV  162 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eE
Confidence            99999999999999999999985321                     2235899999999999999999999987   99


Q ss_pred             EeccCCCceeeCCCCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCC-C
Q 006155          449 HRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQR-N  527 (658)
Q Consensus       449 HrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~-p  527 (658)
                      ||||||+||||+.++++||+|||+++.+.............||+.|+|||++.+..++.|+|||||||++|||++|.. |
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p  242 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  242 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence            999999999999999999999999987765544444556788999999999999999999999999999999999975 5


Q ss_pred             CccCCCCCcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          528 NCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       528 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      +..   ....+++..+.    ++...     .......+   .+.+|+..||+.+|++||||.||+++|+..
T Consensus       243 ~~~---~~~~e~~~~v~----~~~~~-----~~p~~~~~---~~~~li~~cl~~~P~~RPt~~ev~~~L~~i  299 (301)
T d1lufa_         243 YYG---MAHEEVIYYVR----DGNIL-----ACPENCPL---ELYNLMRLCWSKLPADRPSFCSIHRILQRM  299 (301)
T ss_dssp             TTT---SCHHHHHHHHH----TTCCC-----CCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             CCC---CCHHHHHHHHH----cCCCC-----CCCccchH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            532   22333433332    22221     11222222   356788899999999999999999999864

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-49  Score=400.09  Aligned_cols=247  Identities=28%  Similarity=0.410  Sum_probs=196.0

Q ss_pred             CcccccCceEEEEeEecC---CcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEecCC
Q 006155          330 NKLGQGGFGAVYKGRLYD---GAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFVPN  404 (658)
Q Consensus       330 ~~lG~G~fg~Vy~~~~~~---g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  404 (658)
                      ++||+|+||+||+|.+.+   ++.||||+++....  ....+|.+|+.+|++++|||||+++|++.+ +..+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            479999999999998543   46799999975432  234569999999999999999999999864 567899999999


Q ss_pred             CChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCc-c
Q 006155          405 TSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ-G  483 (658)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~-~  483 (658)
                      |+|.+++.   ....++|..+++|+.||++||.|||+.+   ||||||||+||||+.++.+||+|||+++.+...... .
T Consensus        92 g~L~~~l~---~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CcHHHHHh---hccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            99999984   3456999999999999999999999987   999999999999999999999999999877544332 2


Q ss_pred             ccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCCCC
Q 006155          484 NTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTLSS  562 (658)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~  562 (658)
                      ......||+.|||||.+.++.++.++|||||||++|||+| |+.||...   ...++......    +..     +....
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~---~~~~~~~~i~~----~~~-----~~~p~  233 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM---KGSEVTAMLEK----GER-----MGCPA  233 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC---CHHHHHHHHHT----TCC-----CCCCT
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCC---CHHHHHHHHHc----CCC-----CCCCc
Confidence            2334678999999999999999999999999999999998 89998532   22333333322    211     11122


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          563 GSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       563 ~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      ...++   +.+++.+||+.||++||||++|+++|+.
T Consensus       234 ~~~~~---~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         234 GCPRE---MYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             TCCHH---HHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             ccCHH---HHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence            22233   4467789999999999999999999865

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-49  Score=396.13  Aligned_cols=245  Identities=26%  Similarity=0.382  Sum_probs=203.2

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccC---CcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRD---SGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ++|++.+.||+|+||+||+++.. +|+.||||++...   .......+.+|+.++++++|||||++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57899999999999999999864 5889999998643   2234567899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ||+++|+|.+++.   +...+++..++.++.||++||.|||+++   ||||||||+||||+.++.+||+|||+++.....
T Consensus        86 Ey~~~g~L~~~l~---~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            9999999999984   3456999999999999999999999988   999999999999999999999999999865432


Q ss_pred             CCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCC
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT  559 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~  559 (658)
                          ......||+.|||||++.+..++.++|||||||++|||++|+.||..   .+..++.....+    ..      +.
T Consensus       160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~---~~~~~~~~~i~~----~~------~~  222 (263)
T d2j4za1         160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA---NTYQETYKRISR----VE------FT  222 (263)
T ss_dssp             ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC---SSHHHHHHHHHT----TC------CC
T ss_pred             ----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC---CCHHHHHHHHHc----CC------CC
Confidence                23346899999999999999999999999999999999999999843   223333333221    11      11


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          560 LSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       560 l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      +.....++   +.+++..||+.||++|||++|+++
T Consensus       223 ~p~~~s~~---~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         223 FPDFVTEG---ARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             CCTTSCHH---HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCccCCHH---HHHHHHHHccCCHhHCcCHHHHHc
Confidence            22222223   446677999999999999999975

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-49  Score=400.52  Aligned_cols=255  Identities=25%  Similarity=0.350  Sum_probs=192.6

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeecc--CCceEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLE--GNERLL  397 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~l  397 (658)
                      .++|+..+.||+|+||+||+|+. .+|+.||||++.....  .....+.+|+.++++++|||||++++++.+  .+..++
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            36799999999999999999985 4688999999876532  233458899999999999999999999865  456799


Q ss_pred             EEEecCCCChhhhhcCc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcC--CCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          398 IYEFVPNTSLDHFIFDP-TRRAQLDWERRYKIIGGIARGLLYLHEDS--RLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      ||||+++|+|.+++... .....+++..++.++.||+.||.|||+++  ..+||||||||+||||+.++.+||+|||+++
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            99999999999998542 23457999999999999999999999864  2359999999999999999999999999998


Q ss_pred             ccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          475 LFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      .+..+..  ......||+.|||||++.+..++.++|||||||++|||++|+.||...   +..++......    +....
T Consensus       163 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~---~~~~~~~~i~~----~~~~~  233 (269)
T d2java1         163 ILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF---SQKELAGKIRE----GKFRR  233 (269)
T ss_dssp             HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHH----TCCCC
T ss_pred             ecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC---CHHHHHHHHHc----CCCCC
Confidence            8754322  234568999999999999999999999999999999999999998532   23333333222    22111


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          555 IIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       555 ~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                           +.....++   +.+++.+||+.||++|||+.|+++
T Consensus       234 -----~~~~~s~~---l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         234 -----IPYRYSDE---LNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             -----CCTTSCHH---HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----CCcccCHH---HHHHHHHHcCCChhHCcCHHHHHh
Confidence                 11222223   456778999999999999999874

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-49  Score=410.99  Aligned_cols=202  Identities=26%  Similarity=0.377  Sum_probs=178.2

Q ss_pred             hhhccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcc-cHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEE
Q 006155          320 RVATDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQ-GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       320 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  397 (658)
                      ++..++|+..++||+|+||+||+|+. .+|+.||||++...... ....+.+|+.+|++++|||||++++++.+.+..++
T Consensus         2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i   81 (322)
T d1s9ja_           2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   81 (322)
T ss_dssp             CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            34578999999999999999999985 46889999999765333 34568999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCcEEEeccCCCceeeCCCCCeEEecccccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED-SRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF  476 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~  476 (658)
                      ||||+++|+|.+++..   ...+++..+..++.||++||.|||++ +   |+||||||+||||+.++++||+|||+|+.+
T Consensus        82 VmEy~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~  155 (322)
T d1s9ja_          82 CMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQL  155 (322)
T ss_dssp             EEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             EEEcCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence            9999999999999953   35699999999999999999999975 6   999999999999999999999999999876


Q ss_pred             ccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccC
Q 006155          477 EMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFR  531 (658)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~  531 (658)
                      ....    ....+||+.|||||++.+..|+.++||||+||++|||++|+.||...
T Consensus       156 ~~~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~  206 (322)
T d1s9ja_         156 IDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP  206 (322)
T ss_dssp             HHHT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred             CCCc----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            4322    23468999999999999999999999999999999999999999643

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-49  Score=400.23  Aligned_cols=251  Identities=26%  Similarity=0.367  Sum_probs=203.9

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEec
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFV  402 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  402 (658)
                      +.|++.++||+|+||+||+|+.. +|+.||||++..........+.+|+.++++++|||||++++++.+++..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            56888999999999999999854 58899999998776666678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCc
Q 006155          403 PNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ  482 (658)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  482 (658)
                      ++|+|.+++..  ....+++..+..++.||++||.|||+++   |+||||||+|||++.++++||+|||+++......  
T Consensus        92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--  164 (288)
T d2jfla1          92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--  164 (288)
T ss_dssp             TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred             CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--
Confidence            99999998753  2356999999999999999999999998   9999999999999999999999999997654321  


Q ss_pred             cccccccccccccCccccc-----cCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccC
Q 006155          483 GNTSRIVGTYGYMAPEYAM-----HGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID  557 (658)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  557 (658)
                      .......||+.|||||++.     ...|+.++|||||||++|||++|+.||....   ..+.+......    ....+..
T Consensus       165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~---~~~~~~~i~~~----~~~~~~~  237 (288)
T d2jfla1         165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN---PMRVLLKIAKS----EPPTLAQ  237 (288)
T ss_dssp             HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC---GGGHHHHHHHS----CCCCCSS
T ss_pred             ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC---HHHHHHHHHcC----CCCCCCc
Confidence            1233468999999999984     4568999999999999999999999985332   23333333221    1111111


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          558 PTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       558 p~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      |.   ...+   .+.+++..||+.||++|||+.|+++
T Consensus       238 ~~---~~s~---~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         238 PS---RWSS---NFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             GG---GSCH---HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cc---cCCH---HHHHHHHHHccCChhHCcCHHHHhc
Confidence            11   1122   3446777999999999999999864

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-48  Score=396.57  Aligned_cols=249  Identities=22%  Similarity=0.288  Sum_probs=201.5

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccC---CcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRD---SGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  398 (658)
                      .++|+..+.||+|+||+||+|+. .+|+.||||++...   .......+.+|+.++++++||||+++++++.+++..++|
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv   86 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG   86 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence            36799999999999999999985 46889999998653   223445689999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccccc
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~  478 (658)
                      |||+++|+|.+++.   ....+++..++.++.||+.||.|||+.+   ||||||||+|||+++++.+||+|||+++.+..
T Consensus        87 mEy~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          87 LSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             ECCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EEccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceeccc
Confidence            99999999999884   3457999999999999999999999998   99999999999999999999999999998765


Q ss_pred             CCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCC
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP  558 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp  558 (658)
                      ..........+||+.|||||++.+..++.++|||||||++|||++|+.||...   +..++.....+    +.      +
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i~~----~~------~  227 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---NEYLIFQKIIK----LE------Y  227 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHT----TC------C
T ss_pred             CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc---CHHHHHHHHHc----CC------C
Confidence            54444455578999999999999999999999999999999999999998532   22333332221    11      1


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 006155          559 TLSSGSITEMIRCIHIGLLCVQENVASRPTMASVV  593 (658)
Q Consensus       559 ~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv  593 (658)
                      .+.....++   +.+++..||+.||++|||++|++
T Consensus       228 ~~p~~~s~~---~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         228 DFPEKFFPK---ARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             CCCTTCCHH---HHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             CCCccCCHH---HHHHHHHHccCCHhHCcCHHHHc
Confidence            122222222   45677899999999999999874

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-48  Score=390.35  Aligned_cols=246  Identities=25%  Similarity=0.372  Sum_probs=193.1

Q ss_pred             cccCcccccCceEEEEeEec-CCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeecc----CCceEEEE
Q 006155          327 SDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLE----GNERLLIY  399 (658)
Q Consensus       327 ~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lv~  399 (658)
                      +..++||+|+||+||+|+.. +++.||+|++....  ......|.+|+++|++++|||||++++++.+    +...++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            45568999999999999854 57899999986542  2334568999999999999999999999864    34578999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeC-CCCCeEEecccccccccc
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLD-AEMTPKIADFGMARLFEM  478 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~-~~~~~kl~DFGla~~~~~  478 (658)
                      ||+++|+|.+++.   +...+++..++.++.||++||+|||+++ ++|+||||||+||||+ +++.+||+|||+++....
T Consensus        92 E~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHh---ccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            9999999999994   3457999999999999999999999875 4599999999999996 578999999999986432


Q ss_pred             CCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCC
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP  558 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp  558 (658)
                      .    .....+||+.|||||++.+ +++.++|||||||++|||++|+.||...  .....+....    ..+.....+  
T Consensus       168 ~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~--~~~~~~~~~i----~~~~~~~~~--  234 (270)
T d1t4ha_         168 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC--QNAAQIYRRV----TSGVKPASF--  234 (270)
T ss_dssp             T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC--SSHHHHHHHH----TTTCCCGGG--
T ss_pred             C----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc--ccHHHHHHHH----HcCCCCccc--
Confidence            2    2345689999999998865 6999999999999999999999998422  1222222222    222111111  


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          559 TLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       559 ~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                        .....++   +.+++.+||+.||++|||+.|+++
T Consensus       235 --~~~~~~~---~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         235 --DKVAIPE---VKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             --GGCCCHH---HHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --CccCCHH---HHHHHHHHccCCHhHCcCHHHHhC
Confidence              1112223   456778999999999999999975

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-48  Score=397.64  Aligned_cols=268  Identities=26%  Similarity=0.350  Sum_probs=200.8

Q ss_pred             chhhhhhhccCCcccCcccccCceEEEEeEec------CCcceeEEEeccCCc-ccHHHHHHHHHHHHhc-CCCCceeee
Q 006155          315 DFNTIRVATDNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANL-QHRNLVRLL  386 (658)
Q Consensus       315 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~  386 (658)
                      +.+.+++..++|+..++||+|+||.||+|+..      +++.||||++..... .....+.+|...+.++ +|+||+.++
T Consensus         4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~   83 (299)
T d1ywna1           4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   83 (299)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence            34445566788999999999999999999843      246799999876433 3344577888888777 689999999


Q ss_pred             eeeccC-CceEEEEEecCCCChhhhhcCcC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEecc
Q 006155          387 GFSLEG-NERLLIYEFVPNTSLDHFIFDPT-------------RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDL  452 (658)
Q Consensus       387 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl  452 (658)
                      +++... ...++||||+++|+|.++|....             ....++|..++.++.||++||.|||+++   ||||||
T Consensus        84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDl  160 (299)
T d1ywna1          84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL  160 (299)
T ss_dssp             EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcC
Confidence            987654 46899999999999999986432             1345899999999999999999999988   999999


Q ss_pred             CCCceeeCCCCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCC-CCccC
Q 006155          453 KTSNVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQR-NNCFR  531 (658)
Q Consensus       453 k~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~-p~~~~  531 (658)
                      ||+||||++++++||+|||+++...............||+.|||||++.++.++.++|||||||++|||++|.. |+...
T Consensus       161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~  240 (299)
T d1ywna1         161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  240 (299)
T ss_dssp             CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999987765554445556789999999999999999999999999999999999865 55322


Q ss_pred             CCCCcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          532 NGETVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       532 ~~~~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      .  ....+......    +..     +.......+   .+.+++.+||+.||++|||+.||+++|++.
T Consensus       241 ~--~~~~~~~~~~~----~~~-----~~~~~~~~~---~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         241 K--IDEEFCRRLKE----GTR-----MRAPDYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             C--CSHHHHHHHHH----TCC-----CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C--HHHHHHHHHhc----CCC-----CCCCccCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            1  12222222222    211     112222223   345677899999999999999999999753

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-47  Score=397.12  Aligned_cols=255  Identities=27%  Similarity=0.429  Sum_probs=199.8

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCc----ceeEEEeccC-CcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGA----EIAVKRLSRD-SGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  397 (658)
                      ++|+..++||+|+||+||+|+.. +|+    +||||++... ..+...+|.+|+.++++++|||||+++|++.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            56999999999999999999853 344    5889988654 334567899999999999999999999999865 5678


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFE  477 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~  477 (658)
                      ++||+.+|+|.+++..  ....++|..+++++.||++||.|||+++   ||||||||+||||+.++.+||+|||+++.+.
T Consensus        88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence            8999999999988754  3567999999999999999999999987   9999999999999999999999999999876


Q ss_pred             cCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCccccc
Q 006155          478 MDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNII  556 (658)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  556 (658)
                      ............||+.|||||++.++.++.++|||||||++|||+| |+.|+....   ..++........+        
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~---~~~~~~~i~~~~~--------  231 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP---ASEISSILEKGER--------  231 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC---GGGHHHHHHHTCC--------
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC---HHHHHHHHHcCCC--------
Confidence            6554444555679999999999999999999999999999999999 677775332   2333333322211        


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          557 DPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       557 dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                       +.......+   .+.+++.+||+.||++|||+.||++.|+..
T Consensus       232 -~~~p~~~~~---~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         232 -LPQPPICTI---DVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             -CCCCTTBCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CCCCcccCH---HHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence             111112222   345678899999999999999999988653

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9e-48  Score=396.75  Aligned_cols=244  Identities=30%  Similarity=0.431  Sum_probs=198.3

Q ss_pred             cCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcc---cHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQ---GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      +.|+..++||+|+||+||+|+. .+|+.||||++......   ....+.+|+.++++++|||||++++++.+++..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            4588999999999999999984 46888999999765433   2345889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ||+++|+|..++.   ....+++..++.++.||+.||.|||+++   ||||||||+||||+.++.+||+|||+++.... 
T Consensus        95 E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-  167 (309)
T d1u5ra_          95 EYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (309)
T ss_dssp             ECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             EecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence            9999999987763   3457999999999999999999999998   99999999999999999999999999986533 


Q ss_pred             CCccccccccccccccCcccccc---CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccccc
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMH---GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNII  556 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  556 (658)
                           .....||+.|||||++.+   +.|+.++|||||||++|||++|+.||...   ...+.+......    ..    
T Consensus       168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~---~~~~~~~~i~~~----~~----  231 (309)
T d1u5ra_         168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---NAMSALYHIAQN----ES----  231 (309)
T ss_dssp             -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHHHHHS----CC----
T ss_pred             -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC---CHHHHHHHHHhC----CC----
Confidence                 234589999999999863   56899999999999999999999998432   222222222221    11    


Q ss_pred             CCCCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          557 DPTLSSG-SITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       557 dp~l~~~-~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                       |.+... ..+   .+.+++..||+.||++|||+.|+++
T Consensus       232 -~~~~~~~~s~---~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         232 -PALQSGHWSE---YFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             -CCCSCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -CCCCCCCCCH---HHHHHHHHHCcCChhHCcCHHHHHh
Confidence             111111 122   3446778999999999999999975

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.2e-47  Score=400.50  Aligned_cols=253  Identities=22%  Similarity=0.295  Sum_probs=206.8

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      -++|++.++||+|+||.||+|+. .+|+.||||++..........+.+|+.++.+++|||||++++++.+++..+|||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            36899999999999999999985 46899999999876666667789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeC--CCCCeEEeccccccccccC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLD--AEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~--~~~~~kl~DFGla~~~~~~  479 (658)
                      +++|+|.+++..  ....+++..++.|+.||+.||.|||+++   ||||||||+||||+  .++.+||+|||+++.+...
T Consensus       105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            999999999854  2346999999999999999999999998   99999999999995  4678999999999876543


Q ss_pred             CCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCC
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT  559 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~  559 (658)
                      .   ......||+.|||||++.+..++.++|||||||++|||++|+.||...   +..+++........  ..    ++.
T Consensus       180 ~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~--~~----~~~  247 (350)
T d1koaa2         180 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE---NDDETLRNVKSCDW--NM----DDS  247 (350)
T ss_dssp             S---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCC--CS----CCG
T ss_pred             c---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCC--CC----Ccc
Confidence            2   233468999999999999999999999999999999999999998432   33333333322110  00    011


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          560 LSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       560 l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                      ......+   .+.+++..||+.||++|||+.|+++.
T Consensus       248 ~~~~~s~---~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         248 AFSGISE---DGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             GGGGCCH---HHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             cccCCCH---HHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1111112   34567789999999999999999874

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.3e-48  Score=399.01  Aligned_cols=252  Identities=22%  Similarity=0.298  Sum_probs=188.5

Q ss_pred             hccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          322 ATDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       322 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ..+.|+..+.||+|+||+||+|+.. +|+.||||++..... .....+.+|+.++++++|||||++++++.+++..+|||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            3567999999999999999999854 588999999976533 23345789999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeC---CCCCeEEecccccccc
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLD---AEMTPKIADFGMARLF  476 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~---~~~~~kl~DFGla~~~  476 (658)
                      ||+++|+|.++|..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||+.   +++.+||+|||+++..
T Consensus        87 E~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          87 QLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             CCCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             eccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            99999999999953   457999999999999999999999988   99999999999994   5789999999999876


Q ss_pred             ccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccccc
Q 006155          477 EMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNII  556 (658)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  556 (658)
                      ....   .....+||+.|||||++.+..|+.++|||||||++|||++|+.||...   ...++.......    .. . .
T Consensus       161 ~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i~~~----~~-~-~  228 (307)
T d1a06a_         161 DPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE---NDAKLFEQILKA----EY-E-F  228 (307)
T ss_dssp             ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHTT----CC-C-C
T ss_pred             cCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC---CHHHHHHHHhcc----CC-C-C
Confidence            4332   233468999999999999999999999999999999999999998432   222333332221    11 0 1


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          557 DPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       557 dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .+.......+   .+.+++..||+.||++|||+.|+++
T Consensus       229 ~~~~~~~~s~---~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         229 DSPYWDDISD---SAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             CTTTTTTSCH---HHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCccccCCCH---HHHHHHHHHccCCHhHCcCHHHHhc
Confidence            1111112122   3456778999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-47  Score=393.87  Aligned_cols=263  Identities=26%  Similarity=0.436  Sum_probs=213.9

Q ss_pred             hhhhccCCcccCcccccCceEEEEeEec------CCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeecc
Q 006155          319 IRVATDNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLE  391 (658)
Q Consensus       319 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~  391 (658)
                      +++..++|...++||+|+||+||+|.+.      ++..||||+++.... .....|.+|+.++++++|||||+++|++..
T Consensus        15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~   94 (308)
T d1p4oa_          15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   94 (308)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence            3455688999999999999999999753      357899999976533 333458999999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhhhhcCc-------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCC
Q 006155          392 GNERLLIYEFVPNTSLDHFIFDP-------TRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMT  464 (658)
Q Consensus       392 ~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~  464 (658)
                      ++..++||||+++|+|.+++...       .....++|..+++++.|+++||.|||+++   |+||||||+||||+++++
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~  171 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFT  171 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCC
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCce
Confidence            99999999999999999988532       22345899999999999999999999987   999999999999999999


Q ss_pred             eEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCC-CCccCCCCCcchHHHHH
Q 006155          465 PKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQR-NNCFRNGETVEDLLSSA  543 (658)
Q Consensus       465 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~-p~~~~~~~~~~~l~~~~  543 (658)
                      +||+|||+++.+.............||+.|+|||.+.++.++.++||||||+++|||+||.. |+.   .....+.+...
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~---~~~~~~~~~~i  248 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ---GLSNEQVLRFV  248 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTT---TSCHHHHHHHH
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCC---CCCHHHHHHHH
Confidence            99999999998766555555556689999999999999999999999999999999999964 442   22333333333


Q ss_pred             HHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          544 WKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       544 ~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      ..    +.....     .....+   .+.+++.+||+.||++||||.+|+++|++.
T Consensus       249 ~~----~~~~~~-----p~~~~~---~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         249 ME----GGLLDK-----PDNCPD---MLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             HT----TCCCCC-----CTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             Hh----CCCCCC-----cccchH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            22    221111     112122   356778899999999999999999999875

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-47  Score=386.90  Aligned_cols=252  Identities=26%  Similarity=0.401  Sum_probs=197.3

Q ss_pred             hhccCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccC-CceEEEE
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEG-NERLLIY  399 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lv~  399 (658)
                      +..++|+..++||+|+||.||+|+. .|.+||||+++..  ...++|.+|+.++++++||||++++|++.++ +..++||
T Consensus         4 i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~   80 (262)
T d1byga_           4 LNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   80 (262)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred             cCHHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence            3456788889999999999999996 5889999999654  3446799999999999999999999998654 5689999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ||+++|+|.++|... ....++|..+++|+.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 ey~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~  156 (262)
T d1byga_          81 EYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  156 (262)
T ss_dssp             CCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             eccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC
Confidence            999999999999542 2335899999999999999999999987   999999999999999999999999999865432


Q ss_pred             CCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcccccCC
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP  558 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp  558 (658)
                           .....+|..|+|||++.++.++.++||||||+++|||+| |+.|+...   ...++......    +..     +
T Consensus       157 -----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~---~~~~~~~~i~~----~~~-----~  219 (262)
T d1byga_         157 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPRVEK----GYK-----M  219 (262)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS---CGGGHHHHHTT----TCC-----C
T ss_pred             -----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC---CHHHHHHHHHc----CCC-----C
Confidence                 223467899999999999999999999999999999998 56666432   33344443322    211     2


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          559 TLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       559 ~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      .+.....++   +.+++.+||+.||.+||||.+|+++|+..
T Consensus       220 ~~~~~~~~~---~~~li~~cl~~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         220 DAPDGCPPA---VYEVMKNCWHLDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             CCCTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCccCCHH---HHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            222222233   44677899999999999999999999753

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-47  Score=390.81  Aligned_cols=263  Identities=28%  Similarity=0.387  Sum_probs=208.6

Q ss_pred             hhhhccCCcccCcccccCceEEEEeEecC--------CcceeEEEeccCCc-ccHHHHHHHHHHHHhc-CCCCceeeeee
Q 006155          319 IRVATDNFSDANKLGQGGFGAVYKGRLYD--------GAEIAVKRLSRDSG-QGDLEFKNEVLLVANL-QHRNLVRLLGF  388 (658)
Q Consensus       319 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~--------g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~  388 (658)
                      +.+..++|+..+.||+|+||.||+|+...        +..||||+++.... ....++.+|+..+.++ +|||||+++++
T Consensus         8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~   87 (299)
T d1fgka_           8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA   87 (299)
T ss_dssp             TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence            34556789999999999999999997432        34699999977654 3346788899999888 79999999999


Q ss_pred             eccCCceEEEEEecCCCChhhhhcCcC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCC
Q 006155          389 SLEGNERLLIYEFVPNTSLDHFIFDPT-------------RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTS  455 (658)
Q Consensus       389 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~  455 (658)
                      +.+++..++||||+++|+|.++|....             ....+++..+++++.||+.||.|||+.+   ||||||||+
T Consensus        88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~  164 (299)
T d1fgka_          88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAAR  164 (299)
T ss_dssp             ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred             cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccc
Confidence            999999999999999999999996432             1346899999999999999999999998   999999999


Q ss_pred             ceeeCCCCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCC
Q 006155          456 NVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGE  534 (658)
Q Consensus       456 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~  534 (658)
                      |||++.++.+||+|||+++...............||+.|+|||++.++.|+.|+||||||+++|||++ |+.|+...   
T Consensus       165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~---  241 (299)
T d1fgka_         165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV---  241 (299)
T ss_dssp             GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC---
T ss_pred             ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC---
Confidence            99999999999999999998776655555666789999999999999999999999999999999998 57776422   


Q ss_pred             CcchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          535 TVEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       535 ~~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      ....+.    ..+..+...     .......+   .+.+++.+||+.||++|||+.||+++|+.+
T Consensus       242 ~~~~~~----~~i~~~~~~-----~~p~~~~~---~l~~li~~cl~~dP~~Rps~~eil~~L~~i  294 (299)
T d1fgka_         242 PVEELF----KLLKEGHRM-----DKPSNCTN---ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  294 (299)
T ss_dssp             CHHHHH----HHHHTTCCC-----CCCSSCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CHHHHH----HHHHcCCCC-----CCCccchH---HHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            222222    222222211     12222223   355788899999999999999999999764

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-47  Score=392.85  Aligned_cols=264  Identities=27%  Similarity=0.370  Sum_probs=210.5

Q ss_pred             hhhhccCCcccCcccccCceEEEEeEec------CCcceeEEEeccCCcc-cHHHHHHHHHHHHhc-CCCCceeeeeeec
Q 006155          319 IRVATDNFSDANKLGQGGFGAVYKGRLY------DGAEIAVKRLSRDSGQ-GDLEFKNEVLLVANL-QHRNLVRLLGFSL  390 (658)
Q Consensus       319 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l-~H~niv~l~~~~~  390 (658)
                      +++..++|+..++||+|+||.||+|++.      .++.||||+++..... ...+|.+|+.++.++ +|||||+++|++.
T Consensus        18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~   97 (311)
T d1t46a_          18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (311)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence            3456689999999999999999999752      4568999999765433 344689999999999 6999999999999


Q ss_pred             cCCceEEEEEecCCCChhhhhcCcC---------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCC
Q 006155          391 EGNERLLIYEFVPNTSLDHFIFDPT---------------RRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTS  455 (658)
Q Consensus       391 ~~~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~  455 (658)
                      +++..++||||+++|+|.++++...               ....+++..+++++.||++||.|||+++   +|||||||+
T Consensus        98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~  174 (311)
T d1t46a_          98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR  174 (311)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccc
Confidence            9999999999999999999986432               2346999999999999999999999998   999999999


Q ss_pred             ceeeCCCCCeEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCC
Q 006155          456 NVLLDAEMTPKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGET  535 (658)
Q Consensus       456 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~  535 (658)
                      |||++.++.+||+|||+++...............||+.|+|||++.++.++.++||||||+++|||+|+..|+.....  
T Consensus       175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~--  252 (311)
T d1t46a_         175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP--  252 (311)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--
T ss_pred             cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC--
Confidence            999999999999999999987655444445557899999999999999999999999999999999996555422221  


Q ss_pred             cchHHHHHHHhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          536 VEDLLSSAWKNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       536 ~~~l~~~~~~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      ....+.....   .+.     .+.......+   .+.+++.+||+.||++||||.+|+++|++
T Consensus       253 ~~~~~~~~i~---~~~-----~~~~~~~~~~---~l~~Li~~cl~~dP~~RPs~~~il~~L~~  304 (311)
T d1t46a_         253 VDSKFYKMIK---EGF-----RMLSPEHAPA---EMYDIMKTCWDADPLKRPTFKQIVQLIEK  304 (311)
T ss_dssp             SSHHHHHHHH---HTC-----CCCCCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHh---cCC-----CCCCcccccH---HHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            1122222111   111     1111112222   35577889999999999999999999975

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-47  Score=386.76  Aligned_cols=256  Identities=22%  Similarity=0.336  Sum_probs=195.1

Q ss_pred             hhccCCcccCcccccCceEEEEeEecC----CcceeEEEeccCCcc-cHHHHHHHHHHHHhcCCCCceeeeeeeccCCce
Q 006155          321 VATDNFSDANKLGQGGFGAVYKGRLYD----GAEIAVKRLSRDSGQ-GDLEFKNEVLLVANLQHRNLVRLLGFSLEGNER  395 (658)
Q Consensus       321 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  395 (658)
                      +..++|+..+.||+|+||.||+|+...    +..||||++...... ....|.+|+.++++++|||||+++|++. .+..
T Consensus         4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~   82 (273)
T d1mp8a_           4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   82 (273)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence            446789999999999999999998542    346899988655433 3456899999999999999999999986 4678


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ++||||+++|+|.+++..  ....+++..++.++.||++||.|||+.+   ||||||||+|||++.++.+||+|||+++.
T Consensus        83 ~iv~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~  157 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY  157 (273)
T ss_dssp             EEEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred             EEEEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhhee
Confidence            999999999999998743  3457999999999999999999999988   99999999999999999999999999987


Q ss_pred             cccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          476 FEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      +..... .......||+.|+|||++.++.++.++|||||||++|||++ |+.|+....   ..++.......    ..  
T Consensus       158 ~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~---~~~~~~~i~~~----~~--  227 (273)
T d1mp8a_         158 MEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK---NNDVIGRIENG----ER--  227 (273)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC---GGGHHHHHHTT----CC--
T ss_pred             ccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC---HHHHHHHHHcC----CC--
Confidence            654332 23344678999999999999999999999999999999998 788875433   33444433322    11  


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          555 IIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       555 ~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                         +.+.....++   +.+++..||+.||++|||+.||++.|+.
T Consensus       228 ---~~~~~~~~~~---~~~li~~cl~~dp~~Rps~~ei~~~L~~  265 (273)
T d1mp8a_         228 ---LPMPPNCPPT---LYSLMTKCWAYDPSRRPRFTELKAQLST  265 (273)
T ss_dssp             ---CCCCTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---CCCCCCCCHH---HHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence               1122222233   4567789999999999999999999875

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-46  Score=384.17  Aligned_cols=251  Identities=24%  Similarity=0.315  Sum_probs=202.9

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCc------ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCce
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSG------QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNER  395 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  395 (658)
                      .+.|+..+.||+|+||+||+|+. .+|+.||||++.....      .....+.+|+.+|++++|||||++++++.+++..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            46799999999999999999985 4689999999865422      2356799999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCC----CeEEeccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM----TPKIADFG  471 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~----~~kl~DFG  471 (658)
                      +|||||+++|+|.++|..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        89 ~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          89 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence            999999999999999843   357999999999999999999999998   99999999999998776    59999999


Q ss_pred             cccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCC
Q 006155          472 MARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGT  551 (658)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  551 (658)
                      +++.+....   ......||+.|+|||++.+..++.++|||||||++|||++|+.||...   ...+.+......-.  .
T Consensus       163 ~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i~~~~~--~  234 (293)
T d1jksa_         163 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSAVNY--E  234 (293)
T ss_dssp             TCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHTTCC--C
T ss_pred             hhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC---CHHHHHHHHHhcCC--C
Confidence            998765432   233467899999999999999999999999999999999999998532   22333332221100  0


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          552 TVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       552 ~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ......+    ...   ..+.+++..||+.||++|||++|+++
T Consensus       235 ~~~~~~~----~~s---~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         235 FEDEYFS----NTS---ALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             CCHHHHT----TSC---HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCchhcC----CCC---HHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000001    111   23456778999999999999999975

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-47  Score=394.85  Aligned_cols=266  Identities=24%  Similarity=0.313  Sum_probs=199.1

Q ss_pred             cCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCC----ceEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGN----ERLLIY  399 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~lv~  399 (658)
                      ++|...++||+|+||.||+|++ +|+.||||++..... ....++.|+..+.+++|||||++++++.+.+    ..++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            5677788999999999999985 789999999865422 1222344555667789999999999997654    578999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhc-----CCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHED-----SRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      ||+++|+|.++|..    ..++|..+++++.|++.||.|||+.     ...+||||||||+||||+.++.+||+|||+++
T Consensus        81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            99999999999943    4699999999999999999999974     12359999999999999999999999999998


Q ss_pred             ccccCCCc--cccccccccccccCccccccCC------CCcccccccccchHhHHHhCCCCCccCCCCCc--------ch
Q 006155          475 LFEMDETQ--GNTSRIVGTYGYMAPEYAMHGQ------YSVKSDVFSFGVLVLEIISGQRNNCFRNGETV--------ED  538 (658)
Q Consensus       475 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~--------~~  538 (658)
                      .+......  .......||+.|||||++.+..      ++.|+|||||||++|||+||..|+........        ..
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence            77543322  2344578999999999987543      67899999999999999999887643221110        00


Q ss_pred             HHHHHHHhccCCCcccccCCCCCCC--CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          539 LLSSAWKNWREGTTVNIIDPTLSSG--SITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       539 l~~~~~~~~~~~~~~~~~dp~l~~~--~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      ...........    +.++|.+...  ..+....+.+++.+||+.||++||||.||+++|+..
T Consensus       237 ~~~~~~~~~~~----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i  295 (303)
T d1vjya_         237 SVEEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             CHHHHHHHHTT----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             hHHHHHHHHhc----cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            11111111111    1223333322  233445577899999999999999999999999753

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=5.8e-47  Score=397.60  Aligned_cols=252  Identities=23%  Similarity=0.265  Sum_probs=206.3

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      .++|++.++||+|+||.||+|+. .+|+.||||++..........+.+|+.++++++|||||++++++.+++..+|||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            36799999999999999999985 46899999999876555566788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeC--CCCCeEEeccccccccccC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLD--AEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~--~~~~~kl~DFGla~~~~~~  479 (658)
                      +++|+|.+++..  ....+++..++.|+.||+.||.|||+.+   ||||||||+||||+  .++.+||+|||+++.+..+
T Consensus       108 ~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         108 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence            999999887743  3346999999999999999999999988   99999999999998  6789999999999877543


Q ss_pred             CCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCC
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT  559 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~  559 (658)
                      .   ......||+.|||||++.+..++.++|||||||++|||++|+.||...   +..+++......    ...  ..+.
T Consensus       183 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~---~~~~~~~~i~~~----~~~--~~~~  250 (352)
T d1koba_         183 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE---DDLETLQNVKRC----DWE--FDED  250 (352)
T ss_dssp             S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHHHHHC----CCC--CCSS
T ss_pred             C---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhC----CCC--CCcc
Confidence            2   234468999999999999999999999999999999999999998432   233333333221    100  1111


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          560 LSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       560 l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ......++   +.+++..||+.||.+|||+.|+++
T Consensus       251 ~~~~~s~~---~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         251 AFSSVSPE---AKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             TTTTSCHH---HHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cccCCCHH---HHHHHHHHccCChhHCcCHHHHhc
Confidence            11122223   446778999999999999999986

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-47  Score=385.64  Aligned_cols=256  Identities=27%  Similarity=0.368  Sum_probs=195.4

Q ss_pred             ccCCcccCcccccCceEEEEeEecC--C--cceeEEEeccCC---cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCce
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLYD--G--AEIAVKRLSRDS---GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNER  395 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~~--g--~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  395 (658)
                      .++|+..+.||+|+||.||+|+...  +  ..||||++....   .+...+|.+|+.++++++|||||+++|++.+ +..
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence            4679999999999999999998532  2  368999987542   2334579999999999999999999999976 467


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ++||||+++|+|.+++..  ....++|..+++++.||++||.|||+++   |+||||||+||||+.++.+||+|||+++.
T Consensus        86 ~lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~  160 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA  160 (273)
T ss_dssp             EEEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             heeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence            899999999999988754  3456999999999999999999999987   99999999999999999999999999998


Q ss_pred             cccCCCcc-ccccccccccccCccccccCCCCcccccccccchHhHHHh-CCCCCccCCCCCcchHHHHHHHhccCCCcc
Q 006155          476 FEMDETQG-NTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIIS-GQRNNCFRNGETVEDLLSSAWKNWREGTTV  553 (658)
Q Consensus       476 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  553 (658)
                      +....... ......||..|+|||++.+..++.++||||||+++|||+| |+.||..   .+..+.+....+   .+.. 
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~---~~~~~~~~~i~~---~~~~-  233 (273)
T d1u46a_         161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG---LNGSQILHKIDK---EGER-  233 (273)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT---CCHHHHHHHHHT---SCCC-
T ss_pred             cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCC---cCHHHHHHHHHh---CCCC-
Confidence            75543322 2334568899999999999999999999999999999998 8999842   233333333322   2211 


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          554 NIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       554 ~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                          +........   .+.+++.+||+.||++||||.||+++|..
T Consensus       234 ----~~~~~~~~~---~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         234 ----LPRPEDCPQ---DIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             ----CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----CCCcccccH---HHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence                111122222   34567889999999999999999999864

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-46  Score=387.79  Aligned_cols=252  Identities=27%  Similarity=0.413  Sum_probs=200.2

Q ss_pred             cCcccccCceEEEEeEecCC----cceeEEEeccCC-cccHHHHHHHHHHHHhcCCCCceeeeeeecc-CCceEEEEEec
Q 006155          329 ANKLGQGGFGAVYKGRLYDG----AEIAVKRLSRDS-GQGDLEFKNEVLLVANLQHRNLVRLLGFSLE-GNERLLIYEFV  402 (658)
Q Consensus       329 ~~~lG~G~fg~Vy~~~~~~g----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e~~  402 (658)
                      .++||+|+||+||+|++.++    ..||||+++... .....+|.+|++++++++||||++++|++.+ +...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46799999999999986442    258999997543 3344679999999999999999999999875 45789999999


Q ss_pred             CCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCc
Q 006155          403 PNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ  482 (658)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  482 (658)
                      ++|+|.+++..  ....+++..+++++.|+++||.|||+.+   |+||||||+||||++++.+||+|||+++........
T Consensus       112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            99999999854  3456789999999999999999999987   999999999999999999999999999877544322


Q ss_pred             --cccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCCC
Q 006155          483 --GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPTL  560 (658)
Q Consensus       483 --~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~l  560 (658)
                        .......||+.|+|||.+.++.++.++||||||+++|||++|+.|+....  ...++........+      ...|  
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~--~~~~~~~~i~~g~~------~~~p--  256 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--NTFDITVYLLQGRR------LLQP--  256 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTTCC------CCCC--
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC--CHHHHHHHHHcCCC------CCCc--
Confidence              22334578999999999999999999999999999999999888874322  22333333332211      1112  


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          561 SSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       561 ~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                       ....+   .+.+++..||+.||++||+|.||++.|++.
T Consensus       257 -~~~~~---~l~~li~~cl~~dP~~RPs~~ei~~~L~~i  291 (311)
T d1r0pa_         257 -EYCPD---PLYEVMLKCWHPKAEMRPSFSELVSRISAI  291 (311)
T ss_dssp             -TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -ccCcH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence             12223   345678899999999999999999999875

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=389.78  Aligned_cols=255  Identities=28%  Similarity=0.430  Sum_probs=202.0

Q ss_pred             cCCcccCcccccCceEEEEeEecC-Cc--ceeEEEeccC-CcccHHHHHHHHHHHHhc-CCCCceeeeeeeccCCceEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLYD-GA--EIAVKRLSRD-SGQGDLEFKNEVLLVANL-QHRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~~-g~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv  398 (658)
                      ++|+..++||+|+||.||+|+..+ |.  .||||++... ......+|.+|+.+|.++ +|||||+++|++.+++..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            678888999999999999998654 33  4788988654 333455799999999999 799999999999999999999


Q ss_pred             EEecCCCChhhhhcCc-------------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCe
Q 006155          399 YEFVPNTSLDHFIFDP-------------TRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTP  465 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~  465 (658)
                      |||+++|+|.++|+..             .....++|..+++++.||++||.|||+.+   |+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            9999999999999653             23467999999999999999999999987   9999999999999999999


Q ss_pred             EEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCC-CCccCCCCCcchHHHHHH
Q 006155          466 KIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQR-NNCFRNGETVEDLLSSAW  544 (658)
Q Consensus       466 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~-p~~~~~~~~~~~l~~~~~  544 (658)
                      ||+|||+++......   ......||..|+|||.+.++.++.++|||||||++|||++|.. |+..   ....++...+.
T Consensus       167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~---~~~~~~~~~i~  240 (309)
T d1fvra_         167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG---MTCAELYEKLP  240 (309)
T ss_dssp             EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT---CCHHHHHHHGG
T ss_pred             EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC---CCHHHHHHHHH
Confidence            999999998654322   2234578999999999999999999999999999999999876 4532   23333333322


Q ss_pred             HhccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 006155          545 KNWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNSY  599 (658)
Q Consensus       545 ~~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~~  599 (658)
                      ...+         +.......+   .+.+++.+||+.||++||||.||++.|++.
T Consensus       241 ~~~~---------~~~~~~~~~---~~~~li~~cl~~dP~~RPs~~eil~~L~~i  283 (309)
T d1fvra_         241 QGYR---------LEKPLNCDD---EVYDLMRQCWREKPYERPSFAQILVSLNRM  283 (309)
T ss_dssp             GTCC---------CCCCTTBCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hcCC---------CCCCccCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            2111         222222223   345677899999999999999999999764

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-45  Score=384.19  Aligned_cols=248  Identities=23%  Similarity=0.261  Sum_probs=204.3

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccC---CcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRD---SGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  398 (658)
                      -++|+..+.||+|+||.||+++. .+|+.||||++.+.   .......+.+|+.+|++++||||+++++++.+++..++|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            46899999999999999999985 46899999999754   223456688999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccccc
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~  478 (658)
                      |||+++|+|.+++.   +...+++..++.++.||+.||+|||+++   ||||||||+|||++.+|.+||+|||+++....
T Consensus        84 ~ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          84 MEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eeccCCCchhhhhh---cccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            99999999999984   3456899999999999999999999998   99999999999999999999999999986543


Q ss_pred             CCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCC
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP  558 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp  558 (658)
                      ..  ......+||+.|||||++.+..|+.++||||+||++|||++|+.||...   +...+......    +.      +
T Consensus       158 ~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~---~~~~~~~~i~~----~~------~  222 (337)
T d1o6la_         158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ---DHERLFELILM----EE------I  222 (337)
T ss_dssp             TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHH----CC------C
T ss_pred             CC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCc---CHHHHHHHHhc----CC------C
Confidence            22  2334578999999999999999999999999999999999999998533   23333333222    11      1


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 006155          559 TLSSGSITEMIRCIHIGLLCVQENVASRPT-----MASVVL  594 (658)
Q Consensus       559 ~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPt-----m~evv~  594 (658)
                      .+.....++   +.+++..||+.||++||+     ++|+++
T Consensus       223 ~~p~~~s~~---~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         223 RFPRTLSPE---AKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CCCTTSCHH---HHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCCccCCHH---HHHHHHhhccCCchhhcccccccHHHHHc
Confidence            122222223   446778999999999995     778775

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.2e-45  Score=380.27  Aligned_cols=244  Identities=23%  Similarity=0.312  Sum_probs=201.6

Q ss_pred             cCCcccCcccccCceEEEEeEe-cCCcceeEEEeccC---CcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRD---SGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ++|++.++||+|+||+||+++. .+|+.||||++...   .......+.+|+.+++.++|||||++++++.+++..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            5789999999999999999985 46899999998643   2234567899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ||+++|+|..++.   ....+++..+..++.||+.||.|||+++   ||||||||+||||+.++.+||+|||+++.....
T Consensus        84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            9999999999884   3456889999999999999999999988   999999999999999999999999999876432


Q ss_pred             CCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCC
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT  559 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~  559 (658)
                           ....+||+.|||||++.+..|+.++|||||||++|||++|+.||...   +..++......    +.      +.
T Consensus       158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~---~~~~~~~~i~~----~~------~~  219 (316)
T d1fota_         158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS---NTMKTYEKILN----AE------LR  219 (316)
T ss_dssp             -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHH----CC------CC
T ss_pred             -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc---CHHHHHHHHHc----CC------CC
Confidence                 23468999999999999999999999999999999999999998532   22333333222    11      11


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 006155          560 LSSGSITEMIRCIHIGLLCVQENVASRP-----TMASVVL  594 (658)
Q Consensus       560 l~~~~~~e~~~~~~i~~~Cl~~~p~~RP-----tm~evv~  594 (658)
                      +.....++   +.+++.+||+.||.+||     |++++++
T Consensus       220 ~p~~~s~~---~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         220 FPPFFNED---VKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             CCTTSCHH---HHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCCCHH---HHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            11121222   44677799999999996     8999975

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.5e-45  Score=373.65  Aligned_cols=257  Identities=25%  Similarity=0.346  Sum_probs=197.0

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcc---cHHHHHHHHHHHHhcCCCCceeeeeeeccCC----c
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQ---GDLEFKNEVLLVANLQHRNLVRLLGFSLEGN----E  394 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~  394 (658)
                      .++|++.+.||+|+||+||+|+. .+|+.||||+++.....   ....+.+|+.+++.++|||||++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            47799999999999999999984 46899999999765332   2346899999999999999999999987654    3


Q ss_pred             eEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          395 RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      .+|||||+++++|.+++.   ....+++..++.++.||++||.|||+.+   ||||||||+||||+.++..+|+|||.++
T Consensus        86 ~~lvmE~~~g~~L~~~~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhhc---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence            789999999999999884   3457999999999999999999999988   9999999999999999999999999987


Q ss_pred             ccccCCC-ccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcc
Q 006155          475 LFEMDET-QGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTV  553 (658)
Q Consensus       475 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  553 (658)
                      ....... .......+||+.|||||++.+..++.++|||||||++|||+||+.||...   ...+.....   ...+...
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~---~~~~~~~~~---~~~~~~~  233 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD---SPVSVAYQH---VREDPIP  233 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHH---HHCCCCC
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc---CHHHHHHHH---HhcCCCC
Confidence            6543322 22344568999999999999999999999999999999999999998532   222222222   2222111


Q ss_pred             -cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHhcc
Q 006155          554 -NIIDPTLSSGSITEMIRCIHIGLLCVQENVASRP-TMASVVLMLNS  598 (658)
Q Consensus       554 -~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RP-tm~evv~~L~~  598 (658)
                       ....+    ...+   .+.+++.+||+.||++|| |++++...|..
T Consensus       234 ~~~~~~----~~s~---~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         234 PSARHE----GLSA---DLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             GGGTSS----SCCH---HHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             Cchhcc----CCCH---HHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence             11111    1122   344677899999999999 89999887754

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.1e-45  Score=375.20  Aligned_cols=251  Identities=22%  Similarity=0.303  Sum_probs=201.0

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcc---------cHHHHHHHHHHHHhcC-CCCceeeeeeecc
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQ---------GDLEFKNEVLLVANLQ-HRNLVRLLGFSLE  391 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~---------~~~~~~~E~~~l~~l~-H~niv~l~~~~~~  391 (658)
                      .++|+..+.||+|+||+||+++. .+|+.||||++......         ....+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            36899999999999999999985 46889999998765321         1234788999999997 9999999999999


Q ss_pred             CCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccc
Q 006155          392 GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFG  471 (658)
Q Consensus       392 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFG  471 (658)
                      ++..+|||||+++|+|.++|..   +..+++..++.++.||++||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CcceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence            9999999999999999999953   457999999999999999999999988   9999999999999999999999999


Q ss_pred             cccccccCCCccccccccccccccCcccccc------CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHH
Q 006155          472 MARLFEMDETQGNTSRIVGTYGYMAPEYAMH------GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWK  545 (658)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~  545 (658)
                      +++.+....   ......||+.|+|||++.+      ..++.++||||+||++|||++|+.||...   ...+.......
T Consensus       156 ~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~---~~~~~~~~i~~  229 (277)
T d1phka_         156 FSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR---KQMLMLRMIMS  229 (277)
T ss_dssp             TCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHH
T ss_pred             heeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC---CHHHHHHHHHh
Confidence            998765432   2234689999999999853      35788999999999999999999999533   22233222222


Q ss_pred             hccCCCcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          546 NWREGTTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       546 ~~~~~~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                          +... ...+.. ....+   .+.+++.+||+.||++|||+.||++
T Consensus       230 ----~~~~-~~~~~~-~~~s~---~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         230 ----GNYQ-FGSPEW-DDYSD---TVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             ----TCCC-CCTTTG-GGSCH---HHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ----CCCC-CCCccc-ccCCH---HHHHHHHHHccCChhHCcCHHHHHc
Confidence                1110 111111 11112   3556778999999999999999864

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-45  Score=376.65  Aligned_cols=259  Identities=23%  Similarity=0.273  Sum_probs=195.8

Q ss_pred             cCcccccCceEEEEeEec-CCcceeEEEeccCCccc-----HHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEec
Q 006155          329 ANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQG-----DLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEFV  402 (658)
Q Consensus       329 ~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~-----~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  402 (658)
                      +++||+|+||+||+|+.. +|+.||||++.......     ...+.+|+.++++++|||||++++++.+++..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            578999999999999854 58899999986543222     235889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCCc
Q 006155          403 PNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDETQ  482 (658)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~  482 (658)
                      .++++..++   .....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+..... 
T Consensus        83 ~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-  155 (299)
T d1ua2a_          83 ETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-  155 (299)
T ss_dssp             SEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred             cchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence            998887766   23456899999999999999999999998   99999999999999999999999999987654322 


Q ss_pred             cccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccC----
Q 006155          483 GNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIID----  557 (658)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d----  557 (658)
                       .....+||+.|+|||++..+ .++.++|||||||++|||++|+.||....   ..+.+....+...........+    
T Consensus       156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~---~~~~l~~i~~~~~~~~~~~~~~~~~~  231 (299)
T d1ua2a_         156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS---DLDQLTRIFETLGTPTEEQWPDMCSL  231 (299)
T ss_dssp             -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred             -cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC---HHHHHHHHHHhcCCCChhhccchhcc
Confidence             23346899999999998755 57999999999999999999999985332   2333333322211111000000    


Q ss_pred             ------CCCCCCCHHHH-----HHHHHHHHHhcCCCCCCCCCHHHHHH--Hhcc
Q 006155          558 ------PTLSSGSITEM-----IRCIHIGLLCVQENVASRPTMASVVL--MLNS  598 (658)
Q Consensus       558 ------p~l~~~~~~e~-----~~~~~i~~~Cl~~~p~~RPtm~evv~--~L~~  598 (658)
                            .........++     ..+++++.+||+.||++|||++|+++  .|++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~  285 (299)
T d1ua2a_         232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN  285 (299)
T ss_dssp             TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred             chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence                  00011111111     24667888999999999999999986  3543

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.5e-45  Score=380.64  Aligned_cols=244  Identities=21%  Similarity=0.258  Sum_probs=202.3

Q ss_pred             cCCcccCcccccCceEEEEeEe-cCCcceeEEEeccC---CcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRD---SGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  399 (658)
                      ++|+..++||+|+||.||+++. .+|+.||||++...   .......+.+|+.+|+.++|||||++++++.+.+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            6899999999999999999985 46899999998643   2233456889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccC
Q 006155          400 EFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMD  479 (658)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~  479 (658)
                      ||+.+|+|..++.   +...+++..++.++.||+.||.|||+.+   ||||||||+||||+.++.+||+|||+++.+...
T Consensus       121 e~~~~g~l~~~l~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            9999999999984   3356999999999999999999999988   999999999999999999999999999876432


Q ss_pred             CCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCC
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT  559 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~  559 (658)
                           .....||+.|||||++.+..++.++|||||||++|||++|+.||..   .+...+.......    .      +.
T Consensus       195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~---~~~~~~~~~i~~~----~------~~  256 (350)
T d1rdqe_         195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA---DQPIQIYEKIVSG----K------VR  256 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHHC----C------CC
T ss_pred             -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC---cCHHHHHHHHhcC----C------CC
Confidence                 2346899999999999999999999999999999999999999843   2233333333221    1      11


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCC-----CCHHHHHH
Q 006155          560 LSSGSITEMIRCIHIGLLCVQENVASR-----PTMASVVL  594 (658)
Q Consensus       560 l~~~~~~e~~~~~~i~~~Cl~~~p~~R-----Ptm~evv~  594 (658)
                      ......++   +.+++..||+.||.+|     ||++++++
T Consensus       257 ~p~~~s~~---~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         257 FPSHFSSD---LKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CCTTCCHH---HHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCccCCHH---HHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            11122223   4466779999999999     48999985

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.5e-45  Score=385.14  Aligned_cols=249  Identities=24%  Similarity=0.300  Sum_probs=196.2

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHH---HHHHHHhcCCCCceeeeeeeccCCce
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKN---EVLLVANLQHRNLVRLLGFSLEGNER  395 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~---E~~~l~~l~H~niv~l~~~~~~~~~~  395 (658)
                      -++|++.++||+|+||.||+|+.. +|+.||||++....   ......+.+   |+.+++.++|||||++++++.+.+..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            368999999999999999999854 68999999986431   122233444   46667777899999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARL  475 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~  475 (658)
                      ++||||+++|+|.++|.   +...+++..++.++.||+.||.|||+.+   ||||||||+||||+.++.+||+|||+++.
T Consensus        83 ~ivmE~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~  156 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD  156 (364)
T ss_dssp             EEEECCCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred             EEEEEecCCCcHHHHHH---hcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence            99999999999999994   3456899999999999999999999998   99999999999999999999999999987


Q ss_pred             cccCCCccccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          476 FEMDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      +....    .....||+.|||||++..+ .|+.++|||||||++|||++|+.||..........+..   .... .    
T Consensus       157 ~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~---~~~~-~----  224 (364)
T d1omwa3         157 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---MTLT-M----  224 (364)
T ss_dssp             CSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH---HSSS-C----
T ss_pred             cCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hccc-C----
Confidence            65432    3346899999999999754 68999999999999999999999996544333222111   1111 1    


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 006155          555 IIDPTLSSGSITEMIRCIHIGLLCVQENVASRPT-----MASVVL  594 (658)
Q Consensus       555 ~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPt-----m~evv~  594 (658)
                        .+.+.....++   +.+++..||+.||++|||     ++|+++
T Consensus       225 --~~~~~~~~s~~---~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         225 --AVELPDSFSPE---LRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             --CCCCCSSSCHH---HHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             --CCCCCCCCCHH---HHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence              11111122223   456778999999999999     578863

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-45  Score=377.27  Aligned_cols=247  Identities=26%  Similarity=0.341  Sum_probs=199.6

Q ss_pred             cCCcccCcccccCceEEEEeEec-CCcceeEEEeccCC---cccHHHHHHHHHHHH-hcCCCCceeeeeeeccCCceEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDS---GQGDLEFKNEVLLVA-NLQHRNLVRLLGFSLEGNERLLI  398 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~~~~~~lv  398 (658)
                      ++|...+.||+|+||+||+|+.. +|+.||||++.+..   ......+..|..++. .++|||||++++++.+++..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57899999999999999999854 68899999996532   233445666666654 68999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccccc
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEM  478 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~  478 (658)
                      |||+++|+|.+++.   ....+++..++.++.||+.||+|||+++   |+||||||+|||+++++++||+|||+++....
T Consensus        82 mEy~~~g~L~~~i~---~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence            99999999999994   3456899999999999999999999998   99999999999999999999999999986543


Q ss_pred             CCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCC
Q 006155          479 DETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDP  558 (658)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp  558 (658)
                      ..  .......||+.|+|||++.++.++.++|||||||++|||++|+.||...   +..++......    +.      +
T Consensus       156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~---~~~~~~~~i~~----~~------~  220 (320)
T d1xjda_         156 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ---DEEELFHSIRM----DN------P  220 (320)
T ss_dssp             TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHH----CC------C
T ss_pred             cc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC---CHHHHHHHHHc----CC------C
Confidence            32  2334468999999999999999999999999999999999999999532   33333333221    11      2


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHH
Q 006155          559 TLSSGSITEMIRCIHIGLLCVQENVASRPTMA-SVVL  594 (658)
Q Consensus       559 ~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~-evv~  594 (658)
                      .+.....++   +.+++.+||+.||++||++. ++++
T Consensus       221 ~~p~~~s~~---~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         221 FYPRWLEKE---AKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             CCCTTSCHH---HHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             CCCccCCHH---HHHHHHHhcccCCCCCcCHHHHHHh
Confidence            222222223   45677799999999999996 6753

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-45  Score=377.94  Aligned_cols=251  Identities=22%  Similarity=0.269  Sum_probs=202.7

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      .++|++.+.||+|+||+||+|+.. +|+.||||.++... .....+.+|+.+|+.++|||||++++++.+++..+|||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            467999999999999999999854 58899999997653 3345688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCC--CCeEEeccccccccccC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAE--MTPKIADFGMARLFEMD  479 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~--~~~kl~DFGla~~~~~~  479 (658)
                      +++|+|.++|..  ....+++.+++.|+.||+.||.|||+.+   |+||||||+|||++.+  ..+||+|||+++.....
T Consensus        83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            999999999953  2346999999999999999999999988   9999999999999854  58999999999876433


Q ss_pred             CCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcccccCCC
Q 006155          480 ETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVNIIDPT  559 (658)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~dp~  559 (658)
                      .   ......||+.|+|||.+.+..++.++||||+||++|||++|+.||...   ...+++......-  ........+.
T Consensus       158 ~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~---~~~~~~~~i~~~~--~~~~~~~~~~  229 (321)
T d1tkia_         158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE---TNQQIIENIMNAE--YTFDEEAFKE  229 (321)
T ss_dssp             C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHHTC--CCCCHHHHTT
T ss_pred             C---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCC--CCCChhhccC
Confidence            2   233467899999999999999999999999999999999999998533   2333333332210  0000000011


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          560 LSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       560 l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      +    .   ..+.+++..||+.||++|||+.|+++
T Consensus       230 ~----s---~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         230 I----S---IEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             S----C---HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             C----C---HHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1    1   13457788999999999999999987

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-44  Score=370.98  Aligned_cols=266  Identities=23%  Similarity=0.344  Sum_probs=200.8

Q ss_pred             cCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      ++|+..++||+|+||+||+|+. .+|+.||||++.....  .....+.+|+.++++++|||||++++++.+++..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5899999999999999999985 5689999999965432  235678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      |+.++.+.....  .....+++..+..++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence            997665544432  23456999999999999999999999988   9999999999999999999999999998764332


Q ss_pred             CccccccccccccccCccccccCC-CCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCC---cccc-
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGT---TVNI-  555 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~-  555 (658)
                        .......||+.|+|||.+.... ++.++|||||||++|||++|+.||...+   ..+.+...........   .... 
T Consensus       157 --~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~  231 (298)
T d1gz8a_         157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS---EIDQLFRIFRTLGTPDEVVWPGVT  231 (298)
T ss_dssp             --BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             --ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC---HHHHHHHHHHhcCCCchhhccccc
Confidence              2333468999999999887665 5789999999999999999999985332   2222222222111100   0000 


Q ss_pred             ----cC---CCCCCCCHHHH-----HHHHHHHHHhcCCCCCCCCCHHHHHHH--hccC
Q 006155          556 ----ID---PTLSSGSITEM-----IRCIHIGLLCVQENVASRPTMASVVLM--LNSY  599 (658)
Q Consensus       556 ----~d---p~l~~~~~~e~-----~~~~~i~~~Cl~~~p~~RPtm~evv~~--L~~~  599 (658)
                          ..   +..........     ..+.+++.+||+.||++|||+.|+++.  +++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence                00   01111111111     245677889999999999999999873  6544

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-44  Score=377.22  Aligned_cols=251  Identities=22%  Similarity=0.239  Sum_probs=194.7

Q ss_pred             ccCCcccC-cccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhc-CCCCceeeeeeecc----CCce
Q 006155          323 TDNFSDAN-KLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANL-QHRNLVRLLGFSLE----GNER  395 (658)
Q Consensus       323 ~~~~~~~~-~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~~~  395 (658)
                      .++|.+.. .||+|+||+||+|+. .+|+.||||+++.     ...+.+|+.++.++ +|||||++++++.+    +...
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            46788765 599999999999985 5689999999854     24578899887655 89999999998865    4568


Q ss_pred             EEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCC---CCCeEEecccc
Q 006155          396 LLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDA---EMTPKIADFGM  472 (658)
Q Consensus       396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~---~~~~kl~DFGl  472 (658)
                      ++||||+++|+|.++|... ....+++..++.|+.||+.||+|||+.+   |+||||||+|||++.   ++.+||+|||+
T Consensus        85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence            9999999999999999642 2346999999999999999999999998   999999999999985   56799999999


Q ss_pred             ccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCc
Q 006155          473 ARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTT  552 (658)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  552 (658)
                      ++......   ......||+.|||||++.+..|+.++|||||||++|||++|+.||..........   ........+. 
T Consensus       161 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~~~~~i~~~~-  233 (335)
T d2ozaa1         161 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRIRMGQ-  233 (335)
T ss_dssp             CEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCS-
T ss_pred             eeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH---HHHHHHhcCC-
Confidence            98765433   2344689999999999999999999999999999999999999996443322111   1111111111 


Q ss_pred             ccccCCCCCCCCHHH-HHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          553 VNIIDPTLSSGSITE-MIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       553 ~~~~dp~l~~~~~~e-~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                           ..+....... -..+.+++..||+.||++|||+.|+++
T Consensus       234 -----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         234 -----YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             -----SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -----CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                 1111111111 124567788999999999999999987

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=6.3e-44  Score=365.06  Aligned_cols=257  Identities=23%  Similarity=0.347  Sum_probs=198.8

Q ss_pred             cCCcccCcccccCceEEEEeEecCCcceeEEEeccCC--cccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEEe
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDS--GQGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYEF  401 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  401 (658)
                      ++|...++||+|+||+||+|+..+|+.||||++....  ......+.+|+.+|++++|||||++++++...+..++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5889999999999999999998889999999996653  22356789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCCC
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDET  481 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~  481 (658)
                      +.++.+..+..   ....+++..+..++.||+.||+|||+.+   ||||||||+|||++.++.+||+|||++....... 
T Consensus        82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-  154 (286)
T d1ob3a_          82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-  154 (286)
T ss_dssp             CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc-
Confidence            99888777763   3467999999999999999999999987   9999999999999999999999999998765332 


Q ss_pred             ccccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcc------c
Q 006155          482 QGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTV------N  554 (658)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~------~  554 (658)
                       .......|++.|+|||.+.+. .++.++|||||||++|||++|+.||....   ..+.+.............      +
T Consensus       155 -~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~  230 (286)
T d1ob3a_         155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS---EADQLMRIFRILGTPNSKNWPNVTE  230 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             -cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC---HHHHHHHHHHhhCCCChhhccchhh
Confidence             223345789999999998754 57899999999999999999999985332   223333322211111000      0


Q ss_pred             c--cCCCC-----------CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          555 I--IDPTL-----------SSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       555 ~--~dp~l-----------~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .  .+...           .....   ..+.+++.+||+.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~s---~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         231 LPKYDPNFTVYEPLPWESFLKGLD---ESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCC---HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhcccccccccCcchhhhcccCC---HHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0  00000           01111   23457788999999999999999973

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-44  Score=363.27  Aligned_cols=240  Identities=25%  Similarity=0.397  Sum_probs=192.3

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcc------cHHHHHHHHHHHHhcC--CCCceeeeeeeccCC
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQ------GDLEFKNEVLLVANLQ--HRNLVRLLGFSLEGN  393 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~  393 (658)
                      .++|++.++||+|+||+||+|+. .+|+.||||++......      ....+.+|+.++++++  |||||++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            46799999999999999999985 46899999998654211      1223678999999996  899999999999999


Q ss_pred             ceEEEEEecCC-CChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCC-CCCeEEeccc
Q 006155          394 ERLLIYEFVPN-TSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDA-EMTPKIADFG  471 (658)
Q Consensus       394 ~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~-~~~~kl~DFG  471 (658)
                      ..++||||+.+ +++.+++.   ....+++..++.++.||++||.|||+.+   |+||||||+|||++. ++.+||+|||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence            99999999976 67777773   3457999999999999999999999988   999999999999985 4799999999


Q ss_pred             cccccccCCCccccccccccccccCccccccCCC-CcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCC
Q 006155          472 MARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQY-SVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREG  550 (658)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  550 (658)
                      +++.....    ......||+.|||||++.+..+ +.++|||||||++|||++|+.||...     .+    ..+.    
T Consensus       157 ~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-----~~----i~~~----  219 (273)
T d1xwsa_         157 SGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-----EE----IIRG----  219 (273)
T ss_dssp             TCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----HH----HHHC----
T ss_pred             cceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc-----hH----Hhhc----
Confidence            99865432    2334689999999999988776 56789999999999999999998421     11    1111    


Q ss_pred             CcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          551 TTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       551 ~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      .      ..+.....++   +.+++.+||+.||++|||++|+++
T Consensus       220 ~------~~~~~~~s~~---~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         220 Q------VFFRQRVSSE---CQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             C------CCCSSCCCHH---HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             c------cCCCCCCCHH---HHHHHHHHccCCHhHCcCHHHHhc
Confidence            0      0111121223   456777999999999999999975

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-43  Score=365.46  Aligned_cols=258  Identities=24%  Similarity=0.329  Sum_probs=193.7

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cC-CcceeEEEeccCCc--ccHHHHHHHHHHHHhc---CCCCceeeeeeecc----
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YD-GAEIAVKRLSRDSG--QGDLEFKNEVLLVANL---QHRNLVRLLGFSLE----  391 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~-g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~----  391 (658)
                      .++|++.++||+|+||+||+|+. .+ ++.||||++.....  .....+.+|+.+++.|   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            47899999999999999999985 33 56799999865422  2223456777777666   79999999998853    


Q ss_pred             -CCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecc
Q 006155          392 -GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADF  470 (658)
Q Consensus       392 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DF  470 (658)
                       ....+++|||++++++.....  .....+++..++.++.||+.||+|||+++   ||||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence             346789999999988765543  24456899999999999999999999988   999999999999999999999999


Q ss_pred             ccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCC
Q 006155          471 GMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREG  550 (658)
Q Consensus       471 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  550 (658)
                      |+++......   ......||+.|||||++.+..|+.++||||+||++|||++|+.||....   ..+.+..........
T Consensus       161 g~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~  234 (305)
T d1blxa_         161 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS---DVDQLGKILDVIGLP  234 (305)
T ss_dssp             CSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCC
T ss_pred             hhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC---HHHHHHHHHHhhCCC
Confidence            9998654332   3345689999999999999999999999999999999999999985332   223333222211100


Q ss_pred             Cccc---------ccC--------CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          551 TTVN---------IID--------PTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       551 ~~~~---------~~d--------p~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ....         ...        +.+.....+   .+.+++.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~---~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDE---LGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCH---HHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             chhcccccccchhhhhccccccchhhccccCCH---HHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0000         000        001111112   2446778999999999999999874

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-42  Score=359.96  Aligned_cols=266  Identities=20%  Similarity=0.303  Sum_probs=195.5

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccC--CcccHHHHHHHHHHHHhcCCCCceeeeeeecc--------
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRD--SGQGDLEFKNEVLLVANLQHRNLVRLLGFSLE--------  391 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------  391 (658)
                      -++|++.++||+|+||+||+|+. .+|+.||||++...  .......+.+|+.+|++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            37899999999999999999985 46899999998554  23345678899999999999999999998755        


Q ss_pred             CCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccc
Q 006155          392 GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFG  471 (658)
Q Consensus       392 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFG  471 (658)
                      ....++||||+.++.+..+.   .....++...+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence            34678999999988776655   23456889999999999999999999988   9999999999999999999999999


Q ss_pred             cccccccCCCc--cccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhcc
Q 006155          472 MARLFEMDETQ--GNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWR  548 (658)
Q Consensus       472 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~  548 (658)
                      +++.+......  ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  242 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  242 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            99876543321  223345799999999998765 689999999999999999999999853322111111111111111


Q ss_pred             CCCccccc---------CCCCCCCCHHHH-------HHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          549 EGTTVNII---------DPTLSSGSITEM-------IRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       549 ~~~~~~~~---------dp~l~~~~~~e~-------~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ........         ..........+.       ..+++++.+||+.||++|||++|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            11000000         000011112211       13457888999999999999999984

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-42  Score=364.77  Aligned_cols=253  Identities=25%  Similarity=0.348  Sum_probs=190.2

Q ss_pred             CCcccCcccccCceEEEEeEec-CCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceeeeeeeccC------CceEE
Q 006155          325 NFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRLLGFSLEG------NERLL  397 (658)
Q Consensus       325 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~l  397 (658)
                      +|...++||+|+||+||+|+.. +|+.||||++......    +.+|+.+|++++||||+++++++...      ...+|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            5788889999999999999964 5899999999765432    34799999999999999999998532      34689


Q ss_pred             EEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCC-CeEEecccccccc
Q 006155          398 IYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM-TPKIADFGMARLF  476 (658)
Q Consensus       398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~-~~kl~DFGla~~~  476 (658)
                      ||||++++.+..+.........+++..+..++.||+.||+|||+.+   |+||||||+||||+.++ .+||+|||+++.+
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999987755554432334567999999999999999999999987   99999999999999775 8999999999876


Q ss_pred             ccCCCccccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHH-----------
Q 006155          477 EMDETQGNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAW-----------  544 (658)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~-----------  544 (658)
                      .....   .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.....   .+.+....           
T Consensus       174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~---~~~l~~i~~~~g~~~~~~~  247 (350)
T d1q5ka_         174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG---VDQLVEIIKVLGTPTREQI  247 (350)
T ss_dssp             CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH---HHHHHHHHHHHCCCCHHHH
T ss_pred             cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH---HHHHHHHHHHhCCChHHhh
Confidence            54332   234589999999998765 4689999999999999999999999854322   22222111           


Q ss_pred             HhccCCCcccccCCCC---------CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          545 KNWREGTTVNIIDPTL---------SSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       545 ~~~~~~~~~~~~dp~l---------~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ....... .+..-+..         .....+   .+.+++.+||+.||++|||+.|+++
T Consensus       248 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~---~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         248 REMNPNY-TEFKFPQIKAHPWTKVFRPRTPP---EAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HHHCC----CCCCCCCCCCCGGGTSCTTSCH---HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhccch-hhccccccccCchhhhcccCCCH---HHHHHHHHHccCChhHCcCHHHHhc
Confidence            1111100 00000110         011112   3456778999999999999999985

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-42  Score=359.69  Aligned_cols=263  Identities=20%  Similarity=0.296  Sum_probs=195.3

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCc-ccHHHHHHHHHHHHhcCCCCceeeeeeeccCC----ceE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSG-QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGN----ERL  396 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~  396 (658)
                      .++|+..++||+|+||+||+|+. .+|+.||||++..... .....+.+|+.+|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            46799999999999999999984 5789999999976443 23456889999999999999999999986543    345


Q ss_pred             EEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccccc
Q 006155          397 LIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLF  476 (658)
Q Consensus       397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~  476 (658)
                      ++++|+.+|+|.+++.    ...+++..++.++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+++..
T Consensus        87 ~l~~~~~~g~L~~~l~----~~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          87 YLVTHLMGADLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEEECCCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeecCCchhhhhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            6667788999999984    246999999999999999999999998   999999999999999999999999999876


Q ss_pred             ccCCCc-cccccccccccccCcccccc-CCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCccc
Q 006155          477 EMDETQ-GNTSRIVGTYGYMAPEYAMH-GQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTVN  554 (658)
Q Consensus       477 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  554 (658)
                      ...... ......+||+.|+|||++.. ..++.++||||+||++|||++|+.||.....   .+................
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~  236 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY---LDQLNHILGILGSPSQED  236 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCSCCHHH
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH---HHHHHHHhhhccCCChhh
Confidence            544322 23455689999999999854 4678999999999999999999999854322   111111111111000000


Q ss_pred             -------------ccCCCCCCCCHHHH-----HHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006155          555 -------------IIDPTLSSGSITEM-----IRCIHIGLLCVQENVASRPTMASVVLM  595 (658)
Q Consensus       555 -------------~~dp~l~~~~~~e~-----~~~~~i~~~Cl~~~p~~RPtm~evv~~  595 (658)
                                   ...+.........+     .++++++..||+.||++|||+.|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                         00011111111111     245678889999999999999999863

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5e-42  Score=353.16  Aligned_cols=259  Identities=18%  Similarity=0.249  Sum_probs=193.9

Q ss_pred             cCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCceee-eeeeccCCceEEEEEe
Q 006155          324 DNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLVRL-LGFSLEGNERLLIYEF  401 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l-~~~~~~~~~~~lv~e~  401 (658)
                      ++|++.++||+|+||.||+|+. .+|+.||||++......  .++..|+++++.++|+|++.. .++..+++..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            5799999999999999999985 46889999988765332  357889999999987775555 5556777888999999


Q ss_pred             cCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeC---CCCCeEEecccccccccc
Q 006155          402 VPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLD---AEMTPKIADFGMARLFEM  478 (658)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~---~~~~~kl~DFGla~~~~~  478 (658)
                      +. ++|...+..  ....+++..++.++.|++.||+|||+++   ||||||||+|||++   .+..+||+|||+++.+..
T Consensus        85 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          85 LG-PSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             CC-CBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             cC-Cchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            95 555555432  3456999999999999999999999998   99999999999975   456799999999998765


Q ss_pred             CCCc-----cccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCcc
Q 006155          479 DETQ-----GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTTV  553 (658)
Q Consensus       479 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  553 (658)
                      ....     .......||+.|||||.+.+..++.++|||||||++|||++|+.||...........+............ 
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-  237 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-  237 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH-
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh-
Confidence            4322     1234568999999999999999999999999999999999999999654443332222221111000000 


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          554 NIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       554 ~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      +    .+....+++   +.+++..||+.+|++||++.++.+.|+.
T Consensus       238 ~----~~~~~~p~~---~~~li~~cl~~~p~~RP~~~~i~~~l~~  275 (299)
T d1ckia_         238 E----VLCKGYPSE---FATYLNFCRSLRFDDKPDYSYLRQLFRN  275 (299)
T ss_dssp             H----HHTTTSCHH---HHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred             h----HhccCCCHH---HHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence            1    111112223   4466779999999999999999888875

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-42  Score=359.51  Aligned_cols=258  Identities=24%  Similarity=0.328  Sum_probs=190.8

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeeccCC------
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGN------  393 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------  393 (658)
                      .++|+..++||+|+||+||+|+. .+|+.||||+++....  .....+.+|+.+|+.++|||||++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            57899999999999999999985 4589999999976432  22346889999999999999999999987654      


Q ss_pred             ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccc
Q 006155          394 ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMA  473 (658)
Q Consensus       394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla  473 (658)
                      +.++||||+ +.+|..++.    ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence            569999999 567777662    356999999999999999999999998   999999999999999999999999999


Q ss_pred             cccccCCCccccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCC--
Q 006155          474 RLFEMDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREG--  550 (658)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--  550 (658)
                      +.....     .....||+.|+|||++.+. .++.++||||+||++|||++|+.||.....   .+.+..........  
T Consensus       169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~---~~~~~~~~~~~~~~~~  240 (346)
T d1cm8a_         169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH---LDQLKEIMKVTGTPPA  240 (346)
T ss_dssp             EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCH
T ss_pred             eccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh---HHHHHHHHhccCCCcH
Confidence            875432     2346899999999998764 578999999999999999999999854321   11111111100000  


Q ss_pred             -------------------CcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--hccC
Q 006155          551 -------------------TTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLM--LNSY  599 (658)
Q Consensus       551 -------------------~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~--L~~~  599 (658)
                                         .......+.+.....+   .+++++.+||+.||++|||+.|+++.  |+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~---~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASP---LAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCH---HHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HHHhhhcchhhhhhhccCCcccccchHHhccCCCH---HHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence                               0000000011111112   24467789999999999999999873  5544

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.4e-41  Score=348.48  Aligned_cols=260  Identities=16%  Similarity=0.241  Sum_probs=203.9

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhcCC-CCceeeeeeeccCCceEEEEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQH-RNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lv~e  400 (658)
                      .++|++.++||+|+||+||+|+. .+|+.||||++.....  ...+.+|++.+..++| +|++.+++++..+...++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            46899999999999999999984 4688999998865432  2346889999999975 899999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCC-----CCCeEEeccccccc
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDA-----EMTPKIADFGMARL  475 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~-----~~~~kl~DFGla~~  475 (658)
                      |+ +++|.+++..  ....+++..+..++.|++.||+|||+.+   ||||||||+|||++.     ++.+||+|||+++.
T Consensus        82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            98 6899888853  3346899999999999999999999998   999999999999974     57899999999998


Q ss_pred             cccCCCc-----cccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCC
Q 006155          476 FEMDETQ-----GNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREG  550 (658)
Q Consensus       476 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  550 (658)
                      +......     .......||+.|||||.+.+..++.++||||||+++|||++|+.||..................-...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  235 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence            7543221     12345689999999999999999999999999999999999999996544443333322221111111


Q ss_pred             CcccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 006155          551 TTVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVLMLNS  598 (658)
Q Consensus       551 ~~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~~L~~  598 (658)
                      ...++     ....+++   +.+++..|++.+|++||+++.+.+.|+.
T Consensus       236 ~~~~l-----~~~~p~~---l~~ii~~~~~~~~~~rP~y~~l~~~l~~  275 (293)
T d1csna_         236 PLREL-----CAGFPEE---FYKYMHYARNLAFDATPDYDYLQGLFSK  275 (293)
T ss_dssp             CHHHH-----TTTSCHH---HHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             ChHHh-----cCCCCHH---HHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence            11111     1122233   4456678999999999999999887765

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-41  Score=346.22  Aligned_cols=261  Identities=25%  Similarity=0.340  Sum_probs=201.2

Q ss_pred             cCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeeccCCceEEEEE
Q 006155          324 DNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLEGNERLLIYE  400 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  400 (658)
                      ++|+..++||+|+||+||+|+. .+|+.||||+++....  .....+.+|+.+++.++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5799999999999999999985 4688899999865432  234578999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccccccccCC
Q 006155          401 FVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMARLFEMDE  480 (658)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~  480 (658)
                      ++.+++|..++.   ....+++..++.++.|+++||+|||+++   |+||||||+|||++.++.+||+|||.++......
T Consensus        82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            999999988874   3457899999999999999999999988   9999999999999999999999999998765433


Q ss_pred             CccccccccccccccCccccccCC-CCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCc------c
Q 006155          481 TQGNTSRIVGTYGYMAPEYAMHGQ-YSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTT------V  553 (658)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~------~  553 (658)
                      .  ......+++.|+|||++.... ++.++|||||||++|||++|+.|+..  ..+..+.+......+.....      .
T Consensus       156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (292)
T d1unla_         156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP--GNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC--CSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC--CCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence            2  233346788999999987665 68999999999999999999999732  22333333333222111100      0


Q ss_pred             cccC----C------CCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006155          554 NIID----P------TLSSGSITEMIRCIHIGLLCVQENVASRPTMASVVL  594 (658)
Q Consensus       554 ~~~d----p------~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv~  594 (658)
                      ...+    +      .........-..+.+++.+||+.||.+|||++||++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000    0      000000011123456778999999999999999875

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-41  Score=353.63  Aligned_cols=253  Identities=23%  Similarity=0.303  Sum_probs=198.5

Q ss_pred             ccCCcccCcccccCceEEEEeEe----cCCcceeEEEeccCC----cccHHHHHHHHHHHHhcCC-CCceeeeeeeccCC
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL----YDGAEIAVKRLSRDS----GQGDLEFKNEVLLVANLQH-RNLVRLLGFSLEGN  393 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~  393 (658)
                      -++|+..++||+|+||+||+|+.    .+|+.||||++.+..    ......+.+|+.++++++| |||+++++++.+..
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            37799999999999999999974    247889999986542    2234567899999999976 89999999999999


Q ss_pred             ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccc
Q 006155          394 ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMA  473 (658)
Q Consensus       394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla  473 (658)
                      ..++||||+.+|+|.+++..   ...+.......++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a  176 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS  176 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             ceeeeeecccccHHHHHHHh---cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccch
Confidence            99999999999999999843   345788899999999999999999988   999999999999999999999999999


Q ss_pred             cccccCCCccccccccccccccCccccccC--CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCC
Q 006155          474 RLFEMDETQGNTSRIVGTYGYMAPEYAMHG--QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGT  551 (658)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  551 (658)
                      +.+...... ......|++.|+|||.+.+.  .++.++|||||||++|||++|+.||...........+......   ..
T Consensus       177 ~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~---~~  252 (322)
T d1vzoa_         177 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK---SE  252 (322)
T ss_dssp             EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH---CC
T ss_pred             hhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc---CC
Confidence            876543322 23446899999999999765  4788999999999999999999998654433322222222111   11


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 006155          552 TVNIIDPTLSSGSITEMIRCIHIGLLCVQENVASRPT-----MASVVL  594 (658)
Q Consensus       552 ~~~~~dp~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPt-----m~evv~  594 (658)
                            +.+.....+   .+.+++..||+.||++|||     ++|+++
T Consensus       253 ------~~~~~~~s~---~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         253 ------PPYPQEMSA---LAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             ------CCCCTTSCH---HHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ------CCCcccCCH---HHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                  112222222   3445667999999999994     788875

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.3e-40  Score=347.18  Aligned_cols=194  Identities=23%  Similarity=0.380  Sum_probs=167.8

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhcC-CCCceeeeeeecc--CCceEEE
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQ-HRNLVRLLGFSLE--GNERLLI  398 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~--~~~~~lv  398 (658)
                      .++|++.++||+|+||+||+|+. .+|+.||||+++..   ....+.+|+.+|.+++ ||||+++++++..  ....++|
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            36899999999999999999985 46889999998653   3457889999999995 9999999999864  4568999


Q ss_pred             EEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCC-CeEEeccccccccc
Q 006155          399 YEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEM-TPKIADFGMARLFE  477 (658)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~-~~kl~DFGla~~~~  477 (658)
                      |||+++++|..+.      ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++ .+||+|||+++.+.
T Consensus       111 ~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         111 FEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             EECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred             EeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceecc
Confidence            9999999997764      35899999999999999999999998   99999999999998655 58999999998765


Q ss_pred             cCCCccccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccC
Q 006155          478 MDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFR  531 (658)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~  531 (658)
                      ....   .....||+.|+|||.+.+. .++.++||||+|++++||++|+.||...
T Consensus       182 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~  233 (328)
T d3bqca1         182 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG  233 (328)
T ss_dssp             TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             CCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence            4332   3346789999999998765 4799999999999999999999998543

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-40  Score=349.76  Aligned_cols=262  Identities=24%  Similarity=0.326  Sum_probs=193.9

Q ss_pred             ccCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeeccC-----Cc
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLEG-----NE  394 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~  394 (658)
                      .++|++.++||+|+||+||+|+. .+|+.||||++.....  .....+.+|+.++++++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            57899999999999999999984 5699999999976532  2334678999999999999999999998643     34


Q ss_pred             eEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          395 RLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      .++++||+.+|+|.+++.    ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+|++|||++.
T Consensus        97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence            577788889999999984    346999999999999999999999998   9999999999999999999999999997


Q ss_pred             ccccCCCccccccccccccccCccccccC-CCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHhccCCCc-
Q 006155          475 LFEMDETQGNTSRIVGTYGYMAPEYAMHG-QYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKNWREGTT-  552 (658)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~-  552 (658)
                      ....     ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.....   ................ 
T Consensus       170 ~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~---~~~~~~i~~~~~~~~~~  241 (348)
T d2gfsa1         170 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH---IDQLKLILRLVGTPGAE  241 (348)
T ss_dssp             CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCHH
T ss_pred             ccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCChH
Confidence            5432     23346789999999987665 468899999999999999999999853322   1111111111000000 


Q ss_pred             ----------ccccC--CCCCCCCHHH-----HHHHHHHHHHhcCCCCCCCCCHHHHHH--HhccC
Q 006155          553 ----------VNIID--PTLSSGSITE-----MIRCIHIGLLCVQENVASRPTMASVVL--MLNSY  599 (658)
Q Consensus       553 ----------~~~~d--p~l~~~~~~e-----~~~~~~i~~~Cl~~~p~~RPtm~evv~--~L~~~  599 (658)
                                .....  +.........     -..+.+++.+||+.||++|||+.|+++  .+...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence                      00000  0000001111     123457788999999999999999986  45543

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-40  Score=349.63  Aligned_cols=256  Identities=23%  Similarity=0.272  Sum_probs=186.2

Q ss_pred             ccCCcccCcccccCceEEEEeEec-CCcceeEEEeccCCc--ccHHHHHHHHHHHHhcCCCCceeeeeeecc------CC
Q 006155          323 TDNFSDANKLGQGGFGAVYKGRLY-DGAEIAVKRLSRDSG--QGDLEFKNEVLLVANLQHRNLVRLLGFSLE------GN  393 (658)
Q Consensus       323 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~  393 (658)
                      .++|++.++||+|+||+||+|+.. +|+.||||++.....  .....+.+|+.++++++|||||++++++..      ..
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            368999999999999999999854 689999999976532  233458899999999999999999999863      46


Q ss_pred             ceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEeccccc
Q 006155          394 ERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIADFGMA  473 (658)
Q Consensus       394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla  473 (658)
                      ..++||||+.++.+..+.      ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+|++|||++
T Consensus        96 ~~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~  166 (355)
T d2b1pa1          96 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_dssp             EEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             eeEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence            789999999776555442      35899999999999999999999998   999999999999999999999999998


Q ss_pred             cccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcchHHHHHHHh-------
Q 006155          474 RLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVEDLLSSAWKN-------  546 (658)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~-------  546 (658)
                      +......   ......||+.|+|||++.+..++.++||||+||+++||++|+.||....   ...........       
T Consensus       167 ~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~---~~~~~~~i~~~~~~~~~~  240 (355)
T d2b1pa1         167 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD---YIDQWNKVIEQLGTPCPE  240 (355)
T ss_dssp             -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHHCCCCHH
T ss_pred             hcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC---HHHHHHHHHHhccCCCHH
Confidence            8654332   2334578999999999999999999999999999999999999985332   11111111100       


Q ss_pred             -c----------cCCC-------cccccCCCC-CCC---CHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 006155          547 -W----------REGT-------TVNIIDPTL-SSG---SITEMIRCIHIGLLCVQENVASRPTMASVV  593 (658)
Q Consensus       547 -~----------~~~~-------~~~~~dp~l-~~~---~~~e~~~~~~i~~~Cl~~~p~~RPtm~evv  593 (658)
                       |          ....       ......... ...   ....-..+.+++.+||+.||++|||++|++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL  309 (355)
T d2b1pa1         241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL  309 (355)
T ss_dssp             HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             HHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence             0          0000       000111111 111   112233567888999999999999999997

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.4e-36  Score=317.03  Aligned_cols=262  Identities=20%  Similarity=0.224  Sum_probs=188.0

Q ss_pred             cCCcccCcccccCceEEEEeEe-cCCcceeEEEeccCCcccHHHHHHHHHHHHhcC-----------CCCceeeeeeecc
Q 006155          324 DNFSDANKLGQGGFGAVYKGRL-YDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQ-----------HRNLVRLLGFSLE  391 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~~  391 (658)
                      ++|++.++||+|+||+||+|+. .+|+.||||++.... .....+.+|+.+++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            3599999999999999999985 568999999997543 22346788998888775           5789999988754


Q ss_pred             --CCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCcEEEeccCCCceeeCCCCC----
Q 006155          392 --GNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHE-DSRLRIIHRDLKTSNVLLDAEMT----  464 (658)
Q Consensus       392 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NILl~~~~~----  464 (658)
                        ....+++++++..+..............+++..+..++.||++||.|||+ .+   |+||||||+||||+.++.    
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence              34567777777665543333333455678999999999999999999998 55   999999999999986654    


Q ss_pred             --eEEeccccccccccCCCccccccccccccccCccccccCCCCcccccccccchHhHHHhCCCCCccCCCCCcc---hH
Q 006155          465 --PKIADFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVLVLEIISGQRNNCFRNGETVE---DL  539 (658)
Q Consensus       465 --~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvll~elltG~~p~~~~~~~~~~---~l  539 (658)
                        ++|+|||.+......     ....+||+.|+|||++....++.++||||+||+++||++|+.||.........   +.
T Consensus       169 ~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         169 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             ceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence              899999999764322     23467999999999999999999999999999999999999998643322111   11


Q ss_pred             HHHHHHhccC------------------CCcccccCC-----------CCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 006155          540 LSSAWKNWRE------------------GTTVNIIDP-----------TLSSGSITEMIRCIHIGLLCVQENVASRPTMA  590 (658)
Q Consensus       540 ~~~~~~~~~~------------------~~~~~~~dp-----------~l~~~~~~e~~~~~~i~~~Cl~~~p~~RPtm~  590 (658)
                      +.........                  ......+..           ............+.+++..||+.||++|||++
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence            1111110000                  000000000           00011234445677899999999999999999


Q ss_pred             HHHH
Q 006155          591 SVVL  594 (658)
Q Consensus       591 evv~  594 (658)
                      |+++
T Consensus       324 e~L~  327 (362)
T d1q8ya_         324 GLVN  327 (362)
T ss_dssp             HHHT
T ss_pred             HHhc
Confidence            9985

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.87  E-value=3.2e-23  Score=197.24  Aligned_cols=168  Identities=19%  Similarity=0.161  Sum_probs=119.5

Q ss_pred             cccCcccccCceEEEEeEecCCcceeEEEeccCCcc------------------cHHHHHHHHHHHHhcCCCCceeeeee
Q 006155          327 SDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQ------------------GDLEFKNEVLLVANLQHRNLVRLLGF  388 (658)
Q Consensus       327 ~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~------------------~~~~~~~E~~~l~~l~H~niv~l~~~  388 (658)
                      .+.++||+|+||+||+|+..+|++||||++......                  .......|...+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            456899999999999999888999999987532110                  01224568889999999999988866


Q ss_pred             eccCCceEEEEEecCCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEEeccCCCceeeCCCCCeEEe
Q 006155          389 SLEGNERLLIYEFVPNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKTSNVLLDAEMTPKIA  468 (658)
Q Consensus       389 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~  468 (658)
                      .    ..+++|||+++..+..          +++.....++.|++++|.|||+.+   |+||||||+|||++++ .++|+
T Consensus        83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred             c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence            3    2379999998876543          334445679999999999999988   9999999999999965 48999


Q ss_pred             ccccccccccCCCccccccccccccccCccccccCCCCcccccccccch
Q 006155          469 DFGMARLFEMDETQGNTSRIVGTYGYMAPEYAMHGQYSVKSDVFSFGVL  517 (658)
Q Consensus       469 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvl  517 (658)
                      |||+++............+.+.   . -.|. ..+.|..++|+||..--
T Consensus       145 DFG~a~~~~~~~~~~~l~rd~~---~-~~~~-f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         145 DFPQSVEVGEEGWREILERDVR---N-IITY-FSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             CCTTCEETTSTTHHHHHHHHHH---H-HHHH-HHHHHCCCCCHHHHHHH
T ss_pred             ECCCcccCCCCCcHHHHHHHHH---H-HHHH-HcCCCCCcccHHHHHHH
Confidence            9999976543221100000000   0 0111 13567889999996533

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.48  E-value=2.4e-07  Score=90.27  Aligned_cols=142  Identities=16%  Similarity=0.129  Sum_probs=98.7

Q ss_pred             cCCcccCcccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcC-CCCceeeeeeeccCCceEEEEEec
Q 006155          324 DNFSDANKLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQ-HRNLVRLLGFSLEGNERLLIYEFV  402 (658)
Q Consensus       324 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~  402 (658)
                      ..|+..+..+.+....||+.. .+++.+.||+...........+.+|...+..+. +--+.+++.+..+++..++||+++
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~-~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l   92 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLV-GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA   92 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEE-CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred             hceEEEEcCCCCCCCcEEEEE-eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEec
Confidence            455555544444457899886 466778899887665555556788988888774 444677888888888889999999


Q ss_pred             CCCChhhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhhhcC---------------------------------------
Q 006155          403 PNTSLDHFIFDPTRRAQLDWERRYKIIGGIARGLLYLHEDS---------------------------------------  443 (658)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------  443 (658)
                      ++.++.......        .....++.++++.|..||+..                                       
T Consensus        93 ~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (263)
T d1j7la_          93 DGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF  164 (263)
T ss_dssp             SSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSC
T ss_pred             cccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccc
Confidence            998886554211        112234555566666666421                                       


Q ss_pred             -----------------CCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          444 -----------------RLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       444 -----------------~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                                       ...++|+|+.|.|||+++++.+-|.||+.+.
T Consensus       165 ~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                             1127999999999999987666799999875

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.89  E-value=4.1e-05  Score=73.39  Aligned_cols=130  Identities=18%  Similarity=0.145  Sum_probs=84.6

Q ss_pred             cccccCc-eEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCC--CCceeeeeeeccCCceEEEEEecCCCCh
Q 006155          331 KLGQGGF-GAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQH--RNLVRLLGFSLEGNERLLIYEFVPNTSL  407 (658)
Q Consensus       331 ~lG~G~f-g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lv~e~~~~gsL  407 (658)
                      .+..|.. +.||+....++..+.+|.......   ..+..|...++.+..  -.+.+++++..+++..++||||+++.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            3444543 679999877777888897654432   246777887777643  3366778888888888999999998776


Q ss_pred             hhhhcCcCCCCCCCHHHHHHHHHHHHHHHHHhh-----------------------------------------------
Q 006155          408 DHFIFDPTRRAQLDWERRYKIIGGIARGLLYLH-----------------------------------------------  440 (658)
Q Consensus       408 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-----------------------------------------------  440 (658)
                      .+...        .   ...++.++++.|.-||                                               
T Consensus        94 ~~~~~--------~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          94 LSSHL--------A---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             TTSCC--------C---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             ccccc--------c---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence            43210        0   0111222222233333                                               


Q ss_pred             ----hc----CCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          441 ----ED----SRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       441 ----~~----~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                          +.    ..+.++|+|+.|.|||++++..+-|.||+.+.
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                21    12238999999999999987667899999875

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.15  E-value=0.00083  Score=68.60  Aligned_cols=76  Identities=12%  Similarity=0.082  Sum_probs=47.0

Q ss_pred             cCcccccCceEEEEeEecC-CcceeEEEeccC------Ccc-cHHHHHHHHHHHHhcC-C--CCceeeeeeeccCCceEE
Q 006155          329 ANKLGQGGFGAVYKGRLYD-GAEIAVKRLSRD------SGQ-GDLEFKNEVLLVANLQ-H--RNLVRLLGFSLEGNERLL  397 (658)
Q Consensus       329 ~~~lG~G~fg~Vy~~~~~~-g~~vavK~l~~~------~~~-~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~~~~~l  397 (658)
                      .+.||.|..-.||+....+ ++.++||.-...      ... .......|...|..+. +  ..+.+++.+  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            3468999999999998654 668899964321      111 1223456777776653 2  345556654  4456689


Q ss_pred             EEEecCCCC
Q 006155          398 IYEFVPNTS  406 (658)
Q Consensus       398 v~e~~~~gs  406 (658)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.96  E-value=0.0018  Score=64.11  Aligned_cols=134  Identities=14%  Similarity=0.143  Sum_probs=78.1

Q ss_pred             eEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCce--eeee-----eeccCCceEEEEEecCCCChhhh
Q 006155          338 GAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNLV--RLLG-----FSLEGNERLLIYEFVPNTSLDHF  410 (658)
Q Consensus       338 g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv--~l~~-----~~~~~~~~~lv~e~~~~gsL~~~  410 (658)
                      =.||+.+..+|..+++|+.... .....++..|...+..|...+|.  ..+.     ....+...+.++++++|..+...
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            3799999989999999987544 33556788899988888543332  1221     12234556889999987543210


Q ss_pred             --------------hc----C--cCCCCCCCHHH-------------------HHHHHHHHHHHHHHhh----hcCCCcE
Q 006155          411 --------------IF----D--PTRRAQLDWER-------------------RYKIIGGIARGLLYLH----EDSRLRI  447 (658)
Q Consensus       411 --------------l~----~--~~~~~~l~~~~-------------------~~~i~~~ia~gL~yLH----~~~~~~i  447 (658)
                                    +|    .  ...+..+++..                   +..+...+.+.++.+.    +.....+
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence                          01    0  11122222221                   1111112222333332    2223458


Q ss_pred             EEeccCCCceeeCCCCCeEEecccccc
Q 006155          448 IHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       448 vHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      ||+|+.+.|||++++  ..+.||+-+.
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~  219 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDAR  219 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred             ecCCCCcccEEEeCC--ceEEechhcc
Confidence            999999999999743  4689999875

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.27  E-value=0.0064  Score=61.73  Aligned_cols=73  Identities=14%  Similarity=0.207  Sum_probs=49.2

Q ss_pred             cCcccccCceEEEEeEecCC--------cceeEEEeccCCcccHHHHHHHHHHHHhcC-CCCceeeeeeeccCCceEEEE
Q 006155          329 ANKLGQGGFGAVYKGRLYDG--------AEIAVKRLSRDSGQGDLEFKNEVLLVANLQ-HRNLVRLLGFSLEGNERLLIY  399 (658)
Q Consensus       329 ~~~lG~G~fg~Vy~~~~~~g--------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~  399 (658)
                      .+.|+.|-.=.+|+....++        +.|.+++.. . .....+..+|..+++.+. +.-..++++++.+    .+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            35677777788999876543        345555544 2 334456778999988885 4334577777753    6899


Q ss_pred             EecCCCCh
Q 006155          400 EFVPNTSL  407 (658)
Q Consensus       400 e~~~~gsL  407 (658)
                      ||+++.+|
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987654

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.81  E-value=0.24  Score=47.59  Aligned_cols=154  Identities=14%  Similarity=0.069  Sum_probs=77.0

Q ss_pred             hhhhhccCCcccC-----cccccCceEEEEeEecCCcceeEEEeccCCcccHHHHHHHHHHHHhcCCCCc--eeeee---
Q 006155          318 TIRVATDNFSDAN-----KLGQGGFGAVYKGRLYDGAEIAVKRLSRDSGQGDLEFKNEVLLVANLQHRNL--VRLLG---  387 (658)
Q Consensus       318 ~~~~~~~~~~~~~-----~lG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~~---  387 (658)
                      ++.....+|...+     .|..|--=+.|+.+..+| .+++|+......  ..++..|+.++..|.+.++  ...+.   
T Consensus         7 el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi~~~~   83 (316)
T d2ppqa1           7 ELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPLPRKD   83 (316)
T ss_dssp             HHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTT
T ss_pred             HHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccceecC
Confidence            3444445554433     344555577899886555 588998754322  2345556777777643322  22111   


Q ss_pred             ---eeccCCceEEEEEecCCCChhhh--------------hc----Cc--CCCCCC------------------CHHHHH
Q 006155          388 ---FSLEGNERLLIYEFVPNTSLDHF--------------IF----DP--TRRAQL------------------DWERRY  426 (658)
Q Consensus       388 ---~~~~~~~~~lv~e~~~~gsL~~~--------------l~----~~--~~~~~l------------------~~~~~~  426 (658)
                         +.........++.++.+......              ++    ..  ......                  ......
T Consensus        84 g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (316)
T d2ppqa1          84 GELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLR  163 (316)
T ss_dssp             CCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHH
T ss_pred             CCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHH
Confidence               11123445667777766433211              00    00  000000                  001111


Q ss_pred             HHHHHHHHHHHHhhhc-CCCcEEEeccCCCceeeCCCCCeEEecccccc
Q 006155          427 KIIGGIARGLLYLHED-SRLRIIHRDLKTSNVLLDAEMTPKIADFGMAR  474 (658)
Q Consensus       427 ~i~~~ia~gL~yLH~~-~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~  474 (658)
                      ..+..+...+.-.+.. -+..+||+|+.+.||+++.+...-|.||+.+.
T Consensus       164 ~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         164 EEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             HHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            2222222223332221 12349999999999999988777899999875